<SEC-DOCUMENT>0001367644-23-000155.txt : 20230809
<SEC-HEADER>0001367644-23-000155.hdr.sgml : 20230809
<ACCEPTANCE-DATETIME>20230808184241
ACCESSION NUMBER:		0001367644-23-000155
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		133
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20230809
DATE AS OF CHANGE:		20230808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emergent BioSolutions Inc.
		CENTRAL INDEX KEY:			0001367644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				141902018
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33137
		FILM NUMBER:		231152899

	BUSINESS ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
		BUSINESS PHONE:		240-631-3200

	MAIL ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ebs-20230630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:d762cff5-452b-4406-9554-de3e14af5e28,g:a97db4f5-924f-4868-bfbf-bd6f1cbf2843,d:26b3b087cdd44df68137aa5405612fee--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:ebs="http://emergentbiosolutions.com/20230630" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ebs-20230630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-25">0001367644</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-26">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-27">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-29">Q2</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-273" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-857">33.33</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-274" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-858">33.33</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-275" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-859">33.33</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-276" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-860">33.33</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-277" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-861">33.33</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-278" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-862">33.33</ix:nonFraction><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-1014">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-1015">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1018">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1019">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-1022">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-1023">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ebs-20230630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="category"><xbrli:measure>ebs:category</xbrli:measure></xbrli:unit><xbrli:unit id="product"><xbrli:measure>ebs:product</xbrli:measure></xbrli:unit><xbrli:unit id="category2"><xbrli:measure>ebs:Category</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>ebs:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ebs:DevelopmentBasedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ebs:SalesBasedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:UnallocatedResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:UnallocatedResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:JansenPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ebs:MeasurementInputProbabilityOfPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ebs:MeasurementInputProbabilityOfPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:OtherLongTermDebtFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:OtherLongTermDebtFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-07</xbrli:startDate><xbrli:endDate>2020-08-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-07</xbrli:startDate><xbrli:endDate>2020-08-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-07</xbrli:startDate><xbrli:endDate>2020-08-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingIn2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingAfter2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:UntilMarch312024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ebs:SOFREURIBOROrCDORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingAfterMarch312024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ebs:SOFREURIBOROrCDORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingAfterMarch312024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ebs:SOFREURIBOROrCDORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ebs:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingAfterMarch312024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingAfterMarch312024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-11</xbrli:startDate><xbrli:endDate>2022-11-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ebs:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ebs:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ebs:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:JansenPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:JansenPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-07-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsAndServicesSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsAndServicesSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsAndServicesSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsAndServicesSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-31</xbrli:startDate><xbrli:endDate>2023-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">ebs:TwoYearOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-31</xbrli:startDate><xbrli:endDate>2023-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="productcandidate"><xbrli:measure>ebs:productCandidate</xbrli:measure></xbrli:unit><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">ebs:TwoYearOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">ebs:FiveYearOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-31</xbrli:startDate><xbrli:endDate>2023-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">ebs:FiveYearOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ebs:RidgebackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ebs:BARDAContractPayableInThirdQuarterOf2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ebs:RidgebackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ebs:BARDAContractContractNotCeasedPriorToJune12026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanAugust2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-08</xbrli:startDate><xbrli:endDate>2023-08-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>ebs:employee</xbrli:measure></xbrli:unit><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanAugust2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanAugust2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-08</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i26b3b087cdd44df68137aa5405612fee_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.194%"><tr><td style="width:0.1%"></td><td style="width:2.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:4pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June&#160;30, 2023</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-top:4pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.194%"><tr><td style="width:0.1%"></td><td style="width:2.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:4pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from    to        </span></div><div style="margin-top:4pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission file number: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-33137</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><img src="ebs-20230630_g1.jpg" alt="emergent logo gray + carmine  r.jpg" style="height:20px;margin-bottom:5pt;vertical-align:text-bottom;width:150px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">EMERGENT BIOSOLUTIONS INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">14-1902018</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">400 Professional Drive Suite 400</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Gaithersburg,</ix:nonNumeric>  </span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-11">MD</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">20879</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address and zip code of Principal Executive Offices)</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">240</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">631-3200</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant's Telephone Number, Including Area Code)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par Value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">EBS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#9746; <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric> &#9744; No</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#9746; <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric> &#9744; No</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"></td><td style="width:41.218%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.218%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.583%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; No <ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of August&#160;1, 2023, the registrant had <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">51,807,027</ix:nonFraction> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sh</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ares of common stock outstanding.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Form 10-Q</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.504%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Page</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_10">Part I. Financial Information</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_13">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_16">Condensed Consolidated Balance Sheets&#8212;</a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_16">June 30</a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_16">, 2023 and December 31, 202</a>2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_16">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_19">Condensed Consolidated Statements of Operations&#8212;Three </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_19">and Six </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_19">Months Ended </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_19">June 30</a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_19">, 2023 and 202</a>2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_19">6</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_22">Condensed Consolidated Statements of Comprehensive </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_22">Loss</a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_22">&#8212;Three </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_22">and Six </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_22">Months Ended </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_22">June 30</a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_22">, 2023 and 202</a>2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_22">7</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_25">Condensed Consolidated Statements of Cash Flows&#8212;</a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_25">Six</a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_25"> Months Ended </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_25">June 30</a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_25">, 2023 and 202</a>2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_25">8</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_28">Condensed Consolidated Statements of Changes in Stockholders' Equity&#8212;Three </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_28">and Six </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_28">Months Ended </a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_28">June 30</a><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_28">, 2023 and 202</a>2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_28">9</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_31">10</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_100">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_100">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_100">31</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_124">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_124">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_124">46</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_127">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_127">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_127">46</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_130">Part II. Other Information</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_133">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_133">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_133">47</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_136">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_136">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_136">47</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_139">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_139">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_139">77</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_142">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_142">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_142">77</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_145">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_145">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_145">77</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_148">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_148">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_148">77</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_151">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_151">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_151">77</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i26b3b087cdd44df68137aa5405612fee_157">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i26b3b087cdd44df68137aa5405612fee_157">79</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EMERGENT BIOSOLUTIONS INC.</span></div></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including statements regarding our future performance, business strategy, operations, financial position, revenues and earnings, projected costs, prospects, plans and objectives of management are forward-looking statements. We generally identify forward-looking statements by using words like "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "goal," "intend," "may," "plan," "predict," "should," "will," "would," and similar expressions or variations thereof, the negative thereof, but these terms are not the exclusive means of identifying such statements. Forward-looking statements are based on our current intentions, beliefs and expectations regarding future events. You should realize that if underlying assumptions prove inaccurate or if known or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. You are therefore cautioned not to place undue reliance on any forward-looking statement contained herein. Any forward-looking statement speaks only as of the date on which such statement is made and, except as required by law, we do not undertake any obligation to update any forward-looking statement to reflect new information, events or circumstances.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of important factors that could cause our actual results to differ materially from those indicated by such forward-looking statements, including, among others:</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the availability of U.S. Government ("USG") funding for contracts related to procurement of our medical countermeasures, including CYFENDUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Anthrax Vaccine Adsorbed (AVA), Adjuvanted), previously known as AV7909, BioThrax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Anthrax Vaccine Adsorbed) and ACAM2000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Smallpox (Vaccinia) Vaccine, Live) among others, as well as contracts related to development of medical countermeasures; </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to meet our commitments to quality and compliance in all of our manufacturing operations;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to negotiate additional USG procurement or follow-on contracts for our medical countermeasures ("MCM") products that have expired or will be expiring;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the commercial availability, including the timing of availability, of over-the-counter NARCAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (naloxone HCI) Nasal Spray;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the impact of a generic marketplace on NARCAN&#174; (naloxone HCI) Nasal Spray and future NARCAN sales;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to perform under our contracts with the USG, including the timing of and specifications relating to deliveries;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to provide contract development and manufacturing ("CDMO") services for the development and/or manufacture of product and/or product candidates of our customers at required levels and on required timelines;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the ability of our contractors and suppliers to maintain compliance with current good manufacturing practices and other regulatory obligations;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to negotiate new CDMO contracts and the negotiation of further commitments related to the collaboration and deployment of capacity toward future commercial manufacturing under our existing CDMO contracts;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to collect reimbursement for raw materials and payment of service fees from our CDMO customers;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the results of pending stockholder litigation and government investigations and their potential impact on our business;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to comply with the operating and financial covenants required by our revolving credit facility (the "Revolving Credit Facility") and our term loan facility (the "Term Loan Facility" and, together with the Revolving Credit Facility, the "Senior Secured Credit Facilities"), as well as our 3.875% Senior Unsecured Notes due 2028 ("Senior Unsecured Notes");</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to resolve the going concern qualification in our consolidated financial statements and otherwise successfully manage our liquidity in order to continue as a going concern;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the procurement of our product candidates by USG entities under regulatory authorities that permit government procurement of certain medical products prior to United States Food and Drug Administration (&#8220;FDA&#8221;) marketing authorization, and corresponding procurement by government entities outside of the U.S.;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to realize the expected benefits of the sale of our travel health business to Bavarian Nordic; </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the impact of the organizational changes we announced in January 2023;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to identify and acquire companies, businesses, products or product candidates that satisfy our selection criteria;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EMERGENT BIOSOLUTIONS INC.</span></div></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the impact of cyber security incidents, including the risks from the interruption, failure or compromise of our information systems or those of our business partners, collaborators or other third parties;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the success of our commercialization, marketing and manufacturing capabilities and strategy; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the accuracy of our estimates regarding future revenues, expenses, capital requirements and needs for additional financing.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from our expectations in any forward-looking statement. When evaluating our forward-looking statements, you should consider this cautionary statement along with the risk factors identified elsewhere in this document, including in the sections entitled "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K for our fiscal year ended December 31, 2022, "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Quantitative and Qualitative Disclosures about Market Risk" in this Quarterly Report on Form 10-Q, as well as the risks identified in our other reports filed with the SEC. New factors may emerge from time to time, and it is not possible for management to predict all such factors, nor can it assess the impact of any such factor on the business or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE REGARDING COMPANY REFERENCES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References in this report to &#8220;Emergent,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Emergent BioSolutions Inc. and its consolidated subsidiaries.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE REGARDING TRADE NAMES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emergent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CYFENDUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioThrax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, BaciThrax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, RSDL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, BAT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Trobigard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Anthrasil</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CNJ-016</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ACAM2000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, NARCAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, TEMBEXA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and any and all Emergent BioSolutions Inc. brands, products, services and feature names, logos and slogans are trademarks or registered trademarks of Emergent BioSolutions Inc. or its subsidiaries in the United States or other countries. All other brands, products, services and feature names or trademarks are the property of their respective owners.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_13"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div><span><br/></span></div><div id="i26b3b087cdd44df68137aa5405612fee_16"></div><div><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">(unaudited)</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="background-color:#ededed;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#1b51bf;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-30">88.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-31">642.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-32">290.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-33">158.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-34">354.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-35">351.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-36">44.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-37">57.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="f-38">777.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-39">1,210.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-40">395.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-41">817.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-42">592.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-43">728.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-44">218.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-45">218.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-46">194.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-47">191.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-48">2,178.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-49">3,166.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-50">108.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-51">103.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="f-52">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="f-53">34.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-54">69.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-55">88.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt, current portion</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:NotesPayableCurrent" scale="6" id="f-56">455.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NotesPayableCurrent" scale="6" id="f-57">957.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="f-58">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="f-59">45.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-60">693.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-61">1,229.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt, net of current portion</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-62">448.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-63">448.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-64">57.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-65">71.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-66">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-67">33.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-68">1,222.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-69">1,783.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-70"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-71">0.001</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-72"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-73">15.0</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="f-74"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-75"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-76"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="f-77">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-79">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-80"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-81">0.001</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="f-82"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="f-83">200.0</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-84">57.4</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-85">55.7</ix:nonFraction> shares issued; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-86">51.8</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-87">50.1</ix:nonFraction> shares outstanding, respectively</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-88">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-89">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-90">5.6</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-91">5.6</ix:nonFraction> common shares, respectively</span></div></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="f-92">227.7</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="f-93">227.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="f-94">895.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="f-95">873.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-96">1.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-97">3.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retained earnings</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-98">289.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-99">734.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-100">956.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-101">1,383.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-102">2,178.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-103">3,166.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_19"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited, in millions, except per share amounts)</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.527%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#1b51bf;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales, net</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-104">302.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-105">237.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-106">445.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-107">474.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract development and manufacturing ("CDMO"):</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-108">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-109">2.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-110">39.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-111">54.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-112">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" sign="-" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-113">4.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-114">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-115">4.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total CDMO revenues</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-116">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" sign="-" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-117">1.8</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-118">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-119">59.0</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-120">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-121">7.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-122">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-123">16.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-124">337.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-125">242.7</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-126">503.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-127">550.2</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product sales</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-128">134.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-129">91.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-130">237.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-131">171.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of CDMO</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-132">55.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-133">78.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-134">107.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-135">154.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-136">306.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-137">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-138">306.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-139">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-140">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-141">49.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-142">66.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-143">96.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-144">91.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-145">81.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-146">191.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-147">165.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-148">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-149">14.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-150">33.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-151">28.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="f-152">630.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="f-153">314.7</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="f-154">944.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="f-155">615.8</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-156">292.9</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-157">72.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-158">441.0</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-159">65.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other income (expense):</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-160">28.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-161">7.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-162">46.5</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-163">16.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of business</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-164">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="f-165">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-166">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="f-167">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-168">3.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-169">3.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-170">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-171">5.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-172">42.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-173">10.8</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-174">29.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-175">21.0</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss before income taxes</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-176">250.2</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-177">82.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-178">411.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-179">86.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income tax provision (benefit)</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-180">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-181">26.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-182">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-183">26.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-184">261.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-185">56.4</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-186">444.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-187">60.1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss per common share</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-25" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-188">5.15</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-26" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-189">1.13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-190">8.80</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-27" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-191">1.19</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-25" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-192">5.15</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-26" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-193">1.13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-194">8.80</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-27" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-195">1.19</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted average shares outstanding</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-196">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-197">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-198">50.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-199">50.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-200">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-201">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-202">50.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-203">50.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_22"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited, in millions)</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-204">261.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-205">56.4</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-206">444.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-207">60.1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-208">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-209">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-210">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-211">0.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains (losses) on hedging activities</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="f-212">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="f-213">1.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="f-214">3.2</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="f-215">6.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification adjustment for gains on hedging activities</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-216">2.9</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-217">0.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-218">0.5</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-219">2.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification adjustment for gains on pension benefit obligation</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="f-220">3.5</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:fixed-zero" scale="6" id="f-221">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="f-222">3.5</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:fixed-zero" scale="6" id="f-223">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-224">2.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-225">3.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-226">4.7</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-227">10.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive loss, net of tax</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-228">263.9</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-229">53.2</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-230">449.0</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-231">50.1</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_25"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited, in millions)</span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.163%"><tr><td style="width:1.0%"></td><td style="width:63.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Activities</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-232">444.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-233">60.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-234">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-235">22.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term incentive plan expense</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ebs:LongTermIncentivePlanNoncashExpense" scale="6" id="f-236">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ebs:LongTermIncentivePlanNoncashExpense" format="ixt:fixed-zero" scale="6" id="f-237">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-238">67.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-239">75.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value of contingent obligations, net</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-240">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-241">1.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-242">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-243">2.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="f-244">10.2</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="f-245">2.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of travel health business</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-246">74.9</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="f-247">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-248">306.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-249">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-250">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-251">2.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-252">130.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-253">97.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-254">23.8</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-255">75.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-256">17.8</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-257">19.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-258">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-259">7.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-260">13.8</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-261">36.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-262">13.4</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-263">14.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes receivable and payable, net</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="f-264">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="f-265">46.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-266">7.7</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-267">2.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-268">298.4</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-269">52.9</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing Activities</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-270">27.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-271">64.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from sale of travel health business, net </span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="f-272">270.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:fixed-zero" scale="6" id="f-273">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-274">242.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-275">64.3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Activities</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="f-276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-277">81.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on revolving credit facility</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="f-278">347.8</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="6" id="f-279">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on term loan facility</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RepaymentsOfMediumTermNotes" scale="6" id="f-280">156.8</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:RepaymentsOfMediumTermNotes" scale="6" id="f-281">16.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from stock-based compensation activity</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="f-282">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="f-283">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taxes paid for stock-based compensation activity</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-284">2.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-285">5.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from at-the-market sale of stock, net of commissions and expenses</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-286">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="6" id="f-287">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net cash used in financing activities:</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-288">497.4</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-289">101.2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-290">0.8</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-291">0.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net change in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-292">554.0</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-293">218.0</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-294">642.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-295">576.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-296">88.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-297">358.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for interest</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="f-298">38.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="f-299">14.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for income taxes</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-300">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-301">20.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental information on non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property, plant and equipment unpaid at period end</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-302">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-303">7.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_28"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Changes in Stockholders' Equity</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited, in millions)</span></div><div style="margin-bottom:5pt;margin-top:2pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.299%"></td><td style="width:0.1%"></td></tr><tr style="height:32pt"><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-304"><ix:nonFraction unitRef="usdPerShare" contextRef="c-28" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-305"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-306"><ix:nonFraction unitRef="usdPerShare" contextRef="c-29" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-307"><ix:nonFraction unitRef="usdPerShare" contextRef="c-30" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-308"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-309">0.001</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> Par Value </span></div><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Common Stock</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Treasury Stock</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Additional Paid-In Capital</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Retained Earnings</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total Stockholders' Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-310">55.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-311">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-33" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-312">5.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-313">227.7</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-314">873.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-315">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-316">734.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-317">1,383.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-318">183.0</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-319">183.0</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation activity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-320">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-321">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-322">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-323">2.1</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-324">2.1</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-325">56.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-326">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-43" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-327">5.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-328">227.7</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-329">878.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-330">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-331">551.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-332">1,202.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-333">261.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-334">261.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation activity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-335">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-336">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-337">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At-the-market sale of stock, net of commissions and expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="f-338">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-339">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-340">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-341">2.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-342">2.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-343">57.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-344">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-52" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-345">5.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-346">227.7</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-347">895.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-348">1.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-349">289.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-350">956.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.666%"></td><td style="width:0.1%"></td></tr><tr style="height:32pt"><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-351"><ix:nonFraction unitRef="usdPerShare" contextRef="c-28" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-352"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-353"><ix:nonFraction unitRef="usdPerShare" contextRef="c-29" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-354"><ix:nonFraction unitRef="usdPerShare" contextRef="c-30" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-355"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-356">0.001</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> Par Value </span></div><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Common Stock</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Treasury Stock</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Additional Paid-In Capital</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Retained Earnings</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total Stockholders' Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-357">55.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-358">0.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-57" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-359">3.8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-360">152.2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-361">829.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-362">16.1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-363">957.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-364">1,619.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-365">3.7</ix:nonFraction>)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-366">3.7</ix:nonFraction>)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation activity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-367">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-368">5.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-369">5.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repurchases of common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-65" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="f-370">1.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="f-371">52.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="f-372">52.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-373">6.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-374">6.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-67" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-375">55.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-376">0.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-68" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-377">4.9</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-378">204.4</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-379">834.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-380">9.3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-381">954.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-382">1,575.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-383">56.4</ix:nonFraction>)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-384">56.4</ix:nonFraction>)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation activity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-73" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-385">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-386">14.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-387">14.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repurchases of common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-75" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="f-388">0.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="f-389">23.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="f-390">23.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-391">3.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-392">3.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-77" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-393">55.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-394">0.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-78" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-395">5.6</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-396">227.7</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-397">849.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-398">6.1</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-399">897.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-400">1,513.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_31"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMERGENT BIOSOLUTIONS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited, dollar and share amounts in tables in millions, except per share data)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i26b3b087cdd44df68137aa5405612fee_34"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-401" continuedAt="i3e1ae374c2494fd5b61bc51b965e3ffb" escape="true">Nature of the business and organization</ix:nonNumeric></span></div><ix:continuation id="i3e1ae374c2494fd5b61bc51b965e3ffb" continuedAt="i350eda9d16884d769a0a10b3e1b17c84"><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization and business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emergent BioSolutions Inc., including its consolidated subsidiaries (&#8220;Emergent,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) is a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate, and naturally occurring Public Health Threats ("PHTs"). The Company's solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing ("CDMO") services portfolio.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is focused on the following <ix:nonFraction unitRef="category" contextRef="c-1" decimals="INF" name="ebs:NumberOfCategoriesOfPublicHealthThreats" format="ixt-sec:numwordsen" scale="0" id="f-402">four</ix:nonFraction> PHT categories: chemical, biological, radiological, nuclear and explosives ("CBRNE"); emerging infectious diseases ("EID"); emerging health crises; and acute/emergency care. The Company has a current product portfolio of <ix:nonFraction unitRef="product" contextRef="c-1" decimals="INF" name="ebs:NumberOfRevenueGeneratingProducts" scale="0" id="f-403">12</ix:nonFraction> products (vaccines, therapeutics, and drug-device combination products). The revenue generated by the products comprises a substantial portion of the Company's revenue. The Company structures the business with a focus on markets and customers. As such, the key components of the business structure include the following <ix:nonFraction unitRef="category2" contextRef="c-1" decimals="INF" name="ebs:NumberOfProductAndServiceCategories" format="ixt-sec:numwordsen" id="f-404">four</ix:nonFraction> product and service categories: Anthrax - Medical Countermeasures ("MCM") Products, NARCAN, Smallpox - MCM Products and CDMO Services. The Company operates as <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" id="f-405"><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" id="f-406">two</ix:nonFraction></ix:nonFraction> operating segments: (1) a products segment ("Products") consisting of the Anthrax - MCM products, NARCAN, Smallpox - MCM products and Other products and (2) a services segment ("Services") focused on CDMO services (Note 17, "Segment information</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company's products and services include:</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Anthrax - MCM Products</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Anthrasil</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Anthrax Immune Globulin Intravenous (human)), the only polyclonal antibody therapeutic licensed by the United States Food and Drug Administration (&#8220;FDA&#8221;) and Health Canada for the treatment of inhalational anthrax in combination with appropriate antibacterial drugs;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">BioThrax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Anthrax Vaccine Adsorbed), the only vaccine licensed by the FDA for the general use prophylaxis and post-exposure prophylaxis of anthrax disease;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">CYFENDUS&#8482; (Anthrax vaccine adsorbed (AVA), adjuvanted), previously known as AV7909, which was recently approved by the FDA for post-exposure prophylaxis of disease following suspected or confirmed exposure to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bacillus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">anthracis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. CYFENDUS&#8482; is procured by certain authorized government buyers for their use;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Raxibacumab injection, the first fully human monoclonal antibody therapeutic licensed by the FDA for the treatment and prophylaxis of inhalational anthrax;</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">NARCAN</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">NARCAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone approved by the FDA (including in over-the-counter form) and Health Canada for the emergency treatment&#160;of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression;</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Smallpox - MCM Products</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">ACAM2000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (Smallpox (Vaccinia) Vaccine, Live), the only single-dose smallpox vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">CNJ-016</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Vaccinia Immune Globulin Intravenous (Human) (VIGIV)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada to address certain complications from smallpox vaccination; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">TEMBEXA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an oral antiviral formulated as 100 mg tablets and 10 mg/mL oral suspension dosed once weekly for two weeks which has been approved by the FDA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients, including neonates.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i350eda9d16884d769a0a10b3e1b17c84"><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Products</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">BAT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)), the only heptavalent antitoxin licensed by the FDA and Health Canada for the treatment of symptomatic botulism; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Ebanga&#8482; (ansuvimab-zykl), a monoclonal antibody with antiviral activity provided through a single IV infusion for the treatment of Ebola. Under the terms of a collaboration with Ridgeback Biotherapeutics ("Ridgeback"), Emergent will be responsible for the manufacturing, sale, and distribution of Ebanga&#8482; in the U.S. and Canada, and Ridgeback will serve as the global access partner for Ebanga&#8482;;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">RSDL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Reactive Skin Decontamination Lotion Kit), the only medical device cleared by the FDA that is intended to remove or neutralize chemical warfare agents from the skin, including: tabun, sarin, soman, cyclohexyl sarin, VR, VX, mustard gas and T-2 toxin; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Trobigard&#174; atropine sulfate, obidoxime chloride auto-injector, a combination drug-device auto-injector procured product candidate that contains atropine sulfate and obidoxime chloride. It was approved in Belgium in 2021 but has not been approved by the FDA. Trobigard is procured by certain authorized government buyers under special circumstances for potential use as a nerve agent countermeasure outside of the U.S.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Sale of Travel Health Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2023 the Company completed the sale of its products segment's travel health business, including rights to Vivotif&#174;, the licensed typhoid vaccine; Vaxchora&#174;, the licensed cholera vaccine; the development-stage chikungunya vaccine candidate CHIKV VLP; the Company&#8217;s manufacturing site in Bern, Switzerland; and certain of its development facilities in San Diego, California. For additional information refer to Note 3, "Divestiture".</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Services - Contract Development and Manufacturing</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's services line focused on CDMO offerings cover development services, drug substance manufacturing, drug product manufacturing, and when necessary, suite reservations, which depending on facts and circumstances could be considered a lease. These services are provided to customers from across the pharmaceutical and biotechnology industries as well as the U.S. Government (&#8220;USG&#8221;) and non-governmental organizations. The Company's technology platforms include mammalian, microbial, viral, plasma and advanced therapies utilizing the Company's core capabilities for manufacturing to third parties on a clinical and commercial (small and large) scale.&#160;Additional services include fill/finish formulation and analytical development services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, aseptic filling, lyophilization, final packaging and stability studies, as well as manufacturing of vial and pre-filled syringe formats on multiple platforms.</span></div></ix:continuation><div id="i26b3b087cdd44df68137aa5405612fee_37"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-407" continuedAt="i44de2bc55da441e8add49d94f887cf34" escape="true">Summary of significant accounting policies</ix:nonNumeric></span></div><ix:continuation id="i44de2bc55da441e8add49d94f887cf34" continuedAt="ic8b33758549a485c8fdccfffa4ff6c61"><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of presentation and consolidation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-408" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements include the accounts of Emergent and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements included herein have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X issued by the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022, as filed with the SEC.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All adjustments contained in the accompanying unaudited condensed consolidated financial statements are of a normal recurring nature and are necessary to present fairly the financial position of the Company as of June&#160;30, 2023. Interim results are not necessarily indicative of results that may be expected for any other interim period or for an entire year.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ic8b33758549a485c8fdccfffa4ff6c61" continuedAt="id04760836be6408a973a8993eaeac36b"><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Going concern</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, there is $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-409">250.2</ix:nonFraction>&#160;million outstanding on the Company's Revolving Credit Facility and $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-410">206.1</ix:nonFraction>&#160;million on Term Loan Facility that matures in May 2025. The Company determined that there is substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. This evaluation considered the mitigating effect of management&#8217;s plans that have been implemented as of June&#160;30, 2023. Management may evaluate the mitigating effect of its plans to determine if it is probable that (1) the plans will be effectively implemented within one year after the date the financial statements are issued, and (2) when implemented, the plans will mitigate the relevant conditions or events that raise substantial doubt about the entity&#8217;s ability to continue as a going concern. The Company's plans include (A) amending the agreement for the Senior Secured Credit Facilities which occurred on May 15, 2023 with the Fourth Amendment to Amended and Restated Credit Agreement, Waiver and First Amendment to Amended and Restated Collateral Agreement (the &#8220;Credit Agreement Amendment&#8221;), and (B) the execution of the capital raise requirement prescribed in the Credit Agreement Amendment, as further described below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company executed the Credit Agreement Amendment and extended the maturity date on the Senior Secured Credit Facilities to May 15, 2025, the Credit Agreement Amendment also requires the Company to raise at least $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="ebs:DebtInstrumentCovenantConsiderationThreshold" format="ixt:num-dot-decimal" scale="6" id="f-411">75.0</ix:nonFraction>&#160;million through the issuance of equity and/or unsecured indebtedness by April 30, 2024. As a result of this provision, the Company has determined it is appropriate to continue to classify the debt as a current liability on the Condensed Consolidated Balance Sheets. While the Company expects to complete these actions, management cannot make the assumption that it is probable that the Company will be successful. As a result, the Company continues to evaluate a number of uncertain factors related to its assessment of its ability to satisfy the capital raise requirement, including its ability to comply with the terms and operating and financial covenants required by the Senior Secured Credit Facilities, other market conditions, economic conditions, particularly in the pharmaceutical and biotechnology industry, disruptions or volatility caused by factors such as lingering impacts of the COVID-19 pandemic, regional conflicts, inflation, and supply chain disruptions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Condensed Consolidated Financial Statements have been prepared assuming the Company will continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-launch inventory</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-412" escape="true">Within the Company's Products segment, costs relating to raw materials and production of inventory in preparation for product launch prior to regulatory approval are capitalized when the review process has progressed to a point where objective and persuasive evidence exists that regulatory approval is probable, the future economic benefit is expected to be realized, and the Company believes that material uncertainties related to the ultimate regulatory approval have been significantly reduced. Pre-launch inventory is recorded to research and development expense unless these criteria are met. For pre-launch inventory that is capitalized, the Company considers a number of specific facts and circumstances, including the product candidate&#8217;s current status in the drug development and regulatory approval process, results from related clinical trials, results from meetings with relevant regulatory agencies prior to the filing of regulatory applications, potential obstacles to the approval process, historical experience, viability of commercialization and market trends. This policy is not applicable to pre-launch inventory purchased to satisfy a performance obligation related to a CDMO contract as CDMO pre-launch inventory may be capitalized if it has future economic benefit based on the terms of the contract.</ix:nonNumeric></span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant accounting policies</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of the policy on pre-launch inventory discussed above, there have been no significant changes to the Company's summary of significant accounting policies during the six months ended June 30, 2023 contained in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022, that have materially impacted the presentation of the Company's financial statements.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="id04760836be6408a973a8993eaeac36b"><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value measurements</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-413" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value include:</span></div><div style="margin-bottom:9pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Observable inputs for identical assets or liabilities such as quoted prices in active markets;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs other than quoted prices in active markets that are either directly or indirectly observable; and</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use.</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, the Company measures and records money market funds (Level 1), interest-rate swap arrangements and time deposits (Level 2) and contingent purchase consideration (Level 3) using fair value measurements in the accompanying financial statements. The carrying amounts of the Company's short-term financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable approximate their fair values due to their short maturities. The carrying amounts of the Company&#8217;s long-term variable interest rate debt arrangements (Level 2) approximate their fair values.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New accounting standards</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board that the Company adopts as of the pronouncement's specified effective date. There were no new accounting pronouncements that were issued or became effective since the issuance of the Company&#8217;s 2022 Annual Report on Form 10-K that had, or are expected to have, a material impact on its consolidated financial position, results of operations or cash flows.</span></div></ix:continuation><div id="i26b3b087cdd44df68137aa5405612fee_40"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="c-1" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="f-414" continuedAt="iccf171f7970940d9bb9bbf48e379c06a" escape="true">Divestiture</ix:nonNumeric></span></div><ix:continuation id="iccf171f7970940d9bb9bbf48e379c06a"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;15, 2023, pursuant to the Purchase and Sale Agreement (the &#8220;Purchase and Sale Agreement&#8221;), by and between the Company, through its wholly owned subsidiaries Emergent International Inc. and Emergent Travel Health Inc. and Bavarian Nordic ("Bavarian Nordic&#8221;), the Company completed the previously announced sale of the Company&#8217;s travel health business, including rights to Vivotif&#174;, the licensed typhoid vaccine; Vaxchora&#174;, the licensed cholera vaccine; the development-stage chikungunya vaccine candidate CHIKV VLP; the Company&#8217;s manufacturing site in Bern, Switzerland; and certain of its development facilities in San Diego, California.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing, Bavarian Nordic paid a cash purchase price of $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="f-415">270.0</ix:nonFraction>&#160;million, exclusive of customary closing adjustments for cash, indebtedness, working capital and transaction expenses of the business at closing. Bavarian Nordic may also be required to pay milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="ebs:DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="f-416">80.0</ix:nonFraction>&#160;million related to the development of CHIKV VLP and receipt of marketing approval and authorization in the U.S. and Europe, and earn-out payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="ebs:DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="f-417">30.0</ix:nonFraction>&#160;million based on aggregate net sales of Vaxchora and Vivotif in calendar year 2026.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the divestiture, during the three months ended June&#160;30, 2023, the Company recognized a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="f-418">74.9</ix:nonFraction>&#160;million, net of transaction costs of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ebs:DispositionOfBusinessTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="f-419">4.0</ix:nonFraction>&#160;million, which was recorded within "Gain on sale of business" on the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the disposal of the travel health business does not qualify for reporting as a discontinued operation since it does not represent a strategic shift that has or will have a major effect on our operations and financial results. No adjustments were made to prior period results as a result of the disposal. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the divestiture, the Company entered into a Transition Services Agreement (&#8220;TSA&#8221;) with Bavarian Nordic to help support its ongoing operations. Under the TSA, the Company will provide certain transition services to Bavarian Nordic, including information technology, finance and enterprise resource planning, research and development, human resources, employee benefits and other limited services. Income from performing services under the TSA was recorded within "Other income (expense), net" on the Condensed Consolidated Statements of Operations and was $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="f-420"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="f-421">1.0</ix:nonFraction></ix:nonFraction>&#160;million for the three and six months ended June 30, 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="f-422" continuedAt="i81f943780a684bb9845d41a94f5b0411" escape="true">Restructuring and impairment charges</ix:nonNumeric></span></div><ix:continuation id="i81f943780a684bb9845d41a94f5b0411" continuedAt="i885638319b1b4ca38f0c32a59434be74"><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Impairment of long-lived assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests its long-lived assets that are held and used for recoverability whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. During the preparation of our financial statements for the three months ended June&#160;30, 2023, due to deterioration in performance and resulting downward revisions to our internal CDMO forecast made during the second quarter, including future expected cash flows, the Company determined there were sufficient indicators of impairment on certain asset groups within the CDMO reporting unit to require an impairment analysis. As a result, the Company performed recoverability tests on certain asset groups within the CDMO reporting unit and concluded that the impacted asset groups were not recoverable as the undiscounted expected cash flows did not exceed their carrying values. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset groups are written down only to the extent that their carrying value is higher than their respective fair value. The Company, with the assistance of a third-party valuation firm, applied valuation methods to estimate the fair values for each of the assets within the different asset classes. An orderly liquidation value was applied to estimate the fair value of the personal property assets and market and cost based approaches were applied to estimate the fair value of the real property assets, each representing Level 3 non-recurring fair value measurements. Based on this analysis, the Company allocated and recognized a non-cash impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-423">306.7</ix:nonFraction>&#160;million during the three months ended June&#160;30, 2023.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" id="f-424" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the total impairment charge by asset class for the three months ended June&#160;30, 2023:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Buildings, building improvements and leasehold improvements</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-425">81.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-426">117.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-427">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction-in-progress</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-428">107.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total impairment on long-lived assets</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-429">306.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">January 2023 Organizational Restructuring Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company initiated an organizational restructuring plan (the &#8220;January 2023 Plan&#8221;) intended to reduce operating costs, improve operating margins, and continue advancing the Company&#8217;s ongoing commitment to profitable growth. As part of the January 2023 Plan, the Company eliminated approximately <ix:nonFraction unitRef="number" contextRef="c-94" decimals="2" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" format="ixt-sec:numwordsen" scale="-2" id="f-430">five</ix:nonFraction> percent of its total headcount. The Company made a $(<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="f-431">0.1</ix:nonFraction>)&#160;million adjustment to the incurred charges in connection with the January 2023 Plan during the three months ended June&#160;30, 2023 and incurred approximately $<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="f-432">9.6</ix:nonFraction>&#160;million in charges during the six months ended June 30, 2023. These charges consist primarily of charges related to employee transition, severance payments and employee benefits. All activities related to the January 2023 Plan were substantially completed during the first quarter of 2023. Restructuring costs are recognized as an operating expense within the Condensed Consolidated Statement of Operations and are classified based on the Company's classification policy for each category of operating expense.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i885638319b1b4ca38f0c32a59434be74"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="f-433" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total restructuring costs associated with the Company&#8217;s segments as well as unallocated corporate and research and development ("R&amp;D") charges for the three and six months ended June 30, 2023:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.011%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="f-434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-435">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="f-436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="f-437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring costs by segment</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="f-438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-439">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-440">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-441">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="f-442">0.2</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-443">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring costs</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="f-444">0.1</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-445">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total restructuring costs, by function, for the three and six months ended June 30, 2023:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee transition</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="f-446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-447">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severance payments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-448">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-449">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee benefits</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="f-450">0.2</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-451">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring costs</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="f-452">0.1</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-453">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="f-454" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of and changes in the Company's restructuring accrual during the three and six months ended June 30, 2023:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.997%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Employee Transition</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Severance Payments</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Employee Benefits</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-456">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-457">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-458">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-459">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-460">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-461">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-462">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash payments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-463">0.2</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-464">2.0</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-465">0.1</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-466">2.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-467">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-468">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-469">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-470">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-472">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="f-473">0.2</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="f-474">0.1</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash payments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-476">3.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-477">0.1</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-478">3.7</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-479">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-480">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-481">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-482">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;padding-left:18pt"><span><br/></span></div><div id="i26b3b087cdd44df68137aa5405612fee_46"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryDisclosureTextBlock" id="f-483" continuedAt="id1c166a328cd4ec4b2f250259baf322d" escape="true">Inventories, net</ix:nonNumeric></span></div><ix:continuation id="id1c166a328cd4ec4b2f250259baf322d"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-484" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:59.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials and supplies</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="f-485">140.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="f-486">143.4</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-487">149.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-488">116.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-489">64.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-490">92.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventories, net</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-491">354.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-492">351.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is stated at the lower of cost or net realizable value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-493" continuedAt="i8c0f02a68dc9469fa89927ec4c1f7c11" escape="true">Property, plant and equipment, net</ix:nonNumeric></span></div><ix:continuation id="i8c0f02a68dc9469fa89927ec4c1f7c11"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-494" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023 </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land and improvements</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-495">30.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-496">54.9</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Buildings, building improvements and leasehold improvements</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-497">226.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-498">327.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-499">412.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-500">567.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-501">64.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-502">65.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction-in-progress</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-503">53.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-504">185.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, gross</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-505">786.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-506">1,201.4</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Accumulated depreciation &amp; amortization</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="f-507">391.4</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="f-508">383.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property, plant and equipment, net</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-509">395.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-510">817.6</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended June&#160;30, 2023, the Company recorded a non-cash impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-511">306.7</ix:nonFraction> million related to certain CDMO long-lived assets. See Note 4, "Restructuring and impairment charges" for more details regarding the impairment charge.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, construction-in-progress primarily included costs incurred to advance the Company's MCM Product capabilities. As of December&#160;31, 2022, construction-in-progress primarily included costs incurred due to construction to advance the Company's CDMO capabilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net is stated at cost, less accumulated depreciation and amortization. During the year ended December&#160;31, 2022, the Company recorded accelerated depreciation of $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-512">12.7</ix:nonFraction>&#160;million reflecting a shortening of the useful life of certain property, plant and equipment which were to be used in the manufacturing process to fulfill the manufacturing services agreement with Janssen (the "Agreement"). For additional information related to the termination of the Agreement, refer to Note 13, "Revenue recognition".</span></div></ix:continuation><div id="i26b3b087cdd44df68137aa5405612fee_52"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-513" continuedAt="i855c762bc5424cdeac3c6a2c87121c76" escape="true">Intangible assets and goodwill</ix:nonNumeric></span></div><ix:continuation id="i855c762bc5424cdeac3c6a2c87121c76" continuedAt="i47c58108d2eb401898dc2f24375fa86d"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's intangible assets consist of products acquired via business combinations or asset acquisitions. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-514" continuedAt="i83589c9a881e48e38acf8f5896920672" escape="true">The following table summarizes the Company's Intangible assets, net:</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><ix:continuation id="i83589c9a881e48e38acf8f5896920672"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:16.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.000%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Weighted Average Useful Life in Years</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr style="height:35pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net Carrying Amount </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-139" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-515">13.6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-516">849.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-517">256.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-518">592.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-519">982.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-520">253.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-521">728.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-141" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-522">0.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-523">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-524">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="f-525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-526">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-527">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="f-528">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-143" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-529">0.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-530">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-531">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="f-532">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-533">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-534">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="f-535">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-536">883.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-537">290.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-538">592.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-539">1,016.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-540">287.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-541">728.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the Company sold $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" scale="6" id="f-542">102.9</ix:nonFraction> million of intangible assets, net as part of the sale of its travel health business to Bavarian Nordic. See Note 3, "Divestiture" for more information on the sale of the business.</span></div></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="f-543" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense associated with the Company's intangible assets was recorded as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-544">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-545">14.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-546">33.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-547">28.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i47c58108d2eb401898dc2f24375fa86d"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-548" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the changes in the carrying amount of goodwill by reportable segment:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Products </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Services </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-549">218.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="6" id="f-550">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-551">218.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-552">218.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="6" id="f-553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-554">218.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.37pt;font-weight:400;line-height:120%;position:relative;top:-3.43pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">Amounts for the Company's Products segment include gross carrying values of $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="f-555"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="f-556">259.9</ix:nonFraction></ix:nonFraction>&#160;million as of June&#160;30, 2023 and December&#160;31, 2022 and accumulated impairment losses of $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-557"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-558">41.7</ix:nonFraction></ix:nonFraction>&#160;million.</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.37pt;font-weight:400;line-height:120%;position:relative;top:-3.43pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">Amounts for the Company's Services segment include gross carrying values of $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="f-559"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="f-560">6.7</ix:nonFraction></ix:nonFraction>&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, and accumulated impairment losses of $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-561"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-562">6.7</ix:nonFraction></ix:nonFraction>&#160;million.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-563">218.2</ix:nonFraction>&#160;million of total goodwill which is attributable to its Products segment. Quantitative impairment assessments performed during the quarter ended June&#160;30, 2023 indicated that the fair value of the reporting unit was approximately 14% in excess over its carrying value as of the assessment date. There is the risk of future impairments in our reporting unit as any further deterioration in their performance compared to forecast, changes in order volumes or delivery schedules for major customers, decline in our stock price, as well as any changes in economic forecasts and expected recovery in the biopharmaceutical industry, may require the Company to complete additional impairment tests in future quarters and could result in a reporting unit&#8217;s fair value falling below carrying value in subsequent quarters. In the event the Company experiences factors that it believes indicate a decline in fair value, including negative changes to long-term growth rates or if discount rates increase, we may be required to record impairments of goodwill and other identified intangible assets. Further, if the composition of the Company&#8217;s reporting units' assets and liabilities were to change and result in an increase in a reporting unit&#8217;s carrying value, it could lead to additional impairment testing and further impairment losses.</span></div></ix:continuation><div id="i26b3b087cdd44df68137aa5405612fee_55"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-564" continuedAt="i849b4285fe9a4167bd9e87d817d45335" escape="true">Fair value measurements</ix:nonNumeric></span></div><ix:continuation id="i849b4285fe9a4167bd9e87d817d45335" continuedAt="i618c4553c8af4b5eb8a8af3ffd230193"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="f-565" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about the Company's assets and liabilities that are regularly measured and carried at fair value and indicates the level within the fair value hierarchy of the valuation techniques the Company utilized to determine fair value:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="12" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="12" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market accounts</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-566">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-567">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-568">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-569">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-570">320.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-571">320.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-572">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-573">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time deposits</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-578">170.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-579">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-580">170.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-581">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-582">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-584">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-585">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-586">8.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-587">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-588">8.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-589">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-590">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-591">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-593">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-594">500.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-595">320.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-596">179.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-597">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-598">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-600">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-601">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-602">6.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-603">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-604">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-605">6.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-606">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-607">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-609">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-610">6.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-611">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-612">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-613">6.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Contingent consideration</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration payments in an asset acquisition not required to be accounted for as derivatives are recognized when the contingency is resolved, and the consideration is paid or becomes payable. Contingent consideration liabilities associated with business combinations are measured at fair value. These liabilities represent an obligation of the Company to transfer additional assets to the selling shareholders and owners if future events occur or conditions are met. These liabilities associated with business combinations are measured at fair value at inception and at each subsequent reporting date. The changes in the fair value are primarily due to the expected amount and timing of future net sales, which are inputs that have no observable market. Any changes in fair value for the contingent consideration liabilities related to the Company&#8217;s products are classified in the Company's statement of operations as "Cost of product sales."</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i618c4553c8af4b5eb8a8af3ffd230193"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-614" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below is a reconciliation of the beginning and ending balance of the Company's contingent consideration liability: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.342%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-615">6.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-616">1.5</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="f-617">0.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-618">7.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-619">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="f-620">0.6</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-621">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, the current portion of the contingent consideration liability was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-622">3.6</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-623">3.1</ix:nonFraction>&#160;million, respectively, and was included in "Other current liabilities" on the Condensed Consolidated Balance Sheets. The non-current portion of the contingent consideration liability is included in "Other liabilities" on the Condensed Consolidated Balance Sheets.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-624" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurement for the Company's contingent consideration liability include the following significant unobservable inputs: </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Contingent Consideration Liability</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Fair Value as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Valuation Technique</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Unobservable Input</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Range</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty based</span></td><td colspan="3" rowspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-625">7.4</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discounted cash flow</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discount rate</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-173" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-626">9.7</ix:nonFraction>%</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Probability of payment</span></td><td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-174" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-627">0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-175" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-628">75</ix:nonFraction>%</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected year of payment</span></td><td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 - 2028</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derivative instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9, "Derivative instruments and hedging activities</span><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information about the Company's derivative instruments.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Non-variable rate debt</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and December&#160;31, 2022, t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he fair value of the Company's <ix:nonFraction unitRef="number" contextRef="c-176" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-629"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-630">3.875</ix:nonFraction></ix:nonFraction>% Senior Unsecured Notes was $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-631">252.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-632">225.1</ix:nonFraction>&#160;million, respectively. The fair value was determined through market sources, which are Level 2 inputs and directly observable. The carrying amounts of the Company&#8217;s other long-term variable interest rate debt arrangements approximate their fair values (see Note 10, "Debt").</span></div></ix:continuation><div id="i26b3b087cdd44df68137aa5405612fee_58"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-633" continuedAt="iba0a974d963a4a5484cbb37402b284b7" escape="true">Derivative instruments and hedging activities</ix:nonNumeric></span></div><ix:continuation id="iba0a974d963a4a5484cbb37402b284b7" continuedAt="i174f122d279a4375a3bf5689bef4f8d1"><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risk management objective of using derivatives</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk primarily by managing the amount, sources and duration of its assets and liabilities and the use of derivative financial instruments. From time to time, the Company enters into interest rate swap transactions to manage exposures that arise from payments of variable interest rate debt associated with the Company's senior secured credit agreements. The objective and strategy with respect to these interest rate swaps is to protect the Company against adverse fluctuations in interest rates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June&#160;30, 2023, the Company terminated its designated interest rate swap transactions with a total notional value of $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-634">350.0</ix:nonFraction> million. Hedge accounting was also discontinued at that time. As of June&#160;30, 2023, the remaining accumulated other comprehensive income associated with the terminated interest rate swaps, before tax, was $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:AociBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="f-635">3.5</ix:nonFraction>&#160;million and will be amortized to earnings over the remaining term of the interest rate swaps prior to termination.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i174f122d279a4375a3bf5689bef4f8d1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="f-636" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company&#8217;s derivative financial instruments designated as hedges as well as their classification on the Condensed Consolidated Balance Sheets:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.149%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Fair Value of Asset Derivatives</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Current Assets</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="f-637">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-638">8.5</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-639" escape="true">The valuation of the interest rate swaps is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each interest rate swap. This analysis reflects the contractual terms of the interest rate swaps, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments (or receipts) and the discounted expected variable cash receipts (or payments). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. We incorporate credit valuation adjustments in the fair value measurements to appropriately reflect both our own nonperformance risk and the respective counterparty&#8217;s nonperformance risk. These credit valuation adjustments were not significant inputs for the fair value calculations for the periods presented. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as the posting of collateral, thresholds, mutual puts and guarantees. The valuation of interest rate swaps fall into Level 2 in the fair value hierarchy.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="f-640" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amount of gains or losses reclassified from "Accumulated other comprehensive income (loss), net" into "Interest expense" on the Condensed Consolidated Statement of Operations during the three and six months ended June 30, 2023 and 2022:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:23.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.210%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps gain (loss)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-641">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-642">0.9</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-643"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-644">5.3</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-645">2.3</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i26b3b087cdd44df68137aa5405612fee_61"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-646" continuedAt="ib47f86bf88a34e24869ecbd720da1724" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="ib47f86bf88a34e24869ecbd720da1724" continuedAt="ia8810dfe1ec34259a675362c35dece1e"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtTableTextBlock" id="f-647" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the components of the Company&#8217;s debt:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.148%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior secured credit agreement - Term loan due 2025</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-648">206.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-649">362.8</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior secured credit agreement - Revolver loan due 2025</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-650">250.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-651">598.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-652">3.875</ix:nonFraction>% Senior Unsecured Notes due 2028</span></div></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-653">450.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-654">450.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-655">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-656">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-657">909.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-658">1,413.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Unamortized debt issuance costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="6" id="f-659">6.1</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="6" id="f-660">8.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Current portion of long-term debt, net</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-661">455.2</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-662">957.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-current portion of debt, net</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-663">448.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-664">448.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, excludes the unamortized debt issuance costs related to the revolver loan which are included within "Other current assets" on the accompanying Condensed Consolidated Balance Sheet.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June&#160;30, 2023, the Company reclassified the debt issuance costs associated with the revolver loan to "Other current assets." Prior to the second quarter of 2023, the debt issuance costs associated with the revolver loan were classified as a direct offset to the carrying value of the debt within "Other current liabilities." As of June&#160;30, 2023 and December&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredFinanceCostsCurrentNet" format="ixt:num-dot-decimal" scale="6" id="f-665">13.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredFinanceCostsCurrentNet" format="ixt:num-dot-decimal" scale="6" id="f-666">1.3</ix:nonFraction>&#160;million of debt issuance costs associated with the revolver loan, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ia8810dfe1ec34259a675362c35dece1e"><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><ix:nonFraction unitRef="number" contextRef="c-189" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-667">3.875</ix:nonFraction>% Senior Unsecured Notes due 2028 </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 7, 2020, the Company completed its offering of $<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-668">450.0</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="c-189" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-669">3.875</ix:nonFraction>% Senior Unsecured Notes due 2028 (the "2028 Notes") of which the majority of the net proceeds were used to pay do</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">wn the Revolving Credit Facility. Interest on the 2028 Notes is payable on February 15th and August 15th of each year until maturity, beginning on February 15, 2021. The 2028 Notes will mature on August 15, 2028.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after August 15, 2023, the Company may redeem the 2028 Notes, in whole or in part, at the redemption prices set forth in the related Indenture, plus accrued and unpaid interest. Prior to August 15, 2023 the Company may redeem all or a portion of the 2028 Notes at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="c-190" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-670">100</ix:nonFraction>% of the principal amount of the 2028 Notes plus a &#8220;make-whole&#8221; premium and accrued and unpaid interest. Prior to August 15, 2023, the Company may redeem up to <ix:nonFraction unitRef="number" contextRef="c-191" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-671">40</ix:nonFraction>% of the aggregate principal amount of the 2028 Notes using the net cash proceeds of certain equity offerings at the redemption price set forth in the related Indenture. Upon the occurrence of a change of control, the Company must offer to repurchase the 2028 Notes at a purchase price of <ix:nonFraction unitRef="number" contextRef="c-192" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-672">101</ix:nonFraction>% of the principal amount of such 2028 Notes plus accrued and unpaid interest.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Negative covenants in the Indenture governing the 2028 Notes, among other things, limit the ability of the Company to incur indebtedness and liens, dispose of assets, make investments, enter into certain merger or consolidation transactions and make restricted payments.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Senior Secured Credit Facilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2023, the Company entered into the Credit Agreement Amendment. The Credit Agreement Amendment amends the Existing Credit Agreement to, among other things, (a) extend the maturity date of the Senior Secured Credit Facilities from October 13, 2023 to May 15, 2025, (b) reduce the available commitments under the Revolving Credit Facility from $<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-673">600.0</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-674">300.0</ix:nonFraction>&#160;million, (c) remove the Company's ability to incur incremental loans and (d) amend certain mandatory prepayment triggers, affirmative covenants, negative covenants and events of default thereunder. In connection with the Credit Agreement Amendment, the Company used the approximately $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="f-675">270.0</ix:nonFraction>&#160;million of proceeds from the sale of its travel health business to Bavarian Nordic, which closed on May 15, 2023, together with approximately $<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="6" id="f-676">217.2</ix:nonFraction>&#160;million of cash on hand, to repay approximately $<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-677">144.4</ix:nonFraction>&#160;million in outstanding principal amount of loans under the Term Loan Facility and $<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-678">342.8</ix:nonFraction>&#160;million outstanding principal amount of loans under the Revolving Credit Facility.The Credit Agreement Amendment also requires that we make quarterly principal payments on the Term Loan Facility of approximately $<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="f-679">3.9</ix:nonFraction>&#160;million, which commenced on June 30, 2023 and will extend through March 31, 2025.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement Amendment also (w) amends the consolidated debt service coverage ratio financial covenant to require the minimum level to be <ix:nonFraction unitRef="number" contextRef="c-199" decimals="INF" name="ebs:DebtInstrumentCovenantInterestCoverageRatioMinimum" scale="0" id="f-680">2.25</ix:nonFraction> to 1.00 for the fiscal quarters ending March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, and then <ix:nonFraction unitRef="number" contextRef="c-200" decimals="INF" name="ebs:DebtInstrumentCovenantInterestCoverageRatioMinimum" scale="0" id="f-681">2.50</ix:nonFraction> to 1.00 for each fiscal quarter ending thereafter, (x) amends the consolidated leverage ratio to require the maximum level to be <ix:nonFraction unitRef="number" contextRef="c-201" decimals="INF" name="ebs:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="f-682">4.50</ix:nonFraction> to 1.00 for the fiscal quarter ending March 31, 2024 and each fiscal quarter ending thereafter, (y) adds minimum Consolidated EBITDA requirements and maximum capital expenditure requirements for each of the months ending April 30, 2023 through February 29, 2024 and a minimum liquidity requirement as of the end of each calendar month and (z) requires the Company to increase its liquidity by April 30, 2024 by raising at least $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="ebs:DebtInstrumentCovenantConsiderationThreshold" format="ixt:num-dot-decimal" scale="6" id="f-683">75.0</ix:nonFraction>&#160;million of equity or unsecured indebtedness.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Credit Agreement Amendment replaces the interest rate benchmark such that borrowings under the Revolving Credit Facility and the outstanding principal amount of the Term Loan Facility shall bear interest at a rate per annum equal to (a) a rate based on SOFR, EURIBOR or CDOR plus a margin of <ix:nonFraction unitRef="number" contextRef="c-202" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-684">6.00</ix:nonFraction>% until March 31, 2024 and thereafter, a margin ranging from <ix:nonFraction unitRef="number" contextRef="c-203" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-685">2.75</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-204" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-686">4.00</ix:nonFraction>% depending on the Company&#8217;s consolidated leverage ratio, or (b) a base rate (which is the highest of the prime rate, the federal funds rate plus <ix:nonFraction unitRef="number" contextRef="c-205" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-687">0.50</ix:nonFraction>%, and a SOFR rate for an interest period of one month plus <ix:nonFraction unitRef="number" contextRef="c-206" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-688">1</ix:nonFraction>%) plus a margin of <ix:nonFraction unitRef="number" contextRef="c-207" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-689">5.00</ix:nonFraction>% until March 31, 2024 and thereafter, a margin ranging from <ix:nonFraction unitRef="number" contextRef="c-208" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-690">1.75</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-209" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-691">3.00</ix:nonFraction>% depending on the Company&#8217;s consolidated leverage ratio. In addition, the commitment fee the Company is required to pay in respect of the annual daily unused commitments under the Revolving Credit Facility shall be <ix:nonFraction unitRef="number" contextRef="c-210" decimals="4" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-692">0.15</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-211" decimals="4" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-693">0.40</ix:nonFraction>% per annum, depending on the Company&#8217;s consolidated leverage ratio.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Credit Agreement Amendment, the Company and the other guarantors have also agreed to provide a lien over certain assets as additional collateral for the benefit of the lenders, including owned real property, equity interests of foreign subsidiaries and certain deposit accounts.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-694" continuedAt="i6e9d209e6e884ac8bdfac1ce42c615b8" escape="true">Stock-based compensation and stockholders' equity</ix:nonNumeric></span></div><ix:continuation id="i6e9d209e6e884ac8bdfac1ce42c615b8" continuedAt="if183211491f94a1b9e60bd3068c9a610"><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stock-based compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the Company granted stock options to purchase <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-695">0.7</ix:nonFraction>&#160;million shares of common stock, <ix:nonFraction unitRef="shares" contextRef="c-212" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-696">1.4</ix:nonFraction>&#160;million restricted stock units and <ix:nonFraction unitRef="shares" contextRef="c-213" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-697">0.5</ix:nonFraction>&#160;million performance stock units under the Emergent BioSolutions Inc. Stock Incentive Plan. Performance stock units are presented at the target payout percentage of <ix:nonFraction unitRef="number" contextRef="c-214" decimals="2" name="ebs:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage" scale="-2" id="f-698">100</ix:nonFraction>% of target shares granted. Typically, the stock options and restricted stock unit grants vest over three equal annual installments beginning on the day prior to the anniversary of the grant date. The performance stock units settle in stock at the end of the <ix:nonNumeric contextRef="c-213" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-699">three-year</ix:nonNumeric> performance period based on the Company's results compared to the performance criteria. During the six months ended June 30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" format="ixt:num-dot-decimal" scale="6" id="f-700">0.6</ix:nonFraction>&#160;million of stock options and <ix:nonFraction unitRef="shares" contextRef="c-212" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-701">0.4</ix:nonFraction>&#160;million shares of restricted stock units were forfeited prior to the completion of the applicable vesting requirements or expiration. Additionally, an immaterial amount of performance stock units were forfeited during the six months ended June 30, 2023, as the award targets or vesting requirements were not achieved. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-702" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense, net of forfeitures was recorded in the following financial statement line items:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:44.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product sales</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-703">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-704">1.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-705">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-706">3.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of CDMO</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-707">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-708">0.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-709">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-710">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-711">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-712">1.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-713">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-714">2.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-715">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-716">8.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-717">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-718">15.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-719">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-720">12.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-721">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-722">22.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">2021 Share Repurchase Program</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 11, 2021, the Company announced that its Board of Directors authorized a stock repurchase program of up to an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-723">250.0</ix:nonFraction>&#160;million of Common Stock (the "Share Repurchase Program"), of which $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="f-724">187.9</ix:nonFraction>&#160;million was utilized to purchase approximately <ix:nonFraction unitRef="shares" contextRef="c-232" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="f-725">4.4</ix:nonFraction>&#160;million shares. The Share Repurchase Program expired on November 11, 2022. During the three and six months ended June 30, 2022, the Company utilized $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="f-726">23.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="f-727">75.5</ix:nonFraction>&#160;million to purchase approximately <ix:nonFraction unitRef="shares" contextRef="c-75" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="f-728">0.7</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="c-233" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="f-729">1.8</ix:nonFraction>&#160;million shares, respectively. The Share Repurchase Program did not obligate the Company to acquire any specific number of shares. Repurchased shares are available for use in connection with the Company's stock plans and for other corporate purposes.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">At-the-Market Equity Offering Facility</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, from time to time, sell up to $<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="ebs:SaleOfStockConsiderationReceivedOnTransactionGross" format="ixt:num-dot-decimal" scale="6" id="f-730">150.0</ix:nonFraction>&#160;million aggregate gross sales price of shares of our common stock through Evercore Group L.L.C. and RBC Capital Markets, LLC, as sales agents, under an &#8220;at-the-market&#8221; equity offering program (the &#8220;ATM Program&#8221;) that we entered into on May 18, 2023. During the three months ended June&#160;30, 2023, we sold <ix:nonFraction unitRef="shares" contextRef="c-235" decimals="-5" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="6" id="f-731">1.1</ix:nonFraction>&#160;million shares of our common stock under the ATM Program for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="ebs:SaleOfStockConsiderationReceivedOnTransactionGross" format="ixt:num-dot-decimal" scale="6" id="f-732">9.1</ix:nonFraction>&#160;million, representing an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-236" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-733">8.22</ix:nonFraction> per share. As of June&#160;30, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" name="ebs:SaleOfStockAmountRemainingAvailableForSaleOfShares" format="ixt:num-dot-decimal" scale="6" id="f-734">140.9</ix:nonFraction>&#160;million aggregate gross sales price of shares of our common stock remains available for issuance under the ATM Program. We intend to use proceeds obtained from the sale of shares under the ATM Program for general corporate purposes.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="if183211491f94a1b9e60bd3068c9a610"><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accumulated other comprehensive income (loss), net of tax</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-735" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes changes in accumulated other comprehensive income (loss), net of tax by component:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.756%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.830%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Defined Benefit Pension Plan</span></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Derivative Instruments</span></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Foreign Currency Translation Adjustments</span></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December&#160;31, 2022</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-736">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-737">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-738">6.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-739">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-740">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-741">4.4</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-742">0.1</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-743">4.5</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-745">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-747">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-749">2.0</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-750">0.1</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-751">2.1</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-752">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-753">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-754">6.7</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-755">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-756">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-757">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-758">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-759">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-760">3.5</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-761">2.9</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-762">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-763">6.4</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-764">3.5</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-765">1.7</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-766">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-767">2.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="6" id="f-768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-769">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-770">4.1</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-771">1.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-772">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-773">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-774">7.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-775">16.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-776">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-777">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-778">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-779">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-780">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-781">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-782">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-783">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-784">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-785">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-786">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-787">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-788">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-789">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-790">7.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-791">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-792">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-793">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-794">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-795">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-797">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-798">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-799">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-801">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-802">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-803">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-804">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-805">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-806">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-807">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="f-808" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present the tax effects related to each component of other comprehensive income (loss):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit pension plan</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-809">4.1</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-810">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-811">3.5</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-813">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-814">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-815">2.4</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-816">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-817">1.7</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-818">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-819">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-820">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-821">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-822">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-823">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-824">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-825">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-826">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total adjustments</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-827">4.4</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-828">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-829">2.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-830">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-831">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-832">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit pension plan</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-833">4.1</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-834">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-835">3.5</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-837">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-839">5.0</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-840">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-841">3.7</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-842">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-843">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-844">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-845">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-846">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-847">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-848">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-849">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-850">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total adjustments</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-851">7.1</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-852">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-853">4.7</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="6" id="f-854">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-855">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-856">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-863" continuedAt="i42cf46ac9b8040288f95962f9289e9c2" escape="true">Loss per common share</ix:nonNumeric></span></div><ix:continuation id="i42cf46ac9b8040288f95962f9289e9c2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic loss per common share is calculated using the treasury method by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted loss per common share adjusts basic loss per common share for the effects of potentially dilutive common shares and is calculated using the treasury stock method. Potentially dilutive common shares include the dilutive effect of shares issuable under our equity compensation plans, including stock options, restricted stock units and performance stock units. Diluted loss per share excludes anti-dilutive securities, which represent the number of potential common shares related to shares issuable under our equity compensation plan that were excluded from diluted loss per common share because their effect would have been antidilutive.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-864" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted loss per share:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#1b51bf;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-865">261.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-866">56.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-867">444.3</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-868">60.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average number of shares outstanding-basic</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-869">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-870">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-871">50.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-872">50.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average number of shares outstanding-diluted</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-873">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-874">50.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-875">50.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-876">50.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss per common share - basic</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-25" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-877">5.15</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-26" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-878">1.13</ix:nonFraction>)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-879">8.80</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-27" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-880">1.19</ix:nonFraction>)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss per common share - diluted</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-25" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-881">5.15</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-26" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-882">1.13</ix:nonFraction>)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-883">8.80</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-27" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-884">1.19</ix:nonFraction>)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-dilutive securities</span></td><td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-885">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-886">1.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-887">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-888">3.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i26b3b087cdd44df68137aa5405612fee_76"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-889" continuedAt="ibaf1b3fd060343c4b9d9e0c24eea4990" escape="true">Revenue recognition</ix:nonNumeric></span></div><ix:continuation id="ibaf1b3fd060343c4b9d9e0c24eea4990" continuedAt="ica7582a2903d43028a7b3e9ee7eda327"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" id="f-890"><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" id="f-891">two</ix:nonFraction></ix:nonFraction> operating segments (see Note 17, "Segment information"). <ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-892" continuedAt="ib122523f94fd49d9bc1926df68552453" escape="true">The Company's revenues disaggregated by the major sources were as follows:</ix:nonNumeric></span></div><ix:continuation id="ib122523f94fd49d9bc1926df68552453"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales, net</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-893">150.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-894">151.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-895">302.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-896">118.2</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-897">119.0</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-898">237.2</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-899"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-900">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-901">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-902">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-903">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-904">2.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-905">2.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" format="ixt:fixed-zero" scale="6" id="f-906"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" format="ixt:fixed-zero" scale="6" id="f-907">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-908">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-909">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" format="ixt:fixed-zero" scale="6" id="f-910">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" sign="-" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-911">4.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" sign="-" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-912">4.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total CDMO</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-913">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-914">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-915">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-916">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" sign="-" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-917">1.8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" sign="-" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-918">1.8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-919">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-920">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-921">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-922">6.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-923">1.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-924">7.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-925">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-926">182.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-927">337.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-928">124.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-929">118.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-930">242.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales, net</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-931">176.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-932">269.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-933">445.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-934">221.6</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-935">252.7</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-936">474.3</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-937"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-938">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-939">39.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-940">39.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-941">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-942">54.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-943">54.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" format="ixt:fixed-zero" scale="6" id="f-944"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" format="ixt:fixed-zero" scale="6" id="f-945">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-946">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-947">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" format="ixt:fixed-zero" scale="6" id="f-948">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-949">4.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" scale="6" id="f-950">4.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total CDMO</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-951">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-952">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-953">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="f-954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-955">59.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-956">59.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-957">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-958">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-959">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-960">15.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-961">1.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-962">16.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-963">186.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-964">316.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-965">503.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-966">236.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-967">313.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-968">550.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ica7582a2903d43028a7b3e9ee7eda327" continuedAt="i8e3535722e834450a430fb51ad988319"><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Termination of manufacturing services agreement with Janssen Pharmaceuticals, Inc.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2020, the Company, through its wholly owned subsidiary, Emergent Manufacturing Operations Baltimore, LLC, entered into the Agreement with Janssen, one of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, for large-scale drug substance manufacturing of Johnson &amp; Johnson&#8217;s investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant based on the AdVac technology (the &#8220;Product&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 6, 2022, the Company provided to Janssen a notice (the &#8220;Notice&#8221;) of material breach of the Agreement for, among other things, failure by Janssen (i) to provide the Company the requisite forecasts of the required quantity of Product to be purchased by Janssen under the Agreement and (ii) to confirm Janssen&#8217;s intent to not purchase the requisite minimum quantity of the Product pursuant to the Agreement and instead, wind-down the Agreement ahead of fulfilling these minimum requirements. Later on June 6, 2022, the Company received from Janssen a purported written notice of termination (the &#8220;Janssen Notice&#8221;) of the Agreement for asserted material breaches of the Agreement by the Company, including alleged failure by the Company to perform its obligations in compliance with current good manufacturing practices ("cGMP") or other applicable laws and regulations and alleged failure by the Company to supply Janssen with the Product. Janssen alleged that the Company&#8217;s breaches were not curable and that, therefore, termination of the Agreement would be effective as of July 6, 2022. The Company disputes Janssen's assertions and allegations, including Janssen's ability to effect termination pursuant to the Janssen Notice. The Company and Janssen disagree on the monetary amounts that are due to the Company as a result of termination by any means. The Company believes the amounts due to the Company include, but are not limited to, compensation for services provided, reimbursement for raw materials purchased and non-cancelable orders, and fees for early termination. Janssen has alleged that no additional amount is due to the Company and that the Company should pay Janssen an unspecified amount as a result of the Company's alleged failure to perform under the Agreement. The Company has not recorded any contingent liabilities related to Janssen's allegations as the Company believes they are without merit and intends to vigorously defend the Company's position during the dispute resolution process through arbitration.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023, there were no impacts on previously recognized revenue or depreciation related to the conclusion of the Agreement. As of June&#160;30, 2023, the Company has no billed or unbilled net accounts receivable related to the Agreement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the fourth quarter of 2022, because the arbitration process is expected to extend longer than one year, the Company reclassified amounts related to the Janssen Agreement from "Inventories, net" and from "Prepaid expenses and other current assets" to "Other assets", resulting in $<ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-969">152.7</ix:nonFraction>&#160;million in long-term assets related to the Janssen Agreement on the Condensed Consolidated Balance Sheet as of December&#160;31, 2022. The long-term asset balance within "Other Assets" related to the Agreement as of June&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-970">154.0</ix:nonFraction>&#160;million. These assets include termination penalties, certain inventory related items and raw materials inventory representing materials purchased for the Agreement which Janssen has not reimbursed. The Company evaluated the net realizable value of the inventory as of June&#160;30, 2023, concluding that because the Agreement specifies the Company is entitled to, among other things, reimbursement of raw materials and non-cancelable orders in the event of a contract termination for any reason, the Company is entitled to payment from Janssen for these raw materials. Additionally, the Company has $<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-5" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-971">5.2</ix:nonFraction>&#160;million of non-cancelable orders as of June&#160;30, 2023 which have not been received and Janssen has not reimbursed.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CDMO operating leases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain multi-year CDMO service arrangements with commercial customers include operating leases whereby the customer has the right to direct the use of and obtain substantially all of the economic benefits of specific manufacturing suites operated by the Company. The associated revenue is recognized on a straight-line basis over the term of the lease. The weighted average remaining term on the Company's operating lease components approximates <ix:nonNumeric contextRef="c-329" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="f-972">3.2</ix:nonNumeric> years. The Company utilizes a cost-plus model to determine the stand-alone selling price of the lease component to allocate contract consideration between the lease and non-lease components. Excluding future amounts related to the Agreement as discussed above, the Company estimates future operating lease revenues to be $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="f-973">0.6</ix:nonFraction>&#160;million in the remainder of 2023, $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="f-974">0.9</ix:nonFraction>&#160;million in 2024, $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears" format="ixt:num-dot-decimal" scale="6" id="f-975">0.9</ix:nonFraction>&#160;million in 2025, $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears" format="ixt:num-dot-decimal" scale="6" id="f-976">0.9</ix:nonFraction>&#160;million in 2026, $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears" format="ixt:num-dot-decimal" scale="6" id="f-977">0.9</ix:nonFraction>&#160;million in 2027 and $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="ebs:LessorOperatingLeasePaymentToBeReceivedAfterYearFour" format="ixt:num-dot-decimal" scale="6" id="f-978">0.9</ix:nonFraction>&#160;million in years beyon</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d 2027.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i8e3535722e834450a430fb51ad988319"><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transaction price allocated to remaining performance obligations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company has future contract value on unsatisfied performance obligations of approximately $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-979">452.0</ix:nonFraction>&#160;million associated with all arrangements entered into by the Company. The Company expects to recognize $<ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-980">443.2</ix:nonFraction>&#160;million of unsatisfied performance obligations within the next <ix:nonNumeric contextRef="c-330" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="f-981">24</ix:nonNumeric> months. The amount and timing of revenue recognition for unsatisfied performance obligations can change. The future revenues associated with unsatisfied performance obligations exclude the value of unexercised option periods in the Company&#8217;s revenue arrangements. Often the timing of manufacturing activities changes based on customer needs and resource availability. Government funding appropriations can impact the timing of product deliveries. The success of the Company's development activities that receive development funding support from the USG under development contracts can also impact the timing of revenue recognition.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers accounts receivable and deferred costs associated with revenue generating contracts, which are not included in inventory or property, plant and equipment and that the Company does not currently have a contractual right to bill, to be contract assets. As of June&#160;30, 2023 and December&#160;31, 2022, the Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">had $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-982">30.3</ix:nonFraction> million an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-983">34.8</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, of contract assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> recorded within "Accounts receivable, net" on the Condensed Consolidated Balance Sheets.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract liabilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performance obligations are not transferred to a customer at the end of a reporting period, cash received associated with amounts allocated to those performance obligations is reflected as contract liabilities on the Condensed Consolidated Balance Sheets and is deferred until control of these performance obligations is transferred to the customer. <ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-984" continuedAt="id72425110bb34e6288ed1a6c5ee02e07" escape="true">The following table presents the roll forward of the contract liability balances:</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><ix:continuation id="id72425110bb34e6288ed1a6c5ee02e07"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-985">31.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-986">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.6pt;font-weight:400;line-height:120%">Revenue recognized in the period from amounts included in contract liability at the beginning of the period:</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-987">6.8</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, the current portion of contract liabilities was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-988">14.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-989">26.4</ix:nonFraction>&#160;million, respectively, and was included in "Other current liabilities" on the Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts receivable and allowance for expected credit losses</span></div><ix:nonNumeric contextRef="c-1" name="ebs:ScheduleOfAccountsReceivableNetTableTextBlock" id="f-990" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, including unbilled accounts receivable contract assets, consist of the following:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:61.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Billed</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:BilledContractReceivables" scale="6" id="f-991">238.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:BilledContractReceivables" scale="6" id="f-992">102.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unbilled</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="f-993">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="f-994">56.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowance for expected credit losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-995">0.2</ix:nonFraction>)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-996">0.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-997">290.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-998">158.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for expected credit losses, which represents the estimated aggregate amount of credit risk arising from the inability or unwillingness of specific customers to pay our fees or disputes that may affect our ability to fully collect our billed accounts receivable. We estimate the current-period provision for expected credit losses on a specific identification basis and we consider factors such as the age of the receivables balance, knowledge of the specific customers' circumstances and historical collection experience for similar customers. Accounts receivable, net of the allowance for expected credit losses, represents the amount we expect to collect. Our actual experience may vary from our estimates. At each reporting date, we adjust the allowance for expected credit losses to reflect our current estimate.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-999" continuedAt="i51e96c41e8a54fb4a2897f67b1f62d63" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i51e96c41e8a54fb4a2897f67b1f62d63"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is the lessee for operating leases for offices, R&amp;D facilities and manufacturing facilities. The Company determines if an arrangement is a lease at inception. Operating leases are included in right-of-use assets and liabilities. For a discussion of lessor activities, see Note 13, "Revenue recognition."</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-1000" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:&#160;</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-1001">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-1002">1.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-1003">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-1004">2.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-1005">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-1006">0.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-1007">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-1008">0.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-1009">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-1010">1.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-1011">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-1012">3.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs are reflected as components of cost of product sales, cost of contract development and manufacturing, R&amp;D expense and selling, general and administrative expense.</span></div><ix:nonNumeric contextRef="c-1" name="ebs:AssetsAndLiabilitiesLesseeTableTextBlock" id="f-1013" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to lessee activities is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.583%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.863%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Leases</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1014"><span style="-sec-ix-hidden:f-1015">Other assets</span></span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-1016">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-1017">19.4</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current portion</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1018"><span style="-sec-ix-hidden:f-1019">Other current liabilities</span></span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-1020">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-1021">5.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1022"><span style="-sec-ix-hidden:f-1023">Other liabilities</span></span></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-1024">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-1025">14.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-1026">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-1027">20.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1028">6.3</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1029">5.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1030">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1031">4.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i26b3b087cdd44df68137aa5405612fee_85"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1032" continuedAt="id761935922a14dc98c90b16120965960" escape="true">Income taxes</ix:nonNumeric></span></div><ix:continuation id="id761935922a14dc98c90b16120965960" continuedAt="i80027493562048808b1709640adb0a1f"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated effective annual tax rate for the years ended December&#160;31, 2023 and 2022, excluding the impact of discrete adjustments, was (<ix:nonFraction unitRef="number" contextRef="c-331" decimals="2" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1033">8</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="c-332" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1034">29</ix:nonFraction>%, respectively. The decrease in the estimated effective annual tax rate is primarily due to a valuation allowance charge. The Company recorded a discrete tax expense of $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:fixed-zero" scale="6" id="f-1035">0.0&#160;million</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:fixed-zero" scale="6" id="f-1036">0.0&#160;million</ix:nonFraction> for the three and six months ended June 30, 2023, respectively, and $<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-1037">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-1038">0.6</ix:nonFraction>&#160;million for the three and six months ended June 30, 2022, respectively. The discrete tax expense in 2023 was due to share-based compensation activity which was entirely offset by a valuation allowance charge. The discrete expense in 2022 was primarily due to share-based compensation activity offset by return to provision adjustments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes valuation allowances for deferred income tax assets in accordance with U.S. GAAP, which provides that such valuation allowances shall be established unless realization of the income tax benefits is more likely than not. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. At each reporting period, the Company considers the scheduled reversal of deferred tax liabilities and assets, available taxes in carryback periods, tax planning strategies and projected future taxable income in making this assessment.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i80027493562048808b1709640adb0a1f">In 2022, the Company determined that it was more likely than not that certain deferred tax assets would not be realized due to reductions in estimates of future profitability and disclosure related to substantial doubt about the Company's ability to continue as a going concern. Accordingly, the Company recorded an additional valuation allowance charge of $<ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1039">127.5</ix:nonFraction> million in calculating the estimated annual tax rate for the year ended December&#160;31, 2023.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="f-1040" continuedAt="if2e79ddc595a4a978c1dc83557acd429" escape="true">Litigation</ix:nonNumeric></span></div><ix:continuation id="if2e79ddc595a4a978c1dc83557acd429" continuedAt="i13f2b43e9d9548da9ae1c6ae7688c490"><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Securities and shareholder litigation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the specific legal proceedings and claims described below, unless otherwise noted, the amount or range of possible losses is not reasonably estimable. There can be no assurance that the settlement, resolution, or other outcome of one or more matters, including the matters set forth below, during any subsequent reporting period will not have a material adverse effect on the Company's results of operations or cash flows for that period or on the Company's financial condition.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2021, May 14, 2021, and June 2, 2021, putative class action lawsuits were filed against the Company and certain of its current and former senior officers in the United States District Court for the District of Maryland on behalf of purchasers of the Company&#8217;s common stock, seeking to pursue remedies under the Securities Exchange Act of 1934. These complaints were filed by Palm Tran, Inc. &#8211; Amalgamated Transit Union Local 1577 Pension Plan; Alan I. Roth; and Stephen M. Weiss, respectively. The complaints allege, among other things, that the defendants made false and misleading statements about the Company's manufacturing capabilities with respect to COVID-19 vaccine bulk drug substance (referred to herein as "CDMO Manufacturing Capabilities"). These cases were consolidated on December 23, 2021, under the caption In re Emergent BioSolutions Inc. Securities Litigation, No. 8:21-cv-00955-PWG (the "Federal Securities Class Action"). The Lead Plaintiffs in the consolidated matter are Nova Scotia Health Employees&#8217; Pension Plan and The City of Fort Lauderdale Police &amp; Firefighters&#8217; Retirement System. The defendants filed a motion to dismiss on May 19, 2022 and the Lead Plaintiff filed an opposition to that motion on July 19, 2022. A hearing on the motion to dismiss was conducted on April 19, 2023 and a decision on the motion is expected in the coming months. The defendants believe that the allegations in the complaints are without merit and intend to defend the matters vigorously. Given the uncertainty of litigation, the preliminary stage of the cases, and the legal standards that must be met for, among other things, class certification and success on the merits, the Company cannot reasonably estimate the possible loss or range of loss, if any, that may result from the consolidated action.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2021, Lincolnshire Police Pension Fund (&#8220;Lincolnshire&#8221;), and on August 16, 2021, Pooja Sayal, filed putative shareholder derivative lawsuits in the United States District Court for the District of Maryland on behalf of the Company against certain of the Company's current and former officers and directors for breach of fiduciary duties, waste of corporate assets, and unjust enrichment, each allegation related to the CDMO Manufacturing Capabilities. In addition to monetary damages, the complaints seek the implementation of multiple corporate governance and internal policy changes. On November 16, 2021, the cases were consolidated under the caption In re Emergent BioSolutions Inc. Stockholder Derivative Litigation, Master Case No. 8:21-cv-01595-PWG. On January 3, 2022, the Lincolnshire complaint was designated as the operative complaint in the consolidated action. On April 13, 2022 the Court approved the parties' joint stipulation to and stay of the proceedings and discovery until the close of fact discovery in the Federal Securities Class Action. The defendants believe that the allegations in the complaints are without merit and intend to defend the matter vigorously.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 15, 2021, September 16, 2021 and November 12, 2021, putative shareholder derivative lawsuits were filed by Chang Kyum Kim, Mark Nevins and Employees Retirement System of the State of Rhode Island, North Collier Fire Control and Rescue District Firefighters Pension Plan, and Pembroke Pines Firefighters &amp; Police Officers Pension Fund, respectively, in The Court of Chancery of the State of Delaware on behalf of the Company against certain of its current and former officers and directors for breach of fiduciary duties, unjust enrichment and insider trading, each allegation related to the CDMO Manufacturing Capabilities. In addition to monetary damages, the complaints seek the implementation of multiple corporate governance and internal policy changes. On February 2, 2022, the cases were consolidated under the caption In re Emergent BioSolutions, Inc. Derivative Litigation, C.A. No. 2021-0974-MTZ with the institutional investors as co-lead plaintiffs. On March 4, 2022, the defendants&#8217; filed a motion to dismiss the complaint. Ruling on this motion is stayed pursuant to a March 29, 2022 order staying all proceedings pending a final, non-appealable judgment in the Federal Securities Class Action.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2021, December 22, 2021 and January 18, 2022, putative shareholder derivative lawsuits were filed by Zachary Elton, Eric White and Jeffrey Reynolds in the Circuit Court for Montgomery County, Maryland on behalf of the Company against certain of its current and former officers and directors for breach of fiduciary duty, unjust enrichment, waste of corporate assets, failing to maintain internal controls, making or causing to be made false and/or misleading statements and material omissions, insider trading and otherwise violating the federal securities laws, each allegation related to the CDMO Manufacturing Capabilities. The complaints seek monetary and punitive damages. On February 22, 2022, the Court entered an order consolidating these actions under case number C-15-21-CV-000496. On March 9, 2022, the parties filed a Joint Stipulation of Stay of Proceedings and Discovery, pursuant to which the parties agreed to stay all proceedings until 30 calendar days after a ruling on the defendants&#8217; motion to dismiss the Federal Securities Class Action. The Court approved the Joint Stipulation on March 14, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i13f2b43e9d9548da9ae1c6ae7688c490">In addition to the above actions, the Company has received inquiries and subpoenas to produce documents related to these matters from the Department of Justice, the SEC, the Maryland Attorney General&#8217;s Office, and the New York Attorney General&#8217;s Office. The Company produced or is producing documents as required in response and will continue to cooperate with these government inquiries. The Company also received inquiries and subpoenas from Representative Carolyn Maloney and Representative Jim Clyburn, members of the House Committee on Oversight and Reform and the Select Subcommittee on the Coronavirus Crisis and Senator Murray of the Committee on Health, Education, Labor and Pensions. The Company produced documents and provided testimony and briefings as requested in response to these inquiries.</ix:continuation></span></div><div id="i26b3b087cdd44df68137aa5405612fee_91"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1041" continuedAt="i65f6e5a003d94fdba47ae3f1c777d087" escape="true">Segment information</ix:nonNumeric></span></div><ix:continuation id="i65f6e5a003d94fdba47ae3f1c777d087" continuedAt="ie676f3c7241d497882686a7c1c314521"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-1042" escape="true">The Company reports segment information based on the internal reporting used by management for making decisions and assessing performance. We manage our business with a focus on <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" id="f-1043"><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" id="f-1044">two</ix:nonFraction></ix:nonFraction> reportable segments. Our Products segment, which includes the Anthrax - MCM products, NARCAN products, Smallpox - MCM products and Other products, and our Services segment consisting of our CDMO services. The Company evaluates the performance of these reportable segments based on revenue and Adjusted Gross Margin, which is a non-GAAP financial measure. Segment revenue includes external customer sales, but it does not include inter-segment services. The Company defines Adjusted Gross Margin as segment revenue less segment cost of sales reduced for significant restructuring events, inventory step-up provisions and changes in fair value of contingent consideration. The Company does not allocate research and development, selling, general and administrative costs, amortization of intangibles assets, interest and other income (expense) or taxes to operating segments in the management reporting reviewed by the chief operating decision maker ("CODM"). The accounting policies for segment reporting are the same as for the Company as a whole.</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its assets on a total company basis, not by operating segment, as the Company's operating assets are shared or commingled. Therefore, the Company's CODM does not regularly review any asset information by operating segment and, accordingly, the Company does not report asset information by operating segment.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ie676f3c7241d497882686a7c1c314521" continuedAt="i4c934c0a39b74aad83015da4f37ab292"><ix:nonNumeric contextRef="c-1" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="f-1045" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes segment revenues and a reconciliation of the Company's segment adjusted gross margin to the consolidated statement of operations for each of the Company's reporting segments:</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.281%"><tr><td style="width:1.0%"></td><td style="width:42.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues:</span></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1046">302.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1047">237.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1048">445.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1049">474.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1050">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" sign="-" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1051">1.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1052">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1053">59.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total segment revenues</span></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1054">331.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1055">235.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1056">489.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-5" name="ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1057">533.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants revenues</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1058">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1059">7.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1060">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1061">16.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-1062">337.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-1063">242.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-1064">503.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-1065">550.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Less: Cost of sales:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Products</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1066">134.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1067">91.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1068">237.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1069">171.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Services</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1070">55.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1071">78.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1072">107.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1073">154.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cost of sales</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1074">190.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1075">169.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1076">345.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1077">325.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-1078">167.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-1079">146.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-1080">207.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-1081">303.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" sign="-" name="us-gaap:GrossProfit" scale="6" id="f-1082">26.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" sign="-" name="us-gaap:GrossProfit" scale="6" id="f-1083">80.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" sign="-" name="us-gaap:GrossProfit" scale="6" id="f-1084">63.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-5" sign="-" name="us-gaap:GrossProfit" scale="6" id="f-1085">95.4</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-1086">140.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-1087">65.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-1088">144.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-1089">207.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjustments to gross margin:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in fair value of contingent consideration</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-1090">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-1091">1.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-1092">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-1093">1.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring costs</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="6" id="f-1094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="6" id="f-1095">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="us-gaap:RestructuringCosts" scale="6" id="f-1096">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="6" id="f-1097">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory step-up provision</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="ebs:InventoryStepUp" scale="6" id="f-1098">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="ebs:InventoryStepUp" format="ixt:fixed-zero" scale="6" id="f-1099">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="ebs:InventoryStepUp" scale="6" id="f-1100">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="ebs:InventoryStepUp" format="ixt:fixed-zero" scale="6" id="f-1101">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products adjusted gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="ebs:AdjustedGrossMargin" scale="6" id="f-1102">169.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="ebs:AdjustedGrossMargin" scale="6" id="f-1103">147.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="ebs:AdjustedGrossMargin" scale="6" id="f-1104">213.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="ebs:AdjustedGrossMargin" scale="6" id="f-1105">304.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services adjusted gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" sign="-" name="ebs:AdjustedGrossMargin" scale="6" id="f-1106">26.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" sign="-" name="ebs:AdjustedGrossMargin" scale="6" id="f-1107">80.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" sign="-" name="ebs:AdjustedGrossMargin" scale="6" id="f-1108">63.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-5" sign="-" name="ebs:AdjustedGrossMargin" scale="6" id="f-1109">95.4</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated adjusted gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="ebs:AdjustedGrossMargin" scale="6" id="f-1110">143.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="ebs:AdjustedGrossMargin" scale="6" id="f-1111">66.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ebs:AdjustedGrossMargin" scale="6" id="f-1112">150.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="ebs:AdjustedGrossMargin" scale="6" id="f-1113">209.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other reconciling items:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants revenue</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1114">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1115">7.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1116">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1117">16.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to gross margin</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="ebs:GrossProfitAdjustments" scale="6" id="f-1118">2.3</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="ebs:GrossProfitAdjustments" scale="6" id="f-1119">1.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="ebs:GrossProfitAdjustments" scale="6" id="f-1120">5.8</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="ebs:GrossProfitAdjustments" scale="6" id="f-1121">1.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-1122">306.7</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 10pt 0 1pt;text-indent:-9pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-1123">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="f-1124">306.7</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="f-1125">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1126">26.0</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1127">49.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1128">66.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1129">96.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-1130">91.4</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-1131">81.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-1132">191.9</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-1133">165.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1134">16.1</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1135">14.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1136">33.1</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1137">28.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-1138">28.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-1139">7.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-1140">46.5</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-1141">16.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of business</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="f-1142">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 10pt 0 1pt;text-indent:-9pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="f-1143">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="f-1144">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="f-1145">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1146">3.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1147">3.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1148">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1149">5.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss before income taxes</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1150">250.2</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1151">82.8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1152">411.3</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1153">86.6</ix:nonFraction>)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Total segment revenues less total cost of sales.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Consolidated gross margin plus adjustments to gross margin.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i4c934c0a39b74aad83015da4f37ab292"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1154" escape="true"><div style="margin-bottom:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes depreciation expense for each segment:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:41.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.572%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation:</span></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1155">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1156">6.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1157">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1158">14.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1159">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1160">20.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1161">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1162">28.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1163">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1164">1.0</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1165">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1166">2.4</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1167">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1168">28.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1169">34.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-1170">45.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i26b3b087cdd44df68137aa5405612fee_97"></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1171" continuedAt="ib5abf92c99fd4ed9b1b1ed6fedbf93cc" escape="true">Subsequent events</ix:nonNumeric></span></div><ix:continuation id="ib5abf92c99fd4ed9b1b1ed6fedbf93cc"><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">FDA Approval of CYFENDUS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2023, the FDA approved CYFENDUS&#8482; for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. In December 2018, CYFENDUS vaccine was the subject of a pre-emergency use authorization package submitted to the FDA. The following year, the USG began procuring this product for national preparedness efforts.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Ebanga Procurement Contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2023, the Company was awarded a <ix:nonNumeric contextRef="c-349" name="ebs:RevenueFromContractWithCustomerTermOfContract" format="ixt-sec:durwordsen" id="f-1172">10-year</ix:nonNumeric> contract by the Biomedical Advanced Research and Development Authority ("BARDA") for advanced development, manufacturing scale-up, and procurement of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> treatment for Ebola. The contract consists of a base period of performance with <ix:nonFraction unitRef="productcandidate" contextRef="c-350" decimals="INF" name="ebs:RevenueFromContractWithCustomerNumberOfOptionPeriods" format="ixt-sec:numwordsen" id="f-1173">two</ix:nonFraction> option periods valued at approximately $<ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-1174">121</ix:nonFraction>&#160;million, and <ix:nonFraction unitRef="productcandidate" contextRef="c-352" decimals="INF" name="ebs:RevenueFromContractWithCustomerNumberOfOptionPeriods" format="ixt-sec:numwordsen" id="f-1175">five</ix:nonFraction> option periods for procurement of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over <ix:nonNumeric contextRef="c-352" name="ebs:RevenueFromContractWithCustomerTermOfContract" format="ixt-sec:durwordsen" id="f-1176">five years</ix:nonNumeric> valued at up to $<ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-1177">583</ix:nonFraction>&#160;million. If all option periods are exercised, the total contract value will be valued at up to approximately $<ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-1178">704</ix:nonFraction>&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emergent is responsible for the manufacturing, sale and distribution of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and Canada pursuant to a collaboration agreement with Ridgeback, the developer of the treatment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, Emergent will pay Ridgeback $<ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1179">6.3</ix:nonFraction>&#160;million in contingent consideration as a result of the award of the BARDA contract payable in the third quarter of 2023. In addition, the Company could owe up to $<ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-5" name="ebs:RevenueRemainingPerformanceObligationVariableConsiderationAmount" format="ixt:num-dot-decimal" scale="6" id="f-1180">50.4</ix:nonFraction>&#160;million in contingent consideration to Ridgeback if activities under the awarded contract have not ceased by June 1, 2026.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">August 2023 Organizational Restructuring Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2023, The Company announced an organizational restructuring plan (the &#8220;August 2023 Plan&#8221;) intended to strengthen its core business and financial position by reducing investment in and de-emphasizing focus on its CDMO services business for future growth. The August 2023 Plan includes a reduction of the Company&#8217;s current workforce by approximately <ix:nonFraction unitRef="employee" contextRef="c-357" decimals="INF" name="us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" scale="0" id="f-1181">400</ix:nonFraction> employees. Decisions regarding the elimination of positions are subject to local law and consultation requirements in certain countries, as well as the Company&#8217;s business needs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates that it will incur approximately $<ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-5" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="f-1182">19.0</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-5" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="f-1183">21.0</ix:nonFraction>&#160;million in charges in connection with the August 2023 Plan, which it expects to incur in the third quarter of fiscal 2023. These charges consist primarily of cash charges related to severance (base bonus), transition services, and estimated benefits cost.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimates of the charges and expenditures that the Company expects to incur in connection with the August 2023 Plan, and the timing thereof, are subject to a number of assumptions, including local law requirements in various jurisdictions, and actual amounts may differ materially from estimates. In addition, the Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the August 2023 Plan.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_100"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and accompanying notes and other financial information included elsewhere in this quarterly report on Form 10-Q and our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022. Some of the information contained in this discussion and analysis or set forth elsewhere in this quarterly report on Form 10-Q, includes information with respect to our plans and strategy for our business and financing, as well as forward-looking statements that involve risks and uncertainties. You should carefully review the "Special Note Regarding Forward-Looking Statements" section of this Quarterly Report on Form 10-Q and the "Risk Factor Summary" and "Risk Factors" sections in Part I, Item 1A of our Annual Report on Form 10-K for our fiscal year ended December 31, 2022 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></div><div id="i26b3b087cdd44df68137aa5405612fee_103"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS OVERVIEW</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emergent BioSolutions Inc. (&#8220;Emergent,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) is a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate, and naturally occurring Public Health Threats ("PHTs"). The Company's solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing ("CDMO") services portfolio.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently focused on the following four PHT categories: chemical, biological, radiological, nuclear and explosives ("CBRNE"); emerging infectious diseases ("EID"); public health crises; and acute, emergency and community care. We have a product portfolio of 12 products that contribute a substantial portion of our revenue and are sold to government and commercial customers. Additionally, we have a development pipeline consisting of a diversified mix of both pre-clinical and clinical stage product candidates. Finally, we have a fully integrated portfolio of CDMO services. Our CDMO service offerings cover development services, drug substance manufacturing and drug product manufacturing and packaging. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company structures the business with a focus on markets and customers. As such, the key components of the business structure include the following four product and service categories: Anthrax - Medical Countermeasures ("MCM") Products, NARCAN, Smallpox - MCM products and CDMO Services. The Company operates as two operating segments: (1) a products segment ("Products") consisting of the Anthrax - MCM, NARCAN, Smallpox - MCM and Other products and (2) a services segment ("Services") consisting of our CDMO services.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products Segment:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our product revenue comes from the following products and procured product candidates:</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Anthrax - MCM Products</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Anthrasil</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Anthrax Immune Globulin Intravenous (human)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada for the treatment of inhalational anthrax in combination with appropriate antibacterial drugs;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">BioThrax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Anthrax Vaccine Adsorbed), the only vaccine licensed by the FDA for the general use prophylaxis and post-exposure prophylaxis of anthrax disease;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">CYFENDUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Anthrax vaccine adsorbed (AVA), adjuvanted), previously known as AV7909, which was recently approved by the FDA for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. CYFENDUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is procured by certain authorized government buyers for their use; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Raxibacumab injection, the first fully human monoclonal antibody therapeutic licensed by the FDA for the treatment and prophylaxis of inhalational anthrax.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">NARCAN</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">NARCAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone approved by the FDA (including in over-the-counter form) and Health Canada for the emergency treatment&#160;of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Smallpox - MCM Products</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">ACAM2000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (Smallpox (Vaccinia) Vaccine, Live), the only single-dose smallpox vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">CNJ-016</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Vaccinia Immune Globulin Intravenous (Human) (VIGIV)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada to address certain complications from smallpox vaccination; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">TEMBEXA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an oral antiviral formulated as 100 mg tablets and 10 mg/mL oral suspension dosed once weekly for two weeks which has been approved by the FDA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients, including neonates.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Products</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">BAT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)), the only heptavalent antitoxin licensed by the FDA and Health Canada for the treatment of symptomatic botulism; </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Ebanga&#8482; (ansuvimab-zykl), a monoclonal antibody with antiviral activity provided through a single IV infusion for the treatment of Ebola. Under the terms of a collaboration with Ridgeback Biotherapeutics ("Ridgeback"). Emergent will be responsible for the manufacturing, sale, and distribution of Ebanga&#8482; in the U.S. and Canada, and Ridgeback will serve as the global access partner for Ebanga&#8482;;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">RSDL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Reactive Skin Decontamination Lotion Kit), the only medical device cleared by the FDA that is intended to remove or neutralize chemical warfare agents from the skin, including: tabun, sarin, soman, cyclohexyl sarin, VR, VX, mustard gas and T-2 toxin; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Trobigard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> atropine sulfate, obidoxime chloride auto-injector, a combination drug-device auto-injector procured product candidate that contains atropine sulfate and obidoxime chloride. It was approved in Belgium in 2021 but has not been approved by the FDA. Trobigard is procured by certain authorized government buyers under special circumstances for potential use as a nerve agent countermeasure outside of the U.S.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services Segment:</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Services - Contract Development and Manufacturing</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our services revenue consists of distinct but interrelated CDMO services: drug substance manufacturing; drug product manufacturing (also referred to as "fill/finish" services) and packaging; development services including technology transfer, process and analytical development services; and, when necessary, suite reservation obligations. These services, which we refer to as "molecule-to-market" offerings, employ diverse technology platforms (mammalian, microbial, viral and plasma) across a network of nine geographically distinct development and manufacturing sites operated by us for our internal products and pipeline candidates and third-party CDMO services. We service both clinical-stage and commercial-stage projects for a variety of third-party customers, including government agencies, innovative pharmaceutical companies, and non-government organizations.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Strategic Activities</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">January 2023 Organizational Restructuring Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company initiated an organizational restructuring plan (the &#8220;January 2023 Plan&#8221;) intended to reduce operating costs, improve operating margins, and continue advancing the Company&#8217;s ongoing commitment to profitable growth. As part of the January 2023 Plan, the Company eliminated approximately five percent of its total headcount. The Company incurred approximately $9.6&#160;million in charges in connection with the January 2023 Plan during the six months ended June 30, 2023. These charges consist primarily of charges related to employee transition, severance payments and employee benefits. All activities related to the January 2023 Plan were substantially completed during the first quarter of 2023.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Travel Health Business to Bavarian Nordic</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;15, 2023, pursuant to the Purchase and Sale Agreement (the "Purchase and Sale Agreement"), by and between the Company, through its wholly owned subsidiaries Emergent International Inc. and Emergent Travel Health Inc., and Bavarian Nordic, the Company completed the previously announced sale of the Company's travel health business, including rights to Vivotif</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the licensed typhoid vaccine; Vaxchora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the licensed cholera vaccine; the development-stage chikungunya vaccine candidate CHIKV VLP; the Company&#8217;s manufacturing site in Bern, Switzerland; and certain of its development facilities in San Diego, California.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing, Bavarian Nordic paid a cash purchase price of $270.0&#160;million, exclusive of customary closing adjustments for cash, indebtedness, working capital and transaction expenses of the business at closing. Bavarian Nordic may also be required to pay milestone payments of up to $80.0&#160;million related to the development of CHIKV VLP and receipt of marketing approval and authorization in the U.S. and Europe, and earn-out payments of up to $30.0&#160;million based on aggregate net sales of Vaxchora and Vivotif in calendar year 2026.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the divestiture, the Company recognized a pre-tax gain of $74.9&#160;million during the quarter, net of transaction costs of $4.0&#160;million, which was recorded within "Gain on sale of business" on the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">FDA Approval of CYFENDUS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2023, the FDA approved CYFENDUS&#8482; for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. In December 2018, CYFENDUS vaccine was the subject of a pre-emergency use authorization package submitted to the FDA. The following year, the USG began procuring this product for national preparedness efforts.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Ebanga Procurement Contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2023, the Company was awarded a 10-year contract by the Biomedical Advanced Research and Development Authority ("BARDA") for advanced development, manufacturing scale-up, and procurement of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> treatment for Ebola. The contract consists of a base period of performance with two option periods valued at approximately $121&#160;million, and five option periods for procurement of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over five years valued at up to $583&#160;million. If all option periods are exercised, the total contract value will be valued at up to approximately $704&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emergent is responsible for the manufacturing, sale, and distribution of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and Canada pursuant to a collaboration agreement with Ridgeback, the developer of the treatment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, Emergent will pay Ridgeback $6.3&#160;million in contingent consideration as a result of the award of the BARDA contract payable in the third quarter of 2023. In addition, the Company could owe up to $50.4&#160;million in contingent consideration to Ridgeback if activities under the awarded contract have not ceased by June 1, 2026. </span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Impairment of long-lived assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests its long-lived assets that are held and used for recoverability whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. During the preparation of our financial statements for the three months ended June&#160;30, 2023, due to deterioration in performance and resulting downward revisions to our internal CDMO forecast made during the second quarter, including future expected cash flows, the Company determined there were sufficient indicators of impairment on certain asset groups within the CDMO reporting unit to require an impairment analysis. As a result, the Company performed recoverability tests on certain asset groups within the CDMO reporting unit and concluded that the impacted asset groups were not recoverable as the undiscounted expected cash flows did not exceed their carrying values. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset groups are written down only to the extent that their carrying value is higher than their respective fair value. The Company, with the assistance of a third-party valuation firm, applied valuation methods to estimate the fair values for each of the assets within the different asset classes. An orderly liquidation value was applied to estimate the fair value of the personal property assets and market and cost based approaches were applied to estimate the fair value of the real property assets, each representing Level 3 non-recurring fair value measurements. Based on this analysis, the Company allocated and recognized a non-cash impairment charge of $306.7&#160;million during the three months ended June&#160;30, 2023.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">August 2023 Organizational Restructuring Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2023, The Company announced an organizational restructuring plan (the &#8220;August 2023 Plan&#8221;) intended to strengthen its core business and financial position by reducing investment in and de-emphasizing focus on its CDMO services business for future growth. The August 2023 Plan includes a reduction of the Company&#8217;s current workforce by approximately 400 employees. Decisions regarding the elimination of positions are subject to local law and consultation requirements in certain countries, as well as the Company&#8217;s business needs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates that it will incur approximately $19.0&#160;million to $21.0&#160;million in charges in connection with the August 2023 Plan, which it expects to incur in the third quarter of fiscal 2023. These charges consist primarily of cash charges related to severance (base bonus), transition services, and estimated benefits cost.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimates of the charges and expenditures that the Company expects to incur in connection with the August 2023 Plan, and the timing thereof, are subject to a number of assumptions, including local law requirements in various jurisdictions, and actual amounts may differ materially from estimates. In addition, the Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the August 2023 Plan.</span></div><div id="i26b3b087cdd44df68137aa5405612fee_109"></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL OPERATIONS OVERVIEW</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Revenues</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate product revenues from the sale of our marketed products and procured product candidates. The U.S. Government ("USG") is the largest purchaser of our Government - MCM products and primarily purchases our products for the Strategic National Stockpile ("SNS"), a national repository of medical countermeasures including critical antibiotics, vaccines, chemical antidotes, antitoxins, and other critical medical supplies. The USG primarily purchases our products under long-term, firm fixed-price procurement contracts, generally with annual options. Our opioid overdose treatment product, NARCAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nasal Spray, is sold commercially through wholesalers and distributors, physician-directed or standing order prescriptions at retail pharmacies and to state and local community healthcare agencies, practitioners and hospitals.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also generate revenue from our CDMO services, which is based on our established development and manufacturing infrastructure, technology platforms and expertise. Our services include a fully integrated molecule-to-market CDMO services business offering across development </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services, drug substance and drug product for small to large pharmaceutical and biotechnology industry and government agencies/non-governmental organizations. From time to time, clients require suite reservations at our various manufacturing sites, which may be considered leases depending on the facts and circumstances.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received contracts and grant funding from the USG and other non-governmental organizations to perform research and development ("R&amp;D") activities, particularly related to programs addressing certain CBRNE threats and EIDs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue, operating results and profitability vary quarterly based on the timing of production and deliveries, the timing of manufacturing services performed and the nature of our business, which involves providing large scale bundles of products and services as needs arise. We expect continued variability in our quarterly financial results.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cost of product sales and CDMO services</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The primary expenses that we incur to deliver our products consist of fixed and variable costs. We determine the cost of product sales for products sold during a reporting period based on the average manufacturing cost per unit in the period those units were manufactured. Fixed manufacturing costs include facilities and utilities costs. Variable </span><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacturing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> costs primarily consist of costs for materials and personnel-related expenses for direct and indirect manufacturing support staff, contract manufacturing operations, sales-based royalties, shipping and logistics. In addition to the fixed and variable manufacturing costs described above, the cost of product sales depends on utilization of available manufacturing capacity. For our commercial sales, other associated expenses include sales-based royalties (which include fair value adjustments associated with contingent consideration), shipping, and logistics.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The primary expenses that we incur to deliver our CDMO services consist of fixed and variable costs, including personnel, equipment, and facilities costs. Our manufacturing process includes the production of bulk material and performing drug product work for containment and distribution of biological products. For drug product customers, we receive work in process inventory to be prepared for distribution. </span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">R&amp;D expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense R&amp;D costs as incurred. Our R&amp;D expenses consist primarily of:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">personnel-related expenses;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">fees to professional service providers for, among other things, analytical testing, independent monitoring or other administration of our clinical trials and obtaining and evaluating data from our clinical trials and non-clinical studies;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">costs of CDMO services for our clinical trial material; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">costs of materials intended for use and used in clinical trials and R&amp;D.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In many cases, we seek funding for development activities from external sources and third parties, such as governments and non-governmental organizations, or through collaborative partnerships. We expect our R&amp;D spending will be dependent upon such factors as the results from our clinical trials, the availability of reimbursement of R&amp;D spending, the number of product </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">candidates under development, the size, structure and duration of any clinical programs that we may initiate, the costs associated with manufacturing and development of our product candidates on a large-scale basis for later stage clinical trials, and our ability to use or rely on data generated by government agencies.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Selling, general and administrative expenses</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses consist primarily of personnel-related costs and professional fees in support of our executives, sales and marketing, business development, government affairs, finance, accounting, information technology, legal, human resource functions and other corporate functions. Other costs include facility costs not otherwise included in cost of product sales and CDMO services or R&amp;D expense.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Income taxes</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertainty in income taxes is accounted for using a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. We recognize in our financial statements the impact of a tax position if that position is more likely than not of being sustained on audit, based on the technical merits of the position.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the assumptions and estimates related to the provision for income taxes are critical to the Company&#8217;s results of operations. </span></div><div id="i26b3b087cdd44df68137aa5405612fee_112"></div><div style="margin-bottom:7pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the U.S., requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and exp</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enses. Actual results may differ from these estimates. There have been no significant changes to our critical accounting policies and estimates contained in "Critical Accounting Policies and Estimates" in the Management's Discussion and Analysis, in Part II, Item 7, of our Annual Report on Form 10-K for the year ended December&#160;31, 2022, as filed with the SEC.</span></div><div style="margin-bottom:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New accounting standards</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of new accounting standards please see Note 2, "Summary of significant accounting policies", in Part I item 1, of this Quarterly Report on Form 10-Q. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_115"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.377%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.377%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.377%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.089%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.377%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.377%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="21" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="21" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(in millions, except %)</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">$ Change</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">% Change</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">$ Change</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product sales, net:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#1b51bf;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 20.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthrax MCM</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.2&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(78)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(162.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(79)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 20.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NARCAN</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">234.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 20.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smallpox MCM</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 20.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Products sales</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.2&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 38.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total product sales, net</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302.2&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">445.6&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">474.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.7)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract development and manufacturing ("CDMO"):</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total CDMO revenues</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14.7)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 38.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">337.9&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">242.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">503.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">550.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(47.2)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product sales</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of CDMO</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">630.8&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">314.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">316.1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">944.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">615.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">328.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(292.9)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(220.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(441.0)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(65.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(375.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other income (expense):</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.6)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46.5)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of business</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.6)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53.5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21.0)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(250.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(82.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(167.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(411.3)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(86.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(324.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision (benefit)</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(261.3)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(56.4)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(204.9)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(444.3)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(60.1)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(384.2)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr style="height:8pt"><td colspan="48" style="padding:0 1pt"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM - Not meaningful</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023 Compared with Three Months Ended June 30, 2022</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues and gross margin</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues increased $95.2 million, or 39%, to $337.9 million for the three months ended June&#160;30, 2023. The increase was due to increases in Products revenue of $65.0 million and Services revenue of $30.9 million, partially offset by a decrease in Contracts and grants revenue of $0.7 million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated gross margin increased $75.1 million, or 114%, to $140.7 million for the three months ended June&#160;30, 2023. Consolidated gross margin percentage increased 15 percentage points to 42.5% for the three months ended June&#160;30, 2023. These increases were due to increases in Products gross margin of $21.1 million and Services gross margin of $54.0 million. Consolidated gross margin percentage excludes contracts and grants revenues because the related costs are R&amp;D expenses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See "Segment Results" for an expanded discussion of revenues and gross profit margin.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of long-lived assets</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a non-cash impairment charge of $306.7&#160;million during the three months ended June&#160;30, 2023 related to certain asset groups within our CDMO reporting unit. The asset groups were written down only to the extent their carrying value was higher than their respective fair values. The Company, with the assistance of a third-party valuation firm, applied valuation methods to estimate the fair values for each of the assets within the different asset classes to determine the amount of the impairment. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to recording the impairment charge, the Company performed recoverability tests on the impacted asset groups within the CDMO reporting unit and concluded that the asset groups were not recoverable as the undiscounted expected cash flows did not exceed their carrying values. The indicators for the impairment were related to the deterioration in performance and resulting downward revisions to our internal CDMO forecasts, including future expected cash flows, that took place during the preparation of our financial statements for the three months ended June&#160;30, 2023.</span></div><div style="margin-bottom:7pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unallocated corporate operating expenses</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">R&amp;D expenses</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses decreased $23.8&#160;million, or 48%, to $26.0&#160;million for the three months ended June&#160;30, 2023. The decrease was primarily due to the sale of our development program for CHIKV VLP to Bavarian Nordic, which was a significant contributor to prior period R&amp;D expense. </span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selling, general and administrative expenses </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased $10.3&#160;million, or 13%, to $91.4&#160;million for the three months ended June&#160;30, 2023. The increase was primarily due to higher professional services fees related to general corporate initiatives, including organizational transformation consulting fees and legal remediation services fees. Selling, general and administrative costs as a percentage of total revenue decreased 6.4% to 27.0% for the three months ended June&#160;30, 2023. </span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amortization of intangible assets</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets increased $2.1&#160;million, or 15%, to $16.1&#160;million for the three months ended June&#160;30, 2023. The increase was primarily due to amortization expense for intangible assets related to TEMBEXA, which was newly acquired in the third quarter of 2022 and did not factor into the prior period. The increase was partially offset by a decrease in amortization expense resulting from the intangibles sold with our travel health business to Bavarian Nordic.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $20.8&#160;million to $28.6&#160;million for the three months ended June&#160;30, 2023. The increase was primarily due to higher interest costs related to our syndicated borrowings and one-time debt service costs attributable to the negotiation of the Credit Agreement Amendment, partially offset by a decrease related to the termination of our interest rate swap hedging agreements.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on sale of business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of business was $74.9&#160;million for the three months ended June&#160;30, 2023, which was attributable to the sale of our travel health business to Bavarian Nordic on May 15, 2023. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other, net</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net increased $0.6&#160;million to $3.6&#160;million in expense for the three months ended June&#160;30, 2023. The increase was primarily due to a decrease in interest income due to lower cash balances, partially offset by an increase from favorable foreign exchange revaluations.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax provision (benefit)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision increased $37.5&#160;million to $11.1&#160;million for the three months ended June&#160;30, 2023. The increase was primarily due to a valuation allowance charge.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2023 Compared with Six Months Ended June 30, 2022</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues and gross margin</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues decreased $47.2 million, or 9%, to $503.0 million for the six months ended June 30, 2023. The decrease was due to declines in Total product sales of $28.7 million, Services revenue of $14.7 million and contracts and grants revenue of $3.8 million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated gross margin decreased $63.4 million, or 31%, to $144.2 million for the six months ended June 30, 2023. Consolidated gross margin percentage decreased 9 percentage points to 29.4% for the six months ended June 30, 2023. The decrease was due to a decrease in Products gross margin of $95.2 million, partially offset by an increase in Services gross margin of $31.8 million. Consolidated gross margin percentage excludes contracts and grants revenues because the related costs are R&amp;D expenses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See "Segment Results" for an expanded discussion of revenues and gross profit margin.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of long-lived assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, we recognized a non-cash impairment charge of $306.7 million. See the three months ended June&#160;30, 2023 explanation above for more details related to the reason for the impairment charge.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unallocated corporate operating expenses</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">R&amp;D expenses</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses decreased $29.6&#160;million, or 31%, to $66.6&#160;million for the six months ended June 30, 2023. The decrease was primarily due to the sale of our development program for CHIKV VLP to Bavarian Nordic, which was a significant contributor to prior period R&amp;D expense. </span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selling, general and administrative expenses </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased $26.0&#160;million, or 16%, to $191.9&#160;million for the six months ended June 30, 2023. The increase was primarily due to higher professional services fees related to general corporate initiatives, including organizational transformation consulting fees and legal remediation services fees. Selling, general and administrative costs as a percentage of total revenue increased 8.0% to 38.2% for the six months ended June 30, 2023.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amortization of intangible assets</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets increased $5.1&#160;million, or 18%, to $33.1&#160;million for the six months ended June 30, 2023. The increase was primarily due to amortization expense for intangible assets related to TEMBEXA, which was acquired in the third quarter of 2022 and did not factor into the prior period. The increase was partially offset by a decrease in amortization expense resulting from the intangibles sold with our travel health business to Bavarian Nordic.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $30.5&#160;million, or 191%, to $46.5&#160;million for the six months ended June 30, 2023. The increase was primarily due to higher interest costs related to our syndicated borrowings and one-time debt service costs attributable to the negotiation of the Credit Agreement Amendment, partially offset by a decrease related to the termination of our interest rate swap hedging agreements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other, net</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net decreased $6.3&#160;million to $1.3&#160;million in income for the six months ended June 30, 2023. The decrease was primarily due to higher interest rates, partially offset by lower average cash balances during the period.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on sale of business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of business was $74.9&#160;million for the six months ended June 30, 2023, which was attributable to the sale of our travel health business to Bavarian Nordic on May 15, 2023. </span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax provision (benefit)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision increased $59.5&#160;million to $33.0&#160;million for the six months ended June 30, 2023. The increase was largely due to the decline in income before income taxes and a valuation allowance charge in the second quarter of 2023. The effective tax rate was (8)% for the six months ended June 30, 2023 as compared with 31% in 2022. The effective annual tax rate decreased largely due to a valuation charge. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEGMENT RESULTS</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCTS SEGMENT</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">&#160;&#160;</span></td><td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Products Segment</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June&#160;30,</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in millions)</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">% Change</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales, net</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302.2&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">445.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">474.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of sales</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Changes in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Restructuring costs</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Inventory step-up provision</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted cost of sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.6&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">232.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169.5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">303.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross margin % </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">213.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">304.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted gross margin % </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="36" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted cost of sales, which is a non-GAAP financial measure, is calculated as cost of sales less restructuring costs and other special items and non-cash items related to changes in fair value of contingent consideration and inventory step-up provision. The Company's management utilizes Adjusted cost of sales for purposes of evaluating our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP operating measure, when reviewed collectively with our GAAP financial information, provides useful supplementary information to investors in assessing our operating performance.</span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin is calculated as revenues less cost of sales. Gross margin % is calculated as gross margin divided by revenues. </span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Adjusted gross margin, which is a non-GAAP financial measure, is calculated as revenues less Adjusted cost of sales. Adjusted gross margin %, which is a non-GAAP financial measure, is calculated as Adjusted gross margin divided by revenues. The Company&#8217;s management utilizes Adjusted gross margin and Adjusted gross margin % for purposes of evaluating our ongoing operations and for internal planning and forecasting purposes. We believe that these non-GAAP operating measures, when reviewed collectively with our GAAP financial information, provide useful supplemental information to investors in assessing our operating performance.</span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM - Not meaningful</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023 Compared with Three Months Ended June 30, 2022</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Anthrax MCM </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthrax MCM sales decreased $74.6&#160;million, or 78%, to $21.2 million for the three months ended June&#160;30, 2023. The decrease reflects the impact of timing of sales related to CYFENDUS and BioThrax, partially offset by an increase in Anthrasil sales. Anthrax vaccine product sales are primarily made under annual purchase options exercised by the USG. Fluctuations in revenues result from the timing of the exercise of annual purchase options, the timing of USG purchases, the availability of governmental funding and Company delivery of orders that follow.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">NARCAN</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NARCAN sales increased $32.3&#160;million, or 32%, to $133.9&#160;million for the three months ended June&#160;30, 2023. The increase was primarily driven by higher branded NARCAN sales to U.S. public interest channels and Canadian retail sales, partially offset by the cessation of authorized generic NARCAN sales related to the termination of the Company's relationship with Sandoz and a reduction in commercial retail sales in the U.S.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Smallpox MCM</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smallpox MCM sales increased $107.9&#160;million to $123.9&#160;million for the three months ended June&#160;30, 2023. The increase was primarily due to the exercise and full delivery in the quarter of a $120&#160;million option by the USG to purchase ACAM2000, under which we delivered the full amount, partially offset by lower VIG sales due to timing. Fluctuations in revenues result from the timing of the exercise of annual purchase options, the timing of USG purchases, the availability of governmental funding and Company delivery of orders that follow.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Products</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Products sales decreased $0.6&#160;million, or 3%, to $23.2&#160;million for the three months ended June&#160;30, 2023. The decrease was primarily due to lower BAT product sales, partially offset by higher RSDL sales, due to timing.  </span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cost of Sales and Gross Margin</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product sales increased $43.9&#160;million, or 48%, to $134.9&#160;million for the three months ended June&#160;30, 2023. The increase was primarily due to higher sales of ACAM2000 and NARCAN, partially offset by lower sales of CYFENDUS, coupled with higher allocations to product COGS at our Bayview facility and an increase in Trobigard inventory related costs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross margin increased $21.1&#160;million, or 14%, to $167.3&#160;million for the three months ended June&#160;30, 2023. Product gross margin percentage decreased 7 percentage points to 55% for the three months ended June&#160;30, 2023. The decrease in gross margin percentage was largely due to increases in shutdown related costs and inventory write-offs. Product adjusted gross margin excludes the impacts of non-cash items related to the inventory step-up provision of $1.9 million and the changes in the fair value of contingent consideration of $0.4 million. </span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2023 Compared with Six Months Ended June 30, 2022</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Anthrax MCM </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthrax MCM sales decreased $162.1&#160;million, or 78%, to $43.1 million for the six months ended June 30, 2023. The decrease reflects the impact of timing of sales related to CYFENDUS and BioThrax, partially offset by an increase in Anthrasil sales. Anthrax vaccine product sales are primarily made under annual purchase options exercised by the USG. Fluctuations in revenues result from the timing of the exercise of annual purchase options, the timing of USG purchases, the availability of governmental funding and Company delivery of orders that follow. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">NARCAN</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NARCAN sales increased $39.7&#160;million, or 20%, to $234.3&#160;million for the six months ended June 30, 2023. The increase was primarily driven by higher branded NARCAN sales to U.S. public interest channels and Canadian retail sales, partially offset by the cessation of authorized generic NARCAN sales related to the termination of the Company's relationship with Sandoz and a reduction in commercial retail sales in the U.S.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Smallpox MCM</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smallpox MCM sales increased $91.7&#160;million to $131.1&#160;million for the six months ended June 30, 2023. The increase was primarily due to the exercise and full delivery in the quarter of a $120&#160;million option by the USG to purchase ACAM2000, under which we delivered the full amount, partially offset by lower VIG sales due to timing. Fluctuations in revenues result from the timing of the exercise of annual purchase options, the timing of USG purchases, the availability of governmental funding and Company delivery of orders that follow.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Products</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Products sales increased $2.0&#160;million, or 6%, to $37.1&#160;million for the six months ended June 30, 2023. The increase was primarily due to higher Vivotif and Vaxchora product sales, partially offset by lower RSDL and BAT product sales, due to timing.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cost of Sales and Gross Margin</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product sales increased $66.5&#160;million, or 39%, to $237.8&#160;million for the six months ended June 30, 2023. The increase was primarily due to higher sales of ACAM2000 and NARCAN, partially offset by lower sales of CYFENDUS, coupled with higher allocations to product COGS at our Bayview facility, shutdown costs and inventory write-offs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross margin decreased $95.2&#160;million, or 31%, to $207.8&#160;million for the six months ended June 30, 2023. Product gross margin percentage decreased 17 percentage points to 47% for the six months ended June 30, 2023. The decrease was largely due to lower sales volumes and higher shutdown related costs and inventory write-offs. Product adjusted gross margin excludes the impacts of restructuring costs of $2.0 million, non-cash items related to the inventory step-up provision of $1.9 million and the changes in the fair value of contingent consideration of $1.9 million.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERVICES SEGMENT</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.563%"><tr><td style="width:1.0%"></td><td style="width:25.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Services Segment</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in millions)</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">% Change</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO revenues</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of services</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.6)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63.6)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(95.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross margin % </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(91)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(144)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(162)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Gross margin is calculated as revenues less cost of services. Gross margin % is calculated as gross margin divided by revenues. </span></div></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM - Not meaningful</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023 Compared with Three Months Ended June 30, 2022</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CDMO revenues</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO services revenues increased $23.7&#160;million to $26.4&#160;million for the three months ended June&#160;30, 2023. The increase was driven by a recognition of revenue related to the resolution of a customer's outstanding obligation and work at our Canton facility for a CDMO customer. In the prior year quarter, there was a reversal of revenue related to the halt in manufacturing under the Janssen Agreement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO lease revenues increased $7.2&#160;million, or 160%, to $2.7&#160;million for the three months ended June&#160;30, 2023. The lease revenue in the current year quarter is related to a CDMO customer in our Canton facility. In the prior year quarter, we had a reversal of revenue recognized related to the Janssen Agreement termination.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cost of Services and Gross Margin</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services decreased $23.1&#160;million, or 29%, to $55.7&#160;million for the three months ended June&#160;30, 2023. The decrease was primarily due to reduced production activities at our Bayview facility related to the halt in manufacturing under the Janssen Agreement, partially offset by higher costs at our Camden facility related to additional investments in quality enhancements and improvement initiatives as well as increased in production at our Canton facility related work for a CDMO customer. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services gross margin increased $54.0&#160;million to $(26.6)&#160;million for the three months ended June&#160;30, 2023. Services gross margin percentage improved to (91)% for the three months ended June&#160;30, 2023. The improvement was primarily due to one-time costs and reserves related to the Janssen Agreement in the prior year quarter, partially offset by additional investments in quality enhancement and improvement initiatives at the Company's Camden facility in the current year.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2023 Compared with Six Months Ended June 30, 2022</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CDMO revenues</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO services revenues decreased $14.7&#160;million, or 27%, to $39.8&#160;million for the six months ended June 30, 2023. The decrease was driven by $10.9&#160;million less revenue related to reduced production activities at the Company's Bayview facility as a result of a halt in manufacturing under the Janssen Agreement in 2022. Additionally, the decrease also reflects reduced production at the Camden facility. The decreases were slightly offset by an increase in production at our Canton facility for a CDMO customer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO lease revenues were consistent with prior year at $4.5&#160;million for the six months ended June 30, 2023.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cost of Services and Gross Margin</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services decreased $46.5&#160;million, or 30%, to $107.9&#160;million for the six months ended June 30, 2023. The decrease was primarily due to reduced production activities across our CDMO network, partially offset by increased costs at our Camden facility for additional investments in quality enhancement and improvement initiatives and increased costs associated with production activities at our Canton facility for a CDMO customer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services gross margin increased $31.8&#160;million to $(63.6)&#160;million for the six months ended June 30, 2023. Services gross margin percentage improved 18 percentage points to (144)% for the six months ended June 30, 2023. The improvement was primarily due one-time costs and reserves related to the Janssen agreement in the prior year quarter, partially offset by the full six month impact of additional investments in quality enhancement and improvement initiatives at the Company's Camden facility in the current year.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER REVENUE</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023 Compared with Three Months Ended June 30, 2022</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contracts and Grants</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract and grants revenue decreased $0.7&#160;million, or 10%, to $6.6&#160;million for the three months ended June&#160;30, 2023. The decrease was due to changes in the mix and timing of developmental initiatives.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2023 Compared with Six Months Ended June 30, 2022</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contracts and Grants</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract and grants revenue decreased $3.8&#160;million, or 22%, to $13.1&#160;million for the six months ended June 30, 2023. The decrease was due to changes in the mix and timing of developmental initiatives.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_121"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial condition is summarized as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.997%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in millions)</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Change %</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial assets:</span></td><td colspan="3" style="background-color:#ededed;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">642.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(86)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrowings:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt, current portion</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">455.2&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">957.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt, net of current portion</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">448.0&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">448.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total borrowings</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">903.2&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,405.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(36)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working capital:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">777.7&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,210.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(36)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">693.2&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,229.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(44)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total working capital</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84.5&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19.2)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM - Not Meaningful</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Principal Sources of Capital Resources</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically financed our operating and capital expenditures through existing cash and cash equivalents, cash from operations, development contracts and grant funding and borrowings under our Revolving Credit Facility, our Term Loan Facility, and other lines of credit we have established from time to time. We also obtain financing from the sale of our common stock upon exercise of stock options and participation in an at-the market equity offering program (the "ATM Program"). As of June&#160;30, 2023, we had unrestricted cash and cash equivalents of $88.6&#160;million and remaining capacity under our Revolving Credit Facility of $49.3&#160;million.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Going Concern</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared on the going concern basis of accounting, which assumes the Company will continue to operate as a going concern and which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, there is $250.2&#160;million outstanding on our Revolving Credit Facility and $206.1&#160;million on our Term Loan Facility that mature in May 2025. The Company determined that there is substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. This evaluation considered the potential mitigating effect of management&#8217;s plans that have not been fully implemented. Management may evaluate the mitigating effect of its plans to determine if it is probable that (1) the plans will be effectively implemented within one year after the date the financial statements are issued, and (2) when implemented, the plans will mitigate the relevant conditions or events that raise substantial doubt about the entity&#8217;s ability to continue as a going concern. The Company's plans include (A) amending the agreement for the Senior Secured Credit Facilities, which occurred on May 15, 2023 with the Fourth Amendment to Amended and Restated Credit Agreement, Waiver and First Amendment to Amended and Restated Collateral Agreement (the &#8220;Credit Agreement Amendment&#8221;), and (B) the execution of the capital raise requirement prescribed in the Credit Agreement Amendment, as further described below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company executed the Credit Agreement Amendment and extended the maturity date on the Senior Secured Credit Facilities to May 15, 2025, the Credit Agreement Amendment also requires the Company to raise at least $75.0 million through the issuance of equity and/or unsecured indebtedness by April 30, 2024 and that we make quarterly principal payments on the Term Loan Facility of approximately $3.9 million commencing with the quarter ended June 30, 2023. As a result of this provision, the Company has determined it is appropriate to continue to classify the debt as a current liability on the condensed consolidated balance sheets. While the Company expects to complete these actions, management cannot make the assumption that it is probable that the Company will be successful. As a result, the Company continues to evaluate a number of uncertain factors related to its assessment of its ability to satisfy the capital raise requirement, including its ability to comply with the term and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating and financial covenants required by the Senior Secured Credit Facilities, other market conditions, economic conditions, particularly in the pharmaceutical and biotechnology industry, disruptions or volatility caused by factors such as lingering impacts of the COVID-19 pandemic, regional conflicts, inflation, and supply chain disruptions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had $88.6 million of cash on hand at June&#160;30, 2023. On January 9, 2023, the Company announced the 2023 Plan intended to reduce operating costs, improve operating margins, and continue advancing the Company&#8217;s ongoing commitment to profitable growth. The Plan includes a reduction of the Company&#8217;s current workforce by approximately five percent. These actions, in combination with other cost reduction initiatives, are expected to result in annualized savings of over $60.0&#160;million when fully implemented.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">At-the-Market Equity Offering Facility</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, from time to time, sell up to $150.0 million aggregate gross sales price of shares of our common stock through Evercore Group L.L.C. and RBC Capital Markets, LLC, as sales agents, under an &#8220;at-the-market&#8221; equity offering program (the &#8220;ATM Program&#8221;) that we entered into on May 18, 2023. During the three months ended June 30, 2023, we sold 1.1 million shares of our common stock under the ATM Program for gross proceeds of $9.1&#160;million, representing an average price of $8.22 per share. As of June 30, 2023, $140.9&#160;million aggregate gross sales price of shares of our common stock remains available for issuance under the ATM Program. We intend to use proceeds obtained from the sale of shares under the ATM Program for general corporate purposes. </span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our cash flows for the six months ended June 30, 2023 and 2022:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#ededed;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(298.4)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">242.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(64.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(497.4)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(101.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.8)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net change in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(554.0)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(218.0)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operating Activities:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $298.4&#160;million for the six months ended June 30, 2023 compared with $52.9 million for the six months ended June 30, 2022. The increase of $245.5&#160;million in net cash used in operating activities was primarily due to net loss excluding non-cash items of $116.4&#160;million, including impairment of long-lived asset charges of $306.7&#160;million, coupled with negative working capital changes of $182.0&#160;million, primarily due to increases in receivables, an accumulation of inventory and prepaid expenses, and an increase in payments for taxes, partially offset by an increase in our accounts payable.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investing Activities:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities was $242.6&#160;million for the six months ended June 30, 2023 compared with net cash used in investing activities of $64.3 million for the six months ended June 30, 2022. The increase of $306.9&#160;million in net cash provided by investing activities was primarily due to proceeds from the sale of the travel health business during the second quarter of 2023, partially offset by purchases of property, plant and equipment.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financing Activities:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $497.4&#160;million for the six months ended June 30, 2023 compared with $101.2 million for the six months ended June 30, 2022. The increase of $396.2&#160;million in net cash used in financing activities was primarily due to principal payments on the Senior Secured Credit Facilities, partially offset by proceeds from the sale of stock through our ATM Program.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company has $909.3&#160;million of fixed and variable rate debt with varying maturities. See Note 10, "Debt" in the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Form 10-Q) for further discussion.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Uncertainties and Trends Affecting Funding Requirements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to fund our short-term and long-term anticipated operating expenses, capital expenditures and debt service requirements from the following sources:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">existing cash and cash equivalents;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">net proceeds from the sale of our products and CDMO services;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">development contracts and grant funding; </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">proceeds from the sale of our common stock through the ATM Program; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our Senior Secured Credit Facilities and any replacement or other lines of credit we may establish from time to time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous risks and uncertainties associated with product sales and with the development and commercialization of our product candidates. We may seek additional external financing to provide additional financial flexibility. Our future capital requirements will depend on many factors, including (but not limited to):</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the level, timing and cost of product sales and CDMO services;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the extent to which we acquire or invest in and integrate companies, businesses, products or technologies;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the acquisition of new facilities and capital improvements to new or existing facilities;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the payment obligations under our indebtedness;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the scope, progress, results and costs of our development activities;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to obtain funding from collaborative partners, government entities and non-governmental organizations for our development programs; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the costs of commercialization activities, including product marketing, sales and distribution.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our capital resources are insufficient to meet our future capital requirements, we will need to finance our cash needs through public or private equity or debt offerings, bank loans, collaboration and licensing arrangements, cost reductions, assets sales or a combination of these options. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise funds by issuing equity securities, including through the ATM Program, our stockholders may experience dilution. Public or bank debt financing, if available, may involve agreements that include covenants, like those contained in our 3.875% Senior Unsecured Notes due 2028 (the "Senior Unsecured Notes") and the Senior Secured Credit Facilities, which could limit or restrict our ability to take specific actions, such as incurring additional debt, making capital expenditures, pursuing acquisition opportunities, buying back shares or declaring dividends. If we raise funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish valuable rights to our technologies or product candidates or grant licenses on terms that may not be favorable to us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic conditions, including market volatility and adverse impacts on financial markets as a result of the lingering impacts of the COVID-19 pandemic, may make it more difficult to obtain financing on attractive terms, or at all. Any new debt funding, if available, may be on terms less favorable to us than our Senior Secured Credit Facilities or the Senior Unsecured Notes. If financing is unavailable or lost, our business, operating results, financial condition and cash flows would be adversely affected, and we could be forced to delay, reduce the scope of or eliminate many of our planned activities.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Unused Credit Capacity</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available room under the Revolving Credit Facility as of June&#160;30, 2023 and December&#160;31, 2022 was:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.474%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Capacity</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">300.0&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">600.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less:</span></div></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding Letters of Credit</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding Indebtedness</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">250.2&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">598.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unused Capacity</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.3&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i26b3b087cdd44df68137aa5405612fee_124"></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET&#160;RISK</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of additional risks arising from our operations, see &#8220;Item&#160;1A-Risk Factors&#8221; of this Quarterly Report on Form 10-Q. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have interest rate and foreign currency market risk. Because of the short-term maturities of our cash and cash equivalents, we believe that an increase in market rates would likely not have a significant impact on the realized value of our investments.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest rate risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have debt with a mix of fixed and variable rates of interest. We terminated our interest rate swaps in June 2023, and we are satisfied with the current fix-float mix of the Company's debt portfolio. Floating rate debt carries interest based generally on the eurocurrency rate, as defined in our Amended Credit Agreement, plus an applicable margin. Increases in interest rates could result in an increase in interest payments for our floating rate debt. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have assessed our exposure to changes in interest rates by analyzing the sensitivity to our operating results assuming various changes in market interest rates. A hypothetical increase of one percentage point in the eurocurrency rate as of June&#160;30, 2023 would increase our interest expense by approximately $4.6&#160;million annually.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign currency exchange rate risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have exposure to foreign currency exchange rate fluctuations worldwide and primarily with respect to the Euro, Canadian dollar, Swiss franc and British pound. We manage our foreign currency exchange rate risk primarily by either entering into foreign currency hedging transactions or incurring operating expenses in the local currency in the countries in which we operate, to the extent practical. We currently do not hedge all of our foreign currency exchange exposure and the movement of foreign currency exchange rates could have an adverse or positive impact on our results of operations.</span></div><div id="i26b3b087cdd44df68137aa5405612fee_127"></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our interim chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures as of June&#160;30, 2023. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act"), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of June&#160;30, 2023, our interim chief executive officer and chief financial officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act that occurred during the three months ended June&#160;30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div id="i26b3b087cdd44df68137aa5405612fee_130"></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="i26b3b087cdd44df68137aa5405612fee_133"></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 16, "Litigation" in Part I, item 1, of this Quarterly Report on Form 10-Q. </span></div><div id="i26b3b087cdd44df68137aa5405612fee_136"></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following risk factors and other information included in this Quarterly Report on Form 10-Q should be carefully considered. The occurrence of any of the following risks or of unknown risks and uncertainties may adversely affect our business, operating results and financial condition. </span></div><div style="margin-bottom:3pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTOR SUMMARY</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of government contracting risks that could impact our business, financial condition, operating results and cash flows, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Reduced demand for and/or funding for procurement of CYFENDUS and/or BioThrax vaccines or ACAM2000 and discontinuation of funding of our other USG procurement and development contracts.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Inability to secure follow-on product procurement contracts with the USG upon the expiration of any of our existing procurement contracts.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of manufacturing risks that could impact our business, financial condition, operating results and cash flows, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Our inability to maintain quality and manufacturing compliance at our manufacturing facilities for our products and for product candidates for our CDMO customers.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Disruption at, damage to or destruction of our development and/or manufacturing facilities may impede our ability to manufacture our products, as well as deliver our CDMO services.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Our operations, including our use of hazardous materials, chemicals, bacteria and viruses expose us to significant potential liabilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of product development and commercialization risks that could impact our business, financial condition, operating results and cash flows, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Clinical trials of product candidates are expensive and time-consuming, and their outcome is uncertain. </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">We may fail to capitalize on the most scientifically, clinically or commercially promising or profitable product candidates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of regulatory and compliance risks that could impact our business, financial condition, operating results and cash flows, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Failure to comply with complex laws and regulations pertaining to government contracts and resources required for responding to related government inquiries.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Conditions associated with approvals and ongoing regulation of products may limit how and the extent to which we manufacture and market them.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Failure to comply with various health care laws could result in substantial penalties.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Failure to comply with obligations under USG pricing programs may require reimbursement for underpayments and the payment of substantial penalties, sanctions and fines.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">The extent to which we may be able to lawfully offer to sell and sell unapproved products in many jurisdictions may be unclear or ambiguous and such activities may subject us to regulatory enforcement actions. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of competitive and political risks that could impact our business, financial condition, operating results and cash flows, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Development and commercialization of pharmaceutical products are subject to evolving private and public sector competition.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">NARCAN Nasal Spray is currently subject to branded and generic competition in the U.S. and may be subject to branded and generic competition in Canada. In addition, the success of NARCAN Nasal Spray is subject to our ability to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Biologic products may be affected by the approval and entry of follow-on biologics, or biosimilars in the United States and other jurisdictions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of risks related to our intellectual property that could impact our business, financial condition, operating results and cash flows, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Challenges in obtaining or maintaining intellectual property rights and defense or enforcement of such rights, including against current or potential infringers.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Potential discrepancies or challenges with respect to licenses, including our failure to comply with obligations under such licenses.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Potential loss of proprietary information and know-how, which carries the risk of reducing the value of our technology and products.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Entry of competing generic drugs upon patent and/or regulatory expires or with patents no longer in force.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of risks related to reliance on third parties that could impact our business, financial condition, operating results and cash flows, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">The loss of sole-source suppliers or an increase in the price of inventory.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">If other parties do not perform as contractually required or as expected, we may not be able to obtain regulatory approval for or commercialize our product candidates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of legal and reputational risks that could impact our business, financial condition, operating results and cash flows, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Unfavorable results of legal proceedings and government investigations could adversely impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Our work on PHTs has exposed us to criticism and may expose us to further criticism, from the media, government personnel and others, which could further harm our reputation, negatively affect our share price, operations and our ability to attract and retain talent.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">The potential for cyber security incidents involving us, our business partners, collaborators or other third parties to harm our ability to operate our business effectively in light of our heightened risk profile, including the impact of a recent cyber security incident at one of our business partners.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">We could face product liability exposure associated with the use of our medical products. There can be no assurance that the SAFETY Act, PREP Act, or other liability protections will be sufficient to limit or avoid product liability, and defending such cases requires significant resources.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of financial risks that could impact our business, financial condition, operating results and cash flows, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Our ability to maintain sufficient cash flow from our operations to pay our substantial debt, both now and in the future.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Our ability to obtain additional funding and be able to raise capital when needed, including in order to be able to continue as a going concern.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Our ability to comply with the covenants under our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Credit Facility and Term Loan Facility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other debt agreements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of risks related to our strategic acquisitions, divestitures and collaborations that could impact our business, financial condition, operating results and cash flows, including:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Our failure to successfully integrate acquired businesses and/or assets into our operations and our ability to realize the benefits of such acquisitions.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Our failure to realize the full benefits from the sale of our travel health business to Bavarian Nordic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of risks associated with our common stock, including, but not limited to:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Our business or our share price could be negatively affected as a result of the actions of shareholders.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">The price of our common stock has been and remains subject to extreme volatility.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk factors below contain more detailed descriptions of the risks identified above, as well as additional risks that may materially harm our business, financial condition or results of cash flows.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT CONTRACTING RISKS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We currently derive a substantial portion of our revenue from USG procurement of the CYFENDUS vaccine and the TEMBEXA (brincidofovir), oral antiviral and have historically derived a substantial portion of our revenue from USG procurement of the ACAM2000 vaccine and of BioThrax. If the USG&#8217;s demand for and/or funding for procurement of CYFENDUS, BioThrax and/or ACAM2000 vaccines and/or TEMBEXA</span><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(brincidofovir), oral antiviral are substantially reduced, our business, financial condition, operating results and cash flows would be materially harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a substantial portion of our current and expected future revenues from USG procurement of CYFENDUS. As with any approved product, there is a risk that we may encounter challenges causing delays or an inability to deliver CYFENDUS, which may have a material effect on our ability to generate and recognize revenue.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The success of our business and our future operating results are significantly dependent on anticipated funding for the procurement of our anthrax vaccines and the terms of such procurement by the USG, including the price per dose, the number of doses and the timing of deliveries. We have no certainty that funding will be made available for the procurement of our anthrax vaccines. If priorities for the SNS change generally, or as a result of the conclusion of the USG&#8217;s audit of the SNS, or with respect to the level of procurement of our anthrax vaccines, funding to procure future doses of CYFENDUS or BioThrax vaccines may be delayed, limited or not available, BARDA may never complete the anticipated full transition to stockpiling CYFENDUS in support of anthrax preparedness, and our future business, financial condition, operating results and cash flows could be materially harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in the past we have derived a substantial portion of our revenues from sales of ACAM2000 vaccine to the USG. If priorities for the SNS change with respect to ACAM2000 vaccine or the USG decides not to exercise additional options under our ACAM2000 contract, our future business, financial condition, operating results and cash flows could be materially harmed. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our USG procurement and development contracts require ongoing funding decisions by the USG. Any reduction or discontinuation of funding of any of these contracts could cause our business, financial condition, operating results and cash flows to suffer materially.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The USG is the principal customer for our MCMs and the primary source of funds for the development of most of our product candidates in our development pipeline. We anticipate that the USG will also be a principal customer for any MCMs that we successfully develop from within our existing product development pipeline, as well as those we acquire in the future. Additionally, a significant portion of our revenue comes from USG development contracts and grants. Over its lifetime, a USG procurement or development program, such as for CYFENDUS under our development and procurement contract with BARDA, may be implemented through the award of many different individual contracts and subcontracts. The funding for such government programs is subject to Congressional appropriations, generally made on a fiscal year basis, even for programs designed to continue for several years. These appropriations can be subject to a number of uncertainties, including political considerations, changes in priorities due to global pandemics, the results of elections and stringent budgetary constraints.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our government-funded development contracts typically give the USG the right, exercisable in its sole discretion, to extend these contracts for successive option periods following a base period of performance. The value of the services to be performed during these option periods may constitute the majority of the total value of the underlying contract. For example, the September 2016 contract award from BARDA for the development and delivery to the SNS of CYFENDUS for post-exposure prophylaxis of anthrax disease consists of a five-year base period of performance and includes options for the delivery of additional doses of CYFENDUS to the SNS and options for an additional clinical study and post-marketing commitments. This contract was extended in September 2021 through 2025 and provides for additional procurement of CYFENDUS for the SNS over 18 months. If levels of government expenditures and authorizations for public health </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">countermeasure preparedness decrease or shift to programs in areas where we do not offer products or are not developing product candidates, or if the USG otherwise declines to exercise its options under our existing contracts, our revenues would suffer, as well as our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">There can be no assurance that we will be able to secure follow-on product procurement contracts with the USG upon the expiration of any of our existing procurement contracts.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our revenue is substantially dependent upon product procurement contracts with the USG and foreign governments for our MCMs. Upon the expiration of a procurement contract, we may not be able to negotiate a follow-on procurement contract for the particular product on similar terms. We intend to negotiate follow-on procurement contracts for most of our MCMs upon the expiration of a related procurement contract, but there can be no assurance that we will be successful obtaining any follow-on contracts. Even if we are successful in negotiating a follow-on procurement contract, it may be for a lower product volume, over a shorter period of performance or be on less favorable pricing or other terms. An inability to secure follow-on procurement contracts for our approved products or product candidates could materially and adversely affect our revenues, and our business, financial condition, operating results and cash flows could be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The government contracting process is typically a competitive bidding process and involves unique risks and requirements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business involves government contracts and grants, which may be awarded through competitive bidding. Competitive bidding for government contracts presents many risks and requirements, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the possibility that we may be ineligible to respond to a request for proposal;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the commitment of substantial time and attention of management and key employees to the preparation of bids and proposals;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the need to accurately estimate the resources and cost structure that will be required to perform any contract that we might be awarded;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the submission by third parties of protests to our responses to requests for proposal that could result in delays or withdrawals of those requests for proposal; and</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">in the event our competitors protest or challenge contract or grant awards made to us through competitive bidding, the potential that we may incur expenses or delays, and that any such protest or challenge could result in the resubmission of bids based on modified specifications, or in the termination, reduction or modification of the awarded contract.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The USG may choose not to award us future contracts for either the development of our new product candidates or for the procurement of our existing MCM products and may instead award such contracts to our competitors. If we are unable to secure particular contracts, we may not be able to operate in the market for products that are provided under those contracts. Additionally, if we are unable to consistently win new contract awards over an extended period, or if we fail to anticipate all of the costs or resources that we will be required to secure and, if applicable, perform under such contract awards, our growth strategy and our business, financial condition and operating results and cash flows could be materially and adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The amounts we are paid under our fixed price government procurement contracts are based on estimates we have made of the time, resources and expenses required for us to perform under those contracts. If our actual costs exceed our estimates, we may not be able to earn an adequate return or may incur a loss under these contracts, which could harm our operating results and materially reduce our net income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current procurement contracts with the U.S. Department of Health ("HHS") and the U.S. Department of Defense ("DoD") are generally fixed price contracts. We expect that any future procurement contracts we successfully secure with the USG would likely also be fixed price contracts. Under a fixed price contract, we are required to deliver our products at a fixed price regardless of the actual costs we incur. Estimating costs that are related to performance in accordance with contract specifications is difficult, particularly where the period of performance is over several years, and when factoring in higher levels of inflation. Our failure to anticipate technical problems, estimate costs accurately or control costs during performance of a fixed price contract could reduce the profitability of such a contract or cause a loss, which could harm our operating results and materially reduce our net income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unfavorable provisions in government contracts, some of which may be customary, may subject our business to material limitations, restrictions and uncertainties and may have a material adverse impact on our business, financial condition, operating results and cash flows.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government contracts customarily contain provisions that give the USG substantial rights and remedies, many of which are not typically found in commercial contracts, including provisions that allow the USG to:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">terminate existing contracts, in whole or in part, for any reason;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">unilaterally reduce or modify contracts or subcontracts;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">decline, in whole or in part, to exercise an option to purchase product under a procurement contract or to fund additional development under a development contract;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">decline to renew a procurement contract;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">claim certain rights to facilities or to products, including intellectual property, developed under the contract;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">require repayment of contract funds spent on construction of facilities in the event of contract default;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">take actions that result in a longer development timeline than expected;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">direct the course of a development program in a manner not chosen by the government contractor;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">suspend or debar the contractor from doing business with the government or a specific government agency;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">pursue civil or criminal remedies under acts such as the False Claims Act and False Statements Act; and</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">control or prohibit the export of products.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, government contracts contain provisions permitting unilateral termination or modification, in whole or in part, at the USG&#8217;s convenience. Under general principles of government contracting law, if the USG terminates a contract for convenience, the government contractor may recover only its incurred or committed costs, settlement expenses and profit on work completed prior to the termination. If the USG terminates a contract for default, the government contractor is entitled to recover costs incurred and associated profits on accepted items only and may be liable for excess costs incurred by the government in procuring undelivered items from another source. All of our development and procurement contracts with the USG are terminable at their convenience with these potential consequences.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our USG contracts grant the USG the right to use technologies developed by us under the government contract or the right to share data related to our technologies, for or on behalf of the USG. Under our USG contracts, we may not be able to limit third parties, including our competitors, from accessing certain of these technology or data rights, including intellectual property, in providing products and services to the USG.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANUFACTURING RISKS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">An inability to maintain manufacturing compliance at our manufacturing facilities, which could adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA conducts periodic inspections of our manufacturing facilities for compliance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">current good manufacturing practices ("</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cGMP") requirements. The Company's failure to maintain compliance with cGMP requirements at our manufacturing facilities has hindered and could continue to hinder our ability to continue manufacturing for our own products and for CDMO customers, which could adversely affect our business, financial condition, operating results and cash flows. For example</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in February 2022, FDA inspected Emergent&#8217;s Camden facility and issued a Form FDA 483. In August 2022, FDA issued a warning letter to Emergent related to the February 2022 inspection. The warning letter included issues pertaining to equipment cleaning and maintenance; aseptic sterilization technique and procedures; and quality systems. Emergent has responded to the warning letter and sends regular updates to the FDA on remediation activities and improvements. Emergent continues to make significant progress with, and is approaching completion of, the corrective and preventive action commitments in the Company&#8217;s warning letter responses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disruption at, damage to or destruction of our manufacturing facilities could impede our ability to manufacture anthrax vaccines, our ACAM2000 vaccine or our other products or product candidates, as well as impact the delivery of CDMO services, which would harm our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any interruptions in our manufacturing operations could result in our inability to produce products and product candidates for delivery to satisfy the demands of our customers in a timely manner, which would reduce our revenues and materially harm our business, financial condition, operating results and cash flows. A number of factors could cause interruptions, including:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">equipment malfunctions or failures;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">technology malfunctions;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">cyber-attacks;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">work stoppages or slowdowns, particularly due to the impact of COVID-19;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">civil unrest and protests, including by animal rights activists;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">injunctions;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">damage to or destruction of our manufacturing equipment, or of one or more of our facilities; </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">findings and recommendations of health authorities or qualified persons in connection with facility inspections;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">ongoing supply chain interruptions from the COVID-19 pandemic, including lower available plasma levels caused by the pandemic (which has the potential to impact our plasma based products); and</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">product contamination or tampering.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The factors listed above could cause disruptions at any of our manufacturing facilities. We do not have any redundant manufacturing facilities for any of our products. Accordingly, any damage to, or disruption or destruction of one or more of our facilities could impede our ability to manufacture our products, and our product candidates and our ability to provide manufacturing and development services for external customers, result in losses and delays, including delays in the performance of our contractual obligations or delays in our clinical trials, any of which could be costly to us and materially harm our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Providers of MCMs could be subject to an increased risk of terrorist activities. The USG has designated both our Lansing, Michigan and our Bayview bulk manufacturing facility in Baltimore, Maryland as facilities requiring additional security. Although we continually evaluate and update security measures, there can be no assurance that any additional security measures would protect these facilities from terrorist efforts determined to disrupt our manufacturing activities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Problems may arise during the production of our products and product candidates, as well as those we produce for our CDMO customers, due to the complexity of the processes involved in their development, manufacturing and shipment or other factors. Significant delays in product manufacturing or development and our ability to ramp up production to meet the needs of our customers could cause delays in recognizing revenues, which would harm our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our products and product candidates are biologics. Manufacturing biologics, especially in large quantities, is complex. The products must be made consistently and in compliance with a clearly-defined manufacturing process. Problems during manufacturing may arise for a variety of reasons, including problems with raw materials, equipment malfunction and failure to follow specific protocols and procedures. Slight deviations anywhere in the manufacturing process, including obtaining materials, maintaining master seed or cell banks and preventing genetic drift, seed or cell growth, fermentation, contamination including from particulates among other things, filtration, filling, labeling, packaging, storage and shipping, potency and stability issues and other quality control testing, may result in lot failures or manufacturing shut-downs, delays in the release of lots, product recalls, spoilage or regulatory action. Such deviations may require us to revise manufacturing processes or change manufacturers. Additionally, as our equipment ages, it will need to be replaced, which has the potential to result in similar consequences. Success rates can also vary dramatically at different stages of the manufacturing process, which can reduce yields and increase costs. From time to time, we may experience deviations in the manufacturing process that may take significant time and resources to resolve and, if unresolved, may affect manufacturing output and could cause us to fail to satisfy customer orders or contractual commitments, lead to a termination of one or more of our contracts, lead to delays in our clinical trials, result in litigation, or other restrictions on the marketing or manufacturing of a product, any of which could be costly to us, damage our reputation and negatively impact our business. Regulatory action, including the issuance of Forms FDA 483 and warning letters can also have an impact.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if changes are made to the manufacturing process, we may be required to provide the FDA with pre-clinical and clinical data showing the comparable identity, strength, quality, purity or potency of any impacted products before and after the changes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are contractually required to ship our biologic products at a prescribed temperature range and variations from that temperature range could result in loss of product and could significantly and adversely impact our revenues, which would harm our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may not be able to ramp up our manufacturing processes to meet the rapidly changing demand or specifications of our customers on the desired timeframe, if at all. Our inability to ramp up manufacturing to meet the demand or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specifications of our customers or the inability to timely obtain regulatory authorization to produce the products or product candidates of our customers could also harm our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our products and product candidates procured by the USG and other customers require us to perform tests for and meet certain potency and lot release standards prescribed by the FDA and other agencies, which may not be met on a timely basis or at all.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are unable to sell any products and product candidates that fail to satisfy certain testing specifications. For example, we must provide the FDA with the results of certain tests, including potency tests, before certain lots are released for sale. Potency testing of each applicable lot is performed against qualified control lots that we maintain. We continually monitor the status of such reference lots for FDA compliance and periodically produce and qualify a new reference lot to replace the existing reference lot. If we are unable to satisfy USG requirements for the release of our products or product candidates, our ability to supply such products and product candidates to authorized buyers would be impaired until such time as we become able to meet such requirements, which could materially harm our future business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our operations, including our use of hazardous materials, chemicals, bacteria and viruses, require us to comply with regulatory requirements and expose us to significant potential liabilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations involve the use of hazardous materials, including chemicals, bacteria and viruses, and may produce dangerous waste products. Accordingly, we, along with the third parties that conduct clinical trials and manufacture our products and product candidates on our behalf, are subject to federal, state, local and foreign laws and regulations that govern the use, manufacture, distribution, storage, handling, exposure, disposal and recordkeeping with respect to these materials. Under the Federal Select Agent Program, pursuant to the Public Health Security and Bioterrorism Preparedness and Response Act, we are required to register with and be inspected by the CDC and the Animal and Plant Health Inspection Service if we have in our possession, or if we use or transfer, select biological agents or toxins that could pose a threat to public health and safety, to animal or plant health or to animal or plant products. This legislation requires stringent safeguards and security measures for these select agents and toxins, including controlled access and the screening of entities and personnel and establishes a comprehensive national database of registered entities. We are also subject to a variety of environmental and occupational health and safety laws. Compliance with current or future laws and regulations in this area can require significant costs and we could be subject to substantial fines and penalties in the event of noncompliance. In addition, the risk of contamination or injury from these materials cannot be completely eliminated. In such event, we could be held liable for substantial civil damages or costs associated with the cleanup of hazardous materials. From time to time, we have been involved in remediation activities and may be so involved in the future. Any related cost or liability might not be fully covered by insurance, could exceed our resources and could have a material adverse effect on our business, financial condition, operating results and cash flows. In addition to complying with environmental and occupational health and safety laws, we must comply with special regulations relating to biosafety administered by the CDC, HHS, U.S. Department of Agriculture and the DoD, as well as regulatory authorities in Canada and Switzerland.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCT DEVELOPMENT AND COMMERCIALIZATION RISKS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The product candidates that we work on for our CDMO customers may not be safe or effective and even if they are, we may be unable to manufacture sufficient quantities to meet demand.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may provide CDMO services for the development and/or manufacture of various product candidates. There can be no assurance that these product candidates will be safe or effective or that they will be authorized for emergency use or approved by the FDA or any other health regulatory authority. Even if product candidates are found to be safe and/or effective and receive authorization or approval by a health regulatory authority or we receive authorization to produce drug substance or drug product at our facilities, the manufacturing processes for our CDMO programs are under development and are complex. There can be no assurance that we will be able to produce sufficient clinical or commercial quantities of any product candidate in a timely basis or at all. Difficulties manufacturing COVID-19 product candidates for certain CDMO customers and the November 2021 termination of the termination of the Center for Innovation in Advanced Development and Manufacturing (&#8220;CIADM&#8221;) agreement with BARDA for COVID-19 vaccine development and manufacturing (the &#8220;BARDA COVID-19 Development Public Private Partnership&#8221;) caused us to suffer considerable reputational and financial damage and resulted in the instigation of shareholder litigation and government investigations described elsewhere in this Annual Report. Any future failure to satisfy manufacturing commitments could adversely affect our reputation, subject us to potential legal liability and harm our business, financial condition, operating results and cash fl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ou</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">r growth depends on our success in developing and commercializing our product candidates. If we are unable to commercialize these product candidates or experience significant delays or unanticipated costs in doing so, our business would be materially and adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have invested significant efforts and financial resources in the development of our vaccines, therapeutics and medical device product candidates and the acquisition of additional product candidates. In addition to our product sales, our ability to generate revenue is dependent on a number of factors, including the success of our development programs, the USG's interest in providing development funding for or procuring certain of our product candidates, and the commercial viability of our acquired or developed product candidates. The commercial success of our product candidates can depend on many factors, including accomplishing the following in an economical manner:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">successful development, formulation and cGMP or QSR scale-up of manufacturing that meets FDA and/or foreign regulatory requirements;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">successful program partnering;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">successful completion of clinical or non-clinical development;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">receipt of marketing approvals, clearances, or other authorizations from the FDA and equivalent foreign regulatory authorities;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">establishment of commercial manufacturing processes and product supply arrangements;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">training of a commercial sales force for the product;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">successful registration and maintenance of relevant patent and/or other proprietary protection;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">competitive pricing and market access; and </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">acceptance of the product by potential government and other customers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, the success of NARCAN Nasal Spray, including in over-the-counter form, is subject to our ability to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical trials of product candidates are expensive and time-consuming, and their outcome is uncertain. We must invest substantial amounts of time and financial resources in these trials, which may not yield viable products. Failure to obtain regulatory approval for product candidates, particularly in the United States, could materially and adversely affect our financial resources, which would adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before obtaining regulatory approval or other authorization of our product candidates, we and our collaborative partners, where applicable, must conduct pre-clinical studies and clinical trials to establish proof of concept and demonstrate the safety and efficacy of our product candidates. Pre-clinical and clinical testing is expensive, difficult to design and implement, can take many years to complete and is uncertain as to outcome. Success in pre-clinical testing and early clinical trials does not ensure that later clinical trials will be successful, and interim results of such trials do not necessarily predict final results. An unexpected result in one or more of our clinical trials can occur at any stage of testing.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may experience unforeseen events or issues during, or as a result of, pre-clinical testing, clinical trials or animal efficacy studies. These issues and events, which could delay or prevent our ability to receive regulatory approval for a product candidate, include, among others:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our inability to manufacture sufficient quantities for use in trials;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the unavailability or variability in the number and types of subjects for each study;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">safety issues or inconclusive or incomplete testing, trial or study results;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">drug immunogenicity;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">lack of efficacy of product candidates during the trials;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">government or regulatory restrictions or delays; and</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">greater than anticipated costs of trials</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-clinical and clinical testing for certain of our MCM product candidates may face additional difficulties and uncertainties because they cannot ethically or feasibly be tested in human subjects. In the U.S. we expect to rely on the Animal Rule to obtain regulatory approval for some of our MCM product candidates. The Animal Rule permits, for certain limited diseases and circumstances, the use of animal efficacy studies, together with human clinical safety and immunogenicity trials, to support an application for marketing approval. For a product approved under the Animal Rule, certain additional post-marketing requirements apply. For example, to the extent feasible and ethical, applicants must conduct post-marketing clinical studies, such as field studies in the event of an outbreak or act of bioterrorism, to assess the drug's safety and effectiveness. It is possible that </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">results from the animal efficacy studies used to support approval under the Animal Rule may not be predictive of the actual efficacy of our product candidates in humans.</span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the PHSA and the FDCA, the Secretary of HHS can contract to purchase MCMs for the SNS prior to FDA approval, clearance, or other authorization of certain MCM product candidates. If the USG does not provide funding for and procure our MCM product candidates, they generally will have to be approved by the FDA through traditional regulatory mechanisms prior to sale and distribution in the United States. </span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may fail to select or capitalize on the most scientifically, clinically or commercially promising or profitable product candidates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate our product development strategy and, as a result, may modify our strategy in the future. In this regard, we may, from time to time, focus our product development efforts on different product candidates or may delay or halt the development of various product candidates. We may change or refocus our existing product development, commercialization and manufacturing activities based on government funding decisions and other factors. This could require changes in our facilities and our personnel. Any product development changes that we implement may not be successful. In particular, we may fail to select or capitalize on the most scientifically, clinically or commercially promising or profitable product candidates or choose candidates for which government development funds are not available. Our decisions to allocate our R&amp;D, management and financial resources toward particular product candidates or therapeutic areas may not lead to the development of viable commercial products and may divert resources from better business opportunities. Similarly, our decisions to delay or terminate product development programs could also cause us to miss valuable opportunities.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGULATORY AND COMPLIANCE RISKS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">There are a number of complex laws and regulations that pertain to government contracts and compliance with those laws and regulations require significant time and cost, which could have a material adverse effect on our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a manufacturer and supplier of MCMs to the USG addressing PHTs, we must comply with numerous laws and regulations relating to the procurement, formation, administration and performance of government contracts. These laws and regulations govern how we transact business with our government clients and, in some instances, impose additional costs and related obligations on our operations. For a detailed description of the most significant regulations that affect our government contracting business, see the prior discussion under &#8220;Regulation - Government Contracting.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to government investigations of compliance with government acquisition regulations. USG agencies routinely audit and investigate government contractors for compliance with applicable laws and standards. Even though we take significant precautions to identify, prevent and deter fraud, misconduct and non-compliance, we face the risk that our personnel or outside partners may engage in misconduct, fraud or improper activities. If we are audited or investigated and such audit or investigation were to uncover improper or illegal activities, we could be subject to civil and criminal fines and penalties, administrative sanctions, including suspension or debarment from government contracting, and suffer significant reputational harm. The loss of our status as an eligible government contractor or significant fines or penalties associated with contract non-compliance or resulting from investigations could have a material adverse effect on our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our long-term success depends, in part, upon our ability to develop, receive regulatory approval for and commercialize product candidates we develop or acquire and, if we are not successful, our business, financial condition, operating results and cash flows may suffer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates and the activities associated with them are subject to extensive FDA regulation and oversight. This includes, but is not limited to, laws and regulations governing product development, product labeling, product testing, manufacturing, storage, product distribution, record keeping, and advertising and promotion. In limited circumstances, governments may have the authority to procure products that have not obtained regulatory approval to stockpile for emergency preparedness and to respond to public health emergencies. In other circumstances, failure to obtain regulatory approval for a product candidate will prevent us from selling and commercializing the product candidate.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, to obtain authorization from FDA to market and sell any of our future drug, biologic, or vaccine products, we will be required to submit an NDA or BLA to the FDA. Under the FDCA, the PHSA, and FDA&#8217;s implementation of those statutes, a company must support an NDA or BLA with substantial evidence that the product candidate is effective and evidence that the product is safe. Ordinarily, FDA requires data from adequate and well-controlled clinical trials, including Phase 3 trials conducted in patients with the disease or condition being targeted, to demonstrate that a drug meets the statutory standards for approval. Once an NDA or BLA is submitted, the FDA has substantial discretion and may refuse to accept our application or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may decide that our data are insufficient to support approval and require additional pre-clinical, clinical or other studies. Even if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for which the product may be marketed, or to conditions of approval, or contain requirements for costly post-marketing testing and surveillance to monitor the safety or efficacy of the product. Likewise, the data in our device submissions may be insufficient to support approval, de novo classification or clearance where required, and we may not be able to demonstrate to the satisfaction of the FDA that our devices are safe or effective for their intended uses or, for a 510(k) device, that they are substantially equivalent to the predicate. Even if we are granted 510(k) clearances, de novo authorizations, or PMA approvals, they may include significant limitations on the indications for use for the device.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before we can market a new medical device, or an existing medical device for a new use, or make significant modifications to an existing product, we must first receive either clearance under Section 510(k) of the FDCA, de novo authorization, or approval of a PMA from the FDA, unless an exemption applies. These marketing submissions must also be supported by appropriate data, including in many cases clinical data. Likewise, changes to our combination products, including changes to the device constituent part, may also require a new submission to, and approval from, FDA.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, our MCM product candidates may be eligible for approval under the FDA's &#8220;Animal Rule,&#8221; under which findings from adequate and well controlled animal efficacy studies may serve as the basis of an approval when it is not feasible or ethical to conduct efficacy trials in humans. We cannot guarantee that the FDA will permit us to proceed with approval or licensure of any of our MCM product candidates under the Animal Rule. Even if we are able to proceed under the Animal Rule, product development can take a considerable amount of time, and the FDA may decide that our data are insufficient to support approval and require additional pre-clinical, clinical or other studies, refuse to approve our products, or place restrictions on our ability to commercialize those products. Furthermore, products approved under the Animal Rule are subject to certain additional post-marketing requirements. We cannot guarantee that we will be able to meet this regulatory requirement even if one or more of our product candidates are approved under the Animal Rule.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of obtaining these regulatory approvals is expensive, often takes many years if approval is obtained at all, and can vary substantially based upon the type, complexity and novelty of the product candidate involved. Changes in the regulatory approval process may cause delays in the approval or other marketing authorization, or rejection of an application. There is a high rate of failure inherent in the medical product development process, and potential products that appear promising at early stages of development may fail for a number of reasons, and positive results from pre-clinical studies may not be predictive of similar results in human clinical trials. Similarly, promising results from earlier clinical trials of a product candidate may not be replicated in later clinical trials.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to successfully develop future product candidates may materially adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unapproved and investigational stage products are also subject to the FDA's laws and regulations governing advertising and promotion, which prohibit the promotion of both unapproved products and unapproved uses of approved products. There is some risk that the FDA could conclude that our communications relating to unapproved products or unapproved uses of approved products constitute the promotion of an unapproved product or product use in violation of FDA laws and regulations.&#160;There is also a risk that a regulatory authority in another country could take a similar position under that country's laws and regulations and conclude that we have violated the laws and regulations related to product development, approval, or promotion in that country.&#160;If the FDA or any foreign regulatory authority determines that any of our communications constitute pre-approval promotion or promotion of an off-label use, FDA could request that we modify our promotional materials, issue an untitled letter or warning letter, or subject us to regulatory or enforcement actions, including injunction, seizure, civil fine or criminal penalties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Even if we or our collaborators obtain marketing approvals for our product candidates, the conditions of approvals and ongoing regulation of our products may limit how we manufacture, market and sell our products, which could materially impair our ability to generate revenue.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once marketing authorization has been granted, we and our business partners will remain subject to ongoing regulatory oversight of our medical products, including with respect to labeling; safety surveillance and reporting; registration and listing requirements; cGMP and QSR requirements relating to manufacturing, quality control, quality assurance, and corresponding maintenance of records and documents; advertising and promotional activities; requirements regarding the distribution of samples to physicians and related recordkeeping; medical device design, development and manufacturing.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and other agencies, including the U.S. Department of Justice (&#8220;DOJ&#8221;) and the HHS Office of Inspector General (&#8220;OIG&#8221;), closely regulate and monitor the marketing and promotion of medical products to ensure that they are marketed in a manner consistent with the FDA-approved label. For drugs products, we must promote the product in a manner consistent with </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the full prescribing information or, for 510(k) cleared devices, consistent with the cleared indication. The FDA, DOJ, and OIG impose stringent restrictions on manufacturers&#8217; communications regarding unapproved/uncleared products and unapproved/uncleared uses of approved/cleared products. If we market unapproved/uncleared products or market our approved/cleared products for unapproved/uncleared indications, we may be subject to enforcement action. Violations of the FDCA and other statutes, including the False Claims Act, relating to the promotion and advertising of prescription products may lead to investigations and enforcement actions alleging violations of federal and state health care fraud and abuse laws, as well as state consumer protection laws.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our products are subject to post marketing requirements (&#8220;PMRs&#8221;), which we are required to conduct, and post marketing commitments, which we have agreed to conduct. The FDA has the authority to take action against sponsors who fail to meet the obligations of a PMR, including civil monetary penalties and/or misbranding charges.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, discovery of previously unknown adverse events or other problems with our products, manufacturing partners or manufacturing processes, or failure to comply with regulatory requirements, may result in various penalties and sanctions. For all FDA-regulated products, if the FDA finds that a manufacturer has failed to comply with applicable laws and regulations, or that a product is ineffective or poses an unreasonable health risk, it can institute or seek a wide variety of enforcement actions and other remedies, including but not limited to:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">restrictions on such products, manufacturers or manufacturing processes;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">restrictions on the labeling or marketing of a product;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">restrictions on distribution or use of a product;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">requirements to conduct post-marketing studies or clinical trials;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">warning letters or untitled letters;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">refusal to approve pending applications or supplements to approved applications that are submitted;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">delay in or refusal to approve/clear/authorize pending PMA applications, 510(k) premarket submissions, or de novo authorization requests;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">fines, restitution or disgorgement of profits or revenues; </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">suspension or withdrawal of marketing approvals;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">refusal to permit the import or export of our products;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">product seizure; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">injunctions or the imposition of civil or criminal penalties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we and our collaborators are not able to comply with post-approval regulatory requirements, we could have the marketing approvals for our products withdrawn by regulatory authorities and our ability to market and sell any products could be limited, which could adversely affect our ability to achieve or sustain profitability. Further, the cost of compliance with post-approval regulations may have a negative effect on our operating results and financial condition.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any product candidate for which we or our collaborators obtain marketing approval could be subject to restrictions or withdrawal from the market and we may be subject to substantial penalties if we fail to comply with regulatory requirements or if we experience unanticipated problems with our product candidates, when and if any of them are approved.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Likewise, non-compliance with EU requirements regarding safety monitoring or pharmacovigilance, and with requirements related to the development of products for the pediatric population, can also result in significant financial penalties. Similarly, failure to comply with the EU and other legal and regulatory requirements regarding the protection of personal information can also lead to significant penalties and sanctions. Non-compliance with similar requirements in other foreign jurisdictions can also result in enforcement actions and significant penalties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current and future legislation may increase the difficulty and cost for us and any collaborators to obtain marketing approval of and commercialize our product candidates and may affect the prices we, or our collaborators, may obtain.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the health care system that could prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any product candidates for which we obtain marketing approval. We expect that current laws, as well as other health care reform measures that may be adopted in the future, may result </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in more rigorous coverage criteria and additional downward pressure on the price that we, or any collaborators, may receive for any approved products.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively, the "ACA"), passed in 2010 and substantially changed the way health care is financed by both governmental and private insurers, and significantly impacted the U.S. biopharmaceutical industry. However, some provisions of the ACA have yet to be fully implemented and certain provisions have been subject to legal and political challenges, as well as efforts by the last Presidential administration to repeal or replace certain aspects of the ACA. On January 28, 2021, however, the President issued an executive order to strengthen implementation of the ACA. Concurrently, Congress considered legislation that would repeal or repeal and replace all or part of the ACA. While Congress has not passed comprehensive repeal legislation, it has enacted laws that modify certain provisions of the ACA, such as removing penalties as of January 1, 2019 for not complying with the ACA&#8217;s </span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">individual mandate to carry health insurance, delaying the implementation of certain ACA-mandated fees, and increasing the point-of-sale discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#8217;s decision, the current Presidential administration issued an executive order initiating a special enrollment period during 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare. It is unclear how healthcare reform measures enacted by Congress or implemented by the current Presidential administration or other challenges to the ACA, if any, will impact the ACA or our business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, there has been recent heightened federal governmental scrutiny over the manner in which manufacturers set prices for their marketed products. For example, there have been several recent Congressional inquiries and has been proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;), was signed into law on August 16, 2022. While the IRA is still subject to rulemaking (with more information to come via guidance documents from the responsible federal agencies), the IRA, as written, will, among other changes, give the U.S. Department of Health and Human Services (the &#8220;HHS&#8221;) the ability and authority to directly negotiate with manufacturers the price that Medicare will pay for certain high-priced drugs. The IRA will also require manufacturers of certain Part B and Part D drugs to issue to HHS rebates based on certain calculations and triggers (i.e., when drug prices increase and outpace the rate of inflation). At this time, we cannot predict the implications the IRA provisions will have on our business. These types of laws may have a significant impact on our ability to set a product price we believe is fair and may adversely affect our ability to generate revenue and achieve or maintain profitability.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in October 2020, HHS and the FDA published a final rule allowing states and other entities to develop a Section 804 Importation Program ("SIP"), to import certain prescription drugs from Canada into the United States. The final rule is currently the subject of ongoing litigation. At least six states (Vermont, Colorado, Florida, Maine, New Mexico, and New Hampshire) have passed laws allowing for the importation of drugs from Canada, and at least three states (Colorado, Florida, and New Mexico) have submitted SIPs to FDA for review and approval.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the state level, individual states are increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. A number of states, for example, require drug manufacturers and other entities in the drug supply chain, including health carriers, pharmacy benefit managers, and wholesale distributors, to disclose information about pricing of pharmaceuticals. In addition, regional health care authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other health care programs. These measures could reduce the ultimate demand for our products, once approved, or put pressure on our product pricing. We expect that additional state and federal health care reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for health care products and services, which could result in reduced demand for our product candidates or additional pricing pressures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we fail to comply with foreign, federal, state and local health care laws, including fraud and abuse and health information privacy and security laws, and antitrust laws, we could face substantial&#160;penalties and our business, results of operations, financial condition and prospects could be adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, certain of our products are reimbursed under federal and state health care programs such as Medicaid, Medicare, TriCare, and/or state pharmaceutical assistance programs. Many foreign countries have similar laws. Federal and state laws designed to prevent fraud and abuse under these programs prohibit pharmaceutical companies from offering valuable items or services to customers or potential customers to induce them to buy, prescribe, or recommend our product (the so-called &#8220;anti-kickback&#8221; laws). Exceptions are provided for discounts and certain other arrangements if specified requirements are met. Other federal and state laws, and similar foreign laws, not only prohibit us from submitting any false information to government reimbursement programs but also prohibit us, our employees, or any third party acting on our behalf from doing anything to cause, assist, or encourage our customers to submit false claims for payment to these programs. We are also subject to various federal, state and foreign antitrust and competition laws that prohibit certain activities that may have an impact against potential competitors. Violations of the various fraud and abuse and antitrust laws may result in severe penalties against the responsible employees and us, including jail sentences, large fines, and the exclusion of our products from reimbursement under federal and state programs. Some of the laws that may affect our ability to operate include:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the federal Anti-Kickback Statute makes it illegal for any person or entity, including a prescription drug manufacturer (or a party acting on its behalf) to knowingly and willfully solicit, receive, offer or pay remuneration, directly or indirectly, overtly or covertly, to induce, or in return for, either the referral of an individual, or the purchase, lease, prescribing or recommendation of an item, good, facility or service reimbursable by a federally funded health care program, such as the Medicare or Medicaid program. The term &#8220;remuneration&#8221; has been interpreted broadly and may constrain our marketing practices, educational programs, pricing policies and relationships with health care providers or other entities, among other activities;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the federal False Claims Act imposes criminal and civil penalties, including through civil whistleblower or qui tam actions, against individuals or entities for, among other things, knowingly presenting, or causing to be presented, false or fraudulent claims for payment by a federal health care program or making a false statement or record material to payment of a false claim or avoiding, decreasing or concealing an obligation to pay money to the federal government, with potential liability, including mandatory treble damages and significant per-claim penalties.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the U.S. federal Health Insurance Portability and Accountability Act of 1996 (HIPAA), which imposes criminal and civil liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any health care benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any health care benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statement, in connection with the delivery of, or payment for, health care benefits, items or services. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">HIPAA, as amended by HITECH, and their respective implementing regulations mandates, among other things, the adoption of uniform standards for the electronic exchange of information in common health care transactions, as well as standards relating to the privacy, security and transmission of individually identifiable health information, which require the adoption of administrative, physical and technical safeguards to protect such information. Among other things, HITECH makes HIPAA's security standards directly applicable to &#8220;business associates,&#8221; or independent contractors or agents of covered entities that create, receive or obtain protected health information in connection with providing a service for or on behalf of a covered entity;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the Physician Payments Sunshine Act and its implementing regulations require certain manufacturers of drugs, biologics, medical devices and medical supplies for which payment is available under Medicare, Medicaid or the Centers for Medicare &amp; Medicaid Services (CMS) to report certain </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments and transfers of value made to U.S. physicians, other healthcare providers and teaching hospitals, and ownership or investment interests held by physicians, other healthcare providers and their immediate family members; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws, which may apply to items or services reimbursed by any third-party payor, including commercial insurers; state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts; state, local and foreign laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, obtain pharmaceutical agent licensure, and/or otherwise restrict payments that may be made to health care providers and entities; and state, local and foreign </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">laws that require drug manufacturers to report information related to payments and other transfers of value to health care providers or entities, or marketing expenditures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available under the federal Anti-Kickback Statute, it is possible that some of our business activities could be subject to challenges under one or more of such laws. Moreover, recent health care reform legislation has strengthened these laws. For example, the ACA, among other things, amends the intent requirement of the federal Anti-Kickback Statute and criminal health care fraud statutes, so that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it. In addition, the ACA provides that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any of the laws described above or otherwise, we may be subject to penalties, including civil and criminal penalties, damages, fines, individual imprisonment, integrity obligations, exclusion from funded health care programs and the curtailment or restructuring of our operations. Any such penalties could adversely affect our financial results. We continue to improve our corporate compliance program designed to ensure that our development, marketing, and sales of existing and future products and product candidates are in compliance with all applicable laws and regulations, but we cannot guarantee that this program will protect us from governmental investigations or other actions or lawsuits stemming from a failure to comply with such laws or regulations. If any such actions are instituted against us and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Efforts to ensure that our business arrangements with third parties will comply with health care laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving fraud and abuse or other health care laws and regulations. If our operations are found to be in violation of any of these laws, we may be subject to significant civil, criminal and administrative penalties, damages, fines, individual imprisonment, integrity obligations, exclusion from government funded health care programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations. If a third party fails to comply with applicable laws and regulations while acting on our behalf, we may also be subject to criminal, civil, and administrative penalties, including those listed above.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States government, state governments and private payors regularly investigate the pricing and competitive practices of pharmaceutical companies and biotechnology companies, and many file actions alleging that inaccurate reporting of prices has improperly inflated reimbursement rates. We may also be subject to investigations related to our pricing practices. Regardless of merit or eventual outcome, these types of investigations and related litigation can result in:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Diversion of management time and attention;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Significant legal fees and payment of damages or penalties;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Limitations on our ability to continue certain operations;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Decreased product demand; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Injury to our reputation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, an adverse outcome, or the imposition of penalties or sanctions for failing to comply with the fraud and abuse and antitrust laws, could adversely affect us and may have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we fail to comply with our obligations under U.S. governmental pricing programs, we could&#160;be required to reimburse government programs for underpayments and could pay penalties, sanctions and fines.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of regulations and coverage expansion by various governmental agencies relating to the Medicaid rebate program will continue to increase our costs and the complexity of compliance and will be time-consuming. Changes to the definition of average manufacturer price ("AMP"), and the Medicaid rebate amount under the ACA, the issuance of final regulations implementing those and other changes has affected and could further affect our 340B &#8220;ceiling price&#8221; calculations. Because we participate in the Medicaid rebate program, we are required to report average sales price ("ASP"), information to CMS for certain categories of drugs that are paid for under Part B of the Medicare program. Future statutory or regulatory changes or CMS binding guidance could affect the ASP calculations for our products and the resulting Medicare payment rate and could negatively impact our results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing and rebate calculations vary among products and programs, involve complex calculations and are often subject to interpretation by us, governmental or regulatory agencies and the courts. The Medicaid rebate amount is computed each quarter based on our submission to CMS of our current AMP and &#8220;best price&#8221; for the quarter. If we become aware that our reporting for a prior quarter was incorrect, or has changed as a result of recalculation of the pricing data, we are obligated to resubmit the corrected data for a period not to exceed twelve quarters from the quarter in which the data originally were due. Any such revisions could have the impact of increasing or decreasing our rebate liability for prior quarters, depending on the direction of the revision. Such restatements and recalculations would increase our costs for complying with the laws and regulations governing the Medicaid rebate program. Price recalculations also may affect the &#8220;ceiling price&#8221; at which we are required to offer our products to certain covered entities, such as safety-net providers, under the 340B/Public Health Service ("PHS") drug pricing program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we are found to have made a misrepresentation in the reporting of ASP, we are subject to civil monetary penalties for each such price misrepresentation and for each day in which such price misrepresentation was applied. If we are found to have knowingly submitted false AMP or &#8220;best price&#8221; information to the government, we may be liable for civil monetary penalties per item of false information. Any refusal of a request for information or knowing provision of false information in connection with an AMP survey verification would also subject us to civil monetary penalties. In addition, our failure to submit monthly/quarterly AMP or &#8220;best price&#8221; information on a timely basis could result in a civil monetary penalty per day for each day the information is late beyond the due date. Such failure could also be grounds for CMS to terminate our Medicaid drug rebate agreement, under which we participate in the Medicaid program. In the event that CMS terminates our rebate agreement, no federal payments would be available under Medicaid or Medicare Part B for our covered outpatient drugs. Governmental agencies may also make changes in program interpretations, requirements or conditions of participation, some of which may have implications for amounts previously estimated or paid. We cannot ensure that our submissions will not be found by CMS to be incomplete or incorrect.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order for our products to be reimbursed by the primary federal governmental programs, we must report certain pricing data to the USG. Compliance with reporting and other requirements of these federal programs is a pre-condition to: (i)&#160;the availability of federal funds to pay for our products under Medicaid and Medicare Part B; and (ii)&#160;procurement of our products by the Department of Veterans Affairs ("DVA"), and by covered entities under the 340B/PHS program. The pricing data reported are used as the basis for establishing Federal Supply Schedule ("FSS"), and 340B/PHS program contract pricing and payment and rebate rates under the Medicare Part B and Medicaid programs, respectively. Pharmaceutical companies have been prosecuted under federal and state false claims laws for submitting inaccurate and/or incomplete pricing information to the government that resulted in increased payments made by these programs. Although we maintain and follow strict procedures to ensure the maximum possible integrity for our federal pricing calculations, the process for making the required calculations is complex, involves some subjective judgments and the risk of errors always exists, which creates the potential for exposure under the false claims laws. If we become subject to investigations or other inquiries concerning our compliance with price reporting laws and regulations, and our methodologies for calculating federal prices are found to include flaws or to have been incorrectly applied, we could be required to pay or be subject to additional reimbursements, penalties, sanctions or fines, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be eligible to have our products paid for with federal funds under the Medicaid and Medicare Part B programs and purchased by certain federal agencies and grantees, we also must participate in the DVA FSS pricing program. To participate, we are required to enter into an&#160;FSS contract with the DVA, under which we must make our innovator &#8220;covered drugs&#8221; available to the &#8220;Big Four&#8221; federal agencies-the DVA, the DoD, the PHS (including the Indian Health Service), and the Coast Guard-at pricing that is capped under a statutory federal ceiling price ("FCP") formula set forth in Section&#160;603 of the Veterans Health Care Act of 1992 ("VHCA"). The FCP is based on a weighted average wholesale price known as the Non-Federal Average Manufacturer Price ("Non-FAMP"), which manufacturers are required to report on a quarterly and annual basis to the DVA. Under the VHCA, knowingly providing false information in connection with a Non-FAMP filing can subject us to significant penalties for each item of false information. If we overcharge the government in connection with our FSS contract or Section&#160;703 Agreement, whether due to a misstated FCP or otherwise, we are required to disclose the error and refund the difference to the government. The failure to make necessary disclosures and/or to identify contract overcharges can result in allegations against us under the False Claims Act and other laws and regulations. Unexpected refunds to the government, and responding to a government&#160;investigation or enforcement action, can be expensive and time-consuming, and could have a material adverse effect on our business, financial condition, results of operations and growth prospects.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">From time to time, we sell unapproved MCMs to government entities under certain circumstances. While this is permissible in some cases, the extent to which we may be able to lawfully offer to sell and sell unapproved products in many jurisdictions may be unclear or ambiguous. Such sales could subject us to regulatory enforcement action, product liability and reputational risk.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under certain and narrow circumstances, MCMs may be procured by government entities prior to approval by the FDA or other regulatory authorities, a practice which we follow in connection with certain MCMs, including TROBIGARD (and CYFENDUS, prior to its approval by the FDA) in the United States. In the United States, the Secretary of HHS has the authority to contract to purchase MCMs for the SNS prior to FDA approval of the relevant MCM in specified circumstances. FDA also has the authority to permit the emergency use of medical products that have not yet been approved by the FDA under an EUA. An EUA terminates when the EUA is revoked or the emergency declaration underlying the EUA terminates. An EUA is not a long-term alternative to obtaining FDA approval, licensure, clearance, or other marketing authorization for a product. An EUA has not been granted for TROBIGARD. Absent an applicable exception, our MCM product candidates generally will have to be approved, licensed, or cleared by the FDA or other regulatory authorities in the relevant country through traditional pathways before we can sell those products to governments. Additionally, the laws in certain jurisdictions regarding the ability of government entities to purchase unapproved product candidates can be ambiguous, and the permissibility of exporting unapproved products from the United States and importing them to foreign countries may be unclear in some instances. Nevertheless, government bodies, such as U.S. federal entities other than HHS, state and local governments within the United States, and foreign governments have sought and may further seek to procure our MCM product candidates that are not yet approved. In this situation, we would expect to assess the permissibility and liability implications of supplying our product candidates to such entities on a case-by-case basis, which presents certain challenges, both in the case of U.S. and foreign governments, and particularly under emergency conditions. In addition, agencies or branches of one country&#8217;s government may take different positions regarding the permissibility of such sales than another country&#8217;s government or even other agencies or branches of the same government. If local enforcement authorities disagree with our conclusion that such activities are permissible, they may take enforcement action against us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the sale of unapproved products also could give rise to product liability claims for which we may not be able to obtain adequate indemnification or insurance coverage. For example, despite liability protections applicable to claims arising under U.S. law and resulting from the use of certain unlicensed or unauthorized MCMs, such as a declaration issued under the PREP Act, plaintiffs still may bring lawsuits, among other things, that their claims are not barred under the PREP Act.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that a user of one or more of our products experiences an adverse event, we may be subject to additional reputational risk if the product has not been approved by the FDA or the corresponding regulatory authority of another country, particularly because we will not have approved labeling regarding the safety or efficacy of those products. In addition, legislatures and other governmental bodies that have oversight responsibility for procuring agencies may raise concerns after the fact, even if procurement was permissible at the time, which could result in negative publicity, reputational risk and harm to our business prospects.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a risk that our communications with governments about our unapproved/uncleared products, such as in the procurement context, could be considered promotion of an unapproved/uncleared product or unapproved/uncleared use of an approved product. Therefore, there is a risk that we could be subject to enforcement actions if found to be in violation of such laws or regulations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Even after regulatory approval is received, if we fail to comply with regulatory requirements, or if we experience unanticipated problems with our approved products, they could be subject to restrictions, penalties or withdrawal from the market.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any vaccine, therapeutic product or medical device for which we obtain marketing approval, along with the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for such product, will be subject to the continual requirements of and review by the FDA and other regulatory bodies. Our approved products are subject to these requirements and ongoing review. For drugs and vaccines, these requirements include submissions of safety and other post-marketing information and reports, plasma donor testing, registration requirements, cGMP, requirements relating to potency and stability, quality control, quality assurance, restrictions on advertising and promotion, import and export restrictions and recordkeeping requirements. Requirements for medical devices are similar and include QSR compliance, establishment registration and device listing; record keeping; restrictions on advertising and promotion; post-market surveillance, and restrictions on import and export. In addition, various state laws require that companies that manufacture and/or distribute drug products within the state obtain and maintain a manufacturer or distributor license, as appropriate. Some states have similar requirements for devices. Because of the breadth of these laws, it is possible that some of our business activities could be subject to challenge under one or more of such laws.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government regulators enforce cGMP, QSR, and other requirements through periodic unannounced inspections of manufacturing facilities. The FDA is authorized to inspect domestic and foreign manufacturing facilities without prior notice at reasonable times and in a reasonable manner. Health Canada may conduct similar inspections of our domestic and foreign facilities where products offered and sold in Canada are produced, or related formulation and filling operations are conducted. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, Health Canada, and other foreign regulatory agencies conduct periodic inspections of our facilities. Following several of these inspections, regulatory authorities have issued inspectional observations, some of which were significant, but all of which are being, or have been, addressed through corrective actions. If, in connection with any future inspection, regulatory authorities find that we are not in substantial compliance with all applicable requirements, or if they are not satisfied with the corrective actions we take, our regulators may undertake enforcement action against us, which may include:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">warning letters, untitled letters, and other communications;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">product seizure or withdrawal of the product from the market;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">restrictions on the marketing or manufacturing of a product;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">suspension or withdrawal of regulatory approvals or refusal to approve pending applications or other marketing submissions, or supplements to approved applications;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">fines or disgorgement of profits or revenue; and</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">injunctions or the imposition of civil or criminal penalties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar action may be taken against us should we fail to comply with regulatory requirements, or later discover previously unknown problems with our products or manufacturing processes. For instance, our products are tested regularly to determine if they satisfy potency and stability requirements for their required shelf lives. Failure to meet potency, stability or other specification requirements could result in delays in distributions, recalls or other consequences. In November 2022, a specific batch of our RSDL kits was recalled due to leakage, which could cause the product not to perform as effectively as intended. We identified and remediated the cause leading to the November 2022 recall, as well as completed all required actions, notices and report submissions related to the recalled batch. We are currently awaiting formal closure of the recall. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if regulatory approval, clearance, or other marketing authorization of a product is granted, the approval, clearance, or marketing authorization may be subject to limitations on the indicated uses for which the product may be marketed or sold or to the conditions of approval. Regulatory approval or other authorization may also contain requirements for costly post-marketing testing and surveillance to monitor the safety or efficacy of the product. If we experience any of these post-approval events, our business, financial condition, operating results and cash flows could be materially and adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, companies may not promote unapproved products or unapproved uses of approved products (i.e. &#8220;off-label&#8221; uses or uses that are not described in the product&#8217;s approved labeling and/or that differ from the uses approved or cleared by the applicable regulatory agencies). A company that is found to have improperly promoted an unapproved/uncleared product or an unapproved/uncleared use of an approved/cleared product may be subject to significant liability, including civil and administrative remedies (such as entering into corporate integrity agreements with the USG), as well as criminal sanctions. If our employees or agents engage in marketing of an unapproved/uncleared product or the unapproved/uncleared use of an approved/cleared product, we could be subject to civil or criminal investigations and monetary and injunctive penalties, which could adversely impact our ability to conduct business in certain markets, negatively affect our business, financial condition, operating results and cash flows, and damage our reputation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Failure to obtain or maintain regulatory approval in international jurisdictions could prevent us from marketing our products abroad and could limit the growth of our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently sell certain of our products outside the United States and intend to expand the countries in which we sell our products and have received market authorization under the mutual recognition procedure to sell BioThrax in France, Italy, the Netherlands, Poland, and the United Kingdom. To market or sell our products in foreign jurisdictions under normal circumstances, we generally need to obtain separate regulatory approvals and comply with numerous and varying requirements or use alternative &#8220;emergency use&#8221; or other exemptions from general approval and import requirements. Approval by the FDA in the United States or the mutual recognition procedure in the European member states does not ensure approval by all foreign regulatory authorities. The approval procedures in foreign jurisdictions can vary widely and can involve additional clinical trials and data review beyond that required by the FDA or under the mutual recognition procedure. There is also a risk that a regulatory authority in another country could conclude that we have violated the rules and regulations related to product development, approval or promotion in that country. Therefore, there is a risk that we could be subject to a foreign enforcement action if found to be in violation of such laws and regulations. We and our collaborators may not be able to obtain foreign regulatory approvals on a timely basis, if at all, and we may be unable to successfully commercialize our products in desired jurisdictions internationally if no alternate procurement pathway is identified for authorized government customers in a particular jurisdiction. We have limited experience in preparing, filing and prosecuting the applications necessary to gain foreign regulatory approvals and expect to rely on third-party contract research organizations and consultants to assist us in this process. Our reliance on third parties can introduce additional uncertainty into the process.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2021, the Medicines and Healthcare products Regulatory Agency (the "MHRA"), became responsible for supervising medicines and medical devices in Great Britain, comprising England, Scotland and Wales under domestic law, whereas Northern Ireland will continue to be subject to European Union rules under the Northern Ireland Protocol. The MHRA will rely on the Human Medicines Regulations 2012 (SI 2012/1916) (as amended) (the "HMR"), as the basis for regulating medicines. The HMR has incorporated into the domestic law of the body of European Union law instruments governing medicinal products that pre-existed prior to the United Kingdom's withdrawal from the European Union. Any delay in obtaining, or an inability to obtain, any marketing approvals, as a result of Brexit or otherwise, may force us to restrict or delay efforts to seek regulatory approval in the United Kingdom for our product candidates, which could significantly and materially harm our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laws and regulations governing international operations may preclude us from developing, manufacturing and selling certain products outside of the United States, require us to develop and implement costly compliance programs, and if violated, can lead to financial and other impacts.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to expand our commercialization activities outside of the United States, we are subject to an increased risk of violating, and must dedicate additional resources towards avoiding inadvertently conducting activities in a manner that violates, the FCPA, the U.K. Bribery Act, Canada's Corruption of Foreign Public Officials Act, and other similar foreign anti-bribery laws that prohibit corporations and individuals from corruptly paying, offering to pay, or authorizing the payment of anything of value, directly or indirectly, to any foreign government official, government staff member, political party or party official, or political candidate in an attempt to influence a person working in an official capacity or otherwise obtain an improper advantage. The FCPA also obligates companies whose securities are listed in the United States to comply with certain accounting provisions requiring the Company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. Some anti-bribery laws also apply to private sector bribery. Compliance with the FCPA and other anti-bribery laws is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals and other parts of the health system are operated by the government, and doctors, hospital employees, and other health care providers are considered foreign officials. Certain payments to hospital employees and other health care professionals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many countries, including the U.S., also have various lobbying laws and regulations governing the conduct of individuals and companies who interact with government officials. These laws and regulations typically include certain restrictions and disclosure obligations. If we, our employees, or third parties acting on our behalf do not comply with these laws and regulations, we may be subject to civil and criminal penalties. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many countries, including the United States, restrict the export or import of products to or from certain countries through, for example, bans, sanction programs, and boycotts. Such restrictions may preclude us from supplying products in certain countries, which could limit our growth potential. Furthermore, if we, or third parties acting on our behalf, do not comply with these restrictions, we may be subject to civil and criminal penalties. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various laws, regulations and executive orders also restrict the use and dissemination outside of the United States, or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. If we continue to expand our presence outside of the United States, it will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and product candidates outside of the United States, which could limit our growth potential and increase our development costs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The failure to comply with laws governing international business practices may result in substantial civil and criminal penalties, suspension or debarment from government contracting, and other sanctions, and can cause reputational harm. The SEC also may bring enforcement actions against issuers for violations of the FCPA&#8217;s accounting provisions.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPETITIVE AND POLITICAL RISKS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Development and commercialization of pharmaceutical products, including for PHT preparedness, are routinely subject to evolving private and public sector competition. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development and commercialization of new biopharmaceutical and medical technology products is highly competitive and subject to rapid technological advances. We will continue to face future competition from other companies and governments, universities and other non-profit research organizations in respect to our products, any products that we acquire, our current product candidates and any products we may seek to develop or commercialize in the future. The market for products can be </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to development of safer, more effective, more convenient or less costly products. The market for current products can also depend on what resources can be devoted to marketing or selling products, or how companies are positioned to adapt more quickly to new technologies, respond to scientific advances or patient preferences and needs, initiate or withstand substantial price competition and/or procure third-party licensing and collaborative arrangements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of companies with products or product candidates addressing PHT preparedness that are competing with us for both USG procurement and development resources. Factors to consider include competitors' financial, technical, marketing and selling resources as well as potential leverage that their intellectual property estates may offer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reduction in demand for our products or reduction or loss of development funding for our products or product candidates in favor of a competing product could lead to a loss of market share for our products and cause reduced revenues, margins and levels of profitability for us, which could adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our biologic products may face risks of competition from biosimilar manufacturers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biological products and product candidates, which we refer to as &#8220;Biologic Products,&#8221; can be affected by the approval and entry of &#8220;biosimilars&#8221; in the United States and other jurisdictions. Biosimilar products are licensed through an abbreviated pathway based on a showing that they are &#8220;highly similar&#8221; to a previously licensed product (known as the reference product) notwithstanding minor differences in clinically inactive components, and there are no clinically meaningful differences from the reference product in terms of safety, purity, and potency. Biologic Products in our current pipeline include CYFENDUS, BioThrax, and ACAM2000. If a biosimilar version of one of our Biologic Products were approved, it could have a material adverse effect on the sales and gross profits of the affected Biologic Product and could adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NARCAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (naloxone HCI) is currently subject to generic competition and may be subject to additional branded and generic competition in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NARCAN currently faces generic competition. In 2016, Teva Pharmaceuticals Industries Limited and Teva Pharmaceuticals USA (collectively, Teva) filed an Abbreviated New Drug Application ("ANDA") seeking regulatory approval to market a generic version of NARCAN. In patent litigation related to Teva&#8217;s ANDA filing, a trial Court decided in favor of Teva, and this decision was subsequently affirmed by the Court of Appeals for the Federal Circuit.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA approved Teva's ANDA on April 19, 2019. On December 22, 2021, Teva commenced the launch of its generic naloxone nasal spray. As part of recent state settlements, including in Florida, Texas, Rhode Island, and West Virginia, Teva has agreed to supply Medication- Assisted Treatment ("MAT") and generic opioid overdose reversal agents, like naloxone, to states at no cost in lieu of additional monetary compensation. The terms of these product donation agreements stretch 10 to 15 years. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NARCAN also faces generic competition from Perrigo UK FINCO Limited Partnership (Perrigo, now Padagis), which filed its own ANDA in 2018. Emergent settled with Perrigo on February 12, 2020 providing for a license effective upon the Teva litigation decision. In June 2022, the FDA approved the Padagis ANDA and Padagis launched its generic naloxone nasal spray.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of generic versions of NARCAN at prices lower than our branded product or provided at no cost by Teva have the potential to erode our sales and could impact our product revenue related to NARCAN. For example, certain U.S. state laws allow for, and in some instances in the absence of specific instructions from the prescribing physician, mandate the dispensing of generic products rather than branded products where a generic version is available. In addition, in January 2019, the FDA released new proposed template Drug Facts Labels to assist sponsors of investigational naloxone nasal sprays and auto-injectors seeking approval from the FDA for over-the-counter naloxone products. In November 2022, the FDA announced its preliminary assessment that naloxone nasal spray products up to 4mg and naloxone auto-injector products for intramuscular or subcutaneous use up to 2mg have the potential to be approvable as safe and effective for nonprescription use.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NARCAN </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nasal Spray</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> also faces branded competition Kloxxado</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (naloxone HCI) nasal spray 8mg, a branded product developed by Hikma Pharmaceuticals, Inc., Amphastar Pharmaceuticals, Inc.'s naloxone injection product, Teleflex Medical Inc.'s Intranasal Mucosal Atomization Device and Zimhi</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (naloxone), a branded injectable product developed by Adamis.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Harm Reduction Therapeutics has announced filing of an NDA application for a 3mg naloxone nasal spray formulation intended for OTC use in opioid overdose reversal. NARCAN may face additional generic and branded competition in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Political or social factors may delay or impair our ability to market and sell our products and may require us to spend significant management time and financial resources to address these issues.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products developed to counter the potential impact of PHTs are subject to changing political and social environments. The political responses and social awareness of the risks of these threats on military personnel or civilians and the level of emphasis placed on such risks by the USG may vary over time. If the threat of terrorism were to decline, then the public perception of the risk on public health and safety may be reduced. This perception, as well as political or social pressures (including as a result of negative publicity we have received based on our longstanding ties to the USG), could delay or cause resistance to bringing our products in development to market or limit pricing or purchases of our products, any of which could negatively affect our revenues and our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, substantial delays or cancellations of purchases could result from protests or challenges from third parties. Lawsuits brought against us by third parties or activists, even if not successful, could require us to spend significant management time and financial resources defending the related litigation and could potentially damage the public's perception of us and our products. Any publicity campaigns or other negative publicity may adversely affect the degree of market acceptance of our MCMs and thereby limit the demand for our products, which would adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may not be able to obtain orphan drug exclusivity for product candidates we may develop, and even if we do, that exclusivity may not prevent the FDA or foreign regulatory authorities from approving other competing products.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Orphan Drug Act, the FDA may designate a product as an orphan drug if it is a drug or biologic intended to treat a rare disease or condition. Generally, if a product candidate with an orphan drug designation subsequently receives the first marketing approval for the indication for which it has such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA from approving another marketing application for the same drug for the same rare disease or condition for that time period. The applicable period is seven years in the United States. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order for the FDA to grant orphan drug designation to one of our products, the agency must find, among other requirements, that the product is being or will be investigated for a condition or disease with a patient population of fewer than 200,000 individuals in the United States, or, for a vaccine, diagnostic drug, or preventive drug, it will be administered to fewer than 200,000 persons per year in the United States. Alternatively, FDA may determine that there is no reasonable expectation that the costs of research and development of the drug can be recovered from sales of the drug in the United States. The FDA may conclude that the condition or disease for which we seek orphan drug designation does not meet this standard. Even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different products can be approved for the same condition. In addition, even after a product receives orphan drug exclusivity, the FDA can subsequently approve the same product for the same condition if the FDA or such authorities conclude that the later product is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care; if the FDA determines that the holder of orphan drug exclusivity cannot ensure the availability of sufficient quantities of the product to meet the needs of patients with the rare disease or condition; or if the holder of orphan drug exclusivity consents to the approval of such subsequent product. Additionally, the FDA may revoke orphan drug designation if the FDA determines that the request for designation contained an untrue statement of material fact, omitted material information, or the FDA subsequently finds that the drug in fact had not been eligible for orphan drug designation at the time of submission of the request for designation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face similar risks in the EU and other foreign jurisdictions that have comparable regulations concerning orphan drug exclusivity.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY RISKS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Protection of our intellectual property rights is an important tool for sustaining our business and the failure to do so could impact our financial condition, operating results, and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We actively seek to protect intellectual property rights related to our Company's assets, including patent rights, trademark rights, trade secrets and proprietary confidential information, through defense and enforcement of existing rights and pursuit of protection on new and arising innovations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining, maintaining and defending our intellectual property rights in the United States and other countries remains a critical component of the development and commercialization of our Company's assets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the risks associated with procurement, maintenance and enforcement of intellectual property rights include changes in patent laws or administrative patent office rules, evolving criteria and eligibility of obtaining patent protection on particular subject matter, the validity and enforceability of our intellectual property rights, the potential scope of coverage of our intellectual property rights, and/or the availability or strength of legal remedies in a particular country to defend and enforce intellectual property rights.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other risks include associated costs, such as costs of patent prosecution and maintenance and costs associated with post-grant challenges. For example, such costs include </span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes review</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> proceedings in the United States and oppositions in Europe, as well as costs associated with litigating and enforcing patent and trademark rights. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional risks include limitations on our extent or ability to procure, maintain or defend intellectual property rights associated with in-licensed or acquired intellectual property, where, for example, other parties (e.g., licensors) may have the first right to maintain or defend intellectual property rights in which we have an interest, or may pursue strategies that are divergent to the interest of our Company.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third party claims of for patent infringement could impact our business, financial condition, operating results, and cash flows. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Claims by other parties of alleged patent infringement could delay, stop or affect the development and commercialization of our products and product candidates. Such challenges, while ongoing, could be costly, requiring and utilizing company resources. Such challenges, if successful, may impact marketing or launch of products, or require ongoing license and/or royalty fees associated with potential settlement agreements. These may have the potential to materially harm our business, financial condition, operating results, and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual property licenses with third parties carry risks of challenges, which may be costly and time consuming and could impact the commercialization of our products.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to a number of license agreements and expect to enter into additional license agreements in the future. Such license agreements or collaboration arrangements can be subject to challenges if interests or expectations under such license agreements diverge. Such challenges may be costly, risk time and resources, and could delay or impact development, commercialization or launch of our products.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Potential loss of proprietary information and know-how generally carries the risk of reducing the value of our technology and products.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely upon unpatented proprietary technology, processes, and know-how, particularly as to our proprietary manufacturing processes. These types of confidential information and trade secrets can be difficult to protect. We seek to protect this confidential information, in part, through agreements with our employees, consultants, and third parties, as well as confidentiality policies and audits, although these may not always be successful in protecting our trade secrets and confidential information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One or more of our products could be subject to early competition from generic drugs and biosimilars.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One or more of our products is approved as a drug product under the provisions of the FDCA, which may render it susceptible to potential competition from generic manufacturers via the Hatch-Waxman Act and ANDA process. Other of our products may be susceptible to challenges by entry of biosimilars through the route established under the Biologics Price Competition and Innovation Action of 2009. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we intend to vigorously enforce our intellectual property rights, there can be no assurance that we will prevail in our enforcement or defense of our patent rights. Our existing patents could be invalidated, found unenforceable, or found not to cover a generic form of our product.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO RELIANCE ON OTHER PARTIES </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The loss of any of our non-exclusive, sole-source or single source suppliers, a shortage of related supplies or an increase in the price of inventory supplied to us could have an adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase certain supplies used in our manufacturing processes from non-exclusive, or single sources due to quality considerations, costs or constraints resulting from regulatory requirements. We depend on certain single-source suppliers for key materials and services necessary to manufacture the majority of our products and certain product candidates. For example, we rely on a single-source supplier to provide us with Alhydrogel in sufficient quantities to meet our needs to manufacture CYFENDUS and BioThrax vaccines and the specialty plasma in our hyperimmune specialty plasma products and certain ingredients for the ACAM2000 vaccine. We also rely on single-source suppliers for the materials necessary to produce NARCAN, such as the naloxone active pharmaceutical ingredient and other excipients, along with the vial, stopper and device. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where a particular single-source supply relationship is terminated, we may not be able to establish additional or replacement suppliers for certain components or materials quickly. This is largely due to the FDA approval system, which mandates validation </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of materials prior to use in our products and product candidates, and the complex nature of manufacturing processes. In addition, we may lose a sole-source supplier due to, among other things, the acquisition of a supplier by a competitor (which may cause the supplier to stop selling its products to us) or the bankruptcy of such a supplier, which may cause the supplier to cease operations. Any reduction or interruption by a sole-source supplier of the supply of materials or key components used in the manufacturing of our products or product candidates, a reduction in quality or an increase in the price of those materials or components could adversely affect us. If we are unable to locate or establish alternative suppliers, our ability to manufacture our products and product candidates could be adversely affected and could harm our revenues, cause us to fail to satisfy contractual commitments, lead to a termination of one or more of our contracts or lead to delays in our clinical trials, any of which could be costly to us and otherwise materially harm our business, financial condition, operating results and cash flows. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We depend on third parties to conduct many of our clinical and non-clinical trials. If these third parties do not perform as contractually required or as we expect, we may not be able to obtain regulatory approval for or commercialize our product candidates and, as a result, our business, financial condition, operating results and cash flows may suffer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on third parties, such as independent clinical investigators, contract research organizations and other third-party service providers to conduct the clinical and non-clinical trials of our product candidates and expect to continue to do so. We rely heavily on these third parties for successful execution of our clinical and non-clinical trials, but do not exercise day-to-day control over their activities. Our reliance on these service providers does not relieve us of our regulatory responsibilities, including ensuring that our trials are conducted in accordance with good clinical practice regulations and the plan and protocols contained in the relevant regulatory application. In addition, these organizations may not complete these activities on our anticipated or desired timeframe. We also may experience unexpected cost increases that are beyond our control. Problems with the timeliness or quality of the work of a contract research organization or other third party may lead us to seek to terminate the relationship and use an alternative service provider, which may prove difficult, costly and result in a delay of our trials. Any delay in or inability to complete our trials could delay or prevent the development, approval and commercialization of our product candidates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, government entities and NGOs conduct studies of our product candidates, and we may seek to rely on these studies in applying for marketing approval for certain of our product candidates. These government entities and NGOs have no obligation or commitment to us to conduct or complete any of these studies or clinical trials and may choose to discontinue these development efforts at any time. Furthermore, government entities depend on annual Congressional appropriations to fund their development efforts, which may not be approved.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to obtain any necessary third-party services on acceptable terms or if these service providers do not successfully carry out their contractual duties or meet expected deadlines, our efforts to obtain regulatory approvals for our product candidates may be delayed or prevented.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL AND REPUTATIONAL RISKS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our financial condition and operating results could be adversely impacted by unfavorable results of legal proceedings or government investigations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, legal proceedings and government investigations that have not yet been fully resolved, including stockholder derivative and putative class action lawsuits, and new matters may arise in the future. In addition, agreements entered into by us sometimes include indemnification provisions which can subject us to costs and damages in the event of a claim against an indemnified third party. The number of claims, legal proceedings and government investigations involving us, and the alleged magnitude of such claims, proceedings and government investigations, has generally increased over time and may continue to increase. Certain of these actions include, and future actual or threatened legal actions may include, claims for substantial and indeterminate amounts of damages, or may result in other actions adverse to us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, multiple purported class action lawsuits have been filed against us and certain of our current and former senior officers in the United States District Court for the District of Maryland seeking unspecified damages on behalf of a putative class of persons who purchased or otherwise acquired shares of our common stock during various date ranges. The complaints, allege, among other things, that we made materially false and misleading statements regarding our procedures and quality controls relating to vaccine production, in violation of federal securities laws. As another example, multiple stockholder derivative lawsuits were filed in The Court of Chancery of the State of Delaware and the United States District Court for the District of Maryland on behalf of the Company against certain current and former officers and directors for breach of fiduciary duties, waste of corporate assets, unjust enrichment and insider trading, each allegation related to the Company&#8217;s capabilities to manufacture COVID-19 vaccine bulk drug substance. In addition to monetary damages, the complaints seek the implementation of multiple corporate governance and internal policy changes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regardless of merit, litigation can be both time-consuming and disruptive to our operations and cause significant expense and diversion of management&#8217;s attention. The outcome of litigation or government investigations is also inherently uncertain. If one or more legal matters were resolved against us or an indemnified third party in a reporting period for amounts above management&#8217;s expectations, our financial condition and operating results for that reporting period could be materially adversely affected. Further, such an outcome could result in significant compensatory, punitive or trebled monetary damages, disgorgement of revenue or profits, remedial corporate measures or injunctive relief against us and could require us to change our business practices or limit our ability to offer certain products and services, all of which could materially adversely affect our financial condition and operating results. While we maintain insurance coverage for certain types of claims, such insurance coverage may be insufficient to cover all losses or all types of claims that may arise.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We rely significantly on information technology systems and any failure, inadequacy, interruption or security lapse of that technology, including any cyber security incidents, could harm our ability to operate our business effectively or result in data leakage of proprietary and confidential business and employee information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is increasingly dependent on critical, complex and interdependent information technology systems, including Internet-based systems, to support business processes as well as internal and external communications. We previously contracted with the USG and pharmaceutical companies for the development and manufacture of a significant quantity of COVID-19 vaccines, which raised our security profile and heightened potential risks that malicious actors may seek to disrupt our systems or misappropriate our information. The size and complexity of our computer systems and those of many of our business partners, collaborators and other third parties make them potentially vulnerable to interruption, invasion, computer viruses, destruction, malicious intrusion and additional related disruptions, which may result in the impairment of production and key business processes. Our systems and information are also potentially vulnerable to cyber security incidents through employee error, phishing scams and malfeasance, as well as cyber security incidents involving our business partners, collaborators and other third parties, any of which may expose sensitive data to unauthorized persons. Our systems and those of our business partners and collaborators have in the past been, and in the future likely will be subject to computer viruses, malicious codes, unauthorized access and other cyber security incidents. We are not aware of any significant impact on our operations or financial results from such incidents although, as of the date of this report, we are assessing the potential impact of a cyber security incident involving a business partner of which we were made aware in early May 2023.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No system of protection is adequate to protect against all such threats, even if they are deemed to be industry standard, and there can be no assurance that we will be able to repel any such attacks. Cyber security incidents could lead to the loss of trade secrets or other intellectual property or the public exposure of personal information, including sensitive personal information, of our employees, clinical trial patients, customers and others. Responding to any such threats may also be expensive and time-consuming. Any such unauthorized access to our information, whether through an incident involving our information technology systems or those of our business partners, collaborators or other third parties, could disrupt our business operations, result in the loss of assets, and have a material adverse effect on our reputation, business, financial condition, or results of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant business disruption or a breach in security resulting in misappropriation, theft or sabotage with respect to proprietary and confidential business and employee information could result in significant financial losses, legal, business or reputational harm to us, compromise our business prospects and our commitments to the USG or other customers, any of which could materially and adversely affect our business, financial condition and operating results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e face</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> product liability exposure, which could cause us to incur substantial liabilities and negatively affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face an inherent risk of product liability exposure related to the sale of our products, any other products that we successfully acquire or develop and the testing of our product candidates in clinical trials.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One measure of protection against such lawsuits is coverage under the PREP Act, which was signed into law in December 2005. The PREP Act creates liability protection for manufacturers of biodefense countermeasures when the Secretary of HHS issues a declaration for their manufacture, administration or use. A PREP Act declaration is meant to provide liability protection from all claims under federal or state law for loss arising out of the administration or use of a covered countermeasure under a government contract. The Secretary of HHS has issued PREP Act declarations covering countermeasures for smallpox, mpox, and other orthopox; anthrax; and botulinum toxin. These declarations apply to certain of our products, namely BioThrax, ACAM2000, raxibacumab, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthrasil</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, BAT and VIGIV products, as covered countermeasures.</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers are not entitled to protection under the PREP Act in cases of willful misconduct or for cases brought in non-U.S. tribunals or under non-U.S. law. We cannot predict whether the Secretary of HHS will renew the declarations when they expire, whether Congress will fund the relevant PREP Act compensation programs, or whether the necessary prerequisites for immunity would be triggered with respect to our products or product candidates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain of our products, namely BioThrax and RSDL, are under the SAFETY Act, which provides certain product liability limitations for qualifying anti-terrorism technologies for claims arising from or related to an act of terrorism. Although BioThrax and RSDL are designated and certified under the SAFETY Act, the law may not provide adequate protection from claims made against us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we cannot successfully defend ourselves against future claims that our products or product candidates caused injuries and if we are not entitled to indemnity by the USG, or the USG does not honor its obligations to us under the PREP Act or SAFETY Act, or if the liability protections under the PREP Act and SAFETY Act are not adequate to cover all claims, we may incur substantial liabilities. Regardless of merit or eventual outcome, product liability claims may result in:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">decreased demand or withdrawal of a product;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">injury to our reputation;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">withdrawal of clinical trial participants;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">costs to defend the related litigation;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">substantial monetary awards to trial participants or patients;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">loss of revenue; and</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">an inability to commercialize products that we may develop.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of insurance that we currently hold may not be adequate to cover all liabilities that we may incur. Further product liability insurance may be difficult and expensive to obtain. We may not be able to maintain insurance coverage at a reasonable cost and we may not be able to obtain insurance coverage that will be adequate to satisfy all potential liabilities. For example, we may not have sufficient insurance against potential liabilities associated with a possible large-scale deployment of BioThrax vaccine as a countermeasure to a bioterrorism threat. We rely on PREP Act protection for BioThrax, raxibacumab, ACAM2000, Anthrasil, BAT and VIGIV products, and SAFETY Act protection for BioThrax and RSDL products in addition to our insurance coverage to help mitigate our product liability exposure for these products. Additionally, potential product liability claims related to our commercial products, including NARCAN, may be made by patients, health care providers or others who sell or consume these products. Such claims may be made even with respect to those products that possess regulatory approval for commercial sale. Claims or losses in excess of our product liability insurance coverage could have a material adverse effect on our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL RISKS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have incurred significant indebtedness in connection with our acquisitions and servicing our debt requires a significant amount of cash. We may not have sufficient cash flow from our operations to pay our substantial debt.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make scheduled payments of the principal of, to pay interest on or to further refinance our indebtedness depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. We may also seek additional debt financing to support our ongoing activities or to provide additional financial flexibility. Debt financing can have significant adverse consequences for our business, including:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">requiring us to dedicate a substantial portion of cash flows from operations to payment on our debt, which would reduce available funds for other corporate initiatives;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">increasing the amount of interest that we have to pay on debt with variable interest rates, if market rates of interest increase, to the extent we are unable to offset such risk through our hedging instruments;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">subjecting us, as under our Senior Secured Credit Facilities and the indenture governing the Senior Unsecured Notes, to restrictive covenants that reduce our ability to take certain corporate actions, acquire companies, products or technology, or obtain further debt financing; </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">requiring us to pledge our assets as collateral, which could limit our ability to obtain additional debt financing; </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">limiting our flexibility in planning for, or reacting to, general adverse economic and industry conditions; and </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">placing us at a competitive disadvantage compared to our competitors that have less debt, better debt servicing options or stronger debt servicing capacity.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not have sufficient funds or be able to obtain additional financing to pay the amounts due under our indebtedness. In addition, failure to comply with the covenants under our Senior Secured Credit Facilities and other debt agreements, including </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the maintenance of a specified consolidated net leverage ratio, debt service coverage ratio, Consolidated EBITDA level and minimum liquidity level under our Senior Secured Credit Facilities, could result in an event of default under those agreements. An event of default could result in the acceleration of amounts due under a particular debt agreement and a cross default and acceleration under other debt agreements, and we may not have sufficient funds to pay or be able to obtain additional financing to make any accelerated payments. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our current indebtedness restricts and any additional debt financing may restrict the operation of our business and limit the cash available for investment in our&#160;business operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities include the Term Loan Facility, which had an outstanding principal balance of $206.1 million as of June&#160;30, 2023 and the ability to borrow up to $300.0&#160;million under our Revolving Credit Facility under which we had $250.2 million of outstanding borrowings as of June&#160;30, 2023. On August 7, 2020, we completed an offering of $450.0&#160;million aggregate principal amount of Senior Unsecured Notes, of which $353.0&#160;million of the net proceeds were used to pay down our Revolving Credit Facility. We may also seek additional debt financing to support our ongoing activities or to provide additional financial flexibility. Debt financing can have significant adverse consequences for our business, including:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the level, timing and cost of product sales and CDMO services;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the extent to which we acquire or invest in and integrate companies, businesses, products or technologies;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the acquisition of new facilities and capital improvements to new or existing facilities;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the payment obligations under our indebtedness;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the scope, progress, results and costs of our development activities;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">our ability to obtain funding from collaborative partners, government entities and non-governmental organizations for our development programs;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the extent to which we repurchase common stock under any future share repurchase program; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the costs of commercialization activities, including product marketing, sales and distribution.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our Senior Secured Credit Facilities and our Senior Unsecured Notes each contain cross-default provisions whereby a default under one agreement would likely result in cross defaults under agreements covering other indebtedness. The occurrence of a default under any of these arrangements would permit the holders of the notes or the lenders under our Senior Secured Credit Facilities to declare all amounts outstanding under those borrowing arrangements to be immediately due and payable, and there is no assurance that we would have sufficient funds to satisfy any such accelerated obligations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our hedging programs have been, and any hedging program we initiate in the future will be, subject to counterparty default risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we manage our interest rate risk in part by entering into interest rate swaps with a number of counterparties to swap a portion of our indebtedness that is based on variable interest rates to a fixed rate. As a result, when we are party to such interest rate swaps, we are subject to the risk that the counterparty to one or more of these contracts defaults on its performance under the contract. During an economic downturn, the counterparty's financial condition may deteriorate rapidly and with little notice and we may be unable to take action to protect our exposure. In the event of a counterparty default, we could incur losses, which may harm our business and financial condition. In the event that one or more of our counterparties becomes insolvent or files for bankruptcy, our ability to eventually recover any losses suffered as a result of that counterparty's default may be limited by the liquidity of the counterparty. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We require significant additional funding to be able to continue as a going concern and we may be unable to raise capital when needed or on acceptable terms, which would harm our ability to grow our business, and our results of operations and financial condition. In addition, any capital we raise may result in dilution to our current stockholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, we had unrestricted cash and cash equivalents of $88.6&#160;million and remaining capacity under our Revolving Credit Facility of $49.3 million. Also as of June 30, 2023, there was $250.2 million outstanding on our Revolving Credit Facility and $206.1 million on our Term Loan Facility that mature in May 2025. Certain provisions within the Credit Agreement Amendment require further action from the Company, most notably the requirement to raise not less than $75.0 million through the issuance of equity and/or unsecured indebtedness by April 30, 2024 and that the Company make quarterly principal payments of approximately $3.9 million on the Term Loan Facility. As a result, the Company determined that there is substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the financial </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statements are issued. We will need to obtain substantial additional funding in connection with our continuing operations, which cannot be assured.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our capital resources are insufficient to meet our future capital requirements, we will need to finance our cash needs through public or private equity or debt offerings, bank loans or collaboration and licensing arrangements. In August 2021, we filed an automatic shelf registration statement, which immediately became effective under SEC rules. For so long as we continue to satisfy the requirements to be deemed a &#8220;well-known seasoned issuer&#8221; under SEC rules, this shelf registration statement, effective until August 9, 2024, allows us to issue an unrestricted amount of equity, debt and certain other types of securities through one or more future primary or secondary offerings. If we do not file a new shelf registration statement prior to the expiration of our automatic shell registration statement (whether by lapse of time due to us no longer qualifying as a "well-known seasoned issuer"), the existing shelf registration statement will expire, and we will not be able to publicly raise capital or issue debt until a new registration statement is filed and becomes effective. There can be no assurance that we will be eligible to file an automatically effective shelf registration statement at a future date when we may need to raise funds publicly.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise funds by issuing equity securities, including through our ATM Program, our stockholders may experience dilution. Debt financing, if available, may involve agreements that include covenants, like those contained in our Senior Secured Credit Facilities and the indenture governing the Senior Unsecured Notes, limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, pursuing acquisition opportunities or declaring dividends. If we raise funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish valuable rights to our technologies or product candidates or grant licenses on terms that may not be favorable to us. </span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Senior Secured Credit Facilities as well as the indenture governing the Senior Unsecured Notes restrict our ability to incur additional indebtedness.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic conditions may make it difficult to obtain financing on attractive terms, or at all. If financing is unavailable or lost, our business, operating results, financial condition and cash flows would be adversely affected, and we could be forced to delay, reduce the scope of or eliminate many of our planned activities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may not maintain profitability in future periods or on a consistent basis.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have been profitable on an annual basis since becoming a public company, we have not been profitable for every quarter during that time. Our profitability has been substantially dependent on product sales, which historically have fluctuated significantly from quarter to quarter, and we expect that they will continue to fluctuate significantly based primarily on the timing of our fulfillment of orders from the USG. We may not be able to achieve consistent profitability on a quarterly basis or sustain or increase profitability on an annual basis.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment charges to our intangible assets, goodwill or property, plant and equipment could have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with U.S. GAAP, we are required to assess the value of our intangible assets and goodwill annually, or more frequently whenever events or changes in circumstances indicate potential impairment, such as changing market conditions or any changes in key assumptions. If the testing performed indicates that an asset may not be recoverable, we are required to record a non-cash impairment charge for the difference between the carrying value of the asset and its implied fair value in the period the determination is made. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also periodically monitor the remaining net book values of our property, plant and equipment, or whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. For example, we performed recoverability tests on certain asset groups within the CDMO reporting unit during the three months ended June&#160;30, 2023, and allocated and recognized a non-cash impairment charge of $306.7 million during the three months ended June&#160;30, 2023 related to certain CDMO long-lived assets.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a significant amount of intangible assets and property, plant and equipment on our balance sheet. We have recorded a significant amount of goodwill on our consolidated balance sheet as a result of acquisitions. As of June&#160;30, 2023, the only reporting unit that has goodwill associated with it is our MCM reporting unit.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment tests require us to make an estimate of the fair value of our reporting units. An impairment could be recorded as a result of changes in assumptions, estimates or circumstances, some of which are beyond our control. Since a number of factors may influence determinations of fair value, we are unable to predict whether impairments of intangible assets, goodwill or property, plant and equipment will occur in the future, and there can be no assurance that continued conditions will not result in future impairments of these assets. The future occurrence of a potential indicator of impairment could include matters such as (i) a decrease in expected net earnings, (ii) adverse equity market conditions, (iii) a decline in current market multiples, (iv) a decline </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our common stock price, (v) a significant adverse change in legal factors or the general business climate, and (vi) an adverse action or assessment by a regulator. Any such impairment would result in us recognizing a non-cash charge in our consolidated balance sheets, which could adversely affect our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The expansion of our international operations increases our risk of exposure to credit losses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to expand our business activities with foreign governments in certain countries that have experienced deterioration in credit and economic conditions or otherwise, our exposure to uncollectible accounts will rise. Global economic conditions and liquidity issues in certain countries have resulted and may continue to result in delays in the collection of accounts receivable and may result in credit losses. Future governmental actions and customer specific actions may require us to re-evaluate the collectability of our accounts receivable and we may potentially incur credit losses that materially impact our operating results.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO STRATEGIC ACQUISITIONS, DIVESTITURES AND COLLABORATIONS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our strategy of generating growth through acquisitions may not be successful.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business strategy includes growing our business through acquisition and in-licensing transactions. For example, in September 2022, we completed the acquisition from Chimerix, Inc. of its exclusive worldwide rights to brincidofovir, including TEMBEXA and related assets. We may not be successful in identifying, effectively evaluating, structuring, acquiring or in-licensing, and developing and commercializing additional products on favorable terms, or at all. Competition for attractive product opportunities is intense and may require us to devote substantial resources, both managerial and financial, to an acquisition opportunity. A number of more established companies are also pursuing strategies to acquire or in-license products in the biopharmaceutical field. These companies may have a competitive advantage over us due to their size, cash resources, cost of capital, effective tax rate and greater clinical development and commercialization capabilities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition efforts can consume significant management attention and require substantial expenditures, which could detract from our other programs. In addition, we may devote significant resources to potential acquisitions that are never completed. Even if we are successful in acquiring a company or product, it may not result in a successfully developed or commercialized product or, even if an acquired product is commercialized, competing products or technologies could render a product noncompetitive, uneconomical or obsolete. Moreover, the cost of acquiring other companies or in-licensing products could be substantial, and in order to acquire companies or new products, we may need to incur substantial debt or issue dilutive securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unsuccessful in our efforts to acquire other companies, products, or in-license and develop additional products, or if we acquire or in-license unproductive assets, it could have a material adverse effect on the growth of our business, and we could be compelled to record significant impairment charges to write-down the carrying value of our acquired intangible assets, which could materially harm our business, financial condition, operating results and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our failure to successfully integrate acquired businesses and/or assets into our operations could adversely affect our ability to realize the benefits of such acquisitions and, therefore, to grow our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to integrate any acquired business successfully or operate any acquired business profitably. In addition, cost synergies, if achieved at all, may be less than we expect, or may take greater time to achieve than we anticipate.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issues that could delay or prevent successful integration or cost synergies of an acquired business or products include, among others:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">retaining existing customers and attracting new customers;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">retaining key employees;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">diversion of management attention and resources;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">conforming internal controls, policies and procedures, business cultures and compensation programs;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">consolidating corporate and administrative infrastructures;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">successfully executing technology transfers and obtaining required regulatory approvals;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">consolidating sales and marketing operations;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">identifying and eliminating redundant and underperforming operations and assets;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">assumption of known and unknown liabilities;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">coordinating geographically dispersed organizations; </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">managing tax costs or inefficiencies associated with integrating operations; and</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">risks associated with intellectual property rights related to an acquisition or collaboration.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to successfully integrate pending and future acquisitions with our existing businesses, or operate any acquired business profitably, we may not obtain the advantages that the acquisitions were intended to create, which may materially adversely affect the growth of our business, financial condition, operating results and cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may not realize the expected benefits of the sale of our travel health business to Bavarian Nordic.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2023, pursuant to the Purchase and Sale Agreement, we completed the previously announced sale to Bavarian Nordic of our travel health business, including rights to Vaxchora and Vivotif, as well as our development-stage chikungunya vaccine candidate CHIKV VLP, our manufacturing site in Bern, Switzerland and certain of our development facilities in San Diego, California for a cash purchase price of $270.0&#160;million, subject to certain customary adjustments. In addition, we may receive milestone payments of up to $80.0&#160;million related to the development of CHIKV VLP and receipt of marketing approval and authorization in the U.S. and Europe, and sales-based milestone payments of up to $30.0&#160;million based on aggregate net sales of Vaxchora and Vivotif in calendar year 2026. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that we will be able to realize the expected benefits of the transaction. If we are unable to or do not realize the expected strategic, economic, or other benefits of the transaction, it could adversely affect our business and financial position.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OWNERSHIP OF OUR COMMON STOCK</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business or our share price could be negatively affected as a result of the actions of shareholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, some shareholders have placed increasing pressure on publicly traded companies in our industry and others to effect changes to corporate governance practices, executive compensation practices, social and environmental practices and to undertake certain corporate actions. This may be true even if they only hold a minority of shares. In addition, many institutional investors are increasingly focused on ESG factors. These investors may be seeking enhanced ESG disclosures or to implement policies adverse to our business. There can be no assurances that shareholders will not publicly advocate for us to make corporate governance changes or engage in certain corporate actions. Responding to challenges from shareholders, such as proxy contests, media campaigns or other public or private means, could be costly and time consuming and could have an adverse effect on our reputation and divert the attention and resources of management and our board, which could have an adverse effect on our business and operational results. Any such shareholder actions or requests, or the mere public presence of shareholders with a reputation for taking such actions among our shareholder base, could also cause the market price of our common stock to experience periods of significant volatility.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provisions in our certificate of incorporation and by-laws and under Delaware law may discourage acquisition proposals, delay a change in control or prevent transactions that stockholders may consider favorable.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions in our certificate of incorporation and by-laws may discourage, delay or prevent a merger, acquisition or other changes in control that stockholders may consider favorable, including transactions in which stockholders might otherwise receive a premium for their shares. These provisions may also prevent or frustrate attempts by our stockholders to replace or remove our management.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions include:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the classification of our directors;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">limitations on changing the size of our Board of Directors;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">limitations on the removal of directors;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">limitations on filling vacancies on the Board of Directors;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">advance notice requirements for stockholder nominations of candidates for election to the Board of Directors and other proposals;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the inability of stockholders to act by written consent;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the inability of stockholders to call special meetings; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the ability of our Board of Directors to designate the terms of and issue a new series of preferred stock without stockholder approval.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of a majority of our Board of Directors or the holders of our capital stock representing at least 75% of the voting power of all outstanding stock entitled to vote is required to amend or repeal the above provisions of our certificate of incorporation or by-laws. The affirmative vote of either a majority of the directors present at a meeting of our Board of Directors or holders of our capital stock representing at least 75% of the voting power of all outstanding stock entitled to vote is required to amend or repeal our by-laws.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are subject to Section 203 of the Delaware General Corporation Law ("Section 203"). In general and subject to certain exceptions, Section 203 prohibits a publicly-held corporation from engaging in a business combination with an interested stockholder, generally a person which, together with its affiliates, owns or within the last three years has owned 15% or more of the corporation's voting stock, for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. Accordingly, Section 203 may discourage, delay or prevent a change in control of us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Board of Directors may implement a new stockholder rights plan without stockholder approval, which could prevent a change in control of us in instances in which some stockholders may believe a change in control is in their best interests.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors may implement a stockholder rights plan without stockholder approval, which may have anti-takeover effects, potentially preventing a change in control of us in instances in which some stockholders may believe a change in control is in their best interests. This could cause substantial dilution to a person or group that attempts to acquire us on terms that our Board of Directors does not believe are in our best interests or those of our stockholders and may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable, including transactions in which stockholders might otherwise receive a premium for their shares.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our stock price is volatile, and purchasers of our common stock could incur substantial losses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock price has been, and is likely to continue to be, volatile. The market price of our common stock could fluctuate significantly for many reasons, including in response to the risks described in this &#8220;Risk Factors&#8221; section, or for reasons unrelated to our operations, such as reports by industry analysts, investor perceptions or negative announcements by our customers, competitors or suppliers regarding their own performance, as we</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ll as industry conditions and general financial, economic and political instability. From November 15, 2006, when our common stock first began trading on the New York Stock Exchange, through August&#160;1, 2023, our common stock has traded as high as $137.61 per share and as low as $4.17 per share. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock may be influenced by many factors, including, among others:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">contracts, decisions and procurement policies by the USG affecting our anthrax vaccines and our other products and product candidates;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">CDMO contracts related to COVID-19 with collaboration partners;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the success of competitive products or technologies;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">results of clinical and non-clinical trials of our product candidates;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">announcements of acquisitions, financings or other transactions by us;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">litigation or legal proceedings;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">public concern as to the safety of our products;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">termination or delay of a development program;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the recruitment or departure of key personnel;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">variations in our product revenue and profitability; and</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">the other factors described in this &#8220;Risk Factors&#8221; section.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Because we currently do not pay dividends, investors will benefit from an investment in our common stock only if it appreciates in value.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently do not pay dividends on our common stock. Our Senior Secured Credit Facilities and the indenture governing our Senior Unsecured Notes limit and any future debt agreements that we enter into may limit our ability to pay dividends. As a result, capital appreciation, if any, of our common stock will be the sole source of gain for our stockholders based on current expectations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future sales </span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of our common stock or other securities convertible into common stock, or the perception that such sales or issuances could occur, could result in dilution of our stockholders and could cause our share price to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors is authorized, without stockholder approval, to cause us to issue additional shares of our common stock or to raise capital through the issuance of preferred shares or the sale of debt securities that are convertible into common stock, options, warrants and other rights, on terms and for consideration as our board of directors in its sole discretion may determine. In addition, under the Credit Agreement Amendment, we are required to increase our liquidity by April 30, 2024 by raising at least $75 million of equity or unsecured indebtedness. We also require substantial additional funding to be able to continue as a going concern and we may seek to achieve such funding through future sales of our common stock or other securities convertible into our common stock. Sales of substantial amounts of our common stock or the issuance of preferred shares, convertible debt, options, restricted stock units, performance stock units, warrants and other rights, or the perception that such sales or issuances could occur could cause the market price of our common stock to decrease significantly. As of June&#160;30, 2023, we had 51,792,971 shares of common stock issued and outstanding. We cannot predict the effect, if any, of future sales of our common stock or any preferred shares, convertible debt securities, options, restricted stock units, performance stock units, warrants or other rights or the availability of our common stock for future sales on the value of our common stock. </span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL RISK FACTORS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accuracy of our financial reporting depends on the effectiveness of our internal control over financial reporting. Any material weakness in our internal control over financial reporting could have an adverse effect on our business and financial results and our ability to meet our reporting obligations could be negatively affected, each of which could negatively affect the trading price of our common stock.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal control over financial reporting can provide only reasonable assurance with respect to the preparation and fair presentation of financial statements and may not prevent or detect misstatements. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Failure to maintain effective internal control over financial reporting, or lapses in disclosure controls and procedures, could impact our financial information and disclosures, require significant resources to remediate, and expose us to legal or regulatory proceedings.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review and update our internal controls and disclosure controls and procedures. In addition, we are required under the Sarbanes-Oxley Act of 2002 to report annually on our internal control over financial reporting. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our success is dependent on our continued ability to attract, motivate and retain key personnel, and any failure to attract or retain key personnel may negatively affect our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the specialized scientific nature of our business, our ability to develop products and to compete with our current and future competitors largely depends upon our ability to attract, retain and motivate highly qualified managerial and key scientific and technical personnel (including quality and manufacturing personnel). If we are unable to retain the services of one or more of the principal members of senior management or other key employees, our ability to implement our business strategy could be materially harmed. We face intense competition for qualified employees from biopharmaceutical companies, research organizations and academic institutions. Attracting, retaining or replacing these personnel on acceptable terms may be difficult and time-consuming given the high demand in our industry for similar personnel. We believe part of being able to attract, motivate and retain personnel is our ability to offer a competitive compensation package, including equity incentive awards. If we cannot offer a competitive compensation package to attract and retain the qualified personnel necessary for the continued development of our business, we may not be able to maintain our operations or grow our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_139"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent sales of unregistered securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of proceeds</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of equity securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i26b3b087cdd44df68137aa5405612fee_142"></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i26b3b087cdd44df68137aa5405612fee_145"></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i26b3b087cdd44df68137aa5405612fee_148"></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. OTHER INFORMATION</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023, none of the Company's directors or Section 16 reporting officers <ix:nonNumeric contextRef="c-25" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1184"><ix:nonNumeric contextRef="c-25" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1185">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c-25" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1186"><ix:nonNumeric contextRef="c-25" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1187">terminated</ix:nonNumeric></ix:nonNumeric> any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).&#160;&#160;&#160;&#160;</span></div><div id="i26b3b087cdd44df68137aa5405612fee_151"></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits required to be filed by Item 601 of Regulation S-K are listed in the Exhibit Index immediately preceding the exhibits hereto.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_154"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Index</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.102%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1367644/000136764423000046/consentlimitedwaiverandt.htm">First Amendment to the Consent, Limited Waiver, and Third Amendment to the Amended and Restated Credit Agreement dated February 14, 2023 among the Company, as borrower, certain subsidiaries of the Company, as guarantors, Wells Fargo Bank, National Association, as administrative agent, and certain lenders party thereto</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1367644/000136764423000046/consentlimitedwaiverandt.htm"> (inc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1367644/000136764423000046/consentlimitedwaiverandt.htm">orporated by re</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1367644/000136764423000046/consentlimitedwaiverandt.htm">ference to Exhibit 10.4 to the Company's Annual Report on Form 10-K filed on March 1, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1367644/000136764423000046/consentlimitedwaiverandt.htm">)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2 &#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1367644/000119312523147301/d499270dex101.htm">Fourth Amendment to Amended and Restated Credit Agreement, Waiver and First Amendment to Amended and Restated Collateral Agreement, dated May 15, 2023, among Emergent BioSolutions Inc., the guarantors party thereto, the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 18, 2023).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1367644/000119312523147301/d499270dex102.htm">Equity Distribution Agreement, dated May 17, 2023, between Emergent BioSolutions Inc., Evercore Group L.L.C. and RBC Capital Markets, LLC (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on May 18, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4 #</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="modificationno13effectiv.htm">Modification No. 13, effective March 30, 2023, to the BARDA AV7909 Contract.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5 #</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="modificationno14effectiv.htm">Modification No. 14, effective March 30, 2023, to the BARDA AV7909 Contract.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6 #*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="modificationno9effective.htm">Modification No. 9, effective May 24, 2023, to the ACAM2000 Contract.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.7 #</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="modificationno10effectiv.htm">Modification No. 10, effective May 26, 2023, to the ACAM2000 Contract.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.8*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1367644/000119312523160848/d401818dex44.htm">Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form S-8, filed on June 5, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.9*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1367644/000119312523160848/d401818dex45.htm">Emergent BioSolutions Inc. Amended Employee Stock Purchase Plan (incorporated by reference to Exhibit 4.5 to the Registration Statement on Form S-8, filed on June 5, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.10 #*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ebs-brginterimmanagement.htm">Consulting Agreement, dated as of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ebs-brginterimmanagement.htm">July 7, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ebs-brginterimmanagement.htm"> and effective as of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ebs-brginterimmanagement.htm">Jul 7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ebs-brginterimmanagement.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ebs-brginterimmanagement.htm"> 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ebs-brginterimmanagement.htm">, by and between Emergent BioSolutions Inc. and Haywood Miller.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1 #</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a311-millercert063023.htm">Certification of the Chief Executive Officer, pursuant to Exchange Act Rule 13a-14(a).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2 #</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a312-lindhalcert063023.htm">Certification of the Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1 #</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a321-millercert063023.htm">Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.2 #</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a322-lindhalcert063023.htm">Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101 #</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following financial information related to the Company&#8217;s Quarterly Report on Form </span><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the quarter ended June&#160;30, 2023, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Loss, (iv) the Condensed Consolidated Statements of Cash Flows, (v) the Condensed Consolidated Statement of Changes in Stockholders' Equity; and (vi) the related Notes to the Condensed Consolidated Financial Statements.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104 #</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.<br/></span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain confidential portions of this exhibit were omitted by means of marking such portions with asterisks because of the identified confidential portions (i) are not material and (ii) are items the Company customarily and actually treats such information as private or confidential. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management or compensatory plan or arrangement.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i26b3b087cdd44df68137aa5405612fee_157"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.195%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMERGENT BIOSOLUTIONS INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/HAYWOOD MILLER</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haywood Miller</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interim Chief Executive Officer</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: August 8, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/RICHARD S. LINDAHL</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richard S. Lindahl</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Chief Financial Officer and Treasurer</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Financial and Accounting Officer)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: August 8, 2023</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>2
<FILENAME>modificationno13effectiv.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>modificationno13effectiv</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- modificationno13effectiv001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno13effectiv001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT  2. AMENDMENT/MODIFICATION NO. 3. EFFECTIVE DATE  P00013 See Block 16C  6. ISSUED BY CODE AS PR-BARDA  AS PR-BARDA  200 Independence Ave., s.w. Room 640-G  Washington DC 20201  8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)  MERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.  MERGENT PRODUCT DEVELOPMENT GAITHE  00 PROFESSIONAL DR# 100  1 1. CONTRACT ID CODE  4. REQUISITION/PURCHASE REQ. NO.  OS309412  7. ADMINISTERED BY (If other than Item 6)  AS PR-BARDA  200 Independence Ave.,  Room 638-G  Washington DC 20201  &pound;L  9A. AMENDMENT OF SOLICITATION NO.  98. DATED (SEE ITEM 11)  I  PAGE OF PAGES  1 I 5  1 5. PROJECT NO. (If applicable)  s.w. CODE IASPR-BARDA  E  E  3  G AITHERSBURG MD 208793419  X  10A. MODIFICATION OF CONTRACT/ORDER NO.  HHSO100201600030C  108. DATED (SEE ITEM 13)  CODE 1365869 FACILITY CODE 09/30/2016  11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS  &#9633; The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers Dis extended, Dis not extended.  Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended &#8226; by one of the following methods: (a) By completing  Items 8 and 15, and returning copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted ; or (c) By  separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE  RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR  OFFER. If by virtue of this amendment you desire to change an offer already submitted , such change may be made by letter or electronic communication, provided  each letter or electronic communication makes reference to the solicitation and this amendment. and is received prior to the opening hour and date specified.  12. ACCOUNTING AND APPROPRIATION DATA(/f required) Net Increase: [**]  See Schedule  13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.  CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT  ORDER NO. IN ITEM 10A.  B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office,  appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).  C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:  X FAR Part 43.103(a) - Bilateral Modifications  D. OTHER (Specify type of modification and authority)  E. IMPORTANT: Contractor Dis not Iii] is required to sign this document and return ______ 1 __ copies to the issuing office.  14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)  Tax ID Number: [**] DUNS Number: [**] UEI: [**] The purpose of this modification is to modify ARTICLES B.2 BASE PERIOD, B.3 OPTION PRICES,  F.3 DELIVERIES, G.l CONTRACTING OFFICER, G.4. INVOICE SUBMISSION, AND I.3. ADDITIONAL  CONTRACT CLAUSES. Funds Obligated Prior to this Modification: [**] Funds Obligated with Mod #13:                   [**] Total Funds Obligated to Date:  [**] Continued ...  Except as provided herein, all tenns and conditions of the document referenced in Item 9 A or 1 0A, as heretofore changed, remains unchanged and in full force and effect .  15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)  Kelly Warfield  158. CONTRACTOR/OFFEROR  &#65533; _,,/ Js?  Electronically signed by: Kelly Warfield  11 1 &#65533;- , - &#65533;:r:&#65533;&#65533;&#65533; Tt.1aV:J7t&#65533;oc,rgi;nt  (Signature of person authorized to sign)  Previous edition unusable  SVP, S&amp;D  15C. DATE SIGNED  Mar 30, 2023  YIFAN YANG  16C. DATE SIGNED  Digitally sig ed by Yifan Yang -S  L....l .................... __.,,.,.---&quot;:----L...l.-&quot;'9 --:-::- ---L.Oat@;..J023. 3.30 12:12:41 -04'00'  gO/fic-:,&#8226;J  STANDARD FORM 30 (REV. 11/2016)  Prescribed by GSA FAR (48 CFR) 53.243  Certain identified information has been marked in the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the  Company, if publicly disclosed. Double asterisks denote omissions. </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno13effectiv002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno13effectiv002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">REFERENCE NO. OF DOCUMENT BEING CONTINUED  CONTINUATION SHEET  HHSO100201600030C/P00013  NAME OF OFFEROR OR CONTRACTOR  EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. 1365869  ITEM NO.  (A)  1  10  SUPPLIES/SERVICES  (BJ  Expiration Date: Aug 31, 2025  OTA: N  Period of Performance: 09/30/2016 to 08/31/2025  Change Item 1 to read as follows(amount shown is  the obligated amount):  CLIN 0001 and CLIN 0002 for Licensure, Approval,  and Clearance or Product through the FDA/Initial  Purchase, Storage, and Delivery of Product  Accounting Info:  2016.1990007.26201 Appr. Yr.: 2016 CAN: 1990007  Object Class:  26201 Funded: [**]  Accounting Info:  2023.1995361.26025 Appr. Yr.: 2023 CAN: 1995361  Object Class: 26025  Funded: [**] FOB: Destination  Change Item 10 to read as follows(arnount shown is  the obligated amount):  CLIN 0010 Additional Surge Capacity (EUA)  Accounting Info:  2021.1991073.26088 Appr. Yr.: 2021 CAN: 1991073  Object Class: 26088  Funded: [**] Accounting Info:  2021.1990178.26088 Appr. Yr.: 2021 CAN: 1990178  Object Class: 26088  Funded: [**] NSN 7540-01-152-8067  QUANTITY UNIT  (C) (D) UNIT PRICE  (E)  OF  AMOUNT  (F)  5  [**] OPTIONAL FORM 336 (4-86)  Sponsored by GSA  FAR (48 CFRl 53.110  [**]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno13effectiv003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno13effectiv003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">HHSO 10020160003 0C P000 13 Page 3 of 5  The purpose of this modification is to modify ARTICLES B.2 BASE PERIOD, B.3 OPTION PRICES, F.3 DELIVERIES, G.1  CONTRACTING OFFICER, G.4. INVOICE SUBMISSION, AND 1.3. ADDITIONAL CONTRACT CLAUSES.  ARTICLE B.2. BASE PERIOD is hereby modified as follows:  CLIN Period of Supplies/Services Total Est. Cost Fixed Fee Total Cost Plus  Performance [**] Fixed Fee  COST REIMBURSEMENT  0001 09/30/2016 - Licensure, approval, [**] [**] [**]  (Funded) 08/31/2025 and clearance of (Funded)  product through the  FDA  ARTICLE 8.3. OPTION PRICES - CLIN 0010 is modified as follows:  CLIN  CLIN 0010  {Option  Quantity)***  Period of Supplies/Services Doses Price per Total Cost  Performance Dose  09/30/2021 - Additional Surge [**]   [**] [**]  04/30/2023 Capacity (EUA) [**] [**]  TOTAL [**] [**] [**]  (Funded)  Additional  Doses****  Dose number  TBD  *The first [**] doses procured under the options will be [**] per dose (regardless of the year these doses may be procured). As of the signing of this Modification to the Contract, [**] doses have been delivered. With the exercising of CUN 0010, [**] doses of the [**] doses will be priced at a [**] discount and will fulfill Contractor's per dose cumulative reduction obligation regarding the first [**] doses procured under the options. All doses will be billed at the price of [**]. **Under CLIN 0010, a total of [**] doses are expected to be procured at the unit prices stated above  and may include the delivery of Short Dated Doses and Additional Doses as set forth herein. CUN  0010 pricing includes the [**] within its agreed upon pricing for [**] doses delivered.  ***CUN 0010 is funded  **** Additional Doses may be delivered to BARDA as consideration under the provision Article B.5.1.  In the event Contractor delivers doses [ **] from the date of manufacture (See Article 8.5.1), Contractor  will provide a [**] equivalent of additional doses to the Government. As set forth in Article B.5.1,  BARDA may accept [**] (doses&gt;[**] from the date of manufacture) if such doses are delivered along  with the appropriate number of [**]). [**]shall be calculated as [**].  ARTICLE F.3. DELIVERIES is hereby modified as follows:  Email Addresses: CO -[**]  COR -[**]  ARTICLE G.1. CONTRACTING OFFICER is hereby modified as follows:  The following Contracting Officer (CO) will represent the Government for the purpose of this contract:  Yifan Yang  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno13effectiv004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno13effectiv004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">HHSO 10020160003 0C P000 13  HHS/OS/ ASPR/BARDA  400 7th Street, SW  Washington DC 20024  [**] ARTICLE G.4. INVOICE SUBMISSION is hereby modified as follows:  Electronic Invoicing and Payment Requirements - Invoice Processing Platform (IPP)  Page 4 of 5  &#8226; All Invoice submissions for goods and or services delivered to facilitate payments must be made electronically through the U.S. Department of Treasury's Invoice Processing Platform System (IPP). &#8226; Invoice Submission for Payment means any request for contract financing payment or invoice payment by the Contractor. To constitute a proper invoice, the payment request must comply with the requirements identified in the applicable Prompt Payment clause included in the contract, or the clause 52.212-4 Contract Terms and Conditions - Commercial Items included in commercial items contracts. The IPP website address is: https://www.ipp.gov. &#8226; The Agency will enroll the Contractors new to IPP. The Contractor must follow the IPP registration email instructions for enrollment to register the Collector Account for submitting invoice requests for payment. The Contractor Government Business Point of Contact (as listed in SAM) will receive &#8226; Registration email from the Federal Reserve Bank of St. Louis (FRBSTL) within 3 - 5 business days of the contract award for new contracts or date of modification for existing contracts. o Registration emails are sent via email from ipp.noreply@mail.eroc.twai.gov. Contractor assistance with enrollment can be obtained by contacting the IPP Production Helpdesk via email to IPPCustomerSupport@fiscal.treasury.gov or phone (866) 973-3131. &#8226; The Contractor POC will receive two emails from IPP Customer Support, the first email contains the initial administrative IPP User ID. The second email, sent within 24 hours of receipt of the first email, contains a temporary password. You must log in with the temporary password within 30 days. &#8226; If your company is already registered to use IPP, you will not be required to re-register. &#8226; If the Contractor is unable to comply with the requirement to use IPP for submitting invoices for payment as authorized by HHSAR 332.7002, a written request must be submitted to the Contracting Officer to explain the circumstances that require the authorization of alternate payment procedures. Additional Office of the Assistant Secretary for Preparedness and Response (ASPR) requirements:  (i) The contractor shall submit monthly invoices under this contract unless otherwise agreed upon by all parties. For indefinite delivery and blanket purchase agreement vehicles, separate invoices must be submitted for each order. (ii) Invoices must break-out price/cost by contract line item number (CUN) as specified in the pricing section of the contract. (iii) Invoices must include the Dun &amp; Bradstreet Number (DUNS) of the Contractor. (iv) Invoices that include time and materials or labor hours CLINS must include supporting documentation to (1) substantiate the number of labor hours invoiced for each labor category, and (2) substantiate material costs incurred (when applicable). (v) Invoices that include cost-reimbursement CLINs must be submitted in a format showing expenditures for that month, as well as contract cumulative amounts. At a minimum the following cost information shall be included, in addition to supporting documentation to substantiate costs incurred. &#8226; Direct Labor - include all persons, listing the person's name, title, number of hours worked, hourly rate, the total cost per person and a total amount for this category; &#8226; Indirect Costs (i.e., Fringe Benefits, Overhead, General and Administrative, Other Indirects)- show rate, base and total amount; &#8226; Consultants (if applicable) - include the name, number of days or hours worked, daily or hourly rate, and a total amount per consultant; &#8226; Travel - include for each airplane or train trip taken the name of the traveler, date of travel, destination, the transportation costs including ground transportation shown separately and the per diem costs. Other travel costs shall also be listed; </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno13effectiv005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno13effectiv005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">HHSO 10020160003 0C P000 13 Page 5 of 5  &#8226; Subcontractors (if applicable) - include, for each subcontractor, the same data as required for the prime Contractor; &#8226; Other Direct Costs - include a listing of all other direct charges to the contract, i.e., office supplies, telephone, duplication, postage; and &#8226; Fee - amount as allowable in accordance with the Schedule and FAR 52.216-8 if applicable. 1.3. ADDITIONAL CONTRACT CLAUSES is modified to include the following clause:  HHSAR 352.232-71 Electronic Submission of Payment Requests (FEB 2022)  (a) Definitions. As used in this clause- Payment request means a bill, voucher, invoice, or request for contract financing payment with associated supporting documentation. The payment request must comply with the requirements identified in FAR 32.905(b), &quot;Content of Invoices&quot; and the applicable Payment clause included in this contract. (b) Except as provided in paragraph (c) of this clause, the Contractor shall submit payment requests electronically using the Department ofTreasury Invoice Processing Platform (IPP) or successor system. Information regarding IPP, including IPP Customer Support contact information, is available at www.ipp.gov or any successor site. (c) The Contractor may submit payment requests using other than IPP only when the Contracting Officer authorizes alternate procedures in writing in accordance with HHS procedures. ( d) If alternate payment procedures are authorized, the Contractor shall include a copy of the Contracting Officer's written authorization with each payment request. (End of clause)  End of Modification #13  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>3
<FILENAME>modificationno14effectiv.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>modificationno14effectiv</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1365;"><!-- modificationno14effectiv001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT  2. AMENDMENT/MODIFICATION NO. 3. EFFECTIVE DATE  P00014 See Block 16C  6. ISSUED BY CODE AS PR-BARDA  AS PR-BARDA  200 Independence Ave., s.w. Room 640-G  Washington DC 20201  8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)  MERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.  MERGENT PRODUCT DEVELOPMENT GAITHE  00 PROFESSIONAL DR# 100  1 1. CONTRACT ID CODE  4. REQUISITION/PURCHASE REQ. NO.  OS313747  7. ADMINISTERED BY (If other than Item 6)  AS PR-BARDA  200 Independence Ave.,  Room 638-G  Washington DC 20201  &pound;L  9A. AMENDMENT OF SOLICITATION NO.  98. DATED (SEE ITEM 11)  I  PAGE OF PAGES  1 I 4  1 5. PROJECT NO. (If applicable)  s.w. CODE IASPR-BARDA  E  E  3  G AITHERSBURG MD 208793419  X  10A. MODIFICATION OF CONTRACT/ORDER NO.  HHSO100201600030C  108. DATED (SEE ITEM 13)  CODE 1365869 FACILITY CODE 09/30/2016  11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS  &#9633; The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers Dis extended, Dis not extended.  Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended &#8226; by one of the following methods: (a) By completing  Items 8 and 15, and returning copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted ; or (c) By  separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE  RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR  OFFER. If by virtue of this amendment you desire to change an offer already submitted , such change may be made by letter or electronic communication, provided  each letter or electronic communication makes reference to the solicitation and this amendment. and is received prior to the opening hour and date specified.  12. ACCOUNTING AND APPROPRIATION DATA(lf required) Net Increase: [**] 2023.1995361.26088  13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.  CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT  ORDER NO. IN ITEM 10A  B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office,  appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).  C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:  X FAR Part 43.103(a) - Bilateral Modifications  D. OTHER (Specify type of modification and authority)  E. IMPORTANT: Contractor Dis not Iii] is required to sign this document and return ______ 1 __ copies to the issuing office.  14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)  Tax ID Number: [**] DUNS Number: [**] UEI: [**] The purpose of this modification is to exercise CLIN 0011 and update ARTICLES B.3 OPTION  PRICES, B.5. ADVANCE UNDERSTANDINGS, C.l. STATEMENT OF WORK, AND SECTION J - LIST OF  ATTACHMENTS.  Funds Obligated Prior to this Modification: $[**] Funds Obligated with Mod #14: $[**] Total Funds Obligated to Date: $[**]  Continued ...  Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 1 0A, as heretofore changed, remains unchanged and in full force and effect .  15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)  Paul Williams  158. CONTRACTOR/OFFEROR  'Paul ',vf{,tfM-fJ 'f/;;%g;/f').fp&quot;/g:',,1t,/'J'd:::/&#65533;':r;;n&#8226;ms  Date: Jun 16, 2023 11:03 EDT  (Signature of person authorized to sign)  Previous edition unusable  SVP, Products Business Jona than Gonzalez  15C. DATE SIGNED 168. UNITED STATES OF AMERICA 16C. DATE SIGNED  Jun 16, 2023 Jonathan F. Gonzalez -S g&#65533;&#65533;&#65533;&#65533;;:&#8226;;.&#65533;.&quot;r;&#65533;;&#65533;&#65533;z.i00,.,e,-S (Signature of Contracting Officer)  STANDARD FORM 30 (REV. 11/2016)  Prescribed by GSA FAR (48 CFR) 53.243  Certain identified information has been marked in the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the  Company, if publicly disclosed. Double asterisks denote omissions. </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">REFERENCE NO. OF DOCUMENT BEING CONTINUED  CONTINUATION SHEET  HHSO100201600030C/P00014  NAME OF OFFEROR OR CONTRACTOR  EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. 1365869  ITEM NO. SUPPLIES/SERVICES  (A)  11  (BJ  Expiration Date: Aug 31, 2025  OTA: N  Appr. Yr.: 2023 CAN: 1995361 Object Class: 26088  Period of Performance: 09/30/2016 to 08/31/2025  Add Item 11 as follows:  CLIN 0011 Additional Surge Capacity (EUA and  Licensure)  Obligated Amount: [**] NSN 7540-01-152-8067  QUANTITY UNIT UNIT PRICE  (C) (D) (E)  OF  4  AMOUNT  (F)  [**]  OPTIONAL FORM 336 (4-86)  Sponsored by GSA  FAR (48 CFRl 53.110  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">HHSO100201600030C P00014 Page 3 of 4  The purpose of this modification is to modify ARTICLES B.3 OPTION PRICES, B.5. ADVANCE UNDERSTANDINGS,  ARTICLE C.l. STATEMENT OF WORK, and SECTION J- LIST OF ATTACHMENTS  ARTICLE B.3. OPTION PRICES- CUN 0011 is modified as follows:  CUN Period of Supplies/ Doses*  Performance Services  0011 June 13, Additional TBD  Total Not to Exceed  Cost  [**] (Funded)  (Option 2023 Surge  Quantity) through Capacity  October 31, (EUA and  2023 Licensure)  Price per Dose  [**] ([**] from date of  manufacture)  [**] ([**] from date of  manufacture)  *Under CLIN 0011 no less than [**] and up to [**] doses are expected to be procured at the unit prices stated above. ARTICLE B.5. ADVANCE UNDERSTANDINGS - is modified as follows:  n. CUN 0011 &#8226; For CUN 0011, BARDA agrees to receiving doses that are [**] from their manufacturing date ([**]). &#8226; These anthrax vaccine doses will have two different unit prices depending on the age of the vaccine post-manufacture. Vaccine doses delivered  [**] from their manufacture date will be charged a dose price of [**]per dose. Vaccines delivered with a [**]life greater than [**] post-manufacture will be charged a unit dose price of [**]per dose. BARDA will not accept any vaccine older than [**] post- manufacture. Product  Base Doses  [**] from date of manufacture The following table is provided as an estimate of doses to be delivered under CUN 011 but  Price per  Dose (USO)  [**]  subject to change:  Dating  [**] from date  of manufacture  [**]  Estimated Quantity for Delivery  (Including Camden Lots)  [**]doses  [**] doses  ARTICLE C - DESCRIPTION/SPECIFICATIONS/WORK STATEMENT is modified as follows:  ARTICLE C.l. STATEMENT OF WORK  Independently and not as an agent of the Government, the Contractor shall furnish all the necessary services,  qualified personnel, material, equipment, and facilities not otherwise provided by the Government as needed  to perform the Statement of Work set forth in SECTION J - List of Attachments, attached hereto and made a  part of the contract.  [**] </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">ATTACHMENT 1; STATEMENT OF WORK  NEXT GENERATION ANTHRAX VACCINE  RFP 16-100-SOL-0015  A V7909 Anthrax Vaccine  L!l Contractual Statement of Work  Preamble to the Statement of Work  Independently and not as an agent of the Government, the Contractor shall be required to furnish all the  necessary services, qualified personnel, material, equipment, and facilities, not otherwise provided by the  Government, as needed to perform the Statement of Work submitted in response to RFP 16-100-SOL- 00015.  1! Scope  The scope of work for this contract includes A V7909 development activities through licensure that fall into  the following areas: program management, nonclinical, clinical, regulatory, and chemistry, manufacturing,  and controls (CMC). The scope of work also includes activities to support post-marketing requirements.  !d Obiective  The objective of this Statement of Work (SOW) is to conduct all necessary activities to advance the  development of A V7909 through Biologics License Application (BLA) submission and approval and post&shy; marketing requirements. Activities to meet the objective of this SOW fall in the following nine (9) contract  line item number (CLIN):  &#8226; CLIN 0001 -Approval of Emergency Use Authorization (EUA), licensure, approval, and clearance of product through the FDA  (Base) &#8226; CLIN 000IA-Conduct of a Phase 2 clinical [**] study or other studies required by the FDA [**] (Option) &#8226; CLIN 0012 -Include doxycycline arm in the conduct of the Phase 2 clinical [**] study and qualify a redundant contract filler  (Base) &#8226; CLIN 0002 -Initial purchase, storage, and delivery of product (Base) &#8226; CLIN 0003 -Phase 4 post marketing requirements (Option) &#8226; CLIN 0004 - Surge Capacity-Additional procurement of product (EUA) (Option)-[**] &#8226; CLIN 0006-Surge Capacity-Additional procurement of product (EUA) (Option)-[**] doses &#8226; CLIN 0010-Surge Capacity - Additional procurement of product (EUA) (Option)-[**] doses &#8226; CLIN 0011 -Surge Capacity - Additional procurement of product (EUA and Licensed) (Option)-up to [**] doses U CLJN 0001 - Approval of Emergency Use Authorization fEUA}, Jicensure, approval, and  clearance of product through the FDA lBase}  This section identifies representative tasks and sub-tasks for CLIN 0001 with associated WBS code for each  task or subtask.  [**]Program Management  Emergent shall provide program management activities. The activities shall include but are not limited to:  &#8226; Identification of and management to, distinct stages of the product development pathway that are gates for Go/No Go decisions for advancing to the next stage of the Integrated Product Development Plan. &#8226; Establishment of and tracking of milestones and time lines for the initiation conduct, and completion of product development activities for each stage with a budget (in direct costs)linked to each stage. &#8226; Ongoing evaluation of qualitative and quantitative criteria and accompanying data used to assess the scientific merit and technical feasibility of proceeding to the next stage of product development. June 12, 2023 Page 1  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">&#8226; Maintaining and managing staff (in-house and contracted) to assure the necessary expertise and  dedicated effort to perform the work. &#8226; Directing and overseeing subcontractors and consultants to assure successful performance of planned  activities within the cost and schedule constraints of the contract. &#8226; Conducting performance measurement that shall include establishing an initial plan; defining  measurable parameters; defining how these parameters relate to cost and schedule impacts; their  approach in providing a detailed schedule that generates a critical path for the project; and a  description of the cost-accounting system used or intended to be used based on budget estimates to  monitor all costs related to the contract award for both Emergent and subcontractors on a real time  basis. &#8226; Manage contract activities in accordance with Earned Value Management. In this regard, Emergent  shall: o Provide an Integrated Master Project Plan (including tabular and Gantt forms) to BARDA that  clearly indicates the critical path to support product approval. The Integrated Master Project  Plan shall outline key, critical path milestones, with &quot;Go/No-Go&quot; decision criteria and a  contract Work Breakdown Structure ( due within 90 days of contract award with updates as  requested by the Contracting Officer's Representative(COR). o Submit an updated Integrated Master Schedule in an approved format. o Use principles of Earned Value Management System (EVMS) in the management of this  contract. o Submit a plan for a Performance Measurement Baseline Review (PMBR) electronically via  email to the Contracting Officer (CO) and COR for a PBMR to occur within 90 days of  contract award. &#8226; Develop and maintain a risk management plan. &#8226; Participate in regular meetings to coordinate and oversee the contracting effort. [**] Non-Clinical Toxicology  Emergent shall conduct safety and toxicology of A V7909 using animal models following Good Laboratory  Practice guidelines (GLP: as defined in the U.S. Code of Federal Regulations, 21CFR Part 58), as  appropriate. The activities shall include but are not limited to:  &#8226; [**] [**] Non-Clinical Efficacy  Emergent shall conduct efficacy, pharmacokinetics/pharmacodynamics, bioavailability, solubility,  formulation, dose, route and schedule of the medical countermeasure using both in vitro and animal models  following Good Laboratory Practice guidelines (GLP: as defined in the U.S. Code of Federal Regulations,  21 CFR Part 58), as appropriate. The activities shall include but are not limited to:  &#8226; [**] [**] Clinical Evaluation  Emergent shall design and conduct Phase 2 and Phase 3 clinical studies in accordance with all Federal  regulations and Good Clinical Practice (GCP) guidelines. The activities shall include but are not limited to:  &#8226; [**]  June 12, 2023 Page 2  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">[**]Regulatory Activities  Emergent shall conduct all required regulatory activities to support submission ofBLA licensure for  AV7909. The activities shall include but are not limited to:  [**]  [**] - Chemistry and Manufacturing Controls CCMC}  Emergent shall complete the manufacturing activities necessary to support BLA submission. The activities  shall include but are not limited to:  o [**] 1d CLIN 0001 A - Conduct of a Phase 2 clinical [**] study or other studies required by the FDA  [**]&pound;Option}  This section identifies representative tasks and sub-tasks for CLIN 0001A with associated WBS code for  each task or subtask.  [**] Program Management  Emergent shall provide program management activities. The activities shall include but are not limited to:  &#8226; Identification of and management to, distinct stages of the product development pathway that are gates for Go/No Go decisions for advancing to the next stage of the Integrated Product Development Plan. &#8226; Establishment of and tracking of milestones and time lines for the initiation conduct, and completion of product development activities for each stage with a budget (in direct costs)linked to each stage. &#8226; Ongoing evaluation of qualitative and quantitative criteria and accompanying data used to assess the scientific merit and technical feasibility of proceeding to the next stage of product development. &#8226; Maintaining and managing staff (in-house and contracted) to assure the necessary expertise and dedicated effort to perform the work. &#8226; Directing and overseeing subcontractors and consultants to assure successful performance of planned activities within the cost and schedule constraints of the contract. June 12, 2023 Page 3  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">&#8226; Conducting performance measurement that shall include establishing an initial plan; defining  measurable parameters; defining how these parameters relate to cost and schedule impacts; their  approach in providing a detailed schedule that generates a critical path for the project; and a  description of the cost-accounting system used or intended to be used based on budget estimates to  monitor all costs related to the contract award for both Emergent and subcontractors on a real time  basis. &#8226; Manage contract activities in accordance with Earned Value Management. In this regard, Emergent  shall: o Provide an Integrated Master Project Plan (including tabular and Gantt forms) to BARDA  that clearly indicates the critical path to support product approval. The Integrated Master  Project Plan shall outline key, critical path milestones, with &quot;Go/ No Go&quot; decision criteria  and a contract Work Breakdown Structure ( due within 90 days of contract award with  updates as requested by the Contracting Officer's Representative(COR). o Submit an updated Integrated Master Schedule in an approved format. o Use principles of Earned Value Management System (EVMS) in the management of this  contract. o Submit a plan for a Performance Measurement Baseline Review (PMBR) electronically via  email to the Contracting Officer (CO) and COR for a PBMR to occur within 90 days of  contract award. &#8226; Develop and maintain a risk management plan. &#8226; Participate in regular meetings to coordinate and oversee the contracting effort. [**] Clinical Evaluation  Emergent shall design and conduct a Phase 2 clinical study in accordance with all Federal regulations and  Good Clinical Practice (GCP) guidelines unless other studies are required by the FDA [**]. The activities  shall include, but are not limited to:  &#8226; [**]- AV A.214 Phase 2 [**] Study [**]- Chemistry and Manufacturing Controls fCMC}  Emergent shall complete the manufacturing activities necessary to support AVA.214 Phase 2 [**] Study.  The activities below are specific to conducting a Phase 2 [**] clinical study. If the FDA requires an alternate  strategy for [**], the activities below may no longer be applicable. Upon new guidance from the FDA,  Emergent will update the SOW accordingly.  [**]  1,!i CLIN 0012 - Include doxycycline arm in the conduct of the Phase 2 clinical drug-drug interaction  study and qualify a redundant contract filler rnase}  This section identifies representative activities of CLIN 0012 associated with CLIN000l subtask [**]  - AV A.210 Phase 2 [**] and [**] Chemistry and Manufacturing Controls: &#8226; [**] U CLIN 0002 - Initial purchase, storage, and delivery of product rnase}  Under the Base Period funding Emergent shall manufacture, fill, and deliver [***] doses procured in  fiscal year 2019 as an initial procurement to the Strategic National Stockpile (SNS). Emergent is  approved to use management reserve funding for shipping costs associated with these deliveries.  June 12, 2023 Page4  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">lJ CLIN 0003 - Phase 4 post marketing requirements fQption}  [**] Program Management  Emergent shall provide program management activities. The activities shall include but are not limited to:  &#8226; Identification of and management to, distinct stages of the product development pathway that are  gates for Go/No Go decisions for advancing to the next stage of the Integrated Product  Development Plan. &#8226; Establishment of and tracking of milestones and timelines for the initiation conduct, and  completion of product development activities for each stage with a budget ( in direct costs) linked  to each stage. &#8226; Ongoing evaluation of qualitative and quantitative criteria and accompanying data used to assess  the scientific merit and technical feasibility of proceeding to the next stage of product  development. &#8226; Maintaining and managing staff (in-house and contracted) to assure the necessary expertise and  dedicated effort to perform the work. &#8226; Directing and overseeing subcontractors and consultants to assure successful performance of  planned activities within the cost and schedule constraints of the contract. &#8226; Conducting performance measurement that shall include establishing an initial plan; defining  measurable parameters; defining how these parameters relate to cost and schedule impacts; their  approach in providing a detailed schedule that generates a critical path for the project; and a  description of the cost-accounting system used or intended to be used based on budget estimates  to monitor all costs related to the contract award for both Emergent and subcontractors on a real  time basis. &#8226; Manage contract activities in accordance with Earned Value Management. In this regard,  Emergent shall: o Provide an Integrated Master Project Plan (including tabular and Gantt forms) to BARDA  that clearly indicates the critical path to support product approval. The Integrated Master  Project Plan shall outline key, critical path milestones, with &quot;Go/No Go&quot; decision criteria  and a contract Work Breakdown Structure ( due within 90 days of contract award with  updates as requested by the Contracting Officer's Representative(COR). o Submit an updated Integrated Master Schedule in an approved format. o Use principles of Earned Value Management System (EVMS) in the management of this  contract. o Submit a plan for a Performance Measurement Baseline Review (PMBR) electronically  via email to the Contracting Officer (CO) and COR for a PBMR to occur within 90 days  of contract award. &#8226; Develop and maintain a risk management plan. &#8226; Participate in regular meetings to coordinate and oversee the contracting effort. [**] June 12, 2023 Page 5  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">lrB CLIN 0004 through 11 - Surge Capacity - Additional procurement 0( product fQption}  Emergent shall deliver up to [**] dose regimens ( equivalent to [**]doses of A V7909). This option may  be triggered after EUA pre-authorization approval by FDA, which is currently linked to release of PPQ  lots, and deliveries will start within [**] after trigger.  Under CLIN 0004, Emergent shall manufacture, fill, and deliver [**] doses procured in fiscal year 2019  as an initial procurement to the Strategic National Stockpile (SNS). [**] Under CLIN 0006 Emergent shall manufacture, fill, and deliver [**] doses procured from August 1, 2020  through July 31, 2021, as an additional procurement to the SNS. [**] For CLINs 0004 and 0006, BARDA may accept [**] if such doses are delivered along with the  appropriate number of additional doses (&quot;Additional Doses&quot;). Additional Doses shall be calculated as  [**] of the number of delivered [**].  For CLIN 0011, BARDA agrees to accept [**] at a discounted price.  These anthrax vaccine doses will have [**]. Vaccine doses delivered [**].  For delivery to the SNS, Emergent shall comply with the relevant associated activities and deliverables as  outlined in the Quality Agreement (attached) as signed by Emergent, BARDA, and the SNS. Emergent  shall provide appropriate documentation to BARDA for quality assurance of the final drug  product delivered to the SNS and invoice appropriately.  1.2 Reporting Requirements and Deliverables Reports  As part of the work to be performed under this contract, Emergent will prepare and deliver the following  reports throughout the period of performance.  Monthly Technical Progress Reports  On the fifteenth (15) day of each month for the previous calendar month, Emergent will submit to the  COR and the CO a Technical Progress Report covering the previous calendar month. The first reporting  period consists of the first full month of performance plus any fractional part of the initial month.  Thereafter, the reporting period will consist of each calendar month. The frequency of Technical Progress  Reporting will be determined by the CO and COR during negotiations of the contract. The format and type  of Technical Progress Report and Executive Summary will be provided by the COR. The Technical  Progress Reports will summarize progress for the reporting period, such as: management and  administrative updates, technical progress, issues, proposed work, manufacturing and supply chain  management, and a summary of invoices. A Technical Progress Report will not be required for the period  when the same month Annual Progress Reports or a Final Report are due. Emergent will submit one copy  June 12, 2023 Page 6  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno14effectiv014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno14effectiv014.jpg" title="slide14" width="1365" height="1055">
<DIV><FONT size="1" style="font-size:1pt;color:white">Milestone WBS  Estimated  Milestone  Deliverables Summary (Details  Quantity Completion  # # as specified in the Deliverables)  Date  1 Electronic Copy to  Contract Officer  1 [**] [**] Representative 12/19/2017  (COR);  1 Electronic Copy to  Contracting Officer  (CO)  2 [**]    [**] See Above 1/18/2018  3  [**]  [**]  See Above 5/24/2018  4 See Above 11/6/2018  CUN 0001 5  [**] [**] [**] [**] [**] See Above 11/8/2018  CLIN0012  8 See Above 3/21/2021  9 See Above 8/18/2020  10 See Above 12/31/2021  11 See Above 5/12/2021  12  [**] [**] [**] [**] See Above 12/15/2021  CLIN0002  16 See Above 10/24/2019 Completion of [**]       Delivery of [**] doses of   doses of A V7909                AV7909  [**]  [**]  [**]    [**]  [**]  [**]  [**]    [**]  [**]    [**]  [**]  [**]  [**]  [**]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>4
<FILENAME>modificationno9effective.htm
<DESCRIPTION>EX-10.6
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>modificationno9effective</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- modificationno9effective001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno9effective001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">&#61472;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535; &#61480;&#61560;&#61481; &#61560; &#61495;&#61493;&#61505;&#61493;&#61488;&#61489;&#61489;&#61497;&#61507;&#61488;&#61488;&#61488;&#61495;&#61489; &#61539;&#61551;&#61552;&#61545;&#61541;&#61555;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61541;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61499;&#61472;&#61480;&#61538;&#61481;&#61472;&#61506;&#61561;&#61472;&#61537;&#61539;&#61547;&#61550;&#61551;&#61559;&#61548;&#61541;&#61540;&#61543;&#61545;&#61550;&#61543;&#61472;&#61554;&#61541;&#61539;&#61541;&#61545;&#61552;&#61556;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61545;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61472;&#61551;&#61550;&#61472;&#61541;&#61537;&#61539;&#61544;&#61472;&#61539;&#61551;&#61552;&#61561;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61541;&#61472;&#61551;&#61542;&#61542;&#61541;&#61554;&#61472;&#61555;&#61557;&#61538;&#61549;&#61545;&#61556;&#61556;&#61541;&#61540; &#61499;&#61472;&#61551;&#61554;&#61472;&#61480;&#61539;&#61481;&#61472;&#61506;&#61561;&#61472; &#61555;&#61541;&#61552;&#61537;&#61554;&#61537;&#61556;&#61541;&#61472;&#61548;&#61541;&#61556;&#61556;&#61541;&#61554;&#61472;&#61551;&#61554;&#61472;&#61541;&#61548;&#61541;&#61539;&#61556;&#61554;&#61551;&#61550;&#61545;&#61539;&#61472;&#61539;&#61551;&#61549;&#61549;&#61557;&#61550;&#61545;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61559;&#61544;&#61545;&#61539;&#61544;&#61472;&#61545;&#61550;&#61539;&#61548;&#61557;&#61540;&#61541;&#61555;&#61472;&#61537;&#61472;&#61554;&#61541;&#61542;&#61541;&#61554;&#61541;&#61550;&#61539;&#61541;&#61472;&#61556;&#61551;&#61472;&#61556;&#61544;&#61541;&#61472;&#61555;&#61551;&#61548;&#61545;&#61539;&#61545;&#61556;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61537;&#61550;&#61540;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61472;&#61550;&#61557;&#61549;&#61538;&#61541;&#61554;&#61555;&#61486;&#61472;&#61472; &#61510;&#61505;&#61513;&#61516;&#61525;&#61522;&#61509;&#61472;&#61519;&#61510;&#61472;&#61529;&#61519;&#61525;&#61522;&#61472;&#61505;&#61507;&#61515;&#61518;&#61519;&#61527;&#61516;&#61509;&#61508;&#61511;&#61509;&#61517;&#61509;&#61518;&#61524;&#61472;&#61524;&#61519;&#61472;&#61506;&#61509;&#61472; &#61522;&#61509;&#61507;&#61509;&#61513;&#61526;&#61509;&#61508;&#61472;&#61505;&#61524;&#61472;&#61524;&#61512;&#61509;&#61472;&#61520;&#61516;&#61505;&#61507;&#61509;&#61472;&#61508;&#61509;&#61523;&#61513;&#61511;&#61518;&#61505;&#61524;&#61509;&#61508;&#61472;&#61510;&#61519;&#61522;&#61472;&#61524;&#61512;&#61509;&#61472;&#61522;&#61509;&#61507;&#61509;&#61513;&#61520;&#61524;&#61472;&#61519;&#61510;&#61472;&#61519;&#61510;&#61510;&#61509;&#61522;&#61523;&#61472;&#61520;&#61522;&#61513;&#61519;&#61522;&#61472;&#61524;&#61519;&#61472;&#61524;&#61512;&#61509;&#61472;&#61512;&#61519;&#61525;&#61522;&#61472;&#61505;&#61518;&#61508;&#61472;&#61508;&#61505;&#61524;&#61509;&#61472;&#61523;&#61520;&#61509;&#61507;&#61513;&#61510;&#61513;&#61509;&#61508;&#61472;&#61517;&#61505;&#61529;&#61472;&#61522;&#61509;&#61523;&#61525;&#61516;&#61524;&#61472;&#61513;&#61518;&#61472;&#61522;&#61509;&#61514;&#61509;&#61507;&#61524;&#61513;&#61519;&#61518;&#61472;&#61519;&#61510;&#61472;&#61529;&#61519;&#61525;&#61522;&#61472; &#61519;&#61510;&#61510;&#61509;&#61522;&#61486;&#61472;&#61472;&#61513;&#61542;&#61472;&#61538;&#61561;&#61472;&#61558;&#61545;&#61554;&#61556;&#61557;&#61541;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61545;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61472;&#61561;&#61551;&#61557;&#61472;&#61540;&#61541;&#61555;&#61545;&#61554;&#61541;&#61472;&#61556;&#61551;&#61472;&#61539;&#61544;&#61537;&#61550;&#61543;&#61541;&#61472;&#61537;&#61550;&#61472;&#61551;&#61542;&#61542;&#61541;&#61554;&#61472;&#61537;&#61548;&#61554;&#61541;&#61537;&#61540;&#61561;&#61472;&#61555;&#61557;&#61538;&#61549;&#61545;&#61556;&#61556;&#61541;&#61540; &#61484;&#61472;&#61555;&#61557;&#61539;&#61544;&#61472;&#61539;&#61544;&#61537;&#61550;&#61543;&#61541;&#61472;&#61549;&#61537;&#61561;&#61472;&#61538;&#61541;&#61472;&#61549;&#61537;&#61540;&#61541;&#61472;&#61538;&#61561;&#61472;&#61548;&#61541;&#61556;&#61556;&#61541;&#61554;&#61472;&#61551;&#61554;&#61472;&#61541;&#61548;&#61541;&#61539;&#61556;&#61554;&#61551;&#61550;&#61545;&#61539;&#61472;&#61539;&#61551;&#61549;&#61549;&#61557;&#61550;&#61545;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61484;&#61472;&#61552;&#61554;&#61551;&#61558;&#61545;&#61540;&#61541;&#61540;&#61472; &#61541;&#61537;&#61539;&#61544;&#61472;&#61548;&#61541;&#61556;&#61556;&#61541;&#61554;&#61472;&#61551;&#61554;&#61472;&#61541;&#61548;&#61541;&#61539;&#61556;&#61554;&#61551;&#61550;&#61545;&#61539;&#61472;&#61539;&#61551;&#61549;&#61549;&#61557;&#61550;&#61545;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61549;&#61537;&#61547;&#61541;&#61555;&#61472;&#61554;&#61541;&#61542;&#61541;&#61554;&#61541;&#61550;&#61539;&#61541;&#61472;&#61556;&#61551;&#61472;&#61556;&#61544;&#61541;&#61472;&#61555;&#61551;&#61548;&#61545;&#61539;&#61545;&#61556;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61537;&#61550;&#61540;&#61472;&#61556;&#61544;&#61545;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61484;&#61472;&#61537;&#61550;&#61540;&#61472;&#61545;&#61555;&#61472;&#61554;&#61541;&#61539;&#61541;&#61545;&#61558;&#61541;&#61540;&#61472;&#61552;&#61554;&#61545;&#61551;&#61554;&#61472;&#61556;&#61551;&#61472;&#61556;&#61544;&#61541;&#61472;&#61551;&#61552;&#61541;&#61550;&#61545;&#61550;&#61543;&#61472;&#61544;&#61551;&#61557;&#61554;&#61472;&#61537;&#61550;&#61540;&#61472;&#61540;&#61537;&#61556;&#61541;&#61472;&#61555;&#61552;&#61541;&#61539;&#61545;&#61542;&#61545;&#61541;&#61540;&#61486; &#61523;&#61541;&#61541;&#61472;&#61523;&#61539;&#61544;&#61541;&#61540;&#61557;&#61548;&#61541; &#61511;&#61505;&#61513;&#61524;&#61512;&#61509;&#61522;&#61523;&#61506;&#61525;&#61522;&#61511;&#61472;&#61517;&#61508;&#61472;&#61490;&#61488;&#61496;&#61495;&#61497;&#61491;&#61492;&#61489;&#61497; &#61489;&#61491;&#61494;&#61493;&#61496;&#61494;&#61497; &#61509;&#61517;&#61509;&#61522;&#61511;&#61509;&#61518;&#61524;&#61472;&#61520;&#61522;&#61519;&#61508;&#61525;&#61507;&#61524;&#61472;&#61508;&#61509;&#61526;&#61509;&#61516;&#61519;&#61520;&#61517;&#61509;&#61518;&#61524;&#61472;&#61511;&#61505;&#61513;&#61524;&#61512;&#61509;&#61522;&#61523;&#61506;&#61525;&#61522;&#61511;&#61472;&#61513;&#61518;&#61507;&#61486;&#61472; &#61505;&#61523;&#61520;&#61522;&#61487;&#61523;&#61518;&#61523; &#61505;&#61524;&#61516;&#61505;&#61518;&#61524;&#61505;&#61484;&#61472;&#61511;&#61505;&#61472;&#61491;&#61488;&#61491;&#61492;&#61489; &#61490;&#61497;&#61492;&#61493;&#61472;&#61510;&#61516;&#61519;&#61527;&#61509;&#61522;&#61523;&#61472;&#61522;&#61519;&#61505;&#61508; &#61505;&#61523;&#61520;&#61522;&#61487;&#61523;&#61518;&#61523; &#61525;&#61523;&#61472;&#61508;&#61509;&#61520;&#61524;&#61472;&#61519;&#61510;&#61472;&#61512;&#61509;&#61505;&#61516;&#61524;&#61512;&#61472;&#61478;&#61472;&#61512;&#61525;&#61517;&#61505;&#61518;&#61472;&#61523;&#61509;&#61522;&#61526;&#61513;&#61507;&#61509;&#61523; &#61505;&#61523;&#61520;&#61522;&#61487;&#61523;&#61518;&#61523; &#61505;&#61524;&#61516;&#61505;&#61518;&#61524;&#61505;&#61484;&#61472;&#61511;&#61505;&#61472;&#61491;&#61488;&#61491;&#61492;&#61489; &#61490;&#61497;&#61492;&#61493;&#61472;&#61510;&#61516;&#61519;&#61527;&#61509;&#61522;&#61523;&#61472;&#61522;&#61519;&#61505;&#61508; &#61505;&#61523;&#61520;&#61522;&#61487;&#61523;&#61518;&#61523; &#61505;&#61523;&#61520;&#61522;&#61487;&#61523;&#61518;&#61523; &#61523;&#61541;&#61541;&#61472;&#61506;&#61548;&#61551;&#61539;&#61547;&#61472;&#61489;&#61494;&#61507;&#61520;&#61488;&#61488;&#61488;&#61488;&#61497; &#61472;&#61491;&#61489; &#61489;&#61491;&#61486;&#61472;&#61524;&#61512;&#61513;&#61523;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61519;&#61518;&#61516;&#61529;&#61472;&#61505;&#61520;&#61520;&#61516;&#61513;&#61509;&#61523;&#61472;&#61524;&#61519;&#61472;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61507;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61519;&#61510;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61523;&#61487;&#61519;&#61522;&#61508;&#61509;&#61522;&#61523;&#61486;&#61472;&#61472;&#61513;&#61524;&#61472;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61509;&#61523;&#61472;&#61524;&#61512;&#61509;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61487;&#61519;&#61522;&#61508;&#61509;&#61522;&#61472;&#61518;&#61519;&#61486;&#61472;&#61505;&#61523;&#61472;&#61508;&#61509;&#61523;&#61507;&#61522;&#61513;&#61506;&#61509;&#61508;&#61472;&#61513;&#61518;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61492;&#61486; &#61489;&#61490;&#61486;&#61472;&#61505;&#61507;&#61507;&#61519;&#61525;&#61518;&#61524;&#61513;&#61518;&#61511;&#61472;&#61505;&#61518;&#61508;&#61472;&#61505;&#61520;&#61520;&#61522;&#61519;&#61520;&#61522;&#61513;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61508;&#61505;&#61524;&#61505;&#61472;&#61480;&#61513;&#61542;&#61472;&#61554;&#61541;&#61553;&#61557;&#61545;&#61554;&#61541;&#61540;&#61481; &#61545;&#61555;&#61472;&#61550;&#61551;&#61556;&#61472;&#61541;&#61560;&#61556;&#61541;&#61550;&#61540;&#61541;&#61540;&#61486;&#61545;&#61555;&#61472;&#61541;&#61560;&#61556;&#61541;&#61550;&#61540;&#61541;&#61540;&#61484;&#61472; &#61513;&#61556;&#61541;&#61549;&#61555;&#61472;&#61496;&#61472;&#61537;&#61550;&#61540;&#61472;&#61489;&#61493;&#61484;&#61472;&#61537;&#61550;&#61540;&#61472;&#61554;&#61541;&#61556;&#61557;&#61554;&#61550;&#61545;&#61550;&#61543; &#61519;&#61542;&#61542;&#61541;&#61554;&#61555;&#61472;&#61549;&#61557;&#61555;&#61556;&#61472;&#61537;&#61539;&#61547;&#61550;&#61551;&#61559;&#61548;&#61541;&#61540;&#61543;&#61541;&#61472;&#61554;&#61541;&#61539;&#61541;&#61545;&#61552;&#61556;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61545;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61472;&#61552;&#61554;&#61545;&#61551;&#61554;&#61472;&#61556;&#61551;&#61472;&#61556;&#61544;&#61541;&#61472;&#61544;&#61551;&#61557;&#61554;&#61472;&#61537;&#61550;&#61540;&#61472;&#61540;&#61537;&#61556;&#61541;&#61472;&#61555;&#61552;&#61541;&#61539;&#61545;&#61542;&#61545;&#61541;&#61540;&#61472;&#61545;&#61550;&#61472;&#61556;&#61544;&#61541;&#61472;&#61555;&#61551;&#61548;&#61545;&#61539;&#61545;&#61556;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61551;&#61554;&#61472;&#61537;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61541;&#61540; &#61484;&#61472;&#61538;&#61561;&#61472;&#61551;&#61550;&#61541;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61541;&#61472;&#61542;&#61551;&#61548;&#61548;&#61551;&#61559;&#61545;&#61550;&#61543;&#61472;&#61549;&#61541;&#61556;&#61544;&#61551;&#61540;&#61555;&#61498;&#61472;&#61480;&#61537;&#61481;&#61472;&#61506;&#61561;&#61472;&#61539;&#61551;&#61549;&#61552;&#61548;&#61541;&#61556;&#61545;&#61550;&#61543; &#61524;&#61544;&#61541;&#61472;&#61537;&#61538;&#61551;&#61558;&#61541;&#61472;&#61550;&#61557;&#61549;&#61538;&#61541;&#61554;&#61541;&#61540;&#61472;&#61555;&#61551;&#61548;&#61545;&#61539;&#61545;&#61556;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61545;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61541;&#61540;&#61472;&#61537;&#61555;&#61472;&#61555;&#61541;&#61556;&#61472;&#61542;&#61551;&#61554;&#61556;&#61544;&#61472;&#61545;&#61550;&#61472;&#61513;&#61556;&#61541;&#61549;&#61472;&#61489;&#61492;&#61486;&#61472;&#61472; &#61524;&#61544;&#61541;&#61472;&#61544;&#61551;&#61557;&#61554;&#61472;&#61537;&#61550;&#61540;&#61472;&#61540;&#61537;&#61556;&#61541;&#61472;&#61555;&#61552;&#61541;&#61539;&#61545;&#61542;&#61545;&#61541;&#61540;&#61472;&#61542;&#61551;&#61554;&#61472;&#61554;&#61541;&#61539;&#61541;&#61545;&#61552;&#61556;&#61472;&#61551;&#61542;&#61472;&#61519;&#61542;&#61542;&#61541;&#61554;&#61555; &#61489;&#61489;&#61486;&#61472;&#61524;&#61512;&#61513;&#61523;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61519;&#61518;&#61516;&#61529;&#61472;&#61505;&#61520;&#61520;&#61516;&#61513;&#61509;&#61523;&#61472;&#61524;&#61519;&#61472;&#61505;&#61517;&#61509;&#61518;&#61508;&#61517;&#61509;&#61518;&#61524;&#61523;&#61472;&#61519;&#61510;&#61472;&#61523;&#61519;&#61516;&#61513;&#61507;&#61513;&#61524;&#61505;&#61524;&#61513;&#61519;&#61518;&#61523; &#61510;&#61505;&#61507;&#61513;&#61516;&#61513;&#61524;&#61529;&#61472;&#61507;&#61519;&#61508;&#61509;&#61472;&#61507;&#61519;&#61508;&#61509;&#61472; &#61489;&#61488;&#61506;&#61486;&#61472;&#61508;&#61505;&#61524;&#61509;&#61508;&#61472;&#61480;&#61523;&#61509;&#61509;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61491;&#61481; &#61489;&#61488;&#61505;&#61486;&#61472;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61507;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61519;&#61510;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61487;&#61519;&#61522;&#61508;&#61509;&#61522;&#61472;&#61518;&#61519;&#61486; &#61497;&#61506;&#61486;&#61472;&#61508;&#61505;&#61524;&#61509;&#61508;&#61472;&#61480;&#61523;&#61509;&#61509;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61489;&#61481; &#61497;&#61505;&#61486;&#61472;&#61505;&#61517;&#61509;&#61518;&#61508;&#61517;&#61509;&#61518;&#61524;&#61472;&#61519;&#61510;&#61472;&#61523;&#61519;&#61516;&#61513;&#61507;&#61513;&#61524;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61518;&#61519;&#61486; &#61507;&#61519;&#61508;&#61509;&#61472; &#61496;&#61486;&#61472;&#61518;&#61505;&#61517;&#61509;&#61472;&#61505;&#61518;&#61508;&#61472;&#61505;&#61508;&#61508;&#61522;&#61509;&#61523;&#61523;&#61472;&#61519;&#61510;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61519;&#61522;&#61472;&#61480;&#61518;&#61551;&#61486;&#61484;&#61472;&#61555;&#61556;&#61554;&#61541;&#61541;&#61556;&#61484;&#61472;&#61539;&#61551;&#61557;&#61550;&#61556;&#61561;&#61484;&#61472;&#61523;&#61556;&#61537;&#61556;&#61541;&#61472;&#61537;&#61550;&#61540;&#61472;&#61530;&#61513;&#61520;&#61472;&#61507;&#61551;&#61540;&#61541;&#61481; &#61495;&#61486;&#61472;&#61505;&#61508;&#61517;&#61513;&#61518;&#61513;&#61523;&#61524;&#61509;&#61522;&#61509;&#61508;&#61472;&#61506;&#61529;&#61472;&#61480;&#61513;&#61542;&#61472;&#61551;&#61556;&#61544;&#61541;&#61554;&#61472;&#61556;&#61544;&#61537;&#61550;&#61472;&#61513;&#61556;&#61541;&#61549;&#61472;&#61494;&#61481;&#61507;&#61519;&#61508;&#61509;&#61472;&#61494;&#61486;&#61472;&#61513;&#61523;&#61523;&#61525;&#61509;&#61508;&#61472;&#61506;&#61529; &#61520;&#61505;&#61511;&#61509;&#61472;&#61472;&#61472;&#61519;&#61510;&#61472;&#61472;&#61520;&#61505;&#61511;&#61509;&#61523; &#61492;&#61486;&#61472;&#61522;&#61509;&#61521;&#61525;&#61513;&#61523;&#61513;&#61524;&#61513;&#61519;&#61518;&#61487;&#61520;&#61525;&#61522;&#61507;&#61512;&#61505;&#61523;&#61509;&#61472;&#61522;&#61509;&#61521;&#61486;&#61472;&#61518;&#61519;&#61486;&#61491;&#61486;&#61472;&#61509;&#61510;&#61510;&#61509;&#61507;&#61524;&#61513;&#61526;&#61509;&#61472;&#61508;&#61505;&#61524;&#61509;&#61490;&#61486;&#61472;&#61505;&#61517;&#61509;&#61518;&#61508;&#61517;&#61509;&#61518;&#61524;&#61487;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61507;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61472;&#61518;&#61519;&#61486;&#61472; &#61493;&#61486;&#61472;&#61520;&#61522;&#61519;&#61514;&#61509;&#61507;&#61524;&#61472;&#61518;&#61519;&#61486;&#61472;&#61480;&#61513;&#61542;&#61472;&#61537;&#61552;&#61552;&#61548;&#61545;&#61539;&#61537;&#61538;&#61548;&#61541;&#61481; &#61489;&#61486;&#61472;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61472;&#61513;&#61508;&#61472;&#61507;&#61519;&#61508;&#61509; &#61505;&#61517;&#61509;&#61518;&#61508;&#61517;&#61509;&#61518;&#61524;&#61472;&#61519;&#61510;&#61472;&#61523;&#61519;&#61516;&#61513;&#61507;&#61513;&#61524;&#61505;&#61524;&#61513;&#61519;&#61518;&#61487;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61507;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61519;&#61510;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524; &#61488;&#61496;&#61487;&#61491;&#61488;&#61487;&#61490;&#61488;&#61489;&#61497; &#61505;&#61556;&#61556;&#61550;&#61498;&#61472;&#61523;&#61524;&#61509;&#61526;&#61509;&#61472;&#61472;&#61522;&#61505;&#61517;&#61506;&#61519; &#61509;&#61517;&#61509;&#61522;&#61511;&#61509;&#61518;&#61524;&#61472;&#61520;&#61522;&#61519;&#61508;&#61525;&#61507;&#61524;&#61472;&#61508;&#61509;&#61526;&#61509;&#61516;&#61519;&#61520;&#61517;&#61509;&#61518;&#61524;&#61472;&#61511;&#61505;&#61513;&#61524;&#61512;&#61509; &#61491;&#61488;&#61488;&#61472;&#61520;&#61522;&#61519;&#61510;&#61509;&#61523;&#61523;&#61513;&#61519;&#61518;&#61505;&#61516;&#61472;&#61508;&#61522; &#61518;&#61541;&#61556;&#61472;&#61508;&#61541;&#61539;&#61554;&#61541;&#61537;&#61555;&#61541;&#61498; [**] &#61507;&#61512;&#61509;&#61507;&#61515;&#61472;&#61519;&#61518;&#61509; &#61505;&#61486;&#61472;&#61524;&#61512;&#61513;&#61523;&#61472;&#61507;&#61512;&#61505;&#61518;&#61511;&#61509;&#61472;&#61519;&#61522;&#61508;&#61509;&#61522;&#61472;&#61513;&#61523;&#61472;&#61513;&#61523;&#61523;&#61525;&#61509;&#61508;&#61472;&#61520;&#61525;&#61522;&#61523;&#61525;&#61505;&#61518;&#61524;&#61472;&#61524;&#61519;&#61498;&#61472;&#61480;&#61523;&#61552;&#61541;&#61539;&#61545;&#61542;&#61561;&#61472;&#61537;&#61557;&#61556;&#61544;&#61551;&#61554;&#61545;&#61556;&#61561;&#61481;&#61472;&#61472;&#61524;&#61512;&#61509;&#61472;&#61507;&#61512;&#61505;&#61518;&#61511;&#61509;&#61523;&#61472;&#61523;&#61509;&#61524;&#61472;&#61510;&#61519;&#61522;&#61524;&#61512;&#61472;&#61513;&#61518;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61492;&#61472;&#61505;&#61522;&#61509;&#61472;&#61517;&#61505;&#61508;&#61509;&#61472;&#61513;&#61518;&#61472;&#61524;&#61512;&#61509;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524; &#61506;&#61486;&#61472;&#61524;&#61512;&#61509;&#61472;&#61505;&#61506;&#61519;&#61526;&#61509;&#61472;&#61518;&#61525;&#61517;&#61506;&#61509;&#61522;&#61509;&#61508;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61487;&#61519;&#61522;&#61508;&#61509;&#61522;&#61472;&#61513;&#61523;&#61472;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61509;&#61508;&#61472;&#61524;&#61519;&#61472;&#61522;&#61509;&#61510;&#61516;&#61509;&#61507;&#61524;&#61472;&#61524;&#61512;&#61509;&#61472;&#61505;&#61508;&#61517;&#61513;&#61518;&#61513;&#61523;&#61524;&#61522;&#61505;&#61524;&#61513;&#61526;&#61509;&#61472;&#61507;&#61512;&#61505;&#61518;&#61511;&#61509;&#61523;&#61472;&#61480;&#61555;&#61557;&#61539;&#61544;&#61472;&#61537;&#61555;&#61472;&#61539;&#61544;&#61537;&#61550;&#61543;&#61541;&#61555;&#61472;&#61545;&#61550;&#61472;&#61552;&#61537;&#61561;&#61545;&#61550;&#61543;&#61472;&#61551;&#61542;&#61542;&#61545;&#61539;&#61541;&#61484;&#61472; &#61507;&#61486;&#61472;&#61524;&#61512;&#61513;&#61523;&#61472;&#61523;&#61525;&#61520;&#61520;&#61516;&#61509;&#61517;&#61509;&#61518;&#61524;&#61505;&#61516;&#61472;&#61505;&#61511;&#61522;&#61509;&#61509;&#61517;&#61509;&#61518;&#61524;&#61472;&#61513;&#61523;&#61472;&#61509;&#61518;&#61524;&#61509;&#61522;&#61509;&#61508;&#61472;&#61513;&#61518;&#61524;&#61519;&#61472;&#61520;&#61525;&#61522;&#61523;&#61525;&#61505;&#61518;&#61524;&#61472;&#61524;&#61519;&#61472;&#61505;&#61525;&#61524;&#61512;&#61519;&#61522;&#61513;&#61524;&#61529;&#61472;&#61519;&#61510;&#61498; &#61508;&#61486;&#61472;&#61519;&#61524;&#61512;&#61509;&#61522;&#61472;&#61480;&#61523;&#61552;&#61541;&#61539;&#61545;&#61542;&#61561;&#61472;&#61556;&#61561;&#61552;&#61541;&#61472;&#61551;&#61542;&#61472;&#61549;&#61551;&#61540;&#61545;&#61542;&#61545;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61537;&#61550;&#61540;&#61472;&#61537;&#61557;&#61556;&#61544;&#61551;&#61554;&#61545;&#61556;&#61561;&#61481; &#61472;&#61537;&#61552;&#61552;&#61554;&#61551;&#61552;&#61554;&#61545;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61540;&#61537;&#61556;&#61537;&#61484;&#61472;&#61541;&#61556;&#61539;&#61486;&#61481;&#61472;&#61472;&#61523;&#61509;&#61524;&#61472;&#61510;&#61519;&#61522;&#61524;&#61512;&#61472;&#61513;&#61518;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61492;&#61484;&#61472;&#61520;&#61525;&#61522;&#61523;&#61525;&#61505;&#61518;&#61524;&#61472;&#61524;&#61519;&#61472;&#61524;&#61512;&#61509;&#61472;&#61505;&#61525;&#61524;&#61512;&#61519;&#61522;&#61513;&#61524;&#61529;&#61472;&#61519;&#61510;&#61472;&#61510;&#61505;&#61522;&#61472;&#61492;&#61491;&#61486;&#61489;&#61488;&#61491;&#61480;&#61538;&#61481;&#61486; &#61509;&#61486;&#61472;&#61513;&#61517;&#61520;&#61519;&#61522;&#61524;&#61505;&#61518;&#61524;&#61498; &#61507;&#61551;&#61550;&#61556;&#61554;&#61537;&#61539;&#61556;&#61551;&#61554;&#61472; &#61545;&#61555;&#61472;&#61550;&#61551;&#61556;&#61472; &#61545;&#61555;&#61472;&#61554;&#61541;&#61553;&#61557;&#61545;&#61554;&#61541;&#61540;&#61472;&#61556;&#61551;&#61472;&#61555;&#61545;&#61543;&#61550;&#61472;&#61556;&#61544;&#61545;&#61555;&#61472;&#61540;&#61551;&#61539;&#61557;&#61549;&#61541;&#61550;&#61556;&#61472;&#61537;&#61550;&#61540;&#61472;&#61554;&#61541;&#61556;&#61557;&#61554;&#61550;&#61472;&#61472; &#61472;&#61472;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535; &#61539;&#61551;&#61552;&#61545;&#61541;&#61555;&#61472;&#61556;&#61551;&#61472;&#61556;&#61544;&#61541;&#61472;&#61545;&#61555;&#61555;&#61557;&#61545;&#61550;&#61543;&#61472;&#61551;&#61542;&#61542;&#61545;&#61539;&#61541;&#61486; &#61472;&#61519;&#61522;&#61508;&#61509;&#61522;&#61472;&#61518;&#61519;&#61486;&#61472;&#61513;&#61518;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61488;&#61505;&#61486; &#61506;&#61545;&#61548;&#61537;&#61556;&#61541;&#61554;&#61537;&#61548;&#61472;&#61517;&#61551;&#61540;&#61545;&#61542;&#61545;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61538;&#61561;&#61472;&#61517;&#61557;&#61556;&#61557;&#61537;&#61548;&#61472;&#61505;&#61543;&#61554;&#61541;&#61541;&#61549;&#61541;&#61550;&#61556;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61541;&#61472;&#61520;&#61537;&#61554;&#61556;&#61545;&#61541;&#61555; &#61560; &#61528; &#61472;&#61489; &#61489;&#61494;&#61505;&#61486;&#61472;&#61518;&#61505;&#61517;&#61509;&#61472;&#61472;&#61505;&#61518;&#61508;&#61472;&#61524;&#61513;&#61524;&#61516;&#61509;&#61472;&#61519;&#61510;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61513;&#61518;&#61511;&#61472;&#61519;&#61510;&#61510;&#61513;&#61507;&#61509;&#61522;&#61472;&#61480;&#61524;&#61561;&#61552;&#61541;&#61472;&#61551;&#61554;&#61472;&#61552;&#61554;&#61545;&#61550;&#61556;&#61481;&#61489;&#61493;&#61505;&#61486;&#61472;&#61518;&#61505;&#61517;&#61509;&#61472;&#61505;&#61518;&#61508;&#61472;&#61524;&#61513;&#61524;&#61516;&#61509;&#61472;&#61519;&#61510;&#61472;&#61523;&#61513;&#61511;&#61518;&#61509;&#61522;&#61472;&#61480;&#61524;&#61561;&#61552;&#61541;&#61472;&#61551;&#61554;&#61472;&#61552;&#61554;&#61545;&#61550;&#61556;&#61481; &#61489;&#61493;&#61507;&#61486;&#61472;&#61508;&#61505;&#61524;&#61509;&#61472;&#61523;&#61513;&#61511;&#61518;&#61509;&#61508; &#61489;&#61494;&#61506;&#61486;&#61472;&#61525;&#61518;&#61513;&#61524;&#61509;&#61508;&#61472;&#61523;&#61524;&#61505;&#61524;&#61509;&#61523;&#61472;&#61519;&#61510;&#61472;&#61505;&#61517;&#61509;&#61522;&#61513;&#61507;&#61505;&#61472;&#61489;&#61493;&#61506;&#61486;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61519;&#61522;&#61487;&#61519;&#61510;&#61510;&#61509;&#61522;&#61519;&#61522; &#61489;&#61494;&#61507;&#61486;&#61472;&#61508;&#61505;&#61524;&#61509;&#61472;&#61523;&#61513;&#61511;&#61518;&#61509;&#61508; &#61480;&#61523;&#61545;&#61543;&#61550;&#61537;&#61556;&#61557;&#61554;&#61541;&#61472;&#61551;&#61542;&#61472;&#61552;&#61541;&#61554;&#61555;&#61551;&#61550;&#61472;&#61537;&#61557;&#61556;&#61544;&#61551;&#61554;&#61545;&#61562;&#61541;&#61540;&#61472;&#61556;&#61551;&#61472;&#61555;&#61545;&#61543;&#61550;&#61481; &#61480;&#61523;&#61545;&#61543;&#61550;&#61537;&#61556;&#61557;&#61554;&#61541;&#61472;&#61551;&#61542;&#61472;&#61507;&#61551;&#61550;&#61556;&#61554;&#61537;&#61539;&#61556;&#61545;&#61550;&#61543;&#61472;&#61519;&#61542;&#61542;&#61545;&#61539;&#61541;&#61554;&#61481; &#61515;&#61513;&#61517;&#61506;&#61509;&#61522;&#61516;&#61529;&#61472;&#61516;&#61486;&#61472;&#61511;&#61519;&#61516;&#61508;&#61509;&#61518; &#61523;&#61524;&#61505;&#61518;&#61508;&#61505;&#61522;&#61508;&#61472;&#61510;&#61519;&#61522;&#61517;&#61472;&#61491;&#61488;&#61472;&#61480;&#61522;&#61509;&#61526;&#61486;&#61472;&#61489;&#61489;&#61487;&#61490;&#61488;&#61489;&#61494;&#61481; &#61520;&#61554;&#61541;&#61555;&#61539;&#61554;&#61545;&#61538;&#61541;&#61540;&#61472;&#61538;&#61561;&#61472;&#61511;&#61523;&#61505;&#61472;&#61510;&#61505;&#61522;&#61472;&#61480;&#61492;&#61496;&#61472;&#61507;&#61510;&#61522;&#61481;&#61472;&#61493;&#61491;&#61486;&#61490;&#61492;&#61491; &#61520;&#61554;&#61541;&#61558;&#61545;&#61551;&#61557;&#61555;&#61472;&#61541;&#61540;&#61545;&#61556;&#61545;&#61551;&#61550;&#61472;&#61557;&#61550;&#61557;&#61555;&#61537;&#61538;&#61548;&#61541; &#61489;&#61492;&#61486;&#61472;&#61508;&#61509;&#61523;&#61507;&#61522;&#61513;&#61520;&#61524;&#61513;&#61519;&#61518;&#61472;&#61519;&#61510;&#61472;&#61505;&#61517;&#61509;&#61518;&#61508;&#61517;&#61509;&#61518;&#61524;&#61487;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61507;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61480;&#61519;&#61554;&#61543;&#61537;&#61550;&#61545;&#61562;&#61541;&#61540;&#61472;&#61538;&#61561;&#61472;&#61525;&#61507;&#61510;&#61472;&#61555;&#61541;&#61539;&#61556;&#61545;&#61551;&#61550;&#61472;&#61544;&#61541;&#61537;&#61540;&#61545;&#61550;&#61543;&#61555;&#61484;&#61472;&#61545;&#61550;&#61539;&#61548;&#61557;&#61540;&#61545;&#61550;&#61543;&#61472;&#61555;&#61551;&#61548;&#61545;&#61539;&#61545;&#61556;&#61537;&#61556;&#61545;&#61551;&#61550;&#61487;&#61539;&#61551;&#61550;&#61556;&#61554;&#61537;&#61539;&#61556;&#61472;&#61555;&#61557;&#61538;&#61546;&#61541;&#61539;&#61556;&#61472;&#61549;&#61537;&#61556;&#61556;&#61541;&#61554;&#61472;&#61559;&#61544;&#61541;&#61554;&#61541;&#61472;&#61542;&#61541;&#61537;&#61555;&#61545;&#61538;&#61548;&#61541;&#61486;&#61481; &#61524;&#61537;&#61560;&#61472;&#61513;&#61508;&#61472;&#61518;&#61557;&#61549;&#61538;&#61541;&#61554;&#61498;&#61472;&#61472;[**] &#61508;&#61525;&#61518;&#61523;&#61472;&#61518;&#61557;&#61549;&#61538;&#61541;&#61554;&#61498;&#61472;&#61472;[**] &#61525;&#61509;&#61513;&#61498;&#61472;&#61507;&#61518;&#61520;&#61526;&#61507;&#61522;&#61496;&#61508;&#61515;&#61495;&#61517;&#61496; &#61520;&#61551;&#61545;&#61550;&#61556;&#61555;&#61472;&#61551;&#61542;&#61472;&#61507;&#61551;&#61550;&#61556;&#61537;&#61539;&#61556;&#61498; &#61507;&#61519;&#61522;&#61498;[**] &#61507;&#61519;&#61498;&#61472;[**] &#61505;&#61523;&#61520;&#61522;&#61472;&#61507;&#61551;&#61550;&#61556;&#61554;&#61537;&#61539;&#61556;&#61555;&#61472;&#61507;&#61551;&#61550;&#61555;&#61557;&#61548;&#61556;&#61537;&#61550;&#61556;&#61498;&#61472;[**] &#61509;&#61517;&#61509;&#61522;&#61511;&#61509;&#61518;&#61524;&#61498;&#61472;[**] &#61507;&#61551;&#61550;&#61556;&#61545;&#61550;&#61557;&#61541;&#61540;&#61472;&#61486;&#61486;&#61486; &#61509;&#61560;&#61539;&#61541;&#61552;&#61556;&#61472;&#61537;&#61555;&#61472;&#61552;&#61554;&#61551;&#61558;&#61545;&#61540;&#61541;&#61540;&#61472;&#61544;&#61541;&#61554;&#61541;&#61545;&#61550;&#61484;&#61472;&#61537;&#61548;&#61548;&#61472;&#61556;&#61541;&#61554;&#61549;&#61555;&#61472;&#61537;&#61550;&#61540;&#61472;&#61539;&#61551;&#61550;&#61540;&#61545;&#61556;&#61545;&#61551;&#61550;&#61555;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61541;&#61472;&#61540;&#61551;&#61539;&#61557;&#61549;&#61541;&#61550;&#61556;&#61472;&#61554;&#61541;&#61542;&#61541;&#61554;&#61541;&#61550;&#61539;&#61541;&#61540;&#61472;&#61545;&#61550;&#61472;&#61513;&#61556;&#61541;&#61549;&#61472;&#61497;&#61472;&#61505;&#61472;&#61551;&#61554;&#61472;&#61489;&#61488;&#61505;&#61484;&#61472;&#61537;&#61555;&#61472;&#61544;&#61541;&#61554;&#61541;&#61556;&#61551;&#61542;&#61551;&#61554;&#61541;&#61472;&#61539;&#61544;&#61537;&#61550;&#61543;&#61541;&#61540;&#61484;&#61472;&#61554;&#61541;&#61549;&#61537;&#61545;&#61550;&#61555;&#61472;&#61557;&#61550;&#61539;&#61544;&#61537;&#61550;&#61543;&#61541;&#61540;&#61472;&#61537;&#61550;&#61540;&#61472;&#61545;&#61550;&#61472;&#61542;&#61557;&#61548;&#61548;&#61472;&#61542;&#61551;&#61554;&#61539;&#61541;&#61472;&#61537;&#61550;&#61540;&#61472;&#61541;&#61542;&#61542;&#61541;&#61539;&#61556;&#61472;&#61486; Certain identified information has been marked in the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed.  Double asterisks denote omissions. </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno9effective002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno9effective002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">&#61513;&#61524;&#61509;&#61517;&#61472;&#61518;&#61519;&#61486; &#61523;&#61525;&#61520;&#61520;&#61516;&#61513;&#61509;&#61523;&#61487;&#61523;&#61509;&#61522;&#61526;&#61513;&#61507;&#61509;&#61523; &#61521;&#61525;&#61505;&#61518;&#61524;&#61513;&#61524;&#61529; &#61525;&#61518;&#61513;&#61524; &#61525;&#61518;&#61513;&#61524;&#61472;&#61520;&#61522;&#61513;&#61507;&#61509; &#61505;&#61517;&#61519;&#61525;&#61518;&#61524; &#61518;&#61505;&#61517;&#61509;&#61472;&#61519;&#61510;&#61472;&#61519;&#61510;&#61510;&#61509;&#61522;&#61519;&#61522;&#61472;&#61519;&#61522;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61519;&#61522; &#61472;&#61490;&#61472; &#61472;&#61491;&#61507;&#61519;&#61518;&#61524;&#61513;&#61518;&#61525;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61523;&#61512;&#61509;&#61509;&#61524; &#61522;&#61509;&#61510;&#61509;&#61522;&#61509;&#61518;&#61507;&#61509;&#61472;&#61518;&#61519;&#61486;&#61472;&#61519;&#61510;&#61472;&#61508;&#61519;&#61507;&#61525;&#61517;&#61509;&#61518;&#61524;&#61472;&#61506;&#61509;&#61513;&#61518;&#61511;&#61472;&#61507;&#61519;&#61518;&#61524;&#61513;&#61518;&#61525;&#61509;&#61508; &#61520;&#61505;&#61511;&#61509; &#61519;&#61510; &#61509;&#61517;&#61509;&#61522;&#61511;&#61509;&#61518;&#61524;&#61472;&#61520;&#61522;&#61519;&#61508;&#61525;&#61507;&#61524;&#61472;&#61508;&#61509;&#61526;&#61509;&#61516;&#61519;&#61520;&#61517;&#61509;&#61518;&#61524;&#61472;&#61511;&#61505;&#61513;&#61524;&#61512;&#61509;&#61522;&#61523;&#61506;&#61525;&#61522;&#61511;&#61472;&#61513;&#61518;&#61507;&#61486;&#61472;&#61489;&#61491;&#61494;&#61493;&#61496;&#61494;&#61497; &#61480;&#61505;&#61481; &#61480;&#61506;&#61481; &#61480;&#61507;&#61481; &#61480;&#61508;&#61481; &#61480;&#61509;&#61481; &#61480;&#61510;&#61481; &#61495;&#61493;&#61505;&#61493;&#61488;&#61489;&#61489;&#61497;&#61507;&#61488;&#61488;&#61488;&#61495;&#61489;&#61487;&#61520;&#61488;&#61488;&#61488;&#61488;&#61497; &#61491;&#61472; [**] &#61492;&#61472; [**] &#61472;&#61519;&#61524;&#61505;&#61498;&#61472;&#61518; &#61472;&#61520;&#61541;&#61554;&#61545;&#61551;&#61540;&#61472;&#61551;&#61542;&#61472;&#61520;&#61541;&#61554;&#61542;&#61551;&#61554;&#61549;&#61537;&#61550;&#61539;&#61541;&#61498;&#61472;&#61488;&#61496;&#61487;&#61491;&#61488;&#61487;&#61490;&#61488;&#61489;&#61497;&#61472;&#61556;&#61551;&#61472;&#61488;&#61496;&#61487;&#61490;&#61497;&#61487;&#61490;&#61488;&#61490;&#61497; &#61472;&#61507;&#61544;&#61537;&#61550;&#61543;&#61541;&#61472;&#61513;&#61556;&#61541;&#61549;&#61472;&#61491;&#61472;&#61556;&#61551;&#61472;&#61554;&#61541;&#61537;&#61540;&#61472;&#61537;&#61555;&#61472;&#61542;&#61551;&#61548;&#61548;&#61551;&#61559;&#61555;&#61480;&#61537;&#61549;&#61551;&#61557;&#61550;&#61556;&#61472;&#61555;&#61544;&#61551;&#61559;&#61550;&#61472;&#61545;&#61555;&#61472; &#61472;&#61556;&#61544;&#61541;&#61472;&#61551;&#61538;&#61548;&#61545;&#61543;&#61537;&#61556;&#61541;&#61540;&#61472;&#61537;&#61549;&#61551;&#61557;&#61550;&#61556;&#61481;&#61498; &#61472;&#61519;&#61552;&#61556;&#61545;&#61551;&#61550;&#61472;&#61489;&#61488;&#61488;&#61489;&#61472;&#61485;&#61472;&#61524;&#61537;&#61555;&#61547;&#61472;&#61492;&#61472;&#61472;&#61472; &#61472;&#61522;&#61541;&#61548;&#61537;&#61538;&#61541;&#61548;&#61545;&#61550;&#61543;&#61472;&#61551;&#61542;&#61472;&#61505;&#61507;&#61505;&#61517;&#61490;&#61488;&#61488;&#61488; &#61472;&#61489;&#61472;&#61514;&#61519;&#61506;&#61472;&#61504;&#61472;[**] &#61472;&#61519;&#61538;&#61548;&#61545;&#61543;&#61537;&#61556;&#61541;&#61540;&#61472;&#61505;&#61549;&#61551;&#61557;&#61550;&#61556;&#61498;&#61472;[**] &#61472;&#61505;&#61539;&#61539;&#61551;&#61557;&#61550;&#61556;&#61545;&#61550;&#61543;&#61472;&#61513;&#61550;&#61542;&#61551;&#61498; &#61472;&#61490;&#61488;&#61490;&#61488;&#61486;&#61489;&#61497;&#61497;&#61523;&#61518;&#61490;&#61488;&#61486;&#61490;&#61493;&#61490;&#61491;&#61493;&#61472;&#61505;&#61552;&#61552;&#61554;&#61486;&#61472;&#61529;&#61554;&#61486;&#61498;&#61472;&#61490;&#61488;&#61490;&#61488;&#61472;&#61507;&#61505;&#61518;&#61498;&#61472;&#61489;&#61497;&#61497;&#61523;&#61518;&#61490;&#61488;&#61472; &#61472;&#61519;&#61538;&#61546;&#61541;&#61539;&#61556;&#61472;&#61507;&#61548;&#61537;&#61555;&#61555;&#61498;&#61472;&#61490;&#61493;&#61490;&#61491;&#61493; &#61472;&#61510;&#61557;&#61550;&#61540;&#61541;&#61540;&#61498;&#61472;[**] &#61472;&#61508;&#61541;&#61548;&#61545;&#61558;&#61541;&#61554;&#61561;&#61472;&#61516;&#61551;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61498; &#61472;&#61489;&#61488;&#61494;&#61491;&#61493;&#61472;&#61517;&#61537;&#61554;&#61545;&#61550;&#61537;&#61472;&#61508;&#61554;&#61545;&#61558;&#61541; &#61472;&#61505;&#61556;&#61556;&#61550;&#61498;&#61472;&#61517;&#61545;&#61547;&#61541;&#61472;&#61515;&#61545;&#61550;&#61543; &#61472;&#61519;&#61548;&#61545;&#61558;&#61541;&#61472;&#61506;&#61554;&#61537;&#61550;&#61539;&#61544;&#61484;&#61472;&#61517;&#61523;&#61472;&#61491;&#61496;&#61494;&#61493;&#61492; &#61472;&#61507;&#61544;&#61537;&#61550;&#61543;&#61541;&#61472;&#61513;&#61556;&#61541;&#61549;&#61472;&#61492;&#61472;&#61556;&#61551;&#61472;&#61554;&#61541;&#61537;&#61540;&#61472;&#61537;&#61555;&#61472;&#61542;&#61551;&#61548;&#61548;&#61551;&#61559;&#61555;&#61480;&#61537;&#61549;&#61551;&#61557;&#61550;&#61556;&#61472;&#61555;&#61544;&#61551;&#61559;&#61550;&#61472;&#61545;&#61555;&#61472; &#61472;&#61556;&#61544;&#61541;&#61472;&#61551;&#61538;&#61548;&#61545;&#61543;&#61537;&#61556;&#61541;&#61540;&#61472;&#61537;&#61549;&#61551;&#61557;&#61550;&#61556;&#61481;&#61498; &#61472;&#61505;&#61507;&#61505;&#61517;&#61490;&#61488;&#61488;&#61488;&#61472;&#61522;&#61541;&#61548;&#61537;&#61538;&#61541;&#61548;&#61545;&#61550;&#61543;&#61472;&#61472;&#61472; &#61472;&#61519;&#61538;&#61548;&#61545;&#61543;&#61537;&#61556;&#61541;&#61540;&#61472;&#61505;&#61549;&#61551;&#61557;&#61550;&#61556;&#61498;&#61472;[**] &#61472;&#61505;&#61539;&#61539;&#61551;&#61557;&#61550;&#61556;&#61545;&#61550;&#61543;&#61472;&#61513;&#61550;&#61542;&#61551;&#61498; &#61472;&#61490;&#61488;&#61490;&#61489;&#61486;&#61489;&#61497;&#61497;&#61523;&#61518;&#61490;&#61489;&#61486;&#61490;&#61493;&#61489;&#61488;&#61490;&#61472;&#61505;&#61552;&#61552;&#61554;&#61486;&#61472;&#61529;&#61554;&#61486;&#61498;&#61472;&#61490;&#61488;&#61490;&#61489;&#61472;&#61507;&#61505;&#61518;&#61498;&#61472;&#61489;&#61497;&#61497;&#61523;&#61518;&#61490;&#61489;&#61472; &#61472;&#61519;&#61538;&#61546;&#61541;&#61539;&#61556;&#61472;&#61507;&#61548;&#61537;&#61555;&#61555;&#61498;&#61472;&#61490;&#61493;&#61489;&#61488;&#61490; &#61472;&#61510;&#61557;&#61550;&#61540;&#61541;&#61540;&#61498;&#61472;[**] &#61518;&#61523;&#61518;&#61472;&#61495;&#61493;&#61492;&#61488;&#61485;&#61488;&#61489;&#61485;&#61489;&#61493;&#61490;&#61485;&#61496;&#61488;&#61494;&#61495; &#61519;&#61520;&#61524;&#61513;&#61519;&#61518;&#61505;&#61516;&#61472;&#61510;&#61519;&#61522;&#61517;&#61472;&#61491;&#61491;&#61494;&#61472;&#61480;&#61492;&#61485;&#61496;&#61494;&#61481; &#61523;&#61552;&#61551;&#61550;&#61555;&#61551;&#61554;&#61541;&#61540;&#61472;&#61538;&#61561;&#61472;&#61511;&#61523;&#61505; &#61510;&#61505;&#61522;&#61472;&#61480;&#61492;&#61496;&#61472;&#61507;&#61510;&#61522;&#61481;&#61472;&#61493;&#61491;&#61486;&#61489;&#61489;&#61488; </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno9effective003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno9effective003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">75A50119C00071/P00009 Page 3 of 3 The purpose of this modification to the contract, P00009, is to deobligate the unliquidated funding for  Task 4, Relabeling of ACAM2000 from fiscal years 2020 and 2021 appropriations.    As a result of this deobligation action, the following changes are made:  a. The total value of Line Item 3, Task 4: Relabeling of ACAM2000, added per P00001, is hereby [**]  from a total funded value [**] to a balance of [**]. b. The total value of Line Item 4, Task 4: ACAM Relabeling, exercised per P00003, is hereby [**] from a  total funded value of [**] to a balance of [**]. c. The Total Obligated Value under the contract is hereby [**], from [**] to a Funded Balance of [**]  All other terms and conditions of the contract remain unchanged as a result of this modification,  P00009.     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>5
<FILENAME>modificationno10effectiv.htm
<DESCRIPTION>EX-10.7
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>modificationno10effectiv</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- modificationno10effectiv001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno10effectiv001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">&#61472;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535; &#61480;&#61560;&#61481; &#61560; &#61495;&#61493;&#61505;&#61493;&#61488;&#61489;&#61489;&#61497;&#61507;&#61488;&#61488;&#61488;&#61495;&#61489; &#61539;&#61551;&#61552;&#61545;&#61541;&#61555;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61541;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61499;&#61472;&#61480;&#61538;&#61481;&#61472;&#61506;&#61561;&#61472;&#61537;&#61539;&#61547;&#61550;&#61551;&#61559;&#61548;&#61541;&#61540;&#61543;&#61545;&#61550;&#61543;&#61472;&#61554;&#61541;&#61539;&#61541;&#61545;&#61552;&#61556;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61545;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61472;&#61551;&#61550;&#61472;&#61541;&#61537;&#61539;&#61544;&#61472;&#61539;&#61551;&#61552;&#61561;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61541;&#61472;&#61551;&#61542;&#61542;&#61541;&#61554;&#61472;&#61555;&#61557;&#61538;&#61549;&#61545;&#61556;&#61556;&#61541;&#61540; &#61499;&#61472;&#61551;&#61554;&#61472;&#61480;&#61539;&#61481;&#61472;&#61506;&#61561;&#61472; &#61555;&#61541;&#61552;&#61537;&#61554;&#61537;&#61556;&#61541;&#61472;&#61548;&#61541;&#61556;&#61556;&#61541;&#61554;&#61472;&#61551;&#61554;&#61472;&#61541;&#61548;&#61541;&#61539;&#61556;&#61554;&#61551;&#61550;&#61545;&#61539;&#61472;&#61539;&#61551;&#61549;&#61549;&#61557;&#61550;&#61545;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61559;&#61544;&#61545;&#61539;&#61544;&#61472;&#61545;&#61550;&#61539;&#61548;&#61557;&#61540;&#61541;&#61555;&#61472;&#61537;&#61472;&#61554;&#61541;&#61542;&#61541;&#61554;&#61541;&#61550;&#61539;&#61541;&#61472;&#61556;&#61551;&#61472;&#61556;&#61544;&#61541;&#61472;&#61555;&#61551;&#61548;&#61545;&#61539;&#61545;&#61556;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61537;&#61550;&#61540;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61472;&#61550;&#61557;&#61549;&#61538;&#61541;&#61554;&#61555;&#61486;&#61472;&#61472; &#61510;&#61505;&#61513;&#61516;&#61525;&#61522;&#61509;&#61472;&#61519;&#61510;&#61472;&#61529;&#61519;&#61525;&#61522;&#61472;&#61505;&#61507;&#61515;&#61518;&#61519;&#61527;&#61516;&#61509;&#61508;&#61511;&#61509;&#61517;&#61509;&#61518;&#61524;&#61472;&#61524;&#61519;&#61472;&#61506;&#61509;&#61472; &#61522;&#61509;&#61507;&#61509;&#61513;&#61526;&#61509;&#61508;&#61472;&#61505;&#61524;&#61472;&#61524;&#61512;&#61509;&#61472;&#61520;&#61516;&#61505;&#61507;&#61509;&#61472;&#61508;&#61509;&#61523;&#61513;&#61511;&#61518;&#61505;&#61524;&#61509;&#61508;&#61472;&#61510;&#61519;&#61522;&#61472;&#61524;&#61512;&#61509;&#61472;&#61522;&#61509;&#61507;&#61509;&#61513;&#61520;&#61524;&#61472;&#61519;&#61510;&#61472;&#61519;&#61510;&#61510;&#61509;&#61522;&#61523;&#61472;&#61520;&#61522;&#61513;&#61519;&#61522;&#61472;&#61524;&#61519;&#61472;&#61524;&#61512;&#61509;&#61472;&#61512;&#61519;&#61525;&#61522;&#61472;&#61505;&#61518;&#61508;&#61472;&#61508;&#61505;&#61524;&#61509;&#61472;&#61523;&#61520;&#61509;&#61507;&#61513;&#61510;&#61513;&#61509;&#61508;&#61472;&#61517;&#61505;&#61529;&#61472;&#61522;&#61509;&#61523;&#61525;&#61516;&#61524;&#61472;&#61513;&#61518;&#61472;&#61522;&#61509;&#61514;&#61509;&#61507;&#61524;&#61513;&#61519;&#61518;&#61472;&#61519;&#61510;&#61472;&#61529;&#61519;&#61525;&#61522;&#61472; &#61519;&#61510;&#61510;&#61509;&#61522;&#61486;&#61472;&#61472;&#61513;&#61542;&#61472;&#61538;&#61561;&#61472;&#61558;&#61545;&#61554;&#61556;&#61557;&#61541;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61545;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61472;&#61561;&#61551;&#61557;&#61472;&#61540;&#61541;&#61555;&#61545;&#61554;&#61541;&#61472;&#61556;&#61551;&#61472;&#61539;&#61544;&#61537;&#61550;&#61543;&#61541;&#61472;&#61537;&#61550;&#61472;&#61551;&#61542;&#61542;&#61541;&#61554;&#61472;&#61537;&#61548;&#61554;&#61541;&#61537;&#61540;&#61561;&#61472;&#61555;&#61557;&#61538;&#61549;&#61545;&#61556;&#61556;&#61541;&#61540; &#61484;&#61472;&#61555;&#61557;&#61539;&#61544;&#61472;&#61539;&#61544;&#61537;&#61550;&#61543;&#61541;&#61472;&#61549;&#61537;&#61561;&#61472;&#61538;&#61541;&#61472;&#61549;&#61537;&#61540;&#61541;&#61472;&#61538;&#61561;&#61472;&#61548;&#61541;&#61556;&#61556;&#61541;&#61554;&#61472;&#61551;&#61554;&#61472;&#61541;&#61548;&#61541;&#61539;&#61556;&#61554;&#61551;&#61550;&#61545;&#61539;&#61472;&#61539;&#61551;&#61549;&#61549;&#61557;&#61550;&#61545;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61484;&#61472;&#61552;&#61554;&#61551;&#61558;&#61545;&#61540;&#61541;&#61540;&#61472; &#61541;&#61537;&#61539;&#61544;&#61472;&#61548;&#61541;&#61556;&#61556;&#61541;&#61554;&#61472;&#61551;&#61554;&#61472;&#61541;&#61548;&#61541;&#61539;&#61556;&#61554;&#61551;&#61550;&#61545;&#61539;&#61472;&#61539;&#61551;&#61549;&#61549;&#61557;&#61550;&#61545;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61549;&#61537;&#61547;&#61541;&#61555;&#61472;&#61554;&#61541;&#61542;&#61541;&#61554;&#61541;&#61550;&#61539;&#61541;&#61472;&#61556;&#61551;&#61472;&#61556;&#61544;&#61541;&#61472;&#61555;&#61551;&#61548;&#61545;&#61539;&#61545;&#61556;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61537;&#61550;&#61540;&#61472;&#61556;&#61544;&#61545;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61484;&#61472;&#61537;&#61550;&#61540;&#61472;&#61545;&#61555;&#61472;&#61554;&#61541;&#61539;&#61541;&#61545;&#61558;&#61541;&#61540;&#61472;&#61552;&#61554;&#61545;&#61551;&#61554;&#61472;&#61556;&#61551;&#61472;&#61556;&#61544;&#61541;&#61472;&#61551;&#61552;&#61541;&#61550;&#61545;&#61550;&#61543;&#61472;&#61544;&#61551;&#61557;&#61554;&#61472;&#61537;&#61550;&#61540;&#61472;&#61540;&#61537;&#61556;&#61541;&#61472;&#61555;&#61552;&#61541;&#61539;&#61545;&#61542;&#61545;&#61541;&#61540;&#61486; &#61490;&#61488;&#61490;&#61491;&#61486;&#61489;&#61497;&#61497;&#61523;&#61518;&#61490;&#61491;&#61486;&#61490;&#61494;&#61488;&#61496;&#61496; &#61511;&#61505;&#61513;&#61524;&#61512;&#61509;&#61522;&#61523;&#61506;&#61525;&#61522;&#61511;&#61472;&#61517;&#61508;&#61472;&#61490;&#61488;&#61496;&#61495;&#61497;&#61491;&#61492;&#61489;&#61497; &#61489;&#61491;&#61494;&#61493;&#61496;&#61494;&#61497; &#61509;&#61517;&#61509;&#61522;&#61511;&#61509;&#61518;&#61524;&#61472;&#61520;&#61522;&#61519;&#61508;&#61525;&#61507;&#61524;&#61472;&#61508;&#61509;&#61526;&#61509;&#61516;&#61519;&#61520;&#61517;&#61509;&#61518;&#61524;&#61472;&#61511;&#61505;&#61513;&#61524;&#61512;&#61509;&#61522;&#61523;&#61506;&#61525;&#61522;&#61511;&#61472;&#61513;&#61518;&#61507;&#61486;&#61472; &#61505;&#61523;&#61520;&#61522;&#61487;&#61523;&#61518;&#61523; &#61505;&#61524;&#61516;&#61505;&#61518;&#61524;&#61505;&#61484;&#61472;&#61511;&#61505;&#61472;&#61491;&#61488;&#61491;&#61492;&#61489; &#61490;&#61497;&#61492;&#61493;&#61472;&#61510;&#61516;&#61519;&#61527;&#61509;&#61522;&#61523;&#61472;&#61522;&#61519;&#61505;&#61508; &#61505;&#61523;&#61520;&#61522;&#61487;&#61523;&#61518;&#61523; &#61525;&#61523;&#61472;&#61508;&#61509;&#61520;&#61524;&#61472;&#61519;&#61510;&#61472;&#61512;&#61509;&#61505;&#61516;&#61524;&#61512;&#61472;&#61478;&#61472;&#61512;&#61525;&#61517;&#61505;&#61518;&#61472;&#61523;&#61509;&#61522;&#61526;&#61513;&#61507;&#61509;&#61523; &#61505;&#61523;&#61520;&#61522;&#61487;&#61523;&#61518;&#61523; &#61505;&#61524;&#61516;&#61505;&#61518;&#61524;&#61505;&#61484;&#61472;&#61511;&#61505;&#61472;&#61491;&#61488;&#61491;&#61492;&#61489; &#61490;&#61497;&#61492;&#61493;&#61472;&#61510;&#61516;&#61519;&#61527;&#61509;&#61522;&#61523;&#61472;&#61522;&#61519;&#61505;&#61508; &#61505;&#61523;&#61520;&#61522;&#61487;&#61523;&#61518;&#61523; &#61505;&#61523;&#61520;&#61522;&#61487;&#61523;&#61518;&#61523; &#61519;&#61523;&#61491;&#61489;&#61491;&#61488;&#61492;&#61492;&#61523;&#61541;&#61541;&#61472;&#61506;&#61548;&#61551;&#61539;&#61547;&#61472;&#61489;&#61494;&#61507;&#61520;&#61488;&#61488;&#61488;&#61489;&#61488; &#61489; &#61489;&#61491;&#61486;&#61472;&#61524;&#61512;&#61513;&#61523;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61519;&#61518;&#61516;&#61529;&#61472;&#61505;&#61520;&#61520;&#61516;&#61513;&#61509;&#61523;&#61472;&#61524;&#61519;&#61472;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61507;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61519;&#61510;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61523;&#61487;&#61519;&#61522;&#61508;&#61509;&#61522;&#61523;&#61486;&#61472;&#61472;&#61513;&#61524;&#61472;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61509;&#61523;&#61472;&#61524;&#61512;&#61509;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61487;&#61519;&#61522;&#61508;&#61509;&#61522;&#61472;&#61518;&#61519;&#61486;&#61472;&#61505;&#61523;&#61472;&#61508;&#61509;&#61523;&#61507;&#61522;&#61513;&#61506;&#61509;&#61508;&#61472;&#61513;&#61518;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61492;&#61486; &#61489;&#61490;&#61486;&#61472;&#61505;&#61507;&#61507;&#61519;&#61525;&#61518;&#61524;&#61513;&#61518;&#61511;&#61472;&#61505;&#61518;&#61508;&#61472;&#61505;&#61520;&#61520;&#61522;&#61519;&#61520;&#61522;&#61513;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61508;&#61505;&#61524;&#61505;&#61472;&#61480;&#61513;&#61542;&#61472;&#61554;&#61541;&#61553;&#61557;&#61545;&#61554;&#61541;&#61540;&#61481; &#61545;&#61555;&#61472;&#61550;&#61551;&#61556;&#61472;&#61541;&#61560;&#61556;&#61541;&#61550;&#61540;&#61541;&#61540;&#61486;&#61545;&#61555;&#61472;&#61541;&#61560;&#61556;&#61541;&#61550;&#61540;&#61541;&#61540;&#61484;&#61472; &#61513;&#61556;&#61541;&#61549;&#61555;&#61472;&#61496;&#61472;&#61537;&#61550;&#61540;&#61472;&#61489;&#61493;&#61484;&#61472;&#61537;&#61550;&#61540;&#61472;&#61554;&#61541;&#61556;&#61557;&#61554;&#61550;&#61545;&#61550;&#61543; &#61519;&#61542;&#61542;&#61541;&#61554;&#61555;&#61472;&#61549;&#61557;&#61555;&#61556;&#61472;&#61537;&#61539;&#61547;&#61550;&#61551;&#61559;&#61548;&#61541;&#61540;&#61543;&#61541;&#61472;&#61554;&#61541;&#61539;&#61541;&#61545;&#61552;&#61556;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61545;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61549;&#61541;&#61550;&#61556;&#61472;&#61552;&#61554;&#61545;&#61551;&#61554;&#61472;&#61556;&#61551;&#61472;&#61556;&#61544;&#61541;&#61472;&#61544;&#61551;&#61557;&#61554;&#61472;&#61537;&#61550;&#61540;&#61472;&#61540;&#61537;&#61556;&#61541;&#61472;&#61555;&#61552;&#61541;&#61539;&#61545;&#61542;&#61545;&#61541;&#61540;&#61472;&#61545;&#61550;&#61472;&#61556;&#61544;&#61541;&#61472;&#61555;&#61551;&#61548;&#61545;&#61539;&#61545;&#61556;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61551;&#61554;&#61472;&#61537;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61541;&#61540; &#61484;&#61472;&#61538;&#61561;&#61472;&#61551;&#61550;&#61541;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61541;&#61472;&#61542;&#61551;&#61548;&#61548;&#61551;&#61559;&#61545;&#61550;&#61543;&#61472;&#61549;&#61541;&#61556;&#61544;&#61551;&#61540;&#61555;&#61498;&#61472;&#61480;&#61537;&#61481;&#61472;&#61506;&#61561;&#61472;&#61539;&#61551;&#61549;&#61552;&#61548;&#61541;&#61556;&#61545;&#61550;&#61543; &#61524;&#61544;&#61541;&#61472;&#61537;&#61538;&#61551;&#61558;&#61541;&#61472;&#61550;&#61557;&#61549;&#61538;&#61541;&#61554;&#61541;&#61540;&#61472;&#61555;&#61551;&#61548;&#61545;&#61539;&#61545;&#61556;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61545;&#61555;&#61472;&#61537;&#61549;&#61541;&#61550;&#61540;&#61541;&#61540;&#61472;&#61537;&#61555;&#61472;&#61555;&#61541;&#61556;&#61472;&#61542;&#61551;&#61554;&#61556;&#61544;&#61472;&#61545;&#61550;&#61472;&#61513;&#61556;&#61541;&#61549;&#61472;&#61489;&#61492;&#61486;&#61472;&#61472; &#61524;&#61544;&#61541;&#61472;&#61544;&#61551;&#61557;&#61554;&#61472;&#61537;&#61550;&#61540;&#61472;&#61540;&#61537;&#61556;&#61541;&#61472;&#61555;&#61552;&#61541;&#61539;&#61545;&#61542;&#61545;&#61541;&#61540;&#61472;&#61542;&#61551;&#61554;&#61472;&#61554;&#61541;&#61539;&#61541;&#61545;&#61552;&#61556;&#61472;&#61551;&#61542;&#61472;&#61519;&#61542;&#61542;&#61541;&#61554;&#61555; &#61489;&#61489;&#61486;&#61472;&#61524;&#61512;&#61513;&#61523;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61519;&#61518;&#61516;&#61529;&#61472;&#61505;&#61520;&#61520;&#61516;&#61513;&#61509;&#61523;&#61472;&#61524;&#61519;&#61472;&#61505;&#61517;&#61509;&#61518;&#61508;&#61517;&#61509;&#61518;&#61524;&#61523;&#61472;&#61519;&#61510;&#61472;&#61523;&#61519;&#61516;&#61513;&#61507;&#61513;&#61524;&#61505;&#61524;&#61513;&#61519;&#61518;&#61523; &#61510;&#61505;&#61507;&#61513;&#61516;&#61513;&#61524;&#61529;&#61472;&#61507;&#61519;&#61508;&#61509;&#61472;&#61507;&#61519;&#61508;&#61509;&#61472; &#61489;&#61488;&#61506;&#61486;&#61472;&#61508;&#61505;&#61524;&#61509;&#61508;&#61472;&#61480;&#61523;&#61509;&#61509;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61491;&#61481; &#61489;&#61488;&#61505;&#61486;&#61472;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61507;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61519;&#61510;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61487;&#61519;&#61522;&#61508;&#61509;&#61522;&#61472;&#61518;&#61519;&#61486; &#61497;&#61506;&#61486;&#61472;&#61508;&#61505;&#61524;&#61509;&#61508;&#61472;&#61480;&#61523;&#61509;&#61509;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61489;&#61481; &#61497;&#61505;&#61486;&#61472;&#61505;&#61517;&#61509;&#61518;&#61508;&#61517;&#61509;&#61518;&#61524;&#61472;&#61519;&#61510;&#61472;&#61523;&#61519;&#61516;&#61513;&#61507;&#61513;&#61524;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61518;&#61519;&#61486; &#61507;&#61519;&#61508;&#61509;&#61472; &#61496;&#61486;&#61472;&#61518;&#61505;&#61517;&#61509;&#61472;&#61505;&#61518;&#61508;&#61472;&#61505;&#61508;&#61508;&#61522;&#61509;&#61523;&#61523;&#61472;&#61519;&#61510;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61519;&#61522;&#61472;&#61480;&#61518;&#61551;&#61486;&#61484;&#61472;&#61555;&#61556;&#61554;&#61541;&#61541;&#61556;&#61484;&#61472;&#61539;&#61551;&#61557;&#61550;&#61556;&#61561;&#61484;&#61472;&#61523;&#61556;&#61537;&#61556;&#61541;&#61472;&#61537;&#61550;&#61540;&#61472;&#61530;&#61513;&#61520;&#61472;&#61507;&#61551;&#61540;&#61541;&#61481; &#61495;&#61486;&#61472;&#61505;&#61508;&#61517;&#61513;&#61518;&#61513;&#61523;&#61524;&#61509;&#61522;&#61509;&#61508;&#61472;&#61506;&#61529;&#61472;&#61480;&#61513;&#61542;&#61472;&#61551;&#61556;&#61544;&#61541;&#61554;&#61472;&#61556;&#61544;&#61537;&#61550;&#61472;&#61513;&#61556;&#61541;&#61549;&#61472;&#61494;&#61481;&#61507;&#61519;&#61508;&#61509;&#61472;&#61494;&#61486;&#61472;&#61513;&#61523;&#61523;&#61525;&#61509;&#61508;&#61472;&#61506;&#61529; &#61520;&#61505;&#61511;&#61509;&#61472;&#61472;&#61472;&#61519;&#61510;&#61472;&#61472;&#61520;&#61505;&#61511;&#61509;&#61523; &#61492;&#61486;&#61472;&#61522;&#61509;&#61521;&#61525;&#61513;&#61523;&#61513;&#61524;&#61513;&#61519;&#61518;&#61487;&#61520;&#61525;&#61522;&#61507;&#61512;&#61505;&#61523;&#61509;&#61472;&#61522;&#61509;&#61521;&#61486;&#61472;&#61518;&#61519;&#61486;&#61491;&#61486;&#61472;&#61509;&#61510;&#61510;&#61509;&#61507;&#61524;&#61513;&#61526;&#61509;&#61472;&#61508;&#61505;&#61524;&#61509;&#61490;&#61486;&#61472;&#61505;&#61517;&#61509;&#61518;&#61508;&#61517;&#61509;&#61518;&#61524;&#61487;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61507;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61472;&#61518;&#61519;&#61486;&#61472; &#61493;&#61486;&#61472;&#61520;&#61522;&#61519;&#61514;&#61509;&#61507;&#61524;&#61472;&#61518;&#61519;&#61486;&#61472;&#61480;&#61513;&#61542;&#61472;&#61537;&#61552;&#61552;&#61548;&#61545;&#61539;&#61537;&#61538;&#61548;&#61541;&#61481; &#61489;&#61486; &#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61472;&#61513;&#61508;&#61472;&#61507;&#61519;&#61508;&#61509; &#61505;&#61517;&#61509;&#61518;&#61508;&#61517;&#61509;&#61518;&#61524;&#61472;&#61519;&#61510;&#61472;&#61523;&#61519;&#61516;&#61513;&#61507;&#61513;&#61524;&#61505;&#61524;&#61513;&#61519;&#61518;&#61487;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61507;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61519;&#61510;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524; &#61488;&#61496;&#61487;&#61491;&#61488;&#61487;&#61490;&#61488;&#61489;&#61497; &#61505;&#61556;&#61556;&#61550;&#61498;&#61472;&#61523;&#61524;&#61509;&#61526;&#61509;&#61472;&#61472;&#61522;&#61505;&#61517;&#61506;&#61519; &#61509;&#61517;&#61509;&#61522;&#61511;&#61509;&#61518;&#61524;&#61472;&#61520;&#61522;&#61519;&#61508;&#61525;&#61507;&#61524;&#61472;&#61508;&#61509;&#61526;&#61509;&#61516;&#61519;&#61520;&#61517;&#61509;&#61518;&#61524;&#61472;&#61511;&#61505;&#61513;&#61524;&#61512;&#61509; &#61491;&#61488;&#61488;&#61472;&#61520;&#61522;&#61519;&#61510;&#61509;&#61523;&#61523;&#61513;&#61519;&#61518;&#61505;&#61516;&#61472;&#61508;&#61522; &#61518;&#61541;&#61556;&#61472;&#61513;&#61550;&#61539;&#61554;&#61541;&#61537;&#61555;&#61541;&#61498; [**] &#61507;&#61512;&#61509;&#61507;&#61515;&#61472;&#61519;&#61518;&#61509; &#61505;&#61486;&#61472;&#61524;&#61512;&#61513;&#61523;&#61472;&#61507;&#61512;&#61505;&#61518;&#61511;&#61509;&#61472;&#61519;&#61522;&#61508;&#61509;&#61522;&#61472;&#61513;&#61523;&#61472;&#61513;&#61523;&#61523;&#61525;&#61509;&#61508;&#61472;&#61520;&#61525;&#61522;&#61523;&#61525;&#61505;&#61518;&#61524;&#61472;&#61524;&#61519;&#61498;&#61472;&#61480;&#61523;&#61552;&#61541;&#61539;&#61545;&#61542;&#61561;&#61472;&#61537;&#61557;&#61556;&#61544;&#61551;&#61554;&#61545;&#61556;&#61561;&#61481;&#61472;&#61472;&#61524;&#61512;&#61509;&#61472;&#61507;&#61512;&#61505;&#61518;&#61511;&#61509;&#61523;&#61472;&#61523;&#61509;&#61524;&#61472;&#61510;&#61519;&#61522;&#61524;&#61512;&#61472;&#61513;&#61518;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61492;&#61472;&#61505;&#61522;&#61509;&#61472;&#61517;&#61505;&#61508;&#61509;&#61472;&#61513;&#61518;&#61472;&#61524;&#61512;&#61509;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524; &#61506;&#61486;&#61472;&#61524;&#61512;&#61509;&#61472;&#61505;&#61506;&#61519;&#61526;&#61509;&#61472;&#61518;&#61525;&#61517;&#61506;&#61509;&#61522;&#61509;&#61508;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61487;&#61519;&#61522;&#61508;&#61509;&#61522;&#61472;&#61513;&#61523;&#61472;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61509;&#61508;&#61472;&#61524;&#61519;&#61472;&#61522;&#61509;&#61510;&#61516;&#61509;&#61507;&#61524;&#61472;&#61524;&#61512;&#61509;&#61472;&#61505;&#61508;&#61517;&#61513;&#61518;&#61513;&#61523;&#61524;&#61522;&#61505;&#61524;&#61513;&#61526;&#61509;&#61472;&#61507;&#61512;&#61505;&#61518;&#61511;&#61509;&#61523;&#61472;&#61480;&#61555;&#61557;&#61539;&#61544;&#61472;&#61537;&#61555;&#61472;&#61539;&#61544;&#61537;&#61550;&#61543;&#61541;&#61555;&#61472;&#61545;&#61550;&#61472;&#61552;&#61537;&#61561;&#61545;&#61550;&#61543;&#61472;&#61551;&#61542;&#61542;&#61545;&#61539;&#61541;&#61484;&#61472; &#61507;&#61486;&#61472;&#61524;&#61512;&#61513;&#61523;&#61472;&#61523;&#61525;&#61520;&#61520;&#61516;&#61509;&#61517;&#61509;&#61518;&#61524;&#61505;&#61516;&#61472;&#61505;&#61511;&#61522;&#61509;&#61509;&#61517;&#61509;&#61518;&#61524;&#61472;&#61513;&#61523;&#61472;&#61509;&#61518;&#61524;&#61509;&#61522;&#61509;&#61508;&#61472;&#61513;&#61518;&#61524;&#61519;&#61472;&#61520;&#61525;&#61522;&#61523;&#61525;&#61505;&#61518;&#61524;&#61472;&#61524;&#61519;&#61472;&#61505;&#61525;&#61524;&#61512;&#61519;&#61522;&#61513;&#61524;&#61529;&#61472;&#61519;&#61510;&#61498; &#61508;&#61486;&#61472;&#61519;&#61524;&#61512;&#61509;&#61522;&#61472;&#61480;&#61523;&#61552;&#61541;&#61539;&#61545;&#61542;&#61561;&#61472;&#61556;&#61561;&#61552;&#61541;&#61472;&#61551;&#61542;&#61472;&#61549;&#61551;&#61540;&#61545;&#61542;&#61545;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61537;&#61550;&#61540;&#61472;&#61537;&#61557;&#61556;&#61544;&#61551;&#61554;&#61545;&#61556;&#61561;&#61481; &#61472;&#61537;&#61552;&#61552;&#61554;&#61551;&#61552;&#61554;&#61545;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61540;&#61537;&#61556;&#61537;&#61484;&#61472;&#61541;&#61556;&#61539;&#61486;&#61481;&#61472;&#61472;&#61523;&#61509;&#61524;&#61472;&#61510;&#61519;&#61522;&#61524;&#61512;&#61472;&#61513;&#61518;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61492;&#61484;&#61472;&#61520;&#61525;&#61522;&#61523;&#61525;&#61505;&#61518;&#61524;&#61472;&#61524;&#61519;&#61472;&#61524;&#61512;&#61509;&#61472;&#61505;&#61525;&#61524;&#61512;&#61519;&#61522;&#61513;&#61524;&#61529;&#61472;&#61519;&#61510;&#61472;&#61510;&#61505;&#61522;&#61472;&#61492;&#61491;&#61486;&#61489;&#61488;&#61491;&#61480;&#61538;&#61481;&#61486; &#61509;&#61486;&#61472;&#61513;&#61517;&#61520;&#61519;&#61522;&#61524;&#61505;&#61518;&#61524;&#61498; &#61507;&#61551;&#61550;&#61556;&#61554;&#61537;&#61539;&#61556;&#61551;&#61554;&#61472; &#61545;&#61555;&#61472;&#61550;&#61551;&#61556;&#61472; &#61545;&#61555;&#61472;&#61554;&#61541;&#61553;&#61557;&#61545;&#61554;&#61541;&#61540;&#61472;&#61556;&#61551;&#61472;&#61555;&#61545;&#61543;&#61550;&#61472;&#61556;&#61544;&#61545;&#61555;&#61472;&#61540;&#61551;&#61539;&#61557;&#61549;&#61541;&#61550;&#61556;&#61472;&#61537;&#61550;&#61540;&#61472;&#61554;&#61541;&#61556;&#61557;&#61554;&#61550;&#61472;&#61472; &#61472;&#61472;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535;&#61535; &#61539;&#61551;&#61552;&#61545;&#61541;&#61555;&#61472;&#61556;&#61551;&#61472;&#61556;&#61544;&#61541;&#61472;&#61545;&#61555;&#61555;&#61557;&#61545;&#61550;&#61543;&#61472;&#61551;&#61542;&#61542;&#61545;&#61539;&#61541;&#61486; &#61472;&#61519;&#61522;&#61508;&#61509;&#61522;&#61472;&#61518;&#61519;&#61486;&#61472;&#61513;&#61518;&#61472;&#61513;&#61524;&#61509;&#61517;&#61472;&#61489;&#61488;&#61505;&#61486; &#61506;&#61545;&#61548;&#61537;&#61556;&#61541;&#61554;&#61537;&#61548;&#61472;&#61517;&#61551;&#61540;&#61545;&#61542;&#61545;&#61539;&#61537;&#61556;&#61545;&#61551;&#61550;&#61472;&#61538;&#61561;&#61472;&#61517;&#61557;&#61556;&#61557;&#61537;&#61548;&#61472;&#61505;&#61543;&#61554;&#61541;&#61541;&#61549;&#61541;&#61550;&#61556;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61541;&#61472;&#61520;&#61537;&#61554;&#61556;&#61545;&#61541;&#61555; &#61560; &#61528; &#61472;&#61489; &#61489;&#61494;&#61505;&#61486;&#61472;&#61518;&#61505;&#61517;&#61509;&#61472;&#61472;&#61505;&#61518;&#61508;&#61472;&#61524;&#61513;&#61524;&#61516;&#61509;&#61472;&#61519;&#61510;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61513;&#61518;&#61511;&#61472;&#61519;&#61510;&#61510;&#61513;&#61507;&#61509;&#61522;&#61472;&#61480;&#61524;&#61561;&#61552;&#61541;&#61472;&#61551;&#61554;&#61472;&#61552;&#61554;&#61545;&#61550;&#61556;&#61481;&#61489;&#61493;&#61505;&#61486;&#61472;&#61518;&#61505;&#61517;&#61509;&#61472;&#61505;&#61518;&#61508;&#61472;&#61524;&#61513;&#61524;&#61516;&#61509;&#61472;&#61519;&#61510;&#61472;&#61523;&#61513;&#61511;&#61518;&#61509;&#61522;&#61472;&#61480;&#61524;&#61561;&#61552;&#61541;&#61472;&#61551;&#61554;&#61472;&#61552;&#61554;&#61545;&#61550;&#61556;&#61481; &#61489;&#61493;&#61507;&#61486;&#61472;&#61508;&#61505;&#61524;&#61509;&#61472;&#61523;&#61513;&#61511;&#61518;&#61509;&#61508; &#61489;&#61494;&#61506;&#61486;&#61472;&#61525;&#61518;&#61513;&#61524;&#61509;&#61508;&#61472;&#61523;&#61524;&#61505;&#61524;&#61509;&#61523;&#61472;&#61519;&#61510;&#61472;&#61505;&#61517;&#61509;&#61522;&#61513;&#61507;&#61505;&#61472;&#61489;&#61493;&#61506;&#61486;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61519;&#61522;&#61487;&#61519;&#61510;&#61510;&#61509;&#61522;&#61519;&#61522; &#61489;&#61494;&#61507;&#61486;&#61472;&#61508;&#61505;&#61524;&#61509;&#61472;&#61523;&#61513;&#61511;&#61518;&#61509;&#61508; &#61480;&#61523;&#61545;&#61543;&#61550;&#61537;&#61556;&#61557;&#61554;&#61541;&#61472;&#61551;&#61542;&#61472;&#61552;&#61541;&#61554;&#61555;&#61551;&#61550;&#61472;&#61537;&#61557;&#61556;&#61544;&#61551;&#61554;&#61545;&#61562;&#61541;&#61540;&#61472;&#61556;&#61551;&#61472;&#61555;&#61545;&#61543;&#61550;&#61481; &#61480;&#61523;&#61545;&#61543;&#61550;&#61537;&#61556;&#61557;&#61554;&#61541;&#61472;&#61551;&#61542;&#61472;&#61507;&#61551;&#61550;&#61556;&#61554;&#61537;&#61539;&#61556;&#61545;&#61550;&#61543;&#61472;&#61519;&#61542;&#61542;&#61545;&#61539;&#61541;&#61554;&#61481; &#61515;&#61513;&#61517;&#61506;&#61509;&#61522;&#61516;&#61529;&#61472;&#61516;&#61486;&#61472;&#61511;&#61519;&#61516;&#61508;&#61509;&#61518; &#61523;&#61524;&#61505;&#61518;&#61508;&#61505;&#61522;&#61508;&#61472;&#61510;&#61519;&#61522;&#61517;&#61472;&#61491;&#61488;&#61472;&#61480;&#61522;&#61509;&#61526;&#61486;&#61472;&#61489;&#61489;&#61487;&#61490;&#61488;&#61489;&#61494;&#61481; &#61520;&#61554;&#61541;&#61555;&#61539;&#61554;&#61545;&#61538;&#61541;&#61540;&#61472;&#61538;&#61561;&#61472;&#61511;&#61523;&#61505;&#61472;&#61510;&#61505;&#61522;&#61472;&#61480;&#61492;&#61496;&#61472;&#61507;&#61510;&#61522;&#61481;&#61472;&#61493;&#61491;&#61486;&#61490;&#61492;&#61491; &#61520;&#61554;&#61541;&#61558;&#61545;&#61551;&#61557;&#61555;&#61472;&#61541;&#61540;&#61545;&#61556;&#61545;&#61551;&#61550;&#61472;&#61557;&#61550;&#61557;&#61555;&#61537;&#61538;&#61548;&#61541; &#61489;&#61492;&#61486;&#61472;&#61508;&#61509;&#61523;&#61507;&#61522;&#61513;&#61520;&#61524;&#61513;&#61519;&#61518;&#61472;&#61519;&#61510;&#61472;&#61505;&#61517;&#61509;&#61518;&#61508;&#61517;&#61509;&#61518;&#61524;&#61487;&#61517;&#61519;&#61508;&#61513;&#61510;&#61513;&#61507;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61480;&#61519;&#61554;&#61543;&#61537;&#61550;&#61545;&#61562;&#61541;&#61540;&#61472;&#61538;&#61561;&#61472;&#61525;&#61507;&#61510;&#61472;&#61555;&#61541;&#61539;&#61556;&#61545;&#61551;&#61550;&#61472;&#61544;&#61541;&#61537;&#61540;&#61545;&#61550;&#61543;&#61555;&#61484;&#61472;&#61545;&#61550;&#61539;&#61548;&#61557;&#61540;&#61545;&#61550;&#61543;&#61472;&#61555;&#61551;&#61548;&#61545;&#61539;&#61545;&#61556;&#61537;&#61556;&#61545;&#61551;&#61550;&#61487;&#61539;&#61551;&#61550;&#61556;&#61554;&#61537;&#61539;&#61556;&#61472;&#61555;&#61557;&#61538;&#61546;&#61541;&#61539;&#61556;&#61472;&#61549;&#61537;&#61556;&#61556;&#61541;&#61554;&#61472;&#61559;&#61544;&#61541;&#61554;&#61541;&#61472;&#61542;&#61541;&#61537;&#61555;&#61545;&#61538;&#61548;&#61541;&#61486;&#61481; &#61524;&#61537;&#61560;&#61472;&#61513;&#61508;&#61472;&#61518;&#61557;&#61549;&#61538;&#61541;&#61554;&#61498;&#61472;&#61472;[**] &#61508;&#61525;&#61518;&#61523;&#61472;&#61518;&#61557;&#61549;&#61538;&#61541;&#61554;&#61498;&#61472;&#61472;[**] &#61525;&#61509;&#61513;&#61498;&#61472;&#61507;&#61518;&#61520;&#61526;&#61507;&#61522;&#61496;&#61508;&#61515;&#61495;&#61517;&#61496; &#61520;&#61551;&#61545;&#61550;&#61556;&#61555;&#61472;&#61551;&#61542;&#61472;&#61507;&#61551;&#61550;&#61556;&#61537;&#61539;&#61556;&#61498; &#61507;&#61519;&#61522;&#61498;[**] &#61507;&#61519;&#61498;&#61472;[**] &#61505;&#61523;&#61520;&#61522;&#61472;&#61507;&#61551;&#61550;&#61556;&#61554;&#61537;&#61539;&#61556;&#61555;&#61472;&#61507;&#61551;&#61550;&#61555;&#61557;&#61548;&#61556;&#61537;&#61550;&#61556;&#61498;&#61472;[**] &#61509;&#61517;&#61509;&#61522;&#61511;&#61509;&#61518;&#61524;&#61498;&#61472;[**] &#61507;&#61551;&#61550;&#61556;&#61545;&#61550;&#61557;&#61541;&#61540;&#61472;&#61486;&#61486;&#61486; &#61509;&#61560;&#61539;&#61541;&#61552;&#61556;&#61472;&#61537;&#61555;&#61472;&#61552;&#61554;&#61551;&#61558;&#61545;&#61540;&#61541;&#61540;&#61472;&#61544;&#61541;&#61554;&#61541;&#61545;&#61550;&#61484;&#61472;&#61537;&#61548;&#61548;&#61472;&#61556;&#61541;&#61554;&#61549;&#61555;&#61472;&#61537;&#61550;&#61540;&#61472;&#61539;&#61551;&#61550;&#61540;&#61545;&#61556;&#61545;&#61551;&#61550;&#61555;&#61472;&#61551;&#61542;&#61472;&#61556;&#61544;&#61541;&#61472;&#61540;&#61551;&#61539;&#61557;&#61549;&#61541;&#61550;&#61556;&#61472;&#61554;&#61541;&#61542;&#61541;&#61554;&#61541;&#61550;&#61539;&#61541;&#61540;&#61472;&#61545;&#61550;&#61472;&#61513;&#61556;&#61541;&#61549;&#61472;&#61497;&#61472;&#61505;&#61472;&#61551;&#61554;&#61472;&#61489;&#61488;&#61505;&#61484;&#61472;&#61537;&#61555;&#61472;&#61544;&#61541;&#61554;&#61541;&#61556;&#61551;&#61542;&#61551;&#61554;&#61541;&#61472;&#61539;&#61544;&#61537;&#61550;&#61543;&#61541;&#61540;&#61484;&#61472;&#61554;&#61541;&#61549;&#61537;&#61545;&#61550;&#61555;&#61472;&#61557;&#61550;&#61539;&#61544;&#61537;&#61550;&#61543;&#61541;&#61540;&#61472;&#61537;&#61550;&#61540;&#61472;&#61545;&#61550;&#61472;&#61542;&#61557;&#61548;&#61548;&#61472;&#61542;&#61551;&#61554;&#61539;&#61541;&#61472;&#61537;&#61550;&#61540;&#61472;&#61541;&#61542;&#61542;&#61541;&#61539;&#61556;&#61472;&#61486; 5-26-2023 Certain identified information has been marked in the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed.  Double  asterisks denote omissions. </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno10effectiv002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno10effectiv002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">&#61513;&#61524;&#61509;&#61517;&#61472;&#61518;&#61519;&#61486; &#61523;&#61525;&#61520;&#61520;&#61516;&#61513;&#61509;&#61523;&#61487;&#61523;&#61509;&#61522;&#61526;&#61513;&#61507;&#61509;&#61523; &#61521;&#61525;&#61505;&#61518;&#61524;&#61513;&#61524;&#61529; &#61525;&#61518;&#61513;&#61524; &#61525;&#61518;&#61513;&#61524;&#61472;&#61520;&#61522;&#61513;&#61507;&#61509; &#61505;&#61517;&#61519;&#61525;&#61518;&#61524; &#61518;&#61505;&#61517;&#61509;&#61472;&#61519;&#61510;&#61472;&#61519;&#61510;&#61510;&#61509;&#61522;&#61519;&#61522;&#61472;&#61519;&#61522;&#61472;&#61507;&#61519;&#61518;&#61524;&#61522;&#61505;&#61507;&#61524;&#61519;&#61522; &#61472;&#61490;&#61472;&#61507;&#61519;&#61518;&#61524;&#61513;&#61518;&#61525;&#61505;&#61524;&#61513;&#61519;&#61518;&#61472;&#61523;&#61512;&#61509;&#61509;&#61524; &#61522;&#61509;&#61510;&#61509;&#61522;&#61509;&#61518;&#61507;&#61509;&#61472;&#61518;&#61519;&#61486;&#61472;&#61519;&#61510;&#61472;&#61508;&#61519;&#61507;&#61525;&#61517;&#61509;&#61518;&#61524;&#61472;&#61506;&#61509;&#61513;&#61518;&#61511;&#61472;&#61507;&#61519;&#61518;&#61524;&#61513;&#61518;&#61525;&#61509;&#61508; &#61520;&#61505;&#61511;&#61509; &#61519;&#61510; &#61509;&#61517;&#61509;&#61522;&#61511;&#61509;&#61518;&#61524;&#61472;&#61520;&#61522;&#61519;&#61508;&#61525;&#61507;&#61524;&#61472;&#61508;&#61509;&#61526;&#61509;&#61516;&#61519;&#61520;&#61517;&#61509;&#61518;&#61524;&#61472;&#61511;&#61505;&#61513;&#61524;&#61512;&#61509;&#61522;&#61523;&#61506;&#61525;&#61522;&#61511;&#61472;&#61513;&#61518;&#61507;&#61486;&#61472;&#61489;&#61491;&#61494;&#61493;&#61496;&#61494;&#61497; &#61480;&#61505;&#61481; &#61480;&#61506;&#61481; &#61480;&#61507;&#61481; &#61480;&#61508;&#61481; &#61480;&#61509;&#61481; &#61480;&#61510;&#61481; &#61495;&#61493;&#61505;&#61493;&#61488;&#61489;&#61489;&#61497;&#61507;&#61488;&#61488;&#61488;&#61495;&#61489;&#61487;&#61520;&#61488;&#61488;&#61488;&#61489;&#61488; &#61519;&#61524;&#61505;&#61498;&#61472;&#61518; &#61505;&#61552;&#61552;&#61554;&#61486;&#61472;&#61529;&#61554;&#61486;&#61498;&#61472;&#61490;&#61488;&#61490;&#61491;&#61472;&#61507;&#61505;&#61518;&#61498;&#61472;&#61489;&#61497;&#61497;&#61523;&#61518;&#61490;&#61491;&#61472;&#61519;&#61538;&#61546;&#61541;&#61539;&#61556;&#61472;&#61507;&#61548;&#61537;&#61555;&#61555;&#61498;&#61472;&#61490;&#61494;&#61488;&#61496;&#61496; &#61520;&#61541;&#61554;&#61545;&#61551;&#61540;&#61472;&#61551;&#61542;&#61472;&#61520;&#61541;&#61554;&#61542;&#61551;&#61554;&#61549;&#61537;&#61550;&#61539;&#61541;&#61498;&#61472;&#61488;&#61496;&#61487;&#61491;&#61488;&#61487;&#61490;&#61488;&#61489;&#61497;&#61472;&#61556;&#61551;&#61472;&#61488;&#61496;&#61487;&#61490;&#61497;&#61487;&#61490;&#61488;&#61490;&#61497; &#61505;&#61540;&#61540;&#61472;&#61513;&#61556;&#61541;&#61549;&#61472;&#61497;&#61472;&#61537;&#61555;&#61472;&#61542;&#61551;&#61548;&#61548;&#61551;&#61559;&#61555;&#61498; &#61497; &#61472;&#61472;&#61472; &#61472; [**]&#61505;&#61507;&#61505;&#61517;&#61490;&#61488;&#61488;&#61488;&#61472;&#61526;&#61537;&#61539;&#61539;&#61545;&#61550;&#61541;&#61472;&#61521;&#61556;&#61561;&#61472;[**]&#61472;&#61472;&#61472;&#61472;&#61472; &#61519;&#61538;&#61548;&#61545;&#61543;&#61537;&#61556;&#61541;&#61540;&#61472;&#61505;&#61549;&#61551;&#61557;&#61550;&#61556;&#61498;&#61472;[**] &#61518;&#61523;&#61518;&#61472;&#61495;&#61493;&#61492;&#61488;&#61485;&#61488;&#61489;&#61485;&#61489;&#61493;&#61490;&#61485;&#61496;&#61488;&#61494;&#61495; &#61519;&#61520;&#61524;&#61513;&#61519;&#61518;&#61505;&#61516;&#61472;&#61510;&#61519;&#61522;&#61517;&#61472;&#61491;&#61491;&#61494;&#61472;&#61480;&#61492;&#61485;&#61496;&#61494;&#61481; &#61523;&#61552;&#61551;&#61550;&#61555;&#61551;&#61554;&#61541;&#61540;&#61472;&#61538;&#61561;&#61472;&#61511;&#61523;&#61505; &#61510;&#61505;&#61522;&#61472;&#61480;&#61492;&#61496;&#61472;&#61507;&#61510;&#61522;&#61481;&#61472;&#61493;&#61491;&#61486;&#61489;&#61489;&#61488; </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- modificationno10effectiv003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="modificationno10effectiv003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">The purpose of this modification is to exercise option 3001 for [**] doses of ACAM2000 to  sustain operational capability of ACAM2000 for Fiscal Year (FY) 2023.   1. The period of performance for ACAM2000 product to be delivered for Task 1, under Option  3001 is updated from 10/01/21-10/30/22 to 10/31/22-6/30/23. 2. The minimum annual procurement order for this modification is [**] doses of ACAM2000  kits with a minimum shelf life of [**] with supply ranging from [**]. Quantities Shelf Life * [**]     [**]      [**]      [**] [**] as of June 7, 2023 EPDG will provide the potency testing under CLIN 30001 for existing ACAM2000 doses in  the SNS by [**].  Any further testing for ACAM2000 or Wetvax will be subject to future  discussions. Funding is hereby obligated in the amount of [**] for [**] by doses at [**] per dose. The revised funding obligation amount will be increased from  [**] by [**] to [**]. All other terms and conditions remain the same. 3 of 3 [**] [**] [**] </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>6
<FILENAME>ebs-brginterimmanagement.htm
<DESCRIPTION>EX-10.10
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ebs-brginterimmanagement</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ebs-brginterimmanagement001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs-brginterimmanagement001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">99 High Street, 27th Floor | Boston, MA 02110 Berkeley Research Group, LLC  |  877.696.0391  |  www.thinkbrg.com PRIVILEGED AND CONFIDENTIAL July 7, 2023 Via Email Dr. Zsolt Harsanyi [**] Re: Emergent BioSolutions &#8211; Interim CEO  Dear Dr. Harsanyi: This letter confirms that the Board of Directors (&#8220;Board&#8221;) of Emergent BioSolutions Inc. (collectively with its designated affiliates, the &#8220;Company&#8221;) has engaged Haywood Miller of  Berkeley Research Group, LLC (&#8220;BRG&#8221;) as Interim Chief Executive Officer (&#8220;ICEO&#8221;) for the  Company. This letter and any attachments set forth the agreement (&#8220;Agreement&#8221;) between the  parties. SCOPE OF SERVICES The Board has requested that the ICEO provide professional services as directed by or overseen  by  the Board (&#8220;Services&#8221;): Provide overall executive leadership and foster a culture of collaboration and responsibility for the executive team and other employees; Ensure clear and effective communication; Assume leadership role for strategic initiatives including the development of a long-term business strategy, implementation plan, and related financial projections; Work closely with other members of the senior management team, Board and outside advisors on issues and actions important to the Company; Engage with lenders as needed and appropriate to refinance or restructure the existing indebtedness of the Company; Work together with other members of the senior management team to drive implementation of expense reduction initiatives including any refinement or change management activities as appropriate; Represent the organization to appropriate stakeholders including shareholders, customers, lenders, suppliers and other parties as necessary; Report regularly to the Board of Directors on the above items; and Other items as mutually agreed. For avoidance of doubt, this letter reflects [**] and is not intended to replace existing  agreements. Certain identified information has been marked in the exhibit because it is both (i) not material and (ii) would  likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs-brginterimmanagement002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs-brginterimmanagement002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">CONFIDENTIAL July 7, 2023 Page 2 of 5 Matter Emergent BioSolutions Inc.(Interim CEO) Any services provided by BRG other than the Services provided by the ICEO are subject to the  [**].  The ICEO will perform his duties and responsibilities diligently and to the best of his  abilities, in compliance with all applicable laws, regulations, and the Company&#8217;s internal policies  and procedures. The Company agrees that the ICEO will continue as an employee of BRG and  may continue to provide his services to other companies during the term of this Agreement,  provided, however, that such services do not interfere or conflict with the business of the  company or the terms of this Agreement. The Company acknowledges that all payments for the  time charges of the ICEO incurred in the performance of Services hereunder to Company will be  made to BRG.  The ICEO who provides Services to the Company under this Agreement is an independent  contractor and is not, and will not be deemed to be an employee of the Company.  FEES AND EXPENSES The Company will compensate BRG in the amount of $125,000 per month (or prorated portion  thereof) for the ICEO's Services on this engagement.  The Board acknowledges that completion and success fees are customary components of  engagements as outlined and agree to work with BRG to amend this agreement to include  reasonable and customary completion and success fees, as appropriate and in the sole discretion  of the Board.  In addition to Professional Fees, BRG will be reimbursed for reasonable and documented direct  out-of pocket expenses related to the ICEO&#8217;s provision of Services consistent with the  Company&#8217;s travel and reimbursement policies, a copy of which has been or will be furnished to  ICEO and BRG. BRG will submit reasonably detailed invoices to the Company, for all Services rendered and  expenses incurred. BRG will bill for Services monthly and will provide customary descriptions  regarding the Services rendered. BRG will provide additional details regarding Services rendered  upon request by Company. BRG&#8217;s invoice statements shall be paid within thirty (30) days of the  invoice date. Company agrees it will review BRG&#8217;s invoices upon receipt and will advise BRG of  any objection to or dispute with the invoice and the work reflected in the invoice within fourteen  (14) days of receipt of the invoice. Without liability, BRG reserves the right to withhold delivery of Services, testimony, reports or  data (written or oral), or suspend work, if the account on this engagement is not current. Please remit payments by wire to: [**] </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs-brginterimmanagement003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs-brginterimmanagement003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">CONFIDENTIAL July 7, 2023 Page 3 of 5 Matter Emergent BioSolutions Inc.(Interim CEO) COMPANY RESPONSIBILITIES The Company will undertake responsibilities to (a) provide reliable and accurate detailed  information, materials, and documentation and (b) make decisions and take future actions, as the  Company determines in its sole discretion, on any recommendations made by the ICEO in  connection with this Agreement.  BRG&#8217;s delivery of services and the fees charged are dependent  on the Company&#8217;s timely and effective completion of its responsibilities and timely decisions and  approvals made by the Company&#8217;s management. In connection with any Chapter 11 filing, if the Company wishes to continue to retain the ICEO  for Services, the Company will apply promptly to the Bankruptcy Court for approval of the  Company&#8217;s retention of the ICEO and BRG under the terms of this Agreement.  The form of  retention application and proposed order shall be reasonably acceptable to BRG.  BRG shall have  no obligation to provide any further Services if the Company becomes a debtor under the  Bankruptcy Code unless BRG&#8217;s retention under the terms of this Agreement is approved by a  final order of the Bankruptcy Court reasonably acceptable to BRG.  The Company shall assist, or  cause its counsel to assist, with filing, serving and noticing of papers related to BRG&#8217;s fee and  expense applications. The CEO and BRG reserve the right to request approval of additional  compensation in circumstances where extraordinary results may warrant such additional  compensation. CONFIDENTIALITY and Related Matters ICEO agrees to enter into the usual and customary agreements the Company has with its other  executive officers regarding confidentiality, intellectual property rights, indemnification, non- solicitation of Company personnel and non-competition with the Company&#8217;s business. ARBITRATION This Agreement shall be interpreted and controlled by the laws of the state of Delaware. Any  controversy, dispute, or claim between Company on the one hand and BRG on the other hand of  whatever nature arising out of, in connection with, or in relation to the interpretation,  performance or breach of this Agreement, including any claim based on contract, tort, or statute,  (&#8220;Claims&#8221;) shall be resolved at the request of any party to this agreement, by final and binding  arbitration, administered either by (a) Judicial Arbitration &amp; Mediation Services, Inc. (JAMS),  pursuant to Streamlined Arbitration Rules &amp; Procedures or (b) the American Arbitration Association (&#8220;AAA&#8221;) (with a sole arbitrator) in accordance with its Commercial Arbitration  Rules, and judgment upon any award rendered by the arbitrator may be entered by any State or  Federal Court having jurisdiction thereof. Any such arbitration shall take place in a venue agreed  to by the parties to this Agreement, and in the event the parties are unable to reach an agreement  on venue within a reasonable period of time, such arbitration shall take place in Massachusetts.  If  a party to any arbitration proceeding filed in connection with this Agreement fails to pay any  costs of the arbitration required to be paid by such party in the time required for payment, the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs-brginterimmanagement004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs-brginterimmanagement004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">CONFIDENTIAL July 7, 2023 Page 4 of 5 Matter Emergent BioSolutions Inc.(Interim CEO) arbitrator is authorized to provide an appropriate remedy, including an entry of a default and an  arbitration award on the merits against such party. LIMITATION OF LIABILITY The ICEO will receive the benefit of the indemnification and advancement provisions provided  by the Company to its directors, officers and any equivalently placed employees, whether under  the Company&#8217;s charter or by-laws, by contract or otherwise. The Company shall specifically include and cover the ICEO with direct coverage under the  Company&#8217;s policy for liability insurance covering its directors, officers and any equivalently  placed employees (&#8220;D&amp;O insurance&#8221;). The Company shall, at the request of BRG, provide BRG  a copy of Company&#8217;s current D&amp;O policy, a certificate(s) of insurance evidencing the policy is in  full force and effect, and a copy of the signed board resolutions and any other documents as BRG  may reasonably request evidencing the appointment of the ICEO. Company will maintain such  D&amp;O insurance coverage for the period through which claims can be made against such persons.  Notwithstanding any other provision in this Agreement to the contrary, the Company&#8217;s  indemnification and advancement obligations shall be primary to (and without allocation against)  any similar indemnification and advancement obligations of BRG, its affiliates and insurers to the  indemnitees (which shall be secondary), and the Company&#8217;s D&amp;O insurance coverage for the  indemnitees shall be specifically primary to (and without allocation against) any other valid and  collectible insurance coverage that may apply to the indemnitees (whether provided by BRG or  otherwise). IN NO EVENT SHALL THE COMPANY THE ICEO, OR BRGBE LIABLE FOR ANY  SPECIAL, INCIDENTAL, INDIRECT, OR CONSEQUENTIAL DAMAGES OF ANY KIND  IN CONNECTION WITH THIS AGREEMENT, EVEN IF THEY HAVE BEEN ADVISED OF  THE POSSIBILITY OF SUCH DAMAGES.  THE ICEO AND BRG SHALL NOT BE LIABLE  TO THE COMPANY, OR ANY PARTY ASSERTING CLAIMS ON BEHALF OF THE  COMPANY, EXCEPT FOR DIRECT DAMAGES FOUND IN A FINAL DETERMINATION  TO BE THE DIRECT RESULT OF THE BAD FAITH, SELF-DEALING, OR INTENTIONAL  MISCONDUCT OF BRG.  BRG&#8217;S AGGREGATE LIABILITY, WHETHER IN TORT,  CONTRACT, OR OTHERWISE, IS LIMITED TO THE AMOUNT OF FEES PAID TO BRG  FOR SERVICES UNDER THIS AGREEMENT (THE &#8220;LIABILITY CAP&#8221;). THE LIABILITY  CAP IS THE TOTAL LIMIT OF BRG&#8217;S AGGREGATE LIABILITY FOR ANY AND ALL  CLAIMS OR DEMANDS BY ANYONE PURSUANT TO THIS AGREEMENT, INCLUDING  LIABILITY TO THE COMPANYAND TO ANY OTHERS MAKING CLAIMS RELATING  TO THE WORK PERFORMED BY BRG PURSUANT TO THIS AGREEMENT.  OTHER TERMS The interpretation and application of the terms of this Agreement shall be governed and construed in accordance with the laws of the state of Delaware.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs-brginterimmanagement005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs-brginterimmanagement005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">CONFIDENTIAL July 7, 2023 Page 5 of 5 Matter Emergent BioSolutions Inc.(Interim CEO) The waiver by any party and the breach of any of the provisions of this Agreement shall not  operate or be construed as a waiver of any subsequent breach hereof. This Agreement shall be  binding upon and inure to the benefit of the parties and their respective successors, assigns, legal  representatives, executors, administrators and heirs. The parties may not assign this Agreement or  any rights or obligations hereunder to any party without the prior written consent of the other  parties.  Each of the provisions of this Agreement is a separate and distinct agreement and  independent of all others, so that if any provision hereof shall be held to be invalid or  unenforceable for any reason, such invalidity or enforceability shall not affect the validity or  enforceability of any other provisions hereof.  No amendment or modification of this Agreement  shall be effective unless in writing and signed by both parties hereto. * * * *  We look forward to working with you on this matter. Please sign and return a copy of this  agreement signifying your agreement with the terms and provisions herein.  Sincerely, Eric B. Miller General Counsel AGREED AND ACCEPTED: Board of Directors of Emergent BioSolutions Inc. By______________________________      Dr. Zsolt Harsanyi Emergent BioSolutions Inc. </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>a311-millercert063023.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i70df8f667e5e4b20af0a63e48bc79299_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Haywood Miller, certify that&#58;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Emergent BioSolutions Inc.&#59; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information, and </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date&#58; August&#160;8, 2023 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47;HAYWOOD MILLER</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Haywood Miller</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interim Chief Executive Officer</font></div><div style="height:69.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>a312-lindhalcert063023.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ieff21dcc134140009f165f8882514259_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Richard S. Lindahl, certify that&#58;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Emergent BioSolutions Inc.&#59; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58; </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information, and </font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;&#160;August&#160;8, 2023</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">&#47;s&#47;RICHARD S. LINDAHL</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richard S. Lindahl</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>a321-millercert063023.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2645422277774dc1b04d649b6fdd2817_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form&#160;10-Q&#160;of Emergent BioSolutions Inc. (the &#34;Company&#34;) for the period ended&#160;June&#160;30, 2023&#160;as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), the undersigned, Haywood Miller, Interim Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-indent:-13.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;&#160;August&#160;8, 2023</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;HAYWOOD MILLER</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haywood Miller</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interim Chief Executive Officer</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>a322-lindhalcert063023.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i294bfec9c87e40cbaa6766eb15661a90_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:10pt;font-weight:700;line-height:144%">EXHIBIT 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:144%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:144%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Emergent BioSolutions Inc. (the &#34;Company&#34;) for the period ended&#160;June&#160;30, 2023&#160;as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), the undersigned, Richard S. Lindahl, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;August&#160;8, 2023</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:144%;text-decoration:underline">&#47;s&#47;RICHARD S. LINDAHL</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Richard S. Lindahl</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Chief Financial Officer</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>ebs-20230630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:d762cff5-452b-4406-9554-de3e14af5e28,g:a97db4f5-924f-4868-bfbf-bd6f1cbf2843-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ebs="http://emergentbiosolutions.com/20230630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://emergentbiosolutions.com/20230630">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://emergentbiosolutions.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>0000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinStockholdersEquity" roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity">
        <link:definition>0000007 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical" roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical">
        <link:definition>0000008 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Natureofthebusinessandorganization" roleURI="http://emergentbiosolutions.com/role/Natureofthebusinessandorganization">
        <link:definition>0000009 - Disclosure - Nature of the business and organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Summaryofsignificantaccountingpolicies" roleURI="http://emergentbiosolutions.com/role/Summaryofsignificantaccountingpolicies">
        <link:definition>0000010 - Disclosure - Summary of significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Divestiture" roleURI="http://emergentbiosolutions.com/role/Divestiture">
        <link:definition>0000011 - Disclosure - Divestiture</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuringandimpairmentcosts" roleURI="http://emergentbiosolutions.com/role/Restructuringandimpairmentcosts">
        <link:definition>0000012 - Disclosure - Restructuring and impairment costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventoriesnet" roleURI="http://emergentbiosolutions.com/role/Inventoriesnet">
        <link:definition>0000013 - Disclosure - Inventories, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Propertyplantandequipmentnet" roleURI="http://emergentbiosolutions.com/role/Propertyplantandequipmentnet">
        <link:definition>0000014 - Disclosure - Property, plant and equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Intangibleassetsandgoodwill" roleURI="http://emergentbiosolutions.com/role/Intangibleassetsandgoodwill">
        <link:definition>0000015 - Disclosure - Intangible assets and goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Fairvaluemeasurements" roleURI="http://emergentbiosolutions.com/role/Fairvaluemeasurements">
        <link:definition>0000016 - Disclosure - Fair value measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivativeinstrumentsandhedgingactivities" roleURI="http://emergentbiosolutions.com/role/Derivativeinstrumentsandhedgingactivities">
        <link:definition>0000017 - Disclosure - Derivative instruments and hedging activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://emergentbiosolutions.com/role/Debt">
        <link:definition>0000018 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Stockbasedcompensationandstockholdersequity" roleURI="http://emergentbiosolutions.com/role/Stockbasedcompensationandstockholdersequity">
        <link:definition>0000019 - Disclosure - Stock-based compensation and stockholders' equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Losspercommonshare" roleURI="http://emergentbiosolutions.com/role/Losspercommonshare">
        <link:definition>0000020 - Disclosure - Loss per common share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenuerecognition" roleURI="http://emergentbiosolutions.com/role/Revenuerecognition">
        <link:definition>0000021 - Disclosure - Revenue recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://emergentbiosolutions.com/role/Leases">
        <link:definition>0000022 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incometaxes" roleURI="http://emergentbiosolutions.com/role/Incometaxes">
        <link:definition>0000023 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Litigation" roleURI="http://emergentbiosolutions.com/role/Litigation">
        <link:definition>0000024 - Disclosure - Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segmentinformation" roleURI="http://emergentbiosolutions.com/role/Segmentinformation">
        <link:definition>0000025 - Disclosure - Segment information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Subsequentevents" roleURI="http://emergentbiosolutions.com/role/Subsequentevents">
        <link:definition>0000026 - Disclosure - Subsequent events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesPolicies" roleURI="http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies">
        <link:definition>9954701 - Disclosure - Summary of significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandimpairmentcostsTables" roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsTables">
        <link:definition>9954702 - Disclosure - Restructuring and impairment costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesnetTables" roleURI="http://emergentbiosolutions.com/role/InventoriesnetTables">
        <link:definition>9954703 - Disclosure - Inventories, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentnetTables" roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentnetTables">
        <link:definition>9954704 - Disclosure - Property, plant and equipment, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsandgoodwillTables" roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillTables">
        <link:definition>9954705 - Disclosure - Intangible assets and goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementsTables" roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsTables">
        <link:definition>9954706 - Disclosure - Fair value measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesTables" roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesTables">
        <link:definition>9954707 - Disclosure - Derivative instruments and hedging activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://emergentbiosolutions.com/role/DebtTables">
        <link:definition>9954708 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationandstockholdersequityTables" roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTables">
        <link:definition>9954709 - Disclosure - Stock-based compensation and stockholders' equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LosspercommonshareTables" roleURI="http://emergentbiosolutions.com/role/LosspercommonshareTables">
        <link:definition>9954710 - Disclosure - Loss per common share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuerecognitionTables" roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionTables">
        <link:definition>9954711 - Disclosure - Revenue recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://emergentbiosolutions.com/role/LeasesTables">
        <link:definition>9954712 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationTables" roleURI="http://emergentbiosolutions.com/role/SegmentinformationTables">
        <link:definition>9954713 - Disclosure - Segment information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofthebusinessandorganizationDetails" roleURI="http://emergentbiosolutions.com/role/NatureofthebusinessandorganizationDetails">
        <link:definition>9954714 - Disclosure - Nature of the business and organization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantaccountingpoliciesDetails" roleURI="http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails">
        <link:definition>9954715 - Disclosure - Summary of significant accounting policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestitureDetails" roleURI="http://emergentbiosolutions.com/role/DivestitureDetails">
        <link:definition>9954716 - Disclosure - Divestiture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandimpairmentcostsNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails">
        <link:definition>9954717 - Disclosure - Restructuring and impairment costs - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails" roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails">
        <link:definition>9954718 - Disclosure - Restructuring and impairment costs - Details of Impairment of Long-Lived Assets Held and Used by Asset (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails" roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails">
        <link:definition>9954719 - Disclosure - Restructuring and impairment costs - Restructuring and Related Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails" roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails">
        <link:definition>9954720 - Disclosure - Restructuring and impairment costs - Schedule of Restructuring Reserve by Type of Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesnetScheduleofInventoryDetails" roleURI="http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails">
        <link:definition>9954721 - Disclosure - Inventories, net - Schedule of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails" roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails">
        <link:definition>9954722 - Disclosure - Property, plant and equipment, net - Schedule of Property, Plant, and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyplantandequipmentNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails">
        <link:definition>9954723 - Disclosure - Property, plant and equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails" roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails">
        <link:definition>9954724 - Disclosure - Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsandgoodwillFinitelivedIntangibleAssetsAmortizationExpenseDetails" roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillFinitelivedIntangibleAssetsAmortizationExpenseDetails">
        <link:definition>9954725 - Disclosure - Intangible assets and goodwill - Finite-lived Intangible Assets Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsandgoodwillGoodwillRollForwardDetails" roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails">
        <link:definition>9954726 - Disclosure - Intangible assets and goodwill - Goodwill Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsandgoodwillNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails">
        <link:definition>9954727 - Disclosure - Intangible assets and goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails" roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails">
        <link:definition>9954728 - Disclosure - Fair value measurements - Fair Value Hierarchy of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementsContingentConsiderationRollForwardDetails" roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsContingentConsiderationRollForwardDetails">
        <link:definition>9954729 - Disclosure - Fair value measurements - Contingent Consideration Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementsAdditionalInformationDetails" roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails">
        <link:definition>9954730 - Disclosure - Fair value measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails" roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails">
        <link:definition>9954731 - Disclosure - Fair value measurements - Fair Value Level 3 of Significant Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails">
        <link:definition>9954732 - Disclosure - Derivative instruments and hedging activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails" roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails">
        <link:definition>9954733 - Disclosure - Derivative instruments and hedging activities - Fair Value by Balance Sheet Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails" roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails">
        <link:definition>9954734 - Disclosure - Derivative instruments and hedging activities - Cash Flow Hedging on AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleDetails" roleURI="http://emergentbiosolutions.com/role/DebtScheduleDetails">
        <link:definition>9954735 - Disclosure - Debt - Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/DebtNarrativeDetails">
        <link:definition>9954736 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationandstockholdersequityNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails">
        <link:definition>9954737 - Disclosure - Stock-based compensation and stockholders' equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails" roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails">
        <link:definition>9954738 - Disclosure - Stock-based compensation and stockholders' equity - Schedule of Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails" roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails">
        <link:definition>9954739 - Disclosure - Stock-based compensation and stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails" roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails">
        <link:definition>9954740 - Disclosure - Stock-based compensation and stockholders' equity - Tax Effects Related to Each Component of Accumulated Other Comprehensive (Loss) Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LosspercommonshareDetails" roleURI="http://emergentbiosolutions.com/role/LosspercommonshareDetails">
        <link:definition>9954741 - Disclosure - Loss per common share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuerecognitionNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails">
        <link:definition>9954742 - Disclosure - Revenue recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuerecognitionNarrativeDetails_1" roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails_1">
        <link:definition>9954742 - Disclosure - Revenue recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuerecognitionDisaggregationofRevenueDetails" roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails">
        <link:definition>9954743 - Disclosure - Revenue recognition - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuerecognitionContractLiabilitiesDetails" roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionContractLiabilitiesDetails">
        <link:definition>9954744 - Disclosure - Revenue recognition - Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuerecognitionAccountsReceivableDetails" roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails">
        <link:definition>9954745 - Disclosure - Revenue recognition - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsofLeaseExpenseDetails" roleURI="http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails">
        <link:definition>9954746 - Disclosure - Leases - Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>9954747 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesDetails" roleURI="http://emergentbiosolutions.com/role/IncometaxesDetails">
        <link:definition>9954748 - Disclosure - Income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/SegmentinformationNarrativeDetails">
        <link:definition>9954749 - Disclosure - Segment information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails" roleURI="http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails">
        <link:definition>9954750 - Disclosure - Segment information - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails" roleURI="http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails">
        <link:definition>9954751 - Disclosure - Segment information - Schedule of Segment Reporting Information, by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequenteventsDetails" roleURI="http://emergentbiosolutions.com/role/SubsequenteventsDetails">
        <link:definition>9954752 - Disclosure - Subsequent events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ebs_RevenueFromContractWithCustomerTermOfContract" abstract="false" name="RevenueFromContractWithCustomerTermOfContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ebs_SaleOfStockConsiderationReceivedOnTransactionGross" abstract="false" name="SaleOfStockConsiderationReceivedOnTransactionGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_ContractsAndGrantsMember" abstract="true" name="ContractsAndGrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_FiveYearOptionMember" abstract="true" name="FiveYearOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_DevelopmentBasedMilestonesMember" abstract="true" name="DevelopmentBasedMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_UnitedStatesGovernmentMember" abstract="true" name="UnitedStatesGovernmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_DebtTermsAxis" abstract="true" name="DebtTermsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ebs_GrossProfitAdjustments" abstract="false" name="GrossProfitAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_ProductsSegmentMember" abstract="true" name="ProductsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_RestructuringPlanJanuary2023Member" abstract="true" name="RestructuringPlanJanuary2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_BARDAContractContractNotCeasedPriorToJune12026Member" abstract="true" name="BARDAContractContractNotCeasedPriorToJune12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_DebtInstrumentCovenantConsiderationThreshold" abstract="false" name="DebtInstrumentCovenantConsiderationThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_ContractDevelopmentAndManufacturingMember" abstract="true" name="ContractDevelopmentAndManufacturingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_EmployeeTransitionMember" abstract="true" name="EmployeeTransitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_OtherLongTermDebtFacilityMember" abstract="true" name="OtherLongTermDebtFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" abstract="false" name="RevenueRemainingPerformanceObligationVariableConsiderationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="ebs_NonUnitedStatesGovernmentMember" abstract="true" name="NonUnitedStatesGovernmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_BARDAMember" abstract="true" name="BARDAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_ScheduleOfAccountsReceivableNetTableTextBlock" abstract="false" name="ScheduleOfAccountsReceivableNetTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="ebs_NumberOfProductAndServiceCategories" abstract="false" name="NumberOfProductAndServiceCategories" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ebs_LongTermIncentivePlanNoncashExpense" abstract="false" name="LongTermIncentivePlanNoncashExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_RestructuringPlanAugust2023Member" abstract="true" name="RestructuringPlanAugust2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_AdjustedGrossMargin" abstract="false" name="AdjustedGrossMargin" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_ServicesSegmentMember" abstract="true" name="ServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_EbangaMember" abstract="true" name="EbangaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_TwoYearOptionMember" abstract="true" name="TwoYearOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_MeasurementInputProbabilityOfPaymentMember" abstract="true" name="MeasurementInputProbabilityOfPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_FiscalQuartersEndingAfter2024Member" abstract="true" name="FiscalQuartersEndingAfter2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_InventoryStepUp" abstract="false" name="InventoryStepUp" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_ContractDevelopmentAndManufacturingLeasesMember" abstract="true" name="ContractDevelopmentAndManufacturingLeasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_JansenPharmaceuticalsIncMember" abstract="true" name="JansenPharmaceuticalsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_SOFREURIBOROrCDORMember" abstract="true" name="SOFREURIBOROrCDORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum" abstract="false" name="DebtInstrumentCovenantInterestCoverageRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ebs_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_NumberOfRevenueGeneratingProducts" abstract="false" name="NumberOfRevenueGeneratingProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ebs_AmendedCreditAgreementMember" abstract="true" name="AmendedCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_EmployeeBenefitsMember" abstract="true" name="EmployeeBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ebs_FiscalQuartersEndingIn2024Member" abstract="true" name="FiscalQuartersEndingIn2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_RidgebackMember" abstract="true" name="RidgebackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods" abstract="false" name="RevenueFromContractWithCustomerNumberOfOptionPeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ebs_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ebs_ProductsAndServicesSegmentsMember" abstract="true" name="ProductsAndServicesSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_ChangeinContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeinContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ebs_FiscalQuartersEndingAfterMarch312024Member" abstract="true" name="FiscalQuartersEndingAfterMarch312024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_SeniorUnsecuredNotesDueAugust2028Member" abstract="true" name="SeniorUnsecuredNotesDueAugust2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_DispositionOfBusinessTransactionCosts" abstract="false" name="DispositionOfBusinessTransactionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares" abstract="false" name="SaleOfStockAmountRemainingAvailableForSaleOfShares" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_BARDAContractPayableInThirdQuarterOf2023Member" abstract="true" name="BARDAContractPayableInThirdQuarterOf2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_SalesBasedMilestonesMember" abstract="true" name="SalesBasedMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour" abstract="false" name="LessorOperatingLeasePaymentToBeReceivedAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ebs_UnallocatedResearchAndDevelopmentMember" abstract="true" name="UnallocatedResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_ProductsSegmentAbstract" abstract="true" name="ProductsSegmentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ebs_TravelHealthBusinessMember" abstract="true" name="TravelHealthBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ebs_UntilMarch312024Member" abstract="true" name="UntilMarch312024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ebs_NumberOfCategoriesOfPublicHealthThreats" abstract="false" name="NumberOfCategoriesOfPublicHealthThreats" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ebs_DebtTermsDomain" abstract="true" name="DebtTermsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>ebs-20230630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:d762cff5-452b-4406-9554-de3e14af5e28,g:a97db4f5-924f-4868-bfbf-bd6f1cbf2843-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_dbd0a9ac-bdad-4c00-998f-fe87625c1351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_533cc81e-1b6c-4f9d-af0d-6ac23e6a3b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dbd0a9ac-bdad-4c00-998f-fe87625c1351" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_533cc81e-1b6c-4f9d-af0d-6ac23e6a3b4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8e8773bf-4c8e-4c6e-ae61-b18057a260a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dbd0a9ac-bdad-4c00-998f-fe87625c1351" xlink:to="loc_us-gaap_InventoryNet_8e8773bf-4c8e-4c6e-ae61-b18057a260a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f7ad485a-276e-4539-9b13-2bd483ecfce9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dbd0a9ac-bdad-4c00-998f-fe87625c1351" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f7ad485a-276e-4539-9b13-2bd483ecfce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3c11d07f-dc5a-4494-9445-c8ba6c285697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dbd0a9ac-bdad-4c00-998f-fe87625c1351" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3c11d07f-dc5a-4494-9445-c8ba6c285697" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bc9943a6-4ba7-4fa8-9381-30790359e04b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_9bd92559-bd63-4b05-84ea-1174976b4e40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bc9943a6-4ba7-4fa8-9381-30790359e04b" xlink:to="loc_us-gaap_NotesPayableCurrent_9bd92559-bd63-4b05-84ea-1174976b4e40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_eb1ebac5-d2fd-4b7f-8c27-38bf79c17499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bc9943a6-4ba7-4fa8-9381-30790359e04b" xlink:to="loc_us-gaap_AccountsPayableCurrent_eb1ebac5-d2fd-4b7f-8c27-38bf79c17499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4b1f38d2-774c-492c-851f-9e5ebe803e69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bc9943a6-4ba7-4fa8-9381-30790359e04b" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_4b1f38d2-774c-492c-851f-9e5ebe803e69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8de88f8f-eba1-440a-96a8-b94148450365" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bc9943a6-4ba7-4fa8-9381-30790359e04b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8de88f8f-eba1-440a-96a8-b94148450365" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b6eae2fe-4c45-4e5c-9b59-92039a4f2b96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bc9943a6-4ba7-4fa8-9381-30790359e04b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_b6eae2fe-4c45-4e5c-9b59-92039a4f2b96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c065a503-f5d0-4937-a7db-be2e957e1ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d221fa1a-f267-4a82-95e2-9110079aef14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c065a503-f5d0-4937-a7db-be2e957e1ae7" xlink:to="loc_us-gaap_LiabilitiesCurrent_d221fa1a-f267-4a82-95e2-9110079aef14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_03dc5459-5900-4be1-8118-6858ac2519ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c065a503-f5d0-4937-a7db-be2e957e1ae7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_03dc5459-5900-4be1-8118-6858ac2519ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_97751099-3d27-41cf-8c09-01d0e19c6696" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c065a503-f5d0-4937-a7db-be2e957e1ae7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_97751099-3d27-41cf-8c09-01d0e19c6696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_de6b42ce-cfea-4711-9b64-1ac91b86d50f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c065a503-f5d0-4937-a7db-be2e957e1ae7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_de6b42ce-cfea-4711-9b64-1ac91b86d50f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9d8db4a4-b8f2-4536-a63d-6c4d509e2dea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3ad63e69-957c-4c91-85c2-bc355a18feca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9d8db4a4-b8f2-4536-a63d-6c4d509e2dea" xlink:to="loc_us-gaap_StockholdersEquity_3ad63e69-957c-4c91-85c2-bc355a18feca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_58a8ab05-499c-4208-a25a-ab46f7a81cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9d8db4a4-b8f2-4536-a63d-6c4d509e2dea" xlink:to="loc_us-gaap_Liabilities_58a8ab05-499c-4208-a25a-ab46f7a81cdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f80444b2-2457-49d3-8cb8-247726b17def" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c51401e5-3d60-4e18-869f-458b4f692e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f80444b2-2457-49d3-8cb8-247726b17def" xlink:to="loc_us-gaap_PreferredStockValue_c51401e5-3d60-4e18-869f-458b4f692e6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d67b8849-5d7b-441a-a352-c9881bbd5094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f80444b2-2457-49d3-8cb8-247726b17def" xlink:to="loc_us-gaap_CommonStockValue_d67b8849-5d7b-441a-a352-c9881bbd5094" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_1f06e0ff-099c-4c7e-84c9-3e2dc1c20573" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f80444b2-2457-49d3-8cb8-247726b17def" xlink:to="loc_us-gaap_TreasuryStockValue_1f06e0ff-099c-4c7e-84c9-3e2dc1c20573" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_10e93d27-a265-4dc9-9dc5-191495428041" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f80444b2-2457-49d3-8cb8-247726b17def" xlink:to="loc_us-gaap_AdditionalPaidInCapital_10e93d27-a265-4dc9-9dc5-191495428041" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c7a940ba-3c6c-412b-8335-032531d5b3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f80444b2-2457-49d3-8cb8-247726b17def" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c7a940ba-3c6c-412b-8335-032531d5b3a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2dbd2bf1-8307-4693-ad45-6c20ea564589" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f80444b2-2457-49d3-8cb8-247726b17def" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2dbd2bf1-8307-4693-ad45-6c20ea564589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_aab97090-7e0b-49c3-8acf-094b2f4e452e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_47991ea5-8051-4e59-ab2f-8d4ccb03f952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aab97090-7e0b-49c3-8acf-094b2f4e452e" xlink:to="loc_us-gaap_AssetsCurrent_47991ea5-8051-4e59-ab2f-8d4ccb03f952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_971c1cea-9465-44a6-b777-605579549208" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aab97090-7e0b-49c3-8acf-094b2f4e452e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_971c1cea-9465-44a6-b777-605579549208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e5c74cb1-7818-4616-bd4c-3db67d861eff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aab97090-7e0b-49c3-8acf-094b2f4e452e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e5c74cb1-7818-4616-bd4c-3db67d861eff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f5bca398-5e54-47cb-b4c3-9404179bac57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aab97090-7e0b-49c3-8acf-094b2f4e452e" xlink:to="loc_us-gaap_Goodwill_f5bca398-5e54-47cb-b4c3-9404179bac57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3b4b8cd3-4f30-4995-a850-b78c0cde5002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aab97090-7e0b-49c3-8acf-094b2f4e452e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3b4b8cd3-4f30-4995-a850-b78c0cde5002" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_e8c32573-5a26-4f59-a494-1b4a6841cba7" xlink:href="ebs-20230630.xsd#ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_283a797d-ab18-4e61-b5f7-197dd384f89d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_e8c32573-5a26-4f59-a494-1b4a6841cba7" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_283a797d-ab18-4e61-b5f7-197dd384f89d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d48db8bf-847b-436a-b741-257825c4b533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_e8c32573-5a26-4f59-a494-1b4a6841cba7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d48db8bf-847b-436a-b741-257825c4b533" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_e9d729c8-19dd-42c1-b8d0-efe72a0842b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_18bbf364-8e80-4e4c-aafc-346a6775df1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_e9d729c8-19dd-42c1-b8d0-efe72a0842b2" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_18bbf364-8e80-4e4c-aafc-346a6775df1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_da55dc2f-3d70-4c0b-9ca9-5b47378385bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_e9d729c8-19dd-42c1-b8d0-efe72a0842b2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_da55dc2f-3d70-4c0b-9ca9-5b47378385bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2e3f6ba9-4848-4af2-b548-bd88813e9382" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_e9d729c8-19dd-42c1-b8d0-efe72a0842b2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2e3f6ba9-4848-4af2-b548-bd88813e9382" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_568b4bfa-68f8-4e53-afdb-2efdef0a8873" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_e9d729c8-19dd-42c1-b8d0-efe72a0842b2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_568b4bfa-68f8-4e53-afdb-2efdef0a8873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b5c9cf54-0f09-452c-a737-03a8ed6e9917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_e9d729c8-19dd-42c1-b8d0-efe72a0842b2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b5c9cf54-0f09-452c-a737-03a8ed6e9917" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_470bdcbe-6f5a-4a53-a7c8-5b3c260fa525" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5c61a88e-a6c6-470a-99f1-7e6fad52e5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_470bdcbe-6f5a-4a53-a7c8-5b3c260fa525" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5c61a88e-a6c6-470a-99f1-7e6fad52e5d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_565e5b64-0227-4144-8ceb-9bcd82a05b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_470bdcbe-6f5a-4a53-a7c8-5b3c260fa525" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_565e5b64-0227-4144-8ceb-9bcd82a05b3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3ccfab6a-4754-4e8a-b7bb-4e95452af663" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6d78a53a-abee-4079-96aa-a9d4ff952c80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_3ccfab6a-4754-4e8a-b7bb-4e95452af663" xlink:to="loc_us-gaap_InterestExpense_6d78a53a-abee-4079-96aa-a9d4ff952c80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_538eab1d-a72a-4161-9440-a0a86ecf5a96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_3ccfab6a-4754-4e8a-b7bb-4e95452af663" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_538eab1d-a72a-4161-9440-a0a86ecf5a96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_712d55c9-6b4c-4bfd-bef4-993fd5a45a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_3ccfab6a-4754-4e8a-b7bb-4e95452af663" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_712d55c9-6b4c-4bfd-bef4-993fd5a45a7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a6619bca-0cad-4a85-b7ad-52554cf912ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_c28b591b-78a7-4257-b918-7a2691985b72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_a6619bca-0cad-4a85-b7ad-52554cf912ef" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_c28b591b-78a7-4257-b918-7a2691985b72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_422fbc0a-cced-417b-b4e5-533088037264" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_a6619bca-0cad-4a85-b7ad-52554cf912ef" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_422fbc0a-cced-417b-b4e5-533088037264" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cf88bd85-e4ba-4e6e-b784-db9d8a18fd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5424ffca-d390-4686-9c7e-c70a00b61391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cf88bd85-e4ba-4e6e-b784-db9d8a18fd7a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5424ffca-d390-4686-9c7e-c70a00b61391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dca4ebd8-2f6e-4582-b786-f61e18114102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cf88bd85-e4ba-4e6e-b784-db9d8a18fd7a" xlink:to="loc_us-gaap_OperatingIncomeLoss_dca4ebd8-2f6e-4582-b786-f61e18114102" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e7d48454-7a25-4968-8d37-95937493a2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fdb0e54c-ec63-4c51-ad0c-837ecc946f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e7d48454-7a25-4968-8d37-95937493a2b7" xlink:to="loc_us-gaap_Revenues_fdb0e54c-ec63-4c51-ad0c-837ecc946f2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_c6e7f255-eded-4192-9369-470ea3c132d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e7d48454-7a25-4968-8d37-95937493a2b7" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_c6e7f255-eded-4192-9369-470ea3c132d7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_90c89287-19ac-441e-a0b4-4bd6d9532f69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2b4d170b-d744-42ac-86e5-31a28155c5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_90c89287-19ac-441e-a0b4-4bd6d9532f69" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2b4d170b-d744-42ac-86e5-31a28155c5d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_bb6c50f8-84ef-4a0d-b155-d984ae7df6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_90c89287-19ac-441e-a0b4-4bd6d9532f69" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_bb6c50f8-84ef-4a0d-b155-d984ae7df6aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_70f7456c-d9ca-4d51-b04b-e967fd36ba9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_90c89287-19ac-441e-a0b4-4bd6d9532f69" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_70f7456c-d9ca-4d51-b04b-e967fd36ba9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_fb935f8b-f459-4fd8-a451-c05fa383f660" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_90c89287-19ac-441e-a0b4-4bd6d9532f69" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_fb935f8b-f459-4fd8-a451-c05fa383f660" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f61b7218-2fac-4508-b1b9-c66d8f2bf5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a610182d-dcf4-45de-9d20-8e45c4f91a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f61b7218-2fac-4508-b1b9-c66d8f2bf5d6" xlink:to="loc_us-gaap_NetIncomeLoss_a610182d-dcf4-45de-9d20-8e45c4f91a0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_97264f0a-9291-4016-adfe-14c0f8b81cff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f61b7218-2fac-4508-b1b9-c66d8f2bf5d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_97264f0a-9291-4016-adfe-14c0f8b81cff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d76cc43f-071c-4fa1-a8bd-138d16eac03a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_9a7ebcf0-0e94-4e86-b675-d36875ff4566" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d76cc43f-071c-4fa1-a8bd-138d16eac03a" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_9a7ebcf0-0e94-4e86-b675-d36875ff4566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_40fa1caa-ba7e-4b51-84e8-42dcdf78a978" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d76cc43f-071c-4fa1-a8bd-138d16eac03a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_40fa1caa-ba7e-4b51-84e8-42dcdf78a978" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf67b839-51b1-492e-b1d1-0e0d74383a78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_725a6eff-db98-423d-8bbe-a1415323d4de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf67b839-51b1-492e-b1d1-0e0d74383a78" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_725a6eff-db98-423d-8bbe-a1415323d4de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e237a961-20f7-43e4-9d0c-811cd007d6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf67b839-51b1-492e-b1d1-0e0d74383a78" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e237a961-20f7-43e4-9d0c-811cd007d6ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_99e6276f-26dc-458c-a397-88bc0b4b46aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf67b839-51b1-492e-b1d1-0e0d74383a78" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_99e6276f-26dc-458c-a397-88bc0b4b46aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_28f7d47a-50bf-49bf-8c05-6338ef73cdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf67b839-51b1-492e-b1d1-0e0d74383a78" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_28f7d47a-50bf-49bf-8c05-6338ef73cdd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_904ebba3-85b6-49b7-8e4d-a50f536c4eae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf67b839-51b1-492e-b1d1-0e0d74383a78" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_904ebba3-85b6-49b7-8e4d-a50f536c4eae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_166762af-ff31-416c-a437-8b2e44562273" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf67b839-51b1-492e-b1d1-0e0d74383a78" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_166762af-ff31-416c-a437-8b2e44562273" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6fd2bd58-629e-4954-b549-b910913ef1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6fd2bd58-629e-4954-b549-b910913ef1ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5301be94-4268-4798-b653-566a4b28cbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5301be94-4268-4798-b653-566a4b28cbfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_4e733033-79f8-4820-bef1-cbb20ab7fa74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_4e733033-79f8-4820-bef1-cbb20ab7fa74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_f4eca880-e1ed-4822-9384-07e7ab469c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_f4eca880-e1ed-4822-9384-07e7ab469c1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_92df319a-1b2c-43e7-8407-bcb39876f31c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_92df319a-1b2c-43e7-8407-bcb39876f31c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f12dec48-444a-444f-8e81-c09669669641" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f12dec48-444a-444f-8e81-c09669669641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_LongTermIncentivePlanNoncashExpense_5fbdaa22-2530-4512-bf66-8f1653428b3f" xlink:href="ebs-20230630.xsd#ebs_LongTermIncentivePlanNoncashExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_ebs_LongTermIncentivePlanNoncashExpense_5fbdaa22-2530-4512-bf66-8f1653428b3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_6ada349b-0ba1-43ac-ac6f-d344c3f47b28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_6ada349b-0ba1-43ac-ac6f-d344c3f47b28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dc178a0c-1400-4392-a4dd-d1ec6939a4df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dc178a0c-1400-4392-a4dd-d1ec6939a4df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e0f07c40-6589-4360-aded-7547ca73a248" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e0f07c40-6589-4360-aded-7547ca73a248" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_43e95796-db2c-4fc2-a057-3dcdcd609bba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_NetIncomeLoss_43e95796-db2c-4fc2-a057-3dcdcd609bba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_99d03581-e21e-47b5-ada8-2a34031ce7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_99d03581-e21e-47b5-ada8-2a34031ce7bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_431d824b-c981-4008-9b2a-b1d08f05e0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_431d824b-c981-4008-9b2a-b1d08f05e0fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_db11cff6-4351-4e29-8ad1-178549cb1cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_db11cff6-4351-4e29-8ad1-178549cb1cf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_f0bb5ca3-8a08-4ab5-83d6-55225c21d67b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_f0bb5ca3-8a08-4ab5-83d6-55225c21d67b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_db716a9c-fc6a-4099-b58e-6fd439ff33c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_ShareBasedCompensation_db716a9c-fc6a-4099-b58e-6fd439ff33c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_378b0da2-c8c2-49ea-a99a-4b947858bb48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_378b0da2-c8c2-49ea-a99a-4b947858bb48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_470fa03a-436d-4121-9fba-9e00c24b664e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c2d70946-ab6c-41cb-9f95-dbc795ee2199" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_470fa03a-436d-4121-9fba-9e00c24b664e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_00189c95-31a8-495c-9fd9-08b54e3dba53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_66bd9f3a-e487-4222-8471-1291b77c8071" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_00189c95-31a8-495c-9fd9-08b54e3dba53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_66bd9f3a-e487-4222-8471-1291b77c8071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a8c071c4-9e76-47d2-8b62-2e0968e76213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_00189c95-31a8-495c-9fd9-08b54e3dba53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a8c071c4-9e76-47d2-8b62-2e0968e76213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fe9f8ae5-d487-4a98-ad72-eca01eab7c61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_00189c95-31a8-495c-9fd9-08b54e3dba53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fe9f8ae5-d487-4a98-ad72-eca01eab7c61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_774b20d5-0f7e-4ac3-a702-18d160a11c09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_00189c95-31a8-495c-9fd9-08b54e3dba53" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_774b20d5-0f7e-4ac3-a702-18d160a11c09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#InventoriesnetScheduleofInventoryDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_13121a21-0410-4a0a-bcde-4d78ccad4c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_9775f133-6155-4197-bd45-7530a83e31eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_13121a21-0410-4a0a-bcde-4d78ccad4c8f" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_9775f133-6155-4197-bd45-7530a83e31eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c33fcdbf-7725-4527-b5ec-e2bd4ecb14ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_13121a21-0410-4a0a-bcde-4d78ccad4c8f" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c33fcdbf-7725-4527-b5ec-e2bd4ecb14ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b5b16eeb-b189-4435-9414-4dd39faf5638" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_13121a21-0410-4a0a-bcde-4d78ccad4c8f" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b5b16eeb-b189-4435-9414-4dd39faf5638" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0fe9fb88-da42-45f0-9fc7-d9c6c69dd85e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c66d697c-6464-4479-ad24-970204c760a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_0fe9fb88-da42-45f0-9fc7-d9c6c69dd85e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c66d697c-6464-4479-ad24-970204c760a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e061a2e6-65d9-4ee5-9ac1-9ec9474e16eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_0fe9fb88-da42-45f0-9fc7-d9c6c69dd85e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e061a2e6-65d9-4ee5-9ac1-9ec9474e16eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7cdbf084-aa3d-4a62-9bf9-b8730b80554a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6ee81542-2065-4ca2-a197-dda2d495175e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7cdbf084-aa3d-4a62-9bf9-b8730b80554a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6ee81542-2065-4ca2-a197-dda2d495175e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4f2edd15-5c12-47f4-8943-b9093278585d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7cdbf084-aa3d-4a62-9bf9-b8730b80554a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4f2edd15-5c12-47f4-8943-b9093278585d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_aaa0d6b9-bd3c-4f27-9966-663d9424c439" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a62972f8-6668-45a8-a811-964c1a378709" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_aaa0d6b9-bd3c-4f27-9966-663d9424c439" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a62972f8-6668-45a8-a811-964c1a378709" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_42cc234e-172b-4c90-b824-3cafa2ec87b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_aaa0d6b9-bd3c-4f27-9966-663d9424c439" xlink:to="loc_us-gaap_DerivativeAssets_42cc234e-172b-4c90-b824-3cafa2ec87b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_85c86ced-2c10-4988-809f-7a63c115b015" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_94098dd3-f447-4618-b054-6c56b21ecaac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_85c86ced-2c10-4988-809f-7a63c115b015" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_94098dd3-f447-4618-b054-6c56b21ecaac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_391ce8f3-7dac-4550-b06d-7c587e91ab4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_757e51af-a206-4d10-97b8-21bdec12f98f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_391ce8f3-7dac-4550-b06d-7c587e91ab4e" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_757e51af-a206-4d10-97b8-21bdec12f98f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_57ffd9d3-4479-4d77-9f44-aabca752fcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_391ce8f3-7dac-4550-b06d-7c587e91ab4e" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_57ffd9d3-4479-4d77-9f44-aabca752fcbc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_43a23098-faf0-4171-9566-b3b9ae1e0427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_137fa523-a33a-4a35-a47d-40171b025466" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_43a23098-faf0-4171-9566-b3b9ae1e0427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_137fa523-a33a-4a35-a47d-40171b025466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_9a55433b-7436-426c-848b-5dee7abebe60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_43a23098-faf0-4171-9566-b3b9ae1e0427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_9a55433b-7436-426c-848b-5dee7abebe60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LosspercommonshareDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#LosspercommonshareDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LosspercommonshareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21e8d119-5f62-4f2c-9922-ecc21e6b7929" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_39357b10-ec67-4584-a497-b556088b3e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21e8d119-5f62-4f2c-9922-ecc21e6b7929" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_39357b10-ec67-4584-a497-b556088b3e1f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RevenuerecognitionAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d09a708d-8992-4783-882b-47a39d557181" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_3e502488-39f5-48d4-babc-9445976a0f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_d09a708d-8992-4783-882b-47a39d557181" xlink:to="loc_us-gaap_UnbilledContractsReceivable_3e502488-39f5-48d4-babc-9445976a0f7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_2a5b1c48-1b13-4e01-8ae2-08db1e748cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BilledContractReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_d09a708d-8992-4783-882b-47a39d557181" xlink:to="loc_us-gaap_BilledContractReceivables_2a5b1c48-1b13-4e01-8ae2-08db1e748cfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_cf879e9c-245c-4c27-9cff-87fe11719d47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_d09a708d-8992-4783-882b-47a39d557181" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_cf879e9c-245c-4c27-9cff-87fe11719d47" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_6047a903-a87e-4457-9c9d-14466f0224c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_a792d7a5-435f-430d-beb0-f14852b8b0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_6047a903-a87e-4457-9c9d-14466f0224c9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_a792d7a5-435f-430d-beb0-f14852b8b0cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_c49afbf7-a51c-4f91-b5a3-e8c25d1d4d91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_6047a903-a87e-4457-9c9d-14466f0224c9" xlink:to="loc_us-gaap_OperatingLeaseExpense_c49afbf7-a51c-4f91-b5a3-e8c25d1d4d91" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4982770c-15ff-4377-8c1e-399581e99049" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ed6936c4-fc57-4f72-a8b2-2b9bb963826a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_4982770c-15ff-4377-8c1e-399581e99049" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ed6936c4-fc57-4f72-a8b2-2b9bb963826a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1d2ffd59-77d2-4de4-a1c7-c994db2ef68f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_4982770c-15ff-4377-8c1e-399581e99049" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1d2ffd59-77d2-4de4-a1c7-c994db2ef68f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>ebs-20230630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:d762cff5-452b-4406-9554-de3e14af5e28,g:a97db4f5-924f-4868-bfbf-bd6f1cbf2843-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended" id="i44cc888e9bab4f8793b6ac4681715898_CondensedConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_63ec4085-af10-420f-992d-c7a7861d2d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_63ec4085-af10-420f-992d-c7a7861d2d7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_4c5fb8a6-8212-494c-a1c5-a82e0898db62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_4c5fb8a6-8212-494c-a1c5-a82e0898db62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_1fbae786-b0c6-4735-858a-c38cc3074fd8" xlink:href="ebs-20230630.xsd#ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:to="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_1fbae786-b0c6-4735-858a-c38cc3074fd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_56f44a18-e83b-44f1-be76-3a93d336d7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:to="loc_us-gaap_Revenues_56f44a18-e83b-44f1-be76-3a93d336d7a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0a11658f-e0ff-48df-b9cf-3ff9f197d175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0a11658f-e0ff-48df-b9cf-3ff9f197d175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a4731749-c143-4769-abfa-cfdb1d48785d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a4731749-c143-4769-abfa-cfdb1d48785d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_cde0d34d-95c9-40db-87ea-d6dbbd11a0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_cde0d34d-95c9-40db-87ea-d6dbbd11a0fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a2249512-a9a8-4609-b670-fddc9c943d61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a2249512-a9a8-4609-b670-fddc9c943d61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3162aa78-52da-4ee9-a50e-6c367afabb97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3162aa78-52da-4ee9-a50e-6c367afabb97" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_b0ca86ee-21cf-4915-bce9-44fcf1e55869" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_b0ca86ee-21cf-4915-bce9-44fcf1e55869" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_06dffa98-07b7-4caa-98c0-909c0ca0e2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_OperatingIncomeLoss_06dffa98-07b7-4caa-98c0-909c0ca0e2c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f34978fb-670c-4d77-b043-2e2ae714ea9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:to="loc_us-gaap_InterestExpense_f34978fb-670c-4d77-b043-2e2ae714ea9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_1a5a87a6-ea81-432d-90f8-3f5df3b356ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_1a5a87a6-ea81-432d-90f8-3f5df3b356ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_43e83995-5ed3-4b9e-9d81-a6a82e809ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_43e83995-5ed3-4b9e-9d81-a6a82e809ccd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5a12bf6d-c540-45c4-9cbc-5966eaeeb979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5a12bf6d-c540-45c4-9cbc-5966eaeeb979" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f932381e-969d-47bb-8593-05b594cc3615" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f932381e-969d-47bb-8593-05b594cc3615" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0aaa94ca-9448-49d2-bf12-10e62bdbaa6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0aaa94ca-9448-49d2-bf12-10e62bdbaa6f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7ad17930-22d5-42d0-91b4-ff68e131301e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_NetIncomeLoss_7ad17930-22d5-42d0-91b4-ff68e131301e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_313eb9e2-31d5-488d-bc61-3244b8eff8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_313eb9e2-31d5-488d-bc61-3244b8eff8e9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9f57dc53-d000-41ac-826a-63d8c5be7324" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_313eb9e2-31d5-488d-bc61-3244b8eff8e9" xlink:to="loc_us-gaap_EarningsPerShareBasic_9f57dc53-d000-41ac-826a-63d8c5be7324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_faa10dd0-c53a-4d89-84ef-ac5b74e984fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_313eb9e2-31d5-488d-bc61-3244b8eff8e9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_faa10dd0-c53a-4d89-84ef-ac5b74e984fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e4bf698a-261d-4dd0-8638-58dc59d41a51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e4bf698a-261d-4dd0-8638-58dc59d41a51" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ee380a21-d599-4e98-abde-192b0dfb87f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e4bf698a-261d-4dd0-8638-58dc59d41a51" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ee380a21-d599-4e98-abde-192b0dfb87f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_892f75dc-fdd9-434a-a253-fc762fa3ac3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e4bf698a-261d-4dd0-8638-58dc59d41a51" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_892f75dc-fdd9-434a-a253-fc762fa3ac3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f84593b-2c09-4ede-9e05-191c421ace91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_StatementTable_1f84593b-2c09-4ede-9e05-191c421ace91" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_66275b40-b20d-4760-aad1-a1f9142924eb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1f84593b-2c09-4ede-9e05-191c421ace91" xlink:to="loc_srt_ProductOrServiceAxis_66275b40-b20d-4760-aad1-a1f9142924eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_66275b40-b20d-4760-aad1-a1f9142924eb_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_66275b40-b20d-4760-aad1-a1f9142924eb" xlink:to="loc_srt_ProductsAndServicesDomain_66275b40-b20d-4760-aad1-a1f9142924eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_46158a06-ce10-44e0-a5ff-05d55a36c269" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_66275b40-b20d-4760-aad1-a1f9142924eb" xlink:to="loc_srt_ProductsAndServicesDomain_46158a06-ce10-44e0-a5ff-05d55a36c269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_29e1de51-052e-46ac-8f7e-6d1771b9f61b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_46158a06-ce10-44e0-a5ff-05d55a36c269" xlink:to="loc_us-gaap_ProductMember_29e1de51-052e-46ac-8f7e-6d1771b9f61b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_0389fdde-1fcf-4310-83d3-720940419c86" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_46158a06-ce10-44e0-a5ff-05d55a36c269" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingMember_0389fdde-1fcf-4310-83d3-720940419c86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_c13391f2-e61a-4348-b139-e1a285658851" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingMember_0389fdde-1fcf-4310-83d3-720940419c86" xlink:to="loc_us-gaap_ServiceMember_c13391f2-e61a-4348-b139-e1a285658851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_8c1c98a5-1126-4754-ba1b-745d328aa6ab" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingMember_0389fdde-1fcf-4310-83d3-720940419c86" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_8c1c98a5-1126-4754-ba1b-745d328aa6ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractsAndGrantsMember_c3558fad-c24e-43f8-869e-217eee309885" xlink:href="ebs-20230630.xsd#ebs_ContractsAndGrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_46158a06-ce10-44e0-a5ff-05d55a36c269" xlink:to="loc_ebs_ContractsAndGrantsMember_c3558fad-c24e-43f8-869e-217eee309885" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended" id="ia30de3ba4e894faab15b017dd6de4526_CondensedConsolidatedStatementsofChangesinStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3e809353-0529-4de7-a0d1-409ebd51834e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3e809353-0529-4de7-a0d1-409ebd51834e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ec175c10-7be0-46b0-ad54-b915f19adbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_CommonStockSharesIssued_ec175c10-7be0-46b0-ad54-b915f19adbe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_612c54fe-e18f-46ba-b39d-a2c889b72df2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockholdersEquity_612c54fe-e18f-46ba-b39d-a2c889b72df2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_5723d811-1ffe-4c46-8458-6ac8a62d50d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_TreasuryStockCommonShares_5723d811-1ffe-4c46-8458-6ac8a62d50d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_048a6e37-03b1-4af0-9e13-5acc5c6e1ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_NetIncomeLoss_048a6e37-03b1-4af0-9e13-5acc5c6e1ab5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7da32ed0-3c2c-4d74-a6bf-2bc94b6001a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7da32ed0-3c2c-4d74-a6bf-2bc94b6001a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_277387ed-7a8e-4232-89fe-beaa0a04fa05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_277387ed-7a8e-4232-89fe-beaa0a04fa05" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4152408a-f7c3-4b23-be64-f0dfbbf3f777" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4152408a-f7c3-4b23-be64-f0dfbbf3f777" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4465b809-47db-45cd-bace-6f2bcc7431b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4465b809-47db-45cd-bace-6f2bcc7431b2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_05542ec4-375d-4263-9afe-0e89d4a3bcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_05542ec4-375d-4263-9afe-0e89d4a3bcbb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_5a420bdb-72b0-4d2f-9e4c-810c3475a1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_5a420bdb-72b0-4d2f-9e4c-810c3475a1f4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e90228ec-1cc1-49d6-952b-6b34f2dea37e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e90228ec-1cc1-49d6-952b-6b34f2dea37e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_075d2150-50ae-4a47-bb6b-de3d979be410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_026b2a67-8bd6-46c4-8720-c5ad537c1784" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_58285bb9-d905-4f21-ad2f-34ab7b58bd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_40e53d8e-7f74-4b28-8abf-ceb8a7026271" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3e809353-0529-4de7-a0d1-409ebd51834e" xlink:to="loc_us-gaap_StatementTable_40e53d8e-7f74-4b28-8abf-ceb8a7026271" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1978dcc8-6157-41ae-8d8c-37a41c343b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_40e53d8e-7f74-4b28-8abf-ceb8a7026271" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1978dcc8-6157-41ae-8d8c-37a41c343b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1978dcc8-6157-41ae-8d8c-37a41c343b7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1978dcc8-6157-41ae-8d8c-37a41c343b7b" xlink:to="loc_us-gaap_EquityComponentDomain_1978dcc8-6157-41ae-8d8c-37a41c343b7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1978dcc8-6157-41ae-8d8c-37a41c343b7b" xlink:to="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_05c89562-26cc-41ff-abd8-5f391036f6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:to="loc_us-gaap_CommonStockMember_05c89562-26cc-41ff-abd8-5f391036f6d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_62fc6710-355b-499c-a4e8-f530cffd6c19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:to="loc_us-gaap_TreasuryStockCommonMember_62fc6710-355b-499c-a4e8-f530cffd6c19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c9b50fbd-c544-47e6-b322-3aea4b913fad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c9b50fbd-c544-47e6-b322-3aea4b913fad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9b4324ae-d439-4c5f-8a79-5180d271fd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9b4324ae-d439-4c5f-8a79-5180d271fd7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6614cd36-2d0a-44c6-a81e-80cfd009dced" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:to="loc_us-gaap_RetainedEarningsMember_6614cd36-2d0a-44c6-a81e-80cfd009dced" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#SummaryofsignificantaccountingpoliciesDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails" xlink:type="extended" id="i2cffb19c50f94744be5eaa8c9623066a_SummaryofsignificantaccountingpoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9d7ec580-3449-4204-ad32-e468d5a465d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e1a5e507-30c1-4226-957e-5e099a0f07d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d7ec580-3449-4204-ad32-e468d5a465d7" xlink:to="loc_us-gaap_LongTermDebt_e1a5e507-30c1-4226-957e-5e099a0f07d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantConsiderationThreshold_428f3566-f2e1-4818-80b4-b5bc43d2a911" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantConsiderationThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d7ec580-3449-4204-ad32-e468d5a465d7" xlink:to="loc_ebs_DebtInstrumentCovenantConsiderationThreshold_428f3566-f2e1-4818-80b4-b5bc43d2a911" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d7ec580-3449-4204-ad32-e468d5a465d7" xlink:to="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9b5725e9-cfc8-4126-ba3d-4a71d62ae7db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:to="loc_us-gaap_CreditFacilityAxis_9b5725e9-cfc8-4126-ba3d-4a71d62ae7db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9b5725e9-cfc8-4126-ba3d-4a71d62ae7db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_9b5725e9-cfc8-4126-ba3d-4a71d62ae7db" xlink:to="loc_us-gaap_CreditFacilityDomain_9b5725e9-cfc8-4126-ba3d-4a71d62ae7db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6c3b87e6-1397-466e-bc65-7a3a6d1dd450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_9b5725e9-cfc8-4126-ba3d-4a71d62ae7db" xlink:to="loc_us-gaap_CreditFacilityDomain_6c3b87e6-1397-466e-bc65-7a3a6d1dd450" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e0059dd8-fc24-40e8-9866-45f6f2a23982" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6c3b87e6-1397-466e-bc65-7a3a6d1dd450" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e0059dd8-fc24-40e8-9866-45f6f2a23982" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TermLoanFacilityMember_5f3a2127-8aaa-4111-9fbd-e4a0db5723f8" xlink:href="ebs-20230630.xsd#ebs_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6c3b87e6-1397-466e-bc65-7a3a6d1dd450" xlink:to="loc_ebs_TermLoanFacilityMember_5f3a2127-8aaa-4111-9fbd-e4a0db5723f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a4df3c9a-1f9a-4d42-a382-c72b30f1f1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a4df3c9a-1f9a-4d42-a382-c72b30f1f1a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a4df3c9a-1f9a-4d42-a382-c72b30f1f1a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a4df3c9a-1f9a-4d42-a382-c72b30f1f1a0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a4df3c9a-1f9a-4d42-a382-c72b30f1f1a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_18720dfd-402b-4c4e-8e66-2841dca8af78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a4df3c9a-1f9a-4d42-a382-c72b30f1f1a0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_18720dfd-402b-4c4e-8e66-2841dca8af78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_070ba7f0-92a5-401b-b64d-8ace45af1f77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_18720dfd-402b-4c4e-8e66-2841dca8af78" xlink:to="loc_us-gaap_LineOfCreditMember_070ba7f0-92a5-401b-b64d-8ace45af1f77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_d5429ce8-91d4-41fb-885c-bd452a96d13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_18720dfd-402b-4c4e-8e66-2841dca8af78" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_d5429ce8-91d4-41fb-885c-bd452a96d13e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0c5a403c-6e19-43ac-ac35-97b7413e4aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:to="loc_us-gaap_DebtInstrumentAxis_0c5a403c-6e19-43ac-ac35-97b7413e4aa9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0c5a403c-6e19-43ac-ac35-97b7413e4aa9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c5a403c-6e19-43ac-ac35-97b7413e4aa9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0c5a403c-6e19-43ac-ac35-97b7413e4aa9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fce5914f-505c-4eab-8c69-2579b450c071" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c5a403c-6e19-43ac-ac35-97b7413e4aa9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fce5914f-505c-4eab-8c69-2579b450c071" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AmendedCreditAgreementMember_61f9b0c4-cff8-4970-9b15-e126bdc7873d" xlink:href="ebs-20230630.xsd#ebs_AmendedCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fce5914f-505c-4eab-8c69-2579b450c071" xlink:to="loc_ebs_AmendedCreditAgreementMember_61f9b0c4-cff8-4970-9b15-e126bdc7873d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DivestitureDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DivestitureDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DivestitureDetails" xlink:type="extended" id="i6b130daebe94466ab48ee75eb9ce2e69_DivestitureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_77d56701-dc49-4d18-a5c4-94c3bf8b8908" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_77d56701-dc49-4d18-a5c4-94c3bf8b8908" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable_1bd898ee-4682-4e2b-9d2e-72e493fc8d22" xlink:href="ebs-20230630.xsd#ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable_1bd898ee-4682-4e2b-9d2e-72e493fc8d22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_6868a798-12b9-48ed-9959-d7f864fb7567" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_6868a798-12b9-48ed-9959-d7f864fb7567" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DispositionOfBusinessTransactionCosts_a1e75329-d706-4e9b-8bdc-fce4d6171525" xlink:href="ebs-20230630.xsd#ebs_DispositionOfBusinessTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_ebs_DispositionOfBusinessTransactionCosts_a1e75329-d706-4e9b-8bdc-fce4d6171525" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ed18a435-2fb8-4898-abf6-f2b3e1a4481a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ed18a435-2fb8-4898-abf6-f2b3e1a4481a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f8adab6e-06f9-4364-b702-f9af50c3051f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f8adab6e-06f9-4364-b702-f9af50c3051f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f8adab6e-06f9-4364-b702-f9af50c3051f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f8adab6e-06f9-4364-b702-f9af50c3051f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f8adab6e-06f9-4364-b702-f9af50c3051f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6233732-e9a1-4129-a934-3fb29ab38220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f8adab6e-06f9-4364-b702-f9af50c3051f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6233732-e9a1-4129-a934-3fb29ab38220" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TravelHealthBusinessMember_521ba219-83ac-4ba2-90b0-72b01d64ac13" xlink:href="ebs-20230630.xsd#ebs_TravelHealthBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6233732-e9a1-4129-a934-3fb29ab38220" xlink:to="loc_ebs_TravelHealthBusinessMember_521ba219-83ac-4ba2-90b0-72b01d64ac13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_6370d858-f58e-4f70-aa5d-4c491f2d3a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_6370d858-f58e-4f70-aa5d-4c491f2d3a4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6370d858-f58e-4f70-aa5d-4c491f2d3a4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6370d858-f58e-4f70-aa5d-4c491f2d3a4e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6370d858-f58e-4f70-aa5d-4c491f2d3a4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7a5dbb23-66cf-4098-a4ea-81fc57b87bba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6370d858-f58e-4f70-aa5d-4c491f2d3a4e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7a5dbb23-66cf-4098-a4ea-81fc57b87bba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_7033bc58-15f9-40a6-9676-039efa93d44c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7a5dbb23-66cf-4098-a4ea-81fc57b87bba" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_7033bc58-15f9-40a6-9676-039efa93d44c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_a2ae4648-2763-4b57-8f8c-b41bcd003d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_a2ae4648-2763-4b57-8f8c-b41bcd003d5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a2ae4648-2763-4b57-8f8c-b41bcd003d5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_a2ae4648-2763-4b57-8f8c-b41bcd003d5a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a2ae4648-2763-4b57-8f8c-b41bcd003d5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_105b2d5c-c2e4-4840-946f-e542ca36fa56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_a2ae4648-2763-4b57-8f8c-b41bcd003d5a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_105b2d5c-c2e4-4840-946f-e542ca36fa56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DevelopmentBasedMilestonesMember_8f388655-a4d5-462b-9c13-5afaece36c88" xlink:href="ebs-20230630.xsd#ebs_DevelopmentBasedMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_105b2d5c-c2e4-4840-946f-e542ca36fa56" xlink:to="loc_ebs_DevelopmentBasedMilestonesMember_8f388655-a4d5-462b-9c13-5afaece36c88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SalesBasedMilestonesMember_f0501f28-23b2-44ac-b3b4-3fd410e4c807" xlink:href="ebs-20230630.xsd#ebs_SalesBasedMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_105b2d5c-c2e4-4840-946f-e542ca36fa56" xlink:to="loc_ebs_SalesBasedMilestonesMember_f0501f28-23b2-44ac-b3b4-3fd410e4c807" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RestructuringandimpairmentcostsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails" xlink:type="extended" id="i06041ff2103841b4a4d25b214c7617f0_RestructuringandimpairmentcostsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7a46f832-d2cf-47af-9cd4-222db6d25358" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6ef5eaec-c47d-421e-8873-bc4298a082cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a46f832-d2cf-47af-9cd4-222db6d25358" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6ef5eaec-c47d-421e-8873-bc4298a082cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_cdb903d9-90ad-4499-a669-420316de19bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a46f832-d2cf-47af-9cd4-222db6d25358" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_cdb903d9-90ad-4499-a669-420316de19bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6ba0fc07-a61f-4440-8959-c2858426d943" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a46f832-d2cf-47af-9cd4-222db6d25358" xlink:to="loc_us-gaap_RestructuringCharges_6ba0fc07-a61f-4440-8959-c2858426d943" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e7a54bc-d95c-455c-abfe-f4bd6b1ca4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a46f832-d2cf-47af-9cd4-222db6d25358" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e7a54bc-d95c-455c-abfe-f4bd6b1ca4bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_3b76001a-9884-4a6a-a3e7-54a34d938673" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e7a54bc-d95c-455c-abfe-f4bd6b1ca4bf" xlink:to="loc_us-gaap_RestructuringPlanAxis_3b76001a-9884-4a6a-a3e7-54a34d938673" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_3b76001a-9884-4a6a-a3e7-54a34d938673_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_3b76001a-9884-4a6a-a3e7-54a34d938673" xlink:to="loc_us-gaap_RestructuringPlanDomain_3b76001a-9884-4a6a-a3e7-54a34d938673_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1efff7c1-a0bd-44ae-b670-0f16edc3030e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_3b76001a-9884-4a6a-a3e7-54a34d938673" xlink:to="loc_us-gaap_RestructuringPlanDomain_1efff7c1-a0bd-44ae-b670-0f16edc3030e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RestructuringPlanJanuary2023Member_8cd3560f-553a-4509-87ae-1e62aaac4728" xlink:href="ebs-20230630.xsd#ebs_RestructuringPlanJanuary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1efff7c1-a0bd-44ae-b670-0f16edc3030e" xlink:to="loc_ebs_RestructuringPlanJanuary2023Member_8cd3560f-553a-4509-87ae-1e62aaac4728" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails" xlink:type="extended" id="i120e51e7224f4e188e33ec65197a33c8_RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_ba3e2f4f-1b73-4b22-acad-c356573fb994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_cc932bfd-1c57-48ae-964d-9c173482d406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_ba3e2f4f-1b73-4b22-acad-c356573fb994" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_cc932bfd-1c57-48ae-964d-9c173482d406" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_95bb47a2-e920-48f6-b033-1366816e4052" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_ba3e2f4f-1b73-4b22-acad-c356573fb994" xlink:to="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_95bb47a2-e920-48f6-b033-1366816e4052" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_97e3c0fb-704b-4ad5-abe2-6b1b983c14ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_95bb47a2-e920-48f6-b033-1366816e4052" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_97e3c0fb-704b-4ad5-abe2-6b1b983c14ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_97e3c0fb-704b-4ad5-abe2-6b1b983c14ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_97e3c0fb-704b-4ad5-abe2-6b1b983c14ff" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_97e3c0fb-704b-4ad5-abe2-6b1b983c14ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_97e3c0fb-704b-4ad5-abe2-6b1b983c14ff" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_f210c789-6e2c-42da-ae5b-50cbb6fe1e28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_f210c789-6e2c-42da-ae5b-50cbb6fe1e28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_12e11836-a8cf-4de3-83af-4499baeaf2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_12e11836-a8cf-4de3-83af-4499baeaf2bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_59263fb4-3eaf-4d98-9aff-cf87b167f52a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_59263fb4-3eaf-4d98-9aff-cf87b167f52a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_af30e901-5af4-4f9a-85a6-0a3a0d9693d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:to="loc_us-gaap_ConstructionInProgressMember_af30e901-5af4-4f9a-85a6-0a3a0d9693d6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails" xlink:type="extended" id="i7381f0ec7245496a8542d9a16b862ce7_RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_9e260126-1216-4b29-a757-d666e7979bae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a03cdf05-20a0-44ed-bf8e-9b24aa277218" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9e260126-1216-4b29-a757-d666e7979bae" xlink:to="loc_us-gaap_RestructuringCharges_a03cdf05-20a0-44ed-bf8e-9b24aa277218" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9e260126-1216-4b29-a757-d666e7979bae" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_05bfc3e5-c527-4c17-909a-00be29c154b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_05bfc3e5-c527-4c17-909a-00be29c154b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_05bfc3e5-c527-4c17-909a-00be29c154b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_05bfc3e5-c527-4c17-909a-00be29c154b9" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_05bfc3e5-c527-4c17-909a-00be29c154b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_05bfc3e5-c527-4c17-909a-00be29c154b9" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_UnallocatedResearchAndDevelopmentMember_4512431b-e0f7-4e8c-ae06-249c8efd3bac" xlink:href="ebs-20230630.xsd#ebs_UnallocatedResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:to="loc_ebs_UnallocatedResearchAndDevelopmentMember_4512431b-e0f7-4e8c-ae06-249c8efd3bac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EmployeeTransitionMember_e28dc31e-15e2-431b-b170-fd7cfd9fbdf6" xlink:href="ebs-20230630.xsd#ebs_EmployeeTransitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:to="loc_ebs_EmployeeTransitionMember_e28dc31e-15e2-431b-b170-fd7cfd9fbdf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_812972c5-a774-4102-b1d8-937824a9587e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:to="loc_us-gaap_EmployeeSeveranceMember_812972c5-a774-4102-b1d8-937824a9587e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EmployeeBenefitsMember_5128adfa-8fab-435c-b63e-773502d44b70" xlink:href="ebs-20230630.xsd#ebs_EmployeeBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:to="loc_ebs_EmployeeBenefitsMember_5128adfa-8fab-435c-b63e-773502d44b70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2dad7d58-52f8-423c-a21a-694273371615" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:to="loc_srt_ConsolidationItemsAxis_2dad7d58-52f8-423c-a21a-694273371615" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2dad7d58-52f8-423c-a21a-694273371615_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_2dad7d58-52f8-423c-a21a-694273371615" xlink:to="loc_srt_ConsolidationItemsDomain_2dad7d58-52f8-423c-a21a-694273371615_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6dda25ac-2f4c-41d8-b4fe-098103502a7e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_2dad7d58-52f8-423c-a21a-694273371615" xlink:to="loc_srt_ConsolidationItemsDomain_6dda25ac-2f4c-41d8-b4fe-098103502a7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6e135f59-0b1c-46b4-b10e-5a5838ac3f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6dda25ac-2f4c-41d8-b4fe-098103502a7e" xlink:to="loc_us-gaap_OperatingSegmentsMember_6e135f59-0b1c-46b4-b10e-5a5838ac3f5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0063d2d7-13f9-40b3-8900-cbc97e5384a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6dda25ac-2f4c-41d8-b4fe-098103502a7e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_0063d2d7-13f9-40b3-8900-cbc97e5384a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6e248084-4522-4508-9c52-73c0ec8c6a09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6e248084-4522-4508-9c52-73c0ec8c6a09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6e248084-4522-4508-9c52-73c0ec8c6a09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6e248084-4522-4508-9c52-73c0ec8c6a09" xlink:to="loc_us-gaap_SegmentDomain_6e248084-4522-4508-9c52-73c0ec8c6a09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f75429cf-e7e8-48d3-a447-b2721738a901" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6e248084-4522-4508-9c52-73c0ec8c6a09" xlink:to="loc_us-gaap_SegmentDomain_f75429cf-e7e8-48d3-a447-b2721738a901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember_eb68abca-b2b8-4272-b2c0-76429807640a" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f75429cf-e7e8-48d3-a447-b2721738a901" xlink:to="loc_ebs_ProductsSegmentMember_eb68abca-b2b8-4272-b2c0-76429807640a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ServicesSegmentMember_db8ec3f0-1ff8-40ef-acdd-b4588ed9b1ef" xlink:href="ebs-20230630.xsd#ebs_ServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f75429cf-e7e8-48d3-a447-b2721738a901" xlink:to="loc_ebs_ServicesSegmentMember_db8ec3f0-1ff8-40ef-acdd-b4588ed9b1ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_6b325c81-cab4-430d-ab8d-62b88000e7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:to="loc_us-gaap_RestructuringPlanAxis_6b325c81-cab4-430d-ab8d-62b88000e7f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_6b325c81-cab4-430d-ab8d-62b88000e7f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_6b325c81-cab4-430d-ab8d-62b88000e7f2" xlink:to="loc_us-gaap_RestructuringPlanDomain_6b325c81-cab4-430d-ab8d-62b88000e7f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_edd82171-17cd-4748-b07d-4cf69d58667b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_6b325c81-cab4-430d-ab8d-62b88000e7f2" xlink:to="loc_us-gaap_RestructuringPlanDomain_edd82171-17cd-4748-b07d-4cf69d58667b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RestructuringPlanJanuary2023Member_1c16485f-f532-4d35-8870-7c3e82a2e2ac" xlink:href="ebs-20230630.xsd#ebs_RestructuringPlanJanuary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_edd82171-17cd-4748-b07d-4cf69d58667b" xlink:to="loc_ebs_RestructuringPlanJanuary2023Member_1c16485f-f532-4d35-8870-7c3e82a2e2ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended" id="idb5288d7b13f467693ed38d4ccd4c913_RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8c4373f2-ccf9-498d-8dd0-27137213b374" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c4373f2-ccf9-498d-8dd0-27137213b374" xlink:to="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_31a67cab-bb62-444a-822d-a25a456580b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:to="loc_us-gaap_RestructuringReserve_31a67cab-bb62-444a-822d-a25a456580b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_549133d4-7229-4a8e-9474-c0cdda27b8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:to="loc_us-gaap_RestructuringCharges_549133d4-7229-4a8e-9474-c0cdda27b8cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_da59883a-1a48-42b5-a05d-40692f2b2f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:to="loc_us-gaap_PaymentsForRestructuring_da59883a-1a48-42b5-a05d-40692f2b2f8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_0709dbf6-136e-4678-8611-eafc69a7a211" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3cd0a10c-f1c8-4a97-aa22-1cf0c10e1cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c4373f2-ccf9-498d-8dd0-27137213b374" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3cd0a10c-f1c8-4a97-aa22-1cf0c10e1cc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_db11d154-8808-4d22-bc8a-bf8b2d34c327" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3cd0a10c-f1c8-4a97-aa22-1cf0c10e1cc6" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_db11d154-8808-4d22-bc8a-bf8b2d34c327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_db11d154-8808-4d22-bc8a-bf8b2d34c327_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_db11d154-8808-4d22-bc8a-bf8b2d34c327" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_db11d154-8808-4d22-bc8a-bf8b2d34c327_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0e09179a-2899-482d-a4af-9f73b4283cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_db11d154-8808-4d22-bc8a-bf8b2d34c327" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0e09179a-2899-482d-a4af-9f73b4283cc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EmployeeTransitionMember_4d92f375-4853-4d2e-8d3b-500985689876" xlink:href="ebs-20230630.xsd#ebs_EmployeeTransitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0e09179a-2899-482d-a4af-9f73b4283cc3" xlink:to="loc_ebs_EmployeeTransitionMember_4d92f375-4853-4d2e-8d3b-500985689876" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_3ee36b21-21e6-4709-9f53-86ef53595c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0e09179a-2899-482d-a4af-9f73b4283cc3" xlink:to="loc_us-gaap_EmployeeSeveranceMember_3ee36b21-21e6-4709-9f53-86ef53595c0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EmployeeBenefitsMember_6fc8e523-480e-4ad4-aad1-31121b105de4" xlink:href="ebs-20230630.xsd#ebs_EmployeeBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0e09179a-2899-482d-a4af-9f73b4283cc3" xlink:to="loc_ebs_EmployeeBenefitsMember_6fc8e523-480e-4ad4-aad1-31121b105de4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_024fe1e2-ee59-46c7-a551-1fb48f05fd99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3cd0a10c-f1c8-4a97-aa22-1cf0c10e1cc6" xlink:to="loc_us-gaap_RestructuringPlanAxis_024fe1e2-ee59-46c7-a551-1fb48f05fd99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_024fe1e2-ee59-46c7-a551-1fb48f05fd99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_024fe1e2-ee59-46c7-a551-1fb48f05fd99" xlink:to="loc_us-gaap_RestructuringPlanDomain_024fe1e2-ee59-46c7-a551-1fb48f05fd99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9898ff44-1bec-4dfb-9949-64b132cdf1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_024fe1e2-ee59-46c7-a551-1fb48f05fd99" xlink:to="loc_us-gaap_RestructuringPlanDomain_9898ff44-1bec-4dfb-9949-64b132cdf1e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RestructuringPlanJanuary2023Member_48cc05b4-87c1-4ad6-88cd-2c1944976ed6" xlink:href="ebs-20230630.xsd#ebs_RestructuringPlanJanuary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_9898ff44-1bec-4dfb-9949-64b132cdf1e9" xlink:to="loc_ebs_RestructuringPlanJanuary2023Member_48cc05b4-87c1-4ad6-88cd-2c1944976ed6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended" id="i40f8e6724ed843e1af2f9bc384f87991_PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36b20644-7f2a-4ca7-b8ea-a15b77e9e2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_276e1eb3-5974-4721-81f7-04526bc45123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36b20644-7f2a-4ca7-b8ea-a15b77e9e2e8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_276e1eb3-5974-4721-81f7-04526bc45123" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a1994652-4583-422e-8eaa-bc1bdbb24474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_276e1eb3-5974-4721-81f7-04526bc45123" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a1994652-4583-422e-8eaa-bc1bdbb24474" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_106fb323-375e-4529-ad3b-c479074c0fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_276e1eb3-5974-4721-81f7-04526bc45123" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_106fb323-375e-4529-ad3b-c479074c0fb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4fcbcf51-4edc-423a-a480-3bce00337bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_276e1eb3-5974-4721-81f7-04526bc45123" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4fcbcf51-4edc-423a-a480-3bce00337bfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3dbef937-b77c-43c2-ae51-a61b776d5faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36b20644-7f2a-4ca7-b8ea-a15b77e9e2e8" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3dbef937-b77c-43c2-ae51-a61b776d5faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90c56bba-7920-47b6-9361-3f4581947896" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36b20644-7f2a-4ca7-b8ea-a15b77e9e2e8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90c56bba-7920-47b6-9361-3f4581947896" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fa039827-d820-4877-bb5c-d5397bafce0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90c56bba-7920-47b6-9361-3f4581947896" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fa039827-d820-4877-bb5c-d5397bafce0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa039827-d820-4877-bb5c-d5397bafce0d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fa039827-d820-4877-bb5c-d5397bafce0d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa039827-d820-4877-bb5c-d5397bafce0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fa039827-d820-4877-bb5c-d5397bafce0d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_22312f90-7b37-4d11-ad47-39950efb48d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_22312f90-7b37-4d11-ad47-39950efb48d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_5c077634-18fc-4423-b1cc-8eff73591b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_5c077634-18fc-4423-b1cc-8eff73591b4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d6282c5c-792a-4e79-8485-af777f40f253" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d6282c5c-792a-4e79-8485-af777f40f253" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_2ecfb87b-7d96-4afe-aadf-0b698e670703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_2ecfb87b-7d96-4afe-aadf-0b698e670703" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_34e08cf3-6c1a-4622-8d5d-e8545e80d468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:to="loc_us-gaap_ConstructionInProgressMember_34e08cf3-6c1a-4622-8d5d-e8545e80d468" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#PropertyplantandequipmentNarrativeDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails" xlink:type="extended" id="icdd1d29bab8b403dbab7f8a425311747_PropertyplantandequipmentNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64e6b6ef-1bf0-41b4-a011-61e2b869fd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_b3a2013d-b1fe-471e-952e-cf078541caf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64e6b6ef-1bf0-41b4-a011-61e2b869fd2f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_b3a2013d-b1fe-471e-952e-cf078541caf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ebb367f6-7572-4d0b-bece-a239e41e4512" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64e6b6ef-1bf0-41b4-a011-61e2b869fd2f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ebb367f6-7572-4d0b-bece-a239e41e4512" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3182a842-91d0-4aa6-875f-41876f024bf1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ebb367f6-7572-4d0b-bece-a239e41e4512" xlink:to="loc_srt_MajorCustomersAxis_3182a842-91d0-4aa6-875f-41876f024bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3182a842-91d0-4aa6-875f-41876f024bf1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_3182a842-91d0-4aa6-875f-41876f024bf1" xlink:to="loc_srt_NameOfMajorCustomerDomain_3182a842-91d0-4aa6-875f-41876f024bf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_6990e732-86ee-40e1-836e-faffa324b948" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_3182a842-91d0-4aa6-875f-41876f024bf1" xlink:to="loc_srt_NameOfMajorCustomerDomain_6990e732-86ee-40e1-836e-faffa324b948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_JansenPharmaceuticalsIncMember_29edc17b-6eaf-4b73-9601-ede4b6b93c7d" xlink:href="ebs-20230630.xsd#ebs_JansenPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_6990e732-86ee-40e1-836e-faffa324b948" xlink:to="loc_ebs_JansenPharmaceuticalsIncMember_29edc17b-6eaf-4b73-9601-ede4b6b93c7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_894e4fa6-19e5-4ccf-809c-765a4ab0a032" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ebb367f6-7572-4d0b-bece-a239e41e4512" xlink:to="loc_srt_ProductOrServiceAxis_894e4fa6-19e5-4ccf-809c-765a4ab0a032" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_894e4fa6-19e5-4ccf-809c-765a4ab0a032_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_894e4fa6-19e5-4ccf-809c-765a4ab0a032" xlink:to="loc_srt_ProductsAndServicesDomain_894e4fa6-19e5-4ccf-809c-765a4ab0a032_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f14baacf-07d6-4f0d-a9c7-1ff0023c98ea" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_894e4fa6-19e5-4ccf-809c-765a4ab0a032" xlink:to="loc_srt_ProductsAndServicesDomain_f14baacf-07d6-4f0d-a9c7-1ff0023c98ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_68435a34-db66-4667-a03c-d9e97904892e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f14baacf-07d6-4f0d-a9c7-1ff0023c98ea" xlink:to="loc_us-gaap_ServiceMember_68435a34-db66-4667-a03c-d9e97904892e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="extended" id="i3793d01409504a7998a328b53e9cd48c_IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_379fb1f7-1d74-48ab-8e2b-ddcebbf7c30d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_379fb1f7-1d74-48ab-8e2b-ddcebbf7c30d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_bbc62738-127a-460d-baeb-cf625350e4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_bbc62738-127a-460d-baeb-cf625350e4e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ecffbcb7-2072-4c30-9aee-6904c0880b56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ecffbcb7-2072-4c30-9aee-6904c0880b56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_890bfdc5-9a62-4e50-b74f-53629d72dfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_890bfdc5-9a62-4e50-b74f-53629d72dfc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_78509936-5ed5-48cf-815d-3fa1d2710c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_78509936-5ed5-48cf-815d-3fa1d2710c53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_853112ab-8f65-4dc6-a50e-38c2939e7c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_853112ab-8f65-4dc6-a50e-38c2939e7c9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_853112ab-8f65-4dc6-a50e-38c2939e7c9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_853112ab-8f65-4dc6-a50e-38c2939e7c9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_853112ab-8f65-4dc6-a50e-38c2939e7c9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e98ccc37-f131-4be6-af78-fab737453d30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_853112ab-8f65-4dc6-a50e-38c2939e7c9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e98ccc37-f131-4be6-af78-fab737453d30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_ad271dfe-006b-434b-a87a-4c742f66b06b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e98ccc37-f131-4be6-af78-fab737453d30" xlink:to="loc_us-gaap_ProductMember_ad271dfe-006b-434b-a87a-4c742f66b06b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_eaf88589-9186-4d95-9635-bc5a5137f055" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e98ccc37-f131-4be6-af78-fab737453d30" xlink:to="loc_us-gaap_CustomerRelationshipsMember_eaf88589-9186-4d95-9635-bc5a5137f055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_6cae8999-bcae-4b9d-a3d4-376863abb51c" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e98ccc37-f131-4be6-af78-fab737453d30" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingMember_6cae8999-bcae-4b9d-a3d4-376863abb51c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_226f1ae5-6de7-462b-888d-df5a20a10767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_226f1ae5-6de7-462b-888d-df5a20a10767" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_226f1ae5-6de7-462b-888d-df5a20a10767_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_226f1ae5-6de7-462b-888d-df5a20a10767" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_226f1ae5-6de7-462b-888d-df5a20a10767_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c771fb1f-66e6-4cf8-92e8-e3901fe55966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_226f1ae5-6de7-462b-888d-df5a20a10767" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c771fb1f-66e6-4cf8-92e8-e3901fe55966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_edc8ad26-f22c-421b-918c-f84ae7b155d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c771fb1f-66e6-4cf8-92e8-e3901fe55966" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_edc8ad26-f22c-421b-918c-f84ae7b155d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5aab136b-d3e4-4f4c-9510-5da95e9741e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5aab136b-d3e4-4f4c-9510-5da95e9741e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5aab136b-d3e4-4f4c-9510-5da95e9741e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5aab136b-d3e4-4f4c-9510-5da95e9741e7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5aab136b-d3e4-4f4c-9510-5da95e9741e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_173c409a-8f87-484c-82a4-0c3d4a10ee69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5aab136b-d3e4-4f4c-9510-5da95e9741e7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_173c409a-8f87-484c-82a4-0c3d4a10ee69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TravelHealthBusinessMember_8a430902-bfe7-42a3-a86c-f32766432007" xlink:href="ebs-20230630.xsd#ebs_TravelHealthBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_173c409a-8f87-484c-82a4-0c3d4a10ee69" xlink:to="loc_ebs_TravelHealthBusinessMember_8a430902-bfe7-42a3-a86c-f32766432007" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#IntangibleassetsandgoodwillGoodwillRollForwardDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails" xlink:type="extended" id="i921722c89d2c4fd78955eb08869b6285_IntangibleassetsandgoodwillGoodwillRollForwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9b22d84a-487f-45f9-ab8f-c4aac6578be6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_fb6afacb-7e48-4f87-9c0a-136312961cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9b22d84a-487f-45f9-ab8f-c4aac6578be6" xlink:to="loc_us-gaap_GoodwillRollForward_fb6afacb-7e48-4f87-9c0a-136312961cc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3a60ca51-33f3-4954-b874-2d806d296174" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_fb6afacb-7e48-4f87-9c0a-136312961cc4" xlink:to="loc_us-gaap_Goodwill_3a60ca51-33f3-4954-b874-2d806d296174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_a9e1779f-d779-4eda-862e-9f7b217c980a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9b22d84a-487f-45f9-ab8f-c4aac6578be6" xlink:to="loc_us-gaap_GoodwillGross_a9e1779f-d779-4eda-862e-9f7b217c980a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e481709c-7607-465b-b9d1-cdda7d1bf537" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9b22d84a-487f-45f9-ab8f-c4aac6578be6" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e481709c-7607-465b-b9d1-cdda7d1bf537" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_195f99e5-f30a-4ce8-b963-ca242fcb3785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_9b22d84a-487f-45f9-ab8f-c4aac6578be6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_195f99e5-f30a-4ce8-b963-ca242fcb3785" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6a7e216d-d441-496a-829d-4a3a6f314cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_195f99e5-f30a-4ce8-b963-ca242fcb3785" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6a7e216d-d441-496a-829d-4a3a6f314cbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6a7e216d-d441-496a-829d-4a3a6f314cbd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6a7e216d-d441-496a-829d-4a3a6f314cbd" xlink:to="loc_us-gaap_SegmentDomain_6a7e216d-d441-496a-829d-4a3a6f314cbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3f1e322c-f243-4f40-930e-1e3ebc726d95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6a7e216d-d441-496a-829d-4a3a6f314cbd" xlink:to="loc_us-gaap_SegmentDomain_3f1e322c-f243-4f40-930e-1e3ebc726d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember_bea3a2e2-cf37-4a60-8b8a-d8af7c1d0e62" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3f1e322c-f243-4f40-930e-1e3ebc726d95" xlink:to="loc_ebs_ProductsSegmentMember_bea3a2e2-cf37-4a60-8b8a-d8af7c1d0e62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ServicesSegmentMember_a69f9018-1eeb-4a8f-b65f-51663f9d1c8a" xlink:href="ebs-20230630.xsd#ebs_ServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3f1e322c-f243-4f40-930e-1e3ebc726d95" xlink:to="loc_ebs_ServicesSegmentMember_a69f9018-1eeb-4a8f-b65f-51663f9d1c8a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#IntangibleassetsandgoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails" xlink:type="extended" id="i08ddc39ba30842ed806de0fd1b266b5f_IntangibleassetsandgoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_ec2360b4-da03-4795-b252-a79beda4cd35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a4b30ac1-8e4f-459f-8682-b9796c54c61b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_ec2360b4-da03-4795-b252-a79beda4cd35" xlink:to="loc_us-gaap_Goodwill_a4b30ac1-8e4f-459f-8682-b9796c54c61b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_694af681-2128-4410-895f-135f053749f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_ec2360b4-da03-4795-b252-a79beda4cd35" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_694af681-2128-4410-895f-135f053749f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8c4aedc2-fe08-4550-a54e-10a9c42b758c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_ec2360b4-da03-4795-b252-a79beda4cd35" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8c4aedc2-fe08-4550-a54e-10a9c42b758c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_67e718ad-038d-4192-bd91-93e67afa171c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8c4aedc2-fe08-4550-a54e-10a9c42b758c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_67e718ad-038d-4192-bd91-93e67afa171c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_67e718ad-038d-4192-bd91-93e67afa171c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_67e718ad-038d-4192-bd91-93e67afa171c" xlink:to="loc_us-gaap_SegmentDomain_67e718ad-038d-4192-bd91-93e67afa171c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e51ebffb-8164-4da7-bfe7-0b9886b6deb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_67e718ad-038d-4192-bd91-93e67afa171c" xlink:to="loc_us-gaap_SegmentDomain_e51ebffb-8164-4da7-bfe7-0b9886b6deb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember_d5356cb2-bae9-4d1b-8f49-bb802a19a335" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e51ebffb-8164-4da7-bfe7-0b9886b6deb5" xlink:to="loc_ebs_ProductsSegmentMember_d5356cb2-bae9-4d1b-8f49-bb802a19a335" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails" xlink:type="extended" id="ia9959019030b489dbd35afb151475648_FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c9350a4e-5c06-419b-bdf9-f6d9d123cb84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c9350a4e-5c06-419b-bdf9-f6d9d123cb84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_14240c41-404e-4b1c-9292-01d06f9ff698" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_DerivativeAssets_14240c41-404e-4b1c-9292-01d06f9ff698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e155cbba-bb05-49e9-a904-4f8324021546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e155cbba-bb05-49e9-a904-4f8324021546" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2298c8db-02b9-494b-b31c-f2670a177b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2298c8db-02b9-494b-b31c-f2670a177b1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_e020920c-3df6-4d2f-904f-8612629e946b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_e020920c-3df6-4d2f-904f-8612629e946b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1898da38-8525-4f1e-acbf-1d43116ef462" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1898da38-8525-4f1e-acbf-1d43116ef462" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_4f78d65c-7685-4646-bd8f-351605d41c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1898da38-8525-4f1e-acbf-1d43116ef462" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_4f78d65c-7685-4646-bd8f-351605d41c5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_4f78d65c-7685-4646-bd8f-351605d41c5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_4f78d65c-7685-4646-bd8f-351605d41c5b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_4f78d65c-7685-4646-bd8f-351605d41c5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3079ceb0-e1a5-41a0-bba6-0cfe27dbe17c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_4f78d65c-7685-4646-bd8f-351605d41c5b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3079ceb0-e1a5-41a0-bba6-0cfe27dbe17c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ee841f2f-524b-4f06-a64f-d441854dbe83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3079ceb0-e1a5-41a0-bba6-0cfe27dbe17c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ee841f2f-524b-4f06-a64f-d441854dbe83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_6f0614e6-83e2-48e6-a758-df7a6188f630" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3079ceb0-e1a5-41a0-bba6-0cfe27dbe17c" xlink:to="loc_us-gaap_BankTimeDepositsMember_6f0614e6-83e2-48e6-a758-df7a6188f630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee50710a-d6c5-4742-917c-e41e4716df8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1898da38-8525-4f1e-acbf-1d43116ef462" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee50710a-d6c5-4742-917c-e41e4716df8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee50710a-d6c5-4742-917c-e41e4716df8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee50710a-d6c5-4742-917c-e41e4716df8d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee50710a-d6c5-4742-917c-e41e4716df8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c813fa2-f056-4ca3-9ec5-a61def46086f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee50710a-d6c5-4742-917c-e41e4716df8d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c813fa2-f056-4ca3-9ec5-a61def46086f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_cc4e3b66-7832-43af-97bc-14ddcd3ee205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c813fa2-f056-4ca3-9ec5-a61def46086f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_cc4e3b66-7832-43af-97bc-14ddcd3ee205" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6531c82f-d707-4aac-bd7a-61bfe1344d81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c813fa2-f056-4ca3-9ec5-a61def46086f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6531c82f-d707-4aac-bd7a-61bfe1344d81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0a19336d-33eb-4d93-ace3-3abdd744182b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c813fa2-f056-4ca3-9ec5-a61def46086f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0a19336d-33eb-4d93-ace3-3abdd744182b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#FairvaluemeasurementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails" xlink:type="extended" id="i14da501d2a884797bb99c228c1d07bdc_FairvaluemeasurementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f4991a7c-5e45-4983-813c-6d66e1da4044" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_def322c7-2f8f-4544-ad6c-53b6819f8d78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4991a7c-5e45-4983-813c-6d66e1da4044" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_def322c7-2f8f-4544-ad6c-53b6819f8d78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2773e841-f1f1-4d19-a874-215a04984375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4991a7c-5e45-4983-813c-6d66e1da4044" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2773e841-f1f1-4d19-a874-215a04984375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_a5241678-84b4-4cc6-84a1-1d6fe01092d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4991a7c-5e45-4983-813c-6d66e1da4044" xlink:to="loc_us-gaap_LongTermDebtFairValue_a5241678-84b4-4cc6-84a1-1d6fe01092d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e1442db1-f0b8-4bf9-9f20-9923dce29971" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4991a7c-5e45-4983-813c-6d66e1da4044" xlink:to="loc_us-gaap_DebtInstrumentTable_e1442db1-f0b8-4bf9-9f20-9923dce29971" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9750ba6f-e825-40c2-a366-f0aca46fe86d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e1442db1-f0b8-4bf9-9f20-9923dce29971" xlink:to="loc_us-gaap_DebtInstrumentAxis_9750ba6f-e825-40c2-a366-f0aca46fe86d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9750ba6f-e825-40c2-a366-f0aca46fe86d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9750ba6f-e825-40c2-a366-f0aca46fe86d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9750ba6f-e825-40c2-a366-f0aca46fe86d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_166cedf8-2297-4e8b-9f7f-d51d475244d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9750ba6f-e825-40c2-a366-f0aca46fe86d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_166cedf8-2297-4e8b-9f7f-d51d475244d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_6d842b40-ac57-4932-8f99-0c55e6e5bc38" xlink:href="ebs-20230630.xsd#ebs_SeniorUnsecuredNotesDueAugust2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_166cedf8-2297-4e8b-9f7f-d51d475244d7" xlink:to="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_6d842b40-ac57-4932-8f99-0c55e6e5bc38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7552baec-1fe2-4b13-96df-236dcd256c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e1442db1-f0b8-4bf9-9f20-9923dce29971" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7552baec-1fe2-4b13-96df-236dcd256c22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7552baec-1fe2-4b13-96df-236dcd256c22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7552baec-1fe2-4b13-96df-236dcd256c22" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7552baec-1fe2-4b13-96df-236dcd256c22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ca5c83d6-5a3f-4389-b497-0b201fc7163b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7552baec-1fe2-4b13-96df-236dcd256c22" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ca5c83d6-5a3f-4389-b497-0b201fc7163b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3c2a8fb6-be71-4b69-9b29-1a757cfbdcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ca5c83d6-5a3f-4389-b497-0b201fc7163b" xlink:to="loc_us-gaap_SeniorNotesMember_3c2a8fb6-be71-4b69-9b29-1a757cfbdcd8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails" xlink:type="extended" id="i7132549f052d4d129d8b152061ba7761_FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ca97c4a6-b556-4edf-9443-b61cbe4b1e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5b248b91-7447-4535-990c-a1879287fcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ca97c4a6-b556-4edf-9443-b61cbe4b1e1e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5b248b91-7447-4535-990c-a1879287fcd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_bec0b666-a89f-49ab-87cd-8e89ef5d2543" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ca97c4a6-b556-4edf-9443-b61cbe4b1e1e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_bec0b666-a89f-49ab-87cd-8e89ef5d2543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ca97c4a6-b556-4edf-9443-b61cbe4b1e1e" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_c288de4a-4f37-421a-83f4-3a8560ec489e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_us-gaap_ValuationTechniqueAxis_c288de4a-4f37-421a-83f4-3a8560ec489e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_c288de4a-4f37-421a-83f4-3a8560ec489e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_c288de4a-4f37-421a-83f4-3a8560ec489e" xlink:to="loc_us-gaap_ValuationTechniqueDomain_c288de4a-4f37-421a-83f4-3a8560ec489e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_368f934a-6bdc-492d-9480-692a7dfad6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_c288de4a-4f37-421a-83f4-3a8560ec489e" xlink:to="loc_us-gaap_ValuationTechniqueDomain_368f934a-6bdc-492d-9480-692a7dfad6c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_fa1103a9-2e68-4ccc-9475-c51df9e866f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_368f934a-6bdc-492d-9480-692a7dfad6c8" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_fa1103a9-2e68-4ccc-9475-c51df9e866f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11ef71c0-9a5b-49da-8048-d9646a075da6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11ef71c0-9a5b-49da-8048-d9646a075da6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11ef71c0-9a5b-49da-8048-d9646a075da6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11ef71c0-9a5b-49da-8048-d9646a075da6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11ef71c0-9a5b-49da-8048-d9646a075da6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7593f263-2c5e-4be1-809e-59318e9486dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11ef71c0-9a5b-49da-8048-d9646a075da6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7593f263-2c5e-4be1-809e-59318e9486dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a3fdb5e5-2725-40c2-8e78-69c3f89877b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7593f263-2c5e-4be1-809e-59318e9486dd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a3fdb5e5-2725-40c2-8e78-69c3f89877b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_462ff446-aa5f-4982-a5ad-31456952f128" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_462ff446-aa5f-4982-a5ad-31456952f128" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_462ff446-aa5f-4982-a5ad-31456952f128_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_462ff446-aa5f-4982-a5ad-31456952f128" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_462ff446-aa5f-4982-a5ad-31456952f128_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4dd7b6ac-a7d6-4d15-a71f-6119a7962527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_462ff446-aa5f-4982-a5ad-31456952f128" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4dd7b6ac-a7d6-4d15-a71f-6119a7962527" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7f7facae-5dd2-4944-9823-a050d233e817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4dd7b6ac-a7d6-4d15-a71f-6119a7962527" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7f7facae-5dd2-4944-9823-a050d233e817" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_727313f6-0723-43dd-9785-4cc767ce7a21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_727313f6-0723-43dd-9785-4cc767ce7a21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_727313f6-0723-43dd-9785-4cc767ce7a21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_727313f6-0723-43dd-9785-4cc767ce7a21" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_727313f6-0723-43dd-9785-4cc767ce7a21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_f72a3bea-da23-442d-87b0-a1fd7fa18324" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_727313f6-0723-43dd-9785-4cc767ce7a21" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_f72a3bea-da23-442d-87b0-a1fd7fa18324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_ca15e60b-674b-4be3-951f-9dfeb7a8e7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_f72a3bea-da23-442d-87b0-a1fd7fa18324" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_ca15e60b-674b-4be3-951f-9dfeb7a8e7b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_MeasurementInputProbabilityOfPaymentMember_ffd8a7a7-05f6-41b9-a611-445fa822b25a" xlink:href="ebs-20230630.xsd#ebs_MeasurementInputProbabilityOfPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_f72a3bea-da23-442d-87b0-a1fd7fa18324" xlink:to="loc_ebs_MeasurementInputProbabilityOfPaymentMember_ffd8a7a7-05f6-41b9-a611-445fa822b25a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5244c6b8-7d89-4d0f-8bc9-2540c0d01ec1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_srt_RangeAxis_5244c6b8-7d89-4d0f-8bc9-2540c0d01ec1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5244c6b8-7d89-4d0f-8bc9-2540c0d01ec1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5244c6b8-7d89-4d0f-8bc9-2540c0d01ec1" xlink:to="loc_srt_RangeMember_5244c6b8-7d89-4d0f-8bc9-2540c0d01ec1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e8e8c9bb-6f3b-42ac-9d8c-c515b1b0121c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5244c6b8-7d89-4d0f-8bc9-2540c0d01ec1" xlink:to="loc_srt_RangeMember_e8e8c9bb-6f3b-42ac-9d8c-c515b1b0121c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4917e69c-3a7e-409e-95ef-64d9ab7d0a9f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e8e8c9bb-6f3b-42ac-9d8c-c515b1b0121c" xlink:to="loc_srt_MinimumMember_4917e69c-3a7e-409e-95ef-64d9ab7d0a9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b5a79e41-a817-4b40-86f8-202b0e419b4b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e8e8c9bb-6f3b-42ac-9d8c-c515b1b0121c" xlink:to="loc_srt_MaximumMember_b5a79e41-a817-4b40-86f8-202b0e419b4b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails" xlink:type="extended" id="i17996f6eaadc49e580fd787b7cb67554_DerivativeinstrumentsandhedgingactivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f396c62-2422-4856-a61e-227b4985f3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_111f4f60-621b-49be-9545-00d5e5ce7c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f396c62-2422-4856-a61e-227b4985f3cb" xlink:to="loc_us-gaap_DerivativeNotionalAmount_111f4f60-621b-49be-9545-00d5e5ce7c0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociBeforeTaxAttributableToParent_b2a19d00-c203-47c5-9bf3-ba8521a3de61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AociBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f396c62-2422-4856-a61e-227b4985f3cb" xlink:to="loc_us-gaap_AociBeforeTaxAttributableToParent_b2a19d00-c203-47c5-9bf3-ba8521a3de61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_dc54addd-5b63-4ee6-aa81-a43e3a71831e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f396c62-2422-4856-a61e-227b4985f3cb" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_dc54addd-5b63-4ee6-aa81-a43e3a71831e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_11e59940-8d91-48b5-9245-3d5f54551229" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_dc54addd-5b63-4ee6-aa81-a43e3a71831e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_11e59940-8d91-48b5-9245-3d5f54551229" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_11e59940-8d91-48b5-9245-3d5f54551229_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_11e59940-8d91-48b5-9245-3d5f54551229" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_11e59940-8d91-48b5-9245-3d5f54551229_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3ac13b9a-7d1d-41f4-af2e-6864fe8d6da0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_11e59940-8d91-48b5-9245-3d5f54551229" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3ac13b9a-7d1d-41f4-af2e-6864fe8d6da0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_13e15e7a-8225-4e85-b8e9-42d5598482ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3ac13b9a-7d1d-41f4-af2e-6864fe8d6da0" xlink:to="loc_us-gaap_InterestRateSwapMember_13e15e7a-8225-4e85-b8e9-42d5598482ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7cc713db-b2d4-4caa-ac46-85e9558253ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_dc54addd-5b63-4ee6-aa81-a43e3a71831e" xlink:to="loc_us-gaap_HedgingDesignationAxis_7cc713db-b2d4-4caa-ac46-85e9558253ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7cc713db-b2d4-4caa-ac46-85e9558253ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7cc713db-b2d4-4caa-ac46-85e9558253ca" xlink:to="loc_us-gaap_HedgingDesignationDomain_7cc713db-b2d4-4caa-ac46-85e9558253ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_564bfc40-e2c5-467f-b1ad-9a8bfb060f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7cc713db-b2d4-4caa-ac46-85e9558253ca" xlink:to="loc_us-gaap_HedgingDesignationDomain_564bfc40-e2c5-467f-b1ad-9a8bfb060f0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_64427afb-2eb5-4518-97e2-d85e8e86e0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_564bfc40-e2c5-467f-b1ad-9a8bfb060f0b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_64427afb-2eb5-4518-97e2-d85e8e86e0d4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails" xlink:type="extended" id="i8a2f22b640e444b7a469802bbdcaf222_DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_472e8b07-523e-439a-857d-6f5b45ef5c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0dae073f-0e7a-400f-b0ae-ac05cd7c4aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_472e8b07-523e-439a-857d-6f5b45ef5c50" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0dae073f-0e7a-400f-b0ae-ac05cd7c4aa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_472e8b07-523e-439a-857d-6f5b45ef5c50" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7ec03e96-3426-4093-a7e5-39336c92e532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7ec03e96-3426-4093-a7e5-39336c92e532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7ec03e96-3426-4093-a7e5-39336c92e532_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7ec03e96-3426-4093-a7e5-39336c92e532" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7ec03e96-3426-4093-a7e5-39336c92e532_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8adac579-ff35-42c7-8888-fc00686d38ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7ec03e96-3426-4093-a7e5-39336c92e532" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8adac579-ff35-42c7-8888-fc00686d38ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7be64baa-9b84-4e0a-aaff-f815209e2db1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8adac579-ff35-42c7-8888-fc00686d38ac" xlink:to="loc_us-gaap_InterestRateSwapMember_7be64baa-9b84-4e0a-aaff-f815209e2db1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b4f91904-d824-4866-886d-93366bc417ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:to="loc_us-gaap_HedgingDesignationAxis_b4f91904-d824-4866-886d-93366bc417ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b4f91904-d824-4866-886d-93366bc417ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b4f91904-d824-4866-886d-93366bc417ce" xlink:to="loc_us-gaap_HedgingDesignationDomain_b4f91904-d824-4866-886d-93366bc417ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_74974ceb-eae7-4486-9af0-1e57ff2f7a75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b4f91904-d824-4866-886d-93366bc417ce" xlink:to="loc_us-gaap_HedgingDesignationDomain_74974ceb-eae7-4486-9af0-1e57ff2f7a75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d6181f89-12bb-4f0d-83cd-b709b4be82a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_74974ceb-eae7-4486-9af0-1e57ff2f7a75" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d6181f89-12bb-4f0d-83cd-b709b4be82a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_20046cd2-a5ae-415f-84ae-e1aa27463957" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_20046cd2-a5ae-415f-84ae-e1aa27463957" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_20046cd2-a5ae-415f-84ae-e1aa27463957_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_20046cd2-a5ae-415f-84ae-e1aa27463957" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_20046cd2-a5ae-415f-84ae-e1aa27463957_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_de046c4b-4c3e-4bdf-b314-1648523c85ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_20046cd2-a5ae-415f-84ae-e1aa27463957" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_de046c4b-4c3e-4bdf-b314-1648523c85ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_7dc40e95-1846-45a6-80b1-914a12c617f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de046c4b-4c3e-4bdf-b314-1648523c85ac" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_7dc40e95-1846-45a6-80b1-914a12c617f3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails" xlink:type="extended" id="i4c07d2028de74061b8641bcc86a95c41_DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_bccf9788-32b3-4dba-9d30-b104f6b7ac83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_bfaa0aa8-01ba-4547-bf49-11dea20c894c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_bccf9788-32b3-4dba-9d30-b104f6b7ac83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_bfaa0aa8-01ba-4547-bf49-11dea20c894c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_bccf9788-32b3-4dba-9d30-b104f6b7ac83" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d5a1cfbf-b30a-4f53-a096-a9498789c67a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d5a1cfbf-b30a-4f53-a096-a9498789c67a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d5a1cfbf-b30a-4f53-a096-a9498789c67a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d5a1cfbf-b30a-4f53-a096-a9498789c67a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d5a1cfbf-b30a-4f53-a096-a9498789c67a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_11b31085-6e9f-4c9c-bd84-9b23163a6697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d5a1cfbf-b30a-4f53-a096-a9498789c67a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_11b31085-6e9f-4c9c-bd84-9b23163a6697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_76ccc20f-2b40-462e-8707-04c97c491504" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_11b31085-6e9f-4c9c-bd84-9b23163a6697" xlink:to="loc_us-gaap_CashFlowHedgingMember_76ccc20f-2b40-462e-8707-04c97c491504" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_65763c10-3b87-4430-9645-4e62712448d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_65763c10-3b87-4430-9645-4e62712448d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_65763c10-3b87-4430-9645-4e62712448d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_65763c10-3b87-4430-9645-4e62712448d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_65763c10-3b87-4430-9645-4e62712448d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b25b5fd4-371b-4210-a3be-6b0bf2bc8edd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_65763c10-3b87-4430-9645-4e62712448d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b25b5fd4-371b-4210-a3be-6b0bf2bc8edd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_63e49761-96e0-4125-bafc-192104e70b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b25b5fd4-371b-4210-a3be-6b0bf2bc8edd" xlink:to="loc_us-gaap_InterestExpenseMember_63e49761-96e0-4125-bafc-192104e70b3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_54c16330-6462-4592-a388-56af3fdfc3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_54c16330-6462-4592-a388-56af3fdfc3c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_54c16330-6462-4592-a388-56af3fdfc3c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_54c16330-6462-4592-a388-56af3fdfc3c1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_54c16330-6462-4592-a388-56af3fdfc3c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_41f21237-1f54-4b43-a406-50fed3d2582f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_54c16330-6462-4592-a388-56af3fdfc3c1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_41f21237-1f54-4b43-a406-50fed3d2582f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d2df6b25-f5e4-45d8-9366-906fc3209886" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_41f21237-1f54-4b43-a406-50fed3d2582f" xlink:to="loc_us-gaap_InterestRateSwapMember_d2df6b25-f5e4-45d8-9366-906fc3209886" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DebtScheduleDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DebtScheduleDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DebtScheduleDetails" xlink:type="extended" id="i22a33256f05648888c2141c7bfec095c_DebtScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a386fa7e-6093-40ce-8018-74e70b42b213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a386fa7e-6093-40ce-8018-74e70b42b213" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_21b6e074-6aae-4ae3-a6df-7dd0426280f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_LongTermDebt_21b6e074-6aae-4ae3-a6df-7dd0426280f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ae440eb5-bd9f-49df-ac7b-ae91390fe477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ae440eb5-bd9f-49df-ac7b-ae91390fe477" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_c88a7523-8053-40b0-984b-c5cf3b5884c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_LongTermDebtCurrent_c88a7523-8053-40b0-984b-c5cf3b5884c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_67de124d-4f8a-4f74-8998-20db164873c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_67de124d-4f8a-4f74-8998-20db164873c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3590a445-b6e2-4df9-951f-e24e94d24fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:to="loc_us-gaap_DebtInstrumentAxis_3590a445-b6e2-4df9-951f-e24e94d24fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3590a445-b6e2-4df9-951f-e24e94d24fd3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3590a445-b6e2-4df9-951f-e24e94d24fd3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3590a445-b6e2-4df9-951f-e24e94d24fd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_986bdb90-8672-4380-bc70-d89f6f2db252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3590a445-b6e2-4df9-951f-e24e94d24fd3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_986bdb90-8672-4380-bc70-d89f6f2db252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_37ad0d67-ddc9-41cc-9646-7dd3ed9dcb31" xlink:href="ebs-20230630.xsd#ebs_SeniorUnsecuredNotesDueAugust2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_986bdb90-8672-4380-bc70-d89f6f2db252" xlink:to="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_37ad0d67-ddc9-41cc-9646-7dd3ed9dcb31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OtherLongTermDebtFacilityMember_e57a0323-97ee-407b-8a72-ec0c0a31c8fd" xlink:href="ebs-20230630.xsd#ebs_OtherLongTermDebtFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_986bdb90-8672-4380-bc70-d89f6f2db252" xlink:to="loc_ebs_OtherLongTermDebtFacilityMember_e57a0323-97ee-407b-8a72-ec0c0a31c8fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_383dd8ca-0326-4483-a1e8-47c4dbe9955f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_383dd8ca-0326-4483-a1e8-47c4dbe9955f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_383dd8ca-0326-4483-a1e8-47c4dbe9955f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_383dd8ca-0326-4483-a1e8-47c4dbe9955f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_383dd8ca-0326-4483-a1e8-47c4dbe9955f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2d20a09b-c929-4455-a38a-6c66838ebea0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_383dd8ca-0326-4483-a1e8-47c4dbe9955f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2d20a09b-c929-4455-a38a-6c66838ebea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_c56db5ec-1caf-4598-817e-97945841c4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2d20a09b-c929-4455-a38a-6c66838ebea0" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_c56db5ec-1caf-4598-817e-97945841c4cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_41538ebe-ad52-4aaf-9fb7-78b6f0544e89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2d20a09b-c929-4455-a38a-6c66838ebea0" xlink:to="loc_us-gaap_LineOfCreditMember_41538ebe-ad52-4aaf-9fb7-78b6f0544e89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_5adec8e1-0d83-4c30-8e1c-3edf1832fa81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2d20a09b-c929-4455-a38a-6c66838ebea0" xlink:to="loc_us-gaap_SeniorNotesMember_5adec8e1-0d83-4c30-8e1c-3edf1832fa81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_81d8e1ca-a516-42f3-8189-3556b2490a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:to="loc_us-gaap_CreditFacilityAxis_81d8e1ca-a516-42f3-8189-3556b2490a1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_81d8e1ca-a516-42f3-8189-3556b2490a1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_81d8e1ca-a516-42f3-8189-3556b2490a1d" xlink:to="loc_us-gaap_CreditFacilityDomain_81d8e1ca-a516-42f3-8189-3556b2490a1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1f4d96a6-7f15-4654-84db-a58c915a763e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_81d8e1ca-a516-42f3-8189-3556b2490a1d" xlink:to="loc_us-gaap_CreditFacilityDomain_1f4d96a6-7f15-4654-84db-a58c915a763e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3b1b7838-1ed8-4bda-ae45-3a3f739b5e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1f4d96a6-7f15-4654-84db-a58c915a763e" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3b1b7838-1ed8-4bda-ae45-3a3f739b5e6f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DebtNarrativeDetails" xlink:type="extended" id="iff205d465ca6417c918e87b62dfc577c_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet_1485a230-5d8c-46f4-a65b-156be30e5e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsCurrentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet_1485a230-5d8c-46f4-a65b-156be30e5e5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a8a5d2fd-38d4-4ee2-b612-eb3b80432758" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a8a5d2fd-38d4-4ee2-b612-eb3b80432758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a1cb4159-7068-4128-85b0-2b87ac195554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_LongTermDebt_a1cb4159-7068-4128-85b0-2b87ac195554" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_9d610e88-e11c-4235-b362-bbe751942903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_9d610e88-e11c-4235-b362-bbe751942903" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_701ac722-e986-49e9-8d8d-009a4892a31a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_701ac722-e986-49e9-8d8d-009a4892a31a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_70714af1-191e-4a71-a79b-8188ac1c7d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_70714af1-191e-4a71-a79b-8188ac1c7d1c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_dc1cbc00-10c2-4676-ba7a-89c818829b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_Cash_dc1cbc00-10c2-4676-ba7a-89c818829b0d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_adc5f451-d660-48e5-aa94-433b2bd07756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_adc5f451-d660-48e5-aa94-433b2bd07756" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_ac305162-a540-4597-93db-c5964a61881c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_ac305162-a540-4597-93db-c5964a61881c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum_28962e12-15c3-4b78-87d3-19dc6c7a4c23" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum_28962e12-15c3-4b78-87d3-19dc6c7a4c23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantLeverageRatioMaximum_63ba5009-9b02-460b-b57b-53e1bffb98b1" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_ebs_DebtInstrumentCovenantLeverageRatioMaximum_63ba5009-9b02-460b-b57b-53e1bffb98b1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantConsiderationThreshold_da3ab6a0-6e6e-40d7-aeeb-a9b9b29fee4a" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantConsiderationThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_ebs_DebtInstrumentCovenantConsiderationThreshold_da3ab6a0-6e6e-40d7-aeeb-a9b9b29fee4a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_47b87bdf-777b-41da-b7da-3545847cd183" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_47b87bdf-777b-41da-b7da-3545847cd183" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e692d5d5-a91f-4fdc-bcb7-3cedc2e1573f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e692d5d5-a91f-4fdc-bcb7-3cedc2e1573f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8700290b-0942-4a56-9fa1-41c99c4e9377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_CreditFacilityAxis_8700290b-0942-4a56-9fa1-41c99c4e9377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8700290b-0942-4a56-9fa1-41c99c4e9377_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8700290b-0942-4a56-9fa1-41c99c4e9377" xlink:to="loc_us-gaap_CreditFacilityDomain_8700290b-0942-4a56-9fa1-41c99c4e9377_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4200bc38-5423-446c-999c-5fb1563b10ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8700290b-0942-4a56-9fa1-41c99c4e9377" xlink:to="loc_us-gaap_CreditFacilityDomain_4200bc38-5423-446c-999c-5fb1563b10ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8fbb459d-4dd5-4204-a9ea-c18b9f006f85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_4200bc38-5423-446c-999c-5fb1563b10ce" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8fbb459d-4dd5-4204-a9ea-c18b9f006f85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TermLoanFacilityMember_2b13474a-02c8-4019-ac1e-9c81e5ee152b" xlink:href="ebs-20230630.xsd#ebs_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_4200bc38-5423-446c-999c-5fb1563b10ce" xlink:to="loc_ebs_TermLoanFacilityMember_2b13474a-02c8-4019-ac1e-9c81e5ee152b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f2b3497a-af28-45f4-b6b8-adf5bbb52016" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_DebtInstrumentAxis_f2b3497a-af28-45f4-b6b8-adf5bbb52016" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f2b3497a-af28-45f4-b6b8-adf5bbb52016_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f2b3497a-af28-45f4-b6b8-adf5bbb52016" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f2b3497a-af28-45f4-b6b8-adf5bbb52016_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_aa3f0832-7a13-4cd5-b39f-bcb7a8ab88cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f2b3497a-af28-45f4-b6b8-adf5bbb52016" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_aa3f0832-7a13-4cd5-b39f-bcb7a8ab88cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_7e887d5f-84e7-423a-a7b3-cfe4e457f80d" xlink:href="ebs-20230630.xsd#ebs_SeniorUnsecuredNotesDueAugust2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa3f0832-7a13-4cd5-b39f-bcb7a8ab88cb" xlink:to="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_7e887d5f-84e7-423a-a7b3-cfe4e457f80d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AmendedCreditAgreementMember_da2554f8-e0df-42ce-8c42-3932620dfa0a" xlink:href="ebs-20230630.xsd#ebs_AmendedCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa3f0832-7a13-4cd5-b39f-bcb7a8ab88cb" xlink:to="loc_ebs_AmendedCreditAgreementMember_da2554f8-e0df-42ce-8c42-3932620dfa0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3aac0da9-1957-4db1-babe-4b8197d7e5cd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_srt_RangeAxis_3aac0da9-1957-4db1-babe-4b8197d7e5cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3aac0da9-1957-4db1-babe-4b8197d7e5cd_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3aac0da9-1957-4db1-babe-4b8197d7e5cd" xlink:to="loc_srt_RangeMember_3aac0da9-1957-4db1-babe-4b8197d7e5cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b66783e-10e9-4967-b357-dbc2c0377d4b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3aac0da9-1957-4db1-babe-4b8197d7e5cd" xlink:to="loc_srt_RangeMember_2b66783e-10e9-4967-b357-dbc2c0377d4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_902ec8e6-809c-4d0a-8360-12a5086f4e04" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2b66783e-10e9-4967-b357-dbc2c0377d4b" xlink:to="loc_srt_MaximumMember_902ec8e6-809c-4d0a-8360-12a5086f4e04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fecbf034-8ff8-4600-b5a7-c12459b6276d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2b66783e-10e9-4967-b357-dbc2c0377d4b" xlink:to="loc_srt_MinimumMember_fecbf034-8ff8-4600-b5a7-c12459b6276d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c64d25b8-7755-4c7e-9642-209ec4eb72c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c64d25b8-7755-4c7e-9642-209ec4eb72c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c64d25b8-7755-4c7e-9642-209ec4eb72c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c64d25b8-7755-4c7e-9642-209ec4eb72c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c64d25b8-7755-4c7e-9642-209ec4eb72c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_feb95f12-7522-4920-aeea-34e038dbded6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c64d25b8-7755-4c7e-9642-209ec4eb72c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_feb95f12-7522-4920-aeea-34e038dbded6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d29802b4-525e-43cd-ae5c-407b6150d766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_feb95f12-7522-4920-aeea-34e038dbded6" xlink:to="loc_us-gaap_SeniorNotesMember_d29802b4-525e-43cd-ae5c-407b6150d766" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7d41665f-2387-4a92-8c88-dc4902d52b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_feb95f12-7522-4920-aeea-34e038dbded6" xlink:to="loc_us-gaap_LineOfCreditMember_7d41665f-2387-4a92-8c88-dc4902d52b0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_5abfb33c-fbe2-4827-ad64-7d90795048d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_feb95f12-7522-4920-aeea-34e038dbded6" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_5abfb33c-fbe2-4827-ad64-7d90795048d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_354f6884-45ed-4267-9ac7-28792602f59a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_354f6884-45ed-4267-9ac7-28792602f59a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_354f6884-45ed-4267-9ac7-28792602f59a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_354f6884-45ed-4267-9ac7-28792602f59a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_354f6884-45ed-4267-9ac7-28792602f59a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_04eb4666-fcc6-423b-9812-ea680820ac2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_354f6884-45ed-4267-9ac7-28792602f59a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_04eb4666-fcc6-423b-9812-ea680820ac2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_b3708491-32b9-483b-bef3-bc373640d858" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_04eb4666-fcc6-423b-9812-ea680820ac2a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_b3708491-32b9-483b-bef3-bc373640d858" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_7d082e3d-458b-483d-881b-6b9498656672" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_04eb4666-fcc6-423b-9812-ea680820ac2a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_7d082e3d-458b-483d-881b-6b9498656672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_99a6e2da-ac8d-4762-be00-3c5af2a12ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_99a6e2da-ac8d-4762-be00-3c5af2a12ce9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_99a6e2da-ac8d-4762-be00-3c5af2a12ce9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99a6e2da-ac8d-4762-be00-3c5af2a12ce9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_99a6e2da-ac8d-4762-be00-3c5af2a12ce9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_502d1b40-e7c0-4898-b135-93287a101c45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99a6e2da-ac8d-4762-be00-3c5af2a12ce9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_502d1b40-e7c0-4898-b135-93287a101c45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_09b62ff1-f9cc-447b-9c44-9e298ac3aafd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_502d1b40-e7c0-4898-b135-93287a101c45" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_09b62ff1-f9cc-447b-9c44-9e298ac3aafd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_65a1b483-0382-4d96-aa80-4a44442d33e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_65a1b483-0382-4d96-aa80-4a44442d33e5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_65a1b483-0382-4d96-aa80-4a44442d33e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_65a1b483-0382-4d96-aa80-4a44442d33e5" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_65a1b483-0382-4d96-aa80-4a44442d33e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_794a9a0c-3020-4061-9c98-ce58288eed58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_65a1b483-0382-4d96-aa80-4a44442d33e5" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_794a9a0c-3020-4061-9c98-ce58288eed58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TravelHealthBusinessMember_73b10ab4-427e-42a3-a61c-2c217935755a" xlink:href="ebs-20230630.xsd#ebs_TravelHealthBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_794a9a0c-3020-4061-9c98-ce58288eed58" xlink:to="loc_ebs_TravelHealthBusinessMember_73b10ab4-427e-42a3-a61c-2c217935755a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtTermsAxis_0c147fea-bfc7-4bcb-9a62-08aad0321561" xlink:href="ebs-20230630.xsd#ebs_DebtTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_ebs_DebtTermsAxis_0c147fea-bfc7-4bcb-9a62-08aad0321561" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtTermsDomain_0c147fea-bfc7-4bcb-9a62-08aad0321561_default" xlink:href="ebs-20230630.xsd#ebs_DebtTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ebs_DebtTermsAxis_0c147fea-bfc7-4bcb-9a62-08aad0321561" xlink:to="loc_ebs_DebtTermsDomain_0c147fea-bfc7-4bcb-9a62-08aad0321561_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:href="ebs-20230630.xsd#ebs_DebtTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ebs_DebtTermsAxis_0c147fea-bfc7-4bcb-9a62-08aad0321561" xlink:to="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiscalQuartersEndingIn2024Member_f67024a8-cfe1-4aab-8463-24cb2a5d6a09" xlink:href="ebs-20230630.xsd#ebs_FiscalQuartersEndingIn2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:to="loc_ebs_FiscalQuartersEndingIn2024Member_f67024a8-cfe1-4aab-8463-24cb2a5d6a09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiscalQuartersEndingAfter2024Member_6e073b23-bd71-483e-acfb-8201120d467d" xlink:href="ebs-20230630.xsd#ebs_FiscalQuartersEndingAfter2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:to="loc_ebs_FiscalQuartersEndingAfter2024Member_6e073b23-bd71-483e-acfb-8201120d467d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_UntilMarch312024Member_5cbe1dd1-cbb1-4df4-941b-0e93ae1e0403" xlink:href="ebs-20230630.xsd#ebs_UntilMarch312024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:to="loc_ebs_UntilMarch312024Member_5cbe1dd1-cbb1-4df4-941b-0e93ae1e0403" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiscalQuartersEndingAfterMarch312024Member_f50412c1-87e8-48c1-8468-7189b7d4887f" xlink:href="ebs-20230630.xsd#ebs_FiscalQuartersEndingAfterMarch312024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:to="loc_ebs_FiscalQuartersEndingAfterMarch312024Member_f50412c1-87e8-48c1-8468-7189b7d4887f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2f6581b3-3994-4ffd-9a74-94a5aa356526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_VariableRateAxis_2f6581b3-3994-4ffd-9a74-94a5aa356526" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2f6581b3-3994-4ffd-9a74-94a5aa356526_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_2f6581b3-3994-4ffd-9a74-94a5aa356526" xlink:to="loc_us-gaap_VariableRateDomain_2f6581b3-3994-4ffd-9a74-94a5aa356526_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_2f6581b3-3994-4ffd-9a74-94a5aa356526" xlink:to="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SOFREURIBOROrCDORMember_a75ebb0b-f14b-4dea-9ace-70a70570dcf3" xlink:href="ebs-20230630.xsd#ebs_SOFREURIBOROrCDORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:to="loc_ebs_SOFREURIBOROrCDORMember_a75ebb0b-f14b-4dea-9ace-70a70570dcf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_def95771-e172-4ceb-89c7-4f2e81f9ba62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_def95771-e172-4ceb-89c7-4f2e81f9ba62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SecuredOvernightFinancingRateSOFRMember_f4baff30-0b71-4d6c-a8ee-ea3fca014a75" xlink:href="ebs-20230630.xsd#ebs_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:to="loc_ebs_SecuredOvernightFinancingRateSOFRMember_f4baff30-0b71-4d6c-a8ee-ea3fca014a75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_d1965038-d9b7-40d2-baa3-5d21d2f15b04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:to="loc_us-gaap_BaseRateMember_d1965038-d9b7-40d2-baa3-5d21d2f15b04" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails" xlink:type="extended" id="i04fd010bc7ce497e8698cf9519c84f01_StockbasedcompensationandstockholdersequityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5ad514b5-9bb0-4cd4-b60d-e966167ef3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5ad514b5-9bb0-4cd4-b60d-e966167ef3f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6563c49b-459c-44d3-b900-b531897d07ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6563c49b-459c-44d3-b900-b531897d07ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage_082f670d-29ec-4899-94ba-4d96a6bf0752" xlink:href="ebs-20230630.xsd#ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage_082f670d-29ec-4899-94ba-4d96a6bf0752" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_cd81dc8f-086f-4acb-8089-039f7eab9113" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_cd81dc8f-086f-4acb-8089-039f7eab9113" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cb834b6d-f5aa-4518-9a1d-22e4f9e1c9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cb834b6d-f5aa-4518-9a1d-22e4f9e1c9ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_6d84df24-28cd-473a-b4fc-0f0532d30f86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_6d84df24-28cd-473a-b4fc-0f0532d30f86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c9a5de33-a9b3-422c-865e-acefd01552f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c9a5de33-a9b3-422c-865e-acefd01552f8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f2727d71-10a1-49d2-9a9f-9c4c8f0fa5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f2727d71-10a1-49d2-9a9f-9c4c8f0fa5c5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_476fda79-9357-491e-8db6-db6ac3e62fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_476fda79-9357-491e-8db6-db6ac3e62fdd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_54dd70eb-e520-420d-b638-c70144ad0e94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_54dd70eb-e520-420d-b638-c70144ad0e94" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6bb3d984-14f5-4f42-8407-8c5d067703d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6bb3d984-14f5-4f42-8407-8c5d067703d0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SaleOfStockConsiderationReceivedOnTransactionGross_7ed000d6-f029-4481-a41f-2abd2e18e594" xlink:href="ebs-20230630.xsd#ebs_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_ebs_SaleOfStockConsiderationReceivedOnTransactionGross_7ed000d6-f029-4481-a41f-2abd2e18e594" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_71802552-3191-48ab-8a27-bf604caf5f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_71802552-3191-48ab-8a27-bf604caf5f0d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares_f19cd522-0b6e-408f-ab9f-f5f562a3c7b3" xlink:href="ebs-20230630.xsd#ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares_f19cd522-0b6e-408f-ab9f-f5f562a3c7b3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_132f2423-6bc3-4dd5-96c2-7b4fcb438d08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:to="loc_us-gaap_VestingAxis_132f2423-6bc3-4dd5-96c2-7b4fcb438d08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_132f2423-6bc3-4dd5-96c2-7b4fcb438d08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_132f2423-6bc3-4dd5-96c2-7b4fcb438d08" xlink:to="loc_us-gaap_VestingDomain_132f2423-6bc3-4dd5-96c2-7b4fcb438d08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_daa254eb-d7c9-4e07-96c4-b3a1d1d43d72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_132f2423-6bc3-4dd5-96c2-7b4fcb438d08" xlink:to="loc_us-gaap_VestingDomain_daa254eb-d7c9-4e07-96c4-b3a1d1d43d72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_22e1dc6b-279d-4d29-9e78-0da21305d1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_daa254eb-d7c9-4e07-96c4-b3a1d1d43d72" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_22e1dc6b-279d-4d29-9e78-0da21305d1e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_8bac9f87-2391-4d61-8d4e-71a5f8f9392d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_daa254eb-d7c9-4e07-96c4-b3a1d1d43d72" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_8bac9f87-2391-4d61-8d4e-71a5f8f9392d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_39f164b3-fe1f-469e-a6a2-a2d8a40704d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_daa254eb-d7c9-4e07-96c4-b3a1d1d43d72" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_39f164b3-fe1f-469e-a6a2-a2d8a40704d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_91b6f51e-aa89-4f0c-9780-6f2880f10fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:to="loc_us-gaap_AwardTypeAxis_91b6f51e-aa89-4f0c-9780-6f2880f10fd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91b6f51e-aa89-4f0c-9780-6f2880f10fd7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_91b6f51e-aa89-4f0c-9780-6f2880f10fd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91b6f51e-aa89-4f0c-9780-6f2880f10fd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83dc3a5e-1484-43f5-8421-23fc216d8bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_91b6f51e-aa89-4f0c-9780-6f2880f10fd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83dc3a5e-1484-43f5-8421-23fc216d8bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2210cdec-7ad8-4abb-a5dc-7ac244d8bcdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83dc3a5e-1484-43f5-8421-23fc216d8bf1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2210cdec-7ad8-4abb-a5dc-7ac244d8bcdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_325215f7-6066-402b-b336-fa6f41549ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83dc3a5e-1484-43f5-8421-23fc216d8bf1" xlink:to="loc_us-gaap_PerformanceSharesMember_325215f7-6066-402b-b336-fa6f41549ca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_dd48ebfc-ef1a-425d-9238-12133f921acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83dc3a5e-1484-43f5-8421-23fc216d8bf1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_dd48ebfc-ef1a-425d-9238-12133f921acc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d386b541-9e3e-4936-b447-e45362d3383d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d386b541-9e3e-4936-b447-e45362d3383d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d386b541-9e3e-4936-b447-e45362d3383d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d386b541-9e3e-4936-b447-e45362d3383d" xlink:to="loc_us-gaap_EquityComponentDomain_d386b541-9e3e-4936-b447-e45362d3383d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_364365a6-7531-4a7a-bc1a-7104d51483d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d386b541-9e3e-4936-b447-e45362d3383d" xlink:to="loc_us-gaap_EquityComponentDomain_364365a6-7531-4a7a-bc1a-7104d51483d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_da537185-c4cf-4984-acc6-098d407e0423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_364365a6-7531-4a7a-bc1a-7104d51483d7" xlink:to="loc_us-gaap_TreasuryStockCommonMember_da537185-c4cf-4984-acc6-098d407e0423" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c56c946f-44e5-4a43-897a-a62b64aff46a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_364365a6-7531-4a7a-bc1a-7104d51483d7" xlink:to="loc_us-gaap_CommonStockMember_c56c946f-44e5-4a43-897a-a62b64aff46a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_18667827-a378-4d31-a9c6-eb1f882587e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_18667827-a378-4d31-a9c6-eb1f882587e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_18667827-a378-4d31-a9c6-eb1f882587e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_18667827-a378-4d31-a9c6-eb1f882587e3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_18667827-a378-4d31-a9c6-eb1f882587e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1bfcfbe2-2d3c-4094-a282-94862f1d993b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_18667827-a378-4d31-a9c6-eb1f882587e3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1bfcfbe2-2d3c-4094-a282-94862f1d993b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AtTheMarketOfferingMember_ee4e6866-c375-4623-85bc-67f3ab96df43" xlink:href="ebs-20230630.xsd#ebs_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1bfcfbe2-2d3c-4094-a282-94862f1d993b" xlink:to="loc_ebs_AtTheMarketOfferingMember_ee4e6866-c375-4623-85bc-67f3ab96df43" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails" xlink:type="extended" id="i30123477a6e84a1e82ce81e6d78c0b13_StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6c4eaf8c-7f1e-4a67-b200-ceae100568a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_33f97a2c-6e5c-4844-996a-c943ca31b12b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6c4eaf8c-7f1e-4a67-b200-ceae100568a1" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_33f97a2c-6e5c-4844-996a-c943ca31b12b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_36488739-0ee4-4eb5-86a1-8a0ca25e3af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6c4eaf8c-7f1e-4a67-b200-ceae100568a1" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_36488739-0ee4-4eb5-86a1-8a0ca25e3af9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e963e9a5-3411-4f13-828a-ee54fab0964f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_36488739-0ee4-4eb5-86a1-8a0ca25e3af9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e963e9a5-3411-4f13-828a-ee54fab0964f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e963e9a5-3411-4f13-828a-ee54fab0964f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e963e9a5-3411-4f13-828a-ee54fab0964f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e963e9a5-3411-4f13-828a-ee54fab0964f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4bcb9450-1c5f-40e0-9fba-04ca32f848b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e963e9a5-3411-4f13-828a-ee54fab0964f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4bcb9450-1c5f-40e0-9fba-04ca32f848b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_79369a15-499f-4c99-a2b4-0aa86c324548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4bcb9450-1c5f-40e0-9fba-04ca32f848b6" xlink:to="loc_us-gaap_CostOfSalesMember_79369a15-499f-4c99-a2b4-0aa86c324548" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_7ecc02e7-f02b-4045-a324-9ffdc281f8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4bcb9450-1c5f-40e0-9fba-04ca32f848b6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_7ecc02e7-f02b-4045-a324-9ffdc281f8c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a8516d8e-47f2-4054-88e8-cae9d06ce3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4bcb9450-1c5f-40e0-9fba-04ca32f848b6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a8516d8e-47f2-4054-88e8-cae9d06ce3d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f10db6a0-fcff-44e2-9b14-48c66bba4904" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_36488739-0ee4-4eb5-86a1-8a0ca25e3af9" xlink:to="loc_srt_ProductOrServiceAxis_f10db6a0-fcff-44e2-9b14-48c66bba4904" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f10db6a0-fcff-44e2-9b14-48c66bba4904_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f10db6a0-fcff-44e2-9b14-48c66bba4904" xlink:to="loc_srt_ProductsAndServicesDomain_f10db6a0-fcff-44e2-9b14-48c66bba4904_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1cf81148-5947-4b03-9606-63dabe60ea48" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f10db6a0-fcff-44e2-9b14-48c66bba4904" xlink:to="loc_srt_ProductsAndServicesDomain_1cf81148-5947-4b03-9606-63dabe60ea48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_4c1b0b74-8bcd-464e-8536-facd0df55b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1cf81148-5947-4b03-9606-63dabe60ea48" xlink:to="loc_us-gaap_ProductMember_4c1b0b74-8bcd-464e-8536-facd0df55b6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_2feca299-8343-44c6-a182-95af33795247" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1cf81148-5947-4b03-9606-63dabe60ea48" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingMember_2feca299-8343-44c6-a182-95af33795247" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="i5529b0033ad149888e4ceceb62f5fb5c_StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b8652ef0-5939-41cc-8fc3-dad7027a7605" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b8652ef0-5939-41cc-8fc3-dad7027a7605" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a32611a3-45c9-4b31-b33f-1d9e020f3288" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:to="loc_us-gaap_StockholdersEquity_a32611a3-45c9-4b31-b33f-1d9e020f3288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_b14e9e43-0a9c-414d-a41f-a3a31d573d90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_b14e9e43-0a9c-414d-a41f-a3a31d573d90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_49eaecd6-4a98-4639-8599-e5f5e4fb865b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_49eaecd6-4a98-4639-8599-e5f5e4fb865b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a171b21e-9aa7-4f79-9a61-c8c359f75c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a171b21e-9aa7-4f79-9a61-c8c359f75c7c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c3269027-b06d-4bc5-9342-62ccdc710a01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_550c5796-db1b-46b6-bb9b-d124feb037c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b8652ef0-5939-41cc-8fc3-dad7027a7605" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_550c5796-db1b-46b6-bb9b-d124feb037c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_545b1ff6-9ca9-4a5d-8885-cb7c127eb8db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_550c5796-db1b-46b6-bb9b-d124feb037c7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_545b1ff6-9ca9-4a5d-8885-cb7c127eb8db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_545b1ff6-9ca9-4a5d-8885-cb7c127eb8db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_545b1ff6-9ca9-4a5d-8885-cb7c127eb8db" xlink:to="loc_us-gaap_EquityComponentDomain_545b1ff6-9ca9-4a5d-8885-cb7c127eb8db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_720d1297-9949-443e-ada1-f6f7252d8b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_545b1ff6-9ca9-4a5d-8885-cb7c127eb8db" xlink:to="loc_us-gaap_EquityComponentDomain_720d1297-9949-443e-ada1-f6f7252d8b70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3071ee3b-0315-44ab-8a34-ef58e5a7cdf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_720d1297-9949-443e-ada1-f6f7252d8b70" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3071ee3b-0315-44ab-8a34-ef58e5a7cdf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_ea874f47-c07b-40a6-beee-b7c0128b5c04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3071ee3b-0315-44ab-8a34-ef58e5a7cdf7" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_ea874f47-c07b-40a6-beee-b7c0128b5c04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ac8766fe-147f-40ef-8175-7707f54f6469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3071ee3b-0315-44ab-8a34-ef58e5a7cdf7" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ac8766fe-147f-40ef-8175-7707f54f6469" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_16babb87-0f3c-4093-afb5-220a327e5cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3071ee3b-0315-44ab-8a34-ef58e5a7cdf7" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_16babb87-0f3c-4093-afb5-220a327e5cc7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended" id="i02b6b79471014a44bad16fd553c9902d_StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_60f5e33d-e99c-4fda-9a96-e12b9700e427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_7cc25634-cc9f-4190-967b-7dea9e6cea25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_60f5e33d-e99c-4fda-9a96-e12b9700e427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_7cc25634-cc9f-4190-967b-7dea9e6cea25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_c150d9a4-0667-4c66-b19c-776dd21c9161" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_60f5e33d-e99c-4fda-9a96-e12b9700e427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_c150d9a4-0667-4c66-b19c-776dd21c9161" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7c3194da-5c43-4aa1-959d-ad25d9e218fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_60f5e33d-e99c-4fda-9a96-e12b9700e427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7c3194da-5c43-4aa1-959d-ad25d9e218fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9f20e761-32e5-43e6-a3fa-ffb12c0a0ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_60f5e33d-e99c-4fda-9a96-e12b9700e427" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9f20e761-32e5-43e6-a3fa-ffb12c0a0ab1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_bccdff50-1ce4-4c3d-96d1-79dc3e1be931" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9f20e761-32e5-43e6-a3fa-ffb12c0a0ab1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_bccdff50-1ce4-4c3d-96d1-79dc3e1be931" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bccdff50-1ce4-4c3d-96d1-79dc3e1be931_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bccdff50-1ce4-4c3d-96d1-79dc3e1be931" xlink:to="loc_us-gaap_EquityComponentDomain_bccdff50-1ce4-4c3d-96d1-79dc3e1be931_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bfd786c0-f142-4a52-b735-f0a2a78e4dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bccdff50-1ce4-4c3d-96d1-79dc3e1be931" xlink:to="loc_us-gaap_EquityComponentDomain_bfd786c0-f142-4a52-b735-f0a2a78e4dd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e9f8a57f-98f1-485c-9831-9fd2b9830219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bfd786c0-f142-4a52-b735-f0a2a78e4dd2" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e9f8a57f-98f1-485c-9831-9fd2b9830219" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f348646a-35d8-4d80-80f0-d0825c01dcc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bfd786c0-f142-4a52-b735-f0a2a78e4dd2" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f348646a-35d8-4d80-80f0-d0825c01dcc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_29cc5c5e-91b3-41dd-a855-12546197a987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bfd786c0-f142-4a52-b735-f0a2a78e4dd2" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_29cc5c5e-91b3-41dd-a855-12546197a987" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RevenuerecognitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails" xlink:type="extended" id="i9f44164968ff47449ba505875d93b69f_RevenuerecognitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_09cfbc68-5e51-49dc-b587-0d8354ac297e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_09cfbc68-5e51-49dc-b587-0d8354ac297e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_12addc2d-41ed-41e5-845d-3bd5b3477a53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_12addc2d-41ed-41e5-845d-3bd5b3477a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_08784b55-0f57-491d-bf1a-f3eb0f8b03ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_08784b55-0f57-491d-bf1a-f3eb0f8b03ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_cddf39c8-43e2-4dae-8efa-cdf37ec96987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_cddf39c8-43e2-4dae-8efa-cdf37ec96987" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_0e55cc8d-6f48-4782-97b5-c0a084db0b85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_0e55cc8d-6f48-4782-97b5-c0a084db0b85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_f002585a-fc6a-4a06-86e1-ca6683488e49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_f002585a-fc6a-4a06-86e1-ca6683488e49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_a7c5bfb6-775f-40c0-a364-0b74e3da4b07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_a7c5bfb6-775f-40c0-a364-0b74e3da4b07" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_12705f9c-0239-4d89-9423-5a62423e63e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_12705f9c-0239-4d89-9423-5a62423e63e6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_03ac0478-3820-458c-9aaa-d5d59475a176" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_03ac0478-3820-458c-9aaa-d5d59475a176" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_2c17e72b-3db4-40b8-b141-4bc2506ddde3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_2c17e72b-3db4-40b8-b141-4bc2506ddde3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour_766dbdf8-21cb-4d84-86e1-8a16ab6d85d5" xlink:href="ebs-20230630.xsd#ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour_766dbdf8-21cb-4d84-86e1-8a16ab6d85d5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_abf33b6b-cf82-4b88-b1a4-8c0572c816a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_abf33b6b-cf82-4b88-b1a4-8c0572c816a4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e00d36d4-e032-46b1-8095-4e10a63e2494" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e00d36d4-e032-46b1-8095-4e10a63e2494" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_936ce840-1690-47f1-988f-e69283e24cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_936ce840-1690-47f1-988f-e69283e24cf6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bd5ca676-c013-46a6-b33e-1cf80f623211" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bd5ca676-c013-46a6-b33e-1cf80f623211" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:to="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:to="loc_srt_NameOfMajorCustomerDomain_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8b69db38-06be-4e19-9bc1-2419728bf62f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:to="loc_srt_NameOfMajorCustomerDomain_8b69db38-06be-4e19-9bc1-2419728bf62f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_JansenPharmaceuticalsIncMember_983cf3fc-1d92-41fb-9117-fa574a41f1ac" xlink:href="ebs-20230630.xsd#ebs_JansenPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8b69db38-06be-4e19-9bc1-2419728bf62f" xlink:to="loc_ebs_JansenPharmaceuticalsIncMember_983cf3fc-1d92-41fb-9117-fa574a41f1ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:to="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4b3e9949-7162-416c-b0ef-43c6490f977f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:to="loc_srt_ProductsAndServicesDomain_4b3e9949-7162-416c-b0ef-43c6490f977f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5987d9db-b156-4153-88c0-5126e9e14c4e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:to="loc_srt_ProductsAndServicesDomain_5987d9db-b156-4153-88c0-5126e9e14c4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_eab07988-05c8-4130-b6cb-a654c2fd9f85" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5987d9db-b156-4153-88c0-5126e9e14c4e" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_eab07988-05c8-4130-b6cb-a654c2fd9f85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ce8ee37f-4254-40b2-a824-41f68778b45d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ce8ee37f-4254-40b2-a824-41f68778b45d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails_1" xlink:type="simple" xlink:href="ebs-20230630.xsd#RevenuerecognitionNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails_1" xlink:type="extended" id="i7ed3bfacad384aeaabb7ca355d52a49a_RevenuerecognitionNarrativeDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_09cfbc68-5e51-49dc-b587-0d8354ac297e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_09cfbc68-5e51-49dc-b587-0d8354ac297e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_12addc2d-41ed-41e5-845d-3bd5b3477a53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_12addc2d-41ed-41e5-845d-3bd5b3477a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_08784b55-0f57-491d-bf1a-f3eb0f8b03ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_08784b55-0f57-491d-bf1a-f3eb0f8b03ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_cddf39c8-43e2-4dae-8efa-cdf37ec96987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_cddf39c8-43e2-4dae-8efa-cdf37ec96987" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_0e55cc8d-6f48-4782-97b5-c0a084db0b85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_0e55cc8d-6f48-4782-97b5-c0a084db0b85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_f002585a-fc6a-4a06-86e1-ca6683488e49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_f002585a-fc6a-4a06-86e1-ca6683488e49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_a7c5bfb6-775f-40c0-a364-0b74e3da4b07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_a7c5bfb6-775f-40c0-a364-0b74e3da4b07" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_12705f9c-0239-4d89-9423-5a62423e63e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_12705f9c-0239-4d89-9423-5a62423e63e6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_03ac0478-3820-458c-9aaa-d5d59475a176" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_03ac0478-3820-458c-9aaa-d5d59475a176" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_2c17e72b-3db4-40b8-b141-4bc2506ddde3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_2c17e72b-3db4-40b8-b141-4bc2506ddde3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour_766dbdf8-21cb-4d84-86e1-8a16ab6d85d5" xlink:href="ebs-20230630.xsd#ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour_766dbdf8-21cb-4d84-86e1-8a16ab6d85d5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_abf33b6b-cf82-4b88-b1a4-8c0572c816a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_abf33b6b-cf82-4b88-b1a4-8c0572c816a4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e00d36d4-e032-46b1-8095-4e10a63e2494" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e00d36d4-e032-46b1-8095-4e10a63e2494" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_936ce840-1690-47f1-988f-e69283e24cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_936ce840-1690-47f1-988f-e69283e24cf6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bd5ca676-c013-46a6-b33e-1cf80f623211" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bd5ca676-c013-46a6-b33e-1cf80f623211" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:to="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:to="loc_srt_NameOfMajorCustomerDomain_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8b69db38-06be-4e19-9bc1-2419728bf62f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:to="loc_srt_NameOfMajorCustomerDomain_8b69db38-06be-4e19-9bc1-2419728bf62f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_JansenPharmaceuticalsIncMember_983cf3fc-1d92-41fb-9117-fa574a41f1ac" xlink:href="ebs-20230630.xsd#ebs_JansenPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8b69db38-06be-4e19-9bc1-2419728bf62f" xlink:to="loc_ebs_JansenPharmaceuticalsIncMember_983cf3fc-1d92-41fb-9117-fa574a41f1ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:to="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4b3e9949-7162-416c-b0ef-43c6490f977f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:to="loc_srt_ProductsAndServicesDomain_4b3e9949-7162-416c-b0ef-43c6490f977f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5987d9db-b156-4153-88c0-5126e9e14c4e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:to="loc_srt_ProductsAndServicesDomain_5987d9db-b156-4153-88c0-5126e9e14c4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_eab07988-05c8-4130-b6cb-a654c2fd9f85" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5987d9db-b156-4153-88c0-5126e9e14c4e" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_eab07988-05c8-4130-b6cb-a654c2fd9f85" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RevenuerecognitionDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails" xlink:type="extended" id="i812001f526ad4cf7984025d1e9bad97a_RevenuerecognitionDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4698af0-72be-4e9a-bb27-e76acc66852e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4698af0-72be-4e9a-bb27-e76acc66852e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_282022c1-889d-4940-a563-67a979bc5c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_282022c1-889d-4940-a563-67a979bc5c6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_7bc5f4ae-176e-466f-a2c1-7815984b9be5" xlink:href="ebs-20230630.xsd#ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:to="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_7bc5f4ae-176e-466f-a2c1-7815984b9be5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8b9966c0-1caa-44a9-937a-750306c5463b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:to="loc_us-gaap_Revenues_8b9966c0-1caa-44a9-937a-750306c5463b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_cf2cb1a7-8a5b-4b56-8519-8b4f0e9cc5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_cf2cb1a7-8a5b-4b56-8519-8b4f0e9cc5f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c39c8186-a7a0-4b54-96cd-961e311e82fe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_cf2cb1a7-8a5b-4b56-8519-8b4f0e9cc5f2" xlink:to="loc_srt_ProductOrServiceAxis_c39c8186-a7a0-4b54-96cd-961e311e82fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c39c8186-a7a0-4b54-96cd-961e311e82fe_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c39c8186-a7a0-4b54-96cd-961e311e82fe" xlink:to="loc_srt_ProductsAndServicesDomain_c39c8186-a7a0-4b54-96cd-961e311e82fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4112487c-a5e8-4451-94a5-c6e9413f8ae8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c39c8186-a7a0-4b54-96cd-961e311e82fe" xlink:to="loc_srt_ProductsAndServicesDomain_4112487c-a5e8-4451-94a5-c6e9413f8ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_b7581523-5261-4c15-bf10-ea28987cb433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4112487c-a5e8-4451-94a5-c6e9413f8ae8" xlink:to="loc_us-gaap_ProductMember_b7581523-5261-4c15-bf10-ea28987cb433" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_b6d905fe-92b7-484a-97f8-9ae144d5fb94" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4112487c-a5e8-4451-94a5-c6e9413f8ae8" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingMember_b6d905fe-92b7-484a-97f8-9ae144d5fb94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_892b7a6f-6042-4f13-99d2-c14e01331792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingMember_b6d905fe-92b7-484a-97f8-9ae144d5fb94" xlink:to="loc_us-gaap_ServiceMember_892b7a6f-6042-4f13-99d2-c14e01331792" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_75110b4a-b92f-4e67-84fe-477100d509cf" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingMember_b6d905fe-92b7-484a-97f8-9ae144d5fb94" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_75110b4a-b92f-4e67-84fe-477100d509cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractsAndGrantsMember_bce01b42-5c68-4da8-9d0e-27544a2cb82c" xlink:href="ebs-20230630.xsd#ebs_ContractsAndGrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4112487c-a5e8-4451-94a5-c6e9413f8ae8" xlink:to="loc_ebs_ContractsAndGrantsMember_bce01b42-5c68-4da8-9d0e-27544a2cb82c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_5f248647-607b-4f06-a118-9e998bf174dc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_cf2cb1a7-8a5b-4b56-8519-8b4f0e9cc5f2" xlink:to="loc_srt_MajorCustomersAxis_5f248647-607b-4f06-a118-9e998bf174dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_5f248647-607b-4f06-a118-9e998bf174dc_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_5f248647-607b-4f06-a118-9e998bf174dc" xlink:to="loc_srt_NameOfMajorCustomerDomain_5f248647-607b-4f06-a118-9e998bf174dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_fbeac2dd-4042-4664-9819-2ea2a658e28c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_5f248647-607b-4f06-a118-9e998bf174dc" xlink:to="loc_srt_NameOfMajorCustomerDomain_fbeac2dd-4042-4664-9819-2ea2a658e28c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_UnitedStatesGovernmentMember_02ee5e18-e4f8-4ce3-8c09-8ba0184f12fe" xlink:href="ebs-20230630.xsd#ebs_UnitedStatesGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_fbeac2dd-4042-4664-9819-2ea2a658e28c" xlink:to="loc_ebs_UnitedStatesGovernmentMember_02ee5e18-e4f8-4ce3-8c09-8ba0184f12fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_NonUnitedStatesGovernmentMember_d095af00-3764-4760-9d8f-db663ce8b205" xlink:href="ebs-20230630.xsd#ebs_NonUnitedStatesGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_fbeac2dd-4042-4664-9819-2ea2a658e28c" xlink:to="loc_ebs_NonUnitedStatesGovernmentMember_d095af00-3764-4760-9d8f-db663ce8b205" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#IncometaxesDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IncometaxesDetails" xlink:type="extended" id="i6736101537574a58b29097d47a69d376_IncometaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ebs_IncomeTaxesLineItems_494ee538-9b8d-46f8-87cb-b56c0eb324c8" xlink:href="ebs-20230630.xsd#ebs_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cfae29d-cd05-4baa-96f4-0e27d3df7d45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_IncomeTaxesLineItems_494ee538-9b8d-46f8-87cb-b56c0eb324c8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cfae29d-cd05-4baa-96f4-0e27d3df7d45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_59bb0438-0100-48ef-a7e5-4d5ca6134415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_IncomeTaxesLineItems_494ee538-9b8d-46f8-87cb-b56c0eb324c8" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_59bb0438-0100-48ef-a7e5-4d5ca6134415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_26c2b850-a107-4325-8149-650e73e6bdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_IncomeTaxesLineItems_494ee538-9b8d-46f8-87cb-b56c0eb324c8" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_26c2b850-a107-4325-8149-650e73e6bdbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_IncomeTaxesTable_73995289-629a-435b-a629-a7160a812fea" xlink:href="ebs-20230630.xsd#ebs_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ebs_IncomeTaxesLineItems_494ee538-9b8d-46f8-87cb-b56c0eb324c8" xlink:to="loc_ebs_IncomeTaxesTable_73995289-629a-435b-a629-a7160a812fea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_4c23726f-7df4-4582-a693-4b416acca17b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ebs_IncomeTaxesTable_73995289-629a-435b-a629-a7160a812fea" xlink:to="loc_srt_StatementScenarioAxis_4c23726f-7df4-4582-a693-4b416acca17b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4c23726f-7df4-4582-a693-4b416acca17b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_4c23726f-7df4-4582-a693-4b416acca17b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4c23726f-7df4-4582-a693-4b416acca17b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a67c1296-ccf1-4eda-8d9f-de56d3193130" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_4c23726f-7df4-4582-a693-4b416acca17b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a67c1296-ccf1-4eda-8d9f-de56d3193130" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_8ac21866-3b9d-4610-8ec5-982bb4068f85" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a67c1296-ccf1-4eda-8d9f-de56d3193130" xlink:to="loc_srt_ScenarioForecastMember_8ac21866-3b9d-4610-8ec5-982bb4068f85" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails" xlink:type="extended" id="id3a1821ed82446a49bffb3a587074976_SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_657fa41d-b6d5-4c41-a7ea-3a2cb84b5adb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_RevenuesAbstract_657fa41d-b6d5-4c41-a7ea-3a2cb84b5adb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f390936f-9c04-4533-a71c-f2a215b0bfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_657fa41d-b6d5-4c41-a7ea-3a2cb84b5adb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f390936f-9c04-4533-a71c-f2a215b0bfd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_61ce924f-6ede-4d1b-afe2-e752c1654fe8" xlink:href="ebs-20230630.xsd#ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_657fa41d-b6d5-4c41-a7ea-3a2cb84b5adb" xlink:to="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_61ce924f-6ede-4d1b-afe2-e752c1654fe8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_afbcb994-2e9c-4d9c-b364-439f79236aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_657fa41d-b6d5-4c41-a7ea-3a2cb84b5adb" xlink:to="loc_us-gaap_Revenues_afbcb994-2e9c-4d9c-b364-439f79236aa8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_f34993b1-c05c-4917-9fda-41fdaf709489" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_f34993b1-c05c-4917-9fda-41fdaf709489" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a43b537a-e68c-41b1-8455-1e3d0501bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_f34993b1-c05c-4917-9fda-41fdaf709489" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a43b537a-e68c-41b1-8455-1e3d0501bdae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f1c796f8-5b3d-401d-ae1a-d39d7851fa5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_GrossProfit_f1c796f8-5b3d-401d-ae1a-d39d7851fa5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfitAbstract_99dbb81a-31f4-4bf7-857e-dfa118cfe2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfitAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_GrossProfitAbstract_99dbb81a-31f4-4bf7-857e-dfa118cfe2c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentAbstract_6ab304f1-8227-421c-a4f8-c0ad9a5f3a01" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GrossProfitAbstract_99dbb81a-31f4-4bf7-857e-dfa118cfe2c3" xlink:to="loc_ebs_ProductsSegmentAbstract_6ab304f1-8227-421c-a4f8-c0ad9a5f3a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e02c7c95-1a43-4d01-ac36-e99183c07065" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ProductsSegmentAbstract_6ab304f1-8227-421c-a4f8-c0ad9a5f3a01" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e02c7c95-1a43-4d01-ac36-e99183c07065" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_86cf813c-6a25-489e-ab9d-c9968ab2cea6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ProductsSegmentAbstract_6ab304f1-8227-421c-a4f8-c0ad9a5f3a01" xlink:to="loc_us-gaap_RestructuringCosts_86cf813c-6a25-489e-ab9d-c9968ab2cea6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_InventoryStepUp_da1887b7-4114-40e1-9840-b1aa79d8aa08" xlink:href="ebs-20230630.xsd#ebs_InventoryStepUp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ProductsSegmentAbstract_6ab304f1-8227-421c-a4f8-c0ad9a5f3a01" xlink:to="loc_ebs_InventoryStepUp_da1887b7-4114-40e1-9840-b1aa79d8aa08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AdjustedGrossMargin_47fda82b-69cf-41a6-8664-6fe7d8f60ec0" xlink:href="ebs-20230630.xsd#ebs_AdjustedGrossMargin"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_ebs_AdjustedGrossMargin_47fda82b-69cf-41a6-8664-6fe7d8f60ec0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_GrossProfitAdjustments_a91f1a59-8d4f-45ac-8e85-e066aae511e6" xlink:href="ebs-20230630.xsd#ebs_GrossProfitAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_ebs_GrossProfitAdjustments_a91f1a59-8d4f-45ac-8e85-e066aae511e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_2e540e99-59f5-4d3e-b49f-885360bbcf61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_2e540e99-59f5-4d3e-b49f-885360bbcf61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c2b51822-0d91-4dc5-a46d-56680785d54f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c2b51822-0d91-4dc5-a46d-56680785d54f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a41729e4-e608-4226-b108-3b2b4f07159a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a41729e4-e608-4226-b108-3b2b4f07159a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7965fa4b-1b79-47bb-a9a5-149e57e68ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7965fa4b-1b79-47bb-a9a5-149e57e68ac7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_943f9df3-314a-4f71-92dc-62cebc66c4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_InterestExpense_943f9df3-314a-4f71-92dc-62cebc66c4d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a8e3acb5-5e62-42e3-ace9-4ba7efc8c10e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a8e3acb5-5e62-42e3-ace9-4ba7efc8c10e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b9b2c7c9-224a-4711-ad48-c6497763e651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b9b2c7c9-224a-4711-ad48-c6497763e651" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d563a3b-a87a-4373-8c82-abf5cfd928e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d563a3b-a87a-4373-8c82-abf5cfd928e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_64f10e27-043b-4530-8abe-c61cb6490f94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_64f10e27-043b-4530-8abe-c61cb6490f94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c070e8f5-e9a0-4836-b635-8da145590397" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_64f10e27-043b-4530-8abe-c61cb6490f94" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c070e8f5-e9a0-4836-b635-8da145590397" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c070e8f5-e9a0-4836-b635-8da145590397_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c070e8f5-e9a0-4836-b635-8da145590397" xlink:to="loc_us-gaap_SegmentDomain_c070e8f5-e9a0-4836-b635-8da145590397_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_40bb03cc-1584-4313-ad89-4447d56c5438" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c070e8f5-e9a0-4836-b635-8da145590397" xlink:to="loc_us-gaap_SegmentDomain_40bb03cc-1584-4313-ad89-4447d56c5438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsAndServicesSegmentsMember_1724ebf6-7702-4fbc-987e-4ddb03ebdfd4" xlink:href="ebs-20230630.xsd#ebs_ProductsAndServicesSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_40bb03cc-1584-4313-ad89-4447d56c5438" xlink:to="loc_ebs_ProductsAndServicesSegmentsMember_1724ebf6-7702-4fbc-987e-4ddb03ebdfd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember_b6d1a794-9eef-4267-ab55-4d875d2df1e6" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ProductsAndServicesSegmentsMember_1724ebf6-7702-4fbc-987e-4ddb03ebdfd4" xlink:to="loc_ebs_ProductsSegmentMember_b6d1a794-9eef-4267-ab55-4d875d2df1e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ServicesSegmentMember_8352ed03-fa3c-42e8-af4f-cb63bc7f4a45" xlink:href="ebs-20230630.xsd#ebs_ServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ProductsAndServicesSegmentsMember_1724ebf6-7702-4fbc-987e-4ddb03ebdfd4" xlink:to="loc_ebs_ServicesSegmentMember_8352ed03-fa3c-42e8-af4f-cb63bc7f4a45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2eb2b12d-36fc-4036-9377-c129f0200e9b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_64f10e27-043b-4530-8abe-c61cb6490f94" xlink:to="loc_srt_ProductOrServiceAxis_2eb2b12d-36fc-4036-9377-c129f0200e9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2eb2b12d-36fc-4036-9377-c129f0200e9b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2eb2b12d-36fc-4036-9377-c129f0200e9b" xlink:to="loc_srt_ProductsAndServicesDomain_2eb2b12d-36fc-4036-9377-c129f0200e9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_48395648-557c-4bbf-b682-483b60ae7f77" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2eb2b12d-36fc-4036-9377-c129f0200e9b" xlink:to="loc_srt_ProductsAndServicesDomain_48395648-557c-4bbf-b682-483b60ae7f77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractsAndGrantsMember_ddfadb0a-f8d7-4704-8556-fbe2788bd5b0" xlink:href="ebs-20230630.xsd#ebs_ContractsAndGrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_48395648-557c-4bbf-b682-483b60ae7f77" xlink:to="loc_ebs_ContractsAndGrantsMember_ddfadb0a-f8d7-4704-8556-fbe2788bd5b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended" id="iacc62b0bc1b345f3acd34c7798e18634_SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_63cf26ba-c5a6-4579-acc2-b774f83188ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAbstract_7c35f8b6-49b3-4db5-96e0-3b6f7da3787e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63cf26ba-c5a6-4579-acc2-b774f83188ef" xlink:to="loc_us-gaap_DepreciationAbstract_7c35f8b6-49b3-4db5-96e0-3b6f7da3787e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b92781a0-12bd-46c7-904c-e6515a866051" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DepreciationAbstract_7c35f8b6-49b3-4db5-96e0-3b6f7da3787e" xlink:to="loc_us-gaap_Depreciation_b92781a0-12bd-46c7-904c-e6515a866051" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf960146-2944-4128-8448-b0521776de6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63cf26ba-c5a6-4579-acc2-b774f83188ef" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf960146-2944-4128-8448-b0521776de6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_82bd9266-9d0a-4a55-b76a-b92a30b88f60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf960146-2944-4128-8448-b0521776de6a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_82bd9266-9d0a-4a55-b76a-b92a30b88f60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_82bd9266-9d0a-4a55-b76a-b92a30b88f60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_82bd9266-9d0a-4a55-b76a-b92a30b88f60" xlink:to="loc_us-gaap_SegmentDomain_82bd9266-9d0a-4a55-b76a-b92a30b88f60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d23aa26-addc-4bd2-aeaf-94630dd21251" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_82bd9266-9d0a-4a55-b76a-b92a30b88f60" xlink:to="loc_us-gaap_SegmentDomain_0d23aa26-addc-4bd2-aeaf-94630dd21251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember_c0c354b2-2ab2-4304-aff4-c7858602e35c" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d23aa26-addc-4bd2-aeaf-94630dd21251" xlink:to="loc_ebs_ProductsSegmentMember_c0c354b2-2ab2-4304-aff4-c7858602e35c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ServicesSegmentMember_2843f795-103d-4fdd-a0a0-e384b14968ab" xlink:href="ebs-20230630.xsd#ebs_ServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d23aa26-addc-4bd2-aeaf-94630dd21251" xlink:to="loc_ebs_ServicesSegmentMember_2843f795-103d-4fdd-a0a0-e384b14968ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c3250760-a565-44bc-920c-a3b4605c6bbe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf960146-2944-4128-8448-b0521776de6a" xlink:to="loc_srt_ConsolidationItemsAxis_c3250760-a565-44bc-920c-a3b4605c6bbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c3250760-a565-44bc-920c-a3b4605c6bbe_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_c3250760-a565-44bc-920c-a3b4605c6bbe" xlink:to="loc_srt_ConsolidationItemsDomain_c3250760-a565-44bc-920c-a3b4605c6bbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9b1f3cad-980e-4270-ad1a-f38a4f9a317d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_c3250760-a565-44bc-920c-a3b4605c6bbe" xlink:to="loc_srt_ConsolidationItemsDomain_9b1f3cad-980e-4270-ad1a-f38a4f9a317d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_9f05e0b6-3045-48a0-8ffc-73bb980e79d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9b1f3cad-980e-4270-ad1a-f38a4f9a317d" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_9f05e0b6-3045-48a0-8ffc-73bb980e79d0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SubsequenteventsDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#SubsequenteventsDetails"/>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SubsequenteventsDetails" xlink:type="extended" id="i7933fa9df73b4e25a37f4cee08fc42e1_SubsequenteventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RevenueFromContractWithCustomerTermOfContract_9a1e961d-2aaa-455c-ab6e-0449d92047e3" xlink:href="ebs-20230630.xsd#ebs_RevenueFromContractWithCustomerTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_ebs_RevenueFromContractWithCustomerTermOfContract_9a1e961d-2aaa-455c-ab6e-0449d92047e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods_9237a4b2-1e94-430e-9aba-bfe11aea0e72" xlink:href="ebs-20230630.xsd#ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods_9237a4b2-1e94-430e-9aba-bfe11aea0e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_2d155d37-e7c3-406f-81a4-cfb469bbf261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_us-gaap_ContractWithCustomerLiability_2d155d37-e7c3-406f-81a4-cfb469bbf261" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ef40459b-b00e-4bd6-8d8d-ca506801ddb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ef40459b-b00e-4bd6-8d8d-ca506801ddb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_f631273c-53c3-4401-bcab-27d52e0a099f" xlink:href="ebs-20230630.xsd#ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_f631273c-53c3-4401-bcab-27d52e0a099f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_682732c7-8230-4cef-afc5-fb224a23703b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_682732c7-8230-4cef-afc5-fb224a23703b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9bf22ccc-5875-413e-adef-ecaa815ae31f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9bf22ccc-5875-413e-adef-ecaa815ae31f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_7abd9111-1faa-44ae-83f7-2d04b0556472" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_srt_MajorCustomersAxis_7abd9111-1faa-44ae-83f7-2d04b0556472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7abd9111-1faa-44ae-83f7-2d04b0556472_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_7abd9111-1faa-44ae-83f7-2d04b0556472" xlink:to="loc_srt_NameOfMajorCustomerDomain_7abd9111-1faa-44ae-83f7-2d04b0556472_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_eefa8103-56a2-40df-98ce-129d662b980d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_7abd9111-1faa-44ae-83f7-2d04b0556472" xlink:to="loc_srt_NameOfMajorCustomerDomain_eefa8103-56a2-40df-98ce-129d662b980d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_BARDAMember_df93bd27-937c-481f-9910-f273145e1e16" xlink:href="ebs-20230630.xsd#ebs_BARDAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_eefa8103-56a2-40df-98ce-129d662b980d" xlink:to="loc_ebs_BARDAMember_df93bd27-937c-481f-9910-f273145e1e16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_35d9a986-ba99-464a-b352-ae8fcaf3fcdb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_srt_ProductOrServiceAxis_35d9a986-ba99-464a-b352-ae8fcaf3fcdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_35d9a986-ba99-464a-b352-ae8fcaf3fcdb_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_35d9a986-ba99-464a-b352-ae8fcaf3fcdb" xlink:to="loc_srt_ProductsAndServicesDomain_35d9a986-ba99-464a-b352-ae8fcaf3fcdb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_90f545f7-c79b-4186-9b9a-95632864ea21" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_35d9a986-ba99-464a-b352-ae8fcaf3fcdb" xlink:to="loc_srt_ProductsAndServicesDomain_90f545f7-c79b-4186-9b9a-95632864ea21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EbangaMember_15108f6d-3a76-41e9-add0-9252687215ba" xlink:href="ebs-20230630.xsd#ebs_EbangaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_90f545f7-c79b-4186-9b9a-95632864ea21" xlink:to="loc_ebs_EbangaMember_15108f6d-3a76-41e9-add0-9252687215ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_b561d142-ab7a-4795-8151-8836b405ca00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_b561d142-ab7a-4795-8151-8836b405ca00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_b561d142-ab7a-4795-8151-8836b405ca00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_b561d142-ab7a-4795-8151-8836b405ca00" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_b561d142-ab7a-4795-8151-8836b405ca00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_6752c08a-bdf1-485c-b34f-d72be0e79469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_b561d142-ab7a-4795-8151-8836b405ca00" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_6752c08a-bdf1-485c-b34f-d72be0e79469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TwoYearOptionMember_a5ae657e-c283-4abe-b92a-9be8f7eb7bdd" xlink:href="ebs-20230630.xsd#ebs_TwoYearOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain_6752c08a-bdf1-485c-b34f-d72be0e79469" xlink:to="loc_ebs_TwoYearOptionMember_a5ae657e-c283-4abe-b92a-9be8f7eb7bdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiveYearOptionMember_d7a88258-37c7-4c44-ad45-ad5f7b834f2f" xlink:href="ebs-20230630.xsd#ebs_FiveYearOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain_6752c08a-bdf1-485c-b34f-d72be0e79469" xlink:to="loc_ebs_FiveYearOptionMember_d7a88258-37c7-4c44-ad45-ad5f7b834f2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_94c74833-cf5a-4716-9a86-75b59f5b8908" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_94c74833-cf5a-4716-9a86-75b59f5b8908" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_94c74833-cf5a-4716-9a86-75b59f5b8908_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_94c74833-cf5a-4716-9a86-75b59f5b8908" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_94c74833-cf5a-4716-9a86-75b59f5b8908_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4c7017fc-cc94-4239-a878-40a3f221e7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_94c74833-cf5a-4716-9a86-75b59f5b8908" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4c7017fc-cc94-4239-a878-40a3f221e7cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_bd5cac79-12d8-4b6b-adf4-4ee25d8c29d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4c7017fc-cc94-4239-a878-40a3f221e7cd" xlink:to="loc_us-gaap_SubsequentEventMember_bd5cac79-12d8-4b6b-adf4-4ee25d8c29d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8ed59220-4c82-47db-8530-bc65a58c50b7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_srt_CounterpartyNameAxis_8ed59220-4c82-47db-8530-bc65a58c50b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8ed59220-4c82-47db-8530-bc65a58c50b7_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_8ed59220-4c82-47db-8530-bc65a58c50b7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8ed59220-4c82-47db-8530-bc65a58c50b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fe169dcc-2f10-457c-94b5-fe056b8bee3c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_8ed59220-4c82-47db-8530-bc65a58c50b7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fe169dcc-2f10-457c-94b5-fe056b8bee3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RidgebackMember_04ed5751-7366-40ce-87e4-503d09b1c180" xlink:href="ebs-20230630.xsd#ebs_RidgebackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fe169dcc-2f10-457c-94b5-fe056b8bee3c" xlink:to="loc_ebs_RidgebackMember_04ed5751-7366-40ce-87e4-503d09b1c180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_b81425fd-02fc-4065-97b8-be73b260050d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_b81425fd-02fc-4065-97b8-be73b260050d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_b81425fd-02fc-4065-97b8-be73b260050d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_b81425fd-02fc-4065-97b8-be73b260050d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_b81425fd-02fc-4065-97b8-be73b260050d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_495c903c-aeac-4ce0-959d-56d7474e99fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_b81425fd-02fc-4065-97b8-be73b260050d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_495c903c-aeac-4ce0-959d-56d7474e99fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_BARDAContractPayableInThirdQuarterOf2023Member_ccf03aa8-0e0c-42d6-a37a-5fb2656aede7" xlink:href="ebs-20230630.xsd#ebs_BARDAContractPayableInThirdQuarterOf2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_495c903c-aeac-4ce0-959d-56d7474e99fd" xlink:to="loc_ebs_BARDAContractPayableInThirdQuarterOf2023Member_ccf03aa8-0e0c-42d6-a37a-5fb2656aede7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_BARDAContractContractNotCeasedPriorToJune12026Member_5e28cb73-067c-4935-9f06-f2be30ed168c" xlink:href="ebs-20230630.xsd#ebs_BARDAContractContractNotCeasedPriorToJune12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_495c903c-aeac-4ce0-959d-56d7474e99fd" xlink:to="loc_ebs_BARDAContractContractNotCeasedPriorToJune12026Member_5e28cb73-067c-4935-9f06-f2be30ed168c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_94897c50-bc6f-49bf-af82-b897cad10751" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_us-gaap_RestructuringPlanAxis_94897c50-bc6f-49bf-af82-b897cad10751" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_94897c50-bc6f-49bf-af82-b897cad10751_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_94897c50-bc6f-49bf-af82-b897cad10751" xlink:to="loc_us-gaap_RestructuringPlanDomain_94897c50-bc6f-49bf-af82-b897cad10751_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_5ccb3f4f-990c-457a-a164-f40084a05a90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_94897c50-bc6f-49bf-af82-b897cad10751" xlink:to="loc_us-gaap_RestructuringPlanDomain_5ccb3f4f-990c-457a-a164-f40084a05a90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RestructuringPlanAugust2023Member_d77f5794-c7a2-4490-8b4b-c8b0d016da08" xlink:href="ebs-20230630.xsd#ebs_RestructuringPlanAugust2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_5ccb3f4f-990c-457a-a164-f40084a05a90" xlink:to="loc_ebs_RestructuringPlanAugust2023Member_d77f5794-c7a2-4490-8b4b-c8b0d016da08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_de3fe05d-1bc7-419e-a5a4-3dd852cd024f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_srt_RangeAxis_de3fe05d-1bc7-419e-a5a4-3dd852cd024f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_de3fe05d-1bc7-419e-a5a4-3dd852cd024f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_de3fe05d-1bc7-419e-a5a4-3dd852cd024f" xlink:to="loc_srt_RangeMember_de3fe05d-1bc7-419e-a5a4-3dd852cd024f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_96764911-67c4-4266-890b-f8ca2668974d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_de3fe05d-1bc7-419e-a5a4-3dd852cd024f" xlink:to="loc_srt_RangeMember_96764911-67c4-4266-890b-f8ca2668974d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a850fbc5-6f22-4fb1-b115-f23b094c2d13" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_96764911-67c4-4266-890b-f8ca2668974d" xlink:to="loc_srt_MinimumMember_a850fbc5-6f22-4fb1-b115-f23b094c2d13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5b5add16-218e-411e-9294-8b46e6cae023" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_96764911-67c4-4266-890b-f8ca2668974d" xlink:to="loc_srt_MaximumMember_5b5add16-218e-411e-9294-8b46e6cae023" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_PerformanceSharesMember" xlink:type="arc" order="5"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>ebs-20230630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:d762cff5-452b-4406-9554-de3e14af5e28,g:a97db4f5-924f-4868-bfbf-bd6f1cbf2843-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_54de42fc-7593-4e0f-846d-70ecc437ad2f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_25c15b98-ce88-4c5b-845e-ca8aa4a3e648_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_5ec6dddd-c435-46bd-9818-27f0680b72fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_ServicesSegmentMember_4cb1ac7d-674d-4a1a-9cb0-07ef96ee7f98_terseLabel_en-US" xlink:label="lab_ebs_ServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_ebs_ServicesSegmentMember_label_en-US" xlink:label="lab_ebs_ServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Segment [Member]</link:label>
    <link:label id="lab_ebs_ServicesSegmentMember_documentation_en-US" xlink:label="lab_ebs_ServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ServicesSegmentMember" xlink:href="ebs-20230630.xsd#ebs_ServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ServicesSegmentMember" xlink:to="lab_ebs_ServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_3316ed72-7ad7-408b-b3bf-f2c89c4e61e6_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_580263de-1375-4a8b-b62a-5fe998bcb252_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_85c29b64-1779-4301-b32a-992adfa63288_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_84871e6b-a662-473b-ab7c-390e471b357b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_e219d647-56ce-4df3-9ed9-0001169e62ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e0ab2c2c-57cf-4c52-b0ae-d9ff5fb31bd7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_bdd0bbfd-fa2c-45c7-b7eb-be621bb478a1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_31860686-075e-48e9-9467-3a68919d38b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_2107e6ef-3ec1-491b-b729-0b906d4e6a2b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_7cd650ca-7200-485c-81ff-32c653b19077_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, operating lease, remaining lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9621e04f-d6a1-4b89-ab20-a91d3a6f8a5b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_67aee575-de19-42f4-a19a-a8a06c2c67c5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_841830b9-1048-460e-b19d-8c2f96b22f77_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_6ed7abe5-2f10-4811-90f9-28fadb94a12c_verboseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c8e4c381-ab91-469e-bf1b-423c1b9ffa49_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_9dbcfcbb-6261-4b9c-a868-45e8cb5edc38_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_a46e04ec-035f-41ee-a133-bcd72e7ba221_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_900ad29f-c4b4-442a-a04d-8307cd5c646e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_ed7eaf00-aa56-4e65-b614-ee35847d33bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impaired Long-Lived Assets Held and Used [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impaired Long-Lived Assets Held and Used [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_0cd0d06d-346d-466d-9a25-c6a7950ba418_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_e49859ef-49d0-498d-a686-2bc7cdf3809a_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e3cf3998-5497-4f25-9e02-40b3e295a6eb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_LongTermIncentivePlanNoncashExpense_0b49a9ff-fcd7-4bdb-9b91-3aa80e861aaa_terseLabel_en-US" xlink:label="lab_ebs_LongTermIncentivePlanNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term incentive plan expense</link:label>
    <link:label id="lab_ebs_LongTermIncentivePlanNoncashExpense_label_en-US" xlink:label="lab_ebs_LongTermIncentivePlanNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Incentive Plan, Noncash Expense</link:label>
    <link:label id="lab_ebs_LongTermIncentivePlanNoncashExpense_documentation_en-US" xlink:label="lab_ebs_LongTermIncentivePlanNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Incentive Plan, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_LongTermIncentivePlanNoncashExpense" xlink:href="ebs-20230630.xsd#ebs_LongTermIncentivePlanNoncashExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_LongTermIncentivePlanNoncashExpense" xlink:to="lab_ebs_LongTermIncentivePlanNoncashExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_da2f0673-3f7c-4c44-b52a-990f7e762178_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0da80dda-3bec-4ff9-be8c-ac20f4449b04_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_313d0b7e-4c76-40ec-9a36-7b50f6abbfcc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from at-the-market sale of stock, net of commissions and expenses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_79e17554-461b-470f-a24f-3d8c7304f0a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_09454f0f-bdbf-4f95-bf35-646f88afa74b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_aa194283-098c-427d-9d92-6f09a972c01a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other reconciling items:</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment, Reconciliation of Other Items from Segments to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:to="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_605e68b2-24f0-4544-a273-cd69aa4eb7b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0715e2b0-c228-42f6-b348-7c79011c29ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_DebtInstrumentCovenantLeverageRatioMaximum_aa4d48cb-c586-46a3-be06-757f7e2d7439_terseLabel_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, leverage ratio, maximum</link:label>
    <link:label id="lab_ebs_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_ebs_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum allowed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_ebs_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_b296f5f9-079f-498a-a38b-bb54bee76125_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income, Lease Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAbstract_1f9307c3-069f-4155-8bd1-edd8a85dcf19_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation:</link:label>
    <link:label id="lab_us-gaap_DepreciationAbstract_label_en-US" xlink:label="lab_us-gaap_DepreciationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAbstract" xlink:to="lab_us-gaap_DepreciationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_AtTheMarketOfferingMember_163bb9ca-4b8a-4412-ad47-39c3ddef0371_terseLabel_en-US" xlink:label="lab_ebs_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering</link:label>
    <link:label id="lab_ebs_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_ebs_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering [Member]</link:label>
    <link:label id="lab_ebs_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_ebs_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AtTheMarketOfferingMember" xlink:href="ebs-20230630.xsd#ebs_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AtTheMarketOfferingMember" xlink:to="lab_ebs_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_750754e8-2211-4ef2-9391-cdcf003a74f3_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_4622ca79-0681-45aa-9dee-e2fb744b9aa3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_577ec61e-e1a6-4c35-8d51-141773b737c7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, impaired, accumulated impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_50e9fbec-2009-45dd-8657-b6eb0a4ed526_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_d1b986cf-8058-4304-bc48-4152ab218899_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.001 per share; 15.0 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_75f56e9c-f037-4105-8227-f225440a985b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_3791c563-a044-4cfb-b75b-198ce781fcfe_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_17c385e4-5de8-4189-b032-d05207736ff9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c25f14b1-575f-4217-a258-9129273c9a0e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_d5ee8498-7ee6-4874-8a5d-8903764d885d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5be6349f-c8bb-48df-833d-82a5ce7826ca_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_faf77f93-3f38-4db6-9da1-d54e70decfd8_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_baf99343-7e07-432b-b33d-0260a91e5fc4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3769a1a9-6402-4644-99ad-76e21dd8dc7c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2e65f6db-9e69-4380-bcdf-a78b264c9433_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_3d931e89-448f-4ab3-8f0c-201b14ffe876_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost, 5.6 and 5.6 common shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_d40fcebd-60b4-4c0d-bab1-b29d9d9495db_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_f3d8d4b0-527e-4e8b-b313-3a5a24e8802d_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_d4103848-da3a-4108-9b2d-d69fafae52f2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_4bddf760-afe9-484e-803e-cc9b485eb9d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for gains on hedging activities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_4c4c5ef1-dc28-42d1-bdb7-4de6ea0f370c_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember" xlink:to="lab_us-gaap_LandAndLandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_423cb8fb-c430-4881-991d-27eb60f895a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_5c03e940-ea2a-4027-b970-4fb4fcf365df_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_95322267-cedf-4195-94da-52b8fc6afe9b_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_a2f2b9a9-7c17-425f-84a7-6be1df1ad64f_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_99c910ec-af0b-45e5-a488-070d0c16dd97_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_ContractsAndGrantsMember_df5de1bc-5601-4925-b4a4-e8421289f713_terseLabel_en-US" xlink:label="lab_ebs_ContractsAndGrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts and grants</link:label>
    <link:label id="lab_ebs_ContractsAndGrantsMember_label_en-US" xlink:label="lab_ebs_ContractsAndGrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts and Grants [Member]</link:label>
    <link:label id="lab_ebs_ContractsAndGrantsMember_documentation_en-US" xlink:label="lab_ebs_ContractsAndGrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of revenue earned from products sold or services provided under the terms of a contract, including, but not limited to, government contracts and grants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractsAndGrantsMember" xlink:href="ebs-20230630.xsd#ebs_ContractsAndGrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContractsAndGrantsMember" xlink:to="lab_ebs_ContractsAndGrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_FiscalQuartersEndingAfter2024Member_bfd2fe1c-51af-4fb8-ae13-4a96bb1f56e2_terseLabel_en-US" xlink:label="lab_ebs_FiscalQuartersEndingAfter2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarters Ending After 2024</link:label>
    <link:label id="lab_ebs_FiscalQuartersEndingAfter2024Member_label_en-US" xlink:label="lab_ebs_FiscalQuartersEndingAfter2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarters Ending After 2024 [Member]</link:label>
    <link:label id="lab_ebs_FiscalQuartersEndingAfter2024Member_documentation_en-US" xlink:label="lab_ebs_FiscalQuartersEndingAfter2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarters Ending After 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiscalQuartersEndingAfter2024Member" xlink:href="ebs-20230630.xsd#ebs_FiscalQuartersEndingAfter2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_FiscalQuartersEndingAfter2024Member" xlink:to="lab_ebs_FiscalQuartersEndingAfter2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_6434307f-9aa2-48d9-8a93-1a64207f66c7_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings, building improvements and leasehold improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_950985f3-e82a-4ff3-b313-4bebb456667f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_a4cb7605-baab-4907-bbfb-d835a3a8031a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_1b0464cc-15f2-4345-bec0-510b9ce79cbc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e85dcb3e-721b-4afd-bc62-f8ea83e532e9_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5cb8c2d3-9c42-4708-9b9a-b319254613c5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_cee58f37-7439-48c4-8924-44df4b46cef0_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_f85071a4-2b0b-4ec8-979d-0f24e5e9d358_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_d057b8ff-4303-45fa-a8cd-bad2e30a7406_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_RestructuringPlanJanuary2023Member_627d52c5-f9e2-4741-8570-8aebc6bace61_terseLabel_en-US" xlink:label="lab_ebs_RestructuringPlanJanuary2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2023 Restructuring Plan</link:label>
    <link:label id="lab_ebs_RestructuringPlanJanuary2023Member_label_en-US" xlink:label="lab_ebs_RestructuringPlanJanuary2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan January 2023 [Member]</link:label>
    <link:label id="lab_ebs_RestructuringPlanJanuary2023Member_documentation_en-US" xlink:label="lab_ebs_RestructuringPlanJanuary2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan January 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RestructuringPlanJanuary2023Member" xlink:href="ebs-20230630.xsd#ebs_RestructuringPlanJanuary2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_RestructuringPlanJanuary2023Member" xlink:to="lab_ebs_RestructuringPlanJanuary2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_4f8e2c7b-6a8d-4786-bed0-dd31b89ab4d1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_366570cc-9d7c-4a61-83e1-f0a8232983b5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f5bd1e8d-b7a7-4746-a587-bbe8cbe080d0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_d74b41d1-3aaf-4c97-97e0-7d2d68652617_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_444e1fbf-b50e-4e77-8420-2c7ec85f255f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_51f2b49c-f8a3-4a0e-a370-a4f03c33da1d_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period, value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_f003b7cd-42fd-4b49-b36b-78604ee06f7e_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Funds Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a35884f4-68c1-4a38-8e23-af7338748e19_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_c25bc0d1-0f77-4c2b-8d68-629d06591f2f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_94261930-35c0-4cec-991e-b3822411b12a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_ebad0ba5-d4ad-4ab8-b768-f5bf8b4824ca_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_8ace6dda-a004-4533-837d-f418ac3b14e7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_de84ca59-536e-46cb-8961-8f13a070f741_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5b43ee25-9ee5-45a3-8fcd-0cfa3aa0cf3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and Diluted Net Income per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_c30b995e-19ce-4a3d-aeaf-fd7c8771175f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f56a2420-86b7-4876-9383-821ad98065dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum_29f9ae2f-31c3-4d9a-bb2c-5a9bcd97b044_terseLabel_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, interest coverage ratio, minimum</link:label>
    <link:label id="lab_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum_label_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Interest Coverage Ratio, Minimum</link:label>
    <link:label id="lab_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum_documentation_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Minimum Consolidated Interest Coverage Ratio Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:to="lab_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_88f67e86-60f2-4963-942b-bdc62aa2e2c0_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, year four</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_e8876f07-4e31-4f4c-8673-5ebd2c58f21a_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant accounting policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_930c80ba-d07a-4d00-a338-19579cdc7519_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_49b0fdd5-ec2e-4a66-835a-d6611eea79fa_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_BARDAContractContractNotCeasedPriorToJune12026Member_110cf2b4-0ef0-4847-b328-3cd1bf30ae93_terseLabel_en-US" xlink:label="lab_ebs_BARDAContractContractNotCeasedPriorToJune12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BARDA Contract, Contract not Ceased Prior to June 1, 2026</link:label>
    <link:label id="lab_ebs_BARDAContractContractNotCeasedPriorToJune12026Member_label_en-US" xlink:label="lab_ebs_BARDAContractContractNotCeasedPriorToJune12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BARDA Contract, Contract Not Ceased Prior To June 1, 2026 [Member]</link:label>
    <link:label id="lab_ebs_BARDAContractContractNotCeasedPriorToJune12026Member_documentation_en-US" xlink:label="lab_ebs_BARDAContractContractNotCeasedPriorToJune12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BARDA Contract, Contract Not Ceased Prior To June 1, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_BARDAContractContractNotCeasedPriorToJune12026Member" xlink:href="ebs-20230630.xsd#ebs_BARDAContractContractNotCeasedPriorToJune12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BARDAContractContractNotCeasedPriorToJune12026Member" xlink:to="lab_ebs_BARDAContractContractNotCeasedPriorToJune12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_5897bbfc-e987-42ad-b2ce-9a58ff5c221e_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_995c7d13-dbbf-4607-bd68-434bc511ce74_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_224247ef-fc92-4e7f-bad1-d67cf4356534_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_8bd8911e-54e4-4c9c-a29b-b4c1adbaa000_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_74cc6b4c-31d3-40e2-903b-599575333b3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_e0183a1a-71eb-43df-8320-b69f98d200e0_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_9703c24e-2c20-4c72-9daf-d02cfcd96c96_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_DebtTermsDomain_c610bdcb-58e4-4490-a8e2-528cc0da3ecb_terseLabel_en-US" xlink:label="lab_ebs_DebtTermsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Terms [Domain]</link:label>
    <link:label id="lab_ebs_DebtTermsDomain_label_en-US" xlink:label="lab_ebs_DebtTermsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, terms [Domain]</link:label>
    <link:label id="lab_ebs_DebtTermsDomain_documentation_en-US" xlink:label="lab_ebs_DebtTermsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, terms [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtTermsDomain" xlink:href="ebs-20230630.xsd#ebs_DebtTermsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtTermsDomain" xlink:to="lab_ebs_DebtTermsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_b1d9a375-271f-4780-bc00-fceff96fc689_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e04d3ffe-ca99-4d11-8339-52c597d85f71_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_083d2d3b-4d91-4433-8fdf-c239ca4fffae_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_734ed891-1053-479f-bd96-f7e7b58a0dc8_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_EbangaMember_64ba5f96-c390-4c0c-b766-52113ac99c44_terseLabel_en-US" xlink:label="lab_ebs_EbangaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ebanga</link:label>
    <link:label id="lab_ebs_EbangaMember_label_en-US" xlink:label="lab_ebs_EbangaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ebanga [Member]</link:label>
    <link:label id="lab_ebs_EbangaMember_documentation_en-US" xlink:label="lab_ebs_EbangaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ebanga</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EbangaMember" xlink:href="ebs-20230630.xsd#ebs_EbangaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EbangaMember" xlink:to="lab_ebs_EbangaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_387f1e1d-d4b6-40a0-a5e8-52cca91029f0_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_3e73884a-b046-4933-a048-41783eb45dcb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_92c90180-4613-4635-842c-93812d106377_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_258b2f33-0ab7-45c1-9dd2-5aaa69e5e9c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_264e7bd7-c63e-491e-b1b3-63b51ae0e5a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_BARDAMember_84d151c4-4a25-4673-9474-dfff472d1c92_terseLabel_en-US" xlink:label="lab_ebs_BARDAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BARDA</link:label>
    <link:label id="lab_ebs_BARDAMember_label_en-US" xlink:label="lab_ebs_BARDAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BARDA [Member]</link:label>
    <link:label id="lab_ebs_BARDAMember_documentation_en-US" xlink:label="lab_ebs_BARDAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BARDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_BARDAMember" xlink:href="ebs-20230630.xsd#ebs_BARDAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BARDAMember" xlink:to="lab_ebs_BARDAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_260f9d0c-6bc1-4a9c-a5ee-c2b89c902232_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_OtherLongTermDebtFacilityMember_840b0f53-0b7e-4cb5-adec-16e815cb0139_terseLabel_en-US" xlink:label="lab_ebs_OtherLongTermDebtFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ebs_OtherLongTermDebtFacilityMember_label_en-US" xlink:label="lab_ebs_OtherLongTermDebtFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Debt Facility [Member]</link:label>
    <link:label id="lab_ebs_OtherLongTermDebtFacilityMember_documentation_en-US" xlink:label="lab_ebs_OtherLongTermDebtFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Debt Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OtherLongTermDebtFacilityMember" xlink:href="ebs-20230630.xsd#ebs_OtherLongTermDebtFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_OtherLongTermDebtFacilityMember" xlink:to="lab_ebs_OtherLongTermDebtFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_9ab0888d-c95a-406a-a8fc-c7c9c36117ed_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_f2d70f73-f881-456e-813e-69fc4ab6aaa0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_990bc9b1-a10a-46b9-928c-f049acbd5c44_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_NumberOfRevenueGeneratingProducts_1f923492-c674-4820-b8b7-3fd2e175f175_terseLabel_en-US" xlink:label="lab_ebs_NumberOfRevenueGeneratingProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of revenue generating products</link:label>
    <link:label id="lab_ebs_NumberOfRevenueGeneratingProducts_label_en-US" xlink:label="lab_ebs_NumberOfRevenueGeneratingProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Revenue Generating Products</link:label>
    <link:label id="lab_ebs_NumberOfRevenueGeneratingProducts_documentation_en-US" xlink:label="lab_ebs_NumberOfRevenueGeneratingProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to the number of revenue generating products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_NumberOfRevenueGeneratingProducts" xlink:href="ebs-20230630.xsd#ebs_NumberOfRevenueGeneratingProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NumberOfRevenueGeneratingProducts" xlink:to="lab_ebs_NumberOfRevenueGeneratingProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_86ba70c5-b2cf-4052-89c0-25394d2a3f0e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e331fa1a-f635-4737-b17e-6010ac094c45_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_2f102a9d-e5fe-406b-bee8-25bed0a70946_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on term loan facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Medium-term Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfMediumTermNotes" xlink:to="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_40123055-b68d-4e49-9524-069b2829bd56_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_DebtInstrumentCovenantConsiderationThreshold_241444c5-4d29-4a75-b2be-55a5ba6aa597_terseLabel_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantConsiderationThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, consideration threshold</link:label>
    <link:label id="lab_ebs_DebtInstrumentCovenantConsiderationThreshold_label_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantConsiderationThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Consideration Threshold</link:label>
    <link:label id="lab_ebs_DebtInstrumentCovenantConsiderationThreshold_documentation_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantConsiderationThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Consideration Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantConsiderationThreshold" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantConsiderationThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtInstrumentCovenantConsiderationThreshold" xlink:to="lab_ebs_DebtInstrumentCovenantConsiderationThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_7724eee3-dc76-4698-9028-d21b7360d999_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_0e0b82b5-b4a3-434c-9955-0cdc76cf72bf_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_997dbb1a-709d-42c8-9e0d-e3d0404017bf_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociBeforeTaxAttributableToParent_cc5ac8bf-dfe1-4199-98a9-145e8fef64d8_terseLabel_en-US" xlink:label="lab_us-gaap_AociBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI before tax, attributable to parent</link:label>
    <link:label id="lab_us-gaap_AociBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_AociBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AociBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_AociBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_8b986aff-bce4-415c-be5d-1d3282abcc21_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_abf130cc-4076-41ab-8810-7ffe08899c6a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_f9c694d4-5d11-41d8-9203-e85d9c77207e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_59be26fc-85ab-4463-a5de-0bb2fdb06037_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_d952421f-b86f-4ad1-9dce-179990fe230c_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_f23152c2-1338-412b-b1b2-327d71293026_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_edd5b35f-ca59-4f8f-b63a-66d3322f485b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d5b4f427-0162-4795-81fb-c8eb929f87bd_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7c2e515c-c3f5-4599-9c09-31ea39cb8b23_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_36d7285e-5c43-4d45-a738-a6a71c8883d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity instruments other than options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_9bc7e373-9839-4465-95c4-4b4ab804f5a7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Cost of sales:</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_b10475b7-a3c1-42ea-bfaa-25f1b232dadc_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_72819cd7-49a4-4c72-abd9-db00d811f9fa_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_c8de1244-4b6f-49bc-9380-1a738c866665_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3c8ab21a-722c-44a0-9d0c-24e55f986671_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment unpaid at period end</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c638ad60-1bdd-42b0-813c-8e5aa6db11f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_d022c887-c012-4263-ae6d-3a3ea5ce522d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_20775405-c301-421c-bff5-642e9aa70ee8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_0b7893f8-e204-433e-8be4-395cee1b5018_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_5724f104-5d7b-4239-a874-ed6b79544ec6_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_RevenueFromContractWithCustomerTermOfContract_ae5fc4e7-37b9-4255-a5d2-91a18e306e4f_terseLabel_en-US" xlink:label="lab_ebs_RevenueFromContractWithCustomerTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_ebs_RevenueFromContractWithCustomerTermOfContract_label_en-US" xlink:label="lab_ebs_RevenueFromContractWithCustomerTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Term Of Contract</link:label>
    <link:label id="lab_ebs_RevenueFromContractWithCustomerTermOfContract_documentation_en-US" xlink:label="lab_ebs_RevenueFromContractWithCustomerTermOfContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Term Of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RevenueFromContractWithCustomerTermOfContract" xlink:href="ebs-20230630.xsd#ebs_RevenueFromContractWithCustomerTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_RevenueFromContractWithCustomerTermOfContract" xlink:to="lab_ebs_RevenueFromContractWithCustomerTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_e85975f0-0080-420f-a502-3b222cee0cf3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_c47d5314-5a93-4ea2-bab4-37b861d1ac3f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, liability, measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_2e330736-6210-48e7-8fbf-939a3dd854b5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8f142870-a546-4cc5-9a86-cf70772d1821_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_28bbcd49-ba24-487e-956b-061f15e8fa9b_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting unit, percentage of fair value in excess of carrying amount</link:label>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_label_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:to="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b12da463-573b-49c0-ada5-8c890b5db825_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2a4bd9af-bfe6-4cc5-afe4-4153af915cf2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_12a4375a-8e21-40fc-877d-188ba93079e2_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable_5b3a5291-4497-4c10-b7c5-7fc30db43fbf_terseLabel_en-US" xlink:label="lab_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments receivable</link:label>
    <link:label id="lab_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable_label_en-US" xlink:label="lab_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Maximum Contingent Consideration Receivable</link:label>
    <link:label id="lab_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable_documentation_en-US" xlink:label="lab_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Maximum Contingent Consideration Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable" xlink:href="ebs-20230630.xsd#ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable" xlink:to="lab_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_947fbad6-0b28-4a23-a9a7-e20b685371ec_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_b250eef6-4cf9-41b0-9c32-87187ff9aa0d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable and payable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9c4859f1-7797-4355-86c6-c8d659c8420d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_276ac2e7-6017-4cc7-bb54-5a0308df1aa2_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a5fbe585-21e8-4b55-aad1-bc4ba132a465_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_d042faea-6ce5-48d4-8cac-5f7cea9080d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_848e9707-4eaf-436a-907b-54650660ea7d_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_d00752fa-6e73-48e2-80b8-27228a9c4342_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_NonUnitedStatesGovernmentMember_a9279534-f211-4fd7-b6ef-d5bcbcfcb545_terseLabel_en-US" xlink:label="lab_ebs_NonUnitedStatesGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-USG</link:label>
    <link:label id="lab_ebs_NonUnitedStatesGovernmentMember_label_en-US" xlink:label="lab_ebs_NonUnitedStatesGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-United States Government [Member]</link:label>
    <link:label id="lab_ebs_NonUnitedStatesGovernmentMember_documentation_en-US" xlink:label="lab_ebs_NonUnitedStatesGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-United States Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_NonUnitedStatesGovernmentMember" xlink:href="ebs-20230630.xsd#ebs_NonUnitedStatesGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NonUnitedStatesGovernmentMember" xlink:to="lab_ebs_NonUnitedStatesGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_38f9e7f7-d854-4b54-ac91-550fa3752478_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_149f1564-167d-4200-87ae-facb792168ef_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_be14db8a-7eeb-49e6-b817-6bb1c1214ead_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_168374ca-fc66-4f78-90a0-4e4048197480_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required quarterly principal payments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8d18148c-abc3-4a9f-9619-93bfe35c47c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_73f5e006-1336-406f-b706-a11ec913cea4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8685afcb-3860-4acd-acf9-0bfb34819a16_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4ebe7b9b-25dd-42f3-a868-c393ebc98cb9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_AdjustedGrossMargin_e6b43fab-ea02-4ecd-8ab7-9265f3fd7259_terseLabel_en-US" xlink:label="lab_ebs_AdjustedGrossMargin" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Gross Margin</link:label>
    <link:label id="lab_ebs_AdjustedGrossMargin_label_en-US" xlink:label="lab_ebs_AdjustedGrossMargin" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Gross Margin</link:label>
    <link:label id="lab_ebs_AdjustedGrossMargin_documentation_en-US" xlink:label="lab_ebs_AdjustedGrossMargin" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Gross Margin</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AdjustedGrossMargin" xlink:href="ebs-20230630.xsd#ebs_AdjustedGrossMargin"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AdjustedGrossMargin" xlink:to="lab_ebs_AdjustedGrossMargin" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_99162bfa-6fa1-427e-befa-ebedb38efde3_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b939525a-d7ec-4576-9ffd-d58dc88bde6a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_ScheduleOfAccountsReceivableNetTableTextBlock_b2cd87ce-9eab-43d2-9489-4057b47f9194_terseLabel_en-US" xlink:label="lab_ebs_ScheduleOfAccountsReceivableNetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Receivable, Net</link:label>
    <link:label id="lab_ebs_ScheduleOfAccountsReceivableNetTableTextBlock_label_en-US" xlink:label="lab_ebs_ScheduleOfAccountsReceivableNetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Accounts Receivable, Net [Table Text Block]</link:label>
    <link:label id="lab_ebs_ScheduleOfAccountsReceivableNetTableTextBlock_documentation_en-US" xlink:label="lab_ebs_ScheduleOfAccountsReceivableNetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Accounts Receivable, Net [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ScheduleOfAccountsReceivableNetTableTextBlock" xlink:href="ebs-20230630.xsd#ebs_ScheduleOfAccountsReceivableNetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ScheduleOfAccountsReceivableNetTableTextBlock" xlink:to="lab_ebs_ScheduleOfAccountsReceivableNetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_7cc795fb-f2c5-49b7-8fc7-8e7cd6df366d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_38ca52ee-328a-4e3d-9917-231b3142eaf2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_1a892b5e-834b-4e62-b508-34b521913cf5_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_126a1d3a-b993-49bf-80cd-47d639c4ff86_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_7302cee8-20d0-46fe-98cc-c02e7f4213a4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f88de43d-c9b2-49a8-aa3f-fa145ab017d6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_d7aac616-0ab4-40f8-b3f7-281fb028ce42_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_5346e63f-cf71-4ebf-8f12-05b6f8fff196_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_16080d36-0c2b-42dd-ad2d-107ec99d5c2a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_8b374d1a-89c9-4ea8-b989-53a08bfccb27_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_f96568b3-dd87-423a-a0ed-efb02435d2f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_75d397ec-c7e7-4f7d-8002-11518cc0a2c0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets disposed of in sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_11ef0156-8538-49b3-a49d-ff02a74bed32_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss), net</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods_a42b431d-0610-4b4b-9e84-ed0242b70617_terseLabel_en-US" xlink:label="lab_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of option periods</link:label>
    <link:label id="lab_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods_label_en-US" xlink:label="lab_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Number Of Option Periods</link:label>
    <link:label id="lab_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods_documentation_en-US" xlink:label="lab_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Number Of Option Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods" xlink:href="ebs-20230630.xsd#ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods" xlink:to="lab_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7d0e9995-6a0f-4008-9340-92eb914784ff_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_faad37f2-cf4b-4a5c-b058-ba718cb23467_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_15583cbe-ee14-4c47-a365-8ccd887949cc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_dc6370ac-bda5-4d49-8846-560b3cc1426e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments and hedging activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_c1d04f47-127a-495d-90ab-b81fb385aaa1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_3bb218c5-b820-4f0b-8796-a2174630dcfb_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_921982d4-708b-41d2-a84d-6fd932572c98_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c443c90c-5227-40c8-a572-2ed6168c8b53_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_6db24740-f675-4cab-95f9-b679df021ff4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_cee53ce1-50ea-462f-a99f-ac6aec71d9d6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_a5a87e76-5cf3-4b17-be3a-4b6a9dead3ff_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:to="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_DebtTermsAxis_26f7cc03-1640-4314-98cd-80ba2cf408ed_terseLabel_en-US" xlink:label="lab_ebs_DebtTermsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Terms [Axis]</link:label>
    <link:label id="lab_ebs_DebtTermsAxis_label_en-US" xlink:label="lab_ebs_DebtTermsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Terms [Axis]</link:label>
    <link:label id="lab_ebs_DebtTermsAxis_documentation_en-US" xlink:label="lab_ebs_DebtTermsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtTermsAxis" xlink:href="ebs-20230630.xsd#ebs_DebtTermsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtTermsAxis" xlink:to="lab_ebs_DebtTermsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_3e88f5e8-68ff-4440-a530-c71c39be3ba7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension Plan</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_ProductsSegmentMember_ef49fe27-7247-4ab9-be9f-3cceda920745_terseLabel_en-US" xlink:label="lab_ebs_ProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_ebs_ProductsSegmentMember_label_en-US" xlink:label="lab_ebs_ProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products Segment [Member]</link:label>
    <link:label id="lab_ebs_ProductsSegmentMember_documentation_en-US" xlink:label="lab_ebs_ProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ProductsSegmentMember" xlink:to="lab_ebs_ProductsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_ContractDevelopmentAndManufacturingMember_2c444f43-464a-4f66-b5c5-6a744cfa812b_verboseLabel_en-US" xlink:label="lab_ebs_ContractDevelopmentAndManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CDMO</link:label>
    <link:label id="lab_ebs_ContractDevelopmentAndManufacturingMember_6d465ca8-3667-4663-98a7-3a0aa34d4cbf_terseLabel_en-US" xlink:label="lab_ebs_ContractDevelopmentAndManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Development And Manufacturing [Member]</link:label>
    <link:label id="lab_ebs_ContractDevelopmentAndManufacturingMember_label_en-US" xlink:label="lab_ebs_ContractDevelopmentAndManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Development And Manufacturing [Member]</link:label>
    <link:label id="lab_ebs_ContractDevelopmentAndManufacturingMember_documentation_en-US" xlink:label="lab_ebs_ContractDevelopmentAndManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue earned during the period arising from manufacturing sale under the terms of a contract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingMember" xlink:to="lab_ebs_ContractDevelopmentAndManufacturingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c523fa16-0e76-4b31-976f-a1aa20d7fa73_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_0b9b5c7b-9821-4ea4-b86d-8cdf86669492_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-launch inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_RidgebackMember_171f072b-fcbd-4636-96b8-17ad31d1de2a_terseLabel_en-US" xlink:label="lab_ebs_RidgebackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ridgeback</link:label>
    <link:label id="lab_ebs_RidgebackMember_label_en-US" xlink:label="lab_ebs_RidgebackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ridgeback [Member]</link:label>
    <link:label id="lab_ebs_RidgebackMember_documentation_en-US" xlink:label="lab_ebs_RidgebackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ridgeback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RidgebackMember" xlink:href="ebs-20230630.xsd#ebs_RidgebackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_RidgebackMember" xlink:to="lab_ebs_RidgebackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_98327df3-b98b-4a7c-88d1-d637e06922b3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_6bec7600-86e4-4d56-8c32-5d1704f23217_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_87981210-dcc2-4512-ace6-81e30c776087_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, remainder of fiscal year</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1928b8a2-00a7-4869-8af6-1dba79b6b31a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_f5afed36-2504-482a-baa1-96ab2bb18e98_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_NumberOfCategoriesOfPublicHealthThreats_561d1253-5ad1-4bc9-be3b-925dde50f677_terseLabel_en-US" xlink:label="lab_ebs_NumberOfCategoriesOfPublicHealthThreats" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of categories of public health threats</link:label>
    <link:label id="lab_ebs_NumberOfCategoriesOfPublicHealthThreats_label_en-US" xlink:label="lab_ebs_NumberOfCategoriesOfPublicHealthThreats" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Categories Of Public Health Threats</link:label>
    <link:label id="lab_ebs_NumberOfCategoriesOfPublicHealthThreats_documentation_en-US" xlink:label="lab_ebs_NumberOfCategoriesOfPublicHealthThreats" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to the number of categories of public health threats.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_NumberOfCategoriesOfPublicHealthThreats" xlink:href="ebs-20230630.xsd#ebs_NumberOfCategoriesOfPublicHealthThreats"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NumberOfCategoriesOfPublicHealthThreats" xlink:to="lab_ebs_NumberOfCategoriesOfPublicHealthThreats" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c6a8ff6c-e4f9-4d02-bc09-de8b5d1eed7d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_68a51435-0b3b-43bd-a6eb-5bfd8b19079c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f6eac3a8-a1d3-4f30-a9d4-1368b2da4386_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_cb5fb063-9b98-433a-b427-7284e52916a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_1116b440-149e-41ec-a5d9-f30a2f25ca0d_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, year one</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7941cb62-4b8b-4a22-ad14-be6251927d04_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-the-market sale of stock, net of commissions and expenses (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_01e1caee-a735-4a22-9345-a94b5df07e5a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_191f0805-ab4c-4c52-8e82-f2a7ed76c711_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_613d9743-40c8-4cf9-91b0-e80ef3fe4b93_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_4ac530f4-1f28-458f-8ca3-acc9fe89bdd7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, gross</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e23f1cfe-4f6c-4254-9dcd-b65cc593c203_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_daad9f19-9592-464a-8447-39e463089941_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_9a2da5a2-9ea1-4ded-89a6-a3385fdb8d45_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring costs by segment</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_64412e2e-042d-4d47-94f2-3a3a3e22f880_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation activity</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_294f07d1-9200-43e1-8890-e4ee4405cf37_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_JansenPharmaceuticalsIncMember_1b645687-b754-44b9-b821-8b7d201528d7_terseLabel_en-US" xlink:label="lab_ebs_JansenPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jansen Pharmaceuticals, Inc.</link:label>
    <link:label id="lab_ebs_JansenPharmaceuticalsIncMember_label_en-US" xlink:label="lab_ebs_JansenPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jansen Pharmaceuticals, Inc. [Member]</link:label>
    <link:label id="lab_ebs_JansenPharmaceuticalsIncMember_documentation_en-US" xlink:label="lab_ebs_JansenPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jansen Pharmaceuticals, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_JansenPharmaceuticalsIncMember" xlink:href="ebs-20230630.xsd#ebs_JansenPharmaceuticalsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_JansenPharmaceuticalsIncMember" xlink:to="lab_ebs_JansenPharmaceuticalsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_9277b623-bfd4-41d5-b8e3-b6b229833f72_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b0ee9610-6f22-42e6-8c49-92996ce1db76_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_ca2d4232-5054-4c9f-836d-d93a8313b8fb_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_0d71cb91-256c-4aa5-94e4-c7fb7f7bd76c_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_8b3d38d2-6d06-4005-a030-779804c208cc_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_DevelopmentBasedMilestonesMember_cd2e9eb4-10c7-474a-8f2f-c40f05bcf175_terseLabel_en-US" xlink:label="lab_ebs_DevelopmentBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development-Based Milestones</link:label>
    <link:label id="lab_ebs_DevelopmentBasedMilestonesMember_label_en-US" xlink:label="lab_ebs_DevelopmentBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development-Based Milestones [Member]</link:label>
    <link:label id="lab_ebs_DevelopmentBasedMilestonesMember_documentation_en-US" xlink:label="lab_ebs_DevelopmentBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development-Based Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DevelopmentBasedMilestonesMember" xlink:href="ebs-20230630.xsd#ebs_DevelopmentBasedMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DevelopmentBasedMilestonesMember" xlink:to="lab_ebs_DevelopmentBasedMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_4c26cdfb-dea1-44e1-938d-a4cca9b98335_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_9d35b69a-67c8-47a9-92b2-df5368d4dbff_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_23129de5-2b18-4b44-abf8-3314f3d346cd_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a6401bcb-9286-4c82-80df-54dd4b17c533_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_00af9f1a-edac-4424-af57-eca17af829e2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_663e879b-f202-4578-8abe-dc5e80164200_terseLabel_en-US" xlink:label="lab_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of Impairment of Long-Lived Assets Held and Used by Asset</link:label>
    <link:label id="lab_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_label_en-US" xlink:label="lab_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of Impairment of Long-Lived Assets Held and Used by Asset [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:to="lab_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0f9c0e7f-ee10-4a53-b5eb-7db0b4ad5af2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_bae0ea5b-6d78-40c0-bbf0-b739a50d06e6_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales, net</link:label>
    <link:label id="lab_us-gaap_ProductMember_a7df54a6-442f-4bd6-a5f7-40b16dbe0c5a_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_a16a9997-b2ae-4957-9f3e-7d14fa5b217d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward_75183972-5783-4550-9f9d-71ed995cac9d_terseLabel_en-US" xlink:label="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract With Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward" xlink:href="ebs-20230630.xsd#ebs_ChangeinContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward" xlink:to="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_346fbdc3-59fe-4e5f-8c8d-63e4de973850_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental information on non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_3d496588-c193-4bad-929c-461801e42d2f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_56e946fd-f3c4-4f2a-b457-f2d69a9060b8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_937ead17-f7b7-4923-b17e-401fcc3fccae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2470eef-c4f6-4457-a1e5-63ed56e87e3c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_72d4b50c-950a-4849-b7ee-6a4ec5de8871_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ca610586-7b52-4680-a580-9320e8ba4c2b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_341dc48b-50ea-45f7-8f92-6e62ec5f5bca_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d7f0ed3f-215c-4bcc-972c-1c44c8d765cc_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_14e776e0-8a51-4ac9-933f-abe6b8660368_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_6e1ef903-51d1-4d25-b111-270356b21b31_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_06cca597-fedd-4c09-b62a-1eed31da6d8e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_31aaf7f5-80ab-42f2-a657-6cc186b104da_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_c50e0999-ee52-4709-b1d0-412f4770fc31_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4f50e21a-f5e5-4c95-b707-9eb8c92d869b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_UnitedStatesGovernmentMember_0d10b8f5-c7a7-43d0-a92d-48a3dd253a04_terseLabel_en-US" xlink:label="lab_ebs_UnitedStatesGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USG</link:label>
    <link:label id="lab_ebs_UnitedStatesGovernmentMember_label_en-US" xlink:label="lab_ebs_UnitedStatesGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Government [Member]</link:label>
    <link:label id="lab_ebs_UnitedStatesGovernmentMember_documentation_en-US" xlink:label="lab_ebs_UnitedStatesGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_UnitedStatesGovernmentMember" xlink:href="ebs-20230630.xsd#ebs_UnitedStatesGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_UnitedStatesGovernmentMember" xlink:to="lab_ebs_UnitedStatesGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsCurrentNet_ba532f89-e5b7-441f-afaa-f414c2b7d8d2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsCurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs, current, net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsCurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsCurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Current, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsCurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsCurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsCurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_ContractDevelopmentAndManufacturingLeasesMember_a3037d4e-dc50-48e6-bad7-ab95182cb8b5_terseLabel_en-US" xlink:label="lab_ebs_ContractDevelopmentAndManufacturingLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_ebs_ContractDevelopmentAndManufacturingLeasesMember_label_en-US" xlink:label="lab_ebs_ContractDevelopmentAndManufacturingLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Development And Manufacturing, Leases [Member]</link:label>
    <link:label id="lab_ebs_ContractDevelopmentAndManufacturingLeasesMember_documentation_en-US" xlink:label="lab_ebs_ContractDevelopmentAndManufacturingLeasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Development And Manufacturing, Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember" xlink:to="lab_ebs_ContractDevelopmentAndManufacturingLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_531a6626-7bbb-4143-8ed7-68c75d9f2843_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_638141d8-2b87-45b5-a471-3f7b5d851249_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_24209bc8-1965-4910-8c25-ef58282d1ea9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_4e4d20b9-4ddd-4522-b004-990a089787ca_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, asset, noncurrent</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6ed63633-1287-45ba-9b62-38cae3c8870d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_BARDAContractPayableInThirdQuarterOf2023Member_c3db44fd-db05-49ee-9eec-26c933e1c23d_terseLabel_en-US" xlink:label="lab_ebs_BARDAContractPayableInThirdQuarterOf2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BARDA Contract, Payable in Third Quarter of 2023</link:label>
    <link:label id="lab_ebs_BARDAContractPayableInThirdQuarterOf2023Member_label_en-US" xlink:label="lab_ebs_BARDAContractPayableInThirdQuarterOf2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BARDA Contract, Payable In Third Quarter Of 2023 [Member]</link:label>
    <link:label id="lab_ebs_BARDAContractPayableInThirdQuarterOf2023Member_documentation_en-US" xlink:label="lab_ebs_BARDAContractPayableInThirdQuarterOf2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BARDA Contract, Payable In Third Quarter Of 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_BARDAContractPayableInThirdQuarterOf2023Member" xlink:href="ebs-20230630.xsd#ebs_BARDAContractPayableInThirdQuarterOf2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BARDAContractPayableInThirdQuarterOf2023Member" xlink:to="lab_ebs_BARDAContractPayableInThirdQuarterOf2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_40d2c733-452d-462c-a116-56008856a3ad_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_efd471ec-6154-4428-b5b1-d5a7a6ce1ff3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_794a0508-7885-4323-bebd-2956fbff5dfe_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9c22f499-d567-4bba-a303-4b272a87743d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_188795b7-423e-4e31-b0eb-0317d1e64a7f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_e1a85c12-930f-4a98-8649-56ad3a91ebda_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1fc2aac3-7f0a-4488-92a2-80ffe16b2df4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b528014a-e334-4782-89ae-a1c0ac5e804d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_251c2864-dcfd-49ff-a5b1-9955359d62da_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_db27f3de-fc37-4014-a88b-243b27bf3acd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_441ad6f3-f94a-43f9-85a0-e92760c450a8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective annual tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b2e92962-4072-4d86-b002-c1269540819c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour_82b14e4a-2631-4af1-924c-963eb21aa65a_terseLabel_en-US" xlink:label="lab_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, after year four</link:label>
    <link:label id="lab_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour_label_en-US" xlink:label="lab_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment To Be Received, After Year Four</link:label>
    <link:label id="lab_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour_documentation_en-US" xlink:label="lab_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment To Be Received, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour" xlink:href="ebs-20230630.xsd#ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour" xlink:to="lab_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_58857c81-b5ca-4468-9a37-99df8538c618_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_6cd0f0d6-a8df-426c-b274-078fab6ed771_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_8e1381f6-e8e3-4903-a7ce-bf4108effbd1_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_eedff96c-9bad-40ee-919f-d2de10a11a95_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_ecb29199-6d64-4418-b6d1-cd674175f5ef_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Income Statement Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Income Statement Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c517d774-7d27-4990-a29f-6a4e915455c7_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of the business and organization</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_418f385e-8262-4d6d-97de-0c84e6b79e04_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0417822e-fca3-48a6-9433-7aaad0b45290_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash purchase price for sale of business</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_de387547-f4c1-4ad9-89ae-a0b7fd6b903d_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7b85f598-1c2f-4ddc-a295-6944377cb00b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d156ec8e-3788-4a7e-8181-9f2148328941_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_92ba69aa-5979-4801-b788-0e6b18f4ae8a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_f80a9a2d-76be-4043-b16b-ec301331350f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_b33c9b92-56ed-4aa0-80c4-d54e1209cc05_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8af4b964-3d3f-47d0-9879-eb1e47f60e33_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_96d118ec-5782-4108-a7f2-e6d73f7c85b9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax expense (benefits)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_84c6f18a-f2ac-4487-8a64-1934a33ce872_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, year three</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e36e43f2-b3c0-4211-a875-1a35030c87da_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2d2c1381-95f9-4e73-8b29-9f88eafe0520_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_2766c020-1a8e-4cce-8534-3acdd4aa8c8c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_b61f0b52-6595-4cc8-a0ac-0966f907ae44_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0cbc81c6-cc7a-49f2-a393-027fb941f60f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_GrossProfitAdjustments_b1f9f84a-7830-4c59-8143-1e0596564da5_terseLabel_en-US" xlink:label="lab_ebs_GrossProfitAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to gross margin</link:label>
    <link:label id="lab_ebs_GrossProfitAdjustments_label_en-US" xlink:label="lab_ebs_GrossProfitAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit, Adjustments</link:label>
    <link:label id="lab_ebs_GrossProfitAdjustments_documentation_en-US" xlink:label="lab_ebs_GrossProfitAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit, Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_GrossProfitAdjustments" xlink:href="ebs-20230630.xsd#ebs_GrossProfitAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_GrossProfitAdjustments" xlink:to="lab_ebs_GrossProfitAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_c02fed1f-6229-467a-8701-eac61421d07f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_97e68f11-0a74-4852-a640-0a79dcb641dd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_68fbc2c2-02ab-4032-897a-ccf632abf476_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_99bd3807-cdcd-4deb-90f4-cefaaca1e3ac_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_930cdfbf-9283-4e6f-98a6-61f4119608e8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.001 per share; 200.0 shares authorized, 57.4 and 55.7 shares issued; 51.8 and 50.1 shares outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_0f611d94-cf56-4c0f-9e59-9e52ececf45b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_41fc8d0c-9265-42f7-b0fa-21863740b025_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Expense</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cdd90ef6-031f-4830-955e-36df83246684_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_ffb6d6c4-a905-4234-86d9-6defe50e759b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_8e48c813-63ae-405e-8edb-e29e13ec046f_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_8a6ea4b4-63bb-4eb9-90d6-cfa07f4d99fe_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_98476bce-be76-45e4-98ce-0ed581b31197_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_57cfb1e1-95d8-4ce0-b866-63aac5519598_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7e3b8157-9f39-482c-9549-d4abc0bd62a2_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_8c5cd115-4052-4edc-b9bf-1abed0e19a85_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_4f099fcd-3673-40bc-84d5-5f84dc4250dc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_679c4cad-909d-4769-843f-54d5263f5f32_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_6dc709ae-001f-4b1b-b4aa-e2a26c308be1_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_25a6475e-fb09-4172-b1dd-490e2b357d31_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_fb60fc76-1778-42f9-8418-e8b7cf2eee3c_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_ed4278c8-3f6d-4f9a-9064-dbc1670eae85_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_ead755fe-a8dc-45d2-b29c-5caee96f07e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d0f026dd-6834-4c76-b0c7-08eb21154458_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c3ba9d25-3226-43db-b691-f1d29379b515_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5f913e52-b0e0-4324-ab64-b223c8e24b86_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_UntilMarch312024Member_94bfc569-da95-4439-ac5a-c5fc3610eccb_terseLabel_en-US" xlink:label="lab_ebs_UntilMarch312024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Until March 31, 2024</link:label>
    <link:label id="lab_ebs_UntilMarch312024Member_label_en-US" xlink:label="lab_ebs_UntilMarch312024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Until March 31, 2024 [Member]</link:label>
    <link:label id="lab_ebs_UntilMarch312024Member_documentation_en-US" xlink:label="lab_ebs_UntilMarch312024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Until March 31, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_UntilMarch312024Member" xlink:href="ebs-20230630.xsd#ebs_UntilMarch312024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_UntilMarch312024Member" xlink:to="lab_ebs_UntilMarch312024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_9b9d34f9-6087-4119-a4e6-701cee4fbef8_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_212fdd94-daa4-4f35-a10c-9db159cb0c0d_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6a7bcaac-387e-4bea-b40f-0ce937e4d4c3_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b81ecdab-3b6b-4c7b-b334-0ac75eb04f0c_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f46a2413-3750-45c5-aaf9-4b542777d037_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_29b7fbf0-73d1-4e9b-ba55-38fd7acec8e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_15714f92-0dc7-497d-86a3-db152794af30_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_82974acb-9d24-4b08-a79f-fcc62cb1a38b_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_MeasurementInputProbabilityOfPaymentMember_ac2d2ae7-4705-4edf-a70c-e2ef7d13b082_terseLabel_en-US" xlink:label="lab_ebs_MeasurementInputProbabilityOfPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability of payment</link:label>
    <link:label id="lab_ebs_MeasurementInputProbabilityOfPaymentMember_label_en-US" xlink:label="lab_ebs_MeasurementInputProbabilityOfPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Of Payment [Member]</link:label>
    <link:label id="lab_ebs_MeasurementInputProbabilityOfPaymentMember_documentation_en-US" xlink:label="lab_ebs_MeasurementInputProbabilityOfPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Of Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_MeasurementInputProbabilityOfPaymentMember" xlink:href="ebs-20230630.xsd#ebs_MeasurementInputProbabilityOfPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_MeasurementInputProbabilityOfPaymentMember" xlink:to="lab_ebs_MeasurementInputProbabilityOfPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6affc736-dfcf-4ce2-92a9-0a1c90c088c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_2fabc47c-57dd-4f13-9368-9436e7b7d558_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_AssetsAndLiabilitiesLesseeTableTextBlock_08c449bf-5f87-4461-8075-d7657b62ef73_terseLabel_en-US" xlink:label="lab_ebs_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leases Supplemental Balance Sheets</link:label>
    <link:label id="lab_ebs_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_ebs_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_ebs_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_ebs_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="ebs-20230630.xsd#ebs_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_ebs_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_884e8fa7-c317-4da4-bf90-093e5c83cb91_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_41214079-d281-4911-be6e-3c0cd72cae8c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, liability, current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_d29af037-990c-4053-be5c-bc38e709c0fa_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_InventoryStepUp_ce2a8638-9d39-4f5e-9cad-d03964573173_terseLabel_en-US" xlink:label="lab_ebs_InventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step-up provision</link:label>
    <link:label id="lab_ebs_InventoryStepUp_label_en-US" xlink:label="lab_ebs_InventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Step Up</link:label>
    <link:label id="lab_ebs_InventoryStepUp_documentation_en-US" xlink:label="lab_ebs_InventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Step Up</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_InventoryStepUp" xlink:href="ebs-20230630.xsd#ebs_InventoryStepUp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_InventoryStepUp" xlink:to="lab_ebs_InventoryStepUp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_3d63475e-b146-47ea-96d1-03e50c4f5002_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_b6c3ed3f-5ea5-4543-8b23-f5f8a1081c36_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6b7b728c-ae50-45be-9ad4-c3c0b93941b7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_8f00186d-f22b-479e-a061-cf9347d9b46a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_8a6a0ee5-f513-4e51-b9c6-3f4c9e143aeb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_84e28c7a-6d62-43dc-b996-6be8ae261f7c_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_d2883450-a38b-4a81-a941-ee4ee1275452_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of travel health business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_ProductsAndServicesSegmentsMember_f6782483-b736-4cc2-8fb3-a724a5f4eb8c_terseLabel_en-US" xlink:label="lab_ebs_ProductsAndServicesSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products And Services Segments</link:label>
    <link:label id="lab_ebs_ProductsAndServicesSegmentsMember_label_en-US" xlink:label="lab_ebs_ProductsAndServicesSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products And Services Segments [Member]</link:label>
    <link:label id="lab_ebs_ProductsAndServicesSegmentsMember_documentation_en-US" xlink:label="lab_ebs_ProductsAndServicesSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products And Services Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsAndServicesSegmentsMember" xlink:href="ebs-20230630.xsd#ebs_ProductsAndServicesSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ProductsAndServicesSegmentsMember" xlink:to="lab_ebs_ProductsAndServicesSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_2ca93852-0e04-4857-a115-02c05bd9f5cb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_79faf19f-8c5e-4801-a9e1-0500165f8228_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5d5648f2-9a44-4c94-ada7-b6cace1c2a2f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_19cc1580-aa3d-4f81-bf52-ed0446350d52_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af662b4d-849a-4c71-9f5f-5984bc7ca204_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_DispositionOfBusinessTransactionCosts_80b64fa9-0e71-44eb-b566-06f53c7a4cfe_terseLabel_en-US" xlink:label="lab_ebs_DispositionOfBusinessTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_ebs_DispositionOfBusinessTransactionCosts_label_en-US" xlink:label="lab_ebs_DispositionOfBusinessTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition Of Business, Transaction Costs</link:label>
    <link:label id="lab_ebs_DispositionOfBusinessTransactionCosts_documentation_en-US" xlink:label="lab_ebs_DispositionOfBusinessTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition Of Business, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DispositionOfBusinessTransactionCosts" xlink:href="ebs-20230630.xsd#ebs_DispositionOfBusinessTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DispositionOfBusinessTransactionCosts" xlink:to="lab_ebs_DispositionOfBusinessTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e522a49-23bc-40f6-aff7-a4a81f8971c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_003180ec-9772-43f2-a955-2475d79958c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_dcadfe57-c57d-46a0-9b27-d8ee7e368710_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized in the period from amounts included in contract liability at the beginning of the period:</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0f7f13b-f07a-45a2-bc7c-1efbbcc43e14_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_7b1aa3c1-fea8-47c9-89de-64c1f331d94a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_b81d053d-a4a2-45fc-8b16-882725bd8cf9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c19f1de9-b573-43df-bfc0-33132cafb12b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6ac311df-7eb3-4da0-83ff-50435a4aaf02_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_RestructuringPlanAugust2023Member_79c5ff8a-cc27-459b-8019-b032016b8286_terseLabel_en-US" xlink:label="lab_ebs_RestructuringPlanAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2023 Restructuring Plan</link:label>
    <link:label id="lab_ebs_RestructuringPlanAugust2023Member_label_en-US" xlink:label="lab_ebs_RestructuringPlanAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan August 2023 [Member]</link:label>
    <link:label id="lab_ebs_RestructuringPlanAugust2023Member_documentation_en-US" xlink:label="lab_ebs_RestructuringPlanAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan August 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RestructuringPlanAugust2023Member" xlink:href="ebs-20230630.xsd#ebs_RestructuringPlanAugust2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_RestructuringPlanAugust2023Member" xlink:to="lab_ebs_RestructuringPlanAugust2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_4e03d42a-6a2f-461a-b9c2-4ea44baa5d85_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_dda82b26-6892-445b-9c3e-4a8b9a8cbd56_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_c08e4238-6eb7-44a6-aaac-2778acd40870_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and impairment costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9711b79d-f349-4847-9043-3913a5d276a3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_6b56892b-9c76-48f9-aa03-52e4584f469b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_f5fe63b7-ba31-4d61-b96b-cbd852f6a70d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_4044068f-01af-4e46-807c-7e4e8fa0f852_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_62ed8689-fd89-4510-a323-68e866ca520c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_4f1f5d45-ada7-4ccd-a330-e2bfca455200_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_1b11e5d8-cedf-42e1-9a0b-ef951a7ebf84_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3d7af189-c5f6-4812-9792-f3b3b3e11739_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8fdedfed-20b9-43b1-99bd-7303d06188b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_cbe35f9a-dc9c-48c9-8866-9b69b191a55d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_464732be-ab0f-4f92-b9be-41450b6a8913_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Useful Life in Years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_651aab74-e789-4d33-a501-0fb063d67fa5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_5fe3ed5d-63d8-409f-b09b-43a7ab5074b5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_12eb229a-d3b4-4b73-8ae6-49e8aca34189_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$0.001 Par Value Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0c0aae0d-3ea5-493d-b133-dd0670502061_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_eeef98f9-a85b-46a3-9349-30fa4bd665cd_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_739983a6-12df-40d0-a24c-ab98d0b397b3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_381e6f30-878b-43bf-83f5-7337d49e1aa2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per common share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_4032ed5e-f4b7-45a7-996d-7e17b3dc7298_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_01f1e05b-96a7-4071-9e67-c6ee7ccd3c4b_verboseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and Services [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_2d7b2207-51dd-49b7-a065-6db616079d90_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected workforce reduction</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_216d458f-c4d8-475e-b2f5-4ebabfc860c2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_f8a2568c-abf8-49e2-862b-45cd37112032_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted cash flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_4e5bb394-a751-4af8-ba90-fca2f376ef3a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9cc2b119-5c4f-41b6-865a-3a17f3115ec7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c5b4bdf3-a8d2-43d0-b4dc-f816cb133fe0_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_ProductsSegmentAbstract_8789a9dc-b92b-4f4a-b4e6-50bd96aa7201_terseLabel_en-US" xlink:label="lab_ebs_ProductsSegmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products:</link:label>
    <link:label id="lab_ebs_ProductsSegmentAbstract_label_en-US" xlink:label="lab_ebs_ProductsSegmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products Segment [Abstract]</link:label>
    <link:label id="lab_ebs_ProductsSegmentAbstract_documentation_en-US" xlink:label="lab_ebs_ProductsSegmentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentAbstract" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ProductsSegmentAbstract" xlink:to="lab_ebs_ProductsSegmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_47b5fcc5-9441-4b29-b766-7fbaa57d7d6d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f514106a-0db5-4bc9-80bf-ccecb41e28ab_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_63efa81e-8d28-4703-beb7-dac12c38f476_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e1613fc6-75e5-4cb3-bab9-dfe1679f5b6b_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_27259131-4e1c-40cd-9517-7ff053b75f14_terseLabel_en-US" xlink:label="lab_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum contingent consideration</link:label>
    <link:label id="lab_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_label_en-US" xlink:label="lab_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:label id="lab_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_documentation_en-US" xlink:label="lab_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:href="ebs-20230630.xsd#ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:to="lab_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_328a5d05-8450-408f-a37a-658dd3b697dc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_21292d72-f0da-4b4c-8d26-072dc7e5f31a_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_d0db402c-bf81-4bc7-8792-190985659d64_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_f1defb93-1538-4a05-a6db-71e0c4cab68f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_UnallocatedResearchAndDevelopmentMember_41d7f058-c3a8-4389-9b72-8876b514d87a_terseLabel_en-US" xlink:label="lab_ebs_UnallocatedResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D</link:label>
    <link:label id="lab_ebs_UnallocatedResearchAndDevelopmentMember_label_en-US" xlink:label="lab_ebs_UnallocatedResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated Research And Development [Member]</link:label>
    <link:label id="lab_ebs_UnallocatedResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_ebs_UnallocatedResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_UnallocatedResearchAndDevelopmentMember" xlink:href="ebs-20230630.xsd#ebs_UnallocatedResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_UnallocatedResearchAndDevelopmentMember" xlink:to="lab_ebs_UnallocatedResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_34279633-73c6-4338-82b4-dc6a5216b547_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0c1f6133-fe68-4346-a0a5-7aff6a3b0db6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_cd1eca67-a88e-460d-aa2e-088c199bcd36_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_3ed3b340-b96b-4527-85f7-c0eea18317f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9a0fda5a-4b85-498e-a3e3-f72548cc9da8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid for stock-based compensation activity</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BilledContractReceivables_daf271a6-dcef-4086-a30b-1a4a19f2003e_terseLabel_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Billed</link:label>
    <link:label id="lab_us-gaap_BilledContractReceivables_label_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Billed Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BilledContractReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BilledContractReceivables" xlink:to="lab_us-gaap_BilledContractReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_5000465d-07ea-4745-b8f1-921263e21cc3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_d953d51d-b181-4982-8899-5ab40205c0e3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_NumberOfProductAndServiceCategories_e3608e6d-7134-49be-a2b8-5cd6ac741fad_terseLabel_en-US" xlink:label="lab_ebs_NumberOfProductAndServiceCategories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of product and service categories</link:label>
    <link:label id="lab_ebs_NumberOfProductAndServiceCategories_label_en-US" xlink:label="lab_ebs_NumberOfProductAndServiceCategories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Product And Service Categories</link:label>
    <link:label id="lab_ebs_NumberOfProductAndServiceCategories_documentation_en-US" xlink:label="lab_ebs_NumberOfProductAndServiceCategories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Product And Service Categories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_NumberOfProductAndServiceCategories" xlink:href="ebs-20230630.xsd#ebs_NumberOfProductAndServiceCategories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NumberOfProductAndServiceCategories" xlink:to="lab_ebs_NumberOfProductAndServiceCategories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_6ce5f270-9dbd-4c54-8a75-83d9bbe78dd5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_3b67fd30-94ef-40e0-9dc8-21d328cb7015_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_2ecd26ab-f27a-4633-ad8f-e0183cb2d08a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion of long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_684ed349-0046-46c6-8ba1-c9d75e3cbfe0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_49de57c1-a548-49f9-a5ec-cf4ef3f2d754_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a5aa5f59-12db-4b97-8c6e-294dc2931782_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_a96a57b8-257b-40b2-9809-4859367ca817_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_344c88d7-a68c-4387-855d-fb8a8d219e7c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_59cf0d51-70d6-4c1b-95d4-528090ebbcb1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cancelable orders</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b8b01aa8-f0f2-4002-80d3-c5de7056bde9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4a24b383-8153-4b0b-84f8-27fa197c9f79_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8df4750f-495e-4894-9904-50903197f706_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_01bdbe40-ee59-4d1c-805a-664cea1b6f2c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_01398a73-b05b-4fd7-8e63-08ea2e0a2b8a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_47f0efa3-3253-4822-b46a-2d10d24f7ee6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions eliminated, percent</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated, Period Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_233b3f5c-656c-40e3-84e1-8241e63224c4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_fcc97ed9-48e6-4696-984a-b80dde752456_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_4e1f2efd-eb6f-4752-9c68-ccb746727093_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_221b2f40-01e4-49bd-b05a-7f40fd4a63ea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0d1961da-d1a8-4d48-be5f-f8c85beb7f32_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_EmployeeBenefitsMember_092f8102-a0d6-40bc-8279-b162c09d62dd_terseLabel_en-US" xlink:label="lab_ebs_EmployeeBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefits</link:label>
    <link:label id="lab_ebs_EmployeeBenefitsMember_label_en-US" xlink:label="lab_ebs_EmployeeBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits [Member]</link:label>
    <link:label id="lab_ebs_EmployeeBenefitsMember_documentation_en-US" xlink:label="lab_ebs_EmployeeBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EmployeeBenefitsMember" xlink:href="ebs-20230630.xsd#ebs_EmployeeBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EmployeeBenefitsMember" xlink:to="lab_ebs_EmployeeBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_a606f930-fe02-42c7-badd-64fb4f11a5aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_1f6e93f7-b9c9-4612-8f28-cb59af73b3bd_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation and consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_97418224-14a9-422b-b38e-360fcee6520c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_139ec464-5f76-4c35-ab1d-9fbc71f6c501_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_1eb432b8-d5ac-41d6-befb-7ff8a0f211e0_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_a38533c8-553c-4ce5-8656-437ca106db4e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_7cb3196e-62c2-4d30-a208-b99634dede13_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_f4a62763-caf7-4d23-8089-68ef4564d4d0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_8872d113-bcaf-4efc-a2c3-c7acd36bfccc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_1cbf39bb-6f1a-4bc1-a4b4-ae32d05ed24b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_7ecd55f8-1564-4f14-aece-460bb0501304_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_FiscalQuartersEndingAfterMarch312024Member_485fa90c-cdba-473f-b0b3-e62f9083119e_terseLabel_en-US" xlink:label="lab_ebs_FiscalQuartersEndingAfterMarch312024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarters Ending After March 31, 2024</link:label>
    <link:label id="lab_ebs_FiscalQuartersEndingAfterMarch312024Member_label_en-US" xlink:label="lab_ebs_FiscalQuartersEndingAfterMarch312024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarters Ending After March 31, 2024 [Member]</link:label>
    <link:label id="lab_ebs_FiscalQuartersEndingAfterMarch312024Member_documentation_en-US" xlink:label="lab_ebs_FiscalQuartersEndingAfterMarch312024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarters Ending After March 31, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiscalQuartersEndingAfterMarch312024Member" xlink:href="ebs-20230630.xsd#ebs_FiscalQuartersEndingAfterMarch312024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_FiscalQuartersEndingAfterMarch312024Member" xlink:to="lab_ebs_FiscalQuartersEndingAfterMarch312024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_835fae23-7df9-41d1-ac5e-6458fae47740_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_5bbbe7f2-ea69-4ba9-8932-be5cde56a0c9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_99765ad6-98a7-4b42-b0ab-887749734538_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance, deferred tax asset, increase, amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6de8630a-36d0-4387-8e5b-9ac1e4061675_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_53f04fae-8b72-46d3-8bf8-97a2663539b2_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_5e31459a-68eb-48e0-9d66-96066be224a7_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used [Line Items]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_a0063127-5568-4613-8de2-e336268e7470_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, current portion</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_e2b528d5-23c8-4a0a-b219-f4bbf611fb69_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_IncomeTaxesLineItems_702ee86b-2ae7-40b3-b890-871ccf6d2bd9_terseLabel_en-US" xlink:label="lab_ebs_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_ebs_IncomeTaxesLineItems_label_en-US" xlink:label="lab_ebs_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_ebs_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_ebs_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_IncomeTaxesLineItems" xlink:href="ebs-20230630.xsd#ebs_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_IncomeTaxesLineItems" xlink:to="lab_ebs_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_TravelHealthBusinessMember_0a795057-1ea6-4472-8a79-39b2fe98fefb_terseLabel_en-US" xlink:label="lab_ebs_TravelHealthBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Travel Health Business</link:label>
    <link:label id="lab_ebs_TravelHealthBusinessMember_label_en-US" xlink:label="lab_ebs_TravelHealthBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Travel Health Business [Member]</link:label>
    <link:label id="lab_ebs_TravelHealthBusinessMember_documentation_en-US" xlink:label="lab_ebs_TravelHealthBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Travel Health Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TravelHealthBusinessMember" xlink:href="ebs-20230630.xsd#ebs_TravelHealthBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TravelHealthBusinessMember" xlink:to="lab_ebs_TravelHealthBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_d4ba3b63-3e4f-4d0c-adcb-c67f2969ebd3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_7d05aec8-0917-4b02-b4ff-c09c1a82e60c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested options forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_df261af6-446f-466f-9c7e-a124a1d28952_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_8ac924f3-7b70-44b9-854f-bea2812d127f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_1c1ecd29-031d-4b82-96ee-1288d876a1fd_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_088d906c-775d-4eeb-8b42-c196114a8e82_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_FiscalQuartersEndingIn2024Member_2e0f02e0-b2ad-4e89-a69a-88dc99a89c47_terseLabel_en-US" xlink:label="lab_ebs_FiscalQuartersEndingIn2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarters Ending in 2024</link:label>
    <link:label id="lab_ebs_FiscalQuartersEndingIn2024Member_label_en-US" xlink:label="lab_ebs_FiscalQuartersEndingIn2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarters Ending in 2024 [Member]</link:label>
    <link:label id="lab_ebs_FiscalQuartersEndingIn2024Member_documentation_en-US" xlink:label="lab_ebs_FiscalQuartersEndingIn2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Quarters Ending in 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiscalQuartersEndingIn2024Member" xlink:href="ebs-20230630.xsd#ebs_FiscalQuartersEndingIn2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_FiscalQuartersEndingIn2024Member" xlink:to="lab_ebs_FiscalQuartersEndingIn2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_0150bb56-dae2-4387-882b-6d3048efc215_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche Three</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_bff249e7-f9b4-4a07-bcf8-66522a074e5c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d954e501-6c54-415c-81ff-655171754e23_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c074811c-2dda-4287-97c9-90aadddac62b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity instruments other than options, forfeited in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b96c5d2-d9a7-4015-a5e4-483587c8c57b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_80ee32df-7ec0-49c8-9d72-50e27e336368_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for expected credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_9c9b035f-dd9b-4225-a228-71cfe5580116_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_77e6eeac-fa61-4704-8dee-aba70ae9e2d9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_SaleOfStockConsiderationReceivedOnTransactionGross_65568102-e8c9-4103-acf6-035f3168c82e_terseLabel_en-US" xlink:label="lab_ebs_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, consideration received on transaction, gross</link:label>
    <link:label id="lab_ebs_SaleOfStockConsiderationReceivedOnTransactionGross_label_en-US" xlink:label="lab_ebs_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Consideration Received On Transaction, Gross</link:label>
    <link:label id="lab_ebs_SaleOfStockConsiderationReceivedOnTransactionGross_documentation_en-US" xlink:label="lab_ebs_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Consideration Received On Transaction, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:href="ebs-20230630.xsd#ebs_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:to="lab_ebs_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_93b88c2c-6453-4958-8209-d96844287113_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of travel health business, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_827a8125-2ca1-413f-9088-f475cec8e55f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_005652bc-8c4c-4dd7-8cc4-0f674b1b3785_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior to August 15, 2023</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d42c8b4c-227d-4573-885f-73bf1f736543_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation activity (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_TermLoanFacilityMember_0aa29822-0273-4ed4-b052-1d9483b937a1_terseLabel_en-US" xlink:label="lab_ebs_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured credit agreement - Term loan due 2025</link:label>
    <link:label id="lab_ebs_TermLoanFacilityMember_label_en-US" xlink:label="lab_ebs_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_ebs_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_ebs_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan dated December 2013.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TermLoanFacilityMember" xlink:href="ebs-20230630.xsd#ebs_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TermLoanFacilityMember" xlink:to="lab_ebs_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_07ed3241-0bf4-411c-bb82-e2dfd4a23fba_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_492db42e-2edb-43f6-aea2-c31ea5299de5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_6fbdb2f8-7659-4435-806f-b956453f1f82_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of product sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_89e35374-40f9-41d7-b1b6-e16d6352f1a0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent obligations, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_73f5a390-8aa9-4974-b79d-2e0579362302_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_d5d9392c-d702-441c-bd0c-77b73e3fd80b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance payments</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_cb80b3a1-4b6d-4953-ba26-d7709b90352d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ed3a8ae7-b435-4e35-a39d-a95a9b5b8d72_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_929fdc80-afbc-45d6-8b64-0037f8db754f_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation &amp; amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_06d65c4d-1de9-40af-9d6e-e1bd255e4631_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_1f599986-74b0-45a8-a7a6-de4e18577b76_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_6855e643-8d8e-48ea-9eb9-e935861a425e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_308ced14-b33e-4dd3-a30f-10f80a14afe3_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_e56b2acd-667e-41ae-957a-377bf8e12dad_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_6cbc3416-a865-4f1d-a5fa-50ad89a685b1_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_60611f8d-ec1b-4be5-9c17-abdf1ccecbf0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b7179751-2f3a-4bcc-9b5e-ee19876c0db2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_2e92dab8-964b-452a-9406-f9c5cbf4de25_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_c309135c-91b6-4903-a346-01cbf20e36db_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_f430b232-4446-40a3-bb2f-bc2f06c6fd32_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_24b79462-0169-421d-a93a-88ccb95289c4_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_f3d7c846-0570-4c91-8445-65eea6840f32_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_5d790e49-5e46-44c4-bbbc-3cbcfad34677_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage_39c0f82c-12da-47bf-a05e-6a0104f421d8_terseLabel_en-US" xlink:label="lab_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout percentage</link:label>
    <link:label id="lab_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage_label_en-US" xlink:label="lab_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Target Payout Percentage</link:label>
    <link:label id="lab_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage_documentation_en-US" xlink:label="lab_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Target Payout Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage" xlink:href="ebs-20230630.xsd#ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage" xlink:to="lab_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_cc763492-5aa2-4958-a79d-2f40198dcc08_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_FiveYearOptionMember_c205ac56-53ff-46e3-9b87-f53dfccb0117_terseLabel_en-US" xlink:label="lab_ebs_FiveYearOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option</link:label>
    <link:label id="lab_ebs_FiveYearOptionMember_label_en-US" xlink:label="lab_ebs_FiveYearOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option [Member]</link:label>
    <link:label id="lab_ebs_FiveYearOptionMember_documentation_en-US" xlink:label="lab_ebs_FiveYearOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiveYearOptionMember" xlink:href="ebs-20230630.xsd#ebs_FiveYearOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_FiveYearOptionMember" xlink:to="lab_ebs_FiveYearOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f0dd0071-a8eb-46b0-b393-af9f376f9ca0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_50e6480c-4464-47db-807a-9d899294e290_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_1d375cdb-686f-4201-bdfa-cd90d95f6878_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_d728d4ac-4a44-4382-abcb-bf2dd02909c7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_955efc75-23c9-40d4-9ea0-6af25ff78bf9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-the-market sale of stock, net of commissions and expenses</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_b5d62795-eec4-4bd2-b549-5a70f9ea4639_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_049b4cb3-bdf0-4c2b-8cab-0fcaec9e9c25_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9b1af3d-4b4c-4ed3-8e2c-ccb46183b3b1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6a74acec-3e79-4d73-b7ea-5226fcbf7100_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_21b9105f-9120-470e-86de-e023fbbadcb2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_6291c501-c9c4-4ec3-af79-ab5d9b1804c1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_SeniorUnsecuredNotesDueAugust2028Member_848ca863-f5f5-44ee-bd0a-fdd4ffc82780_terseLabel_en-US" xlink:label="lab_ebs_SeniorUnsecuredNotesDueAugust2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% Senior Unsecured Notes due 2028</link:label>
    <link:label id="lab_ebs_SeniorUnsecuredNotesDueAugust2028Member_label_en-US" xlink:label="lab_ebs_SeniorUnsecuredNotesDueAugust2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due August 2028 [Member]</link:label>
    <link:label id="lab_ebs_SeniorUnsecuredNotesDueAugust2028Member_documentation_en-US" xlink:label="lab_ebs_SeniorUnsecuredNotesDueAugust2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due August 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member" xlink:href="ebs-20230630.xsd#ebs_SeniorUnsecuredNotesDueAugust2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member" xlink:to="lab_ebs_SeniorUnsecuredNotesDueAugust2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_41197952-8b19-4462-8232-7ef68f3f25fa_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_704a4064-12f5-46f3-8ea0-b8ef3c7271f7_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, year two</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_93cfcadd-ce00-4404-b13e-03a63722906b_totalLabel_en-US" xlink:label="lab_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CDMO</link:label>
    <link:label id="lab_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_8c0a28ad-065d-41da-8877-d3d33e5ba1a6_terseLabel_en-US" xlink:label="lab_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="ebs-20230630.xsd#ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_563ac130-0010-4a65-a7b7-6a7a765bf21c_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market accounts</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfitAbstract_d16335ee-3cd6-433f-b83a-01a6f43ce185_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to gross margin:</link:label>
    <link:label id="lab_us-gaap_GrossProfitAbstract_label_en-US" xlink:label="lab_us-gaap_GrossProfitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfitAbstract" xlink:to="lab_us-gaap_GrossProfitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_21976527-7626-4e7e-8fce-50aa6be0e77d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_aac79d5b-9ca8-465b-893b-b06708835594_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6de77328-9459-4ab3-8cad-2f1153a6c4bd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_fa9ee3ea-e7c2-4c5b-b64c-89dbaa83c672_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_fe4a45b6-18d3-4a3b-b357-f9d812566c81_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_4f3a7f86-b46a-43a9-85c4-6f49a425ba30_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time deposits</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_76c8139b-7e79-41a6-854d-5d06451b1a19_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a5c1cf3c-ce5c-484a-9ffa-9b7bdc69a71a_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_cbbb0367-9af5-4899-879d-70587ea101f7_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_842038b7-5347-4c92-bf2f-3a2dd06a20f9_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_2ae50f8e-43e0-49bd-8f85-f79260d9202c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63c92f6b-2ce3-40c6-87cd-cd985f6bc17b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_afa548b3-7026-4ff1-ac7c-4d6d2d8f4890_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares outstanding-diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_SecuredOvernightFinancingRateSOFRMember_a1537d30-82d8-4099-8f05-5730e1f63418_terseLabel_en-US" xlink:label="lab_ebs_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_ebs_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_ebs_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_ebs_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_ebs_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SecuredOvernightFinancingRateSOFRMember" xlink:href="ebs-20230630.xsd#ebs_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_ebs_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2bba3d68-47fe-4f56-835a-2102e8f83c82_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_2c9f8cc5-1075-4911-bd3e-3c555c5c2af9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_1cff3f7b-636e-414a-9f74-05818f5895c2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_f4935d7a-3fa7-42cb-999d-74cb772660fc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:to="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5ca80962-aa60-42dd-b26b-399fb7375462_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_EmployeeTransitionMember_933f2fbd-c161-4213-9740-fa2e9a6613c7_terseLabel_en-US" xlink:label="lab_ebs_EmployeeTransitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee transition</link:label>
    <link:label id="lab_ebs_EmployeeTransitionMember_label_en-US" xlink:label="lab_ebs_EmployeeTransitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Transition [Member]</link:label>
    <link:label id="lab_ebs_EmployeeTransitionMember_documentation_en-US" xlink:label="lab_ebs_EmployeeTransitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Transition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EmployeeTransitionMember" xlink:href="ebs-20230630.xsd#ebs_EmployeeTransitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EmployeeTransitionMember" xlink:to="lab_ebs_EmployeeTransitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e93a21b8-30ba-4b7f-8e0c-829ba3fedc0d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_334ab2f2-e5c5-431b-b7b1-d032b0b6bcd8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on hedging activities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_5a0efe83-5bf5-4d3e-bdcf-ccf35c3006de_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_48af8d31-bb14-4216-9e37-e1d0495d5dae_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_f659f340-1334-4aff-85b3-8a79f45d3c07_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4d5c7780-1f20-4051-9760-25d5e0845cd0_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_SalesBasedMilestonesMember_d16e5b0a-e109-4332-976c-aded5f3fc121_terseLabel_en-US" xlink:label="lab_ebs_SalesBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Based Milestones</link:label>
    <link:label id="lab_ebs_SalesBasedMilestonesMember_label_en-US" xlink:label="lab_ebs_SalesBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Based Milestones [Member]</link:label>
    <link:label id="lab_ebs_SalesBasedMilestonesMember_documentation_en-US" xlink:label="lab_ebs_SalesBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Based Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SalesBasedMilestonesMember" xlink:href="ebs-20230630.xsd#ebs_SalesBasedMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_SalesBasedMilestonesMember" xlink:to="lab_ebs_SalesBasedMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ea963117-6cbe-466d-8e0d-c1ae2d477cf0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_b219a2c8-568d-4f73-8bd7-9e0f4c51b8a2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_1066038a-ccac-4b59-8953-dbe1c4671d1c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_b1b189dc-fa60-491e-8ed0-5a77017b4b8e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_228219b9-d6f8-4c79-a502-a7c0709f3dcc_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ba9ece6b-0e1a-432b-ba53-dee8c9875f9b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_bcbe6d6e-0953-4738-ae5a-fac12cd3d8a0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_67938541-fed6-4004-bc6c-7fa2b3115831_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_16671b61-a627-4f1e-829f-d371c98977ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_AmendedCreditAgreementMember_0b958aac-7928-4023-a3cb-8492f733c61b_terseLabel_en-US" xlink:label="lab_ebs_AmendedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Agreement</link:label>
    <link:label id="lab_ebs_AmendedCreditAgreementMember_label_en-US" xlink:label="lab_ebs_AmendedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Agreement [Member]</link:label>
    <link:label id="lab_ebs_AmendedCreditAgreementMember_documentation_en-US" xlink:label="lab_ebs_AmendedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended credit agreement dated October 15, 2018.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AmendedCreditAgreementMember" xlink:href="ebs-20230630.xsd#ebs_AmendedCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AmendedCreditAgreementMember" xlink:to="lab_ebs_AmendedCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_b2075f90-7f4c-4213-aeb1-03b71c8fa843_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_f9f81039-cfe3-47fe-b033-12e84343ed26_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2fd1fd2d-7e02-4dea-83c3-cdad487232e7_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c1b83cd9-2244-478c-a72a-c0dfa957546f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_IncomeTaxesTable_56d48394-4b01-4d68-824a-6b42ceb75204_terseLabel_en-US" xlink:label="lab_ebs_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_ebs_IncomeTaxesTable_label_en-US" xlink:label="lab_ebs_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_ebs_IncomeTaxesTable_documentation_en-US" xlink:label="lab_ebs_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_IncomeTaxesTable" xlink:href="ebs-20230630.xsd#ebs_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_IncomeTaxesTable" xlink:to="lab_ebs_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ba1dc461-8d2f-445e-8c6b-310fb5af0619_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_08e70c34-014a-496d-96d5-929c08690eba_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_TwoYearOptionMember_55ffee00-ffb0-4cae-8ccf-ad6dfe48198c_terseLabel_en-US" xlink:label="lab_ebs_TwoYearOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Year Option</link:label>
    <link:label id="lab_ebs_TwoYearOptionMember_label_en-US" xlink:label="lab_ebs_TwoYearOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Year Option [Member]</link:label>
    <link:label id="lab_ebs_TwoYearOptionMember_documentation_en-US" xlink:label="lab_ebs_TwoYearOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Year Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TwoYearOptionMember" xlink:href="ebs-20230630.xsd#ebs_TwoYearOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TwoYearOptionMember" xlink:to="lab_ebs_TwoYearOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_429637ec-9b88-44f8-a64b-48b1be3751f3_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_6cb2596f-f39f-4f68-b1b2-3726aa5fc89b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_464023be-1caf-4e91-ad00-a65c50f48882_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36a8ec75-16f1-42d7-ab22-747bad16101f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares outstanding-basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_71c24a14-9d45-410d-a0ac-bd2f9d844352_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b2ced5d3-7856-4429-8469-0051e86357ec_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_bc2aabb2-7676-40b2-9f59-3213d3bd04de_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upon the occurrence of a change in control</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_95806620-d1d7-40c2-ad74-a690caffe167_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9f5ac26c-13db-428b-8601-3679d1cc47f5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock-based compensation activity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_33f0de5a-8d8c-42d6-b75b-c0e092243c4a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, unused capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_2758c4a8-4b2b-4484-b718-8a42567e16a4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_64694e34-94a2-435b-9b56-dd3da597fba6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f1b19064-efa1-4be4-a36a-d82545b5df12_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_92ecb01b-09a2-4477-8c9b-95d5030dabf3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for gains on pension benefit obligation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_8c133e28-4bee-4923-b65e-9f335a699ad4_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_252f3d11-3ebb-48a8-a3ec-f87f27c0be74_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_3ed90cdb-33e0-4367-a619-7c3ac392c6d7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares_2d981eed-0321-4159-a4bd-2709a5cd5906_terseLabel_en-US" xlink:label="lab_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, amount remaining available for sale of shares</link:label>
    <link:label id="lab_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares_label_en-US" xlink:label="lab_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Amount Remaining Available For Sale Of Shares</link:label>
    <link:label id="lab_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares_documentation_en-US" xlink:label="lab_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Amount Remaining Available For Sale Of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares" xlink:href="ebs-20230630.xsd#ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares" xlink:to="lab_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ebs_SOFREURIBOROrCDORMember_e910dda6-cee0-4844-8262-b62713abf089_terseLabel_en-US" xlink:label="lab_ebs_SOFREURIBOROrCDORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR, EURIBOR, or CDOR</link:label>
    <link:label id="lab_ebs_SOFREURIBOROrCDORMember_label_en-US" xlink:label="lab_ebs_SOFREURIBOROrCDORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR, EURIBOR, Or CDOR [Member]</link:label>
    <link:label id="lab_ebs_SOFREURIBOROrCDORMember_documentation_en-US" xlink:label="lab_ebs_SOFREURIBOROrCDORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR, EURIBOR, or CDOR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SOFREURIBOROrCDORMember" xlink:href="ebs-20230630.xsd#ebs_SOFREURIBOROrCDORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_SOFREURIBOROrCDORMember" xlink:to="lab_ebs_SOFREURIBOROrCDORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_b516d8d8-dd0d-41b8-b448-7d30346ac92f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a1c799f3-c56a-47c3-b0d1-0e408d2ec219_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_e6eba3d9-addb-4236-b6ee-857dd8e4335c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>ebs-20230630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:d762cff5-452b-4406-9554-de3e14af5e28,g:a97db4f5-924f-4868-bfbf-bd6f1cbf2843-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CoverPage" xlink:type="simple" xlink:href="ebs-20230630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_43b1250b-9645-4aa3-9e9c-d2722b2787a7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_DocumentType_43b1250b-9645-4aa3-9e9c-d2722b2787a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_1689701f-bdac-459a-857c-66c374aea816" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_DocumentQuarterlyReport_1689701f-bdac-459a-857c-66c374aea816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c84d46c1-5eb5-439a-bfa7-758e8f7ec072" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_DocumentPeriodEndDate_c84d46c1-5eb5-439a-bfa7-758e8f7ec072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_60fa27cd-f0b3-4b28-8970-4a721b47ce85" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_DocumentTransitionReport_60fa27cd-f0b3-4b28-8970-4a721b47ce85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e8cc9280-7bdf-46d3-8569-3df99b60ac22" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityFileNumber_e8cc9280-7bdf-46d3-8569-3df99b60ac22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f4921ed9-2b1c-470e-808b-580e96025147" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityRegistrantName_f4921ed9-2b1c-470e-808b-580e96025147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ea431e2e-86c9-4be5-9343-385217e8595c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ea431e2e-86c9-4be5-9343-385217e8595c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f6d6ac8e-c28c-4786-91fd-397a7c23bd89" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityTaxIdentificationNumber_f6d6ac8e-c28c-4786-91fd-397a7c23bd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_652d61c6-0faa-4e22-b774-adb5d839dae9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityAddressAddressLine1_652d61c6-0faa-4e22-b774-adb5d839dae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_82d74ce3-a792-4cfe-bb7c-6508bbfc5fda" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityAddressCityOrTown_82d74ce3-a792-4cfe-bb7c-6508bbfc5fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f4fce6f6-6101-4095-9aed-1ca634488bf1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityAddressStateOrProvince_f4fce6f6-6101-4095-9aed-1ca634488bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8f29f86a-495c-4fae-8a29-611874679364" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityAddressPostalZipCode_8f29f86a-495c-4fae-8a29-611874679364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3cb513f8-386b-49ab-9cf4-b8c3dd360ef3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_CityAreaCode_3cb513f8-386b-49ab-9cf4-b8c3dd360ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a2c559ef-f978-486b-aa79-7da24c2bfd7f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_LocalPhoneNumber_a2c559ef-f978-486b-aa79-7da24c2bfd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a081744b-7475-499e-81ea-943ce7b85522" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_Security12bTitle_a081744b-7475-499e-81ea-943ce7b85522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b3c0bc9e-d54f-40ef-b843-1c7dd9eaa1f2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_TradingSymbol_b3c0bc9e-d54f-40ef-b843-1c7dd9eaa1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_50e81ce5-be2b-4bb7-9223-74de25f4baad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_SecurityExchangeName_50e81ce5-be2b-4bb7-9223-74de25f4baad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_00728781-82b4-4ffa-99db-2b7b1bef6463" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityCurrentReportingStatus_00728781-82b4-4ffa-99db-2b7b1bef6463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ee9d7e29-a9fd-4b68-9dc4-7dc496dc7874" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityInteractiveDataCurrent_ee9d7e29-a9fd-4b68-9dc4-7dc496dc7874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_be9bd8d5-f579-408f-a89b-63f1fdb44de5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityFilerCategory_be9bd8d5-f579-408f-a89b-63f1fdb44de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_2a06f5cf-a86e-4913-806a-d6949f7c471d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntitySmallBusiness_2a06f5cf-a86e-4913-806a-d6949f7c471d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_80a4a3b0-2150-4ebc-8a44-d7a3461c17b8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityEmergingGrowthCompany_80a4a3b0-2150-4ebc-8a44-d7a3461c17b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f5b49e96-c4f2-4334-8bf5-51eca057c5f3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityShellCompany_f5b49e96-c4f2-4334-8bf5-51eca057c5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_8cdd6323-dd63-458f-b726-75e7ff0da530" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_8cdd6323-dd63-458f-b726-75e7ff0da530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f2323c39-a0bb-4e0c-aaf0-80672f1d7185" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_EntityCentralIndexKey_f2323c39-a0bb-4e0c-aaf0-80672f1d7185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7ada6c5d-5c9c-4a27-97e8-5ea134ce2895" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_CurrentFiscalYearEndDate_7ada6c5d-5c9c-4a27-97e8-5ea134ce2895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d2098db0-37a2-4ac7-8470-f08fddecf39d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_AmendmentFlag_d2098db0-37a2-4ac7-8470-f08fddecf39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a6853eb2-259a-4966-b043-d9d8d4d8f678" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_DocumentFiscalYearFocus_a6853eb2-259a-4966-b043-d9d8d4d8f678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7af13653-874c-498e-b145-a8d61e94a259" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0579ac63-bbfd-4843-b049-b2e2a4ce383a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7af13653-874c-498e-b145-a8d61e94a259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_67a00bf0-f1b9-4582-b3a9-4f9c42b71b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ae0b7f02-e0f5-4235-b9bc-fdf13e321390" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_67a00bf0-f1b9-4582-b3a9-4f9c42b71b3e" xlink:to="loc_us-gaap_AssetsAbstract_ae0b7f02-e0f5-4235-b9bc-fdf13e321390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_af929833-f8b7-42ac-a9d2-a7a41e514862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ae0b7f02-e0f5-4235-b9bc-fdf13e321390" xlink:to="loc_us-gaap_AssetsCurrentAbstract_af929833-f8b7-42ac-a9d2-a7a41e514862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_355abcdb-3228-4b22-860b-065b7b75e1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_af929833-f8b7-42ac-a9d2-a7a41e514862" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_355abcdb-3228-4b22-860b-065b7b75e1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1a5a4312-a150-4119-9123-e3111fc3a3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_af929833-f8b7-42ac-a9d2-a7a41e514862" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1a5a4312-a150-4119-9123-e3111fc3a3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1cefedb9-aba8-4588-ad71-f7adb0c52048" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_af929833-f8b7-42ac-a9d2-a7a41e514862" xlink:to="loc_us-gaap_InventoryNet_1cefedb9-aba8-4588-ad71-f7adb0c52048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2ec1aaf7-de2a-4a41-812f-77b2e9d616bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_af929833-f8b7-42ac-a9d2-a7a41e514862" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2ec1aaf7-de2a-4a41-812f-77b2e9d616bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_752e5d47-5203-47b6-bdfa-c1b649ca3083" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_af929833-f8b7-42ac-a9d2-a7a41e514862" xlink:to="loc_us-gaap_AssetsCurrent_752e5d47-5203-47b6-bdfa-c1b649ca3083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a0895810-d8cb-49d4-9ad1-e6647aa3b0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ae0b7f02-e0f5-4235-b9bc-fdf13e321390" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a0895810-d8cb-49d4-9ad1-e6647aa3b0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd196bd8-fb30-4276-8d59-bb195e7f6d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ae0b7f02-e0f5-4235-b9bc-fdf13e321390" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd196bd8-fb30-4276-8d59-bb195e7f6d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_be52ec79-9c9c-44df-a689-d72b11bf8202" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ae0b7f02-e0f5-4235-b9bc-fdf13e321390" xlink:to="loc_us-gaap_Goodwill_be52ec79-9c9c-44df-a689-d72b11bf8202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5c9dd028-1312-4691-9c49-ec46fa5ec0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ae0b7f02-e0f5-4235-b9bc-fdf13e321390" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5c9dd028-1312-4691-9c49-ec46fa5ec0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5303ea02-ef19-4442-8714-87690dfebc67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ae0b7f02-e0f5-4235-b9bc-fdf13e321390" xlink:to="loc_us-gaap_Assets_5303ea02-ef19-4442-8714-87690dfebc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5c09d260-e43f-4dd6-b9fe-1ba97c16048e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_67a00bf0-f1b9-4582-b3a9-4f9c42b71b3e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5c09d260-e43f-4dd6-b9fe-1ba97c16048e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1502e894-3fd5-4d81-9cc2-3d6c6769aaae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5c09d260-e43f-4dd6-b9fe-1ba97c16048e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1502e894-3fd5-4d81-9cc2-3d6c6769aaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_621db62b-68b7-4f38-90b1-2b1703efdf98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1502e894-3fd5-4d81-9cc2-3d6c6769aaae" xlink:to="loc_us-gaap_AccountsPayableCurrent_621db62b-68b7-4f38-90b1-2b1703efdf98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_65826462-a6b0-4a53-ab2e-71f2e25559d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1502e894-3fd5-4d81-9cc2-3d6c6769aaae" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_65826462-a6b0-4a53-ab2e-71f2e25559d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_29c43d62-0496-49d5-a2d0-74e276a7cefa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1502e894-3fd5-4d81-9cc2-3d6c6769aaae" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_29c43d62-0496-49d5-a2d0-74e276a7cefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_7928c815-7ae3-42c1-b986-149b3d9d6a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1502e894-3fd5-4d81-9cc2-3d6c6769aaae" xlink:to="loc_us-gaap_NotesPayableCurrent_7928c815-7ae3-42c1-b986-149b3d9d6a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f6f9a74e-6cd7-4344-b664-82c94d4b38f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1502e894-3fd5-4d81-9cc2-3d6c6769aaae" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f6f9a74e-6cd7-4344-b664-82c94d4b38f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d2ffa957-6351-40c9-b34e-3c278753a44f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1502e894-3fd5-4d81-9cc2-3d6c6769aaae" xlink:to="loc_us-gaap_LiabilitiesCurrent_d2ffa957-6351-40c9-b34e-3c278753a44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_172f8800-8899-4d3a-8539-1579c3b06fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5c09d260-e43f-4dd6-b9fe-1ba97c16048e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_172f8800-8899-4d3a-8539-1579c3b06fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9670485f-e3ee-4e76-84d6-166d5d4cd57a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5c09d260-e43f-4dd6-b9fe-1ba97c16048e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9670485f-e3ee-4e76-84d6-166d5d4cd57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5dbc023c-de95-494e-a794-44fff983755b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5c09d260-e43f-4dd6-b9fe-1ba97c16048e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5dbc023c-de95-494e-a794-44fff983755b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f6d9661e-baaf-4aef-abd8-400280d068d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5c09d260-e43f-4dd6-b9fe-1ba97c16048e" xlink:to="loc_us-gaap_Liabilities_f6d9661e-baaf-4aef-abd8-400280d068d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ff1e60b-f6db-42ec-8e83-ef563daec591" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5c09d260-e43f-4dd6-b9fe-1ba97c16048e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ff1e60b-f6db-42ec-8e83-ef563daec591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_3f5bcbc5-e002-47c5-a012-af4a9dd30246" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ff1e60b-f6db-42ec-8e83-ef563daec591" xlink:to="loc_us-gaap_PreferredStockValue_3f5bcbc5-e002-47c5-a012-af4a9dd30246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f88203e7-d150-4d47-a779-70f6eaf0b019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ff1e60b-f6db-42ec-8e83-ef563daec591" xlink:to="loc_us-gaap_CommonStockValue_f88203e7-d150-4d47-a779-70f6eaf0b019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_5a3cb120-cdbc-4d8f-9ca7-3e9efbc39e33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ff1e60b-f6db-42ec-8e83-ef563daec591" xlink:to="loc_us-gaap_TreasuryStockValue_5a3cb120-cdbc-4d8f-9ca7-3e9efbc39e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_cf93ac1c-1a2f-45ee-b69a-07b3644813e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ff1e60b-f6db-42ec-8e83-ef563daec591" xlink:to="loc_us-gaap_AdditionalPaidInCapital_cf93ac1c-1a2f-45ee-b69a-07b3644813e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cb475d4d-071b-4fd5-accd-106072c6fa56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ff1e60b-f6db-42ec-8e83-ef563daec591" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cb475d4d-071b-4fd5-accd-106072c6fa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_21291cf4-5fb8-4ebf-b691-45f2822612ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ff1e60b-f6db-42ec-8e83-ef563daec591" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_21291cf4-5fb8-4ebf-b691-45f2822612ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_41816c46-6451-40a6-b331-45f4ea1a9368" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ff1e60b-f6db-42ec-8e83-ef563daec591" xlink:to="loc_us-gaap_StockholdersEquity_41816c46-6451-40a6-b331-45f4ea1a9368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_617d9d8f-6dea-448e-806a-d4b12b2efa04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5c09d260-e43f-4dd6-b9fe-1ba97c16048e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_617d9d8f-6dea-448e-806a-d4b12b2efa04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3c845a9f-068e-432b-a001-4a8328f0a4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_783c6f43-b8b4-4782-9bf3-5e7bc4f8d1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3c845a9f-068e-432b-a001-4a8328f0a4ac" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_783c6f43-b8b4-4782-9bf3-5e7bc4f8d1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_783c6f43-b8b4-4782-9bf3-5e7bc4f8d1c2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0f19196b-e9ec-4eab-874f-048882a90b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0f19196b-e9ec-4eab-874f-048882a90b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_3b2d91ad-a348-4c55-b1b3-a84861b78722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_3b2d91ad-a348-4c55-b1b3-a84861b78722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_8536430b-faf7-4793-a104-e85292ef7309" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:to="loc_us-gaap_PreferredStockSharesIssued_8536430b-faf7-4793-a104-e85292ef7309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_abc1e62a-fc58-4dcb-b83e-44c80ae738da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_abc1e62a-fc58-4dcb-b83e-44c80ae738da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4dfe6875-2062-452e-ac9f-c31ae12f9674" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4dfe6875-2062-452e-ac9f-c31ae12f9674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8ae6663c-7abd-44b2-bc18-50e118896afd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8ae6663c-7abd-44b2-bc18-50e118896afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4993cec3-6632-40cd-9897-0a7b3899e69d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:to="loc_us-gaap_CommonStockSharesIssued_4993cec3-6632-40cd-9897-0a7b3899e69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cff7f8bb-8dac-4bbf-8fee-1eb6527fc442" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cff7f8bb-8dac-4bbf-8fee-1eb6527fc442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_3bf5533f-ce59-4fd7-9e4c-c2b9e9f50572" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_8d2aed6e-526e-47a3-a9ee-ddd90fac2cc2" xlink:to="loc_us-gaap_TreasuryStockCommonShares_3bf5533f-ce59-4fd7-9e4c-c2b9e9f50572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_577ce9dd-d4b8-4828-bd29-f25aca1b2a72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f84593b-2c09-4ede-9e05-191c421ace91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_577ce9dd-d4b8-4828-bd29-f25aca1b2a72" xlink:to="loc_us-gaap_StatementTable_1f84593b-2c09-4ede-9e05-191c421ace91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_66275b40-b20d-4760-aad1-a1f9142924eb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f84593b-2c09-4ede-9e05-191c421ace91" xlink:to="loc_srt_ProductOrServiceAxis_66275b40-b20d-4760-aad1-a1f9142924eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_46158a06-ce10-44e0-a5ff-05d55a36c269" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_66275b40-b20d-4760-aad1-a1f9142924eb" xlink:to="loc_srt_ProductsAndServicesDomain_46158a06-ce10-44e0-a5ff-05d55a36c269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_29e1de51-052e-46ac-8f7e-6d1771b9f61b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_46158a06-ce10-44e0-a5ff-05d55a36c269" xlink:to="loc_us-gaap_ProductMember_29e1de51-052e-46ac-8f7e-6d1771b9f61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_0389fdde-1fcf-4310-83d3-720940419c86" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_46158a06-ce10-44e0-a5ff-05d55a36c269" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingMember_0389fdde-1fcf-4310-83d3-720940419c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_c13391f2-e61a-4348-b139-e1a285658851" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingMember_0389fdde-1fcf-4310-83d3-720940419c86" xlink:to="loc_us-gaap_ServiceMember_c13391f2-e61a-4348-b139-e1a285658851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_8c1c98a5-1126-4754-ba1b-745d328aa6ab" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingLeasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingMember_0389fdde-1fcf-4310-83d3-720940419c86" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_8c1c98a5-1126-4754-ba1b-745d328aa6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractsAndGrantsMember_c3558fad-c24e-43f8-869e-217eee309885" xlink:href="ebs-20230630.xsd#ebs_ContractsAndGrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_46158a06-ce10-44e0-a5ff-05d55a36c269" xlink:to="loc_ebs_ContractsAndGrantsMember_c3558fad-c24e-43f8-869e-217eee309885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f84593b-2c09-4ede-9e05-191c421ace91" xlink:to="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_63ec4085-af10-420f-992d-c7a7861d2d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_63ec4085-af10-420f-992d-c7a7861d2d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_4c5fb8a6-8212-494c-a1c5-a82e0898db62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_4c5fb8a6-8212-494c-a1c5-a82e0898db62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_1fbae786-b0c6-4735-858a-c38cc3074fd8" xlink:href="ebs-20230630.xsd#ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:to="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_1fbae786-b0c6-4735-858a-c38cc3074fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_56f44a18-e83b-44f1-be76-3a93d336d7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bc7f837c-90ff-46cc-b575-7c6a349c5b66" xlink:to="loc_us-gaap_Revenues_56f44a18-e83b-44f1-be76-3a93d336d7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0a11658f-e0ff-48df-b9cf-3ff9f197d175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0a11658f-e0ff-48df-b9cf-3ff9f197d175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a4731749-c143-4769-abfa-cfdb1d48785d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a4731749-c143-4769-abfa-cfdb1d48785d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_cde0d34d-95c9-40db-87ea-d6dbbd11a0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_cde0d34d-95c9-40db-87ea-d6dbbd11a0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a2249512-a9a8-4609-b670-fddc9c943d61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a2249512-a9a8-4609-b670-fddc9c943d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3162aa78-52da-4ee9-a50e-6c367afabb97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3162aa78-52da-4ee9-a50e-6c367afabb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_b0ca86ee-21cf-4915-bce9-44fcf1e55869" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_230650eb-3a74-441a-81a8-c9351de7b27c" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_b0ca86ee-21cf-4915-bce9-44fcf1e55869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_06dffa98-07b7-4caa-98c0-909c0ca0e2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_OperatingIncomeLoss_06dffa98-07b7-4caa-98c0-909c0ca0e2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f34978fb-670c-4d77-b043-2e2ae714ea9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:to="loc_us-gaap_InterestExpense_f34978fb-670c-4d77-b043-2e2ae714ea9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_1a5a87a6-ea81-432d-90f8-3f5df3b356ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_1a5a87a6-ea81-432d-90f8-3f5df3b356ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_43e83995-5ed3-4b9e-9d81-a6a82e809ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_43e83995-5ed3-4b9e-9d81-a6a82e809ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5a12bf6d-c540-45c4-9cbc-5966eaeeb979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d51a0020-f81f-460d-ad97-8d021508011d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5a12bf6d-c540-45c4-9cbc-5966eaeeb979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f932381e-969d-47bb-8593-05b594cc3615" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f932381e-969d-47bb-8593-05b594cc3615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0aaa94ca-9448-49d2-bf12-10e62bdbaa6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0aaa94ca-9448-49d2-bf12-10e62bdbaa6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7ad17930-22d5-42d0-91b4-ff68e131301e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_NetIncomeLoss_7ad17930-22d5-42d0-91b4-ff68e131301e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_313eb9e2-31d5-488d-bc61-3244b8eff8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_313eb9e2-31d5-488d-bc61-3244b8eff8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9f57dc53-d000-41ac-826a-63d8c5be7324" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_313eb9e2-31d5-488d-bc61-3244b8eff8e9" xlink:to="loc_us-gaap_EarningsPerShareBasic_9f57dc53-d000-41ac-826a-63d8c5be7324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_faa10dd0-c53a-4d89-84ef-ac5b74e984fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_313eb9e2-31d5-488d-bc61-3244b8eff8e9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_faa10dd0-c53a-4d89-84ef-ac5b74e984fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e4bf698a-261d-4dd0-8638-58dc59d41a51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a83f8d48-d84e-4bca-91a9-2c102a4079df" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e4bf698a-261d-4dd0-8638-58dc59d41a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ee380a21-d599-4e98-abde-192b0dfb87f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e4bf698a-261d-4dd0-8638-58dc59d41a51" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ee380a21-d599-4e98-abde-192b0dfb87f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_892f75dc-fdd9-434a-a253-fc762fa3ac3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e4bf698a-261d-4dd0-8638-58dc59d41a51" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_892f75dc-fdd9-434a-a253-fc762fa3ac3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5aea6a8c-adc8-4032-962e-1bed093c7224" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6b7d9f7f-f3a2-46d0-a55b-143e460f95ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5aea6a8c-adc8-4032-962e-1bed093c7224" xlink:to="loc_us-gaap_NetIncomeLoss_6b7d9f7f-f3a2-46d0-a55b-143e460f95ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9eaa45cd-232c-4804-bda2-6d57e6fdf928" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5aea6a8c-adc8-4032-962e-1bed093c7224" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9eaa45cd-232c-4804-bda2-6d57e6fdf928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d1d5aa42-07f8-4ac1-bb17-194efd94908c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9eaa45cd-232c-4804-bda2-6d57e6fdf928" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d1d5aa42-07f8-4ac1-bb17-194efd94908c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6f8c0d7f-1ca7-4774-8146-bf87fca8c265" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9eaa45cd-232c-4804-bda2-6d57e6fdf928" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6f8c0d7f-1ca7-4774-8146-bf87fca8c265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9bbe6e35-2c3e-4c1c-a968-a7b24185766c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9eaa45cd-232c-4804-bda2-6d57e6fdf928" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9bbe6e35-2c3e-4c1c-a968-a7b24185766c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_f9916598-28fa-4b19-8b4f-5b3c8910af68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9eaa45cd-232c-4804-bda2-6d57e6fdf928" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_f9916598-28fa-4b19-8b4f-5b3c8910af68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2c3783dd-5205-49d0-895a-68e75a3dbb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9eaa45cd-232c-4804-bda2-6d57e6fdf928" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2c3783dd-5205-49d0-895a-68e75a3dbb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c51f766d-4771-41df-82b0-3baa937013f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5aea6a8c-adc8-4032-962e-1bed093c7224" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_c51f766d-4771-41df-82b0-3baa937013f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_7ef8b09b-b617-4da5-9b23-1f96a4393dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_530d1471-f486-4486-9ed4-4b3334dd589d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7ef8b09b-b617-4da5-9b23-1f96a4393dc4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_530d1471-f486-4486-9ed4-4b3334dd589d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cfba6c74-1067-4fb0-82d9-705cb44c0757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_530d1471-f486-4486-9ed4-4b3334dd589d" xlink:to="loc_us-gaap_NetIncomeLoss_cfba6c74-1067-4fb0-82d9-705cb44c0757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_530d1471-f486-4486-9ed4-4b3334dd589d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5a44d027-dfac-476f-8999-c707f87e34d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:to="loc_us-gaap_ShareBasedCompensation_5a44d027-dfac-476f-8999-c707f87e34d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_LongTermIncentivePlanNoncashExpense_52d65509-099c-4fc7-928c-7174d26b186d" xlink:href="ebs-20230630.xsd#ebs_LongTermIncentivePlanNoncashExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:to="loc_ebs_LongTermIncentivePlanNoncashExpense_52d65509-099c-4fc7-928c-7174d26b186d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6c22af1b-e315-41f4-ba8a-aa15426ebc64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6c22af1b-e315-41f4-ba8a-aa15426ebc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f4e66814-78bb-4d75-bbbe-dad9e69821c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f4e66814-78bb-4d75-bbbe-dad9e69821c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_541fb330-887a-4515-b061-35c7014043f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_541fb330-887a-4515-b061-35c7014043f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_1c2cdb19-3fe2-4e1f-b16c-88b993aaff3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_1c2cdb19-3fe2-4e1f-b16c-88b993aaff3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_dc76d21f-745a-4e68-a37f-6a41cb28c56b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_dc76d21f-745a-4e68-a37f-6a41cb28c56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_b7f83b82-aac7-4f00-8ed4-422f192b8450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_b7f83b82-aac7-4f00-8ed4-422f192b8450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_a8a103c9-45c3-4f24-88e2-665d1fd60f65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_a8a103c9-45c3-4f24-88e2-665d1fd60f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef35a97-08d3-4f98-ac0c-56df3eb0311a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_21ebcae8-ff31-4fd5-9fe4-74a96dffb0d5" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef35a97-08d3-4f98-ac0c-56df3eb0311a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_29472475-0122-46a8-bbf0-a9ff1a3aac6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef35a97-08d3-4f98-ac0c-56df3eb0311a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_29472475-0122-46a8-bbf0-a9ff1a3aac6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c299f5d8-7865-40f2-a3ce-f701b025b0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef35a97-08d3-4f98-ac0c-56df3eb0311a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c299f5d8-7865-40f2-a3ce-f701b025b0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1fd2444c-3757-4dd1-bd62-7cc1745b1dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef35a97-08d3-4f98-ac0c-56df3eb0311a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1fd2444c-3757-4dd1-bd62-7cc1745b1dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c5c37390-3d1b-43d4-bf59-b5a8f156d99b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef35a97-08d3-4f98-ac0c-56df3eb0311a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c5c37390-3d1b-43d4-bf59-b5a8f156d99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e9d8278a-af77-4758-aed1-a473c290ef3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef35a97-08d3-4f98-ac0c-56df3eb0311a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e9d8278a-af77-4758-aed1-a473c290ef3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_344ae468-d357-4a57-a31d-366f32c3482b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef35a97-08d3-4f98-ac0c-56df3eb0311a" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_344ae468-d357-4a57-a31d-366f32c3482b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_796dcb00-4e92-4dbd-be4e-ef4b63f117e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef35a97-08d3-4f98-ac0c-56df3eb0311a" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_796dcb00-4e92-4dbd-be4e-ef4b63f117e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e4f25c14-e12a-406b-bc44-09bf5d88a2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef35a97-08d3-4f98-ac0c-56df3eb0311a" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e4f25c14-e12a-406b-bc44-09bf5d88a2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08d40a43-8920-4ae2-abc9-4d606cb6ffcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_530d1471-f486-4486-9ed4-4b3334dd589d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08d40a43-8920-4ae2-abc9-4d606cb6ffcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_af2c7478-2835-47af-8d7c-ca88a3b68116" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7ef8b09b-b617-4da5-9b23-1f96a4393dc4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_af2c7478-2835-47af-8d7c-ca88a3b68116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5159b42f-f300-43b1-994a-20db4eaf43b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_af2c7478-2835-47af-8d7c-ca88a3b68116" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5159b42f-f300-43b1-994a-20db4eaf43b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_28a12173-e7f6-4a27-a1ef-3290585b716e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_af2c7478-2835-47af-8d7c-ca88a3b68116" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_28a12173-e7f6-4a27-a1ef-3290585b716e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4fe5c372-7577-4b62-abfb-5340b7714c31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_af2c7478-2835-47af-8d7c-ca88a3b68116" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4fe5c372-7577-4b62-abfb-5340b7714c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_76328ded-3acc-4b6c-a0cf-2ad703dc4d08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7ef8b09b-b617-4da5-9b23-1f96a4393dc4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_76328ded-3acc-4b6c-a0cf-2ad703dc4d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_55fa8657-a73d-4227-a1af-41a9dfdf4424" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_76328ded-3acc-4b6c-a0cf-2ad703dc4d08" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_55fa8657-a73d-4227-a1af-41a9dfdf4424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_1f52ba3a-1cc7-41e9-a4eb-21e9dd8fd131" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_76328ded-3acc-4b6c-a0cf-2ad703dc4d08" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_1f52ba3a-1cc7-41e9-a4eb-21e9dd8fd131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_606da0c2-50e5-4046-8a9d-469d103d0d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_76328ded-3acc-4b6c-a0cf-2ad703dc4d08" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_606da0c2-50e5-4046-8a9d-469d103d0d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9f075820-c904-432c-81f1-a665f986acb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_76328ded-3acc-4b6c-a0cf-2ad703dc4d08" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9f075820-c904-432c-81f1-a665f986acb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_cdd04d8e-0c7f-44c7-a14c-5a2a33da66aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_76328ded-3acc-4b6c-a0cf-2ad703dc4d08" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_cdd04d8e-0c7f-44c7-a14c-5a2a33da66aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5da5d9c2-c2e2-491c-be0f-db5ac81075bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_76328ded-3acc-4b6c-a0cf-2ad703dc4d08" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5da5d9c2-c2e2-491c-be0f-db5ac81075bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_42e56f0b-f9bb-41d6-9f9f-867a08318736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_76328ded-3acc-4b6c-a0cf-2ad703dc4d08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_42e56f0b-f9bb-41d6-9f9f-867a08318736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_360ce2fc-0fa6-4688-94b8-86aec0273ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7ef8b09b-b617-4da5-9b23-1f96a4393dc4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_360ce2fc-0fa6-4688-94b8-86aec0273ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b4485299-e7ff-4aa1-8f56-bf119f0baa4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7ef8b09b-b617-4da5-9b23-1f96a4393dc4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b4485299-e7ff-4aa1-8f56-bf119f0baa4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_90c19ab3-4096-4a97-920d-69df9c11c9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7ef8b09b-b617-4da5-9b23-1f96a4393dc4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_90c19ab3-4096-4a97-920d-69df9c11c9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_044ce60c-8f45-497c-940e-95e4ea85efc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7ef8b09b-b617-4da5-9b23-1f96a4393dc4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_044ce60c-8f45-497c-940e-95e4ea85efc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_9445c453-dd2a-465b-a157-ec8631f7dfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7ef8b09b-b617-4da5-9b23-1f96a4393dc4" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_9445c453-dd2a-465b-a157-ec8631f7dfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_dd979239-a0ed-42ce-991b-c426cb0ef53f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_9445c453-dd2a-465b-a157-ec8631f7dfa9" xlink:to="loc_us-gaap_InterestPaidNet_dd979239-a0ed-42ce-991b-c426cb0ef53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_8b759c72-9f73-4772-93ea-24c2500e9211" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_9445c453-dd2a-465b-a157-ec8631f7dfa9" xlink:to="loc_us-gaap_IncomeTaxesPaid_8b759c72-9f73-4772-93ea-24c2500e9211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c2751dff-f779-488b-ae67-e7e29f46d536" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7ef8b09b-b617-4da5-9b23-1f96a4393dc4" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c2751dff-f779-488b-ae67-e7e29f46d536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1de08ce7-c0e3-4a4e-8013-701813ff851a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c2751dff-f779-488b-ae67-e7e29f46d536" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1de08ce7-c0e3-4a4e-8013-701813ff851a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_83a67fb0-90b6-469c-bdd5-7d2eca4c164d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_40e53d8e-7f74-4b28-8abf-ceb8a7026271" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_83a67fb0-90b6-469c-bdd5-7d2eca4c164d" xlink:to="loc_us-gaap_StatementTable_40e53d8e-7f74-4b28-8abf-ceb8a7026271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1978dcc8-6157-41ae-8d8c-37a41c343b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_40e53d8e-7f74-4b28-8abf-ceb8a7026271" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1978dcc8-6157-41ae-8d8c-37a41c343b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1978dcc8-6157-41ae-8d8c-37a41c343b7b" xlink:to="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_05c89562-26cc-41ff-abd8-5f391036f6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:to="loc_us-gaap_CommonStockMember_05c89562-26cc-41ff-abd8-5f391036f6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_62fc6710-355b-499c-a4e8-f530cffd6c19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:to="loc_us-gaap_TreasuryStockCommonMember_62fc6710-355b-499c-a4e8-f530cffd6c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c9b50fbd-c544-47e6-b322-3aea4b913fad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c9b50fbd-c544-47e6-b322-3aea4b913fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9b4324ae-d439-4c5f-8a79-5180d271fd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9b4324ae-d439-4c5f-8a79-5180d271fd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6614cd36-2d0a-44c6-a81e-80cfd009dced" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d67aa1bc-09a0-44ac-88df-cf5e616049c3" xlink:to="loc_us-gaap_RetainedEarningsMember_6614cd36-2d0a-44c6-a81e-80cfd009dced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3e809353-0529-4de7-a0d1-409ebd51834e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_40e53d8e-7f74-4b28-8abf-ceb8a7026271" xlink:to="loc_us-gaap_StatementLineItems_3e809353-0529-4de7-a0d1-409ebd51834e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3e809353-0529-4de7-a0d1-409ebd51834e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ec175c10-7be0-46b0-ad54-b915f19adbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_CommonStockSharesIssued_ec175c10-7be0-46b0-ad54-b915f19adbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_612c54fe-e18f-46ba-b39d-a2c889b72df2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockholdersEquity_612c54fe-e18f-46ba-b39d-a2c889b72df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_5723d811-1ffe-4c46-8458-6ac8a62d50d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_TreasuryStockCommonShares_5723d811-1ffe-4c46-8458-6ac8a62d50d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_048a6e37-03b1-4af0-9e13-5acc5c6e1ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_NetIncomeLoss_048a6e37-03b1-4af0-9e13-5acc5c6e1ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7da32ed0-3c2c-4d74-a6bf-2bc94b6001a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7da32ed0-3c2c-4d74-a6bf-2bc94b6001a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_277387ed-7a8e-4232-89fe-beaa0a04fa05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_277387ed-7a8e-4232-89fe-beaa0a04fa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4152408a-f7c3-4b23-be64-f0dfbbf3f777" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4152408a-f7c3-4b23-be64-f0dfbbf3f777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4465b809-47db-45cd-bace-6f2bcc7431b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4465b809-47db-45cd-bace-6f2bcc7431b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_05542ec4-375d-4263-9afe-0e89d4a3bcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_05542ec4-375d-4263-9afe-0e89d4a3bcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_5a420bdb-72b0-4d2f-9e4c-810c3475a1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_5a420bdb-72b0-4d2f-9e4c-810c3475a1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e90228ec-1cc1-49d6-952b-6b34f2dea37e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e90228ec-1cc1-49d6-952b-6b34f2dea37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_075d2150-50ae-4a47-bb6b-de3d979be410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_CommonStockSharesIssued_075d2150-50ae-4a47-bb6b-de3d979be410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_026b2a67-8bd6-46c4-8720-c5ad537c1784" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_StockholdersEquity_026b2a67-8bd6-46c4-8720-c5ad537c1784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_58285bb9-d905-4f21-ad2f-34ab7b58bd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3dc37310-44ff-4922-a964-668aa57d764a" xlink:to="loc_us-gaap_TreasuryStockCommonShares_58285bb9-d905-4f21-ad2f-34ab7b58bd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical" xlink:type="simple" xlink:href="ebs-20230630.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c4f8d9d2-ae1c-48f9-8b84-71bf44fe2e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_100034f9-9698-42a2-962d-bf00c7212860" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c4f8d9d2-ae1c-48f9-8b84-71bf44fe2e2e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_100034f9-9698-42a2-962d-bf00c7212860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Natureofthebusinessandorganization" xlink:type="simple" xlink:href="ebs-20230630.xsd#Natureofthebusinessandorganization"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Natureofthebusinessandorganization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f19eb807-83dd-44e0-922f-19f45520e154" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0e053711-6dd0-4c3c-b1e6-76a979f383e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f19eb807-83dd-44e0-922f-19f45520e154" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0e053711-6dd0-4c3c-b1e6-76a979f383e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Summaryofsignificantaccountingpolicies" xlink:type="simple" xlink:href="ebs-20230630.xsd#Summaryofsignificantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Summaryofsignificantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ce3d87f0-40cb-4d1d-98e4-c3895af7ee2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a84be1cb-f49b-40aa-891b-4f883f70753d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ce3d87f0-40cb-4d1d-98e4-c3895af7ee2c" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a84be1cb-f49b-40aa-891b-4f883f70753d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Divestiture" xlink:type="simple" xlink:href="ebs-20230630.xsd#Divestiture"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Divestiture" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2c6f75a0-0281-4532-b45a-ae32cba07790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_2eb36576-dd2d-4bd1-91a9-51ea521cc8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2c6f75a0-0281-4532-b45a-ae32cba07790" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_2eb36576-dd2d-4bd1-91a9-51ea521cc8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Restructuringandimpairmentcosts" xlink:type="simple" xlink:href="ebs-20230630.xsd#Restructuringandimpairmentcosts"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Restructuringandimpairmentcosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c2bbff71-fe2d-4a39-922e-f4ccffc05578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_afa4be85-af4d-4620-81f9-f949be794056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c2bbff71-fe2d-4a39-922e-f4ccffc05578" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_afa4be85-af4d-4620-81f9-f949be794056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Inventoriesnet" xlink:type="simple" xlink:href="ebs-20230630.xsd#Inventoriesnet"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Inventoriesnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c98a6c32-d3c3-4dd4-87c5-21d2779ae7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_771b84bb-4020-4737-939a-5a1a72a1a051" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c98a6c32-d3c3-4dd4-87c5-21d2779ae7f4" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_771b84bb-4020-4737-939a-5a1a72a1a051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Propertyplantandequipmentnet" xlink:type="simple" xlink:href="ebs-20230630.xsd#Propertyplantandequipmentnet"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Propertyplantandequipmentnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_3d973ca3-317d-491f-800e-128914522f21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_45975180-56ab-4b03-a4f9-57e16b35bb55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_3d973ca3-317d-491f-800e-128914522f21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_45975180-56ab-4b03-a4f9-57e16b35bb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Intangibleassetsandgoodwill" xlink:type="simple" xlink:href="ebs-20230630.xsd#Intangibleassetsandgoodwill"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Intangibleassetsandgoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c6176dcd-f489-4253-b036-fe786459f36c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_50655081-b7d0-4f6e-840d-d438072079c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c6176dcd-f489-4253-b036-fe786459f36c" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_50655081-b7d0-4f6e-840d-d438072079c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Fairvaluemeasurements" xlink:type="simple" xlink:href="ebs-20230630.xsd#Fairvaluemeasurements"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Fairvaluemeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4a991682-4827-4a55-8704-2d5b0faa0a01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_0c1c21ae-65f7-4fe6-81a9-0b878cc02eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4a991682-4827-4a55-8704-2d5b0faa0a01" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_0c1c21ae-65f7-4fe6-81a9-0b878cc02eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Derivativeinstrumentsandhedgingactivities" xlink:type="simple" xlink:href="ebs-20230630.xsd#Derivativeinstrumentsandhedgingactivities"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Derivativeinstrumentsandhedgingactivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_baa7102a-a227-450e-be56-345111360947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c66c387d-71ef-4ad9-89c1-a3fc3e249757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_baa7102a-a227-450e-be56-345111360947" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c66c387d-71ef-4ad9-89c1-a3fc3e249757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Debt" xlink:type="simple" xlink:href="ebs-20230630.xsd#Debt"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c9a1d32e-a216-4273-b466-41c903483f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_8f43f90c-24cc-4d36-9264-d003bde084e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c9a1d32e-a216-4273-b466-41c903483f8c" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_8f43f90c-24cc-4d36-9264-d003bde084e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Stockbasedcompensationandstockholdersequity" xlink:type="simple" xlink:href="ebs-20230630.xsd#Stockbasedcompensationandstockholdersequity"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Stockbasedcompensationandstockholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_fb5edc28-f30f-4d69-a699-4134bcf0e624" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d7160851-2501-4f08-bbd5-e229f811c09b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_fb5edc28-f30f-4d69-a699-4134bcf0e624" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d7160851-2501-4f08-bbd5-e229f811c09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Losspercommonshare" xlink:type="simple" xlink:href="ebs-20230630.xsd#Losspercommonshare"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Losspercommonshare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ef7c2d33-21bc-4866-b905-3c9c3d4df7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_6dc94944-7512-45f2-b0eb-817123466b85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ef7c2d33-21bc-4866-b905-3c9c3d4df7c7" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_6dc94944-7512-45f2-b0eb-817123466b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Revenuerecognition" xlink:type="simple" xlink:href="ebs-20230630.xsd#Revenuerecognition"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Revenuerecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f09eb0a4-1b58-4a3e-aa54-566e2a5d3376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_45f7ea3d-cfb2-48eb-8586-40f720a5ea5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f09eb0a4-1b58-4a3e-aa54-566e2a5d3376" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_45f7ea3d-cfb2-48eb-8586-40f720a5ea5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Leases" xlink:type="simple" xlink:href="ebs-20230630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bb4da777-dd30-4857-8b58-ceaca57e9aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_e8c297f5-bece-40b9-824c-365b9866b198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bb4da777-dd30-4857-8b58-ceaca57e9aa6" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_e8c297f5-bece-40b9-824c-365b9866b198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Incometaxes" xlink:type="simple" xlink:href="ebs-20230630.xsd#Incometaxes"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Incometaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d5aa067d-0bb0-4477-b446-ef03dca5f1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_77ac8159-f1e6-4fb3-b89d-690199659703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d5aa067d-0bb0-4477-b446-ef03dca5f1a5" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_77ac8159-f1e6-4fb3-b89d-690199659703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Litigation" xlink:type="simple" xlink:href="ebs-20230630.xsd#Litigation"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Litigation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_44e94d6b-d0ac-4126-a594-f165fce5f0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_eeee4e4d-3420-4c48-aff4-abe0da8be1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_44e94d6b-d0ac-4126-a594-f165fce5f0f0" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_eeee4e4d-3420-4c48-aff4-abe0da8be1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Segmentinformation" xlink:type="simple" xlink:href="ebs-20230630.xsd#Segmentinformation"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Segmentinformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_43f96765-68f7-4dc0-bf12-0409ebad0c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_a8289d27-ccbd-4442-ae68-0130b08251a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_43f96765-68f7-4dc0-bf12-0409ebad0c0a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_a8289d27-ccbd-4442-ae68-0130b08251a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Subsequentevents" xlink:type="simple" xlink:href="ebs-20230630.xsd#Subsequentevents"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Subsequentevents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_13572cd1-b9e6-4029-b2b2-b4a340f24a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_b037030a-d70e-45f7-ae76-21ea0a00f346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_13572cd1-b9e6-4029-b2b2-b4a340f24a92" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_b037030a-d70e-45f7-ae76-21ea0a00f346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="ebs-20230630.xsd#SummaryofsignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2124bc7b-fa49-4ac1-8823-2b9b9213c7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_8f074fbf-6e12-403f-8716-0a5b589afd38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2124bc7b-fa49-4ac1-8823-2b9b9213c7b5" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_8f074fbf-6e12-403f-8716-0a5b589afd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_8eb624ba-b2dd-469a-a1c2-f7e6b3efbfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2124bc7b-fa49-4ac1-8823-2b9b9213c7b5" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_8eb624ba-b2dd-469a-a1c2-f7e6b3efbfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_ca6eddf7-bde2-4d4f-8338-87fd576f5f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2124bc7b-fa49-4ac1-8823-2b9b9213c7b5" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_ca6eddf7-bde2-4d4f-8338-87fd576f5f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_345a9e80-c9c5-46ce-8d4f-dd5e0ec551b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2124bc7b-fa49-4ac1-8823-2b9b9213c7b5" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_345a9e80-c9c5-46ce-8d4f-dd5e0ec551b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2c1508f7-808f-4d92-bd8d-85da07f40b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2124bc7b-fa49-4ac1-8823-2b9b9213c7b5" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2c1508f7-808f-4d92-bd8d-85da07f40b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#RestructuringandimpairmentcostsTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_66e99f22-2ead-41bd-a44f-02f3532fb0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_75ddc015-5a25-4aa2-8809-ffd12489aa3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_66e99f22-2ead-41bd-a44f-02f3532fb0c0" xlink:to="loc_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_75ddc015-5a25-4aa2-8809-ffd12489aa3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_473adffc-b7cd-4179-ba47-82eead41817b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_66e99f22-2ead-41bd-a44f-02f3532fb0c0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_473adffc-b7cd-4179-ba47-82eead41817b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_86f48e8d-2489-46b3-b6ed-7de28373725e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_66e99f22-2ead-41bd-a44f-02f3532fb0c0" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_86f48e8d-2489-46b3-b6ed-7de28373725e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesnetTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#InventoriesnetTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/InventoriesnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6d9d9b46-0881-480e-a46d-114233939779" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_bf328f52-7765-4066-b985-2b603a8bfaba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6d9d9b46-0881-480e-a46d-114233939779" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_bf328f52-7765-4066-b985-2b603a8bfaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentnetTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#PropertyplantandequipmentnetTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/PropertyplantandequipmentnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_2da4cac4-6373-44bc-895e-c532832abae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5bd880c7-230e-4e46-9206-4504c4e68707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_2da4cac4-6373-44bc-895e-c532832abae6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5bd880c7-230e-4e46-9206-4504c4e68707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#IntangibleassetsandgoodwillTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_db896cf5-711f-4bbd-b656-a91aae6dc4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cd93bdfb-eb3e-42c4-b7b0-3596b384400b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_db896cf5-711f-4bbd-b656-a91aae6dc4b7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cd93bdfb-eb3e-42c4-b7b0-3596b384400b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_a897e104-5daa-4162-bdc5-17b544e88a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_db896cf5-711f-4bbd-b656-a91aae6dc4b7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_a897e104-5daa-4162-bdc5-17b544e88a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_9405d8bf-f245-46aa-a015-1286d869c6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_db896cf5-711f-4bbd-b656-a91aae6dc4b7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_9405d8bf-f245-46aa-a015-1286d869c6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#FairvaluemeasurementsTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/FairvaluemeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_557384c7-2039-4499-b5ae-bdfb6d9935b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_ef20353f-dcd2-438d-ae5b-cb64f591bcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_557384c7-2039-4499-b5ae-bdfb6d9935b7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_ef20353f-dcd2-438d-ae5b-cb64f591bcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_8c4efd33-53a4-407b-8bfc-9cd0274277ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_557384c7-2039-4499-b5ae-bdfb6d9935b7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_8c4efd33-53a4-407b-8bfc-9cd0274277ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_3449d9e0-60d8-4fef-b1aa-b37304c431f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_557384c7-2039-4499-b5ae-bdfb6d9935b7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_3449d9e0-60d8-4fef-b1aa-b37304c431f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#DerivativeinstrumentsandhedgingactivitiesTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f621c938-8272-48c5-a1ff-a29a115263f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_96455267-7845-4ae4-b2f3-9eee8ed24e40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f621c938-8272-48c5-a1ff-a29a115263f9" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_96455267-7845-4ae4-b2f3-9eee8ed24e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1e60bdb1-7803-4915-b2f2-8da9e0450f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f621c938-8272-48c5-a1ff-a29a115263f9" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1e60bdb1-7803-4915-b2f2-8da9e0450f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DebtTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1bd30376-dd53-453f-9899-a55c2f3f916f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_b7fe89ae-4dc9-4978-a188-d259c5b6e090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1bd30376-dd53-453f-9899-a55c2f3f916f" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_b7fe89ae-4dc9-4978-a188-d259c5b6e090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7699340d-37d3-4560-835c-1f9c45253b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_12ca338b-7cf7-420c-b058-f123fc23e7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7699340d-37d3-4560-835c-1f9c45253b81" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_12ca338b-7cf7-420c-b058-f123fc23e7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d0c7ce3c-c387-4311-9e03-a8d3d2f07edd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7699340d-37d3-4560-835c-1f9c45253b81" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d0c7ce3c-c387-4311-9e03-a8d3d2f07edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_5c6bbadc-d6c5-45ea-a363-d00cbd0ca726" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7699340d-37d3-4560-835c-1f9c45253b81" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_5c6bbadc-d6c5-45ea-a363-d00cbd0ca726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LosspercommonshareTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#LosspercommonshareTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LosspercommonshareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6d7d57d7-f5a0-4ad1-97c7-1b9282b20fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1ed644d9-9241-4c4b-a550-963310cd528c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d7d57d7-f5a0-4ad1-97c7-1b9282b20fdc" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1ed644d9-9241-4c4b-a550-963310cd528c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#RevenuerecognitionTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_25e16b90-e3df-40f8-a4fd-b9c36454e34b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e8b1eefc-10c4-41cc-a0b9-be2da20638de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_25e16b90-e3df-40f8-a4fd-b9c36454e34b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e8b1eefc-10c4-41cc-a0b9-be2da20638de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d54c00ba-c2bd-47c4-a391-e93bcee444f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_25e16b90-e3df-40f8-a4fd-b9c36454e34b" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d54c00ba-c2bd-47c4-a391-e93bcee444f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ScheduleOfAccountsReceivableNetTableTextBlock_c343ae69-9a9c-4e8f-9eb9-d38f1434987a" xlink:href="ebs-20230630.xsd#ebs_ScheduleOfAccountsReceivableNetTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_25e16b90-e3df-40f8-a4fd-b9c36454e34b" xlink:to="loc_ebs_ScheduleOfAccountsReceivableNetTableTextBlock_c343ae69-9a9c-4e8f-9eb9-d38f1434987a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c4f72756-3eea-48a0-b6fc-ac31492c16d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_0df18568-8789-4829-a007-5a51bded2b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c4f72756-3eea-48a0-b6fc-ac31492c16d4" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_0df18568-8789-4829-a007-5a51bded2b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AssetsAndLiabilitiesLesseeTableTextBlock_517aef88-dcce-44b3-a722-f956bdfc1ea5" xlink:href="ebs-20230630.xsd#ebs_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c4f72756-3eea-48a0-b6fc-ac31492c16d4" xlink:to="loc_ebs_AssetsAndLiabilitiesLesseeTableTextBlock_517aef88-dcce-44b3-a722-f956bdfc1ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentinformationTables" xlink:type="simple" xlink:href="ebs-20230630.xsd#SegmentinformationTables"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SegmentinformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fdafadf0-b3d7-4cbb-81d9-57aff06b90c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_2d8ee302-7001-416d-96c0-12bf4355c0df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fdafadf0-b3d7-4cbb-81d9-57aff06b90c5" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_2d8ee302-7001-416d-96c0-12bf4355c0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_602ae2e1-287a-47e8-8347-fa20ed3327c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fdafadf0-b3d7-4cbb-81d9-57aff06b90c5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_602ae2e1-287a-47e8-8347-fa20ed3327c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/NatureofthebusinessandorganizationDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#NatureofthebusinessandorganizationDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/NatureofthebusinessandorganizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aed3c52a-8a75-4766-95f1-a96d3cef11e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_NumberOfCategoriesOfPublicHealthThreats_a6805d25-cf80-4430-bbca-eb7b6fbabdb1" xlink:href="ebs-20230630.xsd#ebs_NumberOfCategoriesOfPublicHealthThreats"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aed3c52a-8a75-4766-95f1-a96d3cef11e8" xlink:to="loc_ebs_NumberOfCategoriesOfPublicHealthThreats_a6805d25-cf80-4430-bbca-eb7b6fbabdb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_NumberOfRevenueGeneratingProducts_19ca2a83-1020-4200-bd97-88ceb5ba134c" xlink:href="ebs-20230630.xsd#ebs_NumberOfRevenueGeneratingProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aed3c52a-8a75-4766-95f1-a96d3cef11e8" xlink:to="loc_ebs_NumberOfRevenueGeneratingProducts_19ca2a83-1020-4200-bd97-88ceb5ba134c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_NumberOfProductAndServiceCategories_f31d02a8-96a6-4dfb-9504-237ac51e4910" xlink:href="ebs-20230630.xsd#ebs_NumberOfProductAndServiceCategories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aed3c52a-8a75-4766-95f1-a96d3cef11e8" xlink:to="loc_ebs_NumberOfProductAndServiceCategories_f31d02a8-96a6-4dfb-9504-237ac51e4910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_bd2d9e17-7ebd-472d-8358-81d1e6ff868d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aed3c52a-8a75-4766-95f1-a96d3cef11e8" xlink:to="loc_us-gaap_NumberOfOperatingSegments_bd2d9e17-7ebd-472d-8358-81d1e6ff868d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#SummaryofsignificantaccountingpoliciesDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e7b24064-9e63-4f1b-8954-fc596bbe9bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e7b24064-9e63-4f1b-8954-fc596bbe9bf1" xlink:to="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9b5725e9-cfc8-4126-ba3d-4a71d62ae7db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:to="loc_us-gaap_CreditFacilityAxis_9b5725e9-cfc8-4126-ba3d-4a71d62ae7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6c3b87e6-1397-466e-bc65-7a3a6d1dd450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_9b5725e9-cfc8-4126-ba3d-4a71d62ae7db" xlink:to="loc_us-gaap_CreditFacilityDomain_6c3b87e6-1397-466e-bc65-7a3a6d1dd450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e0059dd8-fc24-40e8-9866-45f6f2a23982" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6c3b87e6-1397-466e-bc65-7a3a6d1dd450" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e0059dd8-fc24-40e8-9866-45f6f2a23982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TermLoanFacilityMember_5f3a2127-8aaa-4111-9fbd-e4a0db5723f8" xlink:href="ebs-20230630.xsd#ebs_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6c3b87e6-1397-466e-bc65-7a3a6d1dd450" xlink:to="loc_ebs_TermLoanFacilityMember_5f3a2127-8aaa-4111-9fbd-e4a0db5723f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a4df3c9a-1f9a-4d42-a382-c72b30f1f1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a4df3c9a-1f9a-4d42-a382-c72b30f1f1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_18720dfd-402b-4c4e-8e66-2841dca8af78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a4df3c9a-1f9a-4d42-a382-c72b30f1f1a0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_18720dfd-402b-4c4e-8e66-2841dca8af78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_070ba7f0-92a5-401b-b64d-8ace45af1f77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_18720dfd-402b-4c4e-8e66-2841dca8af78" xlink:to="loc_us-gaap_LineOfCreditMember_070ba7f0-92a5-401b-b64d-8ace45af1f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_d5429ce8-91d4-41fb-885c-bd452a96d13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_18720dfd-402b-4c4e-8e66-2841dca8af78" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_d5429ce8-91d4-41fb-885c-bd452a96d13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0c5a403c-6e19-43ac-ac35-97b7413e4aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:to="loc_us-gaap_DebtInstrumentAxis_0c5a403c-6e19-43ac-ac35-97b7413e4aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fce5914f-505c-4eab-8c69-2579b450c071" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c5a403c-6e19-43ac-ac35-97b7413e4aa9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fce5914f-505c-4eab-8c69-2579b450c071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AmendedCreditAgreementMember_61f9b0c4-cff8-4970-9b15-e126bdc7873d" xlink:href="ebs-20230630.xsd#ebs_AmendedCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fce5914f-505c-4eab-8c69-2579b450c071" xlink:to="loc_ebs_AmendedCreditAgreementMember_61f9b0c4-cff8-4970-9b15-e126bdc7873d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9d7ec580-3449-4204-ad32-e468d5a465d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ae7e0a3-8dd2-4fe7-8e91-243f7a0ccad7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9d7ec580-3449-4204-ad32-e468d5a465d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e1a5e507-30c1-4226-957e-5e099a0f07d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d7ec580-3449-4204-ad32-e468d5a465d7" xlink:to="loc_us-gaap_LongTermDebt_e1a5e507-30c1-4226-957e-5e099a0f07d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantConsiderationThreshold_428f3566-f2e1-4818-80b4-b5bc43d2a911" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantConsiderationThreshold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d7ec580-3449-4204-ad32-e468d5a465d7" xlink:to="loc_ebs_DebtInstrumentCovenantConsiderationThreshold_428f3566-f2e1-4818-80b4-b5bc43d2a911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DivestitureDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DivestitureDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DivestitureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_cc9e271d-2530-45e6-8bb9-69737a83f85f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_cc9e271d-2530-45e6-8bb9-69737a83f85f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f8adab6e-06f9-4364-b702-f9af50c3051f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f8adab6e-06f9-4364-b702-f9af50c3051f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6233732-e9a1-4129-a934-3fb29ab38220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f8adab6e-06f9-4364-b702-f9af50c3051f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6233732-e9a1-4129-a934-3fb29ab38220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TravelHealthBusinessMember_521ba219-83ac-4ba2-90b0-72b01d64ac13" xlink:href="ebs-20230630.xsd#ebs_TravelHealthBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6233732-e9a1-4129-a934-3fb29ab38220" xlink:to="loc_ebs_TravelHealthBusinessMember_521ba219-83ac-4ba2-90b0-72b01d64ac13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_6370d858-f58e-4f70-aa5d-4c491f2d3a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_6370d858-f58e-4f70-aa5d-4c491f2d3a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7a5dbb23-66cf-4098-a4ea-81fc57b87bba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6370d858-f58e-4f70-aa5d-4c491f2d3a4e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7a5dbb23-66cf-4098-a4ea-81fc57b87bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_7033bc58-15f9-40a6-9676-039efa93d44c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7a5dbb23-66cf-4098-a4ea-81fc57b87bba" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_7033bc58-15f9-40a6-9676-039efa93d44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_a2ae4648-2763-4b57-8f8c-b41bcd003d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_a2ae4648-2763-4b57-8f8c-b41bcd003d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_105b2d5c-c2e4-4840-946f-e542ca36fa56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_a2ae4648-2763-4b57-8f8c-b41bcd003d5a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_105b2d5c-c2e4-4840-946f-e542ca36fa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DevelopmentBasedMilestonesMember_8f388655-a4d5-462b-9c13-5afaece36c88" xlink:href="ebs-20230630.xsd#ebs_DevelopmentBasedMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_105b2d5c-c2e4-4840-946f-e542ca36fa56" xlink:to="loc_ebs_DevelopmentBasedMilestonesMember_8f388655-a4d5-462b-9c13-5afaece36c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SalesBasedMilestonesMember_f0501f28-23b2-44ac-b3b4-3fd410e4c807" xlink:href="ebs-20230630.xsd#ebs_SalesBasedMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_105b2d5c-c2e4-4840-946f-e542ca36fa56" xlink:to="loc_ebs_SalesBasedMilestonesMember_f0501f28-23b2-44ac-b3b4-3fd410e4c807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d9556b4b-3d36-4f62-ac41-2ea63484dd89" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_77d56701-dc49-4d18-a5c4-94c3bf8b8908" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_77d56701-dc49-4d18-a5c4-94c3bf8b8908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable_1bd898ee-4682-4e2b-9d2e-72e493fc8d22" xlink:href="ebs-20230630.xsd#ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable_1bd898ee-4682-4e2b-9d2e-72e493fc8d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_6868a798-12b9-48ed-9959-d7f864fb7567" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_6868a798-12b9-48ed-9959-d7f864fb7567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DispositionOfBusinessTransactionCosts_a1e75329-d706-4e9b-8bdc-fce4d6171525" xlink:href="ebs-20230630.xsd#ebs_DispositionOfBusinessTransactionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_ebs_DispositionOfBusinessTransactionCosts_a1e75329-d706-4e9b-8bdc-fce4d6171525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ed18a435-2fb8-4898-abf6-f2b3e1a4481a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7225c149-2651-48c8-9cff-9dd3ae5d28f1" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ed18a435-2fb8-4898-abf6-f2b3e1a4481a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RestructuringandimpairmentcostsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_28a6a105-76c7-4563-9457-3e7d99822764" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e7a54bc-d95c-455c-abfe-f4bd6b1ca4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_28a6a105-76c7-4563-9457-3e7d99822764" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e7a54bc-d95c-455c-abfe-f4bd6b1ca4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_3b76001a-9884-4a6a-a3e7-54a34d938673" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e7a54bc-d95c-455c-abfe-f4bd6b1ca4bf" xlink:to="loc_us-gaap_RestructuringPlanAxis_3b76001a-9884-4a6a-a3e7-54a34d938673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1efff7c1-a0bd-44ae-b670-0f16edc3030e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_3b76001a-9884-4a6a-a3e7-54a34d938673" xlink:to="loc_us-gaap_RestructuringPlanDomain_1efff7c1-a0bd-44ae-b670-0f16edc3030e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RestructuringPlanJanuary2023Member_8cd3560f-553a-4509-87ae-1e62aaac4728" xlink:href="ebs-20230630.xsd#ebs_RestructuringPlanJanuary2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1efff7c1-a0bd-44ae-b670-0f16edc3030e" xlink:to="loc_ebs_RestructuringPlanJanuary2023Member_8cd3560f-553a-4509-87ae-1e62aaac4728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7a46f832-d2cf-47af-9cd4-222db6d25358" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6e7a54bc-d95c-455c-abfe-f4bd6b1ca4bf" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_7a46f832-d2cf-47af-9cd4-222db6d25358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6ef5eaec-c47d-421e-8873-bc4298a082cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a46f832-d2cf-47af-9cd4-222db6d25358" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6ef5eaec-c47d-421e-8873-bc4298a082cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_cdb903d9-90ad-4499-a669-420316de19bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a46f832-d2cf-47af-9cd4-222db6d25358" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_cdb903d9-90ad-4499-a669-420316de19bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6ba0fc07-a61f-4440-8959-c2858426d943" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a46f832-d2cf-47af-9cd4-222db6d25358" xlink:to="loc_us-gaap_RestructuringCharges_6ba0fc07-a61f-4440-8959-c2858426d943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c97a6c4e-d683-4fb8-bc3e-b331f939740b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_95bb47a2-e920-48f6-b033-1366816e4052" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c97a6c4e-d683-4fb8-bc3e-b331f939740b" xlink:to="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_95bb47a2-e920-48f6-b033-1366816e4052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_97e3c0fb-704b-4ad5-abe2-6b1b983c14ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_95bb47a2-e920-48f6-b033-1366816e4052" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_97e3c0fb-704b-4ad5-abe2-6b1b983c14ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_97e3c0fb-704b-4ad5-abe2-6b1b983c14ff" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_f210c789-6e2c-42da-ae5b-50cbb6fe1e28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_f210c789-6e2c-42da-ae5b-50cbb6fe1e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_12e11836-a8cf-4de3-83af-4499baeaf2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_12e11836-a8cf-4de3-83af-4499baeaf2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_59263fb4-3eaf-4d98-9aff-cf87b167f52a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_59263fb4-3eaf-4d98-9aff-cf87b167f52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_af30e901-5af4-4f9a-85a6-0a3a0d9693d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_729d4136-93ef-4d9d-9566-49809ebb2b27" xlink:to="loc_us-gaap_ConstructionInProgressMember_af30e901-5af4-4f9a-85a6-0a3a0d9693d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_ba3e2f4f-1b73-4b22-acad-c356573fb994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_95bb47a2-e920-48f6-b033-1366816e4052" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_ba3e2f4f-1b73-4b22-acad-c356573fb994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_cc932bfd-1c57-48ae-964d-9c173482d406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_ba3e2f4f-1b73-4b22-acad-c356573fb994" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_cc932bfd-1c57-48ae-964d-9c173482d406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c7dc6592-552b-4984-b3f9-4422a059738a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c7dc6592-552b-4984-b3f9-4422a059738a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_05bfc3e5-c527-4c17-909a-00be29c154b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_05bfc3e5-c527-4c17-909a-00be29c154b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_05bfc3e5-c527-4c17-909a-00be29c154b9" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_UnallocatedResearchAndDevelopmentMember_4512431b-e0f7-4e8c-ae06-249c8efd3bac" xlink:href="ebs-20230630.xsd#ebs_UnallocatedResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:to="loc_ebs_UnallocatedResearchAndDevelopmentMember_4512431b-e0f7-4e8c-ae06-249c8efd3bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EmployeeTransitionMember_e28dc31e-15e2-431b-b170-fd7cfd9fbdf6" xlink:href="ebs-20230630.xsd#ebs_EmployeeTransitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:to="loc_ebs_EmployeeTransitionMember_e28dc31e-15e2-431b-b170-fd7cfd9fbdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_812972c5-a774-4102-b1d8-937824a9587e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:to="loc_us-gaap_EmployeeSeveranceMember_812972c5-a774-4102-b1d8-937824a9587e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EmployeeBenefitsMember_5128adfa-8fab-435c-b63e-773502d44b70" xlink:href="ebs-20230630.xsd#ebs_EmployeeBenefitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a474ab9-8709-4718-a1f7-4dcda4d55a74" xlink:to="loc_ebs_EmployeeBenefitsMember_5128adfa-8fab-435c-b63e-773502d44b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2dad7d58-52f8-423c-a21a-694273371615" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:to="loc_srt_ConsolidationItemsAxis_2dad7d58-52f8-423c-a21a-694273371615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6dda25ac-2f4c-41d8-b4fe-098103502a7e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_2dad7d58-52f8-423c-a21a-694273371615" xlink:to="loc_srt_ConsolidationItemsDomain_6dda25ac-2f4c-41d8-b4fe-098103502a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6e135f59-0b1c-46b4-b10e-5a5838ac3f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6dda25ac-2f4c-41d8-b4fe-098103502a7e" xlink:to="loc_us-gaap_OperatingSegmentsMember_6e135f59-0b1c-46b4-b10e-5a5838ac3f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0063d2d7-13f9-40b3-8900-cbc97e5384a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6dda25ac-2f4c-41d8-b4fe-098103502a7e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_0063d2d7-13f9-40b3-8900-cbc97e5384a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6e248084-4522-4508-9c52-73c0ec8c6a09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6e248084-4522-4508-9c52-73c0ec8c6a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f75429cf-e7e8-48d3-a447-b2721738a901" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6e248084-4522-4508-9c52-73c0ec8c6a09" xlink:to="loc_us-gaap_SegmentDomain_f75429cf-e7e8-48d3-a447-b2721738a901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember_eb68abca-b2b8-4272-b2c0-76429807640a" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f75429cf-e7e8-48d3-a447-b2721738a901" xlink:to="loc_ebs_ProductsSegmentMember_eb68abca-b2b8-4272-b2c0-76429807640a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ServicesSegmentMember_db8ec3f0-1ff8-40ef-acdd-b4588ed9b1ef" xlink:href="ebs-20230630.xsd#ebs_ServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f75429cf-e7e8-48d3-a447-b2721738a901" xlink:to="loc_ebs_ServicesSegmentMember_db8ec3f0-1ff8-40ef-acdd-b4588ed9b1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_6b325c81-cab4-430d-ab8d-62b88000e7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:to="loc_us-gaap_RestructuringPlanAxis_6b325c81-cab4-430d-ab8d-62b88000e7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_edd82171-17cd-4748-b07d-4cf69d58667b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_6b325c81-cab4-430d-ab8d-62b88000e7f2" xlink:to="loc_us-gaap_RestructuringPlanDomain_edd82171-17cd-4748-b07d-4cf69d58667b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RestructuringPlanJanuary2023Member_1c16485f-f532-4d35-8870-7c3e82a2e2ac" xlink:href="ebs-20230630.xsd#ebs_RestructuringPlanJanuary2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_edd82171-17cd-4748-b07d-4cf69d58667b" xlink:to="loc_ebs_RestructuringPlanJanuary2023Member_1c16485f-f532-4d35-8870-7c3e82a2e2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_9e260126-1216-4b29-a757-d666e7979bae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_658626f4-4e64-42a7-8f3c-f5a9c1e6a67b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_9e260126-1216-4b29-a757-d666e7979bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a03cdf05-20a0-44ed-bf8e-9b24aa277218" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9e260126-1216-4b29-a757-d666e7979bae" xlink:to="loc_us-gaap_RestructuringCharges_a03cdf05-20a0-44ed-bf8e-9b24aa277218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c680fe54-dd6b-4950-a95d-132f0cb36349" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3cd0a10c-f1c8-4a97-aa22-1cf0c10e1cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c680fe54-dd6b-4950-a95d-132f0cb36349" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3cd0a10c-f1c8-4a97-aa22-1cf0c10e1cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_db11d154-8808-4d22-bc8a-bf8b2d34c327" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3cd0a10c-f1c8-4a97-aa22-1cf0c10e1cc6" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_db11d154-8808-4d22-bc8a-bf8b2d34c327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0e09179a-2899-482d-a4af-9f73b4283cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_db11d154-8808-4d22-bc8a-bf8b2d34c327" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0e09179a-2899-482d-a4af-9f73b4283cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EmployeeTransitionMember_4d92f375-4853-4d2e-8d3b-500985689876" xlink:href="ebs-20230630.xsd#ebs_EmployeeTransitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0e09179a-2899-482d-a4af-9f73b4283cc3" xlink:to="loc_ebs_EmployeeTransitionMember_4d92f375-4853-4d2e-8d3b-500985689876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_3ee36b21-21e6-4709-9f53-86ef53595c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0e09179a-2899-482d-a4af-9f73b4283cc3" xlink:to="loc_us-gaap_EmployeeSeveranceMember_3ee36b21-21e6-4709-9f53-86ef53595c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EmployeeBenefitsMember_6fc8e523-480e-4ad4-aad1-31121b105de4" xlink:href="ebs-20230630.xsd#ebs_EmployeeBenefitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0e09179a-2899-482d-a4af-9f73b4283cc3" xlink:to="loc_ebs_EmployeeBenefitsMember_6fc8e523-480e-4ad4-aad1-31121b105de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_024fe1e2-ee59-46c7-a551-1fb48f05fd99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3cd0a10c-f1c8-4a97-aa22-1cf0c10e1cc6" xlink:to="loc_us-gaap_RestructuringPlanAxis_024fe1e2-ee59-46c7-a551-1fb48f05fd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9898ff44-1bec-4dfb-9949-64b132cdf1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_024fe1e2-ee59-46c7-a551-1fb48f05fd99" xlink:to="loc_us-gaap_RestructuringPlanDomain_9898ff44-1bec-4dfb-9949-64b132cdf1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RestructuringPlanJanuary2023Member_48cc05b4-87c1-4ad6-88cd-2c1944976ed6" xlink:href="ebs-20230630.xsd#ebs_RestructuringPlanJanuary2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_9898ff44-1bec-4dfb-9949-64b132cdf1e9" xlink:to="loc_ebs_RestructuringPlanJanuary2023Member_48cc05b4-87c1-4ad6-88cd-2c1944976ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8c4373f2-ccf9-498d-8dd0-27137213b374" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3cd0a10c-f1c8-4a97-aa22-1cf0c10e1cc6" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_8c4373f2-ccf9-498d-8dd0-27137213b374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c4373f2-ccf9-498d-8dd0-27137213b374" xlink:to="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_31a67cab-bb62-444a-822d-a25a456580b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:to="loc_us-gaap_RestructuringReserve_31a67cab-bb62-444a-822d-a25a456580b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_549133d4-7229-4a8e-9474-c0cdda27b8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:to="loc_us-gaap_RestructuringCharges_549133d4-7229-4a8e-9474-c0cdda27b8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_da59883a-1a48-42b5-a05d-40692f2b2f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:to="loc_us-gaap_PaymentsForRestructuring_da59883a-1a48-42b5-a05d-40692f2b2f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_0709dbf6-136e-4678-8611-eafc69a7a211" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8b88527c-432e-4442-902c-8bc28b2b47e2" xlink:to="loc_us-gaap_RestructuringReserve_0709dbf6-136e-4678-8611-eafc69a7a211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#InventoriesnetScheduleofInventoryDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_ed5da53e-a219-439e-af48-59c7c98fd476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_d4af6374-607c-4948-a029-8e46fc695768" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_ed5da53e-a219-439e-af48-59c7c98fd476" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_d4af6374-607c-4948-a029-8e46fc695768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c480aa84-2137-48d6-b839-67cce5354410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_ed5da53e-a219-439e-af48-59c7c98fd476" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c480aa84-2137-48d6-b839-67cce5354410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_82a2ddaa-134b-4413-8eab-af1d9feec2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_ed5da53e-a219-439e-af48-59c7c98fd476" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_82a2ddaa-134b-4413-8eab-af1d9feec2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3c36a2a1-c142-4218-910b-048a13c0a69e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_ed5da53e-a219-439e-af48-59c7c98fd476" xlink:to="loc_us-gaap_InventoryNet_3c36a2a1-c142-4218-910b-048a13c0a69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_4b5ba525-c7a3-41fd-ba6e-986a3bf15eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90c56bba-7920-47b6-9361-3f4581947896" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_4b5ba525-c7a3-41fd-ba6e-986a3bf15eb1" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90c56bba-7920-47b6-9361-3f4581947896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fa039827-d820-4877-bb5c-d5397bafce0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90c56bba-7920-47b6-9361-3f4581947896" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fa039827-d820-4877-bb5c-d5397bafce0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fa039827-d820-4877-bb5c-d5397bafce0d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_22312f90-7b37-4d11-ad47-39950efb48d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_22312f90-7b37-4d11-ad47-39950efb48d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_5c077634-18fc-4423-b1cc-8eff73591b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_5c077634-18fc-4423-b1cc-8eff73591b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d6282c5c-792a-4e79-8485-af777f40f253" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d6282c5c-792a-4e79-8485-af777f40f253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_2ecfb87b-7d96-4afe-aadf-0b698e670703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_2ecfb87b-7d96-4afe-aadf-0b698e670703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_34e08cf3-6c1a-4622-8d5d-e8545e80d468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c8e0e11-469f-4c7d-85e5-e905c974e63b" xlink:to="loc_us-gaap_ConstructionInProgressMember_34e08cf3-6c1a-4622-8d5d-e8545e80d468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36b20644-7f2a-4ca7-b8ea-a15b77e9e2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90c56bba-7920-47b6-9361-3f4581947896" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36b20644-7f2a-4ca7-b8ea-a15b77e9e2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_276e1eb3-5974-4721-81f7-04526bc45123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36b20644-7f2a-4ca7-b8ea-a15b77e9e2e8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_276e1eb3-5974-4721-81f7-04526bc45123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a1994652-4583-422e-8eaa-bc1bdbb24474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_276e1eb3-5974-4721-81f7-04526bc45123" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a1994652-4583-422e-8eaa-bc1bdbb24474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_106fb323-375e-4529-ad3b-c479074c0fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_276e1eb3-5974-4721-81f7-04526bc45123" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_106fb323-375e-4529-ad3b-c479074c0fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4fcbcf51-4edc-423a-a480-3bce00337bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_276e1eb3-5974-4721-81f7-04526bc45123" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4fcbcf51-4edc-423a-a480-3bce00337bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3dbef937-b77c-43c2-ae51-a61b776d5faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_36b20644-7f2a-4ca7-b8ea-a15b77e9e2e8" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3dbef937-b77c-43c2-ae51-a61b776d5faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#PropertyplantandequipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_58a024f1-151e-4c3a-b6af-eb7312fd7a85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ebb367f6-7572-4d0b-bece-a239e41e4512" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_58a024f1-151e-4c3a-b6af-eb7312fd7a85" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ebb367f6-7572-4d0b-bece-a239e41e4512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3182a842-91d0-4aa6-875f-41876f024bf1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ebb367f6-7572-4d0b-bece-a239e41e4512" xlink:to="loc_srt_MajorCustomersAxis_3182a842-91d0-4aa6-875f-41876f024bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_6990e732-86ee-40e1-836e-faffa324b948" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_3182a842-91d0-4aa6-875f-41876f024bf1" xlink:to="loc_srt_NameOfMajorCustomerDomain_6990e732-86ee-40e1-836e-faffa324b948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_JansenPharmaceuticalsIncMember_29edc17b-6eaf-4b73-9601-ede4b6b93c7d" xlink:href="ebs-20230630.xsd#ebs_JansenPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_6990e732-86ee-40e1-836e-faffa324b948" xlink:to="loc_ebs_JansenPharmaceuticalsIncMember_29edc17b-6eaf-4b73-9601-ede4b6b93c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_894e4fa6-19e5-4ccf-809c-765a4ab0a032" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ebb367f6-7572-4d0b-bece-a239e41e4512" xlink:to="loc_srt_ProductOrServiceAxis_894e4fa6-19e5-4ccf-809c-765a4ab0a032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f14baacf-07d6-4f0d-a9c7-1ff0023c98ea" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_894e4fa6-19e5-4ccf-809c-765a4ab0a032" xlink:to="loc_srt_ProductsAndServicesDomain_f14baacf-07d6-4f0d-a9c7-1ff0023c98ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_68435a34-db66-4667-a03c-d9e97904892e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f14baacf-07d6-4f0d-a9c7-1ff0023c98ea" xlink:to="loc_us-gaap_ServiceMember_68435a34-db66-4667-a03c-d9e97904892e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64e6b6ef-1bf0-41b4-a011-61e2b869fd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ebb367f6-7572-4d0b-bece-a239e41e4512" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64e6b6ef-1bf0-41b4-a011-61e2b869fd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_b3a2013d-b1fe-471e-952e-cf078541caf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64e6b6ef-1bf0-41b4-a011-61e2b869fd2f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_b3a2013d-b1fe-471e-952e-cf078541caf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f218ecc8-b6d1-4286-8b02-f8987a5e57b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f218ecc8-b6d1-4286-8b02-f8987a5e57b2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_853112ab-8f65-4dc6-a50e-38c2939e7c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_853112ab-8f65-4dc6-a50e-38c2939e7c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e98ccc37-f131-4be6-af78-fab737453d30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_853112ab-8f65-4dc6-a50e-38c2939e7c9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e98ccc37-f131-4be6-af78-fab737453d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_ad271dfe-006b-434b-a87a-4c742f66b06b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e98ccc37-f131-4be6-af78-fab737453d30" xlink:to="loc_us-gaap_ProductMember_ad271dfe-006b-434b-a87a-4c742f66b06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_eaf88589-9186-4d95-9635-bc5a5137f055" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e98ccc37-f131-4be6-af78-fab737453d30" xlink:to="loc_us-gaap_CustomerRelationshipsMember_eaf88589-9186-4d95-9635-bc5a5137f055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_6cae8999-bcae-4b9d-a3d4-376863abb51c" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e98ccc37-f131-4be6-af78-fab737453d30" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingMember_6cae8999-bcae-4b9d-a3d4-376863abb51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_226f1ae5-6de7-462b-888d-df5a20a10767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_226f1ae5-6de7-462b-888d-df5a20a10767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c771fb1f-66e6-4cf8-92e8-e3901fe55966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_226f1ae5-6de7-462b-888d-df5a20a10767" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c771fb1f-66e6-4cf8-92e8-e3901fe55966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_edc8ad26-f22c-421b-918c-f84ae7b155d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c771fb1f-66e6-4cf8-92e8-e3901fe55966" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_edc8ad26-f22c-421b-918c-f84ae7b155d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5aab136b-d3e4-4f4c-9510-5da95e9741e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5aab136b-d3e4-4f4c-9510-5da95e9741e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_173c409a-8f87-484c-82a4-0c3d4a10ee69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5aab136b-d3e4-4f4c-9510-5da95e9741e7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_173c409a-8f87-484c-82a4-0c3d4a10ee69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TravelHealthBusinessMember_8a430902-bfe7-42a3-a86c-f32766432007" xlink:href="ebs-20230630.xsd#ebs_TravelHealthBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_173c409a-8f87-484c-82a4-0c3d4a10ee69" xlink:to="loc_ebs_TravelHealthBusinessMember_8a430902-bfe7-42a3-a86c-f32766432007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_02d11ccd-c48d-4849-b946-b76c138310b3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_379fb1f7-1d74-48ab-8e2b-ddcebbf7c30d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_379fb1f7-1d74-48ab-8e2b-ddcebbf7c30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_bbc62738-127a-460d-baeb-cf625350e4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_bbc62738-127a-460d-baeb-cf625350e4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ecffbcb7-2072-4c30-9aee-6904c0880b56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ecffbcb7-2072-4c30-9aee-6904c0880b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_890bfdc5-9a62-4e50-b74f-53629d72dfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_890bfdc5-9a62-4e50-b74f-53629d72dfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_78509936-5ed5-48cf-815d-3fa1d2710c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d71a95f-80f0-4fb4-b591-3c13574f22b9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_78509936-5ed5-48cf-815d-3fa1d2710c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillFinitelivedIntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#IntangibleassetsandgoodwillFinitelivedIntangibleAssetsAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillFinitelivedIntangibleAssetsAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_659263d6-e170-4551-b68a-d363d0ecb5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_912ba11c-a24b-4e2e-bab8-5bb8e7377e48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_659263d6-e170-4551-b68a-d363d0ecb5a3" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_912ba11c-a24b-4e2e-bab8-5bb8e7377e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#IntangibleassetsandgoodwillGoodwillRollForwardDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3809e62d-1443-4913-8a86-4e0f0686432f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_b6ef8ea6-5258-4e7f-ad68-c8b642f8d1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3809e62d-1443-4913-8a86-4e0f0686432f" xlink:to="loc_us-gaap_GoodwillRollForward_b6ef8ea6-5258-4e7f-ad68-c8b642f8d1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_195f99e5-f30a-4ce8-b963-ca242fcb3785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3809e62d-1443-4913-8a86-4e0f0686432f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_195f99e5-f30a-4ce8-b963-ca242fcb3785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6a7e216d-d441-496a-829d-4a3a6f314cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_195f99e5-f30a-4ce8-b963-ca242fcb3785" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6a7e216d-d441-496a-829d-4a3a6f314cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3f1e322c-f243-4f40-930e-1e3ebc726d95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6a7e216d-d441-496a-829d-4a3a6f314cbd" xlink:to="loc_us-gaap_SegmentDomain_3f1e322c-f243-4f40-930e-1e3ebc726d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember_bea3a2e2-cf37-4a60-8b8a-d8af7c1d0e62" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3f1e322c-f243-4f40-930e-1e3ebc726d95" xlink:to="loc_ebs_ProductsSegmentMember_bea3a2e2-cf37-4a60-8b8a-d8af7c1d0e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ServicesSegmentMember_a69f9018-1eeb-4a8f-b65f-51663f9d1c8a" xlink:href="ebs-20230630.xsd#ebs_ServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3f1e322c-f243-4f40-930e-1e3ebc726d95" xlink:to="loc_ebs_ServicesSegmentMember_a69f9018-1eeb-4a8f-b65f-51663f9d1c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9b22d84a-487f-45f9-ab8f-c4aac6578be6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_195f99e5-f30a-4ce8-b963-ca242fcb3785" xlink:to="loc_us-gaap_GoodwillLineItems_9b22d84a-487f-45f9-ab8f-c4aac6578be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_fb6afacb-7e48-4f87-9c0a-136312961cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9b22d84a-487f-45f9-ab8f-c4aac6578be6" xlink:to="loc_us-gaap_GoodwillRollForward_fb6afacb-7e48-4f87-9c0a-136312961cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3a60ca51-33f3-4954-b874-2d806d296174" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_fb6afacb-7e48-4f87-9c0a-136312961cc4" xlink:to="loc_us-gaap_Goodwill_3a60ca51-33f3-4954-b874-2d806d296174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_a9e1779f-d779-4eda-862e-9f7b217c980a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9b22d84a-487f-45f9-ab8f-c4aac6578be6" xlink:to="loc_us-gaap_GoodwillGross_a9e1779f-d779-4eda-862e-9f7b217c980a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e481709c-7607-465b-b9d1-cdda7d1bf537" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9b22d84a-487f-45f9-ab8f-c4aac6578be6" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e481709c-7607-465b-b9d1-cdda7d1bf537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#IntangibleassetsandgoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0c869c8b-b251-41f4-af40-5476ae61834d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8c4aedc2-fe08-4550-a54e-10a9c42b758c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0c869c8b-b251-41f4-af40-5476ae61834d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8c4aedc2-fe08-4550-a54e-10a9c42b758c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_67e718ad-038d-4192-bd91-93e67afa171c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8c4aedc2-fe08-4550-a54e-10a9c42b758c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_67e718ad-038d-4192-bd91-93e67afa171c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e51ebffb-8164-4da7-bfe7-0b9886b6deb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_67e718ad-038d-4192-bd91-93e67afa171c" xlink:to="loc_us-gaap_SegmentDomain_e51ebffb-8164-4da7-bfe7-0b9886b6deb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember_d5356cb2-bae9-4d1b-8f49-bb802a19a335" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e51ebffb-8164-4da7-bfe7-0b9886b6deb5" xlink:to="loc_ebs_ProductsSegmentMember_d5356cb2-bae9-4d1b-8f49-bb802a19a335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_ec2360b4-da03-4795-b252-a79beda4cd35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8c4aedc2-fe08-4550-a54e-10a9c42b758c" xlink:to="loc_us-gaap_GoodwillLineItems_ec2360b4-da03-4795-b252-a79beda4cd35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a4b30ac1-8e4f-459f-8682-b9796c54c61b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_ec2360b4-da03-4795-b252-a79beda4cd35" xlink:to="loc_us-gaap_Goodwill_a4b30ac1-8e4f-459f-8682-b9796c54c61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_694af681-2128-4410-895f-135f053749f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_ec2360b4-da03-4795-b252-a79beda4cd35" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_694af681-2128-4410-895f-135f053749f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2b642cc5-7fdc-4126-a4b1-fed3cd2096d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1898da38-8525-4f1e-acbf-1d43116ef462" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2b642cc5-7fdc-4126-a4b1-fed3cd2096d5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1898da38-8525-4f1e-acbf-1d43116ef462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_4f78d65c-7685-4646-bd8f-351605d41c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1898da38-8525-4f1e-acbf-1d43116ef462" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_4f78d65c-7685-4646-bd8f-351605d41c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3079ceb0-e1a5-41a0-bba6-0cfe27dbe17c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_4f78d65c-7685-4646-bd8f-351605d41c5b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3079ceb0-e1a5-41a0-bba6-0cfe27dbe17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ee841f2f-524b-4f06-a64f-d441854dbe83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3079ceb0-e1a5-41a0-bba6-0cfe27dbe17c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ee841f2f-524b-4f06-a64f-d441854dbe83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_6f0614e6-83e2-48e6-a758-df7a6188f630" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3079ceb0-e1a5-41a0-bba6-0cfe27dbe17c" xlink:to="loc_us-gaap_BankTimeDepositsMember_6f0614e6-83e2-48e6-a758-df7a6188f630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee50710a-d6c5-4742-917c-e41e4716df8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1898da38-8525-4f1e-acbf-1d43116ef462" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee50710a-d6c5-4742-917c-e41e4716df8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c813fa2-f056-4ca3-9ec5-a61def46086f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee50710a-d6c5-4742-917c-e41e4716df8d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c813fa2-f056-4ca3-9ec5-a61def46086f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_cc4e3b66-7832-43af-97bc-14ddcd3ee205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c813fa2-f056-4ca3-9ec5-a61def46086f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_cc4e3b66-7832-43af-97bc-14ddcd3ee205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6531c82f-d707-4aac-bd7a-61bfe1344d81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c813fa2-f056-4ca3-9ec5-a61def46086f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6531c82f-d707-4aac-bd7a-61bfe1344d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0a19336d-33eb-4d93-ace3-3abdd744182b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c813fa2-f056-4ca3-9ec5-a61def46086f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0a19336d-33eb-4d93-ace3-3abdd744182b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1898da38-8525-4f1e-acbf-1d43116ef462" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c9350a4e-5c06-419b-bdf9-f6d9d123cb84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c9350a4e-5c06-419b-bdf9-f6d9d123cb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_14240c41-404e-4b1c-9292-01d06f9ff698" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_DerivativeAssets_14240c41-404e-4b1c-9292-01d06f9ff698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e155cbba-bb05-49e9-a904-4f8324021546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e155cbba-bb05-49e9-a904-4f8324021546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2298c8db-02b9-494b-b31c-f2670a177b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2298c8db-02b9-494b-b31c-f2670a177b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_e020920c-3df6-4d2f-904f-8612629e946b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9fbea5f3-9b77-46e7-b619-3dca43a9d267" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_e020920c-3df6-4d2f-904f-8612629e946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsContingentConsiderationRollForwardDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#FairvaluemeasurementsContingentConsiderationRollForwardDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/FairvaluemeasurementsContingentConsiderationRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bf75e915-5749-4353-b3ba-7418dc7f99c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_04143906-9776-4b34-b80a-37297a0971cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bf75e915-5749-4353-b3ba-7418dc7f99c4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_04143906-9776-4b34-b80a-37297a0971cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_73d539b8-1d55-4a47-ad99-eddc20a53acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_04143906-9776-4b34-b80a-37297a0971cf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_73d539b8-1d55-4a47-ad99-eddc20a53acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f97189db-0465-4ccf-94d0-25b20dfbe8df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_04143906-9776-4b34-b80a-37297a0971cf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f97189db-0465-4ccf-94d0-25b20dfbe8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_fe00089d-6b30-411c-bb49-37668e4d0467" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_04143906-9776-4b34-b80a-37297a0971cf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_fe00089d-6b30-411c-bb49-37668e4d0467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9ba7cc45-ef47-420e-8597-28b01e18a8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_04143906-9776-4b34-b80a-37297a0971cf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9ba7cc45-ef47-420e-8597-28b01e18a8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#FairvaluemeasurementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_49cdd366-1a55-4473-819d-024b7b0e9803" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e1442db1-f0b8-4bf9-9f20-9923dce29971" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_49cdd366-1a55-4473-819d-024b7b0e9803" xlink:to="loc_us-gaap_DebtInstrumentTable_e1442db1-f0b8-4bf9-9f20-9923dce29971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9750ba6f-e825-40c2-a366-f0aca46fe86d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e1442db1-f0b8-4bf9-9f20-9923dce29971" xlink:to="loc_us-gaap_DebtInstrumentAxis_9750ba6f-e825-40c2-a366-f0aca46fe86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_166cedf8-2297-4e8b-9f7f-d51d475244d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9750ba6f-e825-40c2-a366-f0aca46fe86d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_166cedf8-2297-4e8b-9f7f-d51d475244d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_6d842b40-ac57-4932-8f99-0c55e6e5bc38" xlink:href="ebs-20230630.xsd#ebs_SeniorUnsecuredNotesDueAugust2028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_166cedf8-2297-4e8b-9f7f-d51d475244d7" xlink:to="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_6d842b40-ac57-4932-8f99-0c55e6e5bc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7552baec-1fe2-4b13-96df-236dcd256c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e1442db1-f0b8-4bf9-9f20-9923dce29971" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7552baec-1fe2-4b13-96df-236dcd256c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ca5c83d6-5a3f-4389-b497-0b201fc7163b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7552baec-1fe2-4b13-96df-236dcd256c22" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ca5c83d6-5a3f-4389-b497-0b201fc7163b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3c2a8fb6-be71-4b69-9b29-1a757cfbdcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ca5c83d6-5a3f-4389-b497-0b201fc7163b" xlink:to="loc_us-gaap_SeniorNotesMember_3c2a8fb6-be71-4b69-9b29-1a757cfbdcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f4991a7c-5e45-4983-813c-6d66e1da4044" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e1442db1-f0b8-4bf9-9f20-9923dce29971" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f4991a7c-5e45-4983-813c-6d66e1da4044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_def322c7-2f8f-4544-ad6c-53b6819f8d78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4991a7c-5e45-4983-813c-6d66e1da4044" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_def322c7-2f8f-4544-ad6c-53b6819f8d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2773e841-f1f1-4d19-a874-215a04984375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4991a7c-5e45-4983-813c-6d66e1da4044" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2773e841-f1f1-4d19-a874-215a04984375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_a5241678-84b4-4cc6-84a1-1d6fe01092d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4991a7c-5e45-4983-813c-6d66e1da4044" xlink:to="loc_us-gaap_LongTermDebtFairValue_a5241678-84b4-4cc6-84a1-1d6fe01092d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_330c1c40-7492-4a45-8d4b-89642915f97d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_330c1c40-7492-4a45-8d4b-89642915f97d" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_c288de4a-4f37-421a-83f4-3a8560ec489e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_us-gaap_ValuationTechniqueAxis_c288de4a-4f37-421a-83f4-3a8560ec489e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_368f934a-6bdc-492d-9480-692a7dfad6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_c288de4a-4f37-421a-83f4-3a8560ec489e" xlink:to="loc_us-gaap_ValuationTechniqueDomain_368f934a-6bdc-492d-9480-692a7dfad6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_fa1103a9-2e68-4ccc-9475-c51df9e866f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_368f934a-6bdc-492d-9480-692a7dfad6c8" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_fa1103a9-2e68-4ccc-9475-c51df9e866f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11ef71c0-9a5b-49da-8048-d9646a075da6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11ef71c0-9a5b-49da-8048-d9646a075da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7593f263-2c5e-4be1-809e-59318e9486dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11ef71c0-9a5b-49da-8048-d9646a075da6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7593f263-2c5e-4be1-809e-59318e9486dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a3fdb5e5-2725-40c2-8e78-69c3f89877b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7593f263-2c5e-4be1-809e-59318e9486dd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a3fdb5e5-2725-40c2-8e78-69c3f89877b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_462ff446-aa5f-4982-a5ad-31456952f128" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_462ff446-aa5f-4982-a5ad-31456952f128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4dd7b6ac-a7d6-4d15-a71f-6119a7962527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_462ff446-aa5f-4982-a5ad-31456952f128" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4dd7b6ac-a7d6-4d15-a71f-6119a7962527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7f7facae-5dd2-4944-9823-a050d233e817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4dd7b6ac-a7d6-4d15-a71f-6119a7962527" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7f7facae-5dd2-4944-9823-a050d233e817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_727313f6-0723-43dd-9785-4cc767ce7a21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_727313f6-0723-43dd-9785-4cc767ce7a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_f72a3bea-da23-442d-87b0-a1fd7fa18324" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_727313f6-0723-43dd-9785-4cc767ce7a21" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_f72a3bea-da23-442d-87b0-a1fd7fa18324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_ca15e60b-674b-4be3-951f-9dfeb7a8e7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_f72a3bea-da23-442d-87b0-a1fd7fa18324" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_ca15e60b-674b-4be3-951f-9dfeb7a8e7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_MeasurementInputProbabilityOfPaymentMember_ffd8a7a7-05f6-41b9-a611-445fa822b25a" xlink:href="ebs-20230630.xsd#ebs_MeasurementInputProbabilityOfPaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_f72a3bea-da23-442d-87b0-a1fd7fa18324" xlink:to="loc_ebs_MeasurementInputProbabilityOfPaymentMember_ffd8a7a7-05f6-41b9-a611-445fa822b25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5244c6b8-7d89-4d0f-8bc9-2540c0d01ec1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_srt_RangeAxis_5244c6b8-7d89-4d0f-8bc9-2540c0d01ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e8e8c9bb-6f3b-42ac-9d8c-c515b1b0121c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5244c6b8-7d89-4d0f-8bc9-2540c0d01ec1" xlink:to="loc_srt_RangeMember_e8e8c9bb-6f3b-42ac-9d8c-c515b1b0121c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4917e69c-3a7e-409e-95ef-64d9ab7d0a9f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e8e8c9bb-6f3b-42ac-9d8c-c515b1b0121c" xlink:to="loc_srt_MinimumMember_4917e69c-3a7e-409e-95ef-64d9ab7d0a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b5a79e41-a817-4b40-86f8-202b0e419b4b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e8e8c9bb-6f3b-42ac-9d8c-c515b1b0121c" xlink:to="loc_srt_MaximumMember_b5a79e41-a817-4b40-86f8-202b0e419b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ca97c4a6-b556-4edf-9443-b61cbe4b1e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e02dc635-95a2-4f75-8e62-a5e0b5ea6d03" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ca97c4a6-b556-4edf-9443-b61cbe4b1e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5b248b91-7447-4535-990c-a1879287fcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ca97c4a6-b556-4edf-9443-b61cbe4b1e1e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5b248b91-7447-4535-990c-a1879287fcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_bec0b666-a89f-49ab-87cd-8e89ef5d2543" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ca97c4a6-b556-4edf-9443-b61cbe4b1e1e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_bec0b666-a89f-49ab-87cd-8e89ef5d2543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_364f907b-bc4a-4650-b45e-366f9929b7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_dc54addd-5b63-4ee6-aa81-a43e3a71831e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_364f907b-bc4a-4650-b45e-366f9929b7e5" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_dc54addd-5b63-4ee6-aa81-a43e3a71831e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_11e59940-8d91-48b5-9245-3d5f54551229" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_dc54addd-5b63-4ee6-aa81-a43e3a71831e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_11e59940-8d91-48b5-9245-3d5f54551229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3ac13b9a-7d1d-41f4-af2e-6864fe8d6da0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_11e59940-8d91-48b5-9245-3d5f54551229" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3ac13b9a-7d1d-41f4-af2e-6864fe8d6da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_13e15e7a-8225-4e85-b8e9-42d5598482ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3ac13b9a-7d1d-41f4-af2e-6864fe8d6da0" xlink:to="loc_us-gaap_InterestRateSwapMember_13e15e7a-8225-4e85-b8e9-42d5598482ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7cc713db-b2d4-4caa-ac46-85e9558253ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_dc54addd-5b63-4ee6-aa81-a43e3a71831e" xlink:to="loc_us-gaap_HedgingDesignationAxis_7cc713db-b2d4-4caa-ac46-85e9558253ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_564bfc40-e2c5-467f-b1ad-9a8bfb060f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7cc713db-b2d4-4caa-ac46-85e9558253ca" xlink:to="loc_us-gaap_HedgingDesignationDomain_564bfc40-e2c5-467f-b1ad-9a8bfb060f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_64427afb-2eb5-4518-97e2-d85e8e86e0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_564bfc40-e2c5-467f-b1ad-9a8bfb060f0b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_64427afb-2eb5-4518-97e2-d85e8e86e0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f396c62-2422-4856-a61e-227b4985f3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_dc54addd-5b63-4ee6-aa81-a43e3a71831e" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f396c62-2422-4856-a61e-227b4985f3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_111f4f60-621b-49be-9545-00d5e5ce7c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f396c62-2422-4856-a61e-227b4985f3cb" xlink:to="loc_us-gaap_DerivativeNotionalAmount_111f4f60-621b-49be-9545-00d5e5ce7c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociBeforeTaxAttributableToParent_b2a19d00-c203-47c5-9bf3-ba8521a3de61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AociBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8f396c62-2422-4856-a61e-227b4985f3cb" xlink:to="loc_us-gaap_AociBeforeTaxAttributableToParent_b2a19d00-c203-47c5-9bf3-ba8521a3de61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_be19b802-fe5b-41e9-a449-9cc9d0979cec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_be19b802-fe5b-41e9-a449-9cc9d0979cec" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7ec03e96-3426-4093-a7e5-39336c92e532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7ec03e96-3426-4093-a7e5-39336c92e532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8adac579-ff35-42c7-8888-fc00686d38ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7ec03e96-3426-4093-a7e5-39336c92e532" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8adac579-ff35-42c7-8888-fc00686d38ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7be64baa-9b84-4e0a-aaff-f815209e2db1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8adac579-ff35-42c7-8888-fc00686d38ac" xlink:to="loc_us-gaap_InterestRateSwapMember_7be64baa-9b84-4e0a-aaff-f815209e2db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b4f91904-d824-4866-886d-93366bc417ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:to="loc_us-gaap_HedgingDesignationAxis_b4f91904-d824-4866-886d-93366bc417ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_74974ceb-eae7-4486-9af0-1e57ff2f7a75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b4f91904-d824-4866-886d-93366bc417ce" xlink:to="loc_us-gaap_HedgingDesignationDomain_74974ceb-eae7-4486-9af0-1e57ff2f7a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d6181f89-12bb-4f0d-83cd-b709b4be82a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_74974ceb-eae7-4486-9af0-1e57ff2f7a75" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d6181f89-12bb-4f0d-83cd-b709b4be82a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_20046cd2-a5ae-415f-84ae-e1aa27463957" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_20046cd2-a5ae-415f-84ae-e1aa27463957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_de046c4b-4c3e-4bdf-b314-1648523c85ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_20046cd2-a5ae-415f-84ae-e1aa27463957" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_de046c4b-4c3e-4bdf-b314-1648523c85ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_7dc40e95-1846-45a6-80b1-914a12c617f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de046c4b-4c3e-4bdf-b314-1648523c85ac" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_7dc40e95-1846-45a6-80b1-914a12c617f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_472e8b07-523e-439a-857d-6f5b45ef5c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_92e33c40-d7a3-4be3-a226-5ef7ba20ebc9" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_472e8b07-523e-439a-857d-6f5b45ef5c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0dae073f-0e7a-400f-b0ae-ac05cd7c4aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_472e8b07-523e-439a-857d-6f5b45ef5c50" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0dae073f-0e7a-400f-b0ae-ac05cd7c4aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a87782cc-6ca2-4508-a85f-fa5e8cc12fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a87782cc-6ca2-4508-a85f-fa5e8cc12fc3" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d5a1cfbf-b30a-4f53-a096-a9498789c67a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d5a1cfbf-b30a-4f53-a096-a9498789c67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_11b31085-6e9f-4c9c-bd84-9b23163a6697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d5a1cfbf-b30a-4f53-a096-a9498789c67a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_11b31085-6e9f-4c9c-bd84-9b23163a6697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_76ccc20f-2b40-462e-8707-04c97c491504" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_11b31085-6e9f-4c9c-bd84-9b23163a6697" xlink:to="loc_us-gaap_CashFlowHedgingMember_76ccc20f-2b40-462e-8707-04c97c491504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_65763c10-3b87-4430-9645-4e62712448d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_65763c10-3b87-4430-9645-4e62712448d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b25b5fd4-371b-4210-a3be-6b0bf2bc8edd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_65763c10-3b87-4430-9645-4e62712448d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b25b5fd4-371b-4210-a3be-6b0bf2bc8edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_63e49761-96e0-4125-bafc-192104e70b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b25b5fd4-371b-4210-a3be-6b0bf2bc8edd" xlink:to="loc_us-gaap_InterestExpenseMember_63e49761-96e0-4125-bafc-192104e70b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_54c16330-6462-4592-a388-56af3fdfc3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_54c16330-6462-4592-a388-56af3fdfc3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_41f21237-1f54-4b43-a406-50fed3d2582f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_54c16330-6462-4592-a388-56af3fdfc3c1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_41f21237-1f54-4b43-a406-50fed3d2582f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d2df6b25-f5e4-45d8-9366-906fc3209886" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_41f21237-1f54-4b43-a406-50fed3d2582f" xlink:to="loc_us-gaap_InterestRateSwapMember_d2df6b25-f5e4-45d8-9366-906fc3209886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_bccf9788-32b3-4dba-9d30-b104f6b7ac83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a1c3ff24-14ea-412d-a7c8-ef61040a6c74" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_bccf9788-32b3-4dba-9d30-b104f6b7ac83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_bfaa0aa8-01ba-4547-bf49-11dea20c894c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_bccf9788-32b3-4dba-9d30-b104f6b7ac83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_bfaa0aa8-01ba-4547-bf49-11dea20c894c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DebtScheduleDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DebtScheduleDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DebtScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d0f77f75-c894-405f-844d-20645cd63ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d0f77f75-c894-405f-844d-20645cd63ca9" xlink:to="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3590a445-b6e2-4df9-951f-e24e94d24fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:to="loc_us-gaap_DebtInstrumentAxis_3590a445-b6e2-4df9-951f-e24e94d24fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_986bdb90-8672-4380-bc70-d89f6f2db252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3590a445-b6e2-4df9-951f-e24e94d24fd3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_986bdb90-8672-4380-bc70-d89f6f2db252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_37ad0d67-ddc9-41cc-9646-7dd3ed9dcb31" xlink:href="ebs-20230630.xsd#ebs_SeniorUnsecuredNotesDueAugust2028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_986bdb90-8672-4380-bc70-d89f6f2db252" xlink:to="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_37ad0d67-ddc9-41cc-9646-7dd3ed9dcb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OtherLongTermDebtFacilityMember_e57a0323-97ee-407b-8a72-ec0c0a31c8fd" xlink:href="ebs-20230630.xsd#ebs_OtherLongTermDebtFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_986bdb90-8672-4380-bc70-d89f6f2db252" xlink:to="loc_ebs_OtherLongTermDebtFacilityMember_e57a0323-97ee-407b-8a72-ec0c0a31c8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_383dd8ca-0326-4483-a1e8-47c4dbe9955f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_383dd8ca-0326-4483-a1e8-47c4dbe9955f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2d20a09b-c929-4455-a38a-6c66838ebea0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_383dd8ca-0326-4483-a1e8-47c4dbe9955f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2d20a09b-c929-4455-a38a-6c66838ebea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_c56db5ec-1caf-4598-817e-97945841c4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2d20a09b-c929-4455-a38a-6c66838ebea0" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_c56db5ec-1caf-4598-817e-97945841c4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_41538ebe-ad52-4aaf-9fb7-78b6f0544e89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2d20a09b-c929-4455-a38a-6c66838ebea0" xlink:to="loc_us-gaap_LineOfCreditMember_41538ebe-ad52-4aaf-9fb7-78b6f0544e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_5adec8e1-0d83-4c30-8e1c-3edf1832fa81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2d20a09b-c929-4455-a38a-6c66838ebea0" xlink:to="loc_us-gaap_SeniorNotesMember_5adec8e1-0d83-4c30-8e1c-3edf1832fa81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_81d8e1ca-a516-42f3-8189-3556b2490a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:to="loc_us-gaap_CreditFacilityAxis_81d8e1ca-a516-42f3-8189-3556b2490a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1f4d96a6-7f15-4654-84db-a58c915a763e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_81d8e1ca-a516-42f3-8189-3556b2490a1d" xlink:to="loc_us-gaap_CreditFacilityDomain_1f4d96a6-7f15-4654-84db-a58c915a763e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3b1b7838-1ed8-4bda-ae45-3a3f739b5e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1f4d96a6-7f15-4654-84db-a58c915a763e" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3b1b7838-1ed8-4bda-ae45-3a3f739b5e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b96c8c6b-6d2a-4927-bb2e-e072e28b2341" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a386fa7e-6093-40ce-8018-74e70b42b213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a386fa7e-6093-40ce-8018-74e70b42b213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_21b6e074-6aae-4ae3-a6df-7dd0426280f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_LongTermDebt_21b6e074-6aae-4ae3-a6df-7dd0426280f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ae440eb5-bd9f-49df-ac7b-ae91390fe477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ae440eb5-bd9f-49df-ac7b-ae91390fe477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_c88a7523-8053-40b0-984b-c5cf3b5884c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_LongTermDebtCurrent_c88a7523-8053-40b0-984b-c5cf3b5884c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_67de124d-4f8a-4f74-8998-20db164873c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a42f660-a913-4d33-b393-7bf0be47ae28" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_67de124d-4f8a-4f74-8998-20db164873c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_810d350d-e150-41c8-9da0-e7a78ca159f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_810d350d-e150-41c8-9da0-e7a78ca159f7" xlink:to="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8700290b-0942-4a56-9fa1-41c99c4e9377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_CreditFacilityAxis_8700290b-0942-4a56-9fa1-41c99c4e9377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4200bc38-5423-446c-999c-5fb1563b10ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8700290b-0942-4a56-9fa1-41c99c4e9377" xlink:to="loc_us-gaap_CreditFacilityDomain_4200bc38-5423-446c-999c-5fb1563b10ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8fbb459d-4dd5-4204-a9ea-c18b9f006f85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_4200bc38-5423-446c-999c-5fb1563b10ce" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8fbb459d-4dd5-4204-a9ea-c18b9f006f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TermLoanFacilityMember_2b13474a-02c8-4019-ac1e-9c81e5ee152b" xlink:href="ebs-20230630.xsd#ebs_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_4200bc38-5423-446c-999c-5fb1563b10ce" xlink:to="loc_ebs_TermLoanFacilityMember_2b13474a-02c8-4019-ac1e-9c81e5ee152b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f2b3497a-af28-45f4-b6b8-adf5bbb52016" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_DebtInstrumentAxis_f2b3497a-af28-45f4-b6b8-adf5bbb52016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_aa3f0832-7a13-4cd5-b39f-bcb7a8ab88cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f2b3497a-af28-45f4-b6b8-adf5bbb52016" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_aa3f0832-7a13-4cd5-b39f-bcb7a8ab88cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_7e887d5f-84e7-423a-a7b3-cfe4e457f80d" xlink:href="ebs-20230630.xsd#ebs_SeniorUnsecuredNotesDueAugust2028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa3f0832-7a13-4cd5-b39f-bcb7a8ab88cb" xlink:to="loc_ebs_SeniorUnsecuredNotesDueAugust2028Member_7e887d5f-84e7-423a-a7b3-cfe4e457f80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AmendedCreditAgreementMember_da2554f8-e0df-42ce-8c42-3932620dfa0a" xlink:href="ebs-20230630.xsd#ebs_AmendedCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa3f0832-7a13-4cd5-b39f-bcb7a8ab88cb" xlink:to="loc_ebs_AmendedCreditAgreementMember_da2554f8-e0df-42ce-8c42-3932620dfa0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3aac0da9-1957-4db1-babe-4b8197d7e5cd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_srt_RangeAxis_3aac0da9-1957-4db1-babe-4b8197d7e5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b66783e-10e9-4967-b357-dbc2c0377d4b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3aac0da9-1957-4db1-babe-4b8197d7e5cd" xlink:to="loc_srt_RangeMember_2b66783e-10e9-4967-b357-dbc2c0377d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_902ec8e6-809c-4d0a-8360-12a5086f4e04" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2b66783e-10e9-4967-b357-dbc2c0377d4b" xlink:to="loc_srt_MaximumMember_902ec8e6-809c-4d0a-8360-12a5086f4e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fecbf034-8ff8-4600-b5a7-c12459b6276d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2b66783e-10e9-4967-b357-dbc2c0377d4b" xlink:to="loc_srt_MinimumMember_fecbf034-8ff8-4600-b5a7-c12459b6276d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c64d25b8-7755-4c7e-9642-209ec4eb72c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c64d25b8-7755-4c7e-9642-209ec4eb72c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_feb95f12-7522-4920-aeea-34e038dbded6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c64d25b8-7755-4c7e-9642-209ec4eb72c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_feb95f12-7522-4920-aeea-34e038dbded6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d29802b4-525e-43cd-ae5c-407b6150d766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_feb95f12-7522-4920-aeea-34e038dbded6" xlink:to="loc_us-gaap_SeniorNotesMember_d29802b4-525e-43cd-ae5c-407b6150d766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7d41665f-2387-4a92-8c88-dc4902d52b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_feb95f12-7522-4920-aeea-34e038dbded6" xlink:to="loc_us-gaap_LineOfCreditMember_7d41665f-2387-4a92-8c88-dc4902d52b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_5abfb33c-fbe2-4827-ad64-7d90795048d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_feb95f12-7522-4920-aeea-34e038dbded6" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_5abfb33c-fbe2-4827-ad64-7d90795048d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_354f6884-45ed-4267-9ac7-28792602f59a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_354f6884-45ed-4267-9ac7-28792602f59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_04eb4666-fcc6-423b-9812-ea680820ac2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_354f6884-45ed-4267-9ac7-28792602f59a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_04eb4666-fcc6-423b-9812-ea680820ac2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_b3708491-32b9-483b-bef3-bc373640d858" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_04eb4666-fcc6-423b-9812-ea680820ac2a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_b3708491-32b9-483b-bef3-bc373640d858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_7d082e3d-458b-483d-881b-6b9498656672" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_04eb4666-fcc6-423b-9812-ea680820ac2a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_7d082e3d-458b-483d-881b-6b9498656672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_99a6e2da-ac8d-4762-be00-3c5af2a12ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_99a6e2da-ac8d-4762-be00-3c5af2a12ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_502d1b40-e7c0-4898-b135-93287a101c45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99a6e2da-ac8d-4762-be00-3c5af2a12ce9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_502d1b40-e7c0-4898-b135-93287a101c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_09b62ff1-f9cc-447b-9c44-9e298ac3aafd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_502d1b40-e7c0-4898-b135-93287a101c45" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_09b62ff1-f9cc-447b-9c44-9e298ac3aafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_65a1b483-0382-4d96-aa80-4a44442d33e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_65a1b483-0382-4d96-aa80-4a44442d33e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_794a9a0c-3020-4061-9c98-ce58288eed58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_65a1b483-0382-4d96-aa80-4a44442d33e5" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_794a9a0c-3020-4061-9c98-ce58288eed58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TravelHealthBusinessMember_73b10ab4-427e-42a3-a61c-2c217935755a" xlink:href="ebs-20230630.xsd#ebs_TravelHealthBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_794a9a0c-3020-4061-9c98-ce58288eed58" xlink:to="loc_ebs_TravelHealthBusinessMember_73b10ab4-427e-42a3-a61c-2c217935755a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtTermsAxis_0c147fea-bfc7-4bcb-9a62-08aad0321561" xlink:href="ebs-20230630.xsd#ebs_DebtTermsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_ebs_DebtTermsAxis_0c147fea-bfc7-4bcb-9a62-08aad0321561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:href="ebs-20230630.xsd#ebs_DebtTermsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_DebtTermsAxis_0c147fea-bfc7-4bcb-9a62-08aad0321561" xlink:to="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiscalQuartersEndingIn2024Member_f67024a8-cfe1-4aab-8463-24cb2a5d6a09" xlink:href="ebs-20230630.xsd#ebs_FiscalQuartersEndingIn2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:to="loc_ebs_FiscalQuartersEndingIn2024Member_f67024a8-cfe1-4aab-8463-24cb2a5d6a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiscalQuartersEndingAfter2024Member_6e073b23-bd71-483e-acfb-8201120d467d" xlink:href="ebs-20230630.xsd#ebs_FiscalQuartersEndingAfter2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:to="loc_ebs_FiscalQuartersEndingAfter2024Member_6e073b23-bd71-483e-acfb-8201120d467d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_UntilMarch312024Member_5cbe1dd1-cbb1-4df4-941b-0e93ae1e0403" xlink:href="ebs-20230630.xsd#ebs_UntilMarch312024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:to="loc_ebs_UntilMarch312024Member_5cbe1dd1-cbb1-4df4-941b-0e93ae1e0403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiscalQuartersEndingAfterMarch312024Member_f50412c1-87e8-48c1-8468-7189b7d4887f" xlink:href="ebs-20230630.xsd#ebs_FiscalQuartersEndingAfterMarch312024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_DebtTermsDomain_f9c7ceb7-2492-45eb-828b-979215273a9c" xlink:to="loc_ebs_FiscalQuartersEndingAfterMarch312024Member_f50412c1-87e8-48c1-8468-7189b7d4887f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2f6581b3-3994-4ffd-9a74-94a5aa356526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_VariableRateAxis_2f6581b3-3994-4ffd-9a74-94a5aa356526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_2f6581b3-3994-4ffd-9a74-94a5aa356526" xlink:to="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SOFREURIBOROrCDORMember_a75ebb0b-f14b-4dea-9ace-70a70570dcf3" xlink:href="ebs-20230630.xsd#ebs_SOFREURIBOROrCDORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:to="loc_ebs_SOFREURIBOROrCDORMember_a75ebb0b-f14b-4dea-9ace-70a70570dcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_def95771-e172-4ceb-89c7-4f2e81f9ba62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_def95771-e172-4ceb-89c7-4f2e81f9ba62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SecuredOvernightFinancingRateSOFRMember_f4baff30-0b71-4d6c-a8ee-ea3fca014a75" xlink:href="ebs-20230630.xsd#ebs_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:to="loc_ebs_SecuredOvernightFinancingRateSOFRMember_f4baff30-0b71-4d6c-a8ee-ea3fca014a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_d1965038-d9b7-40d2-baa3-5d21d2f15b04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b7a18772-69b2-4623-95c0-fd4e822ded1a" xlink:to="loc_us-gaap_BaseRateMember_d1965038-d9b7-40d2-baa3-5d21d2f15b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_248a5875-8d0c-4d21-b598-85fec65826cd" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet_1485a230-5d8c-46f4-a65b-156be30e5e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsCurrentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet_1485a230-5d8c-46f4-a65b-156be30e5e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a8a5d2fd-38d4-4ee2-b612-eb3b80432758" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a8a5d2fd-38d4-4ee2-b612-eb3b80432758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a1cb4159-7068-4128-85b0-2b87ac195554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_LongTermDebt_a1cb4159-7068-4128-85b0-2b87ac195554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_9d610e88-e11c-4235-b362-bbe751942903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_9d610e88-e11c-4235-b362-bbe751942903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_701ac722-e986-49e9-8d8d-009a4892a31a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_701ac722-e986-49e9-8d8d-009a4892a31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_70714af1-191e-4a71-a79b-8188ac1c7d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_70714af1-191e-4a71-a79b-8188ac1c7d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_dc1cbc00-10c2-4676-ba7a-89c818829b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_Cash_dc1cbc00-10c2-4676-ba7a-89c818829b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_adc5f451-d660-48e5-aa94-433b2bd07756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_adc5f451-d660-48e5-aa94-433b2bd07756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_ac305162-a540-4597-93db-c5964a61881c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_ac305162-a540-4597-93db-c5964a61881c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum_28962e12-15c3-4b78-87d3-19dc6c7a4c23" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum_28962e12-15c3-4b78-87d3-19dc6c7a4c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantLeverageRatioMaximum_63ba5009-9b02-460b-b57b-53e1bffb98b1" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_ebs_DebtInstrumentCovenantLeverageRatioMaximum_63ba5009-9b02-460b-b57b-53e1bffb98b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_DebtInstrumentCovenantConsiderationThreshold_da3ab6a0-6e6e-40d7-aeeb-a9b9b29fee4a" xlink:href="ebs-20230630.xsd#ebs_DebtInstrumentCovenantConsiderationThreshold"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_ebs_DebtInstrumentCovenantConsiderationThreshold_da3ab6a0-6e6e-40d7-aeeb-a9b9b29fee4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_47b87bdf-777b-41da-b7da-3545847cd183" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_47b87bdf-777b-41da-b7da-3545847cd183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e692d5d5-a91f-4fdc-bcb7-3cedc2e1573f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5217222-764c-4d64-b27f-f33702c2529b" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e692d5d5-a91f-4fdc-bcb7-3cedc2e1573f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_e9deba65-81af-4013-926e-d952e5ace545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e9deba65-81af-4013-926e-d952e5ace545" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_132f2423-6bc3-4dd5-96c2-7b4fcb438d08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:to="loc_us-gaap_VestingAxis_132f2423-6bc3-4dd5-96c2-7b4fcb438d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_daa254eb-d7c9-4e07-96c4-b3a1d1d43d72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_132f2423-6bc3-4dd5-96c2-7b4fcb438d08" xlink:to="loc_us-gaap_VestingDomain_daa254eb-d7c9-4e07-96c4-b3a1d1d43d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_22e1dc6b-279d-4d29-9e78-0da21305d1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_daa254eb-d7c9-4e07-96c4-b3a1d1d43d72" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_22e1dc6b-279d-4d29-9e78-0da21305d1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_8bac9f87-2391-4d61-8d4e-71a5f8f9392d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_daa254eb-d7c9-4e07-96c4-b3a1d1d43d72" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_8bac9f87-2391-4d61-8d4e-71a5f8f9392d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_39f164b3-fe1f-469e-a6a2-a2d8a40704d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_daa254eb-d7c9-4e07-96c4-b3a1d1d43d72" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_39f164b3-fe1f-469e-a6a2-a2d8a40704d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_91b6f51e-aa89-4f0c-9780-6f2880f10fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:to="loc_us-gaap_AwardTypeAxis_91b6f51e-aa89-4f0c-9780-6f2880f10fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83dc3a5e-1484-43f5-8421-23fc216d8bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_91b6f51e-aa89-4f0c-9780-6f2880f10fd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83dc3a5e-1484-43f5-8421-23fc216d8bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2210cdec-7ad8-4abb-a5dc-7ac244d8bcdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83dc3a5e-1484-43f5-8421-23fc216d8bf1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2210cdec-7ad8-4abb-a5dc-7ac244d8bcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_325215f7-6066-402b-b336-fa6f41549ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83dc3a5e-1484-43f5-8421-23fc216d8bf1" xlink:to="loc_us-gaap_PerformanceSharesMember_325215f7-6066-402b-b336-fa6f41549ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_dd48ebfc-ef1a-425d-9238-12133f921acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83dc3a5e-1484-43f5-8421-23fc216d8bf1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_dd48ebfc-ef1a-425d-9238-12133f921acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d386b541-9e3e-4936-b447-e45362d3383d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d386b541-9e3e-4936-b447-e45362d3383d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_364365a6-7531-4a7a-bc1a-7104d51483d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d386b541-9e3e-4936-b447-e45362d3383d" xlink:to="loc_us-gaap_EquityComponentDomain_364365a6-7531-4a7a-bc1a-7104d51483d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_da537185-c4cf-4984-acc6-098d407e0423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_364365a6-7531-4a7a-bc1a-7104d51483d7" xlink:to="loc_us-gaap_TreasuryStockCommonMember_da537185-c4cf-4984-acc6-098d407e0423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c56c946f-44e5-4a43-897a-a62b64aff46a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_364365a6-7531-4a7a-bc1a-7104d51483d7" xlink:to="loc_us-gaap_CommonStockMember_c56c946f-44e5-4a43-897a-a62b64aff46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_18667827-a378-4d31-a9c6-eb1f882587e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_18667827-a378-4d31-a9c6-eb1f882587e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1bfcfbe2-2d3c-4094-a282-94862f1d993b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_18667827-a378-4d31-a9c6-eb1f882587e3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1bfcfbe2-2d3c-4094-a282-94862f1d993b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AtTheMarketOfferingMember_ee4e6866-c375-4623-85bc-67f3ab96df43" xlink:href="ebs-20230630.xsd#ebs_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1bfcfbe2-2d3c-4094-a282-94862f1d993b" xlink:to="loc_ebs_AtTheMarketOfferingMember_ee4e6866-c375-4623-85bc-67f3ab96df43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb433af1-4b67-42ea-a70d-d206290217ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5ad514b5-9bb0-4cd4-b60d-e966167ef3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5ad514b5-9bb0-4cd4-b60d-e966167ef3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6563c49b-459c-44d3-b900-b531897d07ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6563c49b-459c-44d3-b900-b531897d07ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage_082f670d-29ec-4899-94ba-4d96a6bf0752" xlink:href="ebs-20230630.xsd#ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage_082f670d-29ec-4899-94ba-4d96a6bf0752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_cd81dc8f-086f-4acb-8089-039f7eab9113" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_cd81dc8f-086f-4acb-8089-039f7eab9113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cb834b6d-f5aa-4518-9a1d-22e4f9e1c9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cb834b6d-f5aa-4518-9a1d-22e4f9e1c9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_6d84df24-28cd-473a-b4fc-0f0532d30f86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_6d84df24-28cd-473a-b4fc-0f0532d30f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c9a5de33-a9b3-422c-865e-acefd01552f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c9a5de33-a9b3-422c-865e-acefd01552f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f2727d71-10a1-49d2-9a9f-9c4c8f0fa5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f2727d71-10a1-49d2-9a9f-9c4c8f0fa5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_476fda79-9357-491e-8db6-db6ac3e62fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_476fda79-9357-491e-8db6-db6ac3e62fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_54dd70eb-e520-420d-b638-c70144ad0e94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_54dd70eb-e520-420d-b638-c70144ad0e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6bb3d984-14f5-4f42-8407-8c5d067703d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6bb3d984-14f5-4f42-8407-8c5d067703d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SaleOfStockConsiderationReceivedOnTransactionGross_7ed000d6-f029-4481-a41f-2abd2e18e594" xlink:href="ebs-20230630.xsd#ebs_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_ebs_SaleOfStockConsiderationReceivedOnTransactionGross_7ed000d6-f029-4481-a41f-2abd2e18e594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_71802552-3191-48ab-8a27-bf604caf5f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_71802552-3191-48ab-8a27-bf604caf5f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares_f19cd522-0b6e-408f-ab9f-f5f562a3c7b3" xlink:href="ebs-20230630.xsd#ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23b82022-159f-4dc1-aeb6-4f9308093b43" xlink:to="loc_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares_f19cd522-0b6e-408f-ab9f-f5f562a3c7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_4cf6c129-0c5c-4198-9816-20ddef51e8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_36488739-0ee4-4eb5-86a1-8a0ca25e3af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4cf6c129-0c5c-4198-9816-20ddef51e8b9" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_36488739-0ee4-4eb5-86a1-8a0ca25e3af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e963e9a5-3411-4f13-828a-ee54fab0964f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_36488739-0ee4-4eb5-86a1-8a0ca25e3af9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e963e9a5-3411-4f13-828a-ee54fab0964f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4bcb9450-1c5f-40e0-9fba-04ca32f848b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e963e9a5-3411-4f13-828a-ee54fab0964f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4bcb9450-1c5f-40e0-9fba-04ca32f848b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_79369a15-499f-4c99-a2b4-0aa86c324548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4bcb9450-1c5f-40e0-9fba-04ca32f848b6" xlink:to="loc_us-gaap_CostOfSalesMember_79369a15-499f-4c99-a2b4-0aa86c324548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_7ecc02e7-f02b-4045-a324-9ffdc281f8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4bcb9450-1c5f-40e0-9fba-04ca32f848b6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_7ecc02e7-f02b-4045-a324-9ffdc281f8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a8516d8e-47f2-4054-88e8-cae9d06ce3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4bcb9450-1c5f-40e0-9fba-04ca32f848b6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a8516d8e-47f2-4054-88e8-cae9d06ce3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f10db6a0-fcff-44e2-9b14-48c66bba4904" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_36488739-0ee4-4eb5-86a1-8a0ca25e3af9" xlink:to="loc_srt_ProductOrServiceAxis_f10db6a0-fcff-44e2-9b14-48c66bba4904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1cf81148-5947-4b03-9606-63dabe60ea48" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f10db6a0-fcff-44e2-9b14-48c66bba4904" xlink:to="loc_srt_ProductsAndServicesDomain_1cf81148-5947-4b03-9606-63dabe60ea48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_4c1b0b74-8bcd-464e-8536-facd0df55b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1cf81148-5947-4b03-9606-63dabe60ea48" xlink:to="loc_us-gaap_ProductMember_4c1b0b74-8bcd-464e-8536-facd0df55b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_2feca299-8343-44c6-a182-95af33795247" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1cf81148-5947-4b03-9606-63dabe60ea48" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingMember_2feca299-8343-44c6-a182-95af33795247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6c4eaf8c-7f1e-4a67-b200-ceae100568a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_36488739-0ee4-4eb5-86a1-8a0ca25e3af9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6c4eaf8c-7f1e-4a67-b200-ceae100568a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_33f97a2c-6e5c-4844-996a-c943ca31b12b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6c4eaf8c-7f1e-4a67-b200-ceae100568a1" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_33f97a2c-6e5c-4844-996a-c943ca31b12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_06748453-4467-415f-8c49-9f2d32687fec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_550c5796-db1b-46b6-bb9b-d124feb037c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_06748453-4467-415f-8c49-9f2d32687fec" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_550c5796-db1b-46b6-bb9b-d124feb037c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_545b1ff6-9ca9-4a5d-8885-cb7c127eb8db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_550c5796-db1b-46b6-bb9b-d124feb037c7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_545b1ff6-9ca9-4a5d-8885-cb7c127eb8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_720d1297-9949-443e-ada1-f6f7252d8b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_545b1ff6-9ca9-4a5d-8885-cb7c127eb8db" xlink:to="loc_us-gaap_EquityComponentDomain_720d1297-9949-443e-ada1-f6f7252d8b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3071ee3b-0315-44ab-8a34-ef58e5a7cdf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_720d1297-9949-443e-ada1-f6f7252d8b70" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3071ee3b-0315-44ab-8a34-ef58e5a7cdf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_ea874f47-c07b-40a6-beee-b7c0128b5c04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3071ee3b-0315-44ab-8a34-ef58e5a7cdf7" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_ea874f47-c07b-40a6-beee-b7c0128b5c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ac8766fe-147f-40ef-8175-7707f54f6469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3071ee3b-0315-44ab-8a34-ef58e5a7cdf7" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ac8766fe-147f-40ef-8175-7707f54f6469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_16babb87-0f3c-4093-afb5-220a327e5cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3071ee3b-0315-44ab-8a34-ef58e5a7cdf7" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_16babb87-0f3c-4093-afb5-220a327e5cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b8652ef0-5939-41cc-8fc3-dad7027a7605" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_550c5796-db1b-46b6-bb9b-d124feb037c7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b8652ef0-5939-41cc-8fc3-dad7027a7605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b8652ef0-5939-41cc-8fc3-dad7027a7605" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a32611a3-45c9-4b31-b33f-1d9e020f3288" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:to="loc_us-gaap_StockholdersEquity_a32611a3-45c9-4b31-b33f-1d9e020f3288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_b14e9e43-0a9c-414d-a41f-a3a31d573d90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_b14e9e43-0a9c-414d-a41f-a3a31d573d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_49eaecd6-4a98-4639-8599-e5f5e4fb865b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_49eaecd6-4a98-4639-8599-e5f5e4fb865b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a171b21e-9aa7-4f79-9a61-c8c359f75c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a171b21e-9aa7-4f79-9a61-c8c359f75c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c3269027-b06d-4bc5-9342-62ccdc710a01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a4bad75c-709b-4464-b0c5-538d25db3f2f" xlink:to="loc_us-gaap_StockholdersEquity_c3269027-b06d-4bc5-9342-62ccdc710a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ec329066-8698-4d32-a5c7-17aeb06eb2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9f20e761-32e5-43e6-a3fa-ffb12c0a0ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ec329066-8698-4d32-a5c7-17aeb06eb2d2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9f20e761-32e5-43e6-a3fa-ffb12c0a0ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_bccdff50-1ce4-4c3d-96d1-79dc3e1be931" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9f20e761-32e5-43e6-a3fa-ffb12c0a0ab1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_bccdff50-1ce4-4c3d-96d1-79dc3e1be931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bfd786c0-f142-4a52-b735-f0a2a78e4dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bccdff50-1ce4-4c3d-96d1-79dc3e1be931" xlink:to="loc_us-gaap_EquityComponentDomain_bfd786c0-f142-4a52-b735-f0a2a78e4dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e9f8a57f-98f1-485c-9831-9fd2b9830219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bfd786c0-f142-4a52-b735-f0a2a78e4dd2" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e9f8a57f-98f1-485c-9831-9fd2b9830219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f348646a-35d8-4d80-80f0-d0825c01dcc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bfd786c0-f142-4a52-b735-f0a2a78e4dd2" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f348646a-35d8-4d80-80f0-d0825c01dcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_29cc5c5e-91b3-41dd-a855-12546197a987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bfd786c0-f142-4a52-b735-f0a2a78e4dd2" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_29cc5c5e-91b3-41dd-a855-12546197a987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_60f5e33d-e99c-4fda-9a96-e12b9700e427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9f20e761-32e5-43e6-a3fa-ffb12c0a0ab1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_60f5e33d-e99c-4fda-9a96-e12b9700e427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_7cc25634-cc9f-4190-967b-7dea9e6cea25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_60f5e33d-e99c-4fda-9a96-e12b9700e427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_7cc25634-cc9f-4190-967b-7dea9e6cea25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_c150d9a4-0667-4c66-b19c-776dd21c9161" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_60f5e33d-e99c-4fda-9a96-e12b9700e427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_c150d9a4-0667-4c66-b19c-776dd21c9161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7c3194da-5c43-4aa1-959d-ad25d9e218fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_60f5e33d-e99c-4fda-9a96-e12b9700e427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7c3194da-5c43-4aa1-959d-ad25d9e218fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LosspercommonshareDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#LosspercommonshareDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LosspercommonshareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_70500fc0-2a0c-4434-9f0c-6f858fca5862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a3bd043d-ec07-46c4-a862-ff0dd3f5d5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70500fc0-2a0c-4434-9f0c-6f858fca5862" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a3bd043d-ec07-46c4-a862-ff0dd3f5d5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_25ac9214-6dd9-475e-9a93-d139dbe4ef37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a3bd043d-ec07-46c4-a862-ff0dd3f5d5b8" xlink:to="loc_us-gaap_NetIncomeLoss_25ac9214-6dd9-475e-9a93-d139dbe4ef37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a2770a87-12fa-4f7d-99b9-8295c3b08ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70500fc0-2a0c-4434-9f0c-6f858fca5862" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a2770a87-12fa-4f7d-99b9-8295c3b08ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32c7a4ec-2fd8-465a-ace1-635c2f0f1193" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a2770a87-12fa-4f7d-99b9-8295c3b08ba8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32c7a4ec-2fd8-465a-ace1-635c2f0f1193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19df5374-ca5b-42b5-bb43-c5f3e491b960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a2770a87-12fa-4f7d-99b9-8295c3b08ba8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19df5374-ca5b-42b5-bb43-c5f3e491b960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3ab262a0-e712-4e32-a207-7480ff5c8269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70500fc0-2a0c-4434-9f0c-6f858fca5862" xlink:to="loc_us-gaap_EarningsPerShareBasic_3ab262a0-e712-4e32-a207-7480ff5c8269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e9bb553c-2770-46d4-8020-9852c909f278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70500fc0-2a0c-4434-9f0c-6f858fca5862" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e9bb553c-2770-46d4-8020-9852c909f278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ba1ccf5b-dbf7-482d-9dbe-6c87179f3479" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70500fc0-2a0c-4434-9f0c-6f858fca5862" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ba1ccf5b-dbf7-482d-9dbe-6c87179f3479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RevenuerecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6b163d2a-56d9-43ed-8aa5-52e563348f80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6b163d2a-56d9-43ed-8aa5-52e563348f80" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:to="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8b69db38-06be-4e19-9bc1-2419728bf62f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_498c7ed2-4bd3-4d0f-a2f2-a6cde9f97e91" xlink:to="loc_srt_NameOfMajorCustomerDomain_8b69db38-06be-4e19-9bc1-2419728bf62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_JansenPharmaceuticalsIncMember_983cf3fc-1d92-41fb-9117-fa574a41f1ac" xlink:href="ebs-20230630.xsd#ebs_JansenPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8b69db38-06be-4e19-9bc1-2419728bf62f" xlink:to="loc_ebs_JansenPharmaceuticalsIncMember_983cf3fc-1d92-41fb-9117-fa574a41f1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:to="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5987d9db-b156-4153-88c0-5126e9e14c4e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4b3e9949-7162-416c-b0ef-43c6490f977f" xlink:to="loc_srt_ProductsAndServicesDomain_5987d9db-b156-4153-88c0-5126e9e14c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_eab07988-05c8-4130-b6cb-a654c2fd9f85" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingLeasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5987d9db-b156-4153-88c0-5126e9e14c4e" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_eab07988-05c8-4130-b6cb-a654c2fd9f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ce8ee37f-4254-40b2-a824-41f68778b45d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ce8ee37f-4254-40b2-a824-41f68778b45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9a177e34-1c85-471c-a1e1-d7044daf09c3" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_09cfbc68-5e51-49dc-b587-0d8354ac297e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_09cfbc68-5e51-49dc-b587-0d8354ac297e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_12addc2d-41ed-41e5-845d-3bd5b3477a53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_12addc2d-41ed-41e5-845d-3bd5b3477a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_08784b55-0f57-491d-bf1a-f3eb0f8b03ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_08784b55-0f57-491d-bf1a-f3eb0f8b03ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_cddf39c8-43e2-4dae-8efa-cdf37ec96987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_cddf39c8-43e2-4dae-8efa-cdf37ec96987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_0e55cc8d-6f48-4782-97b5-c0a084db0b85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_0e55cc8d-6f48-4782-97b5-c0a084db0b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_f002585a-fc6a-4a06-86e1-ca6683488e49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_f002585a-fc6a-4a06-86e1-ca6683488e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_a7c5bfb6-775f-40c0-a364-0b74e3da4b07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_a7c5bfb6-775f-40c0-a364-0b74e3da4b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_12705f9c-0239-4d89-9423-5a62423e63e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_12705f9c-0239-4d89-9423-5a62423e63e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_03ac0478-3820-458c-9aaa-d5d59475a176" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_03ac0478-3820-458c-9aaa-d5d59475a176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_2c17e72b-3db4-40b8-b141-4bc2506ddde3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_2c17e72b-3db4-40b8-b141-4bc2506ddde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour_766dbdf8-21cb-4d84-86e1-8a16ab6d85d5" xlink:href="ebs-20230630.xsd#ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour_766dbdf8-21cb-4d84-86e1-8a16ab6d85d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_abf33b6b-cf82-4b88-b1a4-8c0572c816a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_abf33b6b-cf82-4b88-b1a4-8c0572c816a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e00d36d4-e032-46b1-8095-4e10a63e2494" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_e00d36d4-e032-46b1-8095-4e10a63e2494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_936ce840-1690-47f1-988f-e69283e24cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_936ce840-1690-47f1-988f-e69283e24cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bd5ca676-c013-46a6-b33e-1cf80f623211" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e80f9be5-c308-42be-b937-18129e78926d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bd5ca676-c013-46a6-b33e-1cf80f623211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails_1" xlink:type="simple" xlink:href="ebs-20230630.xsd#RevenuerecognitionNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RevenuerecognitionDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_303e0afa-64f1-4aea-91d5-584f02c0a0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_cf2cb1a7-8a5b-4b56-8519-8b4f0e9cc5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_303e0afa-64f1-4aea-91d5-584f02c0a0a3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_cf2cb1a7-8a5b-4b56-8519-8b4f0e9cc5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c39c8186-a7a0-4b54-96cd-961e311e82fe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_cf2cb1a7-8a5b-4b56-8519-8b4f0e9cc5f2" xlink:to="loc_srt_ProductOrServiceAxis_c39c8186-a7a0-4b54-96cd-961e311e82fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4112487c-a5e8-4451-94a5-c6e9413f8ae8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c39c8186-a7a0-4b54-96cd-961e311e82fe" xlink:to="loc_srt_ProductsAndServicesDomain_4112487c-a5e8-4451-94a5-c6e9413f8ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_b7581523-5261-4c15-bf10-ea28987cb433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4112487c-a5e8-4451-94a5-c6e9413f8ae8" xlink:to="loc_us-gaap_ProductMember_b7581523-5261-4c15-bf10-ea28987cb433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_b6d905fe-92b7-484a-97f8-9ae144d5fb94" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4112487c-a5e8-4451-94a5-c6e9413f8ae8" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingMember_b6d905fe-92b7-484a-97f8-9ae144d5fb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_892b7a6f-6042-4f13-99d2-c14e01331792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingMember_b6d905fe-92b7-484a-97f8-9ae144d5fb94" xlink:to="loc_us-gaap_ServiceMember_892b7a6f-6042-4f13-99d2-c14e01331792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_75110b4a-b92f-4e67-84fe-477100d509cf" xlink:href="ebs-20230630.xsd#ebs_ContractDevelopmentAndManufacturingLeasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingMember_b6d905fe-92b7-484a-97f8-9ae144d5fb94" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingLeasesMember_75110b4a-b92f-4e67-84fe-477100d509cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractsAndGrantsMember_bce01b42-5c68-4da8-9d0e-27544a2cb82c" xlink:href="ebs-20230630.xsd#ebs_ContractsAndGrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4112487c-a5e8-4451-94a5-c6e9413f8ae8" xlink:to="loc_ebs_ContractsAndGrantsMember_bce01b42-5c68-4da8-9d0e-27544a2cb82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_5f248647-607b-4f06-a118-9e998bf174dc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_cf2cb1a7-8a5b-4b56-8519-8b4f0e9cc5f2" xlink:to="loc_srt_MajorCustomersAxis_5f248647-607b-4f06-a118-9e998bf174dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_fbeac2dd-4042-4664-9819-2ea2a658e28c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_5f248647-607b-4f06-a118-9e998bf174dc" xlink:to="loc_srt_NameOfMajorCustomerDomain_fbeac2dd-4042-4664-9819-2ea2a658e28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_UnitedStatesGovernmentMember_02ee5e18-e4f8-4ce3-8c09-8ba0184f12fe" xlink:href="ebs-20230630.xsd#ebs_UnitedStatesGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fbeac2dd-4042-4664-9819-2ea2a658e28c" xlink:to="loc_ebs_UnitedStatesGovernmentMember_02ee5e18-e4f8-4ce3-8c09-8ba0184f12fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_NonUnitedStatesGovernmentMember_d095af00-3764-4760-9d8f-db663ce8b205" xlink:href="ebs-20230630.xsd#ebs_NonUnitedStatesGovernmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fbeac2dd-4042-4664-9819-2ea2a658e28c" xlink:to="loc_ebs_NonUnitedStatesGovernmentMember_d095af00-3764-4760-9d8f-db663ce8b205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_cf2cb1a7-8a5b-4b56-8519-8b4f0e9cc5f2" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4698af0-72be-4e9a-bb27-e76acc66852e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4698af0-72be-4e9a-bb27-e76acc66852e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_282022c1-889d-4940-a563-67a979bc5c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_282022c1-889d-4940-a563-67a979bc5c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_7bc5f4ae-176e-466f-a2c1-7815984b9be5" xlink:href="ebs-20230630.xsd#ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:to="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_7bc5f4ae-176e-466f-a2c1-7815984b9be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8b9966c0-1caa-44a9-937a-750306c5463b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_24bce689-c15c-46ca-9ff4-e3ef6569100e" xlink:to="loc_us-gaap_Revenues_8b9966c0-1caa-44a9-937a-750306c5463b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionContractLiabilitiesDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RevenuerecognitionContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_203e075e-4325-4261-9a3b-9e12ce620b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_3baf3648-153f-40dd-b726-84e936b85e7f" xlink:href="ebs-20230630.xsd#ebs_ChangeinContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_203e075e-4325-4261-9a3b-9e12ce620b4a" xlink:to="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_3baf3648-153f-40dd-b726-84e936b85e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_4657d207-19f0-4ce3-abce-383c21982522" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_3baf3648-153f-40dd-b726-84e936b85e7f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_4657d207-19f0-4ce3-abce-383c21982522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_12b4e8cb-06d0-4bf3-9c82-051f63b13dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_3baf3648-153f-40dd-b726-84e936b85e7f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_12b4e8cb-06d0-4bf3-9c82-051f63b13dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_bd273fe9-bf52-485c-9563-54fdb3216933" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_3baf3648-153f-40dd-b726-84e936b85e7f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_bd273fe9-bf52-485c-9563-54fdb3216933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#RevenuerecognitionAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b35ee1a5-4000-4384-aa70-a6364ad47b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_97a7b496-499d-4046-bb4e-83a0150716e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BilledContractReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b35ee1a5-4000-4384-aa70-a6364ad47b3a" xlink:to="loc_us-gaap_BilledContractReceivables_97a7b496-499d-4046-bb4e-83a0150716e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_876fbe03-4f30-4568-8d88-c0c3332d6e22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b35ee1a5-4000-4384-aa70-a6364ad47b3a" xlink:to="loc_us-gaap_UnbilledContractsReceivable_876fbe03-4f30-4568-8d88-c0c3332d6e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_1a90b761-a161-4949-9c8c-1f65386db858" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b35ee1a5-4000-4384-aa70-a6364ad47b3a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_1a90b761-a161-4949-9c8c-1f65386db858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_752bd500-943e-4720-8c34-70bd979b8837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b35ee1a5-4000-4384-aa70-a6364ad47b3a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_752bd500-943e-4720-8c34-70bd979b8837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_360e3016-0cd8-4cb1-b5bf-d3f0c009d94d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_ad50f16c-948e-4160-a3c5-a1289452b9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_360e3016-0cd8-4cb1-b5bf-d3f0c009d94d" xlink:to="loc_us-gaap_LeaseCostAbstract_ad50f16c-948e-4160-a3c5-a1289452b9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e8bc3e11-7443-4346-8a14-12f0aa96a44d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_ad50f16c-948e-4160-a3c5-a1289452b9f5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e8bc3e11-7443-4346-8a14-12f0aa96a44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_56f16f50-ec68-47cb-a99c-ef59e79e10a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_ad50f16c-948e-4160-a3c5-a1289452b9f5" xlink:to="loc_us-gaap_OperatingLeaseExpense_56f16f50-ec68-47cb-a99c-ef59e79e10a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_de3066af-c1c8-46b7-b3f6-563b85222cba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_ad50f16c-948e-4160-a3c5-a1289452b9f5" xlink:to="loc_us-gaap_LeaseCost_de3066af-c1c8-46b7-b3f6-563b85222cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_79c2f5e8-0ff4-4de8-9dbb-41cd08d4da3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6c619258-7022-4e73-96c7-f8d184278432" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79c2f5e8-0ff4-4de8-9dbb-41cd08d4da3f" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6c619258-7022-4e73-96c7-f8d184278432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_9a22aaf8-3e1a-4e0c-b3d2-cf2125cd3e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6c619258-7022-4e73-96c7-f8d184278432" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_9a22aaf8-3e1a-4e0c-b3d2-cf2125cd3e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0e6b4b42-3f91-4d6c-b711-d2c303ea5b31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6c619258-7022-4e73-96c7-f8d184278432" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0e6b4b42-3f91-4d6c-b711-d2c303ea5b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_d8518102-cdbe-4ddd-8faf-fa146c89f965" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6c619258-7022-4e73-96c7-f8d184278432" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_d8518102-cdbe-4ddd-8faf-fa146c89f965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8656afc1-5a49-43dd-b4b6-0ad3af3ec982" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6c619258-7022-4e73-96c7-f8d184278432" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8656afc1-5a49-43dd-b4b6-0ad3af3ec982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_4a7dab20-0bfa-4f68-ba71-3af3c12bf29d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6c619258-7022-4e73-96c7-f8d184278432" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_4a7dab20-0bfa-4f68-ba71-3af3c12bf29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_244204ab-d101-4606-8eb6-c6bbbde4a98d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6c619258-7022-4e73-96c7-f8d184278432" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_244204ab-d101-4606-8eb6-c6bbbde4a98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c0b56675-dafc-4ecc-99e3-aef1e04343ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6c619258-7022-4e73-96c7-f8d184278432" xlink:to="loc_us-gaap_OperatingLeaseLiability_c0b56675-dafc-4ecc-99e3-aef1e04343ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_3f541429-eb4f-4038-980e-8333f48c3f25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79c2f5e8-0ff4-4de8-9dbb-41cd08d4da3f" xlink:to="loc_us-gaap_LeaseCostAbstract_3f541429-eb4f-4038-980e-8333f48c3f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8ff93cfc-6953-4e7d-a8d2-3ce10992899c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_3f541429-eb4f-4038-980e-8333f48c3f25" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8ff93cfc-6953-4e7d-a8d2-3ce10992899c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_67f5f6cf-86eb-4daa-b33e-cc038c330010" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_3f541429-eb4f-4038-980e-8333f48c3f25" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_67f5f6cf-86eb-4daa-b33e-cc038c330010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#IncometaxesDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IncometaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_144ff8f6-66e2-4a20-925a-a50d262a69bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_IncomeTaxesTable_73995289-629a-435b-a629-a7160a812fea" xlink:href="ebs-20230630.xsd#ebs_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_144ff8f6-66e2-4a20-925a-a50d262a69bc" xlink:to="loc_ebs_IncomeTaxesTable_73995289-629a-435b-a629-a7160a812fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_4c23726f-7df4-4582-a693-4b416acca17b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_IncomeTaxesTable_73995289-629a-435b-a629-a7160a812fea" xlink:to="loc_srt_StatementScenarioAxis_4c23726f-7df4-4582-a693-4b416acca17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a67c1296-ccf1-4eda-8d9f-de56d3193130" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_4c23726f-7df4-4582-a693-4b416acca17b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a67c1296-ccf1-4eda-8d9f-de56d3193130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_8ac21866-3b9d-4610-8ec5-982bb4068f85" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a67c1296-ccf1-4eda-8d9f-de56d3193130" xlink:to="loc_srt_ScenarioForecastMember_8ac21866-3b9d-4610-8ec5-982bb4068f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_IncomeTaxesLineItems_494ee538-9b8d-46f8-87cb-b56c0eb324c8" xlink:href="ebs-20230630.xsd#ebs_IncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_IncomeTaxesTable_73995289-629a-435b-a629-a7160a812fea" xlink:to="loc_ebs_IncomeTaxesLineItems_494ee538-9b8d-46f8-87cb-b56c0eb324c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cfae29d-cd05-4baa-96f4-0e27d3df7d45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_IncomeTaxesLineItems_494ee538-9b8d-46f8-87cb-b56c0eb324c8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cfae29d-cd05-4baa-96f4-0e27d3df7d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_59bb0438-0100-48ef-a7e5-4d5ca6134415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_IncomeTaxesLineItems_494ee538-9b8d-46f8-87cb-b56c0eb324c8" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_59bb0438-0100-48ef-a7e5-4d5ca6134415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_26c2b850-a107-4325-8149-650e73e6bdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_IncomeTaxesLineItems_494ee538-9b8d-46f8-87cb-b56c0eb324c8" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_26c2b850-a107-4325-8149-650e73e6bdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentinformationNarrativeDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#SegmentinformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SegmentinformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e617e66f-41da-4cd8-a549-bb87be876a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_9a0bfd88-ce60-4cb3-bfdc-01d36f87c879" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e617e66f-41da-4cd8-a549-bb87be876a7f" xlink:to="loc_us-gaap_NumberOfReportableSegments_9a0bfd88-ce60-4cb3-bfdc-01d36f87c879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_334ca567-bc48-4e3d-9a44-2f82b5d5df6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_64f10e27-043b-4530-8abe-c61cb6490f94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_334ca567-bc48-4e3d-9a44-2f82b5d5df6a" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_64f10e27-043b-4530-8abe-c61cb6490f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c070e8f5-e9a0-4836-b635-8da145590397" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_64f10e27-043b-4530-8abe-c61cb6490f94" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c070e8f5-e9a0-4836-b635-8da145590397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_40bb03cc-1584-4313-ad89-4447d56c5438" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c070e8f5-e9a0-4836-b635-8da145590397" xlink:to="loc_us-gaap_SegmentDomain_40bb03cc-1584-4313-ad89-4447d56c5438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsAndServicesSegmentsMember_1724ebf6-7702-4fbc-987e-4ddb03ebdfd4" xlink:href="ebs-20230630.xsd#ebs_ProductsAndServicesSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_40bb03cc-1584-4313-ad89-4447d56c5438" xlink:to="loc_ebs_ProductsAndServicesSegmentsMember_1724ebf6-7702-4fbc-987e-4ddb03ebdfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember_b6d1a794-9eef-4267-ab55-4d875d2df1e6" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ProductsAndServicesSegmentsMember_1724ebf6-7702-4fbc-987e-4ddb03ebdfd4" xlink:to="loc_ebs_ProductsSegmentMember_b6d1a794-9eef-4267-ab55-4d875d2df1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ServicesSegmentMember_8352ed03-fa3c-42e8-af4f-cb63bc7f4a45" xlink:href="ebs-20230630.xsd#ebs_ServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ProductsAndServicesSegmentsMember_1724ebf6-7702-4fbc-987e-4ddb03ebdfd4" xlink:to="loc_ebs_ServicesSegmentMember_8352ed03-fa3c-42e8-af4f-cb63bc7f4a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2eb2b12d-36fc-4036-9377-c129f0200e9b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_64f10e27-043b-4530-8abe-c61cb6490f94" xlink:to="loc_srt_ProductOrServiceAxis_2eb2b12d-36fc-4036-9377-c129f0200e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_48395648-557c-4bbf-b682-483b60ae7f77" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2eb2b12d-36fc-4036-9377-c129f0200e9b" xlink:to="loc_srt_ProductsAndServicesDomain_48395648-557c-4bbf-b682-483b60ae7f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ContractsAndGrantsMember_ddfadb0a-f8d7-4704-8556-fbe2788bd5b0" xlink:href="ebs-20230630.xsd#ebs_ContractsAndGrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_48395648-557c-4bbf-b682-483b60ae7f77" xlink:to="loc_ebs_ContractsAndGrantsMember_ddfadb0a-f8d7-4704-8556-fbe2788bd5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_64f10e27-043b-4530-8abe-c61cb6490f94" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_657fa41d-b6d5-4c41-a7ea-3a2cb84b5adb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_RevenuesAbstract_657fa41d-b6d5-4c41-a7ea-3a2cb84b5adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f390936f-9c04-4533-a71c-f2a215b0bfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_657fa41d-b6d5-4c41-a7ea-3a2cb84b5adb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f390936f-9c04-4533-a71c-f2a215b0bfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_61ce924f-6ede-4d1b-afe2-e752c1654fe8" xlink:href="ebs-20230630.xsd#ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_657fa41d-b6d5-4c41-a7ea-3a2cb84b5adb" xlink:to="loc_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax_61ce924f-6ede-4d1b-afe2-e752c1654fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_afbcb994-2e9c-4d9c-b364-439f79236aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_657fa41d-b6d5-4c41-a7ea-3a2cb84b5adb" xlink:to="loc_us-gaap_Revenues_afbcb994-2e9c-4d9c-b364-439f79236aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_f34993b1-c05c-4917-9fda-41fdaf709489" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_f34993b1-c05c-4917-9fda-41fdaf709489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a43b537a-e68c-41b1-8455-1e3d0501bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_f34993b1-c05c-4917-9fda-41fdaf709489" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a43b537a-e68c-41b1-8455-1e3d0501bdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f1c796f8-5b3d-401d-ae1a-d39d7851fa5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_GrossProfit_f1c796f8-5b3d-401d-ae1a-d39d7851fa5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfitAbstract_99dbb81a-31f4-4bf7-857e-dfa118cfe2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfitAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_GrossProfitAbstract_99dbb81a-31f4-4bf7-857e-dfa118cfe2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentAbstract_6ab304f1-8227-421c-a4f8-c0ad9a5f3a01" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GrossProfitAbstract_99dbb81a-31f4-4bf7-857e-dfa118cfe2c3" xlink:to="loc_ebs_ProductsSegmentAbstract_6ab304f1-8227-421c-a4f8-c0ad9a5f3a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e02c7c95-1a43-4d01-ac36-e99183c07065" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ProductsSegmentAbstract_6ab304f1-8227-421c-a4f8-c0ad9a5f3a01" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e02c7c95-1a43-4d01-ac36-e99183c07065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_86cf813c-6a25-489e-ab9d-c9968ab2cea6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ProductsSegmentAbstract_6ab304f1-8227-421c-a4f8-c0ad9a5f3a01" xlink:to="loc_us-gaap_RestructuringCosts_86cf813c-6a25-489e-ab9d-c9968ab2cea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_InventoryStepUp_da1887b7-4114-40e1-9840-b1aa79d8aa08" xlink:href="ebs-20230630.xsd#ebs_InventoryStepUp"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ProductsSegmentAbstract_6ab304f1-8227-421c-a4f8-c0ad9a5f3a01" xlink:to="loc_ebs_InventoryStepUp_da1887b7-4114-40e1-9840-b1aa79d8aa08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_AdjustedGrossMargin_47fda82b-69cf-41a6-8664-6fe7d8f60ec0" xlink:href="ebs-20230630.xsd#ebs_AdjustedGrossMargin"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_ebs_AdjustedGrossMargin_47fda82b-69cf-41a6-8664-6fe7d8f60ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_GrossProfitAdjustments_a91f1a59-8d4f-45ac-8e85-e066aae511e6" xlink:href="ebs-20230630.xsd#ebs_GrossProfitAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_ebs_GrossProfitAdjustments_a91f1a59-8d4f-45ac-8e85-e066aae511e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_2e540e99-59f5-4d3e-b49f-885360bbcf61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_2e540e99-59f5-4d3e-b49f-885360bbcf61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c2b51822-0d91-4dc5-a46d-56680785d54f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c2b51822-0d91-4dc5-a46d-56680785d54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a41729e4-e608-4226-b108-3b2b4f07159a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a41729e4-e608-4226-b108-3b2b4f07159a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7965fa4b-1b79-47bb-a9a5-149e57e68ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7965fa4b-1b79-47bb-a9a5-149e57e68ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_943f9df3-314a-4f71-92dc-62cebc66c4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_InterestExpense_943f9df3-314a-4f71-92dc-62cebc66c4d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a8e3acb5-5e62-42e3-ace9-4ba7efc8c10e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a8e3acb5-5e62-42e3-ace9-4ba7efc8c10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b9b2c7c9-224a-4711-ad48-c6497763e651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_69216d86-a2a3-4fca-b711-efbbd65c8854" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b9b2c7c9-224a-4711-ad48-c6497763e651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d563a3b-a87a-4373-8c82-abf5cfd928e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8e888815-e87c-4da7-bfe4-69219c11f4d3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d563a3b-a87a-4373-8c82-abf5cfd928e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_710039e5-e24c-4473-a451-d4749c023fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf960146-2944-4128-8448-b0521776de6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_710039e5-e24c-4473-a451-d4749c023fd0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf960146-2944-4128-8448-b0521776de6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_82bd9266-9d0a-4a55-b76a-b92a30b88f60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf960146-2944-4128-8448-b0521776de6a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_82bd9266-9d0a-4a55-b76a-b92a30b88f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d23aa26-addc-4bd2-aeaf-94630dd21251" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_82bd9266-9d0a-4a55-b76a-b92a30b88f60" xlink:to="loc_us-gaap_SegmentDomain_0d23aa26-addc-4bd2-aeaf-94630dd21251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ProductsSegmentMember_c0c354b2-2ab2-4304-aff4-c7858602e35c" xlink:href="ebs-20230630.xsd#ebs_ProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d23aa26-addc-4bd2-aeaf-94630dd21251" xlink:to="loc_ebs_ProductsSegmentMember_c0c354b2-2ab2-4304-aff4-c7858602e35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ServicesSegmentMember_2843f795-103d-4fdd-a0a0-e384b14968ab" xlink:href="ebs-20230630.xsd#ebs_ServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d23aa26-addc-4bd2-aeaf-94630dd21251" xlink:to="loc_ebs_ServicesSegmentMember_2843f795-103d-4fdd-a0a0-e384b14968ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c3250760-a565-44bc-920c-a3b4605c6bbe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf960146-2944-4128-8448-b0521776de6a" xlink:to="loc_srt_ConsolidationItemsAxis_c3250760-a565-44bc-920c-a3b4605c6bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9b1f3cad-980e-4270-ad1a-f38a4f9a317d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_c3250760-a565-44bc-920c-a3b4605c6bbe" xlink:to="loc_srt_ConsolidationItemsDomain_9b1f3cad-980e-4270-ad1a-f38a4f9a317d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_9f05e0b6-3045-48a0-8ffc-73bb980e79d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9b1f3cad-980e-4270-ad1a-f38a4f9a317d" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_9f05e0b6-3045-48a0-8ffc-73bb980e79d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_63cf26ba-c5a6-4579-acc2-b774f83188ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf960146-2944-4128-8448-b0521776de6a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_63cf26ba-c5a6-4579-acc2-b774f83188ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAbstract_7c35f8b6-49b3-4db5-96e0-3b6f7da3787e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63cf26ba-c5a6-4579-acc2-b774f83188ef" xlink:to="loc_us-gaap_DepreciationAbstract_7c35f8b6-49b3-4db5-96e0-3b6f7da3787e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b92781a0-12bd-46c7-904c-e6515a866051" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DepreciationAbstract_7c35f8b6-49b3-4db5-96e0-3b6f7da3787e" xlink:to="loc_us-gaap_Depreciation_b92781a0-12bd-46c7-904c-e6515a866051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SubsequenteventsDetails" xlink:type="simple" xlink:href="ebs-20230630.xsd#SubsequenteventsDetails"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SubsequenteventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_f24cb7fb-2922-4948-a4fd-c82d54b59f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_f24cb7fb-2922-4948-a4fd-c82d54b59f4f" xlink:to="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_7abd9111-1faa-44ae-83f7-2d04b0556472" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_srt_MajorCustomersAxis_7abd9111-1faa-44ae-83f7-2d04b0556472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_eefa8103-56a2-40df-98ce-129d662b980d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_7abd9111-1faa-44ae-83f7-2d04b0556472" xlink:to="loc_srt_NameOfMajorCustomerDomain_eefa8103-56a2-40df-98ce-129d662b980d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_BARDAMember_df93bd27-937c-481f-9910-f273145e1e16" xlink:href="ebs-20230630.xsd#ebs_BARDAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_eefa8103-56a2-40df-98ce-129d662b980d" xlink:to="loc_ebs_BARDAMember_df93bd27-937c-481f-9910-f273145e1e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_35d9a986-ba99-464a-b352-ae8fcaf3fcdb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_srt_ProductOrServiceAxis_35d9a986-ba99-464a-b352-ae8fcaf3fcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_90f545f7-c79b-4186-9b9a-95632864ea21" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_35d9a986-ba99-464a-b352-ae8fcaf3fcdb" xlink:to="loc_srt_ProductsAndServicesDomain_90f545f7-c79b-4186-9b9a-95632864ea21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_EbangaMember_15108f6d-3a76-41e9-add0-9252687215ba" xlink:href="ebs-20230630.xsd#ebs_EbangaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_90f545f7-c79b-4186-9b9a-95632864ea21" xlink:to="loc_ebs_EbangaMember_15108f6d-3a76-41e9-add0-9252687215ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_b561d142-ab7a-4795-8151-8836b405ca00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_b561d142-ab7a-4795-8151-8836b405ca00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_6752c08a-bdf1-485c-b34f-d72be0e79469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_b561d142-ab7a-4795-8151-8836b405ca00" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_6752c08a-bdf1-485c-b34f-d72be0e79469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_TwoYearOptionMember_a5ae657e-c283-4abe-b92a-9be8f7eb7bdd" xlink:href="ebs-20230630.xsd#ebs_TwoYearOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain_6752c08a-bdf1-485c-b34f-d72be0e79469" xlink:to="loc_ebs_TwoYearOptionMember_a5ae657e-c283-4abe-b92a-9be8f7eb7bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_FiveYearOptionMember_d7a88258-37c7-4c44-ad45-ad5f7b834f2f" xlink:href="ebs-20230630.xsd#ebs_FiveYearOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain_6752c08a-bdf1-485c-b34f-d72be0e79469" xlink:to="loc_ebs_FiveYearOptionMember_d7a88258-37c7-4c44-ad45-ad5f7b834f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_94c74833-cf5a-4716-9a86-75b59f5b8908" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_94c74833-cf5a-4716-9a86-75b59f5b8908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4c7017fc-cc94-4239-a878-40a3f221e7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_94c74833-cf5a-4716-9a86-75b59f5b8908" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4c7017fc-cc94-4239-a878-40a3f221e7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_bd5cac79-12d8-4b6b-adf4-4ee25d8c29d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4c7017fc-cc94-4239-a878-40a3f221e7cd" xlink:to="loc_us-gaap_SubsequentEventMember_bd5cac79-12d8-4b6b-adf4-4ee25d8c29d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8ed59220-4c82-47db-8530-bc65a58c50b7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_srt_CounterpartyNameAxis_8ed59220-4c82-47db-8530-bc65a58c50b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fe169dcc-2f10-457c-94b5-fe056b8bee3c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_8ed59220-4c82-47db-8530-bc65a58c50b7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fe169dcc-2f10-457c-94b5-fe056b8bee3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RidgebackMember_04ed5751-7366-40ce-87e4-503d09b1c180" xlink:href="ebs-20230630.xsd#ebs_RidgebackMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fe169dcc-2f10-457c-94b5-fe056b8bee3c" xlink:to="loc_ebs_RidgebackMember_04ed5751-7366-40ce-87e4-503d09b1c180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_b81425fd-02fc-4065-97b8-be73b260050d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_b81425fd-02fc-4065-97b8-be73b260050d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_495c903c-aeac-4ce0-959d-56d7474e99fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_b81425fd-02fc-4065-97b8-be73b260050d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_495c903c-aeac-4ce0-959d-56d7474e99fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_BARDAContractPayableInThirdQuarterOf2023Member_ccf03aa8-0e0c-42d6-a37a-5fb2656aede7" xlink:href="ebs-20230630.xsd#ebs_BARDAContractPayableInThirdQuarterOf2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_495c903c-aeac-4ce0-959d-56d7474e99fd" xlink:to="loc_ebs_BARDAContractPayableInThirdQuarterOf2023Member_ccf03aa8-0e0c-42d6-a37a-5fb2656aede7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_BARDAContractContractNotCeasedPriorToJune12026Member_5e28cb73-067c-4935-9f06-f2be30ed168c" xlink:href="ebs-20230630.xsd#ebs_BARDAContractContractNotCeasedPriorToJune12026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_495c903c-aeac-4ce0-959d-56d7474e99fd" xlink:to="loc_ebs_BARDAContractContractNotCeasedPriorToJune12026Member_5e28cb73-067c-4935-9f06-f2be30ed168c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_94897c50-bc6f-49bf-af82-b897cad10751" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_us-gaap_RestructuringPlanAxis_94897c50-bc6f-49bf-af82-b897cad10751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_5ccb3f4f-990c-457a-a164-f40084a05a90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_94897c50-bc6f-49bf-af82-b897cad10751" xlink:to="loc_us-gaap_RestructuringPlanDomain_5ccb3f4f-990c-457a-a164-f40084a05a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RestructuringPlanAugust2023Member_d77f5794-c7a2-4490-8b4b-c8b0d016da08" xlink:href="ebs-20230630.xsd#ebs_RestructuringPlanAugust2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_5ccb3f4f-990c-457a-a164-f40084a05a90" xlink:to="loc_ebs_RestructuringPlanAugust2023Member_d77f5794-c7a2-4490-8b4b-c8b0d016da08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_de3fe05d-1bc7-419e-a5a4-3dd852cd024f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_srt_RangeAxis_de3fe05d-1bc7-419e-a5a4-3dd852cd024f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_96764911-67c4-4266-890b-f8ca2668974d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_de3fe05d-1bc7-419e-a5a4-3dd852cd024f" xlink:to="loc_srt_RangeMember_96764911-67c4-4266-890b-f8ca2668974d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a850fbc5-6f22-4fb1-b115-f23b094c2d13" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_96764911-67c4-4266-890b-f8ca2668974d" xlink:to="loc_srt_MinimumMember_a850fbc5-6f22-4fb1-b115-f23b094c2d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5b5add16-218e-411e-9294-8b46e6cae023" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_96764911-67c4-4266-890b-f8ca2668974d" xlink:to="loc_srt_MaximumMember_5b5add16-218e-411e-9294-8b46e6cae023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_0c9a2a57-e047-4996-b16a-91610d0932ff" xlink:to="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RevenueFromContractWithCustomerTermOfContract_9a1e961d-2aaa-455c-ab6e-0449d92047e3" xlink:href="ebs-20230630.xsd#ebs_RevenueFromContractWithCustomerTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_ebs_RevenueFromContractWithCustomerTermOfContract_9a1e961d-2aaa-455c-ab6e-0449d92047e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods_9237a4b2-1e94-430e-9aba-bfe11aea0e72" xlink:href="ebs-20230630.xsd#ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods_9237a4b2-1e94-430e-9aba-bfe11aea0e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_2d155d37-e7c3-406f-81a4-cfb469bbf261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_us-gaap_ContractWithCustomerLiability_2d155d37-e7c3-406f-81a4-cfb469bbf261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ef40459b-b00e-4bd6-8d8d-ca506801ddb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ef40459b-b00e-4bd6-8d8d-ca506801ddb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_f631273c-53c3-4401-bcab-27d52e0a099f" xlink:href="ebs-20230630.xsd#ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_f631273c-53c3-4401-bcab-27d52e0a099f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_682732c7-8230-4cef-afc5-fb224a23703b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_682732c7-8230-4cef-afc5-fb224a23703b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9bf22ccc-5875-413e-adef-ecaa815ae31f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_4e0378a3-8c98-41f9-bb81-22986eb552d2" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9bf22ccc-5875-413e-adef-ecaa815ae31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_PerformanceSharesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ebs-20230630_g1.jpg
<TEXT>
begin 644 ebs-20230630_g1.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #__@ 23$5!1%1/3TQ3('8R,"XP /_; (0
M!04%" 4(# <'# P)"0D,#0P,# P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0$%" @*!PH,!P<,#0P*# T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-_\0!H@
M 04! 0$! 0$           $" P0%!@<("0H+ 0 # 0$! 0$! 0$!
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M &22I"I>1@BCJS$ #MR3P* &PSQW"[X761<XRC!AGTR"1F@"6@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H KI>022&%)(VD&04#J6!'7*@Y&._''>@"Q0 4
M % !0 4 % !0 4 % !0 4 % !0!E7^NZ=I3B*^NK:U=AN59IHXF*Y(W .RDC
M((R.,@CM0!1_X3'0O^@C8?\ @7!_\<H /^$QT+_H(V'_ (%P?_'* #_A,="_
MZ"-A_P"!<'_QR@ _X3'0O^@C8?\ @7!_\<H /^$QT+_H(V'_ (%P?_'* #_A
M,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\ @7!_\<H /^$QT+_H(V'_ (%P?_'*
M #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\ @7!_\<H /^$QT+_H(V'_ (%P
M?_'* #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\ @7!_\<H /^$QT+_H(V'_
M (%P?_'* #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\ @7!_\<H /^$QT+_H
M(V'_ (%P?_'* #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\ @7!_\<H /^$Q
MT+_H(V'_ (%P?_'* #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\ @7!_\<H
M/^$QT+_H(V'_ (%P?_'* #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\ @7!_
M\<H /^$QT+_H(V'_ (%P?_'* #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\
M@7!_\<H /^$QT+_H(V'_ (%P?_'* #_A,="_Z"-A_P"!<'_QR@">V\3Z1>RK
M!;7UG-*YPL<=Q"[L<9PJJY8G )X'2@#<H * "@ H * "@ H * "@ H * "@#
M.U#6+'2=OV^Y@M/,SL\^6.+?MQNV[V7=MW+G&<9&>HH S?\ A,="_P"@C8?^
M!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\
MA,="_P"@C8?^!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\ A,="_P"@C8?^
M!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\
MA,="_P"@C8?^!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\ A,="_P"@C8?^
M!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\
MA,="_P"@C8?^!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\ A,="_P"@C8?^
M!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\ A,="_P"@C8?^!<'_ ,<H /\
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M_A,="_Z"-A_X%P?_ !R@ _X3'0O^@C8?^!<'_P <H /^$QT+_H(V'_@7!_\
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M_BJ #^U;+_GXA_[^I_\ %4 ']JV7_/Q#_P!_4_\ BJ #^U;+_GXA_P"_J?\
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MT+_H(V'_ (%P?_'* #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\ @7!_\<H
M/^$QT+_H(V'_ (%P?_'* #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\ @7!_
M\<H /^$QT+_H(V'_ (%P?_'* #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C8?\
M@7!_\<H /^$QT+_H(V'_ (%P?_'* #_A,="_Z"-A_P"!<'_QR@ _X3'0O^@C
M8?\ @7!_\<H /^$QT+_H(V'_ (%P?_'* 'Q^+=%E81QZA9.[D*JK=0$DDX
M#Y))X ')- '04 % !0 4 % !0 4 % $4T\=LAEF98XUY9G(50/<D@#\30!A'
MQ?H:D@ZC8@C@@W4&0?\ OY0!JV6IVFI*6LYX;E1U,,B2 ?4H2* +M !0 4 ?
ME;4@% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 ?8G[-O_()OO^OM?_1*4T!]'4P"@ H * "@ H * "@ H *
M/,OC)_R*.H_[D/\ Z4PTF!\C_#'XB3^ K_+[I-.N2!<PCDCL)8P<#S$],@.N
M5.#M94,^^[&^@U*".[M'6:"90\<B'*LI&00?Z=0>#@U0BU0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % 'AWQA^)X\(VYTK3'!U2Y3EA@_9HV&-Y])6_Y9*1P/WAX
M"!T!X)\"6+^+868DL8;DDDY))C.23W)[FD,^[*H04 % !0 4 % !0 4 % !0
M 4 % !0!\9_M'_\ (=M/^O!?_1\]2QGSS0(* "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#T7X2_\C9IO_79O_14
ME S]#:H04 % !0 4 % !0 4 % !0 4 % 'RM^TS_ ,PG_M^_]LZ3 ^5J0!0
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MWQ-X=VI%=M=0KC]U=CSUPO10S$2HN.,)(HQCT& 9[QX:_:)TZ]VPZY;O8N<
MS19FASW8K@2H/91,?>G<1[WI.M6.NP"ZTV>*ZA/\<3A@#UVM@Y5O56 8=P*8
M&G0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?"/QY
M_P"1LG_ZX6__ *+%2,\;H$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0![)\!O^1L@_ZX7'_HLT#/NZJ$% !0 4
M % !0 4 % !0 4 % !0!\V?&C_D*6_\ UZC_ -&RUX6,^-?X?U9]GE'\&?\
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M9^T;_P C';?]@V+_ -*;NI8'@% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5=3PRGD?0@FA&O0!^5M2 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0!]B?LV_P#()OO^OM?_ $2E- ?1U, H
M * "@ H * "@ H * "@#S+XR?\BCJ/\ N0_^E,-)@?GU2 ]W^#?Q0/A6X&CZ
MF_\ Q++A_D=CQ:RL?OY_YXN?]8,@(?W@Q\^XV&?;2L' 92"",@CD$'H0>X-4
M(6@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M 4 % !0 4 % !0 4 % !0 4 % !0  XY% 'JGA/XQ>(/"I6(S&^M%X\BY)?
MZ8CE_P!:F!]T;C&/^>9H&?5/@OXOZ)XP*V^\V-ZW'V><@;SZ0R\))[+\DA[1
MX&:8CU6F 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H ]D^ W_(V0?]<+C_ -%F@9]W50@H * "@ H
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M315(SR.@04 % !0 4 % !0!]<_LU?\>6H_\ 7>#_ - >FAGTS3$% !0 4 %
M!0 4 % !0!\6?M&_\C';?]@V+_TINZE@> 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ;?AK_D+67_ %]V
M_P#Z.2@9^F]4(* "@ H * "@#Y=^/WCV2WQX8L'*%T$EZRD@[6YC@^C+B23'
M52B]"P*8S6^#/PJATRWB\0:O&)+R=1);1. 5MXSRDA4\><XPRG_EFI&,.6V@
M$&N_M"_V)J-UIO\ 9?F_8KF:W\S[9MW^3(T>_;]E;;NVYV[FQG&3UHN(RO\
MAIC_ *A/_D]_]QT7 V]$_:-TV]F$6IV<M@C''FI*+A5SW<>7$X7U*JY]C1<#
MTCQMX'TSXCZ<K IYYC#VEXF"0&&Y/F'WX7SEEY&#N7#8- 'RO\/?%-[\,/$#
MZ;J>8[9YOL][$3\J,#M6X7J#LR&W+D20DXSE"%L,^[001D<@U0C\K:D H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@#[$_9M_Y!-]_P!?:_\ HE*: ^CJ8!0 4 % !0 4 % !0 4 % 'F7QD_
MY%'4?]R'_P!*8:3 _/JD 4 ?5'P1^*6/+\,ZQ)Q]VQG<\^UL['_R 2>/]5G'
MEJ&AGU53$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0!ROC+Q?9>"M.?4KXYQ\L40.'FE()6-
M>#C.,LV"$4%B#@ @'YZ^)?$E[XKOY-3U!]\LIX49V1H/NQQ@D[44=!U)RS$L
M23(S!H$>R? ;_D;(/^N%Q_Z+- S[NJA!0 4 % !0 4 % !0 4 % !0 4 % '
MQG^T?_R';3_KP7_T?/4L9\\T""@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H ]%^$O\ R-FF_P#79O\ T5)0,_0V
MJ$% !0 4 % !0 4 % !0 4 % !0!\K?M,_\ ,)_[?O\ VSI,#Y6I % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %  #CD4 >\_
M#[XX7_API9:T7O[ 84.3NN(1_LLQ'FH/[CG(  1U VD&?8VC:U9:_:I?:=*E
MQ;R#Y70]^ZL.JL/XE8!AW%4(TZ "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H \L\>?%G2?! :WS]LU#'%M$P^0]C._(B'?;AI#P0
MFT[@@/C?QA\0M8\;2[M1EVP*<QVT64@3T^3)+MS]^0L_8$+@!#.(H$% !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!N^'_$NI>%KD7FE3O;2\
M!MIRC@'.V1#E'7V8$ \C!P:!GUYX!^.>G^(=EEK6S3KX\!\XMI6XQM9B3$Q_
MNR$KQQ(6(6G<1[S3 * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M /A'X\_\C9/_ -<+?_T6*D9XW0(* "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@#V3X#?\C9!_P!<+C_T6:!GW=5"
M"@ H * "@ H * "@ H * "@ H ^;/C1_R%+?_KU'_HV6O"QGQK_#^K/L\H_@
MS_Q_^VQ/':\T^C"@#3TG5[K0[E+RR<QRQG\&'=6'1E;H0?T(!JX2=-J4'9HP
MJTH5X.G45XO\/-=F?5W@WQK:^+(/EQ%=QC][!GD=MZ9^]&2?JI.UNQ;Z&C65
M9=I+=?JO+\CX+%X.>$EKK3?PR_1]G^>Z\NTKK/-"@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0!EZUK-KX?LY=1OW$5O;KN=C^051W9F(55'+,0!UH _/OQ_XZN_'>HM
M>3YCMH\K;09^6*,GOS@R/@&5NY  PBJ!(SA:!!0![)\!O^1L@_ZX7'_HLT#/
MNZJ$% !0 4 % !0 4 % !0 4 % !0 4 ?&?[1_\ R';3_KP7_P!'SU+&?/-
M@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * /1?A+_R-FF_]=F_]%24#/T-JA!0 4 % !0 4 % !0 4 % !0 4 ?
M*W[3/_,)_P"W[_VSI,#Y6I % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 =KX(\>:CX%N_M-BVZ%R//MV)\J91ZC^%P,
M[) -RYQRI96!GWIX0\8:?XTL5O\ 3FR/NR1-@20OW2103CU5@2K#E3UQ0CJ:
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H AN;F*RB:>X=8
MHHU+.[L%55'4LQP !ZF@#Y,^(WQWENR^F^&&:&'E7O<%9'['[.#S&O\ TT($
MAX*B/&6D9\T.[2,7<EF8DDDY))Y))/))/4T"&T % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0![?\.?C/?>$REAJF^^TT84 G,UN.
MG[IF/SH!_P LG( P-C)R&!GVAHVM66OVJ7VG2I<6\@^5T/?NK#JK#^)6 8=Q
M5"-.@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /A'X\_\C9/_ -<+
M?_T6*D9XW0(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M3=U+ \ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M%8]2M@!<PCC/831CO&_<=8WRIX*,[ ].I@% !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % $-Q<16D33SLL44
M2EW=R%55499F)P  .23P!0!\(?%?XER>.+S[-:%DTNU8^2AX,K\@SN.N2,B-
M3]Q.P9FJ1GD5 @H * /9/@-_R-D'_7"X_P#19H&?=U4(* "@ H * "@ H *
M"@ H * "@ H ^,_VC_\ D.VG_7@O_H^>I8SYYH$% !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Z+\)?^1LTW_KL
MW_HJ2@9^AM4(* "@ H * "@ H * "@ H * "@#Y6_:9_YA/_ &_?^V=)@?*U
M( H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H ZWP7XQO?!&H)J%D<K]V:$DA)H^Z-CN.J-@E&P<$9!!GZ#^&?$EGXK
ML(M3T]]\4HY4XWQN/O1R#^%U/4=""&4E64FA&]0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0!DZYKMEX;LWU#4I5@MXARQY))Z*JC)9V/"JH)/T
MS0!\,?$?XJ7WCJ4P1YM=,C;,=N#RY'22<CAW[J@^2/@ %LNTC/*J!!0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 =KX(\>
M:CX%N_M%BVZ%R//MV)\N91ZC^%P,[) -R]]REE(,^\?!OC/3_&UD+[3GY7"S
M0M_K(7(SM<=P>=CCY7 .#D,!0CK* "@ H * "@ H * "@ H * "@ H * "@
MH * "@#X1^//_(V3_P#7"W_]%BI&>-T""@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H ]D^ W_(V0?\ 7"X_]%F@
M9]W50@H * "@ H * "@ H * "@ H * /FSXT?\A2W_Z]1_Z-EKPL9\:_P_JS
M[/*/X,_\?_ML3QVO-/HPH * "@">WN)+.19X&:.6-@R.IPRL.001T---IW6C
M1$HJ:<))--6:>S1].> OB''XB5;&^(COU'!X5)P.Z]A)CED'!P63C*K[U#$*
MI[D])_@_^#Y?<?$8W /#-U:6M+\8^3\NS^3[OU*O0/#"@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * /@GXY?\ (W7G^Y;?^DT52,\CH$%
M!0 4 % !0 4 ?7/[-7_'EJ/_ %W@_P#0'IH9],TQ!0 4 % !0 4 % !0 4 ?
M%G[1O_(QVW_8-B_]*;NI8'@% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M='P Z$' .5%".NH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MS%55F !\">/O']]X\O3<7),5K$2+>V!RD2GN>FZ5N-\A&3]U0J!5$C.#H$%
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MJ?%T??U\_P _7?XS'9>Z-ZV'5X;RCUCYKO'\O3;V*O4/G0H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * /@GXY?\ (W7G^Y;?^DT52,\CH$%
M!0 4 % !0 4 ?7/[-7_'EJ/_ %W@_P#0'IH9],TQ!0 4 % !0 4 % !0 4 ?
M%G[1O_(QVW_8-B_]*;NI8'@% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M2 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * /L'X >.CJ-LWAN]?,UFN^U+'EH,_-%GN86(*CD^6V  L5-
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH ]D^ W_ "-D'_7"X_\ 19H&?=U4(* "@ H * "@ H * "@ H * "@#YL^-'
M_(4M_P#KU'_HV6O"QGQK_#^K/L\H_@S_ ,?_ +;$\=KS3Z,* "@ H * "@!0
M<<C@B@1[_P##_P")?F;-+UE\-]V*Y=OO>B3$]^RR$_-P'Y^8^QA\3M3JOTD_
MR?\ G]Y\GCLOM>OAEIO*"6WG'R[KITTT7NM>N?+!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0!\$_'+_D;KS_<MO\ TFBJ1GD= @H * "@ H *
M "@#ZY_9J_X\M1_Z[P?^@/30SZ9IB"@ H * "@ H * "@ H ^+/VC?\ D8[;
M_L&Q?^E-W4L#P"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M(C<<46 ^NM"T*R\-V<>G:;&(+>(<*.I)ZL['EG8\LQY/T %4(UZ /RMJ0"@
MH * "@ H * "@#[@^&O@+P_JGANPN[RPMIYY8B7D>,%F/F.,D]S@ 4QG<_\
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M H * "@ H * "@ H * "@ H * /E;]IG_F$_]OW_ +9TF!\K4@"@ H * "@
MH * /4_@WI%GK?B2&TU"%+F!HIR8Y!N4E8R5./4'D4#/L;_A67A?_H&6G_?H
M4Q!_PK+PO_T#+3_OT* #_A67A?\ Z!EI_P!^A0 ?\*R\+_\ 0,M/^_0H /\
MA67A?_H&6G_?H4 '_"LO"_\ T#+3_OT* #_A67A?_H&6G_?H4 '_  K+PO\
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MD\,["I&>/4""@ H * "@ H * "@ H * "@#MO#'P\UWQ<0VFVKF$G!N)/W<
M]?WC8#XSRL8=O]F@9[_X?_9OMX@)-<O'E;O%:J$0'T\V0,S#Z11GWIV$>Q:1
M\,?#.AX-KI]NS #YYE-PV1W!G,FT_P"[M]L#BBP'<11)"HCC4(B\!5   ] !
MP/PI@/H * "@!KQK*I1P&5A@@@$$>A!X(H X76/ACX9UL'[3I]NK$'YX%^SO
MD]R83'N(Z_/N'J".*5@/'/$/[-\#@R:%>-&W:*[&Y3])HE#*!Z&*0^]%@/GS
MQ-X"UOP@W_$TM7CBS@3+B2$YZ#S4RH)[*Q5_]FD,X^@04 % !0 4 % !0 4
M% !0 4 >A?#CQ[<> ]2%PNY[*<JEW"/XT!X=02!YL>2R$XSED)"N30,_06PO
MX-3MX[RT=9H)T#QNO1E89!'<>X(!!R" 015"+= !0 4 % !0 4 % !0 4 %
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M!EI_WZ% !_PK+PO_ - RT_[]"@ _X5EX7_Z!EI_WZ% !_P *R\+_ /0,M/\
MOT* #_A67A?_ *!EI_WZ% !_PK+PO_T#+3_OT* )(?AQX:MI%FBTZU22-@ZL
M(QE64Y4CW! (I@=K0 4 % !0 4 % !0 4 1RPI.ACE571N"K ,I'N#D'\: ,
M)O"&AL<MIUB2>I-K 3_Z+H U;+3;735*6<,5LIQE8HTC!QTR$ '';TH N4 %
M !0!^5M2 4 % !0 4 % !0 4 ?H=\)?^13TW_K@?_1DE- >B4P"@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MV_\ (6OO^O1?_1JT(9]AU0@H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^5OVF?^83_ -OW_MG2
M8'RM2 * "@ H * "@ H ]D^ W_(V0?\ 7"X_]%F@9]W50@H * "@ H * "@
MH * "@ H * "@ H X/QQ\.]+\=0;+Q/*ND&(KJ,#S8_0'IYD>>3&QQR2I5CN
MI ?"?B_P??\ @J^;3]17!^]%*N?+F3/#H2!]&4_,IX(Z90SE:!!0 4 % !0
M4 % !0!]@?LZ^*#=V-QH,S9>S;SX 2<^3*<2*!V5)3N^LU- ?25, H * "@
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M * "@ H * "@ H * "@#Z/\ @1\0SI=P/#>H/_HMTV;5F/$4[=8L]DF/W1G
MEZ#]XQ AGV'5""@ H * "@ H * "@ H * "@ H * "@#X1^//_(V3_\ 7"W_
M /18J1GC= @H * "@ H * "@#ZP_9H_U.J?[]I_*XIH9]14Q!0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0!\V?&C_D*6_\ UZC_ -&RUX6,^-?X?U9]GE'\&?\ C_\ ;8GCM>:?
M1A0 4 % !0 4 % !0 4 >M^ /B,^A%=.U(E['HC\EX,]!ZM%ZKU7.5X&T^C0
MQ'L_<G\'XK_@>7W'S^.P"KWK4-*G5;*7^4O/KU[GTM#,DZ++$P=' 964@JRD
M9!!'!!'((KW4TU=;'Q33BW&2LUHT]TR2F(* "@ H * "@ H * "@ H * "@
MH * "@ H * /@GXY?\C=>?[EM_Z315(SR.@04 % !0 4 % !0!]<_LU?\>6H
M_P#7>#_T!Z:&?3-,04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % 'SC^TE_R";'_K[;_T2])@?'=( H * "@ H * "@#U7X)_\CCI_P#V]?\
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M@SZ\TW3;72+=+.QB2W@B&$CC4*H'T'4GJS'+,<EB22:H1=H * "@ H * "@
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M]FC_ %.J?[]I_*XIH9]14Q!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\Y_&FWE%_;7&UO*-OL
M#X.W>)'8KGINVD''7'->'C$^>+Z<MK^=V?8Y1)>SG"ZYN:]NMK)7]+GBU>8?
M2A0 4 % !0 4 % !0 4 % 'I?@3X@3>&7%I=[IK!SRO5H2>KQ_[/=H^AZKAL
M[NZAB'1?++6'Y>:_R/%QN!CB5[2G:-5?=+R?GV?WZ;?45I=PW\*7%LZRQ2#<
MCJ<@CV/Z$=000<$5[\6I)2B[I['PTHRIR<)IJ2T:>Z+%40% !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 ?!/QR_Y&Z\_W+;_ -)HJD9Y'0(* "@ H * "@ H
M ^N?V:O^/+4?^N\'_H#TT,^F:8@H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * /G']I+_ )!-C_U]M_Z)>DP/CND 4 % !0 4 % !0!ZK\$_^
M1QT__MZ_]([B@#[]J@"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@#\K:D H * "@ H * "@ H _0[X2_\BGIO_7 _P#HR2F@
M/1*8!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 >9?&3_D4=1_W(?_2F&DP/SZI % !0 4 % !0 4 %
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M * "@ H * "@ H * "@ H * /E;]IG_F$_\ ;]_[9TF!\K4@"@ H * "@ H
M* /9/@-_R-D'_7"X_P#19H&?=U4(* "@ H * "@ H * "@ H * "@ H * "@
M H ^6_VB/!X9(?$MLN&4K;W6!U!_U,IP.QS$S$Y.8E' I,#Y1I % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /RMJ0"@ H *
M"@ H * "@#]#OA+_ ,BGIO\ UP/_ *,DIH#T2F 4 % !0 4 % !0 4 % !0
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M&?/- @H * "@ H * "@#Z/\ V;?^0M??]>B_^C5H0S[#JA!0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0!\K?M,_\PG_ +?O_;.DP/E:D 4 % !0 4 % !0![)\!O^1L@_ZX7'_H
MLT#/NZJ$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 87B?1(_$>E76ER@$7
M4+HN>BOC,;_\ D"N/=><CB@#\S9(VB8QN-K(2I!Z@@X(_ U(#* "@ H * "@
M H * /NKX":B;[PM'$?^7.XG@'T)$X_+S\?3%- >T4P"@ H * "@ H * "@
MH * "@#R/XS^,#X4T)XK=MMYJ)-O"1U1"/WT@X_A0[ 005>1&'0T@/@FD 4
M% !0 4 % !0 4 % 'V'\&?A0-(2/Q#K,?^FN-UK X_U"$<2NI_Y;,"=JG_5+
M@G]X?W;0SZ/IB"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /DKXS
M_"867F>(]$3]R27O+9!_J^I:XC _Y9D\RH/]63O7]WN$:&?,5(04 % 'L?@3
MX,:MXNVW5T#IVGMR)9%_>2#K^YB)!(.1B1]J8.5WD%:!GV%X3\$:3X+@\C2X
M0C,,23/AIY>_SR8!QGD(H5 >0HJA'6T % !0 4 % !0 4 % !0 4 % !0 4
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M * "@ H * "@ H * "@ H * "@#YQ_:2_P"038_]?;?^B7I,#X[I % !0 4
M% !0 4 >J_!/_D<=/_[>O_2.XH ^_:H H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H _*VI * "@ H * "@ H * /T.^$O_(I
MZ;_UP/\ Z,DIH#T2F 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % 'F7QD_Y%'4?]R'_TIAI,#\^J0!0
M4 % !0 4 % !0 4 % '1>%?$][X/U"/4]/;$D?#(<[)8R1NBD (RC8'N&"LN
M&4$ S]"_"7BJS\8Z='J=@?E?Y9(S]^*0 ;HW]USP>C*0PX(JA'2T % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?'_QK^*?]J._AW1Y/]%C8K=S(
M?]<ZGF%"/^62$'>>1(PP/D7,DC/FV@04 % !0 4 % !0 4 % !0![)\!O^1L
M@_ZX7'_HLT#/NZJ$% !0 4 % !0 4 % !0 4 % !0 4 ?&?[1_\ R';3_KP7
M_P!'SU+&?/- @H * "@ H * "@#Z/_9M_P"0M??]>B_^C5H0S[#JA!0 4 %
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MP)\9?%1\3^(9EB;=:Z?FUAP<J2A/FN,<'?)N 8?>14YXJ1GE% @H * "@ H
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M-'^IU3_?M/Y7%-#/J*F(* "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H CFA2X1HI5#HX*LK
M%64C!!!X((X(-)I-6>PTW%J479K5-;IGS/X^^'+Z"6U#30TEB>73JT&3^;1>
MC<E>C_WCX-?#NE[\-8?E_P #S^_N_M<#CU7M1K653H]E/_*7EUZ=CR:O//H
MH * "@ H * "@ H * "@#H_#/B>[\+70N;0Y4\21,3LD7T([$?PL.5/J"0=J
M=25&7-'YKHSBQ&&ABH<E3?I);I_Y=UU/K/PYXDL_$UJ+JS;D8$D9^_$Q'W6'
MY[6'RL!D'J!]'3J1JQYH_-=4? XC#SPL_9U%Z/I)=U^JW1OUL<@4 % !0 4
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M: ]$I@% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0!YE\9/\ D4=1_P!R'_TIAI,#\^J0!0 4 % !0 4
M% !0 4 % !0!W_P[\>W7@+41<QYDM)BJW4 /$B \,H/ ECR3&W'4H3M=J!GZ
M!Z5JEMK=I%?V+B:WN%#QNO0@\$'N&4@JRGE6!4@$$50C0H * "@ H * "@ H
M * "@ H * "@ H * "@ H * /G'XU?%+^QXW\/:/)_IDJXNID/,",/\ 5H0>
M)G'WC_RS0\?.P*(9\=TA!0 4 % !0 4 % !0 4 % !0![)\!O^1L@_ZX7'_H
MLT#/NZJ$% !0 4 % !0 4 % !0 4 % !0 4 ?&?[1_\ R';3_KP7_P!'SU+&
M?/- @H * "@ H * "@#Z/_9M_P"0M??]>B_^C5H0S[#JA!0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M6.-!T"J,#ZD]68\LQ+$DDFJ$7: "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H S=7T>TUZTDT_48EGMI@ \;$@'!##!4AE(8 AE(((!!% $F
MFZ9:Z/;I9V$4=M!$,+'&H51[X'4GJS'+,>6))S0!>H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * /A'X\_P#(V3_]<+?_ -%BI&>-T""@ H *
M "@ H * /K#]FC_4ZI_OVG\KBFAGU%3$% !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ",
MH<%6 96!!!&00>"".X/<4;Z,:=M5N?.WQ ^&S6._5-(0M!RTMNHR8NY>,#K'
MU++UCZC*9V>)B,-RWJ4]NJ[>:\OR]-OK\#F'/:AB':6T9/[7D_/L^OKOXI7E
MGTP4 % !0 4 % !0 4 % !0!M:%KUWX<NEO+)]C#AE/W)%SDHX[J?S!Y4@@&
MM83E2?-!Z_GY,YJU"&)@Z=5:='U3[KS_ *9]8^%/%MIXKMO.@/ES)_K8"070
M^O;<A_A<#!Z'# @?0TJT:RNM'U7;_@>9\#B<+/"2Y9ZQ?PRZ/_)]U^AU5=)P
M!0 4 % !0 4 % !0 4 % !0 4 ?!/QR_Y&Z\_P!RV_\ 2:*I&>1T""@ H *
M"@ H * /KG]FK_CRU'_KO!_Z ]-#/IFF(* "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@#YQ_:2_Y!-C_U]M_Z)>DP/CND 4 % !0 4 % !0!Z
MK\$_^1QT_P#[>O\ TCN* /OVJ * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * /RMJ0"@ H * "@ H * "@#]#OA+_ ,BGIO\
MUP/_ *,DIH#T2F 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % 'F7QD_Y%'4?]R'_ -*8:3 _/JD 4 %
M!0 4 % !0 4 % !0 4 % 'LOPC^)K^"KO[#?,S:5=-\XZ^1(>!,@_NG $JCD
MJ P!90K S[JBE2=%EB8.C@,K*0RLK#(92,@@@@@C@CD50A] !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 >/?%GXFQ^"+3[)9%7U6Z4^4O!\A#QY[KZ_\\E88
M9@2051E* ^$YIGN)&FE8O)(Q9V8Y9F8Y+$GDDDY)/4T@(J "@ H * "@ H *
M "@ H * "@#V3X#?\C9!_P!<+C_T6:!GW=5""@ H * "@ H * "@ H * "@
MH * /C/]H_\ Y#MI_P!>"_\ H^>I8SYYH$% !0 4 % !0 4 ?1_[-O\ R%K[
M_KT7_P!&K0AGV'5""@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@#Y6_:9_YA/_;]_P"V=)@?*U(
MH * "@ H * "@#V3X#?\C9!_UPN/_19H&?=U4(* "@ H * "@ H * "@ H *
M "@ H * "@ H * /B_\ :."CQ!:D'YCI\8(]A<7.#^))_*I8'S[0 4 % !0
M4 % !0!]'_LV_P#(6OO^O1?_ $:M"&?8=4(* "@ H * "@ H * "@ H ^4?V
MD?$!,EEH<9.%#7<HSP2Q:*'\5 F//9@:3 ^6Z0!0 4 % !0 4 % !0!]P_ O
MP6/#VCC5+A<7FI@2<CE+?K$GMYG^M;U#1@C*4T![C3 * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * /A'X\_P#(V3_]<+?_ -%BI&>-T""@ H * "@
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _*VI *
M"@ H * "@ H * /T.^$O_(IZ;_UP/_HR2F@/1*8!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >9?&3_
M )%'4?\ <A_]*8:3 _/JD 4 % !0 4 % !0 4 % !0 4 % !0!]*?!/XI?V8
MZ>'-8DQ:R';:3.>(7)XA<G_EFY/R$G$;?*?D;* SZ^JA!0 4 % !0 4 % !0
M 4 % !0 4 % !0!P?Q"\>6O@+3C=2XDNI<K;09P9'[DXY$:9!=N.R@[F6D!^
M?>L:O=:]=RZA?R&:XN&+NQ]3T '154855&%50%  %(9FT""@ H * "@ H *
M"@ H * "@ H ]D^ W_(V0?\ 7"X_]%F@9]W50@H * "@ H * "@ H * "@ H
M * "@#XS_:/_ .0[:?\ 7@O_ */GJ6,^>:!!0 4 % !0 4 % 'T?^S;_ ,A:
M^_Z]%_\ 1JT(9]AU0@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H ^5OVF?^83_V_?\ MG28'RM2
M * "@ H * "@ H ]D^ W_(V0?]<+C_T6:!GW=5""@ H * "@ H * "@ H *
M"@ H * "@ H * "@#X?_ &@[L7/B<1C'^C6<$1Q[M+-S[XE'3MCOFI \-H *
M "@ H * "@ H ^D_V;(B=2OY.RVT:X_WI,_IL_6A#/K^J$% !0 4 % !0 4
M% !0 4 ?G7\3]:_M[Q+?W0.Z-)C!'CIL@Q"I'LVPO]6-2,X&@04 % !0 4 %
M !0!VGP^\,'Q=KEKIC F%G\R<CC$$?SR<\X+ ;%./ONM S]'$18U"( JJ
M,  <  #@ #@ =*H0Z@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^
M$?CS_P C9/\ ]<+?_P!%BI&>-T""@ H * "@ H * /K#]FC_ %.J?[]I_*XI
MH9]14Q!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M'CA0 4 % !0 4 % !0 4 % 'P3\<O^1NO/\ <MO_ $FBJ1GD= @H * "@ H
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M % !0 4 % !0 4 % !0 4 % !0!YE\9/^11U'_<A_P#2F&DP/SZI % !0 4
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M H ^N?V<?#@@M+O79 -]PXM83SD1QX>4CMM=R@Z]8CT[M ?3-, H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * /A'X\_\C9/_ -<+?_T6*D9XW0(*
M "@ H * "@ H ^L/V:/]3JG^_:?RN*:&?45,04 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?&?[
M1_\ R';3_KP7_P!'SU+&>*>'_$-]X7O$U'3)##/'QGJK*?O(ZGAD;NI[X(PP
M! !]X_#OXCV/CZU+18@OH5'VBV)Y'0>9'W>$MP&^\IPK@94LQ'HU, H * "@
M#RWQ[\.X_$*M?6 $=^HY'"I/CLQX"R8X5SP>%?C#+Y]?#JI[\-)_G_P?/[SW
M<%CWAFJ576E^,/3R[KYKL_F.XMY+.1H)U:.6-BKHPPRL.""#T->"TXNST:Z'
MVT9*:4HM--736S1!2+"@ H * "@ H * "@ H FM[B2TD6:!FCDC(974E64CH
M01R"/:FFT[K1HF45).,DFGHT]4T?3?@+XB1^(%6PU K%?* %;("W&.ZC@"3^
M\@Z\LG&57W:&(53W)Z2_/_@^7W'Q&-P#P[=6C=TNW6'KY=G\GW?JE>B>$% !
M0 4 % !0 4 % !0!\$_'+_D;KS_<MO\ TFBJ1GD= @H * "@ H * "@#ZY_9
MJ_X\M1_Z[P?^@/30SZ9IB"@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H ^<?VDO\ D$V/_7VW_HEZ3 ^.Z0!0 4 % !0 4 % 'JOP3_Y''3_^
MWK_TCN* /OVJ * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * /RMJ0"@ H * "@ H * "@#[0^'7Q/\-:)X=L;"^O5AN((BLB&
M*=BI+N<96)E/!!X)IC.U_P"%R>$?^@BG_?FY_P#C-%Q!_P +D\(_]!%/^_-S
M_P#&:+@'_"Y/"/\ T$4_[\W/_P 9HN ?\+D\(_\ 013_ +\W/_QFBX!_PN3P
MC_T$4_[\W/\ \9HN ?\ "Y/"/_013_OS<_\ QFBX!_PN3PC_ -!%/^_-S_\
M&:+@'_"Y/"/_ $$4_P"_-S_\9HN ?\+D\(_]!%/^_-S_ /&:+@'_  N3PC_T
M$4_[\W/_ ,9HN ?\+D\(_P#013_OS<__ !FBX!_PN3PC_P!!%/\ OS<__&:+
M@'_"Y/"/_013_OS<_P#QFBX!_P +D\(_]!%/^_-S_P#&:+@'_"Y/"/\ T$4_
M[\W/_P 9HN ?\+D\(_\ 013_ +\W/_QFBX!_PN3PC_T$4_[\W/\ \9HN ?\
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MN%Q_Z+- S[NJA!0 4 % !0 4 % !0 4 % !0 4 % 'QG^T?_ ,AVT_Z\%_\
M1\]2QGSS0(* "@ H * "@ H ]N^!WBK2_"FHW<^KSBUCEMPB,5D;+"16QB-'
M(X!.2 />@9]+_P#"Y/"/_013_OS<_P#QFG<0?\+D\(_]!%/^_-S_ /&:+@'_
M  N3PC_T$4_[\W/_ ,9HN ?\+D\(_P#013_OS<__ !FBX!_PN3PC_P!!%/\
MOS<__&:+@'_"Y/"/_013_OS<_P#QFBX!_P +D\(_]!%/^_-S_P#&:+@'_"Y/
M"/\ T$4_[\W/_P 9HN ?\+D\(_\ 013_ +\W/_QFBX!_PN3PC_T$4_[\W/\
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M7.I$@2JAC@!_BGD!6( =]I.]A_<1CVI ?G S%B23DGDD]2:0"4 % !0 4 %
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M  N3PC_T$4_[\W/_ ,9HN ?\+D\(_P#013_OS<__ !FBX!_PN3PC_P!!%/\
MOS<__&:+@'_"Y/"/_013_OS<_P#QFBX!_P +D\(_]!%/^_-S_P#&:+@'_"Y/
M"/\ T$4_[\W/_P 9HN ?\+D\(_\ 013_ +\W/_QFBX!_PN3PC_T$4_[\W/\
M\9HN ?\ "Y/"/_013_OS<_\ QFBX!_PN3PC_ -!%/^_-S_\ &:+@'_"Y/"/_
M $$4_P"_-S_\9HN ?\+D\(_]!%/^_-S_ /&:+@'_  N3PC_T$4_[\W/_ ,9H
MN ?\+D\(_P#013_OS<__ !FBX!_PN3PC_P!!%/\ OS<__&:+@>CV]Q'=Q)/"
M=T<JJZ-R,JP#*<'!Y!!Y -,":@ H * "@ H * "@ H * "@ H * "@ H ^,_
MVC_^0[:?]>"_^CYZEC/GF@1H:5JMUH=U'?V$C07$#;D=>H/<$="K#(92"K*2
MK @D4#/NGX9_%.T\=0BVGVVVJ1+F2$9"R =9(,DDKW9"2Z=]RX8L1ZS3 * "
M@ H X3QCX"L_%2-* (+Y5PDPX#$=%E ^\O& ?O(.A(&T\=:A&MJM)='_ )_U
M?\CU<)C9X1J/Q4[ZQ[><>S_!]>Y\KZMI-SH=R]G>H8Y8SR.Q'9E/1E(Y!'\\
MBOGY1=-N,E9H^ZI585XJI2=XO\/)]F9M0;A0 4 % !0 4 % !0 4 /1VC8.A
M*LI!!!P01R"".00>011L)J^CV/HWX?\ Q(74]FF:LVV[^[%,<!9O17Z 2]@<
M8DZ</]_V\/B>:U.I\71]_)^?Y^N_QN.R_P!E>OAU[F\H]8^:_N_EZ;>RUZA\
MX% !0 4 % !0 4 % 'P3\<O^1NO/]RV_])HJD9Y'0(* "@ H * "@ H ^N?V
M:O\ CRU'_KO!_P"@/30SZ9IB"@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H ^<?VDO^038_\ 7VW_ *)>DP/CND 4 % !0 4 % !0!ZK\$_\
MD<=/_P"WK_TCN* /OVJ * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * /RMJ0"@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * /1?A+_ ,C9IO\ UV;_ -%24#/T-JA!0 4
M% !0 4 % !0 4 % !0 4 % 'F7QD_P"11U'_ '(?_2F&DP/SZI % !0 4 %
M!0 4 % !0 4 % !0 4 % !0!IZ-K%UH%Y%J-@YAN+=@R,/R((/#*PRK*>&4D
M'@T#/T&^'_CFU\=Z<+R#$=Q%M2Y@SS%(1U'.3&^"8V/4 @_,K ,1W-, H *
M"@ H * "@ H ;)(L2EW(5%!9F8@  #)))X  Y)/ % 'PY\8/B<WC"Y.FZ<Y&
ME6S<$<?:9%X\UAU\M3D1*>H_>, S!4D9XE0(* "@ H * "@ H * "@ H * "
M@ H * "@#V3X#?\ (V0?]<+C_P!%F@9]W50@H * "@ H * "@ H * "@ H *
M "@#XS_:/_Y#MI_UX+_Z/GJ6,^>:!!0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % 'Z,_#+_D5],_Z](OY4P.YI@% !0
M4 % !0 4 % !0 4 % !0 4 % 'RM^TS_ ,PG_M^_]LZ3 ^5J0!0 4 % !0 4
M % 'LGP&_P"1L@_ZX7'_ *+- S[NJA!0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % 'Q+\=?'*^(M272+-MUGII8,RG*R7)X=N#@K$/W:G^\92"0PJ1G@] @H
M * "@ H * "@ H _2/P!I!T+P_86+ J\=M&S@C!$D@\V08]I'8?X4P.OI@%
M!0 4 % !0 4 % !0!\Z?M(7IBT>SM!_RVNS(?I%$XQ^<H/3L.1W3 ^.*0!0
M4 % !0 4 % '1^#],&LZU8V#?<N+N!'_ -PR+O\ R3<:!GZ7U0@H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@#X1^//_(V3_\ 7"W_ /18J1GC
M= @H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@#]./#7_ "";+_KTM_\ T4E4!M4 % !0 4 % !0 4 % !0 4 % !0 4
M% 'QG^T?_P AVT_Z\%_]'SU+&?/- @H LV=Y/I\R75K(\,T3!DD1BK*PZ%2,
M$&@#[;^%GQ<@\8(NFZF4M]50 #HJ70 Y>,=%EX)>(<?Q1_+N5&![=3 * "@
MH Y?Q3X3M/%5MY%R-LJ F&8#YHV/Y;D/\2'@CD88!ASU:4:RL]^C[?\  \CN
MPV)GA)\T-8OXH]&OT?9_IH?)_B#P]>>&KIK2]7:1DHXSLD7^\C8&1ZCJIX8
MU\[4IRI/EDO\GYH^^H5X8F"J4GZKK%]FOZOT,*LCJ"@ H * "@ H * "@ H
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M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?E;4@% !0 4 % !0 4 % !0
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M 4 % !0 4 % !0!\K?M,_P#,)_[?O_;.DP/E:D 4 % !0 4 % !0![)\!O\
MD;(/^N%Q_P"BS0,^[JH04 % !0 4 % !0 4 % !0 4 % !0 4 % '@WQC^**
M>&+=M&TMP=3N$Q(ZGFUC8?>..DSJ?W8R"@/F''R;D!\3$YY-( H * "@ H *
M "@ H Z_P%H)\2Z]9:<5+1RSJTH'_/&/]Y+ST'[M6 )[D#DG% S](ZH04 %
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M !N@ _X6UXL_Z"4W_?,7_P ;H ^Y/ ]U<WV@Z?=7SF6XGM(99'.,L9$#AC@
M9(89P.M4(ZF@ H * "@ H * "@ H * "@#X1^//_ "-D_P#UPM__ $6*D9XW
M0(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H _3CPU_R";+_ *]+?_T4E4!M4 % !0 4 % !0 4 % !0 4 % !0 4 %
M'QG^T?\ \AVT_P"O!?\ T?/4L9\\T""@ H DAF>W=98F:.2-@RLI*LK Y#*1
M@@@\@CD&@#[(^$_QB37PFC:ZXCU #;#<,0J7..BMT"SXZ?PRGIAR%9@?0U,
MH * "@#$\0>'K3Q):FTO5W#DHXX>-L8#H>Q]1T8<,"*QJ4XU5RR^3ZKT.JA7
MGAI^TI.W==&NS_K3H?)WBKPG=^%+GR;@;X7)\F8#"R ?GM<9&Y"<@]"5(8_.
MU:4J+M+;H^C_ *ZH^]PV*ABX\T-)+XH]4_U79_KH<M6!WA0 4 % !0 4 % !
M0 4 % 'M7P_^))T_9IFKL6M_NQ3L<F+T20]X_1NJ=#E/N>IA\3R6IU/AZ/MZ
M^7Y>FWS..R_GO7PZ][>45]KS7GW77UW^BE8. RD,K $$'((/0@CJ#V->WOJC
MY!JVCW%H$% !0 4 % 'P3\<O^1NO/]RV_P#2:*I&>1T""@ H * "@ H * /K
MG]FK_CRU'_KO!_Z ]-#/IFF(* "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@#YQ_:2_P"038_]?;?^B7I,#X[I % !0 4 % !0 4 >J_!/_D<=
M/_[>O_2.XH ^_:H H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H _*VI * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H ]%^$O_ "-FF_\ 79O_ $5)0,_0VJ$% !0 4 %
M!0 4 % !0 4 % !0 4 >9?&3_D4=1_W(?_2F&DP/SZI % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % 'I7PS^(=QX"OP[;I-/N"%N80>W02QCH)(^O^VN4
M)&0RFPS[]L+^WU2WCO+-UF@G0/&Z]&5AD'U'N" 0<@@$$50BW0 4 % !0 4
M?/?QH^*/_"/Q-H.DOC4)E_?RJ>;:-AG:I'2:13P>L:'<,,R,J ^,:0!0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0![)\!O^1L@_ZX7'_HLT#/NZJ$% !0
M 4 % !0 4 % !0 4 % !0 4 ?&?[1_\ R';3_KP7_P!'SU+&?/- @H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#]&?A
ME_R*^F?]>D7\J8'<TP"@ H * "@ H * "@ H * "@ H * "@#Y6_:9_YA/\
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MKD#W,I!/X[1^52QGS=0(* "@ H * "@ H ]Z_9UB63Q),S=8]/F9?J9[9/\
MT%C_ #H0'VQ5 % !0 4 % !0 4 % !0 4 ?,W[2O_'EIW_7>?_T!*3&?(U(0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'Z5>!T,
M?A[2T/5=.LP?J+>,50'44 % !0 4 % !0 4 % !0 4 ?"/QY_P"1LG_ZX6__
M *+%2,\;H$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 ?IQX:_Y!-E_UZ6__HI*H#:H * "@ H * "@ H * "@ H *
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MD@(W5K?GMW:+U3JO5.ZMZ%#$.E[D]8?^D_\  \ON\_ QV 5>]6BDJG5;*?\
ME+SZ]>Z^F89H[A%EA97C<!E92"I!Z$$<$?2O>335UL?%-.+<9)IK=/1HDIDA
M0 4 % 'Q=\?/">H6FL2:^4WV%V(4$B9/END2Q[)1CY2Q3*'E6!QG<"*D9\_4
M""@ H * "@ H * /KG]FK_CRU'_KO!_Z ]-#/IFF(* "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@#YQ_:2_Y!-C_U]M_Z)>DP/CND 4 % !0
M4 % !0!ZK\$_^1QT_P#[>O\ TCN* /OVJ * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * /RMJ0"@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * /1?A+_R-FF_]=F_]%24#
M/T-JA!0 4 % !0 4 % !0 4 % !0 4 % 'F7QD_Y%'4?]R'_ -*8:3 _/JD
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M\D(#URSD N0 9X?0(* "@ H * "@ H ]D^ W_(V0?]<+C_T6:!GW=5""@ H
M* "@ H * "@ H * "@ H * /C/\ :/\ ^0[:?]>"_P#H^>I8SYYH$% !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?HS\
M,O\ D5],_P"O2+^5,#N:8!0 4 % !0 4 % !0 4 % !0 4 % !0!\K?M,_\
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M - 2DQGR-2$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0!^F'@\8T/3@?^?&U_P#1$=4!T5 !0 4 % !0 4 % !0 4 % 'PC\>?\
MD;)_^N%O_P"BQ4C/&Z!!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % 'Z<>&O^039?]>EO_Z*2J VJ "@ H * "@ H *
M"@ H * "@ H * "@#XS_ &C_ /D.VG_7@O\ Z/GJ6,^>:!!0 4 % !0 4 ?3
M'PF^,QTX1Z'XADS; !+>[<DM%V6*8\YB[))UCX5LQX,8,^N58. RD$$9!'((
M/0@]P:H0M !0 4 5KRSAU"%[:Y19895*NC#((/\ (CJ",$$ @@@&IE%23C)7
M3Z%PG*G)3@VI)W370^7/'7P_F\,.;JUW36#GANKQ$_PR8'3LK]#T;#8W?/U\
M.Z+YHZP[]O7_ #/N<%CHXE>SG[M5=.DO./GW7W:;>;5Q'M!0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 ?./[27_()L?\ K[;_ -$O28'QW2 * "@
MH * "@ H ]5^"?\ R..G_P#;U_Z1W% 'W[5 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'Y6U(!0 4 % !0 4 % !0 4 %
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M^-<UN[\17LNHZA(9;B=MS$]!Z*H_A1!A44<*H I#,J@04 % !0 4 % !0 4
M.1&D8(@+,Q   R23P  .22>@H ^X_@_\,5\'VHU+44!U6Z3D$?\ 'M&W/E+_
M --&&#*W&#^['"L78'%?M+_ZG2_]^[_E;T,9\GTA!0 4 % !0 4 % 'LGP&_
MY&R#_KA<?^BS0,^[JH04 % !0 4 % !0 4 % !0 4 % !0!\9_M'_P#(=M/^
MO!?_ $?/4L9\\T""@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * /T9^&7_(KZ9_UZ1?RI@=S3 * "@ H * "@ H * "@
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M_P"/+3O^N\__ * E)C/D:D(* "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@#].?#BE-*LU8$$6MN"#P01$F01ZU0&S0 4 % !0 4 %
M!0 4 % !0!\(_'G_ )&R?_KA;_\ HL5(SQN@04 % !0 4 % !0 4 % !0 4
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M(X- 'QQ\6/@X^@&36="0R6!)::W4%FMNY9>I:#U[Q#KE,LLC/GB@04 % !0
M4 ?7/[-7_'EJ/_7>#_T!Z:&?3-,04 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % 'SC^TE_P @FQ_Z^V_]$O28'QW2 * "@ H * "@ H ]5^"?
M_(XZ?_V]?^D=Q0!]^U0!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0!^5M2 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0!Z+\)?^1LTW_KLW_HJ2@9^AM4(* "@ H *
M"@ H * "@ H * "@ H \R^,G_(HZC_N0_P#I3#28'Y]4@"@ H * "@ H * )
M[7_71_[Z_P Q2&?J75B.9\7>%+/QEITFF7P^5_FCD &^*4 [9$SW&2".C*64
M\&@#\\_%'AJ\\(ZA+I=^NV6(_*P^Y(A^Y+&>Z..1W!RK ,K 2,Y^@04 % !0
M 4 % !0 4 *"0<C@B@#[4^#/Q0_X2:%=$U1_^)E;I^ZD8\W,2#]9HU'S]W0>
M9R1(0T![#XC\0V?A6PEU/4'V0PKG ^\['[L<8XW.YX4< <LQ50S!@?GMXT\8
M7GC;47U&\.T?=AB!.R&(?=1<]_XG;JSDG@8 D9R5 @H * "@ H * "@ H *
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M &_?^V=)@?*U( H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * /0/AQX%G\=ZHMJH9+.';)=RC^"//"*3QYDI!5!R
M1\SX*HU S]";*SATZ".TMD$4,"+'&B]%10 H'T [\^O-4(LT % !0 4 % !0
M 4 % !0 4 % 'S!^TM;EK?3+C'$<ERF>>LBPL!Z<^6??CCO28'R92 * "@ H
M * "@ H ]'^$>H#3?%>G2GI),T!_[;QO"/R9P?P[]*!GZ%U0@H * "@ H *
M"@ H * "@#YF_:5_X\M._P"N\_\ Z E)C/D:D(* "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@#]0]*_P"/*W_ZXQ?^@+5 7Z "@ H
M* "@ H * "@ H * /A'X\_\ (V3_ /7"W_\ 18J1GC= @H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#]./#7_()LO\
MKTM__1250&U0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?&?[1_P#R';3_ *\%
M_P#1\]2QGSS0(* "@ H * "@ H ^AOV;_P#D.W?_ %X-_P"CX*$,^S*H04 %
M !0 4 (0&&#R#P0: V/G[Q_\,S;[]3T5,Q\M-;*/N<9+Q#NOK&.5ZIE?E7Q<
M1AN6]2DM.L>WFO+RZ>FWUN!S#FM0Q+UVC-]?*7GV?7KKJ_#*\H^I"@ H * "
M@ H * "@ H * .M\)>+[OPG<>;#F2W<_O8"2%<>HZ[9!_"X!/8@J2#T4JLJ+
MO';JNC_X/F>?BL+#%QY9:27PRMJO\UW7ZGUCH>NVGB&U6\LG#HWWEXWQMW1U
M_A8?D1@J2I!/T5.I&K'F@_\ ->3/@:U&>'FZ=56:V[-=T^J_X9ZFO6ISA0 4
M ! (P>0: /D[XL_!C[-YFN>'(_W0!>YLT!RG=I;=>?DZEXA]S&8P5^1$,^7J
M0@H * "@#ZY_9J_X\M1_Z[P?^@/30SZ9IB"@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H ^<?VDO^038_]?;?^B7I,#X[I % !0 4 % !0 4
M>J_!/_D<=/\ ^WK_ -([B@#[]J@"@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@#\K:D H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@#T7X2_\C9IO_79O_14E S]#:H04
M % !0 4 % !0 4 % !0 4 % !0!YE\9/^11U'_<A_P#2F&DP/SZI % !0 4
M% !0 4 3VO\ KH_]]?YBD,_4NK$% 'FOQ-^'L'CS3]B;8]0MP6MIB.^,F)SU
M\N0X!/.QL. <%60'P#?64^FSR6ETC0SP.4D1AAE93@@C_(/4<4@*M !0 4 %
M !0 4 % !0!9L[R;3YDNK9VAFA8/&Z'#*RG(8$="#0!V?C?XAZGX[:#[>52.
MVC55BCX0R;0))B/[\A' Z(N%7^(L#.#H$% !0 4 % !0 4 % !0![O\ !OX7
MGQ3<#6-30_V9;/\ (C#BZE4_=P>L*'_6'&'/[L9^?:#/ML  8' %4(* /EW]
MI?\ U.E_[]W_ "MZ3&?)](04 % !0 4 % !0![)\!O\ D;(/^N%Q_P"BS0,^
M[JH04 % !0 4 % !0 4 % !0 4 % !0!\9_M'_\ (=M/^O!?_1\]2QGSS0(*
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH _1GX9?\BOIG_7I%_*F!W-, H * "@ H * "@ H * "@ H * "@ H ^5OVF
M?^83_P!OW_MG28'RM2 * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * -[PUX;O?%=_'IFG)OFE/).0D:#[TDC ':BCJ
M<9)PJ@L0"#/T(\%^#[/P3IJ:;9C)'S32D8::4@;G;T'&$7G:@"Y)R36PCK*
M"@ H * "@ H * "@ H * "@ H \)_:&LOM/AI)@.;:\A<GC(5DEB(SUP6=,@
M8R0">E)@?$=( H * "@ H * "@"[IMZ^F74-Y$2)+:6.92."&C<.I!['(% S
M]/K2YCO88[F$[HYD61#ZJZAE/X@BJ$3T % !0 4 % !0 4 % !0!\S?M*_\
M'EIW_7>?_P! 2DQGR-2$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % #D4NP5>K$ ?4\4 ?J7;PK;1)"F2L:J@SUPH &<8&<#G@50$M
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M=( H * "@ H * "@#U7X)_\ (XZ?_P!O7_I'<4 ??M4 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?E;4@% !0 4 % !0 4
M % 'VO\ #CX<>'-8\.6-[>V,4UQ-$6DD8R L?,<9.' Z #@4QG;_ /"I?"?_
M $#8/SD_^.46$'_"I?"?_0-@_.3_ ..46 /^%2^$_P#H&P?G)_\ '*+ '_"I
M?"?_ $#8/SD_^.46 /\ A4OA/_H&P?G)_P#'*+ '_"I?"?\ T#8/SD_^.46
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MD]N=:TM/^)E;)^\1>MS$HZ8[S1@?N\<NN8_F(C 0'Q000<'@BD E !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0!Z3\,_A]/X\U#RSNBL+<AKJ8#H.T2'
MIYDF,#^XNYR#@*P,^_K"PM]+MX[.SC6&"!0D<:C"JHZ ?U)R2<DDDDU0BW0
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M_P#'*+ =S86$&EV\=G:((8(%"1HN<*HZ 9)/'N:8%N@ H * "@ H * "@ H
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M)[>5CRO?_4-%^.:: ]5I@% !0 4 % !0 4 % !0!\S?M*_\ 'EIW_7>?_P!
M2DQGR-2$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &
M]X6LO[2UBQL_^>]W;Q_0/*BDG@\ ')X/':@9^FE4(* "@ H * "@ H * "@
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M?^D=Q0!]^U0!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0!^5M2 4 % !0 4 % !0 4 ?H=\)?^13TW_K@?\ T9)30'HE, H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * /,OC)_R*.H_[D/\ Z4PTF!^?5( H * "@ H * "@">U_UT?^
M^O\ ,4AGZEU8@H * "@#Y+^.'PP^RL_B;2$_=.=U["@^XQZW"@?PL?\ 7#'R
MM^\Y#.50SYAI""@ H * "@ H * "@ H * "@ H * "@ H * .F\(^%+SQEJ,
M>F6 ^9_FDD/W(HP1OD<^BYX'5F(4<D4#/T,\+^&K/PCI\6EZ>NV*(99C]Z20
M@;Y7/=W(R>P&%4!5 %".@H * "@#Y=_:7_U.E_[]W_*WI,9\GTA!0 4 % !0
M 4 % 'LGP&_Y&R#_ *X7'_HLT#/NZJ$% !0 4 % !0 4 % !0 4 % !0 4 ?
M&?[1_P#R';3_ *\%_P#1\]2QGSS0(* "@ H * "@ H ^C_V;?^0M??\ 7HO_
M *-6A#/L.J$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % 'RM^TS_P PG_M^_P#;.DP/E:D 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'J?@
M'X3ZIXW=9R#9Z=GYKF13\X!P1 AP96R""V1&N#EMP"D&?;?A?PGIO@ZS%CI<
M7EIP7<_-)*X&-\KX&YCZ !5Z(JKQ5".DH * "@ H * "@ H * "@ H * "@
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M4 % !0 4 % !0!ZA\&M._M+Q98J?NP-).WMY43LG_D38/Q_"@9^@54(* "@
MH * "@ H * "@ H * /A'X\_\C9/_P!<+?\ ]%BI&>-T""@ H * "@ H * /
MK#]FC_4ZI_OVG\KBFAGU%3$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MO3>TOT?9_@^G9=S78>6% !0 4 >,?%'X2V_C2,W^GA+?5D'WNB7( P(Y<='
M "2XR/N/E=I1 ?#]_87&ESO:7D;03PL5>-QAE8=B/U!'!&""0<T@/J[]FK_C
MRU'_ *[P?^@/30SZ9IB"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H ^<?VDO^038_P#7VW_HEZ3 ^.Z0!0 4 % !0 4 % 'JOP3_ .1QT_\
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M0 4 % !0 4 % !0 4 7]+TRYUFZBL;*-IKBX<)&B]23[] !U9B0JJ"S$ $T
M?H%\.? 5MX"TX6R8DO)]KW4V/ON!PB]_*CR0@/7+.0"Q >P'H-, H * "@#Y
M=_:7_P!3I?\ OW?\K>DQGR?2$% !0 4 % !0 4 >R? ;_D;(/^N%Q_Z+- S[
MNJA!0 4 % !0 4 % !0 4 % !0 4 % 'QG^T?_R';3_KP7_T?/4L9\\T""@
MH * "@ H * /H_\ 9M_Y"U]_UZ+_ .C5H0S[#JA!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\
MK?M,_P#,)_[?O_;.DP/E:D 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0!U7AKP3K'BZ3R]*MI)ESAI2-D*>N^5L(#CG:"7/\*D
M\4#/JCP3\ ].T0K=ZXRZC=+R(@"+5#_ND!IC[R!4YP8B0#3L(]^1%C4(@"JH
M   P !P  .  . !TI@.H * "@ H * "@ H * "@ H * "@ H * "@ H ^%_C
MSH7]D^)6ND&(M1B2<8& '4>5(/\ >)02-_UTJ1GBM @H * "@ H * "@"[IN
MH3:3=0WULVR:VD26-O1D8,/PR.1W'% 'Z4>&=>@\3Z9;ZK;?ZNZC#;<YV/TD
MC/NCAD)[D9'!J@-V@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H Q_$&LP^'M.N-3N/]7:1/(1G&XJ/E0>[MA%]V% 'YGWMY+J%Q+=W
M#%YKB1Y9&/5G=BS'\6)-2!5H * "@ H * "@ H ^E?V;=)\W4+[4R.+>!(%)
M_O3/O./<+#@GKAL=":$!]>U0!0 4 % !0 4 % !0 4 % !0!\(_'G_D;)_\
MKA;_ /HL5(SQN@04 % !0 4 % !0!]8?LT?ZG5/]^T_E<4T,^HJ8@H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M % !0 4 % !0 4 % !0!\X_M)?\ ()L?^OMO_1+TF!\=T@"@ H * "@ H *
M/5?@G_R..G_]O7_I'<4 ??M4 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 ?E;4@% !0 4 % !0 4 % 'Z'?"7_D4]-_ZX'_
M -&24T!Z)3 * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@#S+XR?\BCJ/^Y#_ .E,-)@?GU2 * "@ H *
M "@ H GM?]='_OK_ #%(9^I=6(* "@ H * ,[5M*MM<M)=/OD$MO<(4=#W!Y
M!'HRD!E8<JP# @@&@#\^OB%X$NO >HFTES):RY>UGQQ)'GH<<"2/(61>W# ;
M'4F=AG!T""@ H * "@ H * "@ H * "@ H <JER%4$L2  !DDGH .Y/84 ?<
M7P>^&*^#[8:GJ* ZI=(.#_R[1-SY0_Z:-QYK=O\ 5J<!B[ ]NI@% !0 4 %
M'R[^TO\ ZG2_]^[_ )6])C/D^D(* "@ H * "@ H ]D^ W_(V0?]<+C_ -%F
M@9]W50@H * "@ H * "@ H * "@ H * "@#XS_:/_P"0[:?]>"_^CYZEC/GF
M@04 % !0 4 % !0!]'_LV_\ (6OO^O1?_1JT(9]AU0@H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MQGO@9Q^63^9H 6@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* /G']I+_D$V/_7VW_HEZ3 ^.Z0!0 4 % !0 4 % 'JOP3_Y''3_ /MZ_P#2
M.XH ^_:H H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H _*VI * "@ H * "@ H * /T.^$O\ R*>F_P#7 _\ HR2F@/1*8!0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 >9?&3_D4=1_W(?\ TIAI,#\^J0!0 4 % !0 4 % $]K_ *Z/
M_?7^8I#/U+JQ!0 4 % !0 4 <IXS\(6?C739--O!@GYH90!NAE ^5U_DZ\;D
M)7(R" #\]/$?AZ\\*W\NF:@NR:!L9'W74_=D0\91QRIP#V8!@0)&8= @H *
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M "@ H * "@ H * "@ H * /E;]IG_F$_]OW_ +9TF!\K4@"@ H * "@ H *
M/9/@-_R-D'_7"X_]%F@9]W50@H * "@ H * "@#,UK1[;Q!93:;?+YEO<H4=
M>A]0RGLRL R'LP![4 ?G3XR\*77@S4Y=+N^?+.Z*3&%EB;[DB_4<, 3M<,N2
M5J1G+4""@ H * "@ H * "@#V+X0?$9O!5_]DO6/]EWK 2YY$,GW5G ]!PLH
M'+)AL,T:@@S[N1UD4,A#*P!!!R"#R""."".AJA#J "@ H * "@ H * "@ H
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M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^,_VC_\
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M_E\U_=\NGIM[57JGS04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0!\X_M)?\@FQ_P"OMO\ T2])@?'=( H * "@ H * "@#U7X)
M_P#(XZ?_ -O7_I'<4 ??M4 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 ?E;4@% !0 4 % !0 4 % 'Z'?"7_D4]-_ZX'_T9
M)30'HE, H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * /,OC)_R*.H_P"Y#_Z4PTF!^?5( H * "@ H *
M"@">U_UT?^^O\Q2&?J75B"@ H * "@ H * /+OBC\.H?'=AF$+'J5J";:0X&
M[N8)#_<<]"?]6_S#@N&0'P-=VDUA,]M<HT4T+,DB.,,C*<,K ]"",4@*] !0
M 4 % !0 4 % !0 4 >[?!OX8'Q5<#5]30_V9;/\ *C#BZE4_<YZPH?\ 6'D,
M1Y0S\Y4&?;:J%  & . !T JA"T % !0 4 % !0!\N_M+_P"ITO\ W[O^5O28
MSY/I""@ H * "@ H * /9/@-_P C9!_UPN/_ $6:!GW=5""@ H * "@ H *
M"@ H * "@ H * /C/]H__D.VG_7@O_H^>I8SYYH$% !0 4 % !0 4 ?1_P"S
M;_R%K[_KT7_T:M"&?8=4(* "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * /E;]IG_F$_\ ;]_[9TF!
M\K4@"@ H * "@ H * /9/@-_R-D'_7"X_P#19H&?=U4(* "@ H * "@ H *
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M 009^AGA[Q!9^)[&+4]/<203+G_:1A]Z-Q_"Z'AA^()4@FA&U0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 R65($:65@B("S,Q"JJJ,EF)P  !
MDD\ <F@#X.^+GQ&;QO?BWM"1IEFS"$=/-?HT[#@\CB,'[J9. SN*D9Y#0(*
M"@ H * "@ H * /H?]GGPQ_:&JRZW,O[K3T*1'L9Y@5XXYV1;\]""\9H0S[+
MJA!0 4 % !0 4 % !0 4 % !0 4 ?"/QY_Y&R?\ ZX6__HL5(SQN@04 % !0
M 4 % !0!]8?LT?ZG5/\ ?M/Y7%-#/J*F(* "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /C/]H_\
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M>DP/CND 4 % !0 4 % !0!ZK\$_^1QT__MZ_]([B@#[]J@"@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#\K:D H * "@ H *
M "@ H _0[X2_\BGIO_7 _P#HR2F@/1*8!0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >9?&3_D4=1_W(
M?_2F&DP/SZI % !0 4 % !0 4 3VO^NC_P!]?YBD,_4NK$% !0 4 % !0 4
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MP"@ H * "@ H * "@ H * "@ H ^$?CS_P C9/\ ]<+?_P!%BI&>-T""@ H
M* "@ H * /K#]FC_ %.J?[]I_*XIH9]14Q!0 4 % !0 4 % !0 4 % !0 4
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M0>001P01R".M>WOJCXYJVCT:'4Q!0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % 'SC^TE_R";'_ *^V_P#1+TF!\=T@"@ H * "@ H * /5
M?@G_ ,CCI_\ V]?^D=Q0!]^U0!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M5O28SY/I""@ H * "@ H * /9/@-_P C9!_UPN/_ $6:!GW=5""@ H * "@
MH * "@ H * "@ H * /C/]H__D.VG_7@O_H^>I8SYYH$% !0 4 % !0 4 ?1
M_P"S;_R%K[_KT7_T:M"&?8=4(* "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /E;]IG_F$_\ ;]_[
M9TF!\K4@"@ H * "@ H * /9/@-_R-D'_7"X_P#19H&?=U4(* "@ H * "@
MH * "@""ZM8KZ%[:X1989D:.1&&59&!5E(]""0: /SW^)?@67P)JC6P#-93[
MI+24\[H\\HQZ&2+(5^F05? #BI&>>4""@ H * "@ H * "@#IO"/BF[\&ZE%
MJED?FC.V2,G"RQ-C?$_LP&0<':P5Q\RB@9^B7A[7[3Q/80ZG8-O@G7(S]Y&'
M#1N.SHV58<C(R"5()H1M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '
MS+^T#X&^U0KXFLU_>0!8KP*/O19Q',<#),9/EN3D[&3HL9I,#Y'I % !0 4
M% !0 4 % !0!Z#X!^(NH> KKS+<^=9R$>?:LQ"..,LG7RY0!A7 /HRLO% S[
MJ\*>+]-\96@O=,D#@8$D;8$L+'^&1,G:>#@\JP!*L15".GH * "@ H * "@
MH * "@ H * "@ H * "@"O=W<-A"]S<NL,,2EGD=@JJHZEF. !0!\;?%/XRR
M>) ^D:&6AT[[LLW*R7..J@<%(3_=/SR#[VU24,C/GZ@04 % !0 4 % !0 4
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MO9^_3^'JNW_ _(^SP.8*K:C7=JG26REZ]I?@_70\>KS3Z(* "@ H * "@ H
M* "@ H ]4\!?$23P\5L;\M)8$_*>KP$]U[F//+)VR63G*MWT,0Z7N3UA^7IY
M>7W>?@XW +$7JT;*KUZ*7KV?9_)]U].6]Q'=1K-"RR1R*&5E.593R"".H->^
MFFKK9GQ,HN#<9*S6C3W3):9(4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % 'SC^TE_P @FQ_Z^V_]$O28'QW2 * "@ H * "@ H ]5^"?_(XZ
M?_V]?^D=Q0!]^U0!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0!^5M2 4 % !0 4 % !0 4 ?H=\)?^13TW_K@?\ T9)30'HE
M, H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * /,OC)_R*.H_[D/\ Z4PTF!^?5( H * "@ H * "@">U_
MUT?^^O\ ,4AGZEU8@H * "@ H * "@ H * (Y8DG1HI55XW4JRL RLK##*RG
M((()!!&".#0!\(_%KX:/X(O/M=FI;2KISY3<GR7.6,#DY/0$Q,3ET!!)9&-3
ML,\?H$% !0 4 7M,TVYUBZBL;*-IKB=PD:+U)/Z  9+,<!5!8D $T ?H%\./
M -MX"TX6Z[9+R?#W4X'WGQPBGKY4>2$'&3N<@%B ]@/0J8!0 4 % !0 4 %
M!0 4 ?+O[2_^ITO_ '[O^5O28SY/I""@ H * "@ H * /9/@-_R-D'_7"X_]
M%F@9]W50@H * "@ H * "@ H * "@ H * "@#XS_ &C_ /D.VG_7@O\ Z/GJ
M6,^>:!!0 4 % !0 4 % 'T?^S;_R%K[_ *]%_P#1JT(9]AU0@H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H ^5OVF?\ F$_]OW_MG28'RM2 * "@ H * "@ H ]D^ W_ "-D'_7"
MX_\ 19H&?=U4(* "@ H * "@ H * "@ H XOQ[X,M_'&E2:=-A)A^\MY2/\
M53 ':3CG8V2L@'52<?,%(0'YWZGIMQH]U+8WB&*XMW:.1#V93@\C@@]589#
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MOXF:KXZDVW#?9[)6S':1D^6,=&D/!ED _B8 #G8B9(*&>=4""@ H * "@ H
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M'<4 ??M4 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 ?E;4@% !0 4 % !0 4 % 'Z'?"7_D4]-_ZX'_ -&24T!Z)3 * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@#S+XR?\BCJ/^Y#_ .E,-)@?GU2 * "@ H * "@ H GM?]='_OK_
M #%(9^I=6(* "@ H * "@ H * "@ H R]:T:U\064NG7Z"6WN%*NO?U#*>S*
M0&5NS 'M0!^>_CWP1=^!-2:QN,O ^7MI\866+. >,@.O21,Y4X(RK*QD9Q-
M@H <JER%4$L2  !DDGH .Y/84 ?<7P>^&*^#[8:GJ* ZI=(.#_R[1-SY0_Z:
M-QYK=O\ 5J<!B[ ]NI@% !0 4 % !0 4 % !0 4 ?+O[2_\ J=+_ -^[_E;T
MF,^3Z0@H * "@ H * "@#V3X#?\ (V0?]<+C_P!%F@9]W50@H * "@ H * "
M@ H * "@ H * "@#XS_:/_Y#MI_UX+_Z/GJ6,^>:!!0 4 % !0 4 % 'T?\
MLV_\A:^_Z]%_]&K0AGV'5""@ H * "@ H * "@ H * "@ H * "@ H * "@
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M!F[JFU?E)D6F@/?J8!0 4 % !0 4 % !0 4 % !0 4 % !0!\(_'G_D;)_\
MKA;_ /HL5(SQN@04 % !0 4 % !0!]8?LT?ZG5/]^T_E<4T,^HJ8@H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H ^,_VC_\ D.VG_7@O_H^>I8SYYH$% !0 4 % !0 4 ?0W[-__
M "';O_KP;_T?!0AGV95""@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M *"E_P#^!,O_ ,50 ?\ "P_$O_04O_\ P)E_^*H /^%A^)?^@I?_ /@3+_\
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M9?&3_D4=1_W(?_2F&DP/SZI % !0 4 % !0 4 3VO^NC_P!]?YBD,_4NK$%
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M4+R>"64AXY)Y&1AY;G#*6((R >>XH ^YJH04 % !0 4 % !0 4 % !0 4 %
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M,^@*,!TYZTK@>3Z[\1O$7B/*WU].T;<&*-A#$1Z&.((K?\"#'OG- SB:!!0
M4 % !0 4 % !0 4 % !0 4 ?0GP4^&)U^==>U6/_ $"W?,$;CBXF4_>(/WH8
MB.<_+(_R?,JR+0,^SJH04 % !0 4 % !0 4 % !0 4 % !0 4 % 'PC\>?\
MD;)_^N%O_P"BQ4C/&Z!!0 4 % !0 4 % &UI/B/4]!#C3+JXLQ+M+B"5X]^W
M.W=M(SC<<9Z9/K0,U_\ A8?B7_H*7_\ X$R__%4 '_"P_$O_ $%+_P#\"9?_
M (J@ _X6'XE_Z"E__P"!,O\ \50 ?\+#\2_]!2__ / F7_XJ@ _X6'XE_P"@
MI?\ _@3+_P#%4 '_  L/Q+_T%+__ ,"9?_BJ #_A8?B7_H*7_P#X$R__ !5
M!_PL/Q+_ -!2_P#_  )E_P#BJ #_ (6'XE_Z"E__ .!,O_Q5 !_PL/Q+_P!!
M2_\ _ F7_P"*H /^%A^)?^@I?_\ @3+_ /%4 '_"P_$O_04O_P#P)E_^*H /
M^%A^)?\ H*7_ /X$R_\ Q5 !_P +#\2_]!2__P# F7_XJ@ _X6'XE_Z"E_\
M^!,O_P 50 ?\+#\2_P#04O\ _P "9?\ XJ@ _P"%A^)?^@I?_P#@3+_\50 ?
M\+#\2_\ 04O_ /P)E_\ BJ #_A8?B7_H*7__ ($R_P#Q5 !_PL/Q+_T%+_\
M\"9?_BJ #_A8?B7_ *"E_P#^!,O_ ,50 ?\ "P_$O_04O_\ P)E_^*H ]6^#
M'B_6M8\2PVM_?75S T,Y,<LTCH2L9()5F(R#R/2@#[+JA!0 4 % !0 4 % !
M0 4 % !0 4 ?&?[1_P#R';3_ *\%_P#1\]2QGSS0(* "@ H * "@ H ^AOV;
M_P#D.W?_ %X-_P"CX*$,^S*H04 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M?_V]?^D=Q0!]^U0!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M-&5./W<;#][D89AY7/S[4,^U54*  , < #H!5"%H * "@ H * "@ H * "@
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M@ H * "@ H * "@ H * "@ H ]D^ W_(V0?]<+C_ -%F@9]W50@H * "@ H
M* "@ H * "@ H * /C/]H_\ Y#MI_P!>"_\ H^>I8SYYH$% !0 4 % !0 4
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M H * "@ H * "@ H * "@ H ^<?VDO\ D$V/_7VW_HEZ3 ^.Z0!0 4 % !0
M4 % 'JOP3_Y''3_^WK_TCN* /OVJ * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * /RMJ0"@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /L3]FW_D$WW_7VO_HE
M*: ^CJ8!0 4 % !0 4 % !0 4 % 'F7QD_Y%'4?]R'_TIAI,#\^J0!0 4 %
M!0 4 % $]K_KH_\ ?7^8I#/U+JQ!0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0!\N_M+_ .ITO_?N_P"5O28SY/I""@ H * "
M@ H * /9/@-_R-D'_7"X_P#19H&?=U4(* "@ H * "@ H * "@ H * "@ H
M^,_VC_\ D.VG_7@O_H^>I8SYYH$% !0 4 % !0 4 % !0 4 % !0 4 % !0
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M&2QXMYCPLH[!'X27T 5\_(0QL,^Y 01D<@U0@H * "@ H * "@ H * "@ H
M* "@ H * "@ H * /GOXL?!U?$6_6=#41ZA]Z: 85+GU=>@2?U)^67OA\LR
M^-IH9+9VAF5HY$)5D8%65@<$,#@@@\$'D4@(J "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /8OA?\ "FY\;3+>W@:W
MTF-OFDZ/.5ZQPY[=GDQM7D#+\ &?<>G:=;:1;1V5E&L%O H2.-!A54?J23DL
MQ)9F)9B6)-4(NT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?"/QY_Y&R?
M_KA;_P#HL5(SQN@04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % 'LGP&_P"1L@_ZX7'_ *+- S[NJA!0 4 % !0
M4 % !0 4 % !0 4 ?&?[1_\ R';3_KP7_P!'SU+&?/- @H * "@ H * "@#Z
M&_9O_P"0[=_]>#?^CX*$,^S*H04 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % '(>+O!MIXL@V2XBN8Q^ZG RR]]K#C<A/52>"25(.<\M:C&LM
M=)+9_IZ'HX7%SPDKQU@_BCT?FNS\_O/E#6M$N_#]RUG>H8Y%Y!_A=<D!T/\
M$IQP?P(!! ^>G"5-\LU9_P!:H^]HUH8B"J4G=?BGV:Z,R*S.@* "@ H * /H
MCX*?\>MY_P!=8_\ T!J]G!;3]5^I\?F_QT_\+_-'MM>L?,A0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?./[27_ "";'_K[;_T2])@?'=(
MH * "@ H * "@#U7X)_\CCI__;U_Z1W% 'W[5 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'Y6U(!0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'V)^S;_R"
M;[_K[7_T2E- ?1U, H * "@ H * "@ H * "@#S+XR?\BCJ/^Y#_ .E,-)@?
MGU2 * "@ H * "@ H GM?]='_OK_ #%(9^I=6(* "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * /EW]I?\ U.E_[]W_ "MZ3&?)
M](04 % !0 4 % !0![)\!O\ D;(/^N%Q_P"BS0,^[JH04 % !0 4 % !0 4
M% !0 4 % !0!\9_M'_\ (=M/^O!?_1\]2QGSS0(* "@ H * "@ H * "@ H
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M[."VGZK]3X_-_CI_X7^:/;:]8^9"@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H ^<?VDO^038_P#7VW_HEZ3 ^.Z0!0 4 % !0 4 % 'JOP3_
M .1QT_\ [>O_ $CN* /OVJ * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@H * "@ H * "@ H * "@ H * /E;]IG_F$_]OW_ +9TF!\K4@"@ H * "@
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M?8_P[^"UAX2*7^I%;[4EPRDC]Q W_3)6^^X/25QD$ HJ$9+L(]OI@% !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?"/QY_P"1LG_ZX6__ *+%2,\;
MH$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MKV<%M/U7ZGQ^;_'3_P +_-'MM>L?,A0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 ?./[27_()L?^OMO_ $2])@?'=( H * "@ H * "@#U7X
M)_\ (XZ?_P!O7_I'<4 ??M4 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 ?E;4@% !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?8G[-O_ "";[_K[7_T2E- ?
M1U, H * "@ H * "@ H * "@#S+XR?\ (HZC_N0_^E,-)@?GU2 * "@ H *
M"@ H GM?]='_ +Z_S%(9^I=6(* "@ H * "@ H * "@ H * "@ H * "@ H
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M^P\-6PLM+@2VA7G:@Y8_WG8Y9V/=G).,#. !5"-B@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H ^$?CS_ ,C9/_UPM_\ T6*D9XW0(* "@ H
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M'<4 ??M4 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 ?E;4@% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 ?8G[-O_()OO^OM?_1*4T!]'4P"@ H * "@ H *
M "@ H * /,OC)_R*.H_[D/\ Z4PTF!^?5( H * "@ H * "@">U_UT?^^O\
M,4AGZEU8@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M % !0 4 % !0 4 % 'QG^T?_ ,AVT_Z\%_\ 1\]2QGSS0(* "@ H * "@ H
M^AOV;_\ D.W?_7@W_H^"A#/LRJ$% !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 07-M%>Q-;W"+)%("KHPRK ]014M*2Y9*Z?0J,
MG!J<&TUJFMT?,?CSX=R^'6:]L0TM@QR>[09/"MW*<X5^WW7YPS>#7P[I>]#6
M'Y>OEY_?Y_;X+'K$)4JME5Z=I^:[/NOFNR\MK@/=/HCX*?\ 'K>?]=8__0&K
MV<%M/U7ZGQ^;_'3_ ,+_ #1[;7K'S(4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % 'SC^TE_R";'_ *^V_P#1+TF!\=T@"@ H * "@ H * /5
M?@G_ ,CCI_\ V]?^D=Q0!]^U0!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0!\C_\,U7O_01A_P"_#_\ Q=*PP_X9JO?^@C#_
M -^'_P#BZ+ '_#-5[_T$8?\ OP__ ,718 _X9JO?^@C#_P!^'_\ BZ+ '_#-
M5[_T$8?^_#__ !=%@#_AFJ]_Z",/_?A__BZ+ '_#-5[_ -!&'_OP_P#\718
M_P"&:KW_ *",/_?A_P#XNBP!_P ,U7O_ $$8?^_#_P#Q=%@#_AFJ]_Z",/\
MWX?_ .+HL ?\,U7O_01A_P"_#_\ Q=%@#_AFJ]_Z",/_ 'X?_P"+HL ?\,U7
MO_01A_[\/_\ %T6 /^&:KW_H(P_]^'_^+HL ?\,U7O\ T$8?^_#_ /Q=%@#_
M (9JO?\ H(P_]^'_ /BZ+ '_  S5>_\ 01A_[\/_ /%T6 /^&:KW_H(P_P#?
MA_\ XNBP!_PS5>_]!&'_ +\/_P#%T6 /^&:KW_H(P_\ ?A__ (NBP!_PS5>_
M]!&'_OP__P 718 _X9JO?^@C#_WX?_XNBP!_PS5>_P#01A_[\/\ _%T6 /\
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M_01A_P"_#_\ Q=%@#_AFJ]_Z",/_ 'X?_P"+HL ?\,U7O_01A_[\/_\ %T6
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M^"USX*UB/5I;R.X6..1/+6)E)\Q2N<ER.,YZ46 ^@:8@H * "@ H * "@ H
M* "@ H * "@ H * "@ H \)^(OP4A\97XU2PG2QGD7%P&C+K*PX60!67:^/E
M?J& 4\-N+*P'GO\ PS5>_P#01A_[\/\ _%T6&'_#-5[_ -!&'_OP_P#\718
M_P"&:KW_ *",/_?A_P#XNBP!_P ,U7O_ $$8?^_#_P#Q=%@#_AFJ]_Z",/\
MWX?_ .+HL ?\,U7O_01A_P"_#_\ Q=%@#_AFJ]_Z",/_ 'X?_P"+HL ?\,U7
MO_01A_[\/_\ %T6 /^&:KT?\Q&'_ +\/_P#'*+ ?37AFPO\ 2].AL]4G6]N8
M%V&=5*F15X0N&+$OMP';/SD;CR33$;U !0 4 % !0 4 % !0 4 % !0 4 %
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M,U7O_01A_P"_#_\ Q=%@#_AFJ]_Z",/_ 'X?_P"+HL ?\,U7O_01A_[\/_\
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M_01A_P"_#_\ Q=%@#_AFJ]_Z",/_ 'X?_P"+HL ?\,U7O_01A_[\/_\ %T6
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M>/DQC'>@1[?3 * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * &NBRJ4<!E8$,I (((P00>""."#P12WT8TVG=:-;'SEX_^&S:9
MOU/25+6O+2PCDP^K(.IB[D=8QSROW?$KX;DO.G\/5=O^!^1]C@<P52U#$.T]
MHR_F\GVE^?KOT7P4_P"/6\_ZZQ_^@-6V"VGZK]3CS?XZ?^%_FCVVO6/F0H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /,OB?X E^(%G!:0SI
M:FWF,I9T+@@H5P &7!YSFD!XI_PS5>_]!&'_ +\/_P#%T6&'_#-5[_T$8?\
MOP__ ,718 _X9JO?^@C#_P!^'_\ BZ+ '_#-5[_T$8?^_#__ !=%@#_AFJ]_
MZ",/_?A__BZ+ '_#-5[_ -!&'_OP_P#\718 _P"&:KW_ *",/_?A_P#XNBP'
M7>!/@?<^#];MM9EO8ITMO-S&L3*6\R"6(88N0,&3=TY Q181]%4P"@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H Q-)T&TT6:X>R3RA=,LCH/N
M!AN!*+CY0>I . ?N@#BL84XTW)PTYK-KIUV.JK6G6C!5'?D32?6VF[Z_GW-N
MMCE"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
+* "@ H * "@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ebs-brginterimmanagement001.jpg
<TEXT>
begin 644 ebs-brginterimmanagement001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+\1:P=!T&
MZU,6_P!H, 4B+?LW$L%ZX..OI6I6#XTL+O4_"-_9V,!GN9%39&&52V'4XRQ
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M 97^4,5CQ\RJ6&3D'@X!Q6"W@S7)= DU$ZC=)K;W1U5;#,)A%P#E8]^W=C:
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M7"R;0'7K_'D5HVNGZI8^&[;2]0T#^T],D$P>R25'EMU\S=#&2[!655PI(/!
MQD<T 7[_ ,=6=GX5LM;2SNIOMD0EBMU0Y XR789"@;ASW[9S755QDFA:L?A>
M='D7SM0\K:L?FAMH\S*IO/7:N%SWVUV= !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %4[G2M.O;F*YNK"UGN(?]7++"K,GT)&15RB@ HHHH **** "
MBBB@ ZC!ID,,5O"D,,:1Q(H5$10%4#H !T%/HH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4Y% #Z**B>XAC=4>5%=ONJ6P3]!0!+112$@=30 M%1Q3Q3J6BD20 XRIS4E
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M102 ,GI4<5Q#,"8I4D ."58'!H DHHJ.6XA@QYLJ)DX&YL9H DHI 0>E+G%
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M,_F*^X@E6QV.*Z:BA.P&'X2T.3PYX<M=+EN3</"#F3&!R2<#VK;/W32T4-W
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M>-;S79-3\Z*8N5C"G<=QS\Q]J]!HH3L%@HHHI %%%% !1113 **** "BBB@
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M'\.*TKBVANHC%/&DD9ZHZ@@_@:='$D**D:A448"J, "BZL [G!K@[?XB^?\
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M(?$'PG>^+-,M[:RO?LSQ2;R&SM<>^/2M[0-.ETG0[2PFN&N)8(PC2MU8T6T
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MWFKK9S:-"L<MJT3,TA0Y&TCCFH=.\9V5EH>JS[+:6>ZU@7/V2XB#[HCDGJ,
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M84444 %%%% !1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:*
M $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@ HHHH **** "BBB@ HHHI
M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 445Q?C>ZEFUKPSX>#LEKJETY
MNBIQOCB7<8R?1B0#[#% '6Q7MK.SK%<PR,APP20$J>F#4]9=[X>TV]BM4-K#
M$;2:.:!HT"F,HP8 8Z XP1Z5B77C.Y5'NK#2YKVTBNS;.D,4K2N%?8[KA"IP
MP/&>0.HZ4 =?17*0^(=<OM=U+3K+2;/;I]S'%+++=L 5>,.& "<GD9'Y$]JG
MAOQ%K5QX.T_4;FWAGFN[AP\WF$) F]RSOD<*NT  'TY% '93W$-K"TUQ-'#$
MOWGD8*H[<DU)7"WWB\77@G6-1ETJSO5L+PVDT+R[HI0&4!URIR/F4X/YUJWF
MOZL/%%QH5AIMK)(EDMW'--<E5(+E<, I(Y4],_44 =+4<5Q#,\J131R-$VR1
M48$HV,X/H<$?G6?X;UD>(?#MCJPA,/VF/>8R<[#G!&>_(-84/BF"QA\0W,NE
MP036NHK:A('!-U*ZH$);:.3O49(. .^* .M^T0"Y%MYT?GE2XBW#<5!P3CKC
M)'/O4E<#-<RZ?\3?MVIQ6T21:!/-)+ 2<JLL9.<C/&.O?VK4M/%&HW&I6$/]
MCR-;WT3,LJI*!;L%W*LK%,8;IN'0]CUH ZJFNZQHSNP5%!+,QP /4UQ-AXWU
M&YT_1-3GTFWBL=1O/L;;;DM(CEV52!MP5RO/(//2GV>M:M+-XO:[M[2Y@T^5
MD2 RLH*B%6V\J>H)R?7MB@#L/M5N;470GB^SE=XEWC85ZYSTQ[U%:ZE87S8M
M+VVN#MWXAE5_ER1G@],@C/M7$:QJ%W<Z%X(FL;6VM[>\N[1_LX<JJYC9U3 7
M[H('Y#BK\&H:?H/B36TDT>RLS!IXU*YN[?EY02VX'Y0>J$]3F@#LJCEN((#&
M)IHXS(P1-[ ;F/0#/4^U<Q!XLNUU&V2\TR5+&XMY)FN8XI=MJ47=B0L@&",X
M([C&.]8VNW]UK">#M4>S@CM;G5K>6$EB941E8KGC'S#D@=#@<]: /0)YXK:!
MYYY4BB0;GDD8*JCU)/2G@A@"""#R"*Q?%]^-,\)ZE>O807T<,#/);3MA)%'4
M'@Y^F*IS^(-17Q#;Z+8Z;:L9M.-W'))<%%7#*N& 4X W=LYXZ4 =,S*BEF(5
M0,DDX %0VM[:7T1EL[F&XC#%2T,@< CJ,CO7!:]X@O=;^'=GJ$-O%;M<7T5O
M<Q&4G!6Y6,J"!RI*G/3@]ZW8+MEU[4+'2["Q34Q#'<W\I<A&=LB-<@9)(4\X
MX&.#F@#IZ*XI/'5Q=V^BO8Z4C2ZA<RV<D4UQM,$T:L2IPIR,KUZX['I5B+Q%
MX@EUF313I%A'?I8)=DF\8QY9V7&0F>JGL?K0!UM%<39^-[ZZL-!U1]*ABT_5
M+A+5O]()ECD;(R!MP5W*1USWP*M:CXNN=-OHDN+**.*744L4B>7$SHS!1,!_
M=W'IZ#KVH ZLD*"20 .23VID,\5S D\$J2Q.-R21L&5AZ@CK7*6.KZQ/XC\4
MV\L5K-;V B6*(R,HP8R^/NGD[N3].M&C^)DN-)\.6UA86]O<:G:F>.W4XBMX
MU )Z#GEE   SGMB@#KZ*XJ]\<W-CINJL^F1M?Z5=PV]S )R%*RLH21#MY!#
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M9[J*U%QLN9L^7#-&T3O@$DA6 )& >>E %3PYHUSH[ZL;B6&07U])>+Y>?DW
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MOJMG#;@1Y+Q-&697YX/+=..E=A54:A:G5&TT2'[6L(G*;#C825!SC'4'C.:
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MY-PPRD,"&4C&0?2@"G+>:]96MC#J-U91O)=R1RSP*6DDB 8Q^7'@YD.!D $
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M\VP2!XV#)A0NT $=,=SW.: &?VCJB^-AH;741MWTEKE9!#AQ*)%3)YP1R3C
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MV\8C@A01QHO15 P!^5<Q%X%A@TFPTU-5O?L]A>+=VX81G:58LJ_=Y&2?<^M
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MKBO%&J7GB#P!XJO8+A8;2W,]M'#Y8;S%C.UV8]<DYQC&.,YKT=55$5$4*JC
M ' %<E=^ X9XM8M;?5;RUT_5F:2XM$"%1(WWF4E25SU(]: )H]6U"+QA::2I
MA>SDTA[I4"8?S%=%&6ST^8]A63I_CAA87UY>7+"[T^PDGOM*G@\J:.5=I&SU
MC^\,\]1S70?\(PO]L0:DVH7+2PV+6(5@F&1B"2< ?-E1TQTZ4S_A$K:YEBDU
M2X?4&BLY+)6D159HY  V\K]XD#V')XR<T 2Z?_;K7EC<2W-K/8SVY>X7;M:.
M0@%?+QU7D@[CG@'/:N4\+:S+8^&/#^F6Q5+C4]1O(EE89$:++*[$#N<  >YS
MSC!Z;0_"SZ*D<3:S?WL%NI2TBN=F(!C Y"@L0. 6)P*KQ>![2'1;33UOKGS+
M*Z:[M+K"B2*1F9CVP02S @CD&@"G=>(]9TZ\US2A ;^ZL[>*[M9(HOGDA=MK
M J."ZX8C&-W' IL7C$2:7]HT^_34?M-]%9V^8@DL+,/F613M&X8;&<9X^M;;
M>' _VR=K^==0NC#NNT50R")MRJJX("YSD'.=Q]L5+SP38:E!J7VR64W5^\4C
MW,&(FC>+_5LF.A'/)SG/IQ0!0N_$'B#0[?4'O[0-"\T$.FSSF,,SR,%(D6-B
M,*3G(QD<=:6&"Z@^+%J+F[^T@Z),58QA2#YT>1QQCT[^YJ_+X-BO]$N=/UC5
M+W49)PH%S(51XMIRI3:  0><X)/?/2I+3PM-#K5OJUUK=[=7<-JUKEDB4,C$
M'D!>N5!^OY4 =%7&^%?^1[\;?]?-K_Z(%=/IMI+8:=!:S7DUY)&N&N)\;W]S
M@ 5CVOA:2SU74]0M]9NXYM2=7GQ'$0"J[1MRIQQZYH X^XUE?!OC+QE-91!K
M-+."Z> '"+=.P0?3=D$UU5WJ>IZ1XCTC3[JY6YM]5$D7F+$%:"94W CL4(!X
M.2,#DU:C\&Z0NCZCITL<EPNI9-Y/,^Z69C_$6]1VQ@#L*EL_#WE75C<7M]-?
M2V",ELTJJI7<,%C@?,V!C/N>.: .<M?%6K3>$_#NJ/)#Y][JB6=P!%\K(TS)
MD#/!PHJI#_;L5_XTNM%O+2!K:_\ -,<\!D\XB",[2=PVC Z\GGMCG97P#$MK
M!9KK%^MG:WPO;6%1'^Y8.7QG;EAN)^]GBKS^%4-SJC1:C<Q6^J,&NX5"\G:$
M.UL97*@ ]?;!H PX-635/%WA;5S&8EN=#N+@IUVY\EB/>K6F:UXDU1-%U6UL
MFDL;XJUS$_E*L4+C(9&#[BR\9!'/. .E;+>&[<:WI^I0S/"MC;-:PVR*OE^6
MVW(Z9_A7OVJEH_@R/1;@1V^K7[:7'(98=-=E,439R,-C=M!Y"YQ]: -'Q!>7
M-E9P/;300![A(Y9)>2J'KL7!W.> !@]>AZ5S4'BK53H>K3F">X;3]4^RO)%;
M_OA;X1B_E]V ;ICWQVKI=>T)-<2R/VN>TGLKE;F":':2& *\A@000Q[50M?"
M/V&6[FMM8OEDN;P7A+;"!)L"MD;>0P'([=L4 <_JVL7&J:+H]UINO1W%M/KM
MM")88@"R%E(5QV8,.1@9XZ#BM2\UC7;R;5[718VDN=,*PH=D6R>7RU<[]S@A
M3N ^7IR<GI5N?P7:3V<R"ZFANI=034FN(54$3KC!"D$8PHX.<\DYI+GP;NUE
M]4L=:U&PFN(TCO! 4(N0HP&.Y3AL<;AC\* *3ZGXGOO%#:1#<66GG^S(;TAX
M/-,;LY5D)#8;[I&X8^G>D_X2/6EM?$[+"+N73;^.&)+:'YO)*QLY"DG<P5F(
M&>2/PK;MO#L5KXC_ +8BN90?L:60M\#8(U)9><9SDGG-01^%C ^IR0ZI=1RW
M]TEVSJJ?(Z;< <?=(0 @YXS0!R^OZU#K'@*ZO(-22_MUU.T$;+%MDC EBRDB
M@ []V[L.".*Z"VUK4=2\/7^OZ6R74;Q.UA9!!N)48PYZ[BP/R\8Z9ST6\\%6
M]]!>K+>2QS7US#<W$L**NYHMI0 $' RH)ZD\\U+'X22WN=4EM-2NK9-2(>6*
M((%27 !E3(^5B1D]B>U ">%=>BUQ[MX-2-S'$L:M!-#Y5Q;R?-N61<#_ &<<
M=CR:?)JESJ'BF[T2SN!;+96T<TTNP,S/(6VJ >-H"DGN<C!%7+#1$M=6N-5F
MF\^^GA2!I @0;$)(X'4Y8Y/TQBJ]]X96?Q FMV6H7-A>&'R)S"J,LT8.0&#
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M!J4T6HSVU_J#Q--=6Z*A CQ@ $$<C().3R?8  WZ*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M# G@C:.A/W@:Y31OB+KNJ>!;CQ8NDV4MO:R.)[5)6638N"S*Q!!P#G! Z=:
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M+4SLAOK9SB-^/E=&Z#D<@_AQ0!VU%<+J?C+5;3XF67A"W@LBMY;FX2XD#90
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M)12?I0!QNFZOI%IH,OAZTU*"\.FZ6?/N$E#*@ VJ&;IN/)_#WKSSP'K5C8_
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MC64[75A;W#IY;RQ*[)G.TD XJ3RH_P#GFOY4^@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?T6[MWMK^ULFE:+?D/&RG:Z,,9&00> 016/I&NZAI^E^ --M;198K^P4RN9
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M1Q7=QIG]G6UOYN<+EF+.P&.68=,X"^^!3A\-ZU;6O@QXHK1[G1(C!<1O,0K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *\K\:Z)<:M\5O#UT^DW5UI5O"T5W(
M+=F1=V_C@<]1R.E>J44 >5>#M%UKP1XCU7PT;.YGT&^)EL]1CB+&%B, .1S[
M>Q / )JM\/O#TEK:V.B:]X=U3^T-(O6FM[HRR"U W%O,4[MI/)X .>,]3CUZ
MB@#GO#U]<W>L:[%-X=;2T@N0L=T0/].'(W\ 9X ]?O =C7(_&32M0UFST6#3
MM.NKUH+P32K#"6 3&.3T_"O3Z* .3TR>#3M3BT[1-&O(;6\N7N+B1K-H8;<>
M7SC<!RS*. /XC7FESX>UJ7P1X[LUT>_-QJ.KK/:Q_9VS+'YH;<./0'K7N]%
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M5@/W-N\008';<A/ZUL44 9^EZ7+IOF^9JE_?>9C'VMD.S&>FU5ZY[YZ"O/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'/''.12:CX=M-3U6PU*>6X%S8%FMBC[0A888XQ@Y''.:UZ* .8?P%HCB1?\
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MLDSS$SRF0@L<D GH/05<HH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN[J*&2ZD$4".V#(YZ #O7.GQ%J6_3;$I&+Z^@ENRR6S-Y4*LH4%-^=QWKGG
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MVJF%A#AXP1SEB3DGU&*["@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KGO$>ER3ZAHVM6R-)<:5<,YC49+PR(4D '<@$,!WVX[UT
M-8OB/Q$GAR&TEELY[E;JYCM4\DKD.YPN=Q'&>] %&^\,376O_P!OZ+K<NFSW
M,*Q706%94G1>5.&Z,,G!Y^E3R^%_*UFUU?3;UK>]AMOLDK3Q^<MQ%G=\XRIW
M!LG<".IZU*OB:&+7+72+^RN;*YO%8VS2[&CF*C+*&5CA@.<''MFMR@#EKKP7
M'+I$5E#>F)QJ(U*>=H@QFF$GF9(R !G QZ #WJQ-X62[UO4[Z[N%F@U&Q6QF
MMA%M'EC=T;=U^=OTK?=BL;,J%R!D*,9/MSQ67X:UM?$>@6VJI;M;K.7 B=@Q
M7:[+R1_NT 9>D>$+JSM/L&I:]<ZIIL<30P6TL2H0A4KAW'+X4D=NN<9QB3P]
MX6O-#6"VFUZYOK"T&VTMY(E4QKC #N.7P#@=![<#'35D6&NB^\1ZKH_V22)M
M/2%S(S B02;L8 Z?=[^M &(W@1_^$5N?#RZO)]DDN?.C+0*3$/.\[;P1D[NY
M[=AUK8U_PY;>(K:RBO'*O:W"3AXQC=C(=>OW64LI&>AK:HH Y_Q%X9?6;JQU
M"QU*73-3L2PAN8XQ("C8W(R'A@<#Z8J*]\+7%]:::DVK/)<6=\E_)/)""9I%
M& -H("K@XP/0<YR3IZ]JZ:!HEUJLMO)/#:QF21(B-VT=2,D UFQ>,K=;W2[:
M^T^\L?[4'^B2R[&C=L9"$JQ*L0>,C!]: *5_'IGBSQ3I\44=PTVB73O<RF%X
MT&%XCR0 X9]C<9&$^F>QHHH YV?P;IMSJ.M7<N]AJUL()HOX5^7:S#W8!,_[
M@I+WPFEUX&/AA+QXXW@$,EPR;W?NS=?O,<G\371T4 8,GAV9O$5KK<>HF.XB
ML_LDR"$%95W!QU.5Y'/L>W6LU/ \B>'K?2!J@V0:@+]9/L_);S3+MQNZ;C^7
MYUV%% %#6-.;5M#O=-\X0_:X'@:39NVAE*D@9ZX)K);PI(9O#\Z:F\4^CPO;
MATA&)8V55(P2<'Y%YY[\5>TO71J>LZQIIM)('TV2-&9V!\S>F\$8Z#!%:] '
M.?\ "+/<7^G7.H7R7)TZX>>W<0;91D, C/N.5 ;H ,[5STYL>(_#JZ\EE+%=
MR65_83BXM;E%#;&Q@@J?O*0<$<4EOXB.I7%PFD63WD-M(8I+DR+'&7'WE0GE
MB.A.,9XSUJ[I6J#5([AC:7%J\$QA>*< ,& !SP2,?,,$'F@#GY/ JWSZXVJZ
MG+<C6(88YEBB6(1M&/E9.I!!Y'/US5JR\.:O%8317WB:YO+GRO*MY_LZ1^2,
M@[B!]]N!R3^')STM% '+7/@T7G]LS37<*7FJV0LII8+;8NS# MMW'+_,>2>@
M''KA>)HA:WFBZ9=:JUC%9V9VW4VG">WF?A0-IR%<*I.<CAN.IKT:B@#B+71=
M1U[2+:WN=3B:WL;Z&ZM;A-/,'FB/#!?+W<*&XR,9'3U-G5O!#:O<:U+)JC1'
M4XH$/EP_ZHPMN0C).>2<@]1Z5UU8</B19_%EQX?%A.)X(%N'F++Y>QC@8YSG
M(/&.U %*/P?*^I:E>7FKS3G4;$6=PBPH@. XW+Z##GC]3TJO-X'N'TS1TAUZ
M>#5-(79:WR0+Q&5"E&CZ,I"C.3UY]JV_$NO1>&="N-7GMII[>W :182NX D#
M(R0#UK0M9GN+:.62%H6=0WEL02OUQQ0!SE_X/EOK:PF;69QK-E<&YBU Q*?F
M*[64QC V%0!M&.G7.2;>B^'I]+UK5-4N-2:ZFU'RC(@A6-%*+M!'4_K^?6I#
MXA6XU2YT[3+1[V:T(%S('"11,1D(6/5L<X ..^*LZ9JW]H7%Y;O9W%K-:LJN
MLVWYLC(*E201[_7TH Q]5\'/J.I:M<Q:M-;PZK9"TN81$KG # %6/W>'.1CG
MVIW_  BEQYGAZ3^U=SZ*&V%[<?O24,9S@C VG@#\2:V[C48XM0@L$'F74RF3
M8#C9&" 78]AD@#U)^I%"'Q5I<]M9W$=Q$8[RX\B$F51DXSSSP<#..O(&,G@
M(M!GB\5W6NB]0FXMDMC 8>%52S YW=<L:RF\#R-X8N-$.J#9/?&],OV?D-YH
MEVXW=-P_+\ZNP^*GN=<U32;?1[R6XTWRS,5DB ;S%++M)89X!ZXI/^$SL9/#
M%_KL%O<R1Z>TBW=L0%FA:/EU()QD?6@!U[X7;4-<N-2FORHN-,;37CCBVD(Q
MR6#;N&R>/;\ZJ:=X,N;*^T2[EUR69M*MWM446R(KQ$* .^#\@R>_;%3Q>-+8
M7&DQ7VGWEDFK8%I-+L:-V(R$)5B58CID8]ZT-1UZ&RU*#2X89+O49T,BV\6
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.U2<=!CVJ30[*\62YU/5(+>'4;L(KQP/O6-$!VINP-W+.<X_BQVS0!4^(/\
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M7WA_2M1O$O;BT'VM%V"XB=HY-OIN4@D>V:NVUK!9PB&WB6.,'.%[GN3ZGWH
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MY8)8IIVDCFC9&4&5V!((SR"#0 _PAXO@O-(LXM9U6W.JW-S<1(AVH7VS.J@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9=N8[J&ZC60@@E&^7(YXXSCTXKU32O"&G:1K=]KAEN+O5;Q=LMU<LI8*,?*
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MY>)(XOM!17WD<JVPY !+'@< FLBWT[0O&/PQ73=)")I=U9^7 O4PL.F?]I6
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ML'27S$E#;N5. >-N.1U_ GC_ !18>&?B,-/T^:Z:"ZDCEGTV\C898(^UMO\
M>!PK8[CD8Q2?#B7Q'I^MZWX8UN^_M.#3!$8+TY)^<9"$GG.,'!R1ZD8H ]%H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7.< 8X&:FM;.UL8?)L[:&WBR6V1($&3U.!4]% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M37GVV*&41KM^]&V]5^;'(]?04RZ\%2WK^);::^1=/UEEF 2,^;%*$50=V<$
MH&Z?_7DC\.ZYJNBW>E^)]5MKF&6V:W4V<!C9]PQYCY)!8=@ !UZ\8 ,K4YKZ
M\\7^![V[L[:$3SS.NQRTD>;=SL8XYZYR.,COUK:\<:GJ6EZ39R::8E>;4+:"
M1G)!VO*H(&/7H3Z9JC!X8\0R7'AY[[5-/?\ L:5B)$MWW3J8S'EANP&P>W&>
M?:MKQ3HDVO:0EM;3QP7$-S#<Q/(I9=T;AP" 0<'&* .;E.HV_P 3;YM/LK-[
MY]"@>022E(]WG29)(4DG@ <?E6G:>+KG4]%TC4;:SBMX;ZV:>6XNI<10,, 1
MDCDDDG'3@$^U68=$U*/Q9/K;SVLADTY+/RP&7YE9GW=^"6(QZ=S6/H_@K6-'
M70?*U*S?^S+:6U99869"&8'S$&1A\#;UZ?6@".3Q=JFJV?@Z]TZ&"WBU6Y99
MHI)#G*HYV[@/NY7.<9/'3FNB\8ZC?:3X-U74+#RENK>U>16?)"X&21ZGTK"L
MO!&IV.A:!:1ZG:M=:->-/&[6[;'1@ZD$;LYPY.<@<8]ZZC7M*.M^'-0TDS>6
MUW;/!YNW.TLI&<?TH XZ^:_'C'P=<+;6TFHR6%X"3*0K?+%@L^W/<]CU_&M2
MT\;/+I,37%FL>I/J,NFF&-FD3S(]Q9@0NXKM0GIGH/>I8_#VK-K.@:C<W5F[
M:9;S0NL:,HD\P(.,YQC8/KD]*SF\#:B=.F\G4H;;4H]7EU6SN$0LJ-(3F-U/
M5<,1GWZ>H!O^'M:O-5EU"WO=.EM9+24(LQC=8[A",ADWJ#Z@CG![\UAZE!$W
MQCT-S$A?^R[@[BHSD,N/YG\ZZ;1[?58H7DUF[MY[I\#;:QLD48']T,223DY)
M/IQQ6==Z#>W'CFPUY)K<06MM);>2=VYPY!+9Z#&!QS]: ,?X=LOB&RO_ !+J
M"+->W=Y-'&9!GR(4;:L:YZ#@DXZDY-5_B)H=CI?PW\4-:0I&ER4N&C"@*KY1
M25';.T?CFMJP\.ZCX=U"^;0Y[5].O9VN'L[H,ODRM]XHZY^4]=I''8T_Q/X=
MU#Q#X4O](:]A6>] 5Y2AV1 $'"KU/3J3U.?0  ;;)93:IIT#>''M'56GCN6B
MB7:R@# *$G)#'\,UF^ ''B#^V=>U!%FNY-0FMHO,&?(A3 6-0>G<G'4GFNA^
MSZ])]GB>YL885=#,T2N790<E5R<#.,9YX)^M5;/0+O0=2U&XT9[=[34)C<RV
MEP2@CF(PSHP!X; )4CKT(Z4 9/AZ9]+^)6N>';?C36M8[^&$?=@=CM=5'8,?
MFQTSG'6M/5?$.J6WBB'0M/TRVGEGLGN8YIKDHH*LJD, I('S=LYXZ<D6]%T#
M^SM0O]5NYEN-3OROG2JNU411A8T&3@#\R23[#%U5[E?BOI7V3R&E&D7&4F8J
M&'FQ]P#@]^AZ'Z@ AC\?WLFE6DPT9!>G5QI%W;M<X\J;/53M^92,'/'7O6K;
M:]JL^H)HSV=G%JR6QN;@"=GBC0N5C .T$EL$]!C'?I5*?P9=&UM1!=6_VH:R
M-8NI'4A7<'[B@=!C R<_=Z<UI7F@W:>*H_$6FRPB=K7[)<V\^0DJ!MRL& )#
M D]CD'M0!E2>/)QH<6IKIT:+!J7]G:FDDQ_T1]X0L"%^902#VX85H>(M:FM=
M+\02'3;6^LM/M-TD<TA E;86>,C:1PFT^^X#BI;7PG:KX=U/2KMA,=4DGFNW
M"[07E/)4=@. /]T5"_ABY/@"?P]]L66\N;5X9[N4'YG=2&?'4]>!Z "@"1-<
M:XN[+1["V@^T2V"WDHD)$<,1PJC ZDG( XP%)] >:\'ZU_8_AQ;<VRK>7FLW
ML4<,89TC*R.S?=7)50N.!SQTZC:;PQJEKK.G:SIUW:I>16*V%W%,C-'-&IR&
M4C!# Y_/%4$\":K#I<9@UBWBU6UU.;4+2=;<[!YA;=&X+'*D,1QC'O0!T7AW
M6KO5A>QWNG36DMK-Y8=HW6.=<9#IO4'V([$=:R[KQ-KTFM:UI>E:+:W$VFI#
M(&ENRHE5PQQ]SAOEP!TZY/3.]I$&IQ6[2:O=03W<A&1;1E(HP.@4$D^I))Y_
M 5RU@U^?B3XM73VM=QMK(-YQ/RG9)AN.N/[O&<CD4 $'CR^U4:*-'TF&4ZM9
M37$7VBY*>6\9 9&PIXR<9&<^@ZUI#Q)J-W%JC:?86\LFE82XC:8CS)@@=XT(
M7L& W$<GL.M0:?X-DTG4O#TEG/$;32;6:W99 =\QE*EGXX!RN<>_:IT\.:AI
MNJZQ<:5=6XMM6(EDCG4Y@FV[2ZX^\" "5..1UH QM1UVXUO6? ][I8B:RO7F
MN(TF<J2PMWX8 '[N3Z\_G5B3Q&-&M+U= T(SVMC=M%);6T,F^5]P,ICVH5!!
M8\$\X/3BK@\(2V5QX7739(5M-"5U"39W3;HRAY P#R3WR3VIL?AK7=-UK4'T
MC5[:'2M1G-Q-%/;EY8)&QO,3 @<XS\P(!['N 3_\)6UQX@N=)M$MA<VTL*M;
M7$ACFEB<*S2H".0H8\>JGIQ3K'Q2^I:W<V%JMJ7M;MK>XMWE*SQH/^6NW'*D
MXQCL<Y[5!K?A.XUV?9=-:%(KF*>TO &%S:JI4E5/?)5N<C&[H<4MWX4N-2UF
MROKTVGG65\;F&]B4K/Y6YB(3ZC! )SC Z9YH @M_%=O86?B.\FTN"WEL]2%I
MLMW!-U*RQA&+;1R2ZC)!P!WQ6@WB"]L_$-OHM_:6_GWMO)-92Q2ML=DP7C;*
MY! (.><C/ K.G\#S7^G^(;2[NXX_[4O1?02P@EK>10FW@_>P4![9R16FFBW]
MWJUEJVIM:M=:?!+';QP;MA>0 ,Y)&1PN O.,GD]@#'TWQSJ-Y9>'M2N-)MX;
M#5[@6ORW):6.1M^TXVX*_)CKGG..U6]0\7W6FZC;QW-E#%%/J:6"1/-B9T9M
MHG _N[CT].<]JJVO@S4;;PWX<TK[5:LVCWJ71DPP$P7=A<?PYWGGGI[\1S^"
M=9D2>)=5LRO]L)JD4DENS2,5D#!'.[D*!M&.P'2@"[X>C2/XC>, B*NY+%CM
M&,DH^35[6O$RZ9K=KI0:UAGN8&EA>[D,:2L"!Y:MC[QSGVXX.>'Z7HMW8^*=
M9U6::%XM02!0B@AD\I2N3V.=V?;WIOB+0Y];6:UEAL+O3YH/+,%TIS')DXD4
M@'G!Z<'@<B@"K?>*;N.2>UM+#S+ZUM8YYXF61AO<$B(%%.#P>3ZC@\XJOXPU
MBYOM/LK#056XOM.>\2.]G:)HV4J"CC9D<MUYSQT'--C\(:UHU];7>@:S!YAL
MH;.\74(6D6?RAA91M8$-@GC.#6D- OE\5:=J[7<<R6MG):R>8"'E+LK%^.!R
MO ]/2@!EKXGNEU76=/U.T@M)=/M4ND*2LXFC8'+#Y1P"I4^]-&KRKXLTFSU'
M2;2*YGT^:<W*R;WAVE-\8)4<?,.<\XZ5:UCPS'JNOZ5JHF,3699)U4?Z^(X8
M(?8.J'\QWHO=#N+OQ?8:OYD/V:VM9;9HFSN<2%23GH,;1QWS0!#8>(=2U*+2
M]0M-+672]0? 99<2PQD$K*P/&#@9 Y&1UZ53C\:W-R^GW5GI4UUIUY<B#=%#
M*9(T)($Q.S:5XR1G@'.3TI_AOPUKF@QQ:4=7MY=#M7W6X$+"YV9RL;-NV[1T
MSC) QQ3="\,Z[H3C3(=8MVT".4R0H8&^THA;=Y6_=MVYXS@G'''& "UI/BE]
M8U62VMEM2(+N6WNH#*1<6ZIN <KCD,57'H&')YK5UF_N=/MX7M;43-),L;N[
M;4@0Y+2.?[H _,CIUK$?PI<7FNZ=J=Z;075C<O*M[ I6:6(A@L3>V&&3DYV]
M!FK_ (FT6]UB/3FL;J&*2SNUN3'<(7BF !&U@"#P2&'N!0!CIX^C&BW5[<);
MQBVU3^S7N!(6@'0B4G&0N&'XGKCFNGTJ[N+VT,TZP#YR(WMY-Z2)V<'W].WO
MUKGK'PSK.GMJ1%]87,=]J)O)(9+=E616C"NC<G R 1P<8YSTK3\+>'D\-V-U
M;Q;$CGNGN%MXB?+MPV/D3/;C/0<D\"@#'\2:O-J^A>*;6PM;>:VT^"2"=IV/
M[R3R]S*HQQM#+R>IXXQFHM(U(6P\"V+:;;3-=::3%=NW[R$I I8 ;> V0,@_
MA4UQX2U6"Y\01Z7?VBZ?K8>26*XB8M#,R;&92",@X'7I[]*FM_"VHP77A:5K
MNUE&B6SP/A&3SMT83(Y.W 4'OGVH K6GC747L;_5+O2;>'3-/FN8+ETNB\A:
M([1L7: P8C')'7IQS9_X2^YL[Z9=3TR5+!+.2[:\AAEV1%!EHVWHO..A[XZ"
MBR\'R-X:UO1-2GC>+4[BXG\R $&/S6+8Y[J3P>_I3[/P_KMYI=QIGB75K:[M
M7MWM@;6!HWE#*5+R$L1G!/ &,\\X% %F#5M=FELS_9,/V>\MFE6439%LX *K
M)QSG/5>A!^M8GAWQ;?MX/T:\U%(YK[5966'R][<_.[%@%) 4*< 9[#CJ-?PY
MH_B#38K>TU75K:ZM+-/+@,$#)), -H,I+$<#L!R<'/'.1#X%U2W\,:980:O!
M%?Z/<>;I]RL!VX^8%9 6YW*Q!QB@"Y'XTN8K:X2]TF6*\%]'96FY7CBNVD^Z
MRLZ@@ 9W<'&T]>*KZ2ERGQ9U/[5#;I(='@.Z#.)!YK_,0>A[=^@^@LZGX7UC
M7-'A-_JMNFL6UU%>6LEO"P@B>/.!M+$L#N;)SW'I5G3=#U=/%TFO:A=V1\VP
M2T>"WB?@J[-D,6_VO3^62 9GB,7,/Q)T&73K2":]>PO%'FOY:G!BP68 G YZ
M ]?QII\>W\>DR7=SI,,,ECJ*V&J*UP2MN"5 F4A?F3# ]CS[5NZOHMY<>(M+
MUJQE@\VRBFA:"<$+(LFW)##."-@['.:SKJVT/P_I.H0>(+V$R:Y+*\X8;?.9
ME"[(UY/"A0!U)]S0!O6]_-<:Y=V:11FUMHTW3!CGS&R=F,8X7:<Y_C%5KK6I
MGU]M$TZ.%[N.U%U,\S$(BEBJC &220WT [YQ3?".DS:+X8LK6ZD>6\,8>XDD
M.69R!U/?  7Z**BO-!NH_%:>(=,EA$SVOV2YMY\A)4#;E8,,E6!)['(/:@#)
M/CVXDT[3YK?24:YFU4Z3<P/<8,$XW9P=OS+\O7C@CCM746=U=QZ.+K6(H+6>
M-6>=89#(B $\AB 3P >E<W-X+N$MK!;:Y@,\6L'6+J1U($LA+950/NC#8!YP
M%'6NNN+>.[M9;:9=T4R&-U]01@B@#E6\97$&EZ5KEQ8QKI&HRQH&60F6!9/]
M6[#&"#D9 Z9[U8A\47"W_B"RO;2&&;2XUFB"R%OM$;*2K#@=P5P,\U4M/!]X
M-"L/#U]=PSZ78SQND@4B66.-MT<;#H,$*"P/('09S6GJGAF/4?$^F:R)C&;5
M&CGC _UZ9#H#_NNH;\Z *=]XIOH'NK6VL$FO[*W26XB42NID8%A$I1#S@?>.
M.HX/.*\GB_6+C4;*QT_0D%Q>:8U\B7L[0M&P904==F01NQWR<=!S5C4/#VM0
M>)YM:\/ZE:0?;8DCO+>\@:1&*9"R+M8$, <8S@U830+Y/%MCK!NXY8[>Q>S<
M2 ^9(696+\<#E>G3Z4 167BJ74-9N-/@CM!<6MR(+BU>8B=4P,R@$?,O/'MS
MGM58^-;F4VMW9:5-=Z?-=_9SY4,K2*FXKYW";2N1G&>G.<\5+?\ A2XU75;.
MZO#:>99WPNK>]C4K<+$&+"$^H(.TG.,=L\U'H_AG7=$N)-/M=8M_[ ,[31QM
M WVF)68L8E?=C;DGD@G!XQU  EYXUN426[T_2IKZTANS;.D,,K2N%?8[IA"I
MPP/&>0,Y'2H[_P 8:Q!+XE6VTBT<:$%DD:2[8>:AC\P[<)]['8\#U-2V7AG7
M=*U*]@T[6+=-$O+A[EHI(&,\!<[G6-@P !))!(.,]#3I_"U_-)XL(N+8#78A
M&GWOW.(O*R?[W'/;T]Z .GLKI+ZPM[N,$)/$LJ@]0& (_G4]4](M);#1[*SF
M9&DMX$B9DSAMH R,^N*N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !67J&N0:;J^F:=+#.TFHR-'%(BC8I5"YW'.>BGH#6I7&>-(7N/$?A"&.X
MDMV>^F'FQXW+_H\F<9!&?PH [.BO.5M_$,O_  EGAZSUJ\EGT]8+C3KN1QYF
MYU9C$[8PPRN.>0&^E;GAW64\47-GJ-G+,EG!9CSHO,.#._\  WJR!3G/]\>E
M '55E:[K]KH.C7NISI+/%9#,R6X#.O /0D=B#^-:M>17=MY7P_\ B)(9[B0K
M?74?[V9G& (\'D]>V?2@#UQ&#HK#HPS2UP<U_?Z!XJ9!?7-[!+HD]ZT$Q!42
MQ,F-@ ^4$,1@>W>I=$&N7IT'6TU*#[)<1!KQ7NVD6XWJ"-B% $8-V4^QS0!T
M6O\ B"U\.627E[%.\#2+%NA4-AF.%!&1U)Q3%\26:ZI;Z;=Q7-E=W0/V=+B/
M EP,D*P)7(';.:POBH&/@P!" WVZUP2,@'SE[5G>+C?V'BGPI?:W+!>::-06
M&&.TB,+I<."$=@S-O4<\ K^- 'HU%< -1O\ 6]%\5:E%J%Q:7>EW=S!:+&^$
MC$*@C<O1MQY.[/#<8Q5:_P!=OM4T6>_AN[E+I= CO?LEJQC%G*R,_F2-GYLX
MP$(/W3QSF@#TBJ>JZC'I&DW6HS12R16T32R+$ 6VJ,G )'85Q,EQJNLZWX<M
M?[:O+2+4M%DGG%ML4B0"+YE.W@Y<^OMBH;VXGU[PQXV,U_=+_98N+*%%DV\1
MP@EW P&+DG.1C&,8ZT >@6-VE_I]M>1JRQW$2RJ&Z@, 1GWYJM)K5I']H(+.
MD$BPLZ@8,K$ 1CGELL/89Y(YQ6T>9K?P1831KN>/38W5?4B,&L/P?I-CK_PK
MTRSU6$7<%[#YUPKDC>[.7)R.<[CG- '4R:K:0F\,L@2.SC\RXD;[L8QNP3Z[
M>?H1ZU0B\40.]D)=/U"".^=4MI981MD)&1G!)3@9^<*?QXJ._P#"_AU4U"^N
M;-(C-I[6=S.&8'[.%Y'7'  YQG@5R\<GB#P-=Z;IVK2)K?AV:ZBMK>[8;;FU
M<G$8<=' .!GK^@H ]"DL[6699I+:%Y5QM=D!88Z8-35Y]'=:]XALK[4=.OX+
M.XL]1FB!ENV$<<<4A4I)$$(.4&22<_-D$#BK.GV^H:MXS\16T^NZBEKI]U;M
M#%$ZH"K1!F1B%^[SVP??., '<55@O&GOKNV-I<1+;[,32*!'-N&?D.<G'0Y
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M110 4444 %01V=K%.T\=M"DS9W2*@#'/7)J>B@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I
MCQ1R%"\:L4.Y2PSM/J/2GT4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/+OHX\J V"=K,A.<\9[^DNI:/KFMZ#Y]OHUGHVH6MS!=6MJ9$?S7B;<0[(,
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MOV?_ $JXA$BRFT#C<(QN8=@2%4MC/N,O\76%_?SZ";*S:=;/4XKN8AT7"*K
MXW$9/S#BJ]I8:KH?BC6[V&PDOK/5?+G3RY45H95385?<P^4X!!&<<\4 :*>*
M["Y2W;3DFU SVGVQ%M]N?*SC.&9><\8ZY'.*K1^*+B?QE:Z1%ILYMI=.^V&4
MLF?F=0#C=D 98'N2>!@9/-_\()):^']-TE[">:YL;0FVU.PN%BE@N&9F9069
M24R1CK]*V+;2==M_%6E:C=11WF=&%C>W"2!-LN]69\'D@X;&!U]* +[^---C
MN+$/%<"UOY_L]M>84QR2<[1@-N&[!P2N#^(R[2?%]MK5\;:UTW4MJSS6\L[P
M 1Q21]0QSQGM_2L+PKI&N:-#;:)=:!8O%9.%CU<2(?,B4Y7Y,;@^,#GC/.>Q
MV?!NGWVFVVJI?6C6[3ZG<74675MR2.6'W2<'UH T=1UN*POX;!+6XNKN:)YU
MB@"YV)@$DL0.K 8SGFI](U6UUS2+74[)F-M<QB1-PP<'L1ZUC:[;:S<>(K+R
M[,7NC&W=98?/$868D;6D!^^FW(P >3G!XIW@/3;_ $?P9I^FZE;K!<VR&,JL
M@?(R><CCG/2@"67Q;91O"RVUW)9RWGV);R- T?F[BN.N[&X%=V,9[]ZCF\96
M,&E:QJ#VMX(](G:&Z0*FX$*K$CYL$88=\^U9?AFS\3: C>'SIT,MC'<2/!J?
MVA<>2[E\&/[Q<;B/3ISZY^KZ!K[6'C/2K33%G36)6N+>Y-PBK\T:*4()R&!7
MTQSUH U[F>1?B?8&-[AXI-&GD, E.UF$D>"%)V@X.,\4W2/'1G\.V^K:EIEU
M!'<7QM4*&-@"9VC3.'SQ@ G'7ID5.NG:FWCC2M3>Q*VT.F26TKB5#MD9D8<9
MR1\AYQWK"7PWKT?@,Z3]@0W5CJ0NX!]H7%THN3+P?X<J<?-CGTH ZJ]\6V6G
MW&K03V]WOTRU6[FV(K;HCNY7YO\ 8;KCI4=KXPM;J!9OL&H0K*8A:^=$J?:B
MZEQY9+8. I)SC&*P-0TG7]0O_$MW_9'EIJ>BK9P(;F,LLF)!AN<?QC.#CT)J
MUJ^AZO/X:\.SV=C#+J6D-&[V-RZ[9AY9C=-W*@X.0: .AT7Q!::W)>P1)+#=
M6,HBN()MNY"1D'*D@@CD$&DO/$,-M=7=M;VEU?36<:R7*VP4F,,"0/F898@$
MX&3CZC)H"W;023W>DP:49,!;:-E=AC/+,O&3GH,XQUYP,JWT_5-#\7:W?P6+
MW]EJHBE7RI$5H943858.1E2 "",XYXH J^)?$WVG3O#LVDI/<V.JW\*-+ RK
MYD9#,8^6!!.W!Z#&03VK?LK>R\-:-<SR3W$5FA>Z<74OF?9U(R5!YPHP> 3W
MQ7*CPIJ.E>'O"6EVUM]J;3=16\NGCD554'S"P7<03S)Q["NI\4:._B'PKJ.E
M1R>3+=0%$9NBMU&<=L@9H 9#XGMFU#['=6EW9,;5KM'N44(T:GYCE6.TC()#
M8/-1Q>+;)YM-6:VN[>#4SML[F95"2L1N5>&)4L.0& S]>*H1Q>(O$OA^\TK6
MM-CTKSK.2WEF6X67S792NY O1>2>>>@]352/1=7U;2?#FEZE8_97TFZ@GN+@
M2HR2^2#M\O!W?,<?> P,^V0#*GDG7PC\1L7EV&M;RX,#_:7WQX@C8 -G.,]L
MXKJ_^$CAT^UM;7[-=7=RNG"\D6$+E8P "268 DG. .>*PY=!UB3P_P".+,:>
MXFU>>9[0&6/#!XEC&?FXY4GZ5-?:;K]U<6]L^G"XTUM*$(A>X5%AN>06D )W
MC&,8W8(Z=Z (=0UU#XQ\-ZI8B_N[6^TNXF2V@+'S/]44.PD*IPQY./<UNV7C
M32[[2EO8TN4E-W]A-G)&%G%Q_P \RN< XYZXQSFN?TC1-<TW_A$+N?2R[:9I
MTEC<P0SQF121& PR0I'R'HW<47/A#5 ZZY;QH=2&M?VF;+S  8]GE>7NZ;]G
M.>F21G'- '0R^,;&WAU4W-M=PW&EQ>?<6K(ID\K!(=<,59>#R#QC!Q4<'C.V
MG$&W3-34W3QI:>9"JBX+H7RA+8P%4Y)Q^.167K.@:AJ\^OZJEC)%/=Z*VEVU
ML\B;V+%V+L0Q4#+*!R3@&K-[::\NC>'(;:RD>*#:FI6:7"1R.HCVC#YQM#8)
M /(X]10 :IXX$6@+?Z?87$DO]I+ITT4FQ6AD\T(P/S8)YXP2.1D@5?34;&3Q
MI%;2P7T.I?V:TN)'_<B+>N00&*E\D<@'C/-<J/"^NQ^&M4LTTR!)1KRZC;0Q
MW"[9(Q,K[5. %P!@9Q]!6Y=:1J.H^,TO9K)X;.71I;*6194)1W=6XYR< 'G'
M7\Z +P\8Z?LL;AX;E-/OI1#;7S*OE.QX7HVX!L<$@ \>HJK>>/;&T&JL=-U.
M5-*D"7C1PKB-=H;?RPR,$'CGVK)A\.:Q>>#--\)W]GY8LYH%DOED0QO#"X8%
M!G=N8*!@@8)//JZ\T+6)K'QU"FGONUC(M/WL>&S"L?/S<<C/T_*@#N_/B^S?
M:-X\G9OW#^[C.?RK#L/%UG?W5C +2\A^WVK75F\B+B:-<$X 8D'#*<$#@_A5
M^".]3PXD4*+!?+:[$$I!"R!<#.,@C-<9IFC>(%UWPWJMWH^)[6WGAU":2\1Y
M)'=4^?/]W*MM /&<844 ;%MX_P!.N8;&X6PU)+2[NS9BXDA4)'+O*!6^;/+#
MJ 0,C.#4'C774D\*^(X;&*^D>RMI$DN;5P@@EV;@,[@QQE2< X!Y[BLJ/P[K
M:>"K#33IC_:H-9%ZZ^='CRQ<F7KNZ[3C'K^=.GT3Q#9Z9XOT6#2S>0:PUS<V
MERMQ&H1IDYC<,<@@]",@]R* .XT9BVAZ>S$EC;1DD]3\HJ]5+1XIX-%L8;F,
M1SQP(CH&W $ #KWJ[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW"(H1"I4[F4 N=I(R3W/%.\/^%)]"$-N^N7E[86G%G:S(@$0Q@!F R^ <#/
M].!CI:* .+B^'YBLK&Q77+L6>GWPO+2-8D!CPS-M)P=W+'D]NW>M#_A$_+;7
MA#J4R0ZQN9XC&I$;L@1F!ZGA1@9P#ZUTE% &!/X6@N_!2^&KBX=XDMDMTG5=
MKKL V/\ [P*J?J*-:\*6NKZ-9V$5Q/926+I)9W,!^>%T& >>O!((/7-;]% &
M;H^FW.GPN;W4IM1NY,;YY$5.!T 50 !R??D\U5F\-12^)+C5OM4H2ZM5M;FU
MVJ4E52V,DC(^^<XZUN44 <IHW@N728A8OK]_=:3$I6VLY @\H$$ %P-S!0>
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M:!'@FR""AYZ%1C/OG.:NG3QIT\GB#5KEKRYM+1HU:&W(V1\,Y5 22S;1GZ#
M'.=ZB@#EO#5A:7.M:IXFMK>>%-0"+$)D:,L HW2;&P5W$*.1SY8/>FZ=X+?2
MKZ5;36[Q-&DG,_\ 9FU"BL3N(#XW!">=H_J<]710!RD/@M[35;N6RUN\M],O
M9FN+G3E5"C.W+;7(W(&[@>IP15J[\+G498UO;WS[6*^6^B1H1YD;JVX*KYX7
M/MG&1G%=#10!CZ3;:G!JVK275]+<64LBM:I+&JF(\[E7')7[N"><@_4[%%%
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M(H4%@ W8?C5#1[>ZL MK:I?:CX?DTV<M8WENRW%A\HQ"KD D-]T*>?E!' H
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MPQTN6RFO;00L)2B)M<!",DJQW8QSCBM%H&O?&=]K]K',+%=%^RNWDL#-(7+
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M??$5A971%W;1K 1:O^^(MMA"\?-\W'% ';WFKV-C$DD\_P KH701JTA91C+
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MC:>/6IHXG'Q8U@W%G#;2MI5N3Y,F\2?O'^;.U3GMR.U ';LRHI9V"J!DDG
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M1RNX<''J*L4 %%%% !1110 4444 %<[:^%&L9)$M->U:&RDD>0V@>-E!9BS
M.4,@!))X;//6NBHH 9##';P1PPH$BC4(BCHH P!3Z** "BBB@ HHHH ****
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M2N3=.;@.9K:1@ ^P#Y6!QD9(P?7O>M=%U*P\7:KJD#VLEI?PP@K(S"17C5E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]WWUM9LWVHQ*-[JF=VWH,D=/>N1MM4\0LW@V5M:+#7+;;<1M;1[8V^S^9O3
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M4(FL9GFM+N*8)/"SDE@K!>A).00:Z#3--BTNS%O'+/,2=SS7$A>21O[S-W/
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M B[^9.04V';\O'RC'_U^: ,?6=<U-K9Y[6_,+#1Q>);6D:O(LI!.^3>I41\
M 9!/S=<5&NLZUJ.J>$X8M1%I%J^ER7,XC@1BKA(SE2P.#\YZY'L:UG\#Z<\Y
ME^UZ@I>R6QG5)@HGB4$+OP.HR>1CWS4EGX/L[&XTF:*]OBVE6[6UOOD5OD8
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M(BX@G9B\A0<C&!A>O)Y!Z5T5YK6JZ1X@U31VU"&1#I+ZA:7E\JJMNZML*R%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1^AK@KO3K"S\;:_86=I!%!/X=6:2"- %DD$D@#%>[8QSUK?^'CV3> ]&^Q&
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MDCBX^T1G\@!Z>:/2NQMQH2^)ITMS:C6EM465$(\P0@_+D>F3^H]J ->BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBN.\<_$73_ ;V*WUG<W!O Y3R-OR[=N<Y(_O"@#L:*SM"U>+7]"L
MM6@C>.*[B$JH^-R@]CBM&@ J&2SMI9&DDMX7D9#&S,@)*G^$GT]JFKAM;U&6
MV^(]CI\VLRV.G7&G23.OFJB^8KJ!@L..">* .REL;2<1":U@D$)!C#Q@[#ZC
M/3\*DCABAB$442)&.B*H _*N;37-.T72=1UF?69[[2XF"^8%\[RV'# %!R,X
MY/0YYK0LO$FG7^K3:9$TR7,<7G@2P-&)(\XWH6 W+GC(]10!I/;P20B&2&-H
MA@!&4%1CIQ44FF6$OE^98VS^7]S=$IV_3CBLH>,M'+61WW!BOF9+.5+=W6<K
MUV[03V)R0 0,C(YJ1O%FE+=K 9)-K7GV 3B,^7]H_P">>?7/&>F>,YH U+FR
MM;P(+JVAG"'*^;&&VGU&>E++:6T[J\MO%(Z_=9T!(^E9>H>*=+TPWIN))3'8
M!3>21QEUM]PR-V.>A!X!P""<"I)O$-E% DB)=3,T)G\J.W?S!'TW%2 1T. >
M3@X!H O/86<MRMS):0/.IRLK1@L/H>M6*J6&I6FJ:9#J-C,+BUFC\R-T'WA]
M/7VK)'C31SID&HAKG[-/=?8T;[.^1-NV;2,97YN,G S0!LP6%G;+(L%I!$LO
M^L$<84/]<#FF_P!FV&P)]BMMH.0/*7 /Y5D^(];TZVTS58+RZO[-+>W#S7-I
M&V^)6R 58 X/!^G>F2>)DB\4V6@);W3B>R:X-QY9/\2*O_H1).,#CWH Z"2&
M*:(Q2QH\9ZJR@C\JKOI>GRA!)8VSB/[@:%3M[\<<5QGA?Q;!96,T&KW=Y.YU
MBXM%N7B=T3]\4C5W VKG@ >XZ9KK/$+2Q^&]3D@FD@E2UD=)(R RD*2",_2@
M"U+86<\Z336D$DJ'*N\8++]">E.EM+::9)I;>*25 0CL@+*#U /;-86A:TL?
MA+0'NFGNKVYTZ*78BF223$:EV/XL,D]R.Y%*/&^@M;Z?.MS*R7[O%!MMY"2Z
M@[D(QPPVD;3R3T!H VI;"SGMEMIK2"2W7&V)XP5&.F >*+BPL[M$2XM()E3[
MHDC#!?IGI6;:>*M)N],O+_SI(8K*4PW"SQ,DD;C'RE",Y.Y< =<C%8EOK<DG
MQ,F@EGO+>RCT4W#V]R-B(?-4;QV^[GG)QR..E ': !0   !P *@6QM$^[:P+
M\YDXC ^<]6^OO6;'XITU[Y+-_M,4TL+7$"R6[CST7J4&,DC(^7KSTJK9>.M#
MU"%9K:2Z>%XU>.4VL@20M((PJL1@L6(&.O/L< &U_9MAL*?8K;:3DCREP3^5
M+)I]E*T326=N[1#;&6C!*#T''%-L-1BU 3B..:-[>7RI4E0J5;:K?B,,.1D5
MGZCXLTK2Y;M+B23;9>7]KD2,LMOO^[N(]>O&<#DXH V41(HUCC1411A548 '
ML*B6QM$.5M8%/F>;D1@?/_>^OO5*]U^SL9IXW6>0VR*]P88RXB#9V[L>N#TS
M@<G JSJ>HVVD:;<:A>,ZVUNADD9(V<JHY)PH)H E^QVWVO[7]GA^T[=OG;!O
MQZ;NN*'M+:0R%[>)C* )"4!W@=,^N*R;#Q9I6HZC!8P-<++<P&>!I8'1)D&,
M[&(PV-PSCUIW_"4Z6+RTMVDE5;R0Q6T[1$13.,_*K=,G!QV..,T :4EA9RVP
MMI+2![<'/E-&"N?IC%*]E:2QI'):PND8PBM&"%'L.U9DWBG2[>Y@BEDE6*>X
M^RQW/E'RFFR1LW=,Y!&>F1C.:Y_XA>)!!X/UEM,N;R*>U(C:ZM4.V.3(^0MC
MWP2.AX)!H [$Z?9$N3:6Y+_?/ECYOKQS4EO:V]G%Y5M!%!'G.R) HS]!6?J?
MB&QTE9S.)Y!;1":X,$32>2G/S-CZ$XZX&<4D^O6!6&.WDEN9+FW^T1BT3>WE
M'I)Z8YXSU[ T 7WL[624RO;0M(1@NT8)QTZTS^S;#8$^Q6VT'(7REQG\JP/A
MU?7&I>![&[NKF6YEDDGS+,268"9P,Y]@!5Z7Q9I4-T86DD*+=K8M.(R8UG.,
M1D^O(&>F3C.: 'Z[HB:CH>HV=I#;17-Y;26_G,F-H=2I.0,G&>E2Z'I4>E:9
M;PFWMDN4A2.62%<>85&,DX!.>O/K5"]\;:-8SZC#(;QY=."FZ6*TD8QJ06W'
M"_=P,YZ5?GURR06R1/)<2W<1F@2W7>S1X&7] .1R>Y ZG% %P65H+LW8M81<
MD8,WEC?CTW=:6.TMH96EBMXDD;[SJ@!/U-<U\/=0GU+P[<7%Q<SW)_M"Y1))
M\[]BR$*"#C&!CC Q6A/XLTJ"Y>)Y)"D=TME).L9,:3MC"$^OS+ST!."10!J-
M8VCQ21/:P-'(V]U,8(9O4CN?>D>PLY-V^T@;<0S;HP<D# )_#BL/4/'6B:=<
M7\$K7CRV&W[2D5G*YC4C.XX7[N.=W3D<U)<>--$@DM8UGFG>[MS<VRV]M)(9
MDX^Y@?,>1P.1WQ0!LI96L<HE2VA60# =8P"!C'7Z5)%#%;QB.&)(T'(5% 'Y
M"N>3QYX??3+34%NI?(NKG[(G^CON6;/*,,?*WL>O;-6H?%%A<PP-#%>/-.CN
MML;9EF"HVUF*, 5&>.>O;- &LL$22/(L2+))C>P4 MCID]Z9;65K9!A:VT,
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M!6!+X?U&V2VN5L9W:Y\4?VM)"@!,$."N6YQGHQ R>?:O2Z* &LX2,N0Q &<
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MK@H64,I)3D-QQW.*]5K)U7PY8ZO=0W<K7,%W I2.XM;AX7"DY*DJ1D9 X.:
M,WP7):K;W\$=GJ-K=O<->72W\(C=WE).X $KM^4@8/&WGU/454L-.M].B9(?
M-9F.7DFE:1W/NS$D_3H.U6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMUI8N/L[3;"LNS=M975QD9&1E1WJHF@:A_PE,&NS:C;O)'8-9M&+4J&+.'+
M[^!E0 .>.Y/- &=I_C:6_P!%T:0VZQ:AJ+SQE5C>9(_)8J[!5^9AD# X^]UX
MK:\.:IJ&IVUS_:5@]I-;W#1*QC9$G0<K(H;D YZ'H17/1^ ;VVT738;36UAU
M33+J>XM;M;;Y2)69G1T+'(.['7L*ZO2K2]M;4_VC?"\NY&W.Z1^6@XP%5<G
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MJ6LV?A2QGE#27^ER7,KFY:W:>1"BX#H"<X+,0,9^@P0#TAE### $>XH "C
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MWQ5JT>H7-I>Z9=W4=JL<A"1" 94,GW6W8R=P/WN,8%=/'K<W_"#KKTMMB?\
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M&2WTVW6WF$6F,&LU%U+^Z(&!CYN>"1SG@TLGA319AJ8FLS,NJ8^V++*[B7
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M3K;38I$MD*^;(99&9BS.YZLQ/)/ _  =JHW'A?2;F\NKE[=PUX +I(YG1+@
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M'IM(SGL16AXA-N;KXDHOEE7T>%E Q@LL<H)'N,KGTXKU2LWQ!I3:YH%]I2W
M@%W"T+2&/?M5A@X&1SS0!Q<-II][KO@RZT40"2SBD>\E@ 'EPF'!63'0ER,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;.:ZCLS97FG27. R9#*RR;<;@0<\=#0!L:5XLAUNPTV]TZPNYH;N9X92 O\
MHK+G/F<],C'&>HKH*YVXU'7-/72O,L+24W=T([I(YL?9U8@#9QF3 R2>.%)X
M'3HJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(!],'&,\T >H45QU_KVO7LNLIX?M1)+ILP@C1D0K/($5V#%G4J/G &!VSD]
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MS+G?@-_M>PXIOA7Q3-K>HK;7%U'!>QPN;W2YH#'-!)E<;,GYD^]SSG(.1TH
M[*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *PIO#K2^+X/$/VUEDAMVM5@\L;#&S!CDYSG('/Z5NUC+KLA\9MH#6@"_
M8?MBW'F9W?.$V[<<=^<T 5(?!UI;SZLD<\G]F:KN-SI[*#'N9<.R'JI;J>V:
MBTOPW+X?LV^V>(+V_M+2)EM8KD(!",$<LH!<XX&3WZ5U-% 'G_@70WO_  /X
M=CU"Y9X++9,+4Q;&65<E0Y[A2<@8!X&2>_1Z;X9CLO[92>X-U!JTSS3Q.@4
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M;>)9-:?4))I9+1+1T>-0"JDL&R,?-EC[<]*HV?@HZ=J,[6FM7T6DW$[7$FF
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M3Y8\S;Z;NN/:@#@O#<%MJT'AW7(=?@6X>/9.D",);MF3YTE.\DE3DYQ\N,C
MK&M;80>#=,U=9[DWT/B'RDF:X=B$-XR%>3R"I.<]:]-M?#NBV-_/?6NE6<%W
M< B6:.%59\]<D#OW]:/^$;T/[*+7^R+'[.)/-$7V==@?KNQC&?>@#A[N2#7=
M/\?_ -IX:[L#-#!&S8,$*P@HR^FX[B3WZ= !3+&YCOKW1=$OKBTCM)/#UM+;
M1W499)7.1(5PZC< $QU(!)&.:[J\\-Z)J%U]JO-)LY[CR_*\R2%2VSTSCI27
M?AG0K^R@LKK1[&:UMSF&%X%*Q_[HQQ^% '"_V/%+K7A+2;G6+O5+:2TOX9I_
M.>/[0J;0N<-VR1N!R<=34VHK)H.KM<3VBZAH:7EM&EU#*?M6GLOEJL;!N6C)
M"DX.3O).<UWC:-IC7-M<MI]J9[5=L$GDKNB'HIQ\H^E-.BZ8;QKLV%O]H=Q(
MTGEC+..C'U(P,$\C% %J*YMYY)8X9XI'A;;(J."4/7! Z'ZUP?C,W5I?ZAJ4
MEI'JFD16JI=Q1R;+FP W,98L\$$')Z$[?05UVGZ):Z=JFHZA#%%'-?%3+Y4>
MT-MW8+>K?,<GZ>G,EQHNF7=RUS<6%O).P"N[1@EP.@;U ]#0!QZS0GQ/XR#R
M!;9]+MIU5SM4967+ 'H<@9/K63IT U-_AU#=75TT5YI$WVA!<NHE*Q1'G!Z\
MG)')[\5Z+=Z%I-_?1WMWIUK/=1(42:2(,ZKZ G\:P-1\)++XD\/RVFG6,>DZ
M;'.C1*=A!D" %%"XXV^HZT <;<V]Q8:?>Z;%>W@T^S\3VL%G)]H?*([1EX\Y
M^8*6(&<X-;3Z=_8?BS7K#3I)_P"S)]!>ZGADF:01S[BJL"Q)!90WUVUO>*O#
M<FI:+8Z;IEG9B"&^AN)(I#L0HCAV& IR6YZ^O-;<6D:?':S0"Q@$=P/WZ% P
MDXQAL_>XXYH X*WW)H?PO=))%W?9XV59"%8?96/*YP>0*C@V^(;;4I[K6X-.
MU6PU24-((B;B )*=B+\XRC(%&T+ALGJ>:[[^P='\NUC_ ++L]EH<VZ^0N(3_
M +''R_A22>']&FU=-6DTNS?44QMNFA4R#'3YL9S0!R6F:3:WWCCQ4]U-=,+"
M[MIK?-S)B)O(5B<9Y&2>#D=L4WPG)<:=K]AIVK649NY;*3[+JEI)NBOT!0L\
M@/(D^Z<G.=QP>:[6#2=.MKFXN8+&VBGN?]?*D0#2_P"\1R?QIMEHVFZ:P:RL
M;>W(78OEH%VKUVCT&>PXH P_$;VMSXDTG3Y,SSM!/,+69PMN4&T%Y.#N*Y^4
M#U/3K7&:=))?^%/ 9EOKEW?57MY&2X<%HQYX .#Z(N#U&.#7J%]I&FZG+!+?
MV%M=/;MNA::)7,9]1D<=ORJ%?#FAHL:KI%B!%*9HP+=?ED/5AQPWO0!YU?WT
MOARS\76=E--!80:I9QEA(Q-M%,L?FLI)RO4_0G(K?@L;"Q^+5I]ACCB270Y2
M5C/RG]]'AL>I'?OBNK71=*5KMETVT!O!BY/DK^^'3Y^/F_&H+'PUH>FS1366
MD64$L2E8WC@4,H/7!QD4 8_B:[;_ (2_PQI=Q_R#+QKCS5/W)9%0&-&]1RQP
M>I ]*XWQ/;&/3/&.G,OF:597NGR68<Y$#R,AD12>@ (..V^O5KW3[/4K?R+V
MVBN(MP8)*H8!AT(]"/6HSI&G-ITFGM8V[6<N?,@:,%'SR<CN?K0!R-YI=C>?
M$VSL63-H-"G!BC<J#BXC&#@],]O:L'2M6EC\/^$[*]O$2PN+N]MI);L&2-C&
M[K#&_P PR, X!/)45Z2FA:3%/'/'IEFDT<7DI(L*AEC_ +H..%]NE,;P[HC:
M8^F'2;+["[;FM_(7RRW7.W&,^] ' ZKI2Z?::;:0ZU-<Q-XD@4+;NT:6ZOR8
M5PQX'! S\N>,5Z'8Z19Z9I8TZT65+8;L S.6&XDG#$[NI/?BHO\ A'=%^Q6U
MG_9-D;:U;?!$8%VQ-ZJ,<'WK0DW+$WE(&8#Y5)P#^/:@#QVPL'3X>>&O$=I=
MW;:XMY#&CFY=O.5I]C1E2<$8))X[$^M:.LW<32/J5C.Q>/Q+#;M=3R_OMPD1
M'A0 <1 9&">>3CG-=3X)\*+H'A^PM[^SM/[0M=V98CO!))^8$@8.#@G&:UIO
M#&@W$MS+-HUA))=,&G9[="9""""W'/(!_"@#EM/T>SU?Q_XF6[DN9HK:2RG@
M3[5)M5C&6R &Y'MTY/'-<V+6VM/@GK$EK_H\Z7-QS"Y1L+=, #@],'&.E>K6
M^E:=:7DUY;V-M#=38$LT<05WQTR1R:@;P[HCPW43Z18M'=2>;<(;=2)7_O,,
M<GZT <KJLB:OXTU70M0O+6W1;&)[-+F,G(;?ODC.]<,#@9ZC QCFLW5H;ZTT
M]+GS4\2Z=;Z6L5WE_+N8U!?_ $F(G()90><Y.P$&N\U#P[HNK) FH:59W2V_
M^I$T*ML]AD<#VJ2YT32[N;SKC3[:23RQ$6:,9*#HA]5Y/!XH AO]1M5\*7.I
M-/-!:?8FG,T:_O$39G<!_> Y^M<1I$HLO%FGI',EG;7'A^25L2[W;#1[)9<<
M-)ACR,]^37I,D4<L312(KQLI5D89!!X((]*S;?PQH-IY/V?1K"(PAQ$4MU&P
M,,-CCC(X- '+>$Y+G3_$%KI>K6$:7QL7,&H6DFZ&_C#)N=@>1)]TY.<[CSTJ
MUXHM4NO'GA6"26<0SK>++&DSJK@1@C(!]S_*NGLM(T[3FW65E!;D+L'EH!M7
M^Z/0>PXIT^F6%U>07EQ96\MU!GR9GC!>//7:3R/PH \RCU&32-%FL_M7D:7'
MXIDL7>8LZ0V^"RJQW [-^T'GH<'BK>KX\,65[+!K*OI]UJ%E]KAM4,<=C"[;
M9"AW-M#@<@$8SD8S7>KH.D):W5LNEV8@NR6N(A NV4GJ6&.3[FBUT+2;'3'T
MRUTVTBL7SOMTA4(^>N1C!S[T <=XD:R\.Z7JM]H]\\:3M:-=0PMNAMH3(%>1
M57!4LA;.",XR,8S2RZ2D8U232_$EG;_VA8JJ06T96!'W@+*<.VW=NVDC&1SU
M%=A8Z'I.F6$EC8Z;:V]I)G?#'$H1\\'([\<<U%:^&="L;">QM='L8K2X.9H4
M@4))_O#'/XT <7#)>7=GK6E?8K?0M<C-H6B+E[.<&0[-I7!"R;60C&>>_-1Q
MZG:O;MIEYIUSIFHMK,$<NG1S*8)I#&"J[\8\EE3<0!G/&#GGO3H6E&UEMFT^
MV>&4JTB/&&#E?NDYZXP,>F.*;-X?T>XLFLY],M9K=I!*T<L08,XZ,<]3CC-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6&IW>J^,7L+&[D=FTZXA7RWC6Y\AMTB*^!S@ <'TH ] L=:T_4;F>VMIR;B
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M&T'#D9. <8S@$XZD<UD3#^VO&>A:U9PW4=MI]K<FZ>6W>-F\P*%CVD98@@G
MSC'N*YO3K2Z@\"^![9M-ODGM-6CDN(_L<FZ)09,LPV\#YAS[T >@>)M?M_#.
M@76JW*22)"ORHBDEF/0<#@9[G@5AW?B8V?CBT2:_DCTB;2YI_)>#:?,61%!
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M)+%XUCDWQML";1L  ...<<%C0!UMIXP\/WUQ:06VJ0RR7>?(V@X<C)P#C&<
MG'7'-9GCOQ*FE>%]7>PU!H-0M8=P>.'S!&Y&55B5*J3D<'!Y'J*Y?3;2ZA\"
M^!K9M-ODGM-6CDN(_L<FZ)09,LPV\#YAS[TV]^W6OA#QGX?N]-U"74;B>ZGM
MWBM7D2Y20Y5@Z@@$# P3D8 H ]3MF9[6%V.69%)/OBI:KV#^9IULVQT)B7Y9
M%*L..A!Y%6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M75HS"T3[F&+W9@ J-N  HY.1UQ0!Z+H&BQ>'M$M=*MYYIH+9-D;3;=VWL#@
M?I6E7++XP-I>:S;ZS8BS.FVBWNZ*;S1)"VX?W1ALJ1CD<]:(/%MQ)JZV#Z8K
MF:V>:&6WG,B!EZQR$H AQT/(.#0!U--\R/S?*WKYFW=LSSCUQZ5SWA7Q'?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&-TWX9 ,Y!WG@D8]^E=;10!PNF>$M>TU/#B_:]/G33+,VLD4JOL5OEQ,@[N
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M^'=SC&.M6Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\(Z5<6]FUG"UNH2W8Y\L 8 ![CC@]QB@"GH?B#4-0\/3ZW/;1/"OG^7;6_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+..Y>6= ][]@9# ^Z*?.-C@#Y3S^/;- &X+&T$4D0M8/+D #IY8PV!@9'?@
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M9H@00DB!E&.G!K#UKP_-JGB+1;[;:M::?YPD@E!/F"10N,8P,8S[^U=%10!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTT/9I=I9?:,_9[E9]^S[V)-^,9X]*6YUORIKA8;&XN8K8@3R18^4X!( )RQ
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MNQI)+0****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQCZ5KZ;>27]J;B2V>!6=O+5_O,F>&(QQGTJY14RDI=-2HQ:ZZ&3XB_Y!<?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ebs-brginterimmanagement002.jpg
<TEXT>
begin 644 ebs-brginterimmanagement002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+\1:P=!T&
MZU,6_P!H, 4B+?LW$L%ZX..OI6I6#XTL+O4_"-_9V,!GN9%39&&52V'4XRQ
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M 97^4,5CQ\RJ6&3D'@X!Q6"W@S7)= DU$ZC=)K;W1U5;#,)A%P#E8]^W=C:
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M7"R;0'7K_'D5HVNGZI8^&[;2]0T#^T],D$P>R25'EMU\S=#&2[!655PI(/!
MQD<T 7[_ ,=6=GX5LM;2SNIOMD0EBMU0Y XR789"@;ASW[9S755QDFA:L?A>
M='D7SM0\K:L?FAMH\S*IO/7:N%SWVUV= !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %4[G2M.O;F*YNK"UGN(?]7++"K,GT)&15RB@ HHHH **** "
MBBB@ ZC!ID,,5O"D,,:1Q(H5$10%4#H !T%/HH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\NNZ5#J*Z?+?P)=,0HB+<Y/0?7VH HZ=_;R7(-UIUFAE8&>X%T7.!V5=HX[
M9XSGDYS6D\/W0TF^T2(*+2ZG9UFW?ZN-VW,N.I/W@.W(S7444 8-\NL?;D2V
MTRUGL8 OE*]ULRP[D;3T[#\>N,7!<ZLBVV_3X92ZDS>7/CRV[ 9'S#W_ $J6
M\U>QT]L74_EXV[CM)";C@;B!A<GUQ4]U=V]C;/<W4R0PI]YW. .U %71]._L
MVUE0[0\T\D[A/NJ7.<#V'3_"M"JUCJ%IJ5O]HLKB.>'<5WH<C([59H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%97B*]N+32)%LAF^N2+>U QGS&[\_W1EC[*: %T7Q!
M8:_]N^P2[_L5T]K+_OKC./;G@UJ5YQ8H_A/X@V0-BUEI>M6R66TR*X%Q"O[L
MDCNR97W(J6\MI[_Q-XRMI-4U*."VL;>:".&[>,1N5E.5VD$<J..A[@X& #T*
MBO.6U&^MO#_@_P 7W%[=-;BW@75(Q,PC9)4 \XJ#C*N03QT)]!77>'1)/:3:
ME)+,POY3/$DDC,(XND84$_+E0&('=C0!L45P&KZA>:7XCDFU-+Q])EOH/L^H
M65RVVU(*#R9H@0-K,#EL'._GMB$/J?B2VUJYM]873KS3]2EC$IGDQ;I$_ :(
M$*RL@R<]=Q]!@ ]%HKA+'3Y=5\=^(X+C5=46WLI;.6&&&[=%!,99AP?ND]NG
M/TQ#I,UU'>:CX/N;V]DO8[\31W#W,AD-FW[P-NSGC:8N.Y'K0!V\5S.^I7%L
M]E)'!$B-'<EE*RDYR  <C&!U]:M5YWJNL:CHNJ^.KBUGGF-EI=O/;Q2N72)R
M)<D*> . 3ZXK3N$&EZ<=?TW5[JY']ERO';2S-*EVX3>K\DX/!^[CKCTH [&B
MN&T>"^N#H>NP:\JVT]N1.K3R2K=EDR#M8[492"?E X!'05'X5O[RWUZUTS7(
MKR'4S9OLF%RTUKJ !0F5<GY6&,XP,!O3% '>T5QWBL7$OB_PK9Q:A>6L%W)<
MQSK;S% ZB!F'3O[]1U&" :Y759=5TG1O%^F0ZOJ#0Z;>V1L[E[AFE03,A>,O
MU8 -T/9J /6Z*XB>-M.\8Z3X>-]J#V5\MS>.TUTY>210@$:MD$* 6;:#C\.*
MSWM]:OK'QAHEEJ%[YNEW"/IMP+APY+1K+Y+,#E@,[>23AO84 >C$X!(&3Z>M
M5].N9[O3X;BYLY+.:1<O;R,K-&?0E20:Y[0M0B\61KJUM/<QV?V-8E5)W7$K
M ,^1G!9057/7.[TKFM UN\O-(\ Z=>7EP4U6&>6YG,K"25HURJ%\YY)R><G;
MCH30!W.DZZFJZEJUD+66"339UA?S"IWED#@C!/&"*UJ\IDO7\.7'B_[/<2)&
MVLV4,EQ-*S&**1(@Q+G)  ) /4<>E:/B&;5O"&E:WJ<.J@Q36\7DVQD>8V[&
M14:96<DXP^<=,C/K0!U]QKJ6WB>QT1K67?=PRS)/E=F$VY'7.?F':C6-=31[
MS2[>2UED&H70M4D4J%1BI;G)ST4]!7-SZ?!8_$WPVT$]Q(LEA=C]]</+G'E?
M,-Q/)SSCK@59\?0F>;PM$)9(M^MQC?&<,/W4O0]C0!V-%>=Q:3J+ZMXF\,6F
MM:E]F%I#<VEP]V[26LS[QM\S.XJ=H."3Q]:T?"VK2>)GT^4M<0MIMNT=]#YS
M_P#'UG84;GYMNQSSG[R&@#:\1>(H/#=I!<W%I=7$<TZ6Z_9PA(=SA<[F7C--
M'B:WBUBUTN^L[NPN+P-]F,X0I,5&2H9&8 XYP<>U8GQ0#-X:L0C!7.JV@5B,
MX/F#G%9_BA;W3/&WA.^U2Y34K62\^RV]O''Y1AFD&/-QD[P!ZXQ0!T1\7JVK
MZIID&B:I<7&FK&]QY0AQAP67;F0%L@'@#/%7]/\ $FE:GX=77K>[0::8VD,T
MGR[ N=V[/0@@@_2N#O9->A\9>/)_#YA:[CM[%C$\99W'EOGRSG ;&<9# G%5
M_$-GIZ? J-?#7G7&EH8YY0QS(\8D#2[_ /:!SD=L'M0!WL7B*6XL/[0AT34'
MLRGF(V$$CIUW",MNP1S@X;VK5LKI+ZPM[R($1SQ+*H;J P!&?SK+US5&A\&W
MVL:5/$?*LGNX'V[D<*A8<>AQ4OANZGO?"NEWMP4::XM(IF$:;5!9 V .P&<4
M :U4[S48K2&[95:>6VA\YX(R-^TYQU('.UNI[5YPVK:A<?"Z/QC!>7(UE)O.
M,8F;RV/G[# 8\[<8^7&,Y /7FM.RLXE\9>.9=TX=;>W8 SN1EH7SD9P?;(X[
M8H ['1-436]#L=4CC:-+N!)U1CDJ&&<'\ZOUY;X=6;3;/X=7$%]>'[="+>XA
M:=C$R?9V91Y?W005&"!GU)JYI<FI^(M+@UN+6%LKF#4'\_,TA"JLA4P-%G;R
MNT#C/0]30!Z-4<L\4+Q))(JM,^R,$_>;!; _!2?PKBO#5C-?^(]>FN-5U-ET
M[5RL$7VIMFTPH2K#^)?FZ'ICCJ<R^+K.*Y\:^#?,:8;KFX4^7.\?'V=SQM(P
M?<<]NE &]I&NIJVH:K9BUE@?3IU@?S"IWDH&!&">,$5K5Y5JEM(5^(U_#>WE
MM/92+/ ;>X:/#K:HP)VD;NG0Y'M6EKU]/?0Z@\%]=/=6^AK<-#%.T$=JY5V$
MI93EG..%P0 O)&>0#T.BO/$EN]5U[PC'/J-\D6H:-)-=)#<-&)&"Q'/RXP?F
M/(P?>MKP#<7$V@W4-Q<37!M-1NK6.29R[E$E8+N8\D@<9- &WJ&J0V-I>S!6
MN)+2'SI((B-^W!(ZD#G:>_:ETC44U?1;'4DC:-+NWCG5&.2H=0V#^=</!9Q1
M^(/B'(K3;EBC(!G<CYK8DY!.#[9Z=L57T!9M-D^'<D-]>%=0L?)N8GG8Q,JV
MN]<)]U2"HY !]2: /3:I:MJMMHNFRW]V6\J,J-J#+.S$*J@>I) 'UKAM%DU/
MQ%I.G:_'K"V<Z7I-R#-(RD>85:W:+.T=@.,]#U.3U_B;3]-U;09]/U8LMI<M
M'%N5MK*[.H0@]CNVXH 2#7)&U.WT^ZTJ\M);A6>-W*,A"C)!96.#R./RSBMB
MN TRY\1>&/$VF:#K=Q'K.GWID6QORNVXB9$+;9!W^4$;NOK4&@OJ?B'2-&\1
M)K*VLWVH-=@S2,K@L5:W,>=JG) '&00#W.0#T:BN!\,Z3)K%SK<EWK&L'[)J
M]U;PJE\Z@)M4 '!YQG(]"!COE?"EW=ZA!:Z%>75TVHZ/<R+J$OGOND"?ZLDY
MR1('5N>"%84 =G:7,]Q-=I-926ZPR[(W=E(F7 .\8/ R2,'GBK5>8SZY>Z3I
MOBEVO[CRX]?AM?/ED+&V@<0ARI/3 9L>A.:U_$CR>%-*UC4[+5;EA);Q%;:6
M1I1!\X1YE+$D<-G'3*YYH [>BN)ETS5;>2]N+'7XH([S376"*2XDF42C[LX9
MR2H&X XX.0>M3>$=2>75[ZPO[._T_5(X(FDM+BY:>(J"P\V)R3D$G!Z=!WS0
M!V%%<1J=K-J7Q*.EOJ>HP64FC&9X;>Y:,;Q,%R".1QW&#^!(/.V]SJ\FFZ)9
MW&KWY,/B673#<K,5:Y@028+$?>.5QGV]: /6:*X?3X3)XNO/#%Q>Z@UG8:?%
M);[[N02S&1WW.S@AFVX51SQ6-]NUD^"4UJ6\O)9=!U25)FCF9?MMI%*4<L%(
M#';DY]4]S0!Z3?3S6MA//;VKW4T:%D@1@K2$#A03P,U*CLT"R-$RN5!,>1D'
M'3TS7%:_<2W/@OQ-KUG?W4:O;2-9O#<.H"QJ<.HS@;F#'(ZC;3K>_DU3Q?9Z
M'=3SI;1:+'>!$F:-IY&;:6+*02% Z9ZMGL, '0^'M<C\0::]Y';RVX2XE@,<
MI!8&-RIS@D=1ZUJUY/H5]-I^DZ3I27!2"\UV_@DFEF92Y5Y"JEQR"S =.3C'
M<UIW\NI^'5MM,GUAI(-2UF&#<LCF2TA=68Q^8QW?,4P#U ;CM0!U]KKJ7/B:
M^T3[++'+:01SF5RNUU<L!C!)_A/7%$^NI!XHL]#:UEWW4$DZ3Y79A"H(ZYS\
MP["L#1;..R^*6N1Q/,R-IEJP$LK2;?GD& 6)..,X]S2>)+)=1^(N@6SSW$*/
M87FYK>4QN1F+@,.1^!!H [:BO,([;7)?#>O06NI:A<SZ#JC&RD-RX>YB0([0
MNP(+\%ER><XKK/#NH1>(KN77;2>9M/>&.&W7S&V,<;G?;G&<L$Z9!1J -Y[B
M*.:.%G ED!*)GEL=<5G:!KJ:]!>2I;2VYM;R6T=)2"VY#@G@D=?>L#5[.*7X
MK:$[-,"=.NB=D[J/E:+' (XY.1W[YKEYEFL_#'B76;:^O(;JS\1RM$(IV2/F
MX16#*.'!!(^;/MB@#UVFNQ5&8(7(&0HQD_G7"W37_B37/$NE0Z@;.XL3'';%
M;B2-H0T2L)=JD!OF+=>RXKLM-:1]+M&FN$N93"A>=%VK(=HRP'8'K0!DZ5XO
MT_4]$N]8>*>QL;1Y$EDN]@P4.&^ZS=",>]*_B:1-+?5#HFH_8EC,H;">84QG
M=Y>[=T[=?:O,;N.5_@Y?.JL]O%KLDMTJC.81<DMQZ=#^%>TK/#);"X61&@9-
MXDR-I7&<Y],4 8=SXKB@URTTB/3;ZXN;JW-S$8O*"L@QGEG'/(JY'K<:QWLE
M_:SZ='9H)9'NBFW803N!1F&/E/O7+:M&\OQ4T!;*<6__ !*KC:PC# +N3C!J
MK\1;/4A\.-=M9;PWMSYB7+!%VM]G#ID;1T  /UP3ZT =.WBH)IG]K/I-^NF;
M/,-P53<(^OF&/=NVXYZ;L=JW+>XAN[:*XMY%EAE4/'(AR&4C((/I5.XO+$^'
MY;UI(S8&U,I?^$Q[<Y^F*P/A;:W=G\--$AO599O)9MK=0C.S)_XZ10!U]%>9
MV^HW/]H>&;ZTU"[N;:]U2:%[J6=E%TA64X$.2H1=H /!^7..:=9_;(K3Q=K/
M]I:E//HU_=FTMVN6,9"P*0K+_$,GH>F..IR >E45Q6B6MY-=Z'K4.M@VEQ 5
MFB,\DHO"R;E(#'",I!/RCID=!6AXN.JH+&33(#>K$[R7%A'<F"2>/;C*,",E
M20<'@Y'?% '2UD^(==3P]817<EK+.DEQ% ?+*C87<*"<GIDCIFN1L-66[U?P
M7+I][J/V6ZDOHYHKJ5PY*(YV2*2061@1DYZ=:R]4GGN?"OB*&2[GD$'BF&&%
MI)3(8D$L& "V> 2>.E 'JY)"D@9('0=ZK:=<SW>GP7%S9R6<TBY>WD96:,^A
M*D@UR%O:76E>/9-*@U+4+C3[[3)+B5+BY:1H)%=5#(Q.5W!CP.XXZ5D:)K5]
M<Z%X(L;B\=CJ<$[RS33NK32)C:A<'=SN8XSSM ]J /4*CGGBMH3+/(L<8(!9
MCQDG _4BN!:6_P!$O-)T._UEI[6]U:6-I5D</"GE%X[<R$[B2V.<Y(P*B\8Z
M2EIH#V[:G=W:C6K22.-YWS;J\J#9NSDCJ1DY&1C'% 'H]1P3Q75O'/!(LD4B
MAD=3D,#T(JCJUK&?#E[;;I?+%LZY\UMW"G^+.[]:X/0KI[71OA[I"37$=IJE
ML7N7$[Y+) &6,-G*@GG"X^[CN: /3JBDN8TF$&X-.T;2+$"-S*N <9]V _&N
M9\.37EOXN\1:,TTT^GVHMYK9IG+M$9%8M'N.21E<C/0'Z55:SB;XQ&0M,&_L
M59.)W R)L= <8]NG?% '0>'=<C\1:,FI16\ENKR2Q^7(06!1V0YQQU6M6O(M
M+6:P\(Z+JMM?7D<__"0& QK.PB,;WCHRE!\K9!)R03[UM.VH^)G\0K!JPTZ[
MTZ^:**7SY%^S(@4JQC!"LK#).[.<GT& #T.BF0L6@C9F#,5!) P"<>E/H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "J=UI=I>W=M=3QNTUJQ:%
MA*R["1@G ..A(^AQ5RN>\1ZA?6NI:#96<X@%_>/#+)L#$*(7?C/'510!H:KH
M6FZXL"ZC;^>+>02Q R,NQQT88(Y'8]J9_P (]IGVB\N/(?SKR,17#^?)F10,
M 'YNP)_,^M<[XK\67N@WUKI\"K,^V&:1XR'E9?-"N#'@;0PX#9^\<8[TNK^-
M+BV\(V.IP1V?GWZ.$$-T)=C;6(9!M'F8(!8<8P: +NH:3=FVB\-:?I=NN@RV
M_E37$ER28DSAHUC().5X!R ,^W/3JJHH50 H& !T KFO#^LWGB31II%F2SGM
MYO)9HV61R549WH1A"2<[><#'-6_!^IW.M>$-+U*\*FXN8%DD*K@9/H* +#^'
M],>ZDN'MV9Y95GD4ROY;R+C:Q3.TD;5YQV'H*KW'A#P_=ZV-9GTN%]0!4F7D
M;B.A90<,1Q@D'H*VZXSQIJWB'P]H.L:W;W-D(;8H;>W>V+%E)1268..Y;MTQ
M0!TMMH]C9ZE=:C!"R7=WCSY/,8^9C@9!..!P/2IA8VHU$ZAY"?:S$(3-CYM@
M.=OTR<UR?BN_\3:#X8U74H]0LI/(MA)$XM-I1PP!!!<@Y!X/;!ZYKI;+6M,U
M"[GL[2_MI[JW \Z*.0,R?4#WXH 1-$TZ/4;J_%OFYNT$<[,[,)%'0$$XP,GC
M'<U7T;PKH?A]Y7TO3HK9I 0Q!+8!.2HR3M&>PP*LP:UIES??8H+^WDN<%A$K
MC+ '!(]<'KCI61X]UG4/#WA.YU737A$\#QC;-&75@\BIV(/&[- %K3/!WA[1
MKN:ZT_2X;>:8,&*$X ;J%!.%S_LXJU8:#INFO$]K RM#&8H=\KR>4AQE4W$[
M1P.!CH/2LS4]=NX_$%AX:T]HGU*>!KF>XE3*00J<;MH(R2W &?<^]PQZY;:A
M9QBZBNK*1G6=VAVRQG8Q4C!VE<@#IGIUSP 9OB;1[K5/$WANX2SEEL[&6:2X
MDCF$97=&57;\P;()!X[?E6M/X:TBYTV33I[3?:RR>;*C2/F1\@[G;.6.0.I/
M0>@K \/:OKFLV^M33ZE96R:=J5Q9AOLA(*1'[Q^?\ZMWVOZA;ZAHOAZ,6[:W
M?0F6XE*DQ0(@^=]N<G+<*,_4\<@&U?:-8:E#!'=P&3[.P>&3S&$D; 8RK@[@
M<=\\U/9V-MI\)BMH@BLQ=CDEF8]68GDD^IYKGM4UJ]\+ZAIG]HSI=Z;?W*VA
MF\L))!*V=A.."AP1T!'J:W[_ %&RTNV^TZA=P6L&X+YDSA%R>@R: $M]-L[2
MQ:RMH!#;L78I&2O+L68@CD9))K/D\(Z%+H]OI3Z>ILK9Q)!&'8&%AT*-G<OX
M$5?35M.DU!K!+VW:\5/,, D&\+_>V]<>]49M6M;J^TL6>NV:)-*_[@;7:[ 5
MLJISD;2,DC/3% "P^%-"@COHUTV%EOP%NO,R_G  #YMQ.>@_'GK1IWA/0=)T
MZXT^STR%+6Y7;-&^7\Q<8VDL22.3QT&:PSKNL!/&Z_:8?,TG!M&\GA1Y DP1
MGGDXZ_X5TFAWLEWX:TV^NG7S)K.*:5S@#)0$GT'>@"I9>#]!TZYM;BVT\":T
M5EMW>5Y#$IQD+N)P.!@=NV*T-2TJRU>!(;Z 2K'()8SN*M&XZ,K @J1D\@@\
MU33Q7X>EN;:VCUNP>:Y)$"+<*3(02OR\\\@CZBK-YK6F:=,L5Y?V\#L5&)'
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M=%<H9 $VNTCJ06)YX7_ZU:U[J4$DNDFVUNTMUN9@Z(=KF\C*GY4Y]P=PSTH
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M91&0X479;>1C.-F#GTKUZB@#R^XOOL5IX]TO5(IOMM\9Y[1O)9Q<0- %C"D
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M@-W";=V<L+D,T@('(8$G(ZYKV.B@#C+&>)/B9KEPQ*1-IEL-[*5!*M(6'/<
MC(ZC-<O9?N_AMX&BD1UE@U6V:5"AW1A9&+%AU  (R3ZCUKUNB@#RWQ%>6-IK
MWBW3;B\,$6L6\,<DDUK,XB)BV%D**0PVD'!*X;-6;K4;#2O$.G7\\U[-X>N=
M)CM;:^M?,<)(CL2'\OGY@5[=5]JZ@>'+VWU&[N+'Q!>6T%W,9Y8#%%)AR "4
M9E) P!P<@8K;M+6*RMD@A!VKDY8Y+$G))/<DDD_6@#SZ.PTVP\0^![>QL9;:
MQ@^VM''.&8Q!QE"V[)4L>0#@CIU&*S+A2?"_B%HXI&2+Q2MT0D9)\GSHF+@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=Y+YDFWY%5@0.#D_-[=*YW6?"WB/45U5&AL+F1]1BNK2ZFN&#"%9$80@;#L
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MNFT%+EMH,@&!E"&SC&<#I6EJ^HZSX8LM4OKFZAO;-4A%IYBA95E=PAW!0JE
M64]CU!/>@#K*HW.L6-GJMEID\K+=WN_[.GEL0^U2S?-C P!W-<O?Z[KWAN/5
M-2O[>6XTBWL3,AN#"LHG!P$'ED@H01R1D>]5M0@U >-/!$MYJ'GM*;HNJQ*J
MHYMV/R8&=O/1MQX'- '?T5YZWBC6%\%RZI]I0W4&LFRSY2X>/[2(N1Z[3U&.
M:T([WQ!?^--9TV'5+>VL]/-I,H^R;V9'W%D.6[A?O?3 '.0#LJ*X?3-;\1ZS
M;:/K.GP.UG=S!KB"7R1$ENV>48-OWKQUX// XI^E>);BY\3KI6H7<MCJ N)M
MUA<0!4GA&[8T#X^;C83S_>X% '77=I;W]K):W42RP2J5>-NC ]0?45BMXE\.
M:' UI]I^SP6KBW(6"0I&W0)N"D=P ,^U=#7$_$Z-(O!@5%"@ZA;,0!W,ZDG\
MR: -F;QCH=O!-++=R(L+QI(&MY 5,APF05R 2,9Z5NUQ_P 2XU'@J\E1%\UI
M[1=Q[@7"8!]N3^=5;SQ-J?AS5M?AU"X2_AM-)&IPA81$5.YU,?!/RY4<G)'O
M0!W50W=Y;6%K)=7<\<%O&,O)(P55'N37/:=-XD_MRT,J/-I<\+?:'G\E3%)C
M*F/8Q)4\C#9(X.:S/&DC3>._!&GS_P#(/ENIYI%/W6ECCS$#^))% '2KXDTL
MO"CSRPM.ZQP_:+>2+S68X 7>HW'Z=N>E:M0W5K!>1HDZ!U21)5SV96#*?P(%
M<5+XDU:]\+:SXET^X2-=/FG\JS>-2DL<)(;><;@S!6(P0!D<'G(!W=%<3%K.
MLZUXH-A9W\=G9SZ/#?PM]F#R1EV(P<G!/ _P[UG6'B?Q!-H7A?7)[RW*7]]%
M97%JEN K!F9"^[.0V5S@8';'>@#T>BO/)]4\67:>*9++5+.%M&N6$*&TR)E$
M2OL8EN!R1GKD]L5)?>*=2N=%&IVEREL'T1=0AMH(Q+)YA4L?-W*0L8P #D$_
M-@YH [^BN(.N:WJ&M>'K6VN[>UAU32GNI,0;VC<",Y&3S]\X_7-4O^$CU\>"
MFU?[2KRZ7J,L&H&.!<SV\<I1W4?PL%&[TX/'2@#T2BLC3KZ74=8O)8+D/IL,
M<<:!0"'E(WL0>I&UD_$MZ5F>)M3U&TO)HK6]6%$L'GBB@C$DSR@]7#*0L0 Z
MY&2<9H ZJJ=MI5A9WMQ>6]LD=S<X\Z5?O28Z;CWQV]*Y>+Q1>W</A'S76RBU
MFS,]Q<J!A9/*5Q&N[(&2S'G/"X%99\2^)AX4AU'[5:>8^L)91.;7 FA,_EAP
M=W1ASD#Z4 =X^E6,FIIJ3VR&]C78DY^\J]P#Z>U7*XY[_6H-87P^][-=77V9
M[Q[JUMX8WV&3:BA9&VX&#D\D\=*BM]<\0F32]&U*W:'59K>>>X>S,1;;&ZJI
M4.VT%MX)ZXP0!SD ';45PESKWB/2-'M)M=MIXHDNI8[N[LHDED2$#,<C(-P7
M/\6 <8XZUU.A7G]HZ%;72W\-Z)5)6ZA "N,G!QV.,9'8YH ?J^LV.A:>]]J$
MQBMHR%9U1GP2<#(4'')'YU?KR*]-Y)\+O%DMU?S73C5)HAYH4?<N54'( [ <
M=!V%=='JFLV7BZ^TFXO;:Y1M*-_ 9(A$D+ARNTD$G9T.3DCF@#KZ 0>AS7#Z
M/KNIW/B.RTR6^:>*]TI[@W @556960$PG:-R?/QN!S@')YJU\-6NIO!-G<W=
MY+<R3-*Y,@7(/FODY YR>>: .IN;F*TMY9YF(CB4NY"EB!ZX'-1:=J%MJNG6
M^H6<GF6UQ&)(GVD;E/(.#R*Y"T^V2>-O&*RZA-)#!:6X2%E7:%9)3MZ9 !)/
MJ<\YK+\*:AJVEZ-X#4W<4EAJ,*VKVWD@;,0LZL'SG.5Y[<].] 'IM5[Z^M]-
MLY;R[<QV\2EI'"%MJCDDX!X'K7'6VN>(]8M;?5M(@=X6O&1K>3R1"T"R,C'=
MNWA\+GTSQCO71>*_^1.US_L'S_\ HMJ )X]:TR?1O[5^U1KIS)O\^4%$*'H?
MFQP<]>]0CQ)I6Z%9)Y83.ZQP_:+>2(2LQP I=1N)SV^O2O/FD:6#X4:?-_R#
MYHDEE!^ZTD=NIB!_X$3Q7J-U:07D2QW$8=5D250>S(P93^! H S?^$HTDWUS
M9+-.]U;;?/BCM96:/<,KN 7C(Y'K5A=5TR[TB6]>>+[  ZRO.-B@*2K!@V,<
M@@YKD=)DU!/B?XU^PVUM.3'8;O/N&BQ^Z?&,(V>_I^-5O%;W<DG@:UU&)(DN
M]3C>_C3[C3!=RJ?4;L]>N!0!O:3%X/L-0B.G:=;6-U/D0.UBT'F9&2(V90#Q
MSA>U=37'_%%4/PYU>5FV20(DT,@."DBNI4@]CFMZ'[?=^'(B)?L^HR6JG>4!
M"2E0>0>V>HH TJJZAJ%OIEL+BZ+B,R)'E(V<[F8*.%!/4CFN"M_&=^;?PK=3
MW+*EQ,UKJ\7E+^YE#>7DG'RCS<+[@\=":TM;UO5['PZ=6M;M-DVI11Q*\(/^
MCM,L8P1CJ"6!.>"/K0!THUNP.L3:4)7^VPP?:7C\IO\ 5YQD'&#SQQGI3])U
M:RUO38]0T^4RVLC,J.4*Y*L5/! /4&N?3_DKTO\ V 4_]'M1\-/^1%M/^OBZ
M_P#2B2@#K:*Y&'4M;UZ#4[K1[RWMY++4'M(K>=08Y%C8!S(<%@3\V-N,?+UY
MI4U74]=NO$*:9>"T.E2_9H%,:N)90@<F3(SMRP4!2#P3GG@ ZP@$@D XY'M2
MD@=3BO/K'Q5K'B"\\,_8YX;*WU?3IYY%,&]HW38#@D\\L<?KGI5"]U;5]3\-
MZ6)]1:.YA\3)I\\L,:J)PEQM#$$''W0<#C/MQ0!Z-_:%O_:ITW+_ &D0>?CR
MVV[-VW[V,9SVSFK5<NNHZJ/'<NB?:XFMQI N8V:'D2>9LRV",],X&!S7/Z1X
MF\0RZ/X1UF[OH)8]5NUM)[5;<*,,'PX;.<@H..F/S(!Z117GU[XFU>W\*^,;
MU+I3<Z/>R16SF)>45(V 88P?O'GBM*_UC5M0U35-,TD3QS6%O$RO$L+!I9%+
M#?YA'R<#[O/7F@#KZ*I:9+?2Z/;2ZC!'!?F(&>-'RBOCD \\9KD=+\1ZJVO^
M'[6XNTNX]2BN/M#11 0+(BAAY+X!9>HR=P/K0!W=%<5X>\2W&H:XFG:A=RV>
MIIYAN-,N8 @903M:%\?.OXG/7C%;7B"\N;673HX;N.VBFF99BJ[YW 0D+$FU
M@3D#.1PH)]Z -NBO.5\5Z])X9TZY2:!+HZ]_9DS2P ET\\ID@' .!SC\,5O^
M'M1U-O$^O:-J%VEVMDMO-#,(A&<2A\J0.."G!Z\T =/370.C(V<,,'!Q7,:G
MJ^H7/B&[T73OM$;VUG'.98%A9B\C.%!$A VC9SCDYZC'.?\ VMXI.J^&=.O9
M+2QN=0MKDW:1QB39)$%^93NQSNSCMWSTH Z[3],LM)M?LUA;1VT )81QC"@D
MY.![GFK=>9S^(_$MMX5UC56U*!Y-$U"2V9?LH'VM5D4?/S\N5;'RXY%;-U>>
M(]0\8:OHMAJEM916]G!/#(;3S&4N7&#DX/W1D_D.] '2WNL6.G7ME:74K)/>
MR>5;KY;$.V"<9 P. >IITNDZ=/J<.IRV-N]]"A2*X:,&1%] W4=3^9]:\_36
M[GQ#8>!-0O8DCNVUB2*=4^[O2.9"1[$KG\:U)/$&JZCH?B#6M-N4A_LJXGBA
MM6C5DE$'WMY/S98AL8(P,=>: .XHKC(?$UT-<T*\N9_*T/6K+S(5=%!AN-@<
M*S8Z%-V/=31_;VI[M'LRT[3ZL+BZ1HTB$D<";2B@/A=V'3).>C<>@!V=%<0F
MN>(;-;'2]3MR+Z\OIHH9HO*\Q[=$+A]N[8)#T(SCJ<'I6YX=DUPK>Q:U%@1S
MG[+,Q0221$<;U0E0P.1Q@'TH VZKWE];V$*RW,FU6<(@"EF=CT4 <D^PKG$U
M/4M=U/7[73;P69TMU@A_=J_FRE Y+Y'W>0,#!X)SR,<[>ZM<^*=.\!ZNLTEF
M;O4%W1(JD)((I@6&0<\@XSVH [FU\0Z;>:5-J4,TAMH&=)LPN&C9/O!EQN!'
M?BH(?%VA3PV\ZWX2"X($,TL;QQR$] KL IS]:N:JI70;X%MQ%M)EB,9.T\UY
M7.=7F^!%E ;"V.FFQC-S/'.9)HX006=8BJJ6 &<;^/>@#U#4/$.F:5>6]G>3
MO'<7.?)C$+L9,#)V[0<X')QTJ;3M7T_5XY'L+N.<1.8Y I^:-O[K \J?8UP^
MN7:S>)/AY=Z6INT=;F2#S'V&13;9!)(X./:I?!7F7TWB7Q8 J:C?,(9--4'-
ML\"E0C],N>"3COQ0!T^J:AHMT9])O UY\H\^VB@DGV@] X0'&?0]:M:1=Z;=
M6.W2Y4>V@;R<)G"$ 97GH1D#';IVKF/A2ZS_  \LKP-YMW=/--<R,?FDF,C;
MBQ]> /H!6EX2UC^V9-;<:;%9&VU*2VE*3F3S9$"J7^Z,# 7\J .DHKAO&'B#
M5=(CUNXM;R,&PMHY[>WAB$F>I<SDCY0<87# G!/-6;G4=;O/&HT>TU"&TM9=
M)%VK"W#NC^8%[G!_E[=Z .PJC8:Q8ZG<WMO:2L\ME((IU,;+L8C..0,\$'(K
MC]&\7:AJVG^%[.21(K_5?M'GW"(/E6 D,54Y&YCMZY R>.E6_!D<T/B;QC'<
M3F>07\7[PJ%+#R$QD#C.,9QCZ"@#LZ*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4?+$X"PE<1@A< QG& 34LOA:RN]*GL-0FN;PS3_:#<2L%E608VLI0 *5P ,
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M2=.U6)(M1T^UO(T.Y%N(5D"GU (.*+C2--O#&;G3[28QKL0R0JVU?09' ]J
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MET(_W(8 G83G(;"D]* *_B'Q)#H$VF0R03RM?W2VZF.%G"\$DG:#S@' '/X
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M4OAUWE<'H>AYYZX..AOO$NE:<UP+FX<);$"XD2%W2 D C>R@A>"#ST!!.!7
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MFM#<F9879>755 (&,<G+=!QS7-PV6H6&D^+="N=/N;F74+BZFLI4B+1SK..
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M9-<"1HHB4B5HBB9(''/'M0!EZ]XQEU'P7XHN=+>]L+C3'DCCE,!4G8%SDLN
M22>/O8P>*ZK3?$>FZC?MIL$[F\CA$Q5X70.F<;T9@ ZYXRI(KA]0T_4QX2\<
M:2-*O6N+R]N)K8I'N659-NW:1UZ'/ICGM70>7/)\1-*O5M+H6JZ3+ \I@8*K
ML\;!3D<<*: -+7?$L.B:EI-E);W$C:A,T8:.%W"!49C]T')XZ#W/:L&T\61:
M/XA\4IK.H7,EK:7$'E?N&D\B-H58DB-?E4%OO'\ZT?%MO=_VOX9O[>SGNHK.
M^=IE@4,RJT3H#C/3)&?2L2[L[V5/B(!I]YG480MH/(;]\?LPCP./[W'Z].:
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M^U?1-5\+76IK=WTMQ:W(4/;2)(^\"4DX7:3SP3QP#QD ])HH P ** "BBB@
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MHMQJ5^0D=K 9IMG/09('3/M6*_B>\L;K1AJ5C#%;:NPBA>*4L89BNY4?(YR
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M;:<Z-(OF[[PJ94,8D^3Y/O8/0X'N:FN/&<KZ3#JEC:1+92Z<+U9[N78KN>1
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M:XECAB099Y&"JH]R>E(;F!9T@,T8FD!9(RPW,!U('<5YWXFUQ/$GPQ\6^;#
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M0K*J2 9VL 0".G0T <-I$$]_-=:5=3:#?VNHVSP7,^F2R--''L(4L79_EY(
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MU#/=R-N;R$*1(,8"J"2<>Y.22>G %^BB@ HHHH **** "BBB@ HHHH ****
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MWJFB6>L26<EV)2UG.+B#9*R;9 " W!YX)Z^M5)/">ERIJR.MP5U;_C]'GO\
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MUU]EFDS&V92\;8!(/&TXZ9&2,UJWW@?0M0DU%IX;C;J#*]Q&ES(J,XQA]H.
MWRCG':@#*NQJ5_XWUK2QK=[;VD>FPW$:P;%*.S2#@[>GR@^OOCBJ$>N:HOA3
MPEXLN;Z8VNV)=5B7 5T<;1*>.-KE2<<$$^E=A'X:T^+4)[Z/[2MS/;K;2/\
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M.< J!CMWKNZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HP#VHHH 3 ]!1M&0<#(Z4M% #2B,H5E!4=B*7:
M,$8&#U&*6B@!%544*H  Z #I2X&<]Z** &A%5BP4!FZD#DT[&:** # '048'
MI110 8ICQ1R$%XT8KT+#.*?10 A .,@''/-+110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M))8V#(ZAE8="#T-.H **** "BBB@ HH)P,FJEAJ=CJD4LMA=17,<4AB=XFW
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M_4K+5;475A<QW-N69!)&V5)4X.#WY!JU0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !49MXC<BY,8,RH4#]PI()'Y@
M?E4E,E$C1,(G5)"/E9EW 'Z9&?SH XKX66\5Q\,]$,L8<QR32(3_  L)I.1^
MOYUB^%=7U71?"7AV:/[&VG7.JR64D11C+^\N) '#YP,'^':>._8=KX5\//X7
M\.0Z/'>"X2#?Y4KQ;3\S%OF //+=L5F1>!Y(?#VF:0NJ I87XODD-ORS"0R!
M2-W3<Q_#'UH CO/$^MW"7\^A6 NOL5XUL+9H23/L8+)^\W (<[L<'ISUXZ^8
M[K20D$9C/![<5S'_  AUU;ZS>W6G:_<V5AJ$OG7EDD2L&D(PS(YY3=CG&?;'
M&.FN(GDM)(8'6)V7:K,FX+^&1G\Z /'+*9Y/AO\ #W1V)6RU*^2*['02('9O
M+/LQQGUQ7KU_IMKJ5@UG<Q*T)VD  ?*5(*D>A! (^E<[:^ [1/!=KX:N[N2:
M*S8/:W4:^7+"ZL65P<D;@3^5:MMIVK&-8=1U>.YA7&3#:^3))[,V\CGOM"T
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M!(Q1A'-%.RA& SE6PQR,D BM :KXF;Q3>: )]*$GV-+V"Y^SR8C4NR%&3?\
M.<@?-E?IVJ74/!8U&POHWO@MWJ%U#<W-P(>IB*E%5=W"C8.I)Y//-7QH5P/%
M,FNB]C\Q[(6?E>0=H 8L&SNSG<3^''O0!SEKXSUO4-/\*36UO8)+K#S0S"0.
M51T1SN7!Z93.#SCC(ZU-:>*->5==TZ]AT[^T]*F@W7(8QV[02\^80S9!50Q*
M[N2, UEWNCMX<O/!&CQ:G&7MKVX=9Y(ONJT<A^9=W0LVW.1U'>NBO_!0OX+N
M5M1>/4[F\@O&NDB&T-#CRU\LDY08Z$]23F@#+N?&FJ0:/XMEB6UEGT0))#))
M;R1K*C1A_F0G.1R,YP>#6E#K6NKXFM]*N6T_;?Z?)=6S1PO^Y="HVOEOG'SC
MD;>E1W7@6:[3Q LNMRM_;<,<<^;=<*57;E<8[#@=N^:O7.C-:ZK9Z_<WX*Z9
M92PO&EL3O0[2QX8G/R#  /XT 4=(\3ZGJ>C6B.MI%K9U!K*ZA\IBD10DR<;L
M_<&0<X.Y?6M/QEK%WX?\,76J62P-+ 4^29"RL&=5/0C'6J/ARSL-2\1ZAXKL
MHYDAO(8X8C*C1^80/GD", 1D"-<XY\L]C6SXAT6+Q#H%YI,TKQ)<)M\Q!DH0
M00<=\$"@#.N=;U"/QC/HT0M3#_937L3,C;@XD"88[L$=^ #6)I/B[7;BU\*:
ME>II_P!DUMQ!)##&X>-RC.&#%L8^3&W'XFMB'PM?#7!K-SK;37GV!K)A]F58
MR"V[.T'(YQQGUYQP(;?P5);Z5X>T]=3!31)UFB8V_,F%90&^;T8]/:@#G_&.
MKWWB#X;>(=0M7MH]/21X$C>,EY$CD",^[=@$L"0,'@<]>-[4O$6K2W.KVVAV
MZ23Z;M0(]NT@GE,8DV[@R[!AE&>><GH.:]U\/I)--U?2+76Y+?2=2D:8VQMU
M=H79@S;')^Z3VQQZU<G\'WJ:Y)JNE^(;FPENHT2^401R"<H-H< C"-CC(!'
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MDXO=!D==1<2N#(RC;$2<Y82!O,Y_N4 =]134=) 2CJP!*G!S@CJ*=0 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHSLE_IA$TT0/R3Q+R=R]&*X[]1D>E6?"OAKQ1X5\'V^DPVFC3W]L9?)N7O)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0!YQ.#J?@?P!8VH/V@WEENCQ\T8@7,N1VV["#[X%0QH^G_#+QEI<RDWBW=Y
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MJ/+&SL5.>@Y Y]36OX;;[?>174O@[^Q[J",K-//%&#N/5(F4DE>Y)P.!USP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDY!P"!D5L//<>(?$GB+1QJ$]DVGPPK;&!RI5I$+>:0"-^#@8/'RGUJ_?>"=
MU*?4);JTD;^T /M*+<2*DA  #;0VW< !\V,T7_@O0M1O+>[GMI1<01>2)8KB
M2-GC_NN58%Q_O9H X_Q!K$^A>+["]:0WA70#'/>QQ_*BF>(-.54YVC[V%/XX
MYK8UH75G>>$K6PUR^,%Y=-%+-YJN9U\EVW9(([ C''M71OX<TN34EU V["X6
MV-H-LK!!"<938#MQP.W:JMOX,T2UAT^&&"X6/3G,EHINY2(F((XRWH2,=.:
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MRNXE"J "<GKQ][KGG.: ,;Q-/>>$=+U74[;5Y7A>&)8K>X)E,#&14>8,Q)(
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M:U074O[MQG!SNR<9/7UK+\7^%TF\/>(GTFSGGU75K<1.!.<.0,+P[;0 ,]*
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M[1"'SIIWDD"#^$,QR!WXZGDTNCZ)8Z%:M;:?')'"SM(5>9Y/F8DD_,3C))-
M&A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %17-U;V<)FNIXH(AU>5PJC\34M<3XVU Z1KV@:E>3W%OI$?GQW%S"@80
M2,%\MF!4X& ZYQQN]Z .K75=.:""=;^U,-PP6&03+MD)[*<\GZ4MGJ5CJ$#S
MV5[;W,2,5>2&5752.H)!X->::I::!'IVB261:6SN_$L=R9;H#$NX'S'4$#$9
M/L!GV(I^I)9RS_$JT2X-O$]I Q-NNXC$)#$*.O0 _K0!Z-;ZMIMW)Y=OJ%K,
M_'RQS*QYY' -+;ZII]W<M;6U_:S3H"6BCF5F !P<@'/7BN TG5M&UGQ1'JQO
M],GOK;26MDL+.4O)*<[V*[E4\ $  9^8]*S]#U.RGUWP)/;2*EN+:Y@6VAC8
MK:DQIB(L<EG&.<GMG H ].DU;38K@V\FH6B3 X,;3*&!QGIGT-+<:KIUG-%#
M<W]K#++CRTDF56?/3 )YS7E$%[HDUO!H&H:WIT*6>O27?F7;,D[A9G;:RLN,
MDDKG=]WG':M&[N=+_MCQ)X?\3W5Y!]ON1);PQQ96[A*($$9"$E@5Q@'@].]
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MTU;[3ITEA8GHP) R0,CMD#.#ZTRR\2:7J&M7NE6UW#)=6>T2*'&=Q!) '?
MSZ9K$^%]Q%)X TRW4GSK:,Q3H5(*.&.5/N/3Z>M8&L?;'U'XBZ?IQ==4N[>!
M[6-0=TB" !BOY%<^N!UH ]%MM4T^]F>&UOK:>5!ETBE5F4=,D \5%K,\MOIQ
M>"^M+*4N@$UV,IC<,C&1R1D#GJ:X^6XM-=U3P9<Z"\?FVLA,ZQ];>W\HATD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***QM<\1P:%=:?;RV
M=W<27\IAA^SHIRX4M@Y(QG'T]2!0!LUG:YI;:SI,MDEW+:,Y5EFB )!5@PR#
MP02,$'J,BLN;QE;P6;3-IUX)XK<7%Q:L8TEA4YP"&< MA2< G\,C*R>-+%K9
M+BQMKJ^C:P_M$F%5 $/;[Q'S<'Y?8YQ0!:L]'OS<03:OJ<5ZUNV^$16@A ;!
M7<?F8DX)Z$#GITK9(RI&2,CJ.U8@\46DWV-;*":[DN[/[='''M5C"<8.&8<G
M<./SQ3CXCB>5+>TLKFZNS:K=O!'L5HD;[H8LP 8X( SV/2@"A9>%M2MK :7/
MKWVG2PACV/:*)V0]0TF<$GN=N3USGFNH5550J@ *, >E<R?'6F-:Z3<V]O>7
M$>IRM!#Y<0RDBAB4<$@AAM(]..N.:?#XSM'TZ_N9K&]@GL;I;2:T=5:7S&*[
M -K%2#O7G.* .DHK@_&.N)J7@KQ9:HEW9WVF0?O%\S:067<I#(W(([?7(K6L
M/%=M<:K;Z'=6&H64US 7M9;A BW(4?-L(8D$#G! .* .F[YHKAO!FKQ:;X)M
MGNY99I9=0NH(5:3<\C>?+@;F/95)R3T%=#H?B.TUV6^MX4DANK&417$,A4E2
M1E2"I(((Y!S0!L48KGM7\7VFCMJ)DL[N:'34CDNY8U7;&'Z8R06P.3CM[\47
MGBR.VUJ?2(-*U"\O(K5;H+"J8D0DC(9F Z@]<=.,T =#1C-8-OXML+W3M)NK
M..:=]54M:VX #D 98MDX 7N<]< 9R*R_ <\L][XI\U;E-FK,HCN9-[(/*CXS
MD\9SC!Q0!V5&.<UBZEXDAL)+V.&SNKU["$372VP4F-2"0/F(RQ )VC)Q]1DM
MO$UK=ZNNFPVUT9GL!J$;,JJLD9(  RV0V3T8"@#:Q17.V/C&RU*STV>TMKEI
M=1$Q@MWV(^(FVOG+8ZXX!/7ZXK77BNZ77?#]E!I-UY6I1RROO,8==B_<P6X(
M+ GGMQF@#JZ*YZ]\86=G;WEY]ENIM/L9C#=7<2J5C8$!CC.Y@I/) .,'K@TV
M?Q?"NJ76G6FF7][<P6R70$ CVRQL2 59G _A/7'MF@#HZ*Y:T\=6-X-(GCL;
M];'576*WO'10@E920A&[=GY2,XVY'6IYO&%G!<[6M+O[-_:"Z:;G:H43$@#@
MG=MR0,XZ^W- '145S0\8I)K%WIEMHNJW,]G.D$YCC3:F]=RMDN/E((_KBI++
MQ=:W_AY=8AL;W8US]E%LPC$PD\SR\$;\#YO4].: .AHJIJ.HVVE:?+?7;%(8
MP,X&222 % [DD@ >IK+?Q9:6LM_'J5K=6'V*W%T[3*&5HR2/E9"06R,;>N>F
M: -^BL1/$L2ZM!IEW8W=G=7432VJR[")MHRR@JQPP!!P<?SK+C^(5C)86>HG
M2]36PN;DVIN#$A$<GF&,!E#%CEAU4$<COQ0!J:MHM_=ZI;ZEIVKFSGAB:$QR
MP":)E8@GY<@@Y Y![5<T[3FLVEGN)_M%Y.%$LPC" A<[0%'0#)ZDGGK63_PF
M=O&-76ZTW4+:;2X!=2P.L9=X2&(==KD'[K<$@\5'9^.+*[U/3K*73]1M$U./
M?9W,\86.8[=Q4$,2#CID#...V0#J>M'6N&\)ZK%I6C:Q)=S32@:]=VT*O)O=
MSYI55!8^@ZD\ $DTNL_$%+;0==ELK*4ZEI819()'0A!)]R3(8AE]ASD8('6@
M#N**YRYU&S?Q5H<%W87\.H31W#6Q:0;%  WAPKD$XVXX.,]N:+CQG86UF=1>
MWN3I*W!MWOU"F-6#["Q&[=L#?+NQ[].: .CQ17,WOC.&UO\ 5;*+2=2NI]-B
M2:80I'@HP8[E+. >%/'4]@><;NGWT&IZ;:W]JQ:WN8EFC)&"58 C]#0!9HQF
MN=LO&-I>W>FPBSNXX]3\W['-(J@2>6"3D9W+D D9'3TZ53/Q LA;R73:7J2V
MD%\;&YG9$"P/O"9;Y\D;B/N@X[XH ZZBN=UW6HVM]6T^UMKNZEM;8O<-:N$,
M.Y25&[<#NP,X';ZC+O LCR^ M DD=G=K"$LS'))V#DF@#H**P[+Q+'J*PRVE
MA=36UQYGDSH8]K%,\?>R"<'&<>^.E5X/&EA<:7HFHI:WGV?6)UMX"53*.V[&
M\;N!\IZ9H Z2BN?N_%EK:B:5+.\N+2"Y%K/<P(&5)"0IXSN(!(!(!QSUP<+J
M/BRVL$O94L[R[M["18[N6W16$;'!( R"Q 92< XSZ@B@#?HKGM8\7V.D+>L8
M9KA+% ]T82@,0(W=&8%B%(; SP?7BG_\)7:3-*;&WGOHX8HI9'@V?*L@W*<,
MP)&WD\=/4Y% &]16,?$4+7L]O;VEQ<+;74=I/)$4Q&[[<9!;=@;QDX_D:=XH
MU&XTGPOJE_:Q/)/!:RR)MV_*0A(8[B.!CW/L: ->@@$8(S7#Z)/9:;!IFHO!
M>IJ=_9*AMWN$Q<;55FF;+[<Y8#<3N^;&*U+/QMIE_I\=Q LOGO<R6GV5BBNL
MJ9+J3NVX &<YQR,9) H Z2BN9L_&^G7J*D44PO#>M8&U<H&$RJ7(W;MI&T$@
M@G/UXK<T^\-_9B<VTUN=[H8I@-RE6*GH2.V1@]"* +6.<T52U;5(=&TV2]G2
M61$94"1+N9F9@J@#W)'7BLL^+[&*/5S=P3VTNE&,7$;[3GS "A4@X(.<<D8/
M7% '0T52L=0>[FGADLY[9X=I_>%2'# X*E2<CC':LW5_%=OI$E^ILKNX73[=
M;J[>)5 CC.[&-Q&XX5C@=AZ\4 ;]'2N<O?&%O;:HFFV^FZA>W4MG]MA6WC7$
MB9 X+,,'GOCIZD U8_B%I<NFZ=>QVFH.+ZZ:S$0A'F13J"3&ZYX/RGIF@#K:
M,"N/?XB:?!INKW5UINHV\^DE/M=G(B>:JO\ =<8;:5/J#6DOBB,R)"^F7\-S
M-<-#;02HJM< +O,B_-@(!U)P1TQGB@#>HKE[KQUIUEI>I7EQ:WB2:9,D-W:[
M%,D1?&UOO8*G(((/]:6/QM:G5+G3KC3-2M;F*W:ZA2:)1]IB7J4^;J/[K8/M
M0!T]&.<UPNH^,M-U/P==W]YHNLC1WM(YS*@6,R*QZ*0X((.,]/;(Z[FK>*;?
M2'O4^Q7=R+"T%W=-$%Q'&=W]YAN.$8X'I]* -ZL_6],.L:1<6 NI;4R@8FBQ
MN7!!Z'@@XP0>H)%9$OBB=O%^F:7:V$LUG=V+W?GJR#(W( <%@0 &Y[\C -+/
MXXTRWGM=Z2_9+FZ^R1W89"GF9*C*[MP4D$;L8_ @T 6[31]0::&35]4BOA _
MF1+%:"$;L$ M\S$D9[8%;=4=6U6'2+-;B:.67?*D,<<2Y9W=@JCG ')ZD@"L
M:Z\;V5EI>LWEQ97BOH[A+N!0C.,J&# [L$$,.^?:@#I\8HQBL*T\46]QKDFE
M3V=W9RBV-W%)<JJI+$"%+##$C!(X8 \]*YOQ'K9U.;PE=VEO?16EQK$/E7&\
M+'-&0Q&5#9PV 1N'0=NX!Z#16)XNN[*Q\*:C<:E!<S62PGSTM6VR;>^#N&/S
MJ&Y\40V>K0Z-#IE_<W3V9NH5B"$.H*KC<S#!^;JV!QUR1D Z'I16=H6M6WB#
M1H-3M4E2*7<-DJX=&5BK*0,\@@BN/UGQ!>:KHGCFT>SN;1=,MY5AFCF52&$&
M\$E6W9)(.!D8Z]Q0!Z#17+:!XFB=]*TBXLKR"6XL!-;SS*H2<(J[\88L"-P/
MS 4]/&^F->:=$4E%OJ4ODVEUE"DCD$J,!MP# <$C\J .FQ15#5-5@TJ.W,H9
MGN9UMX44@;W() R2 . ?R[G JJWB.&..!9;.ZCN[BX:VAM&"^8[*"21\VW;M
M!;.>GN0* -FCK7&>(M=@U7P=XKMHQ=6>H:;:2F:%GV21GRRR,&0X*G&00>>0
M?2M"#7H;#2]-MA&]S>-8I,8D=%.W:!DEV Y/ YYY]": .CHQ6=H6MV?B+1K;
M5;!F:VG!*[QAE()!!'J""/PKCO'NO"^\'7DNGPWI@CO(H1>PR!$++,JOP&!9
M<[ES@C/MS0!Z%1BN:.KZ5:^*=7,L5W%=6>GI/<3.Q,1A!<@JH8\\-V!JTGB:
MV6TEO+NWGM+2.U%W]HD*,C1^Q1CD^WN,9H VZ*Y]_%207$T%SI6HPR1V9O5!
M1#OC!PP!#$!AQ\I(ZU!9>-K2\L(KYM.U"WMIXX7MI)D11<-)T1?FZC!SG QS
MG'- '3T5P^L?$%+;1M8>RL93J.G21130N\9""4@)("&(9>>@YSP<=:UI=1LG
M\7Z3;W-C?0ZC):SO 6D'EJHV[PP5R"?N]CUZT =%17.2^,["&TCU!X+G^R9)
M_LXU !?*#;M@8C=N"%N-V,=^AS4%[XYM[.76(UTC4YSI&TW9C2/"H4W[P2XR
M-O.!S[4 =514=O/'=6T5Q"VZ*5 Z-ZJ1D&I* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KFO$NG7U[K/AVXM+4S16-Z9YSO5<*8V3C)Y/S9_"N
MEHH XK4=,UO3?&%WJFG:3:ZO9:C%$LL4LRQ/;R("H8%@<J01D#GC\V:OH_B"
M\O9+>6TM;RPETTQ1H)O+B@N#NW,4Q\PP5"G!QCMDFNW) !). .I-9UEK^EZC
M?-96MV'N!$)PA1EWQDX#J2 &7/\ $N10!QK>%KR]\-Z-I^J:(YN;#3HXH+NR
MNU2>VG5=N0Q*\' /&1QT/:]I6C:]H6O+JDZ_VHU[IT%O?F%U5UGB!&\;RH*G
M<<\@YYQ75ZEJ=EH]A+?:A<);VT0R\C]!5E'62-70Y5@"#ZB@#@8?">I6 T'R
M[<3/#J\VIWFR10J>8)!M7)&<;P/?!/M2W6C^)8YO$L^G6YC:^O[>>,"X5&E@
M5421 P/R,0IP?0]0:[^J6I:MI^CP+/J-W%:PL=HDE;:N>PSZT <)-X1UBZA\
M8VT6GVEE#K%I$ML!/D*ZH5(;"]<\D_SZUOC3;[5=9T34+NQ>S324D<1O(CO+
M*Z;,#:2-H!8Y)!)QP*VK76]+O;K[+;W]O)<;=WDB0;]OKMZX]ZOT >;1>%M>
M@\+Z<8+2#^U-,U.>]2VGD4QW$<C293<,X.V3J>A%=GH7V^2"2>_TVWTUGP%M
M8I!(5QG)9@ "3GH,XQUYXUJ* //?%F@>(=;/B.S^QPW=O=6RKILDEP%6 [?F
M&S'WRV3N]#C(QBM6RL-6C\:/J]QIQ6!M)CM<),C'S%=G(Y(XPP&?7VYKI;Z^
MM=-LIKR\F2&WA4O)(YX4"GV]Q%=VT5S ^^&9!(C8QE2,@_E0!YQI'ACQ#HEG
MX5OHK%)[O2HI[6[L_/4&2.1@=T;$[<@@<'&:Z7PIIVJ66H^(+C4+2.WCOK[[
M3"%F#G'EHN#@<?=]?\:Z>B@#C9;'Q#HOC'4]0TO3X-2L=6$3.KW(A:VE1 F3
MD'*D =,GCIZRW.G:U:^,[+6(+6*^5],-C.1*(A&^\/OP<_*>>!DBNMHH \WL
M/"5XWA/2M&US0UN5@:X<R6MRJS02-)NC=&)7'#-G![#K5Z'0O$5M/X2NYRFH
M76G1W,-T\DP5L2 !6)Q\V H!(Y/7FNZHH X*+P[K%EH/B'PW';+/;ZC+<-:W
MGF*%C2?.X2*3NRI9CP#GCI5[2]$O-(\5S7,=I))81Z3;V,+^8FYVB+'H3QD,
M/QKKZ* /.K/PWK5OX/\ ".FO8$W.E:A%/<@2IC8F_.TYY)W# ]C3-4\/^)M0
M>9KC3X+JY@UF*[M[E[H#-LLH941<?)A1STR1GYC7I%% ',^']/U"T\4>([Z\
MM/)@OY89(6$BM]R)4(.#D<KD>WITJGI^BE/B!J$UO.K:7B._: =%O'5D)!Z<
MH-Q'J0:Z^6))X7BE0/&ZE64]"#P1532='T[0K%;+2[.*UME)(CC&!D]SZGW-
M %#QCHMUKWAJXL[&9(KU7CGMWD^[YD;JZ@^Q*X_&LC5=-\0>,?">H:=J-G!H
M\LL*B)1<";=*K*X8E1PF5 [DY/3'/:44 <H^GZEK>LZ%J6H:>UF=*$LKIYJ.
M99638 F"?EY8Y;!Z<=<8D?AO6T\"V.E'3S]KAU87;J)DQY8N3-P<]<'&/7\Z
M]&HH X'Q'I]\MWXMU62U9+*?P^UNCEU)WHLK'(!SCYQ^52Z=IMYKNG>#WFLV
MMK?3$BNWD9U)E80E55,$G!+9);'0#'/'8WUE;ZE936=VADMYE*2(&*[E/!!(
M(.#2V=I!86<5I;*4@A4)&I8MM4=!DDF@#S]O"VNOH=V8;:&/4(=?EU>UAG=3
M'.C,WR,03@E7(^N/K6AJ^E:WXB\%:O:/I-IIEU<1*L-JLRN2RMN)9U '., =
MNI//';T4 <K>66JWWBSPUJCZ?Y45G'<BY F5O+,BJ% Z9QMYQZ\9K&@\*:M'
MX'N_!+VX:W>1XX=0\Q=GD-)ORRYW;P"1@#!('->AT4 <<NCZC!KWB:X2Q9K>
M]L8;>V(E3+-&K@YR>!\X_(UK^%K&[TWP=I>GW,8BN[6SC@8$AAN50N<@\C(K
M:HH \WL-!\2G4?#>HW^FP/?6$\WVZY>[#/-OC9=Z\<)R,+VZ8'6G7'AO6YO!
MFO:8NGD75]J[7D(,R8\LSK)R<\'"D8]2*]&HH X@:7KNF:]K\EKIZWEEK2+*
MK&=4:VE$>PJX/53@<KG'I6YX/L+S2_"&DZ??Q)'<VMLD+JC[QE0!U_"MNB@#
MAM&\-WMIXEL]4MK&32?,$AU:".=6M[EBN%9$!.&W8.<+QD<]\RR\.>)8- \-
MZ0=,@']C:FDSS&Z7$T:^9\R@ D###@\Y[=Z],HH XG2+#Q-H-]J.F6]E;7&G
M75Y+=6]^UP%-N)&W,K1XRQ!)QC@]R*6RL?$N@:[J\%A8VUYIVI737D5U)<;#
M;.X <.F,L,C(V_3C/':T4 </)I>O:1XIU*XLM)L]7L-39)M\TZQ/;2A%1MV5
M.5(4'@9'/%1>(/#%_J5TUQ:V;6VLVZQ)9:O:2K$, +N$J;LE-V[Y<-P<<=^]
MHH X;5?#=[>^(/[3LK*2PU6.ZCVZC!.JQSVX*[EF3.6.W< -I_AY SCH_$]K
M<W_A;5;&TA\VXNK26"-=P4;G0J"23TYK6HH X.^T77(8O#>J6.G075WIMJ;2
MZT^XE51*C*F2C\@$,@(SU%2:OH^O7,>E:S:Z;8_;[*>1VTLR#8\4B!67S,8W
M\!LXQVYQSW%% ''W^E76M:3%#J_AJV>WFFW2V4,R^9;@*=KJ_P H+[O0C /4
M]VV+Z]X6T"P@F@DU,-?F(F>Y'G06[N1'D\^8X!4$#\\#-=E32B,RLRJ67[I(
MY'TH Q_%<&KW&A/'HA_TOS(RR"3RVDC##>JO_"2N1GM[5S5KH&JVVH>(Y3X?
MLFLM2CM=MHTZD.%^61&XQN().>F>YKOZ* .6\(:#<Z%/J,<?VF#2)#&;*RN9
MA*UN0#OP06PIRN!D]#ZUF^*=$U_6+G7K7['#>65UI_E:>TEP$2WDV,&RF.6)
M((;MTR.:[NB@#SVT>_LOB#I"2Z>TEPGAQHY8895)3$R#(+%0>@[]^]4]2TFY
MT)- E>$27=[XI>^D@C<84R1RG8"< D*!SP"<]J[]M&L6UE=7,+?;EC\D2^:_
M"9SMQG&,C.,=>:-0T:QU26VEO(6D>UD\V$B5UV/TW#!'.">?>@#C/$?A;5-9
MM?$UY#9[+O4[:"SM[=Y$!5(R6+N0<<DG@$\ >IQLZ[I>H7&LZ!X@L;<O/IQE
M6:S9U5GCE4!MISMW*0".0#SS74T4 >8^,](N(/#?B[79XO)FU$V:1V[,"42)
MU W$9&26/0G QS70ZEI-]K&MP:J]B\ L;&XAAB:1"\LLH4'D,0% 7N<DGIQS
MT&J:39:U8M9:A"9K9B"T>]E#8.1G!&>0#^%6T01QJBEB%&!N8L?Q)Y- '"W/
MA[5YO@\GAQ;,?VD+*.U*&5=N5QEMV>G'U]J/$>C^(-9GUBW:PBN;*[TSRK(2
MW 5;68HP8LO.YB2N&YQC&1DUWE% '%6FCZW;ZUX;U$V,)^SZ8]C=)]H'[DDQ
MD-G'S?</ [_G4/AS2/$&B8T.32;":RAF8PZL95W>26+ &/&2X!QG./RY[NB@
M#"\5P:O<:3$NC#=*+F)IXEE\II80?G17_A)'?COS7(7OA77)=,\96EOI-M"F
ML+$;5(KA<*1&JD'@8Z$D^IXSUKTRB@#C=4T*_P!6\2Q3M:R0V<FC7%A+)O0M
M&\I4YP#SC:?TK*31_%,FB>&=+GTF 2:+?6[27 NU\N:*)64,HQN&1C((!SZ]
MO1Z* ,'QIIUWJ_@[5--L8O-N;J!HHU+!0">Y)[5233]2'C:PU8V+BUATE[1_
MWB;A(SHV,;NGR$9]375T4 <YX(TV]TCP[]BOX/)F6YGDP'5@5>5G'(/HP%8U
M]H.M;?&]M!91RQ:U&QMI1.H^9H!%M*GI@C.?3UZ5WE% '%MHFI3ZOX6E>R=8
M+"QGMKIO-3*M(B*,<\_</YBH_"FF^(M)@M-$O=)L/(L<1IJJ2J3+$OW<1XR'
M( !).!R>>E=Q10!B>)].75=-BLYM*34[228"X@9PK!-K?,A)&&#;>X[\URUO
MX4UVP.CZA'+->2:3?3M!:74X:7[)*H387S@NN,C)QCC->B44 </J7AR_OX/%
ME^MJ4N]8L196]LTBY4!&4,Y!VY+.>A. !W.*BN-'U[3]3TO6++2;?4/^);'8
M7EA-,B,A0DJZ,<J>68$>F/P[VB@"IIJ7$=A&+J*&*<Y9HX.43)SM!P,X'&<#
M/7 KSN3PUXFM_ MYX1BTZ*X6*Y#VM[]I55DB^T"7Y@>0PY!XQQU/?T^B@#D)
M--U;_A+-8U1-/C:.XTE+:$22*4>52[;6'7:=X&<>O%8K> [J>RUBPTU)](TR
M^LMJV4TXDCCNMX8/&%+;4XP>F<].*])HH Y6";Q1J6BW4.IZ1!:2BU>(K%<K
M(;B0K@%>@1.IY.>GISG7'AS69/ 'A^UMX84U?13;R""=P8YFC0HREAGA@6P?
MITKNZ* .'UC2M<\0>#=2MVTBTTV[E\DPVBSJY8I(KG<X  SC ';J3SQ>NM/U
M2]\8Z'J<EAY=O;VMQ%/MF4[#)LP!T)QLYQZ\9KJJ* /.X/">K'P&W@BXMP8%
MD$2Z@)%V-;^;OSMSN#[>,8QG!S5NXT/57D\<;+$[=7@6.S/FIR1!Y7S<\<\_
M3WXKN:* *&AP36N@:?;7$9CFAMHXW3(.&50#R..U7Z** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\=*@^*Q(\!7!49875K@9QD^>E7M \(S:$T4!UV_O--MO^/2SF"8B'0 L!N<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0G=,ARRX1!DD+C.!V)J:+7M+N-.COX+Q);>5BD9C!9F<9RH4#<6&#QC/!]*
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MH&=X_-C1T9/,3^\FX#>O3E<CD4T>(M*-[':"\7S969(OD;;(R_>56QM9A@Y
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M 4444 %%%% !1110 4444 %<9\2$FFTG3([>UN;AUU2VF98('D*HCY9CM!P
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M6UG=20:H;2.V@2W<O*T>-[A,9P>F2.=N>F*]4HH X/5VG_X3BXO+72Y[N/\
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M\L]Q/YG-=@KJZ!T8,I&00<@U'-;17#1F5=_EL'4$G&X="1T.#R,]#S0!C^-
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MJDT4@ =20"5/ (.#R* ,^\\=_8=.U>6;3<7ND3Q17=MY_&V0@(Z-M^8$-GD
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M9D9FW-A,#);M_P#6H AMO'%M>V>@RV\44<NLP/-"EW/Y2@KM!3<%.6RW QR
M3[&>Y\5& V]J;:WAU*2T6ZEM[NZ$2Q \!=VTY.0PZ8^4YQQG(L?!U]%X2TOP
M_J=EI.I6EM!)%/')*ZY;(*.C;"00-P/3J,&FP>$O$>B2Z7?:/J-I=7D-BMC>
M1Z@SA)D5BRL&4$@J6(Y'(H T+3QS#?QZ2L%H(+K4H))8X+Z;R,,C!2@.T[FR
M>..@S72VL\L^GPW$ELT4SQ*[0$\HQ&2N?4'BN=U?P_>ZS91V>J6NFZK;O$QE
M69FB,<Q.0T1"L0 #CKG@<]<[.B6%QI7A^RL)[DWES;6ZQM,Y(\Q@,9)Y/\Z
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MO^DF:38,NFX(HVG+;<$YP!D<]<5X-"\3Z1K6H'2;S36TS49S<R?:5?S+:5@
MY0#A@<9 )&#^H?#>M:=K6M3:7+9SV.L(IE6ZD97@E";-R[5(<$ $@XY[T 7_
M  )N'P\\/E "W]G0X!. 3L'>LO0O&%\?#K:AJUO"9I]2DLK6*"8DR2&9HU3E
M1@#'WN> 3@=*Z#PMIEUHOA;3=+O'A>>TMTA9H<[3M&,C//:N8'@?5#H3Z?\
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M<36<EY=Y>.)4VHXAERR[E)YP<9R,'IGFN^UB#4)=#NHM,O&@U#R3Y$Q1&_>
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ME;:X>VD\R,H0ZXW#!Y[US.GZMKESJ^D^'-4N8K?4!I\MY?3VFTB0K((U5<C
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MGOM,@N+JU-K<.#YD!;/EL"01GOTZU<H JZ=8QZ9IMM8Q/(\5O&L49D(+;5&
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M_N)E!# Y(/=5/J<<DUIW.A07>LV&JR7-Q]IL4=(L%0N' #9&WG.!^7&*U:*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *KW5_9V6W[7=P0;ON^;(%S],FK%<1\3N-+T
M)O*,I77;,A%QEOG/ R0,GIR0* .PMKVTO5+6MU#.%ZF*0-C\J@_MK2O,\O\
MM.SWYQM\]<Y^F:X?4KK?\5/#DDMC+HI$<R&><+_IV5 $(,993@_-\Q'L*R[W
M5+#2/$GQ >_TQKRWFELX3\B^6K/  -[$_*I)&6[4 >M51_MK2OM#6_\ :=GY
MZDAH_/7<".N1G->>ZQ'JWA+X4:)HD]^QN[FY@T^>[B<YBCD8D[6]E^0&NO\
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M2>WMDCDU2.Q6V+;IC$[!5GR#A02>%(Z#KFIU\527'B:ZT>&2SBNK>YCC^QW
M*RS0D*6E0Y (&6X /W>O.* .JHKD+CQ7?2:/J^M:;;V\UCI<TL;0OGS)UB_U
MC*P.%Z-@$'..HSP@\4:IJ.OIIVCVUD89]*CU&WN+AW^Z[8&Y0/T![]>U '85
M7GO[2VN(+>>ZABFG;;#&[@-(>N%'4_A7+V'BR^U30=%U&.WMK..]CD-Q/.VY
M(74[0@7<K,6;.,=AWK#OM;N?$-AX&UB&TA2\FU.11$SD(&6.93\V,A<KGIF@
M#T:ZN[:QMGN;NXBMX$&7DE<*JCW)XJ2.1)8UDC8,C@,K Y!!Z&O/=8UV_O\
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M(58D*F"6QD'.WMFH=3\57X;5/[&LOM;Z;*(6@^SRN;APJLRJZC:F P SG)[
M8) .NHKD'\7RRZ\^E1?9K2[40/%:7RE)+E'"EBC9 RN6&W!.5/2M'QI?7NF^
M"]7OM/E2*YM[621'==V,*3P,]?3^M &]17+VVM7OVK2]#1[=M1GL3=R3,C%(
MXE*J/EW99B6QU'0GVJYX;UZ361J%M=0+!?Z==-;7"(<HQP"KKGG# @X/(Y%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,UI-:22+N:";&^,^AP2*LT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRRK+T8;3WZ=L5LZMJEYIGB21M5%\NF37L M-1LYR8H>4!AFC!X#,&&X@_?\
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MI#6L4BL=GF_,V"R8#'D;N.QIMU8^)M/AU..TOH[DRRP36VGM?.90@/[V-9G
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M@DD6XD&4&<# ; QD]/6JH\(:$MA860LB+>P<O:KY\F8B000#NS@@D%2<$=J
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M0 4444 %%%% !1110 4444 %%%% !56[U*QL&1;R]M[<R9V"654W8&3C)YP
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M9UMHCND@"1EF3(PW(W>^,UV7A9]#U+5+W6M&GNKM[F)([BZD#*C%<[5 (&6
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M+GTJ\BNH[)KX+NC8/&&"X!#8W9/0XZ=: -/3]/-D)9)IVN+J8@RS,H7=@8
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M(=L,6'W]N>1T)7MVU[_Q%'9WEW:0VD]Y/9VZW,\<)0,$;<!@,1N/RGI_,XH
MVJ*BNI/*M99#$\H5"2D>-S>PR1S^-<EIOBK2M.\.>'#8Z=J!L]2Q#9ID2,IV
MLP5B6)R0I]1ZD4 =E17*OXYMX=&U;4)])U%)-)E\N\M0(VEC&T-O&'VE=I!X
M/K6Q)K4$<UNC1R>7-;/=--N39%&N,ECN_P!H8QGOZ4 :5%<]'XOM2^EO/:75
MO::HP2SN9 NUV890, <J6'(R/8X/%5M/U[2+1?$%XMM=V[0:@(;E96WM+.50
M*$&XCG<@ &.?2@#JJ*P&\56]M)?QZC9W5DUG&DK&10RR*YPH5E)!;=QCU_.E
MTSQ5::CKLVC-$\%[' +E5+HZR1$[<AD8C(/!!]1U% $FK:%-J6NZ/J27B0C3
M9))%C,.[S"Z%#D[AC@GMUK:K*OM<CM-273HK:6ZO#;M<^3&RAM@..-Q&23V_
M,CC.8GB>[F\9VFDIILPM9=-^V%RR;LET )!.0%R0>I)/3B@#J**YRR\86UY>
M:9#]BNXDU02FSDD"CS/+&2",Y7(!(SVZX/%4]&\9/<:;J5]J=G):QV^H26D2
M[D.Y@XC5 =WWBW4G YZX&: .OHKDIOB!I]M#K!FM+GS]*A%Q-#$T;EXCT=2&
MP1Q@\@CTJ<^,5&J0Z>=&U(375NT]GQ'BX"XW ?/\I&X'Y]O]* .FHKG;7QE8
M7.DI>M#-!,UV]E]EE*"03H3N0G=MX"DYSC _"J4GQ#TV&PO[B2TNS)I]S';7
M,,>QRAD(","&PRG<.F3[4 =?17--XOQ)JUL=)O(KVPM1=K!,T8\^([@&!#$#
ME3D'D>G:H]'\6276B: ]U9R?VCJEJLL<6Z-1)B-6=E.[I\W Z^P&30!U-%5[
M"[^W6,5R8)8#(,F*8 .A]#@D9^A-9=CK\.LK"(+2X:RNS)&ETCJ%^7(.=K;E
M)P<?K@\4 ;E%><^!O$XT_P *>';6\M+YX[R9[9;YBI3S3(Y53EMYSC&[&,]Z
MZ.X\86MM<8>SN_LPU!=--QM4*)F( X)R5R0-V.OMS0!T=%<991[_ (@^*K=I
M9S$UA:-CSF^4GS<[3GY>G;%7/AU(\WP[T*21V=VM5+,QR2>>IH Z>BO-='\3
M?\(U'XFEGT_5+VRM]:G,UQ'B06\>U.3N;<P'7Y<X'7'%=1J7C"PL4F:%&O!!
M;K<R^5(BXC8$C&YAN) )P.WID9 .BHJG9:G;ZCI$&IV6Z>WGA$T6T89P1D#!
MQ@_6N8MOB/87$&EWC:7J<&FZC((8KV6-!&DA)"JV&)&2.N,9[]: .SHKG)?&
M%K#=(CV=V+9]1&F"X*J!YQ..A.=N[C=CK[<TVVU?28/$7B-Y(KBUGL8(9+V>
M=\QM'M<J5&X@  -G@&@#I:*X+4=2FOO'7@N;['>VL,[W++YD@VNOV=R R!CA
MN0>1G\B!U&N:]#H*6<EQ:W$L5S<I;>9%MVQ,YPI?<PP,G&1F@#5HK!3Q5;&_
MUJS>TNHI-(B6:8OY>'1E+ I\W(PIZXJO'JEI-XO6,Z7?QZM_9)G422*%,6]?
MDP'*[]QZGTZXH Z1UWHRY*[AC*G!'TKFK'PM?VU@NE7&O27.E+'Y/E/;()6C
MQC:T@ZY'!.T$^N>:Y;4/$%UKO@G0]9N;>XM7;6K<@1R95T^T$;0%.6P !R.3
MT%=1)XHM;NSU^UO=+OX'TZWWW-L2GF/"ZL0R,KXZ*W\0(Q0!U &!@45RL/BF
MRL+;P]8VNF:A*NI60DLT3:QVK&&VLS-G=@KR>/4UJZ!KL.OV,MQ';S6TD$\E
MM/!-C='(APP)4D'L<@]Z -6BN.EUV[U/5O%&C264\-M8VR!)DE4$%D=MQ(8,
M,X4 #/3G&:J^"_$ZQ:'X4TRZLKU3?6*)#>2;=DDBQ;F7[VX< \D ''&: .[K
MFK/PWJEAYEO#XBF-@\CR>7);(TJ[V+$"0]>2>2I-4!XITK1M/\2:LFFZ@!9W
M^R]0L&9I-J#<H+X"X*]/RI^H^,-0@U'2[:+0+Z);N_:W)F,:M(HC+@H-W?'?
M&,$=: .LMK>*TM8K:! D,*"-%'\*@8 _*I:PK3Q3;W-SK-O)9W5M+I(#3B?R
MQN4J6#+ACP0#R<?H:T[>^672TOYH9;5&B\UHY@ \8QGYL$C./>@"U17,^&Y)
MO$7AE=6N)IH9-3!D7RVVM#"6^5%/8[<9(YR2?3'/Z-JEEHM[XQETS4YKFRTZ
MV686-S-)(\<BHS.RESNV'Y1U/(/MD ]&HKSA;V[T?0/!^NM=32W>I75M'?[Y
M"5E%PI)^7.!M8KMQT QT)KI+74&T_P ;2Z S%K>YL_MMKN.?+*MMD0>W*L!V
MRPZ8  .CHK.U'5XM/N;2T$;SWEVS"&",@$A1EF)) "@8R?<#DFN/\+ZU_9R^
M*+BYM[YF.N"WCMV;S) [I$H7)8C&3G.<8H ]!HKF9_&EO:Z=K-U+IM\TFCN%
MO+>((SJI4/O7Y@"NTYZYZ\5?G\0VUN+1FAF:.XMGNS(FTK%$B@EF^;G[RCY<
M]: ->BLK2]:_M-H=ME/%#/;BXBF9D9'4XXRI/S<CC]33[[6([34(-.BADN;Z
M>-Y4AC(&$7 +,20 ,L![D_7 !I45PWB7QBTGP]UO4=)CN8KRU$EM,K;5DM)1
MP2WS8XR""N>H-=!I&DVU@US?VUE<VLMPBB2U:52"5SA@ Q4,>YSSQF@#9HKR
M_6/$%YKWPX;5;FVN+.2/5(U3RY.&47@CVX0Y;"C!R.3TKL(/%MH;O5+:_M;G
M3GT^W%U)]IV$-"=WSC8S?W3QUH Z"BN>LO%]G=:[!I$D$MO<7,+36Y9T<2!?
MO+\K'# '.#V[UT- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S
M7BK3=0N;S0]1TVW6ZETV\,SP&01ET:-D.">,C<#S72U5O=1M-.-L+J;R_M,Z
MV\7RD[I&S@<#CH>3Q0!YIXFTW5K#PGXQNKZVMXQ?7UM<0A)MW\4*X/'3*]?T
MKI-8\-3^*]3,]["]C!'IMS9H&96=GG 5F^4D;5"\<Y)/08YZ74]*LM9LS9ZA
M!Y]NQ!:,L0"0<C.",X(!_"K2((T5 20HP-Q)/YGDT <5%H.K:GI'A[2=4M4@
M.DW,$TURLJLDWD@[?+ ^;YCM)W 8&>M4KWPSK5SX2\6::ED!<:KJ,EQ;9F3;
ML8IC<<\'Y#QSU%>B57OKVWTVQGO;N3R[>!#)(^"=J@9)P.: ([X33Z1<+' Q
MFDA95B+ '<1C&<X_6N/?PSK1\ >'[.WC@CUC16@E2*9P8IFC0HREAT#*QP:[
MJ*1)HDEC.Y'4,I]0>E.H XC5M*\1:]H(F^P6>FZA:W4%W:V?G"17>)MQ#N !
M\W0 =,9SSQ!:O?ZA\21_:-DEC-+X?D7R5F$I7,ZCE@ /R_\ U=]6+JPT/19Y
M/$NI.+>2&+RFN6=SA,YVX!Y&><8Z\T <EIWA_P 2QZ=X1LI=.MH_[#N1YKFZ
M!$J"-TWK@<#YAP>?IUJ]HNE>)-$N)]'33[&XTUKF26WU)I@'BC=RY5H]I+,"
MQQR!TKN:* .'G\-7D_B>'5K2R;3=02^S<7<$X$5W:AC\LB Y+E<#E>#SGM6I
MX4TS4=(FUF"[@B%O/J5Q=PS)+DNLC[@-N.,=#7244 <Q=6&HVGCIM;M[/[7:
MS:<MF5CE571UD9\D,0-IW=B3[5G7?AF"R^'NHV%_=1Q74KS:@9HSQ%.7,H*=
MR%;:/4X]\5UM]J=EIHC^UW*1-*=L:'EI#Z*HY8_05FM'X<\0:K;321VEWJ%@
M#)$LB_O8,D<E3RO(&,CW% %GP]9W-EHL OBK7\V9[ME'!E?E@/8?='L!6-?Z
M'J.F^,F\3:/#'="ZMUM[ZS:01L^T_)(C'C<!Q@X&.]=;10!SNL:=>^*?#^H:
M;<0G3H;JW>("1E>3>1P3M) 4>@))]L<T/[(U764\.Q:K9K;-I%PMS/(LJLL\
MB(RJ(\'."6W'<!C&.>M=C10!YU<>&M:F\%:[I2V0%U?:J]W"#,FWRVG$G)SP
M<#&/7%:NIZ??OXKN=8-J5LO[#DM"S.NX2%M_0'I@8SZ^W-=A45S;Q7=M);S
MM%(I5@&*Y![9'- 'GWAW3+SQ!X)\&6TEJ8+:R^RWCSLZD.(UR@0 YR3MSD#
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M=56NJU32K#6[!K+4K6.ZM7(8QR#()!R*LPPQ6\$<,$:1Q1J%1$&%4#@ #L*
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MK[;8Q:+]I\CRLA09<-WZG:.:DO\ P$E__;*-K5^L.KPHEU'MC.YU0('SMR.
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MW/=3PR363P>:%D="ID"]"1C.*Y__ (0FTD\%V_AF>[N'AM@GV>Y3"2Q,ARC
MCC<#WQ0!1N;WQK#8:X8;2/=;1"?3YKA$)F(!+Q,B.>>.&&.M:NFZS+KC6$VF
MW,9M9+ 7,K/%GYGXC'!&.CY'^R!QFK6BZ1<Z:C/?ZM<ZI=, HFG1$VJ.P5
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MQ^E2TU P0!V#-CD@8!_"G4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXK\;O'$%:*6((<G@&V4FL;2+\Q^'_ &FW%Q!!8WM@^XW"%HI)55-B, R]BY
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M<8.!VZ\UZ]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF/?\:CF\.:)<:2NE2Z59OIZG*VQA&Q3Z@=OPK4HH SI- TB71QI#Z9:-IRC
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M8Z39VTMR")GBA52X/4'';VK5HH RQX;T1;6"U72;,6]O)YL,0A7;&_\ >4=
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M51C\GWAU]/;KE?#^LZEJ=II^DW%]*NM6MW+'J;JJ9*Q=3C;C:^^+& .'..E
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MXHV:*1WY ++R,#G.3[B@#T*BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-6(] M(M?_MF-YEN?LXM0@8",1 Y"[<=B<YZ_AQ6K10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7&>+;Y+3Q=X63465-'DDG\QY.(_M
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MWDMJ)"BO$;CRP=WD>8OF8Q_L9S[9K,U*VLY?&FE2Z4MLUE<:9<_VBL04Q/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH46I+KVL>)=(FGL[9XXEMY5"QJV"[!=S,S':H^@QSFNP\J/_ )YK^5'E1_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***QM=U:?2#:3JD;VIDQ<Y!W(G=@<]LY/'0&E)J*NP-F
MBL:^U>:'Q!ING6Z1F.=F$TC G;A&8!<'K\ISZ9'K3[GQ'806=Q<(SR^3$9MJ
MQM\ZYQD''(SWI<\=1V-:BLY-:MFO+FW994^SI&S.\; '?G ''7IQU)-,?Q!I
MJ 9ED+>8T6Q8'+;U7<5V@9SCGW'2CGCW%8U**0'<N5XR.,BL#2=9GU"&%I+N
MQ$SSR1FW5#N(1V!Q\QP<+GI0Y).P'045EIXATV0H$DF8N'*!;>0[]IPP'R\D
M'MUI[:YIRV\=P;C,,B(X<(Q 5CA2W'R@GUQ1S1[A8T:*SAKNGM)(@EDS&_EL
M3"X&_<%VYQ@MEAQUYIRZS9.CLCR,4=HRHA?=N7[PQC)Q[4<T>X6+]%93>(]*
M"[OM+,GEI+N6)V4(^0K$@8 X//;O5FRU&*]N+R%$D5K6;RF+*0"=JMD?]]4<
MR?4+%RBN5F\2W-O%?NTEF\MM>?9X[4*1),/EP!\Q^8[CV[5MG4H(KR[26Y&(
M1$#'Y3 J7) Y_BW'@ >GO24TQV+]%8FI:_%;6J3Q.%B%SY%S*\3'[/\ *3EE
MX(YVC/3Y@>E6K?4 MNCW,T4IE8^2ULI82KC.0 2>G6GSJ]@L:-%8LFNQK?V\
MBS(VG264URSJA+#8R#Z]&.1C/%3WFNV=I#,^9)'B6-RBQMG$A(0].A(/Y4<\
M>X6-.BL]=3@6YN1)<?+'Y8\LPLK*7Z#_ &B?0#BD.N:>"@\UR[R-$$$+EMZC
M<5( R#CGW[4<R[BL:-%48]8L9HX7BE9UE577;&Q(!.T$C''/'/H?2HM7OKBR
MDTY8/*Q<W2P/O4G *L<C!'/RT<RM<#3HK.@US3[B=88YFWLTB@M$Z@LA(89(
MQD8/'M4]KJ-K>2M%#(2X19,%"N4;.&&1R.#TIJ2?4"U16+?ZO+'8:S=6@CQI
MT;X\Q20\BIO(X(XY ^N?2I1KUG"HCNIB)U2-I=L+[5W\*<X( R#SFESH=C5H
MK.AUFVEFNHRLJ&WG\CF-OG;:&^7CG@_D,]*:OB#39&A6.:1VF4L@2!V. P0Y
MP.,,<'/3O1SQ[BL:=%9,.N6BV\)DN'F>82,ABMGRP1L'"X)R.!^M6+/6+&_E
M6.VF+L\0F0F-E#H<<J2,'J.G3-"DGU"Q>HK+BOY[[4[VVM3''%9LL;R.A8NY
M4-@#(P "/KGMBJMUJE]::CI]I<364 N$G9W=3@;"NW'S#J&H<UN.QO45BKJT
MTUW96,$EO)-<1/<F=5.P1 @*0,\D[E[^I]J1M7N(;C4+21$>XLXEN1L! FB.
M>,9.&RI'7T/M2YT%C;HJ.":.YMXYXFW1R*'4^H(R*DJQ!1110 4444 %%%%
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MMS%//=1RQ>;<S"2>-E)1E$80*#^ .<?A52T\.-830W-K)$DD<\LGD $1!9
M47TY4'/KGCGCH:*.1!<Y\>&BJK&+A?+-K<PN=O):9P[,/0 CI[TQ_#][/'<^
M==P"26V@A&R(X#1.S ]>AS71T4>SB%S"N="N+B\FNOM,:RF2":/"G :/.01G
MH<GZ>].71)1J<=_YD?F?:FN95P<',/E!1]!SGN:VZ*.2(7.<3PW,+>TC,T:R
MV_W+B/<LB?.6./4$'&T\=ZT]4L);Z2Q:.1$%M<K.=P)W8!&/;[W7VK0HH4$E
M8+G/CP]*RPI+-&46YN9GV@@D3;^!Z8WGGVJW8VFJVE@L$EY;221*L<3>20"H
M(R6&[K@=L#/K6K10H);!<P9-)E>SUS3E8*NH&1XY2,A1(@5L^X.3CT(]Z;<:
M#<SI>KY\2FYMX(?NGY?++'/OG=^E=!11[-!<Y^ZT"YEFGFBN8 YO!>1+)$67
M=Y8C96YY!&>G(S[5;M],GBU*WNWD@_=V\D3)''L&696R!V VX_&M6BCD07,.
MRT6XM)+%S-$QM1<9&"-WF-N_#%+I>BS:?)IQ>:-UL[$VAP""W*G=[?<Z>];=
M%"@D%S+339[/5+J\LI(BEV5::*4'AP-NY2/4 9&.W44ESIUW+JEC>I-$6MHY
M4(92-Q?;TQT V^]:M%/E0KF2VE3_ &RVU!98A=P*\>U5Q&T3$'9ZC&T'/KGC
MGADNG2QC4;TXEOKN(0HJCY4 !VKGTRQ)/Z<5LT4<B'<KV%J+'3K:S5MRP1)$
M#Z[0!_2K%%%4E804444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ebs-brginterimmanagement003.jpg
<TEXT>
begin 644 ebs-brginterimmanagement003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+\1:P=!T&
MZU,6_P!H, 4B+?LW$L%ZX..OI6I6#XTL+O4_"-_9V,!GN9%39&&52V'4XRQ
MZ ]30!'#XAO[?5+.QUK1UL1>L8[>>&Z$\9D"EMC?*I4D!B."#BM&UU[2+V_D
ML;74K2:[CSNACE!88X/'L>OI6#=P:QXFU'3%N-)FTFSLK@W3R3SQ/([A&5%4
M1LP R^221TQWK+M=!UBXTOP]HC:8U@^D9$NH>9&4?$+QYCVMN.\L&.X#'.<F
M@#KH_$VA3-<B/6+%C;*7FQ.OR*#@D\] >":76M>LM$T^]N9W#O:VYN&@1AO*
M9P#@] 3QD\5Q\^C:QJ'@]=!'AZ&VN+72I+474TD9#2;%4"$J20K%<DL%[=^E
MZ6'Q!J.KW^IP:*MH6TQ+:*'4)(W$KB0LRL$9L J2 ?Q([4 :MIKNK>>(]2T6
M.WCD@>:*XM[OSHAM .V1MB["0>#R#@\U9;Q/I%M;V;ZAJ5C:2W,"S+&]RI&"
M.H/&5SP#T-<G9Z!=?VCYFD^';G0+?[/.MW ]S'Y5PS(0BI&CLH(8@[L+P,=Z
MR[I;GP_X?UVTN+*&ZDET2WCG'VB(?92MN4*R!FR5R"5*ALDD>] 'H=QXGT*T
MG2"XUBQBE?;M1YU!.X COW!'YBCQ'K#Z#HKW\=J+F02Q1)$9/+#-)(L8RV#C
MEL].U<F_AO4)_#WBJ-;(&?4=-AAM@64&1EM]N.3QAO7%;GC;2[K5O"$ME;6C
M7<QFMG:W5U4R*DR,X!8@?=4]Q0!;M=3U5#--K.FV>G64,32/<+?^8%QZ@HN!
MC)SGM4T'B70[D3F#5[*00,JRE9U.PL=JYY[G@>]<E)HIET+7++3?!MWIMS=Z
M=/"DLMS RNQ4A4^65L9..<8]ZU+[PPVHZJ(I8 EA)HCV+NI V.70J .O !(/
M08H Z&ZU73[+SOM5[;P>1&LLOF2!=B$D!CGH"00/4BJ$WB>Q*:;+8R17L-[>
MBS\R*4$1ML9B3UY&W&..M<E)X9\0WVA+J%_&PUHZA!<SPV\J;FBA78JHS93.
M<R 'C+8XJ>V\.ZG-=PWOV6^C9]6BGD:\N(FE\M('3S"$PH.6 P"20!G% '86
M^OZ1=W\EC;ZG:2W<>=\*2J6&.O'MW]*2P\0Z-JD_D6&J6=U+L\S9#,K$KZC!
MY'(_.N1T[1M6%AX;TF;26M?[$DWS7QDC*2A8W3]WABQ+ELG<!CG.369H.EZE
MXA\(>%[:#3GTV.TT]S]M9TVR>9;-&NP*2W)<.<@8*]Z /0[#7=)U2XE@L-2M
M;F:(9=(90Q SC/';/&:S]:\3KH]U?0&T,OV72I=2R)-NX(<;.G&?7]*P?#&A
M:E#JFD/>V>I1#3;5XB]S<P&)255=L2QC<RG&?FVXP.,U=\4:'J.HZAJLMK;^
M8D_AZXLHSO4;IF.57D\9]>GO0!9B\4:C!)8/J^B+:6=](D4=S!=B8([_ ' X
MVJ0"<#(SR1716]U;W8D-O/'*(I&B?8P.UUX*GT(]*Y"6#6]?M-+TN?0YM-M;
M>>WFN9[F>)MPB8.%18V8Y+*.3C S766TLKI.9+-X"LKA5+*3(!T<8/&??GUH
M R&\50KXQ70#;MM*!?M6[Y1.5+B+&.OE@MG-5[GQ>]O/?3KII?2;"Y%M<WAF
M 97^4,5CQ\RJ6&3D'@X!Q6"W@S7)= DU$ZC=)K;W1U5;#,)A%P#E8]^W=C:
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M7"R;0'7K_'D5HVNGZI8^&[;2]0T#^T],D$P>R25'EMU\S=#&2[!655PI(/!
MQD<T 7[_ ,=6=GX5LM;2SNIOMD0EBMU0Y XR789"@;ASW[9S755QDFA:L?A>
M='D7SM0\K:L?FAMH\S*IO/7:N%SWVUV= !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %4[G2M.O;F*YNK"UGN(?]7++"K,GT)&15RB@ HHHH **** "
MBBB@ ZC!ID,,5O"D,,:1Q(H5$10%4#H !T%/HH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BD9U7[S ?4TM !1110 44UG5%W,P4>I.*C^U6__
M #\1?]]B@":BH?M5O_S\1?\ ?8J1)8Y!E'5A_LG- #J*,BFLZHNYV"KZDX%
M#J*A^U6__/Q%_P!]BE^U6_\ SWB_[[% $M%-61'&4=6'J#FG9H ***,CUH *
M*IOJVG1R>6^H6JO_ '3,H/Y9JTDB2*&1U93T*G(H =1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M04445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1SF402&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"ZMYF@F6+[A9>Z^Q!!_&M6H;6UCM(?+CR<L69F.2S$Y)/O4U !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7G7Q7\4ZAHMMI&CZ3.;:]U
MFY\@7(ZQ("H)'H<NO/UKT6N/^(/@D^,M,M?LURMKJ=A+YUI,PRH/&5/L<#GV
M% %BY\#V T*:RL)KNUO&B*K?+<OYK-CJ[9RP)Z@\>F.*Y?\ MBZ\5_&:Y\.3
M321Z/I%L9GMT<J+B3Y!E\=0#)TZ?+[UV5K=^);BWCAN-+M+2XP!+/]I\R,>I
M10 3[ X^I[XM[X0O-/\ B&OC'11%*UQ"8+^SD?89%P &1L8S\J\' ..O- &-
MKNK3^"_BGH-I8R2#2M: AFLBQ*))NVAT!^[]Y<@<'!K'\47=YX,^(EKXDBN;
M@:*]_P#8KNW\QC%&#$AR%S@<,S?5/>NPF\)7OB'Q]8^)-82.VM-,CQ9V:OO=
MI,D[W(X&#C !/0<U+KGA:Y\3^'O$6EWMO% ;V;S[23S-VUE1 I;CCE.<9X-
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M&@36UK8R7.Q+V\\[>@52"QC4#))(Z-MP#UH Y_6HM3^(/@OP_JFE74NGZQ/
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M_9PDSJL&U>"H!QG.3GZ5D^,_!WB?Q1X;T6T(M&O[:Z-W=.TY"9)8[$X)(&[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0HL$02$YB4(,1\$?+Z<$CCL:9+86<UU'=2VD$EQ']R5XP77Z'J* /+-38?\
M"M?'YR/^0S<_^C(Z]8EBCGA>*5%DC<896&01[BJG]BZ5Y,D/]F67E2-O=/(7
M:[>I&.35R.-(HUCC1411A548 'L* /(=,O+0>"_AR9+B'[2FI1*Y9QO48E#
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MR6*6+Z?:-:(<I 85,:GV7&!0!SO@J.:VO?$=E&2=*M]1*60SP@**71?15<D
M= <CM3/"K./&/C4SY\T7D'_?OR5V?U_6NMA@BMH5A@B2*)!A410J@>P%4FTL
M1ZV=4MF"2RQK#<H1Q*JDE3[,NYL'N"0>Q !YIIE]I_\ :_@S4+&>&*"YNKK+
MRRAKF5&CD.9F&.K ?+@X('.:ZM=X^,L@CSY1T!3-CIN\\[,^^-]=&FC:7$0T
M6FV:,)?/!6!1^\_O]/O<]>M-T_2UM;R\OY2'O;PKYC@<*JC"HOL,D^Y8GC.
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MY-,T^.WFMTL;989L^;&L2A9,]=PQ@_C3K.QL].MA;V-K!:P Y$4$810?H.*
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M'AC,B>8=KD/&.<'M_,9ZBJ6M76G9FO+*6**2W\20Q--<R W&Y9$1U3H4B"Y
M!SD$],UZDFE:='<)<)86JS1J%200J&4>@.,@4V31M+EDGDDTVS=YR#,S0*3(
M0<C<<<X(&,T ><7316.I?$6ZTJ*W74EABDM&B5?,^:V#,R8YR?F/'4UM>'8-
M"NM<T[5](UBV=Y;5D-M91J@E3&=TP!)RIQR><G'>NT%G:K=M=BVA%RR;#,$&
M\KZ;NN/:HK/2M.TYY7L;"UM7F.Z5H(50N?4X'/XT <QXCO(_^$[\.Z=J.P:7
M<13LJR_ZN6X&W8K9X. 6(![GU KD%O;;1].\0):R10Z:OBE5N]@W)%;E(\DJ
M#]S=@$=,9'3BO6+W3[+4K?[/?VD%U#D-Y<\8=<CO@C%)'IEA##+#%8VR13<2
MHL2A7XQ\PQSQQS0!YAXGTK2(_!OBV>PO[:]CFMXIV@MD3[/ X. Z@$A689)Q
MZ9K7UMM"FUA=/@%E^[TF60+,5^RQQL^"R(/O2%E()!&!]<5V]OI6G6EDUE;6
M%K#:/D-!'"JQG/7*@8YI/[)TW=;-_9]INM1BW/DKF(>B\?+^% 'F^D3K=VOP
MPN6G\Z?YHY'+[CD6K\'WZ>]+JM]/I_\ PG]U SJL>H67GM&"66'RX1(<#G[F
M[\,UZ,NC:6BP*NFV8%O_ *D"!?W?.?EXXY]*DBTZQ@DFDBL[>.2;_6LD2@R?
M[QQS^- 'FVL&VTS1]?UOPOJ\,US)I8W0::BK$@##]\0I.'"EL'N%/I5V6/08
M?'7@FXTDVBQSV]T%>(@&1?+7:3ZGKR><YKNK+2]/TV%XK"QMK6-SN=((50,?
M4@#FHK;0M(LI%DM=*L8'1BRM%;HI!/4@@=3@4 :%%%% !1110 4444 %%%%
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MM?L[_N0(&0YX_O$?SI+Q-5MKOQ;<VFD7$XN=0M)(]UKO+1*D:O)&K##.I4D
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M?[7:;X]3^W^;M;!_?>=MQ]3C.:ZW2M3M-9TJVU*QD\RUN8Q)&V,<'U'8U<H
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M)]!3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG-;U.5?%&B:
M&LS6\5^EQ+)(APS^6%PBGMG=DD<X7WKHZR==\.:=XB@ACODD#V\GFP3P2M'+
M"WJK+R* .?NKW4])O=&T"?5C<'4-1FC:["!9(H50R+$3_?/RC=UQSUYK,U[6
M-9TF/Q?IL&HW&VQTY+^SN2%:2+=N!C8D'(RI()YQWKKY?"NE3:5#I\D<K)#*
M+B.8S,9EE'23S"=V[W)Z<=.*)_"^FW6GWUG<B:5;\!;N5I#YDP P 6'08[#
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MB\TEK6WTN.9X89YXFE:Y*G#. &4*N00.23CM6EI]_=BWO'UF.WM#;SE ZO\
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MOY[96MU(1DC?:",D]>O6N-T+68+'5?"-SJUU''ILGAV.*VN9G C6Z^7S 6/
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MAO;_ $= =N._##CO3HKC2?$5M)J7AO4KRYUR'2IX((U5(_LV4.$D"HN"'"@
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MW[E8+E0P!QW/.":U'FTKPW/X=U"WEN7\,?;[J26YF&8TED0;)   !'N,@!P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVUV+>6_.G+<[5V>>"1C&[=C((SC&?;FLFRU*+2/%WC:ZO+B8V=K#:3$/(SA
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M+A1N(QG'-.HH 0@$8(!'O1@>@I:* # ]*:$13D*H.<Y IU%  1D8-&!Z444
M)@>@I<#THHH 14500J@ G)P.IK(UG2;[5)(8H=5-I8%62[MT@5FG4XX#GE.,
MC(]:V** $50BA5 "@8 '84%58@E02.1D=*6B@!I12FPJ"N,;2.*4JK*5(!4\
M8(XI:* $P, 8&!2%%+!BHW#H<<BG44 &!Z4T(JDE5 +')P.M.HH 3 ]!2;%W
M!MHW#@''(IU%  0",$9%)@>@I:* $P/04FQ-Q;:NX\DXYIU% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5SGB2WUB?4])-G;?:],5I!>VPG$18
MD#RR2?O(#NRO?(X/2NCHH \HET[4] T'PU9W>GQK+%XGWQ10S*?,5S.XQT X
M;C./?%7?&NE7#:)XP\07,!MO/TM+2&%F4MM0LQ9MI(R2V ,GA?? [O4=&L=6
M>V>]B>1K6430XE=-CCHPVD<\G\ZDU/2[/6-/EL+^(S6LHQ)'O90P]#@CCVH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 'KE16US#>6T=S;2+)#*NY'7HP]17G]]ICZ5XPFT^VNKV?3]2TBXENX)[EY
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MX)P.&(P,#':LG1;+5-6M?"\P>_6Y221]6N5N'2.X3#8(=2!("VTKMR /0<4
M>EU5-Q=?VJMN+(FT,!<W?F# ?< $V]>F3GIQ4Z2QR%Q'(KE&VMM.=I]#[URD
MF\_%86YGG-O+H<CM#YS; WG(NX+G ..,C% %^+Q%/=WQ6PTQ[JRCO6LIYTE
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MF6673K.:!K4R.7,9DCW/&">< X('8-5&[TQ=5^)E]87%[J"VG]E07 BAO)$
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M=2\A673]-@N40#@'RW9L>A;:,UJ^#M(M]6\+6&L:S#%J&HZA$+F6:=0Y3?\
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MH?M"8D52 V_^YC<#WZ^O%1VWCBWN=-T^9K=;:ZO+N6R\FYG")'+'NW*7 /\
M<(&!SD5-+I&J2^,=-UCR[006UC+;2)Y[;MSE#D?)@@;/;K659>%=2CT>;3=2
MT_2[^TN+^YN9[=YF(*R,74J2G#J3CM]: .QT^XFNK-9;BU:VEW,K1%MV-K$9
MSW!QD>QK N_&2V^FWFKPV+7&DV4[0SSI)\_R-M=T3'S*ISGD'Y3@'C-[PKH]
MQH6@0Z?<7#3&-Y#&#(7\N,L2D>X\MM4@9/I6!%X3U6UT'6?#4#VS:;?R3&&Y
M:0B2".8DNI3;\Q&6P<\YYQ0 FJSRZO\ $#3M-DM+:\TJ32YIUCDERD@9XE\P
MC:>0"0!Z,>1FK_B>[G\(>$+=-%MTV12P6J"65B8T9U3@D$D\XYZ=><8+TT"]
MMO&6G:A;1VW]FV>FM8!6F;S,%D(.-N. F.O>K?C#1[K7?#LEG9-"MR)H9H_.
M)"$QR*^"0"1G;C.#0!ST\MW:?%&2>UTQ9[V705+0I,%4MYYY+D#L ,XSTX]+
M;^)M-UBS\*:A+I,DJZA> 6[.RC[+,%<$GG)(VN.F*N1:3K'_  FO]N2Q67E'
M3!:%$G;<'\POW3[O.,]>^.U8UAX0UNUT+PO8.+ R:3J#74S"=\.I\SA?DZ_O
M.^.GO0!T-KXE-_J$\%G:I-%;7AM+@B?][$PZLT>/NYZ'//7&*WR0!DG KB[O
MPI=WWB*UU9K>TM+ZVOO,_M"VE8/-;!B1$Z[1N)7"G).,9SVK?\0VVH7ND2V>
MG"'?/B.1I96CQ&3\^TA3\Q7('H3GM0!R6GZO?6OCZUO[N9CI7B2%HK1#TA:(
MDQ?3S$);ZG':NLOM;^SZW;:/;0">^G@DN KR;$6-" 26P>26   ]:Q/%7@J'
M4="6/0M/TVQU:&:*>VN @C$3HP.<JI)Z$8QWJEKS:G>^)]+BM(]+_M>TLGEG
MA:\DA91(P4;) N64[&X*\<$\XH M1?$$3:9IE['H=X5O[XV**9(\B0;@>C>J
M,.<=,\5:E\82P1&&;3X;?4XK?[1/9W%\B; 68*JN 0S-L) Z#C)&161#IFI:
MG8Z1:VFF:=8C1-66:1$O6DC<!&SM?9DL3(<[NX.2<UJZGI'B"S\5/K?A]K&9
M+NW2"\M;QV090L4=64'G#$$8_P#K #T\;V=W:64EFD8GNK7[4(KV<6^Q<[<,
M2#\VX$  $?*>1QF"U\>I?'1%M-(NW?5DF,:NZIY;Q#YE.3Z]^F.1GI2:AHGB
M2VUNSUW2KBQN;TVOV2^M[DM%'(N\NI0J"5*EB!G/'O4]QHNM7/B'P[J4[V<G
MV 7!N<.R\RK@!!M.0N.I()H IR>/YX=&OM2DT&=8],N6M]0 N$/E%2,E/[_#
M ]!UK3UCQ;!IL]W!;QP7$]I"LTT<ER(B002%3(.YL#..!R.>:Q+KPEK5QX7\
M5Z8!8K-K%[)<0MY[[45P@PWR=1L[>M79](\3:=XDFU;1O[.ECU"&)+RUNI74
M1R(-H=&53D8X(('3\@"9/&IO-0LK/3M(N;A[W3C?PM)(L0QN4;6SRN-W/TX!
MJC=>-+Z[T?P]?:;8I'_:.I"SGCGEPT;*SAD& 0<F-AN].W/&D-%U9?&5EK#O
M:SQ0Z:]I(Q<H[R,ZON"[2 ORXQGO[5CP>$-;@\.Z5:C[ ;S3]9;40IG?RY$9
MY&*[MF0<2>AZ4 =\A8HI< -CD YP?K22)YD3IDKN!&1VJG:G5/[0N5NTM!9!
M(_(>)F\QGP=^X'@#.,8J]0!YQK'A[2[#QWX+TZ"S06TR7BS(W/F[(E*E\_>(
M//-2ZIIL&@>.O"RZ99-*S1Z@4B#@=0AQN/1068^V3@=JV]:T74[[QIX>U>V6
MU^RZ8+CS!),RN_FH%X 4CC'KS4VJZ1J%WXPT+58%MS:Z>EPLH>4AV\P*!M 4
MCC;Z]Z *]KXVMI=(6YN+<6MV;Z33C;2S*%6="VX%^FT!2V<=.Q.!5WP_XDCU
MR?4+8P"*XL9%23RY/-B<,,JR. -P//8$$$&N:/@[7ELKB>VGL8-4BUN75K,E
MV>-@^08Y/E!&58C(S77Z/_;#PO-K(M8IGP%@M6+H@&>=S $DY],# ]R0#F]=
M>ZOOB'IFDSV5O<Z<UC<2F&:3Y7.Z-2Q7:1D!F 'N>14D/B6ST/PU]LL-.D?P
M[I\AMC.)RTBHC;&=5.2R*P(SNS@$@8Q6A=Z3J4OCNQUF-+4V5O9RVS!I6$A+
MLC9 VXXV>O>L:+PAJEOX9U/PI&]LVEW4LODW1D(DAAE8LRE-N"PW-@YP<C.,
M4 :;>+;J;7KS2M/T*XNVM?L[O*L\:J8Y<_.,GL!G'4\].])_B!(FE2ZHVA7
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M)*% 948LH/L2!_*@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;<XR,]<YZDBL_2O%>J7&A>'X+BZS?:KJ=S:O=>6HV1QR2]!C;N(15&0>N>:
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M\J[1P.I)YI(-1U2\UV+P]<:@EO=0:8MU<W%HBGS96<I\H<$!05)/&<D=,$$
MZVBN+&IZX=1LO#UQ=![]=/:YN;FP$:F1O,V#:) 0 .2>.I'0<&F]_P"+HK[P
MQI=[J%O;W=Z]U#=/%"D@8)&61_0-C!QTSZCB@#OV8*I9B H&23T%+7DVNZCK
MG_"/>)='U#5)99]*O[)4O(HTC,\,SIA7 &,@,<XQGC/&<]'XFU'5-.&I):ZO
M*SV>F&XBCABC:7S!O)>;*; F%  &"<-@'% '3'6K)=?31"TGVU[=K@*8V"E
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M/J98N8#YY(!3  W$;0V2!WKK_% %OX[\!Z=*6_LM9)R YR&F2+$6?<$\>YH
MZD^)=.1H!,+JW^T2+%$9[26,.['"C+*,$D]#@UKUS7C/69=&M--9;&"[2ZU"
M"VVRR%-CL^4?@'.& -=(,X&<9[XH &(52QS@#/ S6#'XST.:*ZECGNFBM)6A
MN'%C/MB=?O!CLP,=_2M^O-O"SZZ+;QD-&M["27^WKSRS=2LOS_+V"G(Z=Q0!
MV=_XFT?3=*AU2YO,V,VWRYX8WE5MW"\H#U)&*?9>(=,O]0?3X;AUO5C\TV\\
M+PR%.FX*X!(]Q7E;26?_  H2U@L#,?LMY##(MP K"47*EQQD 9/&,\8KJ-.$
MNM_%&2XU54L;[1;=DMK.-B_GQR\&;>0-R]1MQP>IH Z^]UJQL+N.TED=[N12
MZV\,;2R%>FXJH)"YXR<"BQUFRU"[GM('D%S JO+%+$\;*&R <,!P=IY]JY3P
M',USXJ\;2W?_ !_IJ8BPW46ZK^Z_#&36K9ZS-<?$"_TA[&W7[+9I+]J60EW1
MV.%VX[$'O_.@#IJSWUJRCUZ'16:07LL+3JOEMM**0"=V,'DC@5B^+=:O-$N;
M2=UO8]',<GVJZL8EE>!\KL9U()V8WY(!YQ^.-(9]3\8^%WMM65I)M$G+7T$:
MG?S#ET!&T9//(('I0!Z'6?K6M66@:<U]?M(L"LJ$I&S\L0!G XY(&3Q7):7K
MVJW?AW3_ +3J:+<#4Y[.>5(@9[E8VD4"- I7<=JD\8 #'BLO5]5O=5^%VO?;
MW9YK351:!G50Y5+F,+NV_+NP<'''% 'H(UJR/B#^Q-TGV[[,;K:8V"^6&"Y#
M$8/+#I1J&M66EW=A:W32++?3>1!MC8J7P3@MC X!ZFL*3_DKUO\ ]@&7_P!'
MQU'X[65[SPHL,@CD.M(%<KNV_N9><=Z .QHK@XM9U>V@\3V$VLQ&;3;R".&^
MNHE#>7*L;$;47#/\S!<+R2.*DL-0UW4KKQ5I5M>W$-Q9I"]A+<PQ>8IDC)PX
M P5RO< @'UH [BBN/T3Q%/K&EZ7>I<3#R;-[C48]B;BZY3RS\O!WK)TQ]SWJ
M'1]0\2ZI%H6LP2 V=XJR7D,S1",1NN1Y94;]RD@8)YYSS0!VU%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !67JNA0:M>Z?=37%Q%)83>="(BH&_!7
M)RISP2/QK4HSB@#GM6\'V6JZQ'JR7FH:??"/R9);&?RC-'G(5^#D#UZ^]6)/
M#%@VIZ?J$3W$$UC";=!%*0'C)!VOW(RH/7/KFM@$$9!!'M0&##(((]J .:T_
MP/INEZB]S:W6H);-,9QI_P!H/V99"<[@F/7G&<9[<"EE\$V$^D:IIDEW>FWU
M.Y-U<?.FXN2"<';P"5''M72$@ DG '<UB>*]<N/#^A_VC;V\5P!/#$P>0K@2
M2*F1@'/WAQQ0!(?#MO\ V\-9%S=K=FV6WD*R +*JDE2PQ@D%C[<]*IQ^"-,3
M0XM*\Z[,<%R;NWF+J)8)2Q;<K!?5FZ@CDCI70R,_E.80CR ':K-@$^A(!Q^5
M<]H.NZEK_A;2-7M[2U22[D!N(Y)6 CBW$,5..6X& < ^U $]QX5L[RRU*"YN
M+J674HA!<W)*"1HP" @PH51\S=!W)ZT]?#5N-2TN_-W=M-IL+00 E,%6 #;O
MEYSM7\JV2P! ) )Z#UH+*OWB!DXY- &3K'AZVUB\L+R2XNK:ZL6=H9K:0*P#
M##*<@@@@#\JY+Q%X6CTNQTRTTL:I*LFO17TK)OF,"[F9V!P< %L\Y)[YKNIM
M1M;>_M;&24"YN0QBC[D*,L?H./S%%H]\UQ=B[CMTB60"V,3EF9-HY<$<'.>G
M:@#F/%6AA/"7B*2!;N_U/4+)H YCWR, I"(%10  6)Z=22:TM'T2+RM-OKB>
M\GN+:V\N 72A3!N4!L+M!W8&,MDX^ISO!@V<$'!QQ1N!. 1GZT <T_@C3Y-!
MO-&:[O3:WER;J7YTW%R^\X.W@%@#4FH^#K/4-7CU5;[4;.^$0AFFLY_*-P@Z
M!\#!^HP??I6QJ.HVNDZ?-?7LHB@B7+,?T ]23P!ZFK)8*,L0!ZF@#G+KP3I=
MS=W$RRWENES9K9SP03;4EC4$+GC.0">A^N:DB\'V$+Z1(ES?"32XF@BD\_YI
M(SMRKG'(^5>F.E=!2%@.I'7% '/GP9I<ECJUG<-<7$&J3FXN%D<#$G'S*5 *
MD;5Q]*LP>'XHYC<37MW=7?V<VR7,Q3?&A()"X4#)(!)().!6N6 ZD#ZT;@"
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M_@NPO=<DU>*\U&QN)U5+D65R8EN0O W@#J!QD8..]=$2 ,D@ =S2]: .7OO
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MUEZ/X(T[1+OS+2ZU#[(KF2&PDN2UO"Q.<JF/4D@$D \]:Z6B@ HHHH ****
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M/N,FDU">?3=(\>O8;T1-7A\\Q$[DA*0^:1CG[I;Z<UZ>--L5CMXULK8);G=
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M+&UFABQY<<D*LJ8X& 1@4 <]\/A<)H-W#([R6D.HW,5@[G)-LLA"<GJ."![
M5QLNA:/>Z!X^GND N;+4KF2UD#G= XBC*%.>"6 ''7 %>N(BQHJ(H55&%4#
M ]*YGP_X8:PU#5KO4K6PFEN]0:\@D4;WB!50%RRC&-N<CUH YNUT2VUGQS;V
MNOVJSSR>&K>2ZB<D;IA*06(!Z@BJ[B+4O!'BZZU !=>LKNY*R])H9%.;<(>H
M&-@7'7)]37IGV"S^V?;/LD'VK&/.\L;_ /OKK39--L);U;R2RMGNDQMG:)2X
MQTPV,T <+J8F\-ZWH7BFXL@]Q>6HT_4$C0;C.RAHR,=RX*9_VAZ5+J^DV^D:
MGX(B5(EG&I/YKQKM#NT,C.<>[<_E7>R1QRJ%D17 8, PS@@Y!^H(!J&>QM+J
M2.2XM8)GC.4:2,,5^A/2@#R?5I['5/ WCJ35A =8M[JX0B;'F1*I_<A<\A=N
M,8X))]36E=W6F:GXCO=+UO4+.WM9M,@-BUTJ,CQD,)#&S' 8-C..>!Z5Z#/H
M^F75R;FXTZTFG9-AED@5F*^F2,X]J==:7I]ZL2W=A:W"PG,0EA5PA_V<CC\*
M *.F&'3_  C"3=W5U;V]ID7,G^MD15X;W) R/6O/]#N-/3Q)X,DM9K2*WN["
MY0H)0TSJ50KY[C&YR<G&.&W<FO6:IQ:1IL(01:?:1A&9D"0J-I888CC@D=?6
M@#R:WT^QM_!%GJD4*+>V_B/9#<9R\:F]*E5/92I.0.#WKHM5MV\,>+KM;"T7
MRO$T(AC*Q@B*['&6']THQ<_]<V]:[7^Q=*\GRO[,L_+W;MGD+C/KC'6J5IIN
MJ2:RUUJEQ9O:6TCFPAMHF4J&& SDDY8*2HP /F/M@ T;'3K73],@TZWA5;6&
M,1+'CC:!CGU]Z\IGTRP_X5UX_D@L;82Q:A>JCI$NY%4J0 0. .OM7KY (((R
M#U!JM!IMA;+(L%E;1"0$.(XE7<#ZX'- '%M<Z9=_$W2/+GMI1/HTZ.4<'?EH
MB 2.O&>/2N2&@Z2WP,FU<V<4E^+61/M#?,P47!.!GIC'\_4UZ]#H^F6Z*D&G
M6D2HK(JI JA5;J!@=#W%21:?906SVT-G;QV[Y#Q)$H5L]<@#!H XK4+'2;[Q
M[X<M(X+673SI][B&,#RF^>+(*C@C.>.F:YZTODTWP_I=O/.MOH<7B"\M9GD7
M?%$@:7RE8'C8&QUX&!Z5ZH-*TX/&XL+4/$NR-A"N47T'' H72M.6VEMEL+46
M\O\ K(A"NU_J,8- 'F6M:5I-OHQ^P:D+NWEUZRD/D%5A@=I%#K&5X&1@D \9
MSWKTS3-*L=&M/LFG6R6UOO:3RTZ;F.2?SI#H^F&UBM3IUI]FBYCA\A=B?08P
M*N*H50J@  8 ':@#R[5=-@LM+OO''@S5_P"SY5#SWEDS![:Y=?O(R?PR$Y''
M?TSFK%_?VNJ>*)K'Q)-;:?%=:5!):Q7L:E!NW^<%+8 <$J#WP!Z5WAT32C<I
M<'3+(SQXV2FW7<N.F#C(J2\TVQU%46^LK>Z$;;D$\2OM/J,C@T ><0:!I-[X
MNT/3;J234[-]!G3S+EN;A5EC"EL8SQR#[ U=O+)?#7C&ZL["T1+?Q):B*'9&
M"(KA/E;(_N^6V\YZ[#ZUWC6%F]TMTUI ;E1A9C&-X^AQFIFCC=T=D5F0Y0D9
M*G&,CTX)'XT <1?6-MIGQ#\+P6$,<033KR-$' PHCVC]3^M9_A&;0=8T?0KN
M\N /$<%R?/57"W+7&6617'WBO))'0*!V%>@O8VDMTEU):P/<)]R5HP77Z'J*
M2/3K&&]DO8K*W2[D&'G6)0[#T+8R: /,M'_LW7+:"74=82T\06>ILTL2(BW?
MG"1@$!/S,A4@8Z;>.W%^+S=,\4VT\]O::IIMUK$R6]_#\MS:SL74QR#^-!\R
MY!X 'H*[W^S;#[?]O^Q6WVW&W[1Y2^9CTW8SBB/3+"&Z:ZBL;9+AB29EB4.2
M>ISC/- ',_$^.-O US(X&Z.YM2A/8F>,']"14&K6%A-\6-%,UI;2.^GW+L7C
M4EF5HMI.1R0,X/:NQN;.UO8Q'=6T,\8.0LJ!AGUP:C.F6#7"3M8VQF0 )(8E
MW*!TP<9% '+_ !/@MY?!_F7$43K%>VC;I%!" SH">>G!(/L:IR:9I&I_$Q;1
M[:UN+ : -L  ,1'GD?='! _G7=3P0W4#P7$22Q.,-'(H96'N#UJ#^R]/\WS?
ML%KYFS9O\E<[<8QG'3'&* /*-#U-(]'\&6^JWD4.E36UW$LMTH>(S+(!&K;N
M!A P7/O7H7@ZQLM.T:2VTZ_>]LQ<R&*3C8@)R4C(XV*<@>G([5IMH^F/9&R;
M3K1K1CN,!@4H3Z[<8S5J**.")(H8TCC0;51!@*/0 =* .$\"L-'\1^*M$OW$
M=]/JDNH0!S@SPR ;67^]C!!QT-7O'^JO#X6O#9R.4AG@6]>+.4A,@\P9'?;G
M/< YKIK[3-/U-%2_L;:[5#E5GB60 ^V14L5M!!;BWB@CC@ VB)$ 4#TQTH X
M75+"W@\96::3%"EC>:5<G4(H !&T:A?*<@<9R2 >I&>PKGM/TNP'AOX<WBP*
MMU<SQ6\TZDAY(V@DW(6ZE>!QTKU2#2M.M;>2"WT^UAAD^_''"JJWU &#2?V/
MIFR-/[.M-L1S&OD+A#ZCCB@#RKQ#9VEEH?Q(T^TAC@L[:2UEA@B&U(F:)"Q4
M#@9-;FH:;8:!XXT^_P!)62&&?3KN75/L[%FDB504D//+[CPQY-=#XK\,#6/#
M>I:?IMO96]W?*$>=EV<;@2254D]*VK&PMK.(^596MM)(!YH@0 $_7 S^(H \
MST*?3X_%'A VTMG%;WFESH8TD#2NI$103.,;W))/0<[NO6J-CI]E;^"-"U2*
M)%O8O$0CCN,Y=$-XZE0>RE2<CH<YKUF+2--@6-8M.M(Q&6*!(5&TMPQ''&>_
MK3?[%TKRA%_9EGY8;<$\A< ^N,=: .+U:!_"_B^Y:PM$,?B6'R(R(\B*\7@%
MO]EE8L?]P^M=SIUA;Z5IUO86D8CM[>,1HH] /YUFVVFZI+K37.IW%F]G;2.U
MA#;Q,K+N&T-(23E@I8#  ^8^V-N@#QC2=&LQ\._">K:=&%\0?:H$@FC<^8_[
MTAT//W F\D=  :T6_LW6WURUUG6([#5K75)"F$472*KY@,)/)!7:  .<GUKT
MR#3+"VNI+J"QMHKB3.^6.)5=L^I R:)--L);Z.^DLK9[N,82=HE,BCV;&10!
MP FT/5;_ ,5:=XHN8X+V*\'DM(X25+<*AB,)ZCD$_+_$?>K=G'9ZSXC\6V7B
M")"84B\A;C&8[4Q9W(3T^;<2P[@>@KM9M.L;B\BNYK*WDN8?]7,\2ET^C$9'
MX4EUIMA>RQR7=E;7$D?W&EB5ROT)'% 'F.D6TNI7GP^.NQF:ZN-/O!.)LYE0
M*FS>#U^4@D'KDYJA?:7I]O\ #_Q;<Q6\:RZ7K$RV#][0+*A C_N<D],5Z_+8
M6<URES+:023Q_<E:,%E^AZBHO[&TORGB_LVS\MVW.GD+ACZD8Y- ' ZL^FZI
MXH\2Z/XAU*ULAY<7V1KE4!$!C&7B9CP1)O.1SD#TJ+7HIK.WN-140Z[I]OIL
M$>H6UY\EW$BJ6$T;$8#$$L00.5XYKT2;2=.N6@:?3[64V_\ J2\*MY7^[D<?
MA3IM,T^XN1<S6-M+.N,2O$K,,=.2,T 9_B>^M;;P;J=Y=FZ2V%F[/]G.V8*5
M_A/9N>O:N3\-S6MM\1U@@FT^*.;0T(@LW!7<LGR@G^-@I/.!P>E>B.B2QM'(
MJNC AE89!![$57@TVPM6C:WLK:$Q*4C,<2KL4G) P.!GM0!R_BB\CC\:^&K+
M42BZ5<"<D2_ZN2X 7RU;/'0L0#WQW KCGO;/28O$"6LL,.F#Q-$+SRP&2.!H
MDR2H_@W[01TQD>U>N7EE::A;FWO;6&YA)R8YHPZD_0\4V/3K&*&6&.SMTBE&
M)$6)0'&,<C'/'% 'F'B.QTJV\'^*KC2]5CNHKD6LDT5KL%O$PD497;P&8#)Y
M[ ]Q6S+H%A8_$"S32+9!;WFG7!U6%?FCD7Y?*9P<@L6+<GDX/O7;6^G6-I9F
MTMK.WAMCG,,<2JASU^4#%+9V%GI\9CLK2"VC)R5AC" GZ 4 >3:!<6EOX2\!
MPA;<:;<7 34]@&&DV.(A+CL7QU[@5;\360M8_'UK:HJZ2NEI.8EX2*Z*MG:!
MP"5"L0/4'O7I@TVQ%K):BRMOLTI)DA\I=CD]21C!S2#2]/6S^QBQMA:YSY(A
M79G_ '<8H I>'='T[3+!9K&W6-[N..2=P23*P4#<2>I]^]>?ZLUC;:7\3;24
MV\3;O,BA; .3;*0RCUSDY'?->JPPQ6\2Q0QI'&HPJ(H  ]@*KS:5IUS</<3V
M%K+,\9B:1X59F0]5)(R1[4 <%9:;I>L>/;:.Y@@N[>;PW$[QL=R2'S<9(Z'I
MW]!Z5E:!J*C2_ -GJ4@.DS&[1C,<QM*A*PHQ/' S@'N!Z"O4O[+T_P [S?L-
MKYFW9O\ )7.W&,9QTQQBFMH^F/9-9-IUH;1CN,!@783Z[<8H \LGO+72(_%P
ML7BBL4URU-V( &"6Y6+S#M'\.<@CTR*MZ]IVBCPOXMO-,U2&\6XTWS)(;0((
M(V4'8^%X#D?F![5Z9#I]E;QR1PV=O&DH D5(E < 8P0!SQQ]*CCT?2X;,V<6
MFV:6K-N,"P*$)]=N,9H J^']'T[2[$36-NL;W:1R3N"296V@;B3U/OWKS^2#
M3;;2?B<J0VL5V/M(0*JJX0VJ'COM)Y],UZI##%;Q+%#&D<:C"HB@ #V J"73
M;"=Y7ELK:1Y@!*SQ*2X'0-QSCWH X"VLH-+\4^$IM-@CCN;W2;D3L.MP5CB9
M=YZM@],U5\+#2=9M?#VH2:RD>N6\P\^&)$6ZDFQB6.7^(J3DG(Z#/&*](72]
M/22*1;"U5X1B)A"H*#_9../PI8]-L(;V2]BLK9+N08>=8E$C#W;&30!:HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNG#4(-#>U8S6%_\ ,+.;*[4B8\D8W9 )7CKR* .BU?Q+INB7=K:7C3^?=!S
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M;>W@DU*VLRA!&V//"KCH/EP?;BLDSZE8>._%$^FVEG)<KIMI+()9"B9'FD]
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MXBA1F"!I'"@L> .>YKC/#7B#7)_!=KJ5S%!<S7%W(C2[RJ0)YT@9WS_"H
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M.!L;.!P_<'I2:)IFLZ!8HNM:[;3Z;IL1\MT@,;LBJ1F5BQ!VKV '(R3754$
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ML%&0<X!&>E;2L616*E21G!ZBEH YKQ#X?U'5)=+U/3M0BLM8T\OL=HR\,BN
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MLD,Z#)BD1@RMCO@CIZ4^QUV&^U[4](6WGCGT]8FD:0+M<2;MI7!/]T]<5J4
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M#;$W,K3?NCU3YB>#W]<#.<"J6F>"=!TB">&RM98XYHS$0;F1MB'JJ$ME ?\
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M%IL.JWEK:7EK=&9(&522FS!!QD'YCSS[8/-8UAJ.HP0WFC7NLW<QM-<6TMY
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M_P!&OX+MG> 7>BW*@_:_E3:\##D-@CID97VKO;;5+.[U*]T^&1FN;+9YZ%&
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M@=21@>M '23:MIUO=K:SW]K'<,0JQ/*H8D]!@G.3VJU)+'#$TDKJD:C+,QP
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MD>)?$UOH][I>G?;+:WGOY]C22NH\F,(S%\$]RNT9XR>^,5@V]Q;V>I^,]/\
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MB6,HQ'VQ7SC YV@L0!QZ"@#V*BD5E=0RD,I&00<@BEH **** "BBB@ HHHH
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MQ6)"Y+,!EMK8'MVK./CK3'AT>:U@O+J/5F=+<Q1CAU5B48$@AOE(] >I YH
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M1D$X/8UZI5'4M'L=76!;Z%I5@E6:,"1EVN.0WRD<CMZ4 <CX@\)7_B>[U34
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MV\Z!X94*.IZ,I&"/RJ2B@#S>/P-K4>D:8XO4&L:=<"V@N ?NV0W18]SL8O\
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M&_C4Y\RT*[W&?8@ 'UD]Z[.L^ST+2]/U&[U"TL88KR\.Z>95^9S[F@"^
M, = *X74/ DVHWGB"V>55TJ^'VJU0'F.\9=K/^&T-]7/I7=T4 <?<Z9XCC\%
M0QVSJ^M2RQSWX27RS+E@9$1_X3M&P-Z 5@W_ (5UR:T\806VD6\$>L6\"VZ1
MW"_(RKM(;@?4GUZ9ZUZ=10!RWB&PU'49?#4UO8N?L5^EU<*9$!51&Z$#GDY?
M]*SO%.BZ_J]UKMJ+.&\L;K3O*L#)<!$MY2K!B4QRQ)&&[8QD<UW5% '%Z=I6
MKP^)=%U"XT_9%:Z.UG-LF1L2%D(QR,C"<^Y[CFLV#PUKD/AO2XA8J;NPUUM0
M:$SJ/,B:21N&R1D"0=?0UZ-10!G:O%/<Z'-$+&"\ED15DM9&&R0$C>N3[9Y(
MKB9?!6HGPSXCTG3A/;V%W%'_ &?8WDXD\F126<!@6VH<* ,G!STKT>B@#A+K
M1-:U_P 12W=[IZ6-I=Z)-ITF;A7>)G8'.%X/3L<=.>PT/#!\4V]E::=JNFV\
M*6,0C>ZBN _VH*N%V+@;<\$EB.GOQU=% 'G-OX;UN+P;HFFMIY^U6>LK>R@3
M)CRQ<-+P<\G# 8]<UUGBJ'5[CP_,FB'%Z7C.WS/+9T# NJO_  DKD ]OUK:H
MH \SO/!>KZDOBFWCLK;3H=6MK4V["<-LEB).UP!R2<9//4]:U);'Q#K?B'0+
M^]TA+*.UM[J&[_TM6(,BH,IMSD?*<=_7'?N** /,H] \41>$]*\.MI<,CZ5?
M6[I=BY58YXHI P('W@<#!!'TSTK6N/#^J7E]XUS;+%'K%BD%K(TBD;EB=#G'
M(&6&..GITKMZ* .(ETK6KFV\(>9IHC?3+A)+E5G1MJK"T?!XR<MG [=\\4R'
M0-8T[3/$FAPVJW-OJDUQ+:W7FJ%B$X^99 3N^4DGY0<CTKNJ* ..TW0+S1_%
MEI-#;22Z=::''IR2[TW.Z-N'!/0@8SZ^W-9.CZ%XET[2] L)]/2>SM_M"WEI
M]I559V<M&[$9WH 2"OJ<X.!7H]% 'FUIX9UVW\'Z'I;Z?'YVGZRMVXBG4@Q+
M.TF1G')#8 _/%>DCD=,>U%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKVKHZYQ?"\T/]MO;:Q<V\^JRK,TT<:[H64*OR9!XVJ!SFNC'  SGWH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN
M/^(7C1_"&F6JV<"7&J:A-Y%G$Y^7=QEF]AD<>XH ["BN7N=-\56NA32VVO\
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MA7J2W=H(624@,>44C)QZ@?Q>QQI>,-%BO/AQK<F@Z1K#W&J7,,K)/#(997#
MLVPC*@ =2!G'TSZ]10!PWB/0--U7P%9Z?<65W''(L">9:V[>=;E5^5R@&XA>
MA&.A-3?#5-=AT&Z@UUWG>*[>.WNI8RDEQ$H 5V##=VP">< =>#79T4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0DGO61)M(=HXUW+(1&%X7!*R$ DYX(-=?)YUII+EKI&FB@)-Q< *I8#[S;<
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MN32:[X6L=>NK2\DGN[2]M-PANK.;RY%5OO+G!!!]"*V);B"!D66:.-G.$#L
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MO=FV@#U.3_.K@N(6!*RQD*,G##@4 9EAX>M+"XU.4233#4I#)<QS%65F*A>
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M=K?B+5X-*U.R32!I=ZD<L@F9UE@5B#LX)#L5/'W1D5U4D\,3HDDL:/(<(K,
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ME%,]@0QXZ-GO7HD<:11K'&BHBC"JHP /85'+:6T\L<LMO%))&<H[H"5^A[4
M>;16[R:G\.%UV*)]1DMIQ<"=078BWX#9ZD']:U]/M=/D^*VO(T%LS#3[9B"B
MDY+2[C]2",_45V4EI;3/OEMXG?\ O,@)I/L=J9#)]FAWG.6\L9.>O- 'DVEW
M\&F>"O"\TY4:''K5RMZ0,HB^;-Y1?_8#E#SQP*UO$%QHUEI+ZAHTS-I,VL0R
MZK<6I$L(4@ABHY4@,(RV 1^H'H@M+987A%O$(G^\@0;6^H[TY((8X! D4:P@
M;1&J@+CTQTQ0!Y-XHLO#S>$/$VH:9JG]H+</:22NK1&".02* 4** '*_>QSC
M&>M='KFB16&H6!\,G3+6^*W$XL;B/]Q>J1&)"2.C@!,,,]3G@FNR6QLU@6!;
M6 0J<K&(QM!]ATHFL;.XC6.:U@DC3[JO&"%^@- &9X3N8-0\'Z9-%8FS@>W5
M5MF.X(HXP#W''![C%>>:=IMK%\-=;U32[*-]2M[F]CCE@4&5(?/.Y4/;Y,X
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M &[''//?&BEUI-G\39I'EM(;2ZT.(1'*A)L3/PO9N".!ZBNX%M;K;?9A!$(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCS4+B2P,5G)IUM;QRQJ%BWQE]RJ,Y ^88XH V+;7[2[N((X4G:.X=TAG\O\
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M4 %%%% !6:FAVJ>()-;#S?;)(1;L2_RF,$D+MZ<$DYZ\UI44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %(PW*0&*DC&1U%+10!G:-HM
MIH-F]K9&7R6D:7$C[L,Q+,<GU))K1HHH *R[SP_I]_K%MJERDKW%NH6-?.<1
M\'<"4SM)!Y!(]/05J44 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$@AEXRN1[&NDO;_Q+%ITE_#-IJ6\&FBZ9GM78RS89BH D&U0 O7/6O,?%O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@K!D;!)8XSG*@\8'M56'P%';?8Y+?6+R*XM+R>[BF5(R<S9\Q2"I!!R<<9%
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M/!P >/3T!H +0P0GR@$V(0,[1C XKE[;P)'9V>A0VNK7D,NC"1+>95C+-&X
M96!4J>@P<<4 92^+M8_X0ZVUUVA5+74FMM1_<\F!9C&9 ,_*P&">HZU;'BF]
MC\0>(M,DGC=K>%)-,VQ8\TL=A4G/S$2%5XQUK6TWPC:6&AZCI$ES<75I?/,S
MK-M^42DE@" .['DY-$/@[389-"E_>-)HZ,L3L<F3</F+^I+ -_O<T 9.I>)K
MS3==_LJ_OEL)&6(6=Q-;XM[QB/W@+_PMG( R,<'YLXK?\5:X/#?AF^U8QB4V
MZ#8A. S,P503Z9(S4&K>&!K*7UM=7LCZ??,C2VS1J=NT*/D;JN=HSU]L'FM+
M5M*M-;TFYTR^C\RUN8S'(N<''J#V(ZCZ4 85SJNJ:-XET?3[R>.[MM5$D7F+
M%L:"94WC&#RA (P>1@<FJ?@2&Y:Z\2M<W*SH-:F!4Q 9<+'ALYXZ#BMJS\.F
M*ZL;F^OY;Z73XV2U:1%4KN&TNV/O/CC/ Y/'-2:%H/\ 8<FH,MY).+ZZ>[D$
MBJ-KL #C';"C@Y^M &//)J#_ !7MK=;XK:+I#S"'RP1_KHPWXG Y[?G7-Z+J
M>K:)X:BU"VGM_L7]ORV\MLT)+2+)=LA._/!&[@8[<]<#N[SP^MSXCM=;BO9[
M>XAMVMF1 I66,L&P<@D<@=,&LS_A!HO[!_LC^T[CR?MWV[?L3=O\SS<=,8W>
MU %>]UWQ!J#:N?#]J9)-.NOLT4;"/9,RA2X<LX9?O8&!QC/.<#H]4N[^V\.W
M5Y9V1EOTMFDCML[B9-N=O'7GTZUCS^##_;ESJ5AK5_IZWNTWUO;[-D[ 8W#<
M"48@8)7!^AYK>O; 76F2644TEJ&0(DD.-T>.A7/&1B@#@=5\32ZIX#\2W>EZ
MYN-M9CY7@$5S;OAMZ.O&,\ ''KC.,UNW=[JEFMA:B_B1'LWD#QP[YY)!MVJ(
M^?D )W-].1FK%UX.M=175FOYVDN-3LQ932Q((\1C=@@<Y;+=3GH!@"FCP>PU
M*TU#^V[_ .TQ6ALYG"Q_OXMV[!&W"G/=<'^= '.IK>JZ[-\/[U;M;7^T!+)-
M%''E"XMW.>3G')P,]^_%:-SK_B/4(]0N= LC.UE?/:I;MY0281OMDW,SAE/W
MB,# XZYJU:^!(;/3=$M8=6OEDT>1FMY\1[MK*4*$;<8VGKC/>GGP4L>LW=Y9
M:SJ%G:7TGFWEC$5,<SXP2"063=CDJ03ZB@#1\4Z[_P (YX8O-7,0=X54)&QP
M"[,%4$CMN89K/N=5U/1_$^D:;=W$=U;:LLL:R"+8T$R)OXP>4(!X/(QU-;>K
MZ39ZWH]SI=]'OM;B/RW4'! [$>A!P1]*I6GAYH[NRNKZ_EOI["-H[5Y$5=NX
M %VQ]YR!C/ Y/'- &)X#AN6G\2-<W*SH-:N 5,0&7 3#9SQTZ4[Q+_R4OP/]
M;_\ ]$BMS0M!_L-]0*WDEP+VZ>[D$BJ-KOC.,=N.A_.H=7\-'5==TS5AJ,UM
M-IOF>0L:(5_>*%;=N!SP* .>\>(+'Q9X-U.R&S49-36S<IP9+=P=X;U Z\],
MU8M]?\1ZM;VNJZ18F:UDO&1H&\I4-N'*%@Q?=O&,],=L=SN6_AJW76H]8OKF
MXO[^%"D#S[0L /WMBJ  3W)R>V<50LO!*:?J,[VFL7\6ESS&XDTP%#%O)R<$
MC<%)Y*@@'Z<4 9=K=75EJOC^YLFM4N([F HUV^R)?]'CR6/H!DU/;Z[K=Y>>
M(M,L)EEN+.TAN;&6YM2A=G#_ "LO&02G!P.O>KM[X'@OHM<274+D?VO+%.Y0
M*#$\>W85XZ?(N0<YJYIOADV&OSZQ)JEW<W%Q;QPS+(J!7V%L-A5&/O'@<>N3
M0!@6GC2>?4O"TGVF,Z=JUM^_S%@PSE244MG W%)%QZI6BVJZI]FTR5[R&*WO
MI97WK%F?RL$PK''@[F(P6XX&>.X?)X"T>71KW3")!#=WOVTD-\T;>9OPA_A&
M<\#^\?6KVK>'5U+5--U&"_N+&YL!(B&!4(9' #*0P(_A&#VH Y>+Q=KMSX9\
M/7L36:7-[JQTZX\R%L$!Y%W ;N/]6"1[\$5H'4_$!O9]#287&H6=JL\UU;V\
M:AVD=P@V.XP $YP3DGJ.\D/@**WL+*SCU:\\JRU$ZA#O5"0^YFVGCE<NV>YS
MUJYK/A/^T=9@UFQU6[TO48XO(>:V",)8LYVLK@@X).#VS0!IZ'/J5SHEI-K%
MHEIJ+)_I$".&56Z<$$C!Z]3UJQ?WL6G:?<7L^?*@C:1MHR2 ,X [GVJI%I#V
M]S8/#J-TL%JDBR0L0PN&;^)SC.0<GC')IVKZ6^JQ6\0NY($BG29E15(D*,&4
M-GMD \>E 'G^C71T#QW8W,QN0GB*$Q7QF@DC1+P$NF"ZC(P60 ?W172WVHZY
M-XYDT*RO+2WMVTS[4DK6Q=T;S-G]X _IU[UI>)_#D?B?3([*6ZFM?+G2X2:
M+O1T.5()!QS2+X?=?$8UPZA(UR++['M,:["N[=NQUSN]\>U ',Q>+M8;PCH'
MB.9[>.U>X$.JA8L[%\PQ^8ISP-P&1SP?:NMTVZN;W4=1<R*;&*400 +R64#>
M<]P&)7ZJU<]/8VOAKPO'X3%M?:J+V.>.$?9RRDL22)'4;4&7/)Q@#VKI]&TR
M+1=&L]-A8LMO$$WMU<]V/N3DGW- %ZBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK$21C&3*2.6R,87G/%36\<>L:YX(^USRSK=:)*UROGMB1@D)^8 _[1SZYYH
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MW422C38C&O9F\L8'YUPBR23_  VT7Q'8NS>(C=0;I@?WDTK3!)8G[E>6&T\
M*,8Q0!W&IZ]=QZG<:7I-C'>7]O:+=O'+-Y0968JJ@X/S':W7 ''KQMPN\D,;
MR1F-V4%D)!*G'(R..*XRQT^R_P"%MZM)]EA\Q=-MI0VP9#F27+?4\<UVU !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 55U#3;'5K0VNHV<%W;D@
MF*>,.N1T.#WJU5*[U>QLK^TL;B8I<WC%;=-C'S"!D@$#' Y^E "MI.G/IHTU
MK"V-B%"BV,2^6 .@VXQ3?[&TLV+V+:=:M:2'<\+0J4<^I!&"?K4$7B/2IK6^
MN8[EC%8.4NF\EQY3#D@C&<@$$^E<[#XLCTOQ7XDCU?4I!86\=K);HT.3$'5R
M_"KNP,#)/3C)H ZI='TQ+F&X73K19X%V12B!0T:^BG&0/85"?#FAM&T;:-IY
M1I3.RFV0@R?WR,?>]^M%UX@TNS6(R76[S83<((8VE)B&,OA 3MY'/3FJ-[XO
MT^UO]%MHA+<IJH9XIH(7D3RQ&6W J#DG"\#L<T :UYIEAJ$<<=Y9P3I$VZ,2
M1AMA]1Z'Z5/!!#:P)!;Q)%$@PJ1J%51[ 5GWGB+2M/G\JZN_+(D6)G,;&-';
M&%9P-JDY'!(ZCUJ2VUJPO+Z]LH)F>YLL?:(_*<&//(ZCG(&1CKVH MQ6T$%L
MMM%#&D"KL$:J H7TQZ50M?#>AV5M<6UKH]A#!<_Z^)+= LG^\,8/XTDGB/2X
M[**[,\C12Q&9/+@D=C&/X]H4L%Z<D8Y%07/C'P]:1V\DVJP;+B$W$)3+[XP,
MDC:#0!>?1=+>SALVTZT-M P:*'R5VQL.A48P#R>1ZU2U*RU6&&VL_#RZ=:6S
M%UN'D5@T8/1HU7@MDDG=U.*O2ZO80Z/_ &M+<HEAY(G\]L@;",@^O2JMCXIT
M74KZ.RM+Y9+B6+SHUV, Z<9*DC!QD9 .1WH EN=$LY] &C"" VBQ+$L<T0D0
M*N,94\'&!C/<5<L[6*QLK>TA!$4$:Q("<G:HP/T%9]KXETB]N8;>WN]\DZNT
M!\MPLP3[Q1B,/C_9)K/L/'.E7>GWM_.9[6UMKIK<R36\@'#;,D[>,MQCJ.,X
M- &@GA;P_',94T33ED,OG%A;)G?S\W3KR>?>IFT+2&%R&TJR(NB#< VZ?OB#
MD;N/FY'>DGUW3+6]GL[BZ6*>"#[3(KJ1B+.-V<8(SQQ56S\7Z!J"R-:ZC'*$
MBCF)",,JYPF,CDD\8'.>,9H H>*O"[:EX=;3-)M+*/S+J&:42G8K!'5CG"G)
M(7'-=!9:?:62-]GM(8#)@R"-0,D#N>^.E1Z=K%AJKW$=I.6EMF"3Q/&T<D9(
MR-RL 1D<@XYJ+4?$.EZ5))'>7)1HHO.E"QN_E1Y(WOM!VKP>3@<'T- #;?PS
MH5H4-MHUA$8Y#*FRW0;7/5AQP?>K"Z1IBM=LNGV@:\_X^2(5_?\ ;Y^/F_&J
M.H^+] TJ4Q7NIQ1R"#[3M 9SY>0-PV@YZC\.>@IMIK&GG4]9F_MOSXK:.)IK
M=E 2T!5N0<9.[&<9/2@"8^&M)BT:?2K/3+"WM9^7A^S*8V.1RR< G@=?05H6
M-G%I^GVUE "(;>)8H\G)VJ !^@K*U'7=.?2-3)U*73S;P_O9W@9'@W [6"NO
M/0GH>E.D\2Z/I_V2VNM35KB6W\V/*$O*H ^;:HZG(XQGG@4 7(=&TRVO&NX-
M/M8[EF+F5(E#%CU.<=3W/>GVNF:?93S3VEC;033G,LD42JTA]6('/XU6@\1:
M3<Z3%J<-ZCVDS^7&X5LL^[;L"XW;L\;<9I]AKNFZI<SVUG="2X@)$T15E>,C
MLRD CJ/SH FU'3+#5K4VNHV<%W;D@^7/&'7(Z'![TR31=*FM(+273;-[:W(,
M,+0*4C(Z;1C _"EO=5L]/D2.>1_-=2ZQ11-*Y4=6VH"<#(YQCD5"OB+27CL)
M$O8WCU!MEK(@)65N3M# 8!X/!]#Z4 +/X>T6YGGGGTBQEFGC$<LCVZ%I$'\)
M)'(X'Y5)_8VE_:1<_P!FV?GB+R1+Y"[A'C&W.,[<=NE96M^,],T?2-5O 99Y
M=.(26!(GW+(PRH;C@'(^;I@_2M^WG2Y@6:,.%;H)(V1OQ# $4 41X>T06T5L
M-'L/L\+^9%%]F3:C?W@,8!]Q5B'3+"WO9+V&QMH[J48DG2)0[CT+ 9-58_$>
MDRW4-NMV-\[M'"Y1A'*PSE4<C:QX/ )Z'TKG[K6+K6O%6IZ#9:A>::UI;1-#
M/%:%OWS,^2^Y<% $ '(!R>3Q@ ZB]TK3]2,37ME;W#1$F-I8PQ3/7!/2G3Z9
M876GG3Y[*WELBH7[.\0,>!T&W&*L(&$:AV#. -S 8R?7%8,>NZ9:76N74^N^
M9!:,GGQ.H"6?R] 0,G.,]Z - :%I"Z5_90TRS_L__GU\A?*ZY^[C'7FK1M;<
MK I@CVP$-$-HQ&0" 5]."1^-9]CXFT;4M0%C:7RR7)B\Y4V, Z<9*DC#8R,X
M)QWJ]>7UM81+)<R; [!$4*69V/95&23P> .QH DC@BBDEDCC17E8-(RC!<@
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M:7&$Q]L50QB/J 0<GVQ3+KQ-HVG7?V&ZOU%VL'G^4$9G9,@9 4<G)' Y]N*
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M D#3P6C"9I@ # [D9C7C/)4$]^.8='@O[33?A[<S:5J 73TE@N4%LV^-FA*
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M*:.=-\4B2)DC<C C(.#^M.(R".>?0XH S]#UF'7M+2^AM[JV#,RM#=1>7*C
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MFK.LZ/J6L7/Q M+.WN8I;ZVMEMI)(F1)BB$,H<C!S]WKW]*]($T9F:$2(95
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M8XYQZ]*RTL+Z/P1XB\*W=A=3:E/-<BWD$+-'<><Y9)/,QM&"W.3D;?I7IM%
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M;4($CN]\=Q"IPWS[1M8' QCO6KXIT6?7=)CM[::.*>&ZANHS("59HW#A3CD
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M)+M\O:Y5>#O&<CC!JCI_@W5;+1_"UB9K-VT6Z,[N'8"48<8'R\??/Y>].O\
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M]AO(6*[U\Q61D '!Y ;.?P]ZNVUK:^'!KLWB*]TZ&RUB]:1?-FVK\T84QG<
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MT:#[99:?%<&X$@#W"9?"D[>,;3Z]:JV_C;495\/S-H<8M]<B!MRMYETD,?F
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M3YX\A'5@K=B01C\: *$7CUKV+09+#2VE_M666W*23A&@EC5BRL,'(!0C/IR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)4\_.>N1]#S5+S_$>M+K%KI6HK'>:9<+:0RRRA 66-&+R((SNWDGT&.@!&2
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MOR@8X'R]N]0R:UJMKX6\.^)TOY+B2]EMA=VI"^6Z3D J@QE2I88.><<YH ]
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M//L>G05-X4UZ37_#FGZI=+!;RWL?F) C9VC/3)Z_E6TDL<F?+D5MIP=IS@T
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MA'<+Y2@* 5ARZKDX!^;G///)KV,VMN83"8(C$3DIL&T_A3O)B_>?ND_></\
M*/FXQSZ\4 <1?OIC?$7P?/8&UV26]\JO#MPZA4Q@CJ,[OUKG-QOOA5>++A?%
M4%\^<8$ZWOG_ "8[\J5 _P!GVKUC[-;[E;R(]R !3L&5QTQ1]EM_M/VGR(O/
MQM\W8-V/3/6@#S>73=+NO%?CE;VVLY673;9V#*" YCEW-@]^G/7GWKHO!^N6
M"^%_"]C<7\7V^[TV)HHF?YY-L8W8]<?T-=*;2V9F8V\1+?>)0<_6J\NDVLUW
M:7#1H/LK%XE5 ,,01G/7H>GX]A@ P_&E]8VDNA)>!%:34!Y,T\FR")Q&YW2?
MWN,X7C)QR,5P<>J1VV@WJ&XCETZ/Q;G4?+&$6U8YW%><1E\>Q&>O->QRPQ3)
MLEC21<@X=01FD\B(K(OE)MD^^-HPW;GUH \MUJ;1+CQ/XM$$MC)'/X:#G8RL
MKNIEYXZD +^E/AT[23??#D_9[7-W:R+.<#,Z_9@</_>&X#@YKTQ;*T2/RTMH
M53:%VB, 8!R!CTR32_8[8%3]GA^7[OR#COQ0!Y'JL5BG@#XAVJ) (+?5',,0
M VQDK$?E';YMW3OFNEN++2[[XLQ+<V]K.LF@EV5U5@Y$RX)'0\=,UVWV*UP1
M]FAP>2/+'-+]CMLY^SPYQC.P=,8Q^5 'DFFM:GP=X#D+1%XO$!BC8D$J@DG
M4'TP%X^E;5S)-I_B$W$9M-7TFYUE$DB8;;NQN2P3*G^)1C.#@[3Z5Z!]BM,
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MD>IFYT1B,I'*BJ24[!/,#+QQC=73>$;L^(0WB6>T:WDEA6VBC=<,@3_6>_\
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MX9IB!"EUMC^\3P#L# $^I]33[RXT71;[PZL%U)9^&'^UK#=$J\(G9E93F0,
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M21L&0><V O\ GN/6N]K-;0K'[)86:0HEK8LC0Q*HX*8*<GD8(!XZXYXR#I4
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M'.,'!K=U9=7N]1\,ZZNA77F6,LPN;)98C(HDBVY4[]K 'W!QVH K^,=>74/
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M6UU:@.R&.[B,;C:<9P>QZ@UPM]X9U465S<P:?)+<7WB"#4FMUDC!BBC9.I+
M;B$)X)Y..V:]#D03V[QME1(A4^HR* //]6U:YUGX7ZWXDANKFW,L,SV7DRM&
M8XD8A3P1RVW<?][':M_3O%>GWU_#HDL5];W,]N7A:XA:);E0/F,;=21U['O6
M!I6C7MY\&KKPW&B_VE!;SV#1L=H\Q6('/H1M(/HP-;"Z=>:SK?A^^GL)K&+2
M5DD?SV0N\C1^6%&UCP,DD^PQGG !>\/ZK)/J.KZ-=.9+G2YD7S#UDBD7?&Q]
M\94^I7/>HYO$,I\:CPZ+"<Q&Q-P\ZE1U<*"/FR /FSWSC JKX<M7E\;>*]7
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M?6#NX'A^ZD?2@>WVH88/^)#1_5375ZM<7MMI-Q-I]DUW>",^3 &5<OCC)8@
M9Z\UR>O>"8[KP-+:6::@^I1Q"6W#7C9^T@[@Q4OY8);D_4XH Z#6/$]CHE_:
M65Q#=RW-VLC0);P%]^Q=Q ]_;^0YKE;/Q0;'Q9K]S+;ZU<V[V=E<1V:PO(\
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M]^AH [RF2S1P)OED5%R!ECCD\ ?6L+P[K-_?:EK.F:G';"ZTV=$\RV#!)$=
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M_P W&TA1Q_>!]J=H?B2[UW3M$N+=;?S;N"2:ZC9&'E;,*5'/!#G;SG.">V*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPPOS$E<>N",YKH+.RGMM$BL9+KS)D@\KSU39SC&0,\?G^-7J* .4/@J.^O\
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M=C(04W]<-US^%:&G>&Y[/4==N9=1$BZLRL1'#Y;Q$1B,$-N.> #T'/Y5T%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN(H8KQT$,C1R,<;2",$=.A[@X&.S/AO2#>2W7V,!YI1-*@=A')(,8=H\[2W
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MFQMCJ OS GVM8C")<?-L)!*_3(!JM)H.E2Z*^C/8PG3G!#6^/E.3N/ZG/UH
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MWA#P_J6L)JUWI<$M\H \TY&['3< <-CW!JPV@::UW>79@;S[U!'<.)G!D4=
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MS9<?,O/'IG'KFLBUOM6M_"NC>)KN_O9X]*O98+W$SA;JU$C1B5D!PQ7Y6SW
M.<UZ#>:#IM_?"]G@870C\HS12O$S)G.UBI&Y<D\'(JAK-IJ,L$>AZ;IEJNE7
M%NT$UP90GV=#\N%CV_-\N<<@9Z\4 6/#Y:[2[U4S2O%?3%[=6E9D6$ *I4$X
M ;!?C^^/2L'3K*$?%/Q'-NGW+8VC@>>^TD^:#E<X(] 1@=L5VD44<$*0Q($C
MC4*BCH . *HSZ#IESJ9U*6T4WIB\GSE9E;9SQP?<X/49H \T\-)-IOACX?:A
M;WMX)+JZ2TFB,[>4T31RG'EYV\%0<XS[UK:<^I^(],&LQ:PMC=6VHR><3-(0
MBI*R^2T6=N"N!TSR#U-=:GA718[2RM4LRL%C)YMK&)GQ$_."OS<=3^9]:;_P
MB'A_^W3K0TN :@S!S*,\L.C%<[2WOC- #?%MREMH6&O9[1IKB&%&MQF21FD4
M>6O(P6Y7.1C.<\5Q=_>:E;Z5\0K<75U;?8((I[58[MW:!FAW$*YYP2,XZ DX
MKT75-*L=:L7LM1MEN+=B&*-D<@Y!!'((/<5GGP=X?(NQ_9D8^UQK%<$,P,JC
MLQSS[^O?- ')Z]H_DQ^%S_:.HR27NL0/))+<%RA\B0'9G[F?;\,4RY6_T<^-
M=*M]4U"6SMM*%[;2RW+/+;2E9/E$A.['R!L$_P Z[JYT+3;S3X+&XMO,@MV5
MH<R-NC9>C*^=P(]0<T'0M-.GW-BUN6@NL_: TC%ILC!WMG<W'')Z<=* .*BM
MEN_&'@R>>6Y,LFBRN[BXD4D@0G/!]SGU[YJ'3T8:3XFU>^\1:I;?V;J%]##*
M9VD2),;5RA^^5R" >X&*[=_#>D2C3_,LE?\ L\%;4LS$Q@@ C.>1P.#D<#TH
MA\-Z1!9WUFMF#;W[,]U&[LXE9OO$Y)Y/<T <E8FZ'BNZTJ9KR.RGT$3F&6\>
M1]XD*[R<_(Q!Y"L1[UF^'KI['PKX!TY)KB*VU4A;J43OGY8F98U.?D#,!PN.
MA]:[NR\*:'I]W!=VNG1)<0Q&%)269@A[$DG/X]*(_">A1:5_9D>FQ+9^8)5C
M!/R,#D%3G*D'I@C':@#@_%5WJ6E6_C/3K2_O5M;6PAO;:43OOMY&+*4#YW8.
MW.">.U>BZ5I:Z:DY%Y>7+7#^:QN9C)M. #MS]T<9P..>*BF\-Z3<:?<6,]J9
M;>Y(,XDE=FF(X&]B=S< #D]JTH8D@A2*/=L0;5W,6./J>30!Y7J/VS_A&?'%
M\-6U,7&EZA*UFRWC@1;8XV P#\PY(PV1[<FMXR2:1XXT[_B979@OM+N)[H7$
M[2(&C,9#A2=J8#'A0!CM70MX6T9[6^MFM"8;]S)=(9GQ,QZEOF[X'Y"I6\/Z
M8]W;W3V[//;Q&&)GE=MJ'JN"<$' SGKB@#B=(NKM=?\ "82\O9;34[.Y,LT]
MPVZ[ 1660QY(CZY&#D XXQBI;*:[M;W4/!EQ?7SWLEXDUK<O<R&0V;G>6#YR
M"H1TR.Y7UKIK;P9X>L6M9+;2H5DLV9[8EF/ED]@23Q[=!V%)HMKJ-WJ#:SK6
MGV]E>"#[-%#%-YQ1-VYB7P/O$+QVV^YH ;XY 7X>^(%&<#39QR<G_5FN9DBO
MO#VI^&;S3[^_NC?Q/'=6<TYD1PL!<,J]$(*@?* .<5Z%<6\-W;2VUS$DL$J%
M)(W&592,$$=Q5/3]"T[3'5[6!@Z)Y<;22O(8T_NJ6)VKP.!@<#TH X_P\-1U
M>P\.^(X];1!+L:['G2.MP7&&CV$[5(;I@<8]*VO&6J3:>-&MTF$$-]J"VTTK
M.4 !1V"[ARNYE49'OZU<L?"'A_3-6DU2RTN"&\D8L77. 3U(7.%)]0!5_5-*
ML=:T^6PU*UCN;67[\<@R#Z'V/O0!P'B2TU71/#6MD:[./])M);:*&=R]LKRJ
MC*78DLK?,0#P.:EU6W>TUWQ'I(O;Z6SG\/F\9)KIWQ*'=25)/R@@#*C ]L5U
M2>$-!CT<Z2FGJMBSB1HA(_SL,$%CG+$8'4GH/2K9T+33J+7[6Y>Z>#[,TCR,
MVZ+^X03@CO\ 7F@#AM.N9+;3_!&C13M'!J.G&9C+<R#S)%BBVH&!R!AF.T$#
MBC4+/5--70[";Q!=3%]>^SDP3.&2!XF<1.Q.7(XPQYQBNMF\&>';C18](ETJ
M%K&-P\<9+91AP"&SN!QQP>G'2I?^$6T46ME;+9!(;*3S;=4D=?+?GY^#RW)Y
M//)]: .7%O<3^(+[PK'J-R$L[")[9I[V43/O9]TFY2"Y4A1STP/4T_3;J[N_
M%%CX<U/5&NEMM(^T-- [0_:Y?-,98E3D[0O3.,MGL*Z76?"NB>()H)M4T^.X
ME@SY<A+*R@]1E2"1[=*=?>&M'U'[&;BQ3=9#%L\3-$T0QC"E""!CMTH Q?AO
M$(/#U["'=_+U6\7<[;F.)FY)[GWK%;1_[3UWQT_]IW]B\$\3Q26MP8@CBV0A
MFQ][IT.17=Z7HVG:)#)#IMI';1RR-*ZIW8G)-0W'AO2;J\GNY;3,MP +C;(R
MK. ,#S%!"OQQ\P/'% '%0:Q?:;!X5\6ZO=W*65[9I;ZE&TSB**1U!CFV9VC)
M&T\8^85VOAZ">+2DFNFG,]RS7#I-(SF+>=PC&2<!00N!QQ535K74M6OQI,FG
M6PT3,4LERTV6?:P;RQ'M[E5&<],]ZZ"@#S/5=1N5N$U"PU"[G4>(XK9[AIF1
M ID$;0+&"0RCD$D#)Y&>M+J4-S<WWCX-JNIHFGP1SVJQ7CH(G^SE\C!'&[G;
MT]NE=;-X+\.3R7$DNE0LUQ.+B3EL&0$'>!G@D@9(QGOFK'_",Z1NOS]E(^WH
M$NL2N!*H& ",] ./IQTH Y6\U"YTU?"_BNZO;G[!-!%!J49G81(94&R8IG:,
M/P>.C>U=3X=CF.F&\G><R7LC7(261F\I&.40 GY<+MR!WS6??Z5>3B'P[!IE
MNOA[RHQ)<27!9@JMDQ",@DY  !SP#[ 5T] '":KX>U'^VK[Q!X,U5;?43($O
MK"X&ZWN751C(ZHVW'(]NF2:RX[V#Q3JW@'5'MY[,W'VQ7ACG= A2-@0-I'\0
M/(ZCK7<S>&M*FN+BX\B6.6Y.Z=H+B2+S3C'S;&&[CCGM3[GP[H]W!903:?"8
MK$YMD4;1%QC QVQP1T- '#:MJ-RLZZA8:A=SJOB*&V>X:9HT"F14:!8P2&4<
M@D@9/(SUHGD?1=9^(NJV7G-=6D$,T0,SLNXP$Y*DX(!YP1QCC%==-X+\.7$E
MP\NE0LUQ,+B3EL&0$'>!G@Y R1C/?-75T'2EU.345L81=21")WQ]Y0, $=.A
M(SCH<=* ,'2+&[75],U6#6E?3[FW9&@,\DPNB5W*Z[CA6&"3@<CCTJ;Q#J$H
M\7>'-%:22*SOOM#RM&Y0R-&@*IN'('))P>=OIFM#1O">@^'[B6?2M-BM9) 0
MQ4DX!.2%R3M&>PP.*NZCI5EJT,<5[ )1'()8V#%6C<=&5@05/N#0!YKX@O=4
ML-*\:Z?#J%ZL&FRVDEE<"=O,C\W:7C+YRP&>,GHP]J](TS2UTN.=%NKRX\Z4
MREKJ8R%20 0N>B\9P.!DU!/X;TFZTR73I[3S+69_,F1I&)E;CEVSECP.I/0>
M@K3C011K&N[:HP-S%C^)/)H =1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,R=A(<8E_P"_JM']%]ZZW5-9BTV[T^R$9EO-0E:*WCSM!VJ78L>P !]3TXH
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MW\NVF29&.XC*[T!RH8=/PR!0!UE%8_B+Q!%X=MK6>:TN+A+BZCMAY !*L[
MD$Y/7L#6;!XWC%SJMIJ&DW]C>Z?;?;/LS!97FAY&Y-A()R,8SP: .JHKGHO%
M/^GWEA<:=-'>6UDM]Y4<BOOC8D8R2,,".0?S-8.H>/\ 49/#$6K:?H-S%;W
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M3# L[/M'7'  X]3GB[<:/J-UXU353#'':'29+%LR9=7=U;.,<@;<=:ZBB@#
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MI5J^(-0$I\TP@Y"&/;C=CY<YP!SSW[2B@#SVZ\*ZW<>#_$NE+!;BYU/49+J
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M,NAD)+[<(!U)Z@U G@VS@M]&6VO+N*YTB+R+6Z!0OY6T*4<;=K+@#MGC.<T
M8:^,M2ADFT6X:,ZFNLQZ9'=[,*4=/,$A7IN"9&.F[';BK>C03V_Q3UI)[M[G
M_B66Q1W558+ODX.T 'G/8<8K2O/!6FWVERVDLER)Y+L7WVU'"S+<#I("!@$
M  8QCC%3:;X96PUR76)=3OKN\FMTMY#-Y85E4D@X5!@_,>E $5]JUQ/XQ@\.
M6T[6N;![Z6=%5G(WA%5=P(ZDDD@]!ZUQWB75M0U3X<^++2]GVW6E7+6LDL2
M+<IE"I((.TD,,@=QZ'%=YJ?A^#4-3L]4CGFM-0M%9(YX=N61OO(P8$,O /L1
MD8JI>^#K&^\/7NC/<W<<5]*9KJ>-D$LSD@DDE2!T X P  * -N*"6.U\I[J2
M67!'G,JAO8X  X^E>::?JNLZ5\*)M8AU1Y;H7T@)N(E;@W;(V, <G=GG(&.
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M[^[O6L$9+0W&S,65V[N%&YMO&3G@GU- '(0>)/$8\/V>MS:C ZKK'V*6W6V
M$L9N#%G.<@@8(QZ<YKN/$-U?V6@W=QIEL]Q=QJ"D2 %B,C=M!X+!<D#N0*R1
MX%LQH:Z3_:6H_9UO/MH;,6_S/,\SKLQC=SC%;NHV']H6!M3=3P,61Q-"5#J5
M8,",@CJOIB@#SOQ%K<6N?#C7IK;4VO$CFMU\JXA$4UNWFQY210HYSWQ_+-=
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M2[9EFB;1I+N*!P!^^60*!NZX.>]85OXZ:'2-2O9+N9KZQLPUSIE] L,L,Q8
M-P!F/)ZY/;GGC?7P9$U^;^YUC4KB[:Q>Q>5WC&Z-CDG"H "#C&,=.<\U-)X1
ML;R2635)IM0>2R:Q+3A5/E,06!V 9)(!SVQQCG(!GRR>)X[BZ#27":<]C(WV
MB80"6"<#(V!"05(SPP)'K7-6XU$^$OAZPUB['VNZMQ(-L?>!F&?EYP5SSGKS
MGC'::-X2BTF(Q3:KJ6HQK&884O9@PA0C! P!DXXR<G' QSF!/ ]I'HFFZ8NI
MZCC3)TGM)]\?F1;%*JOW-I&UB.03[T 4;GQ)=6GBDZ5J%Y-IS/=1+8M+ IM[
MR+"[E\S;Q(3O&,C^' KMJP+CPK!=AX;F^NYK-[E+DVTA0J'0A@ VW<!E03SS
MSSR:T[.P:TN;V9KVZN!<RB01S."L/ &U!C@<9^IH N5Y7IB2-\(O%QCG>$K-
MJ;$H =P!?CD'@^W->INI9&4,5)& PQD>_-<U:^";2T\.:EH::CJ#6NH-*TS,
M8MX\S._!V8&<GMQVH T?#44D/AS3A).\Y-O&0SJH(&T<< <5JU6T^S&GZ?!9
MK-+,L*+&KR[=Q &!G: .WI5F@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHKE?%,MG)KVA6$X\V>4SR103N!;,%0;FD!!W%0WR@=R>G6@#JJ*Y#X9W/
MG^#(D-PLQAN;B,$-G""9PH')P,#CV%<Y-H6FZK=>/1?RS8LYQ+"YN''V=OLZ
MMO'/7.>OICUH ]2HKR>>Y&I:-LU1M^K0^&HY;G[:P$<)8,0Z+C/FDCDY&,+W
MXJ>.VM]?U'P)'?2R7*7FBS"Z7SVQ*1%%][!Z_,3ZT >DQ7UM/?7%G'*K3VZH
MTJC^#=G;GWX)Q]/6K%>>:%H&B_\ "8^+]-:SMUB*VL4:\;PI@YP3SG@G/7(S
M1X522ZDM?#%]#NE\.3L;B0IQ* ,6[?\  E8L?>,YZT =W>WUMI\"S74JQHTB
M1*3W9V"J![DD58KC/B3;6T^C:8UQ#$X35[/F10=H,JANO0$<&H;*.RU?QMKV
MD:C!#)9VUG;?V?"0-@A*MO=!V._@L.1M44 =S17,?#V>^N?!-A)?RO-*#(J3
M2'+21!V$;$]\J%.>_6N-DO;,W.@:K8SJB3>(70W-Q*#<RJ3*'#$8VQC  4YX
MVYQ0!ZS17D.JZ;:R:'\0[IO-::QNVEM7,S$PN(8V#+SP<]_PK?UN8>&=>TSQ
M88&EMKRW^QWJQKDB0C=$X'J6&P_[RT =_16;H6F_V5I$-NRH)SF2<H.#*QW-
MCVR2!Z  =J\XN+RS-SHVJV,ZHLOB1HS<W$@-S*I9U=3C&V,8P%.>-N<4 >JS
M-(D#M$BO(%)56;:"?0G!Q^59GA?6F\1>&;#5V@$!NX_,\H-NV\GC.!FN7\/:
M+87OBWQ-<7"R2O9:FDEL6G<B-C A)'/.<GKD5S.DZ1#!\/\ PAK6FF5-<^TV
M\43K*Q,JM)AXR,XV;-Q(QQM)]: /5C>SVTFHS:A'!;Z?;J'BN/-R67;ERPQ\
MN#[G-7(94G@CFC.4D4,N?0C->7:Y;120?%&%U\U$MHI$60E]K?9]V1GISS[5
M:O=+TR[U_P %62HOV2XM;I9H8)"J/^Y0X(4_[1/OF@#TJJXOK9M0:P653<I$
M)FC'54)(!/U(/Y&O*?%W]GVND>)O[-?9)I7V6%);F;+V[(J;$@_B QR6)Y.[
M@UTEG;::_P 6-5E,5MODTRV=)  &+%Y5)!ZYP ,CGI0!V&GR7LMKNO[>*WGW
MN-D4GF#:&.TYP.2,'%6J\ETJ\DM_#OANUE=O[,N=?NH+MF8D,/-E\M&)_A+!
M<YZXQWJQXCMGL7\<6-ENCTI=%%WY<;%4@N2'X4#ID*&('L>] 'J5%>?6-G!I
MGC?PN]H&1K_2Y_M1+EC-M$14MD\D9./RZ5>\?PI+-X75Y98UDUJ*%S'*R95D
MDR.#W('/7TH [.BO)-9TM-'A\>Z?IS2QZ4FE)=")96VP7!5\A>>,A58CW'M6
MK=6-II&I^%8%C9=/U>8G4'>1F6>80?NE?)QR>W0E10!Z-17E.MW=WX>G\506
M+2Q:)#+8/((B0+82,//$>/NY3!('3=D8S6KX@;3-(T77-5\-W7[^2RC>6&R<
M&)(PX!E"KT<H6YSR%XZ9H ]!HKS2]2&RL=4USPWJ]K)=2:1*4M=-BVH^T9$S
M+N;YQG /4YQ3XOL<<2^(?#^K6LMU_9DYBM+*''VHB,LIE&]B65@.3SDX)YH
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M+1T6V5-*L5%K_P >X%NG[KO\O'R_A5.Q\7Z'J%Q>P0WNV6RC\Z=9XGB*Q_\
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M("MC(S@G%,\1>)(O#YTY9()Y6OKM+93'$SA<\DG:#S@' ZD_C0!;/A_13!+
M=(L##,^^6/[,FUV]6&.3[FKRQ1I$(E15C VA , #TQZ5Q,/BE-*\7^)AJ=[=
MR6,$%I-!$+=G,*LLA<[47(48&21QQDUU$VN6$4%O,LCSBXB\Z%;>)I6=, [@
MJ@G'(Y]QZT ">']%C2!$TBP5;=BT(%L@$9/)*\<'Z4-H&C.DZ/I%@RSL&F!M
MD(D(Z%N.3]:FT[4[/5].AU"PG6>UF7<DB \]CQU!R",=<US0\86&J^']<N)I
MK_2[>TEEMVN5MW#QA/E+CY2-V<\=1QD"@#H9-#TF6599-,LV=5"!C I(4=!T
MZ#TJU<6T%W;O;W,,<T+C#QR*&5AZ$'@UDR^)])L;B'3Y;F>2[:U^T)&MN[O*
M@P,@*OS'D<#GKQQ4$7CGP_/%9RQWDC0W<@B27[/)L60G:$=MN$;/&&P: -I;
M&T2R^Q):P+:;=GD",!-OIMZ8KGM<\*B6TM+?1M/T9;6&8RSZ?<VX6"X^4@9V
MJ<$9S]T_I6GJ7B32](\TWDTBI!M\^1(7=(=W3>R@A>H//8@]*O75];65A)?3
MR8MHT\QI%4MA>N<#)/X4 <[H_@ZQ@>::[T31K431^4]G9Q!H7&0<OE5#$8X^
M48R>N>-Z;2=.N=._LZ>PM9++  MGA4Q@#I\N,5G67C#1-0B>6VNI'18XI WV
M>0;Q)]P+E?F)/&!DYXJ>W\2Z3<07LOVKROL+!+I)D:-XB1D95@#SD8]>V: +
M7]D:;_9G]F?V?:_8-NW[+Y*^5CKC;C%1#0-&%C%8C2;'[)$VZ.#[.FQ#ZA<8
M!]ZKIXHTM[R:S+W,=S#;FZ>*2TE5O*! W %>1D]N>OH:?'XETF5-+=+HE-5_
MX\V\E\2_*6QG'!P"<''2@"S_ &/IGVA[C^SK/SW3RWE\A=S+_=)QDCVJ-] T
M:33?[-?2;%K'=N^S&W3R\^NW&,UDP^)-&TZTUO4I]7NIK6VO"EQYL+$6S[5_
M=J H.WD'OR>M7H?%.E7*R&"6:1DF,(1;>3<[!=WRC;EA@@[AQCO0!;;1=*>&
MVA?3+-HK;_4(T"D1?[HQ\OX4?V-I>ZY;^S;/==+MN#Y"YF'H_'S#ZU6A\3:1
M<:8E_%=;H7F^SA1&WF>:#@Q[,;MV0>,9XSTK(\+:M<:CXL\4P/=7,MM;26ZP
MQ3Q[##NC)9=N!W[GJ,<F@#J8+:"UMDM[>&.*!%VI'&H55'H . *J+H.CI!<0
M+I-BL-SGSXQ;H%ES_>&.?QK$\3:\;3Q#HFC W:0WK3-</;P2%RJ1D@*RJ?XB
M"=O( YP#5B#6K'P_8/:ZEJUQ>FS;9<7KP$B/<<J)&1=H(5ER3VP3C- &FFA:
M1&&":58J&A$!"VZ#,8.0G3[OMTI?[#TCR[>/^RK'9;',"_9TQ$?51CY?PJCJ
M7C'0])NWM+NZD$ZP?:"D<$DA,>0-PVJ<CGMZ'TJ]JVLV&B:8^HZC,8;5,;I-
MC-C/ X )H ='H^F0W9NXM/M4N"YD,JPJ&+'JV<=3D\]:GN[2VO[5[:\MXKBW
MD&'BF0.K=^0>#639^,-"OK^ZLH;X+/;1&=Q+&T8,0ZR*6 #+_M#(J2T\4:5>
MR^5#+,9#;?:T1K>0&2'IO0%<L.1P.>1QS0!:N=&TN\6%;G3K280#;$)(5;RQ
MC&%R.!CM5Q56.,)&H55&%4< #TK*M_$VDW6B1:Q!<226$T@CCD6WDRS%]@ 7
M;N^]QTJI<^.- M!>&6ZFQ92>5=%+65O). <MA>%P1\QX]Z *WAOPJ;"YU2XU
M2RT^2>YU*6\ADC_>,H8@J"648(]O6MVXT72KNZ>ZN=,LYKAXS"TLD"LS(1@J
M21DC!Z56M?$VDWNK#38+AS<O&98MT+JDRC&3&Y&UP,C[I/6D/B?25O+>V:X=
M3<.T4$C0N(Y7&<JKXVD\'OS@XS0!!<:5J5SJ,5GC3H?#L/E.D,2,)BR'(3'W
M0F0IX[#'>M^N=3QUX>D,>V\D*/<_93)]FEV)+NV[7;;A"3P-V,U+9>)H;WQ7
MJ6AK;W"M9)$3(T#[69]Y/., 848)QDDXS0!;;P_HKR32-I%@SSR"65C;(3(X
M.0S'')![FGG0](;[1NTJQ/VG_7YMT_>_[W'S?C5\G S7G?B'QC-J/@7Q'>Z7
M)>Z?<:=,T22&$J3L95.2RX!))X'S#CI0!TESI.HW%_%8HNG0>'8Q&_E11L)F
M9&W;,?<"9"_@".^:Z"LJQ\1Z7J&I3Z?!._VF&,3,LD+QAHR<;U+ !USQN7(I
M+?Q+I5SJ%O8I.ZS72-);>9"Z+.J\DHQ #8!!X/3GIS0!K4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5R/BM=1L/$6A:_:6%QJ%K9B
M>"ZM[9=TJK(%PZKWP4Y'7!KKJ* .&U>#4+BYT'Q!;:1-%!97\DTUD$ F:.2,
MH92@/+@DG R<'UR*AO\ 1EU'4_$&KW&FW<VG7EM:V@MU1HYI=LF6E"\,"FX8
MS@_*?;/?T4 >8W^DZ_-X-\1:<KWNJ6ZM;MI\EU#LNI%5U=T;(!;;C@D G)J[
MXEM+K4+R;5-*@U?3M96T7[.RP%XKP98B&9.5'/=L8W]>"!Z#10!B^(-.O-:\
M&ZAIRND-[=V3Q94_*'9<8SZ9X^E<ZUK>>(;;PG VGW5E=:9=Q7-X9HBBQ>7&
MRE5;H^YB -I(QR<5WE% '*>&HYX_%GBF:6UN8HKNYAD@DDB95D5850D$CU4]
M:77X+M/&_AK48;*XN;>&.[AE:%0=C2"/:3DC ^4\UU5% 'EU_IVH3>"?&EI'
MIUXUS?:K)-;1^0P,J,8\,..GRGKZ?2K][%-8^+=5EO?#M_JVF:ND3P/;1[C&
MPC"-'(K$;0< Y/')SWQZ%10!E/!/9^%7@LM/MQ<1696&R'^JW!/EC_W<X'TK
MB]'BU#_A)_#VIS:3JJHFFS07+2Q!5BD/EG C!PBC:0  ,X&,FO2:* /-K71M
M2N/@I?:,EA.FHM'<*MO(FQF+2LZXSQR"*VI+=];\3Z!JL5K=00:5%.\SW$#1
MLS/'L$84C+=R2..!@G-=?10!Y=::;J4'@?P\K:9>&:PUXW4\ B/F"(S2MN /
M7AU/']*Z31H[D?$#7KR6RN88;FUM5BDDB(4L@?>N[IQN'L>V:ZVB@#RVWAUF
MYN/#5W<Z%J,=S::G(UU#'&J00AED \M00"OS [_<Y/:KOV+48O"WCK2VTR\,
M]W<7LEN5CRLPE7Y-I'7.>?3'.*]%HH X.QM[[2O$^F:O-:74EA/HL=C((X6=
M[:5&W?,@&[:<D9 /(YXK.DT*_M+6TF%E<M]I\5?VJ84C+&"#)Y8#H<8;'7YO
M8UZ;10!RNAP3Q^//$]S);3QV]RMKY,KQ%5DV(P;!([$CZ]J+F"?_ (6A8W@M
M9VM4TN6W:<1$HLC2(P&?HIKJJ* /-8+":UO]7T35?"USJ:W=]+<6MT%#VTB2
M/O E).%VD\\=N >,K=OJ.B6WC73KK2KR>._^T7EM>Q(#$4:$+M9B?E*[<8/4
M=,]_2:JZC8IJ>FW-C+)(D5Q&T3M&0&VL,'&0>U '"V"75E>^#=66PN[JU_L/
M[*YMH]Y1V6)EW#L#M(ST'?%4(M/U1?"5E;2Z3>I/'XE%VR>5N/E"Y,A;C/&T
M_CVS7I.FV,>EZ;;6$4DCQ6\:Q(9""VU1@ X ["K5 '*:-!.GC_Q+<O:W$<%U
M#:+#,T3!7**X;!([%A]>U8'A:PEM[:PT#5?"MS)?Z=,NV_D4-;$(WRS*Y/WM
MO0 9R>W./2J* /)KFTUFW^'FL^%9=&U"XU!;EWBFBBW1W*//Y@</TSSR#SQ^
M7I&KPS7_ (<OX(HF$UQ:2(D;$ [F0@ \XZFM&B@#SBRMM4MU\%:LVF7H@TRT
M:QO+<Q9ECW1HOF*@R2 R8..<<@$5T/AS39H_$?B+6FCDAM]2E@$,<BE6(CCV
MERIY&23P><**Z:B@#D7$^F?$._U&:RNY+2ZTZ&&*2"%I09$>0E3MR5X8<G ]
MZYBUT#4O"IT:]N-'N-1M/*N8KFTLOGDM3+-YJE5!&X#[IQZ9KU6B@#*\/6T-
MOI>8-+&F1RR-*+8@!AGNX!(W'J>>_K7#6FZ]T/Q[I$-C/<7-YJ=W#"!$3&6>
M-%!+XVK@\G)'3BO3JR]'T*#16OF@GN)/MMPUU*)2I_>-@$C &.@XZ<4 <)KF
MF:O_ &?K>A_V9>3JNC1V]G-:(%6Y=8F#&5\@D@\!"<8)X.:U8K>]G\5>';C[
M#>6\<>D36\DCQ']U(WE[02,@'Y2?;OBNZHH \GC@U>+P'I7AZ70M0.HZ9?VW
MFF.+,<B),&\Q7S@@CGU!SGUKN_&-C<ZKX*UBRLX3)=7%G(D<60"6*\#.<5NT
M4 <:+277-;\,7<=I<V\>DK))/)<0M$P9HO+$:A@"<DY)&1A>O(J*QT:ZM?'5
M[I\>PZ(TB:OLSRD[;EV8_NEU\P>ZUVLD8EB>,E@'4J2IP1GT(Z&L_1=$MM#M
M#!;RW,[,<O/=3-+*^!@99N< < =* (/%5K;WOAZ>VNK.XNX)'C#QVV?,4;U^
M=<<Y7[W']VN+OM+\02>$=7M&:\U2&VOK6>QDGAV74\:/&[A@0"Q&" 2 6Q]*
M]-HH \UU?3=3\2:UK_V;3KRUBU#P^MK!-<((QY@>0[6R<C.0,=0#R*W=*UB\
MU6Q4W7AN]LKFVMF2=[B$<-MP4B()+@D Y Q@>N*ZVB@#S/3]/OX?#O@"W?3[
MM9M/N4:[7R&S"!$Z$GCU85N_$UMO@:X;87Q=6AVCJ?\ 2(^*Z^LS7=#M_$&G
M?8;J:>.$R)(?)(!)5@R\D'H0#0!S&LV=]J7B"?7-,TYI6M-&GMTCNH3&+J5R
M"L95@"5&TYSQ\P&>N*.EQWR>++#5)-*U?R7T26VEDGB *R[XVQL!^084@  9
M[ ]:]'4%452Q8@8+'&3[\4M 'FHTC4I?@9'I*6%P-1AMHU:U9-KEDD5B #UX
M!QCK6QXNCO)+'2_$FEVS1ZI8W"B*"X^0RQRL(VC;KC.58>A [UV594F@6LVO
M+J\LUV\J* D#7#>0K#.'$><;N3S_ %H M:98C3=,M[0.7,:8>0]7<\LQ]R22
M?K7#ZA97LDWQ$"6%VW]H6:16A$#8F86YC(7C^\0/UZ5Z'10!PT=M='7_  1,
M+*Z$=I931W#&!@(F:-% ;CU4UH>-K:ZFBT.YMK2:Y%GJT-Q,D*[G$8#@D#OC
M<*ZFB@#A1!=GQ!XRN'L+M8[W3[>. F%CYCJD@91C()!=1Z'MQ6/:V>H:.GAK
M4+K0K^_M$T6+3[JWMT)FMIDP=VS()!Y!QZ _7U*B@#,T"UBM-(C2#35TV-F9
MUM0 "@)S\V.-QZG'<]ZXB2PU)/!OC?2CI=X;BZN[V2W(CRLPE8E-I'7.>?3'
M->E44 <5;Q7 \<:->FSNA;1:+)!)(8&PLA>-@IXZX4UA/IVH'X=W-B--O/M3
M:V;A8O(;<8_M8EW=.FSG].M>I44 ><R6TMCXBUJUU+PS>ZO9ZI.+BUG@0,A#
M1JICE#$!,%>I[&NPU.!H_"=W;1P?.+)HDA@4L,[,!5'7&>*UJ* //+O3=3_X
M5YX6:WTV:>YT@VTES8,#')(J1&-U7..1N)'KBH]4L9]0T9]6T7PS<VLT5[:7
M4EO<(([B\6%]Q4C)Z#&W)Y(/'3/H]% ' 6]V^L_$9I!975GYOAZ152[38_,P
MZKDD?C69ID&J_P!E^!K-M#U%)-(N52[+Q!0N(73()/*Y(.[ISZUWQT. ^)!K
MOGW'VH6WV79E=GE[MV,8SUYSG]*U* /+]4T[4)_"_CRUBTZ\:;4+XR6J>0V9
M5*1KD<=,HW7^M;7BN*[35-"UV#2KK4;&".:"YM8%(F19-A#JAP204P1[UVU%
M 'G5[87-I<:%X@TSP]/!9VU_-/<V$:#[0ZRQ>7YS("<N#DXR3@COG&MX9%T_
MC/Q-?2:==V]K>?96@EGCV;]L6#P3G/X?7!KKZ* .4U^.=_'/A>YCM;F2WM3<
MF>6.)F6/?'M7) [GT_&LF"RU#3M,\7:'<Z?<W,FHW%S/92QQ%HYUF7A6;HA4
M\'=CC!&:]!HH X71=)N])\9Z3%+#/+#:>'DL'NQ$Q0RAU.-V.X4G/X=:N?$_
MCX<:SQG]VG'K^\6NNK-U[1+?Q#I$VF7<LR6\V/,\D@,0"#C)!QR!0!S&O6E[
MJ^NVNKZ9ISN^FZ==C9=PF,7$LBJ$BPV-PX)/;D<\U3T.#4&\8:'J,FEZJL9T
MJ6WGDN$"".0M&<;,X11M(  &<<9ZUZ'&I2-59V<@8+-C)]S@ 4V>$7%O+ S.
MJR(4+(Q5@",9!'(/O0!QFDZ-=6?C2^TU=AT2&4:K"H/*32[E,>/[H8/(/0E:
MHW5E>R:;\0XEL+LOJ.\6@\AOWV;=8QCC^\#_ #Z5VFC:-;:)9?9[>2XE+'=)
M-<S-++(< 99CR> !^%:- '#26MU+X@\&2K:7:QVUE<17$GD,!"SQHJ@\<<J:
MS_"ME+!:Z=H>J^%+EM0TR1,7TBAK8B,\3(^?O;>@ SD]AG'I-% 'ET^G:@_@
M+6+-=-O3<S:ZUS'%Y#;FC-TL@;ITV@G]*Z&T^UZ=X[\07K:;>36U[9VTD,D4
M8P?*63<IR1ALD #KS784C*'0J<X(P<'!_,4 4-%U5=:TF&_6VGMO,+*T%PNV
M2-E8JRL/4$&O/=1TW5#X*\9:0NE7K7-SJ,\UOMCRLJR2*R[2.O&<^F.>U>GP
MPQV\*Q0HJ1J,*JC %/H X76=.N]6\8S&WAN(X+GP]<62W+0LJI+(ZE03CC@$
M_P#UZ9X50W3Z;!?>$KFSU+3UVRW5RH,2$+M+1-D[MWL. 3D\<][10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI+-Y;:\^SQVH4B28?+@#YC\QW'MVK;.I017EVDMR,0B(&/RF!4N2!S_%N/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ebs-brginterimmanagement004.jpg
<TEXT>
begin 644 ebs-brginterimmanagement004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+\1:P=!T&
MZU,6_P!H, 4B+?LW$L%ZX..OI6I6#XTL+O4_"-_9V,!GN9%39&&52V'4XRQ
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M 97^4,5CQ\RJ6&3D'@X!Q6"W@S7)= DU$ZC=)K;W1U5;#,)A%P#E8]^W=C:
MF=^/PHUOPU?:Q/?VB:3?6J:C-%)(Z7J_9<83<\B!MWF#!&%!4D*<]2 #H;WQ
M1=V,\DTVC2)I<=VEHUR\NV0LSA ZQE?F3<P&=V2.0"*CMO$>N:C/?#3M M98
M+6[EM?,EU'RRQ1L$[?+./SJA+_;E_P"*C/JGAV^FL+2X_P! CBGM_*&.//<&
M0,S=2!CY1V)YK,A\.F#4-6>_\$W>HR3ZA//'<Q7,"AHV;*\-*I''J* .MU/Q
M/%INK:9IC6D\MQ>RK&[(I\N'<&()?&"?E. .>,\56O\ Q<]G<W\D>G&;3-.F
M2&]N_."LC$*253'S!0ZDG([X!Q5K7+*[U$Z%)#;D&#4([B9&9<QH$<'/.#@L
M!QFL#5=&U9[?Q#H<&GO-;ZU<^:EZ)$$<*.B+)O!;=D;6(P#G(Z<T :Y\3W4W
MB*YTNRTV"9+:989)9+U8V)**[;4VDM@..]$GB/4KNZO4T31DOH+*4PS2RW8A
MWR*/F6,;6W$9QDE1G(S6-K6A75]/?6D/AJ"*\GO8YX=8B,8"*&4^8Q+>8' !
M& ,'CG!-7K0:SX9GU.UM]#GU."YNY;NUFMYHD ,AW,DF]@5PQ/(#<$=^* .F
MLKY+S3(;YHIK=)(A(8[A"CQ\9(8'H1WKGH?%>IW-E'JUMX>DFT:4ADD2?-R\
M9/$@A"\C'.-V[';M5N/1-4O8+>35-:N%E:W\NZM;58Q;NQ!#8W(7[_WAT[5E
M:?+XITSP_:Z!;Z*3>VL26L>HM+&;78H"B4C=OSM&=NWKWQS0!=;Q)K$^IZI;
M:;H$5W#ITXA=VOA&[L8TD^52F.C@<M0GC ZC'8+HFGF\N+NW>Y,4TOD>2BL%
M(8X;YMV5QCJ#R *J6SZYHNM^(&A\.W-]'>WBSP31W$"(1Y,:?-N?<.4/\)JM
MI>AZKX5ET^\2Q?4Y#9RPW4=JZ*4E>8S97>R@IN=UZYZ''7 !HWGC"YCT&/7;
M+24FTTVWGR2378B>-LD%-NTY((QQU/ KH=.N)[O3;:YNK1K2>6,.]NS;C&2/
MND^HKE;;PWJ":/X9TJXC5X(+HW>H[7&T,-\BKS]X>:R]OX:V]3T6]OIY9;;Q
M!J%D'B:-88EB,:DJ1NY3=D$Y^]U% %-?&-O+J>M6EO;/(FEVGVAIMV%E8%PR
MKQV*$$^N1VI^D:SKVIQV=S)H5K!9W*+)Y@U$NRJPR#M\L9//3-8$'A'6K"_U
M!$NH[BR.B"SA"P)'O8&7"?>R"-P.X]=WM2^%]'72VTL/X(O;:[AC2.2\-S R
MJVW:S8$I)'7H,^U '16OBFVN_$MUI$=O.J6MNTSW,B%$8J^UE4$?, <Y8<<8
M&:K:5XMEOY=,>YTQK6RU8$V$QG#L_P A<;UP-A9 6&"W3!P:N'3[D^-O[0,0
M-I_9I@+DC[_F;L8Z]/PKE-,\*WLNI:4C66H:;#IK2ON>\66*,F-T5;<9)V_/
MNRZC 4#N10!U6NZY=Z9?Z;8V.G1WES?M(%$EQY*KL7<23M;M[527QBZVERD^
MELFJ07L=B+19PRO*ZJRXDQC;M;))&1@\>N7XA\,WC7&BM/;WWB:WMIIWF6:2
M!) &C"J!_JU(!&?7K56T\,ZI:Q37=GI+6=M!J4%[:Z2UPCO\JE92&W%5+!L@
M;L97J,T ;[>+Y(XWM9--QK"WB60LQ."C.R>8&$F/N; 3G;GY2,9H'B^1D6U7
M3<ZR;TV1LS. @<1^:6\S;]SR\-G;GD#&:RI-'U:;5&\3#39%G34H[A+!I(_-
M:!8&A/.[9O/F,P&[H ,Y-"Z/JR:L/$YTV4SMJ37#:>)(_-$!MQ .=VS?\H;&
M[&"1G- '5:)J_P#:]I,[VYM[FWG>WN(2P;9(O7##J"""#QP1P*S7\2:G=W%[
M_8FBI?6UE*T$LLMV(3)(OWEC7:V[!XR2HR"/>J^E^']3FCNKR;4+[2)KR^DN
MVM[<PL=I5$57+*PSMC!^4_Q'DTRS_MKPRVHV-MH4^I0SW<UU:303Q(H\UBY2
M3>P*X8GD!LC'?B@"YKGC&VT3PW!JSV=RTMPBM%9NICEZ9;<#]W:.I_#N*L>)
MO$UOX:M8'>%[B>>58XX4.#@L SD]E&X<^I [US7B'PCXCU/2;NZ.J0S:G/8I
M;M;);KL!!!81LS#:"W))ZX'H*D\2^#]<O8+RYMM7%S=3K;1F)K5!A8W4G:2W
MRC(9R._3G H U_$?B/5=!WRQZ''=VV](X6%Z$>9VP JIM/.3CKVSQ4=WXPFM
M6U"8:47T_2RJ7]Q]H :-MJNVQ<?.%5@2<KWQFK=SIE[=^)]&EN1YME86\LK2
M\ /<G:BG;G(PID/H-U<YXI\-7FJW>KV=MIUZB:F$0W$-XJVS?*%,DJ%@V]<=
M%!# +GO@ V_^$BUBZU?4[/2]$MKF*PF6%II;_P HLS1I)POEMQAP.M#>(M9F
MUF^TZPT.VG:R$7G/)?\ E_,Z;L >6<XZ9JK9>"[.X\0:[>ZKIRN)[J-K60R'
MYHU@C7HIX^96ZUG:GH#/XPUB^O/"=SJ\%SY'D30W$*!0L>&!#2*>OM0!N77B
M'6(M5M=*M]$MYKV2S-U*K7VQ(P'"X#>6=W)'85H/J\]AHDM_K%FEK(AP(()O
M.+DD!54[5RS$@ 8ZFN2U30Y+K6M,O9?"%U=V,6FFV%HMQ"'MWW@@$F4 _*.Q
M/6M&+P]=7UOI\EE%-X?2PDD:.RN(X[@,[ ?O/E<C(RP'/&3QTH LQ^+Y;O2]
M!GLM-$EYK,1EB@EN/+2,!-S;GVGGD8 7GVQ4D'BB\U+3;&ZTK1GG:Y21Y/.G
M$4</EMM8&0!@23G;@<@$Y KFK;POJEOH/AFWUG36UBULK=TN-/C,8,<A"A&P
M7"R;0'7K_'D5HVNGZI8^&[;2]0T#^T],D$P>R25'EMU\S=#&2[!655PI(/!
MQD<T 7[_ ,=6=GX5LM;2SNIOMD0EBMU0Y XR789"@;ASW[9S755QDFA:L?A>
M='D7SM0\K:L?FAMH\S*IO/7:N%SWVUV= !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %4[G2M.O;F*YNK"UGN(?]7++"K,GT)&15RB@ HHHH **** "
MBBB@ ZC!ID,,5O"D,,:1Q(H5$10%4#H !T%/HH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BD9U7[S ?4TM !1110 44UG5%W,P4>I.*C^U6__
M #\1?]]B@":BH?M5O_S\1?\ ?8J1)8Y!E'5A_LG- #J*,BFLZHNYV"KZDX%
M#J*A^U6__/Q%_P!]BE^U6_\ SWB_[[% $M%-61'&4=6'J#FG9H ***,CUH *
M*IOJVG1R>6^H6JO_ '3,H/Y9JTDB2*&1U93T*G(H =1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M04445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ?I6S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$$'\:U:AM;6.TA\N/)RQ9F;DLQ.23[U-0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*7Q&MJ]R\[(CHSLC0K$"5*+C&XX)*Y .<T >F5%)<QI,(-P:=HVD6($;F5<
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M,3MSM&#D  # )%;GQ/@2;P3*S&0%+NU(V2,O6>,'.",\$]?KUH [&BN.B?\
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M39:KYK%/+0;=RJ3@;F#'(ZC;0!MU0U758-)MX9)06>>=+>&->KR.<*/;U)]
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MGEG: P3+%5!([8XQ6;X/\+?9--D75K!TN/M\UTJ//OC):1G1MBL5W $<D9!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME^7C 0$?='>I(O!]M8ZS>ZII%W<:;-?8-U'"$:.5AGY]K X;D\C&<\@UT=%
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MN]2OX9[N35-1!6>_F96EP>P&W:!P. O8>@JKI'P[T[1/"U_X=L]0U 6%]O\
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M7)V]1T'/?I5>#QQX>N6M1#>NRW4YMXI/L\@3S=Q78S%<*Q(. 2,]JK:A%/\
M\+)TF\%K<-;0Z?<123+"S*K,R%1D#T4US$>GWZ^ ;*S.FWHN8]=%RT7V=]PC
M^UF3=TZ;#G].M '6^+?$$%AH>L1VUW/%>VUHTADMX#)Y+;25W':57.._;G@<
MU)IWB"WM?#6ESW\TTMP^GQ7$OE0O*^-@R[! 2!G//?FN8DCU/38O&NF3:5?W
M)U5I[JRN((2Z2!X0HC8_PE=N,'&>U5[6WO\ 1KW3[S4/#VI7ME=:1:VKI;+N
MEMIH@P*L@8?*=QY[&@#M'\7Z$KV:+?>8U["9[80Q/)YJ#&2NT')Y' YYZ5 O
MCOPZ]M#<B]D\F27R6<VTN(7W;=LOR_NSNX^?%9$>GO:>*_"K6^CR6=G:VMVK
MQPQ$I;^84**2N1G@YP2 >_2L>\T^_E\!>++./3;TW-WK$L]O%]G<-(C3*P8<
M=, F@#MKWQ?HNGWEW:3W,IN;2,2S116TDC*AS\P"J<C@Y(Z=\4R?6--NM2T
MQ:O,GVW?+:Q0J3'=KY9/S':< #YAR.:RXUF_X3G7+XV=W]EFTN"*.3[,^'93
M(2HXZX9:QM&L+^WM/AW'+I]XC:<)%N\P-^YS"R#/']XC^= &C/K$VN>(==TR
M+4-1TT:>D'V>:"U?Y6*L[LX*X(.  &X('')S6YH^L:=%X:TZX75+C4(;@;(+
MB6,M-<GD\*%!)P#VZ#)]:H:+YUOXV\57<UI=I;W'V8PR&W?$FR,AMO'8\>_;
M-<QI-EK.B>'?!6I?V3>S_P!DI/!?64<9\Y1(,!U4_>Q@=.S'WH [R/Q7HTUJ
MD\5V7WW+6BQ")_-\Y<[H]F-P8 $GC@<]*I:GXVTZST6'4K99KI);U++:D#YC
MD,@1@XQE2.>",D\#K6?J=W?R?V5=0:!<V]G->N\YBMU:[B4QD!]O.PLV02/F
M"^A/& NE:JGA;4H1H]^'A\2"^6-QO>2'SU?*_,2Y"CDY.?4T =U#J-E<>*Q
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M4A\L[1&#A%&T@8'.!C<:K6FGW\?@3PW:/IMZ+FVUQ+B:+[.^Y(Q<,Y8\=-K
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MMQ*3&)(RV]MV,[0J$],]![U!X52=/B%XP%Q%!')LLB3!]U_ED^;!Z$]^OU-
M';45S?B/Q%>:*;IX[6 6]O:&X$US+M6=QN_<ICG=A<YYZCBJTGBR_GU+1;2P
MTV!QJU@UY$\UP5V8"'# *>/G'(SGT'6@#K:*XAO'%]'X8CUB338%$&H-9:B/
M..VW"R^6TJG;\R@\XXX/M7307\UQKEU9I%&;6WB0M,&.?,;)V8QCA0#U_B%
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M9R3M.\$*1M*Y)+D #))Y_.LZS\)Z79"..)9S:Q3&XBM7F+11R9+;@#[DD Y
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M]7OI8;F(P.T]V\CB(\&-2Q.U?88K6M],MK?2$TL*TEHL/D;96W$IC&">_'%
M'$#Q'=1>)=9LUO)YK:^MP=&=F&PRAA'(JD#)Q(Z\GH >U:PN=0L_B#::9_:,
MTUJ=&EF*3!<&59(UWD@ \@GVYXQ6Q#X;TJ!-)6.U4?V2"MF>\8*;#]<C]>:=
M/H-G<:VNKN9OM:V[6P(D(7RV()7;TY(!SUXH XFR\5WFG0WG]K+?P:W9:5/<
M26=Q\T%XZ -YL+CC;P1M&,!NG&:VM)BU]]0TC4O[2MY--N8#]J22Y,GG%DW(
M\0\L!3G.0#C'TK7M/#6GVS0%_.N1;P-;P"YD\SRXVP&49ZY"@9.3@8S5?1/!
MND>'Y_,L!=!5SY,,MR\D4&>OEHQPN?7K0!T%%4]+TR#2-.BL;9IFBC+%3-*T
MC\DDY9N3R:N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2RCS6Q(#:LWS#."<C.3S0!Z/15+5-3M](LOM5SN*F1(E5<99W8*H&2!R2.I
MK*O_ !?;:7 LM]I^H0YO4L=HB5SO<*5;Y6.5^8=.>",9H Z*BN:L_&VFSS:E
M!>07FFW&G1">:&\C"L8CT==I.X'IQSGC%2Q^,-/74IK"^CFL)H[5KS-P4*M$
MOWF!1F&1W!P: .@HK#M_$T,U_!9OI]_"]S;M<V[21KB55QD<,=K<@X;'7UXK
ME]1U^.U^%27_ (>AU!8)I1$DDTH,L8:Y"-EF?=DY8#!.,CIC@ ]$HKC;"#2=
M.\;6\8M]6M[Z\MI9HX);C=;Q!=H?"ARNX_*>,_A6G%XLLYI[ ):W9M-0D:*U
MO @,4C $CH=P!P<$@ X^E &_17/0>,+&>YLD%M=K;WUS):V]RRJ$>1-V1C=N
M&=C8)'./I7,7#3+9_$M%NKL?9E+P,+A]T9^RA_E;.0-QSCI0!Z117,:5XABM
ME\.Z1/;W1GO[%7BGPOEL5C!8$EL[L<XQ_6MNQU%+^2[6.&5%MIC"7?;M=@!D
MK@G@9QSCG([4 7**YAM:TRS\0Z])]GU W=E9Q2W(R2C1_.5\M2V,\-DX%/T[
MQI9ZC>Z5;BQOX$U6 S6<\T:A),('*\,2"%.>1@X.": .DHK _P"$MLS):,MK
M=O9W=U]DAO$16C:3)'0'<%RI&[&/?!!K!L-;3P_=^-[^[-Y<6EE>QL5#^8R(
M84)QO;IDG@'Z4 =[166VO6R:]#I#Q3+--:M=)(0OEE%*@\YR"-P[5R7B77?[
M2/A>ZLHK^.TGUFW6.Z#[8IT)/50V2#C(W+V]QD ]!HKG-3\9Z=I237$\4[65
MO.+>XNTV%(G)"G(+;B 2 2 <'Z'&OJNIVVCZ5<ZC=EA;V\9D?8NXD#T ZF@"
MY17/OXMM8&U2.YLKV"?3K9;N6$JC,T1W?,NUB#]U@1D=*9I_C&SU#4--M/L-
M];C4K<SVDT\:A)<*&91AB00#W !P<$T ='17GWC77Q?>'H9]/COA;C4X(4O8
MI D;D3JK9 ;+*<,N2,$_@:[F_OK;3+">]O)1%;P(7D<\X _G]* +%%8<?B>V
M6^FM+ZUNK!HK0WI>Y5=AB!PQW*Q ([@X-,3Q7:FYL(9[.\MAJ*DV<DRH%F.W
M<%X8E6(Y ;'Y\4 ;]%8%EXLM;_1I]2BL[P""Z-H]NX02^:'";<;L?>(')INJ
M^,;#2(KN>6"YEM[)E2[FBV$0D@$Y!8,V P)V@XS[&@#H:*YN7QG:KJ\VF6^G
M:E=SPK#(QMX0RF.0D!P=P^48Y_3/.)?%^O7'A[1X[JVLVN'DN88.&4!-[A<G
M)&>O'OC.!0!OT5PD^IW%C\2IG6SU*X\S1$E%C&X<A_.8$@%]BG '0C..Y-;U
MOXLT^]TO3KZT6:8ZC&9+> ;5<A?O9W$ ;20#SU('.: -VBLO0=>L_$-C)<V@
MD0PSO;SQ2@!XI4.&4X)&>G0D<URT.H-IWCWQ7/<75Y)9:=IT-TMNUR[(N5<O
MA2<<[1VH [VBN/\ "5K-X@\.6FN:Q<W,EW?IYX2*YDBC@1N41%4C&%QSU)SS
M67XNBO-"T;P^DNKWQ+:_%%-.MRZ,]O)*[%6*D9PI _#B@#T2BN6MKS1X;^[N
MK+4+Z;^S[0RW$3W4LJ%&R0<.Q&X>6W(]3ZU5\(PR^*?#,&N:O<71N-0W2I'!
M<R1);IDA50(1R !ECR2>M '9T5R?@G6KN^DUK2-0E,]UH]Z;<7! !EB/*,V.
M-V.#]*OR>*;>.^U>R-C>M/ID"W$BA4_>QMG!C^;YONGTZ8ZT ;M%8UIXCM[Z
MUTJXM[6YD34HC-%C82B!0<M\WN!QGD@5S@\50:;X7L[S1-/OI8KK5_LA%S("
MZ,TY5_O/W.X*,X'&<4 =Y17!/JT^F_$/4Y!9ZE=!M(@G^Q1N'*-YDF[ 9]B\
M < \XXS78Z5J=MK.DVFI6;%K>ZB66,L,'!&>1ZT 7**\^\?Z^+KP9J3Z?'?&
M."X2'[;;R!$#B558<,&9<Y4\$9^F1T#:C8+XUN+<07QU*+31(<,?*>+S.-J[
ML%MV><=NM '0T5RVG>/+#4K&.^CL-1BLYHU>&>6%525V?8(U.[[Y)'MWSP:G
MC\::8)=2ANUFLY]/1))8I0K%E?A"FPL&R>, YSQB@#HJ*Y?5/&7]GV>KG^R;
MU;W3[(WOD2[ LD?/(<,1P0<C.?0&MG1;R;4-&M+JX@>&66)697V\D@'(VDC!
MH OT5@/XMLU>W9;6[DLY[O[$EY&BM'YNXKTSNV[@5W8QGVYI+WQ=964-[=?9
MKJ:QL93%=W4*J4B88W<;MQ"YY*@XY]#@ Z"BL>+Q':R^(DT589_-DM?M<4_R
M>5)'D#*G=D\D<8]^E,'B6W:.'9:W+3SM*(8"8PTBQG:S@EMNW)&"3SD<<T ;
M=%<HOQ TI[.RN([:^D-U>-8B)(@7CG7.4;YL9^4]"14LGC2"*VEE?2=362WL
M_MMS \:*\$66'S L 3\C' )X'N* .FHK'?Q':-<6EM:1S7EQ=6IO(XH@H/DC
M'S$L0!DL !ZGV-5K'QEI^HZ5;7]M#=%;N5HK>)U5'D902V,M@ ;6R21TQUQD
M Z&BLK0_$%IKT=U]G26*:TG-O<02@;HW'/8D$$$$$$@U7D\56D?]N!K6[WZ*
MH>Y0!,LI3>"OS8/R\\X- &[17.2>,K1;NPM8;#4+B>_LS>6ZQ1K\Z_+QDL #
M\PZG'O3[7Q?I]WHUKJ,<5R&N;@VL=HR@3&8,0R8S@$;6).<8&<T =!17!Z)K
M M?%WC.YO_M=O;VRV9\JXD\S82K_ ' &888D8"]SC&>*V'\:6,-U?6ES:7<-
MU:6AO3"0CF2$'!92K$'!X()!H Z2BL?0?$,>OQ^=!I]_;P-#%-%-<1!4E5QG
MY2"<D=_PQD$&L:?7[K4M1\4:0UE<P0V%LH6>.55(9D=MV5;<,_+C'ISC.* .
MQHKA_!OBB,:+X6TR[MKX2WUA&(;N51Y<TBQ!F7.[=G )R1@XX)K5N/&FFVLM
MN9(Y_L<]U]D2\&PQ^9N*@$;MV-P(W;<?AS0!T=%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !3)7:.)G6-I6 R$0@%OID@?K3Z
M9++'!$\LTBQQH"S.YP%'J2>E ',?#[3-0T'P19Z9J-HT5W;>;N59$8/ND9AM
M(/HP'.*P;;P[K</@S0=-;37^U66L+>3*)H\",3M)P=W)PP&/7-=M#X@T>X=$
MAU.T=G(" 2C+Y.!M]>2.GK6E0!P5MI&NZ3K6J6T6A6.H65_=R7<%]+*BFW,A
MRRR*068 Y(V]>G';JM>T6#7_  ]>Z/<L5BNH3$74<J>S >QP?PK3HH YC0KC
MQ!I^F6^F:CHSSW-M&(1>03Q^3*%& QW,'7..1M/MFHKG2]5LO&EKXABA^W))
M8?8;N"%E1D(<NKIO(!&2002#C!YKK** //+CPKJ<5I'+#:&6XN?$::O/$LB#
MR8U8?+DD MM4=.,D\XYK533M2C\5>([_ /L^0V][90PP$21Y9D$F>-W'WQC/
MH:ZZB@#S"SMK_1-4^'EE<6$C75K87D,L*2(3PD0)!W8(_$<?E6A-H6OV\]SJ
M5I;%AJ6JK<7MC'<+')]G6/8J[\XSD!F /.<9/.>LU#3=+-Y%K=]\DM@CLEP\
M[(L*$?.<9"X('.?2KMK=V]]:Q75I/'/;RJ&CEC8,K#U!% 'F\GAC75\.:[IL
M>D0H;O68[V!8;A-OEAXG(YQC C(^IZ8YKJ(+&^'Q#N-6>S>.QDTR.V$C.G#K
M(SG(#9QAL9]17356O["UU2PGL;V%9K:="DD;9PRGMQ0!RWA30WL/$&KJLRR:
M99W#K81@?ZDRA9)5^@; &.F6%:_BC3DU738K.;25U.UDF'VB'>$=4VMAT)(P
MP;;W!QFM*PT^TTNQBLK&W2WMHAA(T& /\^M-GU.QM;^UL9[J)+NZ)$$);YY,
M DX'L : .&7P[K\-EHMNZ75[%8ZW]KC^T3HTL5J$951F+?,V6)X)X[\5->Z5
MXECOO%EWIEJT<E_/:O;GST5I(XU5)%!R=C$!L$^O8UVMMJ%I>3W4%M<)++:R
M>5.JGF-L X/X$59H X&ST+5K;4/%,R:,D$&J6$20(MRK-YBHZD-_M$N"3G'N
M:='HFKII_@:$Z>^_2"GVL>;'\NV QG'S<\G/T_*N\IDTT5O"\TTB1Q1J6=W.
M H'4D]A0!F>([3[?HTEHVF1ZE#*Z+-:NP7>FX;B"2!N'4<CD#D=:X'5=*U'0
MM%M(6-U+9CQ#9-I]K=3B26--RY0ODC&[.,DX&,FO1[#5[#5'N$L[E99+=@DT
M>"KQDC(W*<$9'3UINIZ/8ZPD"7T32+!*LT8$KIM=>0WRD<CM0!R>N^$[WQ/>
M:O?%/L$LNF+8VJS%6)82>;N?:2 NX*,9)^]3AI.L>(_#^H:;J6A66B236DD#
M312I(9)&& 5VCY4[G)ST%=NS+%&69@J*,EF/0#N2:SE\0Z0^FPZDFH0-932B
M"*<-E7<OL ![_,,4 9OAZZ\326\,.L:1%:&UCVRR1W*R?:F P-@'W0>OS$8X
M'N.<_P"$=UP?"B'0!IK'45N5<IYT>T*+D39W;O[O'U_.O2*J1:I8SZE-IT5W
M$]Y @>6%6RR*>A/I0!@:EIE]?^--*OQ92K916-Q;S.9$!1I-F.-V3C:>GJ*K
M>$+?Q/I.GV?A^]TZ!;>PQ$NI+< K-$OW<1_>#$8!S@#D\]*ZJZU"TLI;:*YN
M$BDNI/*@5CR[X)P/P!J%-;TR0WX2^@?[ ,W>UL^3P3\WIP": .$&A^*+B;1;
MJ^TN*;4;'56FN+I[M<2QD2 &,<[4 9?EX/'0G)K0GT75I(O':KI[YUA"MG^]
MC^;]P(N?FXY&>>WOQ7:VUS#>6D-U;2++!,@DC=>C*1D$?A4M '$Z]IER? .G
MLJBVUG2Q;RV@<@_Z0N$"?*3D/DI_P*NJTJQ_LW2X+4OYCHN9)/\ GI(3EV_%
MB3^-0W&@Z5<:U#K5Q91/J%O'Y<<[<E%R3QV[GGKS5FPO[35+&*]L9TGMIANC
ME0\,.E '*7FDZH_B+Q-=QV#O!?:9':V["2,;G429R"W ^<<GT-06NBZM$? F
M_3W']CPF.\/FQ_*3;F+CYN>>?I[\5W=% '$^$[+Q-H-I#X=FT^!K*UE(BU3[
M0N'@W%@/+^]OP=OIWR<<UKSPUJNH6/CFU^R^2=7;=9N\BD-B)4P<$D9*_D:[
M^B@#@Y-)US6O$%E=W6E_8+8Z3<6,Q:Y1WB:39SA<@_=.,'ZXZ52CTCQ0WA[P
MWH\VC)YNBW]LSW ND\N:*+(#+SN!QC(('XUZ310!P-EH^NZ3JNI6*:'87UE>
M7DMU;ZC)*@, D8LRNA&YMI)QCKP..W4>)HM6E\-WL>A.J:D4 A)8+W&0"> 2
MN0#V.*UJ* /.6T#6?[1UNY@T-8(=1T46JJ;M&D$H\S[Y)Y8[QDY/ ZD\5>AT
M;51=>"6:PD5-*MGBNSYL?R%H1&,?-SR,\=O?BNXHH \O7P]XFM_ T7A4:4L[
M6-W"T-X+E%CGB2<2 X)W!L=01CC@GI7:^*]&G\0^$[[3(95@N9XP8V)RJNI#
M+GVR *VZ* .0EMO$'BOPW?Z7K&G1:1Y]H\#,MPLQ>1A@,-O1!R<$Y.<=N8AI
M&K:U;>&[74['[(^DW,=U<3>:C+*T:,JB/!)PQ(/S 8 Q7:4R::.W@DGF<)%&
MI=V/10!DF@#F+?PW=6WC>[O8W0:/<[+QXN_VM5,><>A7#'_:4&LY-)US2/$6
MJI;Z%8ZK8:C<FZANI9D1K9F #*X()9<C(VY_P[6TNH+ZSAN[659;>=!)'(O1
ME(R"/PJ:@#E],TW4+;QWJ=_+:D6<]E;P).&0 M&7)^4'(!WC'':I_&NEWNK>
M'#!I\2S7,=S;W"Q%PN\1RJY&3P#@'K70U6GU"TM;RUM)[A([B[+""-CS(5&Y
ML?0<T <[#9ZI_P )\^LRZ:ZVS:2MM\LL;'S!(7QU'8XSZ^W-<U8^&/$.EZ)X
M:NH])@N[W2UN+>YT^:9 )8Y7#;D?E0057K[UZA10!G:*ERMB7NK&"QDD?<+:
M$AO+& ,%@ "W&3CUQSC)YVWT.\N/&WB*XO=/<:7JEE%:B3S$R0JL&R V0#NX
M_I77SW$-K;O/<2I%#&-SR.P55'J2:IQ:YIDPT\QWL3#403:8/^N 7<=OX<T
M<_X8AUSPQI4.A76ERZA#: QVU[;2Q /%GY=ZNRE6 P#C(XI/%^FZSJEKH?D6
M0N)K35H+Z98Y$55CC8DJ"Q!+8([ 'VZ5V-% &(7O=1O%@DT62WM)8V2ZFN)(
MR63! 0!&8\ELY/0 ^M9GAJRU7PEHJZ&=/FU&"U9A:7,$D:[HR25#AV4AAG'&
M1@9]JZZB@#GO"GA^71H]0N[QXWU'4[IKJY\LDHA/"HI/4*.,]^:@\0^';K4/
M$6FZA9.J1O')9:CD\O;-\^![[EV^WF$UU%% '*^$_#EUH$FH1SL'M897CTR-
M2,QP,WF$?]]-M^D:UAQ^&];7P7#:_8/]-MM;&H" S)^\C^T&7 ;. =I[XY%>
MC44 <E#9:HOC:_U:737$$VEQ6Z[)8SF16=B.2./G SQT-7? ^G7FC^"]+TV_
MA\FZM81%(NX,,CN"">*Z"LZ37=+AU&.PDO8EN9&*(A.-S@9*@]-V.=N<XH X
M";PYXEM_ VI>$8M+6Y N"]I>BY14DC:<2X8$[@PR>V/?UZ;[%J0\?OK#:>YM
M3I M<I*A)E$A? !(.,'&>.?;FM$>+- -]%9?VI;BYF95BC)P9=V=I7^\#@\C
MCWK9H \[M_"NM'X7Z9I0MXH=7TR6.>.&=U:*5HWW;203\K D?6K.HZ-K7B/P
MQ>1#1[/0KT>5);Q>:LI>6.19!N9!@+E0!U/))QBN[HH Y.Y3Q%XD\+ZM9WNE
M1:7+<6$MO'$URLI>5E(!RO"J/S.>@QSM: MVFA645]:BVGCA2-HO,#XPH'4<
M=NU:5% '$^%[+Q-H$7_"/-I\$EA#.[0:I]H&/)9RV#'][>,D>GOQS##H&L6&
MC>)/#\=F+F#4IKA[2\\U D:S@Y$@)W94DG@'(]*[RB@#C]:\*W@TS0!HDXCO
M](*01S/W@91')GU^7#X]4%,\1:%?VNI:-JFB:;;ZC'8P/9RZ?-(J;HFVD%&;
M@,I0=>HKJ'U2QCU.+36NHA>RH9$@W?.5'4X]*MT <5J>F:O>#P_,FCQ0M;:H
MMY-;P21XAC$;)C)(W-\P/ QU&> 2GB?2M>U34-5MA9)>:=<Z<8K/=<!$@F(8
M,74\L3E<'!QCMDFNVHH \U:#6+:_T(6>DM)JFGZ0(+M;2]B62-6*A5;S 4*D
MQL1CG(ZXZJ=)O9=*TF71M!\JZT"ZDCFTJ^F1O/61 7(D!*ECO# GOGZ5V>I>
M&='U:\2\O+,-=(NP3QNT;[>N"RD$CV-:%I:6]C;K;VL*11+T51CZGZ^] %'0
MUNS:O-=Z;!IK2-\MK$RN5 '5F48)/MP!CFN7U31M<35/%RV>G+<P:W9JL,_G
MJ@C=83&58'G)X(P,<\D5WE% '$:=I&KV^N>&KF?3R([#27M+ADF1L2'R\8R0
M2/D/YBLJ'PSX@M+6PU""P#7NG:S=7HM'F0>?#,7R P) 8*W? ZUZ95:RU"TU
M%9FL[A)A#,T$A0_=D4X93[B@#@K_ ,-:[KD_BIS9I8?VE%9O:&:97(D@.X*X
M7(P3@'D_C6G%#KFH:%J*7/AFUTRX>RD@6.&:-VFD88!!& J#W.>?;GLZ;)(D
M,;22.J1H,LS'  ]2: ,SPS;7%EX7TNSNX3#<6UI%#(A8-\RJ%.""01Q6&^E:
MM;>(_%$\5B)[75+:+RI%F4$,D3(5*GOD@YZ8SSGBNHL+^TU2RCO;&X2XMI<E
M)8SE6P2.#]0:LT <#9Z%K$-IX$B?3WW:.-MW^]CPO[@Q<?-SR<_3WXH\/:/K
MNC.=$ET.QGM(IV:#5VD3/E%RV&3&XN <>G3GU[ZJEWJ=C836T-W=10RW4@B@
M1VPTC'L!WH MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_2-6R3&O^SN9SC_:- &-8>(O$&H-H][;Z<LNGZ@H:5?)*FV1EW(^\OAP. <
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M&R5MRE<.VX[A@G@ 9.":L:YH$NK7^EWUMJ#V=SITKNA\L2*P==K J>^#P>U
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M@;'( ))Q^-<M>1Z9XL\66'D1W#2Z)<2&YE:)XTR,8CR0 ^7"/QD?N_<9[&@
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MA@M\D6&/U&#^-5VU"\O?A=<>*DN;B+7X)Y).)&^1UG*B IG&W;A=N.<YZ\T
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M!=;MO#VI263;_P#5M$TF%8JQV;\GD'@<^@K>BT;3(+J"ZAT^VCN((!;Q2K$
MT<0Z(#V7VKEOA;-';_#*PFFD6.*-KEG=S@*!-)DD^E '4:9K6GZQH\>K6-RL
MME(A<2#C '7(Z@C!R/:L[1O%46L2V.VSEAAU"![BSD9E)=$*@[@/ND[U(Z^^
M#Q7!^%=8ET?P^_DQ(B>)/$,ZZ;]H4^7' YX<KQD84X7C)([5'I%F= U>Y\!R
MW,T%[,Z-IFI+.5?[&6WL@.>&&UAM'!)SC S0!Z;J^N6VCFUBD62:[O)/*MK:
M( O*V,G&2  !R22 !5=O$/V/4;2RU:S:R:\;R[:7S \3OC.PL,$,1G (P<<$
MFN;U9%M/BIX5NVD+V#6US912LY<+/Z%B3\Q (YY)!%3?$^)[W2M'T^UYO[C5
MK<VX7[P*DLS_ $5023VH [*]FGM[&>:UMC=7"1EHX X3S& X7<>!GU-21,[P
MHTD?ENR@LF<[3W&>]87CEI$\":Y+%--#+%92R))#(R,K*I((((/45SYMVO\
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M0IRV,  = !5;199H_$WAA(YKD6NHZ5.TCRW+&2ZP(RLLB@X5SN)&"2,XR.E
M'I-%>1V N(O"6@:Q_:&H/>C7A;[Y+N1@8FNWC9"I.&!'<@GWX%;NHW5QX8\5
M7]MYD\\6NVX_LX2RNZQW0.TQC)^53N5^,8PWI0!W]5-5OCIFDW=\('G^SQ-*
M8T(!8*,GD\5'':C3="%LEU(/(MRHN)F+L"%^^Q/4]ZX"VNKJUMM0TG6;.:VU
M,:+<%9X[AIK:^4 ;I1DY#YQG(SANO2@#T+2+\:KHMCJ(C,8N[>.<(3G;N4-C
M/?K5RO,]$A;3;SX>RP7-UG4+!H[E7G9D=5M@ZC83M&"., 4RSOI/[2\*7]G>
M7$MM?:A<1M=S3D/=H5E/S1CY0@*C;W&!P* .H;QALL/$ET=,FSH;LLD?F+F0
M+&)"1V'!]ZW["Z%]IUM=A-@GB27;G.-P!QG\:\^G_P"01\4O^VW_ *1K7;:#
M+&-!TJ(NHD:SB*J3R0$&2!0!IU%<W,-I"9KB18XPRKN;U)  _$D#\:PO%<\8
M;2+1IYQ+<WH6.VB;:+G",2CMV08W'UVXP<XK@;L/>>%;J&\D=_L?BR."%1.[
M")/.C^4-P2!N(&>G;% 'L%86I^)X+$:0\$!NH-2O$M$F1P%0MGGU(^4]/SK1
MNK6%](GM?F:'R60CS&R1C&-V<_K7EUG:1?\ "O/A\B22H9M2M"Y60DC*2#C)
M.W\* /7:*\LO=2N/#DGBJSM[R>*P@U#3U\R:9Y3;1S!/-8,6W =>_&<C%==H
M>E3:;K]S*-8CFMKNW5UL8U8JC X\U2SM@$'&!@'&>QH Z6BN'UVP_M/XBV.G
M2WE]%:7&E7#2Q073Q@D/& 1@\'GJ,9[Y&16:L5SXACU^,:\--N]+OFB29R[2
M6L<>W8V/, *LH))(^;)SG' !Z517GCWAUFP\9SWEU*EWI;216ZQRM%Y"K"&2
M0 $8+,6.3Z8Z"ET.XG?Q!X25[F=DNO#K/,C2L5D<"'YB,X+<GGKS0!Z%17E6
MG:U<KI.CVLNH%;2\UR]MGN+B1W!56D\J,MN!P2 !SS@#H2*U[C2=9TZQN;.P
MU:#4)?[02>/3I6>)2A1F:W$A9B,XW@'@8Y&#0!W,]S#:B,S2*GF2+&F?XF)P
M *EKRF[DLM8M_#3_ &>^MI8O$AMI[:YF;? YBD9D# \C[N".V ,=*[7QKJ5W
MHO@75;_3<FX@MB8F'S%>@W<]< D_A0!T-8'_  D4\]])'I^F/>6UO>BRN94E
M"M&^%)8*1\RKN )R#UP#BL:]1M,\1>%I-)N)Y+?4F>"ZC:9G$\?E%Q*<D_,,
M9W#DYQ3_ (?V,$$_B62/S-RZU<Q#=*[#;A.Q.,^_6@#8UGQ)_9&LZ7IG]GS7
M$NI,Z0-&Z@ HNX[LD8XIUGXDAN=;FT6>TGM-2C@^T)#-M(ECSC<C*2",\'."
M/2L'QI')+XW\$I%.89#<W.)%4,1^Y/8\54@6XTOXQV\5_/\ VG-J&G.()]H1
MK.-#DJ57@JQ_BZYXH U$\?(=.U/46T2_^QZ9<R6UW(C1L4,9^=@N[)49SQV[
M5MWGB+3+'0XM8DGWVDZH8#&I9IB^-BHO4ELC KRQEU$>'?%+I*[:+_PD5VNJ
M0VZ?OS;D@.R,<C@=1C.,\BN@\8_9+%/ VHVA0^';&]BW,AS'&A0+$Y/]T>OO
M0!U=SKM]8V?VR[T2X2#(R(Y4=XP3C+J#@ 9YVEL5NUROQ!U:^T7PH^HZ=<+'
M,DT4>&C5U97D5#D'V:NFC= WD&8/*B@L"1NQZD#UQ0!)17&>*H7N?&OA:T^V
M7D$%U]K2=(+AXQ(%BR.AX/)Y'//6N4U%;_3-&\3Z9!J5_P#9=.U:R2RG-RY=
M%E:(O&6)^8+OQAL]: /7J*X:2WCL/&^F^'3-=G3+JWN;S$UR[F:?<@V;B<E5
M4LVW.,G/:LUK+5[_ $;Q7IEG>7;2:3?;M,E$[AFPBR& L#EEY*<D_>]J /2)
MF=()'CC\R15)5,@;CC@9/3-1V4L\]C!-<VQMIWC5I("X?RV(Y7<.#CID5R5O
M?Q>)M#O]?M)KF*V.G>7;^7.Z$/L+NW!'()"9Z@HP[UEZ-J<M[)X'TB]GD^RW
M6B_:G+2$&YF5$ 5CG+8!9B._&>E '8:#KO\ ;AU,?9'MFL;U[-E=PQ8JJG=Q
MP/O=.>E;%>2VUX=#L=7MX;HV]K/XM-M-/*[-Y<;1H>6R"!D*N<C@]:[CP]I<
M^E:KJ:/JRW,$XCFCLE1L6N002I9V.&(SC@9!Q0 _4/$K6/B6UT-=-GGN+J%Y
MHG21 NU,;LY((/(J73O$D.HW]]IHM9[?4[)5>2UGV@LK?=964D%3ZYX[@5S^
MOQ33?%;PZD%RUN_]GW1WJH8XRG&#Q5?P]Y^G?%C6=/OI1J-W=6$=T+\+M,48
M;:(64?*.N<C&>] %Z'XBVS>'EU^XTB_@TKS3%)<9C?RL/L+,H;.W<,9 -=#J
MVNV>D6D$\I>5KF18K:&$!GG=NBJ.GODD #DD5Y%8QW!^'>F_VE*S^%)-0N$U
M..!=LL:_:&VLS<YCW ;L ''?K78>*76Q^(/@G4I2HTA?/MED'W(Y9(\1\]/F
MZ"@#IIM:O+,VYO='F2.XFCA#Q2K((R[!1OZ8&3VW"MJN4\;ZIJ&E+H;6-R(O
MMFK6]E*&C5QLD)R1D<,,#'\JZH#  SGW- "T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=X]*FOM:TW37*WE[%"54.^X_<4G 9O[HSGDX%1WOB+1M-?9>ZI:0/Y7G;7E
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M1>*_#\\UM#%K%E))=.4@"S ^8P)&!^(('KCB@#8HHHH **** "BBB@ HHHH
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M%D2+Q+*6CDB.54M<,IVD=,$'/IS7L%8^MZ$=9N=,F^UF#^S[H72*(PV]PI4
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MMM&+>59QXB$Y00L'"_:RV_&,XV<Y]*]<HH 0$, 0<@\@TM%% !1110 4444
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M]-"N9-'GM['6&\J&X:525D*LP!4<X(4\^O;'-9'Q"U?^V/A_XA-I8K/96S-
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M5GLKRWM;>R:>2:.24RR.8X8U3&=SX."=PP,>OI4%K?ZN?$[V-S!9&Q%H)1+
M[&1)<J"K C !R=O?Y3^%;7-+U:[\1:;>6HM+FPACD26UNI&55D)4K* %(8@
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MT;4],\7:AK6GI;W$.J0Q+<P2S&,QRQ@JK*=IRI4X(Z\9YZ5GV'@V^TJ^\-/
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M_B+XAU#4X([*.WT:&:9HY/,5@'D.X' ).!C&,Y'TKH!XH:WU#3+?4K!K2/5
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MHH)%B="RGS.!L!!7&??![4R7P]J%EXK?Q+I/V?SKR!(=1LI9"$EV_=='"G#
M<<C!'IUJ2#1M1N?'47B&ZC@MH8;!K-85E,CL6<-N/  '&.IH Z>BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:AL,Z2%2GR#:N %!&!QU^M9VD^!].T6\\RTN]1^QK(98M/>XS;1.3G*ICUY
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MCBNDR,XR,^E!('4B@# O/"&GWNCRZ:\URB3W"W4\J,OF32A@P9B5(ZJO  &
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ML9O"?_"-AYHK#[.+<F-AO9,8.20>3W..]0W'A&UFU*TU*&^OK6_MX!;&X@=
MTT6<[7!4J>>>@(IVIZU>+J\FCZ3!!+?QV7VPBX8JA&[:J9'0DAN>V.ASQLVT
MDDEM$T\0AG9%:2(.&V,1R,]\'C- ',-\/=(.B0:8MQJ"?9KAKFVNDN,3P2,2
M25;'<L>"#G-6I?!]I/86MK+?:@[6]VEX9WE5I)94QM+$J>!@<  <5T.1G&>:
MK7FH6M@;<7,H1KB98(E[N[= /U/T!H RIO".G7=WJT]V\]PNJPI!=0R%=A5
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M1M)A:WMW64 M$0H*-A>1\J^AXZUT54=7OI-/T6]OK>))Y+>%Y5C=]H;:"<9
M..GI0!CR>"+"71+_ $E[V^-M?71NYCN3<7+!S@[. 6 ./:KLGANUGUO^U;B>
MXFF-F;)XWV>6\1.2" O<\]?TXJUHFH-JN@Z=J#HJ275K%.R*<A2ZAL#\ZOT
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MCD^N>M=16'XJUV?0-&6_M[>*X!N(86#R%<!Y%3(P#G[W3B@"L?!-@5UD&\U
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N*^)3*NG^'RQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<<GEE '&<]>*SO\ A);^%;"RO=,6WU:^O);6&(RYC94!8S9'.W:,@=<D#WH
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M!*GJ#CO7-_#YQKYU?Q%?J);R6_FMX=XSY$"$!8U].Y..I/- '<)(D@S&ZL,
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M3<.30!T]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=R&TG4[..WNL@N\4S1DQL<9.T.1GJ>,FM2=]9L?$NO:1I^JS322Z0EW;->R
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M"31;&76XM8>.0WT41A203. $)!(VYV\D#MVK/_X0K019FS%K,MN;@7(C6ZE
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MF>7RD.,JNXG X'OP/2@# \.-=ZSHN@>(_P"W)(WG DNXB=T4V\8\H+G"%6(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO!+0M;JK:=<K(4P 04C(!^I#=>^:PYI8!\(M?CC=!G5Y=B+W!NPPP/3;S]*
M/4[O5M.L)5BO+^UMY& (6694)!.!P3Z\4V[UG2]/=TO-2M+=D3S&6:=4*KD#
M<<G@9(&?<5YSXTU"UN#XQLH5^SSOI<;;D1I'OU$;%2O50BY() SG)R,5>M1I
M>J?$336GCM[B.7P\5Q-&"&8R)@$,.25SCU'M0!W&KW#0:/<S17UM9.(R4N;G
M!CC/8MR./QI)=7T^S0+>:E9Q2+#YSEY53Y. 7P3PN2.?<5C?$58S\.]<1E4Y
MM'6-2.K8X ]ZQU;3YOB/H<SFW=1H<GSM@@-OCQSZX#8]LT =N-1L38+?B\MS
M9LH87'FCRR#T.[.*P?#_ (BEU7Q#XBMGNK2:QL&A\B6 8&UD+-N.3D@\=NG0
M5PFEWJZ=I7AF[F_Y EEK5]]KVC*P[FE$#L!T4%LYZ#(/I4^HW)O+OQU/HRO<
MAI-.N"+9,^?$@4R[3C#94'USGOF@#TR+6])G@GFBU.S>*W_USK.I6/\ WCGC
M\:1=>T=I98EU6Q,D,?G2H+A,HG7<PSP.1R?6O/M4N/#NN:!XCUK3;FYOKA]$
MFMI)Y5*HO!*1D;0#)N)QC)'XBK.S33XC^'^U+8J+.?=@+@$QIMS[[@<>X/>@
M#NDUG2Y+**]34K1K69@D<PG4H[$X #9P3GC%-75["\M;QK'5+)VMP5DD6576
M%\?QX/&/0D5Y9>-9/X9UV$F!E_X2Q71."-AEB)(']W 8YZ<&MZ\:PC\8^*$4
MVZP2:#$"HP%9E,OX$@%?S% &UJWBE-%T/1S-J-C-=W\L$'VE6"QD/C=,!G[H
M&2.<<BK.AW&J-JUQ%?:WI=[!Y>^WBMDQ,4)RLC_,1T..!@\'VKD)+F!/ ?P\
M5I4#)>6&\$\J%0AL^F#P?2K^J;Y_'VN1Z7(@O9O#6R!D8 F;?(5Y]>5/TQ0!
MV\.J:?<W;VD%];2W* EH4E5G !P<@'/!XIL6L:9/.\$.HVDDR*6>-)E+* <$
MD9Z ]?2N-\,ZQH.K:?HPAL)9-7TFT:-K<1.KV9\O;(IS@<E0H'?(/J1AZ)J5
MG/K/@2>W/E6Z)<PBTBB<K:$Q<1%B"S/D<Y/;.!0!VR^*K#6?#]]=Z3K-C;-"
MSQK<W#!D0JQ7<PR/E.#CD9ZUMW>I66G1H]]>VUN&'#2R! <=<9->5W,L!^$'
MB;3Y!_I<%W=!HF0Y5FN&*CD=2#D8[5TT.H16'Q"OKC5)XDL+[38!I]S(P$1"
MEO,0,>,DL&QW 'I0!UTNI6, A,M[;Q^>,Q;I5'F#&?EYYXYX[4MCJ%EJ=M]H
ML+N"Z@R5\R"0.N1U&1Q7E5GIZ6=MX/@OHT6'^V[F2WBG7F.U(E\L$'H.5P#Z
M@5UO@YX1XE\7Q0L@0ZBDBJA&#F% Q'_ @03ZB@#I;K5M.L9EBN[^UMY&P526
M95)R<#@GN>*2ZUC3+%Y$N]1M+=HT\QQ+,JE4R!N.3P,D#/O7F_CF^MY1XUL$
MC-K=?8(RP$;/)>@(2&&<A47)!P,YR216I:3:;=_$RTNG\AE/A\'?*H'S>:#W
M[[<GZ<]* .X;4+););UKN 6C@,LYD&Q@>A#=#FL/PQKT^LZMK\#W%K<6]E=)
M%;R6PPK*T:MR<G)R<?AVK@M"OUTS2/ ]Y=MMT:UN+Z.Y?&4MY&9A"S_W1@L
M3P-PKK?!ES:W'BOQ@UJ0T4MY#*C*I"N# F6!Z')R??K0!U-YJNG:>ZI>W]K;
M,PR!-,J$C.,\GUXI][?VEA"'NKRWM@V0C3.%!.,]R,^M>=^-+ZW>\\6Z>(S:
MW3Z, &$;227PV2$!!R JDD$@9YZC%/TS6X+#Q9I=YJDWE:==:'%#8W,P*QB4
M-F1,GHS84^X44 =!X4\5)J.@0W>KW]C'<374\,9#B-90DK(-@).> .YKH9-1
MLH9)HY;RWC>%/,E5I5!1/[S#/ ]S7FVC:6VK_"^XCTU"E_8:C<7EB#&5VRI.
M[H ".X^7Z-6GJNHQ3>!I?$-_IK.NHRVT@BEW8MX@Z^6S[>2JG,A'^T10!V2:
MQIDEK-=)J-HUO"<2RB9=L9]&.<#\:6VU;3KR[DM+:_M9KF-0[PQS*SJIZ$@'
M(%>6ZA=6\T?Q&5[AKHW.FPR0R-#M64^2Z@IQC&< =<\<FM9_LZ>)_"0TUK>*
M5](NHPT> -Q6(H#C_:#$>X- '>IJFGR7QLDOK9KL9_<"52_'7Y<YXI!JNG&_
M^P"_M3><_P"CB9?,XZ_+G/%<+X.U+1]1TC0M+N+20^(-*^5[>2-P]O* 5>1C
MTP<DY)Y+#O5#PQ-I>I6>CZ-J\NHGQ!I=TLCV10J4F5CNEW!1E""6))P<]R10
M!Z(VOZ,CHCZM8JTDIA0&X0%I!C*#GEN1QUY%36VJ:?>W4]M:WUM/<6YQ-%%*
MK-&?]H Y'XUY/?I8GX>^._+2 R/J\QCV@;F^="NWUZ$C'O70:J(SX[6+1W@C
MGE\.7,4!A(4;RZ&,9''J1^- ';Q:MIL]W):Q:A:R7$8+/$LREU ."2,Y&#4<
M>NZ/+/!!'JMB\MQN\E%N$+2;20=HSS@@@X]#7">%[O0-:_L(227S:OI,11[2
M6/RQ9_)MDW_*!MXQR>>/PQ[(6,/P]T&1!!',GB-9&( # "[8Y/?&PCGT/I0!
MZ98^)=+U+6;[2K6[BDN;,JLBAQDL020!WP,9],XK0NKRUL8A+=W,4$9. TKA
M03Z9-<KX?N(XOB'XMMW)$MQ):S1#:?G06Z@L#TQD$9]>*-;N6TWXBZ/?7[!-
M):QFMXYG.(X;AF4Y8]%W*N 3[CO0!;\1^()K*WT.[TNYM);2]U*"VEDQO#1N
MV"58' Z=>:O76MV]SH&HWVBW]E=26T3L'1Q,BNJDX;:P]/6O.[ZQ\NUN;MXP
M="D\507,>Y<QB' $LGH(RV[GIW[UKSVMJ->\3:OI8A32I-$\F:6' BFN,N00
M1PQ"X!(_O =<T =#I6K76H:3X8NI=1L[>:^MXYIX)%&ZX+1;B(QD8P>>_ K8
MN-6TZTG\FXO[6&7CY))E4\].">^#7GEM+;"V^&#%X_,C15<Y&4_T5E(/I\V!
M]:H:S=Z2'\5>'+_6;2UCOM369IKO>LL7$1.T;<,!M 4[A^0&0#U"XUG2[3R_
MM.I6D/F*&3S)U7<I. 1D\C/>JS^)=*C\1KH37<(O3#YQ0N!CD!5_WCDD#T'T
MKA/%FH6,Q\4V5JBVSR:*AC>*,R-?IY<A41]5"+DY(&><Y&*OZ1?6X\<:3<2,
MPBN_#D<43M&V)'$N6'3L.?ISTH [#3+W-C<W%UJEE<Q)/)^^@PJ1H#PK')&5
M'!-3QZOILUM+<Q:A:/!"<2RK,I5#_M'.!^->6PR/'X;:XME,EC:>+9+F]CB&
M<6WG,0VT=5!V-]!GM6AXE2"^U3Q)JMA+#-IK^&Y(+B6-@T<MP2QB (X9PN?<
M;E]10!Z#;ZOIEY=M:6VH6DURJ"0PQS*SA#C#8!S@Y'/O3H=4T^XNC:P7UM)<
M#),22J6&#@\ YX/%<#:&R@UWX>FW\A,V$ZN8\#K$F <>K ]>^>].\(W$]KK&
MDV-I>0:OH\EO*;:1EVW6GK@'RY<<%3PO(!R/:@#T*XN8+2$S7,\<,0P"\C!0
M,].35"^\0:;9Z#<ZP+NWFM88W<.DRE7*@_*#G&<C&/6L/Q9-)8^*?"VHW&1I
M$$TZW,A^Y#(\>V)V]!]X9/ W5CSQK'%\0M1@D4:5>6H$#*?DEG$#"1D[')*#
M(ZD'N* .E\,ZAJ6KQV^I-?V%SI]Q:([Q0K\\$Y )0$$@K@]#SG'K56VUG7;W
MQGK.B13Z=%#8PPRQR-:.[-Y@/!_>CIM_'-:OA26.7PCHYC=6 LH5.#G!"#(/
MO7&QR:-+\4/$K:C?+#";2U1'%VT(8@-N&589(R/I0!K6WB^_N_#/B.Z6"VBU
M+0Y)XI.&DAE:--V5Y! /'&<CWJO_ ,)AK&GV/A;4=02QN;77)((&2VB>.2!Y
M4W*1EV#J.AZ5B:.)+#P7XXMHPZ: J3KI4DR;'EW1MO ) +C=@!CDGU--TVW3
M0;3PKXI<27^F+806MW'(S3-I\A11YL8.=O/RL!C QQ0!W&I:].?$D'AW2DB:
M^> W4\TP+);PYV@E0068G@#([G/K:4ZY;ZG:1RO:W5E*6$LD<+1O&0I(XW$$
M$C&>,<=<\<M,XT3XDGQ*["70]6L5MVO(_F2WE0_+N(Z(1_%TSUQ4NHW46I_$
MKPV=,O7N;58KE[U;6X9HAA%\LR!3M'.<9ZT =W63-J*6NK73W.K6*64%J))+
M<X$D1R<R,<_=(P,8Z]ZETC7-.UV.XDTZX\Y;:=K>7Y&4JZ]1@@?GTKEY?*;X
MHZLD6PO)H*)A>K/YLA(]S@K^!% '1:9XGTG5-&@U6*]@2VF P7E4;21D*>>&
MQSCK6E;W,%W L]M-'-"_W9(V#*W;@BO,-*E@NO WA);;6O[*U.SAVPSS1YA$
MJQ[7BD#8'()'7(QZ\'M_!UY<7WAJ">ZLX;6<R2AT@)\MR)&S(F>=K?>'L: -
M%=6TY[[[$M_:M=Y(\@3*7R.2-N<\5S-[XHEO]<U72=(U;3+2?3X8I%:Y8.LS
MG>74X.0JJG)'(S[<\E_:MI./#LT*O:);^(G\VP2)V:W+>=DR,0278G.!@?-@
M XS76:)=VP^)/BS,\8S#9XRPYVI)NQ],C/I0!4B\3ZCKMA=7^E:[HUC';W,T
M,B70#JD:DJLN0P.2PR,\8/MD[5SJ]_!XTT;2Q+;O9WEG/*Y6,AB\>SD')&#O
MZ8_$UQ0FMI_@[XHCWQNYN+XHO!)+2N4('OD$5OSW-N_CWPDRS1LO]FW(R&!'
MS"+:/QP<?0T =+8:@BVU]<WFK6$\$=RX66(A%A3C:CG<1N&>3QU'%1ZGXJT?
M2] N=9DOH);2#*EHI VYQ_ ,?Q9XQ7G]OJ%C8:+JLCP0R1?\)8S)*V[R[7+@
MK.P4C*@CCG!..:K:@YN/#GQ&MXGGN9'FBG5C"5+IY<66P% QP<>H&>>M 'JL
MNLZ7!9I>2ZC:):OG;,TZA&QUP<X/0TZ;5=.MH8II[^UBBE7=&[S*%<=<@D\C
MD<UP^LZ_9V?C&UU.]O;FWT.]TT0VU[''F,2B1BRG*G&Y=F#T.VJ<UG:Z1:Z>
M?#FJ?V9-;6<IM[?55S#=P-(6VMNPRG(!&.0"!CK@ ]-CD26-9(W5XW 964Y!
M!Z$&JMOJ^FW=P]O;ZA:S3("S1QS*S  X)P#T!XJGIETTG@^UNGTV2!C8JYL1
MG<GR9\L=\]O6O/=%U*RFUOP//$X2U%I<P?9HXF,=KF-,1%B"688PQ)[9P :
M/2DU[1WF@A35;%I;ABL*"X0F0@X(49Y(((XJAXLU^/0]!U">&^LH=0AM7GAB
MN&!WD D#;N!.2,#W]:\[C%C%\/8Y(Q DZ^(Q(&4 , +S(;UQLYSZ5=O-4M[?
M2?B#IFKN$U*Y:YFMED7)N+<P@1%/[P4#MTY- 'I6E7+W>BV5U,1YDUO'(Y'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP%#'YF2HR-VX*6!&[;C\"#2>._$$_AKPK/>6:JU[)(EO;;QE1([;03].3^%
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M6E##%;01P01I'%&H1$08"@<  =A5)=<TQKN^M1>Q&:Q17NES_J@V<9/3^$T
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M+6+3[5I]PL\&]H]Z@XW*<$<^XK/3P=X?CNWN4TR)7D<NZ*S"-F/4F/.TG\*
M.<CM-8M_$%YJFGZ%;:MIFM+%=+]HE6&2U?RU4AMP.5(53QDCGBNY@5X+.-'"
MO(D8!$:A0Q [#M4U% 'G,7A36IO!?V+[.MMJ=IJS:G;+)*I20B=I54E2<<''
MUK4U'2+_ %G5?[8DT^6V:VTR>UAMWDC+R22XR<JQ4* .YR<GCCGLJ9+*D,3R
MRN$C0;F8] * ,GPG9W6G>$M)L+R$PW-K:1P2+N##*J%)!!/'%9CZ;JEKXTU;
M4(;);BSO["&(.LRJR/'YGRX/7.\8[5L)XBTF33;/4$O4:TO95AMY0K8D=CM4
M#CN1UJ[>7EOI]G+=W<RPV\*EY)'/"@=Z .#LO#VLV^@^";-]/;S=(N5>ZQ+'
M@*(W3*_-SRP/X&IM%T?7M&N9]'.BV%S9&YDEM]5>5<I&[E\.A&YG7) QP>.1
M7;VMU#?6<%W;.)()XUEC< C<K#(//L:FH ***BN;F&SMI+BXD6*&-2SNQP%
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MTMKI_P!@42Q+ADR&W'&.<@=.P]>: ,G2?&-_J>F^'+=A!'J>JS7,4DH0E$6
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M$$C/E3;PYY*Y(R. >GO6I!X=>WUO4M42_9I;^WC@97B!"B,,%(QCGYCGM]*
M.6\'ZS+;>%?!.B6I1+C4;1W,SKN\N.-<G [L2R@9X')YZ5<;QG?66H7^AW20
M/J4-_:VD%P$(C=+@$J[+GJH5\@$9(&,9XO0>!X;72M$MH+^5+O12?L5WL&X*
M1AD=>C C@XQT'2I;_P $66J6-^EY<3&^O)H[AKV+"/')& (R@YP%QP.>IR>:
M '7ESXCTVRU>22339(XO+:RN9V\L!3@2&4=/EY(P1GI6%>^)=4FTOQI:P792
M32[);BVNC;&.0AHW8@J<<Y0X.._0ULW7@^;4=$FL]2UV\NKR1XG6\,<:&,QN
M'3:@&W&1DYSGUX&%'@M'N-9ENM5N[C^U[-;6Z4JB@X5EW#"\<,<#IZYH I0:
MKJFFCP;:&>VF@U']U,3"0X @+C!W$?P\\4DWB?5;OP_K6OZ:UN(-,GG5+62,
MGSTA.');.03AMN!QQG-:*^$Y/^)$9-5FE?2'+QL\2_O#L*8.,8&TGIWYS33X
M-C1=5M;:^EATW59&DNK4("0SC$GEM_"&[\'J<8H HQZ_K6L>(TL-,N+.VM+G
M1XM1AEFMF=TWL1@C> >GMC/0UM>$-9G\0>$].U2Y1$GGCS(L?W=P)4XSVR,T
MD?AP6_B,ZQ;7(C(L5L4@\H%$C5BRGKG.3],<>]3>&]$7PYH-OI,=PUQ';[@D
MCJ Q!)/...I- '.S>*-4M-6TZ.:2VD%UJS6$MO#&62)#OV'S1QYGR@E??H,5
M%K'B[58+'Q+>68@CFT>[2WBLY8BQG5@GS'!!^8N0N,?=[YXM1_#\16UI:IKE
M\MO9:@;ZU39&?+8EB025RW+MR?6L*0S3>(]1N/[8U/3;YKIO+M9=&%R0JX56
MCD\LDJP7=@-@;CWR2 ;OB/7=9TB"^<7-FKVFFFZC6.!G:>1=Q;<@),<8V@9S
MU;[W&*L#Q#J$OB+PY;*+=;35;"6Y9?+)='54(&[."/G].W6HF\'W.I"[N[S4
M[BVGU73DM=1@A1"K,$894D$K]]N ?QJY;^%&M[[1+O\ M.65])MGMX_,B7]X
M'"@EL8[*N,>G.: .<_X2SQ''H<VLRRZ>8;/6#8RP);L#,GV@0Y#%_E/.>_3K
MVK5O/%,\'BR31Y[F/3I3<0BS6YA/EWD)V%RLF<;\EP![#@YXD?P.'\/W6CG4
MY/*N;XWSR"(;@YE$N!SC&X#MTJYJ/A=M66:WOK[SK*:XCN3"81NC9-IQ&V?E
M!*\\$\G!&: */A*34+G7?%(O;U;B&+4/)6,Q8P/*C( YX !QC'/7-2^ ;R2;
M2]3T]R672M4N+")CU\M&!0?@K!?PJ]:Z,FAZGJVJQW5S)%?2"=[145AYNU4R
MN!N.0HXSCK^"^%=&DT;2I1<;?MEY<RWMSM.0))&W%0>^!A<^U &'K7BC5-*N
MI)#);,L>IP6HMHXS(/(D9%W.X^Y(2Q(![ <'.:+[6_$;ZKXJM+.YT^%-)MXK
MB%GMF8MN1WVD;_\ 9QN_3FI[KP"MQ%J$":U>Q6UW?C45B5(SY<V]7)R5R1E>
M >GO5[_A%F%YK=R-1<MJT"02[H@=@12H(]\,<YXSV'2@#/'B?41-X5U"7[/'
MI&LQ(LP\LEH9WC#(-V?NL<KTZX]:Z#1;NYOX;FZF>-K=[AQ:A4P?*4[02<G.
M2"0>."*YK5[&V'AZV\![+VYN&M8HX+A+=@L:HP"R&0?*&3;NZC) ]179VUO%
M:6L-M @2&%!&BC^%0, ?E0!RYUO5-6_X2!](DMXO[)G:VCCFB+^?*B!VW'(P
MOS!1CG@GGI65I6O7WB+QEH%[;W7D65WHDEU]E:/=M/F1!AG(R>P/8=N370/X
M6\K4M3NM/U"2S35 /M<0C# L!M\Q"?NL1U/(. <4H\)6UOJ6E7FG7,MD-.M#
M9)$BJRO"2IVG(SU0<CGKSWH XS1M5U;0_#@U"WEM?L/]OS6\MNT1+R+)=,A(
M?<-I&[@8/3KS@=#?:_K]ZVK_ /"/V8FDTZY^SQQ,J%9W559@S%U*_>P,#C&>
M<X$O_"#C^P#I']IR>4;_ .W^9Y0W;_-\W'7&-WMTJ6?P=*-=N=2T[7+W3EOM
MIOK>!4*3,!C<NX$HQ P2.?QH J_VMXEOO%EYI-K+86B06EM=8F@9V7>S!HSA
M\$_*?F''MSD:OC"^U72O#=UJ6DB)IK1?.>.2,OOC'+XP1R%R1],5):>'A9^)
M;C6([HXFMH[4V^P;51"2N#G.?F-;+*KH490RL,$$<$4 <[<:S>W$-U=Z/+:3
MV\&GB=#-\B/*P+)E\_*H7#'V9>15;0_$%W=>*KC2)IDN8!I\=Y'.(#$26=E8
M#/WDX!!'YFI4\#Z=%X*N?"\<TZVLZLIE#?O!DY7D_P!T!5'LH%/M/"UQ;Z\-
M:DUJYN+PV0M'WQ1A' 8L#A0,8+$X!_&@#EO#FK7VC_#;P:]F8-EU>PVDPDC+
M'8\I!*G(P?J#6MJ^K7NN:5XMCL9H8+;3(Y;3#Q[C-((MSYYX7Y@HQSD$\]*M
M1>!UA\.Z1HR:E)Y6EW2744AB&YRC;E#=L9)SC';\7W7@PO?ZM/8ZM<64.K1D
M7ENL:.K/MV[UW#Y21U]?UH T?"/_ ")>A?\ 8.M__1:US]CXHU4Z]H=G<R6L
MG]I-<1W"0QEHX'C1G4)+T<C;ANO/ITKJM*TM-+T*UTH3RSQV\"P"23 8J!@?
M= [5SMAX"^PC10NN7KKHSO\ 908XQB-E*E3A>>#C/7TP>: ,F7Q9XDAT34=8
M>;3S%INL-920+;L#/&)EBR"7^0X;/?G\JVKW5KW6)_$=EI\T-O%I<7E%GCWF
M65H]Y!Y&% ('').>>.27P.)M!U+26U.3RK^^-])((AN5S()"!SC&X#J#QFII
M_"#G6+[4;+59[-M1B6.^BCB5DE95VAU#9VMCCOG]: )? /\ R3[P]_V#X?\
MT 5T59N@:0N@Z%9Z4ES+<):Q+$DDH4,0!@= *TJ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD23ZKX6L)-2BVSW5G&UQ&,KAF0%AQTY)H JZKXGAT^'2Y[>#[9!?W\=D)4D
M5"S[=WN 0>G7'6MZO'M.M81\,/!*QLZ/-JUGO97.1^\89&>GX5>U&_G\-3>,
MK>SNKB.SMWTY]TDKRF!9FVS."3N^Z,\'KSQ0!ZG56XGNX[ZTBALO.MY2_GS^
M:%\C RORGELGCCI6#HFEFQ\12746M12VMW9AA8PQMY9(8?O@3(V,AL''7KVJ
M/7VDC\?^$0D\RI*UVLD8E8(^(21E<XR">N,T =95>^N6L["XN5B,QBC+^6I
M+8&<9->4W\4L7A+Q;JBWU_\ :]-UN3[(YNY#Y05X^,9Y&"1SGBNA:5->UKQC
M::@[YTZ-(K:$2%?*1HMWF#!^\6)^;T % '6Z#J@US0-/U58C"+RW2<1EMVW<
M,XSWZUH5Y5X<N6OH/#&@SW,,-O)X>BFACF5BLTF=K ;77+*H4CKC)-7/L$]O
MJW@S39M>N]14R7L$UPDKQ><JQO@$!CDK]W=G/'6@#TFBO([RS,/A'QM(EY?A
MM&OIO[/Q=R?N,1QN,<\\L>N>/QKH9;0:K\1EM+JXNS:S:$LTD"7,B(7\T#.
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MXQSD [NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5N/6]/DBN)//*"V*B82QM&R%ON@A@#DY&!WR* (-3\+Z'K4=O'J>EVUVMO\
MZKSDW%!Z GG'M6HD21Q+$B!(U7:JJ, #T&.E9J:I#K$%W%I-Z$O;9@'26,J8
MVQE0Z, P4_AD=#3] UF+7]$MM2B0Q^:"'C)R8W4E64_1@1^% $7_  B^B?93
M:_V;!]G,WGF+!V^9G._'][/.>M22^'M)GFN)IK"*22YC\F9G!8R)_=;/4>U:
M=% %"/1=.B@N(1:(Z7">7,),N9$P0%);)*X)XZ#)JK;>$] M#$;?2;6-H49(
MV"?,@;&<'KV SZ#%;-% &7_PC>C?V,='_LVW.FDY^S%/D'.>!VYYX[U'_P (
MIH&V<#2+0"XB$,V(P/,0=%/J/YUL44 9ZZ'IB75M<BT3S[5/+@DR<QKW53V'
MM45AX9T/2]1FU"PTJTM[N?/F31Q@,<]?IGOCK6K10!DV_A?0K369-8M])M(]
M1DR6N%C 8D]3]3W/>KU[8VNI6<MG>V\5Q;2C:\4JAE8>X-6** ,RT\.Z-8:3
M)I5MIEK'829\RW$8*/GKN!Z_C4]CI5CIH;[);K&6 5FR68@=!DY.!DX'09JY
M10!#':V\-Q-<1PHLT^WS7 Y?:,#/K@5G_P#"+Z%_;G]M?V3:?VEU^T^6-^>F
M?K[]:UJ* *%MHFF6@NQ!91(+PDW(QD3$C!+ ]21ZU17PGH]G"C:7IEC;7EO&
MXM)C"#Y3,,9]2.!^ K=HH \XTSP$%\A)_#.DV%W%MW:E:7C[RPZNBA%Y/H3@
M9[]#V,_A?0KG6H]8FTFTDU&/!6X:,;P1T/N1V/45K44 1SP17-O)!/&DL,JE
M'C<95E(P01W&*SH_#>C0_8_*TZ"/[%G[-L7'E9ZE?0GN>]:M% &/+X5T*>&>
M&72[>2.>83RAESND'1S_ +7OUIZ^&=#2*\B72;-8[Q0MPHA $@ P 1[ "M6B
M@""&SM[:S6T@A6*W5=BQQC: /;%4!X8T1;*"S73H1;6\GG0Q $+&^<[E'8YY
MR/4UK44 9DOAW1[B2[DFT^"5[Q!'<EQN\U1T#9Z@=O3M59_#]EI<+WFAZ/8#
M4XK<Q6Y<; 1R=I8 D#)/YUN44 96B6-S;K<WFH) NH7KB2<0$E$ 4*J!B 2
M!U(ZDU9U+2=/UFW6WU&SANHD<2*LJYVL.A'H:N44 <=XJ\'P77A^ZLM$TFS2
M>\N())\!8U=8Y$8AN.>%P![UL7>D11Z+J"6%GB[NK8Q?.^6)*D*"Q)X&3QG
MYQ6S10!SOA/P[#H^A:5%<6:)?VEJD#,'WA6"@.4[#<1DX SWJ>YTZ;1[2>7P
MWIMFUW<3B29)Y6C60G[SD@'+>^*VZ* *&CZ>=-T\0N4:>1WFG=%P&D=BS$>V
M2<>P%/U#2=/U:.)-0LX+I(I!)&)4#!6'<9^IJY10!FSZ!I5S>O=S6,+SR!1(
MV/\ 6!?N[QT;';.<5I444 8Z^%=!2!(4TJU2))OM"HB;0).N\8[CL>W:K T/
M3!<7=Q]BB:6\3R[EF&[SEQ@!L]1C(P:T** ,S1_#VC^'XY8](TZWLUE;=)Y*
M8W'MDU/<Z58WE];7MQ;))<VV?(E.=T>>NWTSW]:N44 9+>&-%:TN;5M.A:WN
MI/-GB()65_[S#N>G)]!Z47?AG1+^ZCN;O3;>:>./RED=<L4_ND]Q]<UK44 8
MEUX0\.WNF6^G7&BV3V=N<PQ>4 (SWQCIGOZU;;0M+:6RD^PPAK%=MJ57;Y Q
MC"8Z<<<=JT** ,H^&]&:"[@;3XC%>-ON4.2)F]6'\1^M2)H.F1W:W:6BK<K#
MY E!.X1_W,YSM]JT:* ,E/#&B1P6T":;"L-K(9H$4$")_P"\H['D\CU-6!HV
MF#4+B_\ L%O]KN4$<TQC&Z1<8P3W&.*O44 96D^&M$T'S_[*TNUM//\ ];Y4
M8&[V/M[=*CT_PGX?TIKIK#1[.V-VI2<QQ ;U/5?I[#BMFB@"C9:18:<^^TME
MC8((U.22J#HJY^ZOL.*AU/2OM=[8ZC;E5OK%F\LM]UT88=&] < Y[%0>>0=2
MB@"&2U@GF@GEA1IH"6B9ADH2,'!^A(IJV-JD=PB0(BW#EY@O&]B "3CO@"K%
M% &2OAG14MK6W33H5@M'\RWC (6%O[RC^$]>GJ:)?"^A3:VFLR:3:-J28(N3
M&-^1T.?4>O6M:B@#,G\/:/<W%W<3:;;O->1B*XD*#=*F,;6/<8 'T%.70=+2
M:SF6RC$EDI2U;G,*G@A?08XQZ<5HT4 9$'A?0K769-7@TFTCU"3.ZX2,!R3U
M.>Q/<]35O3])L-+\[[#:I!Y\AEEV?QN>K'U)[FKE% '+:_H5QJOB_0+W[*)+
M*P6X$K^;L<-(%"E<<\;>3D=>,UKS>'])N+%+&:PA>U1_,$3#C?G.X^K9YR><
M\UI44 4KW2;#48X4N[99?(;=$Q)WQMC&58<@X[@U/:VEO96ZP6T*11+DA4&!
MDG)/U)))/>IJ* *@TNQ&E_V8+6-;'R_*\A1A=G]W'I56X\,Z+=6%K93Z; ]M
M:$&W0K_J<=-IZK^%:M% &0OA;05L;JR&CV0MKMMT\7DC$A]3].WIVIT'AK1+
M717T>'2[5-.DSOMA&-C9[D=SP.?85JT4 95AX:T73+I;JRTRVAN$C\I9@F7"
M>FX\]ZL7^DV&IM"]Y:I+) 2T4G1XR>NUAR,^QJ[10!D7\6I:?8VUOX<L; @2
M;72=S&D:')+#:#DYY]^:MZ5I\>E:7;V49W")<%L8WL>6;'J22?QJY10!GZCH
M>F:O)#)J%E%<M"=T1D&=A]1Z'WI;31-+L+A[BUL+>*XD78\RH-[+Z%NN/;-7
MZ* *%CHNG:9<3SV5I'!+<-NF=,YD;U;U/N:+'1=,TV&:&RL88(9B3)'&N$8G
MK\O3G-7Z* ,<>%=#$0A_LZ(VX.X6Q),(/7B/.S]*V ,# HHH SK70-*LKGS[
M:QABD#M(NT?*K-]YE7HI.3D@#.34EEI-AIT]Q-9VR0R7#;YF7.9&]6]3[U=H
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDO$\=W:^*_
M#>LK#-/I]HUQ%<K"A=HC(@"R;1R0""">P;ZUUM% 'E^OZ+?7FE^.M1LK2X>'
M4?LOV: 1,'E,07>X0C//0<9.WZ5N23F[^(VD:BMG>BU&EW">;):2*%9G0J#E
M?E)"DX.#7:44 >26L&H6&AZ3J#:9J<MM8:O>O=6L,<D<XBE:39(B\,0 P/'9
MC[UH:O;6D^EV=WIFB:C''<:W:7,QE@F>64(X+R,ARP '&3@G'3IGTNB@#E?&
M%I>(^D:[I-JUQ?:?<@>2.#+#+\CK^JM[;:SO#V@ZEI?B6[TR?=-I22+JB7!Z
M/.ZE73'3&\-)CME:[NB@#SM[6.XO?'"7UAJ36=W<VNUH()%=E"1H7C(7YBC#
M/&?NU0N[?Q)_9EUG[3K5MIM]:7,,ZQ&"YNX5W%X^,;F3((8=3[\5ZG10!S/A
MDZ=>7EUJMAI=_;--&B2W%^)%DE(SA=LASA?7ISQGFLKP+='3/#<,TEM=21ZM
MJUP]OY,1<1I)(Q5FQ]U"!G/^T*[6[MEO+9[>1W6-QA]AP67N,]1GVYJ2.-(8
MDBB14C0!551@*!T % #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJQN;*VN)+E)[T,;:,6<S-)M&3@!.H'.*LV6L6=_<R6T/VA9HT#LD]K+"=I)
M(WJ,\@]*Y3QAYX\<^!_LPC,WG7>T2DA?]0>N.>E=/IO]I&YNCJB6JMO MC 2
M<Q[1GD\YW9_2@"QJ&IV>E6PGO9UB1F"+P2SL>BJHR68^@!-5H_$-@UY;6DAN
M(+BZ8K D]O)'YA"EC@D8Z FN8UAVE^,GAV"Y_P"/:/3[B6V!Z&?.&Q[A/YUV
M=W!'*B.R*TD+>9"6_A?! /ZD?C0!3F\06$5U-;(9[B:#'G+:V[S>4<9PQ4$
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MMQC/&<UR^KBXA^+&B+800,RZ3.H21S&H7>G0A3^6*+9KQOC.IO88(I/^$?;
MAE+@C[0.Y5: .@MO%VD7AN1:M>SFVF:";RM/N&V2+U4X3J,C\ZU;.[AO[.&[
MMF+P3('1BI4D'IP0"/H:\^\*G6A'XU_LA+-I/[=N_+\]F!\S8F.@QCI7HD(5
M8E50HQP0O0'O0!0T_P 0:;JFH7EC:2RO<V;!;A&MY$\LD9 )90.1S4:^)=,E
M,A@>XN(HF*O-;VTDD8(ZC<JD''?&<=ZX&]GN[5?BI-8EA<((RK+U7_1QDCW
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M+#5+5(].OE.R]5S^Y?( $@Q@ D@;L]:U[[4;RVUFSLX8(9(9XY9&8L0R[-O
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MM0N[]X_]6;GRQL.,9PBJ"<=R"?S-9&J>(-5L/$VD:+%9V<KZC%,XE>9D$9C
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MFS[%;;<YQY2XS^53^5'Y7E;%\O;MV8XQZ8]* .*\1SPP_%/P>9940"WOL[F
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M4N90/E5)4""7_<!'+?CTYKM;G3;&\E26ZLK:>1/NO+$K%?H2.*LX!&"!CTH
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M:UDM)9KR<R6\GWHVWD,I^A!KHH+:"V4K!#'$I.2(T"Y_*I%55SM4#)R<#J:
M//\ P?8VMI\1/%=A Y^RV$D,UK;[LK"\Z;I2H[9*CZ9('4Y]!J".QM(9?-BM
M8$D_OK& ?SJ9T61&1U#*PP5(R"* /&/#L.IZ;#?^+M)?[?'9ZE>QW>GL0<PF
M7<SQ'^%\8)_O #T%=7XPU_3/$/PBUG4=-NXYK>2T/(/*DD?*P['VKM4L+.-'
M1+2!5<8<+& &'OZTS^R]/QC[!:X_ZXK_ (4 84_V:XD\,03>5)'.CKL;!$BF
MW.1CN,&N<M['4/"?BG1_#VR2XT">^,VG3DY-J1'(6@8^G.5/ID<]O0AIUD"A
M%G;Y3[I\I?EYSQQQS5AE5L;E!P<C(Z&@#AM,N[:#XM>)O.N(H_\ 0;3[[@=-
M^>OU%,TW'B#XKS:]8?/I=AIOV'[4OW)Y3)N(0_Q!1U(XS79G3+!G+M8VQ8G)
M)B7)/Y59 "@   #H!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M P&&>,$BKWC&QDE\!ZGIFG6CRR2V;6UO!$O<K@#T ^M06=S-%I6DPKH%XU_
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M8_?+ZCYL1^OSYJ?P/?0:3\)-*O[@[8;>P\U\=\9/'N?ZT =DLB.SA'5BAVL
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M!<0YZ;F=E4$]<9SCG&* -"Z2=K21+26.&<KB-W3>JGU*@C/TR*S8-$,?A/\
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M-;W,-W:174$BO!*@D1P>&4C(/Y4 8OC#P]/XGT,Z9#>1V@:6.1I'A,GW'#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6_>+R6FCO)D.S.=N%8#&><4V?PGH]SIUW87$,\MO>,&N!)=RLTA   +%MV,
M<9Q0!Q_Q"BU9?A1>M/>V3P>3!E([-T8CS$Q\QE(_2NL\43226<&E0023R7[[
M)(XBH;R!@RGYB!R,+G/5Q5G4/#>EZIHHT>]AEFL %!B-Q(-P!!&6#9."!U/:
MIH]%LHM2CU "X-S'"85=[F1AL)!(P6P>0.<9X% '(^$)GT3QEK/AZ:TEL[:\
M/]J6$4I0X#'$JC:Q& V"!GH:M>%/^1_\<?\ 7Q:?^B!707OAW3-1U>TU6YBE
M:]LP1!*L\B; >N K <]^.:K+X/TB.^N[V);Z*YNV#7$D6H3H9"!@9PXZ#@4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW#0$]Q\V5/ID<]@#T6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV\.7MVE_<7B">"664126V#YFX2?*6Z8Q\U=1XO-[=:2='TR?R-0U$/%',/\
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M#]&QR*9X=TS4_"&E'18;,ZA90.YLI4E565&8L$D#$="2-RYR,<"NK9@JEF(
M R2>U9 \5:$=*.J#4[<Z>#M-T&_=9SC[W3KQ]: (/#'A^31AJ%Y=R))J6IW)
MN;EH\[%/147/)51QD\GD\=*H7FFZLOQ%BUZWL%FLX]-:R(,ZJY8R!\@>F!]:
MW[C6M.M8()IKD*MQ_J5"DM)W.U0,GCG@5)8:G8ZI#)+8W<5Q'&_ENT;9VL "
M5/H0".* .:TK0-2@\7:QXHNX88I+NW2WBLK>3<6"_P ;L0!N[<=!W-5_">GZ
M_P"'/!5GH\NC07-U;!R#]J41LQ=G7G&1C([=JZ(^)]%"M(=1A$*$AIR3Y((Z
MCS/NY]LU:N=4L;."*:XN8T28@19.3(2,X4=6..PH L6ZRK;1+.X>8(!(RC 9
ML<D#ZUS)TK4?^%FKKGV8?8!I9L=WF#=O\W?NV_W<<>OM6[:ZO87J3-;W"N8/
M]:F"'C[_ #(1N'XBG:=JEAJ\#3Z?=PW,2.8V:)@VUAU4^A]J ,#6M*U&[\=>
M'M5M[8/9Z:ERLS&10S>:J@;1WQMYSBB_TK49OB)IFL16H:QM;26WD;S%#%G(
M((7T&/:M>3Q%I,4%S/)>QI%:MMN'8$"(XSACCC@CKZBF0>)]"N9(8XM6M"\_
M^I4RA3)_NY^]^% &'HEAK>DZ]XAO7TM9(=2NEFA N5#*H0+\P]>.Q-=+I0O!
M8@WT,4$I8[8(6W+$@.%4' SP 3[D]J;=ZWIMA>P65U=QQ7-QD0Q-G=)CKM'?
M'M4EWJ=G8201W4XB>=MD0(/SMR<#U. >/:@#F-,T_6]-\6^)-5&F))!J;P&$
M?:55E\N/8=W!QD\\9J33_#E_;WNLZ_J'E7&L:A"((X+=OW<$0'RH&;!//)8@
M>PKH;S5["PF2"XN%$\@W)"H+R,.Y"J"<>^*KMXFT1(6E;4[8(KK$QW\JYSA2
M.H;@\=>* .+D\*:XWPJT[PTMI$;^W>'>QG7R\)*'R#UY QTK=GT74=.\4IKV
MBP)Y=\H35+&20)O('RRJ>1O'0]B/SK0'C'PZQ<#6+7Y&"/\ /]UCT!]#R*W*
M ..M]/UFT\=ZKK:Z:LEK=VL,$:FX57!0DDD=,?-Z]J76_#NI>)-*RZV^FW]E
M?)>:: =ZHZ<YD( SN);..G'4YSMCQ+HQ=0-0BVL_EK+SY1;.-HD^Z3GC&>M2
MZAK>F:5+#%?WD=N\QQ$).-Y]!ZGVH K6UYKEU$L4^E)938Q),;A9(QZE .6]
MMP6J'CG2=0UK3+&VTZ!9)(K^"Y<O($ 6-MQ'U-;5EK.G:C<206EW'+-$H9XU
M/S*#G!(].#3+S7M+T^]CL[N]CAN903'$^=S@==H[X]J -!260,5*DC)4XR/;
MBN1N=!NKWXA3ZE=6,<ND3:0=.D5G4EB9-Q)7^[@X]?:NBM-7T^_BEDL[R&X6
M$XE$3;BA]"!R#[52A\7>'KC9Y6LV9#OY:DR@!G_N@GC/M0!EZ+IFN:'IE[HD
MD0OK&)633;CS@)!&1\L<@./N]-PSD <5#X<LM?T+P58Z.VCV\]W:0A%9KI?*
M+@Y!Z9P#@].U=A//#:P//<2I%#&I9Y)&"JH]23TK.3Q)I#M$#>HGG.J0F560
M2LQP A8 -G/;- %64:Q%<WD-SI\>IZ=*J! )$#D[ '#(V%VD\]<]>*Y^/P#<
M?\*ZO= CEAMKB:Z:\MHP2T5L?-$B1@XR5& "<=R:[^D) !)Z"@#G;G^V=;L5
MT^XTI;)92HNI6N%=0H(+",+RQ., L%QG/;!J:SINKR>/-+UJSL4GM;.UFA<-
M.$9B^.5'/ QWQ6J/%F@$3'^U;8+ Y29F; B8=0Q/"D>]6K[6],TVRCO;R^AA
MM),;)V;Y#GI\W3G/'K0 S3YM6N+V9[ZTBM+9$ B19A(TC$G);@8Q@ #W/M61
MH.E:C9^-/$FIW-L$M=3-N8") 6'EQ[3N';/;&:VK+6M,U*=X+._MYIXU#/$K
MC>H/0E>H'O3[W5;'3GCCNKA4EESY<0!9WQUVJ,DX]A0!'KNCV_B#0KW2;O(A
MNHC&Q7JOH1[@X/X5E6+>(['0XM--C#/?PQ"%+WS@('P,!V'WP>Y4*>>,]ZV+
M/5]/OY)H[:[CDE@ ::/.'C!SC<IY7H>M16NOZ1>Z0VK6VHV\FGKG=<!QL&#@
MY/:@#D+WP3=:?X9\.Z-I,8NCIVIPW]Q-*X3S"K%G(]R3P.@'>N_0 _O-FUV
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MK3;^]GL[6[CEN;? FB7.Z//3<.V?>K+W5O%=0VSS(L\P9HXR>7"XW8^F1^=
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M=S'9QVDEY)/O$>$"ET51ECQP"0*J:CX0N;#3O">FZ':B:VT6\2YD:64(7 #
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MIIGB#Q-J%Q8_NM1GCFMU252V%0+AN>#QGO3SX536/ =AH>JQM;W-M;Q(DT3
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M4)#> 1D\X)^7./:NSB5DB17<NX4!F(QN/K3J* "BBB@ HHHH **** "BBB@
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MPJ\ZQ$;=H?@=. 2I/N:M6_AU;2?2/(O)!:Z7;^1#;NH8$;0NXGKNVC&?<^M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'T):$(2?](;CYU8?I1XPC%G\,?$>G27[WES!;RR2228W8D=F4-@ 9P>@ [<
M$4 :R^+C;ZII5EJFG/:?VJ"+69)1*A?&=C< J<=."/>ISXCD7QG_ ,(Z]B$=
M[0W<-PTWRR*&VE0-OW@3R/3GFN4AB:S\::#)XCG:ZLI+=1HT[ )'!<%/F1P
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MPQPPQC:D<:A54>@ Z5R^BZU?S^+=9\.W%RMU'9PQRQWL2!70OG]VXY7<,9&
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M;3;23P;XHN([:QN)M!UAO/62"W9WM)\<JX +;&'(S]TY' KNJ:TB(0&=5+'
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M<%9H&WQ2J<,AQ@_@1P1TJS0!Q?Q.AEO?!WV:WL[FZDENK=O*AMWD)59%9L@
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M;=;X7%U!)I\K^4GEL"'7:>A(%+!IA7XC:=?>&M-N-.TU89?[6<VS6\-QQ^[
M1@-S@Y.X#IW[5Z%10!Y[H/G0+XY:6ROT%S>RRP;K.4>:IC505^7GD'I4_A#6
MUT;P#I5I<:9K!OK:U6-K9=-GW%Q_#N*;?QSBN[!!&1THH XFX%P?BQIMT]I<
MF%-*D@DG2WD,2R-(I"[\8Z T[Q2LS>._"$\=K=RPVLURT\L5N[K&&BVKD@$#
M)-=I10 CD*C,V2 ,G S^E<1\-++^S[#68#83V8;5;AX5EMWBS"6^3;N ^7&<
M#MS7<44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q?C2
M]FG\2>&/#*2O%;:K/,]TR,5+Q1)N,>1R Q(!QV&.]=I6!XG\.-KGV"\M+D6N
MJ:;-Y]I.R;ER1AD8<95AP<<T 37/A?2IA:F"S@M)+:>.6-[>,(1L8-M.,94X
MQ@\=^H%8OC];O5;)M%TV]%K=K";XN& .8SF).?[T@S]$-;UM_;DYC6^CL;55
M(+M:SM*9,=AN1=H/X\<>]5]/T5WO-0N]9M+&::XF!B9?WFR,* J?,HQC!/'4
ML>E %>SU:U\5_#X:D8D>.ZLF:2-AD*X4AEY]&!'X5Y[HFGO/X6\$R>'=/GAU
MA9H7NKR*V:)#!SYGF28"N#QQDD]J[71_#6KZ-'X@M(/L'V"_FDGM(1*X^SLX
MPP^Y]TGG Z<CO6OX1TFZT'PM8:3>-"\MI$(M\+$JX'?D#'TH 9XVABF\#:Z)
M8T<+I\[ ,,X(C8@CW%<A<65];^"?!NH:?I"ZG8V=M'->Z;&!F;="H#A>C,IR
M<'J3Z\CNO$5C<ZIX=U'3K4Q"6[MY( TK$*N]2N> <XSTK,L=*U[3=.T.&WEL
MBVGVGV:XB:1]DX"H%(;;E3\A/0]<=\T 0>"KWPYJDFH:EX>81";RTN;/R_+:
M"1=W5/X2<]N"03SS4OB_0=+NM&UK4[FQ@GO!ILB))-&KF,*KL-N1P<L3Q[>E
M3:/H$UOXFU+Q!=I;0W-[%'!Y%LQ90J9.YF(7<QSCH,  <UI:[9W&HZ#?V-KY
M0FN;=X5:5B%7<I&3@'IGI0!SG@SPUHTGA/P]?_V;:K<MIL0DD6%090\:[@_'
MS9.#SW%8'@"ZT]/A%;6TMA<2&2WF\TK8R.KG>^"6"D'MS7=:!87VC^%;#39%
MMY+JSMD@!61@C[5"YSMR,X]#69X7\/:EH'@*/0)&M)KF&*2-)%D8(VYF.3\N
M1C=[]* .$NK2U7X"Z%*;6(OYEJY(C!8DS*&^I(X]Z[^QM]&?Q#;+:Z ;&XAB
M>=+C[((<]$*Y ^;[^2/85C3>"]9?X<Z=X966P\^T>(F<R/M81N''&W.3C'M7
M4@:[/>6WFQV%M;*^Z8Q3/)(X X4910,G&3Z9H L:CHNG:O+;OJ-I%=+;[C''
M,@= 3@9P>^/YFN&\ >'-'O;#4Y9=.MO/MM>N&AF6)0\?ER@J%;&0!C&/3BO1
MVW!"4 +8X!. 3]:YSP=H=_H%IJ$-ZULYN;Z:\5H78X\QL[3E1T]: ,;P$(?%
M>F7GB'5X([JXNKN:.)9T#B"%6VK&H/ '&3CJ3S46D6L%QXN\0^#[R,7&CVQM
M[ZUMY/F6,-R8\'^#< 0O0=.E;>EZ#?\ AJXOX](%K<:?=SM<K;W$K1&WD;[P
M5@K94GG&!CGK5O0M .FWNI:I=RK/J>I2*T\B+A$51M2-0>RCOU))/L #DM%\
M,Z'?>//&]C<:19-;(+-8X_(4",-"=VSCY23SD=ZZ/Q;']KTB/PY#>?9I-11H
M6G+ %(57YV_'*K_P.ET70]1L/%^OZO<&U,&J& JD<C%H_*39SE0#GK[>]6HM
M(FN=>O;W5+:RF@:-(K5<ES&H))R&7 +$Y)![ <XS0!3\#:PWB#PC!]N"O>VQ
M:ROD;YOWL?RMGUSPWXUF_"JUMX/"D[Q0QH[7]T"RJ 2!*P _  "KVE>'M1T7
MQ;J]_9)8KI>H*C?91(RE)57&\87 W#J/QJOX:T7Q+X;T:6PC329RUQ+.LC3R
M+@NQ;!&SG&?44 =DRJZE64,K#!!&017#?#*TMX+/7VB@C1AK=Y'E5 .T.,+]
M!Z5V-G'<P:=$EQ(L]VL8\Q^55WQSCK@9Z>@KEO#VB^)/#\&HQ(FE3_;+^:\#
M-<2+L\PYVXV'./7B@"O\0+2WFUKP<TL$3L=81"60$E=CG'TR <5E>)!_PC7Q
M"'BFW41VD$=O;ZDB# ,,S2+YAQW5E0UT.K^'M:U,^'9&FLWGTV\6\N&9V42/
MA@40;3A?F.">P%7Y]#FU*]UA-1BMFT_4+5+8JDA+@+OR2"H'._UXQ0!R7Q5E
M;4;".VC?-I975J\^.DDDDJA4/J FXD?[2&M#7+"S'Q6\)8M8!FVO,_NQSM5-
MOY9./2DN_ M__P ()9Z!:W<,UTD\4]Q=W+,#(T;*1T!SPJJ,] !UK6U'1-4O
M?&>BZVHLUAT^*:-XS*VYS( #CY,<;?Q]J .=\6^&M%L-1\(0P:9:8EU=4F9H
M5+3 HY.\X^;)YYKN],T>PT=+B/3[:.VBGE\YHHE"H&VJIP!P/NC\<UD>)]#U
M#6-2T.>T-JL>FWHNW$SL"^%*[1A3C@]?TKI1G SUH X3PHR>*M=\2:EJD27
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M/-N&E? &0LSC)/L!^0JEHFK7-GX^BN+NZWVGB>W,D,98?Z/+'DHF.V8B,^K
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M@GZ8H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+/LFD6)!'"TC;VX VJ">M9&D:?8^(? *6-TJSV5Y$ZG!R"I<D,#Z]"#]*RO
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M,;FRD\NX@DC:-XR1D95@#@]CT-<MX%G.D>(-:\+/;RVT"N=1TZ*4 $02'YU
M!(PKY_[ZJKJ.A7RZMJGBCP^H_MJRO65X,X6]@\N,M$WOW4]C^@!V$WB2QMS>
M"1+K-F\<<H6V=CN<J%"@#YB=PZ9ZU4'C726NKNU6+46GM$5YXUT^8M&K E21
MM[@'\JK>#M:LO$KZKJ5GEH99HB4D7#1N(DRK#LP(_2JV@_\ )5/&'_7O8_\
MH#T =1<:G:VVE_VD[.;;8K@I&S,P;&,*!DDY'&*RAXSTLW\EB(=2-W'$)GA&
MGS%PA) ;&WID&M_RTV*FQ=BXPN.!CI^5<;9_\EDU3_L"P?\ HUZ -^3Q%IR0
MV+K))+)?QB6V@CC9I)%P#G;C( !&2< 9YJ2QUJSO[N6R4R0WL*AWMIT*.%/
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M] NK6SNQ<SQ6EXXCM[B:UD2)V)P!O*X'(/4BK^J^(K#1KNSM;SSQ+>.4MQ'
MTF]@,D?*#SCFO(]($VI_#[PAX?U41VF@Z@^UKV,EV:192RQ'.!'N(X;YNF*[
MGQV)CXB\&BW:-9?[2?:9%)4?NFZ@$4 =-!K=M<7#VZP7B3+&9=DELZ;E! .W
M(&>2.!ZU0M?&FDWVE?VG:I?S66&/G)8RD84D-_#G@@_E5ZP&II?7!U.2U96"
M+;&%2O8EA@DG/ /I@#T-<1\.DUMOAWIGV"6S\G[3)N1XVW^7]I;?SNQG&['%
M '9R^)M+@UZST6:=X[V\0R6ZM&P64 9.&QC..V:GUK6M/\/:3-J>ISB"TAQO
M?:6ZD   <GDUR'CG1Y=8NUETPC^T;"R^VV#KS^\CD! 'LPROXUC^+]9@\:?#
MZ^U.VYLK73O.9>N+EQC8?=%+9_ZZ#TH [R[\5:;8G3UG%TK:@<6JBV=C(<9Q
M@#@XYP:F77[5I)(_L]\LD<1EV-:2 LH.#M!'S$9' YY%<GXK$QU'P$+=HUE^
MV?*9%)4?N&Z@$5UU@-32^N#J<EJRD(ML8%*]B6&"2<\#VP!Z&@!VCZYI^O:4
MFI:9/]HMFR 54A@1U!4\@^QJJOBK3WCA>.*^D\YY$14LY&8F,[7R ,@ \9-<
M+86\_@C3-,\4Z=&\FD7=I"=9M(QG8=@_TE!ZC^(=QS[CN/",L%WH$=W R2QR
M7%TT<B\AE:=R"#Z'@T 1V/C32-16-[;[:T4EQ]F$ILI0@DW;=I8K@?-QSWKH
M:XKX9*K^%;D,H(_M2[.".XF)%=K0!DR>(["+7O[$(N#J!@-P(U@8@Q@XW;L8
MQGCK3]'\0:;KINEL)V:2TE,-Q%)&T;Q..Q5@"/KT-<\__);(?^Q=?_TH6LFZ
MT:^L;J[\7>'XB^I6U[<)>6B\"^MQ(<K_ +Z]5/X<\"@#N[;6+2YDO4!DC%BV
MRX:9"BH=H?J>#\K Y'&#5+_A*].-BVH".\.G*I?[6+9S&5'\0XW%?]K&,<YQ
M7GOBG6X=;^&_B75-+E=K&ZU*W\YE&&6(Q6X<'T(/!_&O6HTA-NB1JAAV *%'
MR[<<8]L4 93>*--75K/3,W!N[R'SX%6!B'3&2=V,#&>YJ]J>I6^D:;/J%WO%
MM ADE9$+E5 R3@<X %<E>I%%\5?#4< 40KI5RJ!3D;04QC\*V_&A!\$>((@1
MYC:7<E5SR?W;=OQ'YT :%IJMO>Z3'J=NLSVTL8EC_=$,RD9!"GGH:S)_&6DV
MUGIMU)]K$.I,JVA6UD8REAE1@#()'/-3>%G7_A"=%DW#9_9T!SVQY:UQVJ*5
MT'X:*PP1?60(_P"V#4 =K;^)=+N-3333-)!?2*6C@N8'A:0#KMW@!L>V:3_A
M)+#^W)M&5;EK^&'SWC6!L>7G 8'&#D^]<Q\5Q_Q)=(>W_P"0FNK6_P!A*_>\
MS=R![8SFK5M_R6>__P"P'#_Z.>@#H=%U_3?$%O--ITYD\B5H)D=&1XW7JK*P
M!!^M.MM:LKF*\EW/#%9NR3O.AC5"HR>6[ =^E<$^F7FA-/XQT*%I9EO;Q-4L
M4_Y>X1<R_,!_ST0=/4<>QH>*=7@U/P%-J-G-YND7>NPM=2+T-N=F[/IR%!'X
M4 >@MXKT]+!M1:&^&GJA?[5]E?85Z[L8W;??&,<YQ6U&ZRQK(ARK ,#[&L?Q
M5JDNB^%-0U.VBAF^RP-*8I =LB@<CCIQ]:NZ/*\^BV,TB1HTD"/LC!VKD X&
M?3I0!=HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *H:OHUAKM@;/4
M(/-BW!U(8JR..C*PY5AZBK]<]XMU^[\.VMC/;6T-Q]JO8K,K(Y3:9#@-D ]/
M2@"[::*MNT9GO[Z]$9!C%U(&"D=#P!N/NV35*/PA:0ZI?:E#?ZC%=7Q4W#QS
MX#[1M7C&!@<<5O#S/*&XKYF.PXS6#X5U^[U\ZM]HMH8!8:A+8CRW+;S'C+<@
M8!STH F3PQ:HMH!=7I:VN&N0SS;B\A!&YR0=V 2 #P!C'05+KWAVS\10VT5Z
M\ZK;3K<1&&385D7[K9Z\9/YU43Q7;OXXD\-&-@PMO-28_=>08+1CU(5D;\:;
MXFU^]T2^T:WMK:"<:E=BTS)(5\MBI;/ .1Q0!:;PW;/X@AUMKFZ-]%!]G5]R
M[?+)R05VXY/.>M#>&;";2K_3+LRW5I?.SS1S,#\S')(P!CGGVQQ5:/Q'<V_B
MJ#P_J=G%%-=P/-:SP2ETDV?>5@0"I&<]P?6J^E^)=1U&3Q%&;2UC;2)V@4^8
MQ$Q"ALGCY1@^] &E?^&[/4-3T[4))9XYM.+&U$3!5C+#:>,<Y''.::?#4"RW
M3VU_J%K]KD:2X6&?AV/4C<#LXP/EVGCUYI/"6M7'B+PU9:O<016YNX_,6*-B
MVT9/4D#/Y5!=Z_>0>.++0$MH&ANK9[GSRYW*$(!7;CGJ.<T ;5A8VNF6$%C9
M0K#;0($CC7HH%4'\/6RW]Q>V5Q<6$]S@W!MF7$I P"58$;L<;@ ?>L2\\3>(
M+&]T.TN-+T])=6D:-5^TO^Y(0O\ -\GH,<=Z77_$OB#P_HDFISZ/:R1V]P$N
M?+G<[(3C]ZORY(&>1CC!ZT ;0\-Z?'HUUI<(EB@N]_VAU?,DQ<88LYR22._7
MTQ4$OA'2Y_#=OH,PGDL[;9]G8R8DAV8V%7&"",=>M2:CJ]RBZ8FEI;7<U\P(
MW2%5\K;EI00#\HR/J649YJ_J$M[!8,]E;QW%WE%6-W**<L 22 2  2>AZ4 2
MQ0-%:B#[1*[!<"5\%_KTP3^%85EX+T^PLI;*"[U);6:1Y)(ENF7<S'+'<N&&
M3Z$53@\1:_<^)-1T2+3]-^T65O'.7:Y<*^_.!]S(Z5;'B2XN]6BT6RM(_P"T
M5M4N;TRL?+M W13CEF)S@<<#.?4 LWWA32K[PW_PCPA-MI94(8+8A 5!SC.,
M]>??O3QX>B+6_G7^H3QP.LBQ23?*64Y7< !G! //<"H+;Q!+#XC30-5BCBNY
MX3/:31,3'<*OWA@\JPX..>.<]JOZA-JB7-O%IUK;RJZNTLD\K($QMP!A3DG)
M].AH @_X1VS>TU.UN'FN8-2+&Y25@0Q90IQ@#'"@<>E,O_"]AJ#Z86:>%=,=
M7M$A8*L;*, XQSQQ@\5D^'O$VN:_IT6H1Z99+;F[:VD5;ARZA9"A<#;@],XR
M.*N^&]?O=<N-:BFMK> :=>O9*4<MYC* =W08'S#CF@#4LM*CLK^\O%GN));L
MJ9!*P(X&!@8X '8<?C52+PU:0>(+O6X;BZCO;N,1S%7&UE487Y2,<=CUK%M?
M&.HW'AOQ%JS6-JK:-/<P^4)6(E\D9)SCC/;@UIV&JZW>Z9IVH+96)BNUAD:-
M9VWJCX)(^7!*@DX[XH U-,TR+2]/2QBDEEA3(7SB&(![9QS^-9=UX,TBY\-'
MP\$EATLR-(8(7VCF0R8SC( 8Y 'TK6U34[71M+N=2OI/+MK:,R2-Z >GJ?:L
MNTU#7[W34U*/3[2-98_,BLI96$I4C(W.!A6QVP0.F>] $LGA>PN9[>6_>YOS
M;N'B2ZF+(K#HVP84D=B02*ENM!AN-4?4XKN\M;QX5@:2"08**6(!1@5/+'DC
M/-9Q\4RRSZ3IEM9AM7O[07<D,C%4M8\#+.<9^\=H ')].M2MK\^F:[9:5K$4
M*_VAN6TNH"0C2*,F-E/W3CD')!YZ=P#3TO2;72+:2&U5LRR--+)(VYY9&ZLQ
M[GI^  ' JE<^%[6YU\ZW]KO8[[R/LP>.4*!%NW;<8QUY]:H:3XNDN_&FI^&K
MZT2":V026\R.2MPN 6X(X(W+QSUI?$?BY]&\0:-HUK:+/-J$PCDD=RJP*<[2
M<#DG:^!_LF@#5TKP_I^CW-U=6R2/=W9!N+F:1I)),< $D\ =@, 4R?P]:W'B
M*#7'FN!>01F&/#C8$)R5QCG/KUK+E\1:RWBZ]T&SL+&5[:T2[626X:/>&8@+
MPIP<CK6CX5\20>*M!CU.&![<EVCEAD.3&ZG##(Z_6@#:JAIVE1:;+=R1SSRM
M=S>=*96#?/@+D<<<*HQTXK-\+>*[?Q/_ &D(HFB>SN3%M;J\9 :.0>S*<BJD
MWC(Z;XW3P]JMO'#%<QHUI>HY*,[%@(WR/E8[&QR<XH T+7PO:66IZEJ-M=7D
M=QJ6#<D2#:Q P"%(P"!QD5?LM+M[+28M,&Z:UCB$*K-ALQ@8"GCD8XYJM-?W
MXUXZ?#%;>6;4SK([-G(;;M(';G.?TK-\,>*9]835XM4MX-.OM,F,4]OYI;8N
M,B0D@?*PY!]!0!N:;IEMI&F0Z=9*8K:!=D2YSM'ISZ55T?P]:Z'/?2VLMPQO
MIVN)Q*X8-(<98<<=!P./:G:#>ZAJ.FK=W]K%;&4[HHT9B=F?E+9 P2,'';-4
MM(\5V^K>)]7T5(V1[':T;MTG7)5V7V5U93[B@"_?:':WM_#J :6VOX4,:74#
M!7V$Y*G((9<\X8$9YHLM$MK*YN+M7EEOKA0DEW,P:0J.@'&% SG  &><5BZ_
MXQ/ACQ%IUIJ5L@TN^##[:C']PP*@>8,8"DNHW9[UL7M_=P:OI]I!' T-UOW.
M['*;1G@#KG\* )],TR/2K5K>&::1#(\G[U@Q#.Q9N<#JS$UG3^$-)ET*[T5(
MY+?3[N1Y)H86V@[CE@.. 3S@?RJAI?B+7-6O]:MK?3]/SIET;;,ERZ^:=H;/
M"';P1ZUH>'/$L6OF^MI+62RU+3Y?*N[21@QC)&5(8?>4CD'O0 ]?#<&RWCDO
M]0EAMV1DB>?Y3L(*AL 9&0.#Z5=U?2X=:TNXTZY>5;>X0QRB-L%E(P1G'&?:
ML?Q'KNL:)8:KJ4.GVDEE80^8#+.RO+A=QP I ';.?6EA\07UK8?VIK-M:6^E
MBQ-VT\,S.4(VG:05'4,<8[B@#;TZQCTW3X+*)Y'B@01QF0@D*!@#..>!6=+X
M9MO[3N=1L[J\L+BZQ]H-LZA9B!@$JP(SCC( -5H=6UZZT9=7@TVV$;Q^='8O
M(1,Z$9&6QM5R/X<$9XSWK3T36;/Q!HUKJM@Y>VN4W)D8([$$>H((/TH C?0;
M-M%GTI6F2WN%=9G$F9)-_P!XECDDG/7KZ8JK+X1TN?PW;Z%.)Y+.VV?9V,F)
M(=F-A5Q@@C'7K2>+O%$/A/1UOY87GS,B>6@Y"9R[?14#'\ .]:6H74\>DRW>
MGK!,ZQ&5!(Y".,9^\ <9]<&@"F_AV)KT7R7]_%>B!;<SI*,LBLS ,I!0G+GD
MKG]:D@\.:9#I5WISP>?!>L[71F;<T[,,,6/KC XZ8&,8JCX3\5P^+=#-U;Q_
M9KZ([+FTFSN@D]#T)!Z@]Q^-9NJ>+M8TSPA8^(O[,MIK>4(]TJRMFWC;'S_=
M^8#//2@#8@\+6\44-O+?ZA<V<!4QVL\P9!M^Z"0 S@8'#$CBKQTJ(ZV-5,\Y
MF$)A"%AL"$@D 8[D YZ\#MQ574=6NHSID>EI;7<UZV?FD*J(@,M*" >!D#W+
M*,\U?O[^WTK3+B_OI5CM[>,R2OV  R: *-[X<L[[7[36WEN4O;1&CA,;@*%;
M[P(QR#[YJUI^EIITETZ3SRFYE,TGFL#\Y &1@#' ''3BLJWU;7KW1DU>VTVV
M$4D?G164DA$SH1D98#:K$?PX(SQFG67B"YU^PT[4/#\%O-9W43R/+<R,AC8$
M )@ _-G=GTV]Z -.QTBRTVXO9[. 1/>S>?.%Z,^ "V.Q.!GWYJM9^'K6QUZ]
MUF*:X-W>JBS[G!5P@(48QQC/;\<UC^&_$VN>(=(L]533+)+6>9XG5;AV>,*[
M)NQM /*YZCBKGAC7[W7QK'FVUO ;"_FL5V.6WM'CYCP, YZ4 ='61%X>M8?$
M<VNK-<&]FB$#Y<;#&#D+MQQ@]^OO6!;^--0F\':UKS6%JK:9+/'Y E8B01$@
MG=CC...#6Q::CK=S96%Y]CL3%<^4S(LS;U1\9(RN"0#G''0T 7-0T2TU"[@O
M6,D%];@K%=0-M=5/5>X93Z,".]%EHMM9WTM^SRW-]*@C:YG8%]@.=HP %7/.
M% R>36,GB+6;GQ1K&BVEA8R-IT44H>6X9/-\P$@<*=OW3SS4<'CZTG^'\GBK
M[+)&D>4>W=P-LF_R]I;IC<1\WISCM0!USJ61E#%21@,,9'OS67H?A^T\/6T]
MO92SF*:5IV$KAOG8Y8@X[G\*AAO]9BU&QANK6SEM;K=FYMI&_=D(6 VD<@X^
M]GMTZ4>+-8O=!\/SZE8V:7DT3(HMV<J9"SA0 0#SEJ )-*\.VNCW>H7-M/<F
M6_D\ZX,CA@SXQN QQQV''M5:V\(6-K9:I:17-X(=4DDEN@9 2[N,.0<?+D<<
M8]JO:5KEGJWAVVUN*0+:30"<LQ^X,98'Z<@_2LKP7XHN/%EKJ%W)9"SBMKV2
MU2-F)<[<'+<#!YZ4 6H_"=A%8Z;:1SWB+IHVV;K,5:(;=N,C[PQQALCGG-6[
M#1+>QO9[YI9KF^F18WN;A@6V*20H  "C))P ,D\U0C\5V\GCB7PT8V#+;>:D
MQ^Z\@P7C'J0K(WXFD\1Z_>:-J6BVMO;03)J5V+7=(Y4QG!;=P#G@'CB@#3GT
MJ*?5[;4FGG$MNC)&@8;,-C=D8ZG YZ^E5M5\.6>L:GI^H3RW,=SI[,ULT+A=
MA;ACTYR."#Q[4VWU2^OM<E@LX+>33(!MENRY!,N?F1!C#8[G. 3CD@XJ6^OZ
MC=>,-4T%+:U465O'.LS.WS[\X!&.,8/.30!>NO#ME<:K_:L+SV>HE!&]S;,%
M,BCH'4@JV.V0<=J2U\.6MI<7UVD]RU]?*J3W;N-[*N0H QM7&3T ZUG>$O&2
M>)&O;*XMQ9:M9.RRVQ8L&3<0)$) W*<>G!_"GR^*_P"S=#O=3U2) (;I[6&&
MW)9YW#E% SCECV[>M $T'@S2(?"C>&FCEFTLJ56*5\E.=W#=<@\@]J+KPC:7
MITYKB^U"1].;?;.9AN5L8R3C+'''.:6ZO?$EKI,U^-/L9IDB,GV&.5MW S@2
M8PQ]MHSZUO;U";R0%QDD\8% &7%H:179NS?7TL_E&)'DE#>6"025&,9.!SBJ
M-AX-L]+TH:98ZAJ<%F-V(TN,$;B2<-C(Y)/6DTC7K_Q);-J.DP6T>FEV6WEN
M2Q:Y"D@L /N*2#@G)/7 JEJOBS5=,TFSNI-*@2YGU-=/>!YSA-SE5<,%Y!&#
MT'!H WX-$M[:_ANX99T,-N+9(@PV",8XQCV'.<U4N/".DSZ!<Z&D3V]A=2/)
M-'"VTN7;<W/4#/IV '2MM-^Q=^W?CG;TS6!XC\5V_AR^TBWGC9UOKD12..D*
M'Y0['L-[(.?4^E #[WPI9W[::T]W>E]-.ZV99 I5L8R<#DXXYJU#H:179NS?
M7TL_E&)'EE#>6"0257&,G YQ2>)-4FT3PY?ZK!%',UG \YC=BH<*"2,CH>*Y
M[7/&]YH/A_1=:N-/BFMKUH_M*Q2-NMT9=Y8<?-M /ITH ZG3M,@TW2XM.C:2
M6VB3RT$Q#'9C&TG'(QZTFFZ3:Z1I2:;IZFWMH]WEJO.S+$\9ST)XINK:M%I>
MB3ZF!YRI'NB1#_K6/"*#_M$@#ZUS5IXXFN/"FAZK+:V\-SK5PMO;QM*?+C+;
MCEFQSPIX Y) ]Z .@T'0+3P[:26ME).89)6F*RONP['+$'&>33/#^D2:1'?*
MUQ<2I<733QI<3&5HP0,C)]P3@<#/XTZQO-5_M:2QU"UMUC$(ECN8')$AS@KM
M(^4CCN<Y%4_%6OWF@OI(M;6"X_M"_CL?WLA38SAB&X!R/EZ4 6W\.VK^)%U[
MS[D7RP&V!#C:(BV[;MQCKSGK[U9TW3(],6=8YYY!-*TS>:P.&8Y8C &,GMT]
M*RM-\33S>++KPUJ-G'!>Q6HO(I(93)'+$6VD\@%2&XQS]:@TOQ!K&JZMK-A#
M:6*?V9<+ 7>5_P!YE0P. O'!H V+;0-+M;?4+:*SC%OJ$SS7,)&4=F4*W'N%
MY]R:J67A:VT^!;2&^U$V"C"V;W&Y%7^Z"1OV^V[&..E4=<\2ZKHNE:7<OI]J
MUQ>7\=D\?G-M4NY57#;>1P#T'6NI3=L7?C=CG;TS0!BW_A6SO]9M]5>YO(;J
MVB,,)@EV!$/4  =_?-6;+0[>SEN97FN;M[E%CD-U+YGR#/R@'@#YCGUJCXA\
M5V_A_5-'LYHV87]QY4D@Z0J1A6;TRY4<^_I6GJ4VHQ"W73;:":227;(9Y"BQ
MIM)W< DG( Q[T 9EOX/LK6S&GQ7NH+I@R!8^?^["_P!S.-^W_9W8QQTJSK'A
MNSUN2Q:XEN(_L,HFMU@<($< @-T]#CTK&TGQ-KVK#53#I=@?[-OWLI4%R^Z3
M8%+,OR>C< ^E6K+7]3O_ !/KNBQVMHITM(665I&_>F52P!&/EQM.3S0!HP^'
M+"/4X]2G\Z[O8E*Q37,I?R@>NQ?NJ3W( )IJ^';9/$4VNK<7(OI8?L[-N&WR
MP<A0N,<'G/6L_P '>,8O%=C.K0?8]3MN)[1V)V@\HZG +(PP0<4LGBPV&@-J
M.H6ZF=[U[&VM;=LM/*)6C503CJ5)]AGTH VM,TR/2K=X(III$:5Y3YK D,[%
MV.<#JS$_C4-MX>TJUTZ[TZ.RB^Q7<CR2V[#*$O\ >X]#Z54N[SQ%9:<]X;*Q
MN'5=S6L,CAE'?#$?.1Z87-;U '//X/LY-*;2'OM0;2F7RS9M,"NS^YO(\S;V
MQNK>AACMX(X8EVQQJ$11V & *?10 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %<1\3IHH-(T5Y9$C4:W9DEFP  ^2?RKMZBFM;>X(,T$4I'0N@;
M'YT 4_[=TQKNWM(KV":XN&(2**16; !). >  .OT]:XWP=J]II6D^--0GE3R
MK?7KR0X8<_=P![D\"N\2QM(B3':P(2,$K&!D>E-_LZQP1]CM\'J/*7_"@#SK
MQ/I&LZ/X;L_$+S64EYHUR=1D\J-E>0.?WR;BQ&"K$=.B@5;\<7UCJ;^";F*\
M M;G58Y4F278=AC;D'MU%=^UO \(A>&-HAC"%05&.G%1'3K$@ V=O@=/W2\?
MI0!Y^1'8?%O2O[*O&U1KNUE2^6:3SVLHU&597ZH&;C!ZXJQX8GB^V?$ ^:F%
MU!RQW#@>2O7\C^5=[%;PP(4BACC4]0B@ U$-/L@"!9VX##!Q$O/Z4 <;\/\
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M>/TH XWPUX@?P]?Q>#?$;V\-W%&/[/NU 2*\B' XZ*XQ@KW[5)I,L9^+WB-
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MXQG\-C5I=6T=;+[3%).0TMHV\*(V<=01DC/]WCI4GQ)*$^$XS-Y1;Q!;88$
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MLG)^:(AF!*$\C&<9(]Z ,7PYKUQ<7GB'1DOIKK5CJMS;VL<L[8M[9-F'/.<
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M>2 PNKXW!3U4D$CMZT <UX3:Y\6^'HM>U*[NXFOB[V\%M<-$MO&&(4?*1N;
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ[2*0.K,'(5GZ!G(/)Q^?6H+>&W@^'O@*2V/ENU_IIE$3E=Q8KG< <'IW]*
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MNWA-U/(/-20/$K11 8VQ@$YR><MQCF@#U:BO.AHFG:_XU\6VFH3W#VHM[21
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA=R$8X!^4'(S^58OQ \3K8>%-4;3+^X@O;8JGG00%T5R1\C.5*@X/J",CUH
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MQS0!9ET72Y[*.RETZTDM8SN2%X5**<YR 1C.:>NEZ>E^+Y;&V%X$\L7 B7S
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M%G<+;W,D+)%,R;A&Q& V.^#5JB@#@M-\#@3VK7/ASP]I\MLZ.+VP=C*Q4@\
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MIUK=2P',3S1*Y3Z$BK]% %:RT^STVV%O8VL-M"#D1PQA%SZX%6:** "BBB@
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MIJ74F\K<*5FE.,%W!)(].>>*RM=T2^D\70SV,1-GJUH;'4V!QL53N5_J5,B
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MI'7T/M2YT%C;HJ.":.YMXYXFW1R*'4^H(R*DJQ!1110 4444 %%%% !1110
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ebs-brginterimmanagement005.jpg
<TEXT>
begin 644 ebs-brginterimmanagement005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+\1:P=!T&
MZU,6_P!H, 4B+?LW$L%ZX..OI6I6#XTL+O4_"-_9V,!GN9%39&&52V'4XRQ
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M 97^4,5CQ\RJ6&3D'@X!Q6"W@S7)= DU$ZC=)K;W1U5;#,)A%P#E8]^W=C:
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M7"R;0'7K_'D5HVNGZI8^&[;2]0T#^T],D$P>R25'EMU\S=#&2[!655PI(/!
MQD<T 7[_ ,=6=GX5LM;2SNIOMD0EBMU0Y XR789"@;ASW[9S755QDFA:L?A>
M='D7SM0\K:L?FAMH\S*IO/7:N%SWVUV= !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %4[G2M.O;F*YNK"UGN(?]7++"K,GT)&15RB@ HHHH **** "
MBBB@ ZC!ID,,5O"D,,:1Q(H5$10%4#H !T%/HH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BD9U7[S ?4TM !1110 44UG5%W,P4>I.*C^U6__
M #\1?]]B@":BH?M5O_S\1?\ ?8J1)8Y!E'5A_LG- #J*,BFLZHNYV"KZDX%
M#J*A^U6__/Q%_P!]BE^U6_\ SWB_[[% $M%-61'&4=6'J#FG9H ***,CUH *
M*IOJVG1R>6^H6JO_ '3,H/Y9JTDB2*&1U93T*G(H =1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M04445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ?I6S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:T7DF^R&2.',VS*Q,V/FQT)[5*0#C(!P<C-4;_6],TN1([Z^@MW<959&P2*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIKABA"MM;L<9Q0!Y[I
MVFWFN> ;?3+> ('NG8W3N (P)F)*@<ENW0=>M;NMZU?:8+V9)(B+9X@D*H7W
M(Q4,9#_"3DXZ=.]:VB:0NB:<ME'.\T2LS*7 !&XECT]S5"\\*QW:ZC'_ &A<
MQP7T@E>)0I"R#;R"1G^$<4 +?ZK<IJ5_:1R);"ULA<QM(N1*?FSG/\(P <<\
M]:AM]9U&ZCTZW:/;=W5H;N7RHP#&/E 4!V]6Y.>W3GBGJ:NVNRB:^U"T:...
M.)_L(N$FP"2P^0A3DX(&.GTQ?;1+G4[:SNI[^>WU*V+^5=1QJC,A/1T.1R .
M/Y<B@#3T>749; '5+=8;I793M(PZ@\-@$XR.V:Q=:AU/2+JYUV*:&[LQM:>T
MDA 9(U&"4?KD<G!XZUT-G:_9+<1M-),Y.YY9,;G;U.,#\!50Z5++),MSJ$\]
MK(^_[.R* !G.W(&2OM^!S0!;O;M+'3[B\D!,<$32L!U( S_2L-]8O[2UTC4)
MFCE@OY(HY8E3'E>8/E*GO@X!SU]JZ&:*.>&2&50\<BE74]"#P163:^'T@AL[
M:6ZEGM;)P]O&X&5(^[N/?;GCIT&<T 4]&BG;Q1X@$LZR()80RF/[W[I2._&*
MT=;TV\U*& 6=\MK)"_F#?")%<X( (/;D_P"13[+2OL>I7U[]H:1KQE:1&4
MJNT8_ "I;RTN;B>&2WU"6V"9#(J*RN#ZY'44 5O#][/>6$BW=O'!=6\S03+%
M]PL,<K[$$'\:U:AM;6.TA\N/)RQ9F;DLQ.23[U-0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5G7^JR6
M=Y#:PZ9>7LDB-(3;^6 @! ^8NZ\G/ &>AK1HH YC2/&D>M6%G?VNB:I]CNW9
M(YW$. P+#D"0D9*D9QC)'K6EX<UR/Q'H4&J1020),TBB.0@LNQV3G''\-8'P
MF_Y)GI'UG_\ 1TE<MHJS6'A#PMJ=O?7B3/KGV9HQ.PB,3W,BLIC'RG/7)!.>
M] 'KM%>=L^I>)4UY[?6!IUWIVHR1)+Y\@%LD9&TM&"%964$G=G.X^@QVNJ64
MNJ:)<VD=U+;330E4G@=HVC?'# @YX/.* +]%>46_BB=#X;UFXGNH[6S_ - U
MQ6N7V1SG,:LRYP2'0DD]I%/.>.AF$J/HEM->7QN[^2>Z-AY[C>"N=K2;LHD8
M91@9R<<&@#K+^YGM8$>WLI+MVE1"D;*I520"WS$< <U:KRR/4M2?X=Z9</J%
MT+F+75MC(MPQ9XQ=E-K-U8;>.>O>MS5[^7PSXV2ZGGNIM.U2T>*&!IW*I=)\
MP503@&1>!CNO'6@#MZ*X23[6OB.R\+SWKO\ \2O[26DNY4:>4N0Y#@[CM R%
MSP&]ABE-9ZG%J7A#2;OQ%>7+2RWEO<SVTS1^:J1N0&P>67INZY&>#0!WNJ7P
MTS2KJ_,$DZV\32F./&Y@HR<9('ZT:5?KJNCV6HHAC2[MXYU0G)4,H;'ZU0U:
MU%CX)O[59IIA#I\J"2=][MB,C+,>I]ZXFRM+O2=,\"ZC9:GJ#O?_ &:SN;5[
MAFB>)X"253HI0+D%<'@YS0!ZA17G=I/=VE]J/@V>^O7O9KQ);2Y>Y<R&S?YF
M(?.04".F?4KZUUGB>YCT_P *:A,^H26"I 5%TB^8\9/ (!ZMDC'N: -BBO/(
MIK^#Q%KVG&6\M8/[#CNHXFO&E>.3=(N[<2=K$*,A21QG)JKH[WD'_"OKTZGJ
M$TNJ6_EWBS7+LD@^S%Q\N< A@/F R>Y- 'IM%>=QSWFG:GJ_A":]O7NKZ=)M
M.N7N7:06\GW]K$Y!BVOWY^7UKJ/%ADMO!&LO;3SPRV]A-)%*DA#JRH2#NZYR
M!0!N45YQ''?Z3J7@[4H-6U"Y.I[8+VWN+@O&ZF$OO"GA2NWJ/Q[YBT_4+K^V
M/"=S;:A>7-KJ%S<QR74TS#[6OER.#Y.2JJ"HV]#QT&: /3*CMYXKJWCN()%D
MAE4.CJ<AE/((KSG3-,DU/3O$US>:KJLOV*_OH(HOMKA/+"8"L >0.WICZYCA
MM;C3?AAX9UVPN+[.GVUM=W5NEU(5G@\M?,7;NQP/F Z?+C'- 'IU%8>@3#4Y
M[W68KB62TN7$=J/-8QF-!@N%)P-S;N1U 6N;\8W4S-XE-E?7;W&GZ4)=D<[0
M)9MM=@^5.7=L#@C&%Y(S0!Z!17G\0N=7\9Z;;7&HWZVUUX?^T3107+1*S[XQ
MD;2"IYZC!_ D'/\ #^N7M[;^$-(O;VX:.\DOQ-.92))_(=E1"XYZ8)YR=ON:
M .ZT?74U>^U6U6UE@?3K@6[^85.XE V1@GC#"M"2YC24P@[Y_+,BQ*1N8# [
M\=2!S7)>";=;37_%\"/(ZKJ28,KEVP8(SC)Y..G/I38[.(_&&[DW3!O[&ADP
M)W W><XZ9QC ''3OC- '0>'-;C\1Z%;ZK%!) DQ<".0@LNUV7G''\-:M>1:&
MLVG^$?"6IV][>)+)K7V5XQ.PB:)[B164QCY3ZY()SWK8+ZEXDBUV:WU@:==Z
M=J,D2RF>0"W2-AC=&"%964$G=UW'T& #M==U5=#T.]U1[>6XCM(6F>.(J&*J
M,GJ0.@JU:7 N[."Y"E1+&L@![9&:Q/&Y)^'WB GK_9D^?^_;5S:6=WI&K^$Y
M;/5-0F75$-O>6TMPSH4\DMO5>B%2!]W'6@#T6BO*+"ZO=.^&K>*'U?49KQ&E
MMF,URSQI&UX4+E3D;E7)#=1]  -K4H+G18=3U&3Q*UEI\^G-M1'DN620$ 31
MER><,%P."2#UH [VF3.T<+NL;2LH)")C+>PR0/S->;7>L:KH&I^)/(6=5M]
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M%N)&B\QD!P2/E?IS@]J /1]1N9[/3YKBVLI+V9!E;>-E5GYZ L0/>K7:O/\
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M/S(9%D3<R[E.1E25(_ @BI*XWX6VZ0_#_375I"TBN6#RLP&)'' )('X8KLJ
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MT 48_!^@0RF6/3D64VYMC)O;>8SG@MG)ZD9ZX.,XJ9/#.D1KIZI:L%T[_CT
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MVDZV/]F+:I/%<^6V\2,Q^XP;:01^(Z=ZVG\.Z2[V#?9 AT__ (]1&[((>,'
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M=(I[V*6)W@=%<>2@)!( /(/\Z[*B@#S#QK.]P_C#3X[*Y@F?3D\LV]JSM?\
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M@5'1L%]N6/RGG'4X[9-S4=-U"\\8>']42W1;:QCN%G#2C<#(J@8'?&WGGO0
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M[:^AM8Y1-Y<X$D<FX&-XF.,<%@>0>G6M?2WU[0QX>T>[\J_62-X[JZ:<F56
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M.2'4;HV[R&0AHSL9N%QS]WUK1MWOFOKM+B&!+52GV9TD)=QCYMPQQ@],$Y%
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ME=DC,,.02-R[A][!^F#S71T9![T 8]OX=M[;Q&^M17$ZR-:I:?9QL$2QJ25
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MFIVT/B/5[/1YM,OFCTJZCN7O;F+;&^U#C8_\9)(!&,8W9[5UU!('4T (1D$
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M%G9?:(945 %8-Y;A<G)(RN,\]S71V'A^YFO=.UG4K^Y.I6UL]O@+&%978'+
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N3\5SV!U[0;*ZV-/*
M9Y(4N7 ML*@#,ZD?.0&^4<=3R*ZRJ]U86=]Y?VNT@N/*;?'YL8?8WJ,]#[T
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M\I[G^(X[UVMGHVEZ>RM9:;9VS*"JF&!4(!Y(&!2P:/I=JUPUOIMG"UQ_KS'
MJF7_ 'L#G\: .1^%ND6$?A#2=72'-_+:M"]P7)9D\PG;UQC(J.\AM8/BIJ,\
M=M:F].AQR6^]%!>;S9 "">_W1GKC%=Q:V=K8P^3:6T-O%G.R% BY]<"E>SMI
M+J.Z>WA:XB!6.9D!= >H!ZB@#RY MQ\//#FM:=_R,/VNW5IQQ++,T@69'/4C
M[^0>@7VKM?'%S9VOA*[:_,XMY&BB/DR",DM(H +$$*I)PQ_NDUKQZ7I\-X]Y
M%8VJ73DEIUA4.Q/7+8R:GN+>"[MW@N88YH7&'CD4,K#T(/!H \IG:W7_ (6-
M9^;9*@TJ.9(;1ML:R"&7)49Y(VKD\9P.!6C9:;967B7P4\$"*VHZ9<1W9/)N
M%$49 ?/WL=L]*[S^QM+VE?[-L]K1B(CR%P4'1>G0>G2FOI-BJH]O862SP(1;
MNT"_NSVQCD#/IB@#AM)L!:ZC<> Y+;=:Q78U".1DR&LRV\ GN1(!&<]5^E;G
MQ+C5OAOKF01LMBRX.,$?2M31-/U*%I;[6IK674ID6-OLB,L2(N2 NXD\EB2?
M<#M4?B_2+K7_  IJ&DV;0I-=Q&(/,Q"J#WX!S]* .5N]-LM"\:Z)J&E>9$ES
M974FIF)RYFA6,,LC<G+;R,'OFLW1)[!/$7@R2UEMHK>]L;E67S0T\J%4*^>X
MP&<G)QCAMW)KTO3M.MK& &.QM;:9U E^SH "1[X&>_44D6BZ5"J+%IEE&$9G
M0+ HVLPPQ''!(X/K0!Y99^']*F^#^L:F]FDU[%;ZE&DKDL4432$ 9XX*@CT/
M/>MS5K*QT[1-"\5Z7;6[?V/L>Y6W1</;LH$O _B4'>/H?6N\M].L;2!X+:SM
MX89,[XXXE56SUR .:R=1T>_G:'3+$Z?:: \1CN85A(E(SRJ8(4 C(/&1DT 2
M^&[=3:3ZH8A'-J<IN6^7!"$ 1@^X0+D>I;UKE?$-A%I_BVZ@%HDL'B>R-L%V
M9"W2'ACCH"CEB1_SS)ZUZ(  ,#@4QXHW='=%9HSN0D9*G!&1Z<$C\: .$\%0
MG4[>VLM0M4\WP\DEA*3'@/-G;N4_]<U#?]M?:N;MK:SE^'G@][F*&1$\0["T
MJA@$-Q*""3V.!GUKUX00@2@1(!*<R#:/G. .?7@ ?A58:1I@LVLQIUH+5FW-
M!Y"["?4KC&: .%N-+TO5O%_BB*XMX;BT71[4Q)UC Q+@@#CCC![=JK>&;QM2
MU'PE9:QBXLI_#JR0+.-R2W(*A\@\,P3'7L6]:]$.DZ:TLLIT^U,DJ[9',*Y<
M>A..12/H^ERVB6DFFV;6R-N2%H%**?4+C - 'F$B/:Z;&)&_XEUCXPBCLI7/
M$4'F+N4,?X Q9?PQVIWB(V%U-\2HXS;RK_9D$JJ,,-ZI+EA[@XY[&O49=/LI
M[$V,MI;R6A4*;=XP8\#H-N,8IL6EZ? '$-C;1AXQ$P2%1N0# 4X'(QQB@"#0
MTLAH=JEDEO\ 9_*7*PA=N2!G@<=Z\LF@T^W^%OBF.".VBG&JS(PC55<(+L!0
M<<X&1BO8;>W@M($@MH8X84&$CC4*JCV X%5I-'TR83"33K1Q,XDEW0*?,8="
MW')]S0!Y]KD,F@^*-?70(C!<2^&I+G;%G+S+(0)#_>?!/)Y-:/AN#0[S6=*U
MC2=9MWD>V9&MK.-5,J$9S, 2<J<<GG)QWKLTTVPCN5N4LK9;A5V+*L2A@O3
M.,XI+32]/T^6:2RL+6VDF.96AA5"Y]6('/XT <IXVM+:Y\3>$$N<^7+>RQ.
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MB<8FE2%0\@_VB!D_C4EI8V=@C)9VL%NC')6&,("?7B@"Q1110 4444 %%%%
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MR@C/R@XZ52O=/U%[7Q[%%I.J$:G:1?9&F4NTK>5MQG).<]NPZXZ4 =1?>/\
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M2+RZL;V"TC5$B8>>%#+)L/J-P(Y^E '96>J6U]--##YRRPA3(DL+QD!LX/S
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MNH]P!F#$;48*,Y!!RN,'C(!J1^+['5-+\0-))>Z=!822V[77V=PT85%RXRI
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M$;E(E&<9QDHW]<9JFNGZO;VT>HQ:9>2K8^)KB_DM/**O+!(7 =%.-Q ;..M
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M&ZM;GS#F8 @,N", KD$\G@T =!5+5M*M=:TZ2QO%<PN5;,<A1E92&5@PY!!
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M<M&IECC?<JOCD X&1GO4U !1110 4444 %%%% !1110 4444 %%%% !1110
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M:[A%!-<O)% &ZB-&)"Y_/M0!D:,WB&]&A:VNHVOV*YB5[U)+DLLH=05\M?+
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MV>"6"9HG7<,,,J0<$=:H?\(/HO\ 9L^GJERMK/=?:W07#_ZS=O&.>!NYP.]
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK.W^Q-<D!'A56$J GC[Y)(]"* -GQ+XD@T)+"/SK=9[ZZCMT,K#"!LDN1D9
M"GN.<5>TAM2^QR-JDUG,WF,89K4$*\7!5B"3AO7!(]Z\TB4Z=X2\"V^IRA'7
M6U:);@X=;?\ ?>7G/. I0>V0*]!\5W%O;>#M6GGM9+NV6SDWP0L5,B%3D CD
M<=QTH T;;4;&\$AM;VWG$?WS%*K;?K@\4D6IV$\\<$5];22R)YB1I*I9E_O
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M\;A'O[56,ODA6F4$R<'9U^]R..O->=));ZIX:\$1Z0RKJMI=VP>->)8 JD7
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MMX!Z@4C(KXW*&P<C(S@UC6GB:VOK#2KRVM;J6/4D,D2J$+*H7=EANX[#C/)
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MO;- '1E$8@LJDCID=*7:/0<5S]OXQT^_MM,FTV*XO3J4,DT$<2JIVI@/N+$
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M/;2?+L9&++_M9P>PKI** .$L]%\01:EX0GU!)+U].BN5N[DR)N_> !,\C<0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBD) QD]>E "T444 %%(2 0">O2EH **1F51EB /4FEH **** "BBB@ HH
MI,C)&>10 M%%% !1110 4444 %%(2 0">O2@D 9) 'O0 M%%% !1110 444@
M((R""/:@!:*3(SC//I2T %%%% !1110 4444 %%%% !10"",@Y!I 0>A!^E
M"T444 %%%% !1110 4444 %%%!( ))P!WH **** "BBB@ HHHH **0$$9!!'
MM2T %%%% !1110 44A(! )Z]*6@ HHHH **** "BBB@ HHHH **** "BBB@
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M.BQ:@D#V[,[QR0N03&Z,489'!Y4\UQ^JZMJ&M:#X]M;ZT@6VL(IHHMLNXJ1
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MIKF<0J%R$3@L6=@#M4!3S@\D"L%- U7^U_"ETR6@CTFUEAN )F)8NBKE/DY
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>XN)YE14C@C9V)WJ>P] >:ZJB@#'M]%B>Y74)+R\GNO(,,,TZJK0HV"VU=@
M)PN203P*KP^#M+C\(CPS*9[C3E7:GFN-Z '(PR@<@\@]:Z"B@#+LM#BM;U;Z
M>ZN;V[2'R$FN2FY$)!( 55') R<9.!3[70[&SUN^U>&+;=WRQK,V>#L! QZ<
M8SZX'I6C10!@)X3MHAJ/E7]^CWUTEY(ZN@*RJ5P5^7I\BC!R"![U'>^#+#4+
M'4+:XN;LMJ,D<EU.I17D\O&P<+@ ;1T%='10!C7'AN"75QJL%Y=VE^8!;S30
M%/WZ#D;U92N0<X( //IQ47_"):>KZ.8)+BW7269[=(V4@LP(8MN!+$AFSSW)
MZUO44 <_'X2MX9;N6'4;^.6ZO!>NZLF5E"[>/DQC: "#D5HZ9I%OI;7<D3/)
M/=S>=/+)C<[[0H/  & H' [>N:OT4 8$GA.TEEUN1KR\SK*".Z 9,;0FP;?E
MX^7C_P"OS5:[\"V%R--DBO\ 4K2\T^ 6T5Y:S!)6B'\#_+AA^%=110!AGPM9
M_P!HZ5>I<W:2:8LBPKO#!O,^^7+ EBV.3GKS5>_\%V-[KLFKQ7NI6-Q.JI=+
M97)C6Y"\#>,=0.,@@X[UTE% &/\ \([;+KT>KQ3W$4\=H;)(TV>6L60< %?4
M ]>WIQ5&/P181:-8:6E[?"WL+L7D)W)N$@<N,G9R-Q)Q[UTU% %.RT_[%<7D
MWVN[G^U2^9LGEW+%P!M0?PKQG'J35RBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH **
M** "LM/#]BNO2:R?/>[<  /.[1H0NW*H3M4XXR!GD^ISJ44 1O!%)+'*Z!GC
MR4)_A)X)'OCC/N?6I*** "BBB@ HHHH **** "B@]*Y&X\37?_"=6FD6Z*UC
MS'<2D<B4H7"@^R@$_6JC%RV"YUU%(*6I **** "BBB@ HHHI@%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444@"BBJ]S?6UE"9KJ:.&->K.P
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M6LN6*LB;-E ^*+!P!90W=Z1_S[6[,O\ WU@+^M']I:U<G%MH8A4_QWEPJ_\
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MKRJ/P8D5KP6EO:QK';P11(O18T"@?@*FHH<F]V%@HHHI )@9SBEHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSU ("G'TKNZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC=V=E(W,XPH49'?/7V%=+HT4T&B6,%Q$8IHK=(W0D'!"@'D$CM5ZB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI&941G=@JJ,DDX
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M+;5VMKK2]2G%K%=11F-X9C]U7&XA@V.HQCTKKJ "BN4M/%LDWCZ?0Y80EE)
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6^L:[:Z+H-Y=:HUU+KOV:)$6"-/L[&%I'*D\$MM ^;@$Y QQ0!Z!2,P52S$
M 9)/:N&N=8\1:(DL-_(ACO-1MK6PN)O+,L:RG#EU0!3MP=OKD9J#QU!K5EX,
M\2F76GDM3 C6I5468#[LB.0H!4Y&, 'DC- 'H-%<LVH7<OBV+PS'J$\8BTXW
MLMSLC\V0M)L51\NT 8.<+_=]\\])XHU]]/A@6[CCO+;Q&FD3S^0"MQ&2"'Q_
M"=K#('?.,4 >E45Y_K>K:QX:=;?5=6O19-;'R]8BLXRD<Y=\"=0IVJ%\L @
M'YL^W6ZOJR:5X:O=7 $Z6UH]P AXDVJ6&#Z'UH TZR-3\2Z=I+RK<-,WD;#<
M-#$T@@#G"E\= <'^?2N?GUG5M+M_#&IR7QO(=5N(+:ZMS&@53,N5>,@9 4]B
M6R/?FE\,6TR^/_%S-?W$@2:V!1ECP^8!C.%!X[8Q[YH Z35M?T[1#;#4)9(_
MM,HAAV022;Y#G"C:IY.#Q2VNMV5W>BSC^U).T;2JL]I+%N52 2"Z@'!8<>]<
MS\2?,$7A;R0ID_X2&TVAS@9P^,X[5NH=9:YO3>"S@06ZBTDARY#G?OSN [!.
M* -JBO,[+7?$<F@^#]7;6 SZO.EK/ UJGE_.CG>, -N!7UQ[>MN3Q/JFAKXG
MM;F[-\^GW-I';3S1HC 7&T?,%"J0I8GMGO0!Z#17"ZK=>*]*L==NQ<LMG#I<
MES;R70A::.= 20 @"E",=>0:2XU+7M+T73-0NM5\Z'4;FT2>7[.B"QC9?G8'
M&""VT9;IF@#NZ*\^?Q+J^G6WB&\>[%Y8VMU#:V$S1H%<RF,%BPP&V%R.P..N
M<U;O[CQ3IMOK=Q]I864>FR7%O)="%IHYT!. $ !0C'7D&@#MJ0,&S@@X.#BN
M%T_5-;CUCPLMUJAN(=:L9&EB\A%$3K$KAD(&<\G.21[#I5KX<+<-H%S-<7UQ
M=,U_=+^^VG&)W&<A0<G\O0"@#:NO$NEV>K+I4TEP;YHS*L,=I+(2@."PVJ01
MFI['6].U*&XDL[CS3;$K-&$821MC.&0@,#[$5RFK-=K\7]+-G'#))_8TV1-(
M4&/-7N ?;M5#19[N#QSXM34"MKKT]G'/$(!O@\A 55@3@LV3SN ]N* /0K"\
MCU"P@O(DE2.9 ZK+&48 ^JGD&EO;VVTZSEN[R98;>(9=VZ#_ !.>,=ZXG2/$
M^H:E:^#K&2Y,=UJ]B]W<W2HNX[$4X4$;026';@ ^N0V5+KQ+%XE\)ZGJ#1S6
M%Q;-:ZBJ*K'?B2+<!@%E9<'&,\=* .KM?$.GW5_'8JUQ%=2(9$BGMI(F91U(
MW*,@9'YUJ5P6DZ_J]EXCL=$\8:?%]N=9#8:G:',5QM7+ KU5MHSCH?3I5:7Q
M5JW_  KZ'QO#=%E\P3/I_EIY9@,NS8#C<'"\YSU!XQQ0!VUGK5E?:M?Z9 TA
MNK 1F=6C90-^[;@D<_=/(XK0K@))Y[7Q/X_N;:9H9X=-M)8W"@X98YB."".U
M6H-<U.6\\#@W9":M:NUV@C3#,+?S PXR#N]./:@#J]0U"'3K"XO)5EDC@7+K
M!&9'^@4<D\U9!W*",\\\C%>607^KZ3\.?%.JVNKW#7EM?W>QYTC?[DI7/W1R
M1CV'8"NM;4[K5/%UYH<%Y)91V5E%.\D2(7D>0MC[ZD;0%].2?;D Z>BO-HO%
M.OWEIHJ"ZBM[HZW+I-XRP!EEV"3YP#TSL' [YJY'K'B&WM_$UE%)-JEUI=[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/
MK_AVW\116L=S=74*VMPES'Y!4?O$.5)RIZ'MTK8HH P_^$7M9M6M-2O[J[U"
MYL\FV^T,H2)B,%@J*HW>Y!-1/X.T\MJ")/=166HR&6[LD9?*E8_>/*[ANQR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOTCDAE? A9V$F&4#>-NYL;N];NJZ%J$FA^$X3IMQ=_V>JB\M[:Z6&0#[.T9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%% !1110 4444 %%%% !1110 5SOBW0+SQ!;Z?%:W$$'V2^AO=TJEMQC.0N
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MC^R=-_Z!]K_WY7_"@!?[5T[_ )_[7_O\O^-']JZ=_P _]K_W^7_&D_LG3?\
MH'VO_?E?\*/[)TW_ *!]K_WY7_"@!?[5T[_G_M?^_P O^-']JZ=_S_VO_?Y?
M\:3^R=-_Z!]K_P!^5_PH_LG3?^@?:_\ ?E?\* %_M73O^?\ M?\ O\O^-.CU
M"RFD$<5W;NYZ*L@)/X9IG]DZ;_T#[7_ORO\ A3XM.LH9!)%9V\;KT9(E!'XX
MH LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMXLUCQ'H7@>XUJ*^TYI(DB8*+)@?F=0>3(1_%Z5>U[7KNPGUB.QF6>6UTPW
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MEB?E R>Q)SP,[.J:)8ZS]E^VQR/]EF6XAV3.FV1>C?*1G'O0!H4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO0X/!IL&LZ7=&86^I6DI@&Z79.K>6/5L'@5YWKR2S:_XRMM&"M<S:+;A(H2
M92K2;E&.K;"!^(J[97WAK7W?5[6YN[FZ@T^2&8W">6MO&1DQR#:%SNQ@<]"1
MQ0!VL.MZ3<>9Y.IV4GE1":39.IV(>0QYX4^O2I+;5-/O)#';7UM-(.J1RJQ'
MX UYG'::?'\%M+NX_*MYX8K,R2K#NRZ2H=DNT;MN[KZ=<'H9)9[3Q"/%NH:)
MJ5E/K-YI@BAM+20LX"*P+995)8[MO XP.>: /1H-8TRZ>9+?4;25X5W2JDRL
M4'J<'@>]-AUS2;FYBMH-4LI9Y4\R.))U9G3^\ #DCWKC-(O_  SK]U;ZG!/=
MS7=I:212I.GEK:1E?F20;57J  .>F1P":PM(^Q6WA+X<.GDQ3I?IYI& RYBD
M#;NXY*@Y]J /2=&\2:7KTUY'I]W%,;68PMM<$M@+E@.NW)QGIQ69K.M:M:>,
M]&T6T>R6#48IW+S0.[(8PI[.H.=WX57\#SHE]XFL7W+<KK-Q,4*D81MNUO3!
M[>N#Z5G>+Y=/;XE^%EO;I8H88+OS7\\Q>665-N6!&,X..>: -W2_$5VWBR_\
M.ZDENTUM;)=I<VX*HT;';AE).U@?<Y'/%:.F7P&BB[O=4L;E0[[KN A(L!R
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVDLWEMKS[/':A2))A\N /F/S'<>W:MLZE!%>7:2W(Q"(@8_*8%2Y('/\6X\
M#T]Z2FF.Q?HK$U+7XK:U2>)PL0N?(N97B8_9_E)RR\$<[1GI\P/2K5OJ 6W1
M[F:*4RL?):V4L)5QG( )/3K3YU>P6-&BL6378UO[>19D;3I+*:Y9U0EAL9!]
M>C'(QGBI[S7;.TAF?,DCQ+&Y18VSB0D(>G0D'\J.>/<+&G16>NIP+<W(DN/E
MC\L>6865E+]!_M$^@'%(=<T\%!YKEWD:(((7+;U&XJ0!D''/OVHYEW%8T:*H
MQZQ8S1PO%*SK*JNNV-B0"=H)&..>.?0^E1:O?7%E)IRP>5BYNE@?>I. 58Y&
M".?EHYE:X&G16=!KFGW$ZPQS-O9I%!:)U!9"0PR1C(P>/:I[74;6\E:*&0EP
MBR8*%<HV<,,CD<'I34D^H%JBL6_U>6.PUFZM!'C3HWQYBDAY%3>1P1QR!]<^
ME2C7K.%1'=3$3JD;2[87VKOX4YP0!D'G-+G0[&K16=#K-M+-=1E94-O/Y',;
M?.VT-\O'/!_(9Z4U?$&FR-"L<TCM,I9 D#L<!@AS@<88X.>G>CGCW%8TZ*R8
M=<M%MX3)</,\PD9#%;/E@C8.%P3D<#]:L6>L6-_*L=M,79XA,A,;*'0XY4D8
M/4=.F:%)/J%B]167%?SWVIWMM:F..*S98WD="Q=RH; &1@ $?7/;%5;K5+ZT
MU'3[2XFLH!<).SNZG V%=N/F'4-0YK<=C>HK%75IIKNRL8)+>2:XB>Y,ZJ=@
MB! 4@9Y)W+W]3[4C:O<0W&H6DB(]Q9Q+<C8"!-$<\8R<-E2.OH?:ESH+&W14
M<$T=S;QSQ-NCD4.I]01D5)5B"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
C "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>modificationno10effectiv001.jpg
<TEXT>
begin 644 modificationno10effectiv001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M=W=I&C1K;W$@9=K*4(8XW/\ *Q'S$]?7FH)?!^G3V,UI-)=2"2V6S\QY 76
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MA<O&<$'D$GV.>F<&F7'@_3KI;DS373RS)&@F+C?&J2>8@!QSAL$;L],5A?\
M"E_ '_0"?_P.N/\ XY1_PI?P!_T G_\  ZX_^.4 =+;>'8+/4KB^M[R]C:Y(
M>:)91Y;R;0OF;<?>P!GL<9(J.'PM9V]AH]DEQ=>3I,@>VRRYX1D 8[>1M9A^
M/KS7/?\ "E_ '_0"?_P.N/\ XY1_PI?P!_T G_\  ZX_^.4 ;1\%Z<[K))-<
MR2^9%(\CE"9?*#! _P OS !FY/)SR3Q3E\&Z>MG%8F>[>QB92EM)(&155PZ*
M,C("D<8.<<9QC&'_ ,*7\ ?] )__  .N/_CE'_"E_ '_ $ G_P# ZX_^.4 =
M/J7A^UU+4(+]I;BWNH8WA\RWDVEXFP61N#D9 /J#T(JK8^$+'39[66SN;Z$P
M6\=JRK-@3QQY\L/QR5R1D8..#D5A?\*7\ ?] )__  .N/_CE'_"E_ '_ $ G
M_P# ZX_^.4 ;\7A.RB>V;S[E_L]Y->JKE"&DE#A\_+R")'X_VO88;'X.TM+(
M6;^?+;QVDEC!'(^?(@D #(IQGHJC)R0 .>M87_"E_ '_ $ G_P# ZX_^.4?\
M*7\ ?] )_P#P.N/_ (Y0!T,'A>VM[^&]CO;\3I"D$S"4 7*H24\P 8)&3R,'
M!QTJS?:);WU_'?>;/;W:0O;^; P!:-B"5.01C(!!ZCL1DURO_"E_ '_0"?\
M\#KC_P".4?\ "E_ '_0"?_P.N/\ XY0!MS>"]+EM[JW1[B"WN+&+3S#$RA4@
MCW;57()'WFY]_IB2Z\*VMY)=O+=W>ZZEMYI"&0?-"0R8^7CE03ZXK _X4OX
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M] )__ ZX_P#CE '>T5P7_"E_ '_0"?\ \#KC_P".4?\ "E_ '_0"?_P.N/\
MXY0!WM%<%_PI?P!_T G_ / ZX_\ CE'_  I?P!_T G_\#KC_ ..4 =[17!?\
M*7\ ?] )_P#P.N/_ (Y1_P *7\ ?] )__ ZX_P#CE '>T5P7_"E_ '_0"?\
M\#KC_P".4?\ "E_ '_0"?_P.N/\ XY0!WM%<%_PI?P!_T G_ / ZX_\ CE'_
M  I?P!_T G_\#KC_ ..4 =[17!?\*7\ ?] )_P#P.N/_ (Y1_P *7\ ?] )_
M_ ZX_P#CE '>T5P7_"E_ '_0"?\ \#KC_P".4?\ "E_ '_0"?_P.N/\ XY0!
MWM%<%_PI?P!_T G_ / ZX_\ CE'_  I?P!_T G_\#KC_ ..4 =[17!?\*7\
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M-22>![K6=2T>35M.TRVL(=-NK*ZLK1R43S&&SR_E'&!G/&#TKF[7X7>)]/\
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M<$0W.W\7SX!.?>@!WB7Q3J%CKUCX=T'3X;W5[N%[@_:93'#!"IQO8@$G)X
MK/N_'>KZ3X=6;5?#CQ:W+?KIUI9I,#'=2-]UU?'"$9Y([59\3>'M:_X2RP\5
M>'?LDM];VSV<]K=NR)-"S;AM8 X8-STY_GFZAX1\6:[X?AN-2U6R&OVFJ+J5
MA&B$V\&WI"3@,PP3DGF@"U;>,]<TW78M%\4:39VUQ>6TL]C/97#212F-=SQM
MN (('.>E9.C_ !?75_!]OJL=A''J']HP65S:,Y_=K*V%<'&2"IR/<&KR^&O$
M_B+Q)::UXC33K-=-MIXK*UM)6DWRRIL9W8@8&.@%<_<?"+4_[,\)RVEQ;0ZC
MIY@BU- Y\NXCCDW@@XY92.,@<'KQ0!NW?B[QM!XPC\.QZ'HK7$UN]U"[7L@4
MQ*VWGY.&Z<57OOB)X@BU'Q"EGIFC-:Z)(4E-S?F*23";CM&TBNFN?#U[-\3;
M'Q$K1?8H-,DM'!8[][.&&!C&,#UKD]2^$B:U/XKNKV.T2_OKL7.EW:C<\)51
M@-D?=)'(Y&#ZT :VO?$=]/\  FD:[I^EM<W^K!#;6#MAN4+MR!R H//T]:N:
MGX^BA\*Z+JNEVGVZ[UMXH;&U\S8#(XR=S=@N#GZ5C2^!_$7B77-)O]>U'^RQ
MIFG^5$=(F&XW#<2.-R852H QBJ5K\--=TW0XK"QOK9Y-%U;[?HLEPQ(>(YW1
M2[5&WDGE?7M0!T]GK'C:1-0L[OP[8QZC"B26TZ73&TG!;#*6V[E8#)Z'/M5;
MP3XK\3>)[R[:\TK3;:PL[N:RGDBN7:3S8^NU2H!7)'.?PK4\.1>+I=4O+_Q%
M-96]L\:QV^G6A\Q4(.3(TA4$D],#C%-\$>'KWP[;:U'>M$6O=7N;V+RF)Q'(
M05SD#GB@#J**** "BBB@ HHHH **** "BBB@ KGO$/\ R'O"G_83D_\ 22XK
MH:Y[Q#_R'O"G_83D_P#22XH ORZ;(==_M2.90PLVMU1ER,E@P8\]..E7XA((
M4$I5I=HWE!@$]\#G I]% '-:=H&K:='::=%JL*Z1:29C5+<B9HP25B9BQ7 X
M!(&2!CCK4,/A6_2PL]%EU&!M$LY(FC00$3M'$P:.-FW8P"J@D#) QQG-=710
M!QP\"A&T2:.^\NXT^8-.RQ_+<QAV<*1G@ACD'MEO6KVH^%VO[3Q)!]I51K*!
M 3'GRL1"/GGGIGM71T4 <C>>!H!)?1Z.]OIMCJ<"P7UM# %#@,,LFTC:QC+H
M?JIZCDG\#(EU/-IU_- )!!*HN'DN2L\+Y1\NY)4J2C+D9&,$5UU% &(FF:K<
MVNI)J>HPNUW!Y$<5O"5BA&&!;DDLQW<\@8 &.I,EUHK7/@^?0A.%:2P:S\[;
MP"8]F[&?QQ6O10!R$_A35)4UBR35+6/3=6D#3C[,QF53#'$ZJV_:,A.#M.,]
MZU]6T>:ZFL+O3YXK>\L6;RO-C+QLC+M9& (/H00>"HZ\BMBB@#FGT#5GEM]1
M;587U:"61E+6Y\@1.%#1!=VX#Y%.[=G<">AQ5:3PKJ9NH=434;4ZLM]]KD=[
M=O)QY#PB-5#Y  ?.23DY]<#KJ* .*N_!%U=7$=]/<Z==WS73W,XNK(O V8EB
M553?D!54<DGG)[UU&DVDMCIT=M*EFC)G"V<)BB SGA<G'YU=HH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "N+T;1TU[X8V6FR,JQRA2V]-X(6;<01W
MSMQ^-=I7/>!O^1+TW_<;_P!"- #+GP7I4TUDEM;Q6-C;R-.]O8J;<R2[=J,7
MC*D;07^N1Z54@\&3Z9L;3-0C4PM/'#'=0M,AMY65VB?YPS$."0V>AP0:Z^B@
M#@X_A[);FVEAFTEI(Y9Y'@FTTM;@R",82/S!MP(AW.2QKL=-MI;33X;>;[-O
M0$$6L)BC SQM4DXX]ZMT4 9&K:3<7=]9ZC87,=O?6BR1J9HC)&\;[=RL 0>J
M(00>"O?I68/!B7-Y!>:I/!>S_;FO+E6MAY<A\@PJBJ2=H4%3R220?7CJJ* (
MX8(K:%(8(DBB085(U"JH] !TKGK;P=8VC:A>106)U:XGGGAOWM%:2%G)*\]3
MMSZC/M5CP7/-=>"=%GN)7EFDLXV>21BS,2HR23U-;M '%M\.-/2"W@M+N[B1
M;1[.<O.\ID0@$%=[$(RNJN,#'48YHN_!5[JMU/=:C?:?]I:SFM1/:V)C>3S(
MRFZ0ESD '.T8Y[UVE% '*V/AG4;.SF@BN=(M':)52>QTPQ/N4@C?F0AE.""O
M&<]15KP]X=DTB^OKV5K)9+M8U:&PMC!$-F[YRI9LN=V"?15';-=!10 4444
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M@Q;_ )-_A6'X0\8>'[+PI86USJ<44R(0R,&!'S'VH [VBN>_X3KPQ_T&+?\
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M'@MK:6,ZOJ4MRUREU'>RNCSQR*FP?,5P1MR,$'@GUH >_B:Y7Q*=,%O$T?\
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M=;@@O@]6Q@!0> ..>*M3>'[R^LIK34M9EN(VV/$T<"1M#(C!T=2,\AE!Y&*
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MK/<-"]N(UPP\F5\ECD]47IC\: ->BL3Q!JQL9+.S2X-O)=LW[U8C*X1<9\M
M#N<EE &#@9)!QBF#4)!I]C%I]Z]S->7#0K<7<8S%M#,VY %Y&PKM(!R>>E &
M]16;91:M#?2)=W,-S9^6#'((MD@?/(;!P1C&" *TJ "BBB@ HHHH **** .7
MO+N&P\=27-PQ6--(YP"229L  #DDD@ #DDUK6NK^==I:W-C=64LBEHA<;")
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M">E+;-(RPR-91?OD!QO7C[IYQZC!Z&@#KMP]11N'J*P/^$$\(_\ 0L:/_P"
M4?\ A1_P@GA'_H6-'_\  */_  H W]P]11N'J*P/^$$\(_\ 0L:/_P" 4?\
MA1_P@GA'_H6-'_\  */_  H W]P]11N'J*P/^$$\(_\ 0L:/_P" 4?\ A1_P
M@GA'_H6-'_\  */_  H W]P]11N'J*P/^$$\(_\ 0L:/_P" 4?\ A1_P@GA'
M_H6-'_\  */_  H W]P]11N'J*P/^$$\(_\ 0L:/_P" 4?\ A1_P@GA'_H6-
M'_\  */_  H W]P]11N'J*P/^$$\(_\ 0L:/_P" 4?\ A1_P@GA'_H6-'_\
M */_  H W]P]11N'J*P/^$$\(_\ 0L:/_P" 4?\ A1_P@GA'_H6-'_\  */_
M  H W]P]11N'J*P/^$$\(_\ 0L:/_P" 4?\ A1_P@GA'_H6-'_\  */_  H
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M1_\ P"C_ ,* -_</44;AZBL#_A!/"/\ T+&C_P#@%'_A1_P@GA'_ *%C1_\
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MQQX7U_26DLH?[51U2&UM]EO;$QA 53)YR-Q/&3V[UUD4:PPI$BJJ(H5548
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M"#R+.]M+>+).R&$HN3WP%J?_ (3KPS_T%HO^^&_PH Z&BN>_X3KPS_T%HO\
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M2I-4\(I<>&-)T6T%L\.FO"42]C\Q)%C4J P[YKJ** ./3P6Q\)ZWHSR6<?\
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M* .AHKGO^$Z\,_\ 06B_[X;_  H_X3KPS_T%HO\ OAO\* .AHKGO^$Z\,_\
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/?\
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M2V@:""U@BA;.Z-(PJG/7('%94NF7-KX9%E!<#[6S*TLOF&+SG9PTH##E2^6
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M?4=ZFHH KM86;A0UI P487,8.!Z#BG"TMA 8!;Q"(G)CV#:3]*FHH A%I;+
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MMX!/YXAC\W&/,VC=^=244 -$48#@(N')+#'WOK0T:/&8V12A&"I'&/3%.HH
MAAM+:W8M!;Q1$C!*(%S^5"V=LMTUTMO"+AAM:4(-Y'H3UJ:B@"LVG63L6:SM
MV8G))B4DG\J=<6-I=1B.XM8)D&,+)&& QTX-3T4 ( %4   #@ =J6BB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@"G>Z7;ZA/:33F8/:R>;%Y<S( V",D C/!(Y]34%WH%A?
M7%W-<K,YN[<VLR>>X1HR""-H.!U/(YY/K5J^6\>WV63Q1RLP!DD&X(N>2!W.
M.G;/Y&CIEY<F34+>27[:MHP"3J@4NV,LAQP67CD8'S 8R#0!+:Z+;6US'.9;
MJ=X@1#]HG:01Y&#C)ZXXR<G!(SR:=:Z-:V=_<7D+W/FW#F20/<NR%B ,[2<=
M% Z<8K(TW6IQ=Z.MU?PW/]KQ-(D2(!Y3!-_RD=4P"#NYSCW%6+W5[K_A(+2T
MM/+^R).(;IF7)9V1G"*>V  3_O+[T :4.E6T&IW&H(TYGG4+(&F=D('3"DX'
M?H.YJ*/1;6%;**(R+;V<ADCA+%AG!"CGLN3@=!QZ"LW5M3N;;6I8#=SVMJEK
M'*'CL'G!8M(&W, 0H 5>N.M=%&ZR1JZ.'5@"&4Y!'J* *VHZ=;:I:_9[I7,8
M=9!LD9&5E.5(92""" :KQZ':HEP))+F:2XC\IY99V+A.>%/\/7MBEU^\N-.T
M*]OK9X5DMXFES,A92%&2#@C\\U2L+[4[V8FWU#3+VV&^-YK>!@(I H*Y_>G<
M.1D#\Q0!=30=/0:=F.1VTYB;9WE9F3*E2"2<D8/0Y' ]!4/_  C.GAI5#70M
MY97FEMOM#^4[LQ9B5ST)))4?*<\BI-"NK^\M)IKZ2V=EN)85$$+(!Y<C)DY9
MLYVY]L]ZI_VGJTUA)J]M';-8J&DCMBC&6:,?Q!]V%+ 9"[3VR1G@ Z"BN9;Q
M(T%[,+B> 6TMQ%;6>RW8L3)&KJ[G?C;RV>!TZU#+KNIPV5A-/?:7;B>^GM))
MIH&" )YNUAF48SY73/\ $/3D ZRBN;DU758O#EYJ0FL)51%GMKA8&$<L14-G
M;YF1U/.?PJUIVIW+ZLVGW%Q9W9\DS>;:*5\O! VNI9L9SD'/.UN.* -JBN;T
MO6-3U&6UECETV2.1_P#2;-05GM%P3AB6.6!P"-J]3Z5TE !16#J6H:A!K0M8
MKW3K: VYFW7,+,>" 1GS%'?THBUNZO;&P%K#"+R\+X9B6B1$)#2CH64_+MZ9
MWKTY- &]163!>7ZSW.GW;VJW20B:&Y6-A&ZDD'*%L@J0,C=R"#GJ!#X<U>\U
M*&1=02%9]B3Q&)2H>!\[&())#?*V1DXXH W**YJ'5M8ATV?5+IK&:TMYIDFC
MBA>-Q''(R,X)=@3A2VW'MFNEH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH Y[_FHO_<)_]JUJ?V:O]L?VE]HG\P1>4(LKL"]>F,CGGKV'I67_ ,U%_P"X
M3_[5K6OC?D11V'D(S,=\TZEEC4#^Z""Q)P.HQR?8@%!O#5NPD+7MZ7:Z^UHX
MD"F.3:5RN% Q@\@Y![YR<VK32A;-<2M=W,]U.@1KB4KN"C.T *H48+$]._.:
MIIK4T>@ZA>S)%++9-*A:(E8Y2G<9R5&>#UP0W7%2V6H74>L'2M0FM9;AK?[3
M&UNAC^4-M8%2S$<D8.><G@8Y +&E:6-*M1;1W=S-$H"H)BIV >F%'ZYJ"'0(
M(M,GL)+BYGBFD:7=(R[D<L7W*0!@[SN'H:BBUJ>X\3"QBCC-B$D4RG.YI4*[
M@.VT;L'_ &@1QCFLVNRGQ!=6+:GIMLD%S'"L,L+-(X:-&^]Y@ )+D#CMWH U
MX]/VZF+V29I62W$$88#Y><NV1W;"9_W!3+_24OKJWNUNKFVN;='2.6!@,*Y4
ML"&!5ON+U!K0K-UF_NM/MH9;2WAG9YXX2LLQC WL%!R%;/)H BD\/P26#6QN
M[L.]PES+<!E\R212I4G*XXVKP !\H'2GS>'[&XNKJYD5S+=6IM9B&P'0\$XZ
M;L8&?0#T%1V^H:M.TRBQLFVIF.2.[9HV<,592?+X(P>Q].*ETK5)+O0(-5OH
MH;59(!<%4E+A$*AN25'./:@!MMH:07%O)+?7EREL<V\4[J5C."N<A0S'!(RQ
M;KZ\UJUAKK&H1PPWUWI\<-A,R#B8F:)6("LZ[<=2,@'Y>>3BHX/$<KR?9IX;
M6&\FGGALX3,Y$OE,0Q8A/DX /?K0!T%%<TGB+49(=.E%C8QI=Z>U\[37C*(@
MNS()\OIB0<\=#5BXU;5K>PAE;3;9;A[L6[1O<L%P7VJX;9D@\'H* -VBL9=;
MEABU,7UHJSZ? +ATMI?-#H0Q !(4[OD/!'<<\T^QOM5FNX%N+*T-K-$T@N+6
MY,@0C&%.5&<Y.&'ITH UJ**PIM6U5;^_AAL+%H;15<O)>,A92"?^>9 Z>N/>
M@#=HK'.LRW8LX],MEDFN;<7)^T,46*,XQNP"=Q)P![-R,<M?6IX],U":6VAC
MN[#)GC>8^7M"AMRL%R05_P!GJ".U &U167I6I7.H:9+)-:);:A"S1RVQEW*C
M@9 W8Z%2ISCH:J6&NWTMGI][?6$$-I?+'M>&Y,AC:0#8&!1>"2%R">2.,<@
MWZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM_$>F75VMK').)FD\H"2UE0;]N_:2R@ [><'M4UGK%G?7<UK;F<RP\2![>1
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M9X+_ ,Q_-.%C=;>-&()QE?O8/0CFF:+J6E0Z#+JK3PR&R-SN='!*J\I;&/\
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MTS*!&TA4,54YY(!&>!UK4JM96%KIT<D=I"(EEF>=\$G<[L69B3ZD_P!.E6:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH Y[_FHO_<)_P#:M=#7/?\ -1?^X3_[5KH: "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,W6K<S6)<ZS
M<:5'"3))<0F(?*!SN,BL ._;I63::-/?VRW-GXXU>X@?.V6$VCJ<'!P1#CK5
MOQA;3W?AF>&WBDD<RPD^4NYT42H6=%_B90"P'.2 ,'H:OA(3VD%W'/%>.MS?
M2RPW%Q 8WE4JI+R+@!#NW*!A<A0<<T -.DRAKE3XZU8-:@-<#=:9B!&06_<_
M*,<\]J4Z/,)X(#XYU<37"EH8RUIND P25'D\@9'3U%8/B'0=4%YXIUC3+622
MZD00>2./MD#6Z*0OJRMDK[AE_B--O-*\03W+:Y;VBA])$"VD$BL)I%C7,H0=
M/WGF/'SUVJ: -Q=-+0W4R^/=4,5HS+<N'L]L)498.?)^4@<G/2J<\NG6LX@N
M/B;=12E58))<V*L0PRIP8NA!!'UK&?0=5,FJVL5A/]CUNYN)+DE,;!'*[J2/
M^FJE4^BU+HT>H:1>S^>^MVBO':$1VNF^>DFVVC5LMY;$'*D$9'2@#I;C1;BT
M1'N?&^L0J[K&ID-HH9V.%49AY)/ % T6X-U):CQOK!N(T$CQ VFY5.0&(\G(
M!P>?8U5\7Z-J7B74(=.MTCCL[>WDE::<-M\YPT:%"/XD&]O8LIK)CT_7+S4I
MO$GV"6'6+?3K:-HF&U;DJTPGA!]#\K*?78>F: -"5K""6&*;XEW<<DR+)$KW
M%B"ZM]U@##R#V/>M&XT.YM+:2YN?&VLPP1*7DED^R*J*.I),. *YS05N-'L6
MM;_0]0N3<:)80"!+5G5W2)U>-F^ZIR0#N(ZUJW>DZNWA?PYX>"1S3*D'V^:8
M%HB(54D,1UW.%&.XW4 /O[>#2EA;4?B)J%HLP)B-Q-91AP,9VYAYZC\Q3+M;
M.P2![SXD7MNEPN^%I9[)!(OJI,/(Y'(K/TS^TM$U'1H]3T^]F33+:]L/.M;9
MY5=2UNT)& 3C8NW)[HU)I$5UH>M0WMUI-^MK/#>F.""V:4PB2X5T1@F0I(R<
M=!DB@#2O([73O)^V_$>^MO.3?%YT]DF]?49AY'O3+IK"Q\K[7\2[N#SHQ+%Y
MMQ8KO0]&&8>0<=16;I?AWQ!%<0&SF?29/L-R8]T*2I%YERTD<+=0-JLHP/3B
MJVG6M[IE];.D>NZ;'_9<4+B"Q%R3,LTQ<,?+(ZMD$  AA@8X !O316UO/;PS
M?$6_CEN55H$>:R!D#?=*CR>0>V.M/>UBCU-=-D^(6HK?MC%LTMF)#D9'R^3G
MIS69K\5VUQ?RV5IJ9N+RUC"PR60GMM0PG"R@J#"P)*G+* .?8.O;>^BUJX2U
MLKX2SZA%/)9S6HGLYL%/WPFV@QL N<%N"O"GN :NH:<=*@6;4?'NJVD3-M#S
MO9H"?0$P]:@N8[6RMK>YNOB/?007(S!++/9*LH]5)AP>HZ5?U426'BRSU>:T
MN+FS6SDMPUO"TS02%U;.Q06PP&,@'&T9ZU@66A:M-K5E=0?:M*@EGO[A-L2,
M8$D,6U6# A2Y5GQU&3WS0!LII3R:?]O3QWJK66SS/M :S\O;_>W>3C'O4%O;
M0W=C+?6_Q#U&6TASYLZ2V91,#)W-Y.!QZUH>)K&YFT.T"))?&UNK>>>(*-UP
MB."WR\ GC=CN5Q65JN_67-_::#<^1;W5K+.TL)BEO5C+$J(W 8B,LK#/4@@=
M.0"2""WNK0W=O\1-0EMQ(L1E26R*AV( 7/DXR20 /<4Z^M(M,W?;_B%J-IMV
M[O/ELTQNW;<YA[[&QZ[3Z5E:]I3^*=0FN(]+NAILQL;>=9X&B:X"W(9FV'#
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M_0X:[_WS:_\ QBC_ (1K4/\ H<-=_P"^;7_XQ70T4 <]_P (UJ'_ $.&N_\
M?-K_ /&*/^$:U#_H<-=_[YM?_C%=#10!SW_"-:A_T.&N_P#?-K_\8H_X1K4/
M^APUW_OFU_\ C%=#10!SW_"-:A_T.&N_]\VO_P 8H_X1K4/^APUW_OFU_P#C
M%=#10!SW_"-:A_T.&N_]\VO_ ,8H_P"$:U#_ *'#7?\ OFU_^,5T-% '/?\
M"-:A_P!#AKO_ 'S:_P#QBC_A&M0_Z'#7?^^;7_XQ70T4 <]_PC6H?]#AKO\
MWS:__&*/^$:U#_H<-=_[YM?_ (Q70T4 5-.LI;&U\F;4+J^?<6\ZY";\>GR*
MHQ^%6Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3 W
MX&1QFEHHH **** "BBB@ HHHH *0JK$$J"5.1D=#2T4 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6WD%I<[82CKR4&#C.,]3UH Z*[\&^'KRVLK>73(EAL59;9(6:(1!L;@-A'7
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MK5XYU! 8W$C\$8/#,16U10!2M](T^TU2\U."UCCO;P(+B8#YI HPN?H*R)/
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MY%AA8Y6W555?+&/[K!P3W()H L?VOXD_Z%8?^#"/_"C^U_$G_0K#_P &$?\
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M5A_X,(_\*/[7\2?]"L/_  81_P"%=#10!SW]K^)/^A6'_@PC_P */[7\2?\
M0K#_ ,&$?^%=#10!SW]K^)/^A6'_ (,(_P#"C^U_$G_0K#_P81_X5T-% '/?
MVOXD_P"A6'_@PC_PH_M?Q)_T*P_\&$?^%=#10!SW]K^)/^A6'_@PC_PH_M?Q
M)_T*P_\ !A'_ (5T-% '/?VOXD_Z%8?^#"/_  H_M?Q)_P!"L/\ P81_X5T-
M% '/?VOXD_Z%8?\ @PC_ ,*/[7\2?]"L/_!A'_A70T4 <]_:_B3_ *%8?^#"
M/_"C^U_$G_0K#_P81_X5T-% '/?VOXD_Z%8?^#"/_"C^U_$G_0K#_P &$?\
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M6;I;";R;B:VMA(BMM5B!AMQX8'@=ZT+3Q-IE_>:=;VDQG&HVCWEO*@^1HT*
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MJ"I5"O)4CKVK.TJTNO";^%]3U:TN([=;:^CN?)B:7[(T\R3(K! 3@ %<@8!
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M_%-&T<B:;;JZ.,%2(UR"#T-<O#?'PS'KFE7\U_IL]SJ,UY:ZA;V+7*RI(X?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF0O;&3S9I(5E/\0P@#J,#DG/(Q5;3/'5Y=:O:M=6T46EW%C;,\BDDP7,K2J
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M;CG:V/F/2HK/0=3\/V7B#2;?18M6CED2>*>[.\WT!.'AD9CS(J[@I;@@K[T
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M/V2Z$T,D7_CT>?P-8L_A_6KW9JDVFR)>W^GZJ]S'D$Q22K"D,1/KLC5?JIH
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M1BS-@8R2>I]ZDHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH Y[_ )J+_P!PG_VK70USW_-1?^X3
M_P"U:Z&@ KGO"'_'EJ?_ &%KS_T<U=#7/>$/^/+4_P#L+7G_ *.:@#H:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*TC_ )ZZO_X.;O\ ^.T?\(5I'_/75_\ P<W?_P =H Z&BN>_X0K2/^>NK_\
M@YN__CM'_"%:1_SUU?\ \'-W_P#': .AHKGO^$*TC_GKJ_\ X.;O_P".T?\
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M#17/?\)OH7_/:\_\%UQ_\11_PF^A?\]KS_P77'_Q% '0T5SW_";Z%_SVO/\
MP77'_P 11_PF^A?\]KS_ ,%UQ_\ $4 =#17/?\)OH7_/:\_\%UQ_\11_PF^A
M?\]KS_P77'_Q% '0T5SW_";Z%_SVO/\ P77'_P 11_PF^A?\]KS_ ,%UQ_\
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M (3?0O\ GM>?^"ZX_P#B* .AHKGO^$WT+_GM>?\ @NN/_B*/^$WT+_GM>?\
M@NN/_B* #_FHO_<)_P#:M=#7):;JEKJWCPW%FTC1C2RA,D+QG(E'9P#WZUUM
M !7#V6FR:GH5_'!&C3IXA>4%L#")>J[X/T0_7 KN*Y[PA_QY:G_V%KS_ -'-
M0!GS:%J3ZG);+ GV-]4_M'[5Y@^[Y8^3;UW;QCTV]\\5F>%?#6L:1)I$K6$T
M3Z?IS6\XN-1,XF;8H"Q*Q81 LH.1MX &#V]$HH P/$5M?W']BW=G9_:);.^%
MQ)!YJJ=IAE0X)XX+BL:;PYK6J7LD\[)IZ7E]'=3+$ZRF-($ B4Y&&8R ,>"
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M$LY7NI-/O6FD@@M9$B>';-+((\.NYLH-P;((/!'O6]J&GVVJ6$UE=H7@E&&
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M<KQDD*2 6+$ \5#IG@VPTU+-/M-]=1V,7E6D=Q-N6 ;-F5  &=I(R<G!/J:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:Y\8Q6]U- /%OB";R=*_M9GBLK(J8L!MH)0?/AE..G(YH ]6KGO"'_'EJ?\
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M^P-:_P"AQU/_ ,!;7_XU1_8&M?\ 0XZG_P" MK_\:H Z&BN>_L#6O^AQU/\
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M&+S_ *&W7OSM_P#XS1_PC%Y_T-NO?G;_ /QF@#H:*Y[_ (1B\_Z&W7OSM_\
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MJIF1H]0@MXEC"\H8PX)/UWC\JA_X1B\_Z&W7OSM__C-'_",7G_0VZ]^=O_\
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M))QZ"M'_ (1B\_Z&W7OSM_\ XS1_PC%Y_P!#;KWYV_\ \9H R=7\"W6J#Q%
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M (S0!T-%<]_PC%Y_T-NO?G;_ /QFC_A&+S_H;=>_.W_^,T =#17/?\(Q>?\
M0VZ]^=O_ /&:/^$8O/\ H;=>_.W_ /C- '0T5SW_  C%Y_T-NO?G;_\ QFC_
M (1B\_Z&W7OSM_\ XS0!T-%<]_PC%Y_T-NO?G;__ !FC_A&+S_H;=>_.W_\
MC- '0T5SW_",7G_0VZ]^=O\ _&:/^$8O/^AMU[\[?_XS0!T-%<]_PC%Y_P!#
M;KWYV_\ \9H_X1B\_P"AMU[\[?\ ^,T =#17/?\ ",7G_0VZ]^=O_P#&:/\
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M Y&.I!X/1MX8T5I8)/[/C4P+&B*A*IMC.4!4':VT\C(..U+<>&](NK:&"2S
MCAW^7LD9"H<Y<;E(.&/49P: ,"7Q7J-_):/861MK/^T+6VGDG?;,#(J.RF,K
MP,2*I.X'.>.,UI:SXFETC6[6R:R7[-*(]UW+(R)EG*[00A7<, X9ESD 9YQ<
M/AG1C>17?V&-98F1D"$JH9!A&V@[<@  '&<<=*EO-"TW4+Q+NZM1),H49WL
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MT08\['7_ );-ND_[Z/)J%/#6CQWD5VEDJRQ;2N&;;E5VJQ7.TL%  8C( '-
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M7U[<WXN(#;.MP(P/+.<CY$7KGO4D.@:7!J/V^*T5;G)8-N. Q&TL%S@,1P6
MR1WH QG\8S'Q'+IL&DSRV\5TMH\ZQRG#E0V[(C*!06 .7!ZG'3-&/QIJ&J+
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHS=%MY8YP6V[=VWINV\;L9QQFH%\)Z&D!A33T52RL"&8,FT$+M;.5 #, %(
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M:VY?"NAS6T-O)IT1BB#JHR1D.<N&.<L&/)!R">N:=<>&=%NIYIIM.A=YD9)
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M\EY<VB27";0&)(W;3N7< <-@DD9S@\BH8_#&BQ22.FGQ R=>I ^</A1G"C<
MQ P"0#0!BZ=XIO;N2:"ULDG^REY+F2YNQ&0AN9HE"83!P(6/.,#:,DDFJ%IX
MQU&.6>1XX9+5;2%XUGGPYE>XECYVQ\\)T )X  )-=5)X:T:9XW?3XB8V+#J
M<N7.X9^8;R6P<C)S39?"^BS[=]A'E$"*59E*@/O&"#P0V2#U!)QUH Y&Y\<:
MG/%-,EJ+>"#3M2DG19&63S(&B"LGF19'W^C+_$<@[1G4O?&UQ96LM^^F1M8&
M2[@@87!\QY+=96.Y=N%5O)< @DCC(Y.-C_A%-"\KRO[-BV8E!&3R)0!)GGG=
M@9SU(SUYJ1_#6C27%Q.^GQ,]PKK)G.#O&'(&< L."0 3WH CT;6+N_O;RSOK
M.*VGMXXIAY,YE5DD#8R2JX(*$'\.:PG\=W<>GVMZVD1%-0M1=6"K='+(9(D
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MOV5&#N\LD\T@0)ODD8NQP.@R>!V  J.#PQHMMN\G3XE!9"!R0NQPZA<GY5#
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M_P"PH^V:Y_T![;_P._\ L* -:BLG[9KG_0'MO_ [_P"PH^V:Y_T![;_P._\
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MVFC75]O7&3(%VQ]>P^8_4+1>^(=1@BNQ<PQ6]UITUK+(L$IDCEAE;:5R5!W
M;_Q"GOBMS4-%M=2NHYIU#*();::-ERLT,@&Y#^*J?P([U"WAK3EMDM;:%+>W
M-S'<3(@YE*$%02>< JGX+CI0!E^+[K4(]3T6TL3J!6X:;S([!XDD;:@(YE(7
M /O5#3_&5Y9Z+;B_A:XO'2>*+>P5WN4G\I8'VC;N^9 67@X8@8%=9J6BZ=K
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MA"I9"O#9Y!QU ZD:!I*VPMQI\ A$4D(7;QL<AG'ON*@GU(I'\/:1)?27KZ?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'*9VEN!\V,\=: .)DU[6_P"TY5CN]461]9:SMR\=L++:),;&8CS!\H8#G);
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M=V=M?VDEK=P)/;RC#QR#(851@\-:1;P2Q)9AA,Z/(TCL[N48,F68EB%(R!G
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MG ]S0!QFA+J%YXBOWF_M22WM]0EC2;[?B)54#"F/.3Z=.]96B3:N? S:Q/\
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M.2LDD<TL1 /]TF($=_FQ6]9^&["#2I+"ZB2^6:=KB=KB-3YLK-N+$   YQC
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MK^RDNX?)9B4".BD-GKGS >,8P1SUK:&@Z0MQ;3KI=F)K9%C@<0+F-5X4*<<
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MZ8_><T 4-3\5ZK;>*)[&VM83:VT]M"_F&-3)YI&6#-*I'WL !&R5(SSQE_\
M"?ZDL\A"VDEO-:27%O*8MBH!-%&'/[PLR 2%B2J?<./;H)/#VNRW4=S)KMB]
MQ$,1RMI"%T^AWY%10^&]61YF@UO359RPE*:0@+$_>W8?G/&<T 9E_JVN)K;"
MUU;3II+*PO9)"D#F)RAMV563S.'^<C.XX!]\"]XFU^XT^STG5X(W<BVN+EK9
M7($A6W9PI]1D5)::'JHC,-GXATP)$&C*0Z5'A >2N _&<<BI8M-URXQY7BBP
MD\DE1LTU#Y9QC'W^.* ,,>(M?O+NRMY+BUM2+^W!E"(1(DD<IVE$G? R@();
MG<...:5EXTUZVT:P51!>21:7#>3S2;%\XN[KM+/,NW&S!8!N6' Z'H+?0;_[
M(Z6WB#2?LRR;V6/2H]@<<Y.'QD<<T^3PWJB&(R:YI:F%C+'NTB,;"3DL/GX.
M3R: +NEZMJ4^GZQJ-R()8K>>YCMK:")E<B&1U^9BQW%MHZ 8]\\81\6:UBUM
MXKG2KB>]CM)4GB@<I )I-A#+YGS<'*G*YVFMAM.UZT4AO%-E"I)8YTU5&2>3
M]_N3^M5K;1M14,+7Q'I0#R;V\K2X^7ZY.'Z\$YZ\4 2>)M?U72;K3K&SCA>:
M>WFFEG:-=N8]G 5Y4 SO)^\2 IX/48$'BW6!=3+!"!-?W:OAF29( +&VD*)N
ME13EG8\-T#'!SFNAN="UJ_BCCNO$.GW$;$,BRZ4C@GJ" 7J.30]4OC-:2^(M
M+N#N#RPMI4;\@  L-_7  R?2@"MIWBK5-3,<C3Z78!5M0T,H,IF:8#YD=7QC
M)PN <E3R.HR](\5:\GAN*YDN[&=+;2K.:626%RSR3EEW.V_A4V@MQSAON]NA
M?0-;-U!,^OZ>;B,%87;24WJ.X4[\@?2DBT+68(I5B\0:='&<K(%TI .I)!^?
M_:/YGUH IIX@UVXUS^PX+K36E69T:]%L[(0(DD V"3A@6P?FZ$'CI5/3/%VH
MZE<68C-I92:C#;RM/,'DCC+6WFE0I<#)/3!' ).36K;:-JMNR6UKXCTR-HL[
M8HM+C!3/7 #\4LWAO5WM_(GUO33"VU?+?2$VG'"C!?'':@"U>ZW=+I6AO;7%
MD)=3E2(W>UG@3,3R;E&5)#%-JY(^\.O0X_\ PE^I?OI5NM+ECLY+:%XXXV)O
M#(P4M$2WRCD@##9*L,GK5^YTK6)D-C=>)M.=7 'D2Z8A#>@VEZ9_8NIF\A!\
M1:6;J ;8O^)5'OC&.B_/D<>E &5+XK\2BR>[672POV"]OE0VKD@6[A=A/F<[
M@PYXQCH<U=77_$%YJD4-O/IT,%Q?S64>^U=VC"1&0.3Y@#$[2,8'7.>U6ETK
M5I'-NOB;36<*T9C&F(3@_>7&_H<<BGC2M:2Y6$>)]/%P"9%0:8F[)&"P&_/3
MC- &=8^.;JYTJ&XF6SCN)CI>R+GD7+1A\#.3@,^/ISG!JM+XIUEK2TDN_L;Q
M7R-+&D,<D;1>7=0Q\L'RV1+GMR,<@FM1="U&6ZC"^(=*>X@78F-*C+Q@'.!\
M^0 1TI\>E:M<,(X_$VFR% <*NF(=HR">-_'(!^H% %)_%]^EBUZ]YIB&=Y(H
M+/R7::-A<+" </\ .?FP0=@#$#(&363-XJUB[61Y9X8A:QZE%+$%*><T<2,N
M=DIVL-Q'#'H>AZ=$WAW5)/-=M=TQOM8"R,=(C/G>@/S_ #5$-%O<K;#Q'H^5
M;"Q#2X^&QMX&_KCCZ<4 5?\ A,-2CB%R&L3$;J6S6RV,9EV1,PD+;^0=F[&W
M[K Y]=GPWJ^IWM[+;:D]K(386MZC6\31[?-,@*'+-G'ECGCKTJI)HVIQ2B\D
M\1Z6DDJB(3-I<8+K_=W;^1[5931_$*2X3Q)9K)L XTM0=HS@??Z#)_.@#GSX
MM\2KI3:@9-+VC2I-3\L6KYQ&V#'GS/X@1\W;T-2:OXPU :G-9PM$;.:2[M%=
M(]C(T4$CDAC)N+!H\'"!>?O=,Z[:-K*VQ9_$>GB#9Y9)TM-NP]OOXQ[4Q/#V
MJ32/=QZ[ICO)]^9=)C); QRV_G@D4 8UIXSUAM*T^)+9([R:X%LT4BJ\D*B'
M>"VZ5%=G ###  $_>(-6;/QIJLU[IIN4LXK6?R(Y3#MF_>2,4&2LI*;CM*X5
MQR<MZ7;K1M0DBV7?B/26CF5?EETN,AU'W>K\@9X^M2+H.K2SV]POB#3'F1"(
M)!I2%E4<':=_ Y[4 -\1>(M5TN_U9K5;5[33=-BNVC>,EY'D:91\V\!57RP3
MP>,\CJ,*_P!<UN]DL8[G8JVNI$R1PX5KE5M99@A6*9MIRG0DYRAQP0>F?2/$
M*LSOXELPT@"%CI:Y8<X'W^>IX]S5>VT/5;<16]KXATR+&9HXXM*C7&>"P ?W
MQGWH Q[/QEXAO(K>,1V$<MW]E,<S(K+&)2P/R),Q8<9!)7.",4DOCG7(8]0G
M-K:F.!;Y$5PBX:W5R&QYQ=LE!E=@P''/&3NP^&M:M]WDZWI\6Y_,;9HZ+E_[
MQP_7WH/AK6C/+.=;T\S3)LED_LA-SKZ,=_(]C0!4D\1:U;ZHND3SZ>)YIX46
M[^SL(XE>*5\%"_)S%M!W#[PXXP::^-=7?4Q#%'8W$$,EM%++$55)S*0"Z,\H
M91SA0%?)4C)[:]SX?UN>*1;K7["2.0!9!+I*$-@\ Y?GGI0?#>MM-#,=;L#+
M NV)SI";HQZ*=_ ^E %;Q1KFHZ-XBB>WN8%MS8G]S,AVAVGBC\QB&'"A]Q]@
M>1G(T+#5+^[LM=MY)[:2YL':*.Z@C(1B8E<$KN/*EL$;NW;.!%/H>O2LLEQX
MAL7*@HK2:4AP&X(!+]^GO1::'KUO:I'9^(;&*WQE%ATI%3!YX ?% '-Z%K>N
M0PK?/J%O=0%M+BE22-F9S.(T8JV_"D;\G@Y(/3-;'A+Q7JNN7UN+RUABM[JU
M>Y1045XBKJ-N!*S-][!)5,%>G.!;B\.:Y!%Y46N6$<>0VQ-(0#(.0<;^QYI8
M?#VNV\TLT&NV,4LQS*Z:0BLY]6(?G\: ,C4/&VI:;?:DLJ6K0Q"=;4*FY6,>
M.6D60D;1DL&1<8X)ZFEXC\1:E!]HMY+J"Y:Q$[F:TWPQR@V,\@1@KD@@J#PV
M<%2,'FNC'AS7%NI+E=<L!<2KMDE&D)O<>A._)%-C\,:S#;BWCUG3DA&2(UT=
M HR"#QOQR"0?K0!F:QXGOUTG6KC[3I\<4 NK>.R82+.QCA9PV]7!YV[L #Y2
M"&SUA;Q-J]E'=PK?6\UT;Z]95:WW%(HF Q\TJ* -R\EAP1@'DC:;PWK;SO.^
MMZ>TTB>6\ATA"S)_=)W\CVILGA?6)GWRZSISOY@EW-HZ$[P,!OO]<=Z .>M_
M%>I2W46H2E)XYOLL\=E&74INLI92%(;YLL,<@CVR!B__ ,)9K(:UMH[G2KF:
M\2TD2>*%_+A$TFPAE\P[N.5.1G!K57PYKB2)(FN6"R1J%1AI" J!D  [^ ,G
M\Z2'PUK5N&$.MZ?&&?S&":0@R_\ >.'Z^] #E\0W</A*^O[I[87=K<S6HD6)
MO+=EF,:G9N)YXXW=3U Y&3IOBC7M4OO[,C:R@N%O9K=YI;?=@)#'(/D24C.9
M"#\YZ=CD5L-H/B!X9(7\06;129WH=*4JV>N1OYS3(/#FN6P46^N6$07[OEZ0
MBXXQQA_0 4 <\_BS4]:TRQN!<VEBC7&DE[<!O-F\YX7;8VX87YBN,'(5\GTO
M>-[[5+;5/)L]06")K#>L6&!,GVB(9R&'9L=.F?7C1/AG66DAD.M:>7A4+$QT
M=,Q@<@*=_ X'2I)M U^X='FU^RE=,[&?258KGKC+\=!0!CWGB75K2\NX)FL9
M+NP>YC68[X(G(MX95+*7P/\ 6X.3VR"N:UM-\33/X9UB_OGC2XTSS/-#P% F
MV-9!N"LX/##E6.1[\4YM U]F9FU^R+/G<3I*Y.0 <_/Z #Z 4D'A[7;6V^S6
M^NV,4'(\J/2$5>>O ?% &/:>+=>NM1&E_P"AQW+7D,/FRV_W4>&60Y19FY_=
M#&6'#<CO4#^-M>M--M[B>.QGDN[=7C$4)00M]HCA);=)AA^\W8)7&,9[UN0>
M&=9M0HM]:T^$)RHCT=%V]>F'_P!IOS/K3SX?UYDV'7K$IL*;3I*8VGJ/O]#Z
M4 9">*?$5R[6L8T^WFAAO9GDEB$F_P GR-HVQS$(3YQ!&X_=SQG%,D\2ZCJE
MW82"ZM;2 :G;0&T 832!HED)W;N0=WW=O09S6S%X<UR")(H=<L(XT4HJII"
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MN')/"X"]>];^F>(]2;1M;N;VU26?359T6(H&EQ%OVE4DDVG\>00<5*-!\0
M#Q!9X 8#_B4KP&Z_Q]^]);>']>LH1#::_901 Y"1:2JKGZ!Z ,F7Q9JT%Q!9
M_;M(F>X^R,+M(6$40F+C:1YAR?D!4[AG/3O52Z\=:V@DCM[>TD:UAN)9+C"+
M%<>7,T?REYEV+\OS$%\%A^.G<^"M3N8$@;6K%(5G%P8X](15=QG[PWX.<\U:
M?PSK,L<$<FM:>Z6Y!A5M'0B,CIM&_C\* ,^Y\3:P&DED%F+.2\N+%8!&XD79
M;R2AC('ZY3& !UR#3+;Q3K*)]H"6KV4%U;V?V=8G,LGF6T4N0Y<\[I,#(.0.
M3GFM<Z#X@;KX@LS\Q?G25^\003]_K@D?C1_8&O[2H\068!8-QI2CD  '[_4
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M^0#GANF9AXFUR*_M]-N)M.6:[^RNMU]G81P"5)V(92_S', 4'(R9!QQ@W_\
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MU^RMK]DUOMV>4=)4IM],;\8]J ,)O&VIO;2O'=:;$]K8W%S,MQ;LK2/%(5*
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MRQ>$M+69&1C &5&&"BGE5([84@8]JU;FVAO+=H+B,21/C<C=&&<X/J/;O4M
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M_ =/_BZ/^$JD_P"A;U[_ ,!T_P#BZ .AHKGO^$JD_P"A;U[_ ,!T_P#BZ/\
MA*I/^A;U[_P'3_XN@#H:*Y[_ (2J3_H6]>_\!T_^+H_X2J3_ *%O7O\ P'3_
M .+H Z&BN>_X2J3_ *%O7O\ P'3_ .+H_P"$JD_Z%O7O_ =/_BZ .AHKGO\
MA*I/^A;U[_P'3_XNC_A*I/\ H6]>_P# =/\ XN@#H:*Y[_A*I/\ H6]>_P#
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M_P"$JD_Z%O7O_ =/_BZ .AHKGO\ A*I/^A;U[_P'3_XNC_A*I/\ H6]>_P#
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M^A;U[_P'3_XNC_A*I/\ H6]>_P# =/\ XN@#H:*Y[_A*I/\ H6]>_P# =/\
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MDXY0CL#4=WX)UV]LO/N+ZWGUBT.GM;S2D[)VMLNV_ R SO)TYX!H V_^%@:
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M*-&RAY(#B1<D8X/3U[9JEH>C:R_BJ3Q!K,-G:NNGK80VUK.TV5W[V=F*KSG
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MHK*_X2?0/^@YIG_@7'_C1_PD^@?]!S3/_ N/_&@#5HK*_P"$GT#_ *#FF?\
M@7'_ (T?\)/H'_0<TS_P+C_QH U:*RO^$GT#_H.:9_X%Q_XT?\)/H'_0<TS_
M ,"X_P#&@#5HK*_X2?0/^@YIG_@7'_C1_P )/H'_ $'-,_\  N/_ !H U:*R
MO^$GT#_H.:9_X%Q_XT?\)/H'_0<TS_P+C_QH U:*RO\ A)] _P"@YIG_ (%Q
M_P"-'_"3Z!_T'-,_\"X_\: -6BLK_A)] _Z#FF?^!<?^-'_"3Z!_T'-,_P#
MN/\ QH U:*RO^$GT#_H.:9_X%Q_XT?\ "3Z!_P!!S3/_  +C_P : -6BLK_A
M)] _Z#FF?^!<?^-'_"3Z!_T'-,_\"X_\: -6BLK_ (2?0/\ H.:9_P"!<?\
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M_9&F?] ZT_[\+_A7)6^M^);^#PS/!>Z7"NLVZR,CV$CF)O(\QL'SAD$@XX&
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M=:?]^%_PH_LC3/\ H'6G_?A?\*YFX\<!$UZ6&,K'90VXMA=V\ENSS2EU4,)
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MD;2-QQC/?@/B3Q!<>%FUBTN=.$:72PQRR6$H6[C=T1954R@H!N88.<[<C -
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M_H'6G_?A?\*/[(TS_H'6G_?A?\*Y*Q\2Z]#HVAZKJ,FG7$&KP JD%L\302-
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MG_?A?\*/[(TS_H'6G_?A?\*N44 1P6\-M'Y<$,<29SMC4*,_05)110 4444
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M\M"!'O\ +\HMMQW7&?H*V** .;A\$:3:0-'8FYLW%T]W%+!)AH7<!6"Y!&S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^@7H/_@QF_\ C% '0T5SWVCQE_T"]!_\&,W_ ,8H^T>,O^@7H/\ X,9O_C%
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M\8H^T>,O^@7H/_@QF_\ C% '0T5SWVCQE_T"]!_\&,W_ ,8H^T>,O^@7H/\
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M%Z#_ .#&;_XQ0!T-%<]]H\9?] O0?_!C-_\ &*/M'C+_ *!>@_\ @QF_^,4
M=#17/?:/&7_0+T'_ ,&,W_QBC[1XR_Z!>@_^#&;_ .,4 =#17/?:/&7_ $"]
M!_\ !C-_\8H^T>,O^@7H/_@QF_\ C% '0T5SWVCQE_T"]!_\&,W_ ,8H^T>,
MO^@7H/\ X,9O_C% '0T5SWVCQE_T"]!_\&,W_P 8H^T>,O\ H%Z#_P"#&;_X
MQ0!T-%<]]H\9?] O0?\ P8S?_&*/M'C+_H%Z#_X,9O\ XQ0!T-%<]]H\9?\
M0+T'_P &,W_QBC[1XR_Z!>@_^#&;_P",4 =#17/?:/&7_0+T'_P8S?\ QBC[
M1XR_Z!>@_P#@QF_^,4 =#17/?:/&7_0+T'_P8S?_ !BC[1XR_P"@7H/_ (,9
MO_C% '0T5SWVCQE_T"]!_P#!C-_\8H^T>,O^@7H/_@QF_P#C% '0T5SWVCQE
M_P! O0?_  8S?_&*/M'C+_H%Z#_X,9O_ (Q0!T-%<]]H\9?] O0?_!C-_P#&
M*/M'C+_H%Z#_ .#&;_XQ0!T-%5-.?47M<ZI!:PW&X_+;3-*FWMRRJ<]>U6Z
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(\5_\
M(G:Y_P!@^?\ ]%M5[3?^07:?]<4_]!%4?%?_ ")VN?\ 8/G_ /1;5>TW_D%V
MG_7%/_010!S6M>-CI&J7UK]BMY8[*..23=>!)I-X)Q'&5^<\=,C)P*ZN5I%A
M=HD5Y I**S;0Q[ G!Q]<5RFM^#9]6U#4Y4O;*.#484AE6:P\V6,*I7,;[P%/
M.>5."!73VT,T(=))A)&"!%\I#*H4##')W'()SQU QQD@'+_\)AJ$%IJMW?:/
M;PV^F2^3,R7Q<E\(>,QCC$@YSVZ4_5_'=C8R3)9?9KXQQ1.72[4(#).L(#,
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M]\T ;&@Z\=8EOH)((HY[*18Y#!.)HFW*&&U\#G!Y! (_&L;_ (3MYA9+:Z?
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M1R6TKA"DBR>6READ<,#R,\#-9NJ:E8P^*&DT_7;>SU62$6T\%Q:/,LBHQ*D
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MN92GF;L!"=W\.=N1GO2C7- T_P 27=[+JZ>9?6UNB0^4WW4#L&! YR)1],4
M6;O7-7M_$D&DQ:/:R+/%+-',U\5S'&T:L2OEG!_>+@9/0\U#'XXTZ2SMY%>
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M [0PRM 8W9QYH.P* N7R0PRH.2I]*L3>+=#M[:*XDOU$<L<DJXC<L$C.UR5
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M@-M=6TTD,<5K&QMRNV ,IDSER2[!0.,+D#Y: .OHHHH **** "BBB@ HHHH
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M 4444 %%%% !1110 455U"WNKFT,=G>FSFR")1$LF!Z8;BLC^QO$7_0UR?\
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MS ERJVNFPONC8D!AV/2@#MZ*\Y77[W^P4UJ?Q/J%O8R%/*>;2H@9 PSN &>
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M-<G_ ( 14?V-XB_Z&N3_ , (J .AHKGO[&\1?]#7)_X 14?V-XB_Z&N3_P
M(J .AHKGO[&\1?\ 0UR?^ $5']C>(O\ H:Y/_ "*@#H:*Y[^QO$7_0UR?^ $
M5']C>(O^AKD_\ (J .AHKGO[&\1?]#7)_P" $5']C>(O^AKD_P# "*@#H:*Y
M[^QO$7_0UR?^ $5']C>(O^AKD_\  "*@#H:*Y[^QO$7_ $-<G_@!%1_8WB+_
M *&N3_P BH Z&BN>_L;Q%_T-<G_@!%1_8WB+_H:Y/_ "*@#H:*Y[^QO$7_0U
MR?\ @!%1_8WB+_H:Y/\ P BH Z&BN>_L;Q%_T-<G_@!%1_8WB+_H:Y/_   B
MH Z&BN>_L;Q%_P!#7)_X 14?V-XB_P"AKD_\ (J .AHKGO[&\1?]#7)_X 14
M?V-XB_Z&N3_P BH Z&BN>_L;Q%_T-<G_ ( 14?V-XB_Z&N3_ , (J .AHKGO
M[&\1?]#7)_X 14?V-XB_Z&N3_P  (J .AHKGO[&\1?\ 0UR?^ $5']C>(O\
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M@) X((X['/&*Z2B@#CK+2?$>CW$%Z@MM3NI+!+2?S[ID*LCNR'?L)<8D*DD
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MC#:$WC.,G>>E+I.D^)=%OUF^SV>H8T^&Q,CW9C8B&68JY^0Y+)(A/OFNVHH
MY+7O"5UXBU.]FGU*:S@^R"UM1;[">3O=FWH2#N$>-I!_=@Y](/['\10QWI$%
MM.^I^5<7'E:A);-!<+$D;!75"3&?+!['J,'-=I10!P3> KR\M[L7^IS->OI]
MK;I=1W,@$DL:L':1 0'5B1D-G()Z41^&]5BU:YOGT:TD,X@94AU:6W2(I$J%
M0JK@@%3@GMBN]HH XJU\/:C9^(;V\.FQ3I/?FY28:K+'M4A>L07:2,'ZUEW/
M@'59=.OK-)K40W=O=,\9<X-RWG+$3QTVS*2>QB7&:])HH XFV\.ZC9^(+V\.
MFQ7"3WHN(YAJLL6U=J#F(+M)!4]>M02>"+]%L)K6:"*X&I":^0D[9H!>&X3M
M]]<X'^\P]#7>T4 96GZ=/:Z[K%[(4\J\:$Q@'D;4VG/XUAZIX;OKB\U.<6=C
M?07-]'<"WGD:-BJP+'E7 )1PRD@CJ,C(S78T4 <O;Z'J9\$ZII5Q,#<745PE
MNDEP\WDJZD(AE8;FQGJ1WQSBLV'PUJ+:;]B_LV&U.^V<R-JLMP&\N:-R-KK@
M9"MT]A7=44 <KH7ABZT7Q%J,J31MI3VT<-E%SO@ =V:/_=!?Y?0'':J%QX5U
M$>'?"=F((;F728D2XC%X]N&(@,?RNHSU.>V17<T4 <7_ ,(A+J5Y;27J36$,
M5C-;@6FJ3-(CO(K!O,^4MP#PV0..*HKX2U6*73GDTZSN1:V36C+;W\MH"1)D
M2?(O\0Y(/0D]>M>A44 <DECXAL=6NKRQTZP875C;P 3WS_N7C\S.3Y9+CYQS
MP3BK+>&Y;?PSH6D6TJR?V;+:%I'^7>L3+N/U('2NDHH X*S\$7]C)X>FMYH$
M-N\9U*+)VRE%8(Z''WANVG/48_NBM:]\-7-['XDC\Z.,ZC/#-;/RVUHXXP-P
M]-T?(':NGHH YV"RU?4==L=0U.VM;..P239'!<&8RR. I.2JX4#/N21TQS!'
MX.M[G6=:O-2,TL5Y>)-' EW*L3(L,2?/&&"L=T;=0<C&?2NIHH XR70-9:.X
MTA8;0Z?-J@O_ +69SO5//$[)Y>W[V05!W8P<^U0VW@BXL_L-[&_FWEOJ,UQ+
M;S7,CV\D;S.P(0Y59%5@P( ^8$=\UW-% '%6/AS58-=AN!;VMDJSR27=Q:7<
M@CNT(;@V^-H8DJ2<Y!!P3FHK?0?$D.F:-8+#8(VA0L+:?[0S?:)!;O#'E=GR
M#Y]S<G&,#/6NZHH \^G\!:A963VNG:F]TEQIIL9Q>%%P5.Z-AL0$\M)G=D_/
MG/'.QIOAFYTOQG+?0RQ_V0;:410<[H99)$9P.VPE"P]"Q'3&.IHH RO#>G3Z
M3H%M97!0RQE]Q0Y'+L1^AK+G\-WDVG:K$LL*W$VJIJ-J6)*YC:)U5^. 3'@X
MS@'-=310!@6=EJEYXBAU?4[>WM%M;62WAAAG,I<R,C,S-M7 'EJ /<DXXK)M
M/"6JVU[9ZR=19]1^W/<7-L2GD[)?E=58)O.U F,G!,:].W:T4 <9I&@:S GA
MW3KN&T2ST)MRW$<Y9K@+"\*?)M&WA]QY.",#.<U/J'AF[O-+\0VF8O\ B9:A
M'<1_.1^[58 02!P?W;=/:NLHH XJ^\#?\3&XN-+*0J8;9XO.E=\S0S^< V22
M%. #CU/%)K?A[6?$ZS2WD%K9LEF]K!%'<LY8R21L[,X5< "( 8YY)XXKMJ*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% %74)KV"T+Z?:174^0!%)/Y0([G=M;^59']I>*_^A;L/_!J?_C5
M=#10!SW]I>*_^A;L/_!J?_C5']I>*_\ H6[#_P &I_\ C5=#10!SW]I>*_\
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MS:P.0X*HN,=<DY .G@U_Q#=-BWT/3)3Y:R?)J^[Y&SM;B+H<''TJ?^TO%?\
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M70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\
MZ%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7
MBO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:
MG_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7
MBO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU
M1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[
M#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <
M]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:
MG_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO
M_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70
MT4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[
M#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_
M:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\
MXU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO
M_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\
MXU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!
MJ?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_
M:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!
MJ?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP
M_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4
M <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP
M_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\
MZ%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU
M70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\
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M97]]I^OW"Z<\<M]8BTAM6>/>Q D&]B&VC_6>IX7UX$_]H>+?^A>TO_P;O_\
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MYN>!FQ_:'BW_ *%[2_\ P;O_ /&*AN9?$M[ T%UX6T:>%L9CEU1F4XY'!MZ
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MRS-I5S&R?<@:2(R/],/M'XM69_:'BW_H7M+_ /!N_P#\8H_M#Q;_ -"]I?\
MX-W_ /C% #=.M[ZYT>_TRYL;JP:X:Z9;AGB8+YLCLN-KD[@'!].#S56RTN],
MMA!<VFI#[+(C;FN8?LZE>Z[?G(QP!M&0<'%7/[0\6_\ 0O:7_P"#=_\ XQ1_
M:'BW_H7M+_\ !N__ ,8H IZC9:E+-J'V73;N*XN'.V6.XB:VE^4*IEC=CC@
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MM_Z%[2__  ;O_P#&* .AHKGO[0\6_P#0O:7_ .#=_P#XQ1_:'BW_ *%[2_\
MP;O_ /&* .AHKGO[0\6_]"]I?_@W?_XQ1_:'BW_H7M+_ /!N_P#\8H Z&BN>
M_M#Q;_T+VE_^#=__ (Q1_:'BW_H7M+_\&[__ !B@#H:*Y[^T/%O_ $+VE_\
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M1@%6"E>2,Y! .[:XA1RCS1JP!8J6 .!U-(;JW$:2&>(1R'"-O&&^A[UQ^O\
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M%<XWCKP^APUU<J?>QG'_ +)2?\)YX=_Y_+C_ , I_P#XB@#I**YO_A//#O\
MS]W'_@%/_P#$4?\ ">>'?^?NX_\  *?_ .(H Z2BN;_X3SP[_P _=Q_X!3__
M !%'_">>'?\ G[N/_ *?_P"(H Z2BN;_ .$\\._\_=Q_X!3_ /Q%'_">>'?^
M?NX_\ I__B* .DHKF_\ A//#O_/W<?\ @%/_ /$4?\)YX=_Y^[C_ , I_P#X
MB@#:U""2XLW2.[GMB.=\.W<1CI\P./PY]ZCT2:2XT'3II7+R26L3NQZDE02:
MP;WQMHEQ;&.VU2:W<]7.G3OQZ8VBH-(\7:'IFG16<NK3W(A18XV_LV9"%
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M_%LOB.=&B721;.'8+'J)DN @)"L8O+ &>,_-QF@"S_PF^@_\]KS_ ,%]Q_\
M$4?\)OH/_/:\_P#!?<?_ !%6I?$^D075Q!+=F-K</YCO$XC!4 L ^-I(!' .
M:;_PE.D^1YGFW&[S?)\C[)+YQ?;OP(MN\_+STZ<T 5_^$WT'_GM>?^"^X_\
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MN(ZBL^]\<:?#<+!:?OCY<TK22+)''MC&,JVP[QO*KE<XW=^ 0"?_ (3?0?\
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MU<D\2Z1% D[WJB.1)9$;8WS+&P1B./[S*!ZDC&<T 4_^$WT'_GM>?^"^X_\
MB*/^$WT'_GM>?^"^X_\ B*KKXXT]KBZ+8AL[1V$TMPLD;@)"99/W93(*@IP<
M9W?0&_\ \)7HY1R)YRZR^3Y(M93*S;=_RQ[=S#;SD C'>@"#_A-]!_Y[7G_@
MON/_ (BC_A-]!_Y[7G_@ON/_ (BKZZ_ICZ*NL)<[[!\;)51CO);: JXR26(
M '.1BJLGB[1(HED>ZD"E6=_]&ES"JL5+2#;F, @C+8'!]#0!%_PF^@_\]KS_
M ,%]Q_\ $4?\)OH/_/:\_P#!?<?_ !%-'BZU2^NHKCRX88)94WEF9I GE*2J
MA3D^9+LVYR2.,Y($6H>-]/L[=9X4EN 05,(AE68/YJ1*I39D99L<X/ P#G@
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M%D@ 83^'NZS^'5M960@CN85>%(4M94LT5E$4J2*9#G,A)C3=RH('0'FNVHH
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M$\L<EJLCYCX 5S]U3@9&">N",U9UWPO#KTD[3SE0]J+=%V!@A\P2$D'[P)1
M1W"^];]% '''P&GDH%NK9&,CO,BV*B%]RJH(CSU4+\I8OC<V<Y&"'P*UL=/$
M&J>6+&WCAAD6W F4)'LVAPP_=D_,4(/).".W8T4 <E;>"#:XMTU)O[/WVTAM
MS ,Y@1%C ;/W<QJQ&.3W )S!;_#NSM[BU;SHI8HX[=)?.M5>20Q  $.?NAL
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M]5_M"YO(HM1AU.UA$92\B"X+MN+1DK\I( 4\=G&?4[M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3GM7MYE:5ED^8@Y&!VVCG(/.>U5VT.[ECU.$K:0Q32PO;*A++B+;A77 ^4[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\O\ 8K*VMO,Y?R8E3=]<#FK5% %&/1=*BN1<QZ99).&W"58%#9]<XSFKU%%
M$-U9VM] 8+NVAN(B<F.9 ZY^AI%LK5+/[&MM"MKMV>2(P$V^FWIBIZ* *D6E
MZ?;V;V<-C:QVSYWPI"H1L]<J!@TJZ;8*;<K96P-MGR,1+^ZSUV\?+^%6J* *
MEQI6G7=RES<V%K-<)@++)"K,N.F"1D43Z7I]S=)=7%C;2W$8PDLD*LZ_0D9%
M6Z* *K:98/8BQ>QMFM!T@,2F,<Y^[C'6I+:TMK.W%O:V\4$(Z1Q(%4?@.*FH
MH J6>EZ?I[.UE86MLS_>,,*H6^N!S4L5G:PW,US%;0QSSX\Z5$ :3 P-QZG
MZ9J:B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#&D^UZEJUW;Q7\UG;V@1?W"H7D
M=AN))96X *X '7.:@_XFRR66D3:C^_E%Q/+>1Q*',2. B@$;0V)$!.#]UL=0
M1?NM-F>\-Y8WAM9W0)+F,2)(!G!*\<C)P01UYS@8CDT=VAMF2_N!>VY8I=.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 (74, 6 )Z FAF5%+.P50,DDX KD?%-G'JNL6]JFF2W,MM;M.9
MX%C\R&1LK"<NR]#YC8'0JIJU/*NO:7I#R"WCNFE\TV5SRDDB*RO$V,\JV3GG
M!0'!Q0!T8D1D#JZE",[@>* ZL"58$#J0:Y>*ULUTCQ%:'3+>UE(:2YAB820L
MQB&&7@=E&00#D9[Y)HVCEY+"X72;/3X4M]LIC*EKD,F-C!0!MS\W))R!QR:
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M5FCEAT]T%V3,L9 N)E7@XX9@H X]L56T!KE]"LVO-1MM1N"F7N[90L<ISU4
MD8H TJQ8?%>C3Z<-0%T\=FTAC6::"2)6(!/!91D8!YZ9XSFMJN TCPO9>*?A
MUHMM>$JJ1D[E W8)/ )Z?,%/_ <=Z .NN-<TVT^S?:+GRS<H'A#(P+@LBC Q
MUS(@QUY^M.M=9LKO5+K38FE%W:JKR)) \?RDD!E+ !@2K<J2.*PK_P  :9J!
MT]G.QK-1@J@P[;@23[$&08_Z:$]0,3VD:Q?$6^C0;471K55'H!+/0!TM%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1=QQRVHN[<;E8NF]$8M@G: 9%8GGY<GMBM2+Q/;/X7?73'NA4-A()4EWD-M
M5E.TY.,9(Z\XYI[>%M*-M;0+%*BVUO\ 9X6CF=61-R.,,#G.Z-#GV]S4T7A_
M3H](N-+,+26UP7:;S)&9I&8Y9BV<YSW!XXQC% &!>^)M3FU?3-*@LVLKE[]8
M;O+H^(C"\H*GH<["#QD;2.X-+KOB?5=/UVYLK:R22*+^SRA##=(9YWC9>3@<
M)P>V">XK:M?#>G6L\=P%FEN8Y_M FFF9W+^6T8R2>0$9@!TYSUYJ2ZT#3[S4
MQJ$T<AN-L2G$K!3Y4ADC)4'!(8GGW(Z4 <_=?$2SLU6.:S=+M?.,T#SHNWRG
MV$*2<.2?N@=>^*W+[71 NGK9VDEW/?@M#&&$?R!=Q8ENG! QZD>Y$=QX3TJX
MD:39<0R.TI=X+EXV<2$%U)4C@D X[=L5;O\ 1K/48[=91+&UL<PR02M&Z<;2
M RD'!!QC_ 4 <UI7CB671;:[NK":01P0/?SJ540M+C&%SDX!!..@/&3Q6@GB
MTO;I>'2[D6$TT<,%SO0ARTZ0@D9RN2^X>H!Z'BIH_!FBQ)!''!,D,211F(7#
M[)!&<IO&</CWZ]#D4/X.T=Q*K1W&QLE$%S)B$F02$QC/R'>JMQTP,<<4 5-0
M\:I:7%Q!#IEQ<O;BY>3;(J@) (RYY/?S1@>OIUJ&X\?6]H/+NK%[>Y>2-8HY
MIT565T9PS/G"\(P(YYP!G-:L/A/2(!+B&5VECGCD>2=W9A-L\S))ZGRT^F.,
M4^X\,:9<2"4QRQSKY92:*9D="BLJX(/'RNP/J#S0!D+X^AEC\^#3+F2WCMXK
MBXDWH/*5Y9(L 9^8AHV/'!'(/3-JT\33IX7U?6M1M-HT^:\'EPL"7CA=U&/?
M"X^O/>KJ^&-*6WFA\B0I/!';R%IG9F1&=UR2<YW2.2>ISS4O]@:>=-U'3S'(
M;74&E>>,RL1F3._;S\H)).!W)H PY?'MO;:F-/N[%H;A'BCGC,\9>-I"-H"@
MY< %2Q'0'O@UE6?Q#>QM';5XM]RS3W!B62-/+@61HU5.A=OD;CJ<'D9 KK[C
MP]87.I&_<3K*S(TBQSNB2E#E"Z@X8CCKUP <@"H)?".DR*JA+B(!71O)N7C,
MB.Y=E8@\C<Q/MDXQDT 9EUX\@MBY:Q98C=M9P32SI&DKJ"S$DGY5 7J>23C%
M"^/H98O/M],N9+>.WBN+B3>@\I7EDCX&?F(,;'C@CD'IG9F\.:;-#Y826(BY
M:[22*5D=)6!!96!R,@D8Z8)IJ^&-*6WG@\F1DG@CMY2TSLS(C.RY).<[I&)/
M4YYH S[CQI':V-SJ4NFW TV)WBCN=Z8D=91%@@GY0SG@GC ).*BMO'":ABWL
M-/DN;[,NZ**9"FV-4+,KYPP_>H /4D'&":T)/"&C3/,9(9F24NPB^T/LC9V#
MLR#/R,6 ;(P0>F,FE;PIIKQJ&:\,P=W-Q]KD$K;@%8%\YVD*HQT^4=QF@"I!
MXAF7PMX<U*Y),U_'"TPC088M TA'/09%6M!\2'6I?+DT^:S9K6*\B$CJV^*3
M=C.T\'Y3D>XY]+9T'3CIMCIYA/V:Q"BW7>?E"H4'.<GY21S4EGI%E82QRV\1
M5X[:.T4EB<1IG:.?J>>M '(1^.KJR=I=0@1[*-=0=Y$(5LPW?DQJ 3CH5!)[
MG.1@U>@\=I=E(;/37N;MIGBV17"&/Y8_,W"3.",<>N1C'>M.7PCHTZA7MY-H
M%P"!,XSYTGF29P?[^&']T@8Q4]MX=L+::.?_ $B:=':02SSO(Q++L/)/3: ,
M=/QH K>'_$RZ\^!8S6H>TAO83*RG?%+NVD[2<'Y#D>X_#)T3Q/?W/B"VL;R0
M-)<_:1+:_9F0VC1L-HW'[V5S]>",#BNDT_1;'2S$;2(H8K6*S7+DXBCSL'/I
MN//6F6>@6%C?M>Q+,TN'">9,SK$';<P0$X4$@'CT Z#% '/7'C1(/'Z:2;RS
M%F'2R>$N/.^T.AD# 9SLQL3I]Y_:M76/%":5<W:"QFN(K&V6ZO9490(8F+8(
M!.6.$8D#L/4@5<?0-.DTR?3VA8P33FX?YVW&0R>9NW9R"&P1Z8&.E,U+PWIN
MJW+3W4<I:2,0S+',Z+-&"2%< X8 EN#ZD="10 [1M8?6&O'%E)!;V]Q);I*[
MJ?-:.1D8@#D#*]_6L!=?UMA?6MQ]E@O/[8BL(FB!D6&-X8Y2><;F 9N2 ,D<
M8XKJ[*QM]/A>*V0HCRR3,"2?GD<NQY]68FJEQH&GW,=XKQN#=W"7,CI(RL)4
M5%5E(.5($:]/3W- ''ZQXWO-+TF.(W=BFI)>7,;/.1&DT=ODG )P&?\ =I[%
MR1TKO+*\@U&PM[VU<26]Q&LL;C^)6&0?R-4].T#3M+G\^UB<3>68R[R,Y(+E
MV))/5F8DGJ>/04NF:+!I#LMI)*MMY81+<R,R1_.[D@$\9WX^B@= , &'+X]M
M8=0N[0V4DKP1SNJ6\R2R,8CR"BDE2>HSSCKCI5R'Q)_:/A/4M6M!$KVT4NTI
M,DR%E3<#E3^AP>#Q3AX,T8.3Y=R0!*$3[5(%C$IR^P!OER><CD<8QBKMMH%C
M;6-[:!99$OBQN7EE9WE)0(26)S]U0./2@#GSX]2RM474K![:\9;<QI),@1_.
M60J2V<+CR9,CGH,9R*=_PL*T-L]TNGW#6T-J]U<R!TQ&JNZ8'/S$LG!'!!!R
M*VKGPSIEU)YKQ2+,$A1)8Y65T$6_85(/!'F./<,0<BA/#&E+!-"T#RI/;FVF
M\V5W,B%F8Y).<DNQSUYH P!X]^T7%BEO:Q[#>>3=L)ED58S!)+N1EX)'EG(_
MV2.X--U;QGJ!TN,6>FRVEY=BWDM6E=&S#+,D9;'(#CS%X.1\PZX(K>'A;3=L
M?F&ZF>.X6X$DUU([[@I0 DG[NUF!7H=QSUID'A#1[= HBGD">4(_-N'?REB<
M2(JY/"AE4X[X&<X% &;+XZBL[!KRXT^Z-H8IVMY@R$W!A!+#:#\NX*Q7U YQ
MTI7\>6\&K+IMU9-#<)+%#.GGHSQO)C: H.7 #*21T![X.-!_!VC2>>LD,SQ2
MK*HB:=RD8DYDV+G"YR>G3)QC)JS/X>L+C4S?L)UE9T>1(YW6.5D^XS*#AB,#
MKUP,YP* &7VN26^JG3[73I[R6*%)[CRW5?+1V95P"?F/R.<>B_0'$TSQI<"R
MWZE8."8KJ:*59(U6589=I') 3AEP2<<$G%;^H^'M/U2Z%S<I+YA012>7,R"5
M =P1P" P!)X/J1T)S#<>%-'N;2.UEMW,4:RJF)6!7S'#L00<YW*"#VQ0!E6G
MCI=098++3FN;IKEK8+%<HT9*Q"7<).A7:V.F<]N].B\=17-M#=VNF7,MHWV5
M9I"Z*8FG*[5*YYP'4G'KQGG&K9^&=-L;W[9&L[W/FF8RRSN[,Y01DG)_N@#'
M3BL2[\"*][:I:2I;Z="UJ2BO+N(@<,H(W[7SM W,,@>N!@ 2'XDZ9.9#';R2
M(58V_ER(S2D.J!2N?D+%AC=VSG&,5L>']4OM2NM9COK;[,UI>+#'%N#84P1/
M]X=<EV.?0T@\(:.$FC,4[0R(R+"US(4B#,&.P9^0[@"".1CC%36?AZVT^=9;
M6XNU9KDW,YDG=S.QB\OYB3R  IQT!48H KZWXHCT.[>*6SFEAALWO;B9&4"*
M).O!.2?0"LZV\>Q7;1P6^GO-=R3I L<5Q&Z?/'(X)<'' B8$=1QUR,]%=Z18
MWTTTEU )3-;-:R!B<-$QR5(]ZK6WAK3[:6&;-S--#*)4DN+EY&!",@Y8G@*[
M<>^>O- &1!X[CDL_M,VF36Z/;?:8O.GB4,HD6-MQ+87#,.2>1SUXJN/B!;NB
MW*6\KK''<"2&%D<.T<D"@J^0"/WPQTSDYQBMJ;PCH\UO!"8)%6W0)"R3,&3$
MBR @YZAT4Y]O2FKX.T9=Y,$SLYD+-)<.S,7,;,22>YAC/X>] &=>^.TT^.47
M>FO#/#<M;S"2=%B1A&D@_>D[<LLBX!QSD9&*Z";58X;K38#&Q-^S*A!&%Q&7
MY_!<<56O/#&FWLMQ*XN(Y;B0R2O#</&7S&D9!P>A6-!CVSUYJ6[T&PO+6SMR
MDL*61!MS;S-$T>%*8!4@XVDB@#$B\=1SK'+%I=PUMLMI)I=Z#RQ.Y1>,Y;!'
M/MZ]*;J'BZ].D_;K#2I_(>YAC@F+(1,IN8XF&,_*6#';GZG'2M:#PIH]M9FT
MBMF6$I#&5\UC\L+;HQG/8G\>]-'A'2!+O\J8A9!+'&T[E(F$JR_(N<+ET4X'
MICIQ0!FWGCJ.QLVDN+#RKB.66*6*6ZC0!HPI(4D_.2'!  ]<XJ2/QO!)<;ET
M^X%B)X8'NF90%:6))5^7.<8=0?0GOSB]=>$M)N[J2Y>.=)93)YK17#H7$@0.
MIP1P?+3\O<U+#X9TNWM_(C@8)YT4^"['YXT1$/)[+&HQWQ0!BR_$"&UMDN+S
M3+BWCGMX[BV9Y4Q(LCJB G/R'+@G/ '<]*1O'7VRPF&F:?)<7L<4\CJDJ%$$
M87Y@V</G>N .O.<8INE> DAE<ZE,LL:VR6\*02S 1A'#AE+.3'@JNU5.%QU/
M;6F\(:5/"L<GVLMB17F%W())%DQO5F#9(.U>.V!C% !<>(/[/\-:?J5RL;/<
M)$"7F2% S+G)9C@#@],GD<5F)\0(9K3[5!I=S)!':K=7+B1!Y2&22,XY^8@Q
ML>.H_*M^ZT*QN[2RMV$L8L6#6SQ2LCQD(4X8'/W68?C56'PEHUO9W%I';OY-
MQ!]GD#3.Q*;W?&2<_>D<YZ\^U %*/Q-=7FO:=!;6;QZ=/<W,!N'93YAB5P<#
M.5^9#@]P#TXR^?Q/+!K=QIL%E->7!N?)B0,D:KB!)3EB>GS?7/'3FK\'AG3;
M?5$U"-)A+'))+&GGN8T>3.\A,[06R2>.I)[FIQHE@NJ'4A"?M1D,I?>?O&,1
MYQT^ZH% &-K'B&[E\&6.K:-$RR:A):+'YFW=&LTB+T.1N ;'<9YY J'5/&)A
MT 3VL;K<R07+QO( 0#"X0Y'N3FM]=$L$TFTTM83]DM#"84WGY3$RLG/4X*CZ
MXK/;P7HK22L\4[+(LJB-KF0H@E8-(%7.%RP!X_E0!2N_$&I1>!M8U6%8WO;:
M>\BBR  !'.\:DCOA5!]\4J^,#9VRO=V5R]O&\EJUV63YYXU8N-HQ@91USCJ.
M@&#6XVB6#:5<Z:83]EN7E>5-YY,CEWYZC+,3527PII,]U+/)%*PD=Y#%Y[^4
M)'4JSA,X#$,>?<GJ2: *MGXJN;V6..+0[DOY44\R^;'F*.5B$/7DX4L0.@'4
MGBF^'_&]AXAU!;6VC(66)YH7$BON16 ^8 Y0G<" >HST((J_<>&-,N)HI7CF
M4QQQPE8YW5940Y17 .& )/7U(Z$T_3O#UAI5QYUJ)QM5DCC>=VCB5B"0BDX4
M9 Z=,8&!Q0!D7OCNTL=7FL)+?<8_. V7$;/NCB:4[D!RH*HV">>G S3D\9,T
MR6C:1<)?S&$V]NTJ?O%E65E)8'"X6"4D<_=XSFK<O@[1YIWEDCN"&EFF$?VE
M]BO*K+(0N<98.WTSQBK%SX:TRZD\UXY$F"0HDL<K*Z"+?L*D'@CS7'N&(.10
M!GV?BAK?P9/KNK1,AAN+B-HAM##;</$B9SMSPHSG'?-9%YXVOKYK)-'MU#"Z
MD2YVRHZL$A,H"/T(/0GJ,$<<&NJC\/:;%H;Z,(7:R<N65Y69B6<N6WD[L[B3
MG.0:9%X;TZ/8S"XFD61Y/,FG=V+,GEG))_N\8Z#ZT <QH_C]4M]/M-2!FO72
MW^TN'C4J\P#*%C'+* ZDD= >Y!J]=^,+]M*M[^PT:0V]S<6ZV\TLB[9(Y)TC
MR0#E20V5SZY/0BM9/"NE13PR1)/&(EB!C2X=4D\H 1EU!PQ&!R>N!G.!41\&
MZ.8GC\NY"<>4HN9,08D60"/GY/G13Q_= Z#% &_142P*EQ).&D+2*JE2Y*C&
M>B] >>2.O&>@J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[P6 ,$%O)&)!LCA27 4@\L[9]\)Z"@"XC>+I<^7>>'WQUVPRG'_C]/V>,O\
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M_P"+KH:* .>V>,O^?C0?^_$W_P 71L\9?\_&@_\ ?B;_ .+KH:* .>V>,O\
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MPQ3Q>9;NIF21@J% 1ELL0/Q'8YI7\<Z-&D7_ !]-+(TJF!+=FDC\L*7W*.>
MZ'C.0P(R* .DHK)L_$=A?ZO<:;;B=I8&9'D\EO+W+C<N[ID;AUZ\XSBL74_'
MVGZ5!XD%S<645YI)<06TMRJO<8@24<'GDN5XSTH ZH6D O3>>6/M!C$1D[[0
M2<?F:FK#7Q9I1U$6)DE$GF&'S/*8Q^:%W%-V.N/UXZ\5!'XWTB3S%VWBSKY1
M6W>V82R>82$VKUYVMP<$8YQ0!T=0VMK#9VR6]O&(XDZ*/S))[DGDD]36?X<U
MK^W]*:^$+0K]IN(%5@0<1RO&"00""0N2.V<5K4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/7W_)0=$_[
M!U]_Z';5T-<]??\ )0=$_P"P=??^AVU '0T444 %%%% !1110 4444 %%%%
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M)386!+,V /NXQGJ10!Z-]KMO^?B+_OL4?:[;_GXB_P"^Q7G%];^#K"XNED\
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M^UVW_/Q%_P!]BL3_ (0'P=_T*NB?^ $7_P 31_P@/@[_ *%71/\ P B_^)H
MV_M=M_S\1?\ ?8H^UVW_ #\1?]]BL3_A ?!W_0JZ)_X 1?\ Q-'_  @/@[_H
M5=$_\ (O_B: -O[7;?\ /Q%_WV*/M=M_S\1?]]BL3_A ?!W_ $*NB?\ @!%_
M\31_P@/@[_H5=$_\ (O_ (F@#;^UVW_/Q%_WV*/M=M_S\1?]]BL3_A ?!W_0
MJZ)_X 1?_$T?\(#X._Z%71/_   B_P#B: -O[7;?\_$7_?8H^UVW_/Q%_P!]
MBL3_ (0'P=_T*NB?^ $7_P 31_P@/@[_ *%71/\ P B_^)H V_M=M_S\1?\
M?8H^UVW_ #\1?]]BL3_A ?!W_0JZ)_X 1?\ Q-'_  @/@[_H5=$_\ (O_B:
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MD<TV]TKPUI=A>76H_#;3XO(@,Z"*T@D$F"!LW 85_F'!X/."<' !Z!]KMO\
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MO^?B+_OL4?:[;_GXB_[[%8G_  @/@[_H5=$_\ (O_B:/^$!\'?\ 0JZ)_P"
M$7_Q- &W]KMO^?B+_OL4?:[;_GXB_P"^Q6)_P@/@[_H5=$_\ (O_ (FC_A ?
M!W_0JZ)_X 1?_$T ;?VNV_Y^(O\ OL4?:[;_ )^(O^^Q6)_P@/@[_H5=$_\
M "+_ .)K"\2^"?"MNVC>3X:TB/S-3AC?991C<I#9!XY'M0!W'VNV_P"?B+_O
ML4?:[;_GXB_[[%<?=>'O!%KK]CI!\':8TUV&(E&F1B-,*S8+%<$G:>!D^N.,
MY-NG@">VNKO_ (0S2?LD,7FI)':6[LX+!4!0<JSY!4'J#VY% 'HWVNV_Y^(O
M^^Q1]KMO^?B+_OL5R&G>%/#ES=/;WWP^TNR;RQ(CFS@D1AG!4LHX8<<?D3SB
M/5_#?A73]0L;&U\":/>7%VDKJHM8(PJIMSDE?]L4 =G]KMO^?B+_ +[%'VNV
M_P"?B+_OL5Y]=VO@2T\/G4W\$:<95N&MGLAI\)E61,EQP"#A59^#R!QUI]_H
MWANVU6TL[7X>Z+=QWBEK:=(K=5D 4,3@KQU_&@#OOM=M_P _$7_?8H^UVW_/
MQ%_WV*X+3-&\,:I=,L/@#1%MENIK8S-%;YS'(T;'9MSU0_A4FKZ+X0T_5H],
MMO VC7=TT!N-GV:WB+)G&$W#YVR.@Z<9(R* .Y^UVW_/Q%_WV*/M=M_S\1?]
M]BN"FT_P/&T\2^!].>X62"&*W_L^%7EDE3>%P0-N!DG/0*:AU&Q\):+82W.J
M_#NP@,4T2,(K&&565R1N5@OS;<$E<9Z<<C(!Z']KMO\ GXB_[[%'VNV_Y^(O
M^^Q7G^HV/@BTF>&V\%Z+=MOMUC9;6!4D\X,5(8C&,)U]Z6;1O#D(LHC\.]%:
M[O)GBCA2.W(PJ;RQ;;CL1B@#O_M=M_S\1?\ ?8H^UVW_ #\1?]]BN3T?PQX,
MU:"=CX-TFVN+:8P7$$MA"6C< '&0"""K*P([$5H_\(#X._Z%71/_   B_P#B
M: -O[7;?\_$7_?8H^UVW_/Q%_P!]BL3_ (0'P=_T*NB?^ $7_P 31_P@/@[_
M *%71/\ P B_^)H V_M=M_S\1?\ ?8H^UVW_ #\1?]]BL3_A ?!W_0JZ)_X
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MRP%V*M;F9448^8*S!2/]T>HH ]-HKFO"+73I=M<233*/+59C/))',P!+.@D
M9"2<%02HP,<[JZ6@ KG_ !U_R3[Q)_V"[G_T4U=!7/\ CK_DGWB3_L%W/_HI
MJ +^J::=3@LT$HC\BZAN"2,YV,&Q^.*QKWPG+JEYLO[BV;3UGGF58K?RYF\V
M-XRC,#@@"1N<9.%ST)/4K]P?2EH Y^PTSQ! ;:.YU>VD@M(BB".V*F=MNU6E
MRQX'4A<9/.1TJ;6]*OM2@TQ[:YMHKRRN5N=TD3-&Y$;H1@,"!\^>O:MJB@#D
MG\&S7]T+C5=0\UI;I;JY6U#VX;9'LB1"K[E"DE\YR6]!Q4MMX1-G#%:07C?8
M[?5!?P))N=D4@ED+,26R[.V3_>Q7444 <A)X2N%\1:AJD46B3_:KE+A7O+$R
M31;8XTPK[A_SSR/0FM7Q!I-WJBPB"2RDA4,LUI?VWG0S XP2,@AAC@\C!/'0
MC:HH XN#P%LLC;OJ'/V58HVCBP(9%N#.A0$GY%8J I)X4#--N_!5]JEY<WM]
M>6$=S+;& M:6S)YA+(=S[G.<", #MD\FNVHH XK5? /VR^U6:UO4B@O[?9]F
MEBWQI*9%=VZCY6V#*^I)[FI3X4OQ9"*W&AV4L=U#<QFTL6C5C&V<. _/MTQS
M7844 8^D:3=6M_>ZEJ%U%<7UVL<;>3$8XTCCW;5 +,3R[DDGOVQ6Q110 5SU
M]_R4'1/^P=??^AVU=#7/7W_)0=$_[!U]_P"AVU #-:\*_P!L-K&^:,)?V]M&
MBNFX*T+NX+#NI+#(] :Q[GP-<W,R74D&C2L;Q[E[*: M;#,*Q# QR?EW$X')
M]J[RB@#$\.:/=:%I\-D9;=X TTC)$A18BS[D2,9.$4%ACZ8QTK-U/PQJ5T=:
ML[:[M4T[67#W)D1C+%F-(W"8.#E4&,XP2>M=;10!Q>M>!7U6QU!8KU;>]GNW
MFAG"9"QNJ*\;#N"%_,*>U:$WAF:71M3L1<(&O+_[6K;3A1YB/@^_RX_&NDHH
M Y'6_"<FI>)9=5^PZ+?)):16X34K<R&,HTC$KP<9\P?]\T2>&=6D.N0K>6$5
MMJY4R_N&=HOW$<3!1N _@)&>F1P:ZZB@#SO6/A)I$UE'#HTMS8('!FMENI!!
M.F#E2F2JG.#D+U'3FH+7X7:A#H-K8?\ "6:I"8;N*X6%'22&,)*' 7<F[(V\
M'IG^''%>ET4 >-^-/ 5PEN?.\5:U=ZOK%Y#9VRM.L<6 <AG1%&[8H=LC'-;5
M]X1T;P7X#\56R7"6EEJ,7EQ?*TCH3"L849.7)8$@?[6*L:_KNFV_Q#2ZU"X"
MVV@V64C4;GDNK@X5%4<LVQ#P/[]6[&QN-2U*W\3>+FBLDC<+IFFRR +;LW =
MST:9LX _AZ#F@#-\->"=27^T-:NK;2M,U'48$2.V@M04MH@03$R]"& (<]>>
M#P*ZOPWH4FC2WSF*TM8;AE\NSL@1#%C.6 .,,V>< #Y1[FMZB@#D[;PQJ$.G
M6&B/>6QTFRGCE5PA\YTB</'&1]T8*KEAU Z#.1H^'_#5CH-OF.VM?MK&3S+J
M.!5=PSEL%NI[=^U;=% '(W7@A;F6]U'[?<)K$UV+J*99Y1"A0CRE,(;8P"J%
M)(R<L>,U5N? ,\^G36:ZBB1S6EQ$X\H\R/YH1^O0+.X([X7D8KN** .3_P"$
M3=->O=2%KHUPUS=+<++<VFZ:/"(N WMLR/K6)X@T;3/#,%KJ2V\%SX@.J37%
MG&D"F2[:69G\H@^BL/G_ (-N>F0>XUG5[/0=)N-2OG*6\"[C@99CT"J.Y)P
M.Y-8/AC1[R\OV\4Z_'C4KA-MI:L.+" \B,?[9ZL?7CH* .%\.:=XQ\,>/+&U
MOIK.9]1CO##"TA\J-,I,P4@9'[QR.<]#Z@UWEQX3_M6Z@F\1:C+<E('ACCMI
MI+4;I&+2#,;*67:$4 YX4DY)KFO%7B>UTCXPZ8DT<]Q);:-*T%O;IODEEEE5
M0BCUPA//  S5?Q!I&J2ZEX:U_P 03;=1EURUBMK*&0F*SB)+,O\ MN0OS-^
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M\TX$H)N+@ Y()ZYR=A;=P<#J? 2^7HEU"OEM!'?3""6!"D,B$A@8E.=J L5
MR1E3@X- '4T444 %%%% !1110 5SU]_R4'1/^P=??^AVU=#7/7W_ "4'1/\
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MU+4+<L/(^<?N8]O)? .<= ,=30!ZG->6MO<6]O-<11S7+%88V8!I" 6(4=\
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MVS2.JGN"SQX _NMUQ0!UGF:Y_P! G2NW_+^_;I_RPI?.U[_H%Z7US_R$)/\
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MUD[?&7_/;0?^_4W_ ,570UYOHDNO7/DW\"ZMB.]N3<W%U=QM;20J\@VK'O+
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M2YAN[>999S-EH9<*X<@;E^\ Q&6#+G)%=G0!SVWQE_SVT'_OU-_\51M\9?\
M/;0?^_4W_P 570T4 <]M\9?\]M!_[]3?_%4;?&7_ #VT'_OU-_\ %5T-% %/
M31J0MC_:C6C7&XX-JK!=O&/O$G/6KE%% !1110 4444 %%%% !1110 4444
M%%%% !445K;P0&"&"..$ECY:* OS$D\>Y))^M2T4 9]QH6D70MA<:99RBU4+
M '@4^4!C 7C@<#CV'I4\FG6,SW#RV=N[7"+',S1@F55S@-Z@9. ?4U9HH HK
MHNEK>S7@TVT%U,I66;R5W.#P03CG.!GUP*KKX7T!+8VRZ+IZPEE8H+9 "1G!
MZ=1DX^IK6HH J3:787%@MA-96\EFH4+ T0**%^[A>@Q@8],57F\.:'<0003:
M/820P*4BC>W0JBGJ ,<#VK3HH H3:)I5RRM/IMG(RM(P+PJ<%_OGI_%W]>](
MVA:0UU/<MIEF9[A&2:0P+ND5AA@QQR"  ?7%:%% $26\$<SS1PQK*ZJK.J@%
M@N=H)]!DX^IJE;^'M%M69K?2+&(LRNQ2W49*L'4].S ,/0@&M*B@#/NM"TB^
MQ]KTNSGQ(9?WL"M\Y&"W(ZD 9^E)_8&C?:?M/]E67G[/+\SR%SMV[<9QTV_+
M]..E:-% &2OA?0%A:$:)IXC8J67[,G)7.T].VYL>F34[:'I+VOV9M,LS!Y:Q
M>68%V[%.57&.@)) ['FK]% $-K:6UC;);6D$4$"<+'$@55[\ 5-110 4444
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M9_M$8:#B,(>#$N0QXQD$YR* .VCTRVBOX[M$VM%!]GA0 !(D)!(4#IG:N?\
M='3O<KS_ ,0ZEH=]XAM+>VU>W74)5@E6Z>]5([:$/D&,9&YY.1@9R,;N, UX
M]2N)O%&IRZ]%JEA:RZ;)N .%MX5DP""C$Y(R2P&03Z*#0!Z117*>"9%SK5O%
M)#);17H,+6LA>!5,2?*A/H<EATRQ]<5U= !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4$ C!&1110 $ ]13=BAR^T;B,%L<XIU% #/)B\OR_+39UV[1
MC\J=M'H/6EHH :(T 8!% ;K@=:3RH]JKL7:OW1C@?2GT4 -9$==K*K+Z$9%5
MCIMNVJKJ3>8UPD1A3+DJBD@G"] 3@9/7@5;HH :Z)(I5U5E/9AD4/&DBA716
M Y (S3J* # &>.M(% Q@#CI[4M% "8'/'7K0%4# 48],4M% %>[LH+V.-)ER
M(Y$E0@X*LIR"#_G()'0U.0#G('/!I:* $5510J*%4= !@"D$:*6(106^\0.O
MUIU% "8![5!=V4%\D:7";E21)0N>"RG<N?7! /U JQ10 UD5\;E#8.1D9P:-
MB[]^T;\8W8YQ3J* &>5&2#L7(]J?@9SCFBB@!J(L:A44*HZ # IU%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>modificationno10effectiv002.jpg
<TEXT>
begin 644 modificationno10effectiv002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH HR:WI
M44C1R:G9)(A*LK7"@J1U!&:;_;^C?]!:P_\  E/\:R+OX=^#[Z\FN[KP[82W
M$\C22R/'DNQ.23[DFHO^%8>"/^A8T[_OU0!N?V_HW_06L/\ P)3_ !H_M_1O
M^@M8?^!*?XUA_P#"L/!'_0L:=_WZH_X5AX(_Z%C3O^_5 &Y_;^C?]!:P_P#
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M_P# E/\ &C^W]&_Z"UA_X$I_C6'_ ,*P\$?]"QIW_?JC_A6'@C_H6-._[]4
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M._[]4?\ "L/!'_0L:=_WZH W/[?T;_H+6'_@2G^-']OZ-_T%K#_P)3_&L/\
MX5AX(_Z%C3O^_5'_  K#P1_T+&G?]^J -S^W]&_Z"UA_X$I_C1_;^C?]!:P_
M\"4_QK#_ .%8>"/^A8T[_OU1_P *P\$?]"QIW_?J@#<_M_1O^@M8?^!*?XT?
MV_HW_06L/_ E/\:P_P#A6'@C_H6-._[]4?\ "L/!'_0L:=_WZH W/[?T;_H+
M6'_@2G^-']OZ-_T%K#_P)3_&L/\ X5AX(_Z%C3O^_5'_  K#P1_T+&G?]^J
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MW_?J@#<_M_1O^@M8?^!*?XT?V_HW_06L/_ E/\:P_P#A6'@C_H6-._[]4?\
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MU^!D' XXH95<8901Z$4 >9/<6HGFBL[QSX0_M&!;B>.X9HD!AD+JLF>(_,$
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MB'4_#EW#<QQ+I6H+>2*X),@'88[U!KG@^XU7QK9:['=11Q6^GSVAB93N)D!
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXFNB-M=7VKV5TVD"RN8')FNS(C;TVD%%*G<P)Q]X*.,XR!0!T%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!Q^J?%/P7HVIW&G:AK:PW=NVR6/[/
M*VT^F0I%5/\ A<WP_P#^AA7_ ,!9O_B*[O('XTF1SR..M '"_P#"YOA__P!#
M"O\ X"S?_$4?\+F^'_\ T,*_^ LW_P 17=9&<9YH+J.K =N30!PO_"YOA_\
M]#"O_@+-_P#$4?\ "YOA_P#]#"O_ ("S?_$5W08,,@@CVI Z,6"LI*G#8/3Z
MT <-_P +F^'_ /T,*_\ @+-_\11_PN;X?_\ 0PK_ . LW_Q%=T'5ONL#]#2%
MU#A"PW$9"YY- '#?\+F^'_\ T,*_^ LW_P 11_PN;X?_ /0PK_X"S?\ Q%=S
MO7=C<,^F:!(AZ.OYT <-_P +F^'_ /T,*_\ @+-_\11_PN;X?_\ 0PK_ . L
MW_Q%=SYB8)WK@>]*&!&001ZT <+_ ,+F^'__ $,*_P#@+-_\11_PN;X?_P#0
MPK_X"S?_ !%=R)$9 X=2A_B!XI00PR""/:@#A?\ A<WP_P#^AA7_ ,!9O_B*
M/^%S?#__ *&%?_ 6;_XBNYWKOV;AOQG;GG%*'4G 8$^F: .%_P"%S?#_ /Z&
M%?\ P%F_^(H_X7-\/_\ H85_\!9O_B*[IW5%W.P51W)P*1W5%W.P5?4G% '#
M?\+F^'__ $,*_P#@+-_\11_PN;X?_P#0PK_X"S?_ !%=WD9QWIID0=74?C0!
MPW_"YOA__P!#"O\ X"S?_$4?\+F^'_\ T,*_^ LW_P 17<[T)QN&?3-.R,X[
MT <)_P +F^'_ /T,*_\ @+-_\17)S?$SP<_Q8M=<76D_LY-&>U:7R)>)3*&
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M_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\
MA<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^
MAA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9
MO_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@
M#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#
M_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_
M  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B
M*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP
M_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_
M ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*
M[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^
M%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z
M&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F
M_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\
MA<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^
MAA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9
MO_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@
M#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#
M_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_
M  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B
M*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP
M_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_
M ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*
M[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^
M%S?#_P#Z&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z
M&%?_  %F_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F
M_P#B*/\ A<WP_P#^AA7_ ,!9O_B*[NB@#A/^%S?#_P#Z&%?_  %F_P#B*/\
MA<WP_P#^AA7_ ,!9O_B*[NB@#QCPK\3/!VF>)O%EY=ZTD<&H7L<MLWD2G>HC
M"DX"Y'([UUG_  N;X?\ _0PK_P" LW_Q%=W10!PG_"YOA_\ ]#"O_@+-_P#$
M4?\ "YOA_P#]#"O_ ("S?_$5W=% '"?\+F^'_P#T,*_^ LW_ ,11_P +F^'_
M /T,*_\ @+-_\17=T4 <)_PN;X?_ /0PK_X"S?\ Q%'_  N;X?\ _0PK_P"
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MR?IFN]>:*,@/(BD_WF I//AP#YJ8)P#N')H \VNHM$DAL%\+V8BNXXIA>^7
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M@^QH MT55GU*QM;J*VN+VWBN)B!'$\H5GR<# /)YXJ.ZUG2[&X%O=ZE9V\Q
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MBV=H(@&@B#R1D!,CC@\Y Y9CC!%:UU8V4OB:[)M;=W.F8E)C!)!8@9^NT_\
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M& OC>44 MCID]3B@"W1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2O(V"<*J@D\*3[ $U#9>(--U&6WBMIV,MPLK)&\3(P\IE60," 5(+J,'!YH
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M%0E2&!!!P00:=/XMTJVE>.07Y>.%)Y0FGSOY2,"07VH=IP#P>1B@# V?%?\
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MG_&N[HH XW3E^)0U&W_M.3PJ;'S!YXMEN/,V=]NXXS]:[*BB@ HHHH ****
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MU5\>Q$L?'JI]:V*S4TZ1_$<FIS%=D=L+:V4'D!F#2$_4J@Q_L>]:5 !1110
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MW_"R_!/_ $-&F?\ ?\4?\++\$_\ 0T:9_P!_Q6S_ ,(_HO\ T!]/_P# 9/\
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M_0T:9_W_ !6S_P (_HO_ $!]/_\  9/\*/\ A']%_P"@/I__ (#)_A0!C?\
M"R_!/_0T:9_W_%'_  LOP3_T-&F?]_Q6S_PC^B_] ?3_ /P&3_"C_A']%_Z
M^G_^ R?X4 8W_"R_!/\ T-&F?]_Q1_PLOP3_ -#1IG_?\5L_\(_HO_0'T_\
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M2KCP6LDVF6<K_;;L;G@5C@7$@ R1Z4 ;/_"R_!/_ $-&F?\ ?\4?\++\$_\
M0T:9_P!_Q6S_ ,(_HO\ T!]/_P# 9/\ "C_A']%_Z ^G_P#@,G^% &-_PLOP
M3_T-&F?]_P 4?\++\$_]#1IG_?\ %;/_  C^B_\ 0'T__P !D_PH_P"$?T7_
M * ^G_\ @,G^% &-_P ++\$_]#1IG_?\4?\ "R_!/_0T:9_W_%;/_"/Z+_T!
M]/\ _ 9/\*/^$?T7_H#Z?_X#)_A0!C?\++\$_P#0T:9_W_%'_"R_!/\ T-&F
M?]_Q6S_PC^B_] ?3_P#P&3_"C_A']%_Z ^G_ /@,G^% &-_PLOP3_P!#1IG_
M '_%'_"R_!/_ $-&F?\ ?\5L_P#"/Z+_ - ?3_\ P&3_  H_X1_1?^@/I_\
MX#)_A0!C?\++\$_]#1IG_?\ %'_"R_!/_0T:9_W_ !6S_P (_HO_ $!]/_\
M 9/\*/\ A']%_P"@/I__ (#)_A0!C?\ "R_!/_0T:9_W_%8'CCX@>$;_ ,!Z
M]:6GB+3IKB:PFCCC28%G8H0 !ZUW'_"/Z+_T!]/_ / 9/\*Y#XI:+I5O\,M>
MF@TRSBE6WRKI JD?,.A H D\._$3P=;>&-)@F\2:;'+%9PHZ-. 58( 0?QK2
M_P"%E^"?^AHTS_O^*T+#0-&;3K4G2+ DPH23;)Z#VJS_ ,(_HO\ T!]/_P#
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MTY[;6+S3TTBZMXE3Y8[B\$@VR1@C.U.H9@,8/"Y."V.7^!_^1!\.?]@RV_\
M12UO4 8VJ1ZC)JVG2VUDDL%M(SNYG"GE&7 &.V0:CU#3;K4O$%LTJR1V-M$Q
MCEAN2C&1N"2!SP!@<_Q&MVB@#!TBTU#3]'O;(VL;")I/L2RS[_,5LD*YQP 2
M1WXQ5_15NUT6T6_M+:TNA&!);VIS'&?1>!Q5^B@ /3BN.;0-4GTJ K%#;WL=
MR1(IEW++ TWF$$@=1U''8CC<378T4 %%%% !1110 4444 %%(6 QD@9.!F@D
M $D@ =2: %HHZT@8,,@@CVH 6BD# L0",CJ*6@ HHHH **** "BBB@ HHHH
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MRKC?BQ_R2SQ!_P!>W_LPH ZG3_\ D&6O_7%/Y"K-5M/_ .09:_\ 7%/Y"K-
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MH *XJ]_Y+-I'_8$N?_1L==K7%7O_ "6;2/\ L"7/_HV.@#M:*** "N*^%?\
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M'R4 =[1110 4444 %%%% !1110 4444 %%%% !7(?%)U3X7^(2V<?9&''J2
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MVKPG;(9;62,*< XRP SA@?QJ[#<Q7$D\<;;F@D\N08(PVT-C\F'YT 2T444
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M% !7$6G_ "6S4_\ L!0?^CI*[>N(M/\ DMFI_P#8"@_]'24 =O1110 4444
M%%%% !7$:A_R6C1/^P-<_P#HR.NWKB-0_P"2T:)_V!KG_P!&1T =O1110 5P
M7P:_Y)CI_P#UWN?_ $?)7>UP7P:_Y)CI_P#UWN?_ $?)0!WM%%% !1110 44
M44 %%%% !1110 4444 %<9\6?^26>(/^O8?^A+79UQGQ9_Y)9X@_Z]A_Z$M
M'4Z9_P @JS_ZX)_Z"*M55TS_ )!5G_UP3_T$5:H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/^\M '4:9_R"K/\ ZX)_Z"*M55TT8TNT'_3%/_015J@ HHHH **** "BBB@
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M$'PY_P!@RV_]%+6]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5Q<?_);;G_L78O\ TH>NTKBH_P#DMUS_ -BY%_Z4R4 =K1110 4444 %%%%
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MQ.CR "3R;F2(28&!N"L QQQD\XXZ4^#1[&UOS>P1O'+Y2P;5F<1A%^ZHCSM
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M172444 <WXVTO4]<T,:9IT-NPFGB>66:8IY8CE1^ %.[.TCJ*Z2BB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KBH_^2W7/_8N1?^E,E=K7%1_\ENN?^Q<B_P#2F2@#M:**
M* "BBB@ HHHH *XJ]_Y+-I'_ &!+G_T;'7:UQ5[_ ,EFTC_L"7/_ *-CH [6
MBBB@ KBOA7_R(Z?]?UY_Z425VM<5\*_^1'3_ *_KS_THDH [6BBB@ HHHH *
M*** "BBB@ HHHH **** "N-^+'_)+/$'_7M_[,*[*N-^+'_)+/$'_7M_[,*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q4?\
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M %%%% !1110 4444 %87C;_D0O$7_8,N?_135NUA>-O^1"\1?]@RY_\ 134
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7%1_P#);KG_ +%R+_TIDKM:XJ/_ )+=<_\ 8N1?^E,E ':T444 %%%% !11
M10 5Q5[_ ,EFTC_L"7/_ *-CKM:XJ]_Y+-I'_8$N?_1L= ':T444 %<5\*_^
M1'3_ *_KS_THDKM:XKX5_P#(CI_U_7G_ *424 =K1110 4444 %%%% !1110
M 4444 %%%% !7&_%C_DEGB#_ *]O_9A795QOQ8_Y)9X@_P"O;_V84 =3I_\
MR#+7_KBG\A5FJVG_ /(,M?\ KBG\A5F@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "L+QM_P B%XB_[!ES_P"BFK=K"\;?\B%XB_[!ES_Z
M*:@!/ __ "(/AS_L&6W_ **6MZL'P/\ \B#X<_[!EM_Z*6MZ@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MBH_^2W7/_8N1?^E,E=K7%1_\ENN?^Q<B_P#2F2@#M:*** "BBB@ HHHH *XJ
M]_Y+-I'_ &!+G_T;'7:UQ5[_ ,EFTC_L"7/_ *-CH [6BBB@ KBOA7_R(Z?]
M?UY_Z425VM<5\*_^1'3_ *_KS_THDH [6BBB@ HHHH **** "BBB@ HHHH *
M*** "N-^+'_)+/$'_7M_[,*[*N-^+'_)+/$'_7M_[,* .IT__D&6O_7%/Y"K
M-5M/_P"09:_]<4_D*LT %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5A>-O^1"\1?\ 8,N?_135NUA>-O\ D0O$7_8,N?\ T4U ">!_^1!\
M.?\ 8,MO_12UO5@^!_\ D0?#G_8,MO\ T4M;U !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %<5'_R6ZY_[%R+_ -*9*[6N*C_Y+=<_]BY%_P"E,E ':T44
M4 %%%% !1110 5Q5[_R6;2/^P)<_^C8Z[6N*O?\ DLVD?]@2Y_\ 1L= ':T4
M44 %<5\*_P#D1T_Z_KS_ -*)*[6N*^%?_(CI_P!?UY_Z424 =K1110 4444
M%%%% !1110 4444 %%%% !7&_%C_ ))9X@_Z]O\ V85V5<;\6/\ DEGB#_KV
M_P#9A0!U.G_\@RU_ZXI_(59JMI__ "#+7_KBG\A5F@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "L+QM_R(7B+_L&7/_HIJW:PO&W_ "(7
MB+_L&7/_ **:@!/ _P#R(/AS_L&6W_HI:WJP? __ "(/AS_L&6W_ **6MZ@
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MKS_THDH [6BBB@ HHHH **** "BBB@ HHHH **** "N-^+'_ "2SQ!_U[?\
MLPKLJXWXL?\ )+/$'_7M_P"S"@#J=/\ ^09:_P#7%/Y"K-5M/_Y!EK_UQ3^0
MJS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6%XV_Y$+Q
M%_V#+G_T4U;M87C;_D0O$7_8,N?_ $4U ">!_P#D0?#G_8,MO_12UO5@^!_^
M1!\.?]@RV_\ 12UO4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q4?_);
MKG_L7(O_ $IDKM:XJ/\ Y+=<_P#8N1?^E,E ':T444 %%%% !1110 5Q5[_R
M6;2/^P)<_P#HV.NUKBKW_DLVD?\ 8$N?_1L= ':T444 %<5\*_\ D1T_Z_KS
M_P!*)*[6N*^%?_(CI_U_7G_I1)0!VM%%% !1110 4444 %%%% !1110 4444
M %<;\6/^26>(/^O;_P!F%=E7&_%C_DEGB#_KV_\ 9A0!U.G_ /(,M?\ KBG\
MA5FJVG_\@RU_ZXI_(59H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K"\;?\B%XB_[!ES_ .BFK=K"\;?\B%XB_P"P9<_^BFH 3P/_ ,B#
MX<_[!EM_Z*6MZL'P/_R(/AS_ +!EM_Z*6MZ@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "N*C_ .2W7/\ V+D7_I3)7:UQ4?\ R6ZY_P"Q<B_]*9* .UHH
MHH **** "BBB@ KBKW_DLVD?]@2Y_P#1L==K7%7O_)9M(_[ ES_Z-CH [6BB
MB@ KBOA7_P B.G_7]>?^E$E=K7%?"O\ Y$=/^OZ\_P#2B2@#M:*** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K"\;?\
M(A>(O^P9<_\ HIJW:PO&W_(A>(O^P9<_^BFH 3P/_P B#X<_[!EM_P"BEK>K
M!\#_ /(@^'/^P9;?^BEK>H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !6%XV_Y$+Q%_V#+G_P!%-6[6%XV_Y$+Q%_V#+G_T4U "
M>!_^1!\.?]@RV_\ 12UO5@^!_P#D0?#G_8,MO_12UO4 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#+;_ -%+6]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEM_Z*6MZL'P/_P B#X<_[!EM_P"BEK>H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KBH_^2W7/_8N1?\ I3)7:UQ4?_);KG_L7(O_ $IDH [6BBB@ HHH
MH **** "N*O?^2S:1_V!+G_T;'7:UQ5[_P EFTC_ + ES_Z-CH [6BBB@ KB
MOA7_ ,B.G_7]>?\ I1)7:UQ7PK_Y$=/^OZ\_]*)* .UHHHH **** "BBB@ H
MHHH **** "BBB@ KC?BQ_P DL\0?]>W_ +,*[*N-^+'_ "2SQ!_U[?\ LPH
MZG3_ /D&6O\ UQ3^0JS5;3_^09:_]<4_D*LT %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5A>-O^1"\1?]@RY_]%-6[6%XV_Y$+Q%_V#+G
M_P!%-0 G@?\ Y$'PY_V#+;_T4M;U8/@?_D0?#G_8,MO_ $4M;U !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %<5'_R6ZY_[%R+_P!*9*[6N*C_ .2W7/\
MV+D7_I3)0!VM%%% !1110 4444 %<5>_\EFTC_L"7/\ Z-CKM:XJ]_Y+-I'_
M &!+G_T;'0!VM%%% !7%?"O_ )$=/^OZ\_\ 2B2NUKBOA7_R(Z?]?UY_Z424
M =K1110 4444 %%%% !1110 4444 %%%% !7&_%C_DEGB#_KV_\ 9A795QOQ
M8_Y)9X@_Z]O_ &84 =3I_P#R#+7_ *XI_(59JMI__(,M?^N*?R%6: "BBB@
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M444 %%%% !7%7O\ R6;2/^P)<_\ HV.NUKBKW_DLVD?]@2Y_]&QT =K1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *XJ/_ )+=<_\ 8N1?^E,E=K7%1_\
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M?]@RY_\ 135NUA>-O^1"\1?]@RY_]%-0 G@?_D0?#G_8,MO_ $4M;U8/@?\
MY$'PY_V#+;_T4M;U !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<5'_P E
MNN?^Q<B_]*9*[6N*C_Y+=<_]BY%_Z4R4 =K1110 4444 %%%% !7%7O_ "6;
M2/\ L"7/_HV.NUKBKW_DLVD?]@2Y_P#1L= ':T444 %<5\*_^1'3_K^O/_2B
M2NUKBOA7_P B.G_7]>?^E$E ':T444 %%%% !1110 4444 %%%% !1110 5Q
MOQ8_Y)9X@_Z]O_9A795QOQ8_Y)9X@_Z]O_9A0!U.G_\ (,M?^N*?R%6:K:?_
M ,@RU_ZXI_(59H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ K"\;?\B%XB_P"P9<_^BFK=K"\;?\B%XB_[!ES_ .BFH 3P/_R(/AS_ +!E
MM_Z*6MZL'P/_ ,B#X<_[!EM_Z*6MZ@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N*C_Y+=<_]BY%_Z4R5VM<5'_R6ZY_[%R+_ -*9* .UHHHH **** "B
MBB@ KBKW_DLVD?\ 8$N?_1L==K7%7O\ R6;2/^P)<_\ HV.@#M:*** "N*^%
M?_(CI_U_7G_I1)7:UQ7PK_Y$=/\ K^O/_2B2@#M:*** "BBB@ HHHH ****
M"BBB@ HHHH *XWXL?\DL\0?]>W_LPKLJXWXL?\DL\0?]>W_LPH ZG3_^09:_
M]<4_D*LU6T__ )!EK_UQ3^0JS0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !6%XV_Y$+Q%_P!@RY_]%-6[6%XV_P"1"\1?]@RY_P#134 )
MX'_Y$'PY_P!@RV_]%+6]6#X'_P"1!\.?]@RV_P#12UO4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5Q4?_);KG_L7(O\ TIDKM:XJ/_DMUS_V+D7_ *4R
M4 =K1110 4444 %%%% !7%7O_)9M(_[ ES_Z-CKM:XJ]_P"2S:1_V!+G_P!&
MQT =K1110 5Q7PK_ .1'3_K^O/\ THDKM:XKX5_\B.G_ %_7G_I1)0!VM%%%
M !1110 4444 %%%% !1110 4444 %<;\6/\ DEGB#_KV_P#9A795QOQ8_P"2
M6>(/^O;_ -F% '4Z?_R#+7_KBG\A5FJVG_\ (,M?^N*?R%6: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *PO&W_(A>(O^P9<_^BFK=K"\
M;?\ (A>(O^P9<_\ HIJ $\#_ /(@^'/^P9;?^BEK>K!\#_\ (@^'/^P9;?\
MHI:WJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7%1_\ENN?^Q<B_\ 2F2NUKBH_P#DMUS_ -BY%_Z4R4 =K1110 4444 %%%%
M!7%7O_)9M(_[ ES_ .C8Z[6N*O?^2S:1_P!@2Y_]&QT =K1110 5Q7PK_P"1
M'3_K^O/_ $HDKM:XKX5_\B.G_7]>?^E$E ':T444 %%%% !1110 4444 %%%
M% !1110 5QOQ8_Y)9X@_Z]O_ &85V5<;\6/^26>(/^O;_P!F% '4Z?\ \@RU
M_P"N*?R%6:K:?_R#+7_KBG\A5F@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "N*C_P"2W7/_ &+D7_I3)7:UQ4?_ "6ZY_[%R+_TIDH [6BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7%1_\ );KG_L7(O_2F2NUKBH_^2W7/_8N1
M?^E,E ':T444 %%%% !1110 5Q5[_P EFTC_ + ES_Z-CKM:XJ]_Y+-I'_8$
MN?\ T;'0!VM%%% !7%?"O_D1T_Z_KS_THDKM:XKX5_\ (CI_U_7G_I1)0!VM
M%%% !1110 4444 %%%% !1110 4444 %<;\6/^26>(/^O;_V85V5<;\6/^26
M>(/^O;_V84 =3I__ "#+7_KBG\A5FJVG_P#(,M?^N*?R%6: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *PO&W_(A>(O\ L&7/_HIJW:PO
M&W_(A>(O^P9<_P#HIJ $\#_\B#X<_P"P9;?^BEK>K!\#_P#(@^'/^P9;?^BE
MK>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KBH_^2W7/_8N1?^E,E=K7
M%1_\ENN?^Q<B_P#2F2@#M:*** "BBB@ HHHH *XJ]_Y+-I'_ &!+G_T;'7:U
MQ5[_ ,EFTC_L"7/_ *-CH [6BBB@ KBOA7_R(Z?]?UY_Z425VM<5\*_^1'3_
M *_KS_THDH [6BBB@ HHHH **** "BBB@ HHHH **** "N-^+'_)+/$'_7M_
M[,*[*N-^+'_)+/$'_7M_[,* .IT__D&6O_7%/Y"K-5M/_P"09:_]<4_D*LT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A>-O^1"\1?\
M8,N?_135NUA>-O\ D0O$7_8,N?\ T4U ">!_^1!\.?\ 8,MO_12UO5@^!_\
MD0?#G_8,MO\ T4M;U !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(59JMI__ "#+7_KBG\A5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "L+QM_R(7B+_L&7/_HIJW:PO&W_ "(7B+_L&7/_ **:@!/ _P#R
M(/AS_L&6W_HI:WJP? __ "(/AS_L&6W_ **6MZ@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "N*C_Y+=<_]BY%_P"E,E=K7%1_\ENN?^Q<B_\ 2F2@#M:*
M** "BBB@ HHHH *XJ]_Y+-I'_8$N?_1L==K7%7O_ "6;2/\ L"7/_HV.@#M:
M*** "N*^%?\ R(Z?]?UY_P"E$E=K7%?"O_D1T_Z_KS_THDH [6BBB@ HHHH
M**** "BBB@ HHHH **** "N-^+'_ "2SQ!_U[?\ LPKLJXWXL?\ )+/$'_7M
M_P"S"@#J=/\ ^09:_P#7%/Y"K-5M/_Y!EK_UQ3^0JS0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !6%XV_Y$+Q%_V#+G_T4U;M87C;_D0O
M$7_8,N?_ $4U ">!_P#D0?#G_8,MO_12UO5@^!_^1!\.?]@RV_\ 12UO4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5Q4?_);KG_L7(O_ $IDKM:XJ/\
MY+=<_P#8N1?^E,E ':T444 %%%% !1110 5Q5[_R6;2/^P)<_P#HV.NUKBKW
M_DLVD?\ 8$N?_1L= ':T444 %<5\*_\ D1T_Z_KS_P!*)*[6N*^%?_(CI_U_
M7G_I1)0!VM%%% !1110 4444 %%%% !1110 4444 %<;\6/^26>(/^O;_P!F
M%=E7&_%C_DEGB#_KV_\ 9A0!U.G_ /(,M?\ KBG\A5FJVG_\@RU_ZXI_(59H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!\.?]@RV_P#12UO5@^!_^1!\.?\ 8,MO_12UO4 %%%% !1110 4444 %%%%
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M%% !1110 4444 %%%% !1110 5QOQ8_Y)9X@_P"O;_V85V5<;\6/^26>(/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KBH_\ DMUS_P!BY%_Z4R5V
MM<5'_P ENN?^Q<B_]*9* .UHHHH **** "BBB@ KBKW_ )+-I'_8$N?_ $;'
M7:UQ5[_R6;2/^P)<_P#HV.@#M:*** "N*^%?_(CI_P!?UY_Z425VM<5\*_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH *XJ/_DMUS_V+D7_I3)7:UQ4?_);KG_L7(O\ TIDH [6BBB@
MHHHH **** "N*O?^2S:1_P!@2Y_]&QUVM<5>_P#)9M(_[ ES_P"C8Z .UHHH
MH *XKX5_\B.G_7]>?^E$E=K7%?"O_D1T_P"OZ\_]*)* .UHHHH **** "BBB
M@ HHHH **** "BBB@ KC?BQ_R2SQ!_U[?^S"NRKC?BQ_R2SQ!_U[?^S"@#J=
M/_Y!EK_UQ3^0JS5;3_\ D&6O_7%/Y"K- !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %87C;_D0O$7_ &#+G_T4U;M87C;_ )$+Q%_V#+G_
M -%-0 G@?_D0?#G_ &#+;_T4M;U8/@?_ )$'PY_V#+;_ -%+6]0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K"\;?\B%XB_[!ES_Z
M*:MVL+QM_P B%XB_[!ES_P"BFH 3P/\ \B#X<_[!EM_Z*6MZL'P/_P B#X<_
M[!EM_P"BEK>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;3_^09:_]<4_D*LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5A>-O^1"\1?]@RY_]%-6[6%XV_Y$+Q%_V#+G_P!%-0 G@?\ Y$'PY_V#
M+;_T4M;U8/@?_D0?#G_8,MO_ $4M;U !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %<5'_R6ZY_[%R+_P!*9*[6N*C_ .2W7/\ V+D7_I3)0!VM%%% !111
M0 4444 %<5>_\EFTC_L"7/\ Z-CKM:XJ]_Y+-I'_ &!+G_T;'0!VM%%% !7%
M?"O_ )$=/^OZ\_\ 2B2NUKBOA7_R(Z?]?UY_Z424 =K1110 4444 %%%% !1
M110 4444 %%%% !7&_%C_DEGB#_KV_\ 9A795QOQ8_Y)9X@_Z]O_ &84 =3I
M_P#R#+7_ *XI_(59JMI__(,M?^N*?R%6: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *PO&W_(A>(O^P9<_P#HIJW:PO&W_(A>(O\ L&7/
M_HIJ $\#_P#(@^'/^P9;?^BEK>K!\#_\B#X<_P"P9;?^BEK>H **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KBH_P#DMUS_ -BY%_Z4R5VM<5'_ ,ENN?\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A>-O\ D0O$7_8,N?\
MT4U;M87C;_D0O$7_ &#+G_T4U ">!_\ D0?#G_8,MO\ T4M;U8/@?_D0?#G_
M &#+;_T4M;U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<5'_ ,ENN?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<5'_P ENN?^Q<B_]*9*[6N*C_Y+
M=<_]BY%_Z4R4 =K1110 4444 %%%% !7%7O_ "6;2/\ L"7/_HV.NUKBKW_D
MLVD?]@2Y_P#1L= ':T444 %<5\*_^1'3_K^O/_2B2NUKBOA7_P B.G_7]>?^
ME$E ':T444 %%%% !1110 4444 %%%% !1110 5QOQ8_Y)9X@_Z]O_9A795Q
MOQ8_Y)9X@_Z]O_9A0!U.G_\ (,M?^N*?R%6:K:?_ ,@RU_ZXI_(59H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#\:#/@3Q"/^H9<_\
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MA_;S*"%DN[MP#UP;B2NXK@O@U_R3'3_^N]S_ .CY* .]HHHH **** "BBB@
MHHHH **** "BBB@ KD/BFXC^%_B%F!(-HPX]R!_6NOKC/BS_ ,DL\0?]>P_]
M"6@#JM..=,M#_P!,4_\ 015FJNF?\@JS_P"N"?\ H(JU0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !6%XV_Y$+Q%_V#+G_P!%-6[6%XV_
MY$+Q%_V#+G_T4U ">!_^1!\.?]@RV_\ 12UO5@^!_P#D0?#G_8,MO_12UO4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MB+3_ )+9J?\ V H/_1TE=O7$6G_);-3_ .P%!_Z.DH [>BBB@ HHHH ****
M"N(U#_DM&B?]@:Y_]&1UV]<1J'_):-$_[ US_P"C(Z .WHHHH *X+X-?\DQT
M_P#Z[W/_ */DKO:X+X-?\DQT_P#Z[W/_ */DH [VBBB@ HHHH **** "BBB@
M HHHH **** "N,^+/_)+/$'_ %[#_P!"6NSKC/BS_P DL\0?]>P_]"6@#J=,
M_P"059_]<$_]!%6JJZ9_R"K/_K@G_H(JU0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !6%XV_Y$+Q%_P!@RY_]%-6[6%XV_P"1"\1?]@RY
M_P#134 )X'_Y$'PY_P!@RV_]%+6]6#X'_P"1!\.?]@RV_P#12UO4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5Q%I_P ELU/_ + 4'_HZ2NWKB+3_ )+9
MJ?\ V H/_1TE ';T444 %%%% !1110 5Q&H?\EHT3_L#7/\ Z,CKMZXC4/\
MDM&B?]@:Y_\ 1D= ';T444 %<%\&O^28Z?\ ]=[G_P!'R5WM<%\&O^28Z?\
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M#_\ (@^'/^P9;?\ HI:WJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L+QM_R(7B+_L&7/\
MZ*:MVL+QM_R(7B+_ +!ES_Z*:@!/ _\ R(/AS_L&6W_HI:WJP? __(@^'/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7$6G_);-3_[ 4'_ *.DKMZXBT_Y+9J?_8"@_P#1TE '
M;T444 %%%% !1110 5Q&H?\ ):-$_P"P-<_^C(Z[>N(U#_DM&B?]@:Y_]&1T
M =O1110 5P7P:_Y)CI__ %WN?_1\E=[7!?!K_DF.G_\ 7>Y_]'R4 =[1110
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M^BEK>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KB+3_DMFI_]@*#_P!'
M25V]<1:?\ELU/_L!0?\ HZ2@#MZ*** "BBB@ HHHH *XC4/^2T:)_P!@:Y_]
M&1UV]<1J'_):-$_[ US_ .C(Z .WHHHH *X+X-?\DQT__KO<_P#H^2N]K@O@
MU_R3'3_^N]S_ .CY* .]HHHH **** "BBB@ HHHH **** "BBB@ KC/BS_R2
MSQ!_U[#_ -"6NSKC/BS_ ,DL\0?]>P_]"6@#J=,_Y!5G_P!<$_\ 015JJNF?
M\@JS_P"N"?\ H(JU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_ &+_P")H I_\+'\%_\ 0T:3_P"!2_XT?\+'\%_]#1I/_@4O^-7/^$,\+?\
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MH I_\+'\%_\ 0T:3_P"!2_XT?\+'\%_]#1I/_@4O^-7/^$,\+?\ 0M:/_P"
M,7_Q-'_"&>%O^A:T?_P!B_\ B: *?_"Q_!?_ $-&D_\ @4O^-'_"Q_!?_0T:
M3_X%+_C5S_A#/"W_ $+6C_\ @#%_\31_PAGA;_H6M'_\ 8O_ (F@"G_PL?P7
M_P!#1I/_ (%+_C1_PL?P7_T-&D_^!2_XU<_X0SPM_P!"UH__ ( Q?_$T?\(9
MX6_Z%K1__ &+_P")H I_\+'\%_\ 0T:3_P"!2_XT?\+'\%_]#1I/_@4O^-7/
M^$,\+?\ 0M:/_P" ,7_Q-'_"&>%O^A:T?_P!B_\ B: *?_"Q_!?_ $-&D_\
M@4O^-'_"Q_!?_0T:3_X%+_C5S_A#/"W_ $+6C_\ @#%_\31_PAGA;_H6M'_\
M 8O_ (F@"G_PL?P7_P!#1I/_ (%+_C7,6_BWPQ'\3+W7&\3:/]AETJ*U1OMB
M9\Q9&8C&?0CFNS_X0SPM_P!"UH__ ( Q?_$T?\(9X6_Z%K1__ &+_P")H I_
M\+'\%_\ 0T:3_P"!2_XT?\+'\%_]#1I/_@4O^-7/^$,\+?\ 0M:/_P" ,7_Q
M-'_"&>%O^A:T?_P!B_\ B: *?_"Q_!?_ $-&D_\ @4O^-'_"Q_!?_0T:3_X%
M+_C5S_A#/"W_ $+6C_\ @#%_\31_PAGA;_H6M'_\ 8O_ (F@"G_PL?P7_P!#
M1I/_ (%+_C1_PL?P7_T-&D_^!2_XU<_X0SPM_P!"UH__ ( Q?_$T?\(9X6_Z
M%K1__ &+_P")H I_\+'\%_\ 0T:3_P"!2_XUS%WXM\,3?$G3-;3Q-H_V*WTZ
M>WD;[8F0[.A QGT!KL_^$,\+?]"UH_\ X Q?_$T?\(9X6_Z%K1__  !B_P#B
M: *?_"Q_!?\ T-&D_P#@4O\ C1_PL?P7_P!#1I/_ (%+_C5S_A#/"W_0M:/_
M . ,7_Q-'_"&>%O^A:T?_P  8O\ XF@"G_PL?P7_ -#1I/\ X%+_ (URGPX\
M5>&?#?@FTTO4O$NCI=12SLRI>(PPTKL.0?0BNW_X0SPM_P!"UH__ ( Q?_$T
M?\(9X6_Z%K1__ &+_P")H I_\+'\%_\ 0T:3_P"!2_XT?\+'\%_]#1I/_@4O
M^-7/^$,\+?\ 0M:/_P" ,7_Q-'_"&>%O^A:T?_P!B_\ B: *?_"Q_!?_ $-&
MD_\ @4O^-'_"Q_!?_0T:3_X%+_C5S_A#/"W_ $+6C_\ @#%_\31_PAGA;_H6
MM'_\ 8O_ (F@"G_PL?P7_P!#1I/_ (%+_C1_PL?P7_T-&D_^!2_XU<_X0SPM
M_P!"UH__ ( Q?_$T?\(9X6_Z%K1__ &+_P")H I_\+'\%_\ 0T:3_P"!2_XT
M?\+'\%_]#1I/_@4O^-7/^$,\+?\ 0M:/_P" ,7_Q-'_"&>%O^A:T?_P!B_\
MB: *?_"Q_!?_ $-&D_\ @4O^-'_"Q_!?_0T:3_X%+_C5S_A#/"W_ $+6C_\
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MN0),6<7!+;1CY><L"O&>1CK5E/#O@J2P%\FA:&UJPR)191$'G']WKGC'7/%
M#?\ A8_@O_H:-)_\"E_QH_X6/X+_ .AHTG_P*7_&I4\,>#9;R:S30=#:XA57
MEB%E$60-G:2-O&=K?E50Z7X 62YC;2O#X:V!,H-G%\N#M/\ #S@D XZ$@=:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA>.2V99')54=9.=N[:/,!P<G@8YZ#P_J\>N:);WZ&,LX*2B-MRK(I*N >X#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>modificationno10effectiv003.jpg
<TEXT>
begin 644 modificationno10effectiv003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH X/7WU#1->T^[;4M2<76I1K)*1BR@MV;;Y
M3*"?F/ #X^\1D@<5T>NZU/ILVGV5C:)=:AJ$K1PQR2^7&H52S,S $@ #L"22
M*I3^#8KBZ<2ZI?MILEV+U]/)0QF4,'^\5W[-P#;<XS[<5HZUH::Q]DE6ZGL[
MRSE,MO<P;2R$J5(PP((()!!'ZB@#C-6U[6-;U+1])2#[#(FKO::C'#J#QEBM
MNTJA9%3<4*E6['("D<DCK/$EE<7,$<R7>HK;6X9I;73CLFN&. N'R" .3C(S
MQD\8,-GX/M+2XM+IKNZGNX;V2_DGD*[IY7B,1W    *0  !C:/QN:OHKZE<V
MMW;:E=:?=VP=4E@VL&5L;E97!4CY01QD$?7(!5\$ZA<:GX/T^YO+@SW15DF9
MAA@RL5*N,##C&&XZ@UT%9^BZ/;Z'IB6-LTLBAWD>65LO+([%G=CQR6)/  YK
M0H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI 03P0:
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M-(CDGN-]RLN8%((.7^1>6SBM+1].&E:5#:;_ #)%W/++C'F2,2SOCMEB3^-
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MB%I+Y&X*+F,?NV.>[*2HI^@D:#\9_%%MJ#",ZY%;W%A(YP)A&I5T![L">G7
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MDL9M2M([MV"K \RAR3R %SG)KSVYUO2[KQG\.'@U"VE58;D,R2 A2UNH4$]
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M1(P WU'>HO[)T[R_+_L^UV9SM\E<9]<8K#M?'6FS^ T\62PSPVQ4@V[+F3S
MYC\L#N2XVC^E6[/Q#(=<CT;5+-+*]GMS<VX2;S4D52 Z[MJ_,N1D8Q@Y!/.
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MW,C ]?D14+,V!UZ*OU84 6;JTMKZ P7=O%<0GDQRH'4_@:(;.UMPXAMH8P^
M^Q -V!@9QUP !]*Y<>,;ZW\2:=INI^'I[*UU-VCL[HW"R$N%+;9$'W"0#W/\
M\:'B/Q+_ ,(]/I,;6$TZZC?160E5U"QM(< G)ST!/ _$4 :D&F6%J(Q;V-M"
M(BQC\N)5V;NN,#C.!FG?8+,WOVW[)!]KV[?/\L>9CTW8SBDU"]BTW3;F^FSY
M5O$TK =2%&<#WKF-7\6ZWIT$DMKX5GU!+2)6OI(KI$"-M#,L8/,FT'V].N0
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ML"12<.BQ@*WU'>FP:;8VMLUM;V5M#;M]Z*.)54_4 8JU10!3.E:<8Q&;"UV
MDA?)7 /KC'M5L *H50  , #M2T4 %%%% !1110 4444 %%%% !1110 4444
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MW,UQ<J2GVQXVVK&QSD[1DL,\E1FK_@6SBL/&OCFVA+^6EY;%0[EB 8%.,GG
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M^SM@W'VOR/-;R?.Z^9LSMW9YZ=>>O-:$%A!;QW"1AQ]HD:21MYW%FXSGJ.
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M"0WJSVXECN"@PCX#+M<#(R#C':EM?"TFDVUC%I&HFW:W>62=IX?-%TTIW.7
M*\[N>",=.G%=)10!P]S\-;.31X[>TOYK'48;^34H+ZV0+Y4SGY@J=-F.-N>@
MY)K3A\-ZJEA^^\1SSZJ98Y#>M;HJ[4)P@B7 "G+9YR=QYZ8Z6B@#$T7P]'I6
MJ:IJCR1R7NIM&9VAB\I/D4A<+DG/))))SFH=2\,-<>);;Q%IUZ++4XH#:R%X
MO-CGA)W;77<IR#R""/QKH:* .6N/!B3>&M8TI+TI/K#2/>W9B!9RXVG:N0
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M"Y6-"[$ 9X4<D^PY-<KX"\UT\0W4EK=6\=UK$L\(NH'A=D,<8#;7 .,@]NU
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU.N$^&?^N\9_]C-=_P DH F_X0G7?^B@:Y_WZ@_^(H_X0G7?^B@:Y_WZ@_\
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M25_)8 $E\+\J\CYCQ[T_4?&5M8^*M*T58+B47T,DYGCMWD78H&-NT'/+#)'
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M!_\ $5U]G=PW]C;WEL^^"XC66-L$95AD'!Z<&IJ .*_X0G7?^B@:Y_WZ@_\
MB*/^$)UW_HH&N?\ ?J#_ .(KM:* .*_X0G7?^B@:Y_WZ@_\ B*/^$)UW_HH&
MN?\ ?J#_ .(KM:* .*_X0G7?^B@:Y_WZ@_\ B*/^$)UW_HH&N?\ ?J#_ .(K
MM:* .*_X0G7?^B@:Y_WZ@_\ B*/^$)UW_HH&N?\ ?J#_ .(KM:* .*_X0G7?
M^B@:Y_WZ@_\ B*/^$)UW_HH&N?\ ?J#_ .(KM:* .*_X0G7?^B@:Y_WZ@_\
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MB@:Y_P!^H/\ XBNUHH XK_A"==_Z*!KG_?J#_P"(H_X0G7?^B@:Y_P!^H/\
MXBNUHH XK_A"==_Z*!KG_?J#_P"(H_X0G7?^B@:Y_P!^H/\ XBNUHH XK_A"
M==_Z*!KG_?J#_P"(H_X0G7?^B@:Y_P!^H/\ XBNUHH \VM8=;T#XH:)I=SXF
MU#5+2]L[F1X[D(H#)MQ]U1ZUZ37":W_R6;PK_P!@^\_]DKNZ "BBB@ HHHH
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M9<7?A/4[33PUG(JEX6C9W/D2J058@@';G.6XSBMC_A+?&'_1.KW_ ,&=M_\
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M6WE^8)F8KNQC.WG&>E<58+>:?X:T'57T_4)[/3=7OC?6UNLB3)%,S[90HPQ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW*DABJD@D>@K<KDOA_\ \@[6O^P[?_\ H]JZV@ HHHH **** "BBB@ HHHH
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M?\)_X._Z&K1?_ Z/_&K/_"'^&/\ H7-(_P# &+_XFC_A#_#'_0N:1_X Q?\
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M  G_ (._Z&K1?_ Z/_&C_A/_  =_T-6B_P#@='_C5G_A#_#'_0N:1_X Q?\
MQ-'_  A_AC_H7-(_\ 8O_B: *W_"?^#O^AJT7_P.C_QH_P"$_P#!W_0U:+_X
M'1_XU9_X0_PQ_P!"YI'_ ( Q?_$T?\(?X8_Z%S2/_ &+_P")H K?\)_X._Z&
MK1?_  .C_P :/^$_\'?]#5HO_@='_C5G_A#_  Q_T+FD?^ ,7_Q-'_"'^&/^
MA<TC_P  8O\ XF@"M_PG_@[_ *&K1?\ P.C_ ,:/^$_\'?\ 0U:+_P"!T?\
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MS_P604?\(9XS_P"BDWG_ (+(*[VB@#@O^$,\9_\ 12;S_P %D%'_  AGC/\
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MAGC/_HI-Y_X+(*[VB@#@O^$,\9_]%)O/_!9!1_PAGC/_ **3>?\ @L@KO:*
M."_X0SQG_P!%)O/_  604?\ "&>,_P#HI-Y_X+(*[VB@#@O^$,\9_P#12;S_
M ,%D%'_"&>,_^BDWG_@L@KO:* ."_P"$,\9_]%)O/_!9!1_PAGC/_HI-Y_X+
M(*[VB@#@O^$,\9_]%)O/_!9!1_PAGC/_ **3>?\ @L@KO:Y+XCY;PK''O=5E
MU&RB?8Y4E6N(PPR.>02* ,__ (0SQG_T4F\_\%D%'_"&>,_^BDWG_@L@K/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^W]&_P"@O8?^!*?XT?V_HW_07L/_  )3_&L3_A6/@C_H6--_[]4?\*Q\$?\
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M@C_H6--_[]4?\*Q\$?\ 0L:;_P!^J (KG3_#5TM]$_B,BUOT5+JV^WQLDJA
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MC>'_  B_AR]T%]?#6%[.T\Z&]CW,[-O;YL9 +8-7_P#A6/@C_H6--_[]4?\
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M$L4>& /45O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%9NL:;/JENMO'J5S80G)EDM2%E;T <@[1ZX&>G(YR
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M=I_=N"O*').#@''6@#K**YJ[\>^'[.XU&W>YN'GT[;]JBAM)9&C!!.["J3M
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M?M<47E%@F1\W*'IG./I7LE% '-Z#X@T_Q->B]L-,N%VP%);JZM&A9.0?*!8
MMSDG&0,>]<[X9T>^T_Q5=>&GC!T/29SJ5F^>TP;RXL>B-YQ_!*[S4K:>\TVY
MMK:\DLYY8RL=S&H9HB>C '@U6T/1VTBT=9[V:^O)G\RXNY@JM*V HX4
M >GJ22 3ZM$\^C7T,2EI)+>154=R5( KR:*6Z@\#^!]272]4GMM#Q#J5M'#+
M%,N83&S*.&;8>N..3SUQ[+10!YM<0^&-8T'4[V+2-3CL;Z2V2:_"3)<NZO\
M+(H8%\1G:=V,=>H!K+U&V\07G@+QKI,EP^N016\8T_4%@Q+<C!9D./OE,#D=
M23WR!Z[10!YWXAOX]1U+P-=V\-T84U RNSVSJ43RF7<P(RHW$#)Q^7-06[@:
MM\2W:*4)<I'Y),38FQ;!#LX^;YN.,\UZ710!Y ;J+2- ^&^IRI>17=A:&%_]
M#DE5!Y"K(DB*-P;(7!QQ@DYZ'JOA_=Z+<'67T_47NKZ[O&O;M'MI+<H7 50J
M. =H"XSSDY^@U=:\.W=_K%OJVFZU/IUY#"UN1Y2S1/&S!B"C=#D#D$=*O:9I
M<MG(]S>7TE]>N@1IG14"J#G:JJ, 9.>Y/KP, ',>,Y?[.\;>#]9GBG-A;/=Q
M3RQ0M)Y;21 )D*"<$@CI7(ZDT]QX7^)D8T^_62]NMULCVK@R@QQ@;>.3P>.H
M[@5[/10!Y]J4JS>/? LT*RF**UNUDD$3;8R\<80,<87)!&#Z5QTES<6_P3U;
MP?>V-^/$%JLD3PK:R/Y^9MXD5@""#GKGK]1GW*B@#R_4-0BT3QU=ZCK%CJ[:
M1JUG;_9KFVBGS#)&&!CD1,,"=V1D>OOAUU;6EAKW@%++2)=/L;>XNY3;B%C]
MG1XW"%^#L+$@X/0D^E>G44 (P#*5/0C!KS7P),/A_8W'A37(YK>*VN9'L+TQ
M,T-Q"[;A\X!"N"3E3CMC->ET4 <UK^IK>>$=;>."80-92QPLT;!YG*,,*F-V
M.@![]N,$X?@WQ1I^C?#S1[>\BU!;FUL8TE@73YR^Y5P5 V=<UZ#10!YQXAN)
M)/B7X#NIK>5/L\5V;LI&S);M)"H4,P&!DY%=!;M:7_B_7K.>+S8)K.WA99(S
MLDP9MZY(PV PR/>NGHH \U\+^'=7\+>/8=)+/<^'(;.YDTV9LEH-[Q;H&/MM
MROL3Z<=[JNJ6VC:=)?W8F,$>-_DPM*PR0,[5!..>>*NT4 <'IVC:=<_$*U\0
MZ!:_9K3[#+%?2I 84N69D,8P0-Q&')... :P;;3KS2?A9JG@5+:5]4WW%E:(
M$.)HI9"5E#8QL"N<GL5(/->M44 >>Z;HX\%^-A=3;SI=UH\%I]H"$A)H/E"M
MCIN0Y'J01UQG#7PIJ4>D1^(S:3?:1XH;7&M-A\T6S-LV[>N\)AMO7MUXKUZB
M@#B8+1M=^)\.O0!CING::UNDQ4@2S2/DA<]0JCD^IQU!INF2 _%_6Y-D@BDT
MVWB20QL$9U9RRAL8) (KN** &NZQHSN<*HR2>PKQV+3M1U;X2Z_8Z=;S&_&J
MS7:6LD;1M-&+D2  ,!G<HX]>E>R44 <!JLL7B[7O"5WI:S 6%TUY=2O$R&WC
M\L@QOD<,Q(&WKP3T%6/AN<1>)5:*6-I->NYU$D3)OC9@5<9 R".]=O10!Q'Q
M&CNX%T/6(;.ZO;73;XRWEO:%O-\IHWC+J%()*[LX'J>V:;IFJ:!%::GX@T[1
MKXQ31I&\\\$OFWC#("!7^8@=-QX&>N <=S10!YMX,MYO!'B6X\-W,/F6=^@N
M[2Z@B=HX&.=UL6YPH.2F>Q/<U3LXK&YTCQU!JEI?/9W6N!_W,;K(8V,*B:/
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M"-HW&YXPP 7*MGIZG'2J&HV%]<>%=&\1Z%:R2ZUHE]+(MNR,CS0R2L'C((R
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MNKI=T$)F4/*/51G+#Z5/'?V<M]+91W4+W<*AY(%<%T4]"1U ->76_A[5M/\
MA'X=U$02#7O#X^VP1/\ ?,66+0GN,Q';CU %=UX4)OK"779(W2357%PBN,,D
M. (E/I\@#$=B[4 1>/-1O=*\'7EYIUP;>Z62!$E"*Q7?,B'A@1T8]16%XQ\1
M:UX0LK..W:[OW59/,NIXX LQ*N1]TJ08]H<X3&P')[UJ?$O_ )$.]_Z[VO\
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M!>PU#4;V&.&&2=2-XW%S-(54#/4_RYZ<T ;FAZMX@TSQI=^'=?OH-1MQI_\
M:$%^D A9%#[&1U!(]P1Z?E0_X3/4QX'7QVTG_$O,^\Z?Y:X%H9?+W;L;O,Q\
M_7;VQWJWH>M>'?$%W?Q6^LVE[K6J0,DHM6\P6\*J0J ]E7<>3C+,3QD <NZ2
MR_ F/PFJJ-=+KI7V//SB43#)Q_=V#?GIMYH [@:U>:[XOU+1-,O/LD&EVT4D
M]PD:NSRR@LB_,"-H49/<Y'(QSDP?$"YU'0M#BMXXH=:U/4'TZ48W+ T1/G.
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M/]H7Z0+%(8U(\Z1@I!7&,*2V<<X4\UT5YJVGZ);Q_P!IZE%$0F2\S*I8#JQ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&U[#_84VF'S4O+>\NWEC>)EP&N)"IR1@Y!!X- %/PQX2UW1]$U*RN-4O1+_
M\2V[BX.$.X%T)S@&+$A(P,C'&'_#_P *ZOH$MR-1GF$3I&PB_<M&V4 $>0H<
M>5MVCD*1@@#FN^J"]O8-/LY;NY<I#$,NP0L0/H 2: .9^' QX6F Z?VG??\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"RS>:Y+J.@()Q@=AV[5HT4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-5?E/;@D4 >WK+&[NB2*SIPR@Y*_7TI!/"9S")4,H&3'N&X#UQ7!P:;9:/\
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M/3[>[@C<.D<T88*PZ$>E0-X5\/LERAT6P*W043CR%Q(% "AN.0 !@=.*UZ*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5R7BC_D<O!/_ %_W'_I++76USWB71-0U.^T:_P!,N;6&YTRX>8"YC9T?
M=$T9'RD'^+- $NI>%K+4]4349IKE+F+R_(:-P!"5?<Q48_C^ZV<Y4 <4:SX5
ML=;N$FN)KF-XH]L/DN%\I]RL)%X^^-@&>>,C')SM1[_+7S"I? W;1QGOBG4
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M(9HH60AX_-< *0X;Y0%!)VGOS797.N06EW:Z9:VTMU?30&=+>(J"D2X&YBQ
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' 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>modificationno13effectiv001.jpg
<TEXT>
begin 644 modificationno13effectiv001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M]U@NGC$\"C"K)@_-CW_'-:UUX8TV\\)CPU-'(=-%LEKM#D-L4 #YO7@5L44
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ML/"6E;M<8I*S:W$L5Z3(?G58S&,>GRGM6[10!SJ^"=%5U<0RY72?[''[T_\
M'MZ?7CKUJZ?#NG-X6'AQHF;31:"SV%SGRPNW&>N<=ZU:* .,F^&6A3VUI$UQ
MJJR6]N;0W"7SK+- 6)\J1@?F3G '8<5T3Z%IK^'7T$6RIIC6QM?(0D 1E=N
M>O3O6C10!S.G>!-'TUD=&O)Y$TYM,$EQ<,[>0SEMN3Z$X'H !52[^&?AZZMK
M*!?MUL+2T^PA[6[>-I;?KY<A!^9?KZUV-% $5M;Q6EK#;6Z!(84$<:#HJ@8
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M AN4(C20Y,6UE*L@/3()'K47_"F_!O\ SZ7O_@?-_P#%4?\ "F_!O_/I>_\
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MA<RSVVI'4VF>5-TTQ7;\P"@;<=@!4/\ PIOP;_SZ7O\ X'S?_%4?\*;\&_\
M/I>_^!\W_P 50!+8_#S0;#4;69-3O9+&SN6N[33)+A3;03$D[E&,\$D@$D D
MU9@\#Z'!9Z?;)?7!2QU0ZK$3*F3*2QP?E^[\QXZ^]4?^%-^#?^?2]_\  ^;_
M .*H_P"%-^#?^?2]_P# ^;_XJ@"6V^'NC0:Y:ZE)K.HW26<[7%K:W%RKI"[9
MZ-MWD#)P"QKJM-CCT_3H;1]2DO&C&#/<R*9'YZL0 /TKD/\ A3?@W_GTO?\
MP/F_^*H_X4WX-_Y]+W_P/F_^*H [G[3!_P ]H_\ OH4?:8/^>T?_ 'T*X;_A
M3?@W_GTO?_ ^;_XJC_A3?@W_ )]+W_P/F_\ BJ .Y^TP?\]H_P#OH4?:(/\
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M #Z7O_@?-_\ %4?\*;\&_P#/I>_^!\W_ ,50!W/VF#_GM'_WT*/M,'_/:/\
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MO2IV\'^"KJ/1TT;1-0O[O5+=KI(FU.6)88EQN,C%CC#,%P 3GZ4 >Q?:8/\
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MAI<4D5NTADVR3-(<D =6)/8<5KT %%%% !1110 4444 %%%% !1110 4444
M5=2U"WTK2[K4+IMMO:PM-(WHJC)_E7!>#_B9<^(_#&OWUYIB6>HZ7!]I%KN.
M'B:+S(VYYYP?PQZUM?$30M5\3^&ET33'2*.\N8TO96?:4MP<MM]3P./K7)_\
M*QUC1==N9])U.XU&TU#2)["Z;4)EWH=F(MN%&0" /89H S[?XY7$GP_O-<DT
MJ!=3AOH[:.T#MM973>&]>BO^0JZ_Q5UJ>^TZUL[/0X6N=)@U%WU"],"@R=44
MGKBN?C^#&NC4()F-MY']B^5+$)N&O%MWA3C'09!W?6M$?#KQ%9ZEI=T?#VAZ
MU'!HEO820ZA*"J2I]YERI^F?>@#9UGXK77AFX\,)K%G8-#J@=KN>SN#)'"H<
M*&1L?,,$$_C1J?Q3U&WBUC[%IMI-+9ZU%I<&^5@L@<'#$CIR!TI\W@2_U[5/
M#SZMH^G66G6UE>6EW9V<F4C$@(39P/8^QKF+'X3^*-(\-7NGP-:75PNMV][;
M-)-M$L408#=QP3QQ0!U4_P 1-?T2?5+#Q%H=I;7\.ERZC9M;W!DBG$8Y0\9!
M_P ^E83?'*X7X>KKW]E0?VF=0-H;/>VT((_,W^N,8K4U+P;XL\57&IZKK<6F
MVET-'GT^PM+69G!>0'+.Y'3MQ_\ KYB3X,:ZVH7$P-MY!T58HHO.X%Y]G6%N
M,=.&.[Z4 ='/\4=;EUD6%E::#"!86UVSZC?& $RQABJYZX)JUJ?Q4G\/>(?#
M>G:S:6(M]4MUEN;JVG+QPEF*J5;HR?=.?<UCR?#_ ,06NO\ V[_A&M!UJ%M-
MM+79J,@(C>*,*Q4%3U(K7N?A_>>(M9L)-9TRQL]._L.33YK:TDRL#^9E/+&!
MP %(]"* )#X_\27NE>(+_2='TZ6+1=0NK:?S[AE)BA4,&&!RQYX]A70^!==\
M0>(])35-8T^QM+6YACFM/LTS.S!@2=P(X_A_,US/@CP!K?AWX>>*-!OI(9;S
M4'N?(D63(DWQ!%9B>F2*[?PAI=SHO@[1]+O HN;2TCAEV'(W*H!P: .0_P"$
MW\6Z[/JUSX3T33I]*TV=[8R7L[++<N@RWEA>![9_Q H/\6M0U.?1$T'3]-5=
M2T]KQCJ5T81&RR-&R;NAY4X]:FM_#WCOPE<:S8>&8-)O-,U&ZDNK>:ZE9'M6
MDZA@!\P'&,>GX57T?X0I9:OH$.J6]GJ>E:?I,EO-YPSFX:5I,A3V&XX- '=V
MVM:A!X+FUG4[6V>[@MY;AH+";S4<+N*A&QSD ?B:X[P3\2M9\2:K9K=V6D-I
MUW!),TEA=^9+9;1D"=3R,].G6N]GTHP>'9=+T1X]-98&CM7CC!6!L?*=I&"
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M0JQ'#1DO_"OH!6?:Z%\4;+2-/T2WO-'@M-+"B.[MV;S;I(U(2,JPPN?E!/\
M/N :5K\31<?%"3PO]B4:<9)+6*_W'Y[E$5G3TXSCZXJD?&?C_P#X2[_A&O[
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MQ?#Z[TJX:?1[^WVHT\4-O>Q/-&;:;:SQ.=VXGS%+!L_Q$$&N^HH \VB^&=Q
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MYW_A.O"__0:MO^^C_A1_PG7A?_H-6W_?1_PH Z*BN=_X3KPO_P!!JV_[Z/\
MA1_PG7A?_H-6W_?1_P * .BHKG?^$Z\+_P#0:MO^^C_A1_PG7A?_ *#5M_WT
M?\* .BHKG?\ A.O"_P#T&K;_ +Z/^%'_  G7A?\ Z#5M_P!]'_"@#HJ*YW_A
M.O"__0:MO^^C_A1_PG7A?_H-6W_?1_PH Z*BN;/C[PHKJAUVT#-G"E^33O\
MA.O"_P#T&K;_ +Z/^% '145SO_"=>%_^@U;?]]'_  H_X3KPO_T&K;_OH_X4
M =%17._\)UX7_P"@U;?]]'_"C_A.O"__ $&K;_OH_P"% '145SO_  G7A?\
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M^C_A1_PG7A?_ *#5M_WT?\* .BHKG?\ A.O"_P#T&K;_ +Z/^%'_  G7A?\
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MTK;L8ZKYTH7V8T 06OC&:[\0W6GFZT*U$-\+58)R_G2#"G(P<9.[ ^E5]/\
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MT+=F!_O*3R/=3T-;]IX/N=-N;F73?$%Y:QW+1O)$((7!9(DBSEE)Y6,4R_\
MA]I.HZ;'9SR3EH=3?4XI@0'21Y3(RCC[IW$8],=Q0!!:ZQK*>(=4L]132([+
M3(([FXEC63<8W$AXR<9'E\Y]:R-&^(EQ//JBZOI4%JEKIZWL(C8EG/E1R-&<
M_P 0$R >O-=9J/A2UU)]::2XG0:M;16TX0CA$W\#C^(.P-4M1\ :9J>J&^FG
MN%9K^&],:$!3Y<:Q^6>/N'8I(]J ,C0?%6M^*XH8],L]+M;F*RCN;PW(=U#R
M,X6-0I!Z1L2Q)ZC@U)IGBC6?$5VD&DV.F0,NGQW,JW9=L2&66-D!7L#"><=^
ME:-MX$738H/[(UJ^T^=+<6TLL:1OYT89F7<K*0&!=L$>O.:(O B6-Q')I.M7
M^G 626;^4L3LZJ[ON+.C88M(Q)'K0!S\OQ(E;3KF[BT^T@$5I93?OV)5'FN&
MA<,1U5=I((ZUI)XPD@DTIIWTJ]MKV>='FL=Q"+% TIQD\ME?R-7$^'>F1%EA
MN+B.'R;.()D$_P"CS&4$D]2S'FMK5-!@U;4]*O9I&']GR22+& ")-\;1D'VP
MQH Q] O_ !#J:Z9J-S8:9_9>H0^=MA+"6U5EW1[B3A\\ X P3W K,TWQG>ZV
M-36QM-/B>%#=V33,S"XM0SIN(7D-E <>CKZU>7X?D6D5BWB/5FL;6)XK* &,
M>0&0QCY@N7*JQ"[B<>]7AX%T.WN;*?3K6/3GMHI(#]EB5/.C=-I5SC+8(5A[
MK]: ,*+QE?6=AH-]JUI8?9]4M9KQOLP;,4:6_G8Y/)[5,/$>MV%KI=_JMEIA
MM-44B*.WW[[=S$TJ!B>'!"$$@+@^HK8;P;8O#H$$DLDD&CVSVRHP'[Y&A\H[
MOP]*KP>!U'V6&\UJ_O;.R1ELK:81@0DH8PQ95!=E5B 6/?N>: ,GPYX^.MC0
M;>;38K74+V?RKNW8Y\M3;O/'(GJK!!C\1U%;7C37;GPSIMG=6.EKJ$L]XD!M
MU.&92K,VWU;"\#O2Q>!=+BU3PYJ2O,+O0K?[-%)D?OH_*,8#\<XW$C&,$GUK
M7U328=5DT]Y9'0V5VMTFS'S,JL,'V^8T <C)X[BN4NCI5O:W(DELH-/=B0LC
MW ZOW 7!) YX(ZULZ3J&H?\ "07.B:Q#9-<);)=PSVBLJ.A8J058D@@CU((/
M;%5T^'FCPMJYMY+BW_M*ZBO 8F ^S3(=P>/CCYLG!R.2,8XJU9^&+JVO7U&7
M7;JXU&0Q(]Q)#&!Y",6,2J% 4-DY/7GKP* -_P E/[B_E1Y*?W%_*I** (_)
M3^XOY4>2G]Q?RJ2B@"/R4_N+^5'DI_<7\JDHH C\E/[B_E1Y*?W%_*I** (_
M)3^XOY4>2G]Q?RJ2B@#DM4B4?$70% 7!M;K*X&#]RH+/Q/>-XYC\/WVG64'G
MQS2Q(DQ:9$1@%9QC;\XR0 21WJWJO_)1_#__ %Z77_LE._X0]_[36^_MW49#
M;M/+91SE)%MI)592P)7<P 8X5B0!QZ4 -\9:\?#5IILD0L(_MEZ+5IKURD40
M,<C[B1_N ?C6)>^-I;2'2B+SPVRWTDZF[^T-]G3RPI W==QW&NHUG0)M7M=+
M']IRV]WI]PMRERD2$NXC>,Y4C&"')I(/#\_]HZ??W^JRWES9&;RV,21@B15!
M!"CMMS^- ',WOC*XM=7MM.:Z\.0F6PBNQ<7$[K',9'=0(SW&%!_&GCQC.WB2
M^TI[GP]:-:W:6PBNIV6:7*(VY1[ER!]*Z^/2(H_$4^LB1S+-:1VICXVA4=V!
M^OSG\JS$\,WUKJFH7=AKT]M%?7(N98/LT;C=L1#@L,XP@H S[76=?U8S7VDZ
M;ITNFQWSVBQ2.RS.J2&-Y<_= #!CMZD#KDXJE/XGUZRM?$]S=6.DLFA1L7$3
M29E;R%E7&1P/F /T-:S^"F-S.D.N7\&E3W?VR2PB" &0N'8"3&X(S#)4'N>0
M#5J^\)V]]8^);8W,J?VZ,2M@'ROW*Q?+Z\*#S0!B2^-S;Z7KK3:=%_:>GRQ1
MV]LK<7'GA?((/^TS%3Z;34>E>,9]1UV6PEN?#UNT6H269MGG;[0P1RN57U.,
MBMB[\#6%YXGTK79)YA+81+&81C9.4W>6S>ZEF(]_I4EAX9OM,O9Y+37ITM)[
MV2[>V-M&1EW+LNXC..2* (M2U'5O^$I_L;2;7325L1=L]V7&<N5VC:/:L:]^
M((M]'TJ]CTN-I9O-EOXC)G[-!"_ES.#CYL-TZ9&:Z/4_#=Q>:Z-6LM9N-/G-
MJ+5_*BC?*!BV1O4X.35&R^''AZW+?;+./4U\A8(_MT:RF-069B"1]YG=F8CJ
M3["@!L>IZY)XQ_LA;?2#:F 78F#2%C"9-N.F-V.?2J'@_P 8R>)9K/S+GP^I
MG1G:SAG9KE, \;3QD8Y]JW]$\+1:+<6DXO+BX>VT]=/4RXRT:MN!.._0?A47
MA_PS?>'X;2TCUZ>>PME*+;/;1C*\X!8#/!.?PH Z#R4_N+^5'DI_<7\JDHH
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MSB0*ZL-Q! /8X'?F@#+7Q)J-U_9MC8W6C7%[J-U)&MREM*(84CCWME"^6;D
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MY!!_04 2>'=0N;^34['4H;;[=IMR()9+=2L<H:-9%8*22ORN,C)P0>36/?\
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M,$YH ["BN<NY9M8U;3; 75Q:V[V;WDWV>38SG**J[AR -S$XQT7MD4[2UO\
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M@%<'CK@XK1UKP_X/TR;3(;7P=87TNHLXA"K'&,*F\DEN.E 'H'GP_P#/5/\
MOH4>?#_SU3_OH5Y?;Q> #:6UY?\ A.QL+*5[B"2XF2,I#-"S!D8C(.0K%6!P
M<8ZD9Z'2?!/A+4]*M[V7PA96C3KO$,L*[U4]-WH<8..V<4 =?Y\/_/5/^^A1
MY\/_ #U3_OH5SO\ PKOP=_T+>G?]^!1_PKOP=_T+>G?]^!0!T7GP_P#/5/\
MOH4>?#_SU3_OH5SO_"N_!W_0MZ=_WX%'_"N_!W_0MZ=_WX% '1>?#_SU3_OH
M4>?#_P ]4_[Z%<[_ ,*[\'?]"WIW_?@4?\*[\'?]"WIW_?@4 =%Y\/\ SU3_
M +Z%'GP_\]4_[Z%<[_PKOP=_T+>G?]^!1_PKOP=_T+>G?]^!0!T7GP_\]4_[
MZ%'GP_\ /5/^^A7._P#"N_!W_0MZ=_WX%'_"N_!W_0MZ=_WX% '1>?#_ ,]4
M_P"^A1Y\/_/5/^^A7._\*[\'?]"WIW_?@4?\*[\'?]"WIW_?@4 =%Y\/_/5/
M^^A1Y\/_ #U3_OH5SO\ PKOP=_T+>G?]^!1_PKOP=_T+>G?]^!0!T7GP_P#/
M5/\ OH4>?#_SU3_OH5SO_"N_!W_0MZ=_WX%'_"N_!W_0MZ=_WX% '1>?#_SU
M3_OH4>?#_P ]4_[Z%<[_ ,*[\'?]"WIW_?@4?\*[\'?]"WIW_?@4 =%Y\/\
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MHK1)$ZIE@HR$."0<9Z&KWB?PFVLMHQ@BTZ6/3F<_9]0A,L3@IL&1ZCK7544
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M77@2YD\->%M-*Z;>MHP EBO4)AF_<M'TP>A;(R.U=[10!PW_  @%MJ%SI_\
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MT'3TKFH];U_4-:M[*U2RL4N-.COB+RW=Y8,G!C9 Z[CGOE<8Q@YJ*[\67UE
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M=KR=I2\?/R\G ')X&.M%CX=M;&ZCN%NM1F:+/E)<7LDB)D8Z$X/'=LFM>B@
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M"P@M9/ML[0$SR,NPB-Y > <\1D?B* + TA'TB73KN[NKQ90V^:9P).3G@H%
MQVP!C I-,T:+399YS<W-W=3!5>XN6#/M7.U1@  #<W0=SG-5=/\ $*/9:G-J
M1MK?^S9S#/)#*9(S\BOD' .?G QC.01S5FQUZQU"Z-K']HBN-AD6*YMI(&=
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MJ/)E4*%:,JH(("(.2?NCU.8H/"D*:HFHW6IZC?3B"2V87+QE)(GP2A14"@9
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M\(EF!;Y?W8*K@=N#_*H[#0X-.UC4M2CNKR234"A>*:<O''M&!L7^'.>:U**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#E?^:K_P#<%/\ Z.%=57*_\U7_ .X*
M?_1PKJJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BDSC.<#THS0 M%)FC- "T4F:,T +129HS0 M%)F
MC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +12
M9HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T
M4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0
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M(17\A\>ZOLT]MEV?M$'[@XSAOW7%32Z/'!J-OITOC?64O+E6>&!IX \@7[Q
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M^%KA1D^+=> Z<RP?_&JXK08O'<Z"'49=8A@EN$>9VVB41I#(SJIRV-TAC7(
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M (12Y_Z&S7_^_L'_ ,:H_P"$4N?^ALU__O[!_P#&JZ6B@#FO^$4N?^ALU_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCP2W+@"252R&0#^]M(W?CFO.M.U2ZE\1^'K31=5\6RZA)-'->0:ME(&M>DK
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M/DYVR$CYC_>S[U[=K5P5\.ZG-;RD/':RE71L%6"GOV(- &/_ &[XK_Z%$?\
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M1'_@>G^%=510!RO]N^*_^A1'_@>G^%']N^*_^A1'_@>G^%=510!RO]N^*_\
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M+QYD?RX;CG^E>A44 >3>)?!TVFS:"(]8OIM2U+Q%'/<ZCL0.K""1054+M
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M:U=*W3\1_.N:\$?\@J__ .PI=_\ HUJ .FHHHH **** "BBB@ HHHH ****
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M:YVY"CEB=V .,=2>Q -[_A/]._Z!7B#_ ,%$_P#\31_PG^G?] KQ!_X*)_\
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MNUM[JVL)Y-.-]<W MC)N)E:-452P 'R$DY/;I0!M_P#"?Z=_T"O$'_@HG_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** .5_YJO_ -P4_P#HX5U5<K_S5?\ [@I_]'"NJH 1NGXC
M^=<UX(_Y!5__ -A2[_\ 1K5TK=/Q'\ZYKP1_R"K_ /["EW_Z-:@#IJ*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** .5_P":K_\ <%/_ *.%=57*_P#-
M5_\ N"G_ -'"NJH 1NP]:YGP0W_$IOR589U.[[?]-FKIF^[^(KS+3K'0X-.U
M#4]8U:]LA+JUQ$!'?21JS&8JH5%/)Z=![T >F[AZ'\J-P]#^5<'<V7A:TUE=
M)FUK6EO"Z1E1>7)17?[BLX^56;L"03QZU7TT>$=6O+6UM-7\0&2[W?9S+->1
M)-M!+;'<!6P 3P>U 'HFX>A_*C</0_E7&:OH6@Z':)<WVI:ZL<DJPH(KRXE9
MG;HH5,DD_2JL%IX6N-/O[X:SK<4.GJ6NUN+NYADA&W=ED?#<CIQSVH [W</0
M_E1N'H?RKSJX;PE;6]E<-JGB22"^1'MI8'O95DWYVKE01N.#\I^;VI67PNMR
M]L+SQ7)-&J-(D27\ACWJ&4-M4[3@C@X([T >B;AZ'\J-P]#^5>=R?\(C#=RV
M\NK>(4\F?[-+,TMX(4DR!M:7&P<D=3WK6U+PWH>D637E]JFL10*RKG^T)V)9
MB%50 2222  .>: .NW#T/Y4;AZ'\J\ZM3X1O-573H=6U_P QYG@CE:XNEAED
M3.Y%E/R,1M;H>QIEE/X.U%3);:OXB:$1--YS/>K%L52Q;>0%Q@'OSVH ](W#
MT/Y4;AZ'\JX'1[3PSKT_DZ?J/B1V\OS TLEY$A7CD,X /4=Z@U,^#]'-T+W6
M=>46DACN&CGNY%B8(K_,5! ^5U.>G/L: /1=P]#^5&X>A_*O-&N_!JLBG5?$
M_F.I<1@7Q?;G&2NW(&>Y'-7;6V\)WFI2:=%KFL"\BM!>R12WMQ&4A.,,V[&.
MHX/(SR* .^W#T/Y4;AZ'\JXG2=)\-:YHB:SI^M:M+ISAB)VU"=%PI(8G<00
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M%<M_PL;PK_T$V_\  6;_ .(H_P"%C>%?^@FW_@+-_P#$4 =317+?\+&\*_\
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M?_$4?\+&\*_]!-O_  %F_P#B* .IHKEO^%C>%?\ H)M_X"S?_$4?\+&\*_\
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MZCJ:W2D#/" .VW''IGCTK-E\-ZM<^#]1L9+?%WK&KM-=*95(CMVG /.>?W*
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M2L*>^W#N?0A*7Q1J&H1R6^G64-[%%<*3<7]M;M*T*C VH #\YSP3P!D\G H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]O\ P714?V)XF_Z&]O\ P714 =+17-?V)XF_Z&]O_!=%1_8GB;_H;V_\%T5
M'2T5S7]B>)O^AO;_ ,%T5']B>)O^AO;_ ,%T5 '2T5S7]B>)O^AO;_P714?V
M)XF_Z&]O_!=%0!TM%<U_8GB;_H;V_P#!=%1_8GB;_H;V_P#!=%0!TM%<U_8G
MB;_H;V_\%T5']B>)O^AO;_P714 =+17-?V)XF_Z&]O\ P714?V)XF_Z&]O\
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MX;MQ.&!.T-C- 'L%%>>ZW?:YH>JZ=ILOB2_N;F_BN)($MM+@8GR5#,.2.2"
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M:_L3Q-_T-[?^"Z*C^Q/$W_0WM_X+HJ .EHKFO[$\3?\ 0WM_X+HJ/[$\3?\
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M_P#$4 =-17,_\(QJO_0X:O\ ]^X/_B*/^$8U7_H<-7_[]P?_ !% '345S/\
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M ._<'_Q% &%%X)US2;/PO>:3<:>^K:/IYL)H[K?Y$R$+DAE&X$%<CCG-2_\
M"%:T/ NN:4-0M5U;7+N2XNYD#"*(2E1(J<$GY%P,]2>U;'_",:K_ -#AJ_\
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MFLIX<U"REN].NKJ\N+2ZE:9G"2O&SO+O(7.&+\8[>E=W_P (QJO_ $.&K_\
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M40;<$)!9F;<#\W'%;'_",:K_ -#AJ_\ W[@_^(H_X1C5?^APU?\ []P?_$4
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MW_PC&J_]#AJ__?N#_P"(H_X1C5?^APU?_OW!_P#$4 =-17,_\(QJO_0X:O\
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M+=>N16OI_C/4[F$0V.E_VA<(+F>9KBZ2#$:7,D052$VEODX!VC &6SR=C_A
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MC[<Q@!&*YVLR@##$$C YXJSI_A_2]+>U>SM1$UK:_9(3O8[8L@[>3SRHY/-
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MI_\ 9VF&SM/[0L;:[DN),3*9E61H_+*= K@%MP.>@[UH^-O'[^$;KR8]-CO
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M"&TM1!;+*J?:)[B9HEWL8R5 (/0\;<\YP.@M/!/AZQYM[!E?SHY_--Q(TF]
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M6)14C*8 ;)RR=\=*U=!\7ZGKWBK31]DCM='O+*[G@ E$CS>7+&BLPVC8<$G
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M7@FN(I(G>&XD3:CL&8* V$RR@_+CG/J:Z(#  H **** "BBB@ HHHH ****
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ME;2-8HE+O@HIRJL,_. 22 V<9-6'\*Z'+<R7#Z;$99+Q+]FYYG085^O4#\*
M. L?BAJ5MI5M%+IS:GJ!BN;J8J)!F-;F2-$011,-V$QEMHX&3S5^]^(.H'4[
M2YBL?L^BPWUU;SL9-T\QAMI)&4QE?E&Y>"&S\OH:Z6;P%X9N+.&UETQ6AA\S
M:/-<$AW+NK$-EE+$G:<CVI\W@KP_)J)U%=/2.\PVV1"0%+(8RVS.PDJ<<CGC
M/2@#F)?B9?6<,@OM"ACN'6R:U2&[>97%SYF-^V+<-HB;.U6SV]:UO^$VNE\$
MRZZVC.+J.Z6U%H[O&)&:98@RLZ!MIW \H#VQ5;PY\,=/T>VOX=0G&HK=I A
MC,001%BA7YB0WSGD$8P, "NCA\,:-;Z.-*BL56R$RS^7O;)D#B0,6SDG< <D
M\XYH Y2'XD7G]M26,^@L8[>Y^R7+VS32E) FYF!\H(4!..7#=]M.NOB'J5CI
MEA>7.@PJ-4,/V )=M+D2*[_O%2,NI55S\JL#NP#P:Z>7PGH<VM+J\FGHUZL@
ME#[FV^8!@.4SM+ <;L9]Z@/@?PV8)(?[)B".5.59@R;<[0C Y0#)P%(')]:
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MW$;JJ'I\V\,&'3C/I63J'Q'N=/6[O6T1'TN*ZNK..87>)7F@CD<Y39A5)B<
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MH=F& 6/<GG+,2>I)YS6./ 6C2K)%>P_:85GFEMDW-&8$E(:2/*D;D+Y;!XY
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M+56AD1L*RPK8B8JN%))SN;DYR ,X/"67Q1U&\MX)%\-MF\^SFU+231QYFD5
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M<F[103@2E#&6QG'W21CI[4K^'-)ET./1I+-6T^/'EQ,['9@Y&ULY&.V#QVH
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M,)=HS$S%.F2IY_\ UU'#\.M#@CF57U!F<0A)7O':2#R2QC\MB<KMWL/IU[Y
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MD"KGH"R(3W.!S0!RL_CO6(K?5FL[Y+Z"T>TB:\.DRPM#+).J-'Y1.Z0[&W
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MFVMY<V5Q/&7ELI#+ VXC:Q1D)Z\_*S#GUK*N_!6B7=Z]X8;B"Y><W!DM;N6
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M7AJS8M;:-:Q$R"3Y%QAAG&/0#<W XYI]YX0\/:A:V=M=Z1;30V<8A@1USL0
M#;[KP.#QQ0!B>+?%6H:'=Z/>01*=/:TN[J[@<X=A'#O"CY3@]>XK0\-^(-2U
M'4[G3=6LK6"XCM(+Q&M9FD0I*7&TY (8%#['-;5WI.GWXMQ=6<,HMSF(,OW.
M,''L0<8Z$5%I.@:3H22II=A!:B4@OY:X+8Z9/H,G [4 <)J'C3Q)<66B7=I9
MV-K'J=Y"+9&NB9&4OM*R+MR!@@DKG'3K3=1^)VI6>G!TTNVDO(4O'N8D:60
M6\K1DC:AVJ=I.Y\ =.:[9?"F@)>?:TTBT2X\X3^8L8#;P<@Y'OS[GFH;SP5X
M;OP!=Z/:S8:1OF7J9&+OGU!8DX/&30!SD7Q$OGF6ZDTJ!=+-\]EN6<M,66W:
M?<%VXQA=O7.:IO\ $O5;6W5KK1[9I;JWLI[-+:627BY9E <!-Q*[3]T'/ '6
MNX3PWI$4211V,:+'.;E-N?EE*&/</?:2*YWP[\,=(T2*^BN674([R*.%XY($
M1-L99E.%'WLMU]AC&* +%MXRN3X)U/7+W3UMKBQ:5/*F+Q+(5QM/SJ&4'(X*
MYSQS6+8?$36]1U-=(BT:V74&N&BW3O+"BJ(!*&*LF\=Q@@=C7:P^'-&M]&ET
M>+3;==/EW>9;A/E<GJ3ZD^O6H=/\(Z!I5PD]CI<$$R,6#H#G)7:23GDXXYH
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M"?A\?9/^)/9M]CC6* O$&V(OW1SU ZC/2J\'@3PO;+(L.B6J"1 C84YVA@P
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M D@HA1< Y^8C)R!6WX<\5ZOK_BK3'EBAMM*O-.N[B"&.0L[;)HD4R948(!/
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M,:HP954;N K*"!V(!H J3^/M:ATB#4&?14;4,+:66)7N$;S50J4!_>$ \_<
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MFBN6_LOQE_T,UC_X+O\ [.C^R_&7_0S6/_@N_P#LZ .IHKEO[+\9?]#-8_\
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MVMHEB@A01QQH,!5 P /;% $M%%% !1110 4444 %%%% !1110 4444 %%%%
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M^-'_  G"_P#0M>)?_!<W^- '545RO_"<+_T+7B7_ ,%S?XT?\)PO_0M>)?\
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M"UXE_P#!<W^-'_"<+_T+7B7_ ,%S?XT =517*_\ "<+_ -"UXE_\%S?XT?\
M"<+_ -"UXE_\%S?XT =517*_\)PO_0M>)?\ P7-_C1_PG"_]"UXE_P#!<W^-
M '545RO_  G"_P#0M>)?_!<W^-'_  G"_P#0M>)?_!<W^- '545RO_"<+_T+
M7B7_ ,%S?XT?\)PO_0M>)?\ P7-_C0!U5%<K_P )PO\ T+7B7_P7-_C1_P )
MPO\ T+7B7_P7-_C0!U5%<K_PG"_]"UXE_P#!<W^-'_"<+_T+7B7_ ,%S?XT
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MPA5;@?O/WNX[]I5,# Z<>X!V-I\3O"%]'+)#JC[([9[LF2SFC#1(,LR[D&[
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ME_9QI)/$H/[L-G;D],\=.O3UK$U[PS)>^-/#FM6=M K6DTQN[C #E3"R)[L
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M  DNA?\ 0;TW_P "D_QH U**R_\ A)="_P"@WIO_ (%)_C1_PDNA?]!O3?\
MP*3_ !H U**R_P#A)="_Z#>F_P#@4G^-'_"2Z%_T&]-_\"D_QH U**R_^$ET
M+_H-Z;_X%)_C1_PDNA?]!O3?_ I/\: -2BLO_A)="_Z#>F_^!2?XT?\ "2Z%
M_P!!O3?_  *3_&@#4HK+_P"$ET+_ *#>F_\ @4G^-'_"2Z%_T&]-_P# I/\
M&@#4HK+_ .$ET+_H-Z;_ .!2?XT?\)+H7_0;TW_P*3_&@#4HK+_X270O^@WI
MO_@4G^-'_"2Z%_T&]-_\"D_QH U**R_^$ET+_H-Z;_X%)_C1_P )+H7_ $&]
M-_\  I/\: -2BLO_ (270O\ H-Z;_P"!2?XT?\)+H7_0;TW_ ,"D_P : -2B
MLO\ X270O^@WIO\ X%)_C1_PDNA?]!O3?_ I/\: -2BLO_A)="_Z#>F_^!2?
MXT?\)+H7_0;TW_P*3_&@#4HK+_X270O^@WIO_@4G^-'_  DNA?\ 0;TW_P "
MD_QH U**R_\ A)="_P"@WIO_ (%)_C1_PDNA?]!O3?\ P*3_ !H U**R_P#A
M)="_Z#>F_P#@4G^-'_"2Z%_T&]-_\"D_QH U**R_^$ET+_H-Z;_X%)_C1_PD
MNA?]!O3?_ I/\: -2BLO_A)="_Z#>F_^!2?XT?\ "2Z%_P!!O3?_  *3_&@#
M4HK+_P"$ET+_ *#>F_\ @4G^-'_"2Z%_T&]-_P# I/\ &@#4HK+_ .$ET+_H
M-Z;_ .!2?XT?\)+H7_0;TW_P*3_&@#4HK+_X270O^@WIO_@4G^-'_"2Z%_T&
M]-_\"D_QH U**R_^$ET+_H-Z;_X%)_C1_P )+H7_ $&]-_\  I/\: -2BLO_
M (270O\ H-Z;_P"!2?XT?\)+H7_0;TW_ ,"D_P : -2BLO\ X270O^@WIO\
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M<1O\R#V/(]ZV-$_Y &G<8_T6/K_NB@"'_A%] _Z >F?^ B?X4?\ "+Z!_P!
M/3/_  $3_"L#Q7XY_P"$=\0V%BHM3;A5FU%Y9-KQ1/((T*#/)R68_P"RAKL)
MQ,UO(+=T28H?+:12RAL<$@$$C/;(^M &=_PB^@?] /3/_ 1/\*/^$7T#_H!Z
M9_X")_A7(OXL\1V&D:YJ=]+I,D.F7JV>R&TE4N=\0+Y,AXQ(>,=0.>U+K?Q'
M^SW=PFCB"XBA@MY"TT4BG=)<I$1SCC:Q/U_*@#K?^$7T#_H!Z9_X")_A1_PB
M^@?] /3/_ 1/\*Y<>+M7C\7G3KN2RLXFU#[-#:W5G+&T\/:2.XW>6S'J$Q[=
M:U+[5=<O_$E]I&ARV%L=/M8III;R!Y?->3?L10KKM "'+9/4<<4 :G_"+Z!_
MT ],_P# 1/\ "C_A%] _Z >F?^ B?X5AIXV^PZW<Z;KB16DD5A:W 6)'E_>R
M>9YB[E!! *+@X'4_AC/\3IH;3PW<31V*K=V4-[JFYRIACE947RP3S\Q9CG/R
MH: .U_X1?0/^@'IG_@(G^%'_  B^@?\ 0#TS_P !$_PKB]2^)-[I=QXG@N;*
M!!8B8:7.<[)Y(HED:-^?O88$8QD ^E:6J^)]4.J:O#:7^D:79:2L22W&HQ-(
M)9I$#JO#H%7#*,\G)Z<4 =%_PB^@?] /3/\ P$3_  H_X1?0/^@'IG_@(G^%
M<8?'M_/J36ZZAH]G&MG;3AC:37:R-(I+;7C=1M!'!QSFNFUW5M1@U+2-'TQ[
M5+W4/,<W%Q$SQQQQJ"Q"!@2264 ;AU/I0!=_X1?0/^@'IG_@(G^%'_"+Z!_T
M ],_\!$_PKCK_P <:MIUPFF7=QI5M=Q:DUE<7LD$C0%/L_GHX0.""00I&XX.
M>M&F>--?UF2PMK)]+_TN\N(8K]K2;R9XHXE<.B%PW4LOWB,J<4 =C_PB^@?]
M /3/_ 1/\*/^$7T#_H!Z9_X")_A7&7GCO5[2]BTRXDTRUNH[V>UN;EK:6:)M
MD4<J,B*X8964 @DX(-/U'QS>V-QI\,FM:);PS64MT][/8S!&*R!0JIY@9>#W
M)Z>] '8?\(OH'_0#TS_P$3_"C_A%] _Z >F?^ B?X5S\OB_4X?AB/$LEG"E[
M\N(W1UC<&81APIPP#*0P!YY'6J[>+M7B\7MIUU)964)OUMH;6ZLY4-Q"<?O(
M[C=Y;,3DA,=L=: .H_X1?0/^@'IG_@(G^%'_  B^@?\ 0#TS_P !$_PK$U_Q
M/JUAK&K:=IMA'=RVVCI?0($9G>5I'3& >0 H.!R>>:RHO&>LRZ+JDMG-9ZG<
M6LEN T.GSQRP([8D:2U9BYVJ"PP?FY]#0!V'_"+Z!_T ],_\!$_PH_X1?0/^
M@'IG_@(G^%<SHWC.\O+S3+9KK3KY+K4I+1IX(9(6"+;/*-T3DM&^Y<8).1SQ
MFH-:\=:C8^()]-C>PM8DU VHN)[>2;"BU2;)5&!)+,1],4 =;_PB^@?] /3/
M_ 1/\*/^$7T#_H!Z9_X")_A7.Q:_K]_J6F:?I]]I#M<V=Q=/<O83!3Y<B(%5
M#*"/O\DD]*DG\7WT'P_U36G@M4U'3I)K>53N,)DCE,98<@[3C.,Y'3- &]_P
MB^@?] /3/_ 1/\*/^$7T#_H!Z9_X")_A7'Q^/-26]:!)]*U.#S[*/[;91.L2
M^=/Y;(<NP+!?F&#]15KQ9XTO]#UJ:P@-C#$HLO\ 2+F-W">=),K$A6&0!&N.
MG4T =-_PB^@?] /3/_ 1/\*/^$7T#_H!Z9_X")_A7&1>.=<N=*U.>Q2TU".U
MNH(EU&RL)VBV,3YI\K<6<QXYVM_$/0UH:%XQO+^_TRT>YTZ]CNKJYA:XMHWC
M.V.(.,QL28WR2"ISP >] '1_\(OH'_0#TS_P$3_"C_A%] _Z >F?^ B?X5RF
MM>/;ZPM=0BM8+%M1357LK2.=RB,B0K*S,<]<$@=.2M.E^(PC\0Z7MMXW\/7N
MGP7,EZ"=UN\SLJ%^<;,J%/'!/)Q0!U/_  B^@?\ 0#TS_P !$_PH_P"$7T#_
M * >F?\ @(G^%<E%XH\3WMGX<NK:71XDUB=K?9):2N8F5)7W9$HR/W6,8[]:
MV_%^I:[HFAKJ&GS:<6B,:3I<6SL'9W1,KB0;0-Q.#GZT :7_  B^@?\ 0#TS
M_P !$_PH_P"$7T#_ * >F?\ @(G^%8O]I>);S6YM$L[O2HKFQM8Y[NYDLY&2
M1Y&<(B)YH*@!"22QY(P*T_"VOR^(-)BNIK*2WDVXD/!C9PS(P0YR0"AZ@<$4
M 3_\(OH'_0#TS_P$3_"C_A%] _Z >F?^ B?X5S.K^+=<,-_=:-:0&PMKY;$W
M+V\D[+MW>?*8T(+(K ( .<[CT%.L_'<MOIEHU];C5KJ\,[VK:*@*30Q!<R$.
M_P A^;!!)Y&/:@#I/^$7T#_H!Z9_X")_A1_PB^@?] /3/_ 1/\*YJ'XL>'+C
M5+*RB,[+="']\?+58VE0.BLI;>>",E5(&>3UI\GQ#2:Q@GMM)U.W6\FA2RGN
M;4&.Z5VZIAP1E58@-@X(."* .B_X1?0/^@'IG_@(G^%'_"+Z!_T ],_\!$_P
MKD_#GQ)-_:37.K64ML9C'+I]ND.'FAED:.+'SG<QP">% SZ<UK^*_'NF>$+F
MW@OH+B4S+O)B,8"KNV_QNI8Y[*">.E &K_PB^@?] /3/_ 1/\*/^$7T#_H!Z
M9_X")_A6==^.=+M()I3%=2^7>3V06-%R[Q1-(Y&6'R@(PR<<C\:YS1?B==7>
MI6D&I:+<6\-Q':(S(@_<W$[/M#$ORI0(1@$\DD#H #M/^$7T#_H!Z9_X")_A
M1_PB^@?] /3/_ 1/\*P$^)ND&VN+N6QU*"T2TDO;>>2)0MW"C*I:,!L\EUP&
M"YW"LNY^)]TNJ);6^@W[!KQ;=H98566-%B\V1C^\P3L92!QCG/.!0!V?_"+Z
M!_T ],_\!$_PH_X1?0/^@'IG_@(G^%85SX^MIGLQI,;3K)/8K/(Z?(J7) 50
M0?OA2K8P1@CUKI]16_:S8:;-;0W.00]S"TB8[_*K*?UH J_\(OH'_0#TS_P$
M3_"C_A%] _Z >F?^ B?X5R6G^-]4ATCPSJNM/IXMM:D^86UM*# OD22 ??8L
M=RJ,XZ9X[B"]^(]R^HO#8S6,-H=2-FEU<6LTF$%JLV2@96)W$KVXQ]: .T_X
M1?0/^@'IG_@(G^%'_"+Z!_T ],_\!$_PK.D\2OI_@:\\07,L%^;:&24&V@>!
M9-N<+M<L1R,9_&J&J:MXM\.Z#J.J7YTF[B@T][E3!"\7E3+C"$%R74@GYAM/
MR].: .@_X1?0/^@'IG_@(G^%'_"+Z!_T ],_\!$_PK!N?B'IT6L".&57L(=-
MNKZYD:)T=3$8]H&X '(=O7D#\<5?B-K3^&HYXM.L;G7(]1BM9[."4LC)(AD7
M8V?O%?EYR-RMQ0!W'_"+Z!_T ],_\!$_PH_X1?0/^@'IG_@(G^%<I)\17NK:
M_FTB&WN SV,%AYFY09;ABO[W'0*>H'/!'6H=3\::KHD6I0R:OH%_<VQMUS#$
MZM 7G6)Q)")&8@!P00PYXQ0!V/\ PB^@?] /3/\ P$3_  H_X1?0/^@'IG_@
M(G^%<M<^*]9CT(WEI=6=\?M<<,L]KI-P1:Q$,6<Q;RTG11\I&,Y-;.@Z]>:G
MX5N]022SU*Z@,RQ&S#1K,5&5!1B6C8\ J2<?C0!H?\(OH'_0#TS_ ,!$_P *
M/^$7T#_H!Z9_X")_A7#0>/\ 5XM#U:ZGN-.GO+/3?M9M7LIK26"4$ JT;L2Z
M<_?!'(]ZT7\2ZY)HFJ7]CJ^BW+V%NUPR?V5<1@A58XRTO4XZ]J .H_X1?0/^
M@'IG_@(G^%'_  B^@?\ 0#TS_P !$_PK+NM:U?2_A[?Z[>-8SWL-D]W$L,+Q
MQ\1[@K NQ/.<D$?A68/%VIC21+%>Z9?75U=P65KLLIH$CDD/+/N<E@!DX&.F
M,\\ '3_\(OH'_0#TS_P$3_"C_A%] _Z >F?^ B?X5RFM^+=<\-PZG:WTFFSW
M=O#;7$%TMNZ1>7+.(6WQ[R<KUX;GVQ5/_A-]?N+779]-O=%OH-)LVNGNX[&=
M8F=58F#F3[V%4Y!. >10!V__  B^@?\ 0#TS_P !$_PH_P"$7T#_ * >F?\
M@(G^%8+^++S1K_1+?7I[)H]1M[B=I;:UD7:4\G8H7<Y_Y:-D^PZ=T/C2XE\!
M^(?$-M' [Z?)=BV#(P5UB)VE@2#SCGI^% &__P (OH'_ $ ],_\  1/\*/\
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M&,\'.>U5+KXE(;'37T_R9;F>RGN+A'AD4(T=NTH )QQN&.IX_.@#KO\ A%]
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ML@<+#()$10J!57<,G R<GGIBS>^$M.O;K5I]\\!U:R:SO$A8!9 05$A!!^<
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MYI;A8[*WDMXBC#)5X3$2>.NTY^OY5OT4 8VCZ%<:045M=U&]@CB$207*P!5
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MUJ]110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#:7C/_ *%S3?\ P9G_ .-T?VEXS_Z%S3?_  9G_P"-T =117+_ -I>,_\
MH7--_P#!F?\ XW1_:7C/_H7--_\ !F?_ (W0!U%%<O\ VEXS_P"A<TW_ ,&9
M_P#C=']I>,_^A<TW_P &9_\ C= '445R_P#:7C/_ *%S3?\ P9G_ .-T?VEX
MS_Z%S3?_  9G_P"-T =117+_ -I>,_\ H7--_P#!F?\ XW1_:7C/_H7--_\
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M-_\ !F?_ (W0!U%%<O\ VEXS_P"A<TW_ ,&9_P#C=']I>,_^A<TW_P &9_\
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M_P"A<TW_ ,&9_P#C=']I>,_^A<TW_P &9_\ C= '445R_P#:7C/_ *%S3?\
MP9G_ .-T?VEXS_Z%S3?_  9G_P"-T =117+_ -I>,_\ H7--_P#!F?\ XW1_
M:7C/_H7--_\ !F?_ (W0!U%%<O\ VEXS_P"A<TW_ ,&9_P#C=']I>,_^A<TW
M_P &9_\ C= '445R_P#:7C/_ *%S3?\ P9G_ .-T?VEXS_Z%S3?_  9G_P"-
MT =117+_ -I>,_\ H7--_P#!F?\ XW1_:7C/_H7--_\ !F?_ (W0!U%%<O\
MVEXS_P"A<TW_ ,&9_P#C=']I>,_^A<TW_P &9_\ C= '445R_P#:7C/_ *%S
M3?\ P9G_ .-T?VEXS_Z%S3?_  9G_P"-T =117+_ -I>,_\ H7--_P#!F?\
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M_P#:7C/_ *%S3?\ P9G_ .-T?VEXS_Z%S3?_  9G_P"-T =117+_ -I>,_\
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MBU&*P>W? ;]Y+Y22#U0G//\ LD=J=_PFU[$VL_:O#TT*:1 TUTWVJ-L8B,@
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M;((5A@_2K?B;3/"5]K&KR^)O$=K!-/"EI!%_:)M_(C"!L,H<!R6??\P(P5H
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M7A3SY#O(8$8P0>1CFO2** .3\.:7J-AXN\0RWUS<7B306@BNIHD3?M$N5&T
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MS_\ !5_]MH_LCQ7_ -#19_\ @J_^VT =)D>HHR/45S?]D>*_^AHL_P#P5?\
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M^AHL_P#P5?\ VVC^R/%?_0T6?_@J_P#MM '29'J*,CU%<W_9'BO_ *&BS_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN%NK:6;]Q T?E,C1C )8[A^\] >/?B7_ (1323IMY8/'<R1WJA;J1[N5I95
MQAI-V_&,C&<8)XY-6/["LCJ%G?$W1N+.(PPLUW*1M.,[ANPY.!DL"3@>@H Y
MF3Q!K\.KQ)<^7;6\E^L*!K!Y(9(6EVKB='(#LI!&Y0-QV^]=Q6#;^#]'M9(C
M$MWY,4@ECMFO9FA5PVX'RRVWAN1Q@'GK6]0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME4M8SL!*DA)&).!N."<4 >C?VUXE_P"A3/\ X,(_\*/[:\2_]"F?_!A'_A7
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M\I<D8R 3TJE8VGBG1M*EDB;6HEN;&&ZOMB,S127%V6E,2 ?ZQ(MV<#(W>PH
M]*_MKQ+_ -"F?_!A'_A4,7B77+@@0^&XI"02 FJ1'(!P3QZ'CZUQJ'Q%-;&&
M.Y\1QZ3')>WT4C^8+J6WCBC6.(LPW@O(TA4'YL >V,:&/5_#'FZ]/+JDFI6$
M>E6IM6+*MRLFTRHF1AB7=ACJ"&)ZT >G?\)!X@,Y@'AA?."AS'_:46X*3@'&
M.F0>?:G_ -M>)?\ H4S_ .#"/_"L;PQ:7Z^,5;4+QKN^M-+*ZA*#E4GGE$@B
M7T"JIP/0J>]=[0!S?]M>)?\ H4S_ .#"/_"C^VO$O_0IG_P81_X5TE% '-_V
MUXE_Z%,_^#"/_"C^VO$O_0IG_P &$?\ A7244 <W_;7B7_H4S_X,(_\ "C^V
MO$O_ $*9_P#!A'_A7244 <W_ &UXE_Z%,_\ @PC_ ,*/[:\2_P#0IG_P81_X
M5TE% '-_VUXE_P"A3/\ X,(_\*/[:\2_]"F?_!A'_A7244 <W_;7B7_H4S_X
M,(_\*/[:\2_]"F?_  81_P"%=)10!S?]M>)?^A3/_@PC_P */[:\2_\ 0IG_
M ,&$?^%=)10!S?\ ;7B7_H4S_P"#"/\ PH_MKQ+_ -"F?_!A'_A7244 <W_;
M7B7_ *%,_P#@PC_PH_MKQ+_T*9_\&$?^%=)10!S?]M>)?^A3/_@PC_PH_MKQ
M+_T*9_\ !A'_ (5TE% '-_VUXE_Z%,_^#"/_  H_MKQ+_P!"F?\ P81_X5TE
M% '-_P!M>)?^A3/_ (,(_P#"C^VO$O\ T*9_\&$?^%=)10!S?]M>)?\ H4S_
M .#"/_"C^VO$O_0IG_P81_X5TE% '-_VUXE_Z%,_^#"/_"C^VO$O_0IG_P &
M$?\ A7244 <W_;7B7_H4S_X,(_\ "C^VO$O_ $*9_P#!A'_A7244 <W_ &UX
ME_Z%,_\ @PC_ ,*/[:\2_P#0IG_P81_X5TE% '-_VUXE_P"A3/\ X,(_\*/[
M:\2_]"F?_!A'_A7244 <W_;7B7_H4S_X,(_\*/[:\2_]"F?_  81_P"%=)10
M!S?]M>)?^A3/_@PC_P */[:\2_\ 0IG_ ,&$?^%=)10!S?\ ;7B7_H4S_P"#
M"/\ PH_MKQ+_ -"F?_!A'_A7244 <W_;7B7_ *%,_P#@PC_PH_MKQ+_T*9_\
M&$?^%=)10!S?]M>)?^A3/_@PC_PH_MKQ+_T*9_\ !A'_ (5TE% '-_VUXE_Z
M%,_^#"/_  H_MKQ+_P!"F?\ P81_X5TE% '-_P!M>)?^A3/_ (,(_P#"C^VO
M$O\ T*9_\&$?^%=)10!S?]M>)?\ H4S_ .#"/_"C^VO$O_0IG_P81_X5TE%
M'-_VUXE_Z%,_^#"/_"C^VO$O_0IG_P &$?\ A7244 <W_;7B7_H4S_X,(_\
M"C^VO$O_ $*9_P#!A'_A7244 <W_ &UXE_Z%,_\ @PC_ ,*/[:\2_P#0IG_P
M81_X5TE% '-_VUXE_P"A3/\ X,(_\*/[:\2_]"F?_!A'_A7244 <W_;7B7_H
M4S_X,(_\*/[:\2_]"F?_  81_P"%=)10!S?]M>)?^A3/_@PC_P */[:\2_\
M0IG_ ,&$?^%=)10!S?\ ;7B7_H4S_P"#"/\ PH_MKQ+_ -"F?_!A'_A7244
M<W_;7B7_ *%,_P#@PC_PH_MKQ+_T*9_\&$?^%=)10!S?]M>)?^A3/_@PC_PH
M_MKQ+_T*9_\ !A'_ (5TE% '-_VUXE_Z%,_^#"/_  H_MKQ+_P!"F?\ P81_
MX5TE% '-_P!M>)?^A3/_ (,(_P#"C^VO$O\ T*9_\&$?^%=)10!S?]M>)?\
MH4S_ .#"/_"C^VO$HZ^$S_X,(_\ "NDH/- %/3+F\N[/S;ZQ^Q3;B/*\U9..
MQR.*N4@ '2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** ,?Q5_R*>K?]>DG_H-6=$_Y &G?]>L7_H(JMXJ_Y%/5O^O23_T&K.B?
M\@#3O^O6+_T$4 7Z*** "BBB@ HHHH *B@M;>U\WR(8XO-D,LFQ0-SGJQ]2<
M=:EHH @%G;+?->B",731B)IMHWE 20N?3))Q[U/110 55M],L;.[NKNVLX(;
MFZ(:XE2,!Y2!@;CU./>K5% %6_TRQU6!8-0LX+N%7$@CGC#J&'0X/<4]+.VC
MO)+Q((UN946-Y0HW,JDE03Z#<?S-3T4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 56N-.LKNYMKFYM()I[4EH))(PS1$]2I/0G Z59HH AMK2
MVLQ(+:".(2R-+)L4#<[')8^I/K4U%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%4-3N[^UMP^GZ?]MFWA?+,PB&.YW$'I63
M_;/BC_H4T_\ !DG_ ,30!TM%<U_;/BC_ *%-/_!DG_Q-']L^*/\ H4T_\&2?
M_$T =+17-?VSXH_Z%-/_  9)_P#$T?VSXH_Z%-/_  9)_P#$T =+17-?VSXH
M_P"A33_P9)_\31_;/BC_ *%-/_!DG_Q- %WQ5D^%=5 !)^R28_[Y-6=$!&@Z
M>#U%M&/_ !T5AW5_XBO+>6WG\((\4J%'4ZDG(/;[M/AU/Q);P)#%X118XU"J
MHU). /\ @- '445S7]L^*/\ H4T_\&2?_$T?VSXH_P"A33_P9)_\30!TM%<U
M_;/BC_H4T_\ !DG_ ,31_;/BC_H4T_\ !DG_ ,30!TM%<U_;/BC_ *%-/_!D
MG_Q-']L^*/\ H4T_\&2?_$T =+17-?VSXH_Z%-/_  9)_P#$T?VSXH_Z%-/_
M  9)_P#$T =+17-?VSXH_P"A33_P9)_\31_;/BC_ *%-/_!DG_Q- '2T5S7]
ML^*/^A33_P &2?\ Q-']L^*/^A33_P &2?\ Q- '2T5S7]L^*/\ H4T_\&2?
M_$T?VSXH_P"A33_P9)_\30!TM%<U_;/BC_H4T_\ !DG_ ,31_;/BC_H4T_\
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M/BC_ *%-/_!DG_Q- '2T5S7]L^*/^A33_P &2?\ Q-']L^*/^A33_P &2?\
MQ- '2T5S7]L^*/\ H4T_\&2?_$T?VSXH_P"A33_P9)_\30!TM%<U_;/BC_H4
MT_\ !DG_ ,31_;/BC_H4T_\ !DG_ ,30!TM%<U_;/BC_ *%-/_!DG_Q-']L^
M*/\ H4T_\&2?_$T =+17-?VSXH_Z%-/_  9)_P#$T?VSXH_Z%-/_  9)_P#$
MT =+17-?VSXH_P"A33_P9)_\31_;/BC_ *%-/_!DG_Q- '2T5S7]L^*/^A33
M_P &2?\ Q-']L^*/^A33_P &2?\ Q- '2T5S7]L^*/\ H4T_\&2?_$T?VSXH
M_P"A33_P9)_\30!TM%<U_;/BC_H4T_\ !DG_ ,31_;/BC_H4T_\ !DG_ ,30
M!TM%<U_;/BC_ *%-/_!DG_Q-']L^*/\ H4T_\&2?_$T =+17-?VSXH_Z%-/_
M  9)_P#$T?VSXH_Z%-/_  9)_P#$T =+17-?VSXH_P"A33_P9)_\31_;/BC_
M *%-/_!DG_Q- '2T5S7]L^*/^A33_P &2?\ Q-']L^*/^A33_P &2?\ Q- '
M2T5S7]L^*/\ H4T_\&2?_$T?VSXH_P"A33_P9)_\30!TM%<U_;/BC_H4T_\
M!DG_ ,31_;/BC_H4T_\ !DG_ ,30!TM%<U_;/BC_ *%-/_!DG_Q-']L^*/\
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MVSXH_P"A33_P9)_\31_;/BC_ *%-/_!DG_Q- '2T5S7]L^*/^A33_P &2?\
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M-8UOX:\5:K%?7]]I-Y%?ZK/I\T@FM&D6,I<2(=RG&0J*C$''!YQF@#WPZ[I
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MP-K;".2,T >GO/#&VUYD5L%L,V#@=33?M5OY:2?:(]DAPC;QACZ ]Z\]\3^
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MW3.K=5W#YNQ.>>:)O &NM-HTD=A;F>V8;I7G1D0"[:7YE92?ND$&-@<\'@4
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MT =I17%?\+;\"_\ 0PP_]^9/_B:4?%KP*3@>((?7_4R?_$T =I17%?\ "V_
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MLAQYB\.,'GN!0!Z!Y\.]$\Y-SC*+O&6'J/6H[F\BM8T=_,8.Z(!$C.<LP4'
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M* "BBB@ HHHH **** "BBB@"AJFLV.C6OVF_F,4.\)N"%N3[ 5C?\+#\,_\
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M-TEK]J@6"\\R.51(D; N8U*E3(F?E(P>#0!H?\+#\,_]!!O_  'D_P#B:/\
MA8?AG_H(-_X#R?\ Q-:&AWT^J02RW-I81!6"J;6[%P#QSDA%P>G'/6N?_P"$
M_LS:>(K@::VS28)+F E@!>QQLZ,R'' #QLO?J#WH T/^%A^&?^@@W_@/)_\
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M[B.X4@K*LH8C QQC;^M %3_A8?AG_H(-_P" \G_Q-'_"P_#/_00;_P !Y/\
MXFJ=QXS>6_-CH^CK>SRW+V]J[S"*.7RA^^D+;3A$8JN<$EB0!QFI;7QK80V<
MYUZ!-,O+>]-B\"9N \OEB0>657+ HP(^4'/&,T 3_P#"P_#/_00;_P !Y/\
MXFC_ (6'X9_Z"#?^ \G_ ,34,'Q$\(7._P O4EPL33!GM955T7ABA*8?!X^7
M//%2_P#"=>&!91W1NV"23/;K']CE\TR(H9E\O9OR 0>G>@!?^%A^&?\ H(-_
MX#R?_$T?\+#\,_\ 00;_ ,!Y/_B:KO\ $#PW"LMS+=1C3UAAE6Y2&1S^\4N-
MRA/E&W:<D_Q<@8YNKXQ\-MJ%M8K>H9[D1F,"!]H\P9C#-MVHS#&%8@G(XYH
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MA.>IX'<YR /\0]'37KW3"D<0M+E87GN-T:,!$TLC*=A!V*O0D9SG/(R 7_\
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M<6Z""-YI)'\L2.-BH3A5922,CGG'2@!?^%A^&?\ H(-_X#R?_$T?\+#\,_\
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MGE&7:$WA>=N0?:M>TU*.XU[4-)EM5BGM4CF0Y!$L3Y 8<<89'4CV![T 9O\
MPL/PS_T$&_\  >3_ .)H_P"%A^&?^@@W_@/)_P#$UTOE)_<3_OD4>4G]Q/\
MOD4 <U_PL/PS_P!!!O\ P'D_^)H_X6'X9_Z"#?\ @/)_\372^4G]Q/\ OD4>
M4G]Q/^^10!S7_"P_#/\ T$&_\!Y/_B:/^%A^&?\ H(-_X#R?_$UTOE)_<3_O
MD4>4G]Q/^^10!S7_  L/PS_T$&_\!Y/_ (FC_A8?AG_H(-_X#R?_ !-=+Y2?
MW$_[Y%'E)_<3_OD4 <U_PL/PS_T$&_\  >3_ .)H_P"%A^&?^@@W_@/)_P#$
MUTOE)_<3_OD4>4G]Q/\ OD4 <U_PL/PS_P!!!O\ P'D_^)H_X6'X9_Z"#?\
M@/)_\372^4G]Q/\ OD4>4G]Q/^^10!S7_"P_#/\ T$&_\!Y/_B:/^%A^&?\
MH(-_X#R?_$UTOE)_<3_OD4>4G]Q/^^10!S7_  L/PS_T$&_\!Y/_ (FC_A8?
MAG_H(-_X#R?_ !-=+Y2?W$_[Y%'E)_<3_OD4 <U_PL/PS_T$&_\  >3_ .)H
M_P"%A^&?^@@W_@/)_P#$UTOE)_<3_OD4>4G]Q/\ OD4 <U_PL/PS_P!!!O\
MP'D_^)H_X6'X9_Z"#?\ @/)_\372^4G]Q/\ OD4>4G]Q/^^10!S7_"P_#/\
MT$&_\!Y/_B:/^%A^&?\ H(-_X#R?_$UTOE)_<3_OD4>4G]Q/^^10!S7_  L/
MPS_T$&_\!Y/_ (FC_A8?AC_H(-_X#R?_ !-=+Y2?W$_[Y%(8D_N+_P!\B@"M
MI>K66M68N[";S8"Q7=M*\CKP15VFHH08 'X"G4 %%%% !1110 4444 %%%%
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M\NYG61#&1-+O.["MV49(![5W58]]XCM;#45L9;74'F?.SRK5W5\ $X(&#C-
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MSXBPV(^'9>0W&.I&:E?X>YMQ$FJ%"+ZZOBP@S^\DC:./^+_EFK#Z[1TKMZ*
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M8,&9CP(VX^85#_8NIV45O>VK6USJ*7,MQ/$[&..3S!@JK8)7;\N"0<[><9R
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M2M!(TC+E$52YRQ QN. ,GUX 'X5DZ-*MQJ&LS1A_+:Z4*S(5SB) <9'/((H
MV**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"6BJL.IV%Q%++!?6TL<0S(R2JP0>I(/'2F0ZOIEQ*L4&HVDLC<*B3JQ/T -
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M/80V$VDV,EG"=T5N]NAC0^JJ1@=3T]:?::-I=A-<2V>FV=O)<G,[PP*AE/\
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MNQG/O27?AG0;^[>[O-$TVXN9,;YIK5'=L# R2,GB@";15L8]*BAT[(M86>%
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MX;2-7,GF*0R%"592HR=P8$8&>>E<MYEW+I6C:!!8W&GW$=R!.TEC/<0*86W
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MEB(T+L0/15!)/L!FO/535H=+T[7Y6=B+_P"V-9IH]P;I3)N5XV(8G"HS*"4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ $U!J&O06^C2ZG8&WOXH6 D\J<8 R,\@'D9!Q1XDM&N](&RU^TO#<6\_E
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M062Z=F4H F<D( _)Q_K#CO0!T=MJVFWEU):VNH6D]Q&,O%%,K.H]P#D58-Q
M+D6QFC\\KO$6X;MN<9QUQGO7'6-JUE:>#(H-'N8?LQVS!( /(!A=#N],N5/O
MUK5DA@/C^&8^'Y&G&GE1K&1M5=_^IQUSW_&@#H**** (+V<VUC<7"@%HHF<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<;E<A)H.N)H]UX=MS8?V9<"6,7CROYT<4A)*^5MVLP#$!MX[$CL>N50JA1T
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M252')P$$OS':</C'I)JWA'61;7EM_8]Y?:8/[1BLK.&X"^2\C(89?F<?* '
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M8>(Y+V.RMRB%[<QL@* D+QN! )'2@#M'\3:+'IEKJ3ZG;K97<JPP3%OE=R2
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MYJ(N5R55 WS!N5 ! &,]:P[/Q1X@NY%T[2?$8U,7EY:00:H;2/:C%))+@*%
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MB?\ ?V3_ .)KR[0Y(+AK#^T9='DQH.GLO]KZ@\')\W)3 .XG S^%>LZ_J_\
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MN(U\=C575%\X_:=_VC"(JYR8_*V\8VE>?4T =YO\;?\ /#1/^_LG_P 31O\
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MFNFHH HZ5_:/V3.J);)<ECD6[%DQVY(!S5ZBB@ HHHH **** "BBB@ HHHH
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M!=NTKEGCP1M!S\@^8\+CKFM&WMH;6V2W@C5(D4(J@<  8 _(5+10 4@  P
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ML:J:/\1K#4-;BT74=,U/1-1G&;>+4H1&)_9&!()]J .RHHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** &LZJ,L0.W-)YL?\ ST3\ZSM?@TF32)WUF%);&/$D
MBM&7Y'0[0"2?85P-W-X&M_#VE:NGA6.1=3D:.&!_*A==H8DL9'51]WUZD"@#
MT_S8_P#GHGYT>;'_ ,]$_.O+KV3PE8QW\S>!7DMM.BBEO)8S 1$'0/T\SYL!
MN=N1QQFNNE\$^$8+=YY=%LDBC4NS%.  ,DT ='YL?_/1/SH\V/\ YZ)^=><:
M=9^&+PVUQ<>!S::9=PO/!>R(K+L5=P,@4DQY7D9^G!XIEI!X6E-A-=^"/L=C
MJ.?L=S((SO.PNH90V4+*I(S]#@T =1H?@OPSX<U2ZU/3;1$O[G/FW$L[2N<G
M) +$XR?2NB\V/_GHGYUYAI=QX#UK1M-O[#PPDDE_<&U6U:-5DCD$3R@-DX 9
M4X.<'<#TIH_X1E;#5+V?P"T,.FR>1,2T))ER@V##_P"V#GI[T >H^;'_ ,]$
M_.CS8_\ GHGYUYY;V'A(7]U9:KX1CTN6VLS?,9_+=3"IPQRC'&#V-06X\$W?
MAN'58?"@^T3W(LX]/>)5F,Y/"')VCY?FR3C;S0!Z5YL?_/1/SH\V/_GHGYUY
MA>PZ%IME<W%Y\.94^RR*D^#%M&[;L*L6 <$MCCH0<XJU-IF@B[CL+;P$L^I"
M#[3<6V^)?(0LRIN?=M);:V #T!SB@#T7S8_^>B?G1YL?_/1/SKS.%/"=_-:Q
M:5X)-[)/:FZ91Y41B <QLK;W'S!E(.,]*B>[\ BPL+F/POYCWL#2QP+$N\,)
M5A6,_-C<TC[1@XX)S@4 >H^;'_ST3\Z/-C_YZ)^=>974?A738;U=3\$K;7MM
M'',EL#&_GH\@C!1@V.&(!!QC(]:GN]-T*QBLQ<?#\I<WEU]EM[?S("7/EO(3
MD/M  0]30!Z-YL?_ #T3\Z/-C_YZ)^=><S:;H45_;:>OP^+W\UN]PT D@'EH
MKA<EB^TY+#H:2?3] CU"6QA\ &>YM[2*ZN$5X%\H.7 7+. 3^[;ID4 >C^;'
M_P ]$_.CS8_^>B?G7F4">%-42%M"\%#4MUG%>2A1'%Y2R E%.YN7(!X'''7D
M4L:>$[Z9$T?P5_:*M8Q7S,GE1[$D+@*0[CY@8VR.U 'IGFQ_\]$_.CS8_P#G
MHGYUR6C>&/!NNZ+9ZK::#;""[B65!)%A@",X//6KW_"!^%?^@%9_]^Z -_S8
M_P#GHGYT>;'_ ,]$_.L#_A _"O\ T K/_OW1_P ('X5_Z 5G_P!^Z -_S8_^
M>B?G1YL?_/1/SK _X0/PK_T K/\ []T?\('X5_Z 5G_W[H W_-C_ .>B?G1Y
ML?\ ST3\ZP/^$#\*_P#0"L_^_='_  @?A7_H!6?_ '[H W_-C_YZ)^='FQ_\
M]$_.L#_A _"O_0"L_P#OW1_P@?A7_H!6?_?N@#?\V/\ YZ)^='FQ_P#/1/SK
M _X0/PK_ - *S_[]T?\ "!^%?^@%9_\ ?N@#?\V/_GHGYT>;'_ST3\ZP/^$#
M\*_] *S_ ._='_"!^%?^@%9_]^Z -_S8_P#GHGYT>;'_ ,]$_.L#_A _"O\
MT K/_OW1_P ('X5_Z 5G_P!^Z -_S8_^>B?G1YL?_/1/SK _X0/PK_T K/\
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MZ79:1:?9=/MH[:WW%A'&,#)ZFK= !1110 4444 %%%% !1110 4444 %%%%
M!7%1^$-0M-"TBT@;2;BXL!,K?;;7S$(D).5/WE('IP>AKM:* /*#\)ITM;JR
M4:1<":T@MXK^XB8W%L8XE3?&!T.1N'S<<5Z.+2YNK2^LM1\EK:4&*,QL2S1%
M "7R/O9W=.,8JZ)H]SJ6P4&3N!''KSU%0V=PUSOD. C8,:_Q;.S'ZX./;WS0
M!RMAX:\1?8;31M2U.R.CVMNUJXMHF$MW&8S&H?=PF <G;G)'84R#PKKL\6DZ
M?J=[8-I^DD-#)!&XEG98VC0N#PH 8DXSDCM76WEQY,:A& D=T4?0L 3^M6:
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MB\L>![UIVOC+P]>Z'<ZS;ZI"VGVK%)YB&7RF&.&!&0>1V[UYII?B.XT/X<^
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M^(K*WCOO#WEF06;LT4XE7,04L,@DX!STS6IX_P#'5EX$T(7EPOFW<Y,=I!G
MD?U)[*,@DUYY)%I>O_#'Q-;Z+J\.M>);G9J6H/"C?.Z.K;%4C.T!2JC_ !H
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M=XQ-*.4/DL-LJEL8.""*]"\,7%_=^%M*N-4@\B_DM(VN(]FW:Y49&WMSV[4
M:M<WJ?\ R4+P[_UY7W\X*Z2N;U/_ )*%X=_Z\K[^<% 'F'Q;T>?P=XTTGXC:
M5$Y59U2^1. 3C&3Z!ERI/KCUIWPYL)?B)\1=2^(&I(_V&TE\G38I!W X^FT$
M'_>;/:O1/B?IEUK'PXUFPL8?.N9HT$:;@N2)%/4D#M4'PETJ]T3X::5I^H0>
M3=1&;?'N#8S*Y'()'0B@"3XJ_P#)+O$/_7J?_0A7"?#'PG8>-/@A%H^HRW,5
MN]])(6MV57RK9'+ C]*]%^(NGW6J_#W6[&RB\VYFMRL:;@,G([G K&^#6C:A
MH/P]AL=3M_(N1<2L4WJW!/'*DB@#Q#X8?#G1_&GB'7-/U*XOHH;#_5&WD16/
MSE?FW*>P[8KWK6?AQ::KX)T[PI%JNH6EC9E 7C<;YHU!&Q\  YR#TZ@<5Y]\
M"]-OK+QEXJDN[*X@23&QI8F4-^\;H2.:W?C!K/B=K_1_#'AP75N-18"YO($;
MY0S!57>/NCJ3WQCMG(!C>+O@UX+TS0+DZ?JC6&K00F6$W%XO[PJ,X*G'7'48
MP?RKI_@?XIOO$W@9AJ4[SW5C<&W\YSEG3:I4D]SR1GKQ5&/X%^$=.TFXN-16
M]U2\6%W>::=AE\9R%3!Z]B3^-5OV>+"\L/"VK)>6D]L[7H*K-&4)&Q>1F@#S
M_2]&UG5_C!XJ\-:1J3V,%Y=SM?7"#YQ LA) ^I8#\?3-;WCKX)V/A3PQ-X@\
M.ZIJ"W>G 3.)G4E@",LK* 5(Z]^E:?P_TZ]@_:"\674UG<1VTB7.R9XF"-F:
M,C!(P>!7IWQ BDG^'GB&*&-I)'T^951%R6.P\ #K0!F_"CQ/<>*_A_8WUY)Y
ME[$6M[ASU9E/!/N5*D^YKM:\L^ 5G=6/P]GBN[::WD.H2-LF0H<;$YP:]3H
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M][#:2W<DV&5I&(VJ@&20!G)..0*M>(KCQ5"Y;0;?2&@CA,CO?2R!G;GY5"C
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MP)UC\I(T"[^"TK2+G)X7- '=_P!H^)?^@#;?^!O_ -C1_:/B7_H VW_@;_\
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MEEC4EN1O90!ST)Y Y .U+ZVQR?#&GDXV\W2]/3[M227?B&50LGAVS<*00&O
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MN;^(/_)._$7_ &#IO_0#0!NVP#6D 8 @QC(/T%3XXQ4%K_QZP?\ 7,?R%3T
M-,:%-A12O]W'%!C0@@HI#=>.M.HH *888C*)3&GF 8#[1G'UI]% ",BOC<H.
M#D9'2LG5/#\&L:GIMW=W%P8M/E\^.U5@(WE'W7;C)*\X&<<UKT4 ->-),;T5
ML=,C-"11QDE$5<^@Q3J* &A$7.%49ZX'6F_9X1_RQC_[Y%244 ,>&*1U=XT9
MT^ZQ4$K]*?110 5S>I_\E"\._P#7E??S@KI*YO4_^2A>'?\ KROOYP4 4OBK
M8WNJ?#?5M/TZSFN[NX$:1Q0KDG]XI)^F :P?AC>7OA;P!I^CZGX?UI;N!I2X
MCLRP^:1F'.?0BO4** //?'.K7&O>"-7TJQT#6VNKJW,<8>R*@GCJ<UD_"F74
M_"?@6+2]3\-ZT+I)Y'(CMP1@G(Y+"O6** /%?AQ/XUT3Q#KEUXDTC7Y[2^;S
M(%)$OEMN)Z%N.#CCT^E2?$^V\3>(3I^H^%K7Q)9:A:-M:$#RXY%SD'A\9!]1
MR#[5[-10!X5JNJ?%_7772;O2I='L6VBXO-.BWS$8&=K!^I/ICTS6G\*;SQ9X
M;TJ^LO%&C^(+EFF$EO(P\[ (P5Y;(Y&?QKV*B@#Q?PC/XVM/BGK.JZII.OOH
ME]YJV\+L"L67!CRI;"X4$<=,UV/BC4-<UGPKJNF6?A/6(KF[M9(8G>:U"JS*
M0"2)B0*[>B@#RKX86WB?P=X3;2]7\,:K<W)N7E#PW%LZ[2% &6F![&NV7Q#J
M1#$^$=:&!D R6G/M_KZY#4O$6H)!!J#:I)"TDUS(+1]T<,L:.8UB655)5QM#
M8(.2Q[=,Z\\>Z[9V<QAE-LD<;""74+5I)+F6-(E\DJI55=I'?)'3;TZX .^_
MX2/4O^A/UO\ [^6G_P ?KS7X3:+XQ\$G63K?AW4[K[883#Y-U;OMV[\YW2C'
MWAT]*V;SQOXCLUFNB]H\!2X2...U8F,QSQP"5F+@;2S.V.!M7.>M4[/QSXBN
M(8+Z6]MD6W@E::$VA F#70@20_/P%P6..@_W@0 =GJM_>ZQHMYI\_A'6_*NH
MF@D GM%8*RD$@^=7D7ASP[\8?!:7EGH-@);":0N@O)8"0>F['F':2,9&2.*[
MK4/&_B*YLKJ^T9;9;: --^^M79GC:X,,9(W+M&$DD)/8#IUK2LO$^MGP!-JM
MR;87?VI8(K@P,(Q&TBIYK)GD+N8\'!"YS@YH \N3P'\1F\7Z/XFOK&^O[Z*Z
M2XOA)=6R+A6!"1@28QM!ZXZ]*Z_XK^'O%'Q T73[/3O#TULT$YF<W5U #T*X
MPKMZYZUK^&K_ ,0^(O%-J][>%+&PMY966*!X1=EII$BD(W\ K'N"D$8.>X(B
MM?$-Q]A:\>\U6X\00R7,TNFPH=@1/,*Q,A&%0@* WWB2,$YH Z#2]0\06&D6
M5G)X5N6>W@2)F6\@P2J@9'S^U<#?>$_%UU\9;;QJF@$6<(4& WD/F'$93^]C
MJ<UJGQGXH-K=)#=V,P@CENO[0%@ZQO%'"&=40O\ ,1(Z+G/KQD577Q7XO2YU
M.5;FW<Q)+/);K9M(8%@BCRBC?U=Y#C/92W.0  :WCSP[<^.])^P7OA6Z26)B
MUM=I=P;XCZX+<@X&1_4 UY_IW@GXQ6%HFD1:K<PZ2N4'EW41D5/1<ME?H&XK
M3U#QAXMU_2%MK35H]/N([R4I?P0,$FV11$0A4W[BQF)&,YV=\5APZI\6=0OU
MT]?$4*O)/Y!E50-I9VBZ!.!^Y9N@..>] %'P3IDND_'G[-H^DW$HTZ)Q-#+=
M(S@^5L=V<';R[9P/7%>^_P!L>(_^A5_\J$?^%>+^ [:]\):BLEK<PG5]5GMX
MP+RW=VNXI)&W.C;AM 4;SG))'/:O2_%.H0)XBN[?6K_5;*RBLHWL$L))8S<2
ML7WX,?+N,1@(>.<X.: -W^V/$?\ T*O_ )4(_P#"E75O$1#?\4P%(' .H1\\
M^PKR[5+OQ?L>ZNM8E66QM56:UB$R>:T-O$\@S'*HRTTRH6 SQUP"IZ6W\5ZU
M%'>9U*PACL'>">WGM9F>W1)/+1S*6^=W"E@"1]\$D@<@)7./G\&?%NPUN_O]
M%UAK>WNIWN##->*RJ68L1M(*]^N!1-\*_'7BG5H+GQGK,>I6, #K!!/L#G/*
M@; $'JP&<=,UWI\2:Y<^";W6W@@@;[)));Q%&+O*7<1 @XZCRN,<ECVQ7? 8
M4#':DM2FK(Y2V?Q19VL5G:^&]*AMH4$<21ZJRA5 P /W'I7%^)-4\0:/X^TK
M5;SPQYL:6$T(^S3S7"$LZ'ED@)4\=-O.>M>OT4Q7/%;F[\=7=WJ'C6P\)"V9
M-,-C;VD\S-,P,@8RB+8"W3A3M/'?I5?3=/U36[WQ:WV;5[G[9X=\CSKZR%N)
M9_GP$ C0$#(QD9Z\XQ7N5&!C% 79X%=R>+A9>$M5TC1[NTL=,LC9NL4+>=%*
M54.QC>!B!\N-RJW?D5M>'I-3L+?2#_PAC:E+>:C/<PW=Y.Z-;3-R[LOV5?*4
M]L#%>Q  =!2T"/*?'WC#Q[IL,>FZ?X;2WENT/_$PM7FO%@'3HL(PWIP?I659
M2Z]X>N?#^O67A)WTVWTZ333$DT[2+N<.9'0VXD&64Y(0YW9XKVNB@#R&.]\7
MZ+X2O+NP\/7B:KXAU2:[*1Q^:=/B8(NYE.,OA<@''OC&*W-*DTW3/! TZ7PQ
MXBFM))C'=+/:;YYW8%VF<*Q)!;@D=\#&!7H5% 'F?A%[SPS9ZM+:>']7CT.X
MU&)-,T\Q$S0JP ED*L<K'NR<'I[9KBO%%A=)X;?P4UI.FH2>(O-MG\HB.6*1
MF8,),;<\]"<U] D9&*Y7QL &\.?]ANV_]FH Y+QO:Q:M!]GL/#.MOXFL_+AT
M[4$MV2-&4Y$@ESLV<G.?RKL;_7WB34K&]T#5KJ*WCBCEDMK;>ER)%^;RP#E@
MO\6.17344 >+/X6OK[3?%,7AO1;W3])=;:XL[*]5HC-=12!W**QRH*J%YP":
MZ_2C?>(_B!;:\^DWVFV-AIKVZB^B\MY)I'4D!<_=4+U[D\5W5% '*>.-.O-0
M'AS[);O-]GUVUN)=@SLC7=N8^PS6+\1-2UZXO(- L-)U<Z3.F[4+_3X0\C(<
M_NH\D $XY8] >*]%HH YC1KF/[5I-M:^%;JRM!9.L=Q<1HC6H5@HB(R2,@9X
M/I^%7P]:WNDZGXTOI[&=DFOOM%NB+\TZB!!\GJ201]:[&B@#RWPG>ZKJ7BQM
M:\2>'-;CU&0/!9QFV46MA#UP&+9+M@9;'H.!6FOA6XUZ.T\00R:AX<O4LI+:
M/34C@98068G 9" 6XR1@XQ7?T4 ><:5X=U>Q^!=UHMRMQ-J3Z7-&ELRINC8Q
MD"-=HYY]<GGK7;:/;/'X<L+6=7CD6TCC=<X92$ (R.AK1HH X+Q'X,FM=.L[
MO0_MU_>6&HP7XM[S4))C*(]P9$,K$*2KMZ9(&>U49/!M_P"-=4UC4]72\T2"
MY6V@M[<-$\KQPEG)D'SI@NP^7GA>:]+HH X/PEX:UG2O'OB6_OM1O+FUN$ME
MBEFCA47)"$$G8HQL^Z,8SGG-9.HZ-XDL[3Q=X=T_16NH-?NI9K:_$T:Q0B=0
MLOF G<"N&(P#G->I44 >9OH^O^%K_7[;2-%EU.VU:TA6UF2:-!#,D(A/FAF!
MV\!LC/<5V_AG2#H'A?2])9Q(UG:QPLXZ,RJ 2/;.:U:* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@"CJ7]I?93_ &6+7[3N&/M.[;M[_=YS61_Q6W]W
M0/SFJSXTO+C3_ ^O7EI*T-S!I\\D4B]48(2"/QKC6U/Q-H<@OK:VU)[*=+>U
M6/6KB-MUS+.B*R^668*%9LYQGB@#J?\ BMO[N@?G-1_Q6W]W0/SFKF8O'_B*
M759;--&MY#'=26&0LBJTZ1D[@YXVEQ]WKM.<U53XIMJ4EIJ%M92?8((R\P24
M@O,+.6>2(C'.W:@^I]L4 =A_Q6W]W0/SFH_XK;^[H'YS5AVGCK5X=7TW3=4L
M[#S+_P"RR)):R-M1)A+P=W\0,?7H<]JJW?Q)U..WL[J'3K7[*SS?:)69W$:I
M<F$$A 2@(4MO(*YXH Z;_BMO[N@?G-1_Q6W]W0/SFK/\9>,=1T+58-.TS3UN
M)6LY;R1WC=U"H0-OR].3RQX''7-8%_XXUK46M+FVCAL=/34A:R1B0F=V^R-*
M03C;MR1T_N@T =?_ ,5M_=T#\YJA-KXN-Z+PP^'_ +0(S$),S9V$@D?F!7':
M;XTUB*2.YOG>:T$]N8HHY/GVG36G8,=OS9(!_P!X^@ K2'C[Q#%)IUK-IVF/
M<ZG%:36QBE?9&LS%</D9)7@Y'7F@#=OK'Q9J5G):7EOX>F@DQN1C-U!!!]B"
M 0>Q%%A8>*],LX[.RMO#L%O'G:B&;')R3[DDDD]R:9'XONX_![ZM=6UO]JAU
M,:?*J,1&?]+%N7&>0,'=@UGW?CG5Y-3GL--L;(O%-?(9)W;:%MUB.<#J6,F/
M;K[4 ;?_ !6W]W0/SFH_XK;^[H'YS5D6GQ!FNH8Y/L42F2\TZW"^820+J.-R
M?JN\@>N*S!\2]51+];FPLX)QL-E&?-?S=T_E?*4!$W4'Y#U.,#K0!U7_ !6W
M]W0/SFH_XK;^[H'YS5Q$'C[Q'?ZQ&88K2"2UM]0%S;W&]$<PF%@VWDJV&(Y)
MQDGVIUE\1-6::=;6VDN9+_4F%NLD;RBWB6UAE*[4Y/+GT[F@#KHK/Q;#=W%U
M'#X?6>XV^:^9LMM&%_+)_.I_^*V_NZ!^<U:/AS5)=;\.V&I3VXMY;B(.\0;<
M%/?!]*U* .:_XK;^[H'YS4?\5M_=T#\YJZ6B@#FO^*V_NZ!^<U'_ !6W]W0/
MSFKI:* .:_XK;^[H'YS4?\5M_=T#\YJZ6B@#FO\ BMO[N@?G-1_Q6W]W0/SF
MKI:* .:_XK;^[H'YS4?\5M_=T#\YJZ6B@#BK'0O$.FWD]Y9V'AR&XGSYCJ9L
MG)W$#T!))P,#/-64L_%L=[+>+!X>%S*JH\N9BQ5<X7/H,DX]2:ZRB@#FO^*V
M_NZ!^<U'_%;?W= _.:NEHH YK_BMO[N@?G-1_P 5M_=T#\YJZ6B@#FO^*V_N
MZ!^<U'_%;?W= _.:NEHH YK_ (K;^[H'YS4?\5M_=T#\YJZ6B@#FO^*V_NZ!
M^<U'_%;?W= _.:NEHH YK_BMO[N@?G-1_P 5M_=T#\YJZ6B@#FO^*V_NZ!^<
MU9^N:3XQUS0[[2Y6T.-+R%H793-E01C([5VM% '+Q)XTBA1 N@?* .LU/_XK
M;^[H'YS5TM% '-?\5M_=T#\YJ/\ BMO[N@?G-72T4 <U_P 5M_=T#\YJ/^*V
M_NZ!^<U=+10!S7_%;?W= _.:C_BMO[N@?G-72T4 <U_Q6W]W0/SFH_XK;^[H
M'YS5TM% '-?\5M_=T#\YJ/\ BMO[N@?G-72T4 <U_P 5M_=T#\YJ/^*V_NZ!
M^<U=+10!S7_%:_W= _.:LV?2_&LVOZ;J7_$AS:03Q8W3<^88^O'/W*[>B@#G
M,^-O3P_^<U&?&WIX?_.:NCHH YS/C;T\/_G-1GQMZ>'_ ,YJZ.B@#G,^-O3P
M_P#G-1GQMZ>'_P YJZ.B@#G,^-O3P_\ G-1GQMZ>'_SFKHZ* .<SXV]/#_YS
M49\;>GA_\YJZ.B@#E;6U\7V4)AMXO#L<9=Y-H,_WG8LQ_%F)_&J=_P"'_$&I
MWT%[>Z?X9GN(,>6[^><8.X9'0X/(SG!YKMJ* .<SXV]/#_YS49\;>GA_\YJZ
M.B@#G,^-O3P_^<U&?&WIX?\ SFKHZ* .<SXV]/#_ .<U&?&WIX?_ #FKHZ*
M.<SXV]/#_P"<U&?&WIX?_.:NCHH YS/C;T\/_G-1GQMZ>'_SFKHZ* .*;0?$
M3ZRNKM8^&C?KR)B9\@[=N<=-VWC.,XXZ5I9\;>GA_P#.:NCHH YO/C;T\/\
MYS5;MH_$'V>:2[&F?:RN(Q"T@3VR2,COV-;-% T[')2Z?XLG\CSH?#LGD2"6
M/<9\!QG#8[D9XST//:K.?&WIX?\ SFKI**!;G-?\5M_=T#\YJ/\ BMO[N@?G
M-72U@>-9)H_"%_\ 9M033YW"1I<N[(%+.JXW*"5SG;N'3.>U $/_ !6W]W0/
MSFH_XK;^[H'YS5R'^DC0O%EK+/K6G7^F68O4A&KO<+&3%)M9)L[V4E"2C=",
M@<TFMZAJ=C#IFF:)<:U=74%J-5N&C9[AI'( BA<G)$;D29'^S0!V'_%;?W=
M_.:C_BMO[N@?G-7$ZAXNU.#5-<\0V5[-<>'?LENKPKDFV$L.Y)T],,<,!V.?
MX:T]+$NMZE FHZSJ4$,?ARQN2T-\\($CF7>[8(!/RCD^E '1_P#%;?W= _.:
MC_BMO[N@?G-7GTWC+Q!=Z9H]Q:-J-P^F6:WMXUK"2MT2XVI)C@!H5=_JZ&C7
M]<OYY/$VI6,NKR6J3P)9W]OJ316UHLEM"RN\8)R@9]Q.TC!YH ]!_P"*V_NZ
M!^<U'_%;?W= _.:N1O);I=$\8:W+KU_%?:9=.MH8[QA"66")U41YV,&=B,8Y
MW5K^*Y=3NO$OAZSMTOW6:QNIIK:TOVM"64P8)8$9QN88]Z -?_BMO[N@?G-6
M;K&D>,=6%@9&T-?L=Y'=*%\T[BN>#GMS5>*U_M/Q%JFG:GJFIV,&F6-N;=(]
M2DC8!U8O*[A@9"&&W+9'R].:Y5->UJ_@^WW4.MWXAT&TN773KXVVUF:8-(5#
M#<6"J> >G2@#T0?\)M@?+H/YS4?\5M_=T#\YJX&V\6:GH&JPZGJ>KMJ%C%HM
MJDJQ/NBEFDCF=9%X'+-"$!P,[Q71^&KN^?X8W)UO7Y+6[CNKFWGU)B"T>VX9
M,@G@=,#TX]* -O\ XK;^[H'YS4?\5M_=T#\YJX72]1U*YUY/#>IZK?6=NM_<
M,[+J&]U001O'&+@<M]YWQP1C'('._#KNHW/PZ\-.]W(MWJL]O9RW:<.%8G<X
M/9F53@^K9% &W_Q6W]W0/SFH_P"*V_NZ!^<U<!>:EJZ75W,DFKPE_$$EI#J3
MZB1:0*)L!7BR?EP-O*XR1R*V]!@U/5=5U&6<:O)"NK7<*W$>L-''&BS,H BS
MT  &,=J .D_XK;^[H'YS4?\ %;?W= _.:N8\.:_JNL:EH_AV:\E6]T:6<ZU*
M&P91#^[BR>XDW*Y]=IKL/%S:@/">HRZ7?+9SQV[R>?Y>\A54D[>< G'!YQZ4
M 5O^*V_NZ!^<U'_%;?W= _.:LH7>L?VUX(D;4V^PWD6V:V"<RO\ 9I'+.^>>
M0N!@<@GGC&!JNHWU]83ZA'KE_'<ZG=W,6C6%M/Y0.W;&DK-VC7RV<@\'S.<D
M@4 =I_Q6W]W0/SFH_P"*V_NZ!^<U<A-J6K#4Y[DZW*-2AUVWTV.V\S]P8FCC
MRQB&-V=[/GKP,$8I+C4_$*^&DM/[1DN;N;Q-)82W)F-M^[!8X#J&,:DJ!P"<
M' ZT =A_Q6W]W0/SFH_XK;^[H'YS5SWA;6K\W>@)+>7$_P!HGO\ 3KE)IO.4
MM"SLCJ^!NQM*[L L",\@5Z-0!S7_ !6W]W0/SFH_XK;^[H'YS5TM% '-?\5M
M_=T#\YJ"/&AQN70",_\ 38UTM% %/3/[2^Q_\33[+]IW'_CVW;-O;[W.:N44
M4 %%%% !1110 4444 %%%% !1110 4444 0W=K!?6DUI=1)-;S(8Y8W&5=2,
M$$>A%)<65M=PI%<0)+''(DB*PR%9"&4CW! (^E3T4 9A\.Z*=9_M@Z59G4A_
MR]>2OF=,9W8SG'&?3BBV\.Z-9[/L^F6L02=[A0D8&)'4JS?4@D'V-:=% &+'
MX/\ #<5C/8QZ#IRVL[!Y8A;*%=AT)&.W;T[4C>#O#3QVD;:%IY2T+&W4VZD1
M9;<=O' W<X]:VZ* ,[5M TC74B75M,M+U8B6C%Q$'VD]<9]:AE\*^'Y[];^3
M1K%KM%"+/Y"AP NT#./[IQ]*UZ* ,R/P[HT5Q#<1Z9:I- $$;K& 5"H47GV5
MF4>QQ4=IX5T"PS]CT:QM\S+.?*@5?G7.UN!VR<>F:UZ* *+:/ILFGSV#V-N]
MG<.[S0/&"CLS%F)!X)+$GZU!:>&=#L%5;/2K2!5$@"QQA0 X4/T]0JY^@K5H
MH QV\*>'VN[6[;1K$W-JL:P3>2N^,)C8 >O&!CTJ/_A#?#(2[0:#IP6\(-P/
MLZ_O,'<,\>O/UYK<HH Y]O WA1HHXF\.Z88HR61#;*54G;D@8QSM7/KBK-SX
M5T&\@G@NM)M)XKB<7$B21A@TFT+NYZ': ..U:]% $5M:V]E:Q6UK!'!;Q*%C
MBB4*J =  . *EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M44*,^O%2444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
, !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>modificationno13effectiv002.jpg
<TEXT>
begin 644 modificationno13effectiv002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M +_2_P#Q5'_"G? '_0N0_P#?Z7_XJ@#M/M$'_/:/_OH4?:(/^>T?_?0KB_\
MA3O@#_H7(?\ O]+_ /%4?\*=\ ?]"Y#_ -_I?_BJ .T^T0?\]H_^^A1]H@_Y
M[1_]]"N+_P"%.^ /^A<A_P"_TO\ \51_PIWP!_T+D/\ W^E_^*H [3[1!_SV
MC_[Z%'VB#_GM'_WT*XO_ (4[X _Z%R'_ +_2_P#Q5'_"G? '_0N0_P#?Z7_X
MJ@#M/M$'_/:/_OH4?:(/^>T?_?0KB_\ A3O@#_H7(?\ O]+_ /%4?\*=\ ?]
M"Y#_ -_I?_BJ .T^T0?\]H_^^A1]H@_Y[1_]]"N+_P"%.^ /^A<A_P"_TO\
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M^A1]H@_Y[1_]]"N+_P"%.^ /^A<A_P"_TO\ \51_PIWP!_T+D/\ W^E_^*H
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MT0?\]H_^^A1]H@_Y[1_]]"N+_P"%.^ /^A<A_P"_TO\ \51_PIWP!_T+D/\
MW^E_^*H [3[1!_SVC_[Z%'VB#_GM'_WT*XO_ (4[X _Z%R'_ +_2_P#Q5'_"
MG? '_0N0_P#?Z7_XJ@#M/M$'_/:/_OH4?:(/^>T?_?0KB_\ A3O@#_H7(?\
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MK)(2N05/!8CH3754 %%%% !1110 4444 %%%% !1110 4444 %%>-:%%XO\
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M[O-9E&P'/)&>"?Q+^V2:#1+2QM]&G>;6 LEO9ZO+)%(/LTY DDV;EY&0 #G
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M7HE% 'C7AGP[>:QJT2ZEINFW3PZ/8[QK5J9Y$4R7& N3PVT#.?09Z5[( %
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M!:JT9?)7?G&<*"6 R<GT+H-?U7^S3BXTN_GNKX6NG75K_J9%*!R[@.W*XDR
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M5@J*,%F((^8#CFKUY/>7%]IFDV6IO%YMJ]S->QI&SNJ;%&W(*#<9,YVD8!
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M1_PN#P#_ -#'!_WZD_\ B:ZS^S--! ^PVF3T'E+S^E(=.TM<YL[,8.#F)?\
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MFNHCL]'E=TCMK%VCX<*B$K]?2G+I^EN<)9V;?2)3_2@#E?\ A<'@'_H8X/\
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M5_PH Y+_ (7!X!_Z&.#_ +]2?_$T?\+@\ _]#'!_WZD_^)KK?[*T[_GPM?\
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M?\+@\ _]#'!_WZD_^)KK?[*T[_GPM?\ ORO^%']E:=_SX6O_ 'Y7_"@#DO\
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MID&N>'4U#5= A2_E\51K+'<0*[QH;E-Z;B.4Y;V(KUV*]M9X3-#<PR1#JZ2
MK^8IR7,$C;8YHW;T5@30!X[XC\,RO>>,FT[P_HTUM"\$7SV(>>&+[-&&-N 5
M&5&2%R.14NJW&J:E?'Q1H]JU]8>'(X5M+AIRCRA5#W)";?GWHP3J.5/6O8JB
M:Y@23RVGC5^FTN ?RH \KL;OPVXN_P"V+&2\\0RZN;B 10D74B&8&!XV."(Q
M&4S@@ !@>]:!\,VMOKGC-]$T>RMM0CT^+^SI8K9$,<S12C*$#@DXR1^->C/-
M%&</(BGT9@*3SXL ^:F&. =PY- 'D4RZ%-;:-#X9LUCU"VM)QJ7DP&-XX?LK
MAEG. 2QD,?#9.1GUJ3PMHTNE>(O"-Q=Z;IFGV\E@1#<Z=:;&N)FBYBG;/''S
M#@Y8'D$<^M&:(%@9$!7D@L.*19X7;:DJ,?0,#0!)144=S!*Y2.:-W'55<$BD
MN+RUM-GVFYAAWG"^8X7<?;- $U%1RW$,&/-FCCSTWL!FE6:)E5EE0JW"D,,'
MZ4 /HIK2(IPSJ#C/)[>M-6>%V"K+&S'H P- $E%1_:(1%YIFC\O.-VX8_.D:
MZMT.'GB4XS@N!0!+12*ZNH9&#*>A!R#2T %%01WMI-,T,5U"\J_>19 6'U%.
MBN8)F(BFCD(ZA6!Q0!+143W5O$Y22>)&'4,X!H>X@B($DT:$C.&8"@"6BH_M
M$.U6\Z/:QPIW#!/M1Y\/S_O4^0X;YA\OU]* )**C6>%SA948XSPP-"3PRMMC
ME1SUPK T 245!->6MM(D<]S#$[_<5W"EOH#UISW5O$0))XD)&<,X'% $M%1O
M/#&$+RQKO^[E@-WT]:3[3;Y8>?'E.&&\?+]: ):*:DD<HS&ZN.F5.:B:]M%N
M1;M=0B<](C(-WY=: )Z**CDGBAQYLJ)GIN8#- $E%1K<0L%*S1D.<+AAR?:E
M$L;2-&LB%UZJ#R/PH ?15>.^M)IGABNH'E0X9%D!9?J.U6* "BBH+N]M=/MF
MN;VYAMH$^]+-($4?4GB@">BHI;F"&V:YEFCC@5=[2NP"A?4GICWJ#3]6T[5H
MW?3K^VNT0X<P2JX4^AP>* +E%4I=8TR#4$T^74+5+V3&RW:91(<]/ESFF/KN
MCQ:A_9\FJV*7NX)]F:X02;CC VYSDY'YT :%%4M1UG3-($9U+4;6S$F=GVB9
M4W8ZXR>V:M/+''"TTDB)$J[F=CA0.N2?2@!]%4K+5]-U&WEN+*_MKF"(D221
M2JRJ0,\D' XYI=/U;3M6C>33K^VO$0X9K>57"GKS@T 7**** "BBB@ HHHH
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MU;H \\^T_%[_ )\?"'_?R?\ QH^T_%[_ )\?"'_?R?\ QKT.B@#SS[3\7O\
MGQ\(?]_)_P#&C[3\7O\ GQ\(?]_)_P#&O0Z* ///M/Q>_P"?'PA_W\G_ ,:/
MM/Q>_P"?'PA_W\G_ ,:]#HH \\^T_%[_ )\?"'_?R?\ QH^T_%[_ )\?"'_?
MR?\ QKT.B@#SS[3\7O\ GQ\(?]_)_P#&C[3\7O\ GQ\(?]_)_P#&O0Z* ///
MM/Q>_P"?'PA_W\G_ ,:/M/Q>_P"?'PA_W\G_ ,:]#HH \\^T_%[_ )\?"'_?
MR?\ QH^T_%[_ )\?"'_?R?\ QKT.B@#SS[3\7O\ GQ\(?]_)_P#&C[3\7O\
MGQ\(?]_)_P#&O0Z* ///M/Q>_P"?'PA_W\G_ ,:/M/Q>_P"?'PA_W\G_ ,:]
M#HH \\^T_%[_ )\?"'_?R?\ QH^T_%[_ )\?"'_?R?\ QKT.B@#SS[3\7O\
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MRV_]%+6Y0 4444 %%%% !1110 4444 %<_XSTW4-:\/OI%@2@OI$@N9@0#%
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M44 %4-=_Y%_4O^O67_T U?JAKO\ R+^I?]>LO_H!H YOX2_\DK\/_P#7N?\
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M8  '05T  4 #@#@4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP@_A+_H5M$_\%\7_ ,30!#_PL+P;_P!#3H__ (&1_P"-'_"PO!O_ $-.C_\
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MLXR9'*]6;:3R>IYJ+3=+TN_ALISX!\*^7<>4TD<*I)+%&[%=Y7R!P,'N.AH
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M:ZM;=- TDR7;;;;.BX6?WC8QX<8YW D <YQ6]_P@_A+_ *%;1/\ P7Q?_$T
M0_\ "PO!O_0TZ/\ ^!D?^-'_  L+P;_T-.C_ /@9'_C67KWA+0+&/[1'I'@[
M3;&-"9;G4--C<;L\#&4 'ON/IBJ[>'](N?!UOJUCX,\,+=20>=(MQ9*$1=I)
M*@)ELX& =O!ZT ;G_"PO!O\ T-.C_P#@9'_C1_PL+P;_ -#3H_\ X&1_XU%I
MGA#PI>Z39W<GA70E>>!)&"Z?%@%E!./E]ZM_\(/X2_Z%;1/_  7Q?_$T 0_\
M+"\&_P#0TZ/_ .!D?^-'_"PO!O\ T-.C_P#@9'_C4W_"#^$O^A6T3_P7Q?\
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M_P#0TZ/_ .!D?^-3?\(/X2_Z%;1/_!?%_P#$T?\ "#^$O^A6T3_P7Q?_ !-
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M -#3H_\ X&1_XUPL/C'PT/CE<:F=?TT6)\/B 7/VE/+,GG@[=V<9QSBO0/\
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MZ5<2C4;M \ME&Y"B9@!DCH!P!0!U?_"PO!O_ $-.C_\ @9'_ (T?\+"\&_\
M0TZ/_P"!D?\ C4W_  @_A+_H5M$_\%\7_P 31_P@_A+_ *%;1/\ P7Q?_$T
M0_\ "PO!O_0TZ/\ ^!D?^-'_  L+P;_T-.C_ /@9'_C4W_"#^$O^A6T3_P %
M\7_Q-'_"#^$O^A6T3_P7Q?\ Q- $/_"PO!O_ $-.C_\ @9'_ (T?\+"\&_\
M0TZ/_P"!D?\ C4W_  @_A+_H5M$_\%\7_P 31_P@_A+_ *%;1/\ P7Q?_$T
M0_\ "PO!O_0TZ/\ ^!D?^-'_  L+P;_T-.C_ /@9'_C4W_"#^$O^A6T3_P %
M\7_Q-'_"#^$O^A6T3_P7Q?\ Q- $/_"PO!O_ $-.C_\ @9'_ (T?\+"\&_\
M0TZ/_P"!D?\ C4W_  @_A+_H5M$_\%\7_P 31_P@_A+_ *%;1/\ P7Q?_$T
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M -#3H_\ X&1_XT?\+"\&_P#0TZ/_ .!D?^-3?\(/X2_Z%;1/_!?%_P#$T?\
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MP0HP@ [\DXX&*Z&B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[I9%O+9)4,DHDQB3(#GY2S'=R.N #TNH;F[MK.,275Q% A. TKA1GTR:E!R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5Y]%,DO[0<Z+G,7AD(V?7[2&_D17H->;67_)Q>I?]B\O_
M *.2@#TFBBB@ HHHH **** "O/M8F1?CGX;B.=QTJY_4_P#V)KT&O-M;_P"2
M_P#AC_L%7'_LU 'I-%%% !7!?!^ZCO? ?VN+/ESW]W(FX8.&F8C/YUWM>;?
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MHJ&*XW6L<T\;6S, 6CE9<H?0D$C/T)I+N>6WMFE@M9;IQC$43*&;GL6('ZT
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MP>'9;>-B=A",NTE^%; (([9R<5Z5'!%$\KQQ(CS-OD95 +M@+D^IP /H!4E
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MX]J[:B@ KA/%MK:W?B.-ITN(I(;4!)9M(-_;2!F.4  )5QM&<$9##KCCNZ*
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M$[S_ -'O7;UQ'PK_ .10G_["=Y_Z/>@#MZ*** "BBB@ HHHH **** "BBB@
MHHHH *XSXL_\DL\0?]>P_P#0EKLZXWXKJ7^%OB$*,G[-G\ P- '1:#_R+VF?
M]>D7_H K0K/T'_D7M,_Z](O_ $ 5H4 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5E>*/^12UG_KQG_P#1;5JUE>*/^12UG_KQG_\ 1;4
M9?P[)7X9^'2%+$:=$0H[_(*F\.ZWJNI*PO-'GB7[5<1F<RQ;45)7500&R2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ K@A_R7\_]BL/_ $J-=[7!#_DOY_[%8?\ I4: .]HHHH *
M*** "BBB@ K@M6_Y+;X<_P"P5=?^A+7>UP6K?\EM\.?]@JZ_]"6@#O:*** "
MN(^%?_(H3_\ 83O/_1[UV]<1\*_^10G_ .PG>?\ H]Z .WHHHH **** "BBB
M@ HHHH **** "BBB@ KCOBLYC^%WB$C&3:D?FP']:[&N,^+/_)+/$'_7L/\
MT): .CT'_D7M,_Z](O\ T 5H5GZ#_P B]IG_ %Z1?^@"M"@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "L3QBI?P/KZJ,L=-N !Z_NVK;K
M*\4?\BEK/_7C/_Z+:@#-^''_ "3;PY_V#X?_ $$5T]<Q\./^2;>'/^P?#_Z"
M*Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "N"'_ "7\_P#8K#_TJ-=[
M7!#_ )+^?^Q6'_I4: .]HHHH **** "BBB@ K@M6_P"2V^'/^P5=?^A+7>UP
M6K?\EM\.?]@JZ_\ 0EH [VBBB@ KB/A7_P BA/\ ]A.\_P#1[UV]<1\*_P#D
M4)_^PG>?^CWH [>BBB@ HHHH **** "BBB@ HHHH **** "N-^*ZEOA;XA"C
M)^S9_)A795R7Q/\ ^28^(O\ KR>@#=T'_D7M,_Z](O\ T 5H5GZ#_P B]IG_
M %Z1?^@"M"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!TJ:_P!:M[%+;9'-=RW6?(AM5#-( ,EAD@!0,<D@<@=2* -*BLH>(+%M&75
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MD6(IV7)(4YST5B,@ @$C-%]XGLK"[GADANI(K8J+JYCBS%;[@"-YSGH03@'
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M*** "N(^%?\ R*$__83O/_1[UV]<1\*_^10G_P"PG>?^CWH [>BBB@ HHHH
M**** "BBB@ HHHH **** "N2^)__ "3'Q%_UY/76UQWQ6=D^%OB$J<'[+C\"
MP!H Z'0?^1>TS_KTB_\ 0!6A6?H/_(O:9_UZ1?\ H K0H **** "BBB@ HHH
MH **KWUY%I]G)=3[O+C R$7<3DX  [\FI(I1+"DFUDWC(5QAA[$>M $E%06M
MW#>64-W"V89HEE4GCY6&03Z<4L%U%</,D;9:&0QOD8^; /\ (B@":BJD.HQ3
MZA<6(25)H%5SO0@,I) *GORIJW0 4444 %%%% !1110 4444 %%%% !1110
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M: .]HHHH **** "BBB@ K@M6_P"2V^'/^P5=?^A+7>UP6K?\EM\.?]@JZ_\
M0EH [VBBB@ KB/A7_P BA/\ ]A.\_P#1[UV]<1\*_P#D4)_^PG>?^CWH [>B
MBB@ HHHH **** "BBB@ HHHH **** "N,^+/_)+/$'_7L/\ T):[.N,^+/\
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M+/4;<WB6E]%IOD-<"_GB"0LJ@$]]W0]2N#@X)JY<65R-"-G9+9P3M'L("$1
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZB-.?5+);XD*+8SJ),GD#;G.36?827=MK]SH[ZG->1_9%G$LJQ^; Q8K@E5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5D^*/^12UG_K
MQG_]%M6M6'XS_P"1%\0?]@VY_P#134 4_AR WPU\. C(.G0@@_[HK8T[0M)T
MAG;3=-M+1I.',$*INYSS@>M9'PX_Y)MX<_[!\/\ Z"*Z>@#,O/#FB:C=-=7N
MDV5S.Z;&DF@5R5QC!R/3BFW/AC0KPPFYT>QF,"".(R0*VQ1T49' &3^=:M%
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M_M_N_P#T<U '>T444 %%%% !1110 4444 %%%% !1110 5R7Q/\ ^28^(O\
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MBBJ5MK&F7EW):6NI6<]S'G?#%.K.N#@Y4'(YH NT444 %%%% !1110 4444
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M 4444 %%%% !6'XS_P"1%\0?]@VY_P#135N5A^,_^1%\0?\ 8-N?_134 4/
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M<M.%V,V< )@ENG? Y[UM5S?BA[UYM-CM=)O+L0W<5R[PF/:%4G(^9P<_AWH
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MI%_Z *T*S]!_Y%[3/^O2+_T 5H4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5A^,_^1%\0?\ 8-N?_135N5A^,_\ D1?$'_8-N?\ T4U
M%3X<?\DV\.?]@^'_ -!%=/7,?#C_ ))MX<_[!\/_ *"*SXK2YO\ PG)XC?4K
MZ#5)('O(R+J00P8!98S$&V%0 %;(R>3G/0 [>BN(TFXU:?Q#JZZ7%:00NMO<
MR-<L[_/)&"5501CH23GN.*V([O4->T%7M[>UADD::VNHIW8A61FC<*R\D;E;
M!XXQTH WZ*Y%?$:Z1X'TJZ%O&LDWEVD,9=BBMR 2V"Q "D]"3CWI^G^+B9KM
M+WRIHK>T>\-S:Q2*H5,;E*N.&P01@G//3'(!U=%<_;WGB21K*Y:RL&M;AU\V
M))&\R!&&=VX\.1QD #KQG%5[:X\1MXFU6%18-:HT117E?*H0>@VXR<<^] '4
M445@:VLE_KNF:1]KGMK::*>YF-O(8WE\LQJ$#J0R@F3)P0?EQT)H WZ*Q['0
M%LI[]3>WEQ8W421K;7,[R^41OW%79BV&##C/&W\!%X458=$EC!(CBOKQ%W,3
MM5;B0 9/8 8H W:*XZQ\87%QK%A;M]CGM[Z9HD:V2;"X1W#"1E"."$QQCKD9
MQ3?$GBS4M'U"[@C@MH(HH@\$EW%+Y=R<9(\U1LC /'S'WZ8H [.BN<\1:]>Z
M2MBT%NH@G5C-=-#+.D)&W:I6($_-D_,< ;?<5/I>K7^H^%&U&*"TN+_9-Y44
M$W[J5E9@@#'[N[ SGE22#R* -RBJFES7MQI=K-J-HMI>O&&FMUD$@C;NNX<'
MZU;H **** "BBB@ HHHH *HZ=HVFZ1YO]G6,%KYIR_E(%W')//YG\ZO44 45
MT;34U5M46Q@%^PPUP$&\C&.OT)J]110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<$
M/^2_G_L5A_Z5&N]K@A_R7\_]BL/_ $J- '>T444 %%%% !1110 5P6K?\EM\
M.?\ 8*NO_0EKO:X+5O\ DMOAS_L%77_H2T =[1110 5Q'PK_ .10G_["=Y_Z
M/>NWKB/A7_R*$_\ V$[S_P!'O0!V]%%% !1110 4444 %%%% !1110 4444
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MHH **** "BBB@ HHHH **** "BBB@ K@A_R7\_\ 8K#_ -*C7>UP0_Y+^?\
ML5A_Z5&@#O:*** "BBB@ HHHH *X+5O^2V^'/^P5=?\ H2UWM<%JW_);?#G_
M &"KK_T): .]HHHH *XCX5_\BA/_ -A.\_\ 1[UV]<1\*_\ D4)_^PG>?^CW
MH [>BBB@ HHHH **** "BBB@ HHHH **** "N,^+/_)+/$'_ %[#_P!"6NSK
MD?BDBO\ ##Q"&&1]C8_B""* -[0?^1>TS_KTB_\ 0!6A6?H/_(O:9_UZ1?\
MH K0H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*\4?\
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M>,N4561=S [P<@8/3!/(QQ70T4 <M'I:WW@^^07LFL23I<&"YF4+)\Q)"C
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M;>'/^P?#_P"@BNGH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %8?C/_D1?$'_ &#;G_T4U;E8?C/_ )$7Q!_V#;G_ -%-
M0!4^''_)-O#G_8/A_P#0173US'PX_P"2;>'/^P?#_P"@BF7DVK:?J-BTNKF6
MZN[S8FF1Q(8C!N^8@[?,RB'<6+8W#&.0* .JHKG;MM3U76K^TL=5DT^.QAC
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M ,B]IG_7I%_Z *T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW&G:79VLS+M+PPJIV]<#'0<#@4 :=%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<$/^2_G_L5A_P"E1KO:X(?\E_/_ &*P_P#2HT =[1110 4444 %%%%
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MXSXL_P#)+/$'_7L/_0EH Z/0?^1>TS_KTB_] %:%9^@_\B]IG_7I%_Z *T*
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MT_[MG9RY+  ;AN).#D>U=!10!C7?ANWN+R6ZAO+^R><@SK:3E%E( 7)'.#@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5P0_Y+^?\ L5A_Z5&N]K@A
M_P E_/\ V*P_]*C0!WM%%% !1110 4444 %<%JW_ "6WPY_V"KK_ -"6N]K@
MM6_Y+;X<_P"P5=?^A+0!WM%%% !7$?"O_D4)_P#L)WG_ */>NWKB/A7_ ,BA
M/_V$[S_T>] ';T444 %%%% !1110 4444 %%%% !1110 5R7Q/\ ^28^(O\
MKR>NMKC?BNQ7X6^(2IP?LV/S8"@#HM!_Y%[3/^O2+_T 5H5GZ#_R+VF?]>D7
M_H K0H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#\9_\
MB+X@_P"P;<_^BFK<K%\7H9/!.O(OWFTZX _[]M0!2^''_)-O#G_8/A_]!%=/
M7,?#C_DFWAS_ +!\/_H(KIZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,_\ Z+:@#-^''_)-O#G_ &#X?_0173US'PX_Y)MX<_[!\/\ Z"*Z>@ HHHH
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M![>2S\,I:RZ;)IK17%QBU<#]VK2NRA2"00%8#(XXH Z&21(HVDD=411EF8X
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M5T]<M\.RP^&?ATH 6_LZ+ )P"=@[U)X;U'Q!>(YO[&S$(N[F-I5O"S*%E<*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMY\AER,!QL=@N,D$+UZD8Y-&UF>.RT2*>Z75!?S30B_3"9*B1UW(%&#MC((
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MNX8(DBA_<",J%&.2"<]J9IVC7^G3HBZPSZ?&S%+8VZAL')"E^X&>, '@9)H
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M'_8-N?\ T4U %3X<?\DV\.?]@^'_ -!%=/7,?#C_ ))MX<_[!\/_ *"*Z>@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O.K9 G[0]XPSE_#:L?^_X']*]
M%KSR'_DX6Y_[%I?_ $H% 'H=%%% !1110 4444 %>=:X@'QW\*R<Y;3;H'\
M?\:]%KSS7?\ DN7A3_L'7?\ *@#T.BBB@ KS[X+P+;?#N*!,[(KRY1<]<"5A
M7H-<%\'_ /D1/^W^[_\ 1S4 =[1110 4444 %%%% !1110 4444 %%%% !7%
M?%Q!)\*O$"G.! K<>SJ?Z5VM<9\6?^26>(/^O8?^A+0!T>@_\B]IG_7I%_Z
M*T*S]!_Y%[3/^O2+_P! %:% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=S8*DD]N'0GRVSB16S@K\K>ARI&* .@HK-DU5H];_LPV4I9[62XBD#+MDV%
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M^^:N\KB/A7_R*$__ &$[S_T>] ';T444 %%%% !1110 4444 %%%% !1110
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MVOVN2UO=,%@\N-W:5L$X5%!8G )P!V-6=/U*TU2V-Q9R^8@8HP*E&1AU5E8
MJ1Z$ T 6J*** "N"'_)?S_V*P_\ 2HUWM<$/^2_G_L5A_P"E1H [VBBB@ HH
MHH **** "N"U;_DMOAS_ +!5U_Z$M=[7!:M_R6WPY_V"KK_T): .]HHHH *X
MCX5_\BA/_P!A.\_]'O7;UQ'PK_Y%"?\ ["=Y_P"CWH [>BBB@ HHHH ****
M"BBB@ HHHH **** "N,^+/\ R2SQ!_U[#_T):[.N,^+/_)+/$'_7L/\ T):
M.CT'_D7M,_Z](O\ T 5H5GZ#_P B]IG_ %Z1?^@"M"@ HHHH **** "BBB@
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M.]T?6;ZQ2U2[EE2XG:Z1MRW# H,#J581(/09J&PO;)K+6FU#Q9>PWEC>W,,
M:\VM$J.VSY.DO_ @V>G;%>@/IUC)#'"]G;M%%_JT:)2J?08XK-T709-.,AO+
MBWO6,TDT3_90C1-([.V#N/&6XZ=.] ',)>BX\5_9=<UJZT])M(M;S[)]J-NO
MGL9%DPP(88VK\H/<D@XJ6\U&=_ UU<PZS*K07;+8WK28,R!\*3T\Q>2/]H+G
MWKHFT*67Q#<:C/<P36L\4<36DEJ&P(]Y4ABW7=(QZ>@]ZU+BRM+M%2YM89D3
M[JR1A@/IF@"CHNGQVBR31ZM=Z@90 [S3B1=PSDJ!PN<]%P.!Q4VDZUINNV\L
M^EWD5U%%,T$CQG(5UQE?KR/SJU;VMO:1>5;010QYSMC0*,_0406MO:HRV\$4
M*LQ=A&@4%CU)QW/K0!+7(>(K: ^)=.A^VI;PZEF&_@W >>B*77OQG!0GNK$=
MACKZJSZ;8W4RS7%E;32J  \D2LPQTY(H Y_Q:[I?:)%;ZS)ILD]T89"D@ \H
MPRL3M;C.5&&(.#CKTK8M$M=%TF:=]0GELXPT[3W4YEV(%R?F/.W@GDGJ>V!5
MFYTZQO'#W5E;SN!@-+$K$#TY%2K!"MO]G6*,0[=OEA1MQZ8Z8H AT[4;/5]/
MAO["X2XM)UW1RIT85D^%9H9DU;R?$#ZQMU&56+@#[*>/W(QV7^M;D$$5M"D,
M$211(,*D:A54>@ Z4D-M!;;_ "(8XO,<N^Q0NYCU)QU/O0!+7(ZUJMM<7][H
M>G36MK-(H_M*^<JH@4J!@9^_*5QC/"C!/8'KJIS:3IMS,TL^GVDLC?>=X58G
MZDB@#'O'M-/\0>'Y7FCCL!:7%O"[O\OF'RBG/3.Q),?C5&VU?3-.TC4-3NU2
M>VEU60V2JH8S29P/+SQDLK\]."<@9-=;-:V]Q;FWG@BE@(P8W0,I'T/%-ELK
M2>W6":UADA3&V-XP5&.!@'B@#'\/*99;W4+RZM9-0N5C\Z&WE#I;1KNV)GOU
M<ECU).. *9X<N()-:\3+'-&Q.IJ0%8'(^R6];4%A9VL;QV]I!"DGWUCC"AOJ
M .:CMM(TRSF$UKIUI!*!@/%"JM^8% %RN9TZ[LK#Q-X@6^EAM[N6>.2-YF"F
M2W$*!=I/50XD&!T))[UTU075E:7J*MW:PW"J=RB6,. ?49[T <C=W]C+#HVE
M^'88;F":=KWR(Y1&&BC<ME2W8RE",<$!L<5FN]M-X2ET'4XX(UM=7M[=K=IE
M8+ ]PC(N1V"G;_P ^E>@&SM6N4N3;0FX0;5E*#<H] >HZFHGTG393(9-/M'\
MQM[[H5.YN>3QR>3^= '.:1/<#QI_9]XS/<V>G,OG,/\ 7QF1=DF>F2 0?]I3
MVQ5_1)H9/$GB!(_$#ZA(DD6^Q8#%C\I^48_O=?PK>$:!@P10P&T$#D#T^E,C
MMH(9998H8TDE(,CJH!<C@9/>@"6N=\8S0Q:7:"21$8ZG8'#, <"ZBKHJJW6F
M6%\ZO>6-M<,HPIFB5R![9% &?XA@6ZT^VN8;RV@EM;A+B&2=\1,PR-K'T(+#
M/8X.#BN>TVTGU^#Q6U[?6QL]1A6 7%I_J8V",K[6/W\?+EN 2"/X:[&33+":
MS6SEL;9[5<%86B4H,=,+C%2FV@:V-LT$9MRNPQ%!M*],8Z8]J ./TJXU'4_&
M]M<37FG7$=I8SPS#3R71&=XBN]S_ !-M)"=@"<G(K2TJYMV\9:XJ31$F*U"A
M6'. _2MVUM+:R@$%I;Q01#I'$@51^ JO#HVEVTZSP:;9Q3*<K(D"JP^A H Y
M34[NUMM+\;6EU/$MU.7*1,PWRA[9%CVKU.2-HQU((KH]9O)=+\.W%S&JF\$2
MQ0@_Q3-A8US[NP'XUH26EM-/%/+;Q/-%_JY&0%D^AZBI'1)  ZJP!! (SR#D
M&@#*B2QT#1K+23J$5JP@%O;R2NH9F5>H#?>/<UG>"V<#6H9;U=0DCU [[]0
M)R8TZA?E!480A>/D]<BNCN+:WO(&@N8(IXF^]'*@93]0:6""&VA6&WB2*)!A
M4C4*JCV H DHHHH *X(?\E_/_8K#_P!*C7>UP0_Y+^?^Q6'_ *5&@#O:***
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M_P"2V^'/^P5=?^A+7>UP6K?\EM\.?]@JZ_\ 0EH [VBBB@ KB/A7_P BA/\
M]A.\_P#1[UV]<1\*_P#D4)_^PG>?^CWH [>BBB@ HHHH **** "BBB@ HHHH
M **** "N,^+/_)+/$'_7L/\ T):[.N,^+/\ R2SQ!_U[#_T): .CT'_D7M,_
MZ](O_0!6A6?H/_(O:9_UZ1?^@"M"@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P E_/\ V*P_]*C7>UP0_P"2_G_L5A_Z5&@#O:*** "BBB@ HHHH *X+5O\
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M^=5]*LFT[2;2R>02O!$L;.J[0Q QD#)Q^=7** "BBB@ HHHH **** "BBB@
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MQ_R3;PY_V#X?_0173T %%%% !1110 4444 %%%(S!1EB /4T +1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5YY#_ ,G"W/\ V+2_^E KT.O/XT*?M!S,2,/X8!'_ ($X_I0!Z!1110 4
M444 %%%% !7GFN_\ER\*?]@Z[_E7H=>?:TA?XX>%V!'R:;=,?T']: /0:***
M "N"^#__ "(G_;_=_P#HYJ[VN%^$B&+P2\9()74;M3CVF:@#NJ*** "BBB@
MHHHH **** "BBB@ HHHH *XSXL_\DL\0?]>P_P#0EKLZXSXL_P#)+/$'_7L/
M_0EH Z/0?^1>TS_KTB_] %:%9^@_\B]IG_7I%_Z *T* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *P_&?_(B^(/\ L&W/_HIJW*P_&?\
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M-Y.K".\.TX,9)((7D' '6@#I*R-6UW^R;NTA;3[N:.XFBB:XC"B.(NX1=Q+
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MZ/>NWKB/A7_R*$__ &$[S_T>] ';T444 %%%% !1110 4444 %%%% !1110
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M])<O(L^87U)[E3E/E;+LVUNH&",Y/!QQWBPQ)(TBQ()&^\P4 GZFF):V\?\
MJ[>)?FW_ "H!\WK]?>@#S"RU+4I;&*ZN=2L+36?-43?:-?F!CEW#,9M?*V8_
MA"@=""&)^:MV[N-.FU'6CKNNW.G36\FVWC2_>W$<.P%75%($A)+')#<C;VQ7
M9FV@-Q]H,,?G 8\S:-V/3/6E>"&61))(D=XSE&902I]CVH X:&[LA\%=-GGU
MZ72K9=-M5?4;8Y>(@(., \Y^4CW-=Q;%3:Q%)3*I08D/5QCK^-*UO T)A:&,
MQ'JA4;3^%28P,"@ K+7_ )&N7_KQ3_T-JU*IR:>CZG'?B:9)4C\ME5AM=<D@
M,".Q/;% &=K/AJ/5[^VNC<- 8#O"Q@CS&Z?/@C<-A=<?[9YZ5-K>@0:U81V9
MD:VC4[2\/RR"/NJL#\N2%SUX'3H1KT4 5M/M!8V$-L"K,B_.RJ0';^)L$D\G
M)Y)Z]:J>&O\ D6=,_P"O9/Y5H3Q&:!XUEDB+#&^/&Y?ID$5'8V<>GV$%G"6,
M<$8C4N<D@#')]: +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7!#_DOY_[%8?\ I4:[VN"'_)?S_P!BL/\ TJ- '>T444 %
M%%% !1110 5P6K?\EM\.?]@JZ_\ 0EKO:X+5O^2V^'/^P5=?^A+0!WM%%% !
M7$?"O_D4)_\ L)WG_H]Z[>N(^%?_ "*$_P#V$[S_ -'O0!V]%%% !1110 44
M44 %%%% !1110 4444 %<E\3_P#DF/B+_KR>NMKDOB@0/ACXBR<?Z&] &[H/
M_(O:9_UZ1?\ H K0K/T'_D7M,_Z](O\ T 5H4 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5A^,_\ D1?$'_8-N?\ T4U;E8?C/_D1?$'_
M &#;G_T4U %3X<?\DV\.?]@^'_T$5T]<Q\./^2;>'/\ L'P_^@BNGH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ K@A_R7\_\ 8K#_ -*C7>UP0_Y+^?\
ML5A_Z5&@#O:*** "BBB@ HHHH *X+5O^2V^'/^P5=?\ H2UWM<%JW_);?#G_
M &"KK_T): .]HHHH *XCX5_\BA/_ -A.\_\ 1[UV]<1\*_\ D4)_^PG>?^CW
MH [>BBB@ HHHH **** "BBB@ HHHH **** "N,^+/_)+/$'_ %[#_P!"6NSK
MC/BS_P DL\0?]>P_]"6@#H]!_P"1>TS_ *](O_0!6A6?H/\ R+VF?]>D7_H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK@A_R7\_]BL/_2HUWM<$/^2_G_L5A_Z5&@#O:*** "BBB@ HHHH *X+5O^2V
M^'/^P5=?^A+7>UP6K?\ );?#G_8*NO\ T): .]HHHH *XCX5_P#(H3_]A.\_
M]'O7;UQ'PK_Y%"?_ +"=Y_Z/>@#MZ*** "BBB@ HHHH **** "BBB@ HHHH
M*XSXL_\ )+/$'_7L/_0EKLZXSXL_\DL\0?\ 7L/_ $): .CT'_D7M,_Z](O_
M $ 5H5GZ#_R+VF?]>D7_ * *T* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *P_&?_ "(OB#_L&W/_ **:MRL/QG_R(OB#_L&W/_HIJ *G
MPX_Y)MX<_P"P?#_Z"*Z>N8^''_)-O#G_ &#X?_0173T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5P0_Y+^?^Q6'_ *5&N]K@A_R7\_\ 8K#_ -*C0!WM
M%%% !1110 4444 %<%JW_);?#G_8*NO_ $):[VN"U;_DMOAS_L%77_H2T =[
M1110 5Q'PK_Y%"?_ +"=Y_Z/>NWKB/A7_P BA/\ ]A.\_P#1[T =O1110 44
M44 %%%% !1110 4444 %%%% !7&?%G_DEGB#_KV'_H2UV=<9\6?^26>(/^O8
M?^A+0!T>@_\ (O:9_P!>D7_H K0K/T'_ )%[3/\ KTB_] %:% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG_7I%_Z *T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MP_&?_(B^(/\ L&W/_HIJW*P_&?\ R(OB#_L&W/\ Z*:@"I\./^2;>'/^P?#_
M .@BNGKF/AQ_R3;PY_V#X?\ T$5T] !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^1>TS_KTB_\ 0!6A0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !6'XS_Y$7Q!_V#;G_P!%-6Y6'XS_ .1%\0?]@VY_]%-0!4^''_)-O#G_
M &#X?_0173US'PX_Y)MX<_[!\/\ Z"*Z>@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "L/QG_ ,B+X@_[!MS_ .BFK<K#\9_\B+X@
M_P"P;<_^BFH J?#C_DFWAS_L'P_^@BNGKF/AQ_R3;PY_V#X?_0173T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5P0_Y+^?\ L5A_Z5&N]K@A_P E_/\
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M./\ DFWAS_L'P_\ H(KIZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^+/_ "2SQ!_U[#_T):[.N,^+/_)+/$'_ %[#_P!"6@#H]!_Y%[3/^O2+_P!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %>;67_)Q>I?]B\O_ *.2O2:\
MVLO^3B]2_P"Q>7_T<E 'I-%%% !1110 4444 %>;:W_R7_PQ_P!@JX_]FKTF
MO-M;_P"2_P#AC_L%7'_LU 'I-%%% !7FWP)_Y)58?]=Y_P#T8:])KS;X$_\
M)*K#_KO/_P"C#0!Z31110 4444 %%%% !1110 4444 %%%% !7#?&+_DD^O_
M /7*/_T:E=S7#?&+_DD^O_\ 7*/_ -&I0!U.@_\ (O:9_P!>D7_H K0K/T'_
M )%[3/\ KTB_] %:% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX@_[!MS_ .BFH J?#C_DFWAS_L'P_P#H(KIZYCX<?\DV\.?]@^'_ -!%=/0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7FUE_R<7J7_8O+_Z.2O2:\VLO
M^3B]2_[%Y?\ T<E 'I-%%% !1110 4444 %>;:W_ ,E_\,?]@JX_]FKTFO-M
M;_Y+_P"&/^P5<?\ LU 'I-%%% !7FWP)_P"256'_ %WG_P#1AKTFO-O@3_R2
MJP_Z[S_^C#0!Z31110 4444 %%%% !1110 4444 %%%% !7#?&+_ ))/K_\
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M .C4H ZG0?\ D7M,_P"O2+_T 5H5GZ#_ ,B]IG_7I%_Z *T* "BBB@ HHHH
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MO#G_ &#X?_0173US'PX_Y)MX<_[!\/\ Z"*Z>@ HHHH **** "BBB@ HHHH
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M?]@^'_T$5T] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>;67_)Q>I?\
M8O+_ .CDKTFO-K+_ ).+U+_L7E_]')0!Z31110 4444 %%%% !7FVM_\E_\
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M\#^)= TSP+H=C>:_I$-S!911RQM?Q95@H!'WJZ#_ (3+PM_T,NC_ /@=%_\
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M (3+PM_T,NC_ /@=%_\ %4?\)EX6_P"AET?_ ,#HO_BJS/\ A5W@?_H6=/\
M^_='_"KO _\ T+.G_P#?N@#3_P"$R\+?]#+H_P#X'1?_ !5<)\(=9T?0/AW9
MZ?JNM:5:W:2RLT3W\.0"Y(Z-Z5U'_"KO _\ T+.G_P#?NC_A5W@?_H6=/_[]
MT :?_"9>%O\ H9='_P# Z+_XJC_A,O"W_0RZ/_X'1?\ Q59G_"KO _\ T+.G
M_P#?NC_A5W@?_H6=/_[]T :?_"9>%O\ H9='_P# Z+_XJC_A,O"W_0RZ/_X'
M1?\ Q59G_"KO _\ T+.G_P#?NC_A5W@?_H6=/_[]T :?_"9>%O\ H9='_P#
MZ+_XJC_A,O"W_0RZ/_X'1?\ Q59G_"KO _\ T+.G_P#?NC_A5W@?_H6=/_[]
MT :?_"9>%O\ H9='_P# Z+_XJC_A,O"W_0RZ/_X'1?\ Q59G_"KO _\ T+.G
M_P#?NC_A5W@?_H6=/_[]T :?_"9>%O\ H9='_P# Z+_XJC_A,O"W_0RZ/_X'
M1?\ Q59G_"KO _\ T+.G_P#?NC_A5W@?_H6=/_[]T :?_"9>%O\ H9='_P#
MZ+_XJC_A,O"W_0RZ/_X'1?\ Q59G_"KO _\ T+.G_P#?NC_A5W@?_H6=/_[]
MT :?_"9>%O\ H9='_P# Z+_XJN1^)VO:)K7PXUC3M.US2;B[FC01Q)?Q98B1
M2>K>@-;?_"KO _\ T+.G_P#?NC_A5W@?_H6=/_[]T 3:/XM\-6^B6$,OB+1U
MDCMHT=3?1<$* 1]ZKO\ PF7A;_H9='_\#HO_ (JLS_A5W@?_ *%G3_\ OW5'
M4_!'PST6))=4TG1;.-SM1K@A-Q]!D\T =#_PF7A;_H9='_\  Z+_ .*H_P"$
MR\+?]#+H_P#X'1?_ !5<E<^'OA+9K T]EH:)/'YL3Y!5DSC=N!QC(/-)_P (
M_P#"7[<]E_9^C?:4SNCVG(QG/X<'GVH Z[_A,O"W_0RZ/_X'1?\ Q5'_  F7
MA;_H9='_ / Z+_XJN5E\,_":"X@MY;3P_'-.JO%&\JJSJWW2 3W[>M6HO WP
MUFV^5H^C/NN&M1MP<S+G='U^\-IXZ\4 =!_PF7A;_H9='_\  Z+_ .*H_P"$
MR\+?]#+H_P#X'1?_ !5<\G@CX:2).Z:/I#+;W(M)2!PDQ*J$//#991CW%.U+
MP+\.-%MTN=0T+2[>)G"*SQD@L>0,=^AH W_^$R\+?]#+H_\ X'1?_%4?\)EX
M6_Z&71__  .B_P#BJYF;1?A3:V]O/<V/ARWCN 6A,Z1Q[P#@D!L'&>]%QHOP
MKM+X6=QIF@1SG9@- H7YAE?FQCD$8Y[T =-_PF7A;_H9='_\#HO_ (JC_A,O
M"W_0RZ/_ .!T7_Q5<[_PCWPO^R/=?V5H'D)=?8V?R4P)\X\OI][)Z5-=>$_A
MM8ZA;V%WI'A^"\N<>3!)'&KR9.!@'DY/'UH W/\ A,O"W_0RZ/\ ^!T7_P 5
M1_PF7A;_ *&71_\ P.B_^*KFAHOPH-O<SBS\,F*U<).X$6(V)P 3V)(('T-7
ME\%_#Q]-74ET/0FL64.MP(D,94]"&Z4 :_\ PF7A;_H9='_\#HO_ (JC_A,O
M"W_0RZ/_ .!T7_Q59B> _ 4EW-:)X=T9KB%5>2(6Z%D#9VDCMG:<?2LYM!^%
M2->*UCX:5K+_ (^01%^YYV_-Z?-Q]>.M '2?\)EX6_Z&71__  .B_P#BJ/\
MA,O"W_0RZ/\ ^!T7_P 56+8>#_ASJBAK#1-"N5,8E!AA1@4)(!!';*L/J"*N
M_P#"N/!?_0KZ5_X#+_A0!=_X3+PM_P!#+H__ ('1?_%4?\)EX6_Z&71__ Z+
M_P"*JE_PKCP7_P!"OI7_ (#+_A1_PKCP7_T*^E?^ R_X4 7?^$R\+?\ 0RZ/
M_P"!T7_Q56++Q'H>IW(MK#6=.NYR"1%!=)(V!U. <UE?\*X\%_\ 0KZ5_P"
MR_X5=TOP=X;T6]%YIFAV%G<A2HEAA56 /49% &W1110 4444 %%%% !1110
M4444 %%%% ',>)/!T7B2Z>6:X,/^AF&%T'SPR[PZ2J?4$=._([UAP?#:Z@?2
M\:E9YLX[5#<BR*W2"%45ECE5Q\C;.C!L;F]L>AT4 </9?#R.QU_1=8BO=LUC
M).URBIA;D.)0A(SPR>:1GN./2MJ_\.&_U/4[V2XC+76G?8(%D@#K""7+D@\,
M&+)D="$ K>HH \XN/A6E_I5[#<WL-K<S,[PIIL'D6T3&)8MWE9.3@'G(^\0*
MT8_ =S]M EUR9+"*>XN(!;*8KE7F;<VZ7<01G=T4=:[:B@#DK3P=<VNNPW']
MIK)IT-Z;]89(29C,;?R3NDW8*X);[N<GK5W1?#']EV^EJ^HWCO8VX@,4<I6"
M7K\S1]S\WZ#TKH** .&U3P#-?Z+#IZSZ9(5:\#/>6 GV"XD+[HSN!5ESCK@_
M@*LV_@_49-4NKG4]::=&C,%H\"M#-:Q94[48-C)VC<V,M[#BNPHH \WU3X5'
M4-2FNEU5 S.LJ74UN9+L,L(C5&EWC='D!RN 2>_>FZI\,+K5;BZOKB_TR6_O
MA*EQ)+IY980XC4/ #)E'41C!)/)[5Z510!E6&B_9-<U'5))_.DNDBBCW+S%'
M&OW<]\LSMVZ^U:M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7-ZY8ZG'XAT[7--LHK]K>VFMGMI)Q$0)&C;>I((R/+P1QP?;GI*Y?Q=XF
MO?#\EFMK91R13+(TMS,)3'#MV[0WEHQ&[<?F. -IYY% &+I_@/4)+V>2^O9+
M&&Z@F$L.GRK@&6>20QY9.0%<<@#G-;EUX?G%[?M:H@MWT5;"!2_.Y3)@'/;#
M+S56'XCZ/Y:M=)/$JQ(UQ/&OFP1.T'G[?,7AODS@@8X]Q22_$?2X0%?3]6%S
M@M]F^S#S-H02;L;L8VY/7L1UXH Q;?PMXAL?#FI:#'IME<)JULBO=2W./L[?
M9HX6#+M);:4)7!YSCCK4$?@+6]*O;#4=,:%Y$U&ZO+RUDDPLSYN/(D![$K*J
MM[;?[M=#_P ++T'[?>VF+K?:0K,QV+\X;9M"KNWY)D4#*@$]Z6;XD:/;F436
MNHQM;Q2RW2O" ;<1D [_ )NY*XQG.X>^ #$C\%^(-)TPP07":F9OLES,LA2(
M_:(;E)7P0.=X+_,>?E6NDUC2]1\26&E+<02:?)#?K-,L-U\Z(%<95U[\BLFZ
M^*NCMH%U?Z;!<W=S#'.WV=$#[/*526=D+*$^=/F!/WO8XUM:\90:#KJ6-U9W
M$EN;3[5)/ F[REWA27'91D'/)]J (+C2]6TC7Y;[3;&/5HKFQALV^U7>R2,Q
MM(<EBIW*WF<]\CH<US\'P[U6VTF:'[:SE5M ;2.<I!=I'&JO&W&5!P0#[#/&
M17;V/B33M1DDC@>3?%"9I59"#& [QD-Z'=&XQ_LFN=MO'&H.ME/-9Z7MU&S>
M\M+)-0 NBGEM(F491G.W!VYP3W )H YV3X;:T]VR VWV)[S^TVC\SG[4)W .
M,=/)8'_>45U?BS1=7U;4[1;&UMQ DMM-]J\\HRM%+OQ(F")$ P5'9LGCK6;;
M_$:5='U.YOX;&WN+:*(Q1-,\1$LC%%21945E ;;E\%<$\\5V.@:M'KFA6>I1
MF,B>,%A$X=0XX8!AU 8$9]J /.[[P9XCOM2&HM9Q0"%X"UI::BT8E$?F@"%@
MH,*XDSC/)STZUO2:7J=AX*T6.]S)+8WT-Q=(C>:?*$N<9P-Q0%23C)V$]:[>
MB@#S_2/!?B32M;UB[B\0V_F7Z0L]X]CN>5U:4D%2^!@.H&.P  &.<"7X=>(#
M=R3@EA%</,534&07&ZZ68"(!?]'^4-G'5L'MFO7Z* .&\,:9JEEK6G1WD<BF
MWL[PSDR&4()KA&AC,A \Q@J/D]?7[P)[FBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*U?P]8ZS+!/.UU#<0*
MRQSVMR\,@5L;EW(1D':.#Z"M6N+\8:5>ZQXFT2VMQ&T(M;MY!,TJQY#0 9\M
ME.[EL9/K0 MG\-=$@U"[FF226UD9!#9^=((D1;=8 &7=AFP'^8\_-[5HVG@G
M1;-F=8[F65D>-I9[F25RK($(RQ)P%  ':N0:]UE=1U+4A9W::3>17&G6A$S'
M8(T(B?R\97+I+A\\^:OM5WP/IVHZ9KZQWJ&WCETQ'CCBEFDCG8E=S-O)"2+T
MP!R'SSC@ W)/A]X>FF>66&ZD+1>4JO>2E8A\O*#=A#\J\C'(J>'P5H<5O=0M
M;RS"[A>&X>:=W>57.6)8G.<@<]1@8Z5Q&LW?B<^%I)=/M;IWEU.XEU&:&51(
MFRXV1PJ&((4JJ#(_A7_:)%OP7+K#^/M0:\EO##(+WS()3-^XQ<+Y6_<?+Y3.
MSRP/ESG=UH Z&Z^'>AW=H+=WU%?ED221;V3S)4DV[U=B264[%XZ<5H:QX2TK
M7+^.\OEN&D2+R"L=P\:R1[@Q1PI 8$@9!]*XE/+C%T]W_P )"?$[3W0D$'G^
M5LS)LSG]UY0381CG.,<YI!X:U&'PKH\7DPM<WEW;&4++<!601.3YA+$CD\XQ
MSB@#M?#WAT:-<ZO>3212W6IW1GE,49154#"J 2?<D]RS5#'X%T)'C#174MO$
MKK%:37<KP1!D9&"QEMH&UF7'8'C%<YX7^VZ?J&DVUP\R7;WMY;W%HTDCK#$(
MPP"LY)=0RQE6_P"FI'&<54OKJXMO&6L&6[U&YAG,RS06D-PD]G"MNI#1MO\
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6BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>modificationno13effectiv003.jpg
<TEXT>
begin 644 modificationno13effectiv003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""]>:*QGDMS&)40LOF*
M2N1SR 17*^$_$^J^)/A\OB.2&S@GFCDDAA4,RJ$9AACG)SM[=,]ZZ;5;B&TT
MF[GN)HX84B8L\C!548[DUY+\.;+2)_@M#>3:K>1&&"X$X74Y8TB;>^ 5#A5R
M,'&.<^] &LWQ$UQ?AQI?BL6FGF34+E(%M</A-SE 2^[VST[UT/C?Q+JGA71M
M/N[>*SN9KB[BLW2165=SY&X$'@ CIS]:\GNM0T]OV>/#,+7L2LE]$)%64!TQ
M,Y/0Y! YKJ/BM;Z1I>A:'=+JER^[5K:11/J4DRM&"26"LY! '>@#JYO%E]<>
M-I/"EE+IT%Y;6B3RRW:L?/9OX8D# X Y)R<9Z=Z=<>,KO2/#=A-JUA&VN7MX
M]A!8V[D)+*)60$,W1,*&+'H#T[5B^+K7P7XMU:YL-8O(-,U.Q2*2SU-;A8G*
MLNX%7. P!SQSC.1C-<VL7B#4O#'ACQ%J33:B/#VLN7G2,E[JS#!?/"]6X&?<
M<^] 'H&M:_KOA735UC5XK"[TV-E%XMFCI);JQ WKN8^8 2,C"G'/M4_B3Q-=
MZ3+X?DL;>UN+'5+^"T:9I6W*),D%5 P>!U)].#6+X]U_3?$/@J[T;0;RWU34
MM4006UO:2B1N2,LV/N*!DDG %5O&?V;0-#\!Z==WD"O::O8(S,X7*HI4OS_#
M[]LT =/XD\1SZ;J^BZ)I\<+ZEJTLBQM/DQQ1QKN=R 06XP ,C)/6L.;XC/8^
M'M6DN[2)]9T[4!IOV>)BL<\KD>6P)R54@YYR1@CFCQBB6'Q!\'>))Y%CTR W
M-K<7#'Y(C+'^[+'H 3QGIR/6N)U/2;G4=-\2>*;6*26P'B.VOX"B$F:"#Y7D
M4=U^8D'N%- 'HD?BS4['6]2T+4;.&\U2&Q2^LUL0R"Y5FV%<,3M(? SG&#GC
M!IFG>)O$EKXKT_1/$NE:?"-3BE>UGL)VD"M& S*X8#L>H_\ U9":IIUS\4[[
MQ;'?0-H.F:"+:>^5MT7F-*7VJPX8A<9 SR0.IIV@>./#?B#Q-;:C-J=O)?39
MM=+T^+,DD*-RSOC@.VT$]E"@9SG(!+-\1+U=*O\ Q+%;6I\.V.H_8Y =QGDC
M#B-IE.< !FX4CD \BM_Q!XBOM(U[P_:06MM)9:G=?9WF:5MZG8S?*H&,?+US
M^'>O+9K<VWPJUOP&#NU^356M[>S_ .6DJM.LBR ==FW)W=.#7;^.[RST[6_
MT-S=P1M%JBEM[A<+Y3KN.>@R0,T =%XF\3Q:!]BM8H#=ZKJ,ODV5FK;?,8<E
MF;^%%')/:JGB#Q'J'AG0K1[I;2[U:_O(K*TBA5HXO-D. "222!@DGC..@KF_
M&VG6/_"TO#FJ>((;>306LYK4R70!ACG.2-^>!N' SW%<C;:5/;>'X]6MUE.@
M:7XQ6]M.K*MB&VET']P$YSZ9/O0!Z+)X[;1)/$=KKZ0&YT:U2\5[52BW,3#C
M"L25;<-IY(Y!I^G>+=3@UK1;'7X;.)=;M'N+8V^X>2Z*':)RQ.[Y6SN&.0>*
MXKQ-I$WC75/'%_HI%W:?V/#9PS0G<L\R.)2J$<-C: <=SBM&26W\:>*O!']E
M3K/'I]C<RWSIS]G\R%8U1O[K[L_*>>#0!IVOQ#O9=+T[Q++:VJ>';_4/L<8^
M;SXT+E$F9L[<%EY7' /4U>\2>)/%6AN=2CTJP?1TO([8PO(QNI59Q'O7'RC)
M884Y..3CH//X(FN_A?H'@A"/^$@@U98)[/\ CA5)F=I&'4)MP=W0Y%=/\1KW
M1]?TZ1-%UMG\4Z==*EE;6=VWF+.'P08@<'@MEB.!GG% '3ZKXCOF\7P>%]&2
MU%Z;)KZXGNE9DCC#;% 52"2S>_ &>:RXOB3'/X7TN\AL5?6=1NSI\=AYN +A
M6*OEL'"+C=G'0CUJ"_D@\.?&'^VM5N([73K_ $4VZW,IVQB:.0,4+'@$KR!W
MP:X:ST34M(TOPKXOELKEK2TUB[O+B%8R9([><@+(4Z\!<GO@B@#U:\NO%>FO
M82N-+OH)KN&&Y6""2)X4=PI<$NV[&?0>M7/%^KW6@>%-1U>T6%Y+*%IO+E4D
M. .F01CZ\TEOXOT34#"FE:A!J<LK*!%92+(R@GEG /R*.I+8Z8Y.!6;\4+B&
M#X::_P"=*D?F6;HF]@-S$< >I]J ,]/'&J6%WX6_M:TLWM/$(1(I+4LKP2,H
M8!E;.X?-C((^E5V^(MY_9,OBA;:U'AN+4?L;9W><8MXC,X;.T#>?NXZ=ZN>#
M/#6BW^C>'-=>>;4;FVL8Q;--<&1+=BBAMJ] >W(R,>U>?-:E/A#=?#U6!\0'
M5?LJ6G_+0C[0)1+CKY>SG?T]Z /0]2\8ZI)J?B*#0[:TDB\/VZRW)N-Q-Q(5
M+F-,$;<*/O'/)QCO3_\ A-Y-9U+1--\/+!Y^IZ>=2>:Z4LL$' &54@LQ8[>H
MQ@]:YF6>W\*ZQ\1+;4I1$^IPK<V"M]ZZW1,A6,?Q,'PN!ZBJ_AW37\#^)_"U
M_KLB6=M)X;.GR33,%2*=9/-V,QX!P2!ZE3B@#M-,\7W>J^"+W5[:RM_[2L&F
MAN;:28K&LL6=X#!2<<9''<<CK5_3=;U'4_ VGZS;6,<VH7EI#,MN'V('D"]2
M>0HSD]3@<9-<AX3A.G_#3Q3J5Z1;6^IW=]>P&?Y#Y4@PA.>F<9'U%;?@S7M)
MT[X4Z#J%YJ%O#:06%O%+,SC:C[57:3V.>,4 6/#>NZ]<>)=3T+7K2Q$UI!%<
M1W-@7\ME<L-I#<ALJ?PKK*\[\)VUO'\2-7N?#^H37NA7%BDER_VEKB+[87P-
MKL3D^6.0"<9'L!Z)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5?XR.X YKB6ETS6/B3H&M>%-6DO))1*NI^1=-+$+?8=N\$D)\^,+QDG..,T
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MHHH **** "BBB@ HHHH 0@,,$ CT-($0 @(N#U&*=10 SRH_^>:?]\BE*(0
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M*  @$8--**RE2H*GJ".*=10 @4* %  '0"EHHH **** "BBB@ HHHH ****
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M[5 S2E%+ARHW 8#8Y IU% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>25':U9IBGF@I(KXXC\OCKC\Q0!Z_K_C%?#^F:]?75F%CTU5\C-PG^E,R@@
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MI:?;ZN/]!NIC&T<IV[P#M8E25!QD51M?"-U_946MZQK4^IW5II<J6<7D)#'
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M4HK^7%$A9N#D<ML7/^U6;JGBV_U?P#X7U/2KYK"XU;4+2TGECC5FB+MLD #
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MH>G1V%A%Y<"$MRQ9F9CEF8GDDDDDFKU><S^,[^]^'GAW6;6;R+RYU"TM;P!
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MI"AW8QC!(8GGOWKMZ* .!\!^ +GP7XBUV<7<<VEW0C2PC!.^&,,[;&R,8!?
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M<H&1@X[=*]+HH X&+PGK^J-XCU+6Y=/AU'4]+.FVUO:L[10IA\%F(!)+/V'
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M/W@<'GJ2>:]0HH X^Q\/:]J/BBQUWQ+<6"G3HY%L[.PWLBO(-K.[N 2=O &
M.:PM.\(>-K;PDWA3[7HMII[F:-[V)I99S'([,VU2JJ#AB,Y->FT4 <M8>%'T
MWQE9:C;-&NFVFB#2XXRQ\P$2*RGIC&U>N>O:K'A_0KG2M=\1WT\D31:G>)/"
M$))51$J'=D=<J>F:Z&B@#SBT\!:UIOAGPU]AN[%=>T*6=HS+N:WF25FWH2 &
M&5(YQP1^-:NFZ%XAU+Q59Z_XF;3X?[/ADCL[2P=W :3 =W9@.<#  '>NRHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M927]N5D6(<R/*0,@$B+D]0&QWKK-+L/%7A'XK6]]J>G6MQ;ZIIS6T@T>*0Q
MPH-@;?T;Y549.,&@#JO"/Q"U;Q?=P7-IX5D3P_/-)$NH&]1G7:#@M%C(!(QU
MXSWJ/PO\1=<\67"R6'@R0Z6+LVTMZ=2C'EX(W-L(#' .<"N'T2%7^)&BW7@?
M0_$&BQ2SDZU:W4+1VRH,9X)(S][ ]=N *9\+(+31]5C35+/Q1!JC:E((XTBE
M6TVM\H+C[O<Y)]!0!ZGXZ\9R>#K;3&@TIM2N-1O%M(81.(OF8''S$$=<#\>M
M<W<_&(Z?I.O2ZEX<GM-5T:2%9[$W2N&$I 4B11COGIZ?@_XQ:7>ZJOA2&R2Z
MR-9BWS6R%F@!XW]"!CKD\5B_$'X>1:)\.-?DTYM3U?5M0G@>XN)SYTT@5Q@8
M4#@#V_D* .JN?'FNZ5X6U77M:\'O80V<4<D2?VC'+Y^Y@N,J#MQD'D5#HOQ,
MN[SQ!IND:SX8FTI]4MFN;*47B3K(H4OSM V\#OSTXKD+Z*RN_A3XGT[0[7Q/
M-<M# SIJ<4K$D2+Q'N^A) I-%\,WOA'Q[X7OC;ZEJ=IJ6E^0TMT&F>PE*<@'
M'R+R!@] 6]* .GC^,-M+X*T[7(]&N)+_ %*Z:TL]-BEW-*ZG'WL<#IV/45>T
M?XAZBWBJS\.^)_#,NAWE]&SV;_:DN$EVC)4E1P>/Y>HKR_1-#UW2O!?@GQ F
MBWUP=$U*Y>ZLDB83>6[+\P0\G&T_F.W-=D+VY^(OQ*\,ZE8:/J=EI6B":::Y
MOK<Q;W8 !%'?D#\SZ<@$ME\8=5N]#F\0#P1<MH5O(R37<-_&[H%/)\LJ"<9^
MGO7H,VN1R^$Y==TSRKF,V;75OYL@B1QLW+N9N%'J3T[UX;X<U+7--^%NJ>$(
M/!^OSZG?R7$2R&R9($60;<ESZ#/;'O7IYT&\TCX)7&ANAFO8=#EA:.(;BTAB
M;*KCKR<#UH T;7QQI-OH>F7GB#4=,TRZOH1*(3>(ZX/=6!PP]QQ1X_\ %$_A
M+P1?:]90PW$L'E[$D)V-N=5[>S5XSK&G7>GZ1X:O;"QUA?$,.B06_P!F?2?M
M-M<H2<QMN!V,.<Y'0CZUZ1\4K74=2^#%W"M@YOY(K8O:V\98JWF1EE &>!S^
M5 '7Z1XGT77)'@T_5;*ZN8D#3103J[)V.0#TSQ3;#Q;X=U2_>PL-;L+F[0,6
MABN%9@!UX![5Y?JW@Z6T\>/;>'=*^PQW'A*: 200[(S.=P 9@,;ON\GGH:YW
MX?Z))-JGAZWO!K<&H:9Y^+8Z*L,<64;=OG&"P/09R<G&.: /<[;Q7X>O&D6U
MUS3IC' ;A_+N48+$#@N2#PH/&:R=6\?:2/">LZMH&HV&I3Z=;&8QQS!P#VW
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MDA3A@,$_RH ]7^'OBNX\9>'9=3N88(F6[E@40DE2JD8/)/K6C:^,?#5]J?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8^E
M>&-*T;5=4U.S@87FIR"2ZE>0L6(S@#/0#)X%;%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^@<W_@3+_P#%4?\ "N_"_P#T#F_\"9?_ (J@#IO.B_YZI_WT*/.B_P">B?\
M?0KF?^%=^%_^@<W_ ($R_P#Q58?B+P5H%E<:&MO9/&+C4DAEQ<2_,ACD)'WO
M4#\J /0O.B_YZI_WT*/.B_YZI_WT*YD?#OPO_P! Y_\ P)E_^*K'@T?X:76H
M?V?;WFGRWNXI]G34V,FX<$;?,SGVH [[SHO^>J?]]"CSHO\ GJG_ 'T*YG_A
M7?A?_H'-_P"!,O\ \52/\/?"J(SMI[!5&23<R\#_ +ZH Z?SHO\ GJG_ 'T*
M/.B_YZI_WT*Y&Q\$^#=3L8;VRM1/;3+NCECNI2K#U'S58_X5WX7_ .@<W_@3
M+_\ %4 =-YT7_/5/^^A1YT7_ #U3_OH5QEMX1\$WFI7VG06C/=V!C%S'YTX\
MO>NY>2V#D<\9J[_PKOPO_P! YO\ P)E_^*H Z;SHO^>J?]]"CSHO^>J?]]"N
M!UK0O .@7%G;W]I,L]XQ$,437$K-C&3A22 ,C)/'-;'_  KOPO\ ] YO_ F7
M_P"*H Z;SHO^>J?]]"CSHO\ GJG_ 'T*YG_A7?A?_H'-_P"!,O\ \51_PKOP
MO_T#F_\  F7_ .*H Z;SHO\ GJG_ 'T*/.B_YZI_WT*YG_A7?A?_ *!S?^!,
MO_Q5'_"N_"__ $#F_P# F7_XJ@#IO.B_YZ)_WT*/.B_YZI_WT*X#Q;X'\/Z=
MX3U2\M+)XYX;=G1Q<2\'M_%6M#\/?##0(QTYLE03_I,O_P 50!U/G1?\]4_[
MZ%'G1?\ /5/^^A7 ZIHOPWT6]CL]3N+2SN9 &2*>_=6()P#@OTSWK8_X5WX7
M_P"@<W_@3+_\50!TWG1?\]4_[Z%'G1?\]4_[Z%<S_P *[\+_ /0.;_P)E_\
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M@0[ D+]JER<?\#H ZCSHO^>B?]]"CSHO^>B?]]"N9_X5WX7_ .@<W_@3+_\
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M_P"@<W_@3+_\50!TWG1?\]4_[Z% FB)P)$_[Z%<S_P *[\+_ /0.;_P)E_\
MBJI:QX"\-VVB7]Q#8.DL5O(Z,+F7@A20?O4 =L"",@Y%%8G@YWD\':-(Y)9K
M*(G)R<[16W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S_CG_D1M9_Z
M]7_E705S_CG_ )$;6?\ KU?^5 &W;?\ 'I#_ +@KB/#,$%[\2/&EQ?0H]]!)
M;V\6\9V6YB#*%ST#-N)]3]*[>V_X](?]P5B:WX*T+Q!>I>WUK(MXJ>7]HMKB
M2"1DSG:S(02/8T 8D%I:V7QEM+>S@B@@3P[/MCA0*H)ND)P!QU)-9/B/_D9/
MB#_V*Z_^@SUT]Q\.O#%PEFOV*>'['"T$+6]Y-$P1FWD$JX+9;GG/-7H_"&BQ
M1W2"UD;[79+83M)/([/" P"DELY^9N>O/6@#Q"^,GA+PM'X>D+?V9K<>GZEI
MQ/1)A+"9XO\ V<>@KZ+K$U+PCH6KZ98:=?6"S6M@R-:J78&,H,+A@<]/?GO6
MW0 4444 %%%% !7->+?^/KPW_P!AB/\ ]%R5TM<UXM_X^O#?_88C_P#1<E '
M2UX=H&C:KXE\*Q:7::#!#$FLRSG6IIDR@2Z9SL49?=P5YP/>O<:I:5I%EHEC
M]BT^'R;?S'EV[BWS.Q9CDDGDDT >4WVN>+M8U+Q'/I"ZX;G3M0>TL8;1;?[)
M^[Q_K=[;V+9)..@(Q6\)=;U?QWX@@?6[NRLM(@M)TL[<1[7=T+,KDJ25^4C
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MUFP:!I=MJ%K?06:13VMJ;. H2JI"2#M"CC&5';M6E0 4444 %%%% '/^.O\
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M,?$4>NO;7%QL7>UE'^],F,8&Y"%''ZUZ5:>'M+L;^WO;>VV7%O9"PB?S&.V
M$$+@GGD#D\^]1Q^&-&B\3R^(TL4&K30B%[C<V2G'&,XSP!G&>* /-=/\0:WJ
MT6@:*-4EL_[4UC48IKRW1%D6. LRHN5P">!G&>*T?$5YKFDZMH7AB'4];OHY
MDN+B>ZLT@^URJA 5-S83C=R<9.![UUMUX#\-W>DKIDNG?Z,MR]VFV9U>.5B2
MS*X.X$DGH<5'-\/O#4^E6>G-8.L5F[2V\D=Q(LL;MRS"0-NR3UR>: .4>;QQ
M_P (K:-=1:P([?4)EN3;>0-0EM #Y38Y0MDC<%Y..*[SPQJ%OJGAG3KVTOIK
MZ"6$%;F90KR8X)8   Y!SQUK/E\ ^'YM.M;%X;OR[5W>.1;Z99<N<OEPVX[L
M<Y-;FFZ;9Z/IMOIVGP+!:6Z!(HESA1^/)^M %JBBB@ J.X_X]I?]P_RJ2H[C
M_CVE_P!P_P J ,#P'_R(VA_]>4?\JW+NV@N;=EGACE4 D"10P!Q[UA^ _P#D
M1M#_ .O*/^5=$0""#T- 'C^DW]QH7P+T*[TH16M]=F&T-YY2DQ"2;:7.>N!Z
M]\5;UVWUG2M3NO#8\3:E>6NHZ-<7!DN!$TT#Q%>A" ;7!*D$?0YKOD\+:*GA
M@>&S8H^D"/ROLSLS#;G/4G/7G.<U6T7P1X?T&:XFLK)C-<1^3)+<3/.YC_N9
M<DA?84 <-ILDNC_"[PO#)XAUPSZDEM]GAL(86G(\G/DQDJ JC&=S9/'7FL^V
MU34M2TK18]4GNII;'QQ':1M>*@F$:HQ DV?*6&X@D5WZ_#CPRFDQZ8MI<+;1
M7 N(,7DP:!P,#RVW;E&.P.*MVO@GP_9V\4$%@5CBOQJ2 S2,?M 7;YA);)..
MQX/6@#"^*B3OI_AM+6.WDN#K]J(TN"1&S8? ; )QZ\&I=5MO%L'A%_LUG9V^
MH?:T,T>B. [VPQNV&50/,Z]1TZ<UTFN^'M-\2V4=IJD+RQ13+/'Y<SQ,CKG#
M!D((/)[UFGP#H)TUK$I?-$9EG5FU&=G1P" 5<ON7@GH>] 'G^I ^(9/!5Q8>
M)=9 &J36K-<Q1+/#*$E)W IC>H^3N,>_->Q0#RXDA:8RO&H#,V-S<=3CUKGY
M? 7AR70H-'^PLEI!.;F(QSR+(DISE_,#;MW)Y)K3L="TW3=0NK^UM]EW=1Q1
M3RF1F+K&,)G)/0'KW[T <IHT,%[\7/%4M]$DES:6UI%9^8,[8&1F8J#ZOG/T
M%1ZI'<W/CRS\(Z5?2:%IBZ=+J4C:='&CS2&4+M!*D#DEC@<YKHM=\':)XBN8
MKN_MI!=Q)Y:7-O.\,@3.=I9""1GL:JW/P\\,7.G6=DVGND=F7:"2.XD25"YR
M_P"\#;CD]<DYH XQ-4\67&DW5LMWJ5];:/K4]G>W6G");R:!8P4(##:2&8!@
M!DX^M,,#Z_XX\&ZAI_BC4G@NM+N&CN/+B#X3RPW!3JQ^]QU'&*[:3X>^&7TV
MTL([&2""U9VB-O<RQ/E\;]SJP9MV!G)/2IKGP-X>N;72[;["T,>E@BS,$SQ-
M$#C(W*02#@9SG- '15S3_P#)2X?^P2__ *-6NEKFG_Y*7#_V"7_]&K0!TM<#
M\4_.^Q^&?L]K%=S?V_;[+>5]B2'9)\I.#@'UP:[ZJ.I:19:L;,WL1D-G<I=P
M88KME4$ \'GJ>#Q0!Q5_J.KV.H>%(9M,L](:[U=HIK>UD697C\EB#NV+@Y'8
M9XZUF:/XLUZX\<S^&)-42>#2I;B=[Q8UWWZ*JE;<#:%WH7PY7GY1TYKT?4-&
ML-4N;&XNX3)+8S>?;L'9=C[2N>#SP3UK.M?!.@64.F1V]D8_[,G>XMG$K[U=
M\[R6SEMV>02<_A0!Y]X4USQAK!T'68QK<XO;H->I+';K8+;L2#Y>#Y@*_+@G
MDX.:S?$;ZSX@\!:EXCN]>N$B_M98/[*5$\E(TNEC53QN#@@-G/X<UZ98_#_P
M[IFJ)?V5M<0,DIF2!+N40+(<Y81;MH/)[8J*[^&OA2]OKB[N--9GGF^T/&+F
M18_-R"9 @;:&..2!_,T 4OBSO_X0@>7$LS_VA:;8W. Y\], G!P#]*H>)=;U
M_0O!\LJ:%:Z/>W5[!:1FPE6X8+(V"XRJ#<.@!XR17=:MI%EK=FMI?Q&6%98Y
M@H8K\R,&4Y!]0*75M(L-=TN;3=3MEN+28 21L2,X.0<CD$$ Y% 'FSZ]XJ\-
MZ+XGOW@U>6QMK%)K.365A,JSY*L/W1PR8*MSZ&M#PA-XH7Q%:+<#79]+FLV-
MW+JR6ZA9A@JT7EDG!RPP?:NFTSP7HNE6M[;10W$\5[&(9UN[J2?=& 0$^=C@
M88\#UI-"\%:+X<N_M.G1W2N(C#&LUY+*D:$@E55V( R!^5 '0US/B;_D.^%O
M^PF?_1$M=-7,^)O^0[X6_P"PF?\ T1+0!TU<Q\0K6WG\ >())8(I)(]-N"C.
M@)4^6>A[5T]5M0L+;5--NM/O$\RVNHFAE0,1N1A@C(Y'!H \_P!2N+FPT/P;
MI.CS+I;:R\,-Q>P1)O55AWD#(QN;& 2#WKF?'']L0Z+XQ\-W&OWE[:V5E;W\
M<TR1^:0S,K0R$* 5) 8$ 'CTKUC4_#&D:QHL.D7UIYMG!L,*[V5HR@PK*P(8
M$#OFJ=EX%\.V&E:AIT=@9(-17;>--,\DDXQ@;G8EN!TYX[4 <[XADN]-CT?1
M1XC\17.H2I+*%TZW@,\RC&&9F4(J+G';.?:L7PWJ]]KFI?#/4-2E,MY)%JB2
M2%0I8IA 2!QG"C/O7;/\/?#\EO81/%>$V.\03"^F$H5SEE+AMQ4X'!.*NV'A
M#0],_LO['9>4-*\X68$CD1>:<R=3SGWSCMB@# \3Q17OQ/\ "-EJ$:R60BN[
MB%'Y5[A0NW(Z$JI8CZT_QM))I!TNVT3RM,NM<U*&RN;Z&%/,5-KGN,%N" 3G
M&372:[X=TOQ):);:I;><L;B2)U=D>)Q_$K*05/T-9<?P]\-)I=SI\EE+<17+
M(\LEQ=2R2LR9V$.6W*1DXP1U- '+7<_BW2]6UWPQI6K76JW']F0W]I-<^4)X
MB9BDB!MH4DJI*[AP<5C:[*^N^&])^S:_KB2VGB.VMYXK^&)9X)&=,!L)@E/O
M*1P=W.<#'H-O\//#5MIUW9I9S$7;(T\[74K3L4.5/F%MPQV .*D'@+PZ-"N-
M'-E(UK<3BYE9[B1I7E&,2&0MNW# YS0!'XQ@EM?A=KT$UU)=2QZ3.K3RA0TA
M\MN2% &?H*XW2]%U/5)-!U@^'H=&M-+TR8/,98VEO/,@V@8CSA0?F^8_A7I;
MZ)92^'WT.999;%[<VSK)*S.R%=IRY.XG'?.:LQV4$6GI8HF+=(A"$R?N 8QG
MKTH \U^'FJW<3>#=*^T8LI_#CS&' ^:57C .>OW2U0OK7B?4M*N[F"XU&>QM
M-?O8+IM,6+[2MLA(C$8888 XSCYB*[&[\ >'+W3],LI+.5(M,3R[1H;F2.2-
M" "N]6#$' SDU%_PKCPPMA#9064]M!#+)*@MKR:,@R8WC*L#@[1QTXH U_#=
M_;ZGX;TZ]M;V2^AE@4K<RH%>7C!9@  #D<\=:?X@_P"1;U3_ *])?_0#4^FZ
M=::1IMOI]A L%I;H(XHUZ*H^O)^M0>(/^1;U3_KTE_\ 0#0!4\&?\B5HG_7C
M%_Z *W*P_!G_ ")6B?\ 7C%_Z *W* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "N?\<_\B-K/_7J_P#*N@KG_'/_ "(^L_\ 7J_\J -NV_X](?\ <%2U
M%:\VD)']P?RJ6@ HHHH **** "BBB@ HHHH *YKQ;_Q]>&_^PQ'_ .BY*Z6N
M:\6_\?7AO_L,1_\ HN6@#I:\[@^)>H&R75[GPSY>A&^-FUY'?J[H?-\H,8M@
MXW>A/7O7HG6O+?!/@0:AHB2ZW=:L84U*XG72I7\N ,L[E6*[0S#HW)(H [J]
M\6>'].U5-+O-9LH+YRH$$DP#9;[O';/:FZEXO\-Z-=&UU+7-/M+@$ Q37"JR
MY&1D$\<$'FO*-1TJXBU'Q7HVL3Z[!#JNHO.BV6D+<)=1MM*;9=I(*XQ@D8Q7
M=:!HVSXC>+[JZLF>*2*QCAGFBR) L1W;21@\@9QWQ0!7\(?$&/6M-U'7-4U;
M1+?2XI"(XHY");==[*OG$MC+!01@"NFM/%OAZ_TR;4K76K&6R@8)+.)UV1DD
M !CGC)(QGUKS"RT.\LOAYX-NYM%N94TW5'N;^R2V)F*;Y0K^7C+;=P./0YJ'
MQ-97/BB'Q;JVEZ)J$5A=6=C:JDEHT3W4BW 9G$>-Q"H0,D=CZ4 >G?\ "=>%
M/LGVH^(M,$&6 D-RH!*XW8YYQN7IZBG0^-O"]Q=6EK#X@TZ2>[ ,$:7"DR9.
M!CGKD$8K%U?1A+\4?"\Z:=NL[6SN\NL/[N-R(PO., XSCZ5R-OX;GM_!!2+1
MY4N/^$L$^U;8A_+%R,/C&=H7OTQ[4 >F7/B_PY::RND7&M6,6HLRH+9Y@'W-
MT&/4Y''O3=2\9>&=(N&M]1UW3[:='V-').H96P#@C.1P0?Q%>6^-&US5KO7-
M/:SOHVCU*!K:SM=(W1W$2O&?/:XVDYQG@$'C'3-=&NA227_Q,GFTQW>\14MW
M> DS*+8<(<?,-WIWH [35_%.@Z#'!)JNKV=HMP,PF64#S!ZCU'(Y]Z;J7B[P
M]I$=M)J&M65NETGF0-), )$_O#U'(YZ5YQIC7'AC6="U75]%U.ZM)/"]M9*8
M+-IFAF7!>-E RI.1U^E,UB&[L/&5WJ,R:OI>FZGI5O%!]ETE+H1*%(:W<!6\
MLY(X'!S[4 >PQR1S1)+$ZO&ZAE=3D,#T(/<4ZL;PEI\6E^$=)LH#=&&&U0)]
MK39*!C(#KV(Z8[8K9H Y_P =?\B+K7_7JU;EO_Q[1?[@_E6%XZ./ NM9_P"?
M5ZW;?_CVB_W!_*@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "H[C_CVE_P!P_P JDJ.X_P"/:7_</\J ,#P'_P B-H?_ %Y1_P JZ.N<
M\!G_ (H;0_\ KRC_ )5T= !1110 4444 %%%% !1110 4444 %%%% !7-/\
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M,7_H K<K#\&?\B5HG_7C%_Z *W* "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?]>,7_H K<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN'BTE+;<);QSNC1.#O9B>1@@DD].M &=_P ([XR_Z'O_ ,I$/^-'_".^,O\
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ME_T/?_E(A_QKA]?\93^*/A_XKL[DZ;+)IUQ8@7.F3F6"99)HR,$\Y&"#7L]
M'(?\(]XR_P"A[_\ *1#_ (U%<Z'XSM[2:8>.=QC1GV_V3",X&<=:[2JVH_\
M(,N_^N+_ /H)H X7P]9^--;T#3]3;QH(3=P+,4&E0L$W#.,Y&:U/^$>\9?\
M0]_^4B'_ !JYX!_Y$'0?^O*+_P!!%;MT2+.<C@^6W\J .6_X1[QE_P!#Y_Y2
M(?\ &F0Z)XMN(EE@^("2QM]UTTJ%@?H0:Y'P=X9NM0^!=A!H#I::E>N+A[AI
MY$^<28WY4Y) 48'0X&:;X*\"^+M/^'FK:;>S*EW=PHMG%+>2IY!#,2IV'">N
M4ZYYH ["+1/%LZ%X?B DB@E24TJ$@$<$<'K3_P#A'O&7_0]_^4B'_&N.\ ^
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M)!J%RT)?^RX04Q&SY [_ '<5Z-7*>*?^1H\(?]?\G_HB2@"/_A'?&7_0]_\
ME(A_QH_X1WQE_P!#W_Y2(?\ &NOHH Y#_A'O&/\ T/?_ )2(?\:9#HGBVXC\
MR'X@)(F2-R:5"1D'!&0?6N2\&>'IM2^&&N_V2$BU?4+^8-<//)'DI.=I+(=P
MP,].O?K4?@CP)XOTWPUKUMJ-P&EO()8[:.:[ECVR&1B20APH;[VX?-\V.E '
M8Q:)XLF#F+X@)($8HVW2H3M8=0>>HI__  CWC+_H>_\ RD0_XUQOP_\ A[XA
ML9]<C\5R_:]-NS/&T4EP_P"]8NI\W:#M(<#.X_,,8KHO@JQ;X2Z*6))S<#).
M?^6\E &A_P ([XR_Z'O_ ,I$/^-'_".^,O\ H>__ "D0_P"-=?10!R'_  CO
MC+_H>_\ RD0_XT?\([XR_P"A[_\ *1#_ (UU]% '(?\ ".^,O^A[_P#*1#_C
M1_PCOC+_ *'O_P I$/\ C77T4 <A_P ([XR_Z'O_ ,I$/^-'_".^,O\ H>__
M "D0_P"-=?10!R'_  COC+_H>_\ RD0_XU1UK0/%R:'?M+XW\V,6[ET&E0KN
M&TY&<\5WM9WB#_D6]4_Z])?_ $ T 4_!G_(F:(>G^@P\>GRBMVL/P9_R)6B?
M]>,7_H K<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGXA?\D^UW_K
MS>NFKF?B%_R3[7?^O-Z .AMO^/2'_<%<;J_@.^NM2U:;2/$<NEVNL ?;[<6J
MR[B%V%HV)&PE>#P?6NRMO^/2'_<%9<WB;3X-=N]*D\P26=C]NN90N4B3) ![
M[B QQCH* ,.Z\!W%K?17?A?7&T5_L4=A*IM5G62./A" 2,. 2,\_2H_^%=G3
MH=(?P[K$FF7^FVKVGVB2W6<3QNV]MZDCDO\ -D'J36QH?C;0_$=RL&F3W,K-
M'YJL]E-&C+QR&= #U'>NAH XF3P+?P^#YM"T[7A#+>O.^HWD]F)6N6FSO.T,
MH0\\8S@ 5N>%M(U#0M#@TW4-3CU VZK'#*EMY&V-5"JI&YLG@\Y[UM5F>(-=
MM?#>B7&K7J2O;P% PB4%OF<(, D=V'>@#3HHHH **YC3?'6EZHF@R1174<>N
M";[*\B* &CY*M@G!(#$=<X-=/0 5ROC/_C_\)?\ 8=C_ /1$]=57*^,_^/\
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MX?L]<FU=1I]W(T<,@AD8EQU4J%R"/<5K^'/$^D>+=-;4-%NC<VJRF(N8V3#
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M77UC75]*L[[R\[#<0JY3/7!(XJY9V5IIUI':6-M#;6T8PD4*!$4>P' J>B@
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M)I?^$.\,?]"WH_\ X!1__$T 7/[<TC_H*V/_ ($)_C1_;FD?]!6Q_P# A/\
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M: +G]N:1_P!!6Q_\"$_QH_MS2/\ H*V/_@0G^-4_^$.\,?\ 0MZ/_P" 4?\
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M_P")H N_VYI'_05L?_ A/\:/[<TC_H*V/_@0G^-4_P#A#O#'_0MZ/_X!1_\
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M_P")H N?VYI'_05L?_ A/\:/[<TC_H*V/_@0G^-4_P#A#O#'_0MZ/_X!1_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<]XZEU6/P3JHT2UEN=2D@,4$<7W@7^4L/H"3^%>37OPU\8>&M(\+WUAJ U:7
M1+E9(M.ALDB:-7.Z4>9NRXR,'/KGBO>J* /"M7^%=QXCUKX@WMYIDJW4C1S:
M-.7P)&"L6 &<$'"K\PXS6SXITGQ)XD^%'AF!]'E35H+ZW:ZMD55*+&'4M@<
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M@U03V@@>%+/[.&^4X^\S\^N>YK9O]$\1V_Q1%]X:TC5].^T:BC:E*UPC6-U
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M_P!]B@"6BHOM5O\ \]XO^^Q1]JM_^>\7_?8H EHJ+[5;_P#/>+_OL4?:K?\
MY[Q?]]B@"6BHOM5O_P ]XO\ OL4?:K?_ )[Q?]]B@"6BHOM5O_SWB_[[%'VJ
MW_Y[Q?\ ?8H EHJ+[5;_ //>+_OL4?:K?_GO%_WV* ):*B^U6_\ SWB_[[%'
MVJW_ .>\7_?8H EHJ'[5;_\ />+_ +[%+]JM_P#GO%_WV* ):*B^U6__ #WB
M_P"^Q1]JM_\ GO%_WV* ):*B^U6__/>+_OL4?:K?_GO%_P!]B@"6BHOM5O\
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M]JM_^>\7_?8H EHJ+[5;_P#/>+_OL4?:K?\ Y[Q?]]B@"6BHOM5O_P ]XO\
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M/PKT6N4MO^2KZE_V!;7_ -'34 ,U;PWX(T+2Y]3U+1]-M[. !I93; A02 .
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MB:?<6.JAH4'*B&2WYP%R >F".] 'IW_""^%O^A?T_P#[\+1_P@OA;_H7]/\
M^_"UT5% '._\(+X6_P"A?T__ +\+1_P@OA;_ *%_3_\ OPM=%10!YKXG\(^'
M[;Q%X6A@T:RCCN+V1)46( ./*8@'\174?\(+X6_Z%_3O_ =:I>+?^1J\&_\
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M?6%^8[5WUM+2*UC1SC,+8#@@<G.,F@#W'_A!?"W_ $+^G_\ ?A:/^$%\+?\
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M^'[_ ,(0W%WHME-,;FY4N\()P)Y !GV  _"NG_X07PM_T+^G_P#?A:I?#/\
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M?^(#W'B#6;*/1].@O(;6UN6C02_9M^".RY4Y QG/M0!ZO_P@OA;_ *%_3_\
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M'JV>Q.3D^];5% !1110 4444 <AXM_Y&KP;_ -A"3_T2]=?7(>+?^1J\&_\
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M+3F"WDCUV]T@V;W-S.\C0L\6TA<DA0">U:G]A>.?^AVLO_!(/_CM']A>.?\
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M[AV3:H&"PX)&.M:%<?\ V%XY_P"AVLO_  2#_P".T?V%XY_Z':R_\$@_^.T
M7/'_ /R3WQ%_V#Y__0#6[9_\>-O_ -<E_E7G/C/1_&$7@C7'N_%MI/;I92F2
M)=("%UVG*AO-.,CO@UKVF@^-_LL17QK9A2@V@Z*IP,<?\M: .VHKC_["\<_]
M#M9?^"0?_':/["\<_P#0[67_ ()!_P#': .PHKC_ .PO'/\ T.UE_P""0?\
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M#?ZPY[\<=: /45(VTM<>-#\<'D>-;)1Z?V*#_P"U:/["\<_]#M9?^"0?_':
M.PHKC_["\<_]#M9?^"0?_':/["\<_P#0[67_ ()!_P#': .PHKC_ .PO'/\
MT.UE_P""0?\ QVC^PO'/_0[67_@D'_QV@#L**X_^PO'/_0[67_@D'_QVC^PO
M'/\ T.UE_P""0?\ QV@#L**X_P#L+QS_ -#M9?\ @D'_ ,=H_L+QS_T.UE_X
M)!_\=H ["BN/_L+QS_T.UE_X)!_\=H_L+QS_ -#M9?\ @D'_ ,=H ["BN/\
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MCG_R+0!V-%<?_87CG_H=K+_P2#_X[1_87CG_ *':R_\ !(/_ ([0!V%%<?\
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M^'-C_P!?%W_Z425VU</\(@P^&VGAV#-YUUN8# )^T29..U=Q0 4444 %%%%
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M*Z>L/PSI>H:9:3C4GTPS2R;@NG6GD1JN ,8))8YR<GUK<H **** "N5\9_\
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M% !1110 4444 %%%% !1110 4444 <3\)?\ DG%C_P!?%W_Z4R5VU<3\)?\
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MPKGPY_SPN?\ P*D_^*H_X5SX<_YX7/\ X%2?_%5UU% '(_\ "N?#G_/"Y_\
M J3_ .*H_P"%<^'/^>%S_P"!4G_Q5==10!R/_"N?#G_/"Y_\"I/_ (JC_A7/
MAS_GA<_^!4G_ ,57744 >6:[X'T.V\:>$[:.*817,MTLH:X<D@0,1@D\<UTO
M_"NO#IZP7)Q_T]2?XTGB7_D?O!/_ %WO/_29JZ^@#D?^%<^'/^>%S_X%2?\
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MX_Z^I/Y9KKJ.XH XWX6Q+!X!M8D^ZES=*.<\?:)*[*N0^&?_ ")$'_7W=_\
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MCPC_ -!A?^_$G_Q-=3CZ?E1CZ?E0!RW_  LCPC_T&%_[\2?_ !-'_"R/"/\
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M)/\ XFC_ (61X1_Z#"_]^)/_ (FNIQ]/RHQ]/RH Y;_A9'A'_H,+_P!^)/\
MXFC_ (61X1_Z#"_]^)/_ (FNIQ]/RHQ]/RH Y;_A9'A'_H,+_P!^)/\ XFC_
M (61X1_Z#"_]^)/_ (FNIQ]/RHQ]/RH Y;_A9'A'_H,+_P!^)/\ XFD/Q*\(
M@C.L+_WYD_\ B:ZK'T_*D*Y[_I0!Q_PMECN/ -K-$VZ.2YNF5O4&XDKLJXGX
M3'/P[LS_ -/-W_Z425VU !6-K/A/0/$-Q%/J^DVM[+$NQ'F3<0N<X^F:V:*
M*"Z)I2:2VDIIMHNG,I4VJPJ(B#VVXQ6?9>"/"^G6-W96FA6,5M=KMN(Q$")1
MU .>H';TK?HH Q;3PAX=L=)N-*MM&LDL+CF:#R@5E]"V>O0=:DT/PQHGAM9E
MT;38+,3D&7RAR^,XR3Z9./K6M7(^/-<\1>&]'NM9TN+2Y;*T@\R9+HR>83G^
M';QC&.M '1+I5@LU[*MI$)+X 73;>9L+M&[U^7BL^^\&^&]3MK*WOM%LIX;%
M0ELDD0(B48^4>W XZ<5SVJ^(_%VCVFE17$.A-?ZG?K;0LK2B%$,;-EL\YRO:
MJDOQ"U>S\,>*+JZL].DU'0YXH0UM(S6\WF;,8)YR-_(]: .UM?#NC6)LS:Z;
M;0?8C(UMY<87RC)]_;Z9[TK^'](DL[JT?3X#;W4_VF>,KQ)+N#;S[Y4'\*YH
M^)O$FA:UIEIXGL--:RU*<6L-WITDA\J8YVJZN.C8P"*[>@#G]4\#^%]:O&O-
M2T*RN;EG#M+)&"S$ *,GN, #!XXJQK'A70=?B@CU72;6Z6 8AWIS&/12.0.!
MP*V** ,ZVT'2;,V)MM/@B-A&T5KL3'DJV-P7TS@9K1HHH *#THI",C% '(?#
M%@_@6V8'@W-V?_)B2NPKB?A-S\.K$^MQ=_\ I1)7;4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!R7CO[F@_\ 86@_K76UR7CO[F@_]A:#^M=;
M0!YGX?N?$7@71&\-+X3O]4:VEF^PW5K)&(9D9V==Y9@8R-V#P>E<]X9DN[&R
M\)WUKI6I7TVB->P:M9QVVRXADN,.,(Y&Y0W&0>E>VT4 >/QP^,+;3-4NX=*U
M/3QJ'B-KBYBM?*DNEM&B493.5SD ''(YJ*Q\*ZT^G(LVFWYW^,H-0(O"C2FW
M"KF1]IQVYQ7LM% 'GNN>'M3O_$'C-H+1C'J'A];2WD) 627$HVY_X$OYU7LK
M?5-4U3P!=MHM_9II1N(;L7**I0_9M@;@G*EN >^*]*HH \KM_#M]J7@WQ1X3
MO-,N[2X%W<WEI>N%$+L93)$4<'.<XSP,#-1^%;V:;X>^)O'FLQK'=:M;O)M!
M^[#%&411]2&/ON%>IW%O%=VLMM.N^&9#&ZY(RI&"./:JK:+IKZ/'I#64+:=&
MB(MLRY0*A!48]!@?E0!G^%-(%IX(T'3K^".22UL[?<LB A9$53D9[@C@^U;=
MQ;P7<+0W$,<T38RDBAE.#D<'W -244 1SP0W5O)!<11S0R*5>.10RL#U!!X(
MJ0    8 Z"BB@ KC[#_DK.M?]@JU_P#0Y:["N/L/^2LZU_V"K7_T.6@#L***
M* "BBB@ HHHH **** "BBB@ HHHH **** .4^)7_ "3CQ!_UY/72V?\ QXV_
M_7)?Y5S7Q*_Y)QX@_P"O)ZZ6S_X\;?\ ZY+_ "H Y'QE_P C?X'_ .PE+_Z3
MR5GW&L6/A#XHZO=Z]<"TLM6LK;[)=2@B,-%O#Q[N@/S!L'UKT,@$@D#(Z4DD
M:2H4D174]589% '"^#+F/7/&WB?Q%8!GTJ=+6UM[DJ0L[1A][+GJH+ 9[X-<
M_H^KSZ-^S]9-9Y_M"[#V5FHZF:69T7'TR3^%>N    # ':DVK@#:,#H,4 >0
M:79ZYX-\8>%IM1TVQM-/FM5T%VM+EIM[8+1,P*+@[@1GG[QK5^%7B?0X_"^G
MZ$^J6JZM]HN5^R&0"3/GR-C'TYKTH@'J,TT11AMPC4-ZXYH ?1110 4444 %
M%%% !1110 4444 %%%% !7'^-_\ D*>$_P#L+I_Z U=A7'^-_P#D*>$_^PNG
M_H#4 =AVHH[44 <I=*K_ !3L58!E.B7(((R"/.AJ]I?@[0-&U*2_L-+MH;AL
M;&2-1Y0"!,)@?*"!SCJ:EN]!-QXHL=<COI8)+:"2W>%44K,CE6()(R.54\8Z
M5L4 8-CX,\/:;JS:G::5:Q7)"["L2@18#C* #Y2?,;)'7-5/!7^L\2_]ARX_
M]!2NIK'\.Z"=!M;N-[Z6]FNKI[J6:5%4EF !X4 8XH V**** "BBB@ HHHH
M**** .(\9_\ (Z>!?^PA-_Z(:NWKB/&?_(Z>!?\ L(3?^B&KMZ "BBB@#G/B
M!_R3GQ)_V#+C_P!%M4MWX6T77([*XU#3X)IHEC(D:,%F"@X1CCE<L3MZ5?UO
M2XM<T*_TJ:1XXKRW>!W3&Y0RD$C/?FIM/M9++3X+::ZDNI(D"F>155GQW(4
M?D* ,[4?"6A:K%:QW6FVY6U\L0E8P"B1LK*@./N94?+TXK*UBUM['Q9X)M;2
M"."WBFN4CBC4*J 6SX  Z"NOK'O=!^W>)-,U>2^G5=/$GEVH5=C,ZLI8G&[.
M&Z9QQ0!L4444 %%%% !1110!Q/BC_DIO@+_KI?\ _I.:[8=!7$^*/^2F^ O^
MNE__ .DYKMAT% '*^)/^1R\&?]?ES_Z2RUTXBC$QF$:B5E"E\<D#.!GTY/YU
M4U'1].U9K9M0LXK@VLHF@,@SY;CHP]ZO4 ,\J/SO.\M?-V[=^/FQUQGTKF-
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M=_\ I3)7;5Q/PE_Y)Q8_]?%W_P"E,E=M0 4444 %%%% !1110 4444 %%%%
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M4F:,T +129HS0 M%)FC- "T4F:,T +7'^-_^0IX3_P"PNG_H#5U^:X_QL?\
MB:>%/^PLO_H#T =CVHI,BC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129H
MS0 M%)FC- '$^,_^1T\"_P#80F_]$-7;UQ'C,_\ %9^!SV&H3'_R ]=MGV-
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MT4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HW
M=: .*^$O_).+'_KXN_\ TIDKMJXGX2?\DXL?^OB[_P#2B2NVH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#&\1>'+?Q)916T]W=VIBF69);1PC
MJR]#D@UD?\(%)_T./BK_ ,#D_P#C==A10!Q__"!2?]#CXJ_\#D_^-T?\(%)_
MT./BK_P.3_XW7844 <?_ ,(%)_T./BK_ ,#D_P#C='_"!2?]#CXJ_P# Y/\
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M* ./_P"$"D_Z''Q5_P"!R?\ QNC_ (0*3_H<?%7_ (')_P#&Z["B@#C_ /A
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MR?\ QNNPHH R?#?A^U\,:'!I-G+/+#"SL'G8,Y+.7.2 ,\L>U:U%% !1110
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M#!@J]3@8.<<UHZ;KOB;5KR31?#C:7;1Z1I]H9Y;^*20RR2Q!U50K#"@#D\T
M>D45Y#?_ !3U@Z/H6H)#::5:7D$INKZYM9KF&.>.0Q^6/+(*@E2<G/&/2IKW
MXI7JV^A6J76CV]Y?6;7=S>+'-=P* Y0+&L?S$D@YR?EP1R: /6**Y3P%XHN?
M%&DW<MY'$)[2Z:W,T,3QQSJ "'57^8 AL8/<&NKH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG@:]A149$7<QRKD@X[8R*AM?B3:W%QIWG:#K-I8ZE<+;6M[<0HL<CMG9QOW
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M<[>0&WA<_P 6W%+>_$BRM9+Z6+1]7N]-T^5HKO4;>%3#&RG#]6#,%[D ]#0
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M8[B^B18Y2%W;?E8E25!(# 9Q0!6O?AV\^MZMJ5EXEU73_P"UV7[9#;B/:ZA
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M:^DA0PN5!)SM8E<X.-P% '9T444 %%%% !1110 4444 %%%% !1110 4444
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M$5 PV@Y/0Y(Q[XJ2Q\1:)J=C-?6.KV-Q:09\Z:*=62/'/S$' X]:CL=;\/\
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M8K-GDSIEP\LFP0%=\BE1Y0Y VGG)QVKVVH(;*UMI'D@MH8GD^^R1A2WU(ZT
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPMO:Q8W.03R3@  9))) P*SM/\::!J=C?W<-]Y<>GKONQ<1/"\*XR"RN 0"
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MPN%N+:0L$D3HVUBIQ^((H M4444 %%%% !1110 4444 %%%% !1110 4444
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MX+\,:=]H^Q:!IT!N8VBF,=NHWHPP5Z=".HZ4 <#I-M=^*/$^EV%_K6K)9_\
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MS*HWLHZ*QZX]JKKX7T)(DB72;01QVSVBJ(AA86^]&/\ 9/<4 9.C?\DDT_\
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MEQ-;VVG7,*O$GG2MM(D0LQPO7(//3Z5]6\7^*?"DVH6>K-I=]-_9$^H6<]O
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M^'#=7(MKRY>Y>4;=X9I1+@<8QD8Z=*ZN@ HHHH **** "BBB@ HHHH ****
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M>O2N'T_X>:G#;V<@T_1]-==<M;][6S9R$AB#<%V'SO\ ,>P%>FW</VFSG@!
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M>0RR%1RS$ $_DJ_D* //?!_Q6?Q5XIN]'72TBVJ7@8W"X8*@) 8$^9ELD%0
M%P378^'-8/B7199[NP6V=;B>UFMS()5S&[1MS@9!*GM6C;Z;96ES/<P6T<<T
M[*TC@<L0H4?3"@#CTKDO!VJ1V5H]H\%S(UYKFI(CQ1%D0BXD.7/\(]SWH [2
M**.")8H8UCC485$& /H*?110!$UM ]PEPT,;3H,+(4!91Z ]14M%% !1110
M4444 %-:-&=79%+)G:2.1]*=10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 WRT,@D*+O P&QR!Z9IU%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<Z-]GU2/4O[-GM9[Q4AADV[PS3;<;"O(./PJ>3XEM:^'8K^\T98KVXOOL5K
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MEU!=6FIQW"Q,!TD^4;74$MM(.=I%:,/C;6['PYH#2Z"LMU=68FGN+O4%@@0
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M=6;5HTLUG^S,[QNK)+C.QE(W X'<4 4M6\-:[!XIN-?\,W^GP3WMO';W<%_
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M=6T$-LT<SR"+:@E)8CY Q' YQS5Z'P!<Q^!M"\/F^A,NFZA%=O+L.UPDQD(
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
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MW;BK-D[F48PA[US%Q\4].MO'Z>%'L;KSV;RMWR<N64*1\V-A4LV20WRXVY-
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MLB A$149N,GDG_\ 7S4FE:_!X O_ (?+X:OIKN>>58]2_=_96C>8N)6?=D$
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MC!0<YR,<USGB/3]4TCQ]8^,-.TZ?4H/L#:?>VML5\T)OWJZ!B W/!&<UW5%
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M49 'UQBG6WB#3_%_B'P3;Z.SS2Z<SW-^OE,OV4" IM?(X;<V,>U>IT8 [=:
M/,OBN=+&L>#6UJ(2Z:NH2-.IC+C:(R<LHZJ#@GV!SQ7(:C::9J<&NOHUN!X7
MO=:TJ.!8HS'#(^[;,8UP..5!(&,BO:-1T*UU/5M)U&=YEFTR5Y850@*Q="AW
M9'(P3TQ6H  , 8% 'C7BW1Y+/Q)XFL?#=DELY\*+Y4-I&$'-PY<*%[D;NG4F
MJ6LW/@.Z\/WB^%M,W:A'H=TDLMC"8DMT\KI/TW$D8&03G/UKW*D  S@ 9ZT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR78H"2?J:W*R_#6F2Z)X6TG2IW1Y;.TB@=TSM8JH4D9[<5J4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHM'EU:"/5'#E%^SG=D.1T4MM!- '=YS1G/2O#=?'A.R@GL_#5[-_8DFI6/\
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MS9=.MYK"-YV7,F^0-L!;YCP..:YSPZ=-O-.\#6_BV>,: ^EW+I]KG*0O=";
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M<X+4 =CIGB&TU76M8TN".99]*DCCG9P K%TWC;@Y/'J!6M7G7AW4;/2O'/Q
MN[^YCMK=;RS4R2-A06A  S[D@5Z+0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;6Z".&'0)8XT'15$T0 _*N'\6Z+81^,?&]^D++=1>&6N4D$C K(RRHS=<?=
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M<'_"/SS>5-(Z^:!<[8F?!&?D((S[&O<0   .@H **** "BBB@ HHHH ****
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M#TZ^UG1+OQ"GAJYLY+VZ"+*Z?8S+%""&VEVP57.TXS6]'&D,:QQ(J(HPJJ,
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MJ6/"AF &?]FLFSU+5-$U3QAI%_"OAXZI92ZM8R>=YZP2!=DK H/4!\ 9')H
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M8$KD9&1VXI] %.'2--M[66U@T^TBMY?]9$D*JC_4 8-)-H^F7$4,4^FV<L<
MQ"CP*PC_ -T$<?A5VB@"/[/")A,(8_-5-@?:-P7KC/I[5)110 4444 %%%%
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M!U"C<QZX'UX- '5:;J?AKQ=;S^'9]):(V<:%M+U*S\MDCZ(RH>-O8$=/:H-
MUSP>NN7_ ()TBPCMV@$@EB2V"02D!1(H/\3 , 0:Y77/%VG+XZO_ !5I<\5Y
M8Z'H<D4]S$VZ.2>20>5$&'#'..G3-88TGQ;X2\)Z-X@NM,L-^E7;:G=W"73M
M<3+.<3*R; ,[6&?FXV=Z /:4T'2(M-@TZ/3+1;*W<20VXA4)&X;<&"XP#GG/
MK5?4?"?AW5[[[;J.B:?=W6W9YLUNKL5QC!)'/%8OQ+O _P *=:O+.<[7M!)%
M+&V,@E2""/8URO\ PA.D'XEV6CN+Q["YT5KN[A:\E(N)ED50[_-DGYR?KB@#
MT74O"?A[65@&I:+877V=0D7FP*Q11T4''3VZ5J000VMO';V\210QJ%2.-0JJ
M!T  Z"O!4O(+OP;X)TN_=;AI/MI0:EJ)MK,K'*RKYK %G*C 501[TW09;E/#
M.O7^GSQ2?\(UK27\,5C.\D#0;1YL:,_)0KO/U&10!["G@?PI'-+*GAS2UDE(
M+L+5.2"&]/4 _45)XLT:YU[06LK.>*"X$\$\;S*63,<JR8(!!P=N/QK#^'D\
MNNMK/BV1Y##JMULLD8D!;:+*(0IZ%CN8_45YMXVFL-1U7Q=='^SQ<6;M LNK
M:HZ3JRQC MH(P/ER>"2=QZT >^Q>8(4\XJ9=HWE!@$]\9[4^O%-.GTGQ%J^G
M#QM>H+,^'+.>S%U>&%))&!\Y\[AE\@#UQ3=._P"$8U;7[*SUO5;F?P[%HX;2
MWU6Z,/G-YSJ[DY7<P  '^S@^] 'IXT:]?QT-<EN+?['%8/:0PJA$F7>-RS'.
M"/DXP!UJ?5?"OA_7;B.XU71K&]FC&%DG@5F ],D=/:O%;R>WU#6=&TV"_M[S
MP['I;O8OXCOI;>.=Q,RLVY -[  !0?X<&DA>TD'@^TUO789-#?5-0B\RVNYE
M@$01=D7FN%9D#_+GD$'&: /8?$EIX86TTZ#7=-LYX'NHK2SCEMA(%D<X55&/
ME''TP*QF\-Z#X5\"7-KXAMX=1TV*\DN0GV3?M,LIV!4YY&\#BO.=0T[1KF>X
M@MYS-X8L_$UC':2?:F,48D4?:%5]WW0<<YXYP>37JGQ "#P'.(B#&)K3:0<\
M?:(L<]Z ,74_$?@;PMJ&FZ;-HB6KW$J74<:Z:R%'$9,;JH3YG& F%Y4L :T/
M$_BSPMX3\0V5YJ5EMU.Z18EN_LC;Q$<Y ?;\V"!E <_,.*OZY\/_  YXCU:'
M4M3L%FG0_/G_ ):C8R!3GD ;LC:1R >U.U_P'X>\375M<ZG8K++ 5 )P=R+N
M^0YSA?FR<8)P.>* *#:?X*O/$\,$_ARW.I:G:O<B6?3=HE0CYP6*_?PPW#KS
MS6IJB^'M!B:2XTZW+ZG)#8F*.!6:Z.-J(1W 7/7@ &J-_;Q6GCWPC;0)LAAL
MKV-%SG"@0@#GVJMKY+?%CP@D_P#J!;7K0YZ&;:@_/;N_6@"]=Z/X3\&Z!JVH
M+H=G;V?V=S>+;VRYECQRI'<>W2MN.PTZXBT^9;.$BU4-:$QC,(*[?E_N_*<<
M=J\,\1KH-]X3\:7NOWJIXHAOKB*&.2[99$0,!$B1YY0KCL002:W3#X<U+Q9X
M@C\;7T<*VMK:C3DN+LPA(3#EGC&1D[\Y/)R,4 >K:=HVF:/Y_P#9MA;VGVB0
MRRB",)O?U..]5+KPGX=O=575+K1-/FOU((N)+=2^1T.<<D8X->(W"W>L:7X7
MFU;4=/N+K^Q2S6&MW,MLDB^:0)4E! ,NW:#GG'/>E.IR:]-X8MI_LD>C_P!C
MNUO#KVIR1Q23),T;$R1@>8P55QD8VG- 'OT5C:07EQ>16\27-P%$TJJ T@4$
M+N/?&3CZU1U;PQH6NSQ3:MH]C>RQ#"/<0*Y4=<9(Z>U>)RPO=>%M)MI/$.D3
M6\>KW8M;>XGN?L$J! 1$9R%)V'=M))!Z9.,5Z+\)KR&X\+W=M#"T2V5_+ 5%
MY]JBSPW[J3NGS<#G'J: .C&@>&[_ $N?3UTW39[!YV>6!(D9/-S\Q(' ;/XU
M@2ZCX)T.TUS3QHJ0V-HT<>H"+36,!)12 Q52#A2I)/0'FL2]\(ZKJVO75WX?
MT=?"DAG;?JOVMA)<?-RWV>,[&!Z_.><]*U]#T.TUFY\6Z=K"+?(-5B+EU #N
MMK!\Q7IUYQTH HZ-J?P]D\#S:W;>'[>WTR2-(;M5TXE><.58A?F56/+<@$5+
M#XA\#^(=(A\2W6AB87OE6,TSZ>9-I?;A'?;@J&*KGID8K>L?A[X:L/#@T*/3
MU>S)1Y!)R99$4*'8?=)X!/&">HK$U_PMI7A+X=-I^DP>5']KL/,8_>E99X5W
MMCC<0HS@#)YH V/&MGX5M[!=9\0:%;ZB\+)#$/LJRRNS,%5%SUR3T)Q6UIT%
MI<"#55TLV=V]N(0)HE6:.,'(C."< 'G&<5Q_Q:TNSU'1='-U$S[=7M8QB1E^
M5Y%5AP1U'?MVQ7/#0U%SX^O[-;B74-'^32E,\C?9V%JN"@S@L>.N<X% 'I-W
MX2\.W]E'9W>B6$UM'(TJ1O;J0KL<L1QP2>3ZT^+PMH$*A8M%L(U66.8!+=5
M>,81N!U4< ]J\JTQ/#ME<>!;KPMJ*RZU>7,2WXBO&E>6%HF,QE4DXPP!Y P:
MRK?0H+CP1X<UAKF^74KWQ#]CDN4NY X@>XDC:->?E! [=R: />;NSMM0M)+2
M\MXKBWE&V2*5 RL/0@\&N/L;GP/HULK:9I-K%%=ZA_8CF"T5=\NX@HV<97.>
M>:@\$:=;:/XS\9Z/8J\>G0-9O% 9&94+Q$N1DDC) KSU-"TE=&73+=WC>3QP
MMM.L=R_F)$LDBI_%E3M)^;J>N3B@#VK2O"^@Z%+++I6CV-E),,2-! J%AZ9
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M6V_X1K6K&33HIY]4@<R'5I+C494:3Y_.4 ( 0<$8[@4 >W^%9],U+5?$FJ6
MN!*^H&SN1*BJ/,@4)\N.H]SS] !73UX)$\+3O::K<&#P]<^--034&,IB1B$S
M$KL",*6'KCBDU;[+$^O:9X;U"4:"-1TM8VM;IF6*9W(D$;Y..-I(!X- 'OE%
M>+>);"7PCK'B>Q\*"XMA)X:6Z,4<KN?,$Y1I!DDA@F[D?6I]*'A.U^)WA*/P
MEJ:3+/;W1NXX;QIE;$649P2<-G=UYX]J /8J*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *HS:+I5Q<-<3Z992S/RTCP*S-]21FKU>/
M^.Y]0T?QG?:3:S3JGB^U@MK=E)(BG618Y"/[O[IRQ/J* /4+Q;/2[>74UT\R
M2V\!4"UMP\QC'.Q .3ST6LO4?$.@*+^:]A\V;1[,7LZ26^7AC=6/&1]XA3D
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M:9.^>,^],\/Q_8_$&BRZ=J6@PFX@F\Z/3]4N;N6[3RB?WBLF%(.&RQ7G(]J
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MS]INM-LYYPA3S98%9MIZC)&<>U%YH^EZCY?V[3;.Z\K_ %?GP*^SZ9'%7:*
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M,,9G"&,2[!NVYSMSUQGG%5+70M(L9!)9Z58V[ABX:&W1"&(P3D#J02,UH44
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV&O2ZCJ%PT-[!<2"ZM#@J4E3[NT#(QCU(/ %>]_9;?STG^SQ><B[5DV#<H]
M>PID6G6,%U)=0V=O'<2??E2)0[?4@9- '+_#E?#JZ1J7_"-7EW=6QU&4SO=;
MMRS87<HR =H&W'\Z[&HXH(H PAB2,,Q9@B@9)ZGCO4E !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!7OK*'4=/N;&Y4M!<Q-#(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHI%&,\YH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWIYB%&'L5/(-6Z\FU*Y\->(_B'.?$NHV[Z+_ &7%-I7FW9B@DR["1U((#-D
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M DBR89U+LJG<B IU8=Q76UX3X9TZWTSP?X#NK,2Q37WB%5N")G(<*UP ,$X
MQZ8SWK8\%_\ ".7E[-J.M7L9\8?VO<1A)+MEF#ARJ1A ?N;0!C&* /7J*\#\
M&P76IR:'J;ZCHEMK0U,/>W$NIR?;9OG(D@:$K@97@+G& "*[?X<Z+9SWFMZ[
M<"6;44UF^@BEDF<^5&)"-BKG '4].] '77/B""#Q58^'UB>2ZN;>2Y9E(Q#&
MA !;ZL<#Z&L>Z^(^C6UU=1Q6NJWEO9R&*YO+.R>6"%Q]X%QZ=\9Q52V!_P"%
MVZF'($K:!#Y)QT7SGS_X]BL_X<^)=#T/P#;V.KZI96&H6#S1WT-Q,J2+*)&+
M$J3DYSG(ZYH Z35/'.FZ;JDVF16FIZE>0(KW$6G6;3^2&&5WD< D<XZTT>.]
M(ET[1]2M3)<6.I7JV/FJ-I@E;( D4\CYAM/H2*PO"6M:7H.O>+[#6=0M;*]?
M5Y+Q3=2K%YD#HGEL"Q&0 "..F*YFYQ<_##Q9J-HA\G4?$8N-.<#'F@SPJKI]
M65L4 >UT5R'Q,M+N;P3=7NGNZWVENFH0;21DQ'<0<=<KN&*\KF\3:O)J-[KE
MG+<-#XTCFT_2X^<1.DB0QMC^'Y2[?A0![%KGBVWT&QU2[N+"^,6GO C/Y6U9
MO-95!C8G# %AGTQBK>GZ]!J.O:QI$<4BRZ6T*RNV-K^8F\;?H/6O(O$%N;#3
MOB'IJS2R06<FB0Q!V)P (1GGN<9-=]X8_P"2E>._^NEC_P"DXH [6BO+HM)7
M4/''CK4BDMS?Z8T#Z:C2MLBE^S Y50<9)"]0>E<_X M7N[WPOJ=KJ.APWCEF
MO735))+N]W1L9$DB90-P/S8S\NWB@#W&BOG33VT7_A7_ /:EKJCOXUCU,I:I
M]L8SAOM&%C6//W"A)(Q@Y-=9%IK20?$'Q%;B>76M.OKQ-/<RN?(Q OW%SC/S
MGMV'I0!Z_17BO@JSCCU#2-3L]6T&R@_L^8WK6FJ23SW0\O.^1'4 ,C?,3VR1
M5*TOWT'PWXETO25M)]:AT87(UG2[UIEN8P^TNX).V7!9N_L0,4 >[T5XKH5@
MMN;B\TJ_T&"V.AW/G6^G:I)<27.%&V5E91@J>K=?FQ1INA6FFZ7\.-9@:Y_M
M+4IH8;RX>X=FFCDMW+*<G&. !Z 4 >OV&IV>IBX-E<+,+>=[:7;GY)$.&7ZB
MA=3LGU273%G4WL,*SO#SE48D ^G)!_*O/?A;I.AZ;JOB5+4HFHPZK=P"(W+,
MZVX=2OR%CQT^;&3ZTS^QM!M_CC>2W6V*YET^"ZMQ)<NN^8RN"5&[YN@^7D>U
M '=^&M>@\3^';+6K:*2*&[0NJ28W 9(YQQVK5KP7PQHEKI?@[X?:_:O<C4KG
M5H8))FG<@Q.9 T87.T+@#C'KZTPP7FL:EKLTVH:'9Z[#K++%>7NIR17-LJ2
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MMI8C913H$0$*$#CY.#T''M6_X>T.U\-Z!9:/9M(UO:1[$:0Y9N<DG\2:TZ*
M*":'I$>H&_32[%;TG)N%MT$A/^]C-6_L\/VDW/DQ^>4\OS=HW;<YVYZXSSBI
M** *RZ?9)%#$MG;K'"_F1((E C;GYE&.#R>1ZFF_V7IXU#^T!86OVW&/M/DK
MYF/3=C-6Z* *']B:3_:/]H_V79?;LY^T_9T\S/\ O8S5N&WAMU98(8X@[EV"
M*%RQY)..Y]:DHH QKOP_%<>*].\01SO#<6D$MO(JJ")XGP0K'MM8!A5JXT32
M;N]6]N-+LIKM?NSR6Z,X^C$9J_10!1OM&TO5'1]0TVSNVC^XUQ LA7Z9!Q5;
M5] @U<Z6CR-%;V%VET(8U $C(#L4^@!(/']T5KT4 (RJZE64,I&"",@BJZZ?
M9*D"+9VX2W.85$2XB/JO''X59HH KR:?92^=YEI;OYY4R[HP?,*_=W<<XP,9
MZ5(EO#'-+,D,:RRX\QU4!GP,#)[X%244 1QV\,4LLL<,:22D&1U4 N0,#)[\
M<55AT32;>_:_ATRRCO&SFX2W02'/7Y@,U>HH YWPSX/T[PYIMK;^5!=75L92
MEX\"B0!Y&? /) ^;'6MZ*WA@,AAACC,KEY"B@;V/<XZG@<U)10!0MM#TBSN9
M+FUTNR@GD!#RQ6Z*S ]02!DT^RTK3M-61;'3[6U$ARX@A5-WUP.>IJY10!GV
MNA:18R326FE6-N\RE96BMT0R ]0Q Y'UJS]BM?+@C^S0[+<@PKY8Q&0,#:.V
M!QQ4]% %:/3K**^DOH[.W2\E7;)<+$HD=?0MC)' HGTZQNKJ&YN+.WEN(#F&
M62)6>,_[)(R/PJS10!76PLE@A@6T@$4#!XHQ&-L;#H5&.#R>14$^B:3=7J7M
MQI=E-=H05GDMT9UQTPQ&15^B@ (!&#R*S[70='L;MKJTTFQM[EOO30VZ(Y^I
M S6A10!3_LC3/[0_M#^SK3[;_P _/D+YG_?6,U,UI;-=K=M;Q&Y1=BS%!O"^
M@;KCVJ:B@"C>:)I.H7"7%[IEE<SQ_<DFMT=E^A(R*LBUMQ)-(((@\P E8(,R
M # W'O@>M2T4 0?8;3RH(OLL'EP$-"GEC$9' *CMCVIO]GV1A,)L[?RC)YI3
MREVE\YW8QUSSGUJS10!$+: 3R3B",2R*$>38-S*.@)[CD_G52UT+1[)IFM-*
ML8&G4K*8K=%,@/4-@<CZUH44 0_8[7; OV:';;X,(V#$>!@;?3CCBF1:=907
MLM[%9V\=U,,23I$H=QZ%L9/XU9HH C6WA2X>=88Q-( KR!0&8#H">I R?SJO
M;Z1IEI=R7=MIUI#<R??FC@57;ZL!DU<HH C@MX;6(16\,<,8)(2-0H!)R>!Z
MDDU%-IUC<7<-W/9V\MS#GRIGB5GCSUVL1D?A5FB@"NMA9K#!"MI (H&#0H(Q
MMC8="HQP>3TJ&?1-)NKU+VXTRRFNT(*SR6Z-(N.F&(R*O44 8WB;P^GB33(K
M*2X,"QW4-SN"[L^6X?&/?&*T+33K'3TD2RLK>V21MSK#$J!CZG Y-6:* *-M
MHNE63!K73+* @E@8K=5P2,$\#J1P:H:YX8MM8LM,M$9;2"POH+Q(XXAM/EG.
MS'  -;M% %:STZQT^%H;*SM[:)B69(8E123U) %1VFCZ98&4V>G6EL9O]888
M%3?]<#FKM% %2RTK3M-1TL;"UM5D.7$$*H&^N!SU-,LM%TK3IY)['3+*UFD&
M'D@@5&8>Y R:O44 5;[3;#4XEBO[*VNXU.56XB60 ^H!%/\ L=KB ?9H<6YS
M"/+'[OC'R^G''%3T4 1SP0W4#P7$4<T+C#QR*&5AZ$'K45MIUC9^7]EL[>#R
MX_*3RHE7:F<[1@<#/..E6:* *R:?91>5Y=G;IY)8Q;8E&S=][;QQGOCK3++2
MM.TUI&L;"UM3(<N8(53<?? YJY10!4O=+T_4O+^WV-M=>6=R>?"K[3ZC(XI+
MS2-,U!XWO=.M+EHO]6TT"N4^F1Q5RB@"(6\ N/M AC$^SR_,VC=MSG;GKC/:
MH9=*TZ>S:SFL+62U=BS0/"I0DG))4C&<\U;HH AAM+:V=W@MXHF<*K%$"E@H
MPH..N!P/2H+71]+LI/,M--L[=]Q;=% J'<1@G('4BKM% %2'2]/MKR6\@L+6
M*ZE_UDZ0JKO]6 R:9'HVEQ)(D>FV:++()9 L"@.XZ,>.6]^M7J* "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HIK2(LBHSJ'?.U2>3CKBHY+NVAD5);B)'9@BJS@$L<X ]S@X^E $U%
M9W]OZ2=<_L0:C;'5 GF&U#CS N,YQ].:T: "BBF^8GF^5O7S-N[9GG'KCTH
M=135='+!75BIPP!S@^AIU !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>modificationno13effectiv004.jpg
<TEXT>
begin 644 modificationno13effectiv004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""]>:*QGDMS&)40LOF*
M2N1SR 17*^$_$^J^)/A\OB.2&S@GFCDDAA4,RJ$9AACG)SM[=,]ZZ;5;B&TT
MF[GN)HX84B8L\C!548[DUY+\.;+2)_@M#>3:K>1&&"X$X74Y8TB;>^ 5#A5R
M,'&.<^] &LWQ$UQ?AQI?BL6FGF34+E(%M</A-SE 2^[VST[UT/C?Q+JGA71M
M/N[>*SN9KB[BLW2165=SY&X$'@ CIS]:\GNM0T]OV>/#,+7L2LE]$)%64!TQ
M,Y/0Y! YKJ/BM;Z1I>A:'=+JER^[5K:11/J4DRM&"26"LY! '>@#JYO%E]<>
M-I/"EE+IT%Y;6B3RRW:L?/9OX8D# X Y)R<9Z=Z=<>,KO2/#=A-JUA&VN7MX
M]A!8V[D)+*)60$,W1,*&+'H#T[5B^+K7P7XMU:YL-8O(-,U.Q2*2SU-;A8G*
MLNX%7. P!SQSC.1C-<VL7B#4O#'ACQ%J33:B/#VLN7G2,E[JS#!?/"]6X&?<
M<^] 'H&M:_KOA735UC5XK"[TV-E%XMFCI);JQ WKN8^8 2,C"G'/M4_B3Q-=
MZ3+X?DL;>UN+'5+^"T:9I6W*),D%5 P>!U)].#6+X]U_3?$/@J[T;0;RWU34
MM4006UO:2B1N2,LV/N*!DDG %5O&?V;0-#\!Z==WD"O::O8(S,X7*HI4OS_#
M[]LT =/XD\1SZ;J^BZ)I\<+ZEJTLBQM/DQQ1QKN=R 06XP ,C)/6L.;XC/8^
M'M6DN[2)]9T[4!IOV>)BL<\KD>6P)R54@YYR1@CFCQBB6'Q!\'>))Y%CTR W
M-K<7#'Y(C+'^[+'H 3QGIR/6N)U/2;G4=-\2>*;6*26P'B.VOX"B$F:"#Y7D
M4=U^8D'N%- 'HD?BS4['6]2T+4;.&\U2&Q2^LUL0R"Y5FV%<,3M(? SG&#GC
M!IFG>)O$EKXKT_1/$NE:?"-3BE>UGL)VD"M& S*X8#L>H_\ U9":IIUS\4[[
MQ;'?0-H.F:"+:>^5MT7F-*7VJPX8A<9 SR0.IIV@>./#?B#Q-;:C-J=O)?39
MM=+T^+,DD*-RSOC@.VT$]E"@9SG(!+-\1+U=*O\ Q+%;6I\.V.H_8Y =QGDC
M#B-IE.< !FX4CD \BM_Q!XBOM(U[P_:06MM)9:G=?9WF:5MZG8S?*H&,?+US
M^'>O+9K<VWPJUOP&#NU^356M[>S_ .6DJM.LBR ==FW)W=.#7;^.[RST[6_
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M4 ( %    '0"EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *;Y:9^XO7=T[^M.HH Y"V\(ZQ8R7D5IXG?[#=323%)[%)94
M9SDXD)P1Z;E.!@=JZ33M-MM,TRST^!28+2)8HM_) 48!SZU;HH *0JI8,5!8
M=#CD4M% !3=B;2NQ=IZC'!IU% #(X8HL^7&B9Z[5 S2E%+ARHW 8#8Y IU%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#;F=<(=O3Y<9XXSS6_/X_N;.'1H+CPUJ)U355E^SV:/$2Q0*22P;:JD-G)/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4+]LJ1T'!K2N=.L[N:*:XMHY)(FW(Q'(.UE_'AV&#_>-8VLJ%\6>%U4  27
M ';]R:5-T)I1C#51E=]W9M6!W1T=%%%<)04444 %%%% !1110 4444 %%%%
M!1110 44@;)(P1@XY[TM !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 9VJ:'8:RBI?1R.JR+*FR9XRCKG#!D((/)[UH@8&*
M**IRDTHMZ( JC+H]E/K$&JRQR-=VZE(F,S[4!!!PF=N2#UQFKU%$92C\+L 4
M445(!1110 4444 %%%% !1110 4444 %%%% $<<*QO(RELNVXY/L!Q^52444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTW2SJ-P[_9AL^:.)G/S$ ?*H)ZD=JNT %%9NHZY::9J6EV%P)#-J4S0P;5R
MRH7.[G@8!K2H **** "BLW4-;M--U32].G$GGZE(\4&U<@%$+G<<\< UI4 %
M%%% !1110 45FZWK=IH%E%=7@D,<EQ%;KY:Y.Z1@J]^F3534_%VEZ7I.K:C,
M;AHM+D$4ZI VXN=N%3. V2ZC(..>M &[161HWB&#6':#['?65VD0EDMKR HZ
M*691DC*G.TG )XQ6O0 45FWVMVFGZQI>ES"3[1J32K!M7*YC3>VXYXXK2H *
M**9-*D$,DTC;8XU+,?0#DT /HK$\,>)8?%.F_P!H6VGW]K;-@PM>1!/.0C(=
M<$Y'Y59UG7+30X[-[L2$7=W%9Q^6N?WDAPN>>GK0!I45FZ3K=IK3ZBEJ) ;"
M\>SFWKC]XH4G'/(^85I4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D>*-<B\-^%]2UF7&
M+2!I%!_B;HJ_BQ _&OGO0=1G\)ZIX.UVZT75[*1II8-6O[RV\N*Y$[%E(;/.
M 2>0/NBOI#4M+L=8L7L=2M(;JUD(+PS*&5L'(R/J!3-2T73-8L!8ZC86]U:*
M0PAE0,H(Z<>U 'SSKW_"1C4OBHVC?9&L!-&-121"TIC(<9C[# W$Y[=.E=%X
MXBTS_A47@=M+8RVO]H62QRR*-[*(W!#8[Y'(]J]BCT+2HI-0DCTZV5M1&+PB
M,?Z1P1\_KP3U]34+>&-#?2K;2VTJT-A:R"6"W,0V1N"2&4=CR?S- '!^,HUB
M^,_@%845/EN\ # SY=8/P<U?P]IGA;7K3Q)>6%MJ9U"4W\=\ZJT@P!R&^\,A
M^/7/K7LEQI.GW>H6NH7%G!+>6F[[/.Z O%N&#M/;(K-U#P5X8U74/M]_H&G7
M%T3DRR6ZEF/^UQS^- '!?#[5=-T[XA_$".\O[2U:;48A$LTRH7_UGW03SU'3
MUK(^'-UJEOXK\3+;:UI%G8'Q#-]HMKL?OI1OYV'(QQQTZUZE<^!O"UYJ+:A<
M:!I\EX[B1IFA&XMZY]:23P)X4EU!K]_#VG-=M+YS3&!=Q?.=V?7/- '&_&^(
M#2O#MW=J7T>UUB%]07!8>7TR1W&,C\145IXTN[GXL:-I$=]X?U+2+I)Y[62S
MCW2VR"-]H+9.UL#!P.F:]3N+:"[MWM[F&.:&0;7CD4,K#T(/!K*TWP?X;T:\
M-YINA:=:7)S^]AMU5AG@X(''X4 >?_$3Q(GB72=&MM%L=3UKP]=W1?4I=)MV
ME9DB(/E=L;FQDDC@<9JC\'O%6E:-X,UJ34TETNR@U5RLUS%LC)DZ1KC^)=O(
M[9%>NZ=IEAI%H+33;*"SMPQ8101A%!/4X%5#X7T$Z=+IS:/8M92S&>2W:!2C
M2'DL5(QGWH Y+XW$'X1:P0<@FWP?^VR5Y[X@\+R^*/&^JPV99=3L_#UI>6+K
MPPE0H0!]1D?4CTKWO4-,L=6L)+'4+2&ZM),;X94#*V"",@^A /X4R'2-.M]0
M;4(;*".\:$0&=4 <QCHN?08'% 'SQX=@E^(W@_XBW,L 6_E:VNT0#I-&CD@?
M7##_ (%6OX<U2;XD^*=-U"W\R3_A'O#YSN!YOG4KQ_,'_9KV[3M#TK2)+J33
MM/MK5[I_,G,,87S&YY;'7J?SIFD>'M'T$3C2=,M;$3D-+]GB";R,XSCZG\Z
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M.5P4QCWH [VHEN;=[E[=)XFGC +Q!P64'H2.HKYGUR.WO_$WCR(6>L7FO#4
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MFU&\%H"K@>4=C-DC_@/3WK9)"J2Q  ZDT <WIW@JPL)_$CO++<1:_(7N8I,
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M=#X:\0Q>(]!355A-M&TLL6UW!QY<C)G/OMS^-&N>(8M%DTA3"9QJ5^EDK*X
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M36\4D:XVJZ @8Z8!H \/T32K?6;KP5I]]'--HTMYJQM(978"2U7:T0/<IP,
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M88*L,@_A0!X+J<.G26/BF'PY(8_#DFI:6EN]FY$2S&0>:8B. >4R1WQ7L/\
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M3X2CL=6GU?4-2NM6U&:W%J9KI(U"Q!MVT(BJ.O.3DUT.Q#()-J[P,!L<X]*
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M3<0N=K"$C ?IWQUJ^G@C5E^']KHA-O\ :XM7%ZW[P[?+^U&7KCKM/3UH T-
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M0V[!V8Y ^\O8YK-U#PSXG\4SZAJ&K6MAI\PT>ZTZSMH;DS;Y)1R[OM&%X&
M3UK7U+PQ?W>C^#K6,P^9I%]:SW.6.-L<3*VWCDY(Q0!0D^*]E#%?^9X>UX7&
MFG.H0?9T+6L> 0['?M((.1@DX!.,<UT/BC5;^V\$7^JZ!$+J\%KYUJNPMNR
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/F((*?>  &=W3M0!E7/@/1KK3KNS8W4?VC46U,313%)8;AOXXV'W>_YFHY?
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MS;*+E"9AG'R<_-SQQ0!Q_A#P[KNG^)3>RK>V&EBU:)[2[U9KTS2[@5<9R$
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M./WCD?PG 1?H#6WXB\.V?B73X[2[DN(3#.EQ#/;2;)(I%^ZRGL>3^=<QK?Q
MN+'3=&6WBTJWU74[EHA%>7ZM%#&N_,C.G4'9CCN<=172:;KOF:;>7>KBSL%M
M)VADD%XCQ$ #YMW&W)/W6P1QGK0 VS\*V%G+J,WFW4TVHVT-M<R32;F=8T9
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MUHSF'^Q7>>23S]RNLX."I&/F[+UX%>W:1I=OHFCV>EVF_P"SVD*PQ[SEMJC
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M5E!&QBNWYC_=(I+^VTSP_P"'M&N;'66N+Z"UNFM([S19'M[Z.24L80F#Y9R
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M782/[V3Q_2M-(-,T[XJZ7>:I81@W^C6\=O.]H7W78E/\04X?!7YCCCO7J5%
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MD3<R.LC/N&1@<-CUH P-#\7^)F\$:-?R:&=3NKB*1IIY+F.S7"N0APW=UPV
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M$>(1J1N_BR"3V]*HZG\-Y]0TW5HC<63W$^O?VQ:"XA,D/W%7RY5[@@,#CU%
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MCLK_ $H:A::>0 +:,R[$!_VBJY/NU:_B2[U'5_&VG>$K'4;C38&LGU"\N;;
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MVX;R($?'[I W.T8/YFMC^P-&_P"@18?^ R?X4 :"LKH&5@RL,@@Y!%+2 !0
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MT^>/5+5HM1?R[-Q(,3MZ+ZGB@!)?#&C3V&H6,E@C6NHS&XNX]S8ED.,L>?\
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MUBUAMY@1\[_==5#,GNP##@>M+=_$/PE8O ESKEM&9XDF3.[[C\JQX^7(]<4
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M]-A6ZTV#[-9R#.88\8VCGT)Z^IJI?^ O#&IZL^J76EHUY(09'25T$A'3>JL
MW0=0:GUCQCX=T"9X=5U>VM9D"EHW;Y@&S@[1SCY3S[4EEXS\-ZEJZZ59:S:7
M%\R;UBC?=N&,\'H3CG&<T 5-1^'7A+5M1EO[[1HI;J:3S)9/,=?,. /F 8!A
MP.#Q[<FI[WP+X:U'5QJEWI4<EV"A)WN$8IC82@.TXP,9':KP\0Z0VG1:@-0@
M-I+-]G2;=\K2;]FT>^X8^M5I?&7AV'59=,DU6!;R+=YD?/RE5+L"<8R%!.,Y
MXH EN/"VB75EJ5G/I\<EOJ<OG7D;$XE?Y?FZ\'Y5Z8Z52N_ /AF^LK*TN=-W
MI8J5MG\^021@G) D#;N3ZFF>$/'>C>,XI_[.G7SX7</!NRP0,5#_ $;J/K6)
M'XZ.I?%";P_9:SIL%G9(HDADB+2W,OSF15;("[ O/!_P .WL=,LM-TR/3;2W
M6.SC38L1RPVGJ#G.>IZUD:5X%\-:)?0WNG:5'#<P[O*D\QV,88$$+DG P3P.
M*=I?CCPQK6I#3M.UJUN;LABL:,?GQUVGHV/;-<YX>\<ZKJK>#A<16H_MEK\7
M.Q&&WR"VS;SQT&<Y_"@#=@^'OA2VU 7\.C0K<K.+A&#-B.0-NRBYPO/)  ![
MT:A\/O"FJ7]S>WNC0S3W/,Q+,%=L8W;0<;L?Q8S[U*GCKPO+K(TA-;M&OC+Y
M(B#=9/[F[IN[8SG/%6SXHT(6 OCJMJ+4W'V7S3( OFYQL^N>U %NWTNRM=1O
M-0@@5+N\""XD!.9-@(7/;@$UCP> O#%MK/\ :T&EI%>>=Y^4E<)YG][RPVW/
MOBMJ._M);^>QCN(VNH$1Y8@?F16SM)'OM/Y5Q_\ PL[1;N\\0:;874)U#38I
M&@#MD7#+$7;:!SA2"#]#0!HVGP[\)V37#0:-$/M$3P.'D=P(W^\JAF(4'_9Q
M5_0?"FB>&?/.DV(@>?:)7:1Y'8+]T%G).!DX%9?A+Q[HWB*TTRV.J6;ZU<64
M<\UM"3PY0,X'T)/&21CGI6@GC/P[)K/]D+JUN;[S3!Y>3CS!U3=C;N]LYH =
MJ/A#0=5^W?;=/60WS1/<,'96=HQA#D$$$#N,4R#P7X=MM.M["+2XA;6]VM]&
MI9B?/'20DG+-]2:=XDU]]!?1E2W6;^T=3BL3EL; X8[O?&WI[UR][X^UZW_X
M2&_M]"LI](T.Z>"X8WK).P159F5=A7HV<9[4 =SJ.EV6K6Z6]] LT22I,JDD
M8=&#*>/0@&HY-%TZ6_N+Z2T1[FYMQ:S.V3OB!)VD=,?,?SKDKGQIKMQK>JVN
MA:-8W=MIMM!<RM<W;0O(LJ%P% 0C.%(Y-=)IOB2QO_"5MXCE?[+8RVJW+F4_
MZI2,G)]J *0\ >&!H7]B_P!EC^SQ.+E8C-)E) ,!E;=N7 XX(K&/PMT:_P#$
MNL:AK%G!=6MPMLEH@ED5XUCB",K$$9!P.,G..:WQXW\,FQN;U=9MFMK:802R
MJ21YAZ*,#YB?;-.'C+PZVC/JXU:W^PI+Y#2$D$2?W-N,[O;&: (-1\!>%]5N
MXKF\TB*1XHDA50[JA1/NJ44A6 [ @U!XE\#6.O+/Y6RUDOI[<ZC(%+&Y@B;(
MBZX&< 9]/6E_X3G2M0C@?1-2T^X_T^&TN!.[QE=Y(VJ-N2YP< X''6KC^-/#
M<>H7-@^KVXN;82&9><)L7<X)QC*@$D9R,&@!=7\.G5_$.AW\MR!::7))/]EV
M9\R4KM1LYXV@L>G4U;UK0-*\16L5MJ]E'=PPS+.B29PKC.#Q]3^=8/A[XE^&
M]?T5]1&H06HBDV31S2#,69"B%CT&[ (^M69OB'X2@L(+V37+<6]PSK$X#'>4
MQNP ,X&1STYH U;?0-+M-<N]:@LHTU*\18Y[@9W.J@ #T[#IZ"J<G@OP[*FK
MJ^E0D:NP:_Y/[\@Y!//')SQCFLO5OB=X9TB\T:*74(&@U1#*MP'^6./!(<^Q
M*E?K6I;>([?S=:EO;S3XK'3V0^:DQRB-&&S)D *>>,9XQ0!8O_#&BZGH,>AW
MFGQ2Z9&J*EN20%"8VX(.>,4^+P[I$.N?VU%81)J/V<6WGC.?*'1<=.P[9JEI
MWC?PSJUO>3V.L6TL=E$9K@Y*F.,#.X@@'''6I-,\9>'-:U1]-TW5[6ZO$4N8
MHVSD#@D'H<>U $L?A;1(HX(X]/B1(+PW\84D;9SG+]>OS'VYKF-%^%VBP7=W
M?ZS86UW?R:E/>12*[[=K2%T#KP&(SW!KK-8U_2M @BFU2]CMEE?9&&R6=L9P
M ,D\55?QEX<CTNWU*36;1+.XW^3*TF Y4$L![C!XZT 8$OPRTG5?%>NZOKUG
M!>1WTL+6P61U9%6)497VD9!*YQR*VM>\)66JZ?>+:+'9:A-ISZ=#=HG,43?P
M@=-N:@7XC>#W6U9?$-E_I3E(AOY)SCD?P\^N*L:MXX\,Z%J/]GZGK%O;70"D
MQOGY0W3<0,+GWH Y7PS\-9M(\1:=J<MMHUA'8PR1-'IB29O-Z;?WI<]!UQSS
MWKI]+\!>%]%U-=1T_1X8+I,F-@S,(\]=BDD)U/W0*S_%?BV]T2P\236AT]Y-
M-L8[F%"[-)N8D?O%XPO'&#SS6WKFJRZ9X7GU.-[-)8XE<-=R%(021]X@$@<^
ME $UMX?TFSUR\UJWL8X]1O%5+BX&=S@8P/3L.GI4VF:58Z-9"STZV2WMP[.(
MTZ;F))/XDFLS5O&_AK0IWM]4UFUMITV[XF8EAD9!P!G&.]2:GXP\/:.+<W^J
MV\(N8_.B.2VZ/CY^ <+R.3Q0!MT5R=K\1- N?&-YX:%W&EW;[55B_$LAW;D
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M855<<%L@_+UXK<U+P_=R^*/#ZV5H]O!'HEW:--''A(&98PBDCISG ]C7H-%
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M8SV(J@GPU\KPZ;*+6734?[6&L+>K:H%6XX'$6<;<#&,T 4==^(U[IFM3Z/\
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M,8*Q&0/'GG!&.#[T[6OB!>Z6GB,PZ;%</I5_:6D4?F%3,)@A.3V/S\4^7X;
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M+3UD,@M8$@#D8W;5"YQ^%<Q#X(O)O%-IK6L:\=1%CYPM8OL<<3!9%*D.Z\N
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M()8W50P*$\'Y1@YXJ2Y\#3RWWB,PZT\6GZ]"ZW%H;96*2M%Y>]7SGH,[?UH
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M(5W 8P%X(P><CTK'U2.+Q+XV\0P:NVHS:3H%O;[-.LFD'VB25"Y<K&0SD
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M=U41$ %B26Z=3UZUS_A7P_K^J:%X2U34KNP%GI5C'<6-K:1/OE8P;4\QV/&
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MP\DWV9-[L#D$MC)((!SZBE@T'1[74I-1M]*L8KZ0DO<QVZ+(Q/7+ 9.:T**
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44@8,,J01ZBF)/%)(\
M:2HSI]Y0P)7ZCM0!)1110 4444 %%)N 8 D9/04M !1110 444$@ DG '>@
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M?A.[UM[9KDP[52(-MW,Q &3V'-87PN^)/_"P[._,NGBSN;)T#A'WHROG:0<
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MDC&<9P00,U%J_P /[R^NM;6P\12V&G:VN;VU6V60E]FPE')^4, -PP<XX([
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MS<].>NW/O4,7@35WUU=9OO$XGOK>VFM[2>+3HXG0R #=)R1(5P,# 'YT 7_
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MF*ECM8!FY &,FG7L6FZ#XBL[?PIJL\\5UI%\]^JW[W((2(&.4DL=K;SU&.M
M'L%5K+4+344E>SN(YUAE:"0H<[9%.&4^X->1Z+IGV$_#O4A?ZC+=ZU$4OWFO
M)&$R/;%MN,X&T@8Q@\>O-945E::)\.O'-UIM[=0:I;ZE<0+B]D9DC%RF#M+=
M>GS8R<\GF@#WJBO+O%&E:1HC:)X=2VO=0N+^6>X'VK69;>-W5%WO)("3GH0H
M&,D\"N;TC46O_#G@O2]7U"6/1KK4KZ*YE%XP#",OY,9F!!*D\#D9VB@#VR;4
M+2WO;6RFN(TN;K?Y$3'YI-HRV/7 YJS7CFM>'?"__"7>#5M]1N)-,=KZ!IAJ
MLI5"J%@BR;^,,2.#DXP<XJ[:3Q:1\3$>]D34QJ.HRQV5[:ZFS/;G81Y$L&[&
MU<$9['!/- 'JU%>?^.I(KKQCX9T;5+R6UT2Z6YDGV7+0+/(BKL1G!!QR3C(S
M^%<;.\S1S:-I>L7RZ,/%EK9VMQ#=,S+&\1\V-9"22 Q/<XH ]RK+O]=M=.US
M2=)ECF:?5&E6%D VKY:;VW<Y''3 -9VMVQ\,?#K5H]#$J/9V,\EMND:5U;:S
M9W,2203D9->=Z58Z'9>.?A[/IFJS7ES<VUQ-<A[UY]Y-L3YA5B=I)W#C'3&.
M* /::K66H6FHI*]G<1SK%*T$A0YVNIPRGW!KQ'1+VWO?%GA?4--@GM+75KJY
MC=I=9DGN+F/8^?,BZ)R,@@Y'%):VZ>'OA]XWO-%NKB/5H-1N;4@WDC-%!]H4
M,^TDX8(2=^-W?- 'O%%>;>!]/N[7Q09[9]/MM*ET\AK2WUE[XRR!QME&Y1C@
MD$CKD4S5TT[6_B9JFG>)M0DM]/L]/@DLK<WS6R.7+>9)\K+N(( Z\4 ==XD\
M3Q^'GL(%T^\U"\OY6CM[:U"[FVJ68DL0  !ZUN(Q>-6*E20#M;J/8UX5I&EI
MXBO?A[-JMQ?W#7!U&$3&ZEC>2&+=Y395A@E<988+#&<UZ!\2OM$EIX=M8+VZ
MM!=ZY;V\LEM*8WV,KA@"* .WHKQ*]\-01O\ $.UCU#54M-$MDN=.@6_EQ#*U
MOYA;.[+<J, D@9/K6DDUMXD\56%GXJU&6*Q7P_;7<$1O&MDFE?/F2$JREB,
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M>X$T8AW"1P6(4[\8(QR<5M?"72D7P;INN7%U>7>I7ML!--<7+N-H/RJ%)VC
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MZO ?!FN^(K72;_4(XF\+27A:2=YW^T+(5$@W$X;GG&!WH ]?HKR3X=0:??\
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MDW2P6^JR7@CE^<!][8*OC' ]CGF@#U^T\16EYX@DT:.*X6X2RCO2SH%78[$
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M;0M(N--.G3:7926)8O\ 9F@4Q[B22=N,9R2<^II8M$TF"QCL8=,LX[2)Q)'
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MU&PU#49+F.2SU41VSI(X;]XA<8*]S@YQQ7L=1+=6[7;VJSQ&Y1 [0AQO53D
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MKM[F-M/U1887#JH*2H7&,$$;L'(QZ5[!10 R&%+>".&,82-0BC.< # I]%%
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M%Q:J8R((T+L%R20Q&!G/<UM1>&[*/PNWA\O*]HT;QEB1OPQ)SG&,@GTJC?\
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M9VA5&>@&-HKK/ASIIO)M3UR]O[^ZNH]3O+:!9;ES'%$)6&T)G![\D$C@#@4
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MB70K76+))4MKD%D650&&&*\@$CJ/6O+O"]U<7E[\.9[J>6>9I]8!DE<LQP7
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M;XUE # 9(Y )';UK2KA/AO-+;_!S2IH$WS1V4CHG]Y@6('YUS.@RV5M\/?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9+EA\F">C=^:N>%/">N::G@);NQ:,Z7+J1O,RJ_E"7?L).?FSD=/7G%>IT4
M>>^#+J^\+:1X4\*7FFN;^Z%T\X$H/V:-'9@[8R""64=1R?PJ_P"-+#5E\0^&
M_$.F:<^I+I4EP)[2*14=EECV[EW$ D8Z9[UV'DQ^=YWEIYNW9OVC=MSG&?2G
MT >=7P\1_P#"2:/XP'AF>4I9SVD^FQW,9FA#.&1\DA22%Y /&>]4+3PGKLNH
MV&JW6G"%[CQ,=4FMO-1C;0^244L0<%L@$[<]:]4HH \R\0>$M9U*V^(L5O:9
M;5?LK6.74";RXDW#KQRI'.*EUV3Q7K-]I=TNDZY;:6]M(LUC97D4$Z7&["M(
M^[_5[<]#]1VKTBB@#ROPWX1US3XO!27-B4.G:;?077[Q3Y;R%=@X/.<'I5BQ
M\+:Q#X-^']BUB5N=+U&&>\CWK^Z0)*&/7!Y8=,]:],HH \T\.Z9KEIX\2:PT
M?4](T>1[A]2M[F[CEMG=N4:!0202W)P ,5=\:V?B2Z\16JVD6J3Z*UFZ&/3+
MM+=Q<EN&D8D'R]OIGGM7?44 <WX TR\T;P'HVG:A#Y-W;VX26/<&VG)XR"17
M2444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '!?%*368K#0VTG
M4([,/J]M%)NC8EF:0!>0P^4'.Y?X@>HK.UKQEK-GXC?0#JD%I-96,<MQ=1Z1
M-=">9\X 1"?+4 =223GVKM_$GAZV\3:3]@N9I[?;*D\4]NP62*1&#*RD@C((
M]*R;OP-]HN[?4+?Q#J]GJD=LMM->0-'FY122/,4H5)!)P0!C- &!9^+/%WB'
M4=(TRRBLM)N+S1OM]RUW;N[0N)-A"IN'!..#T!SS531_&OBZXT[PSKM^VF"P
MU/44TV2TBA;?DLR&7>3Q\R$[<=,<UWEGX9MK/6[;5S=WEQ>0:=_9V^=PWF)O
M#[VX&7)'7I[53@\"Z9;Z%H^D)/=FWTJ^6^@8NNYI [/ACMP5RYZ 'IS0!R5Y
MXN\8G3/$VNVTVE1V&@W\\ MG@9GNDC;G+[OD.TC& <G/2M1M>\3>)-?U>S\/
M7EAIUMI44.3<VQF>>62/S,?> 50"!GDYS6?IOPTFU&;Q!_:^H:K9V=_K%Q.]
MC!<*(;J$N&0L,$KGH<$$@<UT>J> ;6^U6YU"RU?5=)DO(TCNTL)51)U5=JY#
M*<$+QD8XH YO3/&OB;Q9?:+9Z0=/T_[=H_\ :%Q+-"TOE,LIC(5=PR"<=>@)
MZTS6_'6J:7XG2.WURPO(!JL5E)80Z=*?+1F"D-<9VB09SM]?RKM=,\'Z5H^J
MVE]8K+$;33O[-BA##8(MX?)XR6R.N:R9?AIITEY-(-4U2.TEU :G]B25!$+@
M.'+<IN()'0G')QCC !0CUKQGK&I>)AI4VF0P:/<2P6\4ENTCW+B(,JD[AMP2
M.1USTXYL^'?'-SXGU'PY#8QPB.YTU[_4\J28L'RU13G@^8'ZYX2NGTG0K71K
MK5+BWDF9M2NS=S"0@A7*JN%P!QA1US7-_#WPD?#UQXAU":S-I+J6HR210LX8
MI &.P<$@9+.V.VX4 /US5_$<WCR'PUHEQ86D3Z:;V2YN(&E9,2;,*H8 YRO7
MIR:Q1XWU6Y\-64ESK&G:3J(OKBRN&%E)=&=H6*YAB4[L="?2M+7_  CJ&M_$
MB#4H;V^TVUBT@PK>V<JJPE\[.PJ<Y!4D\C' [BK0^&VF06>D1V.H:E9W>EO,
M\5]%(C3.TO\ K2^Y2K%OIQVH YF/Q_KT_@S2-4DECMHI+RXM]0U./3Y)EA6,
ML$8PY#*&(&<]/QJ]K7C/5+*ZT?.M6%II=S8QRC5_L#S6US<%L%"P;]TN,$9/
M?KQ6W'\/X[/28-/TSQ#K=@D4L\K/%,C-+YK;F#[D(.#T.,C)Y.:@N?AG93Z1
M;Z-#K>LVVD1VRVLME%,A295.<G*D@G/)7&?:@#%\1?$/6M%;Q1I\=O:RZG:W
M%JNE+L.V>.?ID;N2NU^1CI2W_P 4;M=/NM4T^UMYK.WT6VNF#9XN[B0+&A(/
MW0,DCK[UU=_X&T?4/%NE^(Y1,+O3HO*BC5AY;CYMNX$9)7<<<CK5+3/AEX>T
MOPQJGA]%N);+4I#),99!O7IM"D 8"[01Z4 9MWK_ (J\,:M;V6L7FGZB+^PN
MIX6@M3#Y$L$8<@_,=RG..QJK'XH\8+X1T?59IM,-[XAGM+>QA6W;9:>8I8NY
MW9?Y1G'&#QS706GP_M8[B6YU#6-5U6X-K):0RWLJ,8(Y!AM@"@;B,98Y-6[S
MP7I]YX2T_P /-/=1Q:<L/V2ZC<":)X@ C@XQNX],<GB@#G?!L6K0?$[Q3%K-
MU;75RME9XGMXC$'3,F,J2<'J.O:NQ\1Z';>)/#M]H]UD17413<.J-U5A[@@'
M\*QK/P!:VO\ :\K:SK$UYJUND%S=O<*)1MW89"J@(?FQ@#& ..N>IMX1;VT4
M =W$:! TARS8&,D]S0!Y)X5U#4[W[=XE\1PECX.LIK%8P^?-N8U)FESZE B_
M\"-:UIXD\6V47AC5]5NM-N+'7;F&!K.WMFC:V\Y2R$.6.[&!G(KKM-\+V&FV
MFL6H,D\&K7<UU<),01F4 ,HP!\N!]?>LC2_AU9:==Z?)-J^K:A:Z:P>PL[N9
M6BMV *J0 H)*@X&2<4 9EOXXU67P%HNM,EM]JO-72RE 0[1&;EHC@9X.T#OU
MK>\<Z[J6@:582Z3';27=UJ,%FJW.=G[QL<XY':LP?"S2Q=*PU75Q9Q7XU""Q
M$ZB"*8/O) VY()R,$G )QSS73:WH5KKT5E'=/*@M+R*]C\H@9>-MR@Y!X]?Y
MT >?S:[X]CO/$NFKJ.CM)H=NEXUV;-AYP>,LL83?A?NMELGMQ70^'_%UYK/B
M73K-XH8[6[\.P:J5 .Y9'?!&<_= ]JUW\+6+WVNW9EN/,UJWCM[@;AA51&4%
M..#ASUSVK+NOAW82_P!DM::IJMA/IMBNG+/:3*KRVX ^5SM/]W.1CG\, '+O
MX^UZ7PMH&JS3P:;:WC70O-16P>YC@9)"D:E V5# '+'/3M5N"X\1W?Q:M1;Z
M[8R6,FB1716.!VBDB,H#;1YF-Q.2'[ @8-;(^'5O;Z#::+IVOZU864$<L3)#
M,A\U)&+,&W(1D;B PYQZU;'@6RM]0T:\T^_OK&32[5+)1"ZD3VZD$1R;E.1D
M=1@\F@"GXN_Y'OP+_P!?MS_Z3O7//XU\5/X1E\=Q3Z<-'2X.S3#;MYCP";RL
MF7=P_4_=Q_*O0M1T*UU/5M)U&:299M+E>6%4("L70H=V1R,'MCFN<'PQTP.;
M?^T]5.C&X^TG2#,OV;?OWXQMW;=W.W.,T <[JWCG79M:OK/3-;TFVO8M733;
M?2GMO.FD0LH,Q(<'&&+<# "X)S76_$*[%CX:@E:UMKD_VA:)LN$W*"9E&X#/
M49R*X6;PAXOM[[5CIT6JVNH7.HRW-M=VVI1)8HKN#N:(DOG'WAM.37J.NZ#;
M>(=,CL;R25$2>*?="0"6C<..H/&1S0!P>L^*O%__ !5UWIUQI<%EX>E.U);=
MG>X C5RI.X!>">1USVQFNI\5Z]J6G?#^X\0:1!$]S# ET89@64Q\%QP1R%SS
M[5-+X-T^:R\16K37037F9KDAERA,8C.SCC@=\\UL#3K?^R1ICJ9+;R/L[!^K
M)MV\_A0!YT_Q5\OQ9JL#10G1(-,>YM;@ [I9DB29DSG^Y(.W:J%]JNNW,&NE
MH["QUD>%8;NXN4@;>"?,+H#NR, '!['GFMZ/X/>&TT#3M',M\\-C>&[61I%W
MRD@ HYVX*$!1@ <*.:Z6X\+6%UK&HZE,TS/J%@+":/<-GE@L>.,Y^<]Z /-K
MD>)'TKX<N]_97&I37*M;320N%1&M3_K!N)=@-QSD9..E=SX,UC5KZYUW2]9E
MM[B[TJ\$(N((C&LJ,BNI*Y.#SZT:=X$MK&'1XY=6U*\&CW!FLS<.A*KY?EB,
MX494#\<]^U:^F:%:Z5J>K7\$DS2ZG,LTRN055E0(-N!P,*.N: /.5/B1_$7Q
M$CNM6MY;&WMQYD'D/]UK5B@CRY"8XW<'<03QFI/!^L>)=)M_ EK?W%A+I>K6
M8A2"&!ED@"0;T8N6.XD+SP ,\9KK[OP5;7.OZAJB:E?VXU*W\B]M8F3RIL1F
M-6.5)! ;L>PJ>/PA81IX<437.- 7;:Y9?G'E>5\_'/!SQCF@#@=&^).M:K+I
MFHPOYT%]?B%M+CTJ?,,#.4#_ &C[I8##'MU'%=#\49-:BMO#[:3J,=F'UBVB
M?=&S%F9P%R0P^0<[E_BSU%:.F^!4T>^5]/U_6(-.6<SC35E0P@EBQ497<$R3
M\N:U?$GAZV\3:4+&XGN+<I-'<0SV[!9(I$;<K*2".#[4 </K7C/6;3Q%-H/]
MJ06DUA91RSW,>D370N)GR0 B$^6H [DDY]JDM/%?B[Q#J>E:98QV6DSW6BKJ
M%RUW;N[0N)"A54W#@G'7H,GFMZ[\#>?>0:A;^(=7L]32V2VGNX&CS=*N2#(I
M0J2,G! &,UI6?AFVL];M]7-W>7%Y#IPT[?.X;S$#!M[< ER1R>GM0!P>B^-?
M%MSI_A?7;]M,&GZM?IITEI#"V\$[U\W>3Q\R$[<=,<TZ\\7^,1I7B37[>72D
ML-"U&XMQ:M Q>ZCCDP<ON^0[<8P#DYZ5UUOX%TRVT/1=)2>[-OI%ZM[ Q==S
M.&=@&.W!&7/0#MS7+:9\,YM0DU[^V+_5+2SOM9N;A["&X7R;J(R;D+#!(R.N
M""0!F@#0DUWQ-XBUW6K7P_>6&GVVDQQ#-S;&9[B5X_,P?F 50"!GD]:S],\:
M>)O%FH:-9Z0=/T];W1EU&>6>%I3&PE*$*-PR"0.O09ZUT>J> ;6_U6ZU"TU?
M5=*>]1([R.QE5$G"KM!(*G!V\9&.*OZ9X0TO1]6M;^Q66(VVG#38H0PV"(/O
MSTR6SWS0!Q6L>.M3TWQ5%%;ZY87EN=7BL9+"'3I2(D=PIW7&=OF#/*^OY5>C
MUOQIK%[XG;2YM,B@T>YFM[>%[9I'NG$895)W#;@E>1US[5H/\--.:\DD&J:H
MEHVHKJ8L5E3REN X<M]S<02.A..3CMCH=(T*UT6?4YK:29VU&\:\E$A!"N55
M2%P!QA1US]: .9\/>.+CQ/J?AZ&P2$0W&F-?ZED$F,Y\M44YX/F!^N>%J76]
M7\1S^/8_#6B7%A:1-I@O9+FX@:5D(D*850P!S\O7IS3?AWX2/AU]?OI;,VDN
MI:C+)%"SAC' &/EC@D#[S-CMNJ'7O"&HZU\28M3AO;_3;:+2/(2]LY45O-\X
MDH5(.05.>1C@<Y% &:/&^JW7AG3Y;C6-.TC4#>7%G<%;&2[:=H6*YBB4YQT)
M],U53X@:]/X,T759)8K2&:YN8-0U./3Y)UA$;,J,8@0RAL<D]/QKIA\-M,@L
M](CL-0U*RNM+,IBO8I$:60R_ZTOO4ABQYSCCM3D^'T5IH]OINF>(=;L(HI)W
M9HID9I1*VY@^Y"#@YP<9&3R: ,76?&6IV5]I"MK5A9Z7<V,4JZM]@>:VNIRV
M&0L&Q$N,$9_O=>*@\1?$36]$_P"$HL([:UEU6TNK9-+78=LT4PR,C=R0%?)!
M'(K;NOAG97&E0:/'K>L6^CQVR6TEC',A295.<G*D@GN5QGVK2OO VD:AXOTW
MQ+,)A>6$1BCC5AY3C# %AC)(WMCF@#E-0^)]XMC>:EIMM;S6=OI%I/A\\7=R
MX$:$@_="G)'7WJW>>(/%7A?5([+5[S3]1^VZ==W,#P6IA\B6! Y!&X[E.?8\
M5IZ9\,O#^F>%=3\.H+F6RU&4R2M+(/,4\;0K # 7:,>F*?:_#^T2:>?4=7U7
M5;E[62SBFO948P1R##; % W$8RQ!/% &"OB?Q@OA71]1EFTPWOB&>U@LHEMV
M\NT$BLS.QW9?Y0#CC!XYJQX+BU6#XE^+8M8NK:ZNEM;(":WB,2NN)<$J2<'\
M:Z*^\&:??>%=/T$SW44>G"$VEU&X$T3Q !'!QC=CKQCD\4OA[PA;^']3O]2&
MH7]]?7Z1K<S7<BL6*;L$ * O#8P., <=<@'+>(_'^LZ'>^*--6WMI=0M_LC:
M,FP_OQ.P3##=R5;/3%9VM>/KC6_"UY+;V5C<V*^&UU"\2>,NHGD8!8SST&V0
MX]A7<ZOX*TK6O%>E>([HSB]TT$1JC ))SE=XQD[221@CFL^R^&.A:?X>US1;
M>2[6VUAV:9]Z[XP>B(=N HYQD'J: ,C3G\22_%R>%-5M5L%TNWG-L;=RHB,C
M#:HWX#\'Y\=,<<5SW@O5_$NA>#O"]X+BP;1[K5?L'V3R6\TI).Z^89-V,AL_
M*!C '->E7'A*"3Q-9Z[;ZC>VES! EM+'"R[+B)6+!7!4]R>00>:@A\":9!X=
MTO1%GNS;:;>I>PN77>SK(9 &.W!&6(X ..] ')R>*-2TRVU<Z/9:;%=S>+O[
M-&^-@DF]4&]\');)&2.PZ5TOA35M;?Q+KN@:Y<VMW+8);S17-O 80RRALJ5+
M'H5]>]3MX$TQS(3/=_/K2:T?G7_7+MPOW?N?*..OO6I:Z%:V?B+4=;CDF-S?
MQ0Q2HQ&P"/=MVC&<_,<Y)H \[^+6APO8:I=V_@YM1NI[56DU=I5/V0+QE5)+
MC:!NPBX.?K4NE:=I?C+QO-'JZQ:M8V6AV9LEN$)5Q*&+2[3T8[5YZBNHUSP0
MVN7]U*WB77;6TNT"3V5O<*(F&W:0NY25R.N#SS3=0\ 6-Q<6EQINI:EHT]M9
MK8A["55+P+]U&W*W3L>O- %/X;71M/AW^]=Y(=/GNXH]QRWE1RN%&>^  /PK
MD[J_\4:U#X$UO5KG3_L&H:S;SQVD$#*\&5<H-Y8[P5)SP.<8KU31]#L="T.#
M1[*,BTA0H YW%LDEBQ[DDDGZUS%G\,=.LYM._P")OJ\MKI=R+FPM))U,4!!)
MVXVY8<X^8D@< CG(!B7_ (ZU.R\76MO#KEA?6TVLII\EE!ITH$*,VWFXSM,B
M\97US5E/'FL&VN=)>*T'B--=72XU"'88F.\3%<YQY08]>HK53X::='>)(NJ:
MH+2+41J<-B)4\F.</O)^YN()SP3W./6FQ>$C+\8;GQ1)9F*WAT](8I"X(GG.
M07 !R-J87G'7B@"#P[XIU.^\:7>EZM?V]G.DTZQZ3)8LCO$I^22.8MB3*@$X
M'<\#%=]7*VO@>*+Q!;:O=ZWJVH/9M*UG#=2J4@\P;6P0H8\' R3BMO1M+31=
M(M].2ZN[I800)KN7S)7R2?F;OU_*@"_1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 45'/-';023S.$BC4N['HH R3
M7'^#?BAX>\<ZG=Z?I0NTGMD\W%Q$%$B9 ++@GC)'7!Y'% ':45R>NZ]?Z;XX
MTBP@62:TFL+NXEMH44O,\>S:%)QSR1C('/-8OPHO[W6[*_UB_;6S-<32'_39
M0;;;YK@+"H8[=H4!N!SZT >C45RD'Q TFXT&'54@O!YNH#31:E%\X7!?9L(W
M8X^]UZ?E5.]^)=E:/>S)H^JW&E6$YM[O4XHT,,; X8@%MS!2>2 >] ';T5S_
M /PF&G8\0E8[AET*-9;AE5<2*8O-'E\\_+ZXY_.L^Y^(5G'?6%A9Z3JE]>WU
MA'J$,-O&G$+D\L2P (QS]0!F@#L**QO$?B.W\.6EO));7%W<74ZV]M:VR@R3
M2')P,D   $DDX %9=SX[2TM+(3:!JZZI>S/#!IGEIYSE "S9W;=@!'S;N] '
M6T5Q3?$W2H-->XN]/U."ZBOTT^:Q,(:>.9U+)P&(8,!P03G(JI)\5;>%=023
MPUKHN],&^^MQ"A-O%M#"1FW[2"#P 2>#Q@9H ] HKD;_ .(%G!J=OINGZ5J>
MJ7EQ91W\26D:X:%R0&+,P"XQW_O#&>SD\<I?:)IVIZ/H6JZFE[YG[N"-%: H
M<,LA=@%.<C&3G!Q0!UE%<4?B9I;:5HEY!IVIW,FLF9+6UAA4R>9$<.C#=@8.
M><XX))%/M/B/ID\%H]Q8W]H\^J'29$F1<V]QC(5R&Z'C!&>M '945EZ=KMKJ
MFJZKI]LDQ;3)$AFE('EL[*&VJ<Y) (SP.M<W'XVAT^/4BYU#4YSKKZ9;V_E1
M1L)-BL(T.X H!D[F(/;TH [BBJFG7DE[IT=U-97%G(P.ZWG \Q""1@[20>G&
M#R,5SVF>.1>Z[9Z5>Z!JVERW\<CVCWB(!+L + A6)4X.<$4 =917F/ACQ^=/
M\%>%TU&#4M6U;5DN/($"AWE:.3!!+$8X8<G@!3DBMV^^($=I+>)%H6J78TZW
M2?46A$8^R;EW[6W.-S!>2%S0!V-%<CK7CQ-)MC?0Z#JVH:8EJMY)?6R((EC8
M9R-S L0.2 .*75?'EK97Z6-CI>I:K.;1;V4642GR86^ZQW,,DX.%&3Q0!UM%
M>>?#KQD+S1?#FEZG)=RZG?V$ETES-@K+LD8,N[.=P&#C'3O76:/XCL]<T-]8
MM8YQ:*TH1G4 R"-BI9<'H2IQG'X4 :]%<1:?$W3[O0)-=&DZK'IQ6,6TDD2A
MKJ1SM$<:[LEMQQD\=<''-3/\0[.SBU%=5TO4+"]LDBD-G((WDF65MB>648J<
MO\O48/6@#L:*\\U?X@/_ &3X@BGT[6=#N=+MXII;@1V\Q0.P"A1O*L2,]>P/
M.:Z ^+E?Q/<:+::3?W?V22*.[N8O+\N!I%#+D%@Q&""2 <4 ='17GWAWXCS7
MI\13:SH]Y866EW$V;AXE"Q1HBG9)AV)E^8G"C&,5I6OC^!Y5CU'1=2TQI;*2
M^MA<B,FXCC 9@-KG# $':V.M '7T5Q5O\2;&XT(ZR-(U5+.9H8['S(E#WLDA
M("1KNZY'4X'<$BI7^(=A9V.K2ZKI]_876F"(S6<BH\CB4XCV;&*MN/'7@]<4
M =A17G^A>)]0UCXIS64]EJ6F6\6BB0V5YM +^<,2#:Q!^4XSGL1VJU?^-M0L
M_B5#X<30[VXLVL_-,L4:%BQ=!O!+C]VH8AN,YZ B@#MJ*X>[^)MC;-=W*Z1J
MLVCV=P;>YU2.-/)1@VUB!NW,H)P2%]:Z/7-?M-!L;>\N4EDBGN8K9/) )W2,
M%4\D<9/- &K17-:QXWTO0[K5;>[CN=VFV27LI1%(978JJKS][([X'(YIEQXS
M%AHAO]1T74;2=KE+6WLV\MY+F1\; A5RISD\DC&#0!U%%8>@^)4UJ\O[":PN
MM/U"Q*&>UN2A8*X)5@49E(.#WZBN2\1>+=9T]?B$;:Z5?['M[5[+,2GRR\>6
M/3YN?7- 'I-%>8#Q)K>CZV^FMXC@UP2Z1<WI;[/&CVCQJ"I/E\%6R1@CM4'A
M_P 3Z[%=^#GNO$L.KG7HU:XL3;1(]N#"9"ZF/!PIX.X?E0!ZM14-U/\ 9;.:
MX\J27RHV?RXP"SX&<#..37/VGCK2;ZQ\/W5LMQ(NNN4MD"KN3:I9R_/ 7:0<
M9Y]: .FHKAX/B;83&WNO[(U1-%N;D6T.K/&@@9BVU3C=O"EN Q7%:-QX[TRV
M\/ZUK+P79MM'NY+.X4(N]G1E4E1NP1EAU(^E '3T5D>)?$5IX5T275[^*=[6
M)T60PJ&*!F"[B"1P"1FJ1\<Z*OB75-!:21;K3+/[;<,0-GEX!.#G)(#*>G>@
M#I**\L\0^-);[PUXEO=+OM2MG71;:]@BDB2/[.)-Q#*RDMN('(/ P,&NC\/Z
MC>7'Q!\16<US+);065B\43-E49UDW$#U.!GZ4 =A17&:S\1;72M3U73X=%U>
M_FTI%EO&MHD*1QL@<-N9AG@GCKP>,#-6;_QU:02:;;Z;I]]JUWJ%J+V&"T5<
MK <8=R[ *#G YZT =517FVH_%*3?H3Z5H>H3I=WKVMY"T*^;&Z!MT(!< 2 @
M'GC'?-:_Q(U>[TWX;7NJ6LEQ97"&V;*G$D8::,,O&><$@XH [*BN1L/B#8SW
M=S;:GINHZ/)#9-?K]OC5?,MU^\PVDX([J<'FGZ/XYBU/4=/M+C1]1TX:G$TU
MA+="/;<*H#$85B5.T[L,!QF@#JZ*YKQ!XSM]!UBUTA=-U"_U"[A::"&TC4[@
MI ()+ #@YR>,#KG -+4/B';6,NH,FCZE<V6F%5U"\A$>RV8@%E(+!F*@@MM!
MQ0!V5%<=JOQ$L=.O[RWM]+U+4HK"%)KZYLHU9+=67<N<L"3M^8@ X%:6E^+K
M#5]2L;&WAN5EO=*358S(JA1$Q "G!/S?,..GO0!OT5QEOXQM=8O_  Q-9SW]
MO#J-S=PBW,,9$IB5P?,.25 *$C;G/&:99_$W3+S3+[5O[-U.'2;.-VDO9HE"
M-(K!?+4!B68DC&..V<T =M17(P^/K6*2[BUG3+_1Y;>Q;4-EUL;S(5X8KL9N
M0<94X/(K$@\:7VM?$'PK;)IVK:59W,%U,T=VJJMRGEJ4/RL>1R<'D9'K0!Z3
M17%>+/&E_P"'O%FA:7;:)>7T%Z)3*8(U9GVH2%CRZ_,",MGC:>.:DU/XA06-
MYJ$%KH>K:BFFJ#?SVJ)L@)7<5^9@68+R0N<4 =C169-KUC'X7D\11L\]@EF;
MT&,?,\83?P#CDCL<5S\?Q%M9-(BU)=&U417<T4.G(\:*]\SY(V MP %));''
M- '9T5B:!XDBUR:_M7LKFPO["14N;6YVEDW+N5@4)4@CN#V-4[WQK;VWBEO#
MEOI6HWM^B12R>1&NQ(W)&\L6& ,<CKR,9YP =/17&K\1;)YDE&EZA_9#WOV%
M=5Q'Y)EW;.F[?MW_ "[MN,U'+\1X5N8?L^@:M<V,]^=/AO8A%LDF#%3@%PVT
M%6YQC@T =M17"VOC>*T@EC"ZCJUY/K-S86\'EPQ-NCR2H.X+L4 X).X^E1:G
MX_U*R\5Z'IJ>&=3:&^MI9I8_*C,VX!<!?W@'RY.[/J,9H [^BN-OOB+9V4U_
M(-+U"?2].N!;7NI1A/*ADR W!8.P4L,D*<<U;M_&MO?>*;G0;+2]1N);.817
M=PL:B&'*AE8L6Y!SC &>#QC&0#IZ*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;)&DL3QR*
M'1P596&00>H-<OX6^'7AOP;?W5[HUF\4]RNQF>5GVIG.U<]!D#\A7544 <[J
M&AW=UX\T76HS']ELK6YAE!8[MTFS;@8Z?*:/ VAW?ASPE;:9>F(W$4L[L8F)
M7#RNXY('9A6V]Y;1W<5H]Q$MS,K/'"S@.ZKC<0.I R,_6L[2/%.CZ]?7EGIM
MTT\MFY28B%U0,#@@.0%;!'8F@#@]-\/%_C=J:Q3*^DV>W5G@ XCO9D\OGW*A
MG_$4^7P=XKAT35_"5HFF'1]1N9I%U"2=Q+#%*^YE,>W#,,D [@.E>BWE[8:7
M97FHW,D<4$"&2YE"Y*A1DDXY.!5B":.X@CGB;='(H=&]01D&@#SC5O"'B>WO
M_$MOH8TZ73]>M(X6ENYF5[9DA\H_*%.[*XQR,']=G0?"VH:;XFT[49V@,-OX
M>ATQPK$MYJ/N../NX[_I7957O;ZTTVSDN[ZYAMK:(9>69PBJ/<GB@#G?&>A:
MGJ<NC:GHWV9[_2;O[0D-RY1)E*%67< <'!X.*RM0T?Q?>WVB>)1::4-7TYKA
M&T_[0XC:&55 'F;?O@KGICGVKKM)U_2->BDDTG4[2^2,X<V\JOM/;..E:- '
MFH\#Z[>7::O?/91ZA<Z]::E<012,8XH84V!58J"S8Z\ 5K7/A34)KWQU*K0;
M==LXX+3+'(98&C._C@9(Z9XKM*165U#*P93T(.10!Y+%!XCT7XA65KI%I87E
MW:^%K6"XAGG:-6VR,N5< ]".XY%2'X>Z_;:7H,+K9ZJENUS+?V#W<EO"TTS[
MPX*@[@A)&"/<=:]5\M/,\S8OF8V[L<X],TZ@#S?PSX$U71E\&+.UH1HLE^US
MY3L01-OV;,CG[PSGI[U#XB\+26?@;QS+J%Q##Y]])JUG,K$F,HJ%">.#N3'&
M>M>F[EW[-PW8SC/.*22-)4*2(KH>JL,@T <S\/=,N--\'VLE_P ZE?LU_>MC
M!,LIW$$>P(7_ (#6#=>$-433-=MI-&TO68-2UN6^^S7-RT6(F1 K*X4[7!4_
MAWKT:J\E_:17\-C)<Q+=S(SQ0EAO=5QN('<#(_.@#!\)Z)J^D>"(M*U"^#:@
MJ2JLJNTHA#,Q10S<MM! Y]*X_P *^ -<TWQ+H&I7]I8QOIR3I=W:WLD\UZSI
MM$A#*-O/;/<UZM10!YWX;\#ZKI+>"C<O;'^Q8KY+K8Y.3,1LV\<].>E4M<\
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M=BO.58\@8R0,<9K('PSUBY\-7%L\%C;+'JD-_I^D/>2S01*B[7C,F-P#;F/
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M%HFLR/'I>KV%ZZ#++;7"2%1ZD*34.O>*='\-"V_M6Y:)KIBD*1PO*[D#)PJ
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MT-Y&ES(L<P*A22@;&[ QD<UH'0=.:]TV\-N?/TV)XK5M[?(K@*PQG!X4=<T
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MKGIS7G5C\3M;ENO"9GN%6&#$/B$,BC$CRM I;CY<,A;C'7TKVQ55%"J % P
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M&)$C AF8YRQ.X]<T >:7M]XNL]%\772>++EAX;N2MMNMXBUP,*^)CMY&&P,
M=SSP*M^,[R_U2#QY:B]:W@M]%MK@+%$F6#)*60L5R5.!WR.V*]$F\*:-<6>K
MVLMH6AU=R]ZOFL/,;:%SG/R\*.F*>WAG2'FU"5[0,VHVRVET&=B)(E# +C/'
M#'D<\T >9ZGH.JC4?A]&?%.HEYG<1R&&#,)^SLV5^3!X^7G/'OS5K7/$6N:;
M'XT%C?*ES9:CIT%O*T"' D6(-NP!NSN/7UXQ78/\/M DT2WTEX[PV]K-Y]NY
MO9?-A?&T;'W;@ .,9Q5J;P;H=Q'?)-:,XOI8)KC,SY=X=OEG.>,;%Z=<<YH
MXG4-9U_PAJ'B6REU]]2,&@?VG!->QHOES;W3 "J!@D# /? J]X,EU>]\5&1=
M9UZ[TF&Q4S#4[,0!KIF(*J#&IP ,\9 /<UN^+_!\?B#3=5:S:.#5KVP^P"XE
M)9/*W[]I7IR2>0,C/M6)X2\"WVC>)H-3^RV6DVL-N\+VME?37(N2<89_,  "
MX., GF@!GBS7M2TWQ'XF6SN%B^R>%C>0D1(66422 -DC)Z#@\>U5K6;Q/:Z[
MX?MIO$L]R_B'3;IW#P1JEK*L:,C1@+T&[&&SG'-=S?\ AC2-3NKVYN[4R2WM
ME_9\[>8PW09)V\'CECR.?>I3H.FF\TR[-N?/TR-XK1M[?NU=0K#&>>%'7/2@
M#SC0O'VL:O;Z+:F4C4-/M[NXUU%1=S>1F-4/&!O<@\8Z'%-MM4\26?A[PQXM
MG\23W4FJWEM'<:>T4:V_ESMC:@"[@5!'.3T.:]#TWPMHVD:MJ>J6-BL5YJ;!
MKN3<3YA&>Q.!U).,9K.T_P"'?AC2]1AO;6QD#0.9+>)[F1X8'.?F2,L54\GH
M..V* .-@\1:S>PV.D0ZBUE)J7B.^M7O(88P\<,1=MJC;C<< ;B">O6KOB2]U
M[0]1T#PW'JFLWZ79N9YKJTAA^ULB!=L8+83@MDG&< 5UEUX%\/7FF/I\UBWD
M->/? K,ZND[$DNK@Y4Y)Z'%0R_#[PY-I%MISVL^RVE:>&<74@G61OO/YF[=D
M]^<=/04 <A+>^.%\/V\EU%KJVEOJ,Z3O;1P?VA):[087*X*DAB0VT9.T>]=K
M;7(UOP#%<:=K-PWGV0:/4!&HE8@<L5*[03@Y&/6H9_A_H5Q8VUHYU'%NTC+*
M-0F$K;\;PS[LL#@<'TXQ6Y8Z59:9I,.EV=NL-E#%Y4<2DX"XQC/7\>M 'D/A
M>76;3PCX%T.SUVY@77=[-<>3$6M8HXRYCC^7JQ[MDBK>J>(?$VB'7M$MM<:Y
MN+'4--2VO;F%&<+<'YDD  ! QV .#]*[ZY\$:!=>'[+1)+)A96.#:[)G62$C
M(!5P=P/)[TVW\"^'K73#8)9,T37,=V[O.[222H059G)W'! X)Q0!:CM;S1?#
M%TDNJ7-_=10R2"ZN%0.3@D<* ,#MQ7GNE:OXEM=*\%^(KOQ'+?'6KNWM;FR:
M"-80DB'E=HW!P5R3GDYX XKU+4('NM,NK>,@/+"Z+GID@@5QO@[X9Z3X?L]'
MN;JV+ZK90*#BXD>%)MN'=$)V@GGG'O0!S4?BC4?^$IT>[T_6=;OM.OM8:RD>
MYM88[)T.\;8L#?E2N 3UVG\;6F^+=>GN+3PE+?D^((M<>WN;CRT#-9QCS3)M
MQ@;D*J.._K76VWP\\-6FH17D-E,KPW/VJ"/[5*8H9"224CW;5R2<@"FZ?X5:
M'XD:QXIGBMU,]K#:6QC)+,!R[/QP<A5&.RT <'/K7B]_#[>(8O$KI*FN-I\-
MJ;:,PF,W!C&_C+$9'0CA1WYJ[J?B/Q#X/B\96S:K-JTEA8VUU:37,2!HWE9D
M;A0 5!&[';%=_P#\(CHG]E_V;]C/V3[9]MV>:_\ KO,\S=G.?O<XZ5-<>&])
MN[O4+FXLUEDU"W6UNM[$B2)=V%QG ^\>1S0!YT=4\6Z59:S<(VO-9Q:'<SFY
MU>*W!BND7*-'Y>>#S\IST%6K"X\26^N>&(KOQ-<W(\16%PTR^1$JVTBQ*ZM$
M-O;=CYLYQS74V/@#0;"VN[:-+V2WNK9[1XI[Z:15A?[R*&8[<X'(Y]ZU/^$?
MTW[5I5S]G/FZ5&T=FV]OW:LH0CKSP .<T <=\'K"ZMO"1GFU6XN8I+FY1;>1
M$"QE9Y 6!"@Y8\G)QSQ6'XV\4:C8ZAJU_HVLZW*=.NH(I(HK6+[# 2R!HW9A
MO8G<3D="P%>CZ/X7TO0;V]N=.CFA-XYDEB,[M&&)))5"2%))YP*S]0^'GAK5
M+ZZN[JSF9KMEDGC2ZE2*1QC#E%8+NX'.* ,2]U75=-^(@36;W5K33+F[BATU
M[>*-[.4,H'E2G:75R^[!SZ5L>.]1^QV6GVT>IZE9W-W=".*/3($DN+C"DE%W
M_*H[ECZ>]69/ N@S:\-8E@N)+A9Q=+&UU(85F'201[MN[\*NZ[X<TWQ'#!'J
M,4A:WD\V"6&9XI(FQC*NI!'!Q0!YQH_BW71I&EK<7USO7Q<=*E>ZCC$SP;6(
M23 VALX&1Z=:B^(5]J6IZ9\1=/.I2QVFF1V;Q1(B8*O&2Z$D9P3@]<\#G&17
M>GP#X;.A3Z-]@864US]K8>?)O$W'[P/NW!N!SGU]32V/@/PWI]AJ5E!IY\C4
MXQ'>B2:1S, ",EBQ.?F/.<_E0!Q^K:-JI\<>$-/3Q'=BX-E>F2_,,7G;/W9V
MJ NT'H,X/'O4%OXE\0RZ-8Z'_:[K>S^(KC2'U0Q(9/)B+'(&-N\@ 9Q^M=]I
MOA'2-*EL)H([AYK!)8[>2>YDD9%D(W#+$Y'RC&>F.*9<^"?#]WIMQI\UB3!/
M>-?MB9PRW#')D5@<J<D]"* . U_Q!XD\+0^*-+M]<EO9;**QN;2[NHT,D9EG
M$;HVU0&!&>V0#70R)JNC^,?"VDW&M3WYO([YYYYH8@V1''@+A?E4') ]\'.*
MV8/ /AV#2+O3!9220WCQR7+RW$CRS,C!D+2%MW!48&<?G6K?:'I^HZA:7UU
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M!<,>.GY"NIH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ*-N#@$\"NO\//'KGQ+DU_2]-NK72XM(-I)-/:M;^=*90P 5@"VU5/..,XH
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M'(SUH ]=TG6]*UVV:XTG4;:]A1MC/;RAPI]#CH:@U+Q1H.C7D=IJ>LV-G<R
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MJKIMQ<W6FV\]W;I;W$B!GBCE$JJ?9@!N'O@5:H **** "BBB@ HHHH ****
M"BBB@ HHHH KWUC;:G83V-["LUK<1F.6-NC*1@BL;2_!.BZ1?PWT*7<UQ;J4
MMVN[R6?R%(P0@=B%XXXYQQ70T4 %%%% !1110 4444 %%%% !1110 50LM&L
MK#4M1U"WC9;C4722X8L2&*($7 [< 5?HH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-\0Z8VM
M>&]4TI)1$U[:2VXD(R%+J5SC\:P=?\%/K'AK1K&*YMTOM):*2"6>W\V)V1-A
M5T)Y5@3WXXKL** .!G\#ZGJ'A]H+B71;'4X;V&]LY--LC'"DD1RN\%LOG+>F
M,UE6OAS6-8\7>+=/\0W,+OJ.BPPB>TMV2*++2 !=Q)8CKR>]>IT4 <%I7@SQ
M"NMZ9J6MZW9W7]GV4ME'%;VQ3*LJC>26)+';ST'I4_A_P+/HL_AB1[Z.7^QK
M":T<",CS2Y4AASQC;7;44 >?:CX"U%/$.IZCI#:#)#J4@EECU33_ #FADVA2
MR,",@X!P>,YKJO$&AKKOA2_T,RB 75JT D5.$)& =OH#CBM>B@#D+'PQK$FK
M^'=3U>^LI+C28KF%EM86595D5%4_,3@C9D_7BLV^^&\EUIM[&M];?:VUV36+
M5YK;S(U+#'ENA/S#&0?P/:O0:* ,#PMI%_I<%Q_:,6C1RRL,+I5H84  [Y)+
M'D_2N0U/X77U[J.JO'?:;]GOM134//FLB]TA#(?*$F[ 3Y>..^*].HH \]US
MP%K=[?>(TTO6[6TTW7XQ]JCEMC)(CB/8=AW 88 9R,CM6B?"FJ6?B31M7TV_
MM ;;3TTV\CN(6;S(@X8LA###<'&<CFNQHH X8> 9QX*BT'[?'YB:G]N\WRS@
MC[1YVW&>N.,U'>^"]?AO=<CT/6K*UTW7)&EN4N+1I)879 CF,A@#D#/(XKO:
M* .6T'P<F@:]]LM[C=:)I5OIT43#Y@(BWS$]\@BL&_\ AWJTNBPZ=::K9^6N
ML3:G+%<6[-%.&<NB, P)"DY(S@D#TKT>B@#@-7\$:UK&KZ?J]S>Z-->QV3V5
MPEQ8M) H9]WFQ(7R'Q@<DYIL?@+5=-TGPHNE:G9C4M 26)7N8&:*99%VMD*P
M(/3'->@T4 <'>_#V>Z@U1HM22&\FUM-9LY?)W+#(BJ K+GYA\I[CK4%]X UC
M7K?6;G7-6LVU2^T[^S8?LMNR0P1[]Y."Q+$G'IC%>AT4 <_+X<DD\6:1K(N%
M"6%E-:M%MY<OLP0>V-OZU4\0^&M5N/$=IXBT"_M;;4H;5[.1+R%I(I8F8-CY
M6!!##-=710!PD'P^GCL['SM32:^77EUN\F\K:LKX(*(N3M&-H&2>GO6SXU\-
MR>*O#K:=%<1PR">*=?.CWQ2%&#;'7(RIQS7144 >;?\ "M+V;2/$=O-?:?#/
MK3VC[;.T,4,'DL"0%W'(('7/7FMR;PM?CQGJ&IP75HVEZM;1V^H6TT3&3"*Z
M@QL#@9W<Y%=;10!P/A;P/JOAVZL;>1] N-.LLA+A=-V7CJ%(4%]V 1QEL9./
M>I3X!G/PKD\'?;X_.?=_I/EG;S.9?NY]#BNYHH YC5_"<FJ^))-3%Z8(Y-'G
MTTA%^=3(P.\'VQ6%X5^'=]H6LZ/?7-SI033+.2T5+&R,33!@H$DC%CN?Y>?K
M[UZ)10!YO%\-]2/A >'+C4K!X-/NTNM)F^R%BK*[,1,K-AP0VW QQGK72^%=
M&U'2A<OJ46B1O)L"+I5F8!@9R6))))R..V/>NCHH \I_L/Q3J'B_QQ%I&H6M
MC:7LT,,OVNU9\J;=07B((Y&2,'(JWJ7PMF>XB&GWE@UM_9$>E'^T;0SO"B @
M/$=P 8YYSWYYZ5Z710!Y/XU\%27&F^!M$@FE-Y"5TZ>:%" UIY0$Y8]@0@QG
MN:[F/PX8O&_]O),BP#2UT];<)C&)"^[/I@XQ6_10!PUEX!FM/#/A723?QLVB
M:@EX\@C.)0/,^4#/'W_TJK:_#_4-+U>X^P-H$VF7%XUU_ING>9<0AFW,BN&P
M1UP3TS[5Z'10!Q5SX&FG\/\ B_3!?1AM>NI+A'\LXA#(BX(SS]S]:LR^&=4@
M\96.NZ=>VBH+*.PO(;B)F+1JY?=&01AN2.<BNLHH X#QY9:M=^,?!K:-*L%U
M%+=L)Y83)$G[GHX&.&Y7J#SQS38OA]J$T)NM1U2"75+C6K?5+EXH2L6V' 6-
M 3G[HZFO0:* .3U[PUJTOB>#Q'X?U"TMM02S-E+'>P-)%)$7WC[K @@Y^N:Q
M_P#A7.HV<-AJ&GZS#_PD-K?W-_)<3VY,,SSC;(NP-E5P% P3T]^/1** .!U;
MP3K6J-I>JSW^DW.N6:RQRBZL-]K+&[ A-N[<-N!ALYZYZU+/X/UCR-%O[.ZT
MFTUO3)9F"PV92TD2489"@;=T"_-G.17<T4 >='X<ZG)H>J0S:W$^JW.K1ZM#
M=K;[4CF0)@%,_=RI'7H1UI+CX>ZUJ=KXF;5=:M);W7+.&WS#;%(X"A;@ L21
M@CJ<YS7HU% ')^+O"$GB!-)N;2:T2_TMV:'[9;^=#(K+M977(X/!R.F*IR>&
M/$#:!]C5?"PDEG9KBU.F-]E>,J !MW9+ @G)ZYQVKN** .4\,>%]4\-:9H.F
MQ:RLEE8QS+=Q&W&;AG)9-I))0(2< =1BNKHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X
M?PUXZN=;\5W.GW%I#%ITZROI=PI.;A8I/+DSGCKR,=JZ#Q7)J<?A;4O['MWG
MU%X3';HA (9OEW9/'&<_A7#2^ M<T"#P[=Z?JT^I-HLZ+'9&WBC B?"R@, "
M?E.?F)Z>M &CXQ^)&G:;I][;:3?$ZK#<QVX/V9VC#^8H=-Y79N"EN,UH^+?'
MNDZ!:ZG:+>LNJ6]JTBJMN\BQ.5)CWL%*KDXX)%<A?:1XAC\)ZEX3A\.W$\C:
MD;E;X2((I(C<"4-R<E\?+MQVSFM/5K#7+&[\96-KH$^H+KR;K:ZCD0(N8?+9
M9"Q!&TC(P#G- &FOC9K#3H;S4+FWD"Z#%J,EO'!(9FD8@;LJ"H0DXQC(ZGBI
M],\<6^N66@7=G-#;?;IEBG@N()2VXQ%RD;;0"1_>/RD UEV7AK53J$7F6IC1
MO",>G%V886?)RAY[9^E1:;8:Q=Z7X'MYM%N[231+J.*Z\XIC"6[(77#'*DD"
M@#I+CX@>&K;49+*6_8-%,+>6402&&.3.-K2A=@.2!R>*34_B#X9TB\N+2\U!
MA/:MMN$CMY'\G@'+;5.%PPYZ?D:XM]&\0IX,U#P,- N));FYEV:F9(_LYC>;
M?YC'=NR ?NXSQ6S-X=U+^S_B'&MFS2:FA6S.1F;_ $8(,<_WLCF@#HM9\:Z'
MH,R17UQ/N:#[03!;23!8LD;V**0!P>OI4$'B":[\?6VGV\Z2:7/HOV]"J_>8
MRJH8'KC:>E<GKVF^*98X=.6WU9[!M&2""+3YHHU%SM(;SRQ!VXQTR/QK6\+Z
M%J=CXBT*YN;1HX;?PO'92L2/EF#H2G7K@'VH TM8UW6IO%"^'O#T5D)X[875
MU=7H9DB5F*JH52"6.">H %8U[X\U+0M,\16VNPVR:MIMN)K>6TC=H9PZMY9V
M\E<,N#DX]ZOZM;ZIH'C:7Q%8Z3/JMG>V:6US%;,HFB=&)5@&(# AL8SQBLJ]
MT37->T_Q?J\^ER6EQJ.FBQL;%W4RE5#'<Y!P"S-P,\8H Q5\>7\IT+2HO%5Q
M]HO#)+=7QT1MT>$3;&J; &&XME@.!C)KO(/&%C9Z//?ZKJ%NZK?RV<9M()26
M=6($83!9GXYP,<$CBJ\FD7Y\5^$+L6[>18V-Q%<OD8C9DC"@\]RIZ>E<TOA_
M7=,^PZJFE371L-?OKM[.-U#R0R[@KKDX)&<@9SS0!V;>.-!73[:\^T3L+F5H
M885M93,[K]X>4%W\=^/3UK4TG5['7+!;W3YO-A+,ARI1E93@JRD J0>Q%<#X
MCL]:UC4-$\2#1M8MTMUN(9;2SN8TND1]NUQSCG:<KG/2NJ\%Z=%I^C3-'9ZA
M:M=74EQ(FHR*\S,V 6;:2!G .,T 1S_$#PU;ZB]E)J#!HYOL\DP@D,,<F<;6
MEV[ <X'7BL73O%L^M?$Z]TJ#5I(+&Q"1K:?8&/VA]K%RTC+\F"!CD XXSWPV
MT7Q"O@J]\"#0+AY9[F0+J9DC^SF-YO,\QCNW9 /W<9XKM=!TN\L_&OBF\FA9
M;:[^R?9Y"1B39%M;\C0!%<^/=.M/'*^&)HY@Y@5_.$4C?O&8!4P$Z8;._.!T
M-9GAGXD:=/$+36;[&H/J$UHI6W?8I\UEC5G"[5) '4Y[U?U.#4+'XE6&L1:9
M<WEE/IYL'>WVDPN9E8,P)'RXSR,]*P3X8U8?#J73A8-]M;6_M/E@KDI]K#[L
MY_N<_2@#K=3\;:#I%_-9W=U*)+<*;AHK:21+<-T\QU4JGKR1QS6[)/%%;M</
M(HA5"[/G@*!G/TQ7E6J>'+ZUUWQ%#<Z;XAOK#5IC-&=+NHUC<,@4I(K$8P01
MGTQ77^,=-U"?P5_8>C0R%[KRK)G##]Q"<!W.3SA 1^- %/P3XVN_$=U>P:G9
MQ63>2E[9!2<R6KDA6;)ZC'/;D5J6GCC0+RTNKR.ZF2UMH3.\\MK+&C1YQN0L
MH#C_ '<US$WA#7="\0:)JMK?3:W' C:?-;/##!MMF4XY4 $!@O7/\ZHZ3I>I
MQP:K8CP_K;^&'L"G]E7]Q&7$Q<?+ V[(0)N(R>H&* .PN?%UM/ID=W87 MO]
M.AMI/[0LYXR=[#Y0I .2#P>GK5D^,=%&ISV FN'E@9TD=+25HPZ*79-X7:6"
M@\ Y[=>*X:+2/$]]HCVTEOJDEE%J]E-8IJ<D;72PJRF4N5/0'IDYQ6C;66L6
M_P 0!-I&EZMI]K->R/J8GFC:RF3!_>H,E@[$*> /?O0!I:%\2M&U?1+S4IQ-
M:K:.PD7R97^7S-B$'8,EN/E&2,X-:-MXZ\/W6G7]\+R2&'3RHNQ/;R1O#N^Z
M2K*#@^N*Y*VM_%>E^$-8T;3=,O(+^&^DFCND,>)X7G+'RB2?GV$\$#'UK-F\
M,:Y>:-XW\O3M4)U.WLUM%U&:-YY=A;<"0Q QZ9Z$4 =Y;>/_  Y>"\^S7DKM
M:P?:''V:4%XLXWH-OSKGNN:?X,\7VGC'1([Z"*2&7:#-"ROB,G. '*@/TZBH
M+G2;M_B-97\=N18II$ULTHQA7,B$+CKT!_*HOAQ%J&G^$[;1M2TRYLKC3D$+
M/*5*3<DY0J3D8QUQUH JZ/XD\0Z]X@U"*S;1H;/3]0:UFLYMYNC&I ,F0<#/
M)'RX[9[UKW'CC0+74I+&6[DWQ3+;RS+;R-#%(V,(TH78IY'4\9YKDO$-GJ'B
M#5X#:^$+O3==M[Q"FL++&(UB5QDEU;+@IGY2#UK/_P"$4NX+O5M'U+3/$=Y9
MWVHR7$;V5W&+:1'<,#("05([\<XXH [^\\:Z%8ZR=*FNI#=*Z1R>7;R.D3/C
M:'=5*J3D=31!XV\/7.HW%C#?[Y;;S/M#>4X2$QDA@[D;5QM/4\@9%8.D?VWX
M:\0ZU9_\(_=7\.IZH;N&]BEC$:QN%!#DG*[=IXP<]J9:>%=0G\#>+M):'[-=
M:E?7TD)8@;P[$H21V(P/I0!L)\0O#\MO-+'/<C9;FY19;.:,S1C W1Y3YQR/
MNYZYZ57TCXD:-J/A>WUJX%Q;^84C>!;>61A(P)"+A/GX!Y48XK%\-:+-=:C:
M-?Z5XC@O+*TEB674;J.2WB9E"D)M)+9^G:JUHGBNT\ :/I-OI6JV<FG3QP:A
M]G:+SIH0&R8&+$'G;SP?3O0!V*>._#C:*=7?4?)LEN?LKO-$Z&.7^ZRD94_4
M59TCQ9HVN7#6UE<R?:$A\]H9H)(7$>XKNPZCC(->?67A767TF2.?3;L^;XJM
M[_9=RI)(;<"/+.02">#D>W>K_P 4K+4+>_TC5=&*K?WN_17R<%DG!VG_ ("P
M+4 =L/$FEOX;;7X9VETX(7$J1.2P!QD+C<>1Z>_2N.\'>.XSX5&M^(M=:9[J
M142W6P9/*D.2(XPJYEXQR,].M=M#ID6G>'4TNS3]W!:^1$OL%P*X&#0M;TK0
M? E^-+FNIM$C=;NQC=!)AXRF5R0"5/;/>@#K(_'?AN32YM1;41#;P3K;S&>)
MXVBD;H'5@"N?4C'O6C8ZU:ZIHS:G8^:T.UBOFQ/$3MSV8 X_"O.[[P[K6N2Z
MIJ\FCR6XU'4].9+*9D,@A@.'=\$CG)XSG KU"[1I+*>-!EFC8 >I(H \_P!(
M\:^(VM/#FIZK;:4VG:W/';HMJ9%EB9P2I.XD,/EYQBNCM?'GAN\:Y\C4=T=K
M$\L\QA<1QA3A@6(P&_V>O3BL?P'X$L-)T/1[S4+&7^V+> 9^T3O(('(YV*6*
MK^ JA%X0U.Y^#=_H'V?R-2FEGE$98*7/V@R*"W3YE &?<4 =1:^.-!NHKN07
M,\(M;8WDJW%K+$WDCK(JLH++[C-+I?CCP]K.III]C?F2>16:'="Z),%^\8V8
M /CV)K@[[3VET#Q#J-WIGB."[@T.ZA\[5KE)$&Y<E$VDD],YP!Q5[24UO7KW
MPDRZ!+IT6C6[R/<3NACD+0;$$>TY(.03P, >M '6:7XZT#6-3BT^TNIC<3AV
M@\VUEC68+][8S* V!SQ26OC[PU>K=20:ENAM86FGG,+B.,*0""Q7&[D?+UYZ
M5Q6@:3XHNO%7AK4-8M=8:>RDN/M\UW-$8%9HF4>2B'[N<#.!U%78_"&J7'P5
MFT 6Q@U-GDE\G>%+D7!D +=,LH S[B@#K;'QGH=^+HK<RP&V@^TRK=V\D!$/
M_/0!U&5XZBL.W^(%IK'C71=.TBZ=[.>WN);E9;5XRP55,;+O4$J?FY'7%8<G
MAFY\0Z;K 73?$-OJ<FF/:QS:Q=(R$EE;RUVDY!*_>X%:=LFM:WXO\/ZA+X;N
M=,M;"SN8)6G=,[W11@!23M!7 /?)X% &YI_Q#\+ZI?VMG9:B99+L[8'\B01N
MV-VW>5"[L=LY[=:FN?'&@6FI26,MW)OBF6"69;>1H8I&QA&E"[%/(ZGC/-<M
MI_AK58/!'@6Q:P9+G3]3AGNX\KF)1YFYCSS]X=/6LL^%+N"\U;1]2TSQ%>6=
M]J,EQ&]C=QBVD1W# R D%2._'..* /18O%>DSZVVD12SO<K(869;:0Q"0+N*
M&3;LW =LT:/XJTG7KEX=.EGDPA=9&MI$CD4':2CLH5AD]B:Y%+/6;?QZ9M%T
MG5K*"6\D?4EFFC:RN(]I D09)$C$+T ]^]/\$V6K6/B)XK73=6TWP]]G<O9Z
MC+&Z13[QA8,$MLQN]OTH Z?7?&.C>';D6^HS7 E\KSV$-K)+LCR1N8HI &0>
MOI3-0\<>'M,-LMQ?DR74"W-O'##)(TL;=&4*I)_PYKG/&]IXEOM9N+6WAU6;
M2IM/,=LFG31QK]H.X'SBQ!VXQTR/;-2^%M U*Q\0Z!<W=FT<=KX8CLY'8@[)
MPZ$IUZX!]J -^;QMX?AT.RU@W^ZSOFV6QCB=WE;G@( 6R,'/'&*I^"?$[>)Y
MM=F682V=O?\ DVI\LH0GEJ<$$ YR3UYKEM.T+6M#L/"^I/H\]T^EWE^;BSA9
M3*$G=]KJ"0#@8XST:NF\#66IP7/B*\U+36L&O]1^T11,ZL=AC0<E3C/!S[YZ
M]: ,74_&_B.SC\1:G!!HYTO1;TV[Q3&19I0 A.UL[<G=QQ75:GXRT;2)D@NY
M;CSS!]H>*"VDF:*/^\^Q3M'U]*X?4/AW+J*>*=4^P!-<75&N]+F<@^8%5"HQ
MG:0Q##D=Z?JFDZLGBB\UF?3=?>VU>SM]\>DW**\$BH0T<BDC(YZ@XY- ':W'
MC/0K>XMX/M4DS3Q).IMK>295C<X1V9%(4'U.*@U'X@>&M*O+BTNM083VS;;A
M([>1_)X!W/M4X7##GIU]#7&ZIHFIZ:-.7POHFMV.JP6<$,-PES$UNZ Y,=R"
MV#MRW('/8XJ.2\U./6O'^GV'AZXU(W\P@6:!T"HYMU&)-Q!"\YSSWH [[5?&
M6A:/+;Q7-V\DUQ%Y\4=M \[-'_?P@.%]S45QX\\-6UE8W;ZFK17\;26GE1.[
M3!2 0JJ"=P+ ;>O7C@XYC3],UGP5K4%T-'N=8@DT>TL2UDR;HI8001AV'RG.
M<TGAOPGJ^FZQX6N+RS5?(749KD(P9;=YG5E3/<XR,CC@T =4OC?0'T6WU6.[
MDDM[B8V\2QV\C2M*,Y3RPN[(P>W:I+GQAHUI96-S)-<'[=G[-#':RO-)M^]^
M["[ACOD<5Q<^@W4&E:BE[HFK3-)XANKRVFTN9$N( Q^25<L.""1C\Q56?1/%
M3)X<UO5H-5N;N"UGMKQ-.N(TN8PTF8VZA6.T , >M 'IVE:M9:WIT=_I\WFV
M[D@-M*D$'!!!P00000:Q/#'B*35-)UC6KV8)81WDXM_E "01?+DGJ<E6;GUQ
M5CP;IT6G:$1%9W]H;BXEN'COY%>8LS<LQ4D9.,XSWKA-.L=2U#X8S^$["*07
M"ZO-IM[*, P0F9G=^>HV,![[J .A\)^.=0UFRU5M2TQ(+NVMTOK:WB)S-;R(
M63K_ !<$'MDBI?"/B#Q!KFF1:U<SZ)-ITULTOE6?F>; ^,A&))!(Y!X'-9DW
MAGQ'X>\3Z9KEE=S:\R6TEC-;O'#;;8MI:, J ,;P!D@XS4-CI=WJ/C&#5=-\
M+WF@(()UU,RLB+=EDPBA48AB&YW8'2@"QI'C7Q&UGX<U35;;2FT[6YX[=%M3
M(LL3."5)W$AA\O.,5%'X[\1I9QZQ<6^D-I3ZH; 0(9%N"/.,0*DDJ3WQCIGI
M6AX"\"6.DZ'H]YJ%C+_;%O ,_:)WD$#D<[%+%5_ 5SD/@"ZL='37[32<>);+
M5I;M(RP)N(3,WR<G:,H<@]1@4 =UI^KW@\>ZMH5Y('A^RQ7ME\H!6,DHZDCK
MA@#Z_-5C5_%^B:%?I87]VRWDD8D2".%Y'922,@*#D?*<^F.:RK<&Z^+UY/&,
MQV6BQV\I])))2X7Z[5S^-6?[*NC\4CJYMLV8T86ZSG'$GG%BOKTYH FN?'&@
M6FI26,MW)OBF6"69;>1H8I&QA&E"[%/(ZGC/-,U3Q]X;T:_N+*^OVCEM@#.R
MP2.D61D!F52 2.@SFN%/A2[AN]6T?4M,\17EG?:C)<1O8W<8MI$=PP,@)!4C
MOQSCBE\31:MX>T+QW9-HES=V^J2S7L5]&Z>4D;QJ&#Y.05VG P<T >G6^MZ=
M=7TEG#<!KB.W2Y=-C#$;YVMG&.<'CK69%XIM+W4=):RU"U;3[ZUFN%#0R"60
M)M^93C  R<AAD\8KFO*UK2?$,>IV&B3:G;:CHL%LIAD1?*F3)&\L1A<-UY^E
M0>'_  SK%G'X16>Q=#9:3=V]QEE_=R/MVJ>>^#0!U-O\0/#-W8W5]#J):SMH
MUDDN/(D"8;& "5^9LD#:,G)QC-2Q>-] DL[VZDNY;9+$(;E;JVDA>-7.%8JR
M@X)[XQ7*3>$M5E^#VC:5%:R1ZC8FWN'M8Y%C=RC[F4-T#<D@^N*H:AX<NM9\
M-^()+;1_$ U.XM8+=3JUQ&S2@2ARJ88\#!.3C.: .M_X69X3S*HU&0R1@$1B
MUEWR*<X9%VY=>"=RY&.:T)_&6APZ78:B+MIH-0_X]%@A>62;C)VHH+<#KQQW
MJI_9-S_PM!-5%K_H2Z*;83<8$GG;MOK]VN&A\)ZYI^A>$KM['4S)IJW<5U;Z
M?<)'<1B20E67)P>!R,]Q0!W\GCOPW#IEOJ$NH^7!/*\*;H7#^8@)9"NW<&XZ
M$9)P!U%9NK_$W1;'PM<:W9^;=^3<"V,#121,),C*ME,KA3GD<].IK)L?#4PN
M_#MW::5J440UB>]N_P"T94>8%H2HD;!.,D+QUHUOPQK%YI7CN&"R9I+^\@GM
M%W*/."+$3CGCE".>] '3S>/- ABMY#/=.)XVF58[&9F6-6*EV4)E5R",D"M:
M+6+";69](CN-U_!$LTD6UOE1C@'.,?K7G_BHZMJKVNJZ1X>\0V.N?92EM<0R
MPJ =Y_=7"EB-G ;O][MS7=V=WJ#ZF]I=::4CCMHW-Z'&R20_>0+U&/4T :=%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 56N-/M+NYMKBXMXY9K5R\#L
M,F-B,$CWP2*LT4 %%%% !1110 4444 0W5K!>VDUI=1++;S(8Y(V&0RD8(/X
M4^**."%(8D"1QJ%51T ' %/HH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "J]O86EI<7,]O D<MTXDG=1@R,  "?P %6** "BBB@ HHHH *@AL[:VGN
M)X+>*.6X8/,Z* 9&  !8]S@ 5/10 4444 %%%% $$-G;6TT\L$$<<EPX>9U4
M R,  "3WX 'X5/110 5#=VEO?V<UI=PK-;S(4DC<9#*>"#4U% #8XTBB2.-0
MJ( JJ.@ Z"G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%1SS1VT$D\SA(HU+NQZ*
MH&2:Q=&\3#6+#1KM=,O4CU6-Y8W"!DA0#*F1OX=PQCKR<4 ;U%8_AGQ!'XDT
MDWBP-;RQSRVT\#L"8I(V*LI/?IGZ$5B7'Q'LK;55TU]!\1&[<.T<:V!)D52
M67GD<CGWH [.BL70O$<6NW>J6\=M- VGSK _FX!8M&K].V-V,>U;5 !1110
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M8YY$D!&U!$%)S]=U &O1151[_9JT5A]DNF\R)I?M"QYA7! VEL\,<Y QT!H
MMT444 %%%5+*_P#MLMVGV2Z@^S3&'=/'M$N #O3GE><9]0: +=%%% !1110
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MT71+^QM+R%M:O;:U;4[MXK:W6-Y,>8P^]QPH/?Z4GAYP?#_AJ)'B:"'QJ\<
M@<O$L864@1D\E.>/8U[9+I]E/;FWEL[>2$MO,;Q*5+9SG&,9SWIXL[8!0+>$
M!7\P?(.&_O?7WH Y'X:_\@W7_P#L/W__ *--</H36-EXBO=.M&TO6;O5+6_D
MM]6L+@M<@'YBEPO3.2%!_P!GI7M,<,4(811H@9BS;5 R3U)]ZAM].L;2:2:V
ML[>&64YD>.)59_J0.: /(=%\2:=J4'PNL+348YKR%@MS"DF7C*V[*0X'0Y'
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M)K&-2#W+FS\WR<HKLN0%.%) XSC/>H9-&M_^$=NH!XA\+1V;:O'<6VGB[9K
MLL7SP,W& V0^!D9[5[,FFV,=D;*.RMUM3U@6)0G_ 'SC%1?V+I7V+[%_9EG]
MEW;O(\A=F[UVXQF@# \"7]MJ_P /K6;3[!;&$K-$EO'(712KLIV,>JD@D>QK
MSO1O$=A=^%_AMI4.H(^IPZK$+FV#YDC""56WCJ.2.O6O;XXTAC6.)%1%&%51
M@ >PJ!-.L8Y7E2SMUD=Q(SB)068=&)QR?>@#P^^T6S_X0OQ'XF82MK%EXBD%
MI<M*Q-NHO%&U!G 'S-GCG/TJYXMA\/7FL^/7\3W"KJ-O!&NE)+,R,J&#*^2,
M_,3)G. >>O6O9S:6QB>(V\1C=M[)L&&;.<D=SGFFS6%G<7"7$UI!)-&"J2/&
M&90>H!/(H \/N@+G4?"EKJO]BOIW_",6S6D6M3M% 92 '*D#!DQMZ]NE:.F>
M'8=3UOPAHNL:A'JUFFDW;.;:X9H+A5F78I/!=5!7KW05Z[<:;87ENEO<V5M/
M F-L<L2LJXZ8!&!4J6MO$8S'!$AC78A5 -J^@]!P.* ."^+^E6,_P[EDG@#)
M936[(<D>6OFHK'@]-I-9)\->&=:^)&F:?!'%=:)%X?EDBC@N"\4G^D@$$@_,
M 6)P3U ]*]6DC2:-HY45XV&&5AD$>A%0V]C:6H06]K!"(TV)Y<87:N<X&.@S
MSB@#Q_PM.\4'P\B:>3RH-0U2$;F)Q&BS!0?7  _*K?PVDT[3/%K:3 VE:I<3
MV<LZ:UIUP7DFC\P9%PN2 Y)'.3TQWKU=;2V3R]EO$OEL63" ;2>I'H3DY^M,
MM=.L;%I&M+.WMVD.7,42H6/O@<T >:>)_P#A';SXGW-KXUEMDTV'28Y+!+R;
MRXBQ=O,9>0"_"CUP*SIT\'W_ (PUV+Q==6_V"VL;3^QUO;DH/LYBRSQY(+,6
MZGEN*]=NK"SO@@O+2"X"'<@FC#[3ZC/2DN=/LKQHVNK.WG:,YC,L88H?;(XH
M \:\+:0?$^K^%[+Q,MQ<Q_\ "-/.\$TC 2XN (RX!^;Y6!Y[X-9_]EZ1/X.\
M%W&L*IM;;7I[%YIYF54MP\X52V> -J\^W6O>_)B\X3>6GFA=H?:-VWKC/I44
MEA9RVK6LEI ]NQ):)HP4))R<C&.O- 'G&A:%I&I_$KQ#=2(;JVTM-/DTY%E9
MHXSY.0Z@'!.$7!YX^M<AX6NM.N/'/A'4]*LM,TXWUQ="2&WO9)KLKY;\7&[W
M&>:]YBMX("3##'&6 !**!D 8 X]!TJ./3K&&9IHK.W25G\QG6)0Q;!&XG'7!
M//O0!Y)X$LO!FMV=O)KSV\OBZ[N;J.[B>X87!<M(&0J#D*$]L<#O6W\%+71K
M;P3%]A, U,@KJ")+N=&620('7/R\9QP,UZ"MA9I>M>+:0+=,-K3B,!R/0MC-
M+!96MM+-+!;0Q23'=*\<84R'U8CK^- 'B^O^(+'3/#/Q*TF\U!(-2EU&1[>W
M>3$CH\<>TH.I'!.1P*U+KP]IWB3QCXJ35HI+F*UTFT>&)I6"*[1R?/@'&X;>
M#VR:]2ET^RGG,\UG;R3%#&9'B4L5/5<D=/:I1!"KNXBC#N KL%&6 Z ^HY-
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M:+))C>P4 MCID]Z@_LVP\V:3[%;>9,096\I<R$'(W''.#ZT >)>([<:GXO\
M%T&K7?A^VO$95LI]6NWBEMHO+!1X,#'#$DXYW9S6AJ<EEH_CJSU&_N=(UZYD
MGL;9XOM!6]LYMJJ&B4=4).\CC.37KMUIFGWTB27EC;7#Q_<::)7*_0D<4ITZ
MQ:]%ZUE;F[ P)S$N\#_>QF@".PU>PU22\CLKE9GLIS;7 4$>7( "5.?J.E<!
MX9T[6;KQCXMFL-=%C:QZR/-M_L:2^;^ZC)^8G*Y''%>E)&D98HBJ7.YB!C)]
M32)#%$SM'&B-(VYRJ@%CTR?4T >':M_PC5U'X[NO$]U"OB2VO+A-.6:X*31Q
MJ@-OY*Y!Y.#\HY/6MWP]HB:]X^F?Q#'-/<V6D:;.897(5;@JQ+E0<%@0<>F3
M7I\NGV4UU'=2VEO)<1_<E>,%U^AQD5*(8UE:58T$C@!G"C) Z G\30 ^BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** ,WQ#>'3_#>IWJW)MC;VLLHG$7F&/:I.[82-V,9QGFL"X^
M(&G:<]I8-!J>IZC+817HCLK,LTD; _/@'"\KR,\9 &:VO%6GW&J^$-9TZT4-
M<75C-#$&. 69"!SVY-8>@>'-1T_Q;#J-Q&@MTT"VL"P<$^:CL6&/3!'- %B?
MX@Z,FD:1?VT=[>G5P39VUI!OFD"C+_+GC;WYK$\,^/T;1==U?4WO)(AKLEG9
M6Q@Q.<JFR$)P=V2W!]^:HZ5X3\2>'=+\'WMOI\%[?:1%=6]U9?:%0LLS9#(Y
M^7(P,^H-07'@/Q!?^'KU[VSMCJ)\1_VREI%>,B2H453&)5P5/+ -@<CWH T?
M&/Q&\CP7K;Z=::I9ZO:F.!XY;8>9;&3[LC8) 4C.#D\\5:T;Q&FC&Y6^U76)
M[>ST@ZA);ZE9JMRJB1P79AC)^7 7'0 YYK,N/!E[?^#/$%M:>&3I6I7_ -F4
M"XU5KMYA'(&Y9B0H SCGFM;Q1X5U35=;\175K%&T5]X;;3H"T@&9B\AP?088
M<T :>C>/]*UO5[?3H+;48&NX7FLY[JV,<5TBXR8R3D\$'H..:YN'XES6D?A:
M(6U_K,>J"=I;N'3RC.$WX"(K$;@5Y'/R\]ZW3X=U#^W_  5=B-/)TFTGBNCO
M&59XD5<#ORIKG;'PGXCT3P[X+FM].BO-0T.>Y:>S%RL>]91(N5<\<;@: .GU
M+X@Z7IMU>1&RU.XBL%5KZXM[?=':[ANPYR#D+R0 <"MK5M=T_1=!FUJ\GQ8Q
M1B0R(-VX' 7 '4DD ?6O-]3\$7\7B#6YF\,MK5GJTOG@IK4EJ(RR!6CD0$!E
MR#R 3@X^G9^,/#D^L>!Y=(TM88[B(0O;1R$E,Q.KA"?0[<9]Z ,/3/'$FI?$
M:2VDCU#3=.M]$DNI[;4+?R2&$JXD[\;2>_K6OIWC[3M5N;6W2SU*T^WQ/)8S
MW=N$CN0J[OD.2?N_,,@9%8;^'O$?B?Q'?WVL:;#I5I=Z!/I:HET)I$=W4[FP
M ,=<8STYZXJMX1\(7EC>:8FI>%/)GT^%D743K<D\>[RRFZ.)CQNST(& : )?
M#?C.Y3P[X7O=5U*>:2XTNZN[B%+4.UQY6"6W9&T@= !SFNN7QCH[PZ+,D[-'
MK$;2VS!> BIO9F_N@#K[G%<KX9\&ZMIK^"OMD$6S2M/N[>\'F!L-)MV@>H.#
M53PI\.-4L+O5[3594_LR"UN-/T<H^YEAF=F=CZ,!M'X4 =1I?C_2]5O;&!+/
M4;>'4"PL;NYM]D-R5!/RG.>0"1D#(%4H/BKH%Q9_;TMM4&FAUC:_:T(@1V<)
MM+9Z@L,XXK$\'>#;S3+[1[?5/"N'TT8&IC6Y)8LJA4.D!/!/3&  "?I6OI/@
MZ1?@\WA;61%#*UM.DC;@RQDN[JV?;*G\* .KBUNSF\0W&B1EVN[>W2XEPOR(
MK$A03_>.TG'I6+KGCVQ\/7L\5[I>L&UMVC6>_CM,V\>_&,N2,@;AD@'%97PB
MM;V;PJWB#56#ZEK#+*[XZQ1J(XQ^2EO^!U@^-O!?BG7[WQ!"+5[Z.[,;:=.V
MJ-%#;(H7<AA!PS$@\D$<YR* .OUGXC:1HVI:C8-9ZI=W&FJLEV+.U,@A0H'#
ML<@ 8/UX/'%3:EX]TK3YK.&"WU#4IKNT%ZD>GVQE98#TD8<8!_/VJD_AK4FU
M'Q[,(TV:S;Q1V9WCYBMN8SGT^;UK,LM!\3>&]0TG4-/TNVU!SH-OIES"]T(C
M!+%R&W$'*<D$#GC- &[\-=7N]>\!:?J5[<-<3SO/F1@ 2!,X7@>P KF_ _Q-
MAG\/:2FM+J<D\\[6TFI/:XM_.,C!$+C'.-HR!CWZUU7P_P!%O_#W@JRTS4UC
M6\B>8R"-MR_-*[ @_1A7#:9X6\9-X7TGP??:/:0V=M>QW,NI)>!L1K,9=OEX
MSOSQGI0!TFB^*[JWM?$=S?0ZAJ1M]?FLK:"S@\R14"H54 8P!D\D_C5Q?B1H
M:Z'/JMS'?6D=O>BPGAGMR)8I3C *@GC!!XS7/WWA3Q-%IFJI9*Q%SXD>_EMH
M+SR'NK1E *"0$;22.F1TZU5L? FMQ:3<P_88[<R^)+;4DA-X9RD">7NR[<LP
MVGKZ<9XH V-;\>K>^#_%#Z;#J.F:MIEGYWEWMN(I%# E' .<C@UM0>-M(CM;
MTSW+E=+M4FO[D)F.-B =FX=7[[1ZUA^*/"6K:I?>+Y;6*-DU/1XK2VS(!ND4
MN2#Z?>'-9Y^'FK0^%M?\(6QB.D7T N;.5Y/F@N-P9HFQRR%E!#=0"1S0!NW7
MQ'MH=/OG_L?5X+Z&R:\@M;FUPTZ @;E"L> 2-W0@'.*U_!WB-_%/ARUU*2QN
M;222)&=9H2BLQ0,3'G[R<\&N4T3PG<3O>F[\*MI5T^G36J7DVM27G+@#"JS'
M"GJ2<'@"NF\"PZM9^%+'3=8TU;*>PACM5VW"RB940#>,= <=#S0!F_\ "TM!
MWLWV?4_L<=R;6>^^R'R()=^S:[YXYQR,_>&<9K8E\7:7%9Z[=,9O*T1F2[PG
M.0@<[?7@BO+M(T_Q-XB\&:CX;M-*MO[,O=6GW:F;H PH+DLX,1&6;*G&#CD5
MN:]X;\6+)XRTW2M-M+JQ\0#S8[J6Z$9A8Q!'4IC))V\=N>30!U5SX]TN#68=
M(BM=1N[Z:&*X$5M;%R(GS\Y.< #'/U'6G6GCFPU#6&L+/3]4FA6X:V-^EJ3;
M"1>HWY[$8SC&>]5]!\/W]AXQN-2N(T%L^D6MHK!P3YD9;<,>G(YK/\'Z?XJ\
M,[?#SZ1:S:6EW-*-4^V#F)W9P/+QNWY;'I[T 4/ /Q*BO?#_ (?M]734I;N^
M<VQU%[;;;O/EB$W\9.!C@8S]#727/CVQL]:CTZYTO6(8Y+P627TEIMMVE)P
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M>>'$R1LP8@J-V0R=,9SVK0N_'UI>:!X@> ZAH][I4"R2_;+(&2-6!*N(RWS
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M(4 )#9;Y>O!ZXK=T?53J]K),=/OK%DD,9BO8@C] <C!((YZ@^OI7 VGAF?\
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MK;"Z^SV5L96,1+ MU  &TYR1U'7-5=+^)>A:Q?Z=;VL6H>3J)*VMY):E())
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MB:]I4D]C#'J$$C7X<VIC?<LVSEMK#@X],]CZ&KLUQ#;*K3S1Q*S! 78*"Q.
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M7$VX%D3!4 C'4\T >IT5SWC2YUJU\,RSZ DKW8DC+>1&LDHBW#>8U;Y6?;G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7ZBM2B@#FM#\$V'A^[CEL[_5FAA4K!:3WSR01 C&%0GL.F<XKI:** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** ,'QM!?7/@;7(-,5VO9+*58EC^\Q*GA?<]O>O-K^?0]9^&N
MHV/A+2I%U6#38H[H06#Q2",/'YD);:-S$!N 3G!KV>B@#QR[?1=;U^TN/!VG
MF.ULM(OX[^6&R>W7#1 1Q'*C<VX$XYQUI^D^'K.PM?A?-;:7'#-(I^UR+#AF
MWVK%Q(<9.3V->P44 >#75IIMKX&\>Z+!IZPZRE_.XCCM"KFV-RA3:P7E,8P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9Q6%Q;7-VPDE@>68(R%L#((&<'L:]1T?2I=(TQK>;4[W49&)=I[MPS9(&0,
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M5Y;5)9K:)L8?8"X7/7!)X!)&.: -=_#NDR0:I ]DACU4DWJ[C^^)4*<\\?*
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M3!$9HR^3A@2"!U(^4\X[5-J7BO0=(TVUU&^U6VAM+H V\I;(E!&05QR>.>*
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ML*[<%E"JI)SGCOG/;I0!+I?C7Q U[X>FU?2;&#3-?^6V\B=GFA8QEUWY&"&
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MF+,DHPPW-N&">>E9VA:YKWV33KQ[BYEOE\&WMQ$)"29'64>4Y'<E0O/4Y]Z
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M'J10!Z5KFO:=X<TTW^I3&.'<(T"J6>1ST15'+,?05CK\0-&73[R\NX=2L%M
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M!@WS$9^7!]*WOBA&HN;*]DFLKNVLK::6XTBXU!K5Y4./WL94\LNT@9XYXYH
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M.K.6<G'RCF@#T2BHK:Y@O+6*YMI4F@F021R(<JZD9!![@BI: "BBB@ HHHH
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MB)$S'R(]^6;&!]X#-)+\1=7MO#=K%<M:QZM)K4VE2W:6TDL:"(G=*(ERS'
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M.!HD=9)-A5DW'!!!P0:DUWX<&#0[#2])GU&X6;Q##J-W</<#SXP5VO('XY&
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M*S,V"!C@N<<=A5?3O!<5G<:-<W.K7]]/I F6W><IDI(BIM;:HS@*,'KG.<T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(T0'[H.P7<V2. 2,_6LU_B#HT>N>(-*?S1-H=I]KN&P-KIM#$+SR1D YQR:
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M=6)07,>TCR]Z[EYQ@Y'/%7* .$\,> [GPWJ^B3+=13VUAI$ME(QR'>5Y5D+
M8QMX;OGI75:QH&D>(((X-7TZVO8HVWHL\88*<8R,UH,RHI9B% ZDG%+0!S7B
M_P -/K7@.\\/:6+>W,D,<4"OE8T564@< X&%QTJM_P (M>_VMXRNO-@\O6[:
M&&W&XY0I"R'?QP,D=,\5UI95QN8#)P,GJ:6@#SB#P?XET&YT+4]%?2[B]M-$
MBTB[@NI'2-MA#!T95)^]GJ!Q4^I>!M5UN37I-0N[-9-5T6&R+PAL+.A<EMI_
M@RPQR3BNTCU6REU:?2DG!O8(EFDBVG*HQ(4YQCDJ?RJY0!YU:^$?%&JZU;7O
MB2;2TACTJXTYDLF=F/F!1ORP .<'CC&!USQ%8>$?%S/X6M=1FT@6/AZ="KP-
M(9+E%C9%;!7"D CY><DDY& #Z510!Y5IGPUN=(U;RAH'AJ_L?MIGCOKG>+F.
M,R;RI7:0S $A3D#@9KK/'OA[4/$FBVUKI[P$PWD=Q-;7$C)%=1KG,3LH) .0
M>AZ5U-% 'EUE\-]4M](O;55TJT-QK5KJ*06K/Y44<90L@RN<_*<<8/7C.!V'
MAK0KG1M1\0W%Q)$R:EJ)NX1&22J&-%PV0.<J>F:Z&D+*" 6 )Z GK0!XQIFB
M^*/$6C^*=$LGTR/1[[7;Q)IYBXGA'G?/M4##9 XR1SFMG6OAU<GQ3J.IV>BZ
M!J]OJ C)35&='@=4"'!56W*< D<'.:]"U35+'0]+N-2U"=;>SMUWRR$$X'T'
M).3VI=*U2TUK38K^Q:1K>7.TR1-&W!(.58 CD'J* ,/1O#5QIGBV[U3%I':2
MZ;;6<<,&1L:,MD 8P%PPQS7-VG@/6+OQ/<ZA?V^D:7!<VMQ;7ITN63-\9!@,
MZ, J[>3U)R:],I&947<Q  [DXH \XL/"'BJ>U\/:+J\VDII6AW$$Z3VK2&:X
M\D?NP58 +T&[D].*GE\"ZF_@.^T(3VGVF?5C>H^YM@3[2)<$[<YVC'3KW[UV
MKZK9)K$6DM.!?2PM<)#M.3&I +9QCJ1WJ2XO[2TGMH+BYBBFN7*0([ &1@,D
M*.YP": .%U7PAK>J>.[+5UM='LUM+Q)?[2MY9%N9K=>L+IC:V>A).,=NU=+X
M5U34M8T^ZO=1MDMXWO)19!596>V#8C=@3PQP3VX(XK=HH \]T_P+J=HVB%Y[
M0_8=;NM0DVLW,<OF;0/E^]\XR.G7FH]$\%ZTGC"76;VVTC3(Y;>:*[72Y9"+
MUWQAV1@ N.3W.37HU)N7=MW#=C.,\XH \WTWP9XC3P[X<T>^;3%70M3MYTEA
ME<^=#&'!)!7AOF''3KS5B]\"ZG<^"?%6BI/:"XU?5)KR!BS;%1Y%<!CMR#A3
MT!KT&B@#P'Q1/Y?C7Q3=7,^GEH[B-HM.U&:Y22\\N)2JI'$P2121\N0>>M>N
MZUIUSXL\ W5BZ?8KK4;#:4DR?)D9,[6[\'@UT.!G..110!Q5AH&OW&O>&]6U
M9=/A?3+:YMYH[:5W#;P@0KE1_<)(/3(ZUBZE\-+Z\TVX_P"09<72Z_<:K!#=
M;F@EBDX\N3 R#@YX!P0*]/HH YGP9H4FBV=UYVBZ/I4DT@/E:8S,&4# +L57
M)SGMP*X6"P\4ZIJ'CW3-%.EBROM1DMIY+MG62'="@9E"@AOE/0XP1[U[!2
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M6WM='>QDMK3<%65I%<[ 1]S@\GGVKL** "BBB@ HHHH **** "BBB@ HHHH
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M%$6*5'3_ %>T A<,1@D_6G>.M3F75[73;'5M;AO/LLEQ]CTBVB=RH( D=I.
MH/&!US77/HUB^L6VJM"3>6T#V\4F\_*C$$C&<'[HYJCK7A#1]>OX+Z^AF^TP
MQF$207$D)>,G)C;81N4GL: ."TO7O$OB5/!5HFN26/\ :FESSWLT,$9=VC*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-*T?0;&XATR6**2>XOS$6+QJ_"B-NF<=>U;VD:_:ZS>ZK;6T4P.FW/V661U
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MY *!Y!&JKA,#DD#H: .BD^(4.B:'J&H:S?:7=QVD-NT3Z?-AKEI$+ ;&/RY
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M6V#2J 6V,4++@G()!P: .8@\:^)]7TV;7-#\,VMQHR%S#Y]Z8[BZ12071 A
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKA0SL<*HSW)X H GHK-37+1_$LV@@2?;(K1;MCM^38S%1SGKE3VK2H ****
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M('.?:O1+'PGX>TRQN[&RT:R@M;L8N(DA 648QAO4<GCWJZNE:>L[SBRMQ*\
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M7BNDI?Q>%?"GBF37-6GU&YUN*VD$MX[1&%IWC,>S.",#J><]Z]=\/:':>&M
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M9'0Y).: /*M:\0ZKX1O[FVCN;B5=?T> :3&SEA%>#;$50=N'5SCTKK?&PO-
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M,\,(MXVDMU;;&!M"\CH!P/2M.'3K*WNWNX;6&.X>-86E5 &*+G:N?09.![T
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M;8BE@!D9R!BN>\'>$]1T#Q18-=0AX;;PU!8M<J1M\Y969E'?H17.KX>U73_
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MJ=,U$G4-1L)[=-0FCDGDC1H]Y<@D<!3QG@<4 =O_ ,+)\.RZ7JE[:7$TS:=
M)I(FMI8V96X0@%,E2>-P! ZGBI-#^(.B:OH&FZG+,UH;Z6&V$4D<G%Q(NX1J
MQ4;N_P PX.*J:GH.H7GCS5+N.#%I<^'#9).2-OFF5SM]>A!JCH'B"YT'PEX7
MTG4O#UY%?BXMM*$,S)DE4^:9,%LHH4G/% 'HE%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!#=6L%]9S6
MEU$LMO.C1RQN,AU(P0?8BGPPQV\$<$*!(HU"(B]%4#  IEW.;:SGN!$\IBC9
MQ&@^9L#.![FO+OA7\5]2\>Z_J.G7VEV]M'! 9XI("WRC<%VMDG)^;J,?=/%
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MR"-@#$S,<,>1\P ^E5?"OQ"U/5=>T6SNI].O(]4B=I([*UFC:R8)O 9W)#C
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MEU:;F9?*NH]D@VL5R1D\'&1Z@B@#F=0\!->ZA%?Q^(-0@N6T\:=>2JD3-=1
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MA>>.TCWM&A +<@8Y^M:JL&4$=QF@"II=I<6.G16]U?S7\ZY+W,RJK.22>B@
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MS)I8V! (  "X4  #@5V'2N=L/%L6H?:?*TZ]?R-7?2G\I ^UEZRMS\J>I[4
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MF_M+7;C5I9"-KRPQQ! .P5 .O<FM:C(SC/-&1G&>: "BF22)%&\CL J LQ]
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MQ:)2G_?.,4 <S\.+)[#PY<0_VA87EN;V9K<:?,98;>,D'RE8]E.[\Z\DMGT
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M<NX*>K;R Q )"D9K&\>?$,6NA>([72++5GFL$,$FIVT2^3;SD @%MV[(R,D
M@9JA%\.[JQU:]MI/#.FZM8W5^]S'>2ZC)$8T=]Q#Q8(8KSC'7 JQK/A/Q8-.
M\5Z#I=MITMAK=Q+=I>37!1HC(!NC*!3DY& V< 'GTH [K3]92:_ATMX+LW'V
M%+IKAHCY3 G&-_0MGG'I6O7-Z5JU])XJGT-;9#8:?I\)FN1G(N6_Y9CL1LPW
MMD>M=)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
&4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>modificationno13effectiv005.jpg
<TEXT>
begin 644 modificationno13effectiv005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^'>O+9K<VWPJUOP&#NU^356M[>S_ .6DJM.LBR ==FW)W=.#7;^.[RST[6_
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M1=E!YP@)*!L<A2>2/K4]9'A6WU"U\)Z1;ZJ[/J$=I$MP6;<=X49R>YSWK7H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!"
M PP0"/0T@1 " BX/48IU% #/*C_YYI_WR*4HA !13CID4ZB@!CPQ2+M>)&7.
M<,H(S3Z** &K'&C,R(JLQRQ P3]:4@'J :6B@!&4,I5@"IX((ZTM%% #3%&8
M_+*+L_NXX_*F);01L&2"-6'0A #4M% ";5W;L#=C&<<XH*@]0#2T4 (RJZE6
M4,IZ@C(-+@8QVHHH 15"J%4  = !TH"JN=H R<G ZFEHH 3:H8M@;B,$XYI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>#PQZ_7J* /7!?6C31PK=0&65=\:"0;G7U [CWH:_LUNQ:-=P"Y/2$R#>?\
M@/6O$-#T+3[/P3X(U6&R1=2?Q)%&]U@F7RQ/(FS<>0FU5&WI56&UBN;_ %'2
M]7UK1]-UM];,F^?3I'ORWG QF*7?RI4*!@8"D_6@#W^26.&)I976.-1EF8X
M'J36#8>*K?4/%-_I$(B:"TM(KK[6DP96WLX(X&!C9US6/\5$1O#%FUTKOI4>
MIVSZDJJ6S;!_FW =5SM)]A7#QWOA^TU3QWJ'AS1X+W2SH\#?9H82D%P=SJY4
M #*<<E>/E:@#V"77-,CTZZOQ?6\EM:H7F>*0.% &>QZ^U)9Z]I=[H]OJL5["
MMG/&DBR2.% # $ YZ'!Z&O&=#L;/6=8\26UO#HEY;77AP,(]*LC%;-,KMM^5
MB=SJ<?,/;@$5)#J?AJW^'OA.&PT[06CDDCBU"[O[4O;VETMN-S2H,;I#R!DT
M >X0S17$*S02I+$PRKHP8'Z$5"FH64EV;1+RW:Y7K")5+C_@.<UP_P (!L\,
M:G&IC\I-8NA%Y,1BC";@1L0DE5YR!GC-<%%?VVH>+=#N;>RT;3KQ/$A2:TMK
M1Q>QJ6D#--+G!#==N.<C!X(H ]W2]M9+I[5+F%KA!EHA("ZCW'4=:=/<V]LI
M:>>*)0-Q,CA0!Z\_4?G7DWA*\TVR^(ZV.EOIVKQWL]Y.]T+5H[VP8DLRRL1\
MRD_*,X/3TK=\5:/8ZU\5/#-OJ5JES;+8W<ABD&48@QXW#H1WP>X% '<2:A90
MRQQ2WENDDN#&C2J"^>F!GFG37MI;S1PSW,,4LO$:/(%9_H#UKPKQ!;6J>(_%
MVG:WJ6B:8UPZK:R:AITDLJV_EJ(S;N' &WGY5!.X?A5W74\/V.M^+H?& 6ZO
MI-/MTTN6YA+-*BP8)AZD-YN2<<YY]: /;%FB<J$D1BR[U 8'*^H]JIW&I&*^
ML((;9KB*Z=T>>.1=L.U2>03DY(QQGWKRG0M8LO#.I>"M5U>4VUA<>$TM$G*,
MR^:#&^W@'DCI47A,M(?A])Y<B9U;5F*NI5ER)N"#T/M0![(MY:O+Y2W,+2;=
M^P."=N<9QZ9XS3;:^M+T,;6Z@G"<,8I VWZXKQ:Q\/*OP,U?4M+LA_;5T;@2
MW"H6F:$7)#H#UV[$/RC@\]S426T.HZ?KU[X;UK1IKL:!+!]AT33I+?<NX$%P
M7;YP-P X;YJ /5;CQ9:KXIT?1;7R;H:@EPS313@^28E4X(&<YW>HQCO4/B_Q
M5+X>?3+2QMK:ZU#4;CR8H[BY$*(H5F+LV"<?+CIWK@- ?PA/\1_"$GA*VA14
ML+A+J2& H"?+7:KG&#(/FSWYY[5TGCO1-,U/QSX+-]IMK=>;<SPRF6%7WH(7
M8*<CD!N0/6@#MAJ5M%]GAO+FV@NY54^09AG<>RYP3SQG%327=M"ZI+<1(S,$
M 9P"6/0?4^E>':G_ ,(XMCXVL->LTD\67%Y<C3U>W9YW7 %MY)P2%'RXP>,'
M-=-X4T"WOOB+J]SKEFESJ%CI^F[6G&_RY3&2SC/&[<@^;J/QH [W4O$.F:3J
M.GV%[<K%/?NR0 ]"54L<GL, \FJ6G^++6ZUO6M/N?)M%TZXB@262<#SR\8?@
M'&.N,9-<M\3;'0X_$7A/5]=L[1K".ZD@NY[B$.H0Q.45S@_+OY&> :P=1\/:
M-J3_ !1U";3K>XE@M5^QR.F?* LU92G]TY Y'/ H ]ANKZTLE5KNZ@MU8X4R
MR! 3[9J;<NS?N&W&=V>,5X=JTS1>)-'NM<O-(ALY_#]NMM+K=D]S 7/,H&'4
M*Y^4DGJ,5WFD62:?\'/LL6H_VC%'I<WEW6QD$B%6*X5N0 " ,]A0!U\=[:RW
M!MX[F%Y@H8QK("P'KCKCFJFIZS%86-Q-;JM[<Q1&5;6*9%=P#@XW$#&>YKQ;
MPO+X:NT^'T'AVW4>(8;B.7462%EF$7DMYID8CE22N,G&",5/%H6GP? SQ%JR
M64?]I3M=J]PRYDVBY(V@GD+\H.!QGF@#VR:^M+9-UQ<PP@8!\R0+@GH.33EN
M[9[EK9;B)IU7<T0<%@/4CKCFO*=1T#3-7\7>.Y]1L(KI[;1K;R/-7<$)BERP
M'3=\HP>HYQU-5M$T6UTZZ^&%YI]K'#?WUE.US<8^>9VL]_[QNK#=R >G:@#U
MU+^SDNFM4NX&N%^]"L@+CZCK6?XC\16GAK3DNKF.:>2:9;>VMH%W23RM]U%'
MKP>O85XSX*MK:ZG\.VEWK.D6>N6>H^=<0#3I%U&24%O,224O\P8$Y.,8Q7HO
MQ!+Z?J/ACQ#)!--8:5?.UX(4+F-'C9/,*CDA203]: -S1=>OM0N9[?4O#U]I
M#QH) \[QR1NN<<.C$ CT-:EOJ-E=1R26]Y;S)']]HY58+]2#Q7G/CCQ9I/B?
MP=>0:'=R:A;PRV\FH_9(W/\ HWFKYB[@.NW.0.<9KGM5.@WUWKMWX+@A73(_
M"][%?264)C@9RO[M3P 7^\?7% 'M"WUH\TD*W4#2QKND02 E!ZD=A5+1O$>E
MZ]8?;;"Z1X?,:,[CM(97*=#ZD<>M><V/AS2=/\0?#Y;738(QJ&G74=\=F3<@
MVZL1*3]_))/.:YE++0HOA?JVE6]O;P:U#JR0WR11[)EC^W#9D@9QMQB@#W5]
M5TZ*$32:A:I$6*!VF4*6'49SU]JEEO+6"V%S+<PQP$ B5W 4YZ<]*\Q\;0:'
MH&I:%HL6B^'K*Q>*=DN]2LC-#&WR HJ*5S(V!R3GCO7+Z3+8VOAWX=S>)T5O
M#T2WR3?:8BT*3;V$7F*<]@P7/2@#V:;Q/H\.KV>F/>Q?:;R)YH<,"I5<9.[I
M_$,>M7Y=0LH+E+::[MXYWQLB>0!FSZ G)KR+4+;P-'XK\(ZNNG:?%X?NK>[C
MCEEM-L;2!U*<$<<[RN>QXK+U-O#QTSQI8:Y:++XQN+ZY^Q*]NSW#Y_X]C"V"
M0H&W&#V.: /<Y+NVA=4EN(D=F"*K. 2QZ >Y]*E#*V=I!P<'![UYCX5T"VO?
MB1KUWK5HESJ%C:Z;Y;3C?Y<IBRS#/&[<@^;KQ79>%O[!^R7X\/H%@6_G6YP'
M'^D!OWGWO?TX]* -VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **CN)XK6VEN)G"11(7=CV4#)-<5X(
M^*FA^.]5O-.TV&\AGMX_-'VA !(FX*2,$XY*\'UH [AD5\;E!P<C(Z4$ ]0#
M7&^)+[5=1\8Z=X5TK4GTQ7M)+^\NHHU>7RU8(J)N! RQY.#TK(FUOQ!X/UG5
M-(FNKCQ!'_9+ZC9/*D:SHRN$96(VJRC<&SP< CTH ]*(R,'I2!55=H  ] *\
MDN_'.M77A[P5J\^FZC;RW%_")8;8K_IP:!C\BAS\A;'#8QWZ5U,7Q%M(](U>
MZU'3+RQO-+G2WFL6VO(\D@4QA"I(.[<,<_I0!V0557:J@+Z 4      #L*XJ
MX^(L.F6^J'6M'O=/NM/M4O&MR\<ADA9]FY65B.&X(.*Z'0=7GUJP:[FTJZTY
M&?\ <I=%=\D9 (?"D[<YZ'D8H U:0*%S@ 9.3CO7E6DS>,M3\'W7B:U\52&Z
MAENF2QGM(3 ZQ2.H0D*&&0O7-:]KX[@>5M5F:^\L>&8]8>R4(8U4EB=I^\7X
M(YXP!0!WV 2#@9'2AE5AAE!QSR*XQ?B$K:3;W_\ 8.I+]OGCATR%R@DO2X)#
M ;OD4 $DMCC![T2?$6UMK"_-YI=Y!JEG=169TT%'DDEE ,01E.TA@<YSQ@T
M=F5!() )'3VHP,YP,^M>=>(/'_B#38](V>$K^WEN=42TECF>%]ZE<[48/C<W
M8]!M;-='XI\2S>'_  )=Z^;-DN8[=72VF()25R%56VG'#,,X/8\T ='2 !0
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MK:)I97/\*J,D_D*XZU^(KRS6'VKPSJEG;ZF&_LZ:5HO](?:65" WR,P'&[%
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M6DZ5::)IL.GV,92"+. 6+$DDDL2>22223[U=HH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!KHLB,C
MJ&1@0RD9!'I7.>&O /AKPC>W5WHNG"VGN1M=S(SX7.=HR3@9[#T'I72U3N-4
MLK74K+3YYPEW>^9]GC(.9-@!;G&!@$=: ,'Q'H.KOKUCXB\/2V8U&V@>UE@O
M-PCN(6(;&Y<E2&7(.#UJI8>%]9U'5]0UKQ)-9QW=QIS:=;VUD6:."-CN9BS
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MG=&AD1-F5(5@5( R.O%>G44 <YK7A@:SX G\-CR+,RV0@40*?*B8 8VCKM!
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M_9(EL8P757A+$;RPS]X=S4^G66I6?C7XAW@UVY<6L<<C1/#$5FS:DH&^7HG
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M1#+#?27%H\:12?92FW<1SRIYZ<CN<5B6>FZOI6B>!]2G74K*WLH[V*9X=/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *H:KH]EK,=M'>QLZVUS'=188KB1#E3Q
MUY[5?HH HZQI-GKND76EWZ-):7*;)55BI(^HZ5=50BA1T P*6B@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **KWU[;Z;I]Q?7<GE6UM$TTLA!.U%&2<#GH.U1:
M?JUCJNDPZK97 DL9H_-28@J"OK@@$?C0!=HKC]'^*/@[7M:CTC3=86:\D)$:
MF&1 Y R0&90#T/UKL* "BL+6O&?A[P]J=GINK:G':W=YCR(V1CNR=H)(!"C/
M<XI/$GC3P_X1-L-=U$6AN=WD@Q.^[;C/W5/3(Z^M &]17/:9XY\,ZQI%[JFG
MZO#/9V,9DN7 8-$H!)+*1NZ ]N<50TOXI>"M9U"&QL=>A>YF8+&DD4D>\GH
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M[TFZAE2\T#5$AGCD7#I&6)7<.W+%?^ U]"Z1X:T30&E;2-*L[%I@!(;>$(6
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MC:Z;916=C;Q6UM$NV.*)0JJ/8"@#PFTT>&'X+QM#?WJW4^K1PR*URSB K?,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWS>8)F<\>F".: *-U\1M.M;B[8Z=J4FF6=T+2YU1(T^SQ2;@I'+;R Q )"D
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ML3(L*@@L0,8Z=3VKK/ ^K:UJ,FK6^J)>26]M*GV2\N[$VCSHRY8%" /E8$9
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M6C6LV?+F$R['P"3ALX. "?P- $.B:.-%LY(/[0O[YI)#(TU]/YKYP!@'  '
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MXC-I)//=VMU9NSV]W9S&*6+<,, ?0C&01SBK+^(=%CBN)9-8T]8[=E6=VN4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU8\4:%<P:GXXL_#VGFW^T:!;[([6+8LC!W#  #!;9D>M>P44 >-ZWJ'AC6?
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M:>:Q"69R\1M1G8X7&-V00#UKV.B@#RG5+:U\,_#GPRMGHVGQI.]L+NZN; W
MM28R3,R#EF!)&3T+'UKF8;2:/PE?S36TMSI,/B^.ZO4CL6B66TV(2PAZ[,[3
MCGI7OE% 'D/B>3PIJVC:3KFE:/$=+L]?A>]G&FE0\>PAVV[<LG* \<E>^*]&
MTO6]/N[M--T^WF2)+.*YB<6YCA\ION!2<<X'W<<5L44 %%%% !1110 4444
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M7(P,[>!C)S5SQ)X>UJX\2Z9X@\/W5C%>6L$MK+'?([1R1N5.?EYR"N?>L5/
MNNVOA1-%W:#JBR7=S-=+J-N^Q_,<LKIM^ZPR>/?@C% &K<^(GM?$T!O(+Z"X
M709KZ6R%PC0J5=<@X'+@G 8'&,\<U!H_Q#GU/4=$2X\.W5C8:VC&RNY9T8LP
M3?@H.5! .#WX..:KV'P]OK-+)9-3CN#;^'YM):1PVYI'92&_W1C'KTJZG@^\
MALO!:?:(F?P]&!,%S^](MS'\F?<YYH KVWQ#OKR[TAK?PW(VFZM>-:VMT;Q
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M?E7\?Q.36G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^:QO]>L[>ZA.V2)V.5.,X-;6FZE9:QI\5_I]RES:3 F.6,Y5L$@X_$&N4\?
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M0Z+'J$,MW()9;>4S;" V.A'.#7IGA_2[C2=.*7>JW>HW$K>;+-<L" Q R$
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MI[*:Y5;"'5F/F+$J#+8(W#+ENO91QZ@'17/B'2+--0>YU&WB73MGVPL^/)W
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MVG6]O!=2P&6&8L@VN5 )(!W\<@#K4MGXR\.7^ESZG;:Q:O9V[K'-*6VB-F(
M# \C)(ZT 0VW@3PQ::C+?PZ1$+B7S-Q9F91Y@P^U22J[@2#@#J:;9> ?"^GV
MMW;6VDQK%=P&WF#2.Y:(\[ 68D+ST&*N:-XKT'Q#<7$&D:I;WDMO@RK$V< ]
M#[CW'%6M9O7TW1+Z^C:W5[>!Y5-RY2,$ GYF ) ]30 D&BZ=;7LMY#:JEQ-
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M34:YOX#;W3"1P)4(VD,H.,X&,XS[U@O\4-'TR#0EUF\L%GU,.SR6L^Z&)!N
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MT,I!(P!P371T4 9$/A?1($N$CTV!8[BU2SE3!*O"@(5".F "1^-5='\#>&=
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MP!C'."#6MJ$/B/2T\9W>EV%QYMQJ]N\<@MO-?R?+C#R1(1ARN#CKR/:O4Z*
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MUN+)K.ZQ(\\;Q['W&1N6!YSC'X8K"T(ZE9^/%MM'LM:ATBYN;F74K;4;,+#
MY!(DAE[AG(^4$C!/2O3J* /'=.T[4M%\(?#^^N='U"0Z5=3F\MH;9GFC5UE4
M'9UQDC\Z;K.FWUMXH\3F\'BA-/UQ(V0Z5I\<XF3R@AB?<C,C#D#D#!SQ7LE%
M &'HTS64MIH,6G7RVMKIT12\G VMCY/+)'\8 R:W*** "BBB@ HHHH ****
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MYS*%\O/F_NRF.O'7/>L+0? 6I:6NIVU_K\6H6&J-,][&; 1RS-(""3)O/0<
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M_3&G:"7<2 K$EE/W6QGJV>] 'M5%>867B*._U_X;06FK>>9[&>2ZBCGW%_\
M1A@R#/)W ]>X-<Y:KJ%C\$Y_%46IZC/K%VGD27$UX^(8#<!"%!R%PH^_C(R3
MF@#W*BO'X-)U9(-82QU2PT.PN]+$<8.NO=CSS( DN]@"@8$IE>Y&.:Z'P/KN
ME:?I^J6EW&=)ELKQ(;A9]1-S%YCJNWRY').&X^7L2: ._HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!DL4
M<\+PS1K)$ZE71QD,#P01W%9EEX7T#34=++1-.MEDC:)Q%;(NY&QN4X'(.!D>
MPJ?6]331=!U#5)%W)9VTDY7^]M4MC]*YNP\5C0_!F@7/B":YO-4U*)66*VMS
M)++(R[RJH@Z*#CZ 4 =#=>'M&OHK.*ZTJRFCLB#:J\"D08QC9Q\O0=/05%<^
M%?#]YJBZI<Z)I\M^K!A<O;H9,CH=V,Y&.#VKSS_A.-8OO"GB?Q#874WEZ1K"
MM'!+ (V-LJQ^9$P(R#\S]><CK7?>*=9ETCP7JFM6/EO+;V;W$/F E20N1D<<
M4 :<>GV42W*QVD"+=,7N L8 E8@ EO[Q( '/I35TO3U2S1;&V"V7_'J!$N(/
MEV_)Q\OR\<=J\ZU+Q=?ZAX_T/0X;S5+"$V:7-P;33S()I':/:"S*<1 ,<L.
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MVSZ38M!>2>;<QFW3;,^<[G&/F.0#DU9^PVAN8;G[+#Y\"&.*7RQNC4XRJGJ
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M\2%$N7A4R*I!! ;&<8)X]S7,I\0M-TKPMIFIZM-=W,=Q:B=[VVTZ7RB,XR<
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M#!B<$;E(.,TW0_"&O6\?A8WUC$LEEK-[=W82965$D$FUASDC+#'&?4"O4J*
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M%<6\@P\4J!E8>A!X-38P,"@#R;X5:->+K^J2WTJSV_A_?H>G2#G*"0NQ/^T
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MAMLLOSJ8O*._CGCTQS5/1_ RZ%=P_8-?UA-,AD,D>FF5#"N<_+G;NV#/W<T
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MRW=W.;R?SV6XEWK$< ;4'\*\=* +]%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\X->AT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPU-M2F@L26BA2'<YP2 >6=!DCDDUZ5110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@,G_ ($QS]0:DU'Q!J]]X9\3^+)/&&I6.KZ=JA@M=+BN@D*H'4!3%_%PS?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
IBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>modificationno14effectiv001.jpg
<TEXT>
begin 644 modificationno14effectiv001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M>1(H8U+O([!551R22>@H ?15$:UI9G> :E:&9&C5T\Y<J9.8P1GJW;U[5>H
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MU6"R7%S'=8^9WP5;:&R3DXZ<&O<*Q;4^&/[<D-H=(_M<DB0Q>5YY/?./F^M
M'EVB^,O$U]XNMIFOF"S:U)8S:?+-;+$D*DC"IGS?,4 -DCG^>-JAU_6_A1/K
MVI^)[QXWU)(A;B.-415N=@).,G!P?^ BO=4T/28]5;5$TNR746&&NQ;H)3V^
M_C/ZTYM&TMM-?36TVS-@^2]J8%\ILG)RN,'GGZT >.>*/&NJ:?XC$>E^(KZZ
M2QNK.V<,END#A@N[=SOE9LDY5549X]:M:AK^M17FJ06.HFSDD\8V]@)8X4)6
M)T&001\W//->H'PMX>:3>=!TPOY:P[C:1YV+C:O3H,# [8'I5EM(TQG+MIUH
M6:<7))@7)E'23I]X?WNM '+_  _OM2EN?$FF:AJ,VH#3-2,$$\X42%"BMAMH
M /)/:N)A\1ZJ\L>F?VN=*M;WQ1J%M/?QQQJT<<8W(@)&T%CQDC/'>O98+.VM
MI)I(+>&)YWWRM&@4R-C&6(ZGW-59M"T>YM);2?2K&6VEE,TD+VZ,CR'DN01@
MM[]: /"]+\0:IIVCBRL-3E:+4_%%\EQJ-LT,;RA55AM:3$:ESS^''I6_IVO^
M*-9E\':;+KLEM]ON-1@FN[4PR/-'$@*,2-R!QR.._->J2^']&GLI+*72+"2T
MED,LD#6R%'<_Q%<8+>_6ECL='MY[2".UL8IK.-FM8UC16@0\,4'\(/0XH \6
MCOM3UH^ ;O4]?GCECU:\MFN,1KN\LL%8Y&-Q V_0^M1S0W7B&[\.BYOY(U_X
M2J]@"QQ1@ +DAL%<$@#'.>IKV6/2_#FJZ>D45CI5Y91S&142*.2-9<Y+  $!
MLGKUYJXFD:9&8RFG6BF.5IT*PJ-LC=7''#')R>M 'C$_BO6X0VGV]U+;17?B
M?4;>2XMO(BD5(P"B*TF$!)/5N3CO5NR\5>(-33PQINH^(ETN&Z:\,NIPO QN
M!"1Y8+?-&#R=P'7%>K76B:)-8SV]WI>GO9R2&XFCEMT,;/U+L",$^I/-)+I&
MAW.EV\$NG:?+I\ $D$;PHT48 R&48P..XH XOX3R-_PJ<2B596\V\;S .&/F
MOSCWKF=!U77]8M_#&G0Z[<:?%<Z!/=S-:Q1@LZR8!&5PO;H.F?7->OV2Z7#$
MMG8BS2-T,PA@"@,K'EMHZ@D]>Y--_L_1].C2?['8VJ6\1B23RD01QD\J#CA2
M>W2@#QK3)M0\2>)?A_K5]>S373:3<3F-43#O$?0KP7X!QZ<8K0\,^+=9GN_"
M=^_B/^TI]=GECO=*V1A;90&.4"C<NS SDG->LP:5IUL;=K>PM8C;(4@,<*KY
M2GJ%P/E![@4RVT/2;/4);^UTNR@O9L^;<16Z+(^>N6 R: /&M,UGQ=-X#T#7
M9/%5T;C6-8@L@I@CQ"GG2H2./F)P#SZ5-'K?BFPGEG?Q-=W,6G^*8]($,L46
M)H6(W&0A02V& !&,8/X>M+:Z%%:P6BP:<EO!< 0PA$"QSY+#:O0/DD\<\U8.
MDZ:P<-I]H0\XN6S"OS2CI(>.6X'S=>* /(1XUU2;XC645GK5]-8W&L2V$D4D
M<$<*H 1M2,$R$J?XVP#Z=JSO#<]WIFG:<BZL]U)-XV%O-',L;%1NDRW3(+XR
M3[<8YKVC_A']"CNY+[^R-.6Y:03O<?9D#EUY#EL9R,GFDM]$T%Y#?6VF::SS
MRK<F>.!"9)!G;)N Y8;FPW7D^M 'E5GXQUR233]9/B R7MUKQTZ70-D>V.'S
M"F  -X8 !MQ/?FEM_$'B5;BTU9]?N7B;Q>VD?8C''Y1MRY'/R[B1C@YX_6O6
M5T/24U5M432[)=188-V+=!*>WW\9_6G?V1I@0(-.M-JS_:0OD+@39SYG3[_^
MUUH XCXCVT]YXG\$6]O>26<LFH2J)XE4L@\HY*[@1G&<9!Q7,?\ "8:LOANV
MTZZU[4!??VS>6*36T<"S7,<.<;I)"L<>,C)P2<8]:]BNX;(F.ZO(K<FV)>.:
M95_=$C!()^[QQFJL_A_0[RW$,^D:?/ 93<!'MD9?,/5\$8W'UZT >+GQEXKU
M+P=X6GCUDBXN([HW2P3P07$WER%$<&1=C  <@8)_4=Z-8;7_ (&7NIO<27#S
M:-<[YI(1$SLJ.I)0$@<@]#CTK?DT_P (:DJZ;)9Z)=*DC.MJT<3[7)^8A?4]
MSBMC[%:_8?L7V:'[)Y?E>1Y8\O9C&W;TQCC% 'B.D>*]7\/Z5IHTW6_[:CD\
M,27;VC(A6RDBC79C:,@?PD$Y)![U';>.O%>FZ%JUW'J+ZA_Q)DO%-S+;2/#,
MTBJ758B<1X8G##@J,U[59Z)I.G2RRV.EV5K)*H21X+=4+J. "0.0*BL-&T&P
M:[MM/TW3K8R@?:8K>!$W@YQO '.>>OO0!X]<^+?%%AX5\3F'699OLL5G+;W,
MT]M+/"\DJJP/DDKM8$D9Z<UWGA&[U6W\=>)M!O\ 5I]2@M(K6>&2X1 R&16+
M ;0!C(&!VKHK;0O#MO;SZ5;:5I<<+E9)K2.WC"L<Y#,@'/(X)':M%+.VBNY;
MJ.WA2YF"K+,J .X'0$]3CMF@#QOQ#K_BB.^\1WMGXBN+=--UNWL[>V$,;1[)
M H.[*Y/WN!GU_":Z\4:MHUIXBTJ\\17\CVVL6]G:W:V\+7#B5-YC!;;&O0_.
MW ].E>L/I&FRB82:?:.)I%EEW0J?,<8PS<<D8&">>*9<Z'I%['<1W6EV4Z7+
M!YUEMT82L. 6!'S$=B: /&;+Q7XHU/P]IUI'KEQ!<R^*GTHW1$4L@@V9 8J-
MC,,]1P<#M36U'5]"^)^LZ>;^XCTZ:ZTRWU+60J^8#]GPH(/"^8W!;'R_C7L\
M6AZ1"$\G2K%/+E$R;+=!MD VAA@<,!QGKBI)M)TVX%T)M/M)/M>W[3OA4^=M
M^[OR/FQVSTH \@/C+Q--XTNFBOGC6WU_^S5L))K9(7@!"XVL1*9&'S!AQV%9
MVH:Q?:W<Z+?:AX@+7!\816_]C8C MTCE(4@ ;\@=23@[A7M,>DZ%<ZH=4CL-
M.EU"%C&;I84:5"!C;OQD$#C&:;+HV@#4Q<2Z;IOV^=Q()'@3S9'3D-G&25ZY
M[4 87C&]N+7Q7X,AA=1'<:A(DH**<@1,>"1D?ABN)\+^(/$LA\&ZK=Z_<W2:
MMJ%U9SVDD<8CV*9 IX4'=E>N?0?7V*:SMKF6&6>WAED@;?"[H&,;8QE2>AQZ
M5!'I&F0I;I%IUHB6SF2!5@4")CG++Q\I.3R/4T <%XY@D/Q5\!RG59K.)FNA
M@% H*H#_ !#JX.P^W3!KE/!-WJ^C6?A2Y@U>=K+4=:NK.2P*)Y03?(<YQNW;
M@3G/H/K[/>V.E:G<0PWUK9W<UN1/$D\:NT9SPZ@\CGN*<FD:;$D"1Z?:(EO(
M9856%0(W.<LO'!.3R/4T >0>"/&7B;5_$.C7-U?,Z:E/<)=6,TUL$B5=V!$@
M/F@K@9W#D?G6M\1O$FM6GBZ'1[&_GT^U32WO1+!)!&9)0Y4!FF(!50,E5Y.?
MR]&M]#TFTU&74;;2[*&^FSYES';JLCYZY8#)I=2T72M96-=4TRSOEB.Z,7,"
MR!#ZC<#B@#QWQ-XW\16*>'G37$MI-4TZ)M3$42S1V"F1%^U*0" &R1@DCFE\
M0G4[+Q1X]U32=<N;233M-L9PT:H_VA@C8WD@Y&,],9S[8KV)M(TR0SLVG6C&
MXC$4Q,"GS4 P%;CY@!V-(-&TL131#3;,1S1K#*H@7$B*,*K#'*@< '@4 >+>
M/-6NK_2?&J3.@C&E:7, (P-K/(I;G&2/8FI]?\2:K9:9XPL;?Q"-;M8-,M[V
M*[>.)_)E>4 I\J[2".0"#@5[%+HNE3K,LVF6<@F1$E#P*?,5>5#<<@=@>E,C
M\/Z-%:W-K'I%@EO=-ON(EMD"3-ZL,88_6@#@O"4,B?&3Q:TNK3,3;6C+;/L
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MH/\ 9?W@4'87D0,,'_>(K;UWPK9:]IMQ9RA(3>/";V:*(![E(V!V,>N#C'?
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M!)-);(SN 01EB,G! _(4LN@:--/=3RZ38R37:".YD>W0M,HQ\KG'S#@<'T%
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M\[=QX/H,UW/@/Q#K%[?ZQIVMW'GK:&)H+B:.*"5@ZDE7C1B!C P>X-0-\%/
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MX*>!VW9T^Y.X@MF]FY(Z9^:@#G=1\3ZS93>)UT-K&*Z_MZ*#,<<(FDB,0+%
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M=7L)-/U&&+3HWD%TU_-LG$>!-M^;/R$@'W- 'L'VF#_GM'_WT*/M,'_/:/\
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M1_PIOP;_ ,^E[_X'S?\ Q5 '<_:8/^>T?_?0H^TP?\]H_P#OH5PW_"F_!O\
MSZ7O_@?-_P#%4?\ "F_!O_/I>_\ @?-_\50!W/VF#_GM'_WT*/M,'_/:/_OH
M5PW_  IOP;_SZ7O_ ('S?_%4?\*;\&_\^E[_ .!\W_Q5 '=?:(/^>T?_ 'T*
M3[3!_P ]H_\ OH5PQ^#?@W_GTO?_  /F_P#BJY"S\$>%8OAW;>(KO2[NYN)"
MBF&+4)8PS/,(UP2W'WA0![1]I@_Y[1_]]"C[3!_SVC_[Z%>+3^%?"%F-1M[S
MPUJ::G:FW$=G%JSR&X,[,L85MV <JV<XP!GI5A_!O@NZ728]&T2_O[O4K8W:
M1-JDL2PQ# )D8L<'<P7 !.<^E 'L/VF#_GM'_P!]"C[3!_SVC_[Z%>,2^#?#
M44NGVC^$]3CU"Z%P6@EUAXP@A95)#EL,#O!!'45TUC\(O"5U9133Z9>02N,M
M$-3E?;S_ '@V#0!Z#]I@_P">T?\ WT*/M,'_ #VC_P"^A7ENM_#CPAIEU8V%
MIH]]>ZC?,_DP?VI+&H1 "[LQ8X RHZ$Y85CMX6\(*T%I_P (YJ U1KU[*6U?
M5W41NL7FYWEL%2F"#QUZ"@#VK[3!_P ]H_\ OH4?:8/^>T?_ 'T*\]T_X1^$
M[JQCFN=+O+:5LDQ#4Y9,<\?,&P>.:YB3PIX2BFGE?PUJ/]G0:D-->Z75Y"P<
MR",-LW9(W,/?% 'M/VF#_GM'_P!]"C[3!_SVC_[Z%>-V_AGX=R'6WGT[4X+;
M2XWG$[7\I%S$C,CO'A^<.C+^1[B@>!M!M[9[O4O!VJ6MK]CENED35Y)"NQ=V
MR0 C8Q'3DC(Q0![)]I@_Y[1_]]"C[3!_SVC_ .^A7C0\'>%(=!O-9O/#=]#:
M6]F;L>7K3RL^ "%P&XSGJ>!6AX>^'/A763,)]#NH%5$DCG@UB2XAE#9X5U8?
M,,<C'<'O0!ZK]I@_Y[1_]]"C[3!_SVC_ .^A7#?\*;\&_P#/I>_^!\W_ ,51
M_P *;\&_\^E[_P"!\W_Q5 '<_:8/^>T?_?0H^TP?\]H_^^A7#?\ "F_!O_/I
M>_\ @?-_\51_PIOP;_SZ7O\ X'S?_%4 =S]I@_Y[1_\ ?0H^TP?\]H_^^A7#
M?\*;\&_\^E[_ .!\W_Q5'_"F_!O_ #Z7O_@?-_\ %4 =S]I@_P">T?\ WT*/
MM,'_ #VC_P"^A7#?\*;\&_\ /I>_^!\W_P 51_PIOP;_ ,^E[_X'S?\ Q5 '
M<_:8/^>T?_?0H^T0?\]H_P#OH5PW_"F_!O\ SZ7O_@?-_P#%4C?!SP:!D6=Z
M>?\ G_F_^*H [U'2091E8>H.:=61X=\.:=X7T][#2XI(K=I#)MDF:0Y( ZL2
M>PXK7H **** "BBB@ HHHH **** "BBB@ HHHH JZEJ%OI6EW6H73;;>UA::
M1O15&3_*N"\'_$RY\1^&-?OKS3$L]1TN#[2+7<</$T7F1MSSS@_ACUK:^(FA
M:KXG\-+HFF.D4=Y<QI>RL^TI;@Y;;ZG@<?6N3_X5CK&BZ[<SZ3J=QJ-IJ&D3
MV%TVH3+O0[,1;<*,@$ >PS0!GV_QRN)/A_>:Y)I4"ZG#?1VT=H';:RNF\-Z]
M%?\ (5=?XJZU/?:=:V=GH<+7.DP:B[ZA>F!09.J*3UQ7/Q_!C71J$$S&V\C^
MQ?*EB$W#7BV[PIQCH,@[OK6B/AUXBL]2TNZ/A[0]:C@T2WL)(=0E!5)4^\RY
M4_3/O0!LZS\5KKPS<>&$UBSL&AU0.UW/9W!DCA4.%#(V/F&""?QHU/XIZC;Q
M:Q]BTVTFEL]:BTN#?*P60.#AB1TY Z4^;P)?Z]JGAY]6T?3K+3K:RO+2[L[.
M3*1B0$)LX'L?8US%C\)_%&D>&KW3X&M+JX76[>]MFDFVB6*(,!NXX)XXH ZJ
M?XB:_HD^J6'B+0[2VOX=+EU&S:WN#)%.(QRAXR#_ )]*PF^.5POP]77O[*@_
MM,Z@;0V>]MH01^9O]<8Q6IJ7@WQ9XJN-3U76XM-M+H://I]A:6LS."\@.6=R
M.G;C_P#7S$GP8UUM0N)@;;R#HJQ11>=P+S[.L+<8Z<,=WTH Z.?XHZW+K(L+
M*TT&$"PMKMGU&^, )EC#%5SUP35K4_BI/X>\0^&].UFTL1;ZI;K+<W5M.7CA
M+,54JW1D^Z<^YK'D^'_B"UU_[=_PC6@ZU"VFVEKLU&0$1O%&%8J"IZD5KW/P
M_O/$6LV$FLZ98V>G?V')I\UM:296!_,RGEC X "D>A% $A\?^)+W2O$%_I.C
MZ=+%HNH75M/Y]PRDQ0J&## Y8\\>PKH? NN^(/$>DIJFL:?8VEK<PQS6GV:9
MG9@P).X$<?P_F:YGP1X UOP[\//%&@WTD,MYJ#W/D2+)D2;X@BLQ/3)%=OX0
MTNYT7P=H^EW@47-I:1PR[#D;E4 X- '(?\)OXMUV?5KGPGHFG3Z5IL[VQDO9
MV66Y=!EO+"\#VS_B!0?XM:AJ<^B)H.GZ:JZEI[7C'4KHPB-ED:-DW=#RIQZU
M-;^'O'?A*XUFP\,P:3>:9J-U)=6\UU*R/:M)U# #Y@.,8]/PJOH_PA2RU?0(
M=4M[/4]*T_29+>;SAG-PTK29"GL-QP: .[MM:U"#P7-K.IVML]W!;RW#06$W
MFHX7<5"-CG( _$UQW@GXE:SXDU6S6[LM(;3KN"29I+"[\R6RVC($ZGD9Z=.M
M=[/I1@\.RZ7HCQZ:RP-':O'&"L#8^4[2,$ ]J\NT'X>>(9/%NCZEJND:'IG]
MG^9]KN]/;:]_N0KRB@*,Y)/ ZGZ4 :"_$/Q?J.@77BS2?#^G/X<@,CHL]PRW
M4T49(9P -HZ-P?3OWZ+P_P".1X@\6?V;;VRK8R:1#J44K$[SYA'RD=. :Y&W
M\)_$'1O"UWX(TU-'GTB42PP:C-*RR1PR$E@R <M\S=/6K</A'Q7X4\4PWOAV
MSL-1M8M&@TW-W<&(DQ]6P >N/UH U=6^)#:'XE\36=[:QM8Z-I\=VC(2))'?
M: ISQR6 Z5!9^+/'L+6-SJWA>R.GWL3/NLIF=[7Y=RF7/&/7'OWXK/F^'^N>
M)=6\2W6NQVMDNL:7%;#[/+Y@CF1@0>@R,J#5VUT?XDWK65EJEYI-GI]E$R2M
M8LS/>_)M4,&&%'KT]NU %&7XD^*O^%;67C*WT;2Y;1H7>[5IG4HPF:,!1SD8
M /7UJ_K7C[Q'X<\(0ZAJ6C63ZO>W*Q6-G:S,XD0KN+'C/ !_2HH? NLI\!SX
M/*P?VKY3)CS/DR9R_P!['I4VM> ]7\2^+=+N+G4I]-TW2=/V6TMC,!,;AL!S
MR" NWC\* &ZY\0]<M_ UGXOT;3-/N=+>S2>Y\Z=E>.0L%** .<$X_ T)X\\1
MZ?X@\/6&OZ;IMK#J@N97>WE>0I%%$'!YQSG.1@]*SH?AWK]E\,O$W@V*2*>&
M6YW:5))+R8BZL0^!@'Y2?JQK>U_P=?:OXL\(WNV(V.FV]S#>Y?#8DB"#:._.
M: ,;_A8GC"X\.2^+[3P[IY\-H6D$<ERPNWA5L%\ ;1T)Q[=ZNP?%FU?XBV?A
MZ6W2/3[^UAFM;MF(8O*@=%8=!G./KBL>/PE\0[/PC-X%MUT:32G5[=-4>1@Z
MP,22#'C[V"1_G-6+WX2R7][K%O(Z+:-I=I;:==;OWD<\"X5R!TZ<^Q- %BT^
M*MY>>#M"U9-,@-[JEU/&;?S#M2.)79V!ZDX4?G6/9?'*XN/ >IZU-I4":G;7
M<-O#:!VVR"0;E/KT5S^ J;PG\-O$&G6.FVVIK;!=.TR^BA"2[O\ 2+AR/3IL
MQS[UC6_P8UU=1TR:0VP@CTO9=1B;AKI(Y$C.,<@;DY[<T =;9_$?7O$+:5IW
MAS2;&35+C3EU"\:[F98+=&. HQ\Q)_J/?$-U\4]8LM%U&*YT:U3Q!IVHP6,\
M'FL8&$N=CJW7!QT-5],\$>+O"4NCZQH<6GW5ZFE)I^H65Q*5#%3D,C@?3\O?
MB'4/AWXKO](U74K@V#Z_J>J6MX]M'(5ABC@!"KN(R3@\T :>H?$?Q%X?DU"Q
M\0:'96U\NFRWUB]O<&2*;R_O(W0@]Z9=?$K76U'1+#3['1Q+?Z'#JLCWMT8$
M4N2"BGGVQWZU#K7@OQ?XPEOM2UJ'3;.XCTN>RL+2UF9]SR#!9W(Z8XP/_P!=
MFQ^&C77B30[C7]/LKS3['PU#ITD<I#XN4;.0,=,9Y]Z +5O\1-1L_$3Z?KEI
M8QP0:#)J\\EG(9?NR$81CP05 /3J:CTGQEX[O8])U:7PK:2:+J4JA4M9V>YA
MB?E9'S\N,<_X5+??#Q[OQQ=31Q0VV@S>'&TA5B.&C)?^%?0"L^UT+XHV6D:?
MHEO>:/!::6%$=W;LWFW21J0D95AA<_*"?Y]P#2M?B:+CXH2>%_L2C3C)):Q7
M^X_/<HBLZ>G&<?7%4CXS\?\ _"7?\(U_8&B?;OL?VW/VQ]OE;]G7'7/:L(?!
MW7;/PU97MKKES+XCMKM=0^RRS+]E^T%P7/W<YQWSSBN_7P_J#?%=/$K)$MC_
M &)]B(WY82^=OQCTQWH YN/XJWS:3>E-+AGU5M>DT;3[9'*K(5QAW8]!SSCV
MZ=:OVWC7Q'I7B*/1/%6E6$4]Y:37%C/82NT;M$I9D;<,@X&<_3UK"3X9^((]
M)O)[:6SAUBW\22ZQ8>8Q:.1"  KX'&<?I[YK4C\-^+_$GB:VUSQ)!IU@NFV=
MQ#9VMK*9#))*A1F9CP!B@#+TOXV'4_"4.HKI\":D-3ALI[4R'"I)DK(._0'\
M0:[KQMXK;PKIEJUM9_;=2O[I+.RMMVT/*_3<>P'^'UKS"Z^#&J-H_A.XM?L\
M>JV#)'J,8EPDJ+(65@<<L!Q^(]*](\?^%[[Q)I=A+I,\,.JZ7>QWUH9P?+9T
MS\K8['/Z4 8C>.?$N@ZPFE^*M)TZ.2\LYY[&>PF=HV>)"[(^X9' ZCU'X.\%
M>-O$OBB;3IYK/08K"Z0R.L-\6N$7!_Y9XZYQ5.X\,>,O%NM0:IXBM]-T]-.L
M[J*TMK68R&66:,H2S'@+T_*MWP#X"T[PQHFF23Z591ZY#!LGNHE!8L>OS=Z
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MZ/\ A0!T5%<[_P )UX7_ .@U;?\ ?1_PH_X3KPO_ -!JV_[Z/^% '145SO\
MPG7A?_H-6W_?1_PH_P"$Z\+_ /0:MO\ OH_X4 =%17._\)UX7_Z#5M_WT?\
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MI2^6%,P!2W8RYZ!5C;;GJ!]* -2\^)>D'1+J\TVSN)9EMTGM5N;=H4N0\BQ
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M0RG(Y)4YZXJ>_P#MNHS^(+F+4[JT;2B(K9(6 3>(4F+.N/GR9 N#QA>,$YH
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MNH6*!_LT,PD$P8$KM<@<G!'(&,>F#1:ZW>/K4&F7NE&V>>&29'%PL@PA0'(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M DJQ.6'KE"10!8U6:+_A8WA\^8F/LEU_$/\ 8J2YLM<=[^&/6--ELKQVPMU
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M_P *[\'?]"WIW_?@4?\ "N_!W_0MZ=_WX% '1>?#_P ]4_[Z%'GP_P#/5/\
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M%9^>@'//%='?Z/\ #C1;6SDUS1M(TZ:YC#B%XPY7@;LE1T!(!;I0!WWGP_\
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M_ K/UKPCX&T/1[O5+OPU8^1;)O(2 %F/0 >Y) 'UH [+SX?^>J?]]"CSX?\
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M@4 =,KJXRK!ATR#FEJCI6DV.BV8L].M(K6W#%A'$NU<GKQ5Z@ HHHH ****
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M!R<G/%!K6SC^'8D2&%+T2/\ 8G50'^T><PCVGKG=@?3.>,U;'C7P(J6R"\M
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M'\)?]!A/^_,G_P 31_PL?PE_T&$_[\R?_$T =317+?\ "Q_"7_083_OS)_\
M$T?\+'\)?]!A/^_,G_Q- '4T5C:3XJT779Y(=,OEN'C4,X$;K@9QW K8!S0
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M ";1Z4N!Z"BB@ P/048'H*** # ]!1@>@HHH ,#T%&!Z"BB@ P/048'H***
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M3^UR%YV@;R2/(EZ(9 >A ^]U_*@#HDUS29=.?48]3LWL8SM>Y6=3&ISC!;.
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M>#TP/05N44 9>I>'[#5M2TV_NEE,^FR-+;E)64!B #D X;H.M:E%% !1110
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M4+L"[A0<>@SDGL 35F@# L;/5TEU+4Y(+*"^NEC6.V69GC&S/+/M!R=V.%X
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M,\Y"#(&.PJQ?)H[Z?XPUE;D&^M[EFMY5N&'E.(TV; #@$N"..I&#G&*],HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <K_ ,U7_P"X*?\
MT<*ZJN5_YJO_ -P4_P#HX5U5 !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !129QG.!Z49H 6BDS1F@!:*
M3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6
MBDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&:
M%HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F
M@!:*3-&: %HI,T9H 6BDS1F@#EO^:K_]P4_^CA755R>[_BZ_3_F">O\ TV%=
M7F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI
M,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:
M*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H
M6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T;A0 M%("#2T %%%%
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M;\[20<,#@D?W1GUKGM&\+:VVN6-RTM[HR20:C.QMO)9H?.NHY$A;>KKG;DG
MZKU]0#:N-,M[72?[5G\<:U'8[%<3M- %(/3'[KOD8'?-58AIDVF7.HKX^UD6
MMLVR=WEA4QL<8!4Q9!.1@8YR,5K^,+"\GTW2[BUAEOGTW4(;N2!"HDG1,AL9
MP"PW;L<<KQ6)J*ZEKDBZK;^&IK:*RU*VNO+D5$N;Y$1E;*D_P;E*ACSM[<4
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M:SKC^W=%5M:OI-0_M&**"#3HIKA<W(>\9V@QG)<QB-3QT&?H =W_ ,(I<_\
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MW:<C&.>20* +M\FEZ8\"WOQ$U*W,Z"2+S+NW&Y#T;_5_=]^E)?C2-+G,%_\
M$B^M9A@F.:^MD89&1P8_0BLVP%QX>_M+[?X?U'45U/3K588X;4R*VR 1M Y
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MPBES_P!#9K__ ']@_P#C5=+10!S7_"*7/_0V:_\ ]_8/_C5'_"*7/_0V:_\
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MK_\ ["EW_P"C6KI6Z?B/YUS7@C_D%7__ &%+O_T:U '34444 %%%% !1110
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M_0HC_P #T_PH_MWQ7_T*(_\  ]/\*ZJB@#E?[=\5_P#0HC_P/3_"C^W?%?\
MT*(_\#T_PKJJ* .5_MWQ7_T*(_\  ]/\*/[=\5_]"B/_  /3_"NJHH Y7^W?
M%?\ T*(_\#T_PH_MWQ7_ -"B/_ ]/\*ZJB@#E?[=\5_]"B/_  /3_"C^W?%?
M_0HC_P #T_PKJJ* .5_MWQ7_ -"B/_ ]/\*/[=\5_P#0HC_P/3_"NJHH Y7^
MW?%?_0HC_P #T_PH_MWQ7_T*(_\  ]/\*ZJB@#E?[=\5_P#0HC_P/3_"C^W?
M%?\ T*(_\#T_PKJJ* .5_MWQ7_T*(_\  ]/\*/[=\5_]"B/_  /3_"NJHH Y
M7^W?%?\ T*(_\#T_PH_MWQ7_ -"B/_ ]/\*ZJB@#E?[=\5_]"B/_  /3_"C^
MW?%?_0HC_P #T_PKJJ* .5_MWQ7_ -"B/_ ]/\*/[=\5_P#0HC_P/3_"NJHH
M Y7^W?%?_0HC_P #T_PH_MWQ7_T*(_\  ]/\*ZJB@#E?[=\5_P#0HC_P/3_"
MC^W?%?\ T*(_\#T_PKJJ* .5_MWQ7_T*(_\  ]/\*/[=\5_]"B/_  /3_"NJ
MHH Y7^W?%?\ T*(_\#T_PH_MWQ7_ -"B/_ ]/\*ZJB@#E?[=\5_]"B/_  /3
M_"C^W?%?_0HC_P #T_PKJJ* .5_MWQ7_ -"B/_ ]/\*0Z[XJ/7PC^5^G^%=7
M10!!:--):QO<1&&5E!:/=NV'TSWJ>BB@ HHHH **** "BBB@ HHHH **** "
MBBB@#A=-\#Z_HMJUGI?C.6WM/.DE2(Z=$^TNY<C)Y/+&HM6^%ECK%G=6\^HS
MJ;C5WU-G1 " \8C>+K]UE')]ZU--^(6CZKJMO900:@L=U+)#:WLEL5M[ET!)
M"/W^ZV.F<&BR^(.D7VJP6<<%^D-Q.]M;7\EN5MIY5SE4?/)^5L< ''% %+4O
MAV+N2YFM-7DL[B75X]6CD$"N(G2/RPN"<$=^:L7?@_6-6T34])UGQ3)>V]];
MF$8L8XC$<@[AMZ],8/K4NF?$'2-4U.VLX8-0CBNY'CM+V:V*V]RRY)"/GGA3
MC(&<<5:UWQA8Z!J=MITMIJ-W=W$33)%8VK3-L4@$D#IR10 [7?"T.LG29TN7
MM;[2YUFM[J-06  PR'U5AP16;+X)OK2]O9O#WB:\TB"]F:>>V%O%/&)&^\R;
MQE,]2.F:5_B5H:Z>ER(=2>5KW[";-;-OM"3;2P4QGG[HS5O2_'&EZGJ,^GR0
M7^G74-N;HQZC:M;YB!PS@MQ@$C- &0/ALUC%H?\ 8NO7-E/I*W(6>6!)VE,[
M!G+ X'4'MWJ]<^#]1U2PMK;6?$4E\UOJ$%['(+2.+'EG.S"]CZ]JKI\4=$:&
M.\>RU>'29'")JDMDRVQR<!MW4*3QDC%6KOQY;P:Y?Z3;:'K>H3V#(L[V=NCH
M"Z!UY+CL?2@"2;P/8/\ $&V\812-%>1P-#+&JC;-D;0Q]"!Q[@#TK0T[0$T_
MQ'K6L+.SOJGD;HRN!'Y2;1@]\YS63-\0K&&^:Q&CZ[-=I#'--!!8-*T(D!*A
M]I.#P?R-277CRSM_L,,>DZQ<7]Y$\R6$=IB=(U;:6=6(VC/3)YS0!I0Z D/B
MZ[\0"=C)<6<=J8=O"A&9LY]]WZ4:CH$>H^(M%UAIV1]+,Y2,+D2>8FPY/;'6
MLH_$31CHEMJ445]+)<7364=BD'^D>>N=T90G (P<\X]Z8WQ(T>'1M7U"[M=1
MM'TEHEO+.> +/'YA 0XW8(.>H/8T 6+OP-IUYK>JWLCL+35[,6U_9!<),P^[
M+GJ' XR/YUF_\*^OKN"VT[6/%5]J6BV[HPLG@C0RA#E5ED RX&!Z9QS6IJOC
M>PTS6'TF"QU+4[^*,2S0Z=;>:85/W=YR ">PSFJ[?$OPRFGZ=?27<D<%]=FR
M4R1%3#,.JR \H1WS_+F@"N? ^JP:EJL^G>+;NPMM3NFNIH8;2(L&*A3M=@2.
M%%27'P]MH=.T2'0M1N-*NM%61+6Y5%E)$@_>!U88;<1D].:Z'^VK/_A(QH67
M^V_9/MF-OR^7OV=?7/:J6A>,-'\1ZGJ>GZ=,[SZ=)Y<P9-H;YF7*G^(95AD>
ME &9;_#^WETW6X-:U&XU.\UD(MW=E%B($8Q'L5>%VGD=>>M-M/ ^H2ZOIU[K
MWB>ZU>+37\VTMVMHX0),8#N5Y<@9QTYKHM$UNTU_3S>V1D\D320_.N#N1RC?
MJ#5#7O%]CX?U"TL)K34+NZNHWDCBLK9IFVJ0&) _WA0!8AT!(O%UUX@$[&2X
MLX[0P[> $=FW9]]WZ5FZWX2O[_Q/'KVEZ_+I=TME]B8+:I,&3>7_ (^ASCMV
MIA^(V@C1[[47%\AL)8X;FTDM62XC:0@(#&<'G(Q4NG^.].OM9M=*EL-6L+J[
M#_9Q?V+PK*5&Y@I/&<9- &=<?#>*71IK=-8NCJ=Q?Q:A-J4T:/(\L9&SY0 H
M48  Z"MO1M)UZQO6EU/Q,VIP%"HA-C'#ALC#;EY]>/>K>KZ]9:))81W1<O?7
M26D2H 2'8$Y.3PH"G)HT#7;/Q)H=OJ]CY@M9]VSS5"MA6*Y(R?3/TH QM"\!
M6.A>+]4\0Q7$DLEZ"L4+#Y;8,V^0+_O-S5'3/ ^OZ)9_8M,\9RV]F)9)$B.F
MPOMWN7(R>3RQK>T_Q=HFJ2:L+.^CEBTK'VJ=2#&N5+'##K@ YK-L/B+HMZ7,
M\.H:?']D>]BEOK8Q+/ @!9T/.< @XX.#TH CE\&ZQ#X@U75=)\4O8#4I(Y)8
M?L,<H#(@08+'T%27O@V]&L3:OHGB&?2KV[B1+TBV2:.X9!@/L;A6QQD5:T'Q
MII^O7_V%+/4;*Y:#[3"E];F+SHL@;TY.1DCT/(XKI* .-M/AY:6:Z8XO[B:Z
MM=2.IW%S, SW4Q1D.[H%&", = !6UXIT&/Q/X;O=&EG:!+I54R*NXKA@W3\*
MV** .#U'X7V%_J7B2]^W31MK=MY!0("L!(3>RC/);RU)^E6'\%:M;Z]J6J:/
MXHDT_P#M#R?-B^PQRC,<8C!RWL,_C7:44 <Y:^%Y4\16&N7VJ/=WEK8R6;L8
M502[G#;L#@8QC J+PIX'L/!^H:U<:=(WDZG.LWD%0%AP#\J^V6/TZ5U%% &/
MX7T!/#'AVVTB.=IT@,A$C+M)W.S]/^!8K%?P1?65W>/X>\3WFD6UY,T\MJ+>
M*=%D;[S1[QE,GG'3-=E10!Q.@?#+2=$U".XEE?48X+3[+;Q7D:OY>Z1I)']"
MS,QYP,#BF7?PULYM0GFM;UK6UEU.UU/[)'"-B2PC!V\C&_C/IBNYHH Q[S0$
MO/%.EZX9V5["&>%8@O#^9MR2>V-OZT:3H$>E:QK6H+.TC:I.DS(5P(RL83 /
M?[N:V** ."'PXFM;?1!IFORV=SI,EV\<_P!E23=]H?<P*L<<=*ZC1-/U:P28
M:KK;:HSD&-C:I#Y8[CY>N??TK5HH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH Y7_ )JO_P!P4_\ HX5U5<K_ ,U7_P"X*?\ T<*ZJ@!&
MZ?B/YUR/A73[+4]#OX+^SM[J'^U;MO+GB5UR)6P<$8S77-T_$?SKFO!'_(*O
M_P#L*7?_ *-:@#2D\-:#-?"^ET33I+L;<3M:H7&T #YL9X  'TJW#I]G;P30
M0VL*13N\DJ*@"NSG+$CN22<^M6:* ,JV\,:!9QR1VNAZ; D@ =8K2-0^"",X
M'/(!_"KUQ8VEVRM<VL,S*K(IDC#$*PPP&>Q'!]:GHH S[[0='U2*"+4-)L;N
M. 8A2XMTD$8XX4$<=!T]!5=_"7AN2."-_#^E-' "(5:SC(C!.2%&..23QW-;
M%% %:YL+:ZTV;3Y(P+66%H&C48&PC:0/3BJ">%=$/V%[C3;2[N;*-(X;JY@1
MY1L  .['7C/&.:V** ,4^#_#)N&N#X=TDSLQ8R&RCW$GJ<XSFI;#PQH&E70N
M=.T33;2X *B6WM4C;!ZC(&:U:* (&L[5[AKA[:%IGC\EI"@+%,YVD]=N2>.E
M4KOPUH-_#;PWFBZ=<16R>7 DUJCB)>/E4$?*.!P/2M2B@#,@\.:':QB.WT;3
MXHPR.%CMD4!D)*G '4$DCT)-7K>UM[.+RK:"*&/<S[(T"C<Q))P.Y))/N:EH
MH JMIFGO:W%LUC;&WN&9YXC$NV5FY8L,8)/<FHK72;>UU2\U+=)+=7(5"\A!
M\N-?NHN ,+DL?4ECD],7Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /);O5K;7O&>@W
M&GC58M=M+_RKG29XF,-M!\ZR2D;=@.TY#@Y.X"L_3)5O/#_A;P3&ER-;TS55
M:\C,##R8XFD)D+$;=I!&#GG<*]JHH \<T&\2^T[P1X5AAN1J^BWZ2:A$T#*+
M=8DD4EF(QAB5Q@\YKH?$UCJ-[\5=%73M1?3I!I5R3<+ LO'F1_+AN.?Z5Z%1
M0!Y-XE\'3:;-H(CUB^FU+4O$4<]SJ.Q ZL()%!50NT   =#574_#VIQ:_KVC
M:C>W>IZGJVC3PZ-J$[!5VX!D@95 56R =W<>E>QT4 >2ZGXSTG5?AM)X9L[>
MY?7KFP%@NE?9G$L<I79\V1@*IYW9Q@5)X?\ "EY=^,/%$;:YJ^G&W-E$38R(
MBRD6J D[D;/(KU:B@#QW5[RVTOXGZ]]L\5WVAJ]G9JDD,*2&XPKYSNC;ID=,
M?>J?6=3\/W5WI%Q?ZGJT,/V%Q:^*[61HG=Q)AX754V]L\C!["O65='SM8-C@
MX.<4Z@#QA-2%YX5LI?$MKJ%QIJZQ,MMKT"/;7$$87]U<LJ+GYB64G ' )!K+
MUR^N[[X?>-X+?4+O6='B%G]CU&Z@VRR,95WIOVKY@7CG'&:][HH \UL-;L?
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MR"K_ /["EW_Z-:@#IJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRT!F7)_U>X D=0"3GB@#IO\ A/\ 3O\ H%>(/_!1/_\ $T?\)_IW_0*\0?\
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M)?$GB'PFL\-S=V5X\MC)<VTR6;(8VCDB1@R;VW B4$8(.1[T ;/_  G^G?\
M0*\0?^"B?_XFC_A/]._Z!7B#_P %$_\ \36+?>*=5LM$DNEU3S7-Y:V_F3:#
M<6_E+))M9@CG,AQV7ICW%:O@OQ#>Z[>:O')<QWUE:-&D5ZEE):[I/F\R,HY)
M)7"\_P"UCM0!+_PG^G?] KQ!_P""B?\ ^)H_X3_3O^@5X@_\%$__ ,37,>&_
MB/J>I66AV^HV]O;ZG>WD60JG9/:N'PZ<\$,NTCG!_P!X5H'Q)KK:#+XL2YMA
MIR7;(-.:W.XPK-Y1)DW9#\%NF.@]Z -?_A/]._Z!7B#_ ,%$_P#\31_PG^G?
M] KQ!_X*)_\ XFNJP*,"@#E?^$_T[_H%>(/_  43_P#Q-'_"?Z=_T"O$'_@H
MG_\ B:ZK HP* .5_X3_3O^@5X@_\%$__ ,31_P )_IW_ $"O$'_@HG_^)KJL
M"C H Y7_ (3_ $[_ *!7B#_P43__ !-'_"?Z=_T"O$'_ (*)_P#XFNJP*,"@
M#E?^$_T[_H%>(/\ P43_ /Q-'_"?Z=_T"O$'_@HG_P#B:ZK HP* .5_X3_3O
M^@5X@_\ !1/_ /$T?\)_IW_0*\0?^"B?_P")KJL"C H Y7_A/]._Z!7B#_P4
M3_\ Q-'_  G^G?\ 0*\0?^"B?_XFNJP*,"@#E?\ A/\ 3O\ H%>(/_!1/_\
M$T?\)_IW_0*\0?\ @HG_ /B:ZK HP* .5_X3_3O^@5X@_P#!1/\ _$T?\)_I
MW_0*\0?^"B?_ .)KJL"C H Y7_A/]._Z!7B#_P %$_\ \31_PG^G?] KQ!_X
M*)__ (FNJP*,"@#E?^$_T[_H%>(/_!1/_P#$T?\ "?Z=_P! KQ!_X*)__B:Z
MK HP* .5_P"$_P!._P"@5X@_\%$__P 31_PG^G?] KQ!_P""B?\ ^)KJL"C
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MN-\KR;IV#%=Q)VC@?*,X ]*L444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <K_S5?\ [@I_]'"N
MJKE?^:K_ /<%/_HX5U5 "-T_$?SKFO!'_(*O_P#L*7?_ *-:NE;I^(_G7->"
M/^05?_\ 84N__1K4 =-1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,IO_ (JC_A"=/_Y_M8_\&4W_ ,50!TFX>A_*C</0_E7-_P#"$Z?_ ,_VL?\
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M^*H_X0G3_P#G^UC_ ,&4W_Q5 '2;AZ'\J-P]#^5<W_PA.G_\_P!K'_@RF_\
MBJ7_ (0G3_\ G^UC_P &4W_Q5 '1[AZ'\J-P]#^5<W_PA.G_ //]K'_@RF_^
M*H_X0G3_ /G^UC_P93?_ !5 '2;AZ'\J-P]#^5<W_P (3I__ #_:Q_X,IO\
MXJC_ (0G3_\ G^UC_P &4W_Q5 '2;AZ'\J-P]#^5<W_PA.G_ //]K'_@RF_^
M*H_X0G3_ /G^UC_P93?_ !5 '2;AZ'\J-P]#^5<W_P (3I__ #_:Q_X,IO\
MXJE_X0G3_P#G^UC_ ,&4W_Q5 '1[AZ'\J-P]#^5<W_PA.G_\_P!K'_@RF_\
MBJ/^$)T__G^UC_P93?\ Q5 '2;AZ'\J-P]#^5<W_ ,(3I_\ S_:Q_P"#*;_X
MJE'@K3P>+_6/_!E+_P#%4 =&#D4M4],TV'2K3[-!)<2)N+;IYFD;)]V.:N4
M%%%% !1110 4444 %%%% !1110 4444 %%9NL:]IF@PI-J5SY$;G:I\MGR?^
M @UD?\+&\*_]!-O_  %F_P#B* .IHKEO^%C>%?\ H)M_X"S?_$4?\+&\*_\
M03;_ ,!9O_B* .IHKEO^%C>%?^@FW_@+-_\ $4?\+&\*_P#03;_P%F_^(H Z
MFBN6_P"%C>%?^@FW_@+-_P#$4?\ "QO"O_03;_P%F_\ B* .IHKEO^%C>%?^
M@FW_ ("S?_$4?\+&\*_]!-O_  %F_P#B* .IHKEO^%C>%?\ H)M_X"S?_$4?
M\+&\*_\ 03;_ ,!9O_B* .IHKEO^%C>%?^@FW_@+-_\ $4?\+&\*_P#03;_P
M%F_^(H ZFBN6_P"%C>%?^@FW_@+-_P#$4?\ "QO"O_03;_P%F_\ B* .IHKE
MO^%C>%?^@FW_ ("S?_$4?\+&\*_]!-O_  %F_P#B* .IHKEO^%C>%?\ H)M_
MX"S?_$4?\+&\*_\ 03;_ ,!9O_B* .IHKEO^%C>%?^@FW_@+-_\ $4?\+&\*
M_P#03;_P%F_^(H ZFBN6_P"%C>%?^@FW_@+-_P#$4?\ "QO"O_03;_P%F_\
MB* .IHKEO^%C>%?^@FW_ ("S?_$4?\+&\*_]!-O_  %F_P#B* .IHKEO^%C>
M%?\ H)M_X"S?_$4?\+&\*_\ 03;_ ,!9O_B* .IHKEO^%C>%?^@FW_@+-_\
M$4?\+&\*_P#03;_P%F_^(H ZFBN6_P"%C>%?^@FW_@+-_P#$4?\ "QO"O_03
M;_P%F_\ B* .IHKEO^%C>%?^@FW_ ("S?_$4?\+&\*_]!-O_  %F_P#B* .I
MHKE1\2/"3.R+JV63&Y1;2DKGID;>*7_A8WA7_H)M_P" LW_Q% '4T5RW_"QO
M"O\ T$V_\!9O_B*/^%C>%?\ H)M_X"S?_$4 =317+?\ "QO"O_03;_P%F_\
MB*/^%C>%?^@FW_@+-_\ $4 =317+?\+&\*_]!-O_  %F_P#B*/\ A8WA7_H)
MM_X"S?\ Q% '4T5RW_"QO"O_ $$V_P# 6;_XBC_A8WA7_H)M_P" LW_Q% '4
MT5RW_"QO"O\ T$V_\!9O_B*/^%C>%?\ H)M_X"S?_$4 =317+?\ "QO"O_03
M;_P%F_\ B*/^%C>%?^@FW_@+-_\ $4 =317+?\+&\*_]!-O_  %F_P#B*/\
MA8WA7_H)M_X"S?\ Q% '4T5RW_"QO"O_ $$V_P# 6;_XBC_A8WA7_H)M_P"
MLW_Q% '4T5RW_"QO"O\ T$V_\!9O_B*/^%C>%?\ H)M_X"S?_$4 =317+?\
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MM_X+HJ/[$\3?]#>W_@NBH Z6BN:_L3Q-_P!#>W_@NBH_L3Q-_P!#>W_@NBH
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M[*.1XYUCT:#?;E "3("PP,$$<]Z /7**\AB\<WQCU%KO7=:L6L;>.=H[K1H
M\HD;:@0!B26. .E.G\::A8V>H3:IKFLZ=-8PI</:W.CP"62)W$8=,,00&8 \
MY% 'KE%>4:AXRFL+5[@>+[NX79:O&(=,@/G?:-WEA22!GY&)SC&*W/#LNO\
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M:_L3Q-_T-[?^"Z*C^Q/$W_0WM_X+HJ .EHKFO[$\3?\ 0WM_X+HJ/[$\3?\
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M2E1(J<$GY%P,]2>U;'_",:K_ -#AJ_\ W[@_^(H_X1C5?^APU?\ []P?_$4
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M8U7_ *'#5_\ OW!_\10!A^(? 6JZS=^)E@OK>"UUZ2R21@6\Q((@1*!QC<>
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M_P#$4 =-17,_\(QJO_0X:O\ ]^X/_B*/^$8U7_H<-7_[]P?_ !% '345S/\
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M;X\D[6"L P!)(SG&: .;D^(6J2:@MO9>'H)8I;J[M8))=0*%FMP2S,!&=JD
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MN)92K2[4#;E4H%8')'RN2-IR *N1^$_/GOI-9U*;4UO+,V4D;QK$/*))(^0
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M682,_P"]559_E!5MI^Z"1SUR*V3X'\.&XM)_[,7?:+$L0\U]O[H 1EESARH
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M7-S<063P37$3PN\-Q(F$=@S!0&PF64'Y<=_4UT0&!B@ HHHH **** "BBB@
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MW@+PS<6D5M+I:O%%YFT>:X)#N796(;+*68G:<CGI3KCP1X?FO9;Y+!(;QUD
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ML</$@CC/7LJ@?ASS56Y\"^&;R...?2HW2/?@>8XW!G,A5L'YEW,QVMD#)XH
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M3$Q!?8.1SUQ=D^),]L\]Q<Z*(]-CEOH5D%R3*S6R.Y)38  0A'WB0?SK?NO
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MT/O>9DCS?DRF%&XX##G&<UT7ACPY%X;T^XA$BS7%W=2WEU,L?EB260Y)"Y.
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MMR(6W1CK_"3G^=9&C_#^#2?&$WB#[<9&9IVCA6$)M\U@S9(.#C'& ,]3D\T
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MK103M$NSR]V,X^YQCI[4 </#X_U\:I&\VEVQ2^M+!K.S2[RH-Q)(H=Y/+R"
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MG@@XIVB>#;#2O"TN@W#?;+>>226;<"@8NVX@ '('XD^] &"?B'J<'B!]*N-
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M;'S'+;1G"Y(Y*XSWJS?>%=#U)IVO-/CE>>99Y&+,"9%0(&!!R/E&WC&1UZT
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M]?6%I_AJ*S\3W^O2RI+=7,*6T02(((8%)(3J<DD\GCH.!BMV@ HHHH ****
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M@"3&D?\ 'K\W3]TT7S>ORL?QK)/P^T0Q3P[K[[-*CQK;_:W,4*LP9@B$X7)
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MKADCF56W .H.#@\^M9]U\.- NXIHI!>"*3<8XA<L4M]SAW\M3D+DCGCN0,4
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M-"]],897 4!FCW[6.%7J#G%:6IZ'IVL-&;^W\[RXY8E!8@;9%VN.#SE>* .
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M/^[4,.@.[ %0_P#"2:W<ZU/H4=^87EUQK&.]$*%H8DM5F; (VEV.0"0<9/'
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MN-K/&&VL1@=1SCG-7)_#&D7&EW.FRVFZUN;AKJ1?,8'S6?>7#9RIW<C!&.U
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MW$@1DX4'.0/>NWL/"6@:6RM9:7! 5=I 5S]YDV,>O4J,4K^%-!EM!:R:7;O
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MCT.^TO2+>'2EOH?L\\L$(9C%@@J-W3@GZ$YK7DT+3)=$AT>2U5M/A6)8X<D
M",@ITYX*K^5 'FVJ_$[6Y]&U.?3M*-NGD79M;EXY?W1A)&YBT?EMD*W"DX.
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M7W /.#D58@\,:);:TVL0:9;Q:@Q8M.BX8EOO'TY[^M &M1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 F0*6L_5;;4[BU"Z9?1VD^\'?)#Y@V]QC(ZUBG3?& QGQ/8#/3_
M (EXY_\ 'Z ,.Y^(&J0^+;BR6RMTTRVU%+"1IAM8Y16+^87 S\V0@0D@=:R;
M/XI:Y*RQRV=CNNH();67R7CB3S9TB#-ERS(-X.2$)QTYKI)?!^N3ZFFIRZEH
MLE^@PMT^CH95'LV[-5K?P%?VRSQVUSX=B693',L>AQ@.I()5@#R#@'!]!0!D
M7OC#Q+8>(-6E2]T>[CTW38Y+F*'S&B9A<2KA1N_=R%<9R6QM'7MK>._%-]X8
M\0P7-L'FBCTFYE^R[CL>3S8$5F'MO/X9I;3PCJ'D36UEJOA[R?+$$L4.D1[=
M@)8(0&Z9+''J35DZ%KNIW!N#XAT>ZECC>W+_ -FJY"-C<A^?H=HR/:@#GG\8
M>*[_ %*UM4>TM9(I;E)"(BOF_P"BF1-T8D8J00>K<\&F6?Q$\0V]MI\#6UM<
M""QL);J:5=OGF< D[S(H0X/7#9;/2MNR\)7\=JD5AJGAU;>"83*L&D1A8Y1T
M88; ;WZTK>!]15[5FO/#P>U_X]R=$CS#EL_)\WR_,<\=S0!>TOQ3JLG@;4O$
M^H6]JRPPSSV]M;*P;$1<89B3G.T'@#&>]8Q\;>)EU*TT@+HLU[>/:E+B))#%
M&DT<[$,N_)93!Q\PR#T%;,6B>)K&V%M%XATN"!<XC73551DDGC=W.:IV?A#5
M+)$%EJF@0(DIG40Z0BA9,$;QAOO88C/H: '>,_&>KZ#JD.GZ?:6\D@L'O999
M8RR':0-H_>)L'<L2< C@US-I\0M=B:>&VB66:ZO[V57G!G6".-8B(UPZ#&9.
MN[  S@YKJM1\)Z[K A74]5T6]$9W1"YTA)-I]1N8XJI)X0O;SS;";5?#UQF8
MW#V\FDQO^\.,N5+=>G- %1?'>NZKIMY=6[Z-IR0QQ1>5<2%I'EEMUD!C=6VD
M;G4*,'=@\BH+;QOXGATA&(TV7R(-.B::9),O+=!1O8AN%4L">.<]16VW@[66
MOH+QM1T,W<*>7#,=&3>B@8PIW9  ["DA\'ZQ;V<]M#J>AQVLXV31)HZ!' XP
MPW8/4\4 9DGCKQ*;R^TV&/2&N;!+R26Y\N0Q2B!(7&U=^03YVT_,<$$\]*6R
M\:ZM>:@UI9"SMYKRYD<37[/)%$J6EO)L #+C)E[$  ,<&M&'PEJ]JB6T&JZ%
M"J1/ L4>D(H5'P64 -T; R.^!23^"-5GM&MKF^T&2W:19#%)HR,I<*%#8+8S
MM &?0 4 :6J>)+Z.T\.I8/IWVC6'V_:G+2VT>(6D)7!4OG;A>1GK[5@1>/\
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M70#P7K0M9;4:AH@MYHEADB&C($>-<E5(W8(&XX'N:+CP7K-Y+:R7.H:'-):
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M]MO7R$FD"%6RQR0&&#QT/%:.D>,=7UWQ-'IUI%81VR27;32NK.7CAN1" N&
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M_&7_ $,UC_X+O_LZ .IHKEO[+\9?]#-8_P#@N_\ LZ/[+\9?]#-8_P#@N_\
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M\:/^$X7_ *%KQ+_X+F_QH ZJBN5_X3A?^A:\2_\ @N;_ !H_X3A?^A:\2_\
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MA?\ H6O$O_@N;_&@#JJ*Y7_A.%_Z%KQ+_P""YO\ &C_A.%_Z%KQ+_P""YO\
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M6$?FW, C;Y%XYSC!^\,X)QFL;P!X2/A'2M44V<:7-Q>S2*$?):$$B%<]@%P
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M#;RNFJVE_:6\D^P7"1P&-U)P=K?-P2*9=^!]:\3:G/JFM:9;6Z7^H69GT\7
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ML%"Q[05)R,Y/'- '267Q,\):C_Q[:FYS#).GF6DT8D1%+,4+H Q !.!DTO\
MPLGPMYD,8O+EY)H(KA5BL)Y,1R#*$[4(&1ZUPUIX(\77OAC1-#O-,M+.+1[>
MXQ/]K$C7$CQ.BJ% PHR_))[5J^$OAWJ-GJ<=SJ=U>V:PZ9I]N@L;XQB22)"'
M#A?O '&,^IH Z1OB5X66WM)S?3E;LR^2L=E-(S>6VU^$0D8/K1?_ !(\,::\
M2W-W<*'@2X8BRF(AC<X5I/E^3..C8-<!#\/?$EG;Z"3ITEPUF+X3)::K]D<>
M;-O0B1>2,=14_B?P5XEU2>&>RT!(KS[#%!;W\6L.EQ:NN01,Q)$XZ'(&>2*
M/2O$'BS1O"]K%=:O<R0P2@E9([:25<#')**=O4=<5%9>-= U S""[E#0VAO9
M%EM)8V6$,REL,H/56XZ\5!XTT34-;^'FHZ/;%)K^>V6,%B%#N",GVZ&L'Q1X
M#N_$'BF]OR]Q' =!%G ;>\:$O.'D.UPI&5PPZ\4 ;4OQ(\+131Q?;KB1Y(([
MA1#87$O[N1=R$[4.,CL>:U==\1Z7X<MX9M2G=#/)Y4,4432R2MC.%102>/:O
M+[?P-XCT_4H;@Z3<W2C2[&V/V36S9[9(H]KAMOWQGIGW]:[CQ9HVKW6KZ!X@
MT>&WN+S26FW64\WEK*LJ!6P^#AA@8R,=: 'M\1_# T^TO([V:87<CQ0P0VLC
MS%T^^#&%W#;WR.X]:GMO'OAF[DTJ.+5$\S5'DCM$:)U+.F-R-D?(P) PV#SQ
M7-'1?&5KK&F^*7T_3;W48TN89M-MY_)5(Y&5EVR$89AM^8D#.:RC\,=6U2=;
MC41!;3W,NH7S-#+N^Q7$K0M#M. 6*F+)(]QWH [*[^)/A6QCMY)[^?9<DK"Z
M6$[AV#LA4%4/.Y&&.O&>A%,E^)_A&"9HIM1FC*>7YC/83JL>\ KO8IA<AAU(
MQGFL/3_!^O)X%\)Z==QPG4-/UJ.^O L@VA!/([$'OPPXJAXD^&VL:MJ'B?4(
M+F7-U>6\]O8&[9;:]C1$#)*HQU*G!]A0!Z%+XHT6'Q/#X<DOD&K3Q>=';[&^
M9.3G=C;G"DXSGBL\_$'PT-:&E?;G\\W/V3S!;R>3Y_\ SS\S;MW>V?:N,O?
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M2T44 %%%% !1110 4444 %%%% !1110 4444 %%075Y:V,/G7=S#;Q9V[Y9
M@SZ9-4O^$ET+_H-Z;_X%)_C0!J45E_\ "2Z%_P!!O3?_  *3_&C_ (270O\
MH-Z;_P"!2?XT :E%9?\ PDNA?]!O3?\ P*3_ !H_X270O^@WIO\ X%)_C0!J
M45E_\)+H7_0;TW_P*3_&C_A)="_Z#>F_^!2?XT :E%8=]XLT*TLYKG^UK&01
M1ERD=RA9L#H!GK3[7Q5H,]I#-_;%BGF('VO=(&7(S@\]: -FBLO_ (270O\
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MH7_0;TW_ ,"D_P : -2BLO\ X270O^@WIO\ X%)_C1_PDNA?]!O3?_ I/\:
M-2BLO_A)="_Z#>F_^!2?XT?\)+H7_0;TW_P*3_&@#4HK+_X270O^@WIO_@4G
M^-'_  DNA?\ 0;TW_P "D_QH U**R_\ A)="_P"@WIO_ (%)_C1_PDNA?]!O
M3?\ P*3_ !H U**R_P#A)="_Z#>F_P#@4G^-'_"2Z%_T&]-_\"D_QH U**R_
M^$ET+_H-Z;_X%)_C1_PDNA?]!O3?_ I/\: -2BLO_A)="_Z#>F_^!2?XT?\
M"2Z%_P!!O3?_  *3_&@#4HK+_P"$ET+_ *#>F_\ @4G^-'_"2Z%_T&]-_P#
MI/\ &@#4HK+_ .$ET+_H-Z;_ .!2?XT?\)+H7_0;TW_P*3_&@#4HK+_X270O
M^@WIO_@4G^-'_"2Z%_T&]-_\"D_QH U**R_^$ET+_H-Z;_X%)_C1_P )+H7_
M $&]-_\  I/\: -2BLO_ (270O\ H-Z;_P"!2?XT?\)+H7_0;TW_ ,"D_P :
M -2BLO\ X270O^@WIO\ X%)_C1_PDNA?]!O3?_ I/\: -2BLO_A)="_Z#>F_
M^!2?XT?\)+H7_0;TW_P*3_&@#4HK+_X270O^@WIO_@4G^-'_  DNA?\ 0;TW
M_P "D_QH U**R_\ A)="_P"@WIO_ (%)_C1_PDNA?]!O3?\ P*3_ !H U**R
M_P#A)="_Z#>F_P#@4G^-'_"2Z%_T&]-_\"D_QH U**R_^$ET+_H-Z;_X%)_C
M1_PDNA?]!O3?_ I/\: -2BLO_A)="_Z#>F_^!2?XT?\ "2Z%_P!!O3?_  *3
M_&@#4HK+_P"$ET+_ *#>F_\ @4G^-'_"2Z%_T&]-_P# I/\ &@#4HK+_ .$E
MT+_H-Z;_ .!2?XT?\)+H7_0;TW_P*3_&@#4HK+_X270O^@WIO_@4G^-'_"2Z
M%_T&]-_\"D_QH U**R_^$ET+_H-Z;_X%)_C1_P )+H7_ $&]-_\  I/\: -2
MBLO_ (270O\ H-Z;_P"!2?XT?\)+H7_0;TW_ ,"D_P : -2BLO\ X270O^@W
MIO\ X%)_C1_PDNA?]!O3?_ I/\: -2BLO_A)="_Z#>F_^!2?XT?\)+H7_0;T
MW_P*3_&@#4HK+_X270O^@WIO_@4G^-'_  DNA?\ 0;TW_P "D_QH U**R_\
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M@+EFV%B@(& ,DC!XH ]1_P"$7T#_ * >F?\ @(G^%'_"+Z!_T ],_P# 1/\
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M B?X4?\ "+Z!_P! /3/_  $3_"N1?Q9XCL=(US4[Z729(M+O19[(;252YWQ
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ME947RP3SR68YS\J'U% ';?\ "+Z!_P! /3/_  $3_"C_ (1?0/\ H!Z9_P"
MB?X5Q6H?$N\TZX\407%E!']@:9-,F.=D[QQJ[1OS][#!AC&1GTK4U7Q+JC:I
MK$-GJ&DZ79:2L2RW&H1-()9I%#JO#H%7#*,\G)Z<4 =#_P (OH'_ $ ],_\
M 1/\*/\ A%] _P"@'IG_ (")_A7&#Q[?W&HM NH:/9QK:6TX;[)-=K(TB$MM
M>-U&T$<''-=-KNK:C!J>D:-IC6T=[J'FN;BXB9XXXXU!8A RDDEE &X=SVH
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MXG9MH;+\J4\ML $@,2<=* .V_P"$7T#_ * >F?\ @(G^%'_"+Z!_T ],_P#
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M <XVA77MUSS21^,)+;6?$,6LVJ:=IVE6T5PLKR!GD1FE4L<' !\L;5Z\\\G
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MJWGQ*3[#ISZ?Y,US-8W%S.CPR*$:.W:0 $XR-PQU/'YT ==_PB^@?] /3/\
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M!_T ],_\!$_PH_X1?0/^@'IG_@(G^%:M% &5_P (OH'_ $ ],_\  1/\*/\
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M?]_HO_C==#10!SW_  B]Q_T-&O?]_HO_ (W2'PK.PP?$^O?]_8O_ (W7144
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MF(;>YS@_RK'_ +2\9_\ 0N:;_P"#,_\ QN@#J**Y?^TO&?\ T+FF_P#@S/\
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M_P#:7C/_ *%S3?\ P9G_ .-T?VEXS_Z%S3?_  9G_P"-T =117+_ -I>,_\
MH7--_P#!F?\ XW1_:7C/_H7--_\ !F?_ (W0!U%%<O\ VEXS_P"A<TW_ ,&9
M_P#C=']I>,_^A<TW_P &9_\ C= '445R_P#:7C/_ *%S3?\ P9G_ .-T?VEX
MS_Z%S3?_  9G_P"-T =117+_ -I>,_\ H7--_P#!F?\ XW1_:7C/_H7--_\
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M-_\ !F?_ (W0!U%%<O\ VEXS_P"A<TW_ ,&9_P#C=']I>,_^A<TW_P &9_\
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M_P"A<TW_ ,&9_P#C=']I>,_^A<TW_P &9_\ C= '445R_P#:7C/_ *%S3?\
MP9G_ .-T?VEXS_Z%S3?_  9G_P"-T =117+_ -I>,_\ H7--_P#!F?\ XW1_
M:7C/_H7--_\ !F?_ (W0!U%%<O\ VEXS_P"A<TW_ ,&9_P#C=']I>,_^A<TW
M_P &9_\ C= '445R_P#:7C/_ *%S3?\ P9G_ .-T?VEXS_Z%S3?_  9G_P"-
MT =117+_ -I>,_\ H7--_P#!F?\ XW1_:7C/_H7--_\ !F?_ (W0!U%%<O\
MVEXS_P"A<TW_ ,&9_P#C=']I>,_^A<TW_P &9_\ C= '445R_P#:7C/_ *%S
M3?\ P9G_ .-T?VEXS_Z%S3?_  9G_P"-T =117+_ -I>,_\ H7--_P#!F?\
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M_P#:7C/_ *%S3?\ P9G_ .-T?VEXS_Z%S3?_  9G_P"-T =117+_ -I>,_\
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M4Y/!8$8!J_:>#M*GUJ;Q'HFOV,FCQW]O=LB2AX[?RA,TBJP. "9MV.,9/;%
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MXN]/NS)#;<S%XGC*#;N!(< XQSGI6?IWCS0KV:RLY+R./4+I8R+= [A3(@=
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M&EO?(?[,=)2(2[?EW^<QVY]<$&NBHH YW6+.>;QEX;N8X'>&#[5YL@7(3=&
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M8O9K:_N(_&]BT>GW?V*ZQH[9BFWA I'F9^\0,]/?BH[77-3N]1DL$\42)/$
MTOG>&9XUB4@D,[,0%!VG!) .* /1,CU%&1ZBO/=+UG5-6O(+:W\5*CW*&2V:
MX\/R1)<*.28V9P&XYX[<]*34];U'2;RYM;OQ8/,M462X:'PY-*D*D$@NZ,54
M8!/)[4 >AY'J*,CU%<-]LU7[!J5\/&=D;;3 QNI!HY(0"-9#C]Y\WR,IXSUK
M/N/$MY:RW"R^+L1VT@CGG'AN9H8FP#\T@;:.&'4\9H ])R/449'J*\\EUO4X
M-5?3W\5IN2X2U><:"Y@29\;4,@?:"=RCKU8"K8N]7;3(M1'C&T^RRW(M4?\
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MYRWB"^\V..#Q;]K,EO'<@V7AN:X'EOG8Q,;$#.UN#SP:Z$:3XJ8 CQ1:8/\
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M>*_^AHL__!5_]MH_LCQ7_P!#19_^"K_[;0!TF1ZBC(]17-_V1XK_ .AHL_\
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MM/+U"]CO)]Q/FI!Y0QV&W)_G5R@ HHHH **** "BBB@ HHHH **** "BBB@
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MP=I/&1@X8XIMMH.KVVJSW1T#5X89K6UCC@TW58XEB,<>UD.9%W8/ /I7I]%
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M^=46\.V\'AM]#TV1[2U=?+&6:39&3\RKN.1E<@<X7(..,5L*JHH50%4#  Z
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MEOX2TNWOX+_=?RW=N28I9[^>0J#U7YG/RGN.AP,YQ3IO"VFSZA]N=]1^T?,
MRZG<J%#$%@ ), $J.!QP/2@#:KA_%0NK3Q99:M9+<R26-KYTMO!N8SP^8%==
M@^\0KLP'7*BNXJC)I%I+K,6K-YXNXHC$I6X<(5/."@.T\^H[#T% '%:+<:CI
M$.JO(0VKZAJ4$1-PS/' \L2.5QG[J;F  QG &1G-;5YKFH^'9+I=4DM[Z--.
MGOXV@B,+#R=NY""S9!WK@CI@Y'2M+_A&=+*7Z/%-*M_(LLXEN9'RZXVLN6^0
MC P5QC:/04^Q\/Z?8/,Z)-/+,GER27<[W#%/[F7)(7GH.* .>U6TUD:GX<N=
M1N=,N5&H*"([4HT1,;_ZMRYR.,'@9'/;%:SK-'X[MC*+61);"X\EEA998@KP
M94OO(8$MG[H^Z*;_ ,(5HOFV\C+?.;9Q);!]0G(@(&/D&_"\<<=N.G%3W'A;
M3KG4/MTDNHBXPX#)J5PH4,06"@.  2J\#C@4 9OC&QO-1O\ 0;1)['[)->D/
M!=69G5V6"9P6&]00-HXQU .>,5>OM+>S\)7-G:)IL)\E_.5;(B"0%3N'EJX(
MS_O'\:M:GX?L=6NH+FZ:\$MOS$8;V:$*<,,@(P&<,PSUP<5)=Z-:WUA'9327
MGDQKM^2\E1F&,?,RL&;\2: *-QJKZ=X.MKZ""+S7BMXXHSD1J\A1%SW"@L,^
MPJ6VCUZTOHWOK^PN;#RW,Q6V,+QL,8(.]@5^]G/3 YJ:VT#3[;39=."336DJ
M;&BN;B2<;<8P-[' QZ5':>&=-M+H7.+JXE565#=W<MP(PPP0HD8@9'&1SB@#
M L?$VIRZKI>Z3S[*_N#&K?V7+;IL*.ZLKLYS]T=1R"3Q5UH=??QEJ0MM5LHH
M/L=LR1RV3R!07F])5YXY..>...;$?@K1HY;:3%\QM'#VP?4)V$! QA 7P!@D
M8[CCI5[4M!LM4G6>9KN*4)Y9>UNY8"R\G:Q1AD9)QGIDXZF@"GXN6?\ L977
M[)) D\+30W$+/YF)4V[2'7:0><\]!Q5C7-0NK:73[&Q,275_.8EEF4LD85&=
MCM!&XX7 &1USVI=0\.Z?J=O%;W+7GDQ(J*D=[-&" 01NVL-QX')R:?+H-A/I
MR6,PN)8D?S$>2ZD:5'[,LA;>",GD'OB@#%U#6=:TNSUR"2>QFO+&P^WV\_D,
M%91ORCIOSG*'!#=^G'-VRN]9MM:L[/4[BSG6\MY9<00-'Y+(4X!+'<,.>2 >
M/?%3#PKI7]FWEBZ7,D=ZH2YD>[E:651QM,A;?C&1C..3ZFI_[!L3>V5X3=&>
MRC,4+&[E(VGKN&[#DX&2V2<#TH YIO$&OQ:O$EUY=M!)?"% UB[P/"TFU<3H
MY =E((W #<=N*[BL*W\(:/:R0F)+L10N)([=KV9H5<'<&\LMMX/(XX//6MV@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH H:G=WMK;A['3_MLN\#RO.6/CN<MQ^%97]M>)?^A3/_ (,(_P#"NCP,Y[TM
M '-_VUXE_P"A3/\ X,(_\*/[:\2_]"F?_!A'_A7244 <W_;7B7_H4S_X,(_\
M*/[:\2_]"F?_  81_P"%=)10!S?]M>)?^A3/_@PC_P */[:\2_\ 0IG_ ,&$
M?^%=)10!PWB76?$+^&M227PN8D:VD!?[?&0HV]<59TC6/$::+8JGA8N@MXP&
M^WQC<-HYQCBMCQ5_R*FJGO\ 9)/_ $$U9T3_ ) &G?\ 7K'_ .@B@#G;CQGJ
M-I<_9KG1;2&?C]U)K$"MSTX/-7?[:\2_]"F?_!A'_A7.ZH]A;>)O%:ZEH]W?
M?:[>!;9(].DG$V(F!4,%*CD@<D5U/A1Y(=!L=)NWD;4M/LK>.\W*V/,,8SAR
M,-T/()]Z ,D^-[X7\E@=(LA>1@L]N=9@\Q0!DDKU''--B\=7<Y81:582%5+L
M$UJ X4=2?:N;@M2?#.G^&GTN[;Q)%J4<TTS63A01<!Y)S-C859 W.XD[MN.U
M7-4T1QX7^(B6^F,)IKF06P2W^9U-M /DP,D9#=.X- '1S^)M;M<_:/#D4.$,
MA\S5(E^48RW/89&3[BJL?CB\EBEECTFQ>.( R.NLP$("<#)[<\5SGCG1]?>2
M[-Q.^I[M OHXS;V)3:Q>#"\%LDX.!_LFI-3634O"^H6EE/\ :[EYK,JJZ#+;
M!0+F,DD-C> .2,] : .FL_%>KZBKM8Z!;W00X8P:M"^WZXZ4R^\8:GIB2-?Z
M':VJQH)',^K0IM4G 8YZ#/&?6JOAC2]0TWQWJS:M'&TTMI&+6XLK3R;>2%6)
M(89.) S="QX(QWQ@7PM[W3=1OM4AU R7&NS*U]9VYG:Q^RNRP9C"MN3Y.F,9
MD)[YH ZRP\5ZOJMHMWIWA^"[MF)"RP:K"ZDCW'%6?[:\2_\ 0IG_ ,&$?^%>
M;-JDP?3K:ZAUBR%S'>WUVNCP30RWC%EB@D:-,M'O"YP< ''3-&G1^/'\26D5
M[=ZB+ZS6V_=^7,T,B+ K2;G#"$[WWJ2V6STH ]&F\0Z_;1&2?PPD48(&Y]2B
M49)P!D^I('XU%:^*M8OGG2T\/P7#V[^7,L6JPN8W_NMCH?8UY[;W6J7D6CB.
MY\6W%U.T4NKBXAD6!657FD2,,H*L&0*-HVX9<$G%/T32M>T>?1O#5C>7\4^N
M:=%=:@[S,7LB)"\[C/*LV\(/?GJ* /16U_Q"DB1MX74.^=BG4HLMCK@8YIW]
MM>)?^A3/_@PC_P *Y3Q[:7$GB74+^.[U"T?2_#4]Q9S1R.D0F+.#R/EW85<@
MG)RO7%85]K6J:C?P3:E/XAA74+":^CL-+:7=&'*I:H?+^Z3MD<DX&YL$X&*
M/2/[:\2_]"F?_!A'_A1_;7B7_H4S_P"#"/\ PK@=!A\:3^-[2'5;[44GM9(5
MF41SF!H5A7>2V1"V]BW."V[TQQI^-)M9G\475I;MKD=P(;8:.+'S%@:0N?->
M5E^4X  (<XV]!S0!T<?BK6);^6QC\/0/>0J'DMUU6$R(IZ$KU -6/[:\2_\
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M *%,_P#@PC_PKI** .;_ +:\2_\ 0IG_ ,&$?^%']M>)?^A3/_@PC_PKI**
M.;_MKQ+_ -"F?_!A'_A1_;7B7_H4S_X,(_\ "NDHH YO^VO$O_0IG_P81_X4
M?VUXE_Z%,_\ @PC_ ,*Z2B@#F_[:\2_]"F?_  81_P"%']M>)?\ H4S_ .#"
M/_"NDHH YO\ MKQ+_P!"F?\ P81_X4?VUXE_Z%,_^#"/_"NDHH YO^VO$O\
MT*9_\&$?^%']M>)?^A3/_@PC_P *Z2B@#F_[:\2_]"F?_!A'_A1_;7B7_H4S
M_P"#"/\ PKI** .;_MKQ+_T*9_\ !A'_ (4?VUXE_P"A3/\ X,(_\*Z2B@#F
M_P"VO$O_ $*9_P#!A'_A1_;7B7_H4S_X,(_\*Z2B@#F_[:\2_P#0IG_P81_X
M4?VUXE_Z%,_^#"/_  KI** .;_MKQ+_T*9_\&$?^%']M>)?^A3/_ (,(_P#"
MNDHH YO^VO$O_0IG_P &$?\ A1_;7B7_ *%,_P#@PC_PKI** .;_ +:\2_\
M0IG_ ,&$?^%']M>)?^A3/_@PC_PKI** .;_MKQ+_ -"F?_!A'_A1_;7B7_H4
MS_X,(_\ "NDHH YO^VO$O_0IG_P81_X4?VUXE_Z%,_\ @PC_ ,*Z2B@#F_[:
M\2_]"F?_  81_P"%']M>)?\ H4S_ .#"/_"NDHH YO\ MKQ+_P!"F?\ P81_
MX4?VUXE_Z%,_^#"/_"NDHH YO^VO$O\ T*9_\&$?^%']M>)?^A3/_@PC_P *
MZ2B@#F_[:\2_]"F?_!A'_A1_;7B7_H4S_P"#"/\ PKI** .;_MKQ+_T*9_\
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M^)H Z6BN:_MGQ1_T*:?^#)/_ (FC^V?%'_0II_X,D_\ B: .EHKFO[9\4?\
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M^)H Z6BN:_MGQ1_T*:?^#)/_ (FC^V?%'_0II_X,D_\ B: .EHKFO[9\4?\
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M^)H Z6BN:_MGQ1_T*:?^#)/_ (FC^V?%'_0II_X,D_\ B: .EHKFO[9\4?\
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M$93(2HP<9QDG/..*]7T/PTFF7?B2!;.W@TV_G1K>&-5"%/(C1OD' RRMQWH
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M^AAA_P"_,G_Q-*/BUX%)P/$$/K_J9/\ XF@#M**XK_A;?@7_ *&&'_OS)_\
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M5M9)')!#;6]REPI!659M^,#'&-GZT 5/^%A^&?\ H(-_X#R?_$T?\+#\,_\
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MC/RMU!P0 ?3!WO*3^XG_ 'R* .:_X6'X9_Z"#?\ @/)_\31_PL/PS_T$&_\
M >3_ .)KI?*3^XG_ 'R*/*3^XG_?(H YK_A8?AG_ *"#?^ \G_Q-'_"P_#/_
M $$&_P# >3_XFNE\I/[B?]\BCRD_N)_WR* .:_X6'X9_Z"#?^ \G_P 31_PL
M/PS_ -!!O_ >3_XFNE\I/[B?]\BCRD_N)_WR* .:_P"%A^&?^@@W_@/)_P#$
MT?\ "P_#/_00;_P'D_\ B:Z7RD_N)_WR*/*3^XG_ 'R* .:_X6'X9_Z"#?\
M@/)_\31_PL/PS_T$&_\  >3_ .)KI?*3^XG_ 'R*/*3^XG_?(H YK_A8?AG_
M *"#?^ \G_Q-'_"P_#/_ $$&_P# >3_XFNE\I/[B?]\BCRD_N)_WR* .:_X6
M'X9_Z"#?^ \G_P 31_PL/PS_ -!!O_ >3_XFNE\I/[B?]\BCRD_N)_WR* .:
M_P"%A^&?^@@W_@/)_P#$T?\ "P_#/_00;_P'D_\ B:Z7RD_N)_WR*/*3^XG_
M 'R* .:_X6'X9_Z"#?\ @/)_\31_PL/PS_T$&_\  >3_ .)KI?*3^XG_ 'R*
M/*3^XG_?(H YK_A8?AG_ *"#?^ \G_Q-'_"P_#/_ $$&_P# >3_XFNE\I/[B
M?]\BCRD_N)_WR* .:_X6'X9_Z"#?^ \G_P 31_PL/PS_ -!!O_ >3_XFNE\I
M/[B?]\BCRD_N)_WR* .:_P"%A^&?^@@W_@/)_P#$T?\ "P_#'_00;_P'D_\
MB:Z7RD_N)_WR*0Q)_<7_ +Y% %;2]6LM:LQ=V$WFP%BN[:5Y'7@BKM-10@P
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M%D!9E_O 9Y'O0!RMIX-O=/UBZN[>;1'BGO3=@W.F-)/'G'RK)YHZ8X..*8?
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MJT7DKJ-I>")K4D[((?*\LG?]&!QP>QKNJ* /,+;X/PP66HVIU"U N4:&.9+
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M3WZ-;X2W T*XTZ/6+$"ZNI+F9&TP-"I9$53&N_<C)L.U@W\1SFO4** //_\
MA7>HVUU;7MAXC$=]!<2W'G7%D)=Y:*.%=PWC)5$//<MGV.?<_!RW98VAU*.2
M2)H=@O;3SHRJ)(K;E##)9I7?@C!P,5ZA10!QMUX4NH?"D?AJU:%[*1H8F:.%
M8?)0-OF<@'!+8. HX+#.1DUV5%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .?O;G6I?$K:?87
MEC;P"T6?,]F\K;BY4\B1>.!VJM;ZQJ]U?V%KOM('6ZFM[T>2SAR@# QG>-H9
M3WSC/?'-R]L-8_X2$ZCI[V/EM:K!MN ^00Q;/'7KTJ)O#]Y!;036E[$VIQ73
MW4DDL9$<S.I5E*@Y5<$ 8)(VKG=SD SM2UGQ%:1:R;:;3II;2^MH+>.2V=0R
MRE.&(DZ_O!\V/X3P<\7K#7;O4==TY8)(%T^ZLYYG@> B>*2)XT9"V_&0TA!&
MWC;COFH[CP_JDVF7A-S:-J-Y>P74F580H(C&0B]SQ&.3W)/' J9/#4\7B636
MH;M8C-92126ZKE5N',>95/N(E!'L#U)H R]+\1ZKJ%[9*-4TD7,DV+O1Y(_+
MN+>/G.,ODLN!D[<'DCM7;UR\6BZ]=C3K?6+O3YXK*6.;[5%$PFF=.AP3A"3U
M()R"1@9XZB@#F-2U^^TOQ9#:3"W.DS0*6E$9#V\C-L5F.[#(6P.@P6'.,FG:
M3KUVL<<>J[)Y9M1FLXY;6#RT786 W!G8Y.TG(^GN;%[HUQ>Z^\\RVLNF3V1M
M)X7W;V!))QVQR!^=4K3PO?6'A^&S345N+ZVOGO(KBX0X?+L0'QSG:Q!([\X[
M4 6;_P 6V^G)=M+INHNUK<1V[I%&C,QD.U&4;N0Q('KR,@4VR\4Q:O<&P2RU
M.PED:6!9Y8X\)*@^91\S D=<X*G'4]*H7'AWQ'<2W4TE]I9>YN+2X*B"0"/R
M'5PH^8YR5'/'4\5:&@:K!=1SP7%F6BOI[F,2(V"LH;@X/4%ORH KZ!XS-SX<
MTN_U"QOQ#-%$LVH-$BQ&0@*3M#;PN\XW;=O?..:U9_$J1S7*V^F:A>06K%)[
MBW1"B,!E@ S!G([[ W/'7BL?3?"^N6_AZT\.WFI6,NG11I')+' RS2(,90 M
MM'INZX[9YI+KP0!J-[/:V6A7$=Y,TY;4+'S)(G;[W((WKGG!P1DC/3 !L:EX
MJL-,CT^9XKF>WU# MIK:/S%=BA=5 !W98*<<8]Q5D:R%T:[U*YT^^MA:H[R0
M21AI2%7=\H0D-D=,'KQ5#4-'U5FT9=/DTZ.+36#A7A90S")XL!5.%7#Y [8Q
M6M<1ZA+H\T<,\,.HM RI*$+1I*5X;!Z@'G% "Z9J$6JZ7;:A DJ17$:R(LR%
M' (SR#T-6ZJZ9'>PZ7;1ZC<1W%ZL:B>:--BN^.2!V%6J "LS6I;A(+:.WN'M
MVFN4B,L:J6"GKC<".W<5IUE:[O6"TF6*658KN-W$49=@HSDX')ZT ,\1ZC<Z
M5HDTUK"\]P4,<(4KO,I&$PIP&RV*ECU?S-".J^2J0[/-"O*H_=]22>@.,G&?
MQ%:0PP#8]QD=*" 1@CB@#&\,ZM<ZOI@ENK:2"5#LD67:K[^I!0?=X*D9Z@YQ
MTS/H\EP9M2M[BZDN?LUT(TDD50VTQ1O@[0!U<]JTZR=%+2W&JW!AFCCGO T?
MFQLA8"&)<X8 XRI'X4 :U%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !16"MG'-XROVDEN,?8(-L8N9 @+-,K$*&P"0%YQGBN8>!ET
M71@IU:Z)UJ[A,5OJ,B22H&N %W-(N0/+3JW&WCKR >BT5SGAVQCDTUVEDO8C
M?VL,LMA<7DLDMKN4Y&YFW#)R.,<J:;X2T^&W6^G66[DD6\N(!YUW+* BR$
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MH EHJ&.[MI8$FCN(GB<X217!5C['O3_.B\WRO,3S,9V;AG\J 'T444 %%%%
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M)BMX[G8]NR,\;[MA4$?-G8WY4UK^QFTN759+&>!$+B-Y;9A(V<+N" %@#QU
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!SEUHMUJGBB2YO5DBLH;816DEK?R1/DME]R
MIC@X3N<;/>H](L-7TWPG-IWV& RQ,\=K$;QF'DDG:"Y3.5!QT.=HYYKIZ* ,
MK0H;^T\/6MM>6\,=U;P+$$2;>K;5 !W;1C./3BJF@0ZQ9V^H"\L+9'DGEN(1
M'=%PQ=BP4G8,=N>?I7044 <*WA74O[!BN!$YUU;D79C.J2_9Q-OWE@,8VDY&
MW;T-;)M]:TR^NI]/M+2[@O769X9;DQ-!+M56P=C!E.T'H"#GKGCH:* .9NM(
MU'4=7T>;4[+3+R""&5;DDG"NY7&Q&4YP%QDD9ST'2LZTT#6(8["!M+TQ;:'4
M;F>2%+H[?)E$@  \O''FGCC[OOQV]% '&?\ "-7NG?;;/2;"U73QIC6=KONV
M+LY8L2V4..78YR2<>_$NBZ7JNF26<-KHVGZ;;F57OG@N-WG!8BG"^6 "2$.1
MCI7744 <'+X4U>]T&"-EM;/4H+E^5F,B36\DOF.C':".Q''WD'8FM[7X-6GO
M]*DT^RMYX[2X-PYEN3&3^[D3:!M/]\'/M6]10!AZY%K$EQ!]DL;"_P!/,3K<
MVES)L+N2NPJ2K XPW!QU]J3P]I,^D:;>JMM:VKW$[SQ6<#$PP951M!P."5+'
M '+''J=VB@#.T)]8?1X&U^.SCU([O-2S+&(?,=N-W/3&??-:-%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3*'1BI4D?0@$?0TE]?VFF6<EW?7$=O;Q\O+(V%7ZFL7P%/%<>!M):&X^T*(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M57T48%*CJZ*Z,&5AD,#D$5D>)?$">&M*_M"6TN+J(2!'6#!90<\X)&>G0<T
M;%1F"$S"8Q(90,!]HW >F:QQXGMI?$]OHEO#+.TUJ;IKE"OE(G8$YR2<C@#H
M0>]78-=TBZOVL;?5+*:\0D-!'<*T@(ZY4'/'>@"XT,3RK*T2-(GW7*@D?0T^
ML'Q!XKTW0[2[_P!-TYM0@B,BV<]XL3O@9QT)!(Z<<\5MQ2>;"DF,;E#8],T
M/(R,&HDM;>.+RD@B6/.=@0 9^E4M?U:/0]#N]1<Q_N8RRB1]H8^F:BTO6_[5
MTBYO;6)+B2&>XA6*&53O,<CHHR3@%@H//K0!J>3&'5Q&FY1@':,@4T6MN&#"
M"(,#G(09JAH6IW&J6<TEW9K:3PSO"\2S>8 5_P!K _E^=5CXEC;Q>N@PVS2
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M;\#<H*\]>#BQJ.O,KWMK9Z?J=RUNNV:XLEB/D,5W<"1AN8 AL!6ZC@]*I?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !15:
M\U"RTZ-9+Z\M[6-C@-/*J GTR34L,\-S$)8)8Y8ST>-@P/XB@"2BBB@ HI%=
M7SM8'!P<'H:AEO+>"YM[:69$FN"PA0GE]HR<?0<T 3T444 %%%% !15>[OK2
MP2-[NXB@6618D,C!0SMP%'N:L4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)DV[?O'K4WC#1=:O?$-[+;VNH3R2V]NNDW%M<;(K.178R-(-XZY4YP<@8]J
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MR[9%#%=P],@@UYK'H<D7@WPM!>V.M1)8R3LR:=&OF1,=ZIN0@G&&/('&>>*
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M1M'.>#Q4NJ^(]>T/RQJEYX:LS+DH)[IU+ =2,CH,CFJ'@MK_ $^6&SNY]:A
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M_C;_ )X:)_W]D_\ B:-_C;_GAHG_ ']D_P#B:Z:B@#F=_C;_ )X:)_W]D_\
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M#1/^_LG_ ,37344 <SO\;?\ /#1/^_LG_P 31O\ &W_/#1/^_LG_ ,37344
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M"".<G\O2I/#7@J^TK6-?U+5=66_GUJ&%)V6+R]K(K*=H[+A@!WXYH ;\(O\
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M$FNV%S;Z1.+F'[+9F*65P,#<2Q '<@#_ .MZ#0 4444 %%%% !1110 4444
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M9]R*201M0 '@!L#/]WWI;S0M5O)=> GMX([](Q"\<C[QLXPV ,!AD$@Y&>*
M-*PUV*]OA9265[9W#1--&MS&%\Q%*AB"">A9<@X/S#BJ&DZ_J=YJ5_;SZ#>I
M'%>>2LN^#;&OEHWS8ER?O$\ \$=^*I:+X8O=.\26^J"PT2RA6VEMI(+(-N(9
MD8,7*C<<IC! QDG)K5?2]7AU2YGT_4K.*UNIEFECFLVD<$(B$*PD4 $(.H."
M3UZ  S!X@O\ 3=6U^)[*_P!2M;242^8IB401F)'*#)4L1ECCDXQD\BMK4M:-
MC!;2P64ETEP,AQ+'$JC (R78=<\  ]#TJH^A:BW]O@:C:@:I_J_]$;]S\@CY
M_>?/\JC^[S^55;SPK>W#V%PMUIDMS;6OV9OMFGF:/&0=R+Y@*'CGDYP/2@">
M7Q?"FA6VJQ:;>W"3W)M?*A\MG242&/!^?!&\8R"1WZ<UH:9JS7]S<VEQ8S6=
MW;JCO%*RME'W;6!4D$95AZ\?2L:W\*:E::';Z;#JUI^XU WBR-8$9!E,NS:L
M@ ^8GD8&,#'>M>VTR[A\2WVIR7<#V]Q;Q0K L!5TV%R"7WD'_6-_".WH<@&K
M7"W$D<_AY-:U/Q3=:5-?(9K9Q.$BMP>479T; QNW<DYY'&.ZKGKKPHD]M<64
M.J7MMIMQO$MG&(RA5_O*I9"R@Y/ /&>,4 /DUK4;N_N[?1;&UN8[,JDTMQ=&
M(-(R!PJ[4;/RLI).!\PZ\XK2>)[^?^RAINDQRG4%D!^T77EF!T^^' 1L@8(R
M"<G'&.1=N] DDOY[NPU:\TY[G;]H6!8V60@;0V'5L-@ 9'8#(.!21^&H;>XT
MI[6\N8(=.5E2 ;&63=]XN64L2>YR/6@!;;5=1O-+NVAL(/[2MIS;M ;@^46!
M7D/MSC:P/W<]JKZ/K][>Q:C=7L%C!I]JIV7L5PS1R%<[S\RCY5Q][IG..E//
MA</IVK64FK:@4U*4R.Z&-'CS@$(0G0@ <YXIUOX8B2WFM;O4+V^M);5K3[--
MY21K&>" L:)S@8SV'2@#,T?Q/?W.M65G=&.6.[1V!33+FU$94;N'EXD!&>@!
M[UH2V=M!X^LKB&"..:XT^Z,TBJ TFU[<+N/? )Q3H?"EK%J%M?R7^IW%S;,3
M$\]TS!01@KMZ8/?C/'6GW'AF"XU(7[:AJ2SJ'5-ER0$5RI90.PRJ_D* ,W5O
M$]U%KUSIEFP@%K&C22OIMQ=[V<$@ 18"@ #DDYSTXS5@ZWJ-QX7@U4&UTIED
M?[6U_!(P1%+KN5,HQW,%*@X.UNF<"M"_T"VOKP7BW%W:76P1O+:S&,R("2%8
M=#@DX)&1DX/-1W7AC3KW3K2QG:\>*UF$\3F[E\SS!G#%]VX\L3R>.,=!0 _P
M]/J]SIAGUA($FDD+1+%"T1$7&W>I9L,>21GC('4&M:J&FZ1;:5YY@>X=IW#R
M/<3O*Q(  Y8D] *OT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% #6=5&6(';FD\V/_GHGYUG:_;Z5+I$
M[ZS LUE&!)(AC,F2.F% ))]A7G]Y<>![;P_I.K)X5@8:G(R0PRO% R[0Q)9I
M'"C[OKU(% 'J/FQ_\]$_.CS8_P#GHGYUY;?R>%+%+^8^!A-;Z=#%-=RQ/"?+
M#H'X&_YL _PY!QQFNOE\%>$(+9[B71;)(D0NS&/HH&2?RH Z/S8_^>B?G1YL
M?_/1/SKS?3K+PW>"VNKGP,+32[N%YX;U@KA45=X:55YCRO(SGTX-,M+?PQ*=
M/FO/!"6=AJ619W+E&W':74.H.4+*I(Z^AP: /2_-C_YZ)^='FQ_\]$_.O+=)
MNO FMZ+IM_8>%XWEOKDVHM615DCD\IY5#9.,,J<'I\P/K0/^$<2PU:]N/ (A
MATQS#,3)$Q,HV?*,-Z..>E 'J7FQ_P#/1/SH\V/_ )Z)^=>=067A./4+JRU?
MPC#IDMO9-?EI&CD4PJ<,<HQP1D=:@MQX+NO#D&IQ>$E^USW0LH]/=%67SSR%
M)S@?+\^<_=Y]J /3/-C_ .>B?G1YL?\ ST3\Z\OO[?1=,L;FXN_ARR?995CF
MP\>SYBH0HQ(W@EL''0@YJU+I>A_;$T^U\!PSZDMO]HN;<RQJ($+,J9?)!9MK
M$ =@<XH ]&\V/_GHGYT>;'_ST3\Z\RAC\*ZA+:1:5X)6\>>T-TRDQQ&(+(8V
M5MS?># @XSTJ%KWP&+"PN(_"RR2WL#21VZQIO#B585C/S8RTC8!!Q\I/04 >
MI^;'_P ]$_.CS8_^>B?G7F-U'X8TR*]35/!,5M>VT4<R6ZLCB='D$8*N#C(8
M@$'&,CKFK%WINA6,5F+CP"BW-Y=BU@@$L)+'RWD)W!L  (>IH ]&\V/_ )Z)
M^='FQ_\ /1/SKSB;3M"BO[;3QX!1[Z:W>Y,(EA&Q%<+DL6P<EATHGT_0H]1D
ML(/ 23W$%G%=W"B6%1&'+@+DM@G]VW3B@#T?S8_^>B?G1YL?_/1/SKS&V3PM
MJZ0MH/@J/42UG'>3 E(O*60$HAW'ER >!QQUY%+$GA6_FA31_!27ZR6$=\S;
MHXMBNSJ%.]A\P*,#0!Z;YL?_ #T3\Z/-C_YZ)^=<AH?AGP=KVB6>JVN@6RPW
M40D59(P&7/8X.,UH?\('X5_Z 5G_ -^Z -_S8_\ GHGYT>;'_P ]$_.L#_A
M_"O_ $ K/_OW1_P@?A7_ * 5G_W[H W_ #8_^>B?G1YL?_/1/SK _P"$#\*_
M] *S_P"_='_"!^%?^@%9_P#?N@#?\V/_ )Z)^='FQ_\ /1/SK _X0/PK_P!
M*S_[]T?\('X5_P"@%9_]^Z -_P V/_GHGYT>;'_ST3\ZP/\ A _"O_0"L_\
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M^Z -_P V/_GHGYT>;'_ST3\ZP/\ A _"O_0"L_\ OW1_P@?A7_H!6?\ W[H
MW_-C_P">B?G2>?$/^6B^G6L'_A _"O\ T K/_OW6#XV\&^';#P/KMW::/:PW
M$-C*Z2(F"K!#@T =[YL?>1/^^A1YL?\ ST3\ZX&]TOP/I-UH^GW.A0R7>H,D
M4:QP$A=W\3-T SQUR>P/-543P0_B*_TK_A&;=8[#?]HNV>$(NV,.QV;_ #"!
MG&0N,T >D>;'_P ]$_.CS8_^>B?G7GNCZ5X>U2ZM%E\"-:6M[$TUM<NB.I4
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M[3(SC/-% '"'PGJ/]E7%K!H_ART622-Y+<%IXKM5SF.3=&-O7(8 D$5K^#=
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M9DR,J.)>X ';(ZF@#1\&^)$\7>$=/UU+<VXND8F(MG:RL589[C*G'M5?5/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 51U"XOX80;&SCN92>4>7RP!ZYP:O4=* ,#^T?$
MO_0!MO\ P-_^QH_M'Q+_ - &V_\  W_[&M^B@# _M'Q+_P! &V_\#?\ [&C^
MT?$O_0!MO_ W_P"QK?HH P/[1\2_] &V_P# W_[&C^T?$O\ T ;;_P #?_L:
MWZ* ,#^T?$O_ $ ;;_P-_P#L:/[1\2_] &V_\#?_ +&M^N,\7:C<B]N;9+VZ
MLK>TTUKAI;5"[^9(QB1RHY94PSD=^#VH U/[1\2_] &V_P# W_[&C^T?$O\
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MMO\ P-_^QK?HH P/[1\2_P#0!MO_  -_^QH_M'Q+_P! &V_\#?\ [&M^B@#
M_M'Q+_T ;;_P-_\ L:/[1\2_] &V_P# W_[&M^B@# _M'Q+_ - &V_\  W_[
M&C^T?$O_ $ ;;_P-_P#L:WZ* ,#^T?$O_0!MO_ W_P"QH_M'Q+_T ;;_ ,#?
M_L:X37-7NY[."_FU*[B>XFN)Q9K<3V\4L2,8TB26+E9 !NP1ABQSP!BO<>-=
M:TJQN6BG:W\N$I:R:E#)-)=RQ1Q*(B P57:1I-Q '0<'DT >A_VCXE_Z -M_
MX&__ &-']H^)?^@#;?\ @;_]C7%W_CKQ+96\MVPLFA87*Q)':,?+$4\< E=C
M(!@LS'' "C.>*H1>./$=Q;VVJO<P*;:"3=;?9V5)]UV(%D;#=$ +'TZ_Q# !
MZ'_:/B7_ * -M_X&_P#V-']H^)?^@#;?^!O_ -C7&WOCWQ)=6EY?:1;VPM;4
M/./-M7+21&X,,9(++M&$E<D]@.!6K:^*]9;X>2:U.MO]I-RL,=QY+>6L32JA
MF9<\A06;@X(7.<4 ;O\ :/B7_H VW_@:/_B:B6[\2[MQT*U/I_IH_P#B:PO#
M]YKGB/Q'8SW6H 6%C#-*5AAD@%WNE=(9"-_0K&2 01U./F!7-@UDA)M0>_UF
MX\3027,TNEPM(8E6,2;8FCQL5"%4!L;B2,$YH'<[3^T?$O\ T ;7_P #?_L:
M/[1\2_\ 0!MO_ W_ .QKBU\;^(7@E2"\T^>-(IKDZB+%Q&8XH59U1-_S$2.J
MYSCJ,9%0CQ/XLCNM5N4NH'\N*:>6#[&\GV<6\4>45?,&6=Y?R7/<8!'<_P!H
M>)?^@%;?^!H_^)I?[1\3?] &V_\  T?_ !->?Z=\1];O83%/=VEL#<2QI?"P
M>4.5BB98U1'.YF:0XP3D*<9-%GXG\2_\)'<0QWMM=SW%T8XMT4JQ6S&98-I0
M2<C9#,^#SD@Y&30!Z!_:'B7_ * -M_X&_P#V-(+_ ,2C_F VO_@:/_B:XI/'
M?B&26QMOM%C%=37$44$<EF_^G(]PZ&13OP@6-0V.><^U:_BG4+=/$=U!K5]J
MME8Q64;V"V$DL9N)27WX,?+.,1@(3CG.#F@#?_M'Q+_T ;;_ ,#?_L:/[1\2
M_P#0!MO_  -_^QKR[4[OQ=Y;75WJ\RRV-JJS6L8F3S6AMXI)!F.51EIIE0L!
MGCK@%3KW7CS7=-MY4MY;"5K:9K22UDMY6DM427RA-+*T@5MV"V&*D[@<G!-
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MYG!W#E@8^O0Y[55N_B3J4<5I<P:=;"T:2<7$K,[B-4N3""=@)0$*6WD%<\4
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M _.:C_BMO[N@?G-72T4 <U_Q6W]W0/SFH_XK;^[H'YS5TM% '-'_ (3;'W=
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MJZ6B@#FO^*V_NZ!^<U'_ !6W]W0/SFKI:Y_QM).GA*]%MJ"6$\ACCCN'D:,
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M#X4UN^>[T!)KJ>=;M+ZTG6:82C?;RG:ZN -W&Y=V 6&TGD5Z'0!S7_%;?W=
M_.:C_BMO[N@?G-72T4 <U_Q6W]W0/SFH(\:'&Y= (S_TV-=+10!3TS^TOL?_
M !-/LOVG<?\ CVW;-O;[W.:N444 %%%% !1110 4444 %%%% !1110 4444
M0W5K!?6DUI=0I-;S(8Y(W&5=2,$$>F*2YLK:\@6&Y@26)'21589 9&#*?J"
M1]*GHH S&\.Z*VLC6&TJS.I#I=&%?,Z8SNQG..,^E%OX=T:TV_9],M8MMP]R
M-D8&)74JS_4J2#[&M.B@#$3P=X:CL9[%-!TY;6X</+$MNH5V'0D8[=O3M2'P
M;X::.TC;0M/*6A9K=3;J1%EMQV\<#=SCUK<HH SM6T#2-=2)=6TRTO5B):,7
M$0?:3UQGUJ"7PIX?GOUOY-%L6NU4()O(4.%"E<9QTVG'TK8HH S%\.Z,EQ!<
M)IEJLT 012", J$4HO/LK,![&H[3PKH%@2;/1K&W)F6<F*!5^=>5;@=LG'IF
MM>B@"B^C:9)I]QI\EC;O9W#N\T#1@H[,Q9B0>I+$GZU7L_#&AZ<JK9Z5:6ZJ
M'"B.,*!O"A^GJ$7/K@5K44 8Q\)>'FN[6[.BV)N;58U@E\E=T8CQLP>ORX&*
M9_PAGAG9=I_8.G;;L@W ^SK^\(.X9X]>?KS6Y10!SY\#>%&BCB;P[IACC)9$
M-LI52<9(&,<[5SZXJS<^%=!O()X+K2+2>*>?[3(DL08&7:%W<]#M '':M>B@
M"*VMH+.VCMK6&.&")0D<4:A511T  X J6BB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKFV@O+:2VNH(YX)
M%VO%*@96'H0>"*EKE/B*\R^$&$&\N][9Q[4E,9<-<Q@KN'(R"1GWH V;+P]H
MNG:?/866DV5O9W (F@B@54E!&#N &#D<<]JMPV=K;S2S06T4<LH42.B %PHP
MN3WP.!Z5YV;?Q)X>NXTLV@TZ+6-1@M88);B2]$"B*5I'&XC#-M7@''R^]9UI
M\0_$+:C=)-)IT>P7R^3.8T\HP*^QB%D,G5!NRH&&R. ,@'I\.C:7;03P0:=:
M10SH$FC2%0LB@;0& '(QQ@]JK7?A?P_J$L,M[H>FW,D,8BB::U1RB#HHR. ,
MG KSO3/'VLWL=M9W.JV%DTEX\,VHRQ1M'$! LBJ"LAC8L2<'=T&",U/;^)]9
MU:ZAN7OK*?3HM5T^U06\,D8E:2.*1I VX'&7.%(Q@\YH ]+AL+.V$P@M8(A,
M<RA(PN\[0N3CK\H ^@ J.WTC3;2TEM+;3[6&VE4+)#'"JHX"A " ,$;5"_0
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M&F7.I6$%KX@,6IW<8%JPU'R+>U19/GG." [<;0ISG&  -QK./B'6;CXF7/\
M:J:QIFFM87L-O'';MB../RS]H'!W,?F[''R#G- 'KE%>=_#RY0>(==L[74!?
M:?Y-M/:O'>O=*%.]<NS\K*VT%E''2O1* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>modificationno14effectiv002.jpg
<TEXT>
begin 644 modificationno14effectiv002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M +_2_P#Q5'_"G? '_0N0_P#?Z7_XJ@#M/M$'_/:/_OH4?:(/^>T?_?0KB_\
MA3O@#_H7(?\ O]+_ /%4?\*=\ ?]"Y#_ -_I?_BJ .T^T0?\]H_^^A1]H@_Y
M[1_]]"N+_P"%.^ /^A<A_P"_TO\ \51_PIWP!_T+D/\ W^E_^*H [3[1!_SV
MC_[Z%'VB#_GM'_WT*XO_ (4[X _Z%R'_ +_2_P#Q5'_"G? '_0N0_P#?Z7_X
MJ@#M/M$'_/:/_OH4?:(/^>T?_?0KB_\ A3O@#_H7(?\ O]+_ /%4?\*=\ ?]
M"Y#_ -_I?_BJ .T^T0?\]H_^^A1]H@_Y[1_]]"N+_P"%.^ /^A<A_P"_TO\
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M^A1]H@_Y[1_]]"N+_P"%.^ /^A<A_P"_TO\ \51_PIWP!_T+D/\ W^E_^*H
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MT0?\]H_^^A1]H@_Y[1_]]"N+_P"%.^ /^A<A_P"_TO\ \51_PIWP!_T+D/\
MW^E_^*H [3[1!_SVC_[Z%'VB#_GM'_WT*XO_ (4[X _Z%R'_ +_2_P#Q5'_"
MG? '_0N0_P#?Z7_XJ@#M/M$'_/:/_OH4?:(/^>T?_?0KB_\ A3O@#_H7(?\
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MOI45C<6]SI2Z9+]G;6M1DMPP%P5!5@#NXX7/\..:]@EM+:>(Q2V\4D9;<5=
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MSP1II%\MS,),Y=0!PN!UX[XJCXE\%:CK7C^PUV">V2TM]-N+-U=FW[Y%=00
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MP",<C.#G T[[7Y-/\126%YJNE6=O]A66-KE-K-*69<Y,@!4;0<8SSU[U7N]
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MSJ#77V[SMAV";S!(!MSG;P%ZYQ[U+9:1<SS7]UK!MVFO8$M6AMR3&L2[^,D
MDDR-DX'8=LD I6-QK-E>:.VH:@+I=3#)+#Y2HL$GEM*/+(&2H",N&))X.1SF
M'6=0O](U6RWZV'FO+Z.*#3Q:J(VB9P&!;EMP7<V[< 2/N\XJYI^CZK]JT_\
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MBR3YI@J@%F)4')(SCFF?V!J!;^SO/M1HXO!> @-YW$OG>7C[N-_\7]WC&>:
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M=ZA;W,\:?9ML:QLG=P&QA3@ GG.>O/;4 %%%% !1110 4444 %%%% !1110
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M!X!_Z&.#_OU)_P#$UUO]E:=_SX6O_?E?\*/[*T[_ )\+7_ORO^% ')?\+@\
M_P#0QP?]^I/_ (FC_A<'@'_H8X/^_4G_ ,376_V5IW_/A:_]^5_PH_LK3O\
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M ,376_V5IW_/A:_]^5_PH_LK3O\ GPM?^_*_X4 <E_PN#P#_ -#'!_WZD_\
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MIW_/A:_]^5_PH_LK3O\ GPM?^_*_X4 <E_PN#P#_ -#'!_WZD_\ B:/^%P>
M?^AC@_[]2?\ Q-=;_96G?\^%K_WY7_"C^RM._P"?"U_[\K_A0!R7_"X/ /\
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M()&%XY]:[3_A<'@'_H8X/^_4G_Q-=;_96G?\^%K_ -^5_P */[*T[_GPM?\
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M"<<>M,2[MI'")<1,QZ!7!)H FHJ,W$ B\TS1^7G&_<,?G2-=6Z'#3Q*<9P7
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC&/Y#\A0!=MH%MK6*!22L2! 3U( Q6!XU@CFTJS+V4=VZZA;;(G"\YE4$9/
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MI\V.)3DD]_WF\>X1?05#X=TR&V.G76IZ9IUA.LJ+I[V2Y,NZW.X.VT'^^<$
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M$=T0<#RC( P/^R> ?8FMQ$6.-40850 !Z"DEBCGB>*5%DC=2KHXR&!Z@CN*
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MWV8]&TR+3GTY-/MA9/G?;F(&-L]<KT-)INB:7H_F'3K""V,N-[1H 6QT!/7
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M3Z+FIM(UVQUL3BT:59K=PD\$\+12Q$C(W(P! (Y!Z&@#CO[:^*?_ $*6C?\
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MX9LH-8D:2^16\PLP9@"Q*AB."P4@$CJ036S110 4444 %%%% !1110 4444
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M:2W+32E"066)2P7([%MF?4 CO6W6;JNG37=SIMU;.B3V=R)/GSAHV!21>/\
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ME:Z8O-<%/NF61B[X]MS''M7'?!G_ )$FX_["=U_Z'0!Z'1110 4444 %%%%
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M5C+?K(DI5HBZF554CD!<A1["F^';:2^N([N-]:LS97 66*^NI)!<JT&?NEB
M-TBG//W/>M&QT&;_ (1!O#]W.T4:QO:)+;D%_LX)5/O C=Y> >#SFM33K.2P
MM!!)?7%X0>)+@(& QT^15&/PS0!1TN6:/7M9L99WFC5HKF'><^6LBD%![!HV
M(]-V.U;-9>FV-Q%JFJ7]T4WW,BI$JG.V%%PH/N6+M_P(#M6I0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% &9<^)-"L[A[>ZUK3H)T.'CEND5E/
MN"<BHO\ A+?#?_0PZ3_X&Q_XU5O_  %X4U2^EO;[P_87%U,=TDLD0+,?4FJW
M_"L_!/\ T+&F?]^!0!I_\);X;_Z&'2?_  -C_P :/^$M\-_]##I/_@;'_C69
M_P *S\$_]"QIG_?@4?\ "L_!/_0L:9_WX% &G_PEOAO_ *&'2?\ P-C_ ,:/
M^$M\-_\ 0PZ3_P"!L?\ C69_PK/P3_T+&F?]^!1_PK/P3_T+&F?]^!0!I_\
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M?^#"+_XJH?\ A7O@W_H5M'_\ X_\*/\ A7O@W_H5M'_\ X_\* )O^$X\)?\
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M1_XT?\+"\&_]#3H__@9'_C4W_"#^$O\ H5M$_P#!?%_\31_P@_A+_H5M$_\
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M9W,%F()VN4"2E8@&"MG!P>M>B_\ "#^$O^A6T3_P7Q?_ !-<3+X4\.#XVP6
MT#2OL9\/O,;?[''Y9?SP-VW&-V.,]<4 =A_PL+P;_P!#3H__ (&1_P"-'_"P
MO!O_ $-.C_\ @9'_ (U-_P (/X2_Z%;1/_!?%_\ $T?\(/X2_P"A6T3_ ,%\
M7_Q- $/_  L+P;_T-.C_ /@9'_C7"_"CQCX:TOPC/;W^OZ;:S'4+AQ'-<HK%
M2^0<$]#7H'_"#^$O^A6T3_P7Q?\ Q-<3\(_"GAS4?A?HUW?:!I5U<R";?-/9
MQN[8F<#+$9/  _"@#L/^%A>#?^AIT?\ \#(_\:/^%A>#?^AIT?\ \#(_\:F_
MX0?PE_T*VB?^"^+_ .)H_P"$'\)?]"MHG_@OB_\ B: (?^%A>#?^AIT?_P #
M(_\ &C_A87@W_H:='_\  R/_ !J;_A!_"7_0K:)_X+XO_B:/^$'\)?\ 0K:)
M_P""^+_XF@"K)\2/!49 ;Q1I1S_=N5;^1IG_  LSP3_T,^F?]_Q6@G@WPO$"
M(_#>CH#U"V,0_P#9:?\ \(EX;_Z%[2?_  "C_P * ,S_ (69X)_Z&?3/^_XH
M_P"%F>"?^AGTS_O^*T_^$2\-_P#0O:3_ . 4?^%'_")>&_\ H7M)_P# */\
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MO#?_ $+VD_\ @%'_ (4 9G_"S/!/_0SZ9_W_ !1_PLSP3_T,^F?]_P 5I_\
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M+:P)9>'K6ROI#;QWEY'.A$D:R;G)4#DE6<9Z\]:Z?PQ_R*>C?]>,'_HL5JT
M<1K&BZUJFKW&J_8HDGL&0:;")U,=T V<S\<XZJ/X#R.323W>IKX^$]K:V,ES
M_9,23V<MUL=6:21OD8*<XV\C R"#VP>XJN;&S-W]K-K ;D?\MO+&_IC[W7IQ
M0!CVEKJNFV5Y.+.WN+V_NC/+!%-L2(%%4 ,1\W"+DX&22>*- 75]/\,6UG<:
M9&+FSMHH41;D$2E5"DYQ\O2N@HH Y[PG::CIWA^UTN[L(;-K6W2,212B0.^/
MF;  [\^^:Y^W\/>(%N-)EEM6EFLKA);F>?6II!.=I#,D1&Q>6SR!CH!Z>@T4
M 8=_%JEKK1O]/L8+Q9;98'1[CRBA5F8'[IR#N/N,=ZA\0QZS?:0EK;:;!)+(
M(WE/VK"QLKJQ4$KEAQUP/I7144 <_J%KJE]'IFH1VL,5[8W+2_9))\I(I1HR
M-X'!P^0<=L=\BC>Z7K6IVFMW4MG;075YI_V&WMA<;L [\L[[<=7X !X'7GCK
MJ* ,![;4Y-9T2Y^Q0K#;P2)<?O\ F-F"C &WY@-OMUK?HHH YV5=8M?$]_=V
MNE)<03VT$*.UTL8RAD))&"0/W@'0]#67/H&L6Z6BXFOHOW\LT%IJ#V06>64R
M%MRD%D&XJ 3QC."3QVU% ')Z5H6I)X'U+1;J.&*YG^V+&WVEYE(E=V4EV&XX
MWX)/)QFKEU;ZIXBT;4]*U"PCTZ*ZM9(!*EUYK;F!7( 4<#.>N?:N@HH XS3]
M"OVU"S-[ILO^C2B0S2ZY/-'N /S)&V<GGHV,9[]]QUU/_A+(F6QL3I?V0AKL
MG_2%EW?< _N8Y^M:]% !7/:[IU[JNLZ9 (YDTZ!FGDN(+@1NLNTJHQU(PS9]
MR/2NAHH XR/0=3BM-;T^&)C!)<)=VDMS<[S)(K*S*2!E5)0'/.-QJ633=:UK
M4;TZA906-G>:8]EF*Z\R6,DGYB-H'?C![5UU% '"?;]1N/%'AJPNH]*4VES*
M9/LMT97;%M*N[9M'EKD@')/+*/<]W4,-I;6[R/!;Q1/(<NR(%+'U..M34 9.
MK2ZDK>5!H]OJ-HZ896N C!L]"K+@KC'.<^U9;Z5JEGX$;1[>UAN+J:&:(HDV
MV. /N(52PR53<%' X X'2NJHH S+:\N+;1)+F_LC ]M&6:*-Q*655SD8'4X/
M%4_!EUKE_P"%K.]\0QQ1:C<@RM#'&4$2D_*I!.<XQGW..U;]% !7(WEOKTVN
MS7D^E0WL%L^=.A^UB.-3C_6."I)?.<'^$=!G)/744 8VJVM]'J=IJNG6T5S-
M%#);R0/+Y>Y'*MD-@C(*#@]F-9MQIWB"TT!+73_*-U=7<LUX\<NTQ)([.5B+
M#!(R%#$>IQGBNKHH Q--AOK71)K:VTJUL7A!%K%)<&17.,DNP&1DDY/)/7FH
MK6#5=1UJTO\ 4;&"Q2SCD542X\YI&?:#SM&% 7ZDXX&.>@HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X+3O\
MDN.M_P#8&M__ $8U=[7!:=_R7'6_^P-;_P#HQJ .]HHHH **** "BBB@ K@I
M?^2^6W_8M/\ ^E(KO:X*7_DOEM_V+3_^E(H [VBBB@ K@O@O_P DDT+Z3?\
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MO_)?+;_L6G_]*17>UP4O_)?+;_L6G_\ 2D4 =[1110 5P7P7_P"22:%])O\
MT?)7>UP7P7_Y))H7TF_]'R4 =[1110 4444 %%%% !1110 4444 %%%% !7
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M6IH&F7^F>*I+9X7;2[>RV65P?^>;."(CGG*8('^SM[YH ZU)8Y&=4D5F0X8
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M 4444 %%%% !1110 4444 %<!\;/^20Z[_VP_P#1\==_7 ?&S_DD.N_]L/\
MT?'0!W<'_'O%_N#^525'!_Q[Q?[@_E4E !1110 4444 %%%% !1110 4444
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M:*Y\Y=@.&W':N",CL1SUH VJ*YV#7=8N([*\CT)&TZ[>/:ZW9,Z1N1AVCV8
M () <X'XUFWGQ"M8)KUH3ICV]G+)%(LVII%<.T9(?9$0<\@@;F7./0@D [2B
MLC4]:GMM,LKW3=,GU-;F6-=D+!2D;\^8<]AQQ[UKT %%9?B2\FT_PY?W-LVR
M=8B(WQG8QX#8]B<_A5"RM&T;Q/:V,-Y>SVUU8S2R+=W+S$21/$ P+$E<B4Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M* .^@_X]XO\ <'\JDJ.#_CWB_P!P?RJ2@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "N7^) #?#7Q&" 1_9\IY_P!TUU%<O\1_^2;>(_\
ML'S?^@F@"QX%=I/A]X;=V+,VEVQ+$Y)/E+705SW@+_DG?AK_ +!=M_Z*6NAH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"059_]<$_]!%6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *Y[QZ"WP\\2!023I=SP/^N35T-8?C/\ Y$7Q!_V#;G_T4U $7@+_ ))W
MX:_[!=M_Z*6NAKGO 7_)._#7_8+MO_12UT- !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<%;?\EYOO^Q>C_\ 1YKO:X*V_P"2\WW_ &+T?_H\T =[1110
M 4444 %%%% !7!7W_)=-)_[ 4_\ Z-6N]K@K[_DNFD_]@*?_ -&K0!WM%%%
M!7$?";_DGUM_U]W?_I1)7;UQ'PF_Y)];?]?=W_Z424 =O1110 4444 %%%%
M!1110 4444 %%%% !7#_ !@4M\*-?"C)\I#^4B&NXKC/BS_R2SQ!_P!>P_\
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MKM** "BBB@ HHHH **** "N"MO\ DO-]_P!B]'_Z/-=[7!6W_)>;[_L7H_\
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MP&[N$QM!SD],9K2HH S=%T2ST&R^R64:K$&.WY1NV]@3U; X!.3@#.:;H_\
MQ\:M_P!?S?\ HM*U",@CUJK8Z?;Z=$\=N),.YD8R2M(S,>Y9B3V% %JBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "N=\??\D[\2_\ 8+N?_135T5<[X^_Y)WXE_P"P7<_^BFH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K@K;_D
MO-]_V+T?_H\UWM<%;?\ )>;[_L7H_P#T>: .]HHHH **** "BBB@ K@K[_DN
MFD_]@*?_ -&K7>UP5]_R732?^P%/_P"C5H [VBBB@ KB/A-_R3ZV_P"ON[_]
M*)*[>N(^$W_)/K;_ *^[O_THDH [>BBB@ HHHH **** "BBB@ HHHH ****
M"N&^,7_))]?_ .N4?_HU*[FN&^,7_))]?_ZY1_\ HU* .OTS_D%6?_7!/_01
M5JJNF?\ (*L_^N"?^@BK5 !1110 4444 %%%% !1110 4444 %%%% !1110
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M110 4444 %%%% !7$_%V,2?"KQ I.,0*WY.I_I7;5QGQ9_Y)9X@_Z]A_Z$M
M'4Z9_P @JS_ZX)_Z"*M55TS_ )!5G_UP3_T$5:H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ?MV_9?*7R\9SC;C'7FJR>%O#\<$D*:'IRQ2Q^5(@M4 =,YVGCD9YP>]:U%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5SOC[_ ))WXE_[!=S_ .BFKHJYWQ]_R3OQ+_V"
M[G_T4U "^ O^2=^&O^P7;?\ HI:Z&N>\!?\ )._#7_8+MO\ T4M=#0 4444
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M_7!/_015JJNF?\@JS_ZX)_Z"*M4 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<%;?\EYOO^Q>C_\ 1YKO:X*V_P"2\WW_ &+T?_H\T =[1110
M 4444 %%%% !7!7W_)=-)_[ 4_\ Z-6N]K@K[_DNFD_]@*?_ -&K0!WM%%%
M!7$?";_DGUM_U]W?_I1)7;UQ'PF_Y)];?]?=W_Z424 =O1110 4444 %%%%
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MS7>UP4?R?'V=1SYGAE7/MBY(H [VBBB@ HHHH **** "N"OO^2Z:3_V I_\
MT:M=[7!:G^[^.&A,.3)H]RA]@'4T =[1110 5Q'PF_Y)];?]?=W_ .E$E=O7
M$?"CY?!/D]HM0O$!]1Y[G^M ';T444 %%%% !1110 4444 %%%% !1110 5P
MWQB_Y)/K_P#URC_]&I7<UQ7Q=C$GPJ\0*3C$"M^3J?Z4 =7IG_(*L_\ K@G_
M *"*M51T9S+H>GR$8+6T;$#W45>H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K#\9_P#(B^(/^P;<_P#HIJW*P_&?_(B^(/\ L&W/_HIJ
M *GPX_Y)MX<_[!\/_H(KIZYCX<?\DV\.?]@^'_T$5T] !1110 4444 %%%%
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M!\/_ *"*Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7!#_DOY_[%8?\ I4:[VN"'_)?S_P!BL/\ TJ- '>T444 %%%% !111
M0 5P6K?\EM\.?]@JZ_\ 0EKO:X+5O^2V^'/^P5=?^A+0!WM%%% !7$?"O_D4
M)_\ L)WG_H]Z[>N(^%?_ "*$_P#V$[S_ -'O0!V]%%% !1110 4444 %%%%
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M-O#G_8/A_P#0173T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDV\.?]@^'_T$5T]<Q\./^2;>'/\ L'P_^@BNGH **** "BBB@ HHHH ****
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M6_Y+;X<_[!5U_P"A+0!WM%%% !7$?"O_ )%"?_L)WG_H]Z[>N(^%?_(H3_\
M83O/_1[T =O1110 4444 %%%% !1110 4444 %%%% !7&?%G_DEGB#_KV'_H
M2UV=<9\6?^26>(/^O8?^A+0!T>@_\B]IG_7I%_Z *T*S]!_Y%[3/^O2+_P!
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7!#_DOY_P"Q6'_I4:[VN"'_ "7\_P#8K#_TJ- '>T44
M4 %%%% !1110 5P6K?\ );?#G_8*NO\ T):[VN"U;_DMOAS_ +!5U_Z$M '>
MT444 %<1\*_^10G_ .PG>?\ H]Z[>N(^%?\ R*$__83O/_1[T =O1110 444
M4 %%%% !1110 4444 %%%% !7&?%G_DEGB#_ *]A_P"A+79UQGQ9_P"26>(/
M^O8?^A+0!T>@_P#(O:9_UZ1?^@"M"L_0?^1>TS_KTB_] %:% !1110 4444
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M"*Z>N8^''_)-O#G_ &#X?_0173T %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %8?C/\ Y$7Q!_V#;G_T4U;E8?C/_D1?$'_8-N?_
M $4U %3X<?\ )-O#G_8/A_\ 0173US'PX_Y)MX<_[!\/_H(KIZ "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *X(?\ )?S_ -BL/_2HUWM<$/\ DOY_[%8?
M^E1H [VBBB@ HHHH **** "N"U;_ )+;X<_[!5U_Z$M=[7!:M_R6WPY_V"KK
M_P!"6@#O:*** "N(^%?_ "*$_P#V$[S_ -'O7;UQ'PK_ .10G_["=Y_Z/>@#
MMZ*** "BBB@ HHHH **** "BBB@ HHHH *XSXL_\DL\0?]>P_P#0EKLZXSXL
M_P#)+/$'_7L/_0EH Z/0?^1>TS_KTB_] %:%9^@_\B]IG_7I%_Z *T* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7_R*$_\ V$[S_P!'O0!V]%%% !1110 4444 %%%% !1110 4444 %<9\6?\
MDEGB#_KV'_H2UV=<9\6?^26>(/\ KV'_ *$M '1Z#_R+VF?]>D7_ * *T*S]
M!_Y%[3/^O2+_ - %:% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %8?C/_ )$7Q!_V#;G_ -%-6Y6'XS_Y$7Q!_P!@VY_]%-0!4^''_)-O
M#G_8/A_]!%=/7,?#C_DFWAS_ +!\/_H(KIZ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *P_&?_(B^(/^P;<_^BFK<K#\9_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6'XS_Y$7Q!_
MV#;G_P!%-6Y6'XS_ .1%\0?]@VY_]%-0!4^''_)-O#G_ &#X?_0173US'PX_
MY)MX<_[!\/\ Z"*Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N"'_)?
MS_V*P_\ 2HUWM<$/^2_G_L5A_P"E1H [VBBB@ HHHH **** "N"U;_DMOAS_
M +!5U_Z$M=[7!:M_R6WPY_V"KK_T): .]HHHH *XCX5_\BA/_P!A.\_]'O7;
MUQ'PK_Y%"?\ ["=Y_P"CWH [>BBB@ HHHH **** "BBB@ HHHH **** "N,^
M+/\ R2SQ!_U[#_T):[.N,^+/_)+/$'_7L/\ T): .CT'_D7M,_Z](O\ T 5H
M5GZ#_P B]IG_ %Z1?^@"M"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "L/QG_ ,B+X@_[!MS_ .BFK<K#\9_\B+X@_P"P;<_^BFH J?#C
M_DFWAS_L'P_^@BNGKF/AQ_R3;PY_V#X?_0173T %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_7C/_P"BVH Q_A?_ ,DQ\._]>:5UM<E\+_\ DF/AW_KS2NMH **** "BBB@
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MW:?]BY)_Z4"@#O:*** "BBB@ HHHH *X+7_^2R^#_P#KSOO_ $%:[VN"U_\
MY++X/_Z\[[_T%: .]HHHH *XCX7_ /("U;_L-WW_ *--=O7$?"__ ) 6K?\
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M/AW_ *\TKK: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X*?_ )+W:?\
M8N2?^E KO:X*?_DO=I_V+DG_ *4"@#O:*** "BBB@ HHHH *X+7_ /DLO@__
M *\[[_T%:[VN"U__ )++X/\ ^O.^_P#05H [VBBB@ KB/A?_ ,@+5O\ L-WW
M_HTUV]<1\+_^0%JW_8;OO_1IH [>BBB@ HHHH **** "BBB@ HHHH **** "
MN2^)_P#R3'Q%_P!>3UUM<E\3_P#DF/B+_KR>@#7\+?\ (HZ+_P!>$'_HM:UJ
MR?"W_(HZ+_UX0?\ HM:UJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *RO%'_(I:S_ ->,_P#Z+:M6LKQ1_P BEK/_ %XS_P#HMJ ,?X7_
M /),?#O_ %YI76UR7PO_ .28^'?^O-*ZV@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *X*?_DO=I_V+DG_ *4"N]K@I_\ DO=I_P!BY)_Z
M4"@#O:*** "BBB@ HHHH *X+7_\ DLO@_P#Z\[[_ -!6N]K@M?\ ^2R^#_\
MKSOO_05H [VBBB@ KB/A?_R M6_[#=]_Z--=O7$?"_\ Y 6K?]AN^_\ 1IH
M[>BBB@ HHHH **** "BBB@ HHHH **** "N2^)__ "3'Q%_UY/76UR7Q/_Y)
MCXB_Z\GH U_"W_(HZ+_UX0?^BUK6K)\+?\BCHO\ UX0?^BUK6H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M *+:@#'^%_\ R3'P[_UYI76UR7PO_P"28^'?^O-*ZV@ HHHH **** "BBB@
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M_HMJU:RO%'_(I:S_ ->,_P#Z+:@#'^%__),?#O\ UYI76UR7PO\ ^28^'?\
MKS2NMH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBCHO_7A!_P"BUK6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ K*\4?\BEK/\ UXS_ /HMJU:RO%'_ "*6L_\ 7C/_ .BVH Q_A?\ \DQ\
M._\ 7FE=;7)?"_\ Y)CX=_Z\TKK: "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"25^'_ /KW/_H;5V=<9\)?^25^'_\ KW/_ *&U=G0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7!7__ "7/1_\ L"3_ /HQ:[VN"O\ _DN>C_\ 8$G_
M /1BT =[1110 4444 %%%% !7!>*/^2O> O^N>H_^BDKO:X+Q1_R5[P%_P!<
M]1_]%)0!WM%%% !7!?"[_4^+O^QGOOYK7>UP7PN_U7B[_L9[[^:T =[1110
M4444 %%%% !1110 4444 %%%% !7,?$;_DFWB3_L'3?^@&NGKF/B-_R3;Q)_
MV#IO_0#0!;\%_P#(B>'O^P9;?^BEK<K#\%_\B)X>_P"P9;?^BEK<H **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JAKO_(OZE_UZR_^@&K]
M4-=_Y%_4O^O67_T T <W\)?^25^'_P#KW/\ Z&U=G7&?"7_DE?A__KW/_H;5
MV= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %<%?\ _)<]'_[ D_\ Z,6N
M]K@K_P#Y+GH__8$G_P#1BT =[1110 4444 %%%% !7!>*/\ DKW@+_KGJ/\
MZ*2N]K@O%'_)7O 7_7/4?_124 =[1110 5P7PN_U7B[_ +&>^_FM=[7!?"[_
M %7B[_L9[[^:T =[1110 4444 %%%% !1110 4444 %%%% !7,?$;_DFWB3_
M +!TW_H!KIZYCXC?\DV\2?\ 8.F_] - %OP7_P B)X>_[!EM_P"BEK<K#\%_
M\B)X>_[!EM_Z*6MR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "J>K1B71KZ,G >WD7/U4U<JMJ/\ R"[O_KB__H)H Y7X2_\ )*_#_P#U
M[G_T-J[.N,^$O_)*_#__ %[G_P!#:NSH **** "BBB@ HHHH **** "BBB@
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M* "BBB@ HHHH *YSX@()/AUXE4YP-,N&X]HV/]*Z.N>\>?\ )//$O_8*NO\
MT4U $O@O_D1/#W_8,MO_ $4M;E8?@O\ Y$3P]_V#+;_T4M;E !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %5=38+I-XS$ "!R2>WRFK54-
M=_Y%_4O^O67_ - - '-_"7_DE?A__KW/_H;5V=<9\)?^25^'_P#KW/\ Z&U=
MG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7 7TB'X\:3$&&]="F8CT!E
M&/Y'\J[^O-KO_DXVQ_[%P_\ HYZ /2:*** "BBB@ HHHH *X#Q3(@^,/@%"P
MW>7J/'UB7_ UW]>;>+/^2W> /^N=]_Z)- 'I-%%% !7 ?"F1)K7Q9+&P9'\3
M7S*1W!*XKOZ\V^"__( \0?\ 8?NOY)0!Z31110 4444 %%%% !1110 4444
M%%%% !7.?$"5(OASXE:1MH.F7"Y]S&P'ZD5T=<E\3_\ DF/B+_KR>@#1\%_\
MB)X>_P"P9;?^BEK<K#\%_P#(B>'O^P9;?^BEK<H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JAKO_ "+^I?\ 7K+_ .@&K]4-=_Y%_4O^
MO67_ - - '-_"7_DE?A__KW/_H;5V=<9\)?^25^'_P#KW/\ Z&U=G0 4444
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5#7?^1?U+_KUE_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *H:[_ ,B_J7_7K+_Z :OU0UW_ )%_4O\ KUE_] - '-_"7_DE
M?A__ *]S_P"AM79UQGPE_P"25^'_ /KW/_H;5V= !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O-KO\ Y.-L?^Q</_HYZ])K
MS:[_ .3C;'_L7#_Z.>@#TFBBB@ HHHH **** "O-O%G_ "6[P!_USOO_ $2:
M])KS;Q9_R6[P!_USOO\ T2: /2:*** "O-O@O_R /$'_ &'[K^25Z37FWP7_
M .0!X@_[#]U_)* /2:*** "BBB@ HHHH **** "BBB@ HHHH *Y+XG_\DQ\1
M?]>3UUM<E\3_ /DF/B+_ *\GH T?!?\ R(GA[_L&6W_HI:W*P_!?_(B>'O\
ML&6W_HI:W* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *H
M:[_R+^I?]>LO_H!J_5#7?^1?U+_KUE_] - '-_"7_DE?A_\ Z]S_ .AM79UQ
MGPE_Y)7X?_Z]S_Z&U=G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7FUW
M_P G&V/_ &+A_P#1SUZ37FUW_P G&V/_ &+A_P#1ST >DT444 %%%% !1110
M 5YMXL_Y+=X _P"N=]_Z)->DUYMXL_Y+=X _ZYWW_HDT >DT444 %>;?!?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KS:[_Y.-L?^Q</_HYZ])KS:[_Y.-L?^Q</
M_HYZ /2:*** "BBB@ HHHH *\V\6?\EN\ ?]<[[_ -$FO2:\V\6?\EN\ ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M** "BBB@ KS;Q9_R6[P!_P!<[[_T2:])KS;Q9_R6[P!_USOO_1)H ])HHHH
M*\V^"_\ R /$'_8?NOY)7I->;?!?_D >(/\ L/W7\DH ])HHHH **** "BBB
M@ HHHH **** "BBB@ KDOB?_ ,DQ\1?]>3UUM<E\3_\ DF/B+_KR>@#1\%_\
MB)X>_P"P9;?^BEK<K#\%_P#(B>'O^P9;?^BEK<H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,0^,O"X.#XDT?\ \#HO_BJ/^$R\+?\ 0RZ/_P"!T7_Q5<O?>$_AI8:[
M:Z1=Z!I\=[=Q/-"IB.'"?>&?7&3CV-9MKI?PMO9H$M_"Z2)*(,S+9.8XC,JM
M&';L2'3V&X9- '=?\)EX6_Z&71__  .B_P#BJ/\ A,O"W_0RZ/\ ^!T7_P 5
M7&Z=H/PLU5X$L]!L9'FO9;$+Y!!66-&=@P[#:A(/?(I]_P"&?AQI>I+97OA2
M&)G25TD-L=C+&A=R#GH .OJ0.] '7_\ "9>%O^AET?\ \#HO_BJ/^$R\+?\
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M_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\
MPF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5
M=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q5
M9G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC
M_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\
MPF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5
M=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q5
M9G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC
M_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\
MPF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5
M=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q5
M9G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC
M_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\
MPF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5
M=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q5
M9G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC
M_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\
MPF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5
M=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q5
M9G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC
M_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\
MPF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5
M=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q5
M9G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC
M_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\
MPF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5
M=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q5
M9G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC
M_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\
MPF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5
M=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC_A,O"W_0RZ/_ .!T7_Q5
M9G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\ PF7A;_H9='_\#HO_ (JC
M_A,O"W_0RZ/_ .!T7_Q59G_"KO __0LZ?_W[H_X5=X'_ .A9T_\ []T :?\
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MEC9)=BYF%_#B,O$0N?F[FNG_ .%7>!_^A9T__OW1_P *N\#_ /0LZ?\ ]^Z
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M6=/_ ._=4=3\$?#/18DEU32=%LXW.U&N"$W'T&3S0!T/_"9>%O\ H9='_P#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\%_F//RK72:QI>H^)+#2EN()-/DAOUFF6&Z^=$"N,JZ]^163=?%71VT"ZO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>modificationno14effectiv003.jpg
<TEXT>
begin 644 modificationno14effectiv003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEW JYP& .?EYZ@C&:YU8=>U+PGX:\1:CY^I/X>UMB9XT.^[L@VWSPO5N@/N
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M8L=O48P>M<S+<6_A36OB);:E*(FU.%+FP5NMUNB9"L8_B8/@8'/(JMX=TQ_
M_B;PG?Z[(EG;R>'#ITLTS!4BG63S=C,> 2"0/4J: .UTWQA=ZKX)O]6M[*W_
M +3T]IX+JVDF*QK+%G< P4G& "..X&1UK;\-:I)K?A?2M5G1(Y;RTBN'1,[5
M+*&(&>W-<'X3B.G_  V\6:G>$6UOJEY?WUN9OD/E2#"$YZ9QD?45>T6WO=?^
M#6AV>A7MJLKV-M#.TCL!L"J)(\KDJQ *^HR>] &QH'C Z_XMU;3(;<+8V=O#
M+!<$\S[RX+#_ &?EX]>O0BNJKS/PLFN0_%C68KN'2XXTTZT69;5GPJ#S/+"
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MZ\YQC/OFM:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@"CJVJ1Z/8->2V]W<(I \NTMVFD.?]E03BN?TKXBZ3
MK5_]CL['6FD$_P!GD9M-E"0R<9#MC"8R,YZ5UU<)\-_^/[QK_P!C'<?^@1T
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MZ,00/0^]>I_$O_DFGB/_ *\)/Y4 .T?Q]HFM:I!IL8OK2\N(C-;Q7MI) 9T
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MKRYLF5;C[%I\LZH64, 2H(Z&EU+Q]I6GW_V!+35+V\2!;B:"RLGE>W1AE?,
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M)=FU_<_9''E^6'SG;Y6WM73^,-!7QA\2+VWLY0MU_P (S#=Z?<*?N3+<LT;
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M>GVDI4W5U86,5I%U>27]V0%'7. :V+59$^-H64YE'A5 YSGG[1S0!N:%X_\
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MQR7ZY!R.V*EO=:;3_"UQK=SI]PAM[5KF6TRID7:NXKP<9&.QK'U[XB:-X?\
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MXBT31I(9'EU9IA'(N-J>6F\Y^H]* *&K_#OPGKNHM?ZCH\<UTZJC2"1TR%&
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MF?[1<22O<7,^W;YDKMN8@=AV ] *W:** "BBB@ HHHH **** "BBB@ HHHH
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M2.3@<#/2HO['TS^SY-/_ +.M/L4A)>V\A?+8DY.5Q@Y/- '$_$W_ )$32O\
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M,H92K $$8(/>@#RKXI^)]#\0_#J32M'U*UU"_P!6E@BL[>WD#NS>8C<J.5P
M>N/2I'T_5[OXQ:M'I6LKILD>D6WF.;59]XW-QAB,5WUCX9T'2[MKNPT73K6Y
M;.9H+5$?GKR!FKJV=JEZ]XMM"MU(@C><1@.RCD*6ZD#)XH BFN5TK1WNM0N
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MXRUW2Y]%;1AXHT>1+.$W"2AKF&(K\I3@?(1^0KV![.UENH;J2VA>XA#+%*R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-$B&0QAU+CDJ#R/PH
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MUW"T\T>81C=]WKT&?I0!I445G_V]I'EF3^U+/8+K['N\]<>?G'E=?OY_AZT
M:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ^]:= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'!&:L_\ "N_!G_0K:1_X!I_A0!M?VKIW_/\ VO\ W^7_ !H_M73O^?\ M?\
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M7=_>YZ8['TK>_P"%=^#/^A6TC_P#3_"@#:_M73O^?^U_[_+_ (T?VKIW_/\
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M (!I_A1_PKOP9_T*VD?^ :?X4 ;7]JZ=_P _]K_W^7_&C^U=._Y_[7_O\O\
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M-MJ:#+6@BB,HXS]WKTYJ>S\'_#W4)KF*RT/0+B2UD,5PD5O&QB?^ZV!P?8T
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MRL"Q&<\D <\^E:5 !1110 4444 %<IX"_P"09J__ &'-0_\ 2EZZNN4\!?\
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M,5DI^>.WD=G#$ \<!2/JHSFO5=;^%6EZWXGO-?.L:W8W5Y&L<ZV-T(E=54*
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MF5,7"(7;*[23AN,8&0?IT+ZIXF\6^.3X9TK7VT.VT[28;F26&V5VFD=4/0X
M4;QP/0^O'8/\.](D^'0\$M<7G]F@ >:'7S>)?,Z[<?>]NE5M>^%^DZW?VM_%
MJ&J:7?06XM6N-/N!$\L8P '.#GI[?H, '#^)_%GBEO&=SX9@U358CI>GQ&67
M2=,%P]Q<,BDNP_A3+=J]'^'NHZWJO@C3[KQ%;2V^J$,DRRQ&)FVL0&*D#!(
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M:AJVF""X-R+NSNMD\DA&"7;&#D8&,=A47_"I?#?_  B\>AAKX".[-\EZ)\7
MG/!DWXQG  Z8X'?F@#/^&FK>*+K7-9L=8&K7&EQJDEE>:G8&VE)/WEQC!_\
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M/= \::K'X[\,6MKXKU+6].U-I([@WFG?9XVP.L1(&>?3ICGK74?!C_4^+_\
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M3V9F'V<NQR7V =>N,DXR: //_'NDZQ=?''PREGXA>RDNH)C:2"V1_L@6,[@
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ML?(GS' ]3WJPFI:KX>D^)/AZSUW4+NRTZQ6>UN9K@O+#(0N0''(^\1_P'ZT
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N.\%_\C!XT_P"PP/\
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M_P!^E_PH_LS3_P#GQMO^_2_X4 <-J1^%>K^';30;[6-!ETZS55MT.J(&B"C
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M5DU94>(9SPX?)YYY)YKJ[S4_#5IX?.NK%;76G9 $MG )]V6V<; <\\?A6O\
MV9I__/C;?]^5_P * /.Y=-^$<VAP:0^M:,;6"=KF,_VT/,$A&"V_S-V2/>MW
M0M<^'?AK2TTW1]?T"UM$)8(NI1G)/4DEB2?<FNH_LS3_ /GQMO\ OTO^%']F
M:?\ \^-M_P!^E_PH R?^$[\'_P#0UZ'_ .#"+_XJC_A._!__ $->A_\ @PB_
M^*JYJ4>E:5I5YJ,]A 8;6!YY D*EBJJ6./? INDC2=9T>RU.VT^%8+R!)XQ)
M"H8*RAAG&><&@"K_ ,)WX/\ ^AKT/_P81?\ Q5'_  G?@_\ Z&O0_P#P81?_
M !5:W]F:?_SXVW_?I?\ "C^S-/\ ^?&V_P"_2_X4 <AXN\:^%;GP7KL$'B;1
MI9I=.N$CCCOXF9V,;   -DDGM4_A[QOX3@\-:5%+XGT6.1+.%71[^(%2$ ((
MW<&IO'NG64?P]\1NEG;JRZ9<$,(E!!\MO:KWAO3;%O"VD,UE;DFRA))B7GY!
M[4 -_P"$[\'_ /0UZ'_X,(O_ (JC_A._!_\ T->A_P#@PB_^*K(O?&_@33KY
M[.[=(KA)6B*'3)CEP<$ B/!Z=LU+<>,/!%I!933&-5O5=K=1ILK.X0X8[1'N
M&#Z@4 :7_"=^#_\ H:]#_P#!A%_\51_PG?@__H:]#_\ !A%_\55;_A(O!O\
MPC,GB,2V3:5&P1YUMB2K%@NTJ%W Y(&,9YIFD>)O!NMZE_9UDUM]M*EU@GLF
M@=P.I42(N[\* +G_  G?@_\ Z&O0_P#P81?_ !5'_"=^#_\ H:]#_P#!A%_\
M56M_9FG_ //C;?\ ?I?\*/[,T_\ Y\;;_OTO^% &3_PG?@__ *&O0_\ P81?
M_%4?\)WX/_Z&O0__  81?_%5K?V9I_\ SXVW_?I?\*/[,T__ )\;;_OTO^%
M&3_PG?@__H:]#_\ !A%_\51_PG?@_P#Z&O0__!A%_P#%5K?V9I__ #XVW_?I
M?\*/[,T__GQMO^_2_P"% &3_ ,)WX/\ ^AKT/_P81?\ Q5'_  G?@_\ Z&O0
M_P#P81?_ !5:W]F:?_SXVW_?I?\ "C^S-/\ ^?&V_P"_2_X4 9/_  G?@_\
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MPHX^K"@!O_"=^#_^AKT/_P &$7_Q5'_"=^#_ /H:]#_\&$7_ ,56M_9FG_\
M/C;?]^E_PH_LS3_^?&V_[]+_ (4 9/\ PG?@_P#Z&O0__!A%_P#%4?\ "=^#
M_P#H:]#_ /!A%_\ %5EW/BWPO:Z;?ZA)I_\ HNGZG_9EU(+9,12;E4N>?N L
M.>OM74_V9I__ #XVW_?I?\* ,K_A._!__0UZ'_X,(O\ XJC_ (3OP?\ ]#7H
M?_@PB_\ BJUO[,T__GQMO^_2_P"%']F:?_SXVW_?I?\ "@#)_P"$[\'_ /0U
MZ'_X,(O_ (JC_A._!_\ T->A_P#@PB_^*K6_LS3_ /GQMO\ OTO^%']F:?\
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M#]Q%0!V=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+322Z1!<0F0$,KWDLJG)!)VNQ&<CKC-=!0 4444 %%%% !7'?#;_ )%_4/\
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M\UO\+?$#P$AS;;#C^ZS!6_0FL'Q@+NR\3?#E='M8+BXB^TK!#-*8D8"W Y8
MD<9[=J] UW28==T&_P!)N.(KR!X6/]W<,9_#K^%8^C>&6DTWPS<:ZH;6-%A*
M(\4I*EBGEL??(&: ,CQ%K.OVMSX.%XL>G37>LK!<PVMP94="K84L57.<#C%8
M_B#Q%J]M<?%$0:A,@TRULFLPK?ZAFB)8KZ9/->@^(O#>F^*-.2RU.)VCCE6:
M)XY"CQ2+T96'((R?SK+MOAWX<M-/U:RBMIS%JT:1WK/<.[S;<X)8DG/S')H
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M50G3!Z4 >Y45XSJ.B6.I>+_B NI6XF:+1X)Q$SDH)?*<EL9QD'H>V>.M>A^
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M[?P_>:S%?6MQ:6T;N9(YU*$J,[=P.,GI^-9G@/6]6\1Z!'JVIOI16Y5)(8[
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M*NC_ /7C#_Z *H>/_P#DG7B7_L&7'_HMJO\ AK_D5='_ .O&'_T 4 :E%%%
M!1110 4444 %%%% !1110 4444 %%%% !7*>'/\ D=O&?_7U:_\ I-'75URG
MAS_D=O&?_7U:_P#I-'0!U3*KJ590RD8((R"*CBMH(0HBACC"KL 10,+Z?2G2
M2QQ &1U0,P4;CC)/0?6JO]LZ7]GDG_M*S\F)MDDGGKM1O0G. ?:@">*TMH H
MAMXHPI)78@&">N,>M.6W@2=IUAC$SC#2!1N(]":CEOK2"U%U-=01V[ $2O(
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MXDTFZ:_@C@U*PO);*[BBSM#H>JYYP5*F@#I:*** "BBB@ KCO#7_ "4/QO\
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MOVLSDF1@3NVDX8J1CH,4 >XW-S!9VLMS=31PP1*7DDD8*J*.I)/05DZ+XO\
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MI_V&!_Z3Q4 =C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%C"P,NX@<0@_ZL>6/XMW44[QYX)\6ZQJFDS:5>M;1(T$;".ZEDVNL;@R'/W
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M=,\":I:>*GG00:LL"1JA5@!(;A6Z;!TZ]L5ZY&&6- [;F  )]33J* "BBB@
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MQ-;6,$,@]&5 #^HJWJ&FV>JVRV]] L\*R)+L?."RL&4D=\$ X/I5J@ HHHH
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MG_88'_I/%0!V-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% ''?$7_D'Z%_V']/_P#1RUV-<=\1?^0?H7_8?T__
M -'+78T %%%% !1110 4444 %%%% !1110 5QWPV_P"1?U#_ +#%_P#^E#UV
M-<=\-O\ D7]0_P"PQ?\ _I0] '8T444 %%%% !1110 4444 %%%% !1110 4
M444 <IX'^[XB_P"PY=?S%=77*>!_N^(O^PY=?S%=70 4444 %%%% !1110 4
M444 %%%% !1110!SGC__ ))UXE_[!EQ_Z+:K_AK_ )%71_\ KQA_] %4/'__
M "3KQ+_V#+C_ -%M5_PU_P BKH__ %XP_P#H H U**** "BBB@ HHHH ****
M "BBB@ HHHH **** "N4\.?\CMXS_P"OJU_])HZZNN4\.?\ ([>,_P#KZM?_
M $FCH M>,/$S>&=.M'@L_ME]?7<=E:6Y?8'E?.-S8.  "2<5Q^BWFLM\7=9E
MU+2X8M0AT! L%M<[TGQ*2"KL%QDG'S 8(]*ZWQIX:N?$>GV)L+M+74-.O8[Z
MUDD3<A=,C:P'.TACTKGV\$>(M3U77=2U75+&&?5-'.G(MDCXMSDD8+<L.<D\
M'DC P* )=.\>:K-XI@T*\L-),]Y;32VQL=2\\(\8SLE.P;<^H!^AK(\*^.M<
ML?"?B'7/$MO%+9:?=7($D=QND\Q9 HA"[0-H)P&S^%6/"WPYU72/$.@ZG=+H
M-NFEVTMNZ:; R-/N0*'=B/F8XR<@8YY.:L+\/-2GT3Q/X;N[NR&BZI/-=6TT
M:N9XI'D#J&!^4JI'8Y/M0!)X=^(\^I>)[#1=0@TG=J,,DMN^F:D+KRF0;BDH
M &#CN../RW?%?BB?0[C2M-TZP6^U759FBM87E\M %7<[LV"< <\#-4_#.AZ]
MI]]"=3L?#,<4,17S]/@=9I&Q@'D +WS@FI_%_AO4-6O=&UC1;FVAU;2)G> 7
M08Q2)(NUU;;R,C'(H P=1\9:Y)H_BO2;C2K:WUW3+$W \JZ8PR0LI^=&V@[E
MP?E(&2.H[7_A+IPLO .FRMI%C82W%O$YDMFW-<KL!$DAVCYB6;CG'K3+7P7K
M%U_PDFHZU>V;:OK%@;%$M5806Z!& Y;YFY;).*ZCPWIDFB^&-*TN9TDEL[2*
MW=TSM8J@4D9[<4 :E%%% !1110 4444 %%%% !1110 5QWAK_DH?C?\ ZZV7
M_I.*[&N.\-?\E#\;_P#76R_])Q0!V-%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %<=X+_Y&#QI_P!A@?\ I/%78UQW
M@O\ Y&#QI_V&!_Z3Q4 =C1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!QWQ%_Y!^A?]A_3_P#T<M=C7'?$7_D'
MZ%_V']/_ /1RUV- !1110 4444 %%%% !1110 4444 %<=\-O^1?U#_L,7__
M *4/78UQWPV_Y%_4/^PQ?_\ I0] '8T444 %%%% !1110 4444 %%%% !111
M0 4444 <IX'^[XB_[#EU_,5U=<IX'^[XB_[#EU_,5U= !1110 4444 %%%%
M!1110 4444 %%%% '.>/_P#DG7B7_L&7'_HMJO\ AK_D5='_ .O&'_T 50\?
M_P#).O$O_8,N/_1;5?\ #7_(JZ/_ ->,/_H H U**** "BBB@ HHHH ****
M"BBB@ HHHH **** "N4\.?\ ([>,_P#KZM?_ $FCKJZY3PY_R.WC/_KZM?\
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M@ HHHH *X[P7_P C!XT_[# _])XJ[&N.\%_\C!XT_P"PP/\ TGBH [&BBB@
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MX_\ 1;5?\-?\BKH__7C#_P"@"@#4HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *Y3PY_R.WC/_KZM?_2:.NKKE/#G_([>,_\ KZM?_2:.@#JZ*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X[PU_P E#\;_ /76R_\
M2<5V-<=X:_Y*'XW_ .NME_Z3B@#L:*** "BBB@ HHHH **** "BBB@ HHHH
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M[KO_ (.+C_XNNQHH X[_ (5KHO\ S^Z[_P"#BX_^+H_X5KHO_/[KO_@XN/\
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M[KO_ (.+C_XNNQHH X[_ (5KHO\ S^Z[_P"#BX_^+H_X5KHO_/[KO_@XN/\
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M #^Z[_X.+C_XNNQHH X[_A6NB_\ /[KO_@XN/_BZ/^%:Z+_S^Z[_ .#BX_\
MBZ[&B@#CO^%:Z+_S^Z[_ .#BX_\ BZ/^%:Z+_P _NN_^#BX_^+KL:* .._X5
MKHO_ #^Z[_X.+C_XNC_A6NB_\_NN_P#@XN/_ (NNQHH X[_A6NB_\_NN_P#@
MXN/_ (NHT^%GAZ*:6:.?64EFP9'759PSX&!D[^<#CFNUHH X[_A6NB_\_NN_
M^#BX_P#BZ/\ A6NB_P#/[KO_ (.+C_XNNQHH X[_ (5KHO\ S^Z[_P"#BX_^
M+H_X5KHO_/[KO_@XN/\ XNNQHH X[_A6NB_\_NN_^#BX_P#BZ/\ A6NB_P#/
M[KO_ (.+C_XNNQHH X[_ (5KHO\ S^Z[_P"#BX_^+H_X5KHO_/[KO_@XN/\
MXNNQHH X[_A6NB_\_NN_^#BX_P#BZ/\ A6NB_P#/[KO_ (.+C_XNNQHH X[_
M (5KHO\ S^Z[_P"#BX_^+H_X5KHO_/[KO_@XN/\ XNNQHH X[_A6NB_\_NN_
M^#BX_P#BZ/\ A6NB_P#/[KO_ (.+C_XNNQHH X[_ (5KHO\ S^Z[_P"#BX_^
M+H_X5KHO_/[KO_@XN/\ XNNQHH X[_A6NB_\_NN_^#BX_P#BZ/\ A6NB_P#/
M[KO_ (.+C_XNNQHH X[_ (5KHO\ S^Z[_P"#BX_^+H_X5KHO_/[KO_@XN/\
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MI[N%[9HV;:BF-OG4-C[V".#S0!Z'17,?\+#\+?VL--_M4>>9_LP?R9/*,O\
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MV9S'%Y:EB?+4G&X]6]:ZS5?&.@Z-!9RWE_Q>IOMD@B>9Y5P#N54!)&".<8H
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MTNTT72[?3;"(Q6MNFR-"Q8@?4DD_C5R@#S)='O?M7Q3<Z?/NOH0MLWDG]_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@#S-QJ-W\=-5?PIK&G:<K:/ T<\L0DB>$K#@(.G]TC'85[C8>>-.MA<SQSW
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MR$)VCGVH Y7XD2";XB?#&4*5#WDC8/49,)JG\6M:AN?''AGP_)I][J5G9O\
MVG?VEE!Y[N!\J IW&<YSV:O4M1\/Z5J^H:??WUFLUUISF2TD+,#$QQDC!Y^Z
M.N>E$'A_2K;Q!<Z]%9JNJ7,0AFN-S$L@Q@8)P!\HZ#M0!X%H6K"+X8_$+PPT
M%U:K9%[FTM[N,QRI!(PP&4]",*?^!USOBJTN/!_A2&&W1CI/BK1[*8@=([F+
MRF8_B,G_ ('[5]*7W@OP]J6HWU_=Z9'+=7UM]EN9"[#S(N/E(!Q_"O/7BEU/
MP;X>UG1+31]0TR*?3[,*+>%F8>7M7:,$'/3CK0!YK'/%;_'?PW)/*D48\-)E
MG8*!Q)W-<KXFFM-1\8_$B^T9XY=.&BJD\L',;3%HNXX)^5N?8U[7K7P^\*>(
MKJ"YU71H;F:"%8(V+NNU 20N 1D#)JW#X/\ #UOH-QHD&D6T.FW Q-!$NP2?
M4CDGWSF@#P^ZT"#Q1JGPYT6XP$N_#+HK$?<?R6*M^# '\*@^'VI:OJ7Q'%C=
MH\>L:7H$^F$L>3)&[!3^ *C/MFO>8/"FAVUYIEY#IZ)<:7 ;:S?<V88\;=HY
MYXXYS2V_A70[7Q)/XA@TZ*/5ITV2W*DY8<=LX[#G% 'BG@#7+K1OA%<S^';O
M1K?6;&:XGU.&_4^;(J@E0 ""3@ #/'45M2:;)\0_"OA/7K?7+#1/%5M'+<VR
M* J.#(0?D)) RHYP>IR#FN[UCX8>"]>U![_4=!@DNG.YY$=XMY]6", 3[FI-
M2^&W@_5K"RL;W0X'M[%2ENJNZ&-2<D94@D9YY- &7\*O&.I>+='U :O%;B^T
M^[-M+-;?<FP/O#MGZ<=*U)[_ ,<K<2+!H&BO"'(1FU1P67/!(\G@XK:T;0],
M\/:<MAI%E%9VJDL(XAU)ZDGJ3[FM"@#*AGU-_#\\NIV\%I>B.0E+:<R*N <$
M,54Y_"O)DM]>U?X=>$-7:2]U33[6UFFU.SBU!H)YNNV0/G+;<'@GFO;'198V
MC<95@5(]0:YJ[^'GA2]L[*TGTA##91F&!5ED3:A.2N58$CV.: )])U"VO_ %
MM?:=+<M;OI^Z&2X;,V G!8]VXY/K7DD%C?\ _"&^!-97Q%K:ZGJ^H065S<?;
M7/[F0.I4*?E! 48.,YYSFO<H+"TM=.33[>WCBM(X_*2%!A53&, >F*HKX7T5
M-.TW3UL$%KIDR3V<>YL1.F=K#G)QD]?6@#RR^OM0\'0?$NST>]O6BTZWLI;0
M3SM,T#2J0[*S$GW_  K5N=.3PEXB\%RZ1J^H3R:I<?9[M;B]DG6[C,>XR%6)
M (.#E<?>KT3^P=+^UZC=&RB:;4HTBO"PW"9%4JH8'C&"1^-9VB> _#'AV]^V
MZ7I$4%R%*K*7>0H#U"[B=H^F* /&]<M_[;^#.N>*M1U:^;5I;QXY(OMCB) +
M@*(?*SMP  P&,]#FNZUOSM1\=^)=*GN[M;+_ (1M)1%%<.@5_,8[A@C!X /J
M.#Q72WGP[\(ZA=7-S=:%;227)+2_>"LQZMM!P&/]X#/O6NVB::^I3ZBUJAN[
MBW%K++DY:($G;UQW- 'D.C12:+\//AU)8WM]&=0UNS^T*;IRK*5DR@&<!#@?
M*.*@DA\4^+M1\53V5O>27MIJ<UI97*:VULMD(\;,0@8;/4D_>SVZUZ^/#&C#
M3]-L!8)]ETR5)[./<V(73.TCGG&3USUJCJ?@'POK&HRW][I,;W4H EDCD>/S
M<?WPC -^.: .1AMKGQ+\0-2TWQ!JMW;?V5I=K)%%9W;P#S74F2;Y2,[6&.<C
MIQ6K\&/^25:3AMXWW/S>O^D2<UT.K>#O#VNW,-QJ6E03S0IY:N<J2G]QL$;E
M_P!DY'M6AI6E6.B:='I^FVR6UI&6*1)T4LQ8X_$DT >):KK$D]]9:_HL.MI
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MQ9Q3103-(JI, &&QV0YP2.JFO'H+&XL;+6?&>G1EK[0?%-]),B]9K5F42I^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY!/3'IWKF/$6N>)?$F@>.9K";3[;1]+%UI[6\T#-)<;(_P!ZV\,-IY^7@^]
M'JMO<0W=M%<V\BRP3()(Y%.0RD9!'L14E>8:3KFN72^&/"F@SVEDX\/6]_<W
MES 9MJX5%14#*,D]23TJ.Y\>>);?PCK!^RP2ZMI.JC3[FZA@9XQ%P?/\H'/"
MD97/O[4 >IT5Y=JGQ"NM+\):3/!K6F:E<ZG?&VCU&&UD,4<8!)8PJ2Q<# VY
MZD5%8^/_ !')H7BEK6W76;G3(8Y;&ZCL);87 ?A@8FYRF"< \@4 >K45RG@/
M6Y]=TF:XFURQU;$@ >UMS T7RC*2(22"#FN=LAXC?XW:K"NJVWV1+*"5H6MV
M(,)=L*/GP'ZY;OZ4 >AV&I66IPO-8W,=Q&DC1,T;9 =3AE^H-6J\(TC6_%'A
MGP5K6O6,^G#3+/6Y@UK) S23A[@*QW[@%QN&.#T-==\0/&=[X>N[M+7Q)H]E
M+!:F>&PDLY)YIR 3AB& C!(P./?- 'I-%>1:QJ7B/6O%?P[OM/U&ULO[3LII
MTA>!G1',"N^\!QO&" O3!YYKTCQ#?RZ5X=NKQ;VQM)(D!-S>@^2G(!) .3WP
M,\G S0!JT5Y;X;^(&H7VH>(+(ZG8ZO%9:6;^WO(+1[<;AD%&1B<C@'(/_P!:
M%?'?BG3?AROB[5FTQFOT@2QM8H7VQ,YQO<@DL"/FVCGM0!ZQ5*_UC3-+EMHK
M^_MK62Z?RX$FE"&5N.%!ZGD?F*X?P7XQU35/%DNCW-W'JEFUF;A;Z+39K/RY
M P!C*R=1@Y!%:GB  _$SP9_USO\ _P!%QT =,-3LFU%M/%S&;M8A,8L\["Q4
M'_OH$?A0=3LAJ(T\W,?VLQ&819YV!@I/_?1 _&O+[3X27=O\1(]=-] ;:.1+
MH1B "+?YK$HL8;Y2%((;)^8DXYHN/A)=S?$3^W1?0"V,C71C$ $6_P Y6"&,
M-R=H+%\_? .* /38=:TRXU:;2H=0MI-0@7?+:K*#(B\<E>H'S#\Q1JVL:=H5
M@U]JMY#:6JD*9)6P,GH/<^U85R!_PM?3CW_L6Y_]'05S_P 5X=5FO_!Z65W:
MQ1/K<(5)K<OB;#E7/S#*@9^7@^] 'H=C?6NIV,-[93+-;3H'CD7HRGO5BO/H
M=;\7:C\0;[P_:3Z7#9Z7':374[6[%I-ZY9%7=QNPV#VP.N:RSXP\7W_A74_&
MEA/ID.EV<LIATZ2W9GGAB<JQ:7<-K'#8 7' H ]5HKSN7Q/XEUSQ<NBZ#+I]
ME;RZ/#J7VBZA:5XR[$;0H8 Y^7Z8/7BL/3O'GC&XT'P]XENFTI+"^U*+3Y;.
M.%M[@N8VDWEOE.Y3A<=,<T >P55N]2LK"2VCN[F.%[J40P!VP9'()"CU/!KG
M_B2;]/AWKDFGW*6\L=G*[.R$DH%.X*01M8CH><>E<%K:^(5\+?#UI+RRNM2D
MU2V:U=H61%4P':)/F)8CDD@C/M0![/17F#^/-:\.6OC:/6VM-0GT".WD@E@A
M,(E,R_*K+DXPV.A]:;X6\<ZQ?>*].TRXO(-5M;Z"1II(-+GM19R*NX#=)PZG
MD ]<^G< ]+MKJWO8%GM;B*>%L[9(G#*<'!P1QUJ:O'-(\7:W'X*\%1>'[#2+
M.XUJYN8&C6 I!#AG^95!XQC<1SG\:])O;K4='\&7EY<S07&HVEC)*TBQE8WD
M5"<[<\#(Z9H VJ*\E7Q=X[^S>%;WS-%8>(U$<=OY#@6S-'N60MNRW&25P/3/
M>M?2O%6MQV/BRTU;4-*2\T2X1%U"6)HX"CJ&RZ!LY )X!Y.![T >AT5Y=X9^
M(%_?ZQK6GG5+'6(;72S?P7D%F]N P)!0JQ.1T.1_^J'2_&7B\V_@_6=2ETLV
M&O7,=J]G! P>/>I(?>6/.5)QC Z<]: /5ZR];\1Z/X;MXY]8U&"SCE;9&96Y
M8^PZFN5/C+4QIWC^?;;[]!:46GR'!VP[QOYYY^E<]J<VOZQX^^'UY%>V$;W.
MFS7,:R6C,(V,2&7/SC.<\=,>] 'KJ.LD:R(P9& *D="#3J\E\4_$6_T'6)A;
M^(-&N3!?) ^DQ6DC.(RX7YIMV X!R1C /'/?=N-:\3:_XPUS2/#U[I]A#HJ0
MJ[W5LTQN)9%+XX8;5 &,\F@#O:*\OT[_ (2A_C1?Q2ZI9B)-.@EFA$#LGEES
ME$R_#=?GQSQQ3KGQ_K$7PQ\0>(E2U^VV&HR6L(,9V;!.L8R,\G#'O0!Z=4,-
MU;W+RI!<12M"VR54<,4;T;'0^QKB-1USQ3>_$>?PWHTNG6UG;V<5W+<7$3.^
M"S H &'7CGM@UAW/B^]T71_%^H:9INFQW=OXB6T4+"4$X8Q@M(0>6.X_-^E
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M*3Q*JHT::H-5LX4MUA"88*X4,6!VA<$_6O8Z* .?\4^%D\21V,L=[-87^GW
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBTH6KR&-9C>1[&<<E0<]>1Q[U;U+7]'T>&*;4]5LK.*7_5O<3K&'^F3SU[4
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MV-=U!])\/:GJ,2*\EI:2SJK=&*(6 /MQ0!SVHZ;>R_%G1-12VD:RATVXBDG
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M9%#))&P96!Z$$=10!)1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]E>W5C:RK'8VFF+;,(V3!63:<@*<$!AUZ5Z1J'B&TTSQ!HVBRQ3-<:L9A R
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MZG $\EO<RP><!P-X1@&_&K7BC1)M:\'ZCHEA<+9R7-L8(Y",A01C!]B./QH
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MER]W/AB=\K8W-R>,X' XJ+7?#^F>)+!;+5;;SX%D65 '9&1QT964@@C)Y!H
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M;1984:W@O=2%XZ2@X;:^20I'.#WKOJQM#\+:3X=:=].BG5YPHD>:YDF8A<X
M+L< 9/ ]:V: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.Z;=>%W\.R0XTUK7[)Y:G!5 NT8/J,#GU% 'GOB"^UJS^+>HW&@:9;:E<?\
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MQ7RXWLYC%NC)!,; =5X'% %;QUJL6E:%$TFIWUBT]RD$9T^!9;B9FSB.,,"
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M\8.,UN4 </J'ARW\*_"3Q!I5I--);QZ;=M&)2#L!B;Y00!P.V<GU)KK-)_Y
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MRD5=B*N2<#&2<DTM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?++,9F)PN2/EZ9!%</IOASQ=>ZGX;N-6T[79=0LM76?4+F[OU>V"Y;!AC#\
M CD 8Z<YKKX='U2#QEXQLGTZZ^Q>(8T-OJ,90QPD6Y1@_P VX'=P, YH T['
MXE:)?7ME"MOJ45K?S>19W\UJ4M[A^<*K'GG!QD#-;NO^(-/\,Z6=0U*1UBWK
M&BQH7>1V.%15')8^E>7^$?"*6G]B:=K/A+7FU"PFC<W1U$O9*T9^651YN.V=
MH3OBNT^(FCZCJ6FZ3>:7;?:[G2=4@U#[+N"F=4R"JD\;L-D9]* '6WQ!TZX-
M] ^FZO;:A:6WVHV%Q:%9Y8LXW(N3N&>.M8_P?O;K6/#;:Q?WFM7%[=<S&^+?
M9\[FP8 > N.#CTI]C9ZSXC\='Q'<:+<:396VE2644=VR>=-([9)VJ3M48[GO
M^6U\-],O=&^'FC:=J$#07<$)62)B"5.YCV^M &+XU^(=G::-XDLM.74FNK*V
MDB>^M;9FAMIRAVJSCHP)'.,#/)%7[?QO::7HOA^UN8[_ %+5[W3HKG[-90F:
M5EV#=(W0 9[D\FN7N])\2Z5I'C;P[:^'9K[^V[FZNK2\BFC6+;,O(?<P(9>@
M&.?8<U;@T[7/"WB#1M>30[K4X6\/PZ9<P6K(9K>5"&SAF *GD<'J/S .D/Q&
MT >&_P"V@;IE^U_8?L@@/VC[3G'D[/[_ +5//XXTZTT*'4[NSU*V>>X^S0V,
MMJ1<R2Y.%5.^<9SG&.]<;%X;NU\,:O/X@\+75]_;&M-?FPLIU\^S4@;'W;@"
MX*C.T_Q?45FW/A/Q9J7A?1[G4[;4KY]-U::5+.2]"7C63#"YD5A^\'7[W0XS
MVH [V/XC:%_9&K:A=B\L3I.T7EM=P%)H]_W/EYSNSQ@UL:#KJ:];2S+IVHV#
M1/L,5_;F)SP""!DY'/K7#6>@:8OA[7I4\#:Y*EZ(8KBVO[S=<72*3RNZ5L;,
MY'()[=*UOAO9ZW9P:K'J$>HPZ7]H7^RX-3E62XCBV_,&()XST!/04 ):^/IY
MOB3?^&7TB]^S0)&$F2T<D,6(+N<X$? PV.>:>WQ2T!29_(U(Z6L_V=M6%J?L
M@?=M^_GINXSC'O44MCJ6G_%6[OUTNZN=.U6PAM?M5N4Q;NK-G>"P(&"#D UR
M*Z+XH_X5JWPX'AN?[0&,']IF2,6OE>;O\W.[=G'\.,Y_*@#T3X@WMSI_P^UR
M\LIW@N(K-WCEC;#*<=0:S_#OQ!TW4'T?3IX=2AGOK<&VNKJU:.*Z94!;8QY)
MZGD#/;J*T/&^E7>H_#W5]+L(C/=2V;11(" 7;''7BN6@L/$>O:QX2MKW09-,
MBT"3S;NYDF1XY66/8HBVG+ YR<@8H VW^)NA)=8,.HFP%S]D.J"U/V02YVXW
M^F[C.,9[UTVL:O9:#I%SJFHS"&TMDWR.1G ]AW). ![UXYH7@0:;9IX?U[PK
MKVHR)=$+=6^I$6<J&3<KLOF@+C.2-N<C/4UZ/\1=!O/$O@74=,T]8WO'\N2)
M)&PKE)%?:3[[<?C0!ST?C2;6?B;X:L;:+5=/MY+6ZDGM;V!H?-&U3&^.C#AN
M^1WQ6NOQ-T)[J-1#J/V"6Y^R)JGV4_9&ESMP']-W&<8]ZRE37O$?Q"\/:M<>
M';S2[&SM;J&62>6,N)'0#@*Q^7(P#WYX'?F?#7@<:;9V>@Z]X4UV]N(+D#[5
M!J)^Q.OF;ED*^: N!SMVYR/4T ;=YXDO;1OB'+<:Y=6,.GW=JEO.D(G-L&5,
MA8VX.2<?CFNVM/%>EW%SK5J9G2;1 #>^:FW:I4L''J" 37G_ (D\)Z[>Z5\1
MHK?3I)'U.ZM'LP&7]\J>7N(Y[8/7TJSX_P#!^O7WB<3:!#FUUVT73=6D#A?)
M19%/F\GD[-Z_2@#II?B+I(@TYK6SU2^N+^U%Y%:6EJ7F6 \!V&0%!/3GFFW/
MQ+\.6N@Z;K!EN9+;49&A@6.!FD,J@Y0KU#9&W'KCZUS/BCPA):^.8M7&CZIJ
M&C-IL=F(M)O##-;LC';\H=-RD>_!JR/"CI%X*_LG0KJQM+359+NYM[F8220A
M@_SN2S9).#@$XS0!T5UX^L+4640TS6)M0NX#<#3H;,M<11@XW2+G"C/')Y[4
MC_$701H>GZG;F[NO[1E:&UM+> M</(N=R[.Q7!SG@?B*YKQCX7N6^(*Z_+I6
MJZIIDVGK;.FEWAAFAD5R0<!TW*0>F>M1MX:N=';PEKVA^&KQ(-,GO'N=,EN%
MDN0LXVF0%G(+?+G&[^+'K0!L>!/$=QX@\7^,2TEX+2WFM5@MKI"C0$Q?.NT]
M#N!SZ]:ZJ/7K*3Q--H"F3[=#:K=L-OR[&8J.?7(KF?!%CK"^*_%NL:II4FG1
MZG+;/;QR2*Y*I&5YVD@'ID=B<9/6J^LP:YHOQ..OZ?H<^K6EYI2V9$$J(8I5
MD+#=N(PI!Z\T :4GQ*\/Q:#INLLUW]EU*=[>V"VY9VD4L,;1D\E2!ZY%2V'Q
M T6\T[6+R=;O3AH^/ML-]#Y<D0(RIV@G.1TQR:XS0O"6O6GAOP#:W.G,D^FZ
MM-/>*'4^4A:4ALYY'S#IZU8\0^"]9UJ?XCPPVX0:JM@UB\C +,8D!8=>.5QS
MCK0!9/C>76?B/X0L[.+5K"VGCNY)[>\MVA$Z^4#&WHPR#WR.X&:V9/B;H45T
M08=1-@MS]D;5%M3]D67.W&_TW<9QC/>LE!X@\0^/_">J7'AJZTRSTV*Z2X>>
M6,D2218^4*Q^3( #=\]!BN8T3P(-.LQH&O>%=>U%UNFV7-MJ1%G+&9-RNR^:
M N,Y(VYR,]30!Z1<^/=*@\5MX:CM]0N=2CDB65+:V+K$KA2)&;H$&X9/:J_C
M_P 1ZEH]OI>F:&(1J^L78M;:2<92$8RTA'? [>_?H5\/Z1>VGQ'\8ZG<6Q2T
MOA9"VF)'[S9$0^._!QUJ'XB:%JNHIHNL:';QW6I:+>BY2VD<()T(PZ G@'IC
M- #&LO&'A[3=2OKSQ3'JL,6GSR8EL8XGCF5<JR[."O!R&JY8ZW?S?">'79)0
M=1;1OM9DV#'F^3NSCIU[=*IR:UX@\2Z7JNG_ /"(7VGPRZ?.@FNYXP6E*D*B
MH"2<Y^\<#BLK0[G79?A^/"UQX3U.UGCT5[47$K1>6T@A*@##YY/3B@#)\2>/
M/%=AX?\  UYI;Q3W.H:?)?7\;1+^_$44<C@<?+D%^E=9IWB^76/'^F6MC<*^
MC7N@G4%78,E_-502>HP"01ZUE:?X<U6+4/ABTUBXCTO3KB&^S@B%FMT4!N>Y
M!'%4_!W@G5_#'Q8O#Y#-X=BL9DT^;(Q&LDJ2>5USP=_\^] '2^+M6U:3Q/H7
MA?1KW[!+J"S3W-X(UD>**,#A58$98G&2.*IZ!K/B:.^\5>'I)H=8U+27@:TN
M+@" 2I,NX"38,?+@]!S5CQAIVJ6OBS0/%6F:?+J*V"3V]W:0,HE:.11AEW$
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M>SQJB%@!WX&<=\5=TVSL]?OKZ^TGQ9+JNLQ:)<VUO#'IRVOEAEPH8JH (8C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !2,-RD9(R,9'44M% &%X<\*VGAM[Z:&ZO+R
M[OY%DN;J\D#R2%5VJ. !@#VK=HHH **** "BBB@ HHHH **** "N=UGP=::O
MJXU:._U+3M0^SBV:XL)_++QABP4@@@\D\XSS7144 97A_P /V7AO3WL[(SOY
MDK3S37$ADDFD;[SLQZDX'Y5JT44 %%%% !1110 4444 %%%% !1110 4444
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M??\ 1+;C_P &T?\ \11_PG?C[_HEMQ_X-H__ (BO2:* /-O^$[\??]$MN/\
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M_P#B*/\ A._'W_1+;C_P;1__ !%=G#XH\/W%_#80ZYITMY,H:*!+I&=P1D$
M')R.?I3;[Q9X=TN\-G?Z]IEK<C&8I[M$89]03Q0!QW_"=^/O^B6W'_@VC_\
MB*/^$[\??]$MN/\ P;1__$5Z/'(DL:21NKQN RLIR&!Z$'TIU 'FW_"=^/O^
MB6W'_@VC_P#B*/\ A._'W_1+;C_P;1__ !%>DT4 >;?\)WX^_P"B6W'_ (-H
M_P#XBC_A._'W_1+;C_P;1_\ Q%>DT4 >;?\ "=^/O^B6W'_@VC_^(H_X3OQ]
M_P!$MN/_  ;1_P#Q%>DT4 >;?\)WX^_Z);<?^#:/_P"(H_X3OQ]_T2VX_P#!
MM'_\17I-% 'FW_"=^/O^B6W'_@VC_P#B*/\ A._'W_1+;C_P;1__ !%>DT4
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M ,EN\/\ _8)N?_0EH I_\)WX^_Z);<?^#:/_ .(H_P"$[\??]$MN/_!M'_\
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M^(E]9^*7\,>&?#TNMZM#$);D><(HX%(!&6/?!'IU'4\4 5?^$[\??]$MN/\
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YY\:_\
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M^(R1+*7?;O4 YYV]NQK0\:W6B2ZIX-U'1#96?A/==".:XL'DM4F+'<6BXX)
MQTZ9Z"OH)K:W>#R'@B:'_GF4!7\NE*;> P>088S#C'EE1MQZ8Z4 >=?!_3+&
MQLM=GT[7+35(+F^WL+.V:&&%]H)5 3C&&7IP, 5YUXAOO"%C\6/'3>*[59_,
MMHTLRT3.!)Y*\#'W6/&#VP>17T7##%;QB.&)(XQT5%  _ 5SFG^"K*Q\7:WX
M@>4W#ZJ(M\$L:E(S&N 10!\]PV]_I^@_#Z?6&BM-+7[64EU&T:>"-F<E2\8Z
M@C:1^?05HZ[IEC8_"/Q%-IVN6NJ07.M0NWV.V:&&%\9*H"<8PR].!@"OI:2*
M.:,QRQJZ'@JPR#^%,6TME@$"V\0A'2,(-H_#I0!2T+P_I?AK35T_2+..UM@=
MQ5/XFP!N)[D@#)K3HHH **** "N"U7_DMWA__L$W/_H2UWM<%JO_ "6[P_\
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M'?[QZU[088BY<Q(78;2VT9(]*=L7=NVC=C&<<XH ^6I--MC\$);MK-)/[/\
M$C+O*!FBA(4,H)Y )VY'<XKOG.@ZM\7?!@T>"VDT.XTBZ2.)(-D3(?-##80.
M"<Y&.:]F\M-I78NT]1C@TB0Q1A0D:*$&%PH&!Z"@#Y\\#^']#UOPUXV\(-:V
M\7B7[1<F(&##K$ACV#?CA1(H^7/X4_X027OC'QM9:GJ,;A?#.E+8KN_YZ$LJ
MGZ["V?<5[^84WM(JJLK#!<*,_G7.>"?!5IX)TZ[MX+J>\GN[AKB>YGQO=C].
MW]2: .+^*^DZ?>>// )N;&WF-S?M!.7C!\V,%"$;U')X/J:XS59_#NB>-?']
MOXQLD-Q<VX71_,MBXV!&"",@':<>6 >,;3R,5]&LBL064$@Y&1TICP12.KR1
M(S)RK,H)7Z4 ?.4&@M>6/PATG7[9V262\,D$V03&75D!]MNWCTKV_P 3V5O8
M?#G6[.R@2&WBTJX2**-<*H\IL "N@*(S*S*I9>A(Y%.(R,'I0!\XZ?XYTB3X
M&6_@ZP%Q?^(+F![<6=O;NQ4M*QR3C'0YXS2:_IEUX:\3^$8-<N[.QM8-!CMT
MN+ZR-W;I.,[UVYQNYZ^F*^C(X8H<^5$B9Z[5 HDBCF0I+&LB'JK#(- 'SI<Z
M79:7X#\,QZ=K":M:R^+HY$GBMVA13C!558G@$'D<<U)JV@-KT?Q86)2;FRU"
M"]@(Z@Q^:6Q[["U?0XAB"*@C0*GW5VC ^E*$52Q"@%NI ZT ?/NBSZIX]TCQ
MMXQAAD^U_P!D)IEJBC+$B,-.%QW)Z8_O55\ V6C:IK'@UX_$VFQ:A8M\MA:Z
M4T4[,%RZ22 _-]T_,>#D^N*^C5147:BA1Z 8IBV\*3-,L,:RM]YPH!/XT >(
M?#7P1HOB71/&,U[91/?3:G=V<=RZY:%2@P5]#ER??CTK!^&46H^)/'.@Z/JD
M3"/P?#/O#'_EIYA"CZ@[?P2OH]41,[%5<G)P,9-<SX3\$VOA6^UF_2[GO+S5
MKCSYYI@,CDD*,=AN- '44444 %>;:)_R7[Q/_P!@NW_]EKTFO-M$_P"2_>)_
M^P7;_P#LM 'I-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB2:,^JL 1^AJQ7-?#R*2'X<^'$E&&&G0''IE 1^E=+0 4444 %%%% !1110
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M0<9IE[JMAI[I%=7MM!-+GRHY951I#Z*"<G\* ."_X3;XB?\ 1,'_ /!O%_\
M$T?\)M\1/^B8/_X-XO\ XFN@\)^+XM8\"Z;XAUB:ST\W2L6W2A(P0S+@%C[5
M:U[QEHOA_04UFYNTFLY'5(VMW1S(68+E>0"!G)YX - '*_\ ";?$3_HF#_\
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M)I+Q)I_]HH=\?F9,F_&!@\8KL/\ A-OB)_T3!_\ P;Q?_$U-??\ )?\ 2_\
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M?$3_ *)@_P#X-XO_ (FO2:* /-O^$V^(G_1,'_\ !O%_\31_PFWQ$_Z)@_\
MX-XO_B:])HH \V_X3;XB?]$P?_P;Q?\ Q-'_  FWQ$_Z)@__ (-XO_B:])HH
M \V_X3;XB?\ 1,'_ /!O%_\ $T?\)M\1/^B8/_X-XO\ XFO2:* /-O\ A-OB
M)_T3!_\ P;Q?_$UE> M0U34_C-XCNM8T@Z3>-IL(:U,XEV@%<'<!CD<UZ]7F
MVB?\E^\3_P#8+M__ &6@#TFBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMI,]C'?367G*4::%49MIX(PP(Y'M4NF6$>EZ59Z?$S-':P) C/U(50H)]^*
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M4T16EM!(\D-O%&\AR[(@!;ZD=: )J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\VT3_DOWB?_ +!=O_[+7I->;:)_
MR7[Q/_V"[?\ ]EH ])HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9OVQ@Q[BQX/S,,#/'>NG\)ZQ?ZQ8WQU)+9;FSOIK1C;!@C;"!D!B3S0!@_\
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M#\Z .._X3'QO_P!$UN?_  ;04?\ "8^-_P#HFMS_ .#:"N]HH X+_A,?&_\
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M^$Q\;_\ 1-;G_P &T%'_  F/C?\ Z)K<_P#@V@KO:* ."_X3'QO_ -$UN?\
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MVB?\E^\3_P#8+M__ &6@#TFBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(8'/7BNEL/'?AG4[F6WL]5CE:*%YI6V.$C1#ABSD;1CT)SCGI5)+&['QAFU
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M ^.-PZ&@#3HHHH **** "BBB@#S:[_Y.,L/^Q<;_ -'/7H-__P @ZZ_ZY/\
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MNK&5F6.YA>%F7J P()'OS5;0-*?0]$M=,:]EO%MHQ$DLJ*K;%&%'R@#@ #-
M"WF@Z5?6$UC/80&WF65654"G]X"'((Y!8,V2.>35?4;"TT[PMJ<%G;QPQ_9)
M"0BXW$1XR3W. !D\\5LU0UK3I=6TFXL8;Z6R,RE&FB168*>",,".10!F^'!,
MWPYTD6QQ.=)A$9]&\D8_6O%!-X8/PZ\*VL<5N/$L.JP?:E,?^E1OYV)#(?O
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MVCVNFP&&*25IG!D9RSG&6)8DDG [UH44 %%%% !1110 4444 %%%% !1110
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M]XG_ .P7;_\ LM 'I-%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO^B7R_\ @WC_ /B:])HH \V_X3CXA?\ 1+Y?_!O'_P#$T?\ "<?$+_HE\O\
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M^7_P;Q__ !->DT4 >;?\)Q\0O^B7R_\ @WC_ /B:/^$X^(7_ $2^7_P;Q_\
MQ->DT4 >;?\ "<?$+_HE\O\ X-X__B:/^$X^(7_1+Y?_  ;Q_P#Q->DT4 >;
M?\)Q\0O^B7R_^#>/_P")H_X3CXA?]$OE_P#!O'_\37I-% 'FW_"<?$+_ *)?
M+_X-X_\ XFC_ (3CXA?]$OE_\&\?_P 37I-% 'FW_"<?$+_HE\O_ (-X_P#X
MFC_A./B%_P!$OE_\&\?_ ,37I-% 'FW_  G'Q"_Z)?+_ .#>/_XFC_A./B%_
MT2^7_P &\?\ \37I-% 'FW_"<?$+_HE\O_@WC_\ B:/^$X^(7_1+Y?\ P;Q_
M_$UZ310!XE->?$&7XBP>+?\ A7DH,6G&P^R_VE%SERV[=CWQC'XUTG_"<?$+
M_HE\O_@WC_\ B:])HH \V_X3CXA?]$OE_P#!O'_\31_PG'Q"_P"B7R_^#>/_
M .)KTFB@#S;_ (3CXA?]$OE_\&\?_P 31_PG'Q"_Z)?+_P"#>/\ ^)KTFB@#
MS;_A./B%_P!$OE_\&\?_ ,31_P )Q\0O^B7R_P#@WC_^)KTFB@#S;_A./B%_
MT2^7_P &\?\ \31_PG'Q"_Z)?+_X-X__ (FO2:* /-O^$X^(7_1+Y?\ P;Q_
M_$T?\)Q\0O\ HE\O_@WC_P#B:])HH \V_P"$X^(7_1+Y?_!O'_\ $T?\)Q\0
MO^B7R_\ @WC_ /B:])HH \V_X3CXA?\ 1+Y?_!O'_P#$US=Q>?$&?XAVGBS_
M (5Y*IM[!K+[-_:41W98MNW8XZ],?C7MM% 'FW_"<?$+_HE\O_@WC_\ B:/^
M$X^(7_1+Y?\ P;Q__$UZ310!YM_PG'Q"_P"B7R_^#>/_ .)H_P"$X^(7_1+Y
M?_!O'_\ $UZ310!YM_PG'Q"_Z)?+_P"#>/\ ^)H_X3CXA?\ 1+Y?_!O'_P#$
MUZ310!YM_P )Q\0O^B7R_P#@WC_^)H_X3CXA?]$OE_\ !O'_ /$UZ310!YM_
MPG'Q"_Z)?+_X-X__ (FC_A./B%_T2^7_ ,&\?_Q->DT4 >;?\)Q\0O\ HE\O
M_@WC_P#B:/\ A./B%_T2^7_P;Q__ !->DT4 >;?\)Q\0O^B7R_\ @WC_ /B:
M/^$X^(7_ $2^7_P;Q_\ Q->DT4 >;?\ "<?$+_HE\O\ X-X__B:/^$X^(7_1
M+Y?_  ;Q_P#Q->DT4 >;?\)Q\0O^B7R_^#>/_P")H_X3CXA?]$OE_P#!O'_\
M37I-% 'FW_"<?$+_ *)?+_X-X_\ XFC_ (3CXA?]$OE_\&\?_P 37I-% 'FW
M_"<?$+_HE\O_ (-X_P#XFC_A./B%_P!$OE_\&\?_ ,37I-% 'FW_  G'Q"_Z
M)?+_ .#>/_XFC_A./B%_T2^7_P &\?\ \37I-% 'FW_"<?$+_HE\O_@WC_\
MB:/^$X^(7_1+Y?\ P;Q__$UZ310!YM_PG'Q"_P"B7R_^#>/_ .)H_P"$X^(7
M_1+Y?_!O'_\ $UZ310!YM_PG'Q"_Z)?+_P"#>/\ ^)H_X3CXA?\ 1+Y?_!O'
M_P#$UZ310!YM_P )Q\0O^B7R_P#@WC_^)H_X3CXA?]$OE_\ !O'_ /$UZ310
M!YM_PG'Q"_Z)?+_X-X__ (FC_A./B%_T2^7_ ,&\?_Q->DT4 >;?\)Q\0O\
MHE\O_@WC_P#B:B\$6?B6\^)6M>)-<\//H\5W8QPQQM<)-\RD=U]AGI7IU% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%17-Q%:6LMS.X2&%#
M([GHJ@9)_*OG+PYK>H67C#1/'MY?O]B\0ZG<6LMLTG$,3$+'D9Z @_@@]: /
MI*BOG/Q]>:+'\8]>7Q*^K/I\6GQM$FGNP99-L>#UP!@MUXR:VO#_ (3F\1_!
M6WO_ !)=7LEQ9075S8/'=G/EE05#$$YY3@'D#CCI0![E17SEH_AFSM_@)>^+
M4N+W^U;BSEC=C<,4Q]HV\+V.%'ZU>U:>\\2R?#3P0]]<6VGW^DP75X\3X:;]
MU]TGZ(?Q;/:@#W^BO"OB9X*L/ ?PXU)]"N[^*&ZNK8&![@LJ%2W*]QG(SSV%
M=-\;9YH?A+(\4KQN9;<%E8@]10!Z?17F7PLL="2XN[K2]$\2:=<+ B2/JZNJ
M2ACG]WEB#ROZCUK)\?K/XP^+NB>![B[N+?1A:F[N4A?:9FPYP?;"@>V30!['
M17-^$O!6G>"X[R#2Y[LVMRZN()Y=ZQ$ @[<\C/&?I60WQF^'ZL5/B%,@X/\
MHTW_ ,10!W=%9=IK%EKGAPZII=QY]I/$[12JI7.,CH0".0:\$\&>";36/A#>
M>)UO]1M=;M1<2Q7,-TXP8P2!C/?&,CF@#Z/HKYFUKQ!-XEC^'=[KL6IWR7-K
M<+=6^G9\Z<H[)E54C).T$_C72^*M"NIOAAIO_"+:-KR:4=0,^HZ9=,ZW<D8^
M4@C).WY>@SU!QQ0![I17S\WBKP[H7PEU^Z\"-?V-U+/%#/:W,C%[-WR"RY)Q
MD*PSGJ!T(Q76^&?A3I.C:9INOP7^I#5X[?[1-.+@XG+(259?[O/UXH ]4HKX
M^TJZ@F\.Z5'I5SK*^,KB_P!D$PN"D!7/ W,<9Y'3\:]>-Q=+\;/%L;SO\GAH
MM@,<!ML7(';G- 'L=%?)>A75J-#\-2>'M2U%_&TNH[98(I9"OE;F^\#\N,;.
M_0G-=MXR\ Z38_$_POI<$^HBUUB29KH&Z8G(Y&T]NM 'OU%>*)#'X1^,L=E9
M/<26>G^&Y)$BEE+EL%VY]3FJ7@OX?6GQ&\'2^*?$.I:A/K-\\QCF6<JMOM8J
MNU>F,C..F.!B@#WBBOF&ZU35?&'PS\&6%Q?SBZDUMM.-PSG+# "DGO@.!GVK
M5T?Q7>ZQXC^'FFZA+*FJZ5?75C?QLQRQ0(%9O7(R,GN#0![WJNL:;H=H+O5+
MV"SMRXC$DSA06/0?7K5ZO*?&?_%7?%WPWX57Y[+2P=4OQU&1]Q3^@^DE<+K-
MGI^F_$#69/B39:P([N[)TS6+>5Q' F25"XXX&..2,=.] 'TA17SMXTNO#D_Q
MAUS_ (2;4[F#31I<;VK6\KC,I1"NW;G.06//%8^HW6K2^!_AX/$']JW,<U].
M&AB9C<3V^Z,*%Y!)()"Y/0B@#ZAHKPCQ'JMOX2^#M]=>&+#7='?4+];5O[4W
M+.GRY++EC@$+@$'N?2MM_A3I/A;PM=ZU97^HC4[?2[EIY?M!VW!:!P=R]@"<
MC'H.M 'KE%?,FKW2GX7?#07]S="SEO)A=F%VWM'YN#C').,XK5\5'0[3X8::
M_A2YU/[(_B6(2->,ZOO\IL@;L';C;[9H ^AJ*\3U6P_X61\;M2\.ZO=7*:+H
MUHLBVL4A02N0F2<>[]?115[QSI\?@3X<KX5T2^NC+K>H+:VGVB;<T*N1N ;C
MY1C'_ Z /7J*\=^'-G%=V?BSX<:M?3W,=C<[H9EF(=X'(((8=.0"?]^L/P;X
M!TB_^)OBG2YY]1-KH\L+6H%TP/.2=Q[]* /?J*^;4\4:IH7PT\:7%E=3)=3^
M(GM4F#G=$K#)(/;A2,]LUL>.?AU9> /!B>*-"U+48M;L98GDN7G)\\LP4Y'3
MJ<X].#F@#WJBOFSQI?ZW<_$BX\1:3-,DVEZ3:ZK]G#'#)\F]2/3#DGV!K>T/
M5;_Q9XB^(MUX;NI!/>:9;/9?O,%&:(?*#GY6ZC/8T >ZU1O=9TW3KNSM+R]@
M@N+US';12. TK#&0H[]1^=>*_"3_ (1BQ\26EA>6&JZ1XRCB=)DNY'V7F02Q
MP?H2!@=.IK<BMQX[^-NJRNS'3?#MF;.-E/\ R\2 AB/<9<?5!0!ZY17S19Z[
MK'_"I+WP@ES,^N'7UTQ/WAW@$[^O4#<C#Z&M6V\0WGBWPE\-M CNYQ=7-^RW
MC)(0_EVYP<GJ<H<_A0!]!45XG8:)#\4_B/XM7Q#=7C:?HEPMI:644QC0<NI;
MCN=A/X^@ KG9[B\\.^'?B7X1BO[J:RTP0263R.2T2M(N5W?0KQTX/J: /HZB
MOFGP/-!<>._"$/A2?5H[H6XEUL7<Y$4B[5W;%8_,,[NW=2.F:SX=8U/4-:U;
MP9#>R64&M>(Y4GOY&.%16_U:GU)QQQ_".A- 'U-15/3].BTG1[?3K+*Q6T(B
MB,A+'@8!)[^]?/?A&WTK1?&$%O\ $"SUBR\4'4!-;:J\SF*<AAA<]"I/&<$8
M/44 ?2%%?/VM_#S1K/XP>'?#D-QJ0T_4+:::<&[8MN59",'MRHK;^(MC]KO/
M"_PUTG4)+2+RGN9IGE^98XT81[F[Y(;\<4 >S45Y/X'M++XF?"O3M/UR:Z,^
MF3F"8PSE'WQ@A<D=?D8?C7+?"CPM97?A'5?$\UQ?'4;&:[AA/VAM@40C&5[G
MYS^E 'T#17SQ\';71;]]%ENM'\32ZL)9'&I#?]ARI8KEMV.@"].O%9W@[5;W
MP]\0%U^>\G;3K_7KO2;I7<E%SM:,G_@3$_130!],45\Y7>I7FO?&71_$*W,G
M]FS:X=.M$#':T<(3<P]0Q<G\ZA1-*O\ XC^,8]<TCQ-JH34BD!TD.RPC<X._
M##&<#'T- 'TG17SGX_&L6'Q6U'4=%N)@WA_3[:\$.\D/$I16!]L,2?;-;OA5
M=.^(_C7QLDMQ<MI=]!8S((IBC)\@;&1T((P?QH ]OHSBO!?ACX(TN_\ &GB9
MKB>_;^P=7"60^TMC".^-W][[@KTKQI<6D.N>$8[G3TNGFU0+"[2,OD,$8[P
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M/_+"+_O@5+10!%+"KVSP+A%9"O Z9%>0Z7\)/%EGX:;PPWC.&WT21F,T=M9
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M^1KO:* .1LO#VO7EK?6'B&YT=[*YLY+4_P!GVC12/O&"Q+,0.,\ =3[5C0^
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M:9=1VMY=I%/)#).B$$DQQC+MP.PKS_XDZ3_PD%[X*TK6$B#7EQ-%<" EE5C
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M[!G!(7=GG![UUWA^.^NO%WCK4=<CAL]82P2W^QV^6C,.PE90YY?)&.@QC'T
M/03XIT,6.G7IU&'[/J4BQV;<YG9N@48S6Q7AWPE,8U71QXB_X_#I:?V!G_4^
M3@^;L_Z:Y^]WV].*]QH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH H:WH]KX@T:ZTJ]\S[+<ILE$;
ME6*YSC(]<5'J^@:=KGA^?0[V#-A-&(C&AVX QC'IC Q]*TZ* ,C3_#FGZ;JM
MYJ4 E:YO(88)FD<MN6($+^."<^M4XO ^BP>$+GPO%',FE7&_,8E.5#MN(4]A
MFNCHH R=7\.:?K>C1:5>+(;:)XG4*^#F,@KS^ K/U_P'HOB'4H]3G^UVFHI'
MY0N[&Y:"4I_=)7J/K7344 <?/\-/#\VF6EDC:A!]DN'N8[B*]D$WF.,,Q<DG
M)%$WPYTJ>TLH9=1UIY;*=Y[>Z;4',Z,ZA6 <\XP.GU]:["B@#-T71TT2T>W2
M^U"\#N7\R^N6F<< 8!;H..GN:R-<^'^B:[JW]K.;VRU$H(Y+JPNG@>1!T5MI
MYZ#WX'I74T4 <[8>"-#TU])>V@G#:6TSVQ:X=CNE^^6R?F)]^G:J-]\.=-O]
M9_M:75M>6\4N8GCU%U\D.<LJ?W5]AZ5V%% &?;Z-9VNLWFK1"3[7=QQQREI"
M5(3.W"G@=3TK(\0>!-*\1:DNHS7&HVEV(A"TMC=O"9(\D[6QP1R?SKIZ* ,.
M3PCH[>$&\+1VQATIH?)\J-B"%SD\]<D\Y]:FN_#FGWMQI$UPDCG2G\RV7?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAS6OVJXF*7/V-PS3VICRYEQUZ Y;OF@#U+2==T_6I+^.QF,C6-T]I."I&)%
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M'>OR?>Y^[]:\%TO2]&L/A#XT>V@MHM5C>\MYMA'F+&LORJ1UP.*Z#6].\/\
MA7P3H5G'HMM>3:O=0!VO[ETADF,9)EG;G=U/!&,G..!0!ZTCI(H9&5E/<'(J
MCJFN:?H^CW6JW=P!:6J%Y73YR!]!7@RW%U8>!/B%;V+6L%O'J%LKII4K/!%&
M^T2^6<9P1D'CU]*ZKQAX=\!GP'XA_P"$>M],>ZBT\7!CM)0P4)G;(5!QD9;Y
MNIR: /6H;F&>U2Y1QY+H'#'C@C-/21'3>CJRG^('(KQO4K+P[')X TW%I'X5
MNGFEO$20"WEN!"IC$ASCDYX/6J&H)8VEC\3[/P^R#0H["%ECMVS!'.5.\)C@
M' &0* /<U=6+!6!*G! /2D,L8D$9D42$9"YY/X5S_@KP[IF@>'K;[!!LDNH8
MY;F5F+/-(5R68GJ3DUY[/%I^@?$Y-3N!I6NIJNLK!#<)<?Z9ITV"NP@=44@C
M'&._:@#T3PSXG7Q!_:_F0);&PU6?3E!DW>;Y>/FZ#&<].:WWECB ,CJ@/ W'
M%?/^H^'=+N?!/Q)UR>U$FI6^NW8MYV)S#MD0@I_=/S')'7C/2MCQW>Z?JFKW
MEA+I.BS7=KHR337NLW3)@,K$"%<$;AG.1C)X[4 >EZKXD.F>+O#VABU$@U?[
M3F;?CRO*C#],<YSCJ,4>#O$A\5Z -4-J+8F>:'RP^_[CE<YP.N,UYUH4TD^H
M_!Z2:1I'-A>Y9CDG_1U%=1\(0#X!4$9!O;O(_P"VST :&D>*=1UOQ9JEE:Z?
M:KI&F7!M9[I[D^:T@0,=J!<8!(')_P *ZO(XY'/2O"[3PWIEKX4^*4]AIT4=
MQ;W-Y;0M&O*0B-&V#V[UM0:UINJ>-?A?'8WT%Q)'8W+2I%(&*9ME W =#E6X
M/H: /6?,0,%WKN(R!GF@2QF3RPZ[\9VYYQ]*\9\*^'M-/@?QAX@D@,FIA]3B
MCG=B3%&-_P JCH!R3]2:@TO0=.T>/X6ZK90&/4+UT%S<[R7E#V^2K$GD=@.P
MX% 'KVGZC<7<M^+K3YK*.VG,4<DKJ1.@&?,&#P/K5#Q-XG'A^#2)8H%NEU#4
MX+#(DP$$A(W=#G&.GZUYJVEKKF@^-M/;5K33WE\5R>6;R3;#.RJC>4W()! /
M YXJC>RZ=KG@C2M-BTF#3(XO&,-C=0V,Y:)GY#/$PQ@$,,8Z4 >[)(D@)1U;
M!P=IS@T/)'$,R.J#IECBO.O"6E6.@_%CQ+IVE6R6ED=/M9?(BX3?EAG'K69\
M1;K3;_Q<^D2Z1HL]S!I9N'N]:NFCC2,LPVQ* 1NSDEA@].>* .[UKQ(=(\1>
M'M*%J)1J\TL1E\S'E;$WYQCG/3M1X2\2'Q/IMW=FU%MY%[-:;0^_=Y;;=V<#
MKZ5YCX=FDGL/A \LC.^^Z7<QR<")@!^0 KL?A/\ \BYJG_8:O/\ T90!TUMX
MBT^]O-6L[60R7.ED+<(5( )3< #WX]*@\(^(U\4>%].U=X4MI+R(R>0)-Q7D
MCK@9Z>E<%X7T/0+#XC>-@+.TAOK:2-K)> ZJ]N2Y0>AR<UR^BZ!IFG>!/ASK
MEM;!-4N-=M4EN]Q\QD9W!3/]W  QT_,T >_M+&C*KR*K-PH)P3]*?7@5_I$_
MB?Q/XUAOY?#J7<=VT,4NK2R+/;0A1Y;Q8.%7^+(ZG.<UZW=13V_PWFBN;I;N
MXCTAEDN5.1*PAP7![Y//XT ;_FQ^9Y>]=^,[<\X]<4-+&CJC2*&;[JD\GZ5X
M=I6@Z=I.E?"_6+. QZE=W<*7%UO)DD5X6RI)/W<  #H ,"J$VCW'B?5/&8OK
MGPY!?QZG-&MSJ<TBW5I$N/*:,@X5 .0>_.: /H"26.( R2(@/ W,!FB26.(
MR2*@)P"QQ7D;6FCW_P 2-2LO',UE=16NCVHLVO9 L;@C]](FX@9+=QS65J5E
M#K'Q!GTY#H-SID&D6HTI-:FD9&@9>7B(/+9ZL>>!S0![E))'$NZ1U1?5C@4C
MS11J&>1%4]"S  UXOJOAIX?"'A9+O7-#UB?1H;F5K&]NOW%]$20"I[E%PH)!
M /I47B :9J_AWP[XDMX=*>RL-(:0^&]3N<?N<8W1GKN&P@,1S@=Z /;GECB
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M *N2XN%17_W23SU[5E:_X[T'P_IMA?SWL,UO?SI% T,R$,&."X)8 HN>2.E
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M(&:BCUW2)=);58]4LGTY02UVLZF( <'+YQ^M !INA:1HRR+I>EV5BLG^L%M
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M/(50L/DR&()':@#H**RO#.I3:SX6TG5+A42>\LXIY%C!"AF0,0,DG&3ZUJT
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MO)KT*R1N,JPV/P1W%8+:!I3^-/B:S:9:DPZ9;^2#"N$WP.6VC& 257GVKU_
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M;K?Q$TN2.U@U.1IIK6+RPKF$V^<IQTZYQ5&PTNQL?#'PIN+6SAAFDOX6DE1
M&8O$Q;)ZG)KVPJI8,5&X#&<<T8'' XZ4 ?/+V-I._BS2/$GBBQT:XN=3FDDA
MNM,$DTJ%@8WCD+!B,8VA>F/>O9/%6AW.K_#_ %+1+:4O=36)AC=SC>X7C/ID
MCGZUT+1HS*S(I*]"1TIU '@^L^-=+F^'5K;1:YJVC>*--LEM5TR%Y(6:90JX
M90/FZ<<]#6Z^H:7HGQ+GO_&31Q1W&C6RV,]Y'N3(SYJ@D'#;CDCK^=>LF.-I
M Y12XZ,1R*'1)  ZJP!R,C/- 'A,&EW%G\.HO%-G:31)H^OS:GI\3(58V+.
MRA3]U2N6QZ#WHUBROM2^&]WXI9)$&M:Y%?W>Z RF.Q1ML89/XE4!6QW!KWBB
M@#QFSLM,N(?%>LV7BRQUBY;P]/;RPV-BL"*N"59MK$%N".><?2H]9T33;/\
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M:I87WB;5-3?0I[,MJ=H8Q@@D(H\I"SY'09ZT :OB[XKZ):>#M6O?#^K0W%_
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M[D*C[7.W=@-C;NQ_#G/;&:X[2=/TW4[W4=3M]0\5:CJ<>D3VX_M2S\I45O\
MEG_JDR^>@!/>HH-&O(O!GPPA339TDM=2MI+A! 08AL?<SC'R\GDGN: .JT+X
ME:/KGBO4]!1A'):2!()#N_TC"%G."H";<$<GG%:NB>,_#WB.]EM-(U%;J:)"
MY"QNH*AMI96( 89XR":Y?3I?[)^(OC*VU#3K^6+55AFMFBM7>.=$MR'4,!M!
MX(P2,D@=ZR_ VHS:)JUS8Z?)J\_@^RTV2XSJ=D87LY V3$KLJ[QMR<<X]: /
M6JYNT\?^%[[5HM+MM7CDNIG*1#RW"2,.H5R-K'Z&M+1M8CU[P_::O:02I'=P
M":*.<!6P1D X) _6O%[2X\2Z]J7A2;5?[;DO+;6T>[LFTL0VMDH+ ;7" GC'
M.XC!Y[4 >@:;\5-!OM?UG3)9/(73V_=S;7;SU"%G.-GR[<$8YSCBI/"WQ.T/
MQ%X9EUFXE2P^S@FYB=F81 N43YMH#%L# '/.*K>'Y'TKXJ>*K6[M;M?[5DMY
MK2<6[F%U2##?.!M!!&.2.:Y?1M2US0?A%<Z1IFG7\>NZ7<,LVZQ9MB/<,?,C
M##;(0IR,9]: /2]&\8:!K_VO^SM120V@#7"R(T31J1D$AP#C@\]*Q[KXBZ%J
M&C:O_86JI+J%OI\]U#F%U#;%/S*64*X!QTS7!6>E:SK>H>,#;R:Q>&^\/B&V
MO-1LQ:F9LM\BC:HQVY&>?3!KHK+7X=6^'\V@V^A:O'J%MH,L+B73VC6%Q#MV
M!B!DL>@7.<4 ;/@[XB:+K>GZ)8SZO%+KEW9QO(@C90\OEAI &QLR#G(!XZ5H
MWWQ \+:;JKZ;=ZQ#'<HXCD&QRD;'HKN!M4^Q(KCXM)NHM,^%*1Z?,GV0QFY5
M82/))M_F+\?+\V<Y[US4>@I!'K^@^);WQ;;_ &O49Y1;Z?9B6"\1VW*RL(F^
M8\9RPQ@=* /6==\:^'] NC8W^J107C1>8(RK-M7LS$ A1GNV!4/P\UB]\0>
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M#"')/WB!CDURL>AZM:^$OAU?3Q:S:6^FK=)>FPM]US;&3(5]C*QQQ@_*< T
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MRS >6S?>P%YP>": .OHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JKJ.G6NK:=/I]]%YMK
M<(4ECW%=RGJ,@@XJU10 V.-(8DBB14C10JJHP% Z "G444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>modificationno14effectiv004.jpg
<TEXT>
begin 644 modificationno14effectiv004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-H/@ZPDG4_9=5L(M['&0G!;]* .@UW77T_4])TBT2-M0U25UB,@)2-(UW.Y
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <U#X<U:
MTGN5M?$4@LIYGF,<UHDDB%R20LA[9/&Y6P,#H*WK*SAL+&WLX 1#!&L: G)P
M!@5/10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M17979"IPA(;@\]5-0!]6D\&W;:W#:PZ@;:;S$M'9XP,-C!(STQ7$_">^M/\
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MJ"/JPKC/!.HP^'/BK964&CZMI.FZQIL=GLU.U\@R7$"@!@,D'*@#ZO0!V/\
MPNSP=YWD[]2\W&[9]ADW8]<8J6\^,OA&QNC;7#ZBDF_8 ;&3YCZ#CFJ$W_)R
M=M_V+Y_]&-1\4_\ D;OAY_V&E_FE '4R^/=!@\'?\)3/-/#IF[:#)"RR$[]F
M-G7K^G-:VBZW8>(-$MM7TZ;S+*X0NCD;> 2#D'I@@C\*\U^*.LK<>-?#.@?V
M=?ZG;6DG]JWUK80>=(RKE8P5]-V<Y[$5SG@^_O(OAWX_\*6]M>VES81SSV=M
M=1F.=;>520I7J#@9^KB@#T)/B_X0EU,6<-U=2QF80?:X[5S )"< ;\>IZ]*Z
M+2/%.E:X=4%C,['3+A[:ZW1E=KKUQZCCM7*?"[5_#T7PKT9!>V44:1".=))%
M&)BWS @]RQR/7(KB/"=AXLN]3\>/H&M6=A:KK%R)XY[7S2YRW(/;B@#TFX^*
M'A>V\)6GB:2ZG_LRZG-O$X@8L7&[(V]1]PUMOXFTE/"W_"2&Z']E?9_M/G!3
M]S&>G7/;'7->":=&DWP;^'\4BAD?Q0BLIZ$&27(J[8FYGDA^#\@D98-;9IF.
M<'3U_? $^K$_RH ]47XG^%V\(OXG%U/_ &8EQ]F9O(;<)..-O7N*?:?$C0;O
M3]1O@NH0V^GP^?.T]E)'\O3C(Y/L*\5U(8^!6MA<#'B>0#VY%>D^*(=;@^%_
MBL:UXAL]78V>8OLULL/ECOG!.<\?E0!TL7Q$\-S>#)O%D5X[Z5"VR1Q$V]&W
M!<%>N<L/P.:IZ]\5?#'AN_>TU&2\1U5&+I:.R890P^;&.A%>(^*HY?!_@Z73
MU4_V5XITFRNX0!Q'=QF(R#\5RQ^H]*],^-/_ "2&V_Z[VW\J .C_ .%J>%QH
MHU1IKQ8VN/LL4+6CB6:3 .$3&3P1STK=\.>);#Q18RW5@MR@AE,,L5S T4D;
M@ X*M[$'\:Y_X@>%H_$SZ0UIK<>E:]82/<:>[D'<?EW?(>HSLYYQZ'-1_#+Q
M;JOB2UU:RUN.W;4-(NS:RW-K_JIR,\CWX/3U' H Z^TU.*\U"^LT@N4>S95=
MY82B/N7(V,>& [XZ5=KS.[77]9O_ (A:9I.I2Q7:3V:V@:=D"#R49T0_P;AN
M&1W.?>N@\!WMG-8W]E!;:C9W-E<^7=6=_=-<-!(54X60LV4(Y'/<\"@#K**\
MNO[2XUGQ-X^2XU;5(X--A@DM(;>[>)8I#;;MXVD9Y&<?=R22":KZ3)?6\OP^
MUI]5U">]UOY;_P ZX9HY5: R "/[B[2!C: ?7- 'K-%>1 3:QX+\3^*;S6=0
MM]6L;B\^S^5>21QV9A)V1^6"%.=JYW D[JT[2:Z\6^+[2RU:ZO;6&/0+>_6V
MM;B2WW3R,=SDH03MP  >!GI0!U%CXQL[[3H[V.SOC')J+:<%2'S"KJY0NVW.
MU,K]X]*;<>+E3Q#?:5:Z5>7BZ=$LE]<0[<0[D+JH4G<[$#HH/45YUH=U<67@
MG01:W\S"7QCY,DR28,Z&=\[BN 0W4CH:TK#28;+Q5\2+R"XOUGM8T:(F]E(R
M]KN)(+88@GC.=O&,8H ]/L+Q-0T^WO(XYHTGC614F0HZ@C.&4\@^U6*\=34=
M;U@>#]'$5U?03>'(KZ9%U-[1KF4A%):5?F;;G.,\ELGI5MHO$=I;>&_#NMWE
MQ;6]_J\\;R)>L\OV98V>.%IAAB21MR,$@"@#T*SUZWO?$>IZ(D4JSZ?'#)([
M8VL)0Q&.<\;3FM6O//!EE%IWQ,\96D-W/<1QP6(4SS&5T&V0[2QR3CW).*=X
MTFAU'7WTFWM-8O;RWL?M#I::F;.&W4LP5R0R[GR#QR,"@#T&BO)8?^$A\0_#
M_P 'ZL6N]2MXH&DU.TM[QK:>Z&,*X<$;BI!.W(W$UZ!H-Q8:]X/LY;*>[DL;
MJU"I++*PGVD8Y<'=O_V@<YYS0!%X?\3_ /"1SW3VNFW*:;%))%%?2.FR=D;:
MVU0=P&0<$CG!K>9MJECT S7B.@1RZ1\,]+-A?7UJVKZX+"YN!=.WDQ&YE4E-
MQ(C8X +  DG)YKL;6W;P]\1H]'T^ZO9M/O-*EN)[>YNI)_(='4+(#(21NW$8
MS@X]J -73/'5AJB>&VBMKE!KZS-;[PO[ORU+'?SW XQFNIKQCPAQ;_"7_KE?
M_P#HEJ4R7DWPJ?QVVKZB/$ <W"D7<@B5A-M%OY.=FW^'&,Y- 'LU%>5>*-6U
M72=;UW1X[RY2?Q!;6ITL&4G[/*[B"4(<\8W*_'3K4OA+6-2UW6-#TR6]F$VA
M6=Q_:AWG][.KFWC$G/.=DDG/L: /4**\W\$K<Z1KQT;Q#_:(U^>VEE-V;YYK
M:]0.,NBDXC9<@;=HP#WKM]!L8M-T2VM(-0N=0BC!"W5U/YTDF23DOWZX_"@#
M1HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH KWUC::G8S65];QW%K,NV2*1=RL/<5BZ%X$\+^&9Y9]
M'T:WM9I5*-(,LVT]0"Q) ]A7144 <I9?#/P9IU]!>V?A^UAN8)!)%(N[*L#D
M$<^M6-=\!>%O$UV+O6-%MKFY  \TY5R!T!*D$_C71T4 9%SX6T*\T6#1I]+M
MVTV!E:*V"X1"O3 'U-6-2T33=8DLY-0LX[A[.87%N7S^[D'1A[U?HH Y_7_!
M'AGQ1,D^LZ/;7<R#:)6!5\>FY2"1[59@\+Z':Z#+H<&EVT6F2J5DMD3"N#US
MCDGWZUKT4 8^H^%="U?1[?2=0TR"XL+8*(87!Q'M&U<=Q@<5:U'1]/U?29=*
MO[5)[&5 CPMG! P1T],#\JO44 9^BZ'IGAW34T_2+..TM$)81QYZGJ23R3[F
MM"BB@!LL:31/%(H:-U*LIZ$'J*YC3_AOX/TJ]2\L=!M8;A P61=V0&!4]3Z$
MBNIHH YNY\ ^%;O0K?19]$MGTZV9GAAY'EECDE6!R,D\\UHZ)X>TCPY8?8='
ML(;.V)W%(Q]X^I)Y)]S6G10!0T?1=-T#3UL-*M([6U5BPBCS@$]3S46N>'-&
M\2VBVNLZ=!>Q*<H)5Y0^JGJ/PK4HH QM \):!X6CD31-+M[/S,;V0$LV.F6.
M2?SJUI&B:;H%D;/2K..UMR[2&./.-QZFK]% %"^T73=3O;&\O;..>XL7,EL[
M]8F.,D>_ I-1T/3-6N;*YO[..>:QE\ZV=LYB?CD?D/RK0HH H'1--;75ULV<
M9U-8/LXN.=PCSG;],T:AHFFZK<V5Q?6<<\UC+YUL[9S$_P#>'Y"K]% %"+1=
M-AUJ?68[2-=1GC$,MQSN9!C"_3@?E2)H>F1ZY)K26<:ZE+#Y$EP,[F3(.T]N
MP_*M"B@#E1\-?!BZNNJ+X=LENU?S P4A0V<YV9VYS[5LV&@Z7I9O38V4<'VZ
M5I[G;G]Z[=6/UK1HH PX_!WAZ+3+'38]*@6SL;@75M$,XCE!)##GKDG\ZMIH
M.E1Z])KB6,(U22+R7N0/G9../T'Y5HT4 8,G@OPY-H\VDR:3 UA/.;F2 YVM
M*>K=>M06/P^\)Z;;7EM9Z);0PWL7E7"+NQ(G7!YKI:* ,;4_">@ZQI5KI>HZ
M7;W%E:[?(A<'$>T;1COTXJQJNA:7KFG#3]3LHKFT#*PA<?*"O3IZ5HT4 8WB
M#PEH/BJ&&+6],AO%A),9?(9,XSA@01G []JLZ-H>F>'M/6PTBRAL[526\N)<
M9)ZDGJ3[FM"B@#)N_#&BWRWPN;"-_M[I)<G)!=D "-D'(( &",5-H^A:9H%J
M]MI=HEO%(YD?!+,[GJS,223P.2:T** **Z/IZW&H3BU02Z@%6[;G,H5=HS]%
MXIB:#I:1:;$ME&$TS'V,<_N<+L&/^ DBM&B@# NO!'AN]U.34+G28);B5P\N
MXMLD8=&9,[6/ Y(-6-7\,:+KTL,NIV$<\L*E4?)5@IZJ2I&5/<'BM>B@#)B\
M,:)#9P6D6FP1V]O=?;(8D&%2;<6W@=CDGVJP-&TX3:A*+1/,U$!;MN?WP"[!
MG_@/%7J* ,6]\(Z#J-A8V5SIT;06"A+0(S(T*@!<*RD,!@ =><4/X2T&715T
MB338VL4D\U8V9B5DSG>&SN#9/WLYK:HH R])\.:/H4DTFF6$5J\RJLK)G,FT
MDC<3U.6;D\G-1:KX4T+6[Z*]U'3HKBYC3R@[$C<F<[6 .&7/8Y%;-% &!=>"
M?#EY8VEE-IB?9[-&C@1)'38C=5RI!*G'0\5LVEI;V%G#:6D*06\*!(XHQA44
M<  5-10!E'PUHS:')HC:= VFR%BUL1E268N3]=QSGL:-(\-:/H7G'3K)8GF
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M_,5F^"KVYU+P/H5]>2M-<W%C#++(W5F* D_G6GJ0=M,NEBC:61HF"HN,L2,
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MX@$J5&1G)!XK-OO#]_-I_CC4(K.7[5KMJ+>VM-R[OE@,:LQSM!)8]^ !GG@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$6+&V%U-]GR3D_N=WEX]MN*Z"B@ HHHH **** "BBB@ HHHH **** "BBB@
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M.?2@#2HJA=:C);:AI]K'87-Q'=LX:XB4%( JY!<D\ ]![U?H **** "BBB@
MHK"U3Q-'87=U9VMA=:C=VENES/!:A2ZQL2!@$C<QVL0H]/<9UFO((XX'E?RO
M/94C63Y6+$9"X]>O'L: )Z*R--\00:GKFL:5'!/%-I;Q),TFW#F1=ZE<$\8Q
MUQUJS<:A)!J]G8K874L=PDC-=(H\J';C <YR"V>/I0!>HHHH **** "BBHX9
MXKB,R0R+(@9D)4Y&Y6*L/P((_"@"2BBB@ HJ*:YAMVB6:54,KB.,,?OM@G ]
M3@$_A4M !1110 4444 %%4=1U"2QELDCL+J[%S<"%F@4$0 @G>^3PHQ^M7J
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MP#@\$CGL30!YUH\8\'?%"VLTT^:PTO7K)8(TE=&_TFW7 .58CF/UY)K<M/\
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M1V<2N<?-R>#P.1CH/2ETSPIHNCWWVZRLRMWY M_/DF>1S&#D*6<D]3_(= *
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MG/E(1@@<\Y  Y]!Z4 <CX:U.^M?$UGI?B!+^'4IUF:"Z2Z::RU%1\VY1G$;
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MT-GN ,]ZU;31M/L=3OM2MK81W=_Y?VF0,3YFQ=J<$X&!QQB@"]1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ> .M>9^)? WB&;7](@TRVN$T_7].M+3665#^Y\HIN+'^$[5 YZ_,.]>\T4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
..4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>modificationno14effectiv005.jpg
<TEXT>
begin 644 modificationno14effectiv005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B@G R>E,$T3
M0"<2H82N\2!AMVXSG/3&.] #Z*S/^$CT/_H,Z=_X%)_C3SKNCK$LK:K8B-R5
M5S<)AB,9 .>V1^= &A16<GB#19'5$U>P9F. HN4))_.K\DL<,;22NJ(HRS,<
M ?C0 ZBBJ%YKFD:=.L%]JMC:S,,B.>X1&/X$T 7Z*I2ZQI<"!YM2LXU)*@O.
MH!( )')]"/S%-;7-(2&.9]4LEBDSL<W" -CK@YYQ0!?HK/?7M'C5&?5;%5D&
MY"UP@##)&1SSR"/PJXT\*6YN&EC$(7>9"P"A<9SGICWH DHK/&O:.8FE&K6)
MC4A6?[0F 3G )SUX/Y4B^(-%=U1-7T]F8X %RA)/YT :-%5!JNG&\^QB_M3=
M9V^3YR[\^FW.:275=.@N3;3:A:QSJ,F)YE# 8SG!.>G- %RBLS_A(]#_ .@S
MIW_@4G^-7;:[MKV'SK2XBGBSC?$X9<^F10!-14,MW;02PQ37$4<DS;8D=P#(
M<9PH/4_2IJ "BFR2)%&TDCJB("S,QP !U)-4;77M'OVVV>K6-P>>(;A'[9['
MT!/X4 :%%9G_  D>A_\ 09T[_P "D_QJY:WMI?Q&6SNH;B,-M+PR!P#Z9'?D
M4 3T4U9(W=T5U+I@,H/*YY&?2J=QK6E6D[07.IV4,R_>CDG56'?D$T 7J*H1
MZ[I$V[RM5L7V*7;;<(<*.I//2H_^$CT/_H,Z=_X%)_C0!IT52FUG2[=8VGU*
MSB65=\9>=5#KZC)Y'O5D3PFW%P)8S 4WB0,-NW&<YZ8QWH DHK.&OZ,T;2#5
MK HI 9A<I@$],G/L?RI%\0Z(S!5UC3RQ. !<ID_K0!I454_M73OMGV/[?:_:
ML[?)\Y=^?3;G-$FJ:?#=?99;ZUCN.OE-,H?IGIG- %NBLS_A(]#_ .@SIW_@
M4G^-7+6]M;Z(RV=S#<1@[2\,@< ^F1WYH GHJK?:GI^EQK)J%];6B.<*UQ*L
M8)] 2119:GI^I0M-8WUM=1(<,\$RNH/N0: +5%9G_"1Z'_T&=._\"D_QJ[!=
MVUU;BXM[B*:$YQ)&X9>.O(XH FHK/CUW2)0YCU6Q<1KN<K<(=HZ9// Y%/AU
M?3+F.62#4;25(EW2,DZL$'J2#P* +M%5UOK1[/[8MU ;4 MYXD&S ZG=TJM9
M:_HVHS^18ZM874V,^7!<H[8]< T :-%4)];TFUF:&XU2RBE3ADDN$5A]034]
MO?6=W T]M=031+]Z2.0,H^I% %BBJ5MK&F7LWDVNHVD\N,[(IU9L?0&G6VJZ
M=>S&&UO[6>4 DI%,K,!] : +=%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6&.=!%*'6&3!\N,D$\J T?N<&NF^+?A_3;/X>>+-5CMD:^O6@DDG=06&UHD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3 ]!2T4 '?-&
M*** # ]**** "BBB@ HHHH **** "BBB@ HHHH **** "C%%% !@>E%%% !1
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **\F\>?$;Q)X)\6@?8K6^\/1B%[ETA998A(9 %W;L9_=D@D8[5
MUFG^(;O6_$=M_9>HV<NB76FF\B86Y,F[<$ W;L<$DD8R",4 =;17DOAGQQXG
M\0:SXDLIM3TFQCTB_2RBD.GO)YS/*\:9'FC'*C\_:MK7M5\>:=\/QJ]K!ISZ
MQ:&0WEJ;=RLB*[#='\X(^4!L'.0?PH ] HKS+PYXZU?QKI.B?V!=60OV!;5S
M+:,T=JHR. ''S$CY1DY&2<8J+QSXK\:>$O#U_KIDTL0QWWV>VMI+1RS19(#L
MXDZG&<8Z8H ]2HKE_#ESXFGN+2?5)[&YT^[L!<*]O;-$T4IVG8<NV1AC@\=#
M63X^\=7FAZQH_AK0X89-;U9P(Y+@$QP(6QO(')[\>Q^A .^HKD=3B\8Z8MC-
M8ZE;ZFAN88[R*6S"L(V=0[QE3Q@$G!SQDYXYPO$GB_Q'8?%;2/"5A<:?':ZE
M;F8336C.T6/,XXD&?]7[=: /2Z*XNSU3Q,^FZO=R7NG7%JMC%>:;>Q6;HDF0
MY970R'^ZO0CA@?:N9\"?%+4]:UBZ\,^)H;72]<90]E(L9\N0%00-I;DX^88/
M(/MR >M45Y=XA\;>)-%^$MEXK673Y+Z7RW>/[,WEE9", ?/D$>N>:UM+U;Q5
M=MI$ZW^F7D<PMY;^VBL7C>"*9200WF,#@CTZ<T =W17F-IXN\37WQ<U;P:EW
MIT5M9VPN$N#9LSG(C.TCS /^6G7VK2^'/C?4/%=UX@T[4[>W6ZT:[^SF>V#+
M',,N,A220?D/?N* .\HK@M<^)%OHWQ.T?PJRIY-VA6XF/_+.5L>4H_K_ +ZU
MO:T?$CZM:PZ/-9VUEY$LEQ<7-NTQW@J$50'7J"QS[4 ;]%>2^ ?&7C7QKX=;
M6HY-* @U%+:6T6S?+Q9C+L'\S@A7)Z'I6CIOC#Q!=?&;4?!\LUE_9]G;BY\Q
M;8B1P5C.W._ _P!9UQVH ])HKS7PYXUU?Q[XLUBUT::#3]%THB(SM#YLUPY+
M $9.%7Y2>A/3UX?X>\<:I<^,M;\$:L]LFKV2F2UO8X3Y<R85ANCW<-M8' ..
MO3'(!Z/17CO@?XMZIJ6NKH/BRWM=.O+Z".;3;B.-A&^]<J""QSG(QR.05ZUZ
M)X0O]2U/0A>:I+;R3M/,@^SPF-0J2,@X+-R=N?QH WJ*YGQ_XI'@[P=?:LJJ
M]RJ[+:-AD-*>F1W Y8^RFK?AS75\5^$;+6+"1(FNX P)7>(Y.C C(SA@1U[4
M ;=%>.>#?BYJMUXD70?%UO:V$M]$LFG744;+&^X?+D%CG/;D<@CKTZK3K_QG
MJMK:-;W6F)OO;N&XN#9.5CCAD:-<+Y@RS%<]>,^U '<T5Y#X5\9^.?%4'B0V
MDVD"XT>?RHX?L3_Z3@MQGS?E)V\=>36K/XP\0+\9X?!Z360T]X/M)D-LQD"[
M2VW._';&<?A0!Z317FMMXP\0S?&:Z\'F>Q%A! +GS/LS>8054[<[\?Q=<=NE
M0>&_%OBKQ#XU\3>'_MNF0+I#%8IOL+-YGS$#</,&.G:@#U&BN'^%OCB[\=^'
M+B]OK6&"YMKEK=S!GRWPJG<,Y(^]TR:B_P"%D6X^+@\&E4$!ML";N;G[VS/3
M&WC_ 'N* .]HKA_B9K7BKPUH#:UX=2RN(;;FZ@G@9V"?WU(8<#C(QTY[56T'
MQ?JGC+^QY?#MY9FU^SB3599K1F\F3_GFN''SDYXYP #GD @'H-%9NOG55T.[
MDT1H1J,<9>!9HRZNP&0I (Z],YXKBOA]X_N?%'@+4M9U.ZMK>\LFD$XC@(6
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\3*\^$1-X0C=MPI/3G(QWKV*B@#Q_4/ MM\0/A)H1M 8-<TVQB2WD=3&P=$
M:)LX(!(Z]C@],Y[/X8Q7D/P[TF/44E2] E\]9@0^_P U\YSWS76T4 >>:B\O
MC+QE=:?9W4$%MI=L\)6]L))4N'ERLA7YT'RJ N<G_6-]:Y'X/:K+X2OM<\+:
MDUP^G0S//97QMG$<@7AL<<9 # ?7KFO<:* /(KOP19_$/X2Z3' ##K%A;A;>
M61"C)(H^:-LC.T\?3@_7J/A@MYI_PSL/[9$L5W$URUUYP.\-Y\A8GW[UVM%
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MHB[AR<%B?H/>NVHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH \O^.]U=:=X$BO["]N[2Z2\C026U
MP\9VL&R#M(ST'6N>O]:D?Q9X+MO!.M75]=2E6U:"*^DN8A%F/)D#,RKU?T(_
M*NQ^+GAG6?&'A:+1]'MHI'-PLSRRS! H4'C'?.?TK!UGX?>(8M8T'Q;X9@MK
M/7;>-8=0M))AY<X4;<[@,'(&#[8/!% %'XAZ@-.^,V@6MUJFI6NCW-H9;R*"
M\G16.9!G$;9'W5^[Z5=U&!/^%7Z]XETK4M52UNK)9;-)=1G=X7CDD&]69LC<
MI7(SU%6_$'AKQ/JGQ3\/^*X-)B%MIUNL<T37:;B3OW;?7&_OC.*ZCQIH-W>^
M ]1T/1+1));P.@#RA%CWL6+9/;)Z>] 'D=MJ.N7'A+P;<>%K_6+OQ)+*?M@$
M\TL31[C_ *T,2@'W>N.]?05W#)<6DL,5S);2.N%FB"ED]P&!&?J#7-_#K2=2
MT#P3I^CZK;QQ7-FIC)CE#JXW$Y'IUKI;F26*V=X(//E ^6/<%W'ZGI0!Y3\(
M_$5X?"OBK5=:O[F]^Q7TSO),^YMB1@X'8<#H,"J7@KQK::S>6FM>+YKI)]6N
MGBTF%XV^Q0JIVA5_A+EN-S<].E:WP\\#ZSH^A>(M#UZUACMM6>63SH+@.5$B
M["N,#G'.:R[/X6:])I/ASPY?/:)I^B:@]V;V*4EIT+E@H3'RMDD')P/>@#V$
M3PR'8DZ%ST"L":\M\#7VJM\9/%FF7VKWE_!9VZ+#]H887)4\*H"CKV KJ-'^
M&7A+P_K:ZUIFEM%J$>\K)]ID;E@0>&8CD$UA^%_#/B+3?BEKOB.\T^!+'545
M %N@SQ8VX)&.?N]O6@#AK[Q'J>I^$/&_BX7MS%?Z?JT4.GNDK*((UD4;0N<8
M(8YR.<\UKIXBN?&GC'6(;J2:*RL?#2W<$$4K($GDCCD\SY2,L-Y /;%7M0^&
M6L?8?%'AZP6W_LS7K^.\2[:7'V90X=U*8R3Q@8.#QDBM&\\ 7^C^)[O5- MX
MKFWOM$_LIX9)_+,;JJJDA.""NU%!QS]: -?X6>)IO$'P[TN^U.Y5KS#Q222,
M,R;&*AC[D 9]\UQ?C;Q6_AOXH22>*;*_N?#$]JB6+V\C".-B 6; (#-G/?(&
M,5T.E_!3PLOAW2['6[0W]Y9P&-IUGDC!+.SG 4CC+'&><8K131M<T^]U:R;2
MK/5_#4WDQV=E-<_/$J0HA&'!4J2O3.<@GG- '"^,?'#>&_A;;-X7UZ6__M*^
ME2&_DE:2:*+EBI9OF#C*KSR!SUP:WO&_AL>%_AC)J>F:AJ$&LZ:D4WVW[5(S
MRMN4/OR<,#D\$8Z557X++=?#N]T.>>&UO9M1?4;;RLR1VQ("B+) +#:,$^O/
M..=KQ%HOC'Q1X,3PQ<6UC:RS+%'>ZC]I,B,JD%F1-H;+%1P<8R>>] '!^.?$
MM_KG@;P-KR7-S9W>HW'DW1M9WC#@':>%/0D$^V:]]CCCMX%C3Y8XUP,G. /<
MUY-XW^&VJW7A[PSH7AFW@:WT9Q+YMS/L\QN_ '4GD_6NHU.W\5^(;RQL+O2K
M2QT5I&.H%;\R22QE&&P *N 21GG\J '?$WQ-+X>^'FK:CIMP@O%18XG0@E"[
MJN[Z@$D>^*X1?$%SX-\7>&HH9;B6VO\ PZ;B\BEF9Q),D;R>9\Q/S$K@D=C7
M47WP8\++X>U>QT6R^Q75_;>2)GFDD (977(9CQN1>G.*K:9X U#4_$6B:EX@
MMX8(=(T?^SA$D_F&XD*LC/G PNUCC/.: .'M_$NJ:?X(\(^,FO+F74[_ %IT
MO&,S;9H2[J8RN=H7"#''':NO\9WNJV/QC\'VD>L7IL+V5G>TW!8QMXQA0"W7
M/S$U4LOA;J[:-H7A>^\C^R](U1[UKU9LF>/+%4"8RK'=@Y.!VS6QXP\,^(M7
M^(WA[7K#3X'M-(8[O,N0K2@GG QQ^- ',?&?7+]/$=M:&#Q%#I5G;[Y;K3"T
M2EW/.6QA@%"]Q@DUZ%\,7TR7P/:RZ5JM[J<$CNS3WSYF#9Y5O3' P.._>IM0
ME\:P^)@;*QTF]T&2(*8I9FBFC?')+88$9]!T_6SX,\,1^%-#>R39OFN9;J18
MO]6C.V=B?[*C 'TSQTH Z&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\6>$_&EC8,^GG2-5W16ER\!!AE/ $AW8(!*DGC()[B@#U*1UBC:1SA5!8GT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[%HRRKID$X3;;^8>22 "Y&  3T^O-=G10!SK^$;:^UNWU;6;J74I[5MUI#(
ML%NW]Y4'5O=BQ';%:NKV,VI:5<64%]-8R3)L^T0@%T!ZXR",X[]JNT4 <IJ7
M@B+4_ ,?A*?49A:K&D)F6)-[(A&T8Q@'A>0.U8EU\)+6]\*:9X=N=?U)[339
MS/;MMCWCC"J3MY RV/K["O1J* .-TKX=VFF^)-:UM]2O+F;6(FBNHY BK@^F
MU01@<5E#X/V \$R>%/[<U-M/>X$PW>62@!)VCY>Y.2>IP.W%>CT4 <1I7PW@
MTKQ9%XC76+V6[2S6SVND84HJ!1T7K\H-6_!G@.U\&6NHVUMJ%W=1W\OG.)MJ
ME7(P2"H'7C\JZRB@#RNW^!NE6UE:VT>O:N!:7OVRW.8\1MQG@K@D[5Y.>G3K
MG8\5_#1/&(N5U769I%=D^SG[.FZU5220A_VLC<3R=H]*[RB@"EI-G/IVE6UG
M<7LE[+"@0W$B@-)CH3COC\ZS?$GA#2_%%SI,^H(6?3+H746,?,1_"?\ 9)"D
M_P"Z*WZ* .>\:>$;7QMX<DT:\N9[>-I%D$D)&05/&0>"/:L32_A7INFZ[=ZI
M)J>H7IO;'[#>17)1EG3:%.XA01PJ\#'3TXKO** .(\*_#2S\*&2"WUG5+G3"
MSLFG3RKY*[@0<@ %N">#QWQGFH_#?PPM?"EW.=*UW5XK!Y#*ECYJ^4CD8!/&
M6QQP>N!G-=W10!YM#\&]-@\&7GA==9U'[#=W:W<C$1[]P & =O0[5/X>YJY;
M?"S3XO$(U>YU*\NV-A_9TD$BQA)(?+V8.%!Z<YS7>T4 <5X1^'%MX0D"6VM:
MI<V44C2V]E/*OE1,P()P "3R?;G.,\UVM%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4QI8T95:159ON@G!/TK+U'Q-I6F:UINCW%RO]H:@Y6&!2"V I8LP[+\N,^M
M&O13&EC618VD4.W12>3^%*TB("6=5"\DDXQ0 ZBF>;'O5?,7<PRHSR1ZBAI8
MUD6-I%#MT4GDT /HIK2(@)9U4#DDG&*R?$/B?2O"^E_VAJ=RL<3$+$JD%I6/
M15'<_P#ZZ -BBCK3%EC9V174NO50>10 ^BO/-0^)-_\ \)??Z#H7AUM4.G-"
MMTPN-C?.1DHNTY"YY)(_K5OXB>/;SP%!9WG]AK?6%Q)Y3S_:S'Y+]0&78W!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *R_$KI'X6U9G9546<W+' ^X:U*X3XB_#R[\>&R2+
MQ%<:9!;AM\*1EUE)(P2-ZC(P?7K0!@_!W6M/T3X+)J-_<K%;6DDS3L 6*#><
M<#)YR*KZC-%?_''P3XGMY2VD7^FR)!.X*KN"3-CGH2''!]ZH0?L_ZC;0S0V_
MCV]BBG7;*D=LRB0>C 2\CD]?6I)?@1K,]DME-\0]1DM5 40/"Y0 =!M\W'%
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M+CPR^GI]H:0[XVN-I1C(>A*Y0\\CYO>G_$#P]X<TSP7X/CTRY74--M]6-O\
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MG:/86W,3TR>F<=: .BHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVDE=411EF8X 'N: /"9/".H6OC_Q5:ZOX9U76=(UV87$#VERT41;>742D,H
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MXPN&7:IR2J]13-5\/:]+\./ 'EZ%?O<:3>(]U;",>:J@YSMSG''?'OBO>**
M/#-5\-ZI%\4=5U#4_#.L:GHFO6B*T5C.5:-MJ?)(5=1@%2.6QR",UHWVA:A8
M_%GP7>V^A7:Z7I6F"VF,"M,D)V2*%#GEL;EYKV*B@#Y@?PAXF;X2W6BCPYJ8
MU!]?^V+']G/,7D[<Y^O\ZZW6O#>I0_%34=4O?#VKZOH.NV21,EC(T;H=B#;(
M RX&4.0Q Y]17N5% 'B]_H&H6'Q3\*7MMH%XFEZ7H_V67R$>=(6\N4! QY?&
M]1FL/3/"/B-OV?M9T&31KQ-3%^LT=L\>&=-T9ROKT;CVKZ$HH Q/#?VBY\'6
M$5Q:W-A-]D6)HY@!(A"[<D G'3/KZXKQ$^!?$;?#M/ G]E7*ZBNN>?\ :O+/
MV<P;2/-\SI_P'[WM7T310!Y.;&_7]H2'5?[-U!M.6P^R&[^RR>7YF#_%CI[]
M/>O4KNUAOK.>TN8Q)!/&T4B'HRL,$?D:FHH \;\$_"R[M_#/B?1=:=VBD>>R
MT[S.B1G#>:O^\PC/UCK;^&_@[4=-^%]QIVIO+!JFH12QL9#EH%P4C4>P'S8_
MVC7I-% 'S[;>#/$5WX.\+^$&TFZMK[3=8>XNKAX\0+%N8[Q)T;[W '/':NJT
M30KMOCYXDU:]T>Y.F75GY$-Q- ?*=@L08<]CL89[_C7K%% '@?B[P=KVL_$K
MQ3/8P:G96<^E>3!<0P$1SNB1GRB<9VML(XQD@#D'!]3\ :OK.J^%[<>(-+NK
M#5+<"*83Q[!*1T=?J.OH<^U='!=VUT7%O<12[#AO+<-M/H<=*?)+'"F^5U1<
M@98X&30 ^BBB@ HHI P/0@T +1110 4444 %%%% !1110 4444 %%%% !13%
MEC=W175G3 90<E?KZ4^@ HHI"0.I ^M "T444 %%%% !1110 4444 %%%% !
M13))8X4WRNJ+D#+' R>E/H ***B^TP>4)?.C\LMM#;Q@G.,9]<\4 2T4C,J*
M69@J@9))P *$=9$5T8,K#(8'((]: %HHHH **** "BBB@ HID4L<\:R0R))&
MW1D8$'\13Z "BBF1RQS('B=70YPRG(XXH ?1110 44$@ DG '4U%;W5O=H7M
MIXID!P6C<,,^G% $M%%% !13))8XMOF2(F]@J[F W,>@'O3Z "BF)+'+N\MU
M?:Q5MIS@^A]Z?0 445%]I@\H2^='Y9;:'WC!.<8SZYXH EHHIC2QHZ(SJKN2
M$4G!8XSQZ\4 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O./BS;02OX/,D2,9
M/$5I"Y*C+1G=E2?0^E>CUQ_CKPYJWB-]#_LXV2+INI0Z@S7$SJ7,>?D 5#US
MUS^% %?4/&FIVGB#5]#T[P]#,VF627:N][Y2/&<\8"'!XX'/N14EEX[;6XM"
M@TK3HY+[5K%KYH;B?8EO$, EF"DMECM&!SR3BHY?#.N/XMUW6 NG>5J.F+9)
M&;A]R,H.&)\OI\Q_(5DZ7\/_ !#H0\/:AIMWIO\ :NFV+:;<1S%VAN("VX$$
M*&5@>>A^M &?X&\1P^&/"-^;FWMX+JZ\1W5M#;>;LB1\Y(W[>$4*>=O8<<UK
MW7Q2FM/#>N:FVBK-+I%Q%%((KDF&9)" KQN4&>3R,<>M58OAOX@CT6?9K%E!
MK$6M2ZO8SQ1,8U9\AD<'G:0>P./>H/B+;>((OA!KTOB._LI;V4VRB.R1E@B
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M!N8A6.2Q   ]>F*XOQ=XTO\ 4?A=XGDM[-;/4=/D>POXS<']UDA=T;!?G!#
MC.WJ?3GJ-=\.:A)XMT[Q1HTEJ;VVMWM)[>Z9D2>%CN WJ&*D-S]TYS6/J_@+
M4K[P;X@TZ&6R_M/7[K[1=2N[B*'E<*ORDM@(!DXR23QTH Z/0-"MM.@.H1:1
M86>IS6R0R"VE)1U0'8"=B^O7;GZX%>5ZYK6K>(?AK>:CK-I:R26^OHD!@<LR
ME9U0HJLHP,# .[)R<@5[98BY6P@6[6);A4 D$3EER/0D _I7F<_P\\2?\(]?
MZ%#=:2UI+JW]H02.TBN!YOF8;"D9XQQ]<]J -T?$%K"^UZVU_2Q8'2K1+T-#
M<";S(VR /NKA\C&.1D]>YET+QR^J>)DT:>R@'G6IN([BSN3/&I!YC<E%PW?N
M#5#5_ =_K_B#7;B]EM(;'5=,2QQ%(S21.AW*^"H!&[MD=*U?"^F^,[>5!XFU
M?3[F"W39$+*)E><XQOE+<9QV48R<]J ,SQSJ,M[XQ\+^#A++#::J\TUZT;%6
MDBB0L(LCD!B,'';ZTOBS3/!F@#1IKK2HK"1-0@^QW%E9@'S0P81G9S\P4CGC
MOU%:_C#PC_PDG]GWMG>FPUC2YC-9703>%)^\K+W5L#/^0<S7O#7B+Q9_9$&I
M_P!E6<&GZC#?-);322M*8\_*%9%"YS_>./>@"S>>,K]SKDFC:1%>V^BG9<F6
MZ,3R2! [I& C E01U(R>/>F6OC];SQ#X?LHK!1IVNVC7%I>O.0257<T93;]X
M<?Q?X5%_PB>MZ7J/B(:--8/8:Z[3.+IG5[69EVNRA5(D!X."5^M&O_#Q;WP5
MI&B:1>M9W>D20O9WA)#(4X8\=RI8XZ9Q0!/=^/$M+2V>6WM8Y;Z\FM[/S+HB
M-XXB0TK-L^4?+P #G*^N1DR_%.>'0O[0_L%I98]57398XKCY7W'Y9(F*C>".
M@.WG\ZUO$W@Z\N;70YO#-Y#8:CH9(L_/4M$T90(T;XYP0!S[?B*.M^%?%FNZ
M!90WNH:9+J4>HPWLFT/'!&(CD(@P6.3R6/KTH D/C?Q#'X@LM"G\*QQ:A>0S
MRQ9U%6C 1L LP3(4CGIGMBH$^)L[>']&U+^P2\E_JW]DRP)=#]U+O9<J2HW
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M?>"#CN1R<<9Z'O3B^'WB&'X?Z5X=$VF&>QU(7OG&:0*RB4R!<;,YRQ'X9[\
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MY1\IY^<\\=N.]=!-X=UG_A85[XAA%@UK+I7V!(GG=7W!BX8_(0!DXQSQS[4
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MW_>"%T*Y]P,UQMIX0\3+=>#)KN726'A]7C8122#S%:(1<94\@#=GC.<8&,D
MLVOQ(3^P+Z\U&PCM+ZTU4Z0;?[3NC>?C!$FT87!R3MR #P>!6EX5\7MXAU+5
M-/EM(XI;$QD3V\IE@G1QD%6*J<@@@C%<VWP[UJ?3M:0W]I:7T^M_VWI\\):0
M0R] K@J,C QGWZ<8/7^&K7Q+''+/XFOK&:Y8!$AL(V6% ,Y;+<ECGV QQWH
MWJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBN+\8:OK=CXK\+Z;I=[!;P:G+-#-YEN)
M"-L98,#G]/4<Y'% ':45Y5;>.=<M=/O]/N9?MVHIXC_L:WN(H8T8H5W;MI(3
M=@,!D@9(SGO;NO$_BOP_I^J-JELRQR7=M;Z5=7GD^9^];:QD6%BN$/(Z9_D
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M#)'4?,2>,U4T#6O&6I7>@ZD+2:32K^+S+U9_LR10AU#1F$HYD(!./F!)'H>
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M'[K?%<\Y9<)C!ST(-=W10!Q8^'-J(-?A_MK5"NN(%NBS1D_="LPRG4@?09X
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MJ]O>:7O6UU""94F1&ZIPN"OMCN>>37H%-<N(V,:AGP=H8X!/N<''Y4 <I?>
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MM?7FK/\ 8GL%^U^6,0OC<"452Q..IIGACP#:^&;E)$UC5[^* %;2WO;G?';
MC'R* .<$C)Z D"J$'Q*5+#0M3U'1IK73=:D2&WN$F678[_=#K@$9P>1GI7<R
MNT<+NL;RLJDB-,;F/H,D#/U(H \\\66-Y??%7PS):OJ-JD%K<*][;VID2-G
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M; "":2!6>(#D;21D?A5;_A$/#7V>6W_X1_2O(F<221_8X]KL,X8C&"1D\^]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$"HW(S  CYU]\$&N"\*6]Q*UDM[X!NK74M*MY%ENKJ4M&3Y94B [CN+G X&
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ME=W<9H ]3HHKA]9\6^(K?QO)X:T?1;*[D&GK?))+=%,KYFP@_+P>N!SV.>U
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MK?;$&8*,<9!49SZ\4 =E17!^&/'%]XJ#-8G2MYCEWVK2MY]G(IPJRKU(/.2
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MFBV6K_9KI&^RIN9W>*(&-8\CI^O)X.:U+;XI?9;C6(M6CL95TW3%OWDT^8N
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M6<%MJ*RXMYUN(9(96BDCD7.&5E((/)K+_P"%=>'A;:I;".\$.J8^UK]LD._
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MX9I98P" F_.0N">!@<GU-.NO!^D7OA>#P[.D[6%N$$/[]A)'L.4(?.<C Q0
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MQ%>VAUG3;EKMX%0$M'&I##Y?O'/7\L56O]:D\,_$;7;:ZN+H6]Q!IMI=ZPH
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MABN([ATE\L?PLP()'U]3ZU;/@S1QJFFZA#'-!-ID)@M%AF94B0C!&WH<]\T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-D
MD2*-I)&"H@+,3V IU-DC26)XY%#(X*L#W!H \6FUCPS-\28?&7_"P-&$L,)M
MUMOL3[?*YZGS/O88\]/:K=UXJT=]5UZ\M?BI##'J,*Q6L#Q-(ED>-S(-P&<
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MSD=ZT/\ A']%_P"@18?^ R?X4 <!K/AFVE^( \7Z!XTL-+O)H1#=I((YED4
M#@;AV5>/4 UZ)II06$,<=TUV$0*;AV#&0X!W$CCG.>.*B_X1_1?^@18?^ R?
MX5=A@BMT$<,:QQC@(@  &,<#\* )***YC3?&#:M>VOV+1KV72[J::"/45*E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSGCH_$?A_47T:^\/:'IEN;+4[62.>]GO&\U)6&T,^X%I!C'.2>,=JOZA\/\
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M".H/!JO=>#= O=0FOIK &:XV_: DKHD^WIYB*0KX_P!H&@"J^NZA'\,#X@,
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M<SQ?O9/D<YSCYN%.3E?NGTH XJ?_ )!?Q?\ K)_Z35Z+X9C\WP1H\>YE#Z=
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MCB@#A=%N-0L[[X:7O]KZG<2:O:R"]CGNF=)<6X9?D)V@@]\9/4DFM+PC=?\
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M9$;2/\S8ZC/.#]*ZFL[1-!TOPYIB:=I%E':6B$L(TSR3U))Y)]S6C0 4444
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MN#7*^%]6T._\9:YKDVKZ:+RZLXU^RQL_R11 [G+2(A/7TX KC?"VJ/X?\.>
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M; W6FK<I?3?;B\UVTB!?,9BG)XX&3CID#I?T_P ):_;_  @U+PQ):0?VC/\
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M;4(2;H;5C,B288XZC9C\:]<JJFI6<M_/91W"-<VZ*\R*<^6#TW=AG&<'G'-
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MDSR#G(YX/6KOAGPS<V.N:MXCU9XFU;4RBM'"28[>%!A8U) +'N6P,GM74T4
M<!:_#I!XW\3ZE<N&TO5K7RX[<-PLDJA9VQV)V+S_ +1K2^'/A>[\)^$H;#49
MQ/?ERTT@;<, !(U!]!&B#%=;10!Q_P 2]$U3Q)X0DTG28(Y+B::)RTLH14".
M'_'.,5C>+O#'B/7]9NG^PVEYIUUI;6\$-W=;183D-F38%8.W(PW4>HKTFB@#
MS2S\,^)$E^'[SV%L/[ B:.ZV70.08A$,<<G W'MVR:W/">C:KIOB?Q1?7UM'
M%;:G=)/;E)0QPJ[<,.QX!KKZ* ..UW2-7N?B'X?UJTLXY;+3H+A)29@KL95
M&T'TVCJ>]<I%X*\2IX%TS1C8P?:K37!J#$7(VF,2F3&<?>^;'X5ZY10!B>+M
M)N/$'@W5M*MRB7%W:O''YA^4,1QDCMFN5MM"\32^(O!VHW>F6L,>CVTT%PL=
MWO/SQJ@(RHSC;D_7&3BO1:* /)E\">)3HMV\*64&JP>()=9LEFD\R*57R#&^
M!P<$_IR.H[KPO'KWD37&O6NGV4LFT1VEE\P0#.69^Y.>G0 #U-;]% '&7VC:
MO-\4].UZ.TC.G6UE):.WG .2Y!W!?0?7-85OX)UZV\':CX&6*V;2YYI/(U$S
M\QP/)O(:/&2XRP'.#D<BO4** .+30M3MOB?%K4-HC:7#HW]G*WG#S"P?>#M]
M.-O7WKG;#P)K]IH.DRI%;IJVD:Q-?QPO-^[GBD9BR;@#M;!ZD=1[UZM10!R6
MF^')[WQ'JVNZS:QP_;K)+!;,2>9B(;BQ<CC+%L8'0#KSQR2_"K58_!\%JFJ_
M\3RPO5.G7F>8+9'8*F<?W'=B/4@= *]:HH XKQ5X=U"YN/"D>CV<36NCWT<[
MAY0F(T4H%4=S@_I7.WW@WQ'=^&/&^FK8PK+KFH?:;4FX7"J2N=_H0$[9ZUZO
M10!Y+JL6I:EXVNX[&RMY9K;2(;*^BBU,6TJ^9EBCDHP88P01C&>O/'=^#[N.
MX\-PQ0Z:-/2S)M!;),)47R_E^5QPP[9]00>15C4_"OA_6KI;G5-$T^\G48$D
M]NKMCTR1R/:M.""&V@2"WB2*&-0J1QJ%50.@ '04 >3WO@KQ+=^!O%6C"Q@6
MZU;6FU" FY7:L;2(^&/J-F./45T=WI&N2_$7_A((].C-I_8K6&PW"A_,+^9]
M,9^7.?>NYHH \GL?!OB.U\+>"=->QA,^AZB+FY*W"[60%ON^I(?OCI5[1?#/
MB_0+^?1[2'1Y=$DNI)X=0E!,\$;N6*[,89@2<$\>OI7I5% ''_$_0[G7O MY
M!91M+=6[QW442]9#&P8J/<C('OBM"\O(_$/AV";3--M-6@O$#H+ME$*'_;!!
M.0>P4G((XKH*BAMH+?S/(ACC\US(^Q0-S'JQ]3P.: .8\/Z'8> /#M_=WMU&
MTLLCWE]<A!&I<_PHO91P%7_&H_ACHMWHG@FW2_C,5W=2R7DD)ZQ>8Q8*?<#&
M??-=5/:V]T(Q<01RB-Q(@=0VUAT89[CUJ:@#SC2?#WC7PY?WVCZ8^F-H=W>2
M7,5[(S>?:K(VYEV8PS#G';/)]*6/PKX@TRP\4:!906MQI^MSSS07<D^TVWGK
MAPZ8RVWDC'7OBO1J* //K#PMJFC>,Q=VMFLVF6_A^/286,ZB1VC.X,1V!Z5C
MZ7X*\3Z7H/@D1VEG+?Z!/<>;"]UM2190P#!@IZ;N1C/%>LT4 <#HGA_Q'9VG
MC10L5E=ZM<2W-A.LP?RW:/:N[ X((![USME\/]?N+S3&O=,L;5'TJXT[4)DO
M#)+(TBA6F9BN68\D#)Q_>KV"B@#A/!]AXYTY+#2-8.EIIFFH(A=6S,TETBKM
M1=I&%[$GK\OOFK?PXT36/#7AS^Q=4@MECM99/(FAF+F8-([Y*[1M^\!U/?I7
M844 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 >96-S<V7BGXI7=FT2W$"VLJ&5"ZY6V)Y (ST
M]:;:^*?$EY-X"M;:[L8%U[3I99V-J6,;I$K9 # 8^;@<8QU/2NC7P1LO?$MT
M-6N-^OHJ3CRDQ$%78-O']TD<Y]:KV7P_%E=>&ITUFY;_ (1^%X+96B3YT<!6
M#^OR@#C'2@#!L/'VM-I0L9PMSJSZ]<:0L]O"HRD0+%PC,%W$# !..<\XP>L\
M(WGB.X;4H=?LVBCAF'V*XD5$>:(C^)49@"#QGC.>E9#_  MLIM(OK*;5;WS;
MC4VU6&ZBVQRVURW5D([>QKH_#OA]M"MI!/J=[J=Y,1YMU>/EB!G:H X51D\#
MN30!AWNL:LWQ&O\ 08KFWAM_["-[!*MN#)&_F[.220V,$] .>AQ7+>$_$^L6
MO@CPG;B>>\O]=DG<2+$C21JA=Y"-S ,Q..2>,DX.,'OF\*JWC=O$S7\QD:R^
MPFVV+L\K=NZ]<[N<_A6 OPILU\-VFCC7-3#:?/YVFW2%$DM.3PI51D'<<YZ\
M=,4 9VI>*?&^D: DUY;6\%Q_;45I"]S$NZXMY&PI(1R$;J#U]@*DFU[Q<FK^
M*M(&J6&=)M$OH[K[$=Q#(S>7LWXQE?O$DX]<Y&O>?#L7VB6]A<:_J,TZ7<=Y
M+>3;7DED3[@Y&%4>@'\SFS+X(:36-<U+^V)Q+K%H+291"FU% P"ON 3USUH
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MBBB@ HHHH **** "BBB@ HHHH ***IQ:MIL]_)80ZA:27L?+VZ3*9%^J@Y%
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M6IU.R%Q$K-)$;A=Z!>I(SD =Z +U%4+;7-(O)7BM=5L9Y$C$SI%<(Q5" 0Q
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M9,I40")"5Z@L<G!Z#&<<X] HH P/#%O.? >E6<HN+*Y33H[=\H%DA=8PI(#
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M!A;Y%4<'</4"O0Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJTNLV^EV2ZLZ%?M7D@.>.[ 9]B>N* ,3PE-*GBKQEIZC%G;ZA%)".P:6!'D
M_P"!'=]6/K77UFZ+H\>D6\X\PS7-U,UQ<SD8\R1L G'8  *!V '7K6E0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %>;^'_ (RZ-XA\<GPS;6-VCL\D<5R^-KL@)/'4
M A3C\.E>D5S6G_#_ ,+Z7XFE\0V6DQQ:G*68RAV(!;[Q52=JDY/0=SZF@#I:
MY/QYK-WI=CI5E82F"XU?4X=/%P ,PJ^2S#/&["D#W/M765C^)?#MMXFTG[%/
M))#)'*D]O<18WP3(<JZYXR#^A- $;>'1'>64MMJ&I)'"S>?')?32"9#&R@'<
MQP0Q5LC'3Z5E_#"YNK[X?Z?>WMU/=7,[2M)+/(7)Q*ZCKT   XK6M=/UX;6O
MM:MIGB!\OR+)HE9L$ R#S#N'.< J,_AC'T3P?K.A^&K;08/$,'V6%R6E2Q9)
MBC.790WFD*3DC..![\T 8SRW<UU\1D.I:@JZ<J-9[+N0>0?LWF?+S_>.<'(I
MC^(M2BTF?PWK5S+%K]F]LT-W#(T8OK=ID3S5P>N"0R]CS]-T>#+\3^*I?[8@
MSKZJI7[$<08C\O(_>?-\OTYY]JO:YX0M?$=GI8U&13?:=<17$5U%'M(96!8
M$GY6 P1D]CVH @\>:E=:?I6F6UG,\#ZEJEM8-,C8:-)'^8J>QV@@'KSZUR6J
MZ_J>G>(=1\,V]]<"VEU?3;:*9YF:6&*X5FE59"2W_+,X).1OXZ"O0O$.AQ>(
M-+%I)*T,L<T=Q;SJ,F*6-@R-COR.1W!-8\_@:.]AOI[N\#:M=7<%X+R.':L4
MD./*"H6/RC!R"Q)W-R,\ '*ZEK^IV'B*_P#"\-]<?99-:T^VCG>9C+%#/&TD
MB"0G=_RS(!SD;^#P*U/[0OXHOB!I*7]T$TF-9K.<R%I8P\'F%=[9) 8'!/.#
MC/ K6F\#17<-W/<W@;5[B]AOQ>)%M6.6$ 1A4+'Y  006R=S<C/%A?"C_P!E
MZ[&UZC:CK6?M-UY!V@%!& J;L@*HX!8\DGVH 70]86S^&VEZSJ4[OLTJ&XGE
M<[F<^4I)YZL3^9-9'@77=2EUW6M"UR[BGOXRE_ 8V!40RCF-?41N"N>^16DG
MA2\7P[H.BMJD$EMIIA\[?9Y%TD6-BD;_ )?N@GKD@=N"M]X0:7QEI7B#3[R"
MQ^Q1/#) EIG[0CD9#,&'3 (XX///2@#4OO$N@Z9<FVU#6M.M+@ $Q3W21L >
MAP3FH+SQ3IJ>&M4UG3;RUU&*PMY)F^S3+(,HA;:2I.#Q6I+96D[[YK6&1^FY
MXP3^M(UA:-:36OV:(03*4DC5  P(P00/:@#DM%T>[UWP-:WUQK&H+JVHV8N/
MM,-W(B1/(NX!44[ JY Z<XSUYJ?4O'46G1:M=+8O<:=H\R07UPDH#*Q"EMJ8
M^8*'7/([XSBGZ1X7U;1=/31[77U.D1 I"KVN;F*/LBR[]O X!*$U!>^ 8[F;
M68(K_P K2]:=);ZU,6YRXP&*/N&W<%&<AO;% #+CX@FWN;X'1+@VECJ$-C/<
M>>G!E\O8RKU/^L&1Q@?D*'B_Q'=7D,/]EI-';6FOVME-=QW1C)?S4#KL'WD^
M;:<GKGC S5R^\!7=W;ZS"FLPQ+J6HP7XQ9$^48MFU?\ 6<_ZM.>._J,,O?AY
M=2R74=GKQMK"XU*/5&MFM!(5N ZNV&W [6*YV]CWQQ0!HMXVB1'9[&0>7K2:
M.^) <.Q4!QQROSCT-2P^*;F^F#:;H\EW9-<S6BW*S 8DC# EEQ\J%E*[LGG'
M'(SF7O@&[N+VY>#7?)M9=6BU983:!BLR;<@MN&5.P<8&/4U<T;P==Z)JT[6N
MO7 T62Y>[73?)4;9'.YAYG79N.=N![DC.0"WX*UV\\1>$[35[ZWCMY+C<X5'
MR-NXX_+I^&:HVWCR*X&DW/V!ETW6+A[:QN1*"6<;BN]<?*'V-@@GMG%:7A7P
M_)X;T-=)DO1>6\3,(,PA"D9)(4\G<>>O&?2LG3/ *Z=#IMB;\3:7I-V]WI]N
MT.'C<A]H=]WSJOF-@8!Z9/'(!!X+6[UN\O-:OY;R*:VU*\@2-+UFB= [1A&C
M^[A0HP0!SSW-74\<Q_\ "46^BS6#0M<W<MK$7E E.Q&;S#'C(C;:0K9YZXK0
M\+:!<>'K*ZMY[^.\\^[ENMRP&+:TCEV'WFR,GC^M84?P_NX=9BOH]>(CBU:3
M4XT:T!?]XK*Z,^[GAL*<< =#Q@ ?XYNY+3Q!X53[3?16UU>217,=I)*#(@B=
M@-L9R>0#QS^%<R;_ ,1V5]ITS#5I+1_$;0Z?!/*T<L]L8)#M<.02N]<@OR *
M[S7_  [=:SK.BZA#J$5L-+G:=8WMC)YC,I0@G>,#!/;K^52Z_H,^LWVC7$5Z
MEN--O/M>UH#(93M9-N=PP,.W8]O3D R8_'ADTZ*X_LMH9/MEQ9W!GN D-L\)
M()>7!&"0 O')-0Q_$>WN;729+:R43:G9&[AAN;@1&0@X\I#@AY/;CMZU'#\/
MKZ"ZM[I->030:G<Z@O\ H64_?C#+M+GD9.UL\9/!IB?#BZ_X19/#=QK4%UIJ
MVQM]DVG@M'\S$21G?\K@,!DYY&<=J -&?QW"FLBRMM.N+N%=073Y98<LT;G&
M7*[<;%)P3G(YXQUTO$NEC4K56N-;O-+L;=7DG>TG\AB0!@F3LH&XD=^,].<Z
MR\&WFF:]<7-AX@N8-*NK@75QI_DJQ:7C)60\JK$ L,<\\C-6?%OAO4?$:V<=
MIK*V$$$GFR0O:"=9V&-NX%AP#SCH3CTH ;X!DU1O VG2:U/++=E7/FSC#O'O
M;RV;W*;2<\^O-1VOB2;7;2-X-,N4TN_M9I;>_BFP0%X&X#!0L#E<$GCL:V-(
MT^^M--:WU;4SJEP[,7F:!8AM/ 4*O  ']:P-!\&:AH%F^GQ>(YIM-A21+"UE
MMU_<ALXWL"#(%R<#(_08 ,GPQK+R:=X$6Z&HW-[<Z7+,DHNL)*RQKN$BD_.W
M(P6Z$]:T]#\?MK,VC@Z+<6\.KP32VKM,C%C& 64@=,]CG\J33O ]]IH\->7K
M,+'0K:6WCW61_>AU"Y;]YQ@*O3K@^O#=*\!WNE+X;$>M0O\ V''/&FZR/[X2
MC'S?O.,<=* #P]XHA;0M&MM,M;JXN[]+F:*"]N]SJD<A#EY"#GYF  YZCL,T
MFK_$3^QK%+N]T2XMD%I%<RI=2B)\NQ4Q1C!WNN"2,C QZU#;_#F\L=/T;[#X
MA-MJFE&9(KQ;,%9(I6W,CQEB#ST.>,4:U\.;G5VO?^*AF'VW3TLYWGMEE<E6
M9PRG("@LV2H&. !CC !IZ+-.?B-XHMFN)W@2VLGCB>5F6,L)=VT$X7.!T]*=
M93W5QXQ\21^?.XM(;?[-$)#M4M&Q.%)"DD@=?TJSI/AZ[T_Q+J.L7&I)<F^M
MX(7C%ML(,0.&SN/7<W&/3TY@TE9(/'OB(RPSJEPEKY,AB;8^U&W8;&./K0!G
M^%[CQ3))JHU)93M1MAV+Q/M3Y5W/T] ,IDM\U2^$'\0W4U_%K8E\G+ L,KB7
M/S!3NW  8QMRO7#&NRILDBQ1M(V=JC)VJ6/Y#DT <]X(NKB[\.O)<SR3.E]>
M1!Y&+-M2XD51D\G"@#\*YV_^)%S+X/U#6M(T^VD\B(G#766@;<%VRIMRKC.=
MN><'FN@\"PS0^&G6:&6%WO[V15EC*-M:YD93@\\@@CZUD7/PY;4K:].I:I%)
M?W6G?8&N[>S$32?,K"20;CO8%!Z#!([\ &G?^,O[-_MM+G3F$NDZ>FH2JDP(
M=&WY ./O#RV]NG-87CWQ1<7'A#Q#%H\4ZRV-E'+/<QW1A>!I%W*%V\L0N"1D
M#!'7I5_6/ NH:NU\[>(!%)J.E_V?>D60(?!<JRC=\O\ K"".<CN#S4&I_#BY
MO+?4X+77S;1:M:1P7ZFT#B1T0(LB?,-F5 !'.?8\T :I\8"#4-5TZ>P=+FPM
MH[B(-*/],5R579_P(;>?XB![UJZYK<.@:))J5W&6VE$6)",O([!54$^K,!G\
M:P/[/BU_Q?827&G7L;Z"&5[R:'RH[IB%VA!GYUW#?Z JM;GB;P_;^)]!N-*N
M9'B60JZ2Q_>C=6#*P^A X[T 8.I_$'^QI;ZUOM'F-[:-;%HK>9762.9]BNK'
M;G#<$$#GVYK?.MFS\-3ZSK-G)IPMHI)9X&=9&14)Z%3@Y R/J*Y[5? 5UK"7
M5Q<ZO"NIW/V97N$LR$6."3S%54\S@E^22QXX %=5JNEV^M:-=Z7? O;W4+0R
M[>#AA@D>AH Y/5O'UUIMC<>9HZQWK:5)J=HC7&Y)$0 NK$#AE!!P,@]FK,?Q
M'K%IXJMKS['<71D\.&[FLTN]L2L)!F3#':#CC@9Y^IK:7P&;FT$.K:E]K>+2
MY=*MY(X/**12*%9F^8[GPJ\C Z\<U'!X(U-+A;B?7H)I!I#:5_QX;1M)R'XD
MZC X^M !>?$:VCLXY['3I[USI\&H/ A/F!)<E%4 '<^%8X..W/-7=.\7W&J>
M([C2K;0KL16SQK<74DB*(U>+S$)7.3G@8ZC/-9MKX U'37T^;2_$TME<0V$6
MGW;I:(RW,460C;6)VN 2-W(]NU;FB^'9M)U[6-2>_$\>HF(B(Q$-'Y:;!ERQ
MW$@#)P.>: (M5\6II_B--$CMXI+IH$G59;@1-,&9E(B!!WLNTDC(ZCUK*L?'
M%\(-0N=2TQ$BAUM=+00S;BNYDC!.0,_,V3TZ^U:7B3PG-XEEDAN;Z'^SW$6(
M7M \D+HQ)>*3<-K'@=#TJE=>!)YK?6+>'6?*BO=134[<?9@QMYU='))W?.I*
M#CY<9/6@"Y+XT@CN+ZU-FYNX-2CTV*/S!B:5T$BD'L IR>.-IQGC/*V>L7$-
MKK@U5=1('BF&U1(+]B8 WD;0')!,>YL[0.C$8%;$GP]N9WO;F37F^WRZA%J5
MO<):J!!.D8CY7=\RD C'''<GFD?P!J$EG?12:_&TMYJL.J/(;'A7CV?* ).A
M,:]^GYT 79?'<(UI;*VTZXNH?[0&G230Y9HY.A<KMQY8;@G=D<\8ZVO#?BU/
M$ES*MO;Q+#'YBN1<!I871PNR6/ *,1DCD]#5>S\'WNG>(+J[LO$%Q#I5W=?;
M)].$*G,QP6VR=55B,E<<\\\U+I/A.:SUZ'6K^^@NKZ*U>U,T-H(7F5F4YE.X
M[R-@QTQD^M #+OQE);>(K_2QHUP\.GQQ375WYT82.)PYWX)R<;#P.>OXT8OB
M3;"*>XNM+NXK-+ 7Z7" NK D 1$D +(=R\9(YZUJKX69_$.MZA=7B36FK6D=
MI):B J55 P!W[CG(=\\#MZ<Y,'P_NY/#=UH&J>);N^T]K;[-:+Y*QM H(*LS
M#_6,NU<$X[\<T 3ZAXZFTAM834-(V2:981W[K%<A]\;,RX!VCYAL/M[T>)O%
M4%O9>);&:TO"-/TY+J1[6X$;M')O'RMP58;#^E8,?AR_U/Q/XAT76;^ZNS>Z
M%#:-J(L3%'N#R$A?X20'4D9YR>G0:MUX!U*_CUHWGB&.2;5M.CL)G%B%5 I;
MYE ?T<\$GDYZ<4 76\8O;ZU+I,6C74L-G;P7%Q=M.FV.%]WSG)R<;#D=3@_C
M5A^)5IY4MU=:;=0V"Z>=02Y0%U*\8C;@!9#D8 )'/6M"Q\)S1:S?WU]J$5U#
M?:?%8S0);&/(0,-V[>>N]^,=QZ<Y]K\/;AO#MSX?U7Q'=W^E&V^S6L7DI&\*
M<;2S#[[+@8S@>QH =H]]J<WQ0U&"]CEMHCI$$RVWVLRQAC(X+ <!3@8.!_#U
M.<U0O?$6I:%XU\520:?>ZI:6UE:7#Q+= + N)2Y57/4@#A1SM^F=S1?"^IV'
MB1M:U+7%U"=[%+)E%H(LA79@W#'GYCG^G0+J/A.XN]8U6\M]36"'5K2.TNXV
MM][!4#C,;;@%.';J&[4 11>.[>2YNXC921K'IJ:G;,[@?:HF'&T=B#@$'N1U
MS5GQEKVH>'_"4FIVEG%)<AHD9)),"/>ZIGI\V"P]*SI=)LM8\3:59)I%];P>
M'&!6YEC*12KL 2-#GYQD(Q[ QC/6M[Q/H8\1^';O2OM!MS-M*3!-VQE8.IQD
M9Y4<9H XNZ\5W_ASQ1XLNYK&[O+.UM+.XFB%WE+8$2;]@8]3QPH .WMQG<U7
MQY#I^HW-K;Z=<7PM)XH+GR,F12X5LJH4[@JLI/(Z^U5;_P !:AJ47B%;G782
MVMVD-M*PL<>7Y>1N \SON;CZ>G-E?!NHP:[/J%GXCFM8;X1G4;:.W7$SH@0M
M&Q),1( !QD^^<&@!OQ+NY[#PO#=6US<V\@O[:,M;R.K%&E56'RG)R"1_*L3Q
M=<O;>"?$NK:3>ZW9O9JD*+<33*=X*-YBASN (DV\\''2NN\7^'9_$^DQ6$-^
MEF$N(K@R-!YI)C8,H W+CD#/6G>*_#TOBCPM<Z*;U+;[4JK+,(=_ ()VC<,<
MCN30!@>+Y+GPE%I6MZ;?7IC%[#;75I/</.D\<C!3C>258$@@C'OFHOB%XFU#
M2I$ETJY1$T8Q7VHQ;ANGB9MOE#G^YYCGTVKZUO7/AB75[VPGUO4!=0V,HGAM
M8(3#$TH^Z[@LQ8KU R![&BT\+%;#5(]1ELKZ\OY9)&N'LL ;E"A2N\DA0 !R
M. ._- &_;W$5W;17,#B2&5!)&Z]&4C(/Y5Q.CW.LW/P_6^LYII]2EN) [RN7
M&Q9W4\%AM 4?P\\< FM[PAH-SX8\-6FC7&H_;Q:+Y<4QA\L^7V4C<<XZ9XXQ
M]34\ +)!X4AM9X9H9XII]Z2Q,A&Z:0CJ!G((/'K0!G6-QXH;P"DA6;[?^[V-
M(JEC!L7+-\V[=C.3C?NSA>E1S7&LI\*-4O=0EN8+^VL99K:57*/A8<HQ(;)/
M<[L'.<J.*[RN?\<AY/ NNV\44TLUQ83Q11PQ,[,[1L  %!ZF@"+Q1X@E\.^!
M)]7C"R72PQK%OZ&5RJ*3[;F!-9-S/=OX]TGPA]NNQ:1Z;)J-U,LK+)<OO"!2
MX(*C)+87'8=.*V/$GAYO$O@2XT;?Y,TUNGELP^Y(N&7/MN49I+C2&UV32]=B
M,FF:S9JZ RQ;P W$D3KD;UR,@@CH"#@\@'/ZGXDG\%^+-1M/]+O]-&BOJHAD
MG+R1/&^UPKN<[2IS@DX(XZXHU;XD7]EINI'_ (1Z6UO8]+;4K07$Z,DL0(!)
M*YPR[E.WOGJ.M6/%?AV1/#7B?5KJ1]0UFZTF6RB^SV[ (A4XCCC!8\L<DDDG
MCH!3X?![>(-",FJWN^:YT<Z="R6K0F&-P"Q968DOE5]!\O09- %A_$$%KXCB
MDU2*ZMI(-$FO966YW0>6KIN^0=6'8XZ9%))X]-JENUYI$L9O-/DU"S"3*YD6
M-0S(W0*X5@>XZ\DTX^";F\U"*XU;58KR(Z5+I=S$MIY?FI(0200YVGA0.#QG
MN<B%? ,[V%M;76K).]AI\VGV$IM<&-)%"%G&_P"=@J@<;1U..> "SI/BG_A(
M[R+2KG3+FQ%]I@U""07 W&,E1U4Y5@6&.?RZ5=\':U-K.DW NG#W=A>SV$\@
M7 D:)RN[';*[2?<FL^R\,7.A:AIVK2:A]J33=)_LW[/#9'?,H*D,/G.&RJ\8
MQUZ=M'PAHTVC:/-]K55O+V[FOKA$.0CRN6V@]]HPN>^* -^BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JE%J^F3ZA)I\.HVD
ME['G?;I.ID7'JH.15VO'O"OP9OO#WQ.;Q+)J\4UE'+-+$@#>:YD###YXXW=<
MG..@H ]AK(\2>((?#NFI<R1-////':VMNAP9IG.%4$]/4GL :UZY/Q]HE_JN
MFZ;>:7&)K[2=1AU".W+!?/"9#("> 2&.">] &BU]K\%Y913:99/'<LR/)#=,
M?)(C9AD%.02H7/'4<4SP=XAF\5>&;;69;-+07#.$B6;S,!7*Y)VCJ5-26OB"
M2]VM'I&HPQJ"TYN8&C,8 /"KR78G ^7(Z\] >5\#7FH:#X!T[3)="U(ZG&[Q
M^2T#*@WS,0S/T"@,">_7B@#2D\9:B)?%,<.D6SG0 K-NO&7SP8O-./W9P<8'
MUJ:#QO'?>$AK5C:!IXYH[>ZLIY#&]O*SJC(WRGD%L].1S6"L%\+SXCM_9=_L
MU"-!9M]G;]^?L_E$+Q_>'?L<]*E\2^%;V[N[+7M 1HI;N2UCU6SD0KY\2R(P
M<@XQ(F.O=<CZ@'6^)->7P_I<5P8?/N;BXBM+>'=M$DLC!5!..!SDG'0&L.Y\
M>&QFOM.N;)#J]O>VUE%"DI\N9K@9C;<1D# ;/'&P]>*N^.=)N]3TJPGL8S-<
M:;J5OJ"P@@&41M\RC/?:6Q[URNI^&=3U+6+_ ,4P6DPVZKI]W;VKKMEEAMU9
M7.T]"?,? //RCUH ZNW\53R1>(()+%#J6BD&6%9ODE5DWHP8C@$9[<$'K26_
MB/5-4\):1JNDZ.D][J4*3>3).4BA!7<2S[2?88&23Z9QG6FG7>_QGKCVMP@U
M9$CM;<QGS66.'8&*]068G@\@ 9Q5.SO]<\/_  NT&SLM$U"75!;QVLJI &:V
MVJ SE6(#8QP,X)QSB@#I?"'B.7Q+I,]Q<V)L;RUNI;.Y@\P2*LD9P=K<9%;]
M<QX4C,WAR>SATW5-'4,Z++>;/M,CL-S3'[PW%F)R<\CICB@>$]0!_P"1T\0G
M_P !?_C% $_B/Q%<:%>Z+;Q6,=R-3O5L]S3F/RR59MV-IR,*?2KX\0:*UVEJ
M-7L#<R2&)(1<IO9QU4#.21D<5SGCF&ZFU;PHUK8W5RMKJR7$[0Q%A''L=2Q(
M]"PXZUS$NE7B17TD>AWGFMXNAOU*VQW-;JR$N/;"MQUYZ<T >G-J^G"__L\:
MA:?;SG;;&=1(3C/W<YZ<].E9?ACQ.FMZ3#<7IMK2[FN+B%+<39W>5(Z$KG!;
MA,]*YWP[!J5GJ4NDZKX<N+F6WU6>^@U5MIAV2,Q#@YW;]K%=H![=!69I=CJM
MCIWAR]?1M0<Z?KE[+/ L7[P1S>?L< D9'[Q<^G/I0!Z/+K.F16'VTZC9"V+%
M%F>X41EAGC=G&<@_E61X=\86FJ>$[77-2GLK!)Y)D!:X'EG9(ZY#-C.0F:XS
M1;+7M*N-&U.XT._>VM;[4A/:HJ&5#/+NCE"[OF&,J3GC<3R*I:;I&LZ;IVA7
M5YX<U:>RA74+6YL;641S1B:?S$<!7&Y2!M(S[^E 'L4<\4L"SQRH\+*'616!
M4KUR#TQ7.V'B^VU'Q?>Z1;364]G;6"7?VJ"Y#X)9E*MCA<8SUZ$'O535?#]U
M+\*KK0M%M/[/G>Q:*WM6FW>6#_RS+DGDC*DY(R>N.:Y37-,USQ7=ZVVG:'?:
M8UWX>CM8S=(B R),S-'PW=3M'USTP: /3(=>T>XADF@U:QEBB($CI<(53/3)
M!XSVI\^L:7:JS7&I6<*J%),DZJ &^[U/?MZUP]Q#+>Z]=^(I]!O7L7T,:?-8
M/;D//*TF=NWNJC(+=/FXS3_#^A2/I.M>#/$-O/=1",1IJCPL%N82HVC<V?GC
MS@<]@1SF@#N7U&QC+A[RW4QQ><X:51MC_OGGA??I5:/Q!HLPC,6KV#B20Q)M
MN4.YQC*CGD\CCW%<"=)\2:A\.C>,R7^K>=;.J1MM%W;6\@*C)_YZ -)_P/%:
M&KV,>O>$M5U0:/+H-Y'*NH6TMVJB8W$2@K(RJ3@?*$ZY(SQTH [675=.@CFD
MFO[6-(7$<K/,H$;'HK9/!Y'!]:R+GQ.JZ_H%G9_9;JPU83XNXYMV/+0MQ@8(
MXQG-<]JECKNG1>&M<_L^74)[:[EN]4LK4@N6FC9,H"1N\O=M'? %/:TG'B#P
M?<0>'KBQLX9;V6:%(PPMQ*K;2^W(#,QR0,XS0!TMEXBM/L"W&IZCI,!DEF$3
M17BLCHA/(8XR0HRV.F#Z5<.N:2-/CU ZI9"RD.$N3<)Y;=>C9P>A_(UYII&E
M7BOX66YT2\"VFN7UQ,'MCB..3S3&Q]LR)],'TJO:Z;K%C#IM^^A:M/9VNH:D
M+BSMF,,^R>3?'(@#+N&.",_Q&@#UR.ZMYK1;N.XB>V9/,$RN"A7&=V[IC'>J
M<?B'1)H))XM8T]X8RH>1;E"JEON@G/&>WK6,FD_8?AG<Z9IFB+"?L,ZV^F32
ME_O!B(W;=U.><-P20#CFO.=0TC6KK3]:5]!UBX:_TRPCC\Z! =\4K%UVJ0$
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M]LD\<$G!XXJEX2\7V7B;2+&9KBSBU*X@\][%)PTD8SUV]<=.<=ZJZW'=VGQ
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MBL"QR!Z9P<8&@^*KS2K[4+:ZM+NZLY?$DFGQW<MSN\HN5"* Q+%0?H!GC/-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPP\\&+S3_ =O&!WYJ2#QNM_X3.KV=JJW<,\=O=V-PY5[>5G5&5L#L6R#CD4
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M]/HWA.;3',UFDL]P]O$L@9[2)W)1 ?F&Y00>XSZT\>#[@'_D;O$?_?\ A_\
MC5;FF:I9:SI\=_IUPEQ:R%@DJ=&VL5./Q!JW0!Q7Q!L;G49?#<=OI]U=QVVK
MQW5SY ^Y$J.I.<CG+#@<]:C\4>'(+>'0X-)T4RQKK<-[=B) Q*KG<[ECECR.
MN3Q71WOB;2=/GN8;BZ8-:H'N2D+NL"D9!=E4A>!GDCCFM1'61%=#E6 (/J*
M/*AIVMPWTTJZ%>^2WB.XNC-"L?GK"\.U6BW' W-D,>" <\=12L= UN'PM86T
M6E:Q8:U8VUS%!/&T<D4^Z4D12J20T;?*<G'<\<$^R44 >7V^A:F/$5Y::SX<
MN-12[U"/4+>]CO2MK"P5 =Z;Q@H5X^4EN![UV^N:1>ZG-92VFI?8S:NTFUH!
M*KL1@$@D= 6Q]?85LU0O=9L-/N8K6>9C<RJ72"*-I9"HZMM0$X]\8H P/AEI
M&IZ'X!TW3]6RMS&K?N2H!B!8_*2"<^N?>N.\+Z0^M^'] AM-/DMYK'6[B\DO
MS$H78LLP.ULY8DE5Q[<\ 9]2L-4L=8AG:SG,BQ2&&4;61D? )4@@$$!A],TF
MDZ/8:%9?8]-@,%OO9]F]F 9CDGYB>IY^I)[T >=:3X=UK^RO"FE7>GRI=:!>
M22W-R2/+FC"R ;&SEO,WKD8XYSVS3F\.:\_A;4M/L+/43IWV&%K:RORC36\J
MRHY@C?.60*O&>,@ 'K7K]% '(^.H;S6_AOJ4%KIMRUW=P!8[5@OF DC@X.!Q
M[US?B'2+^]G\:M:Z)=$:AHMO:V9$2C<X$@91SQC>G_?)]*]'@U.TN;N\M8I"
M9;)E6<,C*%++N')&#P1T)JW0!Y#K^EZ]>7MX\6@7^PRZ;<Q"W$:B81F,R&4E
M@3(N"H7H ,^]6+K0[^Z\(^/(QH%PNH:A>3/9AHTWNDD:*,'/ RK9Y_G7JU%
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M+2*S(C4>84!# <\8R.N.E>K44 >8W6C7L_BC58M0\-WNIV&K7$%W:S?;#'%
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M38?,R?[C"NN;P_HKB]#:38D7W_'WFW7]_P!_GX^;\:JZ?H=S;:P]S<WL4EE
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M4O#EU?32.5<Q2QQHZR+D87)<J1T] #6OX5OM2'BJPM+K5;F\BO?#\=_(DY7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJL@^R\0X3R\K\_/R>O?!]JNZUX2L_$-EID>IL'N]/N(KB&YC3:0Z,"<#)P&
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M>-)!)#=O"BB$PN'3"#@G(Y)Y/KQ5:7X?74L]S.WB"1I;C4K?4F9[5>)(54
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK*1E$DD5NI5L\X5F$DF 3V7.,\ '26WBB[=?$5I):0/J>B;2RB0I%,C1^8C
MX8KQD$<\CWJNGC267PMX:OTM8_[0UYH8X8BQV1LZEV8]R%4$^_ XSFH[32KX
M-XPUI[*99=75$MK3Y?,V1P[%)YP"S%CC/ QGGBLRT\/:JG@SP3*;"5-0T"6%
MI[0LN]T"&.0*<X)PVX<\XQWH ZSP[KSZO)JEI<Q+%>Z9=FUF"'Y'^4,KKGH"
MK#@]#D<]:W*Y7PWHETA\17UV)K.36;MI416 DAC$:QJ<C(#_ "[N^,CT-/'@
MUP0?^$H\1_\ @8O_ ,10 FO^*QI7B?2M#$MI:O?Q22+<WA.PE2H$:@$98[O4
M=.^:TM.U<M#!#JQMK+4I7F5;82_?6-V&Y,X)!50W3@&L_P 3V,>JS)8:GX?&
MJZ,UNS2,%5GCER NT%@>1NY7D<5RVFZ%KVBQ>&+F2PO;Z+3[Z\"6_G(]Q#;2
MJRPABS!25&T'YN ?:@#MKCQ=X<M8(YY]>TV.*16=':Z0!E5MI(YY ;CZ\5++
MXDT."Z^S3:O91S;@NQYU'S$;@.3UP0<=<5Y[X=T'5XKSPE'J.@3K'9/J?VEI
M#&Z()W)0_>R002.F>>E5X2J:IJ%Y+IVIS:#!K[ZDDUK'%(GF(-C-O\P-L#!B
M5"$C& 30!Z<-<THZDNG#4;7[:Q95@\T;V*C+ #N0.H[51USQ"^GZMIFBV,*3
MZGJ)<QB1B$BC09>1L<G'  [D]1R:Y/PWH&H6FM)8ZKX>FG:SU">[M]6>]+0[
M)'9]PCW<2'>5(VX[D^NSXGTG48?%FB^*=,M7O39)+;7=I&RK))#)CYDW$ E6
M&<$C(H U3JE_IMW+_;1L8M-2W,QOE<HJL& *L&R!UR#DY]!BI6\4Z EL;F36
M;".$3>07DG50), [.3][!!QZ&L3Q1/K&M^%+Y-/T&0MB-DBO!'YCD2*250DK
ME5!(W$98#@]^)O['4-.@NFO='O\ R;KQ/I]U"+J2.22<$1J5/S$;LJ<@X R
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M=92WE[/'!;1+NDED;"J*GKA?BB7ATS0KR0$Z;::U:SZACH(03\S?[(8J3]*
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M[E#HZ'[PSM^F<\UBZ/XEOKB]\-"\:&P\R_U&SOTMY"+>>2-7.]2>Q?)]<YH
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MU!13GKVZ<5'X8\0WEWJ<$,^JR7-I?>'[BY!GN-S32"10',?2(D%L(I/'7D4
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MKSF@#V#<I8KN&X $C/(!_P#U&EKA_#2HGQ)\6;[R9G86C1Q23E@5:(L=JD]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !116=KNIRZ/HUUJ$-A+?-!&7\F)T0D 9)RQ P/Q/H#0!HT5R_P_\5R>
M-?"<.MRVBVIEED01*^[:%8@<X&33_%VL:]I&FW5WHVG6<ZVENUQ-)>7!C4@
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M5'S-CD[2: .@HJL^HV,=F+R2]MUM3TF:50G7'WLXZU-#-%<0I-#(DD3C*NC
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MY@D_X3$;P,!O(?./3.^M:_\ @AJ=_96:-KULE]:Q+"M\D<WFL@SP?WF._I0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/B1>^*='\<&&RN]/&F6\WV20+AHV1&/SMT#[A]WT&.:K^'OC#X9TKP=X>BU
M3*WV9+=C$@D6)HU53N/&.H.!G@^O%<'HGCS0]'M/B-I\EP'CU9KF2RF0$B7>
M&5% QD'YLG.,8- 'H7PX^)]K/H'AS3==N+Z;5]3:5$NI(#Y<CB5@%W\ G!4<
M9 R,FNBU7XJ^&M&U/4]-O&O!>:<H>:%+<L2O!RN.",,#DXP*^?\ 0?%%E+<_
M#6PC60SZ3?R"X!&!B6X5EP>_%=7X:^(?AF'XV^(/$-[<FWT^^M1##+)$Q (6
M,$$ $@'8>U 'K-Q\3_#\)NRBWMQ#8PQ37LT,&Y;59.5W\@YYY !(P?0U=N/'
MFAP:WI6DB2:6?581/9/$FY)4()!#9XZ=Z\"U#Q9H.G2?$&SM=0%_'XE=);.>
M)" C%V++)N (QO\ 0\"I;_Q7H&B:I\/KZSU&/5!HEJ8;M8%9#NQVW@<9)Y]J
M /9C\6?"P\+77B$S7(L[>Z^QLIAQ(TN VU1GGCGKC@T0_$"SURYUK0[:QU6R
MU&RM'>9I41?).S*G<KMSTQ7S]9:_H:?"35=+U%&DN[K6_M%NB%@4 1 SJ<8)
M )&#C.ZNP\-?$CP3;7/B+4KA]6_MG4K1P]Q=0IM?:F!&@C/&<#D^G44 =)\-
M?BI"/#>DV_B6ZO[C4-0O7MX[IH"8]V0%4OP,_,.F<9YQ7IGBO7U\+^&;[66M
M);H6L9?RHAR?J>P]3V'K7RCI_BBRC\/>$M."2&ZTS6'NI5QP4+1D8/KP1^%>
MS>-/BCX:U32?$7A83S6U\89[027$>V(R+D8W GJ1@<4 97B_XA:[<_"30_$=
MK/=:;?S7RQS/&FQ)%99#\N<Y7Y1S[5Z=HOC_ $/6]3U33X6N;:?3$\VX%Y"8
M<1]=_P W08P><'FOG?7O&%AJ/P3\/:)&0+ZQO@7C#9.Q5?YCZ9+<#GH36I9>
M+]%UGQOX\NWNFL]/UC2VACN)E(V$B-!D#)QD_E0![CHOQ"T/7-2M+*V^U1M?
M)))92S1;4NEC)#%#G/&">0.*Q/C3JVI:!X'&J:3?W%G=QW*1AHFX*MG((/!Z
M5YM\*/%OAR&[T;3-2M((]4L)7A@U&6XD<,)"P58D&0"2P'88YZU+\6?BEX=\
M5>#WT?31="[%TC%9(0H 7.><^_% 'H'AN5M?O+5M)\6:A>_8XX'U%#<H\3^:
MCY0$+D,I4'@]\=:P? =QX@\5:CXVL)O$VI1RZ;=>18RAU_=_-* 6&W#?<7/X
MU<\+_$_X=Z?I,=_]O%G?RV4$5S;?9F#%HE8#[JX).XC.>F.E>=^!?BII7A35
M/&%Z]K<S2ZM=>?9+A0OWI"/,)/RCYQG&>] 'KGPA\<WWC+0+N/5@AU/3IA#-
M*B@"4$':V!P#P0<<<>]5++XB7+_&>70+I6BTB[M_*L'<8$DL;-N<'T)$B^^Q
M?6O/O"GBW1/A[\/-4N+35%U+7=2G D-K&P2V9E;9DN!G #MQU/'3FLSX@>(?
M"C:5X?N_#'B+4[S5=-D1K9+A.+>, '!.Q><JO<]#0!]-:C?0Z7IEUJ%R2(+6
M%YI".RJ"3^@KRV^UG6;_ .#6J>,GU*ZM;^Y7[3:QV\I5+6,2;40 ?>RI)8GJ
M3[#%7Q%\5_#FK?#[[/<-<VDVM:=+'&3&62*3#(0V"3C<.H!XKD9?B1X>'P$C
M\-&YDDUE[;[.8$A;"8DR"6("XV@="3S0!>_X3/5SHO@U_#WB.[U#Q->R 7E@
M\OG(Z]]ZD83H.A'!)[9KUK7/B%HF@W=_:S"YN9=.B2:]%L@;[.C$!2V2,]1P
M,D9&:^<=6\::7X@\$>%/#",^GW&F/NGU"="53 (^39N8]<]!R!]:T_&_C:RU
MW7]<AMYX&L)]-1+>YAS UPZA2#.=N]S]X!#QG;Z9H ][N_B'H-N+ 0O/>27U
MF;Z".VCRY@ R6PQ'O\H^;@\<5)J/CS1]/_LU +FYNM2MS=6]K;QAI3$$WER"
M0 , ]3R1@9KYXU'Q3X6U3PGH&GW\-S!?:?I0%MJ%HW[V&X5V 1ER 4.T-D<C
M/O5C6O%NF1^(?"?B6;44UHQ:6EGJ5M!))!)N <$YPO'S?B5YX- 'LGB/QM%8
M:/HGC?2[YY]"FF2"\A(^4Q.2-X!Y5T;@COR#T%>@JP90RD%2,@CO7SMXV\6^
M$+KX0Q^']&GM+6>2X21+&#S'6%3(6.7(P2.^.^<9%>_:5-#/I-I);R"6$PIL
MD P&7 P: +E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<5XZ\
M#^%O$\MK?>)+EK<0*88W-PL2\\XRPZ\?I7:U5O--L]0DM9+N!93:R^=#NY"O
MM9<X[\,WYT >2_\ "J/A8>/[83G_ *B,7^%6;'X+_#K4_/\ L%U/=>1(8I3#
M=H^QP,E3A>#STJYX#TVRU'5_B%8W=M%+!)K$D;(RC[I7! ]*QHM?UKPQ'\0-
M8TRWL)+:RUII9UN2VZ0$("J[<;2 <Y.>O2@"_+\%?A[#J$&GRW%REY.C/# U
MTH=U7J0-N2!5P_ CP:85B(OS&K%@OG+P3@$_=]A^5;=_KDL?Q$T2Q_LVSE2Y
MT^>>.<IFX0J%RJMT .1]<56\#>-KCQ5=HKWFFD_9W>ZL4B>*YLY0R@(P9SO&
M"P+!1R!ZXH R_P#A0?@K^Y??]_E_^)I/^%!^"O[E]_W^7_XFMKQ?XSE\/:]9
M::UW8Z;!<VSR1WNH0.\,DH8 195E"<<ECGMQ4.I>--2^V/ING0Q_;[?3XKJ<
MBQGNT:20$K&/*/RCY3\Q)ZC /. #.A^!/@ZVGCGA_M!)8V#HPG7*D<@_=IG_
M  H/P5_<O_\ O^O_ ,36S9^+M8UBZTO2;>QBTO6+C36U"Z2_B9Q  XC"!0RD
MDMDY)& .AS63K>L>+VN_ \-P;32KJ^NG2\M=AE7S$5B"65QE" #M!SDC).*
M*2?!3X>R:E+IR7%PU]%&)7MQ<J75#P&(VYQ6W>_"'P_J=JEO?7.H3QIMV@R(
M"-HP.=N>!Q2W/BQ='\7>)C?V%D(]+TJ.[-S#'B>9<MA&8]LC@=B:?_PEFNZ;
M+X9N=5BL)+'79$@V6T;K):RR)NC!8L1(.""<+Z^U &4/@%X*!SLO_P#O^/\
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MU>SMU6.WO/#ZRS1J,!G28JK8]0I(^E2^!+6WLO%'C:WM8(H(4U*+;'$@55S
MA. ..IH [JBN6\?>(=2\+>'AK%C#;S0P3H+P2HS%(68*77!'(R./\*S)/'DE
MKXSU;2+F6S-G#IQO;.>*)R7( 9D/S89@K*<#J&'2@#LI=2LH=1@T^6[A2\N%
M9X8&<!W5>I ZG%)?ZII^EI$^H7MO:K*XCC,T@3>YZ*,]3[5R,VK:I'XW\/Z7
M>V.D_;;K39Y?M0B9G@D4+N523D)DC(SR!VK@;S4=;U3X6C4-3N8;V9O$,8C
MC,9W+<$8SN("\   <#UH ]WHKDO#WB+5[GQCK/A_6(;'?9P0W$4MIO *OGY6
MW'D@CJ,9]!5/QIXMU?0+VY2U&GP6T&G/=QO=(TKW4JD_ND1'5@ !DO@@9H [
MFBO-M0^(]Q$NA[IM/TE=4TF.^BGOXG>&29@#Y.\,H3 .2QSU''K-K7CR]T_7
MO[):XTS3YVLHI[;[=&QCO9&SN1)0X5,8 YSDF@#T.BN/F\0ZSJNN:[IWA_[
MAT=(U=KN)Y//F=2^P;778 , MSR>G'-+1_'T_BI=$MM'C@M;S4+"2^F:Z1I4
MA5'$94*K*6)?.#D<#/M0!V=]J5EIB1/?7<-LLTJPQF5PH=V^ZHSU)]*M5Y_K
M>O:U:>'?#,^MZ'IHO;O5X+2ZMY?WJQ,TA59(^3@X&X9.1D=:J^,/'^L^&KG5
MI1%IRV]C) (;616DGND<J'DRK_NE!; +*02/PH ]*HKSV36M7MOBOJ<-SJ$
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MQ;=7/A^S.^VL'@12@'*AY?O,J^G X';BN5\#Z-/XI\.^(=,&L6PT>YUFY-S
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M0DX5O?![<5D:3\-]1TO_ (14'7X)5\/M*8P; CS5D&TC/F<<9YYY/IQ7HE%
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M?9SY4494J1'%OX/S$Y+$YZ\  9]MX1\0VWA:V\.IXELTLH;=+5I8],99VB
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M]C:/IUGI.KRPW-IJ#ZA)=31"0SR.CHP905 !#]NP]>:[6B@#FM.\,7(\4_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/6EH **3<N[;N&[&<9YQ0S*BEF8*!W)Q0 M%%% !112$A5+,0 .230 M%%%
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M+&-AX (P21G';- &Y#XOU.^N9+"QT -J=K9QW-];3W@C$#2 E8@P5MSD*3T
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M#456\0A!Q\R''SG#9Q@?6L[1? /BG3(?"MM+_9,D&B7]Q<LZW$@:19&;H-A
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MB2YMC<0RV5\MTHQU23:!L8#GN#ZUF^/2UK\1/ MY;6375V);M%C1E5G_ '/
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MMXTFP^VEMWVC[,GF9]=V,YK0HHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYIK::)YU,-K+(PC4[6=E52R@$$9('2MJQO;;4K&"]LITGMIT$D4J'(93T(H
ML4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7G'Q5^&$GQ!BL)[._CM;VSW*!,I*
M.K8ZXY!&/0]:]'HH Y;X>^#_ /A!_"4&CM=?:I0[2RR!=JEF[ >@P*ZFBB@
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M3?%,5RLBV96YFLTR!*\0&[=SW&<8S7L=% 'AGC6WUS6[3QC;_P#"/:M'+/\
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M-+QK5Q'(\0P^'(QZ'WK$AT?56^%M[X N=,O6U<W#QQW!MF,$JM/Y@G\W&P
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M<HYC<-M8=0<=#R.*EH \3_X0OQ/;^%;VW02&;PK>M+X? R6N5#"3+#^+Y#L
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MQ>2W7E0J5CAWD8C0'G: !^M ''W#S7OQ5\11:S;:?-IEMH\:S)*S,%MR[.Q
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "HS;PF;SC#'YN,;]HW?G4E%
M!1110 4444 %%%% !1110 4444 %(RJZE64,IX((R#2T4 ,BAB@0)%&D:#^%
M% %/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P-8\(Z?KFKV
M6J7<UZMU8[_LS0SF/RMPPV-OJ!WK?KG=;\70Z)KNF:.^F7UU=:GYGV7R/*VL
M8U#-DNZXP#WH L6'A72K#5#J@BEN-1V>6+J[G>:1%_NJ6)VCZ8K+3X:^&HO$
M<FMQVTZ323?:'MUG80/+G.\QYP3GGTSVK9T_69+W4);*?2;ZQE2)90;@Q%7!
M)'!1VY&.0<=16C/-%;023SR+'%&I=W8X"J!DDGTH S[SP_IM_KVG:U<0!K[3
MUD6WDS]T.,'/KQT],FLOQ%\/]!\3:I!J=['<Q7L2>7Y]K<-"SIG.UBIY'ZUT
ML4J3PI-$VZ.10RGU!Y%8NI>)DTWQ9HN@O93,VJB8QW 9=B>6FX@C.<].V.>M
M #;GP=I=QJ.CWB^? VCJ5LHX9-J1@C!XQSD<'/:H$\!Z+%/,4%RMG-<?:I+
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M'%XL\.6^LPVTELDSR*(I&!9=CLG)''\.: -NBBFNZ11M)(P1%!9F8X  ZDT
M.HJ*VN(KNUAN;=P\,R"2-QT92,@_E4M !1110 45A:OXE32?$6B:0]G+(=5D
MDC2=64+&40L<C.3T]*W: "BBB@ HHHH **;(S)$[K&TC*I(1<98^@R0/S-8W
MA/Q'%XL\.P:Q#;26Z3/(@BD(+#8[)R1Q_#F@#;HJ"[O+>PMFN;J98H5P"['C
M). /Q) _&JTVH74>NVU@FF3R6TL+R/>AAY<3 \(1UR: -"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.*WTG2W"R2K;P(SEY97E91R226))JE=^%-#OM%31[C3XVTY3N^SAF5&.<Y8
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MYC':2RC&1QGIZ&M#P3)INLZQI$S>'O$$.K:9"\<TNHR2^5:93:RKO;#;C@
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MOG&P+UW9XVXS7-?$&[EM=8\+L+286YNI?,U&"T:XEM#Y>!L0!N7R5R5./2N
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M9WMP"7$?][&.1_7BN4\#OI.J:S=:WINCZW;RO;B">[U5Y-S8((C4.QSCG)'
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M3R(Y4>1TS\Q>7))C#<G!/ITYQV5 !1110 4444 %%%% !1110 4444 %%%%
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MR7UCMC>YM(24AD)'R,^, X(SCD9'2@#T6BJ$E^++0C?S)-,(K<2NL*%W;C/
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MB<@EV&<YRW->WT4 >6:&/$OA^:_\,R^%7U!)]1ENK/4G93;JKOO#RY.0RGG
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MH%K:2RZ3%&T[7,C 22NI98UP.. ,L>Y Q63>^);[P'IL5WXGO)-7N[R3R_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)/\ A5A_Z >D_P#@5-_C1_PJP_\ 0#TG_P "IO\ &O6Z*.1![:9Y)_PJP_\
M0#TG_P "IO\ &C_A5A_Z >D_^!4W^->MT4<B#VTSR3_A5A_Z >D_^!4W^-'_
M  JP_P#0#TG_ ,"IO\:];HHY$'MIGDG_  JP_P#0#TG_ ,"IO\:/^%6'_H!Z
M3_X%3?XUZW11R(/;3/)/^%6'_H!Z3_X%3?XU?T_P#/IJN(O#GA^3>03YY>7&
M/3=G'X5Z911RH/;2.!/A:\_Z%GPH/^W8?_$T?\(M>_\ 0L^$_P#P&'^%=]13
ML+VLC@?^$6O?^A9\)_\ @,/\*/\ A%KW_H6?"?\ X##_  KOJ*=D+VLC@?\
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M(4VMC@/^$6O/^A9\)_\ @,/\*/\ A%KS_H6?"?\ X##_  KOZ*+(?M)' ?\
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MG_0L^$__  &'^%'_  BUY_T+/A/_ ,!A_A7?T460_:2. _X1:\_Z%GPG_P"
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M(@3D-\H4A2QVX!/KUH [*N!\>7\M]_Q0N@Q1G4]7C8W4FWY+2V8XDE?'<Y(
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MJ%\QSQPHX50.@K>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@
MQ1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BB
*B@ Q1BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>modificationno14effectiv006.jpg
<TEXT>
begin 644 modificationno14effectiv006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS%F,$A3NR%))XZ>U;>F02:=\3])M(KZ_>'4=">6Z6:[D<22!E^< G"G_ '<
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M;:9PS !B <CCD#/XUH5X7I=Q?7O@[X?22:KJ0ENM<FMYY%O) TB&6;ACGD\
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M6Z$GKQ@>E6]1FO\ P[I^N:SHWB"TG631FDAL;6:2<!U9?])!=FQA7Y['@\T
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M;==TD,;@LHS@GW /!QT-4O$WB_3O"\FFQ7A)FO[I((U . "?F8D X &3CO\
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MB@*JCL!Z5+10!AZ1X.\.:#J$]_I6C6EI=39#R1)@X/4#^Z/88I]IX2T&QO\
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M(9!)&'SE&]01R*TZ* .=7P'X719!'HUO'OG%P3'E") "H8$'Y3@GIBIG\':
M\$$/]FQJL#O)&R.RNKOC>VX'<6.!DYS6Y10!B7?@_P /7VE6VF7&DV[V=L_F
M0Q $>6W.2".<G)SZYYJ!O ?A9K6>V_L2U6"XE$TR(I42,.A.#SCL.@[5T5%
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M/>.:,(9&YP9."<#/!'O0!T6L?$K3K/1;>_T^"YNFEU)=.9/L[@PR[P'5QU#
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M)G<JOC!/!'H<<9KS30]+UMM>\%W]QH.LQ36JW<%\Q1$BA9X]J^5&&"I&"3R
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M^S[O[$J8BGWJ_P W(55XQGH.: .M@\::)=Z-8ZI:SRSP7\C16J1P.99F4L&
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M#X<>%=7\/1WG]LL9?L6ZPTSD%C:JY<-UZL6 [<1K7H%% 'CH\+^(W\&WL/\
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M@>5AVPN,Y)('(Z]O6:* .?\ !*:A!X/TNTU/3GL+FTMHK=HGD1RVQ%4ME20
M2#@9SBO-;OP]XLN[BSN;[P_=7.H67B..]:=+F(1-;!R0(4W@+Q@DD GN2>GM
M5% 'D=]X>\0W.@_$&V70[D3ZS<B2S7S8L.-JKUW\?=)Y[5H66G>(_#_BN;5X
M-"GU"UU;3K:WEB6>))+2:)=N&W-@J<DY!/\ CZ910!R/PQTO4=$^'NEZ9JMF
MUI=VZNKQLZMP79@<J2.C5S5KX8U4>+K34M,TK4=$DGO)'U91=(;.XB8-\ZH'
M)\P_+_",9.?6O4Z* /,_!EMXTT&RL_"EQH5O]DT^;Y=8-RI22 /NXC^]O*DK
MVQG)]\:\\->)+CP!XKTM- NA=ZCK[7ULAEA^:)I4?)._ ("$8]2/P]EHH \I
MU'0=8L?&6JWZ^![#Q%8ZP8IHVNI(5DM'"!61RX;Y>,_+D?6KL6D^(?#'C&\U
M"UT9=3L]5T^VMW6RD2$6LL2;  KD8C.2>,X]/7TFB@#Q_3/#?B72?!O@:0Z'
M++>Z'>.]S9I-'O:-PXW*=VW/S#C-/E\/>)I_"OCZUDT&1;G6;QIK2-+B)MP8
M*.3N&,;>?TS7KM% 'DE]X?UJQ\01:R/!=IX@MK[3[>">TNI(1+9RQ@C@ME=I
M!YQ_3GT2RTQV\*C39X+:R>6W:-HK-<1P;@?E3&.F<9XSC/%:]% 'G'@N/QII
M]CIWAG4=!M[>WTT")M6%RKK+$N0/+0?,&(P,G&.3UXK,M_"FO?\ "MYOAY/I
MDO\ KS''J@DC,!@,WF>81NW[@,C;MZXYQS7K5% 'F=QHNLC7OB!-'H]R\&JZ
M=%;63B2+]ZZ1-&>KY'+ \XX!K+N/"NHW?AK1;6X\.:K#JVG:/%!:ZA87<4<L
M-P RE&_> %/E0YYZGI7L%% 'G5II7B73O'&B:S=:>VHL?#Z:??30RQJ$G$@=
MVPQ&0><8'7T[4--T7Q;8?"#5=*LM--MK9N)GACE>)MZ/-N)!W%0=I/7O7JE%
M 'E>B:-J]AXNU?4D\-7\-I?:2D:^==QRRF52V=[%SESQW(QC)'2JVA^'?$-I
M;_#J.XT.Y1M%>X%Z?-A(0.I52/GYZYX[5Z[10!X]>^%?$5YX6\;6J:/,EQ?:
MTNH6<;RQ#SHQ)&<9#D X0]<=JO>+=#U;Q!<3:C;>'-4T[7DMU6PO[.]B7!Y/
MES_O,%0>N 1R0"<<^IT4 <?XXT#5=<\(6L5HT<NK65Q;WBH6V)/)&02N>P/.
M.V<=*BALK_5_&MIXFN-)N[&'3M/E@2"9HS+-(Y!( 5B-H"]21DGTYKM:* .)
M^%^F:IHWA:2PU;3Y;.=;N:55=T8,KN6&"K'UIE[8ZW8?%A=;M-(:^T^ZTM+.
M25)T3R664L20QR>#QCJ?3K7<T4 >,OH7B*7X3>)=#_X1Z]74+[4)98(R\7*/
M*'!)WX& ,'W(ZUJ76G^)]&\73^(M,\+IJ]IK%K MU933QQ36TL:[0<ME<8],
M_ACGU*B@"AHRWJZ5"=0@@M[IMS/! <I%DDA0<#) P"<<G)KSO0;+QQX-?4/#
MVGZ#!J%C/=RSV6IM=JBP+(<_O$/S-M)S@=>0*]3HH X&STO6?"OCG6]3CT^X
MU;3M92%V:V:,20SQKM.5=E&UASD'CI7.GPEKFD6GAP1Z5<7<Z^('UF]6!XRL
M"ON&P%F&Y@"O3CKS7L%% 'FL^BZQ?>+O&Y&E7$5KJ^EK9VUS(T>PNL;KR Q(
M!+#!Q^59<MCXHF\,>![.7PK=I-HE_:R3JEQ"Q:.&,HS#Y@ 3G(&?RKUZB@#S
M_P 2V.O77CFRG;0CK&@_8@L=L]PB1PW)?)DE5C\V%Q@X;'89KE--\(>+]-\+
M>%[FUTA/[6\,WEP1:2W" 7<4K-OVD$A>" ,X/7C@9]KHH \X\26/BWQG\/=?
MM[G1X].N+B&);/3C<)(Y9'#LS., ;L  =MO/6NGM-6U^:32!-X<-O%<^9]L+
MWB,UH OR9 ^]N/'!X[UT%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %4=5UG3="LC>:K?6]G;[@OF3N%!)Z 9ZFKU>9_&3P!JOCK
M2=._LB6/[38R.Q@E?:L@8#G/3(V\9]30!Z%IVI6.KV,=[IUW#=6LGW)87#*?
M7D5:KA/A-X-U#P1X.;3M3EB>ZFN6N&6)BRQ@JJA<]S\N?QKNZ "N!U34KG7O
MBE'X26ZEM],L].-]>+!(8WN'+!50LN"% ()P1GH:[ZN+USPUJEKXUM_&&@+!
M/=?9?L5[93OY8GBW;@4?!VN"!U&"!VH OGP]#I&MP:Q;7]U;V$$$HNK:6[D>
M(C (DVL2 1@\^AJK#X_MV&D7-SIEW;:9K$JQ6=[(4VLS#,>]0<J' X_#.*M3
MVVL^)=.NK+4;2/2K.YMI8)(Q,)I7+J5ZCY5 SG@DDXZ <\Y:>%]?O_#_ (=\
M-ZM:00P:/<P227L<X99T@^X$7&X%L+G.,<]: +5W\4K>UL]7O#X?U5K;2+O[
M-?29B'E?=&[[_P W+=%SZG&16KKGB2-Y+_1]/L+K4;F*R^T7 MY1%Y2,#M&X
MD'>V"0!Z=N*Y"_\ "'B*Z\+>.--330)M;U W-J3<)@(2GWN>"-GOU%:2Z%XF
MTCQ5?:QIFG6]Y#K5E!#=03W0B:UEB38#D!@RX/..?Z@$/P\\4+8>#/!.G7<5
MS--JZ2QQW&X, R%V.[)ST';-= GC[3VM=2D:TNEFLM2&EBW^4M/<';M5.<8.
MX<DC&"37*6'@_P 4:5X4\%^78VDVHZ#<N\MJ+K DC=6!PY& PW=.?J:C?P)X
MJN;#6IMEA;:D=?36]/\ WY=&=0!L?Y1QC//<]A0!N>)?B!?:;X7\1W-OHMS!
MJ6DA$99F7RQY@^616Z.!GD#G/'O5B^U6UF\4>$(]3TO4HM2G%P]H4G3RPRQ$
MN'"O\Q( QQCYNO6JFL:/XP\7>!]<LM5@L;&ZN[=8K6RAF\Q0RMN+,^/XN  .
M!CWX??:9XCO_ !+X,U:71XXQI0N#=QQW:OM\R/RP%)VY(QD]N< F@ 7XJ6K6
M0OVT+5$L$U#^S[B=_*Q#)O"\@/EAD\[<CWK5U?QS;:;?:O:P6-Q>MHUJMW?F
M)E7RD8%@!N(W-M!;'IWSQ7%S>#?$LG@/4-'&F*+NXUPZ@F;A-HC,HDY.>O&,
M>]&M6NJ:WXV\0G2-.CN;:2UAL=0CM]32V=_D)9)0T;Y(#XW(1@<9)R  >G:1
MJRZSH=MJL-K<11W,0FBBEV;RI&5Z,5Y&".>_.*XS_A;5D--_M630-6CTF.Z-
MK<WK+'LMV#[.0&)89QDKD#.,D\5U7A6]CO\ PY:216/V%(@UN+82"18_*8QX
M5APR_+P?2O+?#&EZMXE^'6J>'(;)%L[W5)U>_,ZXBC$^7^3[Q;@X'3D9(H [
MC6_B1I>BF]D,+W%K82I%=S12QY1CC.U"P9]H89P._&2#A9/B#'_PDMQHEIH.
MJ7<T'D.\D"HR>5*>)/O?='!QUZ\8!K$7PSXKT'Q#JL6CZ=HVH:7J=T;I+F];
M$EH[ !LC&7&1D ?F*V]%T75;+XC:WJMQ;#[#>6EO!'-O7<6B!!)4= <\?TH
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M%A VH:/K9OF@:Y55EB9I#PXS@C>.H[&@#T/Q+K-SH?A/4-8AL3/-:VS3^09
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MEY#<6XT#ROM#$*WF>8N4"8/)/ P<<D5S0U.Z?XS6$M]9W.FQ?V)-*Z3W(="
MPYPK%5(QS_6JFH>!/$OB!O&;7<5G8MK'V.>T*W!DV20*,(P"\@XP3ZC@$5>?
M0/%/B/Q7:ZAK&DVFGVQTFXTZX\N]\Q@9.K* OY#/U- &S8_$;3;W5]+LC;R1
MQZJ&^Q3^;&V_ R RJQ9-PY&1['!XK=UW7[70;>W>?YYKF80P1!U4N^"3RQ
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MNDP8<M\J@@8X(Q]#G%=EX8T?5+#QOXLU*[M/*M-4E@>W?S%8XC38<@'C/44
M2:Q>Z?'\0]!MI[+4'U'[/<R6DD<JB%@%&]2N[ENF,@#GKZ9UM\4[2XL[&_\
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MX;QAKOBV36-,U9?[.N46V>UO$26T$<8.U"' #,<DXR#GD\#&OH7C72])\/\
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M@<=#0!VU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMJ@$$1CN)0JL_F%G!4'=@!1QC.3G ZKQ!<Z@/ VH7D$AT^_6P>;( D,3A-Q
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M19DV @$84 <'&!C\:ZRZUBWAN+JS@*SW]O;?:3;AMIVY(&3VR0?RJMX2U_\
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MRQH1*C##;R .3@= .E=510!Q&@_#>WT"_C-OKFK2Z3!)YMOI4LV88FSD=LD
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M IZ38'2](M+ SM/]FB6(2N "P48!..,X%7*** "BBB@ HHHH **** "BBB@
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MZ%1V/TH \=\4136/A/Q[86T\Z:9I^J6GV%EE8"%I#&944Y^ZN[[O09KV/1-
ML?#]I-:V/G^5-,TS^=,TIW, "<L2><9^I-$_AS1+G3%TV;2;*2Q5MPMF@4Q@
M]<[<8SGFM"*)(8DBB14C10JJHP !T H \%N;#3[+X<_$X0P0Q7":Q<Q(HX81
M!X2 !_=SBNAN(YO#GCRX;1GG>>7PG-=%))6D\^=&&QB"3SVX^E>AW'A+PY=S
M74UQH6G2RW1!N'>V0F4CIN..?QJ:+PYHL%]#?1:59I=P1B**985#H@& H/4#
M':@#S3P6EA?W_AC6K7Q7IYO'B9+BTM8&$]XS1Y83YE8DJ5+;BH_(BMOXIQ+)
M<>$%:XN(5FUV&WD,,[1Y1E;(X/L.>H[5U]AX:T/2]0FO[#2+*UNY\^9-# JL
MV>3R!W/YUA>/O#-_XG.A1VUO8SV]EJ*7=S'=R%1(B@@H %;.0QZ^E 'G'BW3
M/[!M_'^F:7-=)I,-A:W2Q"X<K!<,^" 2<\J,D'V]!71WNE6>C^)_".D;KAM'
MUB:>XO1<7#2)<7 A78&W'H3EMO0MVXKOAX6T$:8^F_V/9&RD?S)(#"I5V_O,
M,<GW-6+G0]*O=,33;K3K6:RCQL@>(%$QTP.V.V* /*M5BGT[1_B?IMI+/'I-
MC'%-9".5@(97BWR(I!X4':=O09Z<TM[>1ZEXAM]$UG5--L;4Z#;O9_VE$SH[
M,")'0^8@#C"X)R1CC'.>P\1>&-2O-(N?#VB6^CV>AWEJ\,N0Z2Q2,>74*"KC
M'8X)/>MJY\*Z)J&G65EJ>F6M_'9HJ0FYA5RN !W'? S0!YO:7>G+XBT30O$F
MMQZEHPT1S:7MV?*BNIQ,5+<D@L(U&TDG@Y!^:F76F:&?$WPZ5;@ZC91_VA:F
M]NV!,RQ(=N6Z%00<'H1S7J.I>'=%UBUAM=2TJSNX(,>5'-"K+'CCY01QQQQ3
MKS0-'U""V@O-*LKB&U(-O'+ K+$1P-H(P/PH @TFUT>WUC6)=/NDEO9Y4>]C
M%SYAC8+A05R=G';BN%^(#6M_XLDL#BXN+;0YK@PW<OEVT"EL><,<M+Q@#@ <
MY%=SIOARTT[7=2UB..%+J^VK)Y,00$*206[LQSR?88 YS8OM T?4[Z"]O]+L
M[JZMQB*::%79![$B@#R+1XUUG4_AI'?W=S,+O2;A;E3=./-VQJ0&Y]"<^HZY
M%06>I/8^&K+3)KB2+1G\7S6-P[2L ENK$K$6SD*3C//3([UZS;>#?#5G+;RV
MV@Z=%);9\ETMU#1YZX..*EC\+:!%87-A'HU@MG=-NG@$"[)#ZL,8)]Z ..\&
M6>GZ=\6/&EOIR110?9[)A'$1M4E6S@=OI[U!X]:VU#Q@=.^6>XM]$GN6AO)-
MEM I;'F@#EI>, < #G(KNM+\,Z%HDIETO2+&SE*!"\$"HQ4=L@9Q3[_P]HVJ
MWL%[J&E6=U=6XQ%--"KL@]B1Z\T 8_PUNI;SX<:#-/.TTQM$#N[;F)]S],5U
M54],TK3]&LELM,LX+2V4DB*% JY/4X'>KE !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !65J^O:=I3+;7-U*ES-&[QI;P//*%'5]B
M*QP,CDC%:M>?:E+?^'OBJ^M7&FZA?:7?Z:EI%+90-,8)%<MM95Y .<YZ9_0
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MFOXH%FDC"L,IP-RDC##/&5)%/L_%NB7^I0Z?;WA-Q.C/;AX719U7[QC=E"R
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MHLSB&1XX2YPHD=5*IG(QN(ZBG:OXMT30Y9(]0O&C:%%DF*022"%6.%:0HI"
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M5(8R['*D !5!)_ 5Y5H%M>Q7'PL$VE:FG]FPW:7F^PE @9HMB[CMXRW?\>E
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M.%S@G%78_&.A36,MVEZQ2*X%K)'Y$@F68](_*V[]Q],5Y18:=K=K\._#D?\
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M;,H5QCGY2>.>E;E>8)#<^);7P/91:9?65YH]W#<7QN+1XE@6*(JR!R &W-M
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M2W=S,8;:V1%!S)(%;!)( &.>: -]Y$B ,CJ@)"@L<9)Z"@2(9#&'4R 9*YY
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M@H!SD\9KJZ* .+\4^&-=G\367B;PO?65OJ<-LUG-%?(S0S0EMP!V\@AN??\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%>=_%KXC7?P_TRP:PL
MHKB[O9'"M."8T5 ,Y ())W#'([T >B45Q7PO\;7'CSPFVIW=K';W,-PUO(L1
M.QB%5L@')'##C)Z5VM !7.:[XUTOPYKFEZ5J:7$3ZG)Y5M/M4QEL@8)SD<LO
M4=ZZ.O/_ (@^'8_%6JVND-@2S:1?- _39*LEJ4;/;D#\,T ==K^NV/AK0[K5
M]2D*6ELNYRHR3DX  [DD@5)H^J1ZUI%KJ4$,T4%U&LL2S !BC#(. 3C(->.W
MNNW'C_X:7TU[#(G]BZ7/]N61<![\(R >^U0S^QD3N*VX[N2?1_A]IEO>7C2S
M:6LK:=:3-;FX @0!GF5@4122<#))['% 'JM%>(:;JVN7_A'P#++KFHI/=:Q)
M9W$D<_,D8>4 ,<?,0% R?K5N75;O2[#QQI3^(=2ABM=2MH+.9W:XN%\T*3&C
M,P.6Y )(QG.1UH ]DHKR73M2\16TOQ&L[:::";3[6VFL8+R]-S]F9X79OWDA
M/)V@X)*@]\<T_1YM5?5K'4K&;77TZVT(W%Y'>/.$DNP,A?WO4GYLA>.GM0!Z
MO17E?A9]<U6#PUXE76[=(+@C[<K:C+,MRT@YC$)4)&RMT"],8YZUT7CK5Y+*
M_P##>G-<R6EGJ>H>1<W$<AC;:$+*@<8*[F &00<9YH [*BO,?$%S=^&+>'1X
M-?N[E-1U^W@DDDD8RV-M-SY?F$ELG80&)R WT-1ZY+J.A^(/$6D6.IZC]@D\
M-RZE&TER\KVL\;%1LD<E@&QTSV.* /4JB@NH+DRB"59/*D,<FTYVL,9!]^17
MDVCSZC;ZO\-I9-:U2X_MW3Y1?)-=,R/BV5U(7.%8$_>')ZDDYK"2.XTGX/\
MB/4=-U+4;6[AUJ2-)$O).!]I5.06ZX8Y/4]R: />Z*\TU:PGTS7](T.'7];U
M*6Y:YNVLFO&B>0%54%IU*E(E.XA0#RW ..,3POXEU#4]'\ Z;JVIW0BU1KT7
M-R+AHY)FA9A''YBD-SD=P3M'J<@'L-Q=06D:R7$JQHSI&"QQEF8*H^I) _&I
M:\@\7:2MO9>';&?7+S4GM_%D$!D:>17B23YQ&S!LLRJ5PY^89XQ7H'BV[31?
M ^ISC4GT\06A5+Q@9FC.-JGDY9LD=3G- &_17C,&O:YX>U;71&;_ ,N#PO\
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M88Y4GC:,=?I0!ZE17E7A:37=7MO#7B9=;MXX9W'VY6U&65;DR<&,0E=D;*W
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M+$[MW P<Y&!BI8_".C)8WMH8)Y$O8Q%<R2W<KRR(,X0R,Q?;R> <<GU-;=%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8F@#"\-^.=?T?PWX6T[7=%U'4-;U2&=HOF1'?R\E0VXY!V[22<<'/)S73?\
M";7%Q]L33]"N;FXT^VBGOH&E6-H6=-XB'7<X'4<#IS1X@T35+[Q[X6U>T@A:
MSTO[3YY>7:Q\U GRC'.,9JM'H6NZ!XJU[4-)MK6^L]:\N79-<&)K>95VDGY3
MN0\'CD>E $T'Q#LKK4/#D-O9RO9Z^C-:WA=0JLJY9''4,,8QW/>J/C/Q#IMS
MX)UN75=(N;O2;>[6TD^SW 7S"LBC<&R" 'PIQDY!XP,U#JGPZN(_AAIF@:3=
M+_:^D/'<V5TWR@3JVYCWP#N;CZ5:\6^#[Z[^%W_"+:.L4UR5A4RS2; 2LBR.
MYX.2Q4GZM0!:\2^(#-'K>AZ=ILE_+96/F7A6<1"(.K%%!ZER 3C@8QSS6)X/
M\66VB_#WPI9R-#)?75B9%6XN5A4(IY9G;W(  R3GT!(L7/AWQ-I_B;6]3TFU
ML;FW\06T:W,-S<F-K69(R@((4[UP>G'/I679^"?%VAZ9X:O],72Y-6TNR>PN
M;2>1FBGA9@P(;:,,"/\ ZY[@'>^$_$]IXNT&/5+.-XU+M%)&Y!*.IP1D<$>A
M'4&L2;XBQ0:E!%+I-PEE/JW]D1W#2*KM-G&X1GG9GC.?PKI-"BU2/3%.L-;?
M;9&+O':J1%$.RJ3R<8ZGJ2>V*\QN/ WBV::*6XM--O+VVUZ/41J$MVWFSPJQ
M*Q\H?+4 ] 2/0=Z -ZZ^*8M;#6+\^'+\VFCWIM+US+$#'@J,@;CN.6Z#\^:[
MRXCBNK-XY%W1NG(Z9%>6WG@KQ+=^$/&>E&TM5N=<U(W<!^T_*BDH2&XZC9^M
M>F*UTFDJ?LP:Z$0!A$@^]CINZ?C0!Y;X&\6?\(U\(-&UJ]MK[4I;V[:"642[
MWR9F122QR1@  #/X5TMUX_NHH?$L']@RP:GHUF+P03SH5DC()#;E)QC:<C\,
MUS=IX&\36_PLTOPPUI:F\LM02Y9Q<_(R"8R\'&<\XZ5N7GA76=0\4>*;MH((
M;35]'^P1,9LLKA6&6 '3+?I0!-IWCM[?PSX??5(X!JNI6BS*)KI(D=1&I:5F
M/"@E@ H!.3TP"1):?$O3;[0M/OK>VE:ZOM0_LV.U+KQ.#SEQD;0.=PSD$<9X
MK$'A3QE9V/AO4K&'21J^CV9T^6TEF9XKF#:@SNVC:VY,XZ<CDXP3QBFL2:5X
M?L+]])&O76I_:H84F,"PB)"<12$'D?+DD'.\@#'0 UKKXEBSTWQ!=3Z!>;M#
MD$5T$FB*%CC&TE@Q&"#G;WJW_P )O>&.U7_A&-0CN+VZ\BUCF=55X_+\SS68
M9"#'8\YX]<<E-I6K:KX;\1>%8](M(M6U*,74MVNI_:!(Q91F0[ 5.%^4 8(!
MQT-=/XFT/Q!JD7AMK:&TF@M')U'3)[@I%/\ ( N6"G<%.3@@@\<<4 96H?$J
M^N]$T:\TC3-C7>N)IEP))E.QA)\RJ>0P8*1NXP#6KKOQ)LM#-Z'MXY6TY$-[
M']LC21&8!BD:GF0J"">@YP"3D#G(? ?B:WT!+9+?33/9>)1K%NBW#*LR;F)4
M_(=G!&.O?\=,Z!XVT?Q)J%YHT6B7-IJ[)/<1W;/_ *+/L"N5( +J<>Q^G< U
MM5\5Q:G!>Z=H^GR:FRZ<MW.5F\D)'(I,:YZ[V )QQQU(IOPH8R?"W0"Y+$VY
MR2<Y^=JH2^&O$NC>*]2U32!9:E#K-G#!>"ZF,#1RQ)L$@VJP*D$DJ.YK<\ :
M-J'AWP-INDZDD NK6,H?(D+J1DD<D#GG_P"O0!P^AZC>^&?BC<)<W<SZ'K=Y
M-90I)(S+;7$9!0#)X#!B !W^E.\4ZI>ZI\5?#$"7,J:(E]+9F*-V5;B5$#2%
ML'YE!*I@]U>M;5?!FJ^(O"^MZ=<116-[)J1U'3KA9]_EOD%22!D'@CC/WJ76
M/!VIQZOX-.DVT<UGH,CR322SA9)BX 8XQRQ.6))Y)H OZK\18M*N[KS-)N#8
M6M_'I\ER9%1FD<#E$/+*-PR<_2KO_"8M-KMYIUCIIN5L;N&TNG$ZJZ&3;\XC
MZE!O'/'0XZ9KBM=\"^*]3?6Q):Z?>S3:FEW9WT]T1(ENKJ1;JI0[  I)(//H
M>M:6M^#-7UW68=0;2]/L=6AO(Y8M7M;ME=85*[D=0H+G&Y1GJ,9QTH MZ7X]
MNUN_%EUK=HMMIVD7 A4I*K%<*N%[99BWK@9 ]ZGC^)EI]IU.TDL?,NK+3SJ(
M2TNXYUDB4X8;P0 R]P>W3-9M_P" ];OV\8Z>'M(;+6+A+VVN_-8R1RIL*J4V
MXQN3DYZ=CVO1:?XXU/0-5M=9MM&AEEL);2*.S8_OI'&WS&8CY5'/ ZY]A0!M
M^$_%$_BBU^UMHEY86LD$4]O-.RD3!P2<8/&"._4$'O7$:C+I47Q<UNUUF_FM
M].&DQRI&MU)&!(6Y9 A!W8].:] \(V%YI7A#2=-OTC2YL[6.W<1ON4E%"Y!P
M.N,UA66A:S#\6+_Q%):Q#3;FP6S7$P+@JP.XKCIU[YH YSPKXVUS0_"VAV^M
MZ7JFI7FIW4T-D\A59709,>_<0<G'4@#')-=9#XSNKV62TL= N)=1M;6.YO;6
M698S 7!*QYYW.0I..!C'/-'BS1-4U/Q)X8OK""%X-,NVGG,DNTE64KA1@Y/.
M:A;0]:T3QSJ^NZ3;6]]:ZQ#")X9;CRFBEB4JK [2"I4\]\^M %._\5:#KMKX
M-U4V-Y<17VI(MHZR>6+>?YAB0!LG&&XP1Q^<NK_%'2=(FN'98Y;*UNQ:7$JW
M*"57R%9EB^\RJQP3P>#@$<USM[HT.A:9X$T:WNXKVXM?$B-=&!@VV5A+(XQU
M &X\'G K5LO#?C/0M6U'3]*;2)-%OKR2ZCN[@-Y]IYC;G 7&'().W/'KZ4 ;
M>I>.#:'4IK+1[K4+/3+A+:\E@8%A(=NX(G5]H=2>G?K@U%IGB75KWXEZSH<E
MBJ6%C!"582@GY]YWGCO@#';'O69'X>\9Z#XAUJ/P_+ICZ1K%TUX9KHMYMG*Z
M@.0HX?H"![#.*U++0=8T[XD7^KQ+;3Z;J%I!%++),5EC:(,.$"X;.1W&.?I0
M!E?%F1;9?"LS7$EO'+KUM;W$B3-'NA.XLK$$?+Q61;2S7'B#Q?;:5=7MQX47
M1V<-)+(\:76,XB=CG& 20IQG\*ZCX@Z#J^OOX?&EV\3C3M5@U"5I9@F1'GY1
MP>3GZ5TFM0W-YX=OK>VA#7,]L\:1NX4!F4CD^V: .(\+^*)=*\$>$[&#3Y+V
MYGTG[0SM*(HXXXU&2SD$9)( 'YXJ]%\3+>ZMO#<UGHM].-?63[. T8VN@.5.
M6]1UZ8.<]JQ+/P;XI@B\,6]S::?>6.GZ>;2:RGNB(DF!^6XQL(?"@8!&0>F.
MM,T#P7XGTZ#P/#<V=GMT&6X,Y2ZR760$ @;>HR3CT YYX .Y\*^)U\36]^6L
M9;*YL+Q[.X@D=7VNH!X8<$<BLI;Y_$GQ'O=),CKIWA^.":6-&(\ZYDRR;L=5
M51G'3<<G.!4O@G1-4T:_\22ZA!%''J.IO>P;)=Y"L ,'C@_+^M5=-LCH/Q:U
MJ67(M_$-M#+ Y^[YT(*O'G^]M(;'<9]#0!FKXRTGPW8>+=<M]!U!6MM46*_0
MSJQ:0A5#@%B OS 87/7IZ;T'CJ%-<U+3-6TVXTQK+3SJ7F3.CA[<,5+':3@@
MCI7):KX)\37^@>,M/2SM5?6]2CN[=C<\(JLA(;CK^[[>OM6OK'A#5/$'C/4+
MVY@CM]-O_#S:2["8-)&[.7W8QR 3CKVH W-,\4SZEJ-G9W.AW=K!J-HUS;W&
M\,-HQ\K[?N-A@<9/UKD/!7B)/#?A16EMY;B*Z\236"E7YC+RE5)SU'ZUO^$[
M+QS:)9V6N-IBV>G1[%DM&9I+W"%5#9&%'()/7(';-8$?@CQ(O@F:Q$-FFI0:
MZ-6MD,^4D'F[]I;'!ZCI0!UEQX[T^QO?$D%_#) F@PQ33R@AA(L@)4*.N>,8
M/<US4UY?W/QD\,RW>ERV)DTZY8*;@2;Q@?*0.%8=^W/4U%J'@'Q!XDF\8'4U
ML+*/7;6U6+RIVD,,D/*@_*-RYX)X]@:T;72/&.H>,_#^MZOI^EP+IUM/!/Y-
MXS&0N%&]1LXSCA<^N30!6T_QGI'A[0]1U&RT'44CF\02VMU&9E=A<,RAFY8\
M$\ +D<=LUOV?CN$W>O6VJZ;<:9+HUNMW,'=)-T)4MN!0GG"GBN1?P5XG?P]?
M6/V*T$T_B0ZNG^E<"(N'VD[?O<8].:T=:LK[1]9\8>)]0M[./2[K25@7SY-X
MW*I #J!RK%L<&@#7L?'K76J:%92:)<H-;MOM5I(DT;;8P 29 2,$*RG W=>,
MT_QKXDU70]2\/6>G6:RKJ-^L,CF0*< %M@!'?'7M^/'(^%;?4_#]WH,VJ:9:
M7:QI'I]I<1ZP)W@20J#Y<>P C@$X)(4'G KLO&^A:IJTF@WNDQV\MQI>HK=-
M#<2F-73:RD;@K8/([>M %/5_B,FCRWCSZ/<&RL;J&TN)S*JGS) #^[4_?"[A
MDY'MQ6(FIWNC?%;Q>VG:->:K(UI:2&&&55"C:Q)RYZ\\*,D^E4O$'@7Q;JZ:
M^D]KIM[/=7<5Q9WDMTVZ&)71O(12GR@;3DY&?0FNHBT;Q'IOC;4]>M[.QN5U
M2S@B:,W3)]GEC!')V?,G/4<^U %G2_B#8:Q=^'XK.UF:+7()I;>5B!L:+[Z.
M.Q!XXS7+^/?$,7B7X3Z[>1036TMAJ*VA!D_C2=%8@CJ#N/6KJ^!-6\.)X.DT
M(6U_)HGVI;B.XE,(E^T#+,IPV &R<8/&*S[GP+XHD^'GB'0FAT][S4M6:\B=
M+A@H4RK(=P*\?<X )Z^U '4>)/'R^'[C5 -)GN+?2H8IKN<R+&/WA.%C#??;
M )/(].M,U/X@R6FOC1['PYJ&HW#:>NH1^2\8WQ%@I/)XQSUY)& .<USWBGP9
MXHU^]\1%[2PNH=1LXTL'N;HYT]@GSHB[2,LW\0(XZ^E;6C:!KT'CZRUN\M+2
M.V30UTV01W)=E<2;]P^49';ZT =/XBUQ?#VC2:@UK/=,'2.."$?,[NP51[#)
MY/:N:G^),5IIWB.>XTB<W.@-&MU#!.CJ0XR"KDC\1C(]*T_'FE:SK'AO[+HD
MRI<"XCDEB:4Q">('+1[P,KN_^M7$W'@7Q(]GXSMK;2M*M8==@MD@B@N<) 40
M*5QL''4YP.>W.0 =AI_CE;GQ%'I-[I5SIXGL3?V\\TB%7B!&<@$E3SG![>G2
MN1\5:_-X@G\"ZG!ILT&G7&OVYM[IY\&1,G&Z,= V-PR2<#G&:V+KPIJ^I>*-
M,NKBVBBL4T673;DK< NK2#!*C'(&*R8_"/C0:1X9T26UTF2#0-3AN$NQ=LIN
M(H]VT%-AVG! /)Y[4 =1\2_$MWX8\)^=IY5+^\N8[*WD89$3OGYR.^ "1[XJ
M#7?"WAK3/"EQ_:MQ>QJ(B)=3,TSS*Q_Y:,RDD<\_W>W3BMCQIX5@\8^&IM*F
MG:WD+++!<(,F*53E6QW[CZ$U@:SIWC+7/!-WX<OK#3GO;FW,#Z@EV5B;_;*;
M-P)ZX QGO0!9G\;IIMC:0V-E-J*QZ3_:,ER[&",PKA00SCEF.2!QQSWI3\18
MYKG0;>QT2^N7UNS:[M?GC0<*&*G+<$9&2>/3/2L;5/!7B&2]M+=(K#4M,BT1
M=/CCN9V1+6<+@S!-I#'&,'@^XI-"\*>)+'4O!4]U96@CT2QEM9_+NMQ;>JJ"
M/E']W)^O>@"35/B1?3^'-.OM*TIX9YM;32[F.:5<PN) &4=0VX C/;.:U=*\
M4:U??$;4-$GTU(+2ULX9"!.K%2Y8[CQSTQ@>F>_'.IX&\1_\(S/;_9[07L?B
M0:U!&US\DB;]VPL%X/X5TECHFOVOQ$GUQH+$VFH6,$-UBX;=#(F[(0;/G!R,
M$[>Y]J *_P 4]3U"RT?3+.SMW>+4-3M[6=EE"%D9^8_7Y@,$^A-+I<]IX?O]
M4TOPUX?>2Z1$OK^T2Z"QV[NORQIG(W,%)P ![C(JYX_T75M<MM'BTJW@D:SU
M."^D,TWEC$9)VC@\G-0IHFMZ-XWU37=,M;>[M]:@A%S!-<>4T$T2[5(.T@J0
M><<YH @E^)]M+#X?DTS1KZ__ +<24VRHR*1)&#NC8$\$$8)Z#KDXI3\1K@W&
MH6B>%M1^V6-E%>S0R2Q)M1E+$$[N",8QU)[5GV/@/5=&O_!7V46]Q#HSW4MY
M*9"F][@$-L7!X4L>N,C%7;CP]KI\6^*=2CM+=K;4]-6TM\W&&W*&&6&W@'=[
M]* +.F_$6'4;[0$_L>]@LM<1C:74K)RZIN*E <@8R,]_IS5O2_%W]NWWDVVF
M&73VNYK*2?SU+1M&'R7CZJ&*$#)[C(&:YRQ\(^(;>V\!126EKG0"PNB+GA@4
MV#;\O/'/./2I(/!>I2^,--UW^S;+2[V"Y>2^O+.Y.+V$AL*T84#<?E))]^30
M!L^'=4DL?&6K^$9I'EBMH([VP=SN98'^5HR>^UNA/."!VINI>)=7@^)FF^'[
M>Q5K*6SDN'?S0&?#*N>1P%R>.^?;FMX>MSJ_Q0UWQ+ =VGPVD>EP2C[L[JV^
M0J>X5L+GIG/I5S6=#U=_B#H_B#38K6:"&TDM+A9YBA1696WKA3NZ'CCMR.M
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M[)>Z?%;W(^TL6@=&8_*-GSY! S\O<^Q .UHHHH **** "BBB@ HHHH ****
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M')R2>YZYI:!K>L2>(O![?VIJ%U:ZL]XEQ=22;8KL!&93%$23&JX !PI..F*
M/2/$?BS3O#6BW6JW*S7$%K*L,PM0'9&8@ ')&/O+^8K=KP"[L_*^#'C67[3=
M2.-;DB'G3,XPMU'@G)Y;U/4UZ%I$VI:?\6KO19M6N[VSFT9;XI<$$)+YVP[
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M2A!Y>$'S G.<\CMWK9KRZ?25LOBSX2QJ-]>"?3;L,\]PSY.U<NIS\N<_PX'
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MDL8YY(PI&\[1N(.-IP2<@'CGTH 6Y\ Z%=S:O+-'=LVL*JWW^ER 2A?NC&>
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M"2>\X@&U@'/]W<1@-[$YZ<<U9/C/P^NIC3CJ $YNOL8/E/Y?GXSY7F;=F_\
MV<YH GUSPSI?B(VAU&&5GM)#+ \4[Q,A(P>4(."."*J7?@C0[R^NKMX)XVO
M!=Q0W,D<=R ,#S$4@-QQTY'!S7/ZOX^6]TSQA;Z0]U:7FBVSO'<-;-\TBQES
M]]=H' '/7DCL:U_"OC/2M7M=*T]]4CFUF:PBGD0*1O.P%R#C:2"3D \<\<4
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M;AD2%Y2D0."[;%.U<]S@4 /LO#6FZ?K]]K=NLPOKX*MP[3NRN%^[\I.!@<#
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MSPP2SQI+.2(D9@&D(&3M'? &>*@NM5T^RN[:TNKVWAN;IML$,D@#RG_9'4T
M>8QQZ/KNG:K?-X-\31++9K9W<MZ\S7+!I4^2%79RVWYGS@<J!W.,_4=.\1WW
M@KQGI:2:AK-F+6 :?=7=DT5U+ABS1$%0TFWUQU8U[510!YJEY<6GQ L/%%QI
MVIC1[S1OL(8V<C26TBR[OGC4%E5AT./2N?O=%OK/2;"9M.O3'>>-1JZVZ6DC
MM!:[C\SJH.SCYL'GYNF<U[510!XSKVE:MJFM_$5-.L+TO<C3I;;=#)$MSY&#
M(BR$ 9XQP>>U7(%TC7K'5+^3P7XEC+:?]CNY+^29KAE:1?W<(=F+8.YL@#!
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M\[7H[VVMFMS$]U;1N'VJK $#N 0,D5W$"-XC^(^DZ]8VUW!:6&GS17$ES:O
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MH YWP&S_ /"!:%'+;SP20V,,+QSQ&-@RH%/RGGJ#]?I71444 %%%% !1110
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MMEJFF2M);RR1^9&RLNUT=<C((]"","L*\\!:I?#7I)=<@6;59;6X^2S.Q)(
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M(RN-KHZY&5(]""* .4UGQ/K-WX6\=Z3<&TAU31+=O,GBB;RYH)(F9&52^4?
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ML$#G/*Y] .MT;2XM$T.PTJ!W>*SMT@1G^\P50 3[\4 7J*** "BBB@ HHHH
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M!=S#HQ&>GO@ ]*@UQ?\ A()=%O(O(NC&9[4[LK<1 X)!XPRDC*]L@C(/&M7
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M2RQQECA=[ 9/M4@(/0YH X'XFZE;Z>?#;7,<<:'4U9;^?<8K-@K8=E4C<>2
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M06]I;KJNER"SUL:JD\D#F6<Y8_O3NY(W8P/S% %F_P#B1KEK8^)+V/0;)H-
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M_L3ZF=.EC2])E+>84!C!4 CC^(KD]@.:T_#/A7Q;H7V?3[GQ);W>BV(Q:QK
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %9<GB318=373I-4M5O&D$(B,@SYA&0G^\1SCK6I7C_A[4HK.*7PEKGA
M^]O==M]7DN[?,#>7,QE+I/YF, #=R3V'X4 >E7WB?0]-NC:WNJVD$RE0RR2
M;"WW=W]W/;.*;?\ BOP_I=S-;7VLV-O/!&)98Y)U#(I( )&<C.1^=><*XLM"
M\?>'=8MYGU34+R[FLX_)9OMBRH!"8R!@X( P/NX[5/H\ TOXFZ9%JKHTUGX1
MCMIYWY43JX+#<?XMN3ZXH [#5/'V@:8VC_Z=#,NJR!8)(WRFS!RY;I@8Q[GZ
M'%B7Q-X4O[I--EU72[F=IA$D#2(Y,F.% ]?\:\FT!S8^!_AS=SPSB+3M6G6Z
M"0.[0[C+MRJ@GD%>W<5U&@+9S^,?B!>G35O)<P3VJ20X:79#T0D<$-QQR":
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M** "F-%&TB2-&AD3.UB.5SUP:?10 4444 %%%% !1110 A4$@D D=#Z4M%%
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M&!W*6"GD8(& <^U.TSXC3W\_AN230GM]/U[*03-<AI$D"ECE /N\$ YSWP*
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M!L& ,8/7!..:JWFKPS^+O!2:MX>2._O(KB6WG-R2;)A%N=<;1N)&T'.!U]*
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M+E1O\R5E57!^IS[UN^,IM#TWXOV%SK4"-IW]C2S3C[,TJE@YP[*H/0?Q$<4
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M.$8[]VU^XS[9Q[]:]/HH X75_"&JZX-9U*Y6QBU:]TA])MX4G=H88W)+.S[
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M-]HADE2ZBN1+%\F,J254AN?3'N>: .1U[X?>(M1U#7VBOM/NX=2TZ.TAGO\
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M*9XU]73;M&.IPS8]ZMWWB<)K_P#8.EVAO]36(33KY@CCMT/0R/@X)[* 2>O
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MV3;%]AC<27!QC=*6X&!V4=3GM3?B/X:U3Q;X8_LC3&M(W>:.5I;F1E"[&##
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^R/C\+O4G$5KJ6C"ULI7X0R+(&,8/][@G'N/6NP\1F&\TZZT>.51J5Y9SK;
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M9H W0<C(Z5X]X4T&?Q,/'VE_VM-964^OW4=PD$2EW4XR S9QD<=*]@9%="C
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M$#9X<\5>'_%[QR2V*R-8:A$BE\I(I"/M'4@Y'J<@5Z)%%'!"D,2*D:*%1%&
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M@>=--_8UCYLT?E2OY"Y=,8VDXY& .*NV&G66E6BVFGVD-K;)G;%"@11] .*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>GL:?)\,[Z7PI>:$VNVX6ZU,ZB9A8'*L7#E0/-Z;@.?3\Z]%!# $$$'D$4M
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M=^22/EZ8'6N4OGNIOCS(FEZG9VUR- 6(_:(3,K'SBQ3 =2& PW7IVQ7J%!(
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MP.2#P,=,YX[7_![>';7P7H>ESZQ<6]GJQG^TQVWFO;(VX[B53;@,V?F'?TH
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M6E<L[D\LS,>2Q)))]30!YGIWC37V\0^'XY=02ZCU*^N+:X2&W4VD87<4$4N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:17,959$>3 C+?=#'HI/8$BIM5\1Z/HDD$6I:A#;RS@F*-CEW &20HY( [T
M:E%<FOQ-\%-$91XCLO+!"E]QP"<X&<>Q_*MM->TJ2ZLK5;Z$SWT7G6T>?FE3
M&=RCN,4 :-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1139)$BC:21U1$!9F8X"@=230!YQX
M$_Y*M\1?^NUG_P"BWK7L/ )L=3M=177;][J._GO)G;'^D+*%'E-_L@(F/]WM
MQCE/!?B70;;XF^/KF?6]-BM[B6U,$LETBI* C9VDG!Q[5Z#_ ,)IX5_Z&;1O
M_ ^+_P"*H I>(O!2>(]4DO)]4NXD_L^2SAACQMA=FSYR_P"V, ?@*P?BU;26
M7P1U*UEN9+J2&&VC>>7[TI$L8+'W/6NK_P"$T\*_]#-HW_@?%_\ %5P_Q?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-_JSZ<[>G/)(!K:#XDTBTT:^O4U/5;])M6EMXTNU)F\\D#R(U(!"CL#C').
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M+TS4O 6G6MSI@57UHF-E=5& \8 W;V 'TR2?2H+70;N?3/$%GJ_A?4+BUO\
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MX.,@*<Y!(Y&X#/:N4^)_C';X-U0Z)-J<<UI=1V[7UH-D22AU#(7SGH2"1QG
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M1SR*\RTS4)=,\;_$>X@T&?5'26!P(O*VH1"3\V]@>?\ 9!/%6?'=K9Z'XI\
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MO^$N\+W.CB\:T:5D=90F\ JP897(R..F:PH_ ^O1:UJ&KIXICCO;Z&W21TL
M%#1/D8&_[A&05SDYZXXKO*:[%(V8*7(!(5<9/L,T <YX<\*?V)K.KZO-/;/>
M:IY7FK:6WD1+Y8(!"EF)8[B2<U6U+P=>MXLE\0Z)K7]FSW<"V]]$]L)DF5?N
ML,L-K <9Y'MUSJ^%_$=MXJT1-4M8)X(FEDB\N< ."C%3G!(ZCUK9H \V@^%M
MW9>'-"M=/\2RVNKZ*9?LM^ELNTI(<LC1DX89]36AK/@34]:\*QZ3<^)#+=-=
MI=W-[-:!O,=2-H1%=0B_*.!G\R36X/%$#>++KPZ+*[-W;V(O@V$VRH6V@+\W
M7.1SCI4OA?Q%;>*_#]OK-G#-#!.TBJDP <;'9#G!(ZJ>] &;J7A;4;_Q=HNO
MC5;:-],AEC\G[&S"0R##'/F<#@8'ZFL-/AG?IX4LM"&O6^+74_[16;[ V68.
M7"X\WIDGGT_.NUM]4DGUR\TTZ=>1);QHZW;H!#-N_A0YY([UHT <'+X U6#7
MKZ[T?Q9<Z;I^IR^??V4=LC[I",.T;L<QEO4 D?@,.U'P!>'5=8NM$UW^S[;6
M8/*OK:2U$P9@A0.A+#:<'GKFNZK%T'Q+;Z_=:K;PVUQ!)IMU]EE$X7EMH.1M
M)XYH E\-:._A_P -:?I#W7VHV<"PB;R]FX*,#C)QQ[UQMS\,]1NM)UJP;Q!;
M!=4U4:F[#3V_=N&5MH'F],HOZ^O'H]8FL>);?1M9T?39[6X=]4F,,4J!=B,%
M)^;)ST'8&@"G:>%[R#QY<>)I=2@D$]DEFULEJ5P%.[<&WGOGMTX]Z=XD\+W&
MM:WHFK66IBPN]*>8JQ@$H=94"L,$C!P.#S]*Z6L7Q7XDM_"7AZXUJ[MKBXMX
M"H=;<*6&Y@H/S$<9(_.@#E[KX;WUWH?B?3'UZ +K]W]J=Q8']R<C( \WG[J_
MKZ\6-0\":NVMIK6B>*7TF_FMX[>_*6:RQ7 085@CL=K <=3_ #SW0.0#ZT4
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M\ A9TW':60<*<8XZ^O.:WJ* .#F\'>+CK5]J=OXTMX9;KY%SI"N88^R(6DX
MZ^YY-:GB3PM>ZYHVF:?#JJPM93P7#3SP&5Y7B(()PRXR1SUZUU%% '/>)?"D
M7B6VL9)+J2TU2PD$UI?6Z\Q2=_E.05..5/4=Z?::5KLLD7]L:W!/%"XD5+*T
M:W\PCD;R9')&<' VYQSD9%;U% '*>'?"E]HGB?7=8GU2WN5U=XY)(4M#'Y91
M2HVL9&['G(_*CQ-X2O=?\1:%JL.IP6JZ1,TT<3VID,A8 $%MXXP/2NKHH Y&
MW\%S:7XUN?$&BZDEI!?JO]H6#VY>.9P?]8I##8V.^#U)YS4WCSPG<>,_#_\
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M_:3)J4NQ(DD9?(:WV;!E=O.=Q)SGG%=#\9/^23ZY_NP_^CHZU#\//"A\2_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=UPP^[V/!KT+Q_XUTCQ)\./%\6GW,,EM:^3;QW&\;9Y2P8A/7 ';KSV%</\
M\*;\%?\ 13-._P"^X?\ XY2_\*=\%["O_"S=.P2#C?#_ /'* #QO?64O[.GA
M2"*Z@><3Q QK("P*I(&XZ\$C/U'K6]XVOK2Y^*_PW>VN894Q&<QN& !< 'CZ
M'\JP/^%.>"\8_P"%FZ=CTWP__'*M:=\*?!FGZC;W8^)6G.86#!3)",^W^LH
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M4]W>SQ/,EO:QJS>6F S'<0,991UR<\"L+2K'5;'XHZWJ#:5,VG:M;6I6Z\Q
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M-M'B$UTMW;M&WED$AU!Y(('U]JX;7/"^MW<.JZK!HUR9]4UNTNULPT>^*&
M;G.[ 9N3@$]L]ZO:UIGBA_$?C*^TC29!)?:9!!9RS^44=TSN&"QYPQQD8R*
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MFBVQW*( 25.<C@Y^8#(J(>/M'/V28QW:Z==W/V6WU$Q#[/))DJ!G.X D$!B
M#ZUA>%!XOETNP\.:KX?CT^*PM_LLVI?:$<2QB,HOE*.0Q^4DG@8/? K,M_#6
MNW?P\LO E[I,L,MO<1))J =# 84F#^8OS;BQ48VXSD\X% &W\0?%:0^%_$=M
MIG]I-=V%N?-NK$;1;2%<J&?(/<$[<X!YQ6AH/BVU,NA:#="[;4[O38KE9'7*
MRKY8+-OSR<YR.O\ .N2U+1O$NEVGCG1+?0[C4H->DGN[2\@FC 1I$P4<,P(V
MX&, YK0\1Z%J$G@[PM=6FRP\3:0]LENLI5^6VQ.AVD@J1R<'HO;F@#H[[QYI
M&G0VDMW#?HMU?MI\1%LS;I58J>5R,9# =S@X!IB?$/1/[,UF]N1>6G]CLJWD
M-S 5E4OC9A><[LC%9OC'0KQ;3P?9Z587%Y%I>K6]S,R%<B*-6#,=Q&6.[/OS
M6!J^D^+%U'Q]<Z3I,P;4I+)K5W\H^:D2A)-H)(#8Y&1^N* .S/C[2HH-8>ZM
MK^UFTB))KNWD@S(J,"58;201@'OQCG%01_$C19+RUMA;ZGYE[;_:++_0V_TH
M8!(C]2,^P[YQS7$OX>UM9?&IM/#.I)%K6DQPVPFN8Y)/,V.I\QC(26)8'J>.
M_:MNVTS61XE\!73:+=K#IFFRV]XQ:/\ =.T:J!][GE#T[$4 :6N>,-$U7X=Z
MAJK7FKV%FLAMYI;2-DNK>17 *]]IS@$GCG&>:UM5\7Z?H?VB%XKV\:QMA<W9
MMXPY@B.<,Y)')"L<#)P"<8KS^X\.^()OA7XKT==#NA?ZAJLL]O$7C^:-Y5<,
M3OP,!3GWQ6Q)%XH\/^--1U>P\-OJUAKT%MYD)N4B>UEC39M;)(VD<G'_ .L
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M*EN]J9X;[S%*R%2H9=O48W#FMV@ HHHH **** "BBB@ HHHH **** "BBB@
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M<?XN&&0 ?QQ6BWBK4K)]-T-)(7U$Z<M[+.FFW%P@0G:B^7&Q;)(.6+8XZ'/
M!WU%8WA35;_6O#=I?:IIDNFWT@(FMI%*E6#$9 /.#C(SV-<:GQ"U>+Q'IME=
MPZ>JWNIR6+V489IK91NV.\@8IN.W.S .#0!Z74=Q<0VEO)<7,T<,,8W/)(P5
M5'J2> *\MO?B+XGM=!\1:S]ATC[/H6J-931YD+3(&1?E.1@_/G)Z^@QSNZUK
M^I:Q=^)=&T;[#&FE62FY>[C:3S9)(V8(H5EV@*.6.>3TXH [.TO+:_M(KNSG
MCN+>5=T<L3!E<>H(ZU-7(_"__DF/AW_KS7^M96@?$";5=2E2>ZTV$6TEP+W3
M6B=+NV2/=M;+/B0':,X48W"@#T)BJJ68@*!DD] *YSP=HGA71["X?PI':?9I
MY3YLMO,90[J2,%B3TR>,\9JCH6O>)=970]46QLI-&U17DE1 5ELT*EHRS%L2
M9X! 48)[UPWAGQ'K'ACPLUY;6EB^F'Q'-;3+(S>:PDFVY3'"XSWSGV[@'LD5
MG;0W,]S%!&D\^/-D50&? P,GO@5EZQH6C7.IV6OZF[13:6&:&=KIHDA!^\2,
MA<$<'/:N8UCQUJWVC5QH&GF\.EW MC;?V?<2M=. I<+*GR1X#8&<G(YP"*?J
MOB/4]>'B33-(CM+=-,T]6N?ML3.SR2QEQ& K+MPHY8YY/3B@#N;2[MK^TBN[
M2>.>WE4-'+$P97'J".M1ZAJ=AI-HUWJ-[;V=NIP9;B0(N?3)[UYSX)U^\TW2
M/AUH\<<#VFK6,H=F4[XS%'O&#G!!SCIV_*AXS\077B+X0^-_ML4"R:;J3V"M
M$I <1RQ@-@DX)R>] 'K]%<)KGC/48=3U73M#MA+<Z7 C.C:?/<>?*Z[UC#1<
M1_+CYFSRW3 S74VNK%_#<6L7]M+8G[*+F>"4?/#\NYE/N.: -*L[5->TC1 A
MU34[2SW\KY\RID9QGD],D<^]<8?'.M6^@Z)XGNK>Q.CZG<11O;1HXGMXY3A'
MW[BKG[N1M'7BH=/AOM1^,/B:TOGL+BT73[:)XI+=F#0,7(7EL9R3DD$'T% '
MI*LKHKHP96&00<@BJMIJ=A?SW,%G>V]Q+;,$G2*0,8F/9@.AXZ&N.\>W>K:=
MJ'A.RTBZM[6UN=3C@>,PDYPI91PP^0;?NC&>.>QY@ZMK?A_7_B3J>EP:?(;)
M[:XG-QO <+ "555/!/)R3QQUSD 'L=%<#>^.[VYF-KHUN!<QZ=#>R![&>[!>
M524B_=8V\*<LWJ, \XZO0]1O-5\.VE_=:?)8WLT.Z2UGR#&_<'C.,^W2@#3H
MKRB/XC^*#X=L=<;3=*:"353ITD"O('?,A0,K=%Z=P<]>.E; \>W^D77BJ#7[
M:T;^Q+:*Z1K+<!(L@.$.[/.0!GC.>@H [^JEQJEA:7=M:7-[;PW-R2L$,D@5
MY2.NT'D_A7&0^-M7L;V=]6T]Y-*BT^2[DO(M.N+80.@R8SYOW\CHPQSVK"U6
M\UG5=?\ ASJNH"P2WO;LSQPP1L)(=T195+EB'^4\D*O(H ]1MM1LKRZNK:VN
MX9I[5@MQ'&X+1$C(# =,BK5>;#QJ^EW/BMVTK3X[V#4K:QA,(*FXDE "&5L9
M.,^G0'%;5WJ_BW2;+7I+G3+*^-I;I+83P'R$G8@[E96=BNTC).>10!T&MV=A
MJ&B7EIJC[+"6)EN"9C$-A'S98$8&.O-,T"+38-!LH='F6;38X@ELZS&4%!P,
M.2<@=.O:N0T3QA=:YJ6O:+=26%Y':V"7$=W9Q/&DFX$$ ,S;@".&!P:T/A3_
M ,DM\/\ _7M_[,: .QHKB-,\3>(==M[+6=(L[*?2+C46MF@(*S);J[1M/O+;
M>JYV!3P>N:K7/C/6KG1_$&NZ/#8-8:+<2PFWG1S)<K" 96#A@$_BP-K=/>@#
MT"BN-T[Q?=:KXKCTVVC@6RNM"35[:5XVWKO<*%8;L$=^,>E85E\1->U#2/!U
MW;V&G"37YI89 [N!&RE\$>WR@GKZ>] 'I]%>0>)?&?B2;X?^+<RV5IJ&D7ZV
M,LULCXEC<HN4RV4;Y^O/3C!Y'3:MXMU:UU.XT6S$,VHV=HMQ/(FF7$\;NY;R
MXPL;$IPO+,QZC /. #N:*\WG\:^+;C4/#^GV6BV-I>ZM8S3-#J)D4P21XR&Q
M@[?3C)R.E,N?&OBV.;Q;;I9:-'+X>M8;F1F:1PX:%I&08QD\8!XQCOG@ ]+K
M%/A+0CXI_P"$F;3T;6-@C%RS,2 !MX&< XXSC-<WIGC36KC7_"\%]96,5CXB
MLY+B%8G=I8"D:R?,QX8$-T &/4]Z]GX_U?4Y--O],TN2[TR\O?):%-/N \4!
M8J)O//[L] 2H' .,\9H ]&HKS6^^(6KZ?X@MK6XAT]8Y];33!9 ,TZ0L<+.T
MBL54D\A"H)'>KEGXXN[[QA<Z*MSIEM-;W[6[:=<Q.MQ)"!Q,CEPK9Z[0O3O0
M!WU%>;7?Q!U>U\&Z[K)MK)KC2M9;3BFQPDJ"5(]WWLJ?GSWZ8]ZO3>)O%-QX
M\U+0--L])-O8I;SO+</(&,3D[AQ_%@9'&!COF@#NZ*\ZL?'VL:I+I5_IVER7
M>EWUYY+1)I]PKPPDE1,9C^[8# )4#C/4XS70^.]?O/"_A.YUFRC@EDMWB#1S
M D,KR*AP01@C=GOTH Z2JWD65@UU?>7# T@\RXG("E@HZLWH ._2N6U/Q=J.
MG>+-7TF.RCNH[30VU2!8PPDD<,5$?4@YV]0.]4=&\9W.N^']5OX+S1-4A@L!
M-Y<4;Q%),,7CE1F8XP!@X&>: .YL[RVU"SBN[.>.XMIE#1RQ,&5AZ@BIZ\SL
M/&&L>7X'L-+TS2+>/7;"24* ZI;LD8?"JO1?F''?ID=:>GQ&U*#P7J6HW=C:
MMJ5EK#:0?*W"#>'51(<G(7YNF><=1G@ ])JI)J=A%J,.G27MNM],I>.V,@$C
MJ.I"]2..M<[H>OZS=^-]9T"]2Q>#3HH9/M,"/&7\Q20-I9@,8/?TK%\:_;E^
M*?@PZ9';->-;WZH;AB$'R+RV!D@>@Z^HZT >CT5YK;_$;4U$FCWME9IXB75T
MTL>46-N=Z[Q-@G=M"@_+G.<<C/#M>\7>(-.C\4:-+)91ZG8:2VJ6=Y# P22(
M9# H7.UPPP#N(YSCC! .]EU.P@U"#3Y;VW2]N 3#;M(!)( "257J0 #^56Z\
M>E?5CK/PJF+6MU?R6MT8W8,BX-HG+G+%B,DG&,^U=SX'\17_ (AL-3&IPV\=
MYINI3Z?*;;=Y;F/'S*&)(SN[GM0!O?VC9?VG_9GVN'[=Y/G_ &;>/,\O.-VW
MKC/&:M5PVI:]=6GQ!U*RBTS36GM] :]@NG!\U@),>6S8R%R"<#VK.T?Q[X@N
M7\'W5_9Z:MCX@W1E(=_FQ,$+!LDXP<=,<>M 'I5'2N<\<ZQJWA[PI>:QI%O;
MW,MFOFR0SJQW1C[Q!!&"!S] :;9>(+C5]3CATJ2TN+4::EW)*R, 7D_U0!!.
M 0&)&"0 /7@ UHYM+\2:+(8)X+[3KN-XF>&3<DBG*L P/U'%1:!X<TGPOI@T
M[1K)+2U#%RBDL68]22223P.I[5Y?:>)-8U'0? %QI2Z;I-OJ>H2K):6]L1&&
M5I,<!A\ORY(XR><]JZ*W\7>)YO$^N61M=(73M#FB-Y,S2!S"T>]B@Z;@.><#
MMSU !W=O9VUH9C;P1Q&:0RRE% +N>K'U-3UYV?'6M6_A_1O%-S;V)T;4;B-)
M+9$;S[>*1MJ/OW;7/W<C:.M=;XHU*]T?PW>W^G6D=U=PH#'%)($3)(!+$D8
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MNQ*D?EALAA\O?:,<]\==[1-3DUC28;Z73[O3WD+ VUVFV1,,1R/?&1[$5H4
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MJLTK3/(SA1@9+,?SHU;PAHNN:G;:CJ$%Q)=VN?L\J7DT1BSP2NQP%)P,D=:
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M'7ICTJ!?A]X633]0L/[(C:TU"3S;B)G<JS_WER?E/ Y7'2@#AOB3I*Z=\/\
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M'TWP5;:I8Z3<V6K:I%J%Q;W;JCI*TK11D*RQN[ %F ;J>Q%13?#GPG<>'8-
MET>)M.@<O%&9'W(QZD/G<,_6MO1]&T[0-,BTW2K5+6TBSLC3/?DDD\D^YH \
MV:\OM?\ #'C;6VU74+/4=)O+N.T6"Y>-+=8%#(IC!VMNP<E@<[O84R]0ZUX^
M^'-[?-=PW&H:;<331Q7,L81_(1B% 8;>2<XQGOFN\NO!F@7FH7%[-9-YMT5-
MRB3R)'<8Z>9&K!7_ .! U->>%](O];M-9N8)FO[,$6\JW4J"($8("JP7D<'C
MGO0!2^(?_)./$G_8-G_] -9_@6VUP:'X=GN;ZUFTO^QHPMO#;&-E<K$4+,7;
M<0H8<!?UXZ?5M(LM<TV73]0CDDM9AMDC29X]X(P02A!(]NE.TO2[31=-AT^Q
M1X[6!0D2/*\FQ1P "Q)P!T&: /+_  [>:_XDTW2?$\6KV]FW]H9O ^HRLK(9
M"AMS;[=BG!4#G.<')SFL7Q/<2>*?A+XIUZ\O;T746HM$ELMRZQ0QI.BK&8@=
MIX.22"<G.>E>H0_#WPI;^)#X@AT6!-3+F3S06VASU8)G:&]\9[U'J/PX\)ZK
M=WES=Z4&DO"&N%2>1$E8$'<45@N[CKC/7UH YK4[C6?$WBKQ+HEE>K9S:=#"
MMH1J4MLT>^,/YVQ%(D&XX^8XPH&!DDU?LVJZ]X^LM)F\5:C%#-X:BO)9=-N-
MD<DWFA=Z<8 .,].1QT)%=EK/P[\)Z_<6UQJ>C0SS6R".-][J=HZ*V"-P^N:T
M$\,:1%KT>MQVK)J$<'V9)%GD"K%_<";MNWOC'7GK0!Y7>ZSJ0U.TU.PU74+F
M&3Q7'9M=FY:. Q%MIMT@W%64 <N0N3TS78>'_P#DL/C+_KTL?_07J_+\-?"<
MLDSMI9!EN1=D+<RJ%E!SO4!L(<_W<5JV7AC2=.UNYUBUMY([ZY01S2&XD8,H
M^Z-I8J .V!QVH X[XHF<:[X&^RO$DYU@"-I5+*&*X&0""1^(JIX!N7N?&/B:
M_P!?4KXPMT\B6TC&V+[,.4,(ZLK'&223TZ9KNM8\+:1K]W9W6I032S6;B2W9
M;J6,1N.C (P&?>EO?"VCZAK5KK$]J_\ :5JGEQ7,4\D;A?[I*L-P]CGJ?6@#
MS[PO<Z]K]AX>\4)K5M LMTOVX-J,LB3!VVF 0%=B,"0%P<C Y.<U4O+CQ%J1
MUBVAN]7_ +?3Q (K<VDDHMTM,KQE?W0 0MG/S ]>:[ZR^'OA33O$+:]::+!%
MJ)8MYBEMJL>I"9V@\]0*X>W\!WINKHWWA&)]1N+B65M2M-;EMX26<L&\M2&7
M (X"G.,YYH U)[N\MO$WCBP_M.],-MHT-Q;J]RV8WV/EU.>#E03BLU;NXOK?
MX2W=W,\UQ,^^261LL[&W.23W-=K/X#T346MKC5[=KV_CLUM)KDRNGGJ!@[U5
ML-SD\YP?I4H\"^'532T2QDC32FW62QW4JB(^N W)]SGCB@#S=M:U(ZKHVJ6.
MJZA=6UWXH%H]XURR0RQ,6'DI;[BNU0N-Y"G(XSG-7M"L1:+\2[FVO+Z*XM[J
M;RI!=R$C$(8'!)!.1U/.. :[ _#3PD6+?V65_P!)%VH6YE 24$G<@#?+R>0,
M _@*NR^"O#\MYJ%V;%EFU&/R[IH[B1-ZX Z*P"Y  )&"1QWH XCP]JU[KNI>
M$=#U"^O1:R^&UU"62.Y>.2ZG)5<-(I#' RV,\YYS65?:IKL.CO8KK6HI_9_B
MV/38;H2GS)8&(.UV/WRN<<]>^:]*/@?P_P#8-/LULY8X].S]CDCNI5E@!X(6
M0-O QQC.*?=>"] O--MM/FLG^S6T_P!IC5+F5#YN<^8S*P+-DDY8DY.: .%)
MURWUKQWH&E:S=/)%;V;V)OKMF*22 [E5V.5W=!SP2,8K?\ ZNEW?:S9SV^K:
M??6ODFXL-1NFN!"6#8:.1F.Y6Q^8]ZU[CP/X?NKN^NIK2=Y[\1BY<WDW[P(P
M9/X\#! QC&*H:[\/M*U+0[S3X;02R7TD9GN+R[FD?Y,[6W%BS;<\+N Y/(H
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MJVSF-X9,[9 !+D'VR<UF-:Z9K'QQU.*\)DMWTA(%*RNBM('^9-RD9.#]W/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4456
MO]1L=*M6NM1O+>TMU(!EN)5C0$]!DG% %FBH+.]M-1M$N[&ZAN;:092:&0.C
M?0C@U/0 445R'B62:3QSX3L1<W,5K<"\,T<$[Q"3;&I7.TC.#0!U]%><>,]2
MU^T\26<=D;C[.LH-JHB \R;R)LHOSCSN,L5;:,JHW<XJQXZO]7M_#]BT4MS'
M;R6Y-]*8O)V'Y-K%PV8VW'&T!LY(X S0!W]%<C+)J-Y\/;Z[U-KRVU&*"YD^
M4&U>-EW[<!'.0.,'<<C!K7\*3RW/@[1)YY'EFET^!Y)'.69C&I))/4DT :]%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7F'QI\#:UXUT33QHI62:SF9VM6D""4, ,@GC
M(QWQPQKT^B@#S_X/^$-5\&>#9+#6"BW4]TUQY2/O$0*JNTD<9^4GCCFO0***
M "N/\0_\E(\%_2^_]%+785GZAHMAJ=U:W5U$YN+3?Y$L<SQM'N&&P5(/(% %
MYD5BI902IRI(Z'&,C\S0Z+(A5U#*>H89!IP& !Z>M% &5XG_ .13UG_KQG_]
M%M4/@W_D1_#_ /V#;?\ ]%K6CJ&G6VJ6CVMV)&A<$.J3/'N!&"#M(R,'I4EI
M:P6-G!:6T8CMX(UBB0'.U5& .?84 34444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>**X,WA]M]V"H .'0@*<\\(3^(K6TKXCZ):>-_&^L2"Y%MJUI(EK^[^9F.
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M\PJRO(Y*99CG.!D=!NXX[[X$:W%J7C/QK)#&ZQW\PO(]W55\R3@^_P"\'Y4
M3_M)00_\(YH]QY2>=]K*>9M&[;L)QGKBNDT'2?"OBC5/M&CZ59V4NA7=NZ7,
M-GY+R-LW.I&%)&#CGOS7#?M%^)K&Y>Q\-Q+*;VUD%S*Q7"!64@ '.2><],5+
MJ/QXT;R FB6%[;7EYY,=U=W 4")%X+*%)+':2.W;TQ0!Z)I'Q'.I>*-;\/SZ
M0;&]TF!YI/.N1M<*1@@A?ND,#GT(XJ6Y^()MIO#U@^D21ZOK<32PVTTVU(@
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M34]+.IR211R(8$4 L.68-PPP>* *H\&^'?\ HE<W_?=I_P#'Z8W@SPZVX?\
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MD2'XH^ )'MGN #?YBC0,S?NEZ ]?6@#N[G7-)L[%+VYU.SBM)&"I,\ZA&)Z
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MUM=K&X.\+NV,=V/N OZXQ]:9/KNIGQ!X)M[_ $W3#<:I'<2><\+&2U=82X"
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M9ZI9I=Z?=0W5LY(6:!PZ,02#@C@\@BK-<)\'?^2:V'_7Q=?^CY*[N@ HHHH
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M<KK( "0-PVMQUY_2L"/X8ZA#X3L-!C\0Q>79:D+^*5[#<3B0R!2!(.[')^F
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MOVC4_!.C?VG<W,LMKXR6T0_:Y&*1^;C:'R"V.@8\CMBO5/\ A7GA7[!:V/\
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M;\+P6>H:?X8UK_A)KUI+^U:&[MS=2.+R:2/+#&[]VR%7(V@8QCBN.LXGTO\
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MR>SEA1K:2,Q-$1\I0C!7'ICBL5? _AM-)@TQ-*C2U@E\Z$([*\;XQN5P=P.
M!D'H * .:T6TN;ZX\;>%KG5M1BTRTN8OLMZER1/"LD8D9%E;)PIP.<G#5Z%$
MGEQ(FYFVJ!N8Y)]R?6LJ7PKHDV@W&B2V"OI]R2T\;.Q,K9!W,^=Q;(').>*U
MHXTBB2.-0J( J@=@* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA\-QSN]T[2SLV^&-CY*CS&*%0>0VPJ#S@XSC/)J^!_\ D*>,?^PZ_P#Z(AH
M["BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]G_\!W_PH_X6]X/_ .?V?_P'?_"BZ#V53^5G=45PO_"WO!__ #^S_P#@._\
MA1_PM[P?_P _L_\ X#O_ (470>RJ?RL[JBN%_P"%O>#_ /G]G_\  =_\*/\
MA;W@_P#Y_9__  '?_"BZ#V53^5G=45PO_"WO!_\ S^S_ /@._P#A1_PM[P?_
M ,_L_P#X#O\ X470>RJ?RL[JBN%_X6]X/_Y_9_\ P'?_  H_X6]X/_Y_9_\
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M  '?_"C_ (6]X/\ ^?V?_P !W_PHN@]E4_E9W5%<+_PM[P?_ ,_L_P#X#O\
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M[/\ ^ [_ .%'_"WO!_\ S^S_ /@._P#A1=![*I_*SNJ*X7_A;W@__G]G_P#
M=_\ "C_A;W@__G]G_P# =_\ "BZ#V53^5G=45PO_  M[P?\ \_L__@._^%'_
M  M[P?\ \_L__@._^%%T'LJG9G=45RVA_$'P_P"(M26PTVXEDN"I?#1,HP.O
M)KJ <BA.Y#BUN+1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% ",,J1[5Y)XB^'7]J:_>WO]E7\OG2;BZ7
MD:@G&. PS7KE%)I,N$Y0=T>'_P#"J3_T!=2_\&$/^%'_  JD_P#0%U+_ ,&$
M/^%>X45/(C3ZQ4[GA_\ PJD_] 74O_!A#_A1_P *I/\ T!=2_P#!A#_A7N%8
MOB?Q/8>$M*_M+4DN#:^8L;-!'O*D\#(SW/%'(@^L3[GE/_"J3_T!=2_\&$/^
M%'_"J3_T!=2_\&$/^%>VPR&6&.0H\9=0VQQAESV/O3Z.1!]8GW/#_P#A5)_Z
M NI?^#"'_"C_ (52?^@+J7_@PA_PKW"BCD0?6)]SP_\ X52?^@+J7_@PA_PH
M_P"%4G_H"ZE_X,(?\*]PKGM3\;^'])UVRT2YOT;4[R58H[:+YV4MT+8^Z/K1
MR(/K$^YYA_PJD_\ 0%U+_P &$/\ A1_PJD_] 74O_!A#_A7K.O>)+#P[':F\
M$\DMW,(+>"WB,DDKD9P /8$Y.!46B^*]/UO4KS38X[JUU"S"M-:W<1C<*W1A
MV(]P:.1!]8GW/*_^%4G_ * NI?\ @PA_PH_X52?^@+J7_@PA_P *]PKD;OXC
M:-:KJ,JVVIW%IILS07=W!:,T43J<.">IV]R :.1!]8GW//?^%4G_ * NI?\
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M\4L9CDAD7JK*>016K1R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\
MP80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A
M11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^
MYX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I
M/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P
M80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\
M"J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 7
M4O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_
MX5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(
M/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_
M ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%
MU+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X
M4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_
M - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\
MP80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A
M11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^
MYX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I
M/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P
M80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\
M"J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 7
M4O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_
MX5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(
M/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_
M ,*I/_0%U+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%
MU+_P80_X4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X
M4?\ "J3_ - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_
M - 74O\ P80_X5[A11R(/K$^YX?_ ,*I/_0%U+_P80_X4?\ "J3_ - 74O\
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MBRQ\2O?P00W-K>Z?-Y-W:72!9(F.<9VD@@X."">E;U'(@^L3[GA__"J3_P!
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MN?\ KZMO_1JUZ%7"?%2SN-:\.6WA^QMYIKV_NXBFR,E(T1U9W=NB@#U//;-
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MUV\\)V[>(X98]11WC8S1^6\BACM<KV)&*YWXAV=K:Z]X*>WMHHFF\11R2&-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>modificationno14effectiv007.jpg
<TEXT>
begin 644 modificationno14effectiv007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R6))X7BD!*.I5@"
M0<'@\CD4 >=_#K_D>OB%_P!A*/\ ]!:O1ZY&U^&GAJRU&YOH(;U)+D[I5%],
M%8^I&[DUC_$"PL/"/@^[UVSM&F:U*;H9KRXP^YU3@B08QNSWH ]&KSCXR?\
M(&\-_P#8PVG_ +/5M/"=Q%>60FAM9X)7Q,L5W=(Z)M/S#,I!P=H/UIFI>$O
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KSOXWW$,7PJU6&2:-))FA$:,P#.1,A.!WP.:]$I"H;J
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MI=3DT2P\0>)O#/BB^U+3;6]>);&WM+57CN+81JL<<9\IV!4@C ( )XYS7M^
M.PH*J2"5!(Z$CI0!Y FIV>A^,/$EIXD+VZWFD6L.EM>C<9(EB(DBW="V]N0.
MIKJ_A1-%-\+-"P?E2W*/N&,$$YZUVA4-C(!QTR*4  8' H \,T?2K34?!?Q
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M/N@[6(^AK<\2O8WVL>--7T^XMI]'D\+M%<3QN&ADO,OY8#=&<)@<<C</6O8
MH&< #/)]Z%144*J@*.@ XH \JM_!.F:[\']-ET*VM8=7%E:W<%U"J[FN8DR-
MS=SDNISTW'TKKO!$]QK&E?\ "2WUL;:ZU2.-A">L<2KA5^A)=Q_OU;\1Z%J&
MMFS2RU^[TF&)V^T);1J3.AQ\NX\J1@X(]?I6U%%'!"D,2!(XU"HJC 4#@ 4
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M?PAXDT.Q^(OCZ2\UG3[>.6YMC&\URB*X$9!VDG!P>#CI7JU)M7^Z/RH \_\
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MB5/+B>3&T8+!FQN7. >M7O"-OJ26L]QJ.AZ?HCS%0EE:,KE0,Y9W4 $G/0=
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MTMS)92+']FW*2GS%U.[ W87)Q]0#3\*^*4L? _AJW>*YU#4I]+2X,4<B;]@
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M4XKN6>2*"TN(TADE5%#&4;V \O#+R2.3C&:T?#7B2R\4Z6U]9++&(YG@FBF
M#Q2(<,IP2/3H2.:YCQMH6LWVIZ)XCTK1[34I[.*2*XTJ^=!O23:?E8Y4,I7K
M_.NE\,6U[;Z23?Z=9:;-+(9/L=G@I",  %@ &;C)..^.U &!>?$_3[.'5YSH
MVL21:1<>1>ND4>(NGS<OR.>@R?4"MJ\\50Q:B=/L+"[U.[6V%U)':[!Y<;9"
MY+LHRV#@#GBN%OO#'B*YT+Q]9)HT@DUN[\VSS<0\J0H^;Y^/NY_&MBPTK7=!
M\63:[#I$MY;ZGI]O#<VR3Q++;31#:/O,%*D'LV?:@!;_ .)'G?\ "+RZ'IT]
MY:ZS<&-GW1JZ;0=T6UF&'R.<D 8X)S73^*MS>#=897FA=;&5U:.0HZ,$)&&4
MY'([&N$/@C7-(TOPO-9VD5]>V.JS7]W;K.$4>;OR%9L9"Y Z9/7%=]XBANKO
MPKJ5M;VQFN[BTDB2)'499E*_>8@8!/7T'X4 <5I.I61T/X;QZD^JM=W,,36\
ML$N(WD\G)$N3EAC/8UH3?%728+2_O'TK6!:Z=?&RO9O(3;;L&5=Q^?D9;'RY
M/'(&1G*C\/>($L/A[$=&D+Z&5^V@3Q84"/R_E^?GU^GO6=?^$_$UUX%\::2F
MBR"ZUC6FOK4-<0X\MGC;YCOX($?3GEA[X ._T[QA:ZAX@N=$.GZA;7D-K]LC
M%Q$J^?#NV[E 8D<\88*?:N-C\9QZ+X6T^Y\/Z?JEW%J&N_8W:_G1I(W:7#J,
MMWPP7G ZDCOO1Z?J[?%0>(7TF=+ Z&+(DRQ%A+YGFXQOZ?PY]?;FN6B\(>)4
M\#VMK_9.+^Q\1+JBV[7$?[Z+S"^ P8@'#=_3O0!VFK^/;+1X[MY=/O918QI)
M?"(Q$VVX!MK N-S $$A-W!'K3-9\6VMS:7ECI=K?:E)_9PNY'L76/R8W4E#N
M+J0S $@#G KF9_#WB;3O%6HW]OX4T?6;;6#'.PNIT#6,NP*P+,N73C/RC\JM
MC0/$WA_Q3J][8:=;ZK::U96\,Q2=;?[/+%&8P0K?P').!DCTXY -OX8W$UQ\
M,M"GGDDGF:VRS.VYF.X]S5#0OB&]SIWB+4]:TV:QM-,OY+4$,C\IL3R_E;+2
M%R>@V\@ FM7X=Z5J6A^ ]*TO58$@O+:,HR)('&,DCD<9Y[9^M<=/X'\176C>
M*](6UAA-QK4FL6%V]P"LK&1'6,H.0,*02<8..#0!W-CXKAN/$"Z'>Z?>:;?R
M6_VF".Y\LB9 <-M9&89'<'GOTJ]H>K'6],6].GWMAEW3R+V+RY!M8C.,G@XR
M*Y^#3-4UWQEH^O:AICZ7'I5K.@BDFCD:664*#C82-@"GDX))' KH=$NM3O--
M6;5].33[LNX,"3B4!0Q"G</48- &C1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2.L1F;38YY%F"XSMWD%2P';&,]Z\K^,5O/:Q^ ]<>-I-.MX8TD(Y56&QL?B
M?^^:]]?4;*/3/[2DNH5L?*\[[0S@)LQG=GIC% '.6GC)HM7TBQU:"."/6;99
MK"XC)VM)M!:%@>C<Y!Z$<<$<];7DWQQE>WT[PK<VIVS1ZS$T3*.0=I(Q^0KU
MF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBSNYK.%V+1WDDRHP4D;@L@ZX/>@#@O!?PD\<^&?%UCJKWNCK DR&Y,)S(T7
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MY8 "YY/S \=C6]%JMGI?COPQJUTT@L[KPY]DBF2)G#S!T;9\H)W=>/6O5:*
M/ %NHX?@/HD$@>.X75P_E2(58@7+.2 1R I!)&1S6OX^U"&YUKQ5;0JUJ\NA
M#RIX8FF?45VLVU3RJ1KGD@ GKN&*]HHH \7L/$5IH.KZ5J>M6]U+H>H>'+>Q
MAN$MGD5)%/SQE0,_-^N!U[:-U-::3XL^'UXNFW.FZ6EM>V\,+1.[QAE41JP
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MFNUL%!DBB<,(Y0N#\HSG./I7IGP_71YH]4U/1%U&2VOYQ*]U>@K]HDQAF52
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MR1X? @DQP6 R?7UZUZ3110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BLO5]>M-&:WBE2>>ZN6*P6UM'ODDP,L0.P ZDX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9P?44ZB@#COBG_R3G5/]Z#_T='78UG:MH>GZ[;_9]1BDF@.,Q"=T5L$$9"D
M\@'FM&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(Y&,:P'>N."F% );/%:.K)-8?$0ZU!+:Z[ID^N017$6T+=V=U&P4 9&X#*X
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MQ0C\2R1MJ(LD&GM=X5B@SM\L'H3^[.![UZS\(I$D^%>@['5ML#*V#G!#MP:
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M96N3(Q< KY:@* 2G#-\I Z#-?0&CZM9ZYI%KJ=A*);:YC$B,#V(Z'T(Z$>M
M%VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB/Q%K)<PRQ<V3\!XV0G[G8-4!^#/@]FW'Q)KA;U-D^?_ $"@#-\4-ITWQ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!.,>V>:J>"=+U'2O$UE%I4>LP>'VM9#=6.JQ'%C)\I5(789())X4D?+DGI@
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M=;7UU '=&;[>K1AR)\ L0$.T#OR>.@(!Z1I>K6VKPRRVPF7R93#(D\+1,K
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M=I:+S?+R"P7.<'N1VKSJ'4K:>Q\$W-O9S:48?$4MG<6\DN[RV)D+1[A]Y0W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\R(Y/S!"><4 >K445X%<#1[3]H?5[/56MX='%GO,,K[8@QA0Y Z;LDGCG)H
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M-AV^7Y17.>G4XQ7N7_"N_!7_ $376/\ P)7_ .2*3_A77@G_ *)KK'_@2/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ3'JD+S7*P@QL<8?@E3U'?GL!R(M.^)<M_!X;OCH,D.FZY.+5)GN5+I,0W\
M'*94C<2#[>H!Z!17G^L_%*STR6\>"WM[JUL;L6EPJW>+DD$*[1P[3N"DXY89
MP>W)=J/Q"U&UNO%$%KX=6<>'D2:=WO@@DC:,R9'R'YL#I]>1QD [ZBO/W\7:
MS>^./#=G86UJ-,U'3FO]LD[+(P(7[V$(&W=P!U/4BNJ\1ZQ/HFD&[M=.FU"X
M:6.*.WBR,L[!<L0#M49R3@T :U%<);?$J V>NO=6<7VC2KJ*U"6ET)H[B27
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M3&-.K8'3V^M>?>.]6E\0?"KQ')<V=@UM':Q36US:7?VF*0EN<$HN&7 _[Z%
M'J=%<9H_C"Y/B"+0;[1I+7=IGVZVD682-(BD*59 /E;GH":@T;X@W&H>(-(T
MF_T=+)]5MY9X4^U;YH0@R!-&47867D<F@#MS-$%=C(@5.'.X87Z^E/KPB^M+
M9?A'\2(E@B$<'B"Z,2A!B/#Q@;1VP.*]OA9UTZ-D3>XB!5<XW''3/:@"9)$E
M7=&ZNN2,J<BG5Y?HGC2TT;P9X>N='\,&&TU757L5M8[O)BD:1QG+#G.QCC@#
MIFMB+XB?9K?Q)_;&E_9+K0Y(8WBAN!,LQF ,85BJ\DD#D<9H [BD1UD4,C!E
M/0@Y!KE9-2U'4%UC2-:T!;>-;'SEGCE,]O*&!!3<47Y@1TP>.:YSP%XC;2?"
M7@'2C9B6/5H7B$PEP8F16?E<<@@>M 'IU-WIYGE[EWXSMSSCUQ7%CXB1II^K
MS3:<5N;'51I,-ND^[[3,VT+ABHV@[NXX /6N>@U1M$^+/B+5M;L[:Q6W\/I/
M+]EE,HD42?>R54EN-N".PYH ]7II=5959@"QPH)Z_2N-T/Q\NJ^)8-&EM+8&
MYMC<136=Y]I52.L<F%&UL<\9!]:R_'QDM?B+X$O+2P%U>^9>(B*RH7_<\ L>
MB@DGO@9P">" >D45YY)\39[72]5EO=!,&HZ3>06U[9_:L@+,0(Y$?;\P.<XP
M*T=:\9WMEJFO:59Z= UUIVE_VC%++.0DBY(P0%R",$]>>.1G( .RHKG? NHZ
MCJW@K2;_ %18OM%Q:QR;XY"WF H#N(VC:22>!D#U-8NH_$6?3-42*YT816<F
MK+I<;37)2>4D@&9(BF&CR<9W<T =Y17#VWCR_NO$.IZ<GAUQ::7<B*]O#=KM
MBC*%_,VXR<8Y J+3/B9!J.L:1;+:0-:ZKN\B2WNQ++#QE?.C"C9N'HQP>#0!
MWM%<YXN\4R^%UTEDTUKT:AJ$5CA9@A1I#P1D<]#Z?6LE/B*+.+Q/_;>F?8Y]
M \DR)!<><)A,N8PIVKR3@8([]: .YHKDCXKU.TUZST74M(MK:\U&WEDL'CO&
MDB>1!EHW/E@J<8.0&'6H_AGKVK^)?",6J:M';AYIIBC12$Y E<;2I4;0N !R
MV0.<4 =?O7?LW#?C.W/./6B.1)4#QNKJ>C*<@UY_:1K;_&G7WM[9&D;1(7*#
M"^8WF-U/O@#-4= \;6FE>$?"8T7PN\=GK%Q+!!:QW0/DMO?NPYR02>F,T >H
M4UI$5U1G4,^=JD\G'I7G<WQ,U&WTS7+F3PQ^]T.?R[]1?+L"X!!C;;EC@YP5
M ]^U:6L:I82^-_!\<FC+<7-W%<RV%X\^S[.1#N8;0#G(VCGIGVH [2BO--!\
M?ZC%H6L:KK\5FH35WL+=8[DA?,#*BI\R@*@Y8N3ZG;VJ[%\4+2.WUQ[VTCWZ
M8L3(UE<>?%=>8<(J.57YMQ"D$<=: .\WH) A9=Y&0N>2/6G5YE:&_?XZ6DNH
MZ;:6<\F@R'-M<&7?^]7[Q*+R.G0]N:V?&^OZWI&L>&K/2X;5HM0OA#*99F1F
MP"VWA3M4XY/)[8[T =I17&W?C2^\O6[C2]'BO;;1&,=XQNRC/(J!Y%B&P[MH
M(ZE<GBM6S\07&J3Z-/INFM<:/J-L;A[XS!?(^4%%*=23G''2@#=HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZG'3GK4/A/P_XUT7[)I.HZQIDVA6 "PRPQ.+J9%X1'S\J@<9QDG&,\YKNZ*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\CSH5 +;E9<'.%(4\X/M78^ ;.]MO"-G<ZJQDU6^1;F[D(P6<J N?<(J+^%
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MH)(S']T$9P#S@8ZGD]U10!QMWX"==6T_5](URZL=3M;8VDMQ)&L_VJ(MN/F
MX^;<2<CN>G2M#P;X6/A'29K#^T9KX27,EQODC5-I<Y( 'O\ Y%=%10!RUEX2
MN;3QY?>*&U..1KRW6V>V%L0%1<;<-O//')Q^ J?7_#,VM:_H>J1Z@MO_ &3*
MTJ1F#?YA8;6!.X8&/:NBHH Y>Y\)W,7B:\UW1=5%A<7\217D<EL)DD*#".!N
M4JX!QGD>U9\WPVMK:'0WT+4I],OM'1XH;GRUE\U'.7$BG ;))/;!)KN** .
M7X9;O#NO:7/KUS+)JU__ &AY_D(ODS;E;<%'7E5R,XXXQ4Z_#HW6I:I>:UK4
MVH'4[ 6-S&($B4@9PRXSMQG(]^YKN** .-\/>![O20(M4\2WVKVT$+06D$R+
M&L*%=N21R[;> 3T!/'-:7@[PW/X4T"'29-4DOXH/E@+0K'Y:=AQR3SU)_*N@
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ]LL-_(BPN\+,6'/0'G;]WVZ8S/#EYJWB35_!::GJNI1K?Z).]W'#<O$)MC
M*W!X)&"67!/KS746?@HW_P 0/$^IZUI;_8=0$"VSBZV[EC38ZNJ,,JW!P<C
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MVB0^3'C&T MC&.,>G%7M(T?3]!TV/3M+MEMK2(L4B4D@%B6/7GJ30!>HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7('-3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>4C%T3[)'M5CC) QP>!S["N1TSQ-/<_%K4;:6YOK?2X=$%RUO>Q^4L3^8 7
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MT+2)UMUETJQD6V&V /;H1$/1>/E_"H]9U^PT+[(MVTK37DODV\,,9DDE?!)
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M9?&,] >P/!Q0!>'AG0 D2#1--VPL6B7[)'A">I7C@\#I4YT?2VU,:F=-LSJ
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M1A'<Q_V38[+H 7"_9TQ,!TWC'S8QWI1H.CBY@N1I-B)[=0L,HMDW1@= IQD
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MW4KQ7$5M-)#;L\<4LFW:K,!@??7/IN&:R;#XA65QJOB*&ZMKFSL]&P))YH&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA<W(UB 8_P"7EP5*?0'+X[$)4%]I6I7OBGQ^L6G70CU/1UMK29XRJ22+&ZD
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M ' ) /? S0!U,?BZ6+7;?1]3T>>SO+RW>>S43)()R@RT><@!P,'!X]ZR-/\
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MB-YB'#8.",^E6Y/!WC-+#6/*6R#WNO+J4MO#>,GVFWP \);;\H.!SW&<@="
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M 9/+ 4E1D@<GH.W/6I[SP1<3?$R/7H)PFE7$*/J%M_SVN(3^Y)'MD'_@ ]:
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M[]ACN$N(V??DJ&,6=P0L"-WXXP173Z[K=OH&F&]N%>0M(D,4,>-TLCL%1!G
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M;+K<6$B! 1P.1C)'IWH U9OBA!;^''UB;1KM$M]2;3+R/S$_T:4$#+-G!3)
MR/6N@U/6E5M7LWL)[B"TL1/,\$J@L'W#8,D8;"D]1P1ZUR5AI5IH_AWQ/IGC
M6?3]/L];U&ZN8C+=H-R28.!G'SK@'C/:M?P[H.HZ?\-6LYG:\U>ZM#YKRD(6
M8QA$#'MM0(I_W3U)H HZ1XQL-)T;PCIVEZ'J$D&KVSFR3S48KM0MM8LV<].3
MP,]>*NQ_$BR7PUJ6K7EA<VTVGWYTV6T+*S&X!4!58'!!W#GZUB:7X2\16C>
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M).6) XZ<\6=,\7>(=2FT71KJRATK6KN*>>Z,T+.J1QL%!1-P.7)!Y/ !Z\4
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MRQ%R>=HP>!R>N*R[NXU/4/&?@.YTT6-O>W.A2N#)&WDQ;D0G"*02!G &1]:
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MQ&.!@ # ]:AU3QO=VGC>XT*2]LM,*RVXM([VV?%]&VTR%9=P4,,LH&.H'7.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MONL;JV )A^7:5VG@J1@$>U4-3\ WFJ^$WT:[\1SSW4]Q'<7%]-;JS,4(*JB
MA4 *CCGOW.:[>B@#DW\'WEOKE_JNE:R+*;4XD2_C-J)$=U7:)(P6&QL>NX>H
M-<GK6D1Z+XZ\ Z-H=XEDMA:W4222Q^:%W*H7>,CER&[C)Z5ZQ10!PFH?#@WM
MAY:ZOLO9M335+JZ:V#&65,;%"[AM0 8QR??J39E\$WDNL^(M1_MB,-K=HMH\
M?V3B)54J"/GY."W7N?PKLJRV\0:<OB1/#YDD&HO;FY6,Q,%,8(!(;&T\GL:
M.4G^&L_]F:$MAXBN-/U;1K?[)#?P0#]Y#P-KQDD-T'?&>U7)O US+>:#=MKL
MLL^E3O<O+<0!WN9'&UBV& 4;>  ..*[.B@#@KCX;->:/XETZYUC*ZY=+>%X[
M;:8)0RL,98Y'R+P?SKI+'2M5MM3ANKK7YKN%;0PR6[6Z(KR[]WFY7IQ\NWT[
MDULT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7D'QS\:^)/"=OI,6ARFTANC(9;I8
MPQW+C"#(('4GU./8UZ_4%W9VM_ 8+RVAN(2<F.9 ZG\#Q0!Q_P )_$.K>)_
M-IJ6LG?=&1X_-V;?-53@-@<>HX]*[>FQQI#&L<2*D:C"JHP /0"G4 %>9_$W
MP]+XAU:U2SRNIV6EW-[8.OWEGCFMV7'N>5_&O3*R9=#$OB2#6CJ%VLL,+0+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0WX5HVFOP6TVLW6J>(=';3X+A4B,<JK]G&WE)&)QNSVH V1I6G+"\*V%J(I
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M]E+?Z7;22NA(E\ME4L%=58$$[3U_6@#H:*XS3/B#I97PYI^HWL":KJ=A'<R
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MFHVC3B'[08A,NX1?W\9SMY'/3F@"]16<=>T<:8NI_P!J67V!VVK<B=3&QSC
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M&WDDWV5Q;)M+0D#&['RDYSR."* -BBBB@ HHHH **** "BBB@ HHHH ****
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M<<RSL$D?Y'4Q[ 23RV_IU .0/7?'4=A<>"KZ+4)YX+.7RD,]L-SQEI%"N!W
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M+SPX;81+$[!)MZ-Y0 !.<9P#S7JU% '@7AW4I=#\,>!M<N[6[;2-.O+];X+
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M3>I<36J[!%N@VPQN>,-O.0IY&"<5Z/XM\/GQ3X9N]%^U_98[H!9)1'O(4'/
MR.>!S6I9PR6]E!#-*LLD:!6=4VAB!C.,G'YT >0^#+WP_JESX?2X_MO^V-#@
M9)H+J/RHK >7MD+ML VG& "<\CCK3_ UOI%K\$K^],%K%?"VOH99B@$N79]J
M$]>1Y>!W^6O8J* /&M/OGL]"^&.KN2^D:<CP:@5!86\C0[$9P/N[3D9/3/O5
M7QA"D^C_ !%U6S*-I>HQVB6K+]VYG4#>T?\ >XP,CK@^AKV^B@#R7Q1:>'H-
M3\ "VMK!+:6^6:01QJ R^4%5FQU&0HR?05@:D=-?0/BH8UMS/+=CR2%&7!"X
MV^OS!NG>O>:* /%O$NJVTVJ7$"9M9;CPOY<-Y%$TTEZ"&/DH.44 YW':6]QC
M-1^'KW3;CQ!\,R[Q-]GT62.0R+@))Y2 9)]PP!]00*]MHH \$T^]:Q\.VNJ0
MPR7.FZ9XKN+F]AMTW,L+;@DFT=5&<C_ZU;7B+4+*_P!"_P"$@\-:9J*Z4NM6
M]]J-Q!"R27("L'=$<<A#Y9SC!()[$U[#10!PW@!]$O[[6-:T1]3N4OO)\^]O
M%*+,Z!AA5*K]T8R<8.1Z&JAU"'0?BMKD_B"5(+'4+"W33[B<8CVIN\R+<>-Q
M9L[>]>B44 >&W$+Z)\-_!]M?EH"OB**ZB@ER'BMA,[ E3R %()STR!7N".LB
M*Z,&1AE64Y!'J*=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !10>!7':C\3O#&E:C<6%W=3)<6[;)%$#D _7%%QQBY.R1V
M-%<+_P +>\'_ //[/_X#M_A1_P +>\'_ //[/_X#O_A2YD7[&I_*SNJ*X7_A
M;W@__G]G_P# =_\ "C_A;W@__G]G_P# =_\ "BZ#V53^5G=45PO_  M[P?\
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M%O>#_P#G]G_\!W_PHN@]E4_E9W5%<+_PM[P?_P _L_\ X#O_ (4?\+>\'_\
M/[/_ . [_P"%%T'LJG\K.ZHKA?\ A;W@_P#Y_9__  '?_"C_ (6]X/\ ^?V?
M_P !W_PHN@]E4_E9W5%<+_PM[P?_ ,_L_P#X#O\ X4?\+>\'_P#/[/\ ^ [_
M .%%T'LJG\K.ZHKA?^%O>#_^?V?_ ,!W_P */^%O>#_^?V?_ ,!W_P *+H/9
M5/Y6=U17"_\ "WO!_P#S^S_^ [_X4?\ "WO!_P#S^S_^ [_X470>RJ?RL[JB
MN%_X6]X/_P"?V?\ \!W_ ,*/^%O>#_\ G]G_ / =_P#"BZ#V53^5G=45PO\
MPM[P?_S^S_\ @._^%'_"WO!__/[/_P" [_X470>RJ?RL[JBN%_X6]X/_ .?V
M?_P'?_"C_A;W@_\ Y_9__ =_\*+H/95/Y6=U17"_\+>\'_\ /[/_ . [_P"%
M'_"WO!__ #^S_P#@._\ A1=![*I_*SNJ*X7_ (6]X/\ ^?V?_P !W_PH_P"%
MO>#_ /G]G_\  =_\*+H/95/Y6=U17"_\+>\'_P#/[/\ ^ [_ .%'_"WO!_\
MS^S_ /@._P#A1=![*I_*SNJ*X7_A;W@__G]G_P# =_\ "C_A;W@__G]G_P#
M=_\ "BZ#V53^5G=45PO_  M[P?\ \_L__@._^%'_  M[P?\ \_L__@._^%%T
M'LJG\K.ZHKA?^%O>#_\ G]G_ / =_P#"C_A;W@__ )_9_P#P'?\ PHN@]E4_
ME9W5%<+_ ,+>\'_\_L__ (#O_A1_PM[P?_S^S_\ @._^%%T'LJG\K.ZHKA?^
M%O>#_P#G]G_\!W_PH_X6]X/_ .?V?_P'?_"BZ#V53^5G=45PO_"WO!__ #^S
M_P#@._\ A1_PM[P?_P _L_\ X#O_ (470>RJ?RL[JBN%_P"%O>#_ /G]G_\
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M_P */^%O>#_^?V?_ ,!W_P *+H/95/Y6=U17"_\ "WO!_P#S^S_^ [_X4?\
M"WO!_P#S^S_^ [_X470>RJ?RL[JBN%_X6]X/_P"?V?\ \!W_ ,*/^%O>#_\
MG]G_ / =_P#"BZ#V53^5G=45PO\ PM[P?_S^S_\ @._^%'_"WO!__/[/_P"
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MQ+)<%2^&B91@=>374 Y%"=R'%K<6BBBF(**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $894CVKR3Q%\.O[4U^
M]O?[*OY?.DW%TO(U!.,<!AFO7**329<)R@[H\/\ ^%4G_H"ZE_X,(?\ "C_A
M5)_Z NI?^#"'_"O<**GD1I]8J=SP_P#X52?^@+J7_@PA_P */^%4G_H"ZE_X
M,(?\*]PK&\3>)[#PGI7]I:FMQ]E\Q8V:&/?M)X&1[GBCD0?6)]SRC_A5)_Z
MNI?^#"'_  H_X52?^@+J7_@PA_PKVV&3S88Y-CIO4-L<89<]B/6GT<B#ZQ/N
M>'_\*I/_ $!=2_\ !A#_ (4?\*I/_0%U+_P80_X5[A11R(/K$^YX?_PJD_\
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M?_PJD_\ 0%U+_P &$/\ A1_PJD_] 74O_!A#_A7N%%'(@^L3[GA__"J3_P!
M74O_  80_P"%'_"J3_T!=2_\&$/^%>X44<B#ZQ/N>'_\*I/_ $!=2_\ !A#_
M (4?\*I/_0%U+_P80_X5[A11R(/K$^YX?_PJD_\ 0%U+_P &$/\ A1_PJD_]
M 74O_!A#_A7N%%'(@^L3[GA__"J3_P! 74O_  80_P"%'_"J3_T!=2_\&$/^
M%>X44<B#ZQ/N>'_\*I/_ $!=2_\ !A#_ (4?\*I/_0%U+_P80_X5[A11R(/K
M$^YX?_PJD_\ 0%U+_P &$/\ A1_PJD_] 74O_!A#_A7N%%'(@^L3[GA__"J3
M_P! 74O_  80_P"%'_"J3_T!=2_\&$/^%>X44<B#ZQ/N>'_\*I/_ $!=2_\
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M2_\ !A#_ (4?\*I/_0%U+_P80_X5[A11R(/K$^YX?_PJD_\ 0%U+_P &$/\
MA1_PJD_] 74O_!A#_A7N%%'(@^L3[GA__"J3_P! 74O_  80_P"%'_"J3_T!
M=2_\&$/^%>X44<B#ZQ/N>'_\*I/_ $!=2_\ !A#_ (4?\*I/_0%U+_P80_X5
M[A11R(/K$^YX?_PJD_\ 0%U+_P &$/\ A1_PJD_] 74O_!A#_A7N%%'(@^L3
M[GA__"J3_P! 74O_  80_P"%'_"J3_T!=2_\&$/^%>X44<B#ZQ/N>'_\*I/_
M $!=2_\ !A#_ (4?\*I/_0%U+_P80_X5[A11R(/K$^YX?_PJD_\ 0%U+_P &
M$/\ A1_PJD_] 74O_!A#_A7N%%'(@^L3[GA__"J3_P! 74O_  80_P"%'_"J
M3_T!=2_\&$/^%>X44<B#ZQ/N>'_\*I/_ $!=2_\ !A#_ (4?\*I/_0%U+_P8
M0_X5[A11R(/K$^YX?_PJD_\ 0%U+_P &$/\ A1_PJD_] 74O_!A#_A7N%%'(
M@^L3[GA__"J3_P! 74O_  80_P"%'_"J3_T!=2_\&$/^%>X44<B#ZQ/N>'_\
M*I/_ $!=2_\ !A#_ (4?\*I/_0%U+_P80_X5[A11R(/K$^YX?_PJD_\ 0%U+
M_P &$/\ A1_PJD_] 74O_!A#_A7N%%'(@^L3[GA__"J3_P! 74O_  80_P"%
M'_"J3_T!=2_\&$/^%>X44<B#ZQ/N>'_\*I/_ $!=2_\ !A#_ (4?\*I/_0%U
M+_P80_X5[A11R(/K$^YX?_PJD_\ 0%U+_P &$/\ A1_PJD_] 74O_!A#_A7N
M%%'(@^L3[GA__"J3_P! 74O_  80_P"%'_"J3_T!=2_\&$/^%>X5S&J>-(M-
M\41^'DT;4[R^EM_M,?V<0[7C!P3EY%Z'C!HY$'UB?<\V_P"%4G_H"ZE_X,(?
M\*/^%4G_ * NI?\ @PA_PKU/PYXKL/$K7T5M'<V]W82^3=6MT@62)NV<$@@X
M.""1Q6[1R(/K$^YX?_PJD_\ 0%U+_P &$/\ A1_PJD_] 74O_!A#_A7N%%'(
M@^L3[GA__"J3_P! 74O_  80_P"%'_"J3_T!=2_\&$/^%>X5R%YX]2W&K36V
M@:M>6>DR/'=W,2Q*H*#+[0[AGP/04<B#ZQ/N>??\*I/_ $!=2_\ !A#_ (4?
M\*I/_0%U+_P80_X5[-IFHVVKZ7:ZE92>9:W42RQ-C&589'':K5'(@^L3/,?!
M/@(Z!XB2^_LZ\M]L;+OENXY%YQQA1FO30,4M%6E8RG-S=V%%%%!(4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5Y[\:O\ DFUS_P!?5M_Z-6O0JX3XJVEQK/ARV\/V,$TU[J%W
M%Y>R,E$5'5G=VZ* /4\]LT 6]7U"_M?BCX<LHKR5;&]M;HS6_&QFC"E3TSGY
MO7TK*TS5=5F@^($+:I<YTVX<6<IVEH0(@X RN#SZ@UT'B?PG+KVHZ5JECJ\^
MEZCIID\F>.)9 5D #JRMP> /I6?IO@*XTNU\10Q:]-.VM@M)+<P*[(Y7:S<$
M Y&>, #C'3% '+0:IXI@\,>#O$UQXEGFEU&\LX+FT\B(0M'*<'HN[=CDG/7.
M *OZMXAO-2^)&K:&9M;AL-+M8L)I$67>60;M[M@G & !TSFM:X^']W-X.T+P
M^FN*G]DSQ3)<?8\F3RCF,%=_&._/..U6]4\$S3^)7\0Z/KMSI&HSP+!=&*%)
M8YU7[I*." PZ9]/QR 6/ -WKMWX3MV\1PRQZBCO&QECV/(H8[7*CH2,5SGQ#
MLK2TU[P4]O;0PO-XBCDE:- I=B#DDCJ?>N]TNQ?3M/CMI+VYO9%+,T]RP+N2
M23T  '/    P*Y;Q3X(U/Q+J]C>CQ*]I%87*W5I EDC^7( .2Q/S=^#ZT =1
MJMY8:7I\NJ:DT<=O9HTK2N,^6 ,$CWP<<=<XKD/ MC?:MK6H^.=2@-H^J1)!
M8VC#YHK53E6?_:;KCM^/%[Q9X.O_ !7H%CILVOM;O!,LTTJ6BLMPR\J&0G&
M<'!R#BF:5X>UW0;V[UG4_$M_X@:.R>.*R6V2$$Y#?*JD*6.W SZ]: .QK@?'
ME_)>K_P@N@PQG5-8C<W3A?DM+=N))7QW.2 .Y/TSN^!K'6M.\':?;^(;I[G5
M0K-.[OO(+,6"EN^ 0/PKG'^'6O1ZYJ^J6'CBYLY-3EWR[=/B=@HX5 S'.%'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
=110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>modificationno14effectiv008.jpg
<TEXT>
begin 644 modificationno14effectiv008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEA\1/ %K:7%REM/'?+)%]JD96VPY&06Z@LW/7\A0!Z-17@4L,EOX$U#6EO\
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M/+@4$[LY)9FQU/WNM=-/H=EXB^+VMVU_+<^1_8]NVV"Y>')WMR2A!./3I[4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME%<FV?S(3)G]VW]X>A]Z9K&NZ?I*B*ZO1!/+&[1JL;2O@#E]B@G R,GI7-^
M_%[7WPYTS6]?OE>XN998_,6+!E(E<*%1!R=J] ,X!/K0!O/X1T"1[]VTN MJ
M Q=DY_?C.</SS3;[P=X=U+3;73KW1[2XM+3BWCD3/E#T4]0/:L7Q;\0+#2_
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MN,XP"2"!GKVH MIX0\/QM8,FEP*=/S]DP#^XR<G9SQ5=? 'A)3E?#VG@^?\
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MEI\KR1 J2=Y9@N6.<<*, =^U6Z\=VM]/XGTO2YVAO=)M=ZS/$2&EVNQ 4C!
M"KST.[CIS+X+\;:?K&CZ':7NK6\NNW=BDTD0P&=M@9N ,9[E1T':@#L:*QW\
M4Z)'J::<^H1+<O-Y" @[6EQGRP^-N_\ V<YK,A\2V%CJGB*[O_%5I-IUHT*_
M9O+5?L+;3N!<<N6()QU&,4 =716;I'B#2=?6X;2K^&[%O)Y<IB.=K8SBM*@
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M9((YKT&B@#P>XAF;X9:[;QV%X;F;Q*URD8M) [QF=6#@;<D;0>?:NKOK@?\
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M)7 .[&#GVK1U[X>^)M3DUX!])N6O-0CN[6[N97\Y(E=6%OPA"*-IY!.?3G(
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M +(_,^G.9:?#SQ'::+ILT,FG)K.E:K-?VZF9VAFCE)WHQV J<'&<']> #1\
M>?\ \+&\?_:;..TF,MD6ABE\Q03$QR&P,YZ]!UK;\3^,I?#]W<00Z4;A+6P:
M_GN)IO(B"@X"*VTAI#@X7CMS5?PIH.OV/C#Q%K>KII\<6K+;E8;:9Y#&T<>W
M&2JY')Y]JH^+/"&O:UXGN[J#^S[K3[C2WLX4O)&'V.5L@R(@4@L00,Y!]_4
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MH]!\8ZOK>G>"=/DOC!>ZU!/<75Y'$FX+$#\J J5!)QS@X /KF@#U"BO(M?\
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MY$W*\1500 01ABV1[\UZ'0 4444 %%%% !1110 4444 %%%% !1110 4444
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MU:T@B5D9-C?>)W(68DX))/7\:SE^%^D+H::9]OU+,-Z;ZVNQ(BS6\Q.2494
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MNUPEC<3@:BP^QQJ<*7*$?/)P0!E<#)S7?V.E:=I8D&GV%K:"0Y<6\*Q[CZG
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M\67W@:[\V6YMK=[P:<ZF"WC#A&*A?N.4+9[X7/'?V"2..:)HI45XW!5E89#
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MMU@35M\<<!&T*4'0#MG/3BF>(M,TNX^-OAO[186DK3V-RTGF0JQ=E VDY')
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MP+J@>.. C:%*#H!QC.>G%0?$:SFDUNXU&"'2=7CLM*/VW2-0^5UA+.3+"V"
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M&,C?WFR.3SU-33:-I=RUJT^FV<IM/^/8O K>3_N9'R]!T]* /"_"&NV,.B>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS'Y9(S&KD\Y!&Y0<'\* /4J*Y+XD:=JM]X+OI=#OKRTU.U0SPM;3,A?;RR$
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M,",>G.<XYJO_ ,+5TI=,GU"32=8CM[2[-G?LT"?Z')N"8<[\'EA]S<1WQQD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSRV[:-W48 KF="U/?H_@32+N^LK72Y])ED4WRL89KA7"[6PZ\A<XR<9/3.,
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M#(X^1LE5**#V.^IOA+JT][X-&E7YQJ>B3/IURN<D&,X4_3;@9[X- '>4444
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M098G)[C'0UZ+6=/KNFVVNVNBRW.W4+J-I(8=C?.JC+'.,<?6@#@?$.CZS>?
M_3]#M](N7U1;>SA>V#)E6B9"Q)W8Q\AQSW%:L=KJEI\5+C65TBYFT^^TJ*+S
M59!Y+JS,5<%LYP1TSR?J1W5% 'BUAX;\5:?H.E:E::+(VI:/K-S=FPFE13<0
M3;@=K D;@#W]^O0[^NR^,M5T"WNTT!K,2:G \]C;R1M=BV4'>X<D 2$X P00
M!U'./2J* /&H/#FN6_AWX@:=%X=O(_[58O9*TT;EMR  %BYR1SN.2.#R:]3T
M%9H_#>G1W$#P3):QI)%)C<K!0"#@D=JTJCN$62VE1V=492&9&*L!CL1R#]*
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MJ&T7+O.[!]O"_*3@8' P.!0!Y?IVFW?@KQ;X'TV2VFOY[31KE9TM0I8%G!.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFR5B,,RDJ2A8<$@\^QYH R/^$UOKC7O!DZ%(M,UG3;B\GM_*!=2D2OC=]6[
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MGX>UGQC]I,-S;Z3I]O/;1K%LR\A( 8Y)(SC/X\"M.'X:6=OX>T72(=7U&/\
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MWV2WGAVL6AP!L<,"&' /J#S6KHFB6VA6DL,#R2R3SO<7$\I!>:5CEF. !Z#
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M>7'+MW)DGG!)YQ^5:\?PV@_L2_TZ[U_6+Z2]@^S-=74RR21P]T3(P,\9.,G
M]*O:QX*BUGPUIVB3:K>)%8O$ZS((]\AC^X6RN.,#H!F@#E/[7U#1/'OCW5+G
M4);JWTK3X)DMBB@,NR5UC! ^4!B>>ISS6GI>I>-9[^QE:&4Z;=V;O//=1VX6
MWEV[D,2QR%F0],-D]#FMJ7P193^(;_59;RZ9-1M5M;ZT^3RKA55E!;Y=PX8\
M BJ6A?#J#03B+7]9N8849+*"YG#QVF05RJXP2 2!G. 3Q0!S&F>)/&EQ\+;K
MQA<ZM8,#ITDL5N++E71R,DY .0.F,#C@][_B#Q5K=O#:-;Z@D&[0C?>7;0+-
M/+/@'YD((2$#)+<<\9K>M_ -M;?#]_!T>IWIL61HO.81F41L22N=N.YYQFJ\
MOPVM9+R*Y76M2C?^S!I=QY?EC[1".@;*'!]2N.G:@#<\(:K<:[X/TC5;H(+B
M[M(Y9 @PNXKS@5M5D^&M"3PUX?M-(CNY[J.V0(DD^W=M' 'R@# '^36M0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4AK&
MF-J!T\:C:&]!P;83KYG3/W<YZ5=KYV_MG39;CP_>17%O901>*S+-9,2TT.6?
M=)-(3D%L<+@#'][&0 >]R:WI,+;9=3LD;S/)PUP@/F<?+U^]R..O-1:YK-KH
M^GRRS7]E:S%&,'VN4(KL!TY()_"O#M5BT-O!7Q.EC2P,RZL1;E=FY1F/&STY
MW=/0^E=0-=TZT\=>(#XBN8%M]0T>V7299R#'+%L/FHC="3(W3J>* .\\$:Y<
M^)?!>EZS>)$EQ=Q;W6($*#N(X!)/;UK3&L:8=0_L\:C:?;<X^S>>OF=,_=SG
MI7*_"&>.?X6:%Y;!MD+(WL0[<5Y;+K.G2W&B7<5Q;V4,7B\2SV;$M-#EVW2S
M2$Y&<<+@#'][' !]#NZ1QM)(RHBC+,QP /4FJ]EJ>GZE$\MC?6UU&APSP2JX
M4^A(/%<E\4Y;F+P6+J"&2>U@O+>:]AC7+26RR N,=QTR/3.>*Y3Q+J>C^(O"
MOBS4O!,$]W<75M;_ -H7,*2*LB(P!C (&6\LOG Z8SU% 'JMGJ^F:B918ZC:
M71B_U@@G5]GUP>*2/6M*EFAACU.S>6?/E(LZEI,$@[1GG!!''H:X&ZGT?6O'
MWA;4-"GLYK**PNAJ30E?+6U*+Y:2]@-W13Z'T-<'I']CVWPV\!W:&RCNU\3Q
M^9*"H<*)I,Y/4 +M]L8H ]KL?&.AZAJ.IV<&HVY.G$+/(95"@D9.#G^'@$]B
M<5?.M:4MO+<'4[(0PD"60SKM0GD9.<#.1C->.:K-I-L/BM97)M([MT\VWB<*
M&(^SC#*/J1SZD=S5N_3PYHGA;P/<VMI86[7TUM*VHR'$$<J0G]Y+@C>PRV 2
M.<Y/6@#UR/4["6P-]'?6SV8!)N%E4Q@#K\V<5EZOXRT'1_#\FM2ZE;2VBG8C
M0S*_FOV1<'!;_P#77B^G:JNG:3=W$DK7>G6/C22ZU$1Q\^00-DK(!PN\;L8Z
M@8Z5O>,KKPWJWPY\5ZGX=MFDMIKJUN)[S8PCEE\U ^P,.,*HW$#'S?6@#V-9
MEN;;S;6:)PZGRY =ZD^O!Y'XUYU;?$#7;CPEXGU/^S[!=2T"ZDBGLBSX9(QE
MFW9[C<1Q_#[\>@Z?=6=Y80W&GR126CC,3Q8V,,]1CM7E/B#1;N#XN2Z5!"6T
MKQ;;1M>\X"^0P,G_ 'T@V_\ ;6@#M'\2WTWA?0-1T];.:[U9X%5&#!,2#<V,
M'/RJ&)]=IZ5O7.KZ98W$=M>:C9V]Q)C9%+,J,_;@$Y/->;?#.QOX]9O-%O(V
M%EX5GGMK1V.?-,S;E;ZK'Q])*JM=:>MC\2-*\2/ FIW%U/)!'/@// 8P+?R\
M\M@K@!<X/N: /5;G5=.LI#'=W]K ZKO*RS*I"Y S@GID@9]2*YWP]XJGO=4\
M36^K265O!I5ZMO%*I* J5##<6)&>?:N"TS1]/OOB-X?TSQ-;VMU>GPHBW,5Q
MAF:<,.&]7"YZ\\9K.;7/[&\:>)M5=[6\\.VNLQ_VC:K@LH**L<P&?F"./NXZ
M\]0" #W??YUOYEM+&=ZYCD^\IST/!Y'XUY[I?C7Q-JWA34]>M[#2BNGS3QM;
MM)(ID$7WB&Y ) ..*[Z&^M)[%+Z&YA>T=/,697&PKZYZ8KPSPM%X6U'P!KL.
MJ^)I;$SWUW\D.ILFY2>"(@V'SZ;3NH ]>T3Q9IFL>'--UAYXK-+Z'S4CN)54
MC )8<]<8//H,U>FUO2;9+=Y]4LHEN1F!I+A%$H]5R?FZCI7BEL$U"S^%T?B>
MQLX)VFGB>"2%8]T(4B+<G8'Y>,8.>G-7=8;0M'\5^(_#WB+4+S1M+O+:"'3T
MM[5'CEMQ&%,:$Q.P(<L<#')SUH ]AO=7TW3&C6_U"TM3)]P3S+'N^F3S6%>>
M([VV^(FF:$!:G3KRQFN3)@^8&0COG&.?2O,/%%U80R:MI<;/8W47A5(5?4?W
MES=)L8K$B\!6_OL 3D'@8S5>\O[N^N/!">'=1M?[27PTR*K2?ZQ@J;HMP(*L
MVUU![$'H1D 'NJZII[V<EXE_:M:Q_?F$RE%^K9P*YOPOXMEU_P 6^)].$UA/
M8:9]F-M<6C;MXD5V;<VX@D;0.,=ZXW6/%FE:MX<\&ZS8QI#X<M]2C_M.W11B
MT(!""11T56YZ8^Z?2L;5KY-2N_BI_P (S+'</=6MA+']D.?.C52)BI'7Y6.<
M=<T >V6VMZ3>"8VNIV4X@&9?*N%;RQZM@\?C1_;.E^7')_:5GLD8JC>>N&(Z
M@'/)Y%<')/I>N^/O!U]X9EMIH8[6X%[]F((2V,8")(!T^?&%/<'T-<I+X;UD
M:;KW@W3K<QKX?O3K&F710$$',D4*_P"UNWY/MCO0![5+J>GP&437UM&8B!('
MF4;">F<GC/:G6VHV5[+-%:WEO/) VV5(I58QGT8 \'@]:\>\8W$&L?!^X\2:
ME;PV]UJ]U:SQ)(1NCC#HJJIZ_<#-Q_?:N@T<Z7:_'&]M].^R112Z#$1';[0K
M,)2>@ZG;@_2@#H/%GBQ]!U70M)MQ;)<ZO,\:7%V2(80B@DG!!+'( &1DGK4G
M_"17.B1:M/XH:RMK6Q2.2.ZA)"S*V[^%CPV5QMR>WK5/QT/#&H/8:%XJA@^R
M7R3/%<2OL\F1-F,/_"2'/.<<8YS7 )%?6_A3Q[H,6K2:_H5EIWF6-Y(1*8W*
M,3$''#%0!TZ<=,XH ];M?$FD7.FVMZVH6D,=Q#YRB2= 0,9/?MW]*M+JVFO'
M+(NH6C1P@&1A,I"9Z9.>,^]>/O\ \(QKGBKX;0,-.NK>6PN8IDPI5W$*!5;U
M^;(&>X/>I]4GTOPWXD^(EA,T=H+[1+<6,&,>:J6\B80=\8 XZ8]J /6;G5=.
MLK2.ZNM0M8+:3&R:6951L\C!)P:S]1\7:)IFI:783W\'GZD3Y($JXV!&;>3G
M[ORX![DBO+-(\1Z=H5YX2OO$$F-!G\+QV<%P8S)''< CS5. <$J #],5=O6T
M#3=5^'%W#;?8=#BEOHHFO >4,9$9.[G#?>4'GYA0!ZL=6TT0O,=0M!%&VQW\
MY=JMZ$YX/M1/J^FVTGEW&HVD3[0VV295."< X)Z$D 5XGXBO['3-'^*.D7$Z
MQWUU=BXAMR#OD1E0[@.I'7)Z#O6Q9V/AS7_B]#!=PV%[')X9A=8W"L&D$O7'
M=@OXXH ]5;5=.34%T][^U6];E;8S*)#WX7.:-4U.TT;2KK4KZ416MM&997]
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M8))".N#D[CWY/-:GPZU#3;SQUXZ.G30R0RW5O-&T.-K@Q<L".#\V>??WH ]
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M.&5'$-Q<(55L[/WSD#VX(/T->@4 %%%% !1110 4444 %%%% !1110 4444
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M?:W'IURDLX+1L)<% 0N"&"D;NP/3T /371)%(=%8$$$$9R/2A(TCC$:(JH.
MJC 'X5Q:^.M1E\677A^#PO<S36;6_P!IE2Y3;&DO5^>N.N.I&>F*BL_B.9]8
MT>SN='>UAU>>:&U,D^)QY9(W20E055MIQR: .X$,0VXC0;>!A1Q0\43G>\:,
M0",L < ]:Y.W\:W%ZUC=V.B376C7E\;*.[AEW.N&9?-:/;Q'N4C<6SWQS6+I
M_BK5-3L/'#:WI$<UAITDT#6T-R,[%B7<F2!G(+,6SWP!TH ]&9(YHP&5'0X(
M! (]J<R*V-R@X.1D=#7G^G>,8],L_".CZ1X<F,6K:;YUE&+I=L02,-L+-R<
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M*#Y?E)R6SR0..IIGASQE+XEFAEM=/A.G3/*GG)=[Y860G EBVC86P<?,?UH
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MEYI-S+.(KERB2*7D5EW '!Y]*TW^'OB.ZM-=>6]T^VU&XU:/5["6$NRQRH
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M)FBGVN;M(B^\Q ?=YY&XYX8GT F3PGX@M5\:VL TZ2UUQY9;=WG=75Y(PF&
M0@ <G(SGCI7?HZ21K)&RNC %64Y!![@TZ@#SG3?"'B&UU+P//+'IICT"QDM;
MC;=/F0NBIE1Y?8*#SCKCMDX&L:-J.@^%+S2M3DTB*?6O$GVJV,ERX3#-YA4R
M; 8V 3[PSUXYQ7LI( ))P!WKEI_%OA75;>.WN6-W974ZVT<DMA*]M-(6VA0Y
M38WS<9SB@#*\&SW5IXBN[2ZLM,:>^C-S->6.I27;$IM11)O4%1@_+SCY3QUK
M5\0^&+F[\1:9XETB:*/5;!&A,4Y(BN86ZHQ )4@\A@#@]C6_8:98:5"8=.L;
M:SB)R4MXEC4GZ "JMIXAT^]U^^T2%Y3?64:23(T3* K9P02,-T[<4 8.I>'M
M5\6ZAIAUV&TL],T^Y%W]E@G,SW$JYV;F**%09)QSGVI-)T'7+#Q_XCUZ6&Q-
MKJ4,*0HMRV\&)2!N_=X&<]B<>]=G10!YE9>"/$<'PRUWPU*NF_;+^:9XG6Z<
MQJLK9.3Y><CZ<^U2S>%?%^E:W:ZYX=ETG[5-I\5EJ%I>O(T1,?W9$90">/8?
MC7::/XAT_79;^.Q>5FL+@VTXDB:,JX )&& />M&618HGD8,512Q"*6.!Z <D
M^PH X#4?"_B^RUFP\0:'J6GW>J_8_L>H1WZLD4PWEPR[<E=I8@#T ZU8N/#G
MB6Y\4^$M7N9M/N&TO[2UXP=H]QG&W;&NT\(,8R<G'.*ZC0==L/$FCPZKIDC2
M6DQ<(SH4)VL5/!Y'*FM*@ KSK2/!&IQ^,-*\075EI>G7=O'(-0FT^=\:@63
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MQ!'9HFK:C)J5I-;3-(]M(WW>J+R/4=1D5Z@SHK*K,H+G"@G[QQG _ $_A3J
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M# SCL:Z*Z^&&C7FBZ;I\E]JPETT_Z'?I=;;B$8"[58# 7"@8QVSUR:LO\/\
M3&CTE%OM25M,N/M<<AF5WEF[O(SJ2Q(XZXQQB@#9M[*:'PW]CUG4/ML@MV2Y
MNQ&(O,&#EMHX7CTKRR.;7OACI]I8:O%%KO@I9HO(OX0%FM!O#)O7^(!L8_GT
M%>Q7$"W-M+ Y(25"C$=<$8KEQX!LGL+?3+G5-4N](@\O9I\\J-&=A!4,P0.P
M! ."V..F.* ,H:EX@\42^)FT;6DTRXTF_P#L=M#+&AB8(%9WERI;#98#!& !
M[UD7XU";XD>+I]*U7["8]$MYA/%$LC,0'*XW97:>_!)'0CK73ZI\-=#U77YM
M8:?4K62Z"B\@M+MHHKL 8Q(HZC''!&:M/X(LFUC4]32_OXYM1M19RHC1A%B
MP HV<8&<'GK0!RNG^,=;UV+PUI\1N!=7FC?VC=2V?DI([;@@ \WY0,DL0!GI
MT&:FMM>\4?;/#/A;6+E;35;Y[EKN[MQ&SF*)=R@#!0.P*YXX .!SQJ7/PNT2
MYT?2K#[9JD,NE I9WT%P([B)#U7<J@$?49]ZMWGP]T:[TW3K59K^WN-.E::W
MOXK@_:5=OOL78'=N[Y'- 'G7]H:OX8\-?$"_T_5)3?6FOQ_Z1)%&S2*QC0[A
MMV]&[ =*]#BU?41\6[C0VNB^F_V*MZL)1?DE,Q3(8#.,#H2>M,B^&NB+I>MZ
M?-/J%S'K+![MY[C<Q<8(9>, Y .<=O3BK&G>!;/3M:.LKJFK3ZD;/[&;BXN
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M>RWPLQ9$.8]C1 [L$!!SN^;((Y]N*37?"-EKVK:;JDEU>VE[I^\12VDH0E7
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MK;4FT1Y]1U -H[K);LK1@LX&-S_)SQQV'- 'G]YKOBVUT3QI(OB61F\.W/\
MH\AM(=\X*JVV3Y=NWG^$ ^_:MCQ9XDUB.X LM3>';H;WHM+")'G\[J'D,BE5
MA 'J"3D#-;DWP[TZ>VUZWDU'4C'KCA[P;X^2/[OR?+Q@?047/PZTN[OEO)+_
M %-938#3I_+G""XA&<!\*.>>V* .0M[W5-=\4?#:_N-7NXGO]-GGECA$802+
M$N6"E2,MN(.<X'3%>O5Q\/PYTNW@T*.._P!45]%#I;3"X <HX"LC$#[N% ^7
M'ZUT&E:1'I)O2EW>7'VNZ>Y;[3,9/++8^1/[J#' [4 :%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %96J>(]+T>YCM;J:5KF1#(L%O;R3R; <;BL:
ML0N>,D8K5KDIY+OP]XJU+47TN\O[348X=LMG&)'A:,%=C+D':<[@1D9+9QW
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M2]4N/"WQ&M8])U SZI?^99K]E?,RG8,CCC[IZX_6I;W3[[3_ !1>7UYX0O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY@CV0L/D!/.7;G"CT.2.,U[GX@V<5OINRW$5Y?6GVP6U_<):F*/IABW\1/
MST)X H [&BL;PKXDM/%OARUUJR21(;@,-DF-R,I*L#CCJ#S7G.I:A=^%/BS+
MJXNIAH,UU%IUY;F0F.%I8E9) "<+\X.3_C0!Z_17DGQ1U:^N=>T*RL[J6'3;
M;6+2VO3$Y7SI)<MY>0>BH,D?]-%]*Z7Q!\1=-\.S7]O'##.NEHGVE/M4<3C(
M!VQHW+D*03T'( ).0 #MJ*XG6/B-#IT5Q<6FF3W=I;:?'J$UPT@A7RY/NJFX
M?,Q&3CCTZU-=^.U^TQVNEZ<U[<OIJ:F(7G6%VB;.U4!!W-P<CH..>: .PHKF
MQXM#>)-2T,6#_:+*Q6^#&0!9$/&.F0<@UBM\3T>R\.W%IH%_=-KT<K6T:/&"
M&0$[3D^PYZ '.>,4 =]17!:G\3[33;:=Y+$+/9V\<][:S7<<4T1=0_EJI/SN
M%.2!@<@ YX%A_B$)]7;3=+T.\OI6TQ-3@821QK+$YX.2?E_'G/;O0!VM%<)I
MWQ,AU%/#]T-%O8=.UJ46\-U(Z?+-AOEV Y*Y4C=2:U\4M*T:6[=DCFL[*Z%K
M<NMT@E5LA6*Q'YF52<$\=#@$#- '>45P^H?$22TO_$-I;^';RY?0XTGN&\Z-
M5,3(S[@<_P!U<@=3Z#%0R^-]1N_%WA>TT[3R=,U6R:]WM(H=UV X(/W=NX'K
MR?IR =]16%XU4'P/KKY(>*PGDC920498V(((Z$&O'=2UFSM/A?H%WI6HZE!X
MJD6U\J8RSJDDIQO\QG_=E2-W4XZ=J /?Z*Y#Q#XW?0)KJ$:7)=&RT_[?=3>8
M(HPN2-J$CYF.#Q^M)+X]2:6R@TK3C=W-WI:ZHD,LZPLT3?=5<YW/UXZ#UYH
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M,X_7% $E%<CI/CI=8\/3ZG!IDJ3PW_V!K*251()=X4@]ARV?H,U3_MS2-/\
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M&LR.&\U3R-IX;KCKTYH P+GPQXDLO$\>I6'V._\ M&BIIEU+<S-&R2*2?-P
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M^*&J:?',UY96=O<P)YSL#(T$C$LN<,,\X.<=L5ZQ;6\5I;16\*E8HE"("Q;
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MZXSS@X@-E+##?:A9^)H#9W.BS%+6RO9I&E=%WK.&+$J1P"1C.<'K7>Z-X/\
M#OA^WNK?2](M;:*Z&)U";O,'H<YR.3QTYJ#3_ ?A?2H+V&PT:WMDO5V7'E;E
M+K_=SG(7V'% &7\,=*,'A33M7FU+4;RYU&PMVF%U<&1%(7C:#T.#@^N!WR35
M\<2,_P 0? %E+_QY27MQ,X[&5(OW?ZDUVNF:99Z/I\5AI\(@M8AB.(,2%'H,
MGI5'Q'H*Z[9V^R407ME<)=V<Y&1'*O3([J02"/0F@#CK=S9?M!WIOV""^T9$
ML&?H^U@713ZY#''I76^*D6ZT6_L+=T&JW-A<I: <ODI@D>@R5Y]<>U6+[1;'
MQ#IL$.NZ;;RNN'\LG=Y3^J/P1]1@U)I>A:9HRL+"T6)G #.27=@.@+,22/QH
M YWX3W$$WPRT182-T$)AE3&"DBL0P(['/\ZPO 4/VF'Q_>@!]+OM3N#;M_!*
M I#L/4$\9[X]J[:[\):%>W4UQ-8*))SF;RI'C$QZ?.JD!^/[P--UO2+BYT$:
M'I"V]C;3H;>615V_9X2,'RU QNQP.@&<\XP0#)^$]U/>?"W0);ER\@MRF6Z[
M5=E7_P = KG/B#<R7.O:Q!9W5U--8Z!).UN)VMX;0_,1-N4Y>3  "XQQR1FO
M2].T^VTG3;;3[*,16UM$L42#LH&!6=J7A#P_K&I#4=1TJWN;ORO)\QP>4]".
MAZ\9Z=J /.=+^TZYX@\$PWVIZDT-_P"&_.NTCO)$$KA4Y.TC!.<DC!/?O5'0
MM<O9-,\*:'>7]T;"\UJ]MKBX>=A(R1$F*(R9SAF('7) QTKT^S\#^'-/GM9[
M/31!+:QF*!XY9 40]0/F[TA\#>&CH\NDMI,3V$DOGM"[,P$G]\9.5;W&* .<
M^']G;Z?X\\>VEL7\M+JU(#R%R,Q9ZDDXR33/C.DH\+:7=;2UE::O;3WN%R!"
M"021Z9*UU^C^%="\/SSSZ5IEO:S3@++(B_,X P 2>>WXGGK6K+%'/"\4T:R1
MNI5T<9# ]01W% %>ZN[#^RI+JYF@;3VB+/(Q!C:,C\B"#^.:X+P?NL_B_P".
M;>]8BXO$M+FUWC!DA"LI*^RDJI]Q756'@OP[IDZS6>E11E&W(FYF2,YSE4)*
MJ?H!5[4]#TW6/*-]:)*\))BE!*21YX.UU(9<^QH XKQ"CWGQN\()9_,]E:74
MUYM_@B==J;O8MT%>:+<:O;^ M0=V\WPJVOW$6KQ6L>+E(RZG(<DC:<C. #TY
MYR/?K'0-,TV">*SM1#]H_P!=(KMYDG&,M)G<3CH<\5!IOA30](LKJRL;!(K2
M[W>? 79DDW##$JQ(R1U/>@"]I1LCI%D=-*&P\A/LQ0Y7R]HVX]L8K@OB%I]M
M<^.O S3&?][>RQMLN)$X$9(QM88.3U&#7;Z-H6F^'[+['I5M]FMLY$0=F5?H
M"3C\*CU/PWI.L7MM>7]J9KBU.;>3S74Q'U7!&#[CF@#@HL^(H_';WUY>6]WI
M5Q)!9B.Z=#;1QQ QR  ]6(+$G.?I67"FH>*]?\(V^IZIJEI_:7A]Y[M;6Y:+
M>XVX8#HIY#<#GH>.*],O_"6@ZGJ#7]YIL4MRZ".1\D>:HZ*X!PX]F!J>7P]I
M4VLP:O):@W]NNR&;>P*+T( S@ ^F.: -"*/R84B#,^Q0NYSECCN3W->(1ZG=
MOJ_AW5K#4+V>VO?$K0-?37#(;B,E@8Q""5$:@8!."<9VBO<JY@_#OP@22=!M
M.;C[3T/$G/(YX')X'!]* .GKQWPSH>I>(U^(&E0:K#8V-UKUU%<8M#),RD ,
M%8N%7(XY4]_P]A90R%#D C'!P?S'2LO2?#>DZ'/<S:;:F"2Z8O.1*[>8QZLP
M).6]^M 'G^LZ0=,^)O@32=(N!:K:Z;<PPO(GFX54 Y&1DX%.\/)=:1\<-4L]
M5G74[[4-,2>.]C7R_)B5MOEF,9 R1G.?3UKN[_PKHNIZFFHWMD)KQ%VI,TCY
M0=PN#P/I3K/PSHNGK<BRT^&W>Z&V>6+*R2#W<?-^M 'D5C>OX$NO#OBF&VEG
MLM9LSI]Y#",E[A"Q@(']XXV?0&MG0],DTCXVV,-RRO?7'AV2>\D7H\SW!9R/
M8'@>@ ':O1K/P[I-C806,%D@M;>430Q.2XC<'(*[B<8//%12>%=&EUO^V7M7
M_M+;L%R)Y X7^Z"&X7V'% 'B-U<:];:)X\DL&$FB_P#"2W2:M!!'_I/V=B [
M(Y) &W@_+QUSZ>Y>&CI9\,:9_8A!TO[,@M<'/R8XSGG/KGG.:9I?A?1M%-V=
M/LA$+LEKA3([B5CU+!B02?7K4FB>'=*\.6[V^D6@M8'.XQ([%0>>@)('7M0!
MQGCK3+:Z^)7@5Y?.#2S74;-'.\9VB$L,;2,')ZC!/0\5DO--KOA'QQK=S?7E
MMJVEWEVML8[ET^RB!0T:A0=N#CGCYMQKTO6/#^DZ^MNNJV$-V+=_,B$@^ZV,
M'\QU'0U6N?"&@7FH27T^F0M<2[?-(R%EV_=WJ#M?';<#0!;T&ZN;[P[IEW>I
MLNY[2*69,8VNR L,=N2:X:)?^$JU_P ;VNI75W!)IK)!9K%</%]G0Q;A* I
MRS9.3V '2O2:Q]1\*Z'JU]]MO=/CDN3'Y3R!F4R)_=?:1O7V;(H \T\.^(KC
MQ)?^'M-\4W<EO#<^'_M4?[YH/M$YD*[R01E@BA@/]HG'2KT&HVH\1>'/#5_K
MT][I'V"YVWDDS1?;+F.79M9@1NV@-CG!.#SQ7>:UX2T#Q%;06^K:3;745O\
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MZ,#U!'J.:K)X9TB/3+G3DL\6UU_Q\#S'W3<8^=\[FX ')Z<=* ,;X86L-O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 2F(RAL[<Y&=N.G>@#T6BN G\6>*;WQ1KNBZ'INE2'3889XY+F:3]XLBE@N
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MKB(3N7E D5,H<  Y;J>OH,<[B>-K[3->UNP\06EK'%8:7_:JO:.S'R\L"AW
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ2.VM0B(!$2 <DEMIW 9/0@GGI;UCQUJ?A[5?&S7/D7,&D65M+:QK%L^:4D
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M6K:HU];M:M<7D^]XHSV3C YP2<') STH S3JVKZ/<> K!;R&:WU',<^ZW ?
MAW#!SQV'3/'6L"_\9>+[7PQXGUS^U+/_ (D6LO9K"+( 3H'C7!)8E1\^>,GK
MSTKLV\!B1] DEUW4)9-%<O SK%\Y(V_-A!QMXP,?B>:J3_#.VN?#^MZ-+K-\
M;?6+TWMRP2,,)"P8[?EX!*K^7O0!7\3>*=3M/$6L6"7T>EPV.CF^M7=$/VJ3
M)R#O'W1@#"X//7I5'4/&.O:=HGAR_P!:EGL+.^LFGO;ZRT_S/LTI"%$=&W;5
MP6R>I('3FJ^NV=Y_PF]Y-=R>)K8"W@@MKG3[!+N.X"@EF^XXC.YC\N!TSWXZ
M73O#^MW]C%<W^NZA!<F.2 AH8,RP%R5,J;2H?'ICW[B@#?TBXEU+PQ93IJ$4
MT\]HA^V0*"C.5Y=1TQGG%>8>%?$>K:9X'TTMJ/VB^UK77L8YIH@?)+32;Y#C
M&XX!P.@..W%>J:)H]KX?T2STFQ#_ &:TB$4>]LL0.Y/J>M<Q%\,M-CT6?2CJ
M6H-;_;/MMF=R!K*7>7#1D+URQ^]GB@";2M8U2S^(5UX6U&Z%]"^GKJ%K<F-4
M=1O\MD?: #SR" *EU76+VZ\;P^%K"[^PM_9KZA+<B-7<_O!&J*&!'7)/!Z#I
MUK1TKP\MAJ<VJW=[-?ZE-"MN;B947;$I)"*J@ #))/<GZ 50\4^![7Q+?66I
M)J-_I>IV:LD5Y8R!'V-U4Y!R/\: ,M==\0#4?#GAB^N[6#6+N&>:^NK5 ZJL
M? $888W-D9R#C!XY&,R7QYJ^FG4M#NI(9=5AUJVTNWO3%A2EP-RNZ# W*H;(
M& 3BNDF\!6/D:4UI?7MMJ&F/))!?[Q)*[2?ZSS-P(<,3D\?3%+<^ =+O='O;
M*\FN9KB]N5O);[<JS"=<!'4@87:%  QC'KDY ,35_$6O^'];U71FOX[O.BRZ
MG974UNN^-XSAD95VA@>"#V]ZI6OBGQ5;^'- O+_4;*6X\2R6<%ILM=OV0NI,
MCMS\YVX(' W'T%=6_@M;I+^2_P!5N[J_O+(V!NV2-6B@)RRHH4*"<Y)(/;TJ
M.Y\ V%YX-T_PY/>7A73C&UG>*RK/"\?W&! QD#CITH YC3EU'3?B)XY?^T?M
M-U%I=M)%//"O "N0&5-H/0^E):>+/$M]!\/T@O;2$Z]!-]I)M=V&2,MN'('T
M''(Y)'%=%:> /L^H:GJ,OB#4[F^U&S%I/+(L(&T# (4(!D=OZTVR^'<%B?#G
MEZQ>L- WBU#)'\P<;6#?+S\O'&* ,*V\7>(!X9UI9]2LA>:?KYTPWTL00F$%
M<LL8R&DPQ 4#GT/?!\0^*-=U3X>^.(GU">+^R[J.%)'MEBFEADV@HZX^7ANP
M![<5V<WPOM9H+E?[9OUFFU==9295CS%<CN!MP1CL<]*?)\,;&>T\0VUQJ^I3
M1ZYL:XWF/(D7;\XPHYRHXZ#) % $&HZYK[:Y-X=TQ[N:YL[!+B2YMX;?<\DA
M8("LKJ @"\[<DYZC'/5^'+C5KKP[93:[:1VFJ&/%S"CAE5P2.""1SC/4XS7/
M:I\.8M2NK+4$\0:Q::O;0_9WU"WE1))X]Q;:X"A>"3C &/?%=39:5;V&D)IL
M9E>%4*,TKEG?.2S,QY+$DDGU- 'F>D^-]?D\2^&[:XOH;E-4N+J*Y6&W!MHB
M@)00RX!D(P-QR1VX-5I_&7BZW\+ZOKS:G9D:5KK6!@6S $\8E1.3N)7[W&.?
M<]NCL?A9;Z>NBK'X@U5ET:9WLU;ROW:."&3A.<YZG)],5++\,K:;P[J6B2:S
M?&WU&_-_,^R(-YA8.<?+@ L ?PH JZUK&I>(9_&>G6-_]AM=&M/*.V%7:>1X
MF9MQ8'"@8&!@]3GI6Y\.2!\-?#A/0:?%_P"@BJVH_#^&\U:\U*VUG4+"?4+8
M6^H"V\O;= +M#,&4[6P<97''3%;OAS0X?#>@6>CV]Q//#:Q^6CSD%L>G  H
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M[L)0C-&3DHV0<C.3^-(/ EM'JN@W\>IWX?1O-\H.RN9FE_UK2,PR2WX8[8H
MYRZ\6ZOIGBF/2-=U5M-D\^U2VE-D/LE\I">=^\()5R?, &0!\O6EF\4^+]7&
MH7WARPGG6SU)[6.W86ZP2QQOM?>[R"0,>2"  .!@]:Z/4_!,>KR7$5YJ]])I
MUQ=)=261$>T.I4@*VW<JY49 /KR,U2F^&=@^O7>H6^K:M:6E]*9KW3K>XVP7
M#G[Q(QD!N^#S[4 9E]XF\6ZM/K;^&+*>5],OC9PP[;?R9BFWS/,9W#@G)QM
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MC9(\@#"E2 "",D]>?RK&\+6FHV]U81:/?^)?+C>-;B#5-*CMX1",!@6\M26
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HIHDC,K1!U,BJ&9,\@'."1Z'!_(UE>'O$^D>*K*6\T6\%U;Q3- [A&7#@
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MSN_'.J77B;PUK9TF=9-$MHX$C^S-B7;D$GYN,Y_"J=AXNU/3M(\5V8TR9_\
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MOV4[E8#&!\V,<#]: /L/3+MK_2;.\90K7$"2E1T!90<?K5NN6^'.JRZS\/\
M1[N>!H91#Y+(R[3^[)3..V=N?QKJ: "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKR$!995\U>06!VDG!)QGJ/>H=(\1ZKJ7@GP>MUJ]W)>WEY<1206WRW-\L32
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M*,L9"#C R Q!QP<'% 'I_P!E\6_]!C1/_!5+_P#)%4=7G\5Z/I-SJ!O-.NQ
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M4&%XP0/O9SGGIBN@KR-/"PT;Q[X3\.V>I7,,=MHEQ&UQ& )'&\%L$@A<D^Y
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MQI.KR0@;_P!S#;PD9$D?1MRAB2<]>.!B@#TNL=?$EFWB]_#/E7 O5L_MN]D
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MV!T6UF,32R2J29"1R0HP .F2<YH Z[PYK]IXGT"TUFQ29+:Z!:-9E < ,5Y
M)'4>M:E>':#=ZAH7PI\%^)+:\N5TVRF*ZI;1N=KP-,PWX]5)'3J#STKU;PW*
M]]!=ZK]HDDM[Z<R6JLY95A'RJ5]GP7^CCTH M/JP3Q!%I'V&]+26YN/M0BS
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M6&P1AW'4@Y.,8XSFM'3O&1U3XERZ#97FFWFEKI7VU9;5M[K)YH3:S!B.ASC
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MP?#OPS#:ZI;/92W$>J!?MGVFYDE,I7H268_,.N[KGO58>+[[3/&]IX;URWM
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ML)?)P]R@/F?W>3][D<=>:Q[GQ!J%O\2K#P_MMC875A+<[MC>8&1@.N<8Y]*
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MSQD=^#ZFM/Q->KI?Q1\.WNJND6C&SN(8IY3B.*Y8@Y9CPI*# )]Z[Y45<[5
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M/5[K5].M'@>T>VCB2T0IAED*1*" P  W'D@^M>M[5!R%&?7%(J*I8JH!8Y)
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M<8/YUY]I?A?6]0\->%/#^HZ;)IXT.Z@N;BY::.1)O)SM6,*Q)W$C)8+@9ZT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %13VT%R$%Q!'*(W$B>8@;
M:PZ,,]"/6I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@$:)GV0*?]YV->RZ]HL'B'1Y]+NI[B*VN!ME^SN$9U[KG!X/?%1:UX>MM?\
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M\OV>Z?S);J>?SIB<!?O.#T  'I0!S'@?5O[#^".DZC]GFN&BM/EBBC9V9BY
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MWC,(T8 ;,#'R@#&.G)SF@#S_ %B^OO$WP\T'Q3=ZE<9O-;@?[&NWR8T$Y54
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD0<9"2C##ZB@":BBB@ HHJEJ^KV.@Z3<ZIJ5PL%G;KNDD;G Z#@=220 /4T
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MJFD:]IC^&-5:#6YTGNB+&0,&5RXV_+P,G]* /7?%WC;7;70?A_JMO=I$^K-
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M(H)'4R@AE7 <8CRK<9']: /=/"T%M;>$M'BLU46RV4/E[>A78,'\>M<SXO\
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M=C&JV.KZKK>FKK*:39:"9H[:]>95>] 8XV2')^4#/;..] '8?V1XA_Z&@_\
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MM%BN_C/!IWVN^AMQX9;<8[IQ*X^T]#*3OZD'(.>,9QD$ Z[^R/$/_0T'_P
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M[FU2U6WN5+P2"0,)% R67'4#(Y]ZT+:YAO+6&ZMI%E@F19(Y%.0RD9!'L0:
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M9NF^(-(UB:6'3M1M[F6)0SI&X+!3T;'H?7I6E0 4444 %%%% !1110 4444
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MU2XB,A,IB >1T8<1MEEYP#CT//K]% '+?#Z\U.]\*K)JL$4=R+F=?,BC,:W
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M,%C_ .AUV-8FNZ VNSZ>9;SRK>RO(;Q8TCRSO&V0"Q/0_2@#,^)MEJ%_\/\
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MBSNF]Q$"3O3.4R!D9JA_PMB)=+?5Y/#FIII$%T;:[O"T9$#!]F=H;+#.,D9
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M;Y$8[<K(.BDY;'J$)YKI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ JAJVMZ;H5J+G5+M+6W)QYL@.T'H
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M;:R@SN\NWB6-<^N .M7** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH :J(A8JJJ6.6(&,GU-.HHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N?\8^%8
MO&6AMI%S?3VML[J\A@"[F*D,.6!QR*Z"B@#G9/#5]=3VQO?$=]<002K-Y'E0
MHLC*<KN*H"0& .,XR!6*_P ,;>3P[=Z*VMZAY%UJ']H.^V+<)-P8X^7 &X U
MWE% '+OX)M;CQ!J&JWEY/<C4+$6%Q;.J"-HL'T&0>2>O>J6A_#J/0P43Q!K-
MU#%&T=E#=3!TM005RJXP2%) ST!/%=K10!YWK?A>;P_\*QX;TW^U-1MUD2-G
M@VFXC@,@9R%  ? R-N.<X/%1>'+"\O;H6J7FM7FC3QR1W\&K:8EJA1D(&S"(
MQ;.!QD8W9P<5Z310!Q?A_P"'D7AV53#K^L7,%NK+8VUS.'BM205RJX^8@$@9
MX /2H8?AG;P>'M&T6/6;W[/I%^+^W8I'N\P,6 ;Y>0"S?G[5W5% '/Z9X5BT
MKQ-J>LV^H7>-199)K0[/*\P*%W?=W=!TSCD^V+'B;PSIWBS2ET[5(R]NL\<X
M ZY1LX^A&5/LQK8HH Q4\+Z;%XO?Q,D>V_:S%F<8V[ V[/UZ#Z"LO_A!$\SQ
M,_\ :]WGQ FRY^2/]V-NSY/E_NDCG/KUKKJ* ./_ .$"C\GPU'_:]YCP_C[,
M=D>7PNT;_E_N\<8]:V_$F@6OBCP]>:->M(EO=(%9XCAE((8$>X(!K5HH X*\
M\&?V9_:7B"?6=4U'46TF2Q<.B,)5^8CY$3.<D8"XZ9.<FJ?@#PH]UX1\-2:O
M=Z@Z:<%FBTZY@6(0SJ",M\H9MI)VY..G7 KTFB@#SZ\^$]C<V6H:9#K>J6NC
MWMP+EM/A,>R.3>&)0E"P&1TSC-2ZI\+K34WUP-K>I1P:RL?VN%?+P\B !7SL
MSV!P"!GVXKO** .5'@:W_MZ#5GU.^DD%@+"YC81[;J,$M\_R\<DYVXXP.F<U
MO#OPYM?#E[$\.M:O<V%NQ:TTZXN-T$!.>@QSC)QGIUZ\UV=% &'XH\-0^)[*
MT@DNY[26SO([VWG@VEDD3.TX8$'J>"*S!X#3^T-:O#K=^TNKVBV<^]8SA%7:
M"/E^]@GGWKKZ* .#N/A?9R6.CI;:WJEE?Z3!]E@O[9U25H?[C8&"!77:1I<6
MCZ9%90RSS!,EIKB0O)(Q)+,S=R22:O44 <FW@J865[I\/B+4H]/O9)GG@V1,
M0)6+.J,4RH^8^O7C%6KOP7I4T&E"U\VPN=(01V%U;D>9"@7;M^8$,I'!# Y^
MM=%10!ST'A5)-8M=6U:_N-3N[,-]E$JHD<!;@LJ*!\V.,G/MBI?$WA33O%<6
MGQZ@&*V-Y'>1[<?,R_PG_9.>:W** ,,>%=.'C4^*L-]O-E]CQQMV[MV[_>[?
M2G>*_#5MXLT"72KJ>:!7=)%EAQN1U8,#R"#R*VJ* .(/PSL;F[U>;4M4U"_&
MKVT<%XDOEKYA0?*_RJ,$=@,#(R0:?IGPXL;6PNK34]4U/6HY[9K-/M\^[R86
MQE4P!@G:O/7Y1TKM** .-T+X=66DQ20WFJZGJ]O]G>UAAOYMZ00L,,J@ =0
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MZ(R'(4XR,A=H('&0<5JZ+ILFD:1;V,NH76H/$"#<W;[I9,DGYC[9Q] *OT4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'!"@2*-0BJ.P P!^0KD_A9_R371_]V3_ -&O0!V%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF[353BUGMMC1M\I?DEA@;06SCH..>*LZ]KNG^&]%N=6U.;RK2W7+,!DDDX
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M==B$O*P&2?W)&3@>U %KX:_VSXOTS3/$LWBJ[5UNKF#5+9YWV3!L;%10P$9
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M7KZ"@#J?AI<^*=2D\/:Y+J33:9>PSQ7XNK\R&:8%RICC/"$;<87'R@G%;WQ
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MW5OJ+/'-#(4=3MA&<C\:Z 6/B"#X53^,)?%VL2W4VB(ZV_GE4C?*D.I!'.T
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M+,1]XD@'V[5L_#>WU+Q)INC>(V\67LJ30W%MJEG)<N?,F);;L&<1LH*D;0.
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M/%Y>[#D?>.3U/I7>>"=1U6#XT>)- N=7OKZRBL8KA5NI=^V0B(DJ.BC,C<
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M_P :Z&B@#GO^$%\+_P#0%M?R/^-'_""^%_\ H"VOY'_&NAHH Y[_ (03PO\
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M^%6_#O:!]D\8\'/_ "#KC_XS2M\+_AVP4&T\8_*,#_B77'KG_GC[UZMX0O\
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MDB(ZAJ=K;>:I=/-D"[E'5OH,CGIS7E=QXAU'3]+F\"^*9-^K6]U9-8WIZ7\
MNHL-_O@#D>Q]":WM*4ZA\3_B"M\@D6&RM+:%7YQ"\3,P'L6Y- '?7VJV&F6J
MW5[>0V\#L%1Y' #$] /4GT%)%JVG3:7_ &I'?6[6&PN;D2#RPHZDMT&,'->+
M> [N[U#4?AC'>LTD$6G7KQ;^A=6:,?BJ!0/K5;5)[@)KFE)G^SI?'%O%-'_#
MY;_,P^A95./>@#W#3=8T[6(I)-.O8+I8VVOY3@[3C(!';@@U-:W]G>O.EK=0
MSM _ES"*0-Y;X!VMCH<$<5Q$+M%\>[NWCXAN?#B2S*.CNL^U2?<*2*G\ 0Q6
M^M>,X8(DBB76<*B*% _<Q] * .XHKF?'.NWOA[1(;VTBD,9NHX[J:. S&WA.
M=TFP=<8 ]LYYZ5SG_":Z@+3PU=6.JV&J6FIZR+&2>. KF)LE>,Y1P!@@_7%
M'>:MK&GZ%ITFH:I=QVMK']Z20\#_ !JVCK+&LB'<C ,I'<&O)_&6O7^I>&/B
M3I5V86ATM84@9$VL5=0YW<G..G:M./6?%&E:WH>C7MYI[P:[:2K:2P6Q#64L
M<8?D,W[P8[\<]@." >CT5Y%X5\0:]:_"K0=2;4;,OJ%Z1/<W"?/$C2R%RJ[O
MWKD]%49YZ'%3VOQ"UN3PGJ5_)"S&PUYM.GN8[)B\5LH!,K0YR&&0".V>G&*
M/1]0UK3=*GLX+Z\C@EO9A!;(QYD<] !5^O'?%/B2"[\-^$]:EU6#4K2'Q1"X
MNK6$@F-5D.#&,D,!P1U]N:]&\+ZC<:UI::NUY;SVEX/-MHX8\>7&3PK-D[F
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M05U$4B31)+&=R.H93Z@]*=0!R.K> X-1\#V7A6WOGM+2V6$>8D89V\L@@\\
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MX?Q0#PT%U>Z(\/@BUS&GS@KM^?CGY>.,>M5KWX8VMWI>MZ6-:U&.PU:\-Y)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5Y7\=K/Q->>%;-= 2ZD@6<F\CM 3(RX^
M4X7DJ#G/X>E>J44 >:_!"S\0V7@9X_$"7<;&Z9K6.ZSO6+:O8\@;MV :]*HH
MH *X_4?^2MZ#_P!@J\_]#AKL*Q[_ ,/1WNOV6LK>7%O=6D$D"",(597*DY#*
M?[@Z4 7[C3[2ZO+2[G@5Y[1F:!SU0LI5L?4$BC4-/M-4LVM+V!9K=V5F1NA*
ML&'Y$ _A5FB@#'\6?\B;KG_8/N/_ $6U'A+_ )$S0O\ L'V__HM:LZQIG]L:
M7<6#74UO%<1M%(T(4L592"/F!QUJ;3K&/3-+M+"%F:*UA2%&?[Q"J "<=^*
M+-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4V26.)=TCJB],L<4ZN9^(D$<_PY\1K)&KA=.G<
M;AG!"$@_7B@#HA/"8C*)4\L=6W#'YTY)$E7=&ZNOJIR*Y;PW:VZ_"O2X5AC$
M3:/$2FT8),())'UYK#LO$-_H5GX%T+2]*LY4U;3OD=YS'L>. ,<@*>.0<\D\
M\4 >CUS<FFW5SJ5Q!#XUU&.93YC6L:6A,2D\<&$MCL"?S-8-K\1KDZ%<O=Z?
M NL1ZX="B@CE/E2SY&&W$9"X))XS\OO6/!JLGAKXD>,-7UJ.V M=&AF;[&I
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ME/DW+RXV-D@E1U)Z\#C- '2_\([JW_0Y:S_WXL__ (Q1_P ([JW_ $.6L_\
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M2- UFXT:RCT_4M3&FR!;EFE5FD9 RC;C:-O<Y/H*].H **** "BBB@ HHHH
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M0[K:5,;3R?F^Z,]._K6J?"-WK6I07WB>>TG>WLIK.*.SC9%/G +(Y+$G)48
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M>,?"T_B%--N]/O5LM5TNY%S:3.F]"<89&&1E2/2D7Q?'INEVTOB-(+"]GO\
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M9%R' Y XP<]R/6O78;:WMR3#!%&6Z[$ S^5$=K;PS23101)+)]]U0 M]3WH
M\;\,ZQX=N+.WTCQ%%*_B^RUQYS;HC">6X\TE7!'5 K#.3C:OH!6?XAO=/TW0
M_BEI5Q<0Q7MQ>B>&V8X>165&W*O4CJ21TKW3[/!]H^T>3'Y^W;YFT;L>F>N*
M1[.VEE,LEO"\A7:79 21G.,^E 'DMOI?ASQ%\6X8;N"RO()?#,,H7(*O()?O
M<=6"XYZXK(L)]'U)[C2?$6LW]MXBM]:><64-LGG2S"4F,QOL+$%=H^]@ =E
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M,A+D9! X.TCG!X]:/!>H6%O\4H&&I:88)?#"H@M"%B4K*#Y><G>RJ"23SUX
M&*]B%C9ARXM8 Q&TD1C.,8Q^5"V%FH4+:0 *AC&(QPO]WZ>U '%_!B1)/A/H
M@1U8H)5;!S@^:_!JMXRTOPGXH\0R:9JEVNE:W8P1SVFH1SB*558MC:3C(!7I
MVSQC->@PP0VZ%((DB4G.$4*,_A39[.UNE*W%M#,I()$B!AD=.M 'AMW?7=]X
M-T*?Q%<P7T>G>+XK5-4D0!;BU0D>86/&TG()Z'')/6N@L[K1)]>\;VWB%[)8
MIX(GLS,5"/8^3\OE$]@<GY>Y]:]4>WADA$+PQM$,?(R@KQTXILMK;SO&\UO%
M(T9RA= 2I]L]* /$-"U5- OM"C^(!:.SN?#@@MI+I"R(Q<ET/'#E-@/?@ T[
M7VD75/!-KX.<6LR:=?I8)>$[W0 !>I!!=5)4GU'X>SQRZ;K$+^7):WL44I1M
MI614D7J#UPP_,5,]K;R3+,]O$TJ]'* D?C0!XSXGU?PSX@\ >$K^TMK:UM(=
M=M8KF @*UKRWF(QZCIDGN #3M9T[2(-5\=2:-%9+H9\,D7"VX46XO/G,> /E
MWA0#QR"1W-=_XM\(2:]!ID6G2V=D++4(K]MUON$C1DE5P"..3FNC6SM([3R/
ML\"P#DQA $]>G2@#R>"\MS?_  >*W$.?L,H&7'7[(JC_ ,>X^O%9/A2?1=53
M1+/5]9U"/Q18:IYLEA';(LQN/,.\LX3<4()+$MT'L*]GLUTB_A2XL197$2$J
MDL(1U4@\@$>AS^-6A;0"X-P(8Q.PVF0*-Q'IGK0!RGQ5CNI?A?X@2T#&7[+D
MA>NP,"__ (Z&J'7+CPU-X*T*TUZWADT?4S#;JTK;5BS"SHV>WW0,@C&[K7:2
M(DL3QR*K1L"K*PR"#U!K%\-65C;Z,D&GWT%_I*$BR*$2").04#@D,%Y4=P.#
MG&: ."\*)/X7\877AZP\0-J_AD::]ROG2"3[ 0V%0R#@ C.!Q].,FHGAF^C\
M)>%_'/A(#^W+32K875LI^6_A$:AD8#JPQQWX]0*]3MTT:7[3IMLM@_E$&XM8
MPAV$]-Z#IG'<=JN6]M!:1>5;01PQYSLC0*,_04 >6Z=<>'-5^&?AVR\46L2V
M.KW$^QIWV>1(6E=3NXVGJ,\=<=ZL^ 4OM#\:W_AFUUR37/#T5BMS!-(XD:T<
MOM$)<<<J"<>@& ._H=Y/IUC;AKZ6UMX&;8#.RHI+=N>,GT[TR>P:/3);72FA
MT^1AA)$A!$>>I"\ G'3/&<9STH X#P5K-GI&I>,;G4+H06=QXE>VMV;.UYB
M"HQWR/TKTQF5%+,P50,DDX K.TK0K#1]*ATZVAW0Q,9,R_.SR$[B[$]6)).?
M4UH.B2(4=59&&"K#(- 'B_P^BT"\\':G]N\0-9.=2N>/[3:) -V02FX*0>_'
M(K2:?P]XA^,=A=RPVLMK<^'Y) +A%Q+B8;68'J"@W#/;!XKTW^R]/_Y\;;_O
MRO\ A4ALK0MO-K"6QMR8QG&,8_+B@#Y_T>+2;?X=>";Z,6J7@\41H\^1YBH)
MI/EW=0NW!QTYSWK2O[C1;[4_%6B>*M:OK'4)-4:6""&U1I9X@5-N87*,V<
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ML9+625=T08GAP>AP%Q2Z9XUU*\MO$-M<VEI#K.EWJV<5L&8K*7($3D]0KY_
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M1]9$%Q96<<3:O'IZ6KR'[3)"V!]H&#@*2> 1SCK4EG\/=4M-*\)6/]J6;?\
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MEVC1PL=IW#RV)W#D@D'!S[$4 37OQ%US3]"O[R7009+34(;99)8Y;>.YCD(
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M*1XS]U26/']XUA6OPWU.S\'^'=(AU>U^V:'J'VR"X>V8I(,N=K+N!_C/0]J
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M_@._^%%T'LJG\K.ZHKA?^%O>#_\ G]G_ / =_P#"C_A;W@__ )_9_P#P'?\
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M\:2##HK#KAAFE "J%4  = *X;_A;W@__ )_9_P#P'?\ PH_X6]X/_P"?V?\
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M;W@__G]G_P# =_\ "C_A;W@__G]G_P# =_\ "BZ#V53^5G=45PO_  M[P?\
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M%O>#_P#G]G_\!W_PHN@]E4_E9W5%<+_PM[P?_P _L_\ X#O_ (4?\+>\'_\
M/[/_ . [_P"%%T'LJG\K.ZHKA?\ A;W@_P#Y_9__  '?_"C_ (6]X/\ ^?V?
M_P !W_PHN@]E4_E9W5%<+_PM[P?_ ,_L_P#X#O\ X4?\+>\'_P#/[/\ ^ [_
M .%%T'LJG\K.ZHKA?^%O>#_^?V?_ ,!W_P */^%O>#_^?V?_ ,!W_P *+H/9
M5/Y6=U17"_\ "WO!_P#S^S_^ [_X4?\ "WO!_P#S^S_^ [_X470>RJ?RL[JB
MN%_X6]X/_P"?V?\ \!W_ ,*/^%O>#_\ G]G_ / =_P#"BZ#V53LSNJ*Y;0_B
M#X?\1:DMAIMQ+)<%2^&B91@=>374 Y%"=R'%K<6BBBF(**** "BBB@ HHHH
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MGXUT#2=<LM$N=00ZG>2K%';1_.X+="V/NCZT<B#ZQ/N>7_\ "J3_ - 74O\
MP80_X4?\*I/_ $!=2_\ !A#_ (5ZUKOB/3_#L5LUZ9FDNYA!;PP1-))*Y&<
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M%U+_ ,&$/^%'_"J3_P! 74O_  80_P"%>X44<B#ZQ/N>'_\ "J3_ - 74O\
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MGA__  JD_P#0%U+_ ,&$/^%'_"J3_P! 74O_  80_P"%>X44<B#ZQ/N>'_\
M"J3_ - 74O\ P80_X4?\*I/_ $!=2_\ !A#_ (5[A11R(/K$^YX?_P *I/\
MT!=2_P#!A#_A1_PJD_\ 0%U+_P &$/\ A7N%%'(@^L3[GA__  JD_P#0%U+_
M ,&$/^%'_"J3_P! 74O_  80_P"%>X44<B#ZQ/N>'_\ "J3_ - 74O\ P80_
MX4?\*I/_ $!=2_\ !A#_ (5[A11R(/K$^YX?_P *I/\ T!=2_P#!A#_A1_PJ
MD_\ 0%U+_P &$/\ A7N%%'(@^L3[GA__  JD_P#0%U+_ ,&$/^%'_"J3_P!
M74O_  80_P"%>X44<B#ZQ/N>'_\ "J3_ - 74O\ P80_X4?\*I/_ $!=2_\
M!A#_ (5[A11R(/K$^YX?_P *I/\ T!=2_P#!A#_A1_PJD_\ 0%U+_P &$/\
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MA"T<IP>B[MV.2<]<X J_JWB&\U+XD:MH9FUN&PTNUBPFD19=Y9!NWNV"< 8
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M!.EQHFEZ=+%<:O<HN%C"G<D"8XW''/H!]17;ZP+^&V:YT>PL[K4<>6OVF4Q
M+U^\%8D9QQQ]:X&T^%FOV&FSZ=:_$"]AMKB1Y9_+L8U>1V.68R [\GUS[=*Z
MW5M!UFXU^+5M*\1O9;;;[.UI- 9X'^8MOV[UP_.,^@H P?A4R?9=?2Y$BZ[_
M &I(^JJP 03-C'EX)&S'3G/7->@U@^&/#$?AR.^D:Z>\O]0N#<W=RZA-[GC
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MF21V)R22?<]!@#L!5'Q5X8M?%VB/I%[=7<%K(ZO)]F959]IR 2RGC(!XQT%
M%W2-2.K6/VHV-W9@NRB*[C\N0@' ;;V!ZC-7JC@C:*".-Y7F9%"F23&YR!U.
M !D^P J2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>modificationno14effectiv009.jpg
<TEXT>
begin 644 modificationno14effectiv009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHK*\2P27'AO4%BO+FT=8'<2VS
MA7! )X.#CIVYH U:*\V^!EQ/=_#2">YFDFF>ZF+22,69CN[DUI^-? $'C#4(
M;O4=:O[&RL[<A$LY!&=Q)+LQ((Q@+CZ&@#MJ*\^^#VC#3?!KW@FNI4U&YDN(
M#<ON<09VQ9[9*C=P/XJYFXOI_'_QONO#-_+*N@Z-"TK62N46Y==HR^.HW.,#
MIA?<T >ST5S*>"=-M=>MK^QC%O:I!+!/8J3Y$H<#!\O[H(P><<@UP'P)C62[
M\5S29DDAOO)B9R6*)EOE7/0=.GH/2@#V6BO(_P!H7]QX&LKR$F*Y&H)&)D.U
M]I20E<CG&0#CVI/'_@B36CH5CH$S:??Q:=<30M"Y3S6C,.U6(_WVY[$Y]: /
M7:*\2\)^+H/&^K>&]-UZV$?B33+V2*\C==IE58)2&(]G5<KT# >M=3\:]?O?
M#_PYGET^9X+BZG2U\U#AD5@2V#VR%(S[T >B45X1JOB";P/XYU&QT@"WLY?#
M37"P1CY%N%C8K)CIN^7!/?O5.PU.?1;;X7:O:.PO-6N9(=1E+$M=AY$4^8?X
MB-Q(ST[4 ?0=%?-]UK=WJWA'Q[XIDF<:K9:K"EA<YP]K&)0 B'^$8)! ZYYS
M76_$N"+5?A='XAGT[4;S4;JRAGCEMY&\NRRJ,QVAAA?O$G!//)  P >QT5S/
MP_OX;_X>Z'=17DMTGV15:XF&&9E^5MV2>05(ZGIUK>@O[.ZD*6]W!*X&=L<@
M8X]>#0!8HKQCX[B."\\*7 4HTEZ8YF0'<\>5^4XY8<GCWJ6RTO43X\UV\TBS
MO++PDVF.DT5U#)#'-+L/,<4@!Z]P .#Z\@'L5%> ?#/XBW'ASPIH%G?Z7<W-
MMJ>I26RWS7(RK%E'"')(&X=2.]=SXC^*RZ&^NM#HS3P:+-##<M-<&%W,AP#&
MNPA@/<CUZ4 >C45Y_KGQ3M-,U2ST^VLHY9[O3EU"(75S]G$@;[L2':P:0X/!
MP.V231XB^*,&BZM<Z7;:<MS=V6GG4+Q9KD0"-  =B_*=SX8'''UH ] HK/T?
M6;36M!M-8MG*VES )U,G!52,\^F._P!*\K\2^)M1U'XJ>"8HIC#HL]R\D" D
M&?'R^8WL<G:/3G^+  /9**QO%6N_\(SX9OM:^S?:5M$\QHO,V%AD X.#SS7)
M6'Q6\^_\-)?Z%+8V?B%2+.X-RKG>"!M9 . 2RX.>XX'. #T:BO,Y?C#;)87N
MM1Z2TOA^SU$:?)>"X_>LV,EUBV\KR/X@>>E7)?BC;OXOET"PL$N9(I[>)MUS
MY<CK+C,D:;3O50P)^8'&3C S0!Z!17F6B>+_ !%J?QFUG0I;6$:?I\ 41+-C
M:"5(E/R_,Q!''&,_4G>\>>.E\#0Z;-)IDE\E[<?9\12A65NHP",'OW% '7T5
MY;<?&"ZMYO$-JWA.X^UZ(HEG3[:FWR^,DMC@\C@!N_/%;0^(T5S:^&C9::[W
M.OPO+"D\ACBB"+N8/(%;Z# ]SB@#N**\XL/BS!J'PWU'Q?'I+J-/N/(GM3<#
M.<IRK[>?OKV'>L7Q+XWOO%'P]UF0>&KVPT]])6]MM0DD!5GWJ-HP."#NP<Y(
M7. "* /8:*\Y^'OB*>3P_P"&-&MK=+V5M-2>\F:YPULN< L-IR6YP,\X/0<U
M"GQETV6^5H['=I+:F-+%W]H'F&0KG>(L?ZO_ &MV?;M0!Z917E/A_P :^(]5
M\>>,+.ZLH39:7'Y:P)<E/*VAR&!VDLS8&3QCBLOP_P#$+3?!OPGT[5[#2KZX
ML9]0DMO*N;P/,KG<V=VS!'RGCC\<T >U45YY:?%6$7_B:TU71I["30K?[2ZB
M993(G&!P  WS+QDCGKQ5/2/BU=ZIKWA[3#X<2+^W(?M$$GV_<4C#."6'ECG"
M,< \\<T >GT5@^,O$R^#_#%SKDEHUU%;%!)&CA6PS!<C/N17*'XNQ6^D7.KW
M_AS4[33$LHKFWN9 -MRTA $:]LY)[] 3CID ])HKSQ?BUIUM:ZTVK63VESI=
MO%<O#%*)A*DH7:%8 ?-N=5((X)ZD4EE\3+N3Q)X<T>_T*.W?7;=;J"2.\,GE
MQE6;#@H/F^4<#CGKQ0!Z)17F=W\75M(_%;/HC$^'9HXY@+K_ %P>0H"OR\<@
M'!]:KZMXAT[5/&_P]N;FRO4FOK?[5:&*[PD9D0$K(FWYL<<@C/- 'JE%>9-\
M6;V;5];TK3?"%[J-[I-P(I4M[@$,N\J6'RYZ@<8/4G@ FB\^,NG6M_>[+'S-
M,L;Z.QGNC<!9-[9!9(MOS*I')W#KP#0!Z;17G&K_ !4FTWQ)X@T2'PY+=SZ-
M:&\DD2Z54:(*K$G(R/E8< $YX]Z@L/C"E[>^&%?P]<P6?B!VB@N'N%)616"-
M\@&2H8@9)!//% 'IU%>9ZI\9-.T_4-46.Q\[3]*NX[2[N?M 63>Q(8QQ[3O"
ME>3D>U+K7Q9DTK7]?TB'P[)=RZ-;?:Y)$NU5&BPAR<KD<..!GG\Z /2Z*\A\
M8_$G5V\,^$M0T*U6WBURXC61GD^=/F&8P<<9Y&[T[5NW7Q--MXIF\/#2X3J%
MLL'G0O>;7D:0 D0C9B3:"">5)YP#B@#T&BN)^*/B:X\-^%%6Q<I?ZE<I8V\B
M]8F?.7^H ./<BN+\>7,UEXN\(_#G3;B>STBYV/=M%(5DG5I"""_7G:Q)[ELF
M@#VJBO&OBT%^'MMH?B+PRHL+F.[^SRQ1$B*XC*EMLB]&^[UZ\]>E=-<_$BX'
MC&+PU8Z ]W=W%D+R!_M8C4J5W8;*_+T(XSV_  [^BO$_%7Q>O[[X;6VL>'[3
M['-<7YT^Z,DFY[9PN["<8.1_%V],]-S5-7MA\8_#$&K6%Q;:F+&:6-X;_=!&
MI63=O4H-Q^0\@CJ,]* /4**\R3XQ6O\ 9UOKDVDM'X>N-1.GQWGVC,N<$B0Q
M;>$X/\6>.E6-=^*4NC^)]8T*'P_)>3Z;9-?-(ETJJT:J&).5XX/;/.!WR #T
M6BO*/$GC%KKX<Z1\2-+BDM+BWF0R0%\^;$9#')$QZ,,\@XXQD8KU*UN$N[2&
MYBSY<T:R+GK@C(H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ K@?BC\0;'P7I*VEQ;RSW6HPRI" =J   $L>3_$.,<^U=]44
MMM!/CSH8Y,=-Z@X_.@#YE\$_%JV\)_#R\T"/?'J2[WL[M(_,3>QS\RMC&/\
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MRT9A:00NWRD@D8:0CJ!^5>GK8>*D4*K>'54= +64#_T.E^Q^*_\ GIX>_P#
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M9]U]!(69Y"#E=I,A_F*^D/[.\4;=N?#FW&-OV27'Y;Z:=*\2'^#PS_X!2?\
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MH0;_ "EPF[O@=AF@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "N5\<WEU:PZ%';7,L NM9MK:8Q-M+1MNW+D<C/M755Q_P 0
M/N^&/^Q@M/YM0!4\<ZGJNDBQM+!IQ9L8C+,-RNA\^,*//8[?GSL*GDAB<X!J
M>^UW7!X*L;](6%]<2E+B/[%)$43Y]W4YBV@ [VR..GS"NPGMX;F/RYX8Y8]P
M;;(H89!!!P>X(!'N*>Z+(C(ZAE88*D9!'I0!R/@>]O\ 7/#6S4VN $2%(I=K
MQO*GEJ1)YH.)-W7*XZX/.:F^'M]=ZCX0BN+VXDN)OM5U'YDARQ59Y%4$^P '
MX5TT44<$*0PQK'%&H5$0850.  !T%<E\,/\ D2(O^OV]_P#2F6@#L**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%9/B;5;C0_#6HZM;P1W#65N]PT4DA0,J*6(! /.!Z4 :U%>4?\
M"W[VV\%Z5XNOM!@72+ZY-NZP7A::(AG&=I0!ON'N.U>HK=V[1^8)X]H7>26
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M 9E.\?NQ_M>GXT 345C>'?%&E^*K:YN=)G\^W@N&M_,'1RH!)7VYQGOBMF@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=->98[4X@?"$Y0'J!NZ^^>,UR=E9Z6OA/X>W.R%;F;6)8KJ4-AR@E3Y6/4
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MJUO)KWFP2Q0^7%'N0EDB^9LJ#Z'&21U!K?\ !ECIB_'#Q1I%O! ^FSZ1'F+
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M(;:XBF$;F-S&X;:XZJ<="/2@":BBH9[NVM3$+BXBA,T@BC\QPN]ST49ZD^E
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M\_=7C@=<#MQ6KXQ\-W/B.TTPV=W%;76FZA%?PF:,NCLF<*P!!P=W44 <U?\
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M-$C.OW6*@D?0T^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#*UGQ%I'AZ**35]1@LT
ME)5&E;&X@9-7K6YBO+>.X@D66&10R.IR&4C(/Y&J&L^'M)U^*.+5["&]CB.Y
M%E7(4^U:%K;Q6MM';P1B.&)0B(.BJ.@'M0!-1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 445R^L>*[K2_&NB>'8]-BF&K+,T=P;DIY?EKN;*[#^&#^5 '445SGCCQ)+X
M5\*7VK6T5O//;('$,TI3<,@'& 2>O3CZUMPW4;VD$\C)'YJ*P!;')&<4 6**
M:TB)]YU7C/)QQZU2U'6K#2_L8NKA%:\G2WMU!!,CL<#'KZGVH OT5G+<:G_P
MD,EN]M;C2A;!TG$O[PR[L%2O]W'>N2B\7>*M9TP:OX<T;3;NPDFFAC6>[,<B
M!'*"1CC!!*GY1R,CD\X .^HJ+SECBC-PT<3L ""W&[T!/6G22QQ &214!.!N
M.,F@!]%4)]9L+?6+729+A!?7*/)'"#EMB]6/H.WO3;"XU274M2BO;:WBM(G0
M6<D<NYI%*Y8N/X3F@#1HID<L<N?+D1\'!VL#B@2QE@HD0L>0,\F@!]%%,CEC
ME4M'(CJ."58$4 /HKD-%\3:SXAN(;[3;"SDT1KR:V=FF(G58R5\W^Z067[O7
M!'/7'6/-%&ZH\B*S?=!8 F@!]%->1$SO=5P,G)Q@4-(BQ^8SJ$QG<3Q^= #J
M*YGPGXGN/$5WKT%Q;00G3+XVJ&&4R!UV@[LD#U]*Z1Y8T!+NJX&3DXQ0 ZBF
M[TW[-R[\9VYYQZTGG1>;Y7F)YG]S<,_E0 ^BF-+&GWI$7D#DXY-$DT46/,D1
M,]-S 9H ?137D2)=TCJB^K' I2ZA-Y8!<9W9XQ0 M%-$L;('5U*'HP/!I#-$
M%9C*@53ACN& ?0T /HIKR)&A=W55'4L<"C>F%.Y<-T.>M #J*S]5UK3]&T>X
MU6^N8X[.W0N\FX'IV'J3T [FKQD01&1F"H!N+$X % #J*HZ5J]EK6F)J-C,)
M+1RX27LP5BI(]LJ<'TJXDB2KNC=77U4Y% #J**Y?Q;XJE\.W.AQ00V\XU#4X
M;&7?*0\0D/W@H'/ /4CMUH ZBBLZ"XU-M>O()[:W334B1K>99<R.QSN#+V [
M?YPNH:WINEZ7=:E=WD*6ELA>63>#@>GU/0#N: -"BLNZO-2-YI1L+:WEL;AF
M^U22R[7C7;E2H_B.>M:)EC#!3(@).T#/4^E #Z*8\L<;*KR(I8X4,P&?I5,:
MQ8MKAT99U:^6#[0\2G)1,@ GTR3Q]#0!?HIDDL<*[I75%Z98X%4KC6]/MM2L
M-/>Y0W5^6\B-2"6"J6+?3 Z^I% &A13/.B\WRO,3S/[FX9_*AI8U=4:10[=%
M)Y- #Z*8\L<0!D=4!.!N.,FDEGA@ ,LJ1@]-[ 9H DHHIBRQN[(LB,R_>4,"
M1]: 'T5Q]WXGUB\UO5M.\.V-E=/I!A6X6YF*&9I!N*H1PN%[GN<<8YZ&ZUBQ
ML]4L=,FG47EZ7\F('YB%4LS8]!C&?4B@"_17->$O$\_B!=9%[;P6LNGZK+IX
M6.4N'V!3G) R3N/:NB>6.,J'=5+'"ACC)]J 'T44P2QLP42(6(R &&2/6@!]
M%-$B%MH==W3&>:198W=D61&9?O*&!(^M #Z*Y?QUXJE\)>'VU&WAM[B1)8D:
M*64J=KN%R  <]?:NGR/4<4 +13))8XDWR.J+_>8X%4[S6;"QO]/L9[A1<Z@[
M);Q@Y+[4+DX] %Z^X]: +]%%<O!XJEF^(\GAD06[6PTLWZ7$<I9B?,";2,8'
M4]SV^E '444Q98V9E612R_> /(^M.R,9R* %HIAEC618V=0[=%)Y/X5SUAXD
MN;KQ[JGAV6TACBM+2*YCF20LS[R1R,#'3W^M '244Q98W=D21&9?O ,"1]:#
M+&&"F1 2< ;AR?2@!]%,:6-,[W5<8SDXQGI2[TW[-R[\9VYYQZT .HIGFQ^9
MY>]?,(SMSSCZ4-+&IPTB YV\GOZ4 /HJ@=8L?[=711.IOS;M<F(')6,,JY/I
MDL,>N#Z5>+!<9(&3@9- "T4Q98W0NLBE!U8'BJ]YJEC8:;/J%S=11VD"%Y)2
MPVJ![T 6Z*Y6Z\6RQ>+/#6F0VL36.M033"=I")$\N,/C;C'<<Y/?\>H5T90R
MNI4]"#P: '44F1ZBFO-%%M\R1$W=-S 9H ?129&<9&:4$'I0 45RVO\ C*&P
M\/:_?Z2(+Z?1@1/&TA5 P4,5R <D CCUXR*WM-O1?Z=:W!VK)- DK(#G;N4&
M@"W13%FB=V19$++]Y0PR/K532M8L=:@FGT^=9X8IG@,BG*EE.&P>XSQGVH O
M44P31-(8Q(AD'50PR/PI1(A;:'7=R,9YH =13$ECD9E1U8J<, <X^M/H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KR#XY>-_$?A*#28=#E-I'=&0RW0C#'*X
MP@R"!U)]3CZUZ_4%W96FH0&"]M8;F$G)CFC#J3]#Q0!R'PH\1:MXH\ VFI:S
MAKHR/'YH39YJJ<!L#CU'''%=M38XXX8EBB14C0;551@ >@%.H *\[\5.J_&?
MP""P!\J_')]8>*]$JC/HVE75U]JN-,LY;CC]]) K/QTY(S0!X=KUSI-[X'^(
M UO[(/$<>I2;4N"//6,,GDB//.W;TQQU]:T=1O\ 2=1\1WNG^(]8LK*QN-'M
M1ITMU LB-$R'S#&['"MO[CD[1_=KV&YT;2[RX-Q=:;9SS%=ADE@5F*^F2,X]
MJ==:7I]\L2WEA:W A.8A-"K[#_LY''X4 >4Z=H>D7OQ(T&TN5.I6S^&22]ZG
MS7(650C2*>ORX(SZ ]17.Z?;Z=)X"\ 2WT-L\$7B-[=Y+A5*K%YDWR$M_#P.
M#QP*]VET?3+BZ-U-IUI)<$;3*\"ER,8QDC/3CZ4P:%HXM#:#2K$6S.)#"+=-
MA8=&QC&?>@#AK"WTN;XR:O L5I):7&@0.R;5:.1?,/..A&-OX8KA[6PT[_AF
M/4+N.TMEN"9-TRQJ'8BY(7+#DX!P/:O<GT329+B2X?2[)II 5>1K="S C!!.
M,GCBFC0-&%LUN-(L! S!S$+9-I8< XQC/)YH \SU+4?#LOCG7]-\:3V\5G<Z
M7;+IDMR0%$11O-,;'@,7/4<G:/2LOQ7<:->W3VD(&ZW\+GRY=:8$+&0=IBB.
M"9VP,MD8XX)XKV2;1]+N([>.;3;.1+?_ %"O I$7^Z"/E_"I)]/LKF=)Y[.W
MEF12JR21*S*#U )&0* /&=#&C3^)/AY>7_V"3S- *233[#NF18]H)/5QGC/(
MS46LRS6%A\31IH9$34K7[0(#AE@(7S",>HW9]LU[1_9&F[;9?[/M,6IW6X\E
M?W)]4X^4_2BWTG3;2666VT^TADE!$CQPJI<'KD@<T >?W>GZ7_PL31/[!BM/
M[/O-*NAJ4=J%$3VX"^46"\?>8@'TSVS7%^']/L;3P5\,-5A@C34)=;2%[D?Z
MQHRTH*;NNW@<=/SKW*WT;2[2WFM[;3;.&&?_ %L<<"JLG^\ ,'\:C_X1W1/+
M2/\ L;3]B,65?LJ84G&2!C@\#\A0!S/Q6N)[;PA"X+"Q.H6RZB5[6I<;\^QX
M!]B:I1:=8#XJI%I$%H=+NM%8ZE!"JF!_GQ$64?+D@L!Z@'M7H;HDL;1R(KHP
M(96&01Z$55M](TVSM9+6VTZT@MY<^9#%"JH^>N0!@T <)\%;2QC\#"XM[:W2
M9[NX226.-0S 2MM!(Y( /%<;\2+C3KNZ\=E/LR7MM!:QN]\P>4D#<JVR\%!S
MEFR<GMWKV^STVQTX.+&RMK4/@L((E3=CUP.:CGT;2[JXDN+C3;.::6/RI))(
M%9G3^Z21DCVH \R33-&UWXKW(N8+:]MYO#$<L@8ATD<2E=Q[$C Y[8K!\.:C
M"-"^&$>N/'_83K=B1[DYA,ZEEA#YXXYVY_I7M/\ 8.C>89/[)L-Y386^S)G;
MC;C..F.,>E._L3218M8_V99?9&;<T'V=/+)]2N,9H X+X5OIR:[XVM]->V^S
MC5B\:0,"H4J.5 [9!Z<5FZKH^DW_ ,2/&L=Y:P3*-$CF\N3E=^&^<CIN'&#U
M&>.M>K6MC:6086EK!;ASEA%&$W'ISBJ\FAZ1+-+-)I=D\LP(D=K="SYZY..?
MQH \=T&UM+>/X5:G$!]ONV>.>Z+$R2KY)&QF/)4< #H.@K.OKW3)M1L=2M)+
M6!CXSC,K7,BM>GY\.2PQY<0' 4AN,9/:O<1X?T8"(#2+ >4<QXMD^0YSQQQS
M2OH.CR/*[Z38L\SB25C;H2[CD,W')'J: /%]6T?1[JQ^*MR;6WF-LZ2VSG#"
M)C"&W)Z$GN.M2^)[O3]1:\2=K<WT7A-"TNI.'0AD+ 0(<$R$XR^[CC@U[$?#
M^BGS<Z18'SCF3-LGS\YYXYYYI?["TC=$W]E6.Z)#'&?LZ91#G*CC@')X]Z /
M)6UBQ@_X5W>W]Y:WUJNC%9K*:YB7Y_*0>9F5E0MD[2"=W)QGFJ@M8/"W@GPR
ML]Y8KI4^JR-J4]N%NH4R',*28.&525SV!4=<"O0==\'7MQJEI=Z0=&^RV]L;
M=--U"Q\R"/+;BZ!2-K' !]A6GH/A:WTVSO4NX-/D>^96N(;:T$5OP, ",D_B
M223[<  'E&OV&@Q>$;N72]734+637K27S(%$<$$C,-ZQ%3P<8)P>,BM6X\/:
M&/'7C73_ +#;BSCT:.Y6UQ^Z$NULR%.F\<?-C(S[UZH^A:1):16CZ58M;0Y\
MN$VZ%$SUPN,#\*0Z#HYDDD.DV)>1=KM]G3+#T)QR* /'(-6CBTKX?+K=_#;Z
M/-I+@3W< GA^TC:!O#< A-P!/3)I\NC:(B^"+6RO6U.P.N2QQ3LNU&C*$M''
MCK&&R/3J.E>Q-HNE-8?8&TRS-GG=]G,"^7GUVXQ1-HVEW'D^=IMG)Y VP[X%
M/ECT7(X_"@#P[7M.L;?P;\3[&WM($MK/4H9+>%4&V GR\E!_#QD<=J]KM+?2
M;OP\+:QALIM->-D$4"HT+#G(P/EZYR/7-3)HFE1B<)IEDHN%*S;;=1YH/4-Q
MR/K5J""&V@2"WB2*%!M2.-0JJ/0 =* /!-!N+"W^&G@=!]D6PDU6,:WLV\C?
M)Y?G_P"SD#[W' KNM,DL/#_Q(\1W%M-;V?A]--@GO"K*L$=R68 \<!B@&<=<
MC/45W4>E:=%;36T=A:I!,Q:6)85"R$]2PQ@D^]5KC0[,Z)/I5E;6=I;RC;Y8
MM4:,9//[O[I_'CV/2@"6>]-SH,M]I3I<M);-+:LAW+(2N5P>X/%>%->>'G\%
M^ ;T367]M1Z_;-?R.RBX#[V,ID)^;&X DGCI[5[SIFG6^D:7:Z=:@B"VC6-,
M]< =Z9_8NE?:6N?[,LO/9Q(TOV==Q<9PQ.,YY//O0!Y?J-O8R>,?B-9R7Z:9
M%=:=9J]R!D1EPP+,/3+#/L:Q->W-X.\;:5J>BZ3'J-G9VT_VO3$'D3#<P1PN
M/D?!8'V]AS[4=$TEIY9FTNR,LV?,<VZ;GR<\G'/(S3X-)TVUM);6WT^TAMI<
M^9#'"JH^>N0!@T ><:DFCKXR^&TFF+9+;E[N,&VVA/\ 4G(^7C[S'\2:XR^T
MK3(/AQXLU*.VA%W9>*)%M9Q]Z!1<1#"'^$8/;K^%>['0M';R,Z58GR%"PYMT
M_=@'("\<#/I3!X<T,1-$-&T[RV8,4^RI@D9P<8Z\G\Z /,M2O?#-UXM\9Z3X
MXN(K9Y/)^Q2S$!A;[ 1Y+$'!#Y.!U)[U>TV+1X_C49Y[:WMY)]"MYH!=(JRF
M4R$9YY\S'!QS7HTFD:;,]L\NGVCM;8$#-"I,6.FWCY?PJ1[&TEO([R2U@>ZB
M4K'.T8+H#U ;J!0!Q?Q LI[W5=%:PNM+;4;=+B6+3=43,%VN$5N>SKD8/^T>
MV:XVVGT+4-<^&NJW.EV6GV<UK?HT=R$*)Y8 1=Q ! .2N?7BO8[W2]/U((+^
MPM;H)]WSX5?;TZ9''0?E2RZ;8SK;K-96\@MF#0!XE/E$="N1\I^E '@\U]ID
MNH:1JEI+:V^[QB&D:YD5KT@LP<NPQLBZ (0>,9;M5OQ']BU34?&NC27VFSWE
M]=V_V6^N+R&/[(%"$KAV#X49P4# Y(ZYKV=M!T=GD=M)L2TL@ED8VZ9=QT8\
M<D9Z]:Y&3P3K U6^E,OA[4+>\N&F,VIZ89;B,'&$R' 8*  .G H Y?7FT:/Q
MG?Z)KNI6.G:6VE0IIC7-LKQ&,AO,,;$X1MV.1R<#T%5]:M$MM.CO[&[L=?MK
M'0DCNK#64V326NYR)HF/W68 ]OX5SS@5ZO:>&=*M]&L-,FL[>[ALD"Q&XA1M
MI'<#&%_#&*M7.CZ9>SI/=:=9SS)C;)+ K,N.F"1Q0!C:Y?7T_P -;V_TB*6.
M]DTMIK=/^6B,8\@?[P_F*X>&#36L_AOJ'AH0+J$ES$D[V^WS)(#$3<>9CEL$
M<D]&]S7KU5+;2M.LKF6YM;"U@GF_UDL4*JS_ %(&30!Y_P"!-.TN+XD^.3!8
MV:26UU;B%HXE!B#1'<%('&3G.*7QI;:3'\5_!ESJ4-DL3PWHDEN40*Q5$*;B
MWH3QGIGBN^MM(TRRG:>UTZT@F8$&2*!58YZ\@9J2YL;2\>%[JU@G:%]\1EC#
M&-O5<]#[B@#P/7-/T^7P+\1]6:-'O[3Q)(;:<MEH#YL/*?W2<G)'7 ST%;OB
M2XTC4?&GBG2?%.LVFFQR0PBQ>ZMU?]P8QDPNQ^5@^X\<Y]<<>JCP]H@B:(:/
MIXC<AF7[,F"1G!(QVR?SJ671],G%N)M.LY/LV/(WP*?*QTVY'R_A0!G+!'+X
M#2&5YKJ,Z: 7NDQ))^[ZN.S'J1ZUX_HVD:7_ ,('X#U324C'B)]1@C\Z*3,S
MIN82(W.=@0'(Z "O=-2AFN-,NH+<1^=)$R)YA(7)&.2 :P/ _A&+POX?L[2Y
MM;!M1MXO)>\@B :51TRQ /3C'/2@#SO1=!MDT;Q_K&EV@.N:;JVHII[Q,0T'
M[O;A%!QG#'C') ]!5^*#33:?#?4/#0@74)+B))FM]N^2W,1-QYF.6P0,D]&]
MS7JEGIEAIQ<V5C;6QDQO\B)4W8Z9P.>II+;2M.LKF6YM+"U@GF_UDL4*JS_4
M@9/XT ?/^L7>DWGPDU2XU0V8\5QZN6NEF(%PDGV@# S\VT1\#'& ?2NMU.XT
MJQ\9>/?M,MG%%J&APS0!RH%Q\D@W+_>.<=,\UZA-HNE7%R]Q/IEE+.X >5X%
M9FP01DD9." ?P%/N-+T^[G2>YL+6::-2B220JS*IZ@$C(!H \7T+6M'MIO!<
M7B26U.@OX;\NW>XPT"W88"0-G@,$ '/3)'>K=Y9>%;?6?ATT*PRZ)&]]"MUJ
M 4B2-48IEF'*;LE<\="*]<GTG3;JS2SN-/M9K5,%(9(59%QTPI&!3Y].LKI(
M4N+.WF2!@T2R1*PC(Z%<C@CVH Y#XL74]KX%D>/?]D:Z@6^:/.5MBX\SIS@C
M@^Q-<;?76F6WQ.U&;P@]AY\OA"8VPL2F'G#Y0 +P6PJG'7 %>T.B2QM'(BNC
M AE89!'H156TTC3+!P]GIUI;,%V!H8%0A<YQP.F23^- 'DO@R+POK>H>'+NV
MUN">_%K)#<:?!:*KRJT?[P7/4L PSN;JQ'7-6/!^E?9-6U#X=7%B'L=-U'^T
MEE>,%9+8_/$I/=O,VY]0K"O5+?3+"SN9KFVL;:">8YEEBB56D_WB!D_C4XAB
M6=YUB02NH5I HW,!G )[@9/YF@#PRYETG5[WQ'9^(=>33=:@U=WA46H-WM5P
M8/(<\D%0  /4^N3M>(;B^@\;>.7TIF_M!/#<1BV'YP06R1CN <CWQ7J4FF6$
MU]'?2V-L]W&,).T2F11[-C(I$TO3XKYKV.PM4NVSNG6%1(<]<MC- 'ER6^EL
M/AS>^&5MQ=S2I'.;?;NDMC"3-YF/O8(&=W1CZFN771="F^'_ (SNO*A76+/6
MKE+!T?$L+B1?+6, Y7).,#K7O%MI6GV,TUQ9:?:03R_ZR2*)4:0_[1 R:YGP
M;X+_ +">_GU2VTVXO)K^:\AN8X]SQ"0Y*;F4$8/<'G/04 <+<:/87OB/X@+J
MMK!-<1:);SLDF"!-Y#EGQTW _P 749XZT[0[6TMM4^%&H0@"]OK6875R6)DG
M_P!&'#L>6 / !Z=!BO6GT+2))9I7TJQ:2;/FNUNA,F3D[CCGD \T+H.C*82N
MDV ,/^J(MD_=\Y^7CCGGB@#QG1Y=)UCRQK.O)9^)[367D>WCM5%X\PE(5%8_
M,R%2JXZ #' %5]8T;2F\+_$^Y-I"TUGJ9-LY&3 <1G*?W23U(ZXQVKW3^S+
MZA_:!L;;[:!M^T>4OF8]-V,XJO\ \(]HFV1?['T_;(07'V9,,?4\<]: //K>
M+2E^-=E<WD5DLEQX<BECDF5 9)S. &!/5\8 /6K7Q5M;&?4O!AOE01/K*0R.
MS;?D96RI;L#QFN^72M.22WD6PM5>V4K PA4&('J%./E'TKGO&7AB\\27FAO"
M+)K?3[P74T=R21,-I4I@*1@ACR?RH \UUVWTG0;GQG96D$B^'9FL(S!:3".%
M;EFRREB&"*0%WX!X('<57NDL7M?BG:%]*F L[:>".R11"'$+;FC7)Y7NP[C/
M'2O<1H^F+IQTY=.M!8GK;"!?*/?[N,4L6D:; 7,6G6D9DB$+E(5&Z,<!#QRO
MMTH \IFL]"U'Q-\,[*!+.2Q>UO/-A@*A&;R$)#!>#D]0>O.:IV7A>+7_ (9>
M+],L8D,NF:]>2:;&H!$1C965%'8$9&/]JO7DT'1XVA9-)L5,  A(MD'E@'(V
M\<<DGBIK/3;#3M_V*RMK;S,;_(B5-V.F<#GJ: /%VUF^76=-\=66D(D/B2T_
ML@0>2-WGLH,<C>H,@9?]Q ><X#O&5GHEE>:UHUO':Q2:9X:\E&U J5VX8J+>
M/@^8QQE]W!Q\IKVO[+;^5%%Y$7EQ$&--@PA'3 [8J&XTK3KNY%S<V%K-<*AC
M$LD*LP4]5R1G!R>/>@#R:Y2+2=%\$?$*S@%[+9V=O::D(0'DDBDC5-WNZL1[
M_-@UZ?X=TH:1HT<+11QW$K-<77E@ &:0EG/TR2![ 5F2^'-3EUR%%U&U@\,P
M^6Z:9#:*K;T.X#>.B[@&P!VQ744 >%30:18Z!\5(8XK&WO5GG6)%5$D$11.%
M'7;G'3C-:EG;:;H'C;PM=V<7E?:/#L\MT\)S)<;41@2>K-P<$^GM7J<VBZ5<
MRS2SZ99RR38\UW@5C)CIN)'..V:1-$TF.6*5-+LEDA $;K;H"@]CCCK0!XAX
M8DTD>)O $L#Z=':7,%\DD9D5YV5HR1]IDX#LQ/W=HP<]:[7X/IIEMH.I1V\=
MI'>IJ%R)DB51*$$K!00.<#M^E=S#H6CVQC,&E6,1BD,L92W1=CGJPP."?6K%
MO8VEI+-);6L$,D[;YFCC"F1O5B.I]S0!X)I%]I3:GX,U2TFL[>&;5KIG,\JM
M>E6\S<UQ(,  ]EQP,?,:TM)T*VC\.^/]9TNT_P")WINK:BEC)$Q#0+L (10<
M?=9NW4#T%>PKH.CH<KI-@#YOGY%LG^L_O]/O<GGKS4UGIEAIV_[%8VUMYF-_
MD1*F['3.!SU- 'F7@@>&;[Q'I&IZ-KT,UW]B:*2RLK58OW>,YG .?E;&">Y'
M7->KU5M-,L+"262SL;:W>8[I6AB5"Y]6('/XU:H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M54FN"T<UB8',-R\A;RTA7;SMQU3/ .X]37H&K.Z:%=DQ22RFW8;(4+LS$8P
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M>:,D?,,$'W'(KA-)T>\U_3Y-.G\%2Z-J4=A/:R:E=2;E1GB:/]R<DG)()[
M\DXK9\%ZCX@DATC2=3\(RV4NE0>3<7\^UDVJFW]R1DDMA<XXQGKQ0!HZ'XET
MNUTN\N_[8O\ 4TGU:6WB6:W82K*?^6")M!PN#U'8^E+X@\1:?=>'H+AM3U/1
MUDODMQ*EJXD\Q9,&-@5.T$\9. :XZPT=Y_#NH66KZ!K7ES>)+B\CEM4:.>W1
M@S1SICDD$;<=1NZ=,KJ.G>)Y?AY'97MOJ&I7,>N)+;,T'[][6-U(>4#HV >O
M)XH ]$U/Q=I6E7%W!,;F5[.(37?V:W>46Z$$@N5!QP"<=<#.*AN_'6@6EU96
MQNIIIKZW-S:K;VTDOGIC/R;5.XX[#FN=M(M0\/>)?%;3Z3?7]IK12YLY;>'?
MEO+VF*0?P8XP6P,=2*S-#\-ZCX=U[P';3VES,FEZ=<17=Q%"SQQR2X(7('/.
M1D>W2@#M;;QQH=YI-MJ-K-/,ES<-:Q0I _G-*N2R;,9! 4DY["M?2]2@U>P2
M\MTF2-G=-LT9C=61BC J>1RIKR;3M$>;P_/9:OH>N(&UVZO8;FS1XY[4-DQR
MICDYR1CDC/2N^\!0ZW!X9$6NR2R7"7$HADG4+*\.X[&D Z,1R>_//.: .<N]
M9N/$_CG6M CU'5]+AL+:(036T#H%F;<S22$KC;A0!NPI&<>M=-9>--'FETZV
M-Q<_Z=\EI=36SQQ73 9^5B .1DCU[9KEO[)U#4_&7CV!;6\M8-8T^*UM+UX6
M5"ZQ.C<XX&6Z]\<=J@@T[5M<\.^#M!GT>\LKS1;ZUEO)9H\1*EN""4?.'W8&
M-N>O.,4 =;IWQ \/:KK(TFTN+A[S[1);%&M9%"R(NXAB5&W@'&<9VGTK1U?Q
M'I^BW5I:7'GR7=WO,%O;PM*[A!ECA1T&1^=<[\.[6ZM+GQ6;JQN;;[7K<]Y
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M#G@].>@-10_$?PW<VWGP7-Q(&FB@B5;63=,\@)0(,?-D!N1QP:XQW:[T/QE
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=]U% 7<",DG;@'')YP 6Y=<U35_&&K:!H]Q;6G]E6T3S33P&4O+*"54#<,*
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M!CYX/3U'0]P:ZOXC7<<&BZ?;-=W<+WFI6]ND5KP]R2V?)W;EV*P!RV>!Z]*
M.PJ.XN(;2VEN;B18H8D+R2,<!5 R2?PKQ%M=U+1=+\26T]S+;6<?B*UMIS'=
M/*+.VDVF79(<,!VSQC=QBM7QUI>D6_@OQ>EEK$MW%+:PW<=BMRTD=J5.W<"&
M/#]<'@E<]N #TJ[U2XBNM,2TTZ:\M[QR)+A& 6W7;D,P/)!Z5IUYKJ<9T[Q%
M\.[>TNKQ+>=YDEB-W(RR#R"PW L<\DXSTK/LY;S2O%GB#P-/=W\LFJRQW.FW
M#W$C-';/_K0KDY7RPK;>>3B@#TI]0NU\01Z>-,F:T:V,QO@PV*X;'EXZYQSF
MH+_7&CT-]2TBRDU<B3RUAMW +X?8Q!/'!!_*N3O82_Q=;27N+LV$WAJ1FMS=
M2;=WG*N0-W!VC&1R>?4UQ=DC:?\ L[:5?V=U>6]PUQ"6:.ZD4<W.TC&[ !!/
M'3OUH ]WHKR75IKOQ+XG\5Z7+K5MIEQ8M&EH9;F2)[>/RU82H%8 Y8DDG/8'
MC%5_$-Y?Z?++KFI>9K>B"WM%DO;"Z:*73Y BL7\G(!#EU?'7# 'B@#V%F5$+
ML0%49)/85S.A>++G7I[*:#0[A=(OHWDM[_S5. IXWIU7=U')]\=M+Q)!%>>%
M]2CD+[&M9&^1V0\*2.5(/:O*] E^P^%?AQIJ/<16&LR8OI%N9!N98R4C!S\H
M9CT7&=N/6@#VFBO&_$+WFE1?$/2[.]ODL+2P@O+;%S)NMY75MRJ^<[3MSMSB
MO0O!NC+I>C17'VZ^NY;V**:5KJ<R?/L&2H/W0>N!QZ4 =%17C3W-[XC/B"Z;
MQ'::3J&FZK(JR23R"2VBB?Y5\L,%964'L=Q)ZFJGC#4;ECXCU;3;Z\E>RU>V
MM_M37#0BV8-&K0Q1@D..3N+!0<_Q8S0![A6%;^)DG\;77AHV4L<L%FMX)V92
MKJS;> .>N>N.G2N*GFM?$OB+QEINK:W+I5U8/$EBZW)B^S1; PE49 .6R2?3
M X&*BNK"WU[XI7@:\N_LS^%XI T$K0-)F1BI)7##UQQSU]* /5Z*Y'X97USJ
M'PST.[O;AYIVMCOED;<QPQ ))Z\ 5Q_AWS[?6K+1?$=K<276HVEQ]GU:UOWD
M@U)" [$C(*-MP1CUXP#0!ZO:7EO?VXN+699H2S('7H2K%3^H(J>O#?#(@A^&
M/@BTCN;W[1J-X3]CAG8+=;#)E&8L/+0<$[0<X^Z34UM?ZW'\.O$$<5Y*'M/$
MSVAC2Y9W^S^8@,,3MAB?F('0G/O0![917D=^VKZ'9^-_$FF_VG!I\=K$-,AN
M'E548KB:00N>,9!!*]0<<5L^%K0Q>);+4+3Q'9S65Y9%/L4%Q+/YY'S"7+L<
M$=">^<'DT >AT5Y]\1IIO#^I^'_%8NKI=.L[L0:E"DSB,PR#:)&4'!VL?3N*
MY[1;[4!K]]X3O6U!#K-U%J6GNUS*7BLR2SH6)RA"Q[<9X+]\4 >H0ZG<-JVH
MVUQI\EM96D:.E](Z^7-D$M@=1MQSFL^Y\76\/B'P]I<5M)-%K<<DEO=JP" )
M'OZ?>Y&.PZUY_P"(D:YN?BO93W-U+;6^FV\T,3W,A6-C#(YVC/ W<XZ>U+-I
M<,FJ?"JS2>ZBCFM;EG9+A]_-JA(#$DJ#TX(P#QB@#V&BN%^&$DPL?$=E)<SS
MPV&O75K;^?*TC)$NTJNYB2<9/6N)^(.H7)B\9ZGIE]>23:;+:QBX-PT"V+ H
M"D2J3YA))+%@HY[XH ]BUG4?[(T6]U+[/)<"UA:8Q1D!F"C)P20.@INA:JFN
M:!I^K)$T27MM'<"-CDJ&4'&?QJOXL_Y$W7/^P?<?^BVKR_3;"XT30?AQJFF7
M^H-=ZC+:6=W ]RSQ26[Q$L/+SM4(%X*@8ZG)YH ]HJCK6I?V/HE[J7V>2X%K
M"TQBC(#,%&3@D@=!7CTVI7L'PUOY#J5XMU;>*&MHW:Z?S%03J-F2<D;<\'M6
MKJCIXEN?B/#J<TX?2[8QV=N)V011^06\P*" =S<Y.>,#I0!Z5H6JIKF@:=JT
M<1B2]MH[@1L<E0RAL9[XS6A7C]A=7$>C_#2.=IY='DTYA=6MJ'>1W$(V,43Y
MF0'T! )&>U0L^L^&_"FC0ZI>W-M'JFLM%-)J%Y*?*MOG,4;'=F/.%S@CC@]Z
M /7[R\M]/LY;N[F6&"(;G=N@%3UX?XPT<VO@[6HKC6H[^)-1L[BWMH)Y&6S#
MR!6&XL<@X) /W>HQFO5/$1ETKP/J[:>9/.MM/G: L[.VY8V(Y)))SZF@!G_"
M3_:K/5;G2-.GU%+'*1F)E5;F49#)&3UVD8+=,Y S@UM6TCS6L4LD30NZ!FC8
MY*$CD''ITKR^0?8_V;H);&XG@DBTA)EE@E:-@Y +<J0>I/%.CLFU?XFV>G75
M_J/V*X\+I<2P1WLJ*TGFJN1AAC@#IC..>IR >IUB>+?$2^%/#-YK3V<MVELH
M9HXV53@G&<GMS[GVK%^$M]=:C\,='N+RXEN)\2HTLK%F8+*ZC)/7@ ?A7G_B
M%X_$OPW\=ZKJ,T[:C::C+ D1G8"VC210B; <8(SGCDDGZ 'L)U2Z.K6%M%ID
MTEI<P-*]X'&R$@#"D=23FM2O.GDE;XE>&K87=TMM=:),TD*W#JA(" $ ' .#
MU&#7&Z5+>Z9\)!XL_MG4WO9)7LY9)KMWCA@:[VLV.NX '#=1O/H, 'N](S*B
M%F8*JC)). !7CFNW&H>%]'UW5-,\0V\D-Q8Q,EI9323>2/-1&N%9F;;\CGIU
M.#V-:?B#3-"&@>(GTW6YKB"[T&69+!+MY$S&N1-G<2"=R@@\'OF@#TNTNH+Z
MS@N[:026\\:RQ..C*PR#^1J:N<\ VT5MX!T$1&0A[""1M\C/R8USC<3@>PX%
M<5H5Y9:_I\^L:GK\^GZS8ZW(9U6X8%$20JMOY><%63 P <D]SF@#UBBO)M\O
MB#0?'VI7M[=V^IZ7>W4=HT=P\?V5(4#1;5! P2"2?XLFJ6N7NM2Z5#X@U2TE
MU'3VT:W-]%9W;07&FRE2[S+&" V=P///R]@#D ]?^V6_V[[#YR_:O*\XQ=PF
M<9/MGC\#Z4E[/):V<L\-M)<N@W>3&0&<=P,\9QV[UYC:V]I-\4?$NHVUU):E
M]#ANH[EYW"QE@WSL"<$ 8.#P,=*M>!9[G3O%":'K6FW%IK TXM]H2\:XM[]%
M9091N.5?)Z8S\W/:@#T"PU.UU72XM1T]_M$$J%X]G!;_ &<'&#D8(.,'KBN?
MTWQI/K'A(ZWIVA75Q*+IK?[&LB[_ )9-C-GIQU_SFLWX;2R#4_&EJ"?LT.O3
MF(=E+ ,P'XG./>N)@FGM?@TES;75Q;RIK[+NAF:/(:ZP0<$9&#T- 'NE85QX
MF2W\:67AMK.7?=6LERMSN79A" 1CKGGVK@-5LGOO%GQ"AFU'4Q!9Z;#<V\27
MTJK'(8I&W##< $9V_=YZ=,86H:_J]H_@O6[>&2_OAX9>28ELR%3Y?F./[S 9
M.#UH ]YHKRW6M9LH=.\'P:1J6-$U:=_-N[RZE(D*QDHCR;MPRW49'*X/&16?
M>3WFAK8:)-XA%SI^H:_'',]O._\ HL+*6^S^:6+ ,0.^0"1WH ]$TOQ,FI>*
M]:T'[%+!+I:PL97=2)1("00!T''?U[5O5YOX.L;?3/B[XTM;4.L7V>R<*SE\
M$JV>22<<UZ10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8NN^$
M?#_B5X7UG2;:]>#_ %;2KRH],CG'MTK:KGIO&>D0^,XO##3K]M>W,S$G 4[E
M"I[LVXG';;[T 7-0\-:-JBVJW>GQ,;08MV3,;0C&,*RD%1CC .*BN?"6@W=O
M8V\VG1^38/OM41F01-G.X!2/FSWZT\^*-#74%L#JEL+EI?("%^#+_<STW?[.
M<UJ2RQP0O--(L<4:EG=S@*!R23V% &*_@W0)&U%GT\$ZD +T^:_[\#H&^;G_
M  XZ5S>I>!S=>.=%F330=#T^Q>U!%T5>,L05*\[@ !CKT..E=7:>)]$ODNFM
M]4MG%HGF7&7V^4F,[FST7 )STI=,\2:-K,DD>G:C!<21()'16PP0]&P>Q]>E
M $-SX1T"\TNWTR;3(C8V[^9% I955LYW8!&3G)R><DFF7_@KPUJNJ0:G?Z-:
M7-["%"32IECCIN_O8]\T^'Q+I6JF>TTK5K62]$!EC ^;Y>F\#(WKGN#CWK \
M ^/+36_#>B+JVK6?]NW\;L;<,JLQ#,!A1TX'2@#I+CPSHUUK!U>73XCJ)B\G
M[2"0^W!'!!X."1GJ,]:KQ^"_#L6C#2%TJ'^SUE\Y("6(1_[RDG*GW&.I]:U;
MZ_M-,M&NKVX2"!2 7<X&2< >Y)( '>N>U?XA>']*TR&]^V+,LUVMFBKD'S"5
M#9R. H;)S_,T :$OA'09]'DTF73D>QED\R6(NW[UO5SG+G@=2>@]!4D7AK28
M=6BU5+5OMT,(@2=IG9A&/X>3T[X]>>M17GB_P[I[HMWK%I$6C6;YGX",<*Q/
M8'L3BK6HZ]I>E%!?7T4+.C2JI.247[S8'.T9&3T&: ':KHNFZY;);ZE:1W$:
M.)$W<%''1E8<J?<&H&\,:,^CR:2;%/L,K%I8@S#S2>I<YRV>^2<T+XGT)].7
M4(M7LYK1I/*66&82!GQG:-N<MCG'7%7-.U*RU>QCO=/NHKFVDSMEB;<#@X(^
MH- !86%MI.GQV=C"4MX5VQQ;R=H'11D\#T'05P_@OP)'9_VC/KVDP_:I=3EO
M83YWF(59MR;E!VEE/<@XXP:]"HH S;;0-,L]8N=6@M=E_<C;-/YC$N.P.3C
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MJ+W]SID,ES(%$K<@2A>F]0</C_:!HO\ PGH6IWDEW>Z='--*H24EF D4=%8
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M11F5P>8U)4]?3/>NKTO2XM*MWC26:>65_-GGF8%Y7P!N;  Z*!@     5>H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***XBZUO6G^+,/AX6]F^E'2GN61I
MF!=3*B%F&P@D8("]"&)+=@ =I'+',NZ*177)&5.1D<$4^O&/ _BF[\+^$-/5
M=&232IM;ELFG^T!&0R3, 4C"G*CH<D'T'>NHUKXF)ITVHM96,5[#IUR+:>,3
MD7$C @.8T"$';N[L,X;T!(!LW?@BRGU>YU*UU+5M.FNV#W*V5X429@,!BI!
M. !QCI6[86%OIEFEK:H5B4D_,Q9F).2S,>22222>23537-:CT3PU?:TT,DT=
MK;-<>6O#, ,X]OZ5SR>.V@\/WVM74-C<6<20FUDTZ[\Y9Y)&*B/)5=K!MN?0
M-GVH [4D 9)P!3(I8YXEEAD22-AE71@01[$5S7]LZSNU>SU3P_&$M[,3QRQ7
M!:"X!!W1[B@PPQSP>#6#HWC;3K#POX;MM,T^TL6O[1KB*UFN66*WB4\Y<*22
M68 #'/)[4 =1KGA.RUR^M]0:ZO[*_MT:*.ZL;@Q/L)R5/4$$@'D=JN:3HMOI
M"2&.6YN)Y<"6YNI3)*X&< D] ,G &!R>.37&Q?$R\N+70GB\.N9M3O)+)HWN
M=@CE4$Y!*_,A !W<<=B>*H>(?B%KJ^!O%%Q;Z?:V.J:/="SG(N3(JA]H$D9V
M#)^<<$#'7GI0!Z@TT22QQ/(BR29V*6 +8Y.!WIDMY;031PS7$,<LGW$=P"WT
M!ZUR&I:BJ^.?"-IJFAVKZA<)=-;W<=TS_9F6/+@90;MPVC)QU/''/*:?:-XC
MU#QU+X@T'3M0CMKP!E-V^^/RH@52-O+!"]3G*\D\'/(!Z[%+'/$LL4BR1L,J
MZ'((]C3ZX'PYXIA?0_#6F:!H]O!/?V+7<=H]P5BMH5(!RP4DDLP X]3QBNJ\
M/:E>:MHD%YJ&F2Z9=L666UE.2A5BN0<#(.,@XY!% &I17F][\3-2M+'Q!>CP
MY&UMH5[]GNF-]@LGR_,@V<M\V<' QCD]M>T\;3CQ/)I6JZ6MC VFMJ<$_P!H
M\QO*5@")%"X5N<X!8>] '8TA(4$D@ <DGM7 Z=\2'U#4M*ACTV*2VU56,#PW
M#/)"=NY!,NS"[AW!.#QSUJ/2/'&K>)-"OKZ3PI&-+2&Y61FOP0[1G!3&W.TK
MGYL=01CH2 >@12QS1++$ZR1L,JZ'((]C3Z\KL_$NI1O\/++0=,LK/2]4@EE%
MJURX(V0LWEEMAPHW!LX)) Z=3W_B/5KG1=$EO;/3IM0N%9$CMXLY8LP7)(!P
MHSDG!P!0!JT5YV_Q-FBTOQ5.-,M+F?P^8C)]EOM\,RNN<J^S.1@@C'45HV/C
MBZ;Q)!I>JZ3'8P76G-J$$ZW7F$(N-PD7:-IP<\$B@#L))8XMOF2(FY@J[F R
M3T ]ZCO;87MC/:F62(3(4,D>-R@C&1D$9^HKR3Q5K5YXCC\!:VVE6UOI]QXA
MM6M9C-NG"%CC<NW"A@-Q 8XP/P[CXC:UJ7A_P'JFIZ4L/VF&/[\K$>6"<;E
M!RPR, X'Y8(!J^'-!M_#.A6VCVD]Q-;6P*Q&X*E@N<XR ,BM6N(O?&\^FO;:
M8\%A_:OV(7<RRWC"(*250!_+RS-@_P ( QU/&5TWQY/KR:7!I6E;=1O+)[V6
MWO93$+=%?RR"0I))?(' X!/'2@#LVEC1T1Y%5G.$4G!8XSQZT^O)]?U&\O\
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M[@MK?%X;F(CYOGV<$'(QCTYK"GDGM?BEHESH6C02W,_AH[8#,(D5=ZXW/@G
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M:M::AIPBUC3[N"T%K'-N2=I_]2RN5& ><Y'&#UJQ=>,KW1+;6)=>T?[,ECY
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MBVQ^8BP&--F ,'@#\_\ 9Z5JS^#M4OO$FEWUV+$6=OI4FFW,:3N78. &9?D
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M _4Y .FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]M<2>>P,\9E<%7Y^;A%ZY_6DUA+V5/B7*=:UA3I+)+9+'?2((F\G?Q@\C/\
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M.IQIE9,H#@E1SOQU'<E:K:Y>I/X.\'7NB>(M3=-0UVVBFNUNWWL)"V]2I)
M(P$.0,8YYR >NT5XMXBU+5O VK>)+#3M4OY]/.GVMSYEY.\QM'DG$3$.V2,K
MN;OSSVK2U&SU'3=,\17</B%5M9M"FN+>UM=1FG=98QD3I(QRHY (!P>.M 'J
M%W>6]C"LMU,L4;2)$&;N[L%4?4L0/QJL^HSIX@BTT:;<M;O;M,;X8\I6#8\L
M]]QZUY%K'AU?^$1\%ZI=ZKJM[<W^I:6TAN+URL98?,4 (VDY'/7Y000<D]7>
MSW-E\5?L,.IW$-H/#4LH6XN&>*-UD51(0Q/( Y)Y/.>M 'H5%>+0:_JWA>RU
M*#4+*_M_$=MHDTT<S7KW=K?;2N9UW$[6!YQCH3["ND\+VUZ-<T?58O$%O)87
MEJR/;"^EN3=MMW"0;^%88.<8]* /1:*XGQO<&3Q!X;TN.ZNVFN)9W_LZWE,(
MN@L?624,"B(3NXW$],&N#L=0U>Z\)>#S)K.HQS/XF:PE>.[<EX=\GRLQ^_C:
M "U 'N583>)HD\;1^&&LYUF>R:\6X)78RA@N  <YR>X'2O,-2US4?#%KX^L;
M/4KXP6E[8PP37%PTSVJ3JOF,'<DCJ<<\$@UO6^F6NE?'+35M);AXYM!D.9KE
MYLXD'(+DGF@#TZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LG7_#&B^*+
M1+76].AO(HVW('R"A]B,$?@:UJ* *FFZ98Z/I\-AIUK%:VD(Q'%$N%7_ #ZU
M;HHH *SGT.PDUM-8:.4WR1F-9/M$F AQE=N[;@D D8Y(!K1K+UC7=.TE1%=W
M\=M<2QLT0*EVP!RVP<D#(R>E #+SPQHU_I4VESV0^PS2O++!'(T:R,S%F+;2
M,Y))P>*JS^!O#=S_ &?Y^FB4Z>GEVQ>:1BB?W#EOF7_9;(]JR? ?C!M1^'.F
MZYK]]&;BXEEC,@3;YA$KJH55')VJ. ,\9KH5\3Z(^CC5EU.W-B7\L3!N"^<;
M,==V>-O6@#/7X?>%TT^UL$TS9:VL_P!I@C2XE4)+V<8;J.Q[9.,9J9_!.@2#
M4@]G*PU/'VT&ZF_?X_O?-^'TXZ5S>A>,IM3UCQS%-K5O%I^F" 6EU+"(UMRZ
M-DL&P3A@!SUQ[UTEEK]G8>'-+N-4UF&[DN8%9;F./'VD[<EU1<G&.>!Q0 ]O
M!V@//IL\FG+)+IJ>7:N\CL8USD*<GY@"!@-G&.*IVWPW\(VC0&#18E-O,9HO
MWCG8QSG&6^[R?E^[[5HR^*]!BTZTU!M4MS:WG%LZ-N\X]]H&2<8.<#CO69J7
MQ$\/:>-&9+U+F/5I=D$D)W(%YW,2.F",8ZY^AP 3R^ O#<\-_#+82/'J$@EN
MU:ZF(G8'(+?/S_\ J]*M#PII U1-3$-Q]N2W^RK/]KFW"+'W<[NG?Z\]>:?>
M^*=#TZX6"\U*"%SLSN)PN_[NX]%SVSC-9_C'Q59Z'HVI)'J45OJ<5F\\2F,R
ME.#M+*.@)& 3@4 *GP_\,QVEO:)82+!;7'VJ&-;N8".;^^/GX;W]SZFJGB7P
M3#=:3KCZ-;0?VIJJ*ER;R:1DG4$?*V20#M!"MCY<\8K7\'ZC<ZOX,T74;QP]
MS=644LKA0-SL@).!P.:D3Q/HKZHFFKJ4!NW=HTCS]]U^\JGH6'< Y% ''>&O
M!+6>L6=[#X;A\/?9GW2/#JLEP9EVD;-G"[22#D^G [CLM:\-Z1XA^S?VI9K<
M&U?S(6WLK(QX."I!Y[CH:X>^\77FM>)-?T[2?$::4NE)!Y#&T$J3N0S2>9N4
MG   &TCN>:D\,>*[WQ#;1^)F\1V]KID5Q,+NPEMU""$.R1%7QN#G )Y(). !
MT(!T/_"N_"@&$TD1C[3]K"Q3R(%FR2' #  C)QCIDXQFKR>$]$2\U*[-EYDV
MIIY=Z997D6=<8 96)!P.!QP.!2Q>+-!FM;VY&J0)%8X^U>:3&8<\C<&P1GMQ
MS6-JOQ0\+:?ISW5OJ<-ZX>)!% Q8YD^[D@<#&3D^F.O% %[3/ /A;1KZWO;'
M1XHKFV!6&0N[F,'L-Q./;T[5H:OX=TO79;234K=YGLY!-;D3.GEN.C#:P^8=
MCU%37.KV-GH\FK33@6*1^:90I/R^H Y/TK*T?QKI&J^&+?76N$MK>8A0LA^8
M,?NICNQ&.!F@![^"?#\C:F7LI"=4 %[FZE_?@= WS?A]..G%,F\!^&;F6TEG
MTM97M+?[-$9)7;$74(<M\RC/ ;.*U=,UC3]9BEDT^[CG$3F.4+PT;#^%@>0?
M8U2U/Q?X=T:ZEM=1UFSMKB*+S7B>0;E7( )'U(X]Z *]GX$\-Z?/836FGM#)
M8*5M62YE'E@]<?-SD8!SU  Z 5&_P]\+R6;VCZ86A:Z^V$-<RD^=SF0'=D,<
M\D'GOFM)?$NBOI-OJD>HP265P=L,L9W>8W/"@<D\'@#/!]*KOXT\-1V5K>/K
M=DMO=.4A=I0-[#J/;'?/3O0!SWB7X>V1T:6#P_HFG/\ :+R.XO;:>1D%PB\E
M4;GRV)"\@#I3/#'@H6E^;D:(N@VYA>*6WM]5EG:X# 8SC 0#J".<^G==?^(.
MGR7_ (>L-)UB*.#5GE:2^B02&.)$8_*&!7)8!>0<<\5L6?B*TT*S%EXC\16M
MS?0OB6Y$7EJH9OW?F8^5&*E>N* )(/ 7ANVAL(8+"2.+3Y#+:(MU,!"Y.25&
M_C/]3ZFLOQ/X%AGT34(M$L+:6?4+F*:^AO+B0K=*K!BNXEMC'  8#(]N,;>I
M>,_#>CW<EIJ&MV5O<1H'>-Y1E02 "?S'\ZCE\=^%86(DU^P&V<VY/G @2#&0
M3VZCGIS0!S_A3P<VG:U;ZA#H$7A](-PDCBU.2Y-R"I 4J<*%!(;/)RHZ<UUN
MI^'=+UBZANKR"1KB%"D<L4\D3*I()&48'!P,CVHL/$>C:IJ5QIUCJ5M<7EN-
MTL,;Y91G&?<9XXZ&J7B7QCIGABXTVVO7/G7]PL,:@'"@GYG)QP ,_7\\ $MQ
MX.\/7*Z8LNE0%=,!%FJY41 XR, \@X&0<@U2_P"%;^$=Y;^Q8LFX^U#]X^%D
MYY W<#DY X/<<5D6?CJ+3O&7BJT\0:Q:PZ;9&T-F70)@2QLY''+=N?;M777W
MB#2=-MX;BZOHDBG0R1%<OO0#)8!<DJ 0<].10!6M/">CV&I7VHVL%Q'>7ZA;
MF47DV9 !@?Q\8' QT[8J;0O#FE^&K62UTF!X()',C(T\D@W'J1O8XSWQUJTF
MJ6$FE#5([J)[ Q><+A&W(4QG=D=L513Q9H$D%C,FJV[1:@_EVCAOEG;.,*>Y
MS0!#=:%+#XLA\0Z=M\Z2$6E["QVB6+=E7!_OH2?J"1QQ44O@+PW-;W\$MA(\
M6H2"6[1KJ8B=P<@M\_/_ -8>E:4^OZ5:B[,]]%']D=8YPYP49ONKCN3Q@#KG
MBJX\6Z ;"[OFU6V2WLVVW#2-L,3$9 8'!!/;CF@!\7AC28=9AU=()C?PP"W2
M=[F5B(_[IRQ!'?GOSUYJ;6]"TWQ%IQT_5;?[3:,P9HC(RAB.F=I&>><'OBN1
MU[QS'+J?AY/#NL6L\$VL16-\D:ASM=6;&3T^[V_/BNTL]4LK^:XBM9UE>W<Q
MRA0?D8'!!/K[4 4XO#&DQ:RNKK;R&_6 6WG/<2.3%_<(+$$=\'OSUYJ/3?"&
M@Z3=)<6.GK$T99HD\QVCA+?>,:$E4)R?N@=:VZ* .;O_  #X6U2]N[N]T>&:
M:\V^>69L.5Q@[0< \#D#)''<U++X*\.SW$DTFG F39YD8E<1R;  @:,-M8 *
M, @]*WZ* .>U7P)X7UO6(M6U+1;6YOH\8E<'YL=-P!PV/]H&MJ]LK;4;&>RO
M(5FMIXS'+&W1E(P14]% '+P?#KPI:M$T&DB-XH6@1UGDW!#U&[=D^V>G;%3)
MX&\/1V^GVZ64BQ:<_F6:"ZFQ"WJOS<?_ *_6NBHH YG4/AYX3U2]NKN\T6"2
M:Z(,YW,HD((()4$#.1UQGKZFNA2V@CM5M4A06ZIY8BVC;MQC&/3%2T4 8&A^
M"/#7AN\N+O1]'M[2XG&V1T!)QUP,D[1[# I]AX/T#2[M+FRT]8FC=I(D$CF.
M)FSEDC)VH3D\J!U-;E% './X%\.R6E_:/8R-;ZA+YUW&;J8B9_[S?/R?\!Z"
MIYO"&A7%_:WTMD6N[6#[/#.9Y-ZH#D#=NR2#R"<D'D$&MRB@# 3P5X>C\.3>
M'AIJG296W-;-*[+G(;().5Y&>".>:;9^!O#5A<2SV^D0B2:#[/*7+.)(\$88
M,2"<$C)Y(.,UT-% &!HG@CPUX=2[32='M[87:E9\98NI_ARQ/'L.*@D^'GA.
M70ET6318'T]9/,6)F8E6QC(;.X<<<'IQ7344 8,O@OPW-X>BT%](M_[,A;?'
M  1L;^\"#D-R><YY-51X5M?#]M=R>$],M+;4[W;&]Q*S$* ,;VR26P!G ^\>
MIY)KJ** ,OPYH-KX9\/V>CV99H;9,;W^\[$Y9C[DDG\:A'A'0/[0U"^.EP-<
M:@A2Z+Y9900 <J3CD 9P.<<UM44 9&D^&-(T.3S+"T*.(_*5I)7E*)UV*7)V
MKT^48' I=;\-:/XC%M_:MDMP;5_,A;>R,C'@X*D'GTZ&M:B@#FH_A_X7A#>1
MI2P$SM<!H)I(V60@@E2K KP3P, 9-3OX,T!H[5!8M&;4R&%X9Y(W4R$%SO5@
MQ+$#)).:WJ* ,*\\&>'K[3K&PGTN(VUBVZV1&9/*/?!4@\]^>>]5S\/_  L;
M1[5=(CC@>X^U-'%(\8,N<AOE8<CMZ=L5TM% &)K_ (0T#Q1!!#K>F17JP']T
MTA8,OKA@0><#//-:EE96NFV4-E901P6T*A(XHUPJ@=@*GHH YN[\!>&+Z:_E
MN-*1FU!MUUB5U$IX/(# <D GU(!/05;C\*:-%JD&I+:R&\@@^S1RO<2,1%_<
MP6P1['OSUK9HH Y[1O WACP]J<VHZ3HUM:7<P(:1 > >H4$X4>PQ5W5_#VF:
M[):2:C \K6DHF@*SNGEN.C#:PY'8]N:U** ,1/".AI<:G,;$2/JB[;T32O(L
MX[;E8D<#@<<#@5'H_@CPUH%E=V>F:/;0V]X-MPA!?S5Y&UBQ)(Y/'3FM^B@#
M T3P3X:\.1W4>DZ/;6ZW8VSC!?S%_NG<3\O/3I4&G?#WPGI,=_'8:);0+?Q-
M#<[2Q+QMU4$GY0?08KIJ* ,!?!7AY;>X@;3_ #$N(EAD\Z:21O+5MP0,S$JH
M/.T$"G?\(;H!L;VSDT]9X;U52Y^T2O*TBKRH+,2V >@SQVK=HH YC_A7?A,;
M\:-$#)!]G<K(X+ISP3NYZD$GD@X/%&J6FNZ58Z=I?A*RT_[&%:&1KR9S]F3
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MNS"Y56V^;%Q\V<Y/OD]Z]"HH ;&XEB20!@&4, PP1GU%.HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9+-%!&9)I$
MC0=6=@!^9I]>.?'CPGXE\2VNDR:+!->6MN7\^UB;G<<;7V_Q<9'MGW- 'L2L
M&4,I!4C((/!I:X?X2Z'K'A[X?V=AK89+I7=UA9]QB0GA3Z=SCMFNXH *X/Q1
M?ZM%\2?"^C6FL75I9:G'=-.D21$YCC#+M+HV.>M=Y7GWBJ*^/Q0\*ZI;Z7?7
M5GID5T+F2&'(4R1A5 SC//7'2@!VK:UK7@SQ9HD%YJ#ZKHNLW(L@;B.-9K:9
MOND,BJ&4^A&1CK4]OXNT71X?$>KW6M:C<VEM>B.9)K63%HVT#8HVY"\CD\9/
M7GF#5M+U3QKXKT*6;39M.T31[D7K27142W$R_<544G"@]2V,^E<IK6D:O>>&
M?B%90Z-J#3ZIJ,<UDI@(\Y 4R?;[AZX[4 >CVWCC1;V RVK74S&X:WCA2U?S
M)&50Y*J1DKM8'=TP1SR*=!XUT2ZTRWOK:>687$[6T5ND+&8RKG<GEXR"H!)S
MT'-<SXXT_4)-4\/>(K309]7L[:"6"ZT]3LF19-A#*O'(*X(__6,R[TO6--?0
M/%&C>$3;QV5W<O/H\+KY[1S1HID;G!DRA.!G@@>M '1:K\2]-M=-TZ[L+>[N
MOM>IIIS#[.^87W@2*XQG<!G"C))QVJV^N:>GC64OJNI))!I'VB33#:R>6(]X
M/G ;<L_.W ST(Z@USWB2'6]8\/:3J:^&IK4VWB"VU V$(5K@PK]YW ."Y))Q
MZ8SWJQ=K?R?$Z?5CI&HK:2>&S:;O(+8G,GF>7\N03@XR,C/&: -S3_B+X=U.
MXTR*VGN2NIDK:3/:R+%(PSE Y&W=P>,^W6I-1\>Z#I?VM[B><V]E.MM=7$5N
M\D<,IQA"5!YY XS@D \UP.GZ3JUOX8^'5J^D7ZSZ5?B2]3[.W[I0&!)]?O#I
MFJMQ;2W-]XFTW^Q-;F\/WVLFYF%A:QSB5T92Q67S1@,Z<KM)&,9!S0![%<:I
M9VFCR:K<RF&SCA,[O*C(50#.2I&X''8C/;%8UKX[T2Z:X0F\AD@LQ?M'+:2!
MV@/ D5<$L/IS2>)+NZU;X=WMYX?MH[R>[LO,M89X@PD5P#RC<$[3T/?@UP.G
MV&J1>)[G4AH6O&"Z\--:&2Z4,YGWDX*ACL'0!0!] .: .[T[XA>'M4O--MK:
M:YSJ:EK262UD2*4@9*AR-I8#J,\'CKQ7-?$_QLMMX/U1M#O-0BN[.YC@:ZM8
M3Y2R;U#QM(1C@$YQWP,]JS[#3-4ATWX:Q/I-^LFE2'[:/L[?N1L*9/KR>V:R
M]5T?Q+;_  WU_P $GP]J%Y>/>F:WO80K0SQM<+)N+%@0W7(Q[],X /;+N[M[
M"SFN[N9(;>!#))(YP%4#))K%M/&.E7=]#9 7<-Q<0-<6R3VSQFX11DE,CD@$
M';UYZ5!XWT:]\4?#W4]+M%:"]NK8%(Y& (8$-L)!(YQM)SCFL;[/?^*=>\)W
M<FDWFG?V0TD]V;F,( YCV"-#GYLDYR.,#UP* .@L?&FBZEH4NLVDMQ)913_9
MV/V:0/YFX+M"$;B<L!TZFC5/&FC:.\WVN2<0V[I'<W"0.T5NS8P'<#"GYESZ
M9&<9%<YI7A74M-^)&J)&@'AFZE35@,<?:\%2GY_O#[JE8<^BW^G>(]>T^]\$
MOK]OJEZ]W:7@E B ?'R2Y/RA2.N/H#Q0!V]Q\0?#UMKLFC//<F^CEBB=%M)"
M 9#A6SMQMSCYNGS#GFK>G^+=-U2ZABM5NC%.)##<M RPR!/O;7/'KCUQD5@^
M&[&[M?B=XDNI;":.UN;6TB@G\DK&QB4JX4GMDC'KBN9TKPWJS7T%OHMMK&D:
M;?VERNI:???-;VDCQ$*T!/.=[?P]LYQTH ]!M?&>C7>I6=BDLZ/?*[6<LL#)
M'<A>3Y;$8;CD>HY&11#XTT6?4;.S669?MK,EI.\#+#<,O4(Y&#WQZ]LUP7A7
M1KZ>"QT;4/ [6&H6$)ADU>60-$N$*^9%SDLW' X&3Z8I?!6DWUJ^DZ-J?@7R
M[[2W4'5I9 T&U.DB<Y+D#  Z$Y/'% '1VOC#0]'LM?U>[UO4;FSAU(PRB>UD
M_P!$<A?W:C;D+DCD\9/7UV].\8:/J>JW6FPRSQ75M#]H=;FW>$-%G'F*6 RN
M>XXKS'5M)UBZ\&^/+"+1=1:XU/6EN;1/LY'FQ[XSN]N(VZX[>M=/?0RR_$^\
MU:?3KHZ1)X9:T>66,Q(7\PR%"S8V_(>IP >,T ;L7Q T":XT^)9+O&I%A8R"
MSE9;G:>2I"GCODXXYZ5L:MK-IHT4#W1D9[B40011(7>5R"<*![ GZ UY'X2E
MDLT\+S:[I.O16FD*RV<AL%$41F 4&202$NH#8!"+ZD5Z!X\T^WU33[&VN]-U
M&ZA^T^9Y^G,1/9LJ-ME7')YX[]>AH N+XRTG.G+-]JMWU"Y>U@2:V=295)!5
MN/E/RGKU%<W\0?%:OX$\32:'J5U:ZCH[QI,R(49&9EXRPY!!SE?;FL:32O%,
M7A[0+Z_MK[4Y-)U\SJOEK]JEL\,JNR@\OSDCKSS5?4= \0ZSHGQ%BCT*[@EU
M:6":S29HQY@4)E?O?>P/IVS0!Z#I7C?0]3U!].CN98KI(?/47,#PB:,=7C+@
M!U]Q]>E2:?XST?4M2M;&%[A)+R%I[1IH'1+B->K(2.1@@_0YKD]?T"^\>:C8
M7$%I=Z9%9:7>P%[R/RV:6XB$84#.2%Y)/3I@GL[PW-XCU32;/P]J/A>33)[*
MS:TGU*9E90/** PD'))(4GL #UXH Z>+QSH<TUHHFG%O>SFWM;MH'$$TG(VJ
M^,')!P>AQQFJEW\2O#=G_:'F2WI&G2B*[*6,Q\@GN_R\+[GKVS7)V^BZQJ7@
M'1/!ESI%U:WUC=0">Y9!Y"QQ2;O,1\X;*C  YR>0!S4>H:7JDVE_$J&/2;\R
M:K*#9#[.W[X; N1Z<COCB@#LI?'-LOCB'P\EI=O&U@;QKA+=W# LH3;M!RN"
MV6QC.!45K\4/"EW#/-'>S+!!#+-)*]K(JJ(V 89*_>Y'R]?F''(K&M(-2L/'
MVAZNVCW\MH_AU;"1HXN891(&.\$@@  ^I/8&L_3-/\06/P8U>PM-&8ZO]HF9
M+6ZMPPD5YMVX*W#'820#W'2@#NK'QGHU[)?1-+-:2V,"W-PEY"T)2(@D/\PZ
M<'Z5 /'FCDW,8BOQ<0V7V]8&M'62:#.-R CGG'7&,\XKSJZ\+ZOK6H^(X;72
M]9@CU;1(XH;G47!8RHQ8ASN.W<0!M'0'H!77Z/J7B#Q':26]]X3?2IXK&2">
MYN2N9'*X"18YVEN23QP.O4 &AHGCRRU'PMINL7<,\$M^P2&V6!R\CD$A4&/G
MXZL..#TJ>;Q]H%MI&H:E/-<11Z=*(;R)K:3S86/3<@&0#D8;I[UP>D:7KMKH
M_@/4FT/4 WAQI;>\M&51(ZR1[#)&N[Y@OX$YXJ3Q3X?U/5M+\<:I:Z;=A]:B
MM+:SM3%B5_*^\[+_  CJ!NP>/<4 =O;^/M#O HM&N[B5YFACBCM7WR;4#EE!
M RFUE.[IR/45NZ=J$.J:=#?0"18IEW*)4*,.V"IY!]JXOQ;IT&L6VA";3=:B
M:.&22&_TW<EQ8280 %1SA@6!X/W?Q&YX/378O!-FNM@-K C??O 7<=S;"VWC
M)7;GWS0!'8>/M!U&^L[:WEN"+YI5M)FMW$=P8L[PC8P<8/UQQ54?$WPP8_-%
MQ=^0+O['),;*4)#+D#:Y*_)R>^*X'1M/U[^T_!VHWGAW5UN;"ZN1>J(T2&/>
MC!1#&K!53GEL#/<DTZ[T?6)?AQXBT^/1M0^V7?B%KR&(V[ O$9E<-Z?=4_Y-
M 'H'B_Q3:V&F:Q96TU[_ &A;6+3NUE 9#; J2K,<$+G!Z\X!/O5OP'>W&H^
MM"O+N9YKB:RB>21SEG8KR3[UQUW!K6D:]XPVZ)J&HVGB*V62TN+95)C80E/+
MD#$%<<?_ *^*ZGP)87MK\.=)TZ_MYK*[BLQ"Z.1N0@8SP3]?7Z4 3P^-M$GU
M&TLTEFQ>2O#:W!@80SR)G<JOC!Z'GH<<$TVY\<Z':NYEFG%K'<_9)+P0,8$E
MSMVE\8Z\$] >,URG@A_$NEV.E^$[_P *,)-,EV_VI(RFW\H,?G3OO*DJ /7)
MP,BL^#0-:B^'&I^ )M*NI+V2XDC@O=@,$D;S;Q*SYP" 22#SQP#0!V^H>/\
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M4+S+I_VM[9U:2X!V'<H'RDL#VQ5;3-0OS\6];TV6]FELH]-@GB@<C;&S,0<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK247TBD6TS% P4%LA!G"KZ]<#FNADU;36\?6B73ZM9WZ:7).8)7"VPBW#<7
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M4?$.G:W-+<B[TX.+?9)A%#C#Y&.<C /T[5LT44 %%%% !1110 4444 %%%%
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MA<,C<A<<=>?:NEU[3_%>J6_AS5YM(B:\LM6%W)IUO<(3#"4*[?,;"LV>2?\
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M"I/'8COD5#X+\.^(-'EL-&OO!VB(M@ZC^WE:,M+&IX*IMW[R!C)(QU^OJE%
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MI++4?$DAT<3^'XK>.?>+[-ZKM:@+\G088L?3./Y=#10 4444 %%%% !1110
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M:.H!./P]*?H^C>-=0T5_#_B0Z;;:?'926;W%HY>2Z#1F,'! "@ [CW) Z#-
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M%CRN'!8\9SP ,YZUFZCX?\5W6J:)/=6VFZE9QQ2B[T_SC#;QS,V4?&T^8%'
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M!RN.N,XSWQ^%<I;Z%XFEU[P1?W6EVT4>BP30W*I=AS\\2Q@CY1DC;DCWQDT
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M&I7Y>5.6^7/4YZ5TZZ5XCT_QS?>((-.L[I-0L(8&B%YL,$B9ZDI\R\]1S[4
M9&LZ]9^)-2^'NMZ9+,(+K4G4JQ*D81@RLN<9# C\.N*T(_%&B:)J?C35#87L
M%S9RVL=[YLP*RLR[8M@W%47##)XZY/2J*^!-4TBU\&6=C''=KI%Z]Y>S&4)N
M9]VX(#UP7./8"K \/:^FL^,;HZ/8W5OK$]JT4%U,I26.,!)%<8."5R0<'!H
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MN5PT>YR OO\ O.^/N^]'B+2[[2['Q]=ZC;626VNR01V0N9@59\",!L?=)/S
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M]=OMT\Z7RW7GO(2"SD*NUOEX&,8''2@#MJ*** "BBB@ HHHH **** "BBB@
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M< $@9(//0YOC34/&4?@+Q)_:+3V5O#/;K:W#K");F&1U1T<1LP7!/48W#\:
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M!8D@9.>,\=*Z+PIKFHW6O^(_#^J2)<3Z1-$8[I4">;%*F]-P'&X8(., \<4
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MU'%-"D$'E^2&0$J3GYN>_']*Z"@ HHHH **** "BBB@ HHHH **** "BBB@
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MG+J-\@'E6K3"(2<@'YCP,#)_"GKJ=J=373#*OVXP?:&A!R53(7)_$X'K@^E
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M'V/L9O3."?X:TA8^&[?XM>$SHT=E]EN]+N5;R2"LR[?E+?WB03R>3WKTO3M
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MN?*DD9^'))&6)..323^'-#NK*"RGT>PEM;<YA@>W0I&?]E<8'X5I*H50J@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5Y8Y456(*C.,,"*\L>#6XOA[HOA63PWJYU/2=5A:5X[8O#(BRLWF))T((/\
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MF>\AMXW\Q@K6TWFQ2)_"ZM@9!'M0!I45PZ>-]7F\7ZKHD'AZ-X-*F@%W=F]
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MZ-I5MIUO)-)%;IL5IY"[D>['K0!=HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU&6'6-$E:]26\D82,%0A@,_(>3]W&*Y;3;>2S^"NA7%A?W]G<3ZRL+20W<@
M!NG7[I;;T[8P3R<T >_45Y7KFFI8:];>'K+4M6OY(M-N;S[)<7SHJ*SX$KS
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MX]R\05=P4VZ0ABK(!G+-MSZ'K0![=17D?B5M9O=:\9V,;ZG-?"*V&BFP:79
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M#QGM75ZG:'1O%OAGPW)JNIRZ?JUQ<W5U)<7;;I9$B7;&&&"%+?-L!P2<=.*
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MSGD@8ET7X>:<^GW=OJNC6UM97#12)ID5W),D,B;OW@<[2'.X [0!A1UKO**
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR*V%M%!=+MA*( 0?E'N2?7IG.: .WT_QQ#=^(1I%UIEY8-)9&_@FN"FV6$$
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MUT^WT82OB.X\R:X9Q@)]T *,=SW-6]+\-#4I-4U#Q)I"B_NISA//WCR0-L:
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MSH]GJ=JV8+N%)H_HPS@^]<SI7A=-1AU*^\2:.IU&\G=G3S]ZF(?+&@((& @
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MFN)F51.X"D2PKC=&/FXR!QCCO0!ZU'+',I:*174,RDJ<C()!'U!!'X4^O/\
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M%K_49=SZKJ%G/J$8"2SQVR@J >@+%ADCG"^YH ]AIDDL<04R2*@9@HW'&2>
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MWCS25U6STUX-1CN;NY^S();1HPK[-XR6QP1Z9K#^(R)'K?@)(U5$77(@JJ,
M#:>!2_$>"27Q!X*2WF^SS2:L1YRH&9?W3<C/&<9QG(]CTH ]"HKR ^*M:T:T
MU_33J4UTT7B"#3K>[NG57ABE ))?;@8Y )!P3G!QBNS\+VWB*RUO4H=6NHGT
M^5$DLX'NO/FB(X?+;5)4G'7.* -+4/%.FZ7KMCHMS]H%]?[OLR) S"7:,MAA
MQP.N:VJ\]\5_\EC^'W^[J'_HD5S.JZIXB31?'E^GB74$DT2_Q:!1&!C"'#_)
MR.>@QWSF@#V4RQB983(HE92RIGD@8!('H,C\Q3Z\L>:>/XMRZBUY>.(_"XOO
M(60;2?-Y0#'"G:/?/>I?#5UXKU5/#GB(:A +&[ :_66]#1R"0<+'&$&QE;@#
M=GC!).: /3J;(BRQM&XRC JP]0:\>36O$>IBWBAU6^@\0GQ"UK=6MOM98;0,
M02%92H4* =Y!Y[GI6WIZZYJ?Q,\1V+>)[Z&PTF2QG2+9'APREF1OE'RD CCG
MD'/'(!Z';6T%G;1VUM#'#!$H5(XU"JH'8 =!3HYHI6D6.1',;;'"MG:V <'T
M."#^->-6'B367U_PM*FL7UW:ZM?W4$]T"%MIU^;:(8S\P"8 W$#)'<4W2M1O
M/#7A+7+FWOKE[B?Q/+IWFW$X*Q*TP4R$L" VW/S$$9P<'I0![56/)XDLHO%<
M'AQDN!>S6S7*-Y?[LJI /S>O/:N!U[5_%?@O1M>OKB\A^SR10BPCFN?M,MO(
MSK&[Y*+E!O!YS@X'>K']FMIGQLT%3J%Y>"32)_FNI-YR&&2/3/H./2@#L_$O
MBO2O"-BE]K$DT-JSB/S4B9P&/0':#CI6M]I@^R_:O-3[/L\SS,_+MQG.?3'-
M<OX_L;;5--TO3[R,26USJ<,,BGNK!@?YUQGA6_N]0TH_#2]9VOM.NFM;V3!&
M[3TPP;/^V"L8'HQ- 'I'AOQ/IGBO3CJ&DO++:;RBRO$R!B.N,\G%;%>)>#]0
MET_X,:<EMJ1T]YM8-L#$A:64-.<Q1  _.PR >@YY'6M.QU?Q7<Z9XKLK)KR6
MZL-3A2"WGGC^TB A6DC63E=VW=@Y.,\$G% 'J\LL<$32RR+'&O)9C@#\:?7B
M.OZI'K?@ES;:EK<4D&OVT4UI?-LF@W&,>6_]X @LO)Z\]*Z+4+OQ%K/B'7]
MT>\ECFTFW@CMY#>")C(\>_S7'EMO&2!C@<'C)S0!Z917E;OXGUCQS9:(WBB:
MS\[PZMY.UBL;QB<2!"8R5^Z2,\\XR.,\>J#IUS0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6F7&FZC;K<6EPFR6)NC#\.1]>U<W8?#7P[IND7VFV\=UY5]%Y$SR7+/(8O\
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MSM:1F*T%U<-*+9" "$STX &>3CC.*YJS\>WLUAI4\^G:E$UQJ1M+L?V><PL
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MZUXVL-6L;J2/5'\ZR>*U>5+B,Q;!$-H(!7&W:<=?2O3Z:[I'&SNRJB@EF8X
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M01U!% $E>9^#4E^'<^L:'J]M<C39;U[NPU"*%Y8W1\91]@.UACOC/.*],HH
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M03 E%&T!$ '&>OJ2>?7** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:*;RUV#='OZXP<YZYZ9XH2?"ZZNK#5X+C7\3W6IC5K6YAM=KV]R !N^]R."
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M# #/)^7C&#E^G26,_C'0-$UV_35-'CT)GL9[Y<1WDWF[2^ULAF$8&,YX.>]
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MQSE <[=RAL9[]:\@>QTNS@^+0C@MH;A8Y5B  5@K6VYL=\$\FI]-LH]&\2>
M;G2U?[7?Z%<&<M*S&X98$9 V3T!/'IQZ"@#V6LOQ#X@L?#.CRZGJ#/Y2$(J1
MKN>5V.%11W8FO)_!K:;K'_"-:NWB>PBUQ)P+FW@MBM[<R-Q)',3(2R]3G;@
M9& ,5TOQ>AFCT_P[JVUWL=+UJWN[T*,[8@>7(]!_6@#<U#Q)K^E:8-1O/#47
MV?*ATAU#?+$&(&67RPN!GG:S8]^M=76;=:UI<6E"^DNH9;.4 (8SYGG;N J@
M9W$YP .M>;B"RU]OB(?$"QG4+">1;9Y2 ]K;K$#"\9/W,D%LCJ>M 'K55+_4
M[/3%@:[F6/[1.EO$#U>1SA0!WZ_D":\ETJP?7/&7A-?$"2S37?ADR7<4DC 2
MMN3&Y<X]R/7K6):VEG<^!_!!O8HY4@\5&T#S_-MA\R7Y,G^'@<>PH ^@**\H
MTGP_H^I_%;Q3),)'M[!-/N[5(IW"*VPL& 4\]..V&([US6@W-F-;\$:M9211
M17E_>%[F:4&\N4(<EIR, #/ 7G  Y[4 >^5G#5HKI=2CTTI=W=B3&\0?:/-V
M!@A;MU&?3->5^%KSPWJUA9WNN:@MMXOM-9=IUCD"W<DOFLJPX/S-$595VCC
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MTUL_D0R2 221H[ ;5ZD!=O3MB@#O:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHK)U/Q+I6D7:6EU-,UTZ>8(+:VEN) F<;BL:L0,\9/% &M1573M2L]6L
M8[VPN$GMY,[77U!P01U!!X(/(JU0 5E7'AG0;N[GN[G1=/FN+A0LTLELC-(
M00&)'."HZ^@]*U:\NMO%5QJGC?7] U+Q%<:#J$$_EZ7;B.,1RQX^5\NIWLQY
MVY''3O0!KGP*+SX@7NKZIIFD76DRVD5O!#(/,>,IG#;2FT9R1@'\ZZR^T72]
M4LDLK_3;2ZM4P4AGA5T7' P","L^RUZ&SGTC0]5GD_MNYLQ(5\EMLK(H,A#
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MEN2;Q)9+1VM9 MRL?W_+./FQZ#KVH T8?#.@V^FR:=#HNG1V,K!Y+9;9!&[
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M !N8)C.T$CD\'(QG(JK/\2/"\%KIMR;^1XM21WM&CMI'\S;G<HPOWLC&WKG
MQ0!K1^%O#\,EM)'H>FI):\0,MJ@,7.?E./EY)/%8OB+P1#=:4EMH%GH]G_I2
M7-S;362^1>;<X63;@]3G//2MN;5S<>%)=9TB(W3/9-<VD;*5,IV;D7'49X&/
M>N$\%>(+KQ7I6G7EEXKN)M6BFC.JZ;+%"N%W 2*%V!E [,#R!@\] #>\,^#F
MTS5UU6XTW0M-G2)X1%H\!19 Q4DNQ W8V\#'&2<UUMS:V][;26UU!%/!(-KQ
M2H&5AZ$'@UAZEXVT32KB:*ZGF"6\J07$Z0.T4,CXVJ[@8!^9?ID9QFN83QDN
M@?$#Q?!K&H7DUA:PVLT$*0&4PJ49I"%1<A1QECTXR>E '<:;H6D:.7.F:99V
M9?[Y@A5"WU('--B\/:+#=SW46D6$=Q.")I5MD#R ]0QQDY]Z@G\4Z7#:V<\3
MS78O(/M,"6L#RN\6 =^U1D+R.3W('6H1XST.73M-O;:Z>Z34]WV-+>)GDEV_
M>PH&1MP<YQCO0!83PKX>CLI;)-"TQ;65@TD"VB!'(Z$KC!-/NO#>A7UI;VEW
MHVGSVUM_J(9;9&2+_=!&!^%<-X*\<Q0:-KM_KVH7LEO'X@FL[>6XMV+HF$"(
MRJOR<GN!R:[2?7+*ZO\ 4=#M[N:'4[:V\YPL1!16R%92RE3S]: +6HZ)I6KV
MT=MJ6FV=Y!&04CGA5U4CT!'%))H.CS3VL\NE6+S6@"V\C6Z%H0.@0X^7'M7*
M>!O%1;X=>'[W5[BXN]0OD?:J1F268AFR0JCH !D]!QZBNJT77-/\0:<M_ILQ
MEA+M&VY2C(ZG#*RG!4@]C0!HUF6/AS0]+N3<V&CV%K.1M\V"V1&QZ9 S6"WB
M72M-\0>)+RZUN^>+3X(3=636KF.U'S?.N%RV[&21D>^.E_3/'&A:MJMOIUK/
M/Y]U!]HMS+;21I.@ )*,P ;&><&@#4U+1=+UF-(]4TVTO40Y5;F%9 I]@P--
MN]!T>_M(+2\TJRN+: YABFMU=(ST^4$8'X4W6==L-!@@EOG<&XF6W@CBC+O+
M(V<*J@9)X)_"LE_B%X;ATAM3FNY8K9+PV,N^VD#13@@%'&WY<9')XH UI/#V
MBRZC#J$FD6+WL "Q7#6Z&1 .F&QD8[>E<OI_@82>-_$.M:YIND7EMJ$D+VN_
M][)"8T"<AD &[ /!X([]:Z#1_%6E:YJ-YI]H]PMW9A6EAN+:2%MK9VL X!(.
M.M.UCQ-IVB75O:7)GDNKA'DC@MX&E<H@^9L*#@#(ZT 6GT72Y-2CU&33;-KZ
M,82Y:!3(HZ<-C(IESH.CWFI1:E<Z5937T./+N9(%:1,=,,1D5CS?$/PS!:Z7
M<M?2&+5$9[-DMI6\W:"2!A?O<8V]<D#'-,'Q)\+_ -CS:F][+%;P7 M9Q);2
M*\,A. '4KE/J<"@#9/AS1&U+^TCH]@;[=O\ M)MD\S=Z[L9S[TZ;0='N-5CU
M2;2K*34(\;+IX%,JXZ8;&:Q[?XA^'+EM05;FYCDL(/M,T<MG*CF'_GHJE=S+
M[@4EE\1?#.H64UW;WLIAB6%LFWD!D\TD(J#'SL2"N%R<@B@#5;PQH#O=.VB:
M<S7?_'R3:H3-SGY^/FYYYI__  CNB_Z%_P 2BQ_T$YM/]'3]P?\ 8X^7\*H#
MQKHPBU)I7NH9--C$UW!+:R"6.,C(?9C)7KR,XQS5JV\3:9>66EWEO+-)!JC!
M;1A _P Y*EN1C*C"DY.!@4 -7PCX;1BRZ!I@8S"X)%HG,@SA^G49//N:FD\.
MZ)-+>2RZ/8/)>@"Z9K="9P.@?CYN@Z^E4AXST7^T;:S,\R_:IVMK>X:!Q#-*
M,Y19,;2>"!SR0<9KDOB9XW6U\*7[:'?7T5W:WD=NUS;0$Q!]ZAXVD*XX!/0]
M<#/:@#T!-(TV+2SID>GVJ6!4K]E6%1%@]1MQC%37=G:W]K):WEO%<6\@P\4R
M!U8>X/!K+\7ZZ?#?A34M52-Y);>W=XE6)G&\*2N['1<CDG %<UX<U,6EOIFK
MWFLZS<RZC:+&=.GMG8RS[5=I(UV@A0">GR8(H [;3],L=)M%M-.L[>TME.1%
M!&$4'UP*S])T+^Q-3OVLG4:=>R-<O V<Q3MC<4/]UNI'8Y(Z\4IOB#X<M]%D
MU::\ECM8;G[)-NMY T,H(!61<93J.3@<U"GQ)\,O+;1"YNA+<O*D,;64P:1H
MQEE V\GI@#DY''- &O\ \(MX?_M+^TO[#TW[=NW_ &C[*GF;O7=C.?>M"[L[
M6_M7MKRVAN+>08>*9 ZM]0>#7+#XF^%C:+=?;+@0^=Y$S&TE_P!%?=MQ-\O[
MOG@;L9J[K/C;1="N[BVO);AI+6!;BY,%N\H@C8X#.5!QG!]\#- &GINB:5HZ
MNNF:;:68?[_D0JF[ZX'-,L?#^BZ9=275AI-C:W$GWY8+=$=OJ0,FL9O'%JWC
MFT\.0VUS(L]D;O[2MN[(060)M('W?F;+'@<#/6NKH YO5?"L,]C=66D066EI
MJ3$:C<6\"K+)&<[MN!@L<D;CTR3@FM6VT32[06/DV%NK6$7D6K^6"T*8 *JQ
MY ( SZU?HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD9);OP[XHU:]D
MTJ\O[34O*DCFLHQ(\11 AC9<@XXW C(^9LX[]=10!S_A2SNH8=2O;NT^QOJ-
M\UVMJ2"T2E$0!L<;CLW''0MCFN@HHH *\V\46EMXFTS4=.\2>%=1N;F*>=-.
MN;:VW,RY/ELKK]SL/GP#C/(KTFL6S\4Z9?\ B&ZT*!K@ZA:*'GC:W=0BD9!+
M$8Y[<T <(NE>(-"N/ &IZC97FIS:;:7%K?"T ED1I$4(3DC(&,$Y[9S66F@^
M(&\&W ?0;U9X?%?]IF#Y"\D/F[B4&[YB/PSVS7K$>M6DFN2:.HG^V1Q"9@86
M"A"2 =V,<E6'7M6C0!Y3XJTB_P!=N_$7B"UTV]6.7P\VDVT#P%9IY7<L3LZA
M1P,MCOV%36MO??\ "6> KIM*OU@L=*D@NG-L^()&C50IX]5(X]NU>H44 >+3
MZ3JTOPA\5:4ND:A]OO=4EEMX#;,&='F5U;ITPI^GXBNJ2._A^+-IJXTJ^DL;
MW0TM!*L>!#()BQ$FXC;A3GU],UW]9^HZO%IMWI]O);74K7LWDHT$1=8SC.7/
M\(XZT <SX_&I_;O#S6FG75U8K=.;R6QA5[F(;,+Y9/* DD,PP0.XS7!Q:/K$
M'A=M..@:JLD?BP7P#1&0F 2;BVX$EL #GOG@GFO<J* .&T&"Z7XK>)KY[*[C
ML[NUMD@GD@94=HP0P!(]_P >U)XJ@OK'X@>'-?@TR\O[2&WN;69;1 [QL^TJ
M2"1P2",]JZJZU>*TUG3],:VNGDOA(4ECB+11[!D[V_ASV]36A0!X1<V^IZ1X
M0T(:AI-U!./&L=PD)"EI59Y& 7GGTYQFMGQ;X5U?QC/XCU;3+2>U\W3;>TMH
MKI/)>Z>.;S6^4\J, *-V,GVKKM671?%WB5/#]Q)J$=YH[1ZDGECRTWY(1@2/
MFP<^W/>NP'2@#RR6YUW7/'VC:U;^%]2M5M],N89!>HJ(LK#@'YN5S@9[YX'6
ML?P_8:T/$'@C4;GP_K"267VJ*]#1+'#"SQ[5$<8(5(P>X SZL:]KHH \4&@>
M(/\ A$9;*+0;N6ZTGQ"^HF"1A&E[$7?Y8VSDG:V<X[=SQ5S4M#U#7?#-[?Z+
MX1ETBY2YM;G[/=.!<7WDN6*GDX &-N>2<^U>J:IJ=GHVEW&I7\PAM;="\CD$
MX'T')/;%4=*\11ZG/?6[:;J5G/9JC/'=0 %U8$J4*DANAZ'(/6@#D-*DU/5O
MB[;Z\?#^J65@VAFT9[N-4V2><7P1N]L>O?&.:L_%2VO+_3-%@L+"[O)8-6M[
MN18(6?;&A.XD@8[CCK6U9^.]&U&*>2R34KE()6AD:+39V"NOWEX3J*W;"]@U
M+3K:_M7+VUS$LT3%2-R, 0<'D<$=: .#=+D_$S6-3&G7YLIM"6WCF^R28:0,
MS%0,9S@C\>.M<[H^EZSINB_#BYDT3497T>6YCO+>.']XA=&"G#$#'(YSCWKV
M:B@#QNTT2_L=0U+0=2\$3:L;F_EN+746ES;%)'+AI>>"I/(')QQZF+6X)Y_$
MGC"P@TK69-)U.:&.\:PLTN=[(BEBC^8OEDY *E6QC/!.![37,2> ](.HW%Y;
MSZI9FYE,UQ#9ZA-#%*YZL55@,GOC% '/V+_VE\3=$UFQT^]_LI=&>U$TENZB
M*3>#L;(X("D'T/%<QXETCQ%J;ZVLVA:BTL>MQW%JEFB);-;JZ?O2 0996 Y+
M D =J]1\,:UI6JVUY:Z3!+!#I=R;%XI(O+VLH!.!UQR.M*WBW24\5)X:=YUU
M22,RI$;=PK(,_,&QMQP>] '"7^AZQJ.M>/K%-,O(1X@LK=K6Y8*(D9("I1V#
M<'=A<#/7/3FH]-TJ]\1:=<69\%S:)JB:?/;/J-W)N57>,IB$Y)()()/0 'J<
M5Z3<:Y9VVN6NCR>?]LNHVEB"PLRE5QN)8# QD=?45I4 >-HNOWUOX"L7\*ZK
M!/H5W$EXS(GE[4CV;E;=R#C.>G;TSZ!X\6:7P=?6]M;7%S<3*J1QP1,Y)W ]
MN@P#R:NZ'XCL?$#ZBEDLZM871M9A-&4.\ $X!YQR.N*UZ /-I_!][+\2I-2M
MBR>&]4ABO-1A9""\\)&Q=IY&<JQ&.=K ]:Q(+37X=&^(S66ASR76H7IN+&*\
MLR4GC) )VL,$@9(4]\<5[)6)XD\6:1X2M(KO69I8+:201B586=0QS@':#CH>
MM 'FUOI]Y_PD>L74OAC7K[3]0T-(&2\.))6WMN4G=\A(Z*,8X. .:>/#VO-X
M>\6:3I_]K76CS:6%L(M57$Z3?-F)"?F* 8QGCD8[D^N/<0QVK7+RHL"H9#(3
M\H4#.<^F*S?#OB73?%6F#4=)DEELRQ597B:,,0<'&X G!% 'F]_;ZK%J6A>(
MG\)ZGJ%C_92Z=<62G9<0.K;A($#<@Y(Y],G'&;ATJX@\0>!)K?PU+I]I:7%W
M-/;01%UM5E4JA=AD;B>3C./UKU.B@"EJ\EW#HM_+8)OO4MY&MTQG=(%.T8[\
MXKS3Q%H0\1ZQH^JZ1X=U#2O%$-W#)<731>5&D8.9!)(/DDXXXR3TZ9%>L44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-<2+QGJQ.,D<#BN._M?Q2OP\U3Q:OBB\>ZTJ_E1+9XH_*FC6;:5D 7))![$
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MZ(FX,>,  8XP../4T <?8^)]<\0/X;TM)7$]UH*:E.\,ZV[S2,0O!VMP.6(
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M6[4Q&)VV[$39\KJ< ?-DD<YS77P>"].@U+2;]9[UI]*@^S6I:;($9&"",<Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY  SG(] 4L44L-K$<C.<&@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?[9*T>YF'S9C9=K_ '0,=.,4 =];74%Y$9;:598P[QEE.1N5BK#\""/PJ:O
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MIU,O92$ZIC[;_I4O[_'3=\WX?3CI4L/A#1(+W3[R.UD$^G1>3:.;F4^4G]T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\JVNIB:/R?)DDW[G!;>&&3P%.3CGO7JU,BFCG0O%(LBAF7*G(R"01]001^%
M&;JFF//X3O=)MCEWL7MHBQQDF,J,UYY;:/XE?3/ $$OARYC;0YT%U_I,!PBQ
M>7N'S]R20!G@?A7K%% 'D.H>#?$.IIXK:/2ECEFUB#4[!+MXFBNA& "CA6.
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MCE=WV:)45R?3J%S^->9>'M!UW3_A*/"=]X0EN;TPSQYDN+;R=SNQ5L^86XW
M\+G(XKUJB@#S[2O#^L:+!X*TZ:UFU :8D@O+I)$V+OC90H#,&(!('3H/PK/T
M?P%J/AW3?$T2I)?0E;BVT2TC=!Y,,PW-RQ &6(!R?X/>O4:* /'K[PSXDE^#
M^@^'TT"=]2L[B%IHC/ %"QN6/S>9@Y'2MA?#FL>%?' U_P -Z7+-I.K+_P 3
M32UEB1H9.HE3<P4GKD ^OJ,>DT4 <QX_TB]\0_#[5]-L(=UY<V^(XF8 E@0=
MN<XSQCKBL,6.O6WB[2O%JZ)/(KZ6=-O-/2>(S0@/O5QE@AR>" W'O7H=% ',
M>"]#N=(BUB[O(_)N-5U*6^,&X,85; 521P6PN3@D9/4]:PH=)USP_J?BRV@T
MB74K36YFNK6>*:-1'(Z;624.P( (&" W'OQ7HE% 'E%MX7\3^ ]3TB_T/38]
M>B72(]-O+<7*P,KHQ8.K-QMRQXJ[J>G^,M-\1:3XLLM)MM3NS8R6-]IL5RL0
MC1I/,38[<';PI..=O3GCTJB@#SS7-.\37$WA7Q ^DI<7VG7DTL^G6LR QQ2H
M5 #L5#%>,GC))QQ7.7_A?Q7<>%?%5G_8#&ZU/75OX$CNHB#&'C)R2PQPA_/I
M7LU% #8V+Q([(T98 E&QE?8X)&?H:\]O/A[+?^,];$SK_P (SJ\"3W5N.KW2
MAD&!V&"'S_>"^E>B44 >;Z7X:\067PIUG3M0C:^UR[M9K1%1T!*",PQ#<2!C
M: YR<_,>_%0VVB^(+*_\!:@NB2R-INFO8WD/GQ PN410Q.[!7*D\9..V>*].
MHH \;O/#'B:Y\ >+=+30+@7FIZZU];1M<0<Q-*CY)\S ("$$>I'7G'3W=EK+
M?$]=<CT.[>P_L)K,L)8 WFE_,VX\S_@.>F?;FN]HH \?L/#/B2V\'> ].?0K
MC[3H^J+<7BB>#"QJ7Y!\SG.\<>Q]L^JZFD,NG317%B;Z&0;'M@BMY@/8AB!C
MZU;HH X#0/AW:Q:KJ>K7NGV=B;NT-A;65JHQ;VY'.Y@,-(W<] . 2*RK+PEK
MMUI/A3PQ?V!AM=!OUNKB_P#,0QSK%N\H1@,6RVX9W 8P>M>J44 <C\0]"U/6
MM$L9-'5);_3-1@U"*W=]BSF,GY"W09SW]*YBXT_QEJ/BG6]=M-!;3I;G0#9V
MPN+B&0B<,6 (!(Y]^.1GN*]5HH \I\,:)K5AXVTO6[O0;BU@_L=K2\GNKV.1
MQ+O5B[G<3M(!P!G' PHK9\&>'CIWBO7F@NDET:"Y+V,*\B&694>8#V'RXQTW
MM[UV>I:;9ZOIMQI]_ L]I<(4EB;.&!^G-,TK2=/T/38M.TRTCM;2(82*,8 S
MR?J?<T >>:9X9U6'QC8:MI^CWFAO)<R/JZBZC:SN4(;YE0.QWD[?X1C)^I]0
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KR5];U?5/ &O^+X=6NK74+&ZG:"W5OW4<<+X$3Q]&RH.2><MVXKUJ
MN;E\"Z'+>7<_DSK%>2^?=6B7#B">3(.YX\X)) SV/?- ')74;ZE\7?#-U)<W
MD#76C23F))<",_(2HXX![^M>C:K>-IVCWM\L?F-;6\DP3^\54G'Z5GW'A;3K
MKQ+;^()&N?[0MT,<3+.P54/5=O3![UM$ @@@$'J#0!Y]X;DO[O2/#GBIO$<T
ML=S;L]_:.P9+B1TRJ1KT0HXQ@=0#GO6"WB#6C\++/Q]%JER^H&Y266U#Y@>-
MI_*\D)T& 0,_>R,YKM=%^''ACP_K!U/3K!HIP6:-&F=HX2W!*(3A202/H2!4
M]OX%T*TN-\,,ZV_VC[4++[0YMUFSG>(\X'/..@/.,T <-JUWKDM]\2 OB/4H
MH]$@BN;-8BB[6,#2;3A?NYXQW[DFI;3[3J_Q&\(7L^HWBRW7AXW3B.0!0Y\L
MG"XP >_K^%=I+X'TB:76I':\+:T@2^_TAL2*!@#V^7*\=C2'P+HI?2) +M9-
M*B,%LZ73JWE\?(Q!^9>!P?2@#AM%N];?PUXB\07GC&Z@&GW5]:Q"X16A4 [4
M=@%R6!QC'L,=<Q6_BG6]!U35QYFHS00>%_[2BBU%P[/,K[?,P"2BGKMST[#H
M._M_ VAV^AZGHWDS26.I2/+<QRSLVYVY9@2<@DX/'<5%8_#[0;'4([Y5O)YT
MM39LUS>22B2(G[KACAAZ \#TH SM,L+R>VTO41XJNY+74M.*RQM+EIIF3>)(
MC_ 0 _"C&![4WX.1,OPQTF=[B>5IU=R)'W!3YC]/KUK4\/?#WPWX7OGO-+LW
M24@JGF3/(L2GJ$#$[<_G6AX=\,:;X6LGL]+6=+=F+".6=Y @R3M4,3M&2>!Z
MT >9^-O$6KV;>)=1TS5KV5M-O+6*,V[!+>T!9%:-U/\ K'8L<X! R.1TK9\0
MZQ>>'?']Q:W^I7O]EZQIKG3TC?!CNT(RB?[3<8![MBMW4?AKX<U.?4Y+B*["
MZDZRW,4=W(D;2 @[]@.-W YQ6Y/H&FW3:8UQ;^<^FR>;:O*Y=E?:5R23EC@Y
MYSS@]10!P?@OQ%J&JP66F:G?31:MH;W)UEFDX)0[4#=BK;MP/_3,CI61X=UK
M67\3^$$_M74[BUU9;T3W<S@1W95"RO%$<^6JG&"0,^F.OJ<&@Z;;7^IWL5J@
MGU/8+MCR)0J[1D?2L&V^&7AJS:Q:"*^4V+NUJ?M\Q\D,,%5^;A?8<'OF@#A+
M+6_$&F_#?5O&<VOWUW<VKW-K#;2A3%S,$1V&.2I)/IC QQSLSZ:=.^+O@ICJ
M5Y>^=8W>7N9MX+",$LO89ST'' Q7::;X.T72]#N]&AMGDT^[+M-!/*T@8O\
M>^\3C/7CO5'3?ASX?TK4+"^@6_>?3PRVAFOI7$*L -J@MC;@8QTYYS0!UE%9
M^C:+9Z#8?8K$2B'S'DQ)(SG+$D\GGJ:T* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH[:6,2L%$>ZW)>11V;./FZ\^]=UX&EO;7X8:1-JHG:YCL \@;F0J 2/QVXH
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MRO;7"R6SX#"(E%.Y.RDGN.37LFD:S8S1Z?IQO8GU"2PCNO)WY=HR -_TSWH
MV**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&ZL[6^@,%W;0W$).3',
M@=3^!J:B@!L<:11K'&BHBC"JHP /0"G444 %4Y](TRYG:>?3K269NLDD"LQ_
M$BKE<;XA\1:U8^.M!\/V#V"Q:K'.WFSV[NT7E(&[2+G/X8]Z .M@MH+6/R[>
M".%,YVQH%'Y"HQIUB+\WPL[<7A7:;@1+YA'INQG%<IX<\<_:KCQ#9:^+.PFT
M*X2*>Z$NV"17SL8;C\I..A)ZCFM\>)] .G/J UK3_L4<GE/<?:4V*_\ =+9P
M#[=: -(PQ-,LQC0RHI57*C<H.,@'T.!^0J&ZTZQOGB>[L[>X:([HS+$KE#ZC
M(X-8%]\0_"]CJ5E8MK%G)-=3O"3',I6$JI+%SG"\@#!YR15VROYYO$VJ0MJN
MFS64$4>VUB8>?;MSN,G/ ../I0!HR:;837BW<ME;/<IC;,T2EUQTPV,T+IE@
ME^;];&V%X1@W B7S"/\ >QFJUEXBT743,++5K&X,">9+Y4ZML7^\<'@>_2L[
M1=?@AT.SDUSQ!HT]S</($N+:94BFPS<)D\X P<=P: *6E^#6B\::]K>J0:==
M0ZB\,D"M'O>W:)-@(+#N.3C&".]=C69;^(]#O--GU*VUBPFL8"1-<QW"-''C
M^\P.!^-4[SQMX<LM#O-7.L6<UI:<2M!,KD-C(3 /WCV% %]-"T>,*$TJQ4*Y
MD4+;H,,>"PXZGUI/^$?T7R_+_LBP\O.[;]F3&?7&.M5XO%6B-HMKJLVJ64%K
M<*"KO<)MW8R5SG!(YS]*U+>X@N[:.XMIHYH)5#1R1L&5@>A!'!% $$^D:;=.
MCW&GVDS(AC0R0JQ5",%1D<#'&*L>1#]G^S^5'Y!79Y>T;=N,8QTQCM6!:Z]%
M;7>M7&J>(-'.G03(D.R55-M\O*RDG&XGH*U+/7-)U&\N+.RU.SN;JW_UT,,Z
MN\?./F .1S0 W_A']%,8C.D6'E@E@OV9, GJ<8]A^52#1M+$DL@TVS#S*5E;
MR%RX/4,<<@^])?ZUI>E/&FH:E:6CR!BBSS*A8 9)&3S@ DU!/XGT"UMK>YN-
M:T^*"Y3?#(]R@61?[RG/(Y'- $Z:)I,8 33+)0L1A 6W48C)R4Z?=R3QTYI@
M\/Z* H&D6 "G<N+9.#ZCCV'Y4^^UG3-,2-[_ %"UMED!9#-*J[@!DD9/( J.
M+Q%HDS0+%K&GR-<-LA"7*$R-QPN#R>1P/6@"5=&TM!.$TVS43J5FQ H\P'J&
MXY'UH.CZ6SPN=-LRT*>7$Q@7,:?W5XX'L*R/$WB,6GA/7;_1+ZRFO=,MY)'7
M(E",JEMK!6!!.._Y&I+7Q5IMMH&DWFM:I96<]Y9QSD33+'N)0%B 3T!/X4 :
M/]AZ21"/[+LL0#;%_HZ?NQG.%XXYYXIH\/Z*(VC&D6&QB&*_9DP2,X.,>Y_.
MF77B30[$1FZUG3X!+%YR>9<HNZ/&=XR>5QWZ5;DU"RAL/M\MW EGL$GVAI (
M]IZ-NZ8]Z )?L\(MOLWDQ^1LV>5M&W;C&,=,8[56M](TRT>)[;3K2%H5*Q-'
M JE >H7 X!]JK)XGT"262)-;TYI(X!<.HN4RL1 .\\\+@@YZ8(JQ!K6E7.EG
M5(-2M)=/ )-TDRF( =?FSCB@"2YTVPO)DFNK*VGEC^X\L2LR]^"1Q22Z7I\]
MT+J:PM9+@<"5X5+_ )D9J*VUW2;VQFO;;4[.:U@)$TR3J4C(&3N.<# ]:S=3
M\<^'-,T"\UEM6M)[6U.QO(F5R9,9$8 /WCZ?CTH U(]$TF))DCTRR19AB4+;
MH!(/]KCG\:3^PM("QK_95CB(YC'V=/D/7(XXK+EUP7U]H+Z9K>DK;73.TL#R
M!Y+A0IXB(/52#GZ'TJV?%OAP/&AU[3-TLIAC'VM,M(,94<\GD<>XH T+NPL[
M]%2\M(+E%.56:,. ?49J#^P])WE_[+LM[+L+?9TR5QC'3ICC%&H:YI.DNJ:C
MJ5I:,REP)YE0[0<$\GID]:BN/$NA6EK%<SZQ81P2[A'(UPNU\=<'/.._I0!+
M_8>D^5'%_9=EY<3^9&GV=,(_]X#'!]Z9)X=T.5E:31M/=E<R M:H2&)R6Z=2
M>]6_MUJ; 7_VF+[&8O.\_>-FS&=V>F,<YK%T/QMH.OZ/<:K;:A;K:6\CK(\D
MJKL4.5#-G[H;;D9QD4 :"Z!HR_:-ND6 ^TC$^+9/WO.?FX^;GGFJ6N>%[?4=
M#O;'3C#I=S<P" 74%NNY4!'R$<94C(QGH36EIVKZ;JR2/IU_;7:QMMD,$H?8
M?0XZ&DU'5]-TB))-2O[:T1R0K3RA-Q R<9Z\4 <OIO@V\-_:7&K1^'XQ:2K-
M$=+TTPR,PZ9=F.!Z@#GIG&0>K73-/2ZENEL;87$R[991$N]QZ,<9(^M13:WI
M5M80W\VI6D=G-CRIVF4))GD;3G!_"G1ZSI<VEG4X]1M'T\ L;I9E,8 X/S9Q
M0!'_ ,(_HOE^7_9%AY>=VW[,F,^N,=:FATO3K>Y^TPV%K'<8QYJ0J&QTZ@9J
MO!XBT2YM+B[AU>Q>VMO]?*MPNV+_ 'CGY?QI(O$NA3V]Q<0ZSI\D-LB//(MR
MA6)7&5+'/ (Y&>M $\>D:9$MPL>G6B+<_P"O"P*!+_O<?-^-,_L'1]J+_9-A
MM0Y0?9D^4^HXXKE=%\:/JOC/Q)8)J6G2Z986L4T%Q&,+&6W;M[;B#C ST_"M
MC2/$%M;Z)IYUO7](EO9XV?SH)E2*8+DED!/( ')]C0!MQV5K#=2W,5M"EQ-C
MS95C =\=-QZG\:Y6W\&O)X\U;7=2@TZ[L[V.%(H9(][Q&($!OF&,G)Z=/>MZ
M+Q'HD^DOJL6KV+Z=&=KW2W"F)3P,%LX!Y'YBL[5O'?AW2?#EUK9U2UN+6 F/
M]Q,KEY<9$8Q_$?3MU/% &U<:987<L<MS8VTTD?W'EB5BOT)'%1OHVE2M*TFF
M6;M,X>4M I+L.A;CDCU-03>)M"MK&"]N-8L(K:<$Q2O<H$?'7!S@X[^E:44L
M<T22Q.LD;J&1T.0P/0@]Q0!2_L'1\2#^R;'$ARX^SI\W?GCFIX=/LK:1)(+2
MWB=(_*1DC"E4SG:"!P,\XJI!XDT.YU$Z?!K%A+>AF7[.EPI?*_>&W.<COZ5'
M_P )9X<\R*/^WM,WS2F&-?M:9=QC*CGD\CCW% &Q17/>+?$UGX?T>]8ZI86N
MHI;/-;QW3 [B!Q\NX$@GCKU-3^$-4N-;\':/JEWL^T7=I'-+L&!N*@G [<T
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M,G22+>ZE0P+* S*"PZKN"[@#V- &U1110 4444 %%%% !1110 4444 %%%%
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M)R!\I;(!Z$]*X[4&TT_#'QV8/LQN)/$SO!LV[V3SXRI7N1M#D8XP&]Z^A**
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M*8)9? >M6\<;O*VF3HJ9W,6,3 #W.:W:* /$H=1TG4XOA/"TD4L=LHCG21"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8VC^'QHM]J4\%Y*
M\5_=O>20NJX61@H."!G&%%;-%% !6-J'A\:EKFF:E/>2A=.F::&!54*6,;(<
MG&3PQ-;-% &-XG\,Z?XMT5]*U-7:V=U<A&VG(Z<U/H6B6?AW1X-+L%9;: 80
M,<GKGK6E10 4444 %%%% !CFN<TSP5I&D^*[[Q);)*-0O8S',Q<E2"5/ [<J
M*Z.B@ [4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@_\ Y_9__ =_\*/^%O>#_P#G]G_\!W_PHN@]E4_E9W5%<+_PM[P?_P _L_\
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M'_\ /[/_ . [_P"%'_"WO!__ #^S_P#@._\ A1=![*I_*SNJ*X7_ (6]X/\
M^?V?_P !W_PH_P"%O>#_ /G]G_\  =_\*+H/95/Y6=U17"_\+>\'_P#/[/\
M^ [_ .%'_"WO!_\ S^S_ /@._P#A1=![*I_*SNJ*X7_A;W@__G]G_P# =_\
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M_P#S^S_^ [_X4?\ "WO!_P#S^S_^ [_X470>RJ?RL[JBN%_X6]X/_P"?V?\
M\!W_ ,*/^%O>#_\ G]G_ / =_P#"BZ#V53^5G=45PO\ PM[P?_S^S_\ @._^
M%'_"WO!__/[/_P" [_X470>RJ?RL[JBN%_X6]X/_ .?V?_P'?_"C_A;W@_\
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M*I/_ $!=2_\ !A#_ (5[A11R(/K$^YX?_P *I/\ T!=2_P#!A#_A1_PJD_\
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M%U+_ ,&$/^%'_"J3_P! 74O_  80_P"%>X44<B#ZQ/N>'_\ "J3_ - 74O\
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MGA__  JD_P#0%U+_ ,&$/^%'_"J3_P! 74O_  80_P"%>X44<B#ZQ/N>'_\
M"J3_ - 74O\ P80_X4?\*I/_ $!=2_\ !A#_ (5[A11R(/K$^YX?_P *I/\
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MK_@I[>VAA>;Q%')*T:!2[$'))'4^]=[I=B^G:?';27MS>R*69I[E@7<DDGH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>9
M>(9=0B^..CMIMK;W-Q_8LH\NXN#"N/,Y.X(Y_#%>FUS=UX0CN?&]MXI.J7J7
M-O#]G2W41^5Y9Y*G*[N3SG.?3% '-G0)/#>D^*->US7DTJ^UJ>)IKBP4N+=5
M.U$CR-S,02,[0<G@<5#X<O;B'XL'3K=M<@TZ;16N#;:K</)F03*HD7>S,O!Q
MCCZ5VWB?PW9>*]%?3+YYHT+K*DL#;7C=3E6!((R#ZBL6V\"C2]9'B*'5]4O]
M8BM'MR;N9"MPI^8(WR?*-P'W<?CDT >8&]U'6?#<40U37'\:2:P8;F&UN[A(
MU02E6 "'RU0*.HQR.M=9J%]>7_Q)O?#YM]>O--TC3H52'3K[R7:1P#YDCF5&
M<XXZGG)(KF--T[4-,\$K;V&K^,;3Q&J.T6D16LGV=)BY.T%HR-F3DDOTR<UZ
M7<^!AJ=Y9:W+J>H:9KPLTM[JXTZ1%$V "0P92#SG''\A0!9\ 1^((?"Z0>)%
MF%[%-(D;3R*\CPY^0NRD@MC@\]JRM2T'Q#X?/B76]#UFR'VIS??9;FQ+_,D8
M&W>)!C.SKM[UV&E:;'I-@EI'/<S@%F:6YE,DCL3DDD^YZ# '8"N<E^'MFSZF
ML&LZQ:VFJ323WEI#.GER,_W\$H64'H=K"@#7\)ZX?$OA33-9:$0O=P+(T8.0
MK=P/;(-;-5[&QMM,L+>QLH5AMK>,1Q1KT50, 58H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>modificationno14effectiv010.jpg
<TEXT>
begin 644 modificationno14effectiv010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(Y'$C#N^4&6ZD$U@0ZU=Z=\._"?C".9VURXUQUN[IF^>X0L^8W/=<*!CH.U
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y/Q[X]L?
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M:J;6Q$+$O'M<[V*Y49?Y<\\; .>M<CX7\?:1H6O^((5M7B\,ZXCQ26<9+R0
MA@"N< _>(QZ'KQ7T.=,\2DDE?#1)ZDV<G_Q=']E^)/[GAG_P"D_^+H ^8)/&
M"-X=T3P^'5K71]0:Y@G:,AI%+%L%<\<D\9/7KQST_B7Q[IFG^//%%]HYFD75
M[.33[N*YBV^5( $WH03N'R]\=37N[:3XD8$%/#7/_3E)_P#%TITSQ*S%BOAH
MDG))LY.?_'Z /F74_%]G<?"K1/"<.YKBQOWN6F92JE?F( ZDG,A]/NCUXZF;
MXLZ7'\6(/%UK#/\ 9YK);6[ADBRT>,%MGS -T !..N<<8/N/]F>)1_#X:_\
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M<#+,S$815PP)YY4@ \9R]0\#ZGJ/PJTW0'EMH-;TN.!K2XB=BB30X"L"5!Y
M/;C-6]>\%WTOAW18=!OHH-6T:=;BWGN5)29]I$GF8Y^?<Q)'<T 9\_Q8A@T7
M5+[^ROM$FFW<5M,MI=++$ZR$!'CDP-X/IC.1S79Z'J%_J-E)-J.DR:7,LK((
M))ED+*.C97CGTKC=?\-^-?$O@^>SU";1AJ,UQ!(L4+2)!"L;A^I5F9F/!Z 8
M&.^?0XRYC4R*JN0-RJ<@'N <#/Y4 <?<^/&M;;Q7(VF9?PZ5,JB?B92F_*G;
MP<=B.O>HI_'MXVNVNCZ=X<FO+JZTM=2BS=)&NTD#!)' &3SZ@<<Y&9KW@OQ+
M<ZAXPCTV33#8^(H(QON'</ Z1;"-H4@AN.<\>AZ&E'%K.E_%;1[:VMK&ZO8/
M"HBFC>X:)&"S 95MA.<@=1TS0!W/A+Q/%XKT9KU;66TGAG>UNK64@M#,APRY
M'7MS[UB#Q7JT7Q&U;3;N"UBT?3]/6Y:3SCN"$DF0_+R?EQM[#N<UL^$/#TGA
MW3+M;B1)+R_O9K^Z,6=@DD;)5<\X P.>N,\=*Q]4\(:C?^--3O UH=(U;2AI
M]UN=A-'C?R@ P<[NY&/Y@$D?CV5(M#O[[1S;:1K4J16MR+C>Z-(,Q>:FT!0P
M]&;'>N@\2DKX6U<@D$64Q!'^X:Y&R\'Z[<Z-H&@:R;#[#HMQ#,+J"9R]RL.?
M+7RRH"?P[CN/0XZ\==XF_P"14UC_ *\9O_0#0!S6F6-Z/AAHG]@1^3J$UI9R
M,\+)%N;8A9I"RMN'7/!)'2H/ MOJR>$+I3%=QP-9(-/1)43'R-D(K+NC?<>2
MY8=,<#%=)X+_ .1%\/?]@RV_]%+6Y0!YSX'MM?B\0WIO4F\@3O\ ;&610K7'
MDPC+ H"_ &&0A=P;Y1Q6CH=O#:?%'Q%!;0QPP_V=9OY<:A5W%ILG XSP*[6N
M/TO_ )*SXB_[!EE_Z%-0!JZYXA_LJ^TS3;:V%UJ6I2.MO"TGEKM1=SNS8.%
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M<\KQ7;RL);:.4Y=/+VD.1DX.X=>:9XI\ 7VNA[.&QTM$@\E-,U7SWCNK)$5
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MUB P)&>V<8_&N,\%:/X@TCPS:RVL5I%+J6JOJ%]#>;@T-O*22J[?^6@ 7@\
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M%^A0VNIV[:QI\DD>J0VDFX"WV_O(W[[2^Q>?[Q]\>D4 %%%% !1110 4444
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MW!]O\1R 0>N<'K5>\;^RO#GC^STM!#I\&NQ?:(+;@16S;/-VJ.@(!!QVSZ4
M>Z0W$-P"89HY IP2C X/X5DS6MMIUC?W/AZPTL:FT&Y0%6,2$9V[V49VYS^M
M<7?V.FO\0;)M"CLVT^YT6X_M)+8+Y+Q#'DE@.,EBV#U(![ UR^D^'M#3]GFZ
MUI;2%M0FTF5)+AV+$E7; Y.,@@ =Q@4 >VVL[FSMVNS#'<-&K2*CY4,1S@]Q
MG.#4DES!#&))9XT0G 9G !_&O&/%<^GZQ::#X;TBWL9==U;3K=;B_FC5Q96B
MKG=D]"=S8QZ^I%.U*'PM8ZOH_A_39+(0V.D7(CN=0=7ML&38Y5.-\S,K<[@
M,\'I0!ZQ?Z]INFWNGV=S<HMQJ$ACMX\C+X4L3] !U]QZT6D^IOKFH0W,%JNG
MQK$;22.0F5R0=^]>W(X]:\3TA]&FT+X776I-8O%$]Q!=2W!0JH$;%4<GH!D$
M ^HK1UN2>SU'XM#0@L=W]EL7"P<-M,9\UACO@L<^M 'M,=Q#,SK%-&[(<,%8
M$K]?2C[1#O5/.CW,2%&X9)'4#Z5YG):Z1+XM\$W'AA+40SV\ZW8M@NU[3RA_
MK .H#;0,]S7$6NG:9;?#C2M4AMX%O8?%"I'<@#?&@N&^56ZA<<X''>@#Z&)
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M;VD$,UP=TTD<85I#ZL0,D_6K%%% !1110 4444 %%%% !1110 4444 %%%%
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MYK.*02!3D@H#ELDY;.<GBN8O/B%K5EH/BF>6TL!J>@WJPM:[7Q-"V"CCG(+
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MEN. 1US5FTLM-#_;[.VM \Z[OM$,:YD#<YW#J#U]ZY_Q3I-]JOA>T33SMDA
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MCU+1M,AM8WT_2CJ+R72,PE.2 BA6&!QRW/7I0!THT72E,)&F68\@ 18@7]V
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>>JX/ODDFC:>)M5MO"=E92ZC(T<OB6?3'N[NZ9&$*EBJ-,,L"2 -W7&1D=0
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M\>ZG>WEXMQ8W\UK#;I=.B0QQ,H53&#M.[DDL#G/L*]CTP9T>S&<?Z.G3_=%
M$6DZE-J0O/.TZZLOL]T]NHN !YRKC$BX_A.>/I6A7B%QJ6K_ /")ZB\>N:DD
MT'C-K*.47+%A#YBJ$)/4 =NGM78^%FN;#XF^)=%_M"^N;*.UMKB-+NX:8H[;
MMVTL20#Z=* .VO[ZWTS3KF_NY/+MK:)II7QG:JC)/Y"N9M/&MY=7^G0#PIK
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M>IV[6D4OD22!ONR9 V$==V2.,9Y%6M-U6QUBW>XL+A9XDD,;%01M8=00>A%
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ML?G8X)))/J33].TJQTE+A+"V2W2XG:XD5. TC8W-CMG':N3\:^+I+?P&=?\
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M8-*/'OA,VD=U_P )!IX@DD,2N9@/F&,@^G4=?4>M:&J>(-)T4*=1OHK?<AD
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M2ZU Q$P6@ W! "1DG(4,Q[$D=@ ;'A73[_2M1\01W=E(L5[JDMY#.KH4*,J
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M-CM6CC6,9<R*Y;<3[J,8K!L?B!=7/BD6KPVZVLLL=I&//!CW^9*&=9<?.2%
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M:HVL2/E;AA6$S,OP>O+86\YG_M\RK"L+%RGV@/D+C.-H)KWJB@#SVPO8M/\
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M1IK+1I;:YD52R1R%%PI;I_"0*[G0/# T'5-8OA?RW#:I/]HE1T50CXQ\N.V
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME7?G&UE,,\;QO')$X[,C@,/R['TJ;3];LM4O+RUM3.9;-Q'.'MY(PC%0V,L
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M($QNW9XVXS5S5K[3]$B?5+F/,[*L""-=TLQR2L:#N22>/Q/ KS#5-$N-"N?
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M'U-%Q\-/#ESXBFUDQ74<MPXDN;>*X98+AQ_$Z#AOIT/<')JU<>(-0M_B#8Z
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M>IJ-FUJS;%G6=2A;.,!LXSGM44OB'1H;.\NWU6S\BR&;EUF5A#[-@\'CIUH
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M@ HHHH **** "N ^,7E+X#,TH79%>VK,S#[J^:N3["N_I&574JZAE/!!&0:
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M(ON?\2>!7F<^H:7XU\/>([&PU*+4O$VK6#2-':*QCMXXL%(0Q XRV,_Q,Q.
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M?6@#Y\EU&RB^#7B>T:]C:9/$!^5\(Q!N$(.WC&0K'&.QXKZ$CD2:))8G5XW
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MKNM3^%=4\*>+];TO5[W5);G35CGN+J)(H1(I'EJ (T!DZ],D#ZBO<555&%4
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MV&@6.N/]G\0:A9"=K8QLI)507/3"]>A-=$8HV96:-"RG*DJ,CZ4[:"P; R.
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M4 %%%% !6=K6N:=X>TY]0U2=K>T3&^7RG<+DX&=H..2!S6C7#_&+_DD^O_\
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M<JZMB,[7)P.N/3!OQ>)]7URZM=)T?4+BZ:+1H;I[ZR6!6N)7RN\B88"@KD@
M'+8.,8H ].HKRS5O$?BK2-/TF;Q"U[8VQLY%O[W1X(K@0W(? :0%6PFT9^7'
M)([5Z-HUR+S1+"Y%TEUYMO&_VB/[LN5!W#IP>M %VBO(?$WC#7],U#4+JUU:
M2:.UUB&U$-K!&UK%"2H*2NRAC*<G(1CMXZ5K6NI>)[SQWXGMO[>6+3-#GMIO
M(%FC--&T9=X\]1D<9Y.<?B >D45YIX?UGQCK2>']=AWG3[UP][%.]N(%B?@>
M5M_>;E.!\QY[CM7:>*M:_P"$<\*ZIK C$C6=N\JH>C,!P#[9Q0 ^]\0Z=I^N
M:=H]Q)(M[J._[,HB8JVQ2S?-C:, =,YZ5J5Y-=0:B?'/PUOK_6)[Y[I;F1D>
M*-$1S;[CLVJ#CG&"3T'/7-G1O$'B_P 16FE>(--$HL[B])N()VMQ;BUWLI"_
M\M=XP#DGDYXQ@4 =I%XLTF<ZT(GG9M&&;Q3;N&7Y2W (RW [=:T]/OH=3TVV
MO[??Y%S$LL>]2K;6&1D'D'FO-$N[O3]5^*]]8S^1=6JPSQ2; V&2VW#@\=JG
MG\3:WI:^ ]:O=3<Z-JD,,.I*8HP%GDB!1]VW(4MG/( QVH ]-HKSF\\4:ND&
MEB">>3^W]2E6S9%A5XK5%9EV%@%+.%!!;/#]R*S==UCQUH?ARZDGO5@G75((
M[.2=(9)7@D?;ME"#:,'(R "?PH ]8HKSB>_\2VGB.'PJVJW=_<BSDU![NUAM
MH965I-B)B3Y,+@Y(&3E>G.6V>N^*);_PUX8U>Y2RU:ZCN)KZYM5C=BD7"!<@
MH&;(+<'&.,9X .UT7Q#IWB 7O]GR2-]BN6M9Q)$T9610"1A@#W%:E>>_"N&6
MWD\8PSW+W,J>()PTSJH9_E3DA0!GZ "M'QAJ>H6VMZ+866I26R7(F:6WLXUD
MNYRJC8$#JR*H))9FP.G- &[K/B'3]!:Q74))$-]<I:P%8F<&1C@ D#"_CCO6
MI7C$^MW_ (B^&G@;4]4D$M[)XDMDD<*%W;)Y%!('&<*.E=&=9UKQ!'XONM.U
M>73CHMS):VL"11LKM$@8M)O4DAF)'!& /7F@#T2BO+;#Q-XA\2^(O#]O;ZJ=
M-M=5T(WTL<5O&[12!E!*%P>Y[Y&#TSR(+/QMKS?#O1=0NKQ1)+K(L-0U(1(O
MDP"5E,A&-BDX49(P,T >LT5Q7@?4M6U/5O$!N=4:_P!)M;KR+&;RHP)1@,Q#
MH &VD[<CC\:?\0]6U3P[8Z;K5G>/%I]M?1+J<0B1MUNS!68$J2""1T[$T =E
M6>=:M!XA&A_O?MIM?M8_=-L\O=M^]TSGMUK@$\8ZBGB;7]&;5)'%U'&WA^=H
MH@'8OY3@87Y@LA[Y^52>G)T+W4-9_P"%@7OAW^V+@6A\.&[1TBC61)O-V;P=
MO7 )]/F.!TP =5JOB/3=&ET^.\E=6U"Z6TMRD3.K2DX"E@,+WZD=#Z5JUX5%
M'>M\+_AW*-0DFN+C7K1XVN55EB8F3^Z 6&>3DDGUKT'P?J>K2>+/%>AZGJ+:
MA'IDML;>9XDC?;+&6*G8 #@CCB@#LV94&68*,@9)QR3@?K69I_B'3M4UC4]*
MM9)#=Z:8Q<H\3)MW@E<%@,@@$Y''2N3^*$5TTGA/[/J-U:K)K]K"Z0E,-DE@
MQ#*<E2H(!R/4'C'.W8UBT\6_$NZTS6'M)K&PLYS-Y$<CRNENS '(V@'!SA>X
MQC&" >Q45YC#XKU[Q#-I^GV)N8;A]"M]1E>S\@,TLP])LC8I'0#.3U&.>W\,
M2ZO+X;LFU]8%U4*5N1 P9"P8C(QQR "0.AR* ->BBB@ HHHH **** "BBB@
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M!01@<=>>^36Q<6\-W;2V]Q$DL$J%)(W&592,$$=Q4<=]:2RK%'=0/(R[U19
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MO]0@>T:[MX&FCAN)=OF8[ #D_A0!G:E\-=%U'7Y=86YU.REN HNX;&[:&*Z
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ME46?)#+@DD%L%OP%<;>ZEI,WPKDCU66TC\51:V)+Y)BJW D^T<MSS@1D#/3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %4M5TFRUNP-EJ$)EMRZ2
M;0[(=RL&4@J01@@'K5VB@"."!+>%8D,A5>ADD9V_%F))_$U)110 V2-98FC8
ML%8$$JQ4_@1R/J*I:7HUCHT=PEC$T8N9VN)B\KR,\A !8EB3T _*K]% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2BN(VLGA\]9P?E,>,[L^F.:Q_!GB^R\:Z$=4L8WB59Y('B<_,A4\9^JE3^-
M'0T444 %%%% !1110 4453N]4LK*\LK.XG5+B^D:.WCS\SE5+' ] %//T]:
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MYN 5RV5ZKM/'/6M"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME)RQ'M_6NWM-&TNPO)[RSTVTM[J?_7310*CR=_F8#)_&KK*'4JP!4C!!'!%
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ME16IQ$B[4R(UR<+DTE_)I^J_%B_T?Q(MN]E%I2/8071'EN68^9(H/&X<#/4
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MA\4:?XFECNOLFCVW]G?;AL+(T):295/W7+D9(Y& ,\5V'PJ=7^%_A_:P.+4
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M9TGWF20/*B'9@@+C(Y.<\\#'(![917 :WXUUC^T-:M?#]F)Y=**1^4UA-/\
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M5P/KD\9JOX>\$ZUH@2&X\7W6H6=I&R6%M-;*HBRI4&1E(:3 ) &0/R&.VHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPN=6M-5FMD>^LT=()CU0/C=CZX_GZF@#C;U9X?BEI&C?VA?M83Z-.)(C=/\
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M3M_O=3T&>30!T.L_$=-1\!>(-8\-W2PW.FLRH98MQ95(&[:<8R2<9STZ<\=
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MD6+BX7(=NBD9R#UX/H:XCQ;XB@>_\#>*;>*Y$T9N&\J2"5D0/$%='"*S*X)
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MF^U?W297)"]V8MTR3Z5K,+#\,/"T7D2)<0^)UN)H_)8.J"9V+D8S@*5Y]"*
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MLW"#1]'U>&X_MF;3DN+AUBS$'  <%Q\H.XGC_P"M6Q?W$5K83SSN$C1"68T
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MVG>%W<Y*Y(..E/O/B%>1ZEKEE8>'9+HZ3:QW;2/=K&LD3*6ST)!P.!WYSC%
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MIA\ \ \XP:UJ .&U+P_XEU'Q=X:\0M!I*R:5%.LT O),2-*FWY6\K@#KR/\
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M)^\&SR_D_=_W>><<\>]6-.M4\%'Q#_PDU]I,.AZMJ<]Q#)+*0SF;'[M@0%&
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MU>6::)92H8Q1LNT>I QA5(! %>SU0LM#TG39WGL=+LK69_O206Z(S?4@5?H
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M/J*R::Y>RN_M1,UO\H7:K'@+M &W&WVH C\&ZIJ,FN>)M!U"Y>\&DW48@NI
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M&%9BA=R&< K&H5LR$9 X_+J)8O!]C]OM+J[N[^_^QOYEK%>3^8D+XP& QEF
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M@N(OE(:Y;JK<9#(%.<8SO%$^ES>#!?ZKH6F7^MWFIW2O=6YND3D@CS!D #'
MP/Z5J^&=$72-!-N\$=O/=22W-RD#<+)*Q9@"/[N=H/HHH W**HZ-I4&AZ1;Z
M;;2SRPP A7N)#(YR2>6/7K5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !65XFECA\+:J\LB1K]CE&YC@?<-:M<+\0OAW+X\:R
MU^YTV*V#!HHD+K(21@D;AR,?K0!SWP>UW3M$^"XU"^N52"RDF>?9\[("YQE1
MSSFM#Q-;^'[^71OB1;:V^G74-MBU<PB3[2C!L1^4<%F^=@ #GFN=B_9]N((Y
M8X?'&H1I*-LBI 0''H0).>II#^SY.TL4K>-]0,D*[(G,!RB^BGS.!["@#JO@
MYX8U/PYX4N9=7C\F]U*[:[: \&-2  &'8\$X[9 ZUR'C9OM7[1>@0VNJ_8)O
M[.:(74>QC#(1/@$,",\@8([]N#7HG@+P3<>"K:]AGUZZU;[2ZL&N%(\O (P,
ML>N?TKR*[^''AJZOYKI_B>WFR2%R6CRP).>N^@#5\"7]SHNL>,M%U=0/'DL<
MKV][(V3=_)\BIGCKM8 =0>GRUG?"B&RU:7P_=R:]!;ZU87ER)K)+4FYNQ(<L
M97WY9<#J5P.<\TR3X?:%+<I<R?%B9YTQME9267'3!\S(HL_A[X>L;Z6]@^*3
MK<RJP>54*LY([L'R>>: .?AM-%;X?_$"6:.U_M2#4T^R%L>;&/. ^0=1GD''
M7'M76P-=R^.$7QAL,:^#@UJ+W&/-,4?F$9_CW>9GO7/V/PSTJ.8O<?$VUBPW
MFJUNC%O,_O<L.??K6A>_#KP]J2HM_P#%62Z"<CSXR^#Z\R4 8NK_ &R7X+>#
M&OY'6?\ M5UM99#B18><%2>< @8^@]J[#XO>!O#_ (=\+65YIM@J>?K,<ES,
M[ER$9&!!8DD*2 ?K6?<_#_PY=65I;2?%&1DME8(&0D#)SP-_'8?@*2?P'HUU
M;M;W'Q<N986&#'(&92/H9,4 ;UP^D_\ #17AHZ=]D6P;12(Q %$94K-C '&-
MN,>V*\GE@L4^&5W?((A?IXE"1R _.D?E$_+Z D#IUP/05W+_  ^\/R3I._Q5
ME>94V"1D)8#!'7?G&#5;_A5_A;&/^%G<=<>3_P#9T 7_ !U8+=?$7Q7%]JL+
M^2_TN**W\^[BB^PLQ0C/FLHQA&;Y-Q^89'->Q^!M*CT/P1I&GI+:R^3;J'EM
M<>7(W5F!'7)SSWZUX#J/PLT&ZNEE7XDVDY*A7>YA); &!CYCD8 &/:O2O#Z^
M&=!^'$_A)/&L#/(DJK>QC8T9?)RJ[CTSZT <5IL.JZI\3_B#'X9US[%J3HSV
MQC\MA<8897+ X^JD8)I-.UJ%?@'K>E:' ]AKUBP&JPACYSC>!)+ZX(X/I@CT
MJ*'X:^&[:99H/BDT4J_==(BK#Z$/4B_#S04GDG7XKS+-("'D"$,P/7)\S)H
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M $>QKI*Y_P #V$&F>#=/LK;56U6&)7"WK=9078^IZ9QU[5T% !1110 4444
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MWC/1$O[>T>>51<7!M(;@P.())AGY%DQM)R".O4$=:/&NOMX9\(:EJL:2//#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,H5;F,G(PK_*[#!.!G/((Y% 'TO8>,[$>$-%UO6)%LY-3AB*0HK.SR.H.U%
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MB@W$.QYD# $$-G.:BTSXC:AJ<]C86OAR2XO[G18M5&+E(XV#$ C)R0,Y'//
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M<NSE>"Q;A0I[]@30!R?_  K+P=M"_P#" >)< Y_X^8__ (_1_P *R\';0/\
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MPIK)U72/ WB.&Z*,F6FB<!6ZC!G]JHZGX!\+:OJEUJ-YX"\2/<W4K32L+B,
MLQR3@3\<UTGC.^@\+:-8>+-,.(;5X(9U0DBYM'8+@^I7<&4GD<]B<]3X@URT
M\-Z%=ZO>[O(MDW%4&68D@*H]R2 /K0!Y0/AGX-5O^1 \29(/'VJ/_P"/TO\
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MJGEL<9Z=1R>< 'LM%%>9_$T6T7BGP8\\<C0S7TD=PL,;NTJ!,A2J LW/;!H
M],HKBK&;1[";5M8TC3+Z(Z?9D2021/;^?GY\A90#QM(W8YR>N*J6WQ,N)SH#
MGPS="'78B;-EN8RQD"[MI'&%Q_$3^% 'H%%<3;_$:U&AZG>ZC9&RNM/U#^S9
M+=IU*M,2H7$G "G<"2<8 /I5&7XJP06.O2G3HKF?1XHYF%E>K-#-&W=9-HY!
MX(VY^M 'HE%<4?'ES%:6CWGA^>TGU&^BM-/BFG7$P==P=B =@ SD8)SQ3$^(
MT4,&N/J6FM:'2+A;61A<*R22L0$56.W .X')  &<]* .XHKSX_%&%(M<4Z?%
M<W&E6@O#]@O5GAEB[XDPN"IZC&?3-7+#QW=7>M:=ILV@R6QU2Q:\L9'NE/F;
M5#%6 'R=>O/T[  [6BN/^'/B#5_$OAZ34-6@@C9KF94,4F1A9&7;C P%P!G)
MSUXI9?&TT6K>(]-;2@+G1K5;M0UR +J(@G*_+QC&#GOQ[T =?2!U*[@PQTSF
MN:TCQ:=;LM%N[*Q$J:G:O=$+.,PA0,@Y&"=S!>HYSV%>=ZS)I-_\((KS3-)_
MLZ(:VA6%I3(5?[2%=LGUYX[9Q0![3D9QGGTI:X&&*.+X]W#(@4R>'%=R/XC]
MHQD_@ /PK=\1>*%T/4=+TY(K=[O43)Y)NKGR(AL )!?:WS'<,#'/- '0TA(
MR3BN8C\6W"ZUH.E7FDM;7&KP32 &?=Y+Q+ED;Y>>HP17$^-?$<?B+PK:7_\
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MD%J)9[8W,,MG>K=)P>4<J!M<#G'(]#0!V5%%% !1110 4444 %%%% !1110
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MJ7(OK@7#EIPZ -.[%!EL G!_/T]9K*US7=,T.*V&J,ZQWLZVL8$+.K.YP%)
M(&<]\4 <IX;T_2M4^(6J>)-%U!+K3'BB9UA8-";S#*7!'\0B(!_ZZ>O3I/&'
MAU/%GA+4=#>7R?M48"R8SL8$,IQW&0*U;.RM-.MEMK*UAMH%^[%#&$4?0#BI
MZ .-@T+7-6U?0M0U^*QA?1ED=?LL[2?:9F39NY1=BXR<<G)'IR[P/H&L:%=^
M(7U-+,)J>IRW\7V>=I"F_ VG*+TQUKH-+UJSUA[Y;0RDV5T]K-YD;)B1<9QD
M<CD<CBM"@#AM>\/^*;3Q@WB+PG<::S7=LEM>VNH[PC;"2CJ4YR-Q&/YU3U;P
MAXHOM?L[V:YTW4H1ISVTB719$M[AF+&:., @X!"C)!P.O>NZU/4;;2-,N-0O
M&=;:W0R2LD;.54=3A03^E+8:C;ZEI5MJ5JS/;7,*SQ-M.2C+N''7.#TH \QT
M[P)XPT.S\/ZCI4^DKK.FV3:=/;SN[03P%MP^8 $,&R>GISQSN7GAKQ/>:WX5
MU*ZFTZXETVXFN+PB1XU_>*5V1+M/RJ.A)R<<XS6N?B!X847#/J+)';3&"XE>
MVE5(9 <%78KA3GU(KHXY$EC62-U=' 964Y!!Z$&@#E?!F@ZKHE_XBEU%;01Z
MEJ+WL/D3,Y4, -K91?[HZ9ZU2G\.:Z?&NO:Q%#8-:W^F+90JURX?<N<%AY9
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MY/WCG\SWU[8VFI6KVM]:PW-N_P!Z*:,.K?4'@TZUM+>QM8[6T@BM[>,82*)
MJJ/0 <"@#SS3_A_JY^%TOA>\N;6VOX[EKFTN;=VD57\[S4)RH[\'@\<UTGAF
M'Q>SM+XIGTH!(_+CATY7(D.1EW+]^. !CDY[8Z6B@#BO _@>3PG>ZL[W FMG
MG==,ASQ;6['>5''!+GGK]Q:P8_A[K\NEZAYLNG0:@OB(Z]I[),\B;B?]7)\@
M.,9&0#UZ<5ZG6?9:U9ZAJFHZ=;F0W&GLBSAHV4 NNX8)&&X]* .=/A>_UG6;
M_6=62VL[B;26TN&""8S!%<EF=F*KDYP  .@Z\\86D>#O%L-[X+>_.D+%X<66
M!O*FD9ID:,1AA\@P<=O;KS@>GT4 >=:3X(U-/&&E>(+JRTO3KNV20:A/I\[_
M /$P+)@;H]B@?-\Q.3R/Q&MXU\-ZMJE[H^M^'KFVAUC2))&B2[!\J9)%"NC8
MY&0!S_\ KKKF8*I9B H&22> *S&\0Z<GB.+0&ED&HRP&X1#$P4H" 2&QM/7L
M: ./UGPUXRUBQTN:]N-+N[B*^^T7>F;WCM)(]H58\[6+ $;CN&"2>.!67/X
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MCKFLBZ\8ZY%X<\-ZKJ%QJ5OI=WI0FO-1TVTCE,5P0I#2*R-MCQD\ <UU^L^
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M^_CDTR9)K>ZAD59=ZJ5R3MP<@G/%4[KP!975_K%X^JZHKZM:"SN0'C(\H#
MRA.<9&22>3SGF@#GM'U_Q'%XA\#+?:Q]KM_$.GR2W%N;:-%C=(%D#*0-V23S
MDXZX X SYO&'B.Z7;;ZK]FUEO$']GMI(AB8QVV<;MI7><+\^_./PKM(O MG#
M=>'KE=2U%Y- A:&S#-%@JR[2'_=\Y4!>W3/7)K@M*T?5HEN%2+QMINLRS32^
M3!+$UFLC.S#$C@@IR,DG)YXH ]E0,L:AFW,  6QC)]:=4=N)EMHEN&5IP@$C
M*, MCDCVS4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.P%4=2DL+_PUI[:CH>G:?+8^+X+>\6+:]OSM,A0D<(PP2#W'- 'NQ8*I8D
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M!G QM!Z<9)[F@#W^WG2YMHIX\[)$#KGT(S2^;'YGE[U\S&=N>?RK*\-'3O\
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MF?48YYI+*;3HA/=1WD9B9(R,A^>H^F>>* -JVMH+.W2WM8(X(4&$CB0*JCV
MX%0#2=-&H_VB-/M/MV,?:?)7S,=/O8S65;>,]+N=5ATP17T5Y/ UQ#%-:.AD
MC7JPR/T//M3(O'6@S:7I>II<3&TU.Z%G;2>0XS*6*!2,97E3R>.* -C^R--%
M[]M&G6GVO.[S_)7S,^N[&:FNK2VOK=K>[MXKB!L;HYD#J<<\@\5B:GXUT;2)
M9A=R3B""9(+BZ6%FA@D;&%=P,#[RY],C.*JW_P 1?#^GW6J6TC7TDVEA3=I%
M92L8U()W'Y?NX&=W3D<\T ;?]@Z/OD?^R;'=(NUV^S)EAZ'CD<4KZ'I,EDMD
M^EV36BMO$#6Z&,-Z[<8S5*Y\6:5;V]I+&\UT;NW^U0QVL32.T. ?,P.B\CDX
MY..M5[?QUH-W=:-;P7,KMK,;26+"!]LH4$MSC (QR#S0!T2(L:*B*%11A548
M 'H*SV\.Z(^_=H^GMYAR^;5#N/J>.:GLM2@OY;N. 29M9C#(60J-P )P>_4<
MBLW5/%VF:5<7<$@NIWLHA-=_9K=I1;H02"^!QD G'7 SB@"Z-!T<2K*-)L1(
MJ[%<6Z9"XQ@''3'&/2A="TA;1[5=*L1;2,&>$6Z;&(Z$C&":Y'QIXO2-/#=O
MILUV]OK%W%NN;.-COMRK,0C 9#'"]/F STK;M=$U.W\-RV-KX@OGGFG$D5W=
MJK30Q%U)3Y@<D+N +#J>>E &L-'TL7+7(TVS%PP*F7R%W$$8(SC.,<?2F1:#
MHT'E>3I-A'Y081[+9!L#?>Q@<9[^M<192ZS<_$[5O#C^)=3%E;:?%<1D);[]
M['!R?*Z?A6_-XJL_#>GB#5[JYO)[""/^T+N&V+K&2!\S[1A<_>P!P#G &* -
M^STZQTY&2QL[>U5SEA!$J GWP*KGP_HK&4MI%@3-S*3;)\_.?FXYYYYJAJGC
M/1M*21Y)9ITAMQ=3-:Q-*(H3T=BO0'!([D GM7-7WBK[!\4;0_VA>7&D7>@M
M=0VL$9E\Q_,7!1%7<25!/? ST% ':IH6D1RPRII5BLD&!$ZVZ QX.1M...23
MQ4@TG31J/]HC3[3[=C'VGR5\S'3[V,UA'XB>&QIFDZC]KF-MJLABM66VD;<X
M)!4X'#9!&.IQQFHI_&6C:KX9UZ:.\U"P%@CQ7;BUD6XM25R'V%<C .<XQQ0!
MO/H6CR232/I5BTD^?-8VZ$R9.3N..>0#S3QHVEK';QC3;,1V[%X%$"XB8]U&
M.#[BL>'Q-INEZ+IB-<WNH226"W*E83)/)"%&97 '&<CKC).!1+XZT-;?3I;>
M6XO#J-NUS;QVT#.[1*,LQ&. ,XY[\4 :8\.Z((FB&CZ>(W(9D^RI@D9P2,=1
MD_F:M0V%G;RB6"T@BD$8A#I&%(0=%R/X1Z=*X;Q-XD-[!X)U;0M3G6QU+68(
M6"?*LT3!B0P(SU7&/K73^+[BYLO!^L7MG</;W-K933Q2(%)#*A(X(((R* -J
MBO(U\3Z_IFG> =1&M3:A/KLD$=W8S11$%)$!>1-B!AM^I'(S78V/Q&\-ZCJ3
MV$%S<"6.2:.1I;:2-(FB4LX=F "\ ]<=#0!U=%<]9>--(O;ZQM%-S"VH(SV4
MD]NT:7( S\A(]#G!P2*AOO'V@Z?]H>>6X:VM[K[%-<Q6[R1I/_SSRH))Y X!
M&3CK0!T]%<I-\1?#L&L'2GEO/MBM"K1_8I05\TX4D%1@9(R>@R!WJT/&NC?;
M[6U:2=4O)S;6URT+"":49^17Q@G(('8XXS0!T-%85IXMTV^OH;:W2Z:.:66&
M*Z\AA"[Q[MX#].-C?7!Q2Z5XKT_6;J"&TCNREQ"T\$[V[+%,BD E6/7[P(]1
MS0!N4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4V2011-(P8A020JEB?H!R:=44US!;@&>:.+=
MTWL%S^= '"_"NSOM)T35X-1L+JUE?5+BZC66(C=&^"I'J>#QUKDWT;6C\.KR
MP71+_P"V/XA-XL/D\M%YPDW9Z=!]<U[-#=6]P2()XI<==CAL?E4M 'D=WI%_
MI_BK6X[KP2_B&QUBX%U;7 D51&615,<H;[H!7J1^?;>T#3KVS^*&HW,NFR16
MCZ5;VT<\<16'S(_O*N>0.>/I7?44 >/>%] U'3)+;PYJ7@=+N>SN]\6LRR*T
M#1B0L)3SG> > .<XZ<U0U+2O$=Y.);OP]J;WEIXECO/]&5%MOLXDSN1 PWN1
MR78$^K#I7N%% '!Z;%>_\+;U34)-,O8K*YTV*W2=XOD\Q&)*Y'UZ]#CKTKC+
M+P]XBM_ 7AV ^&[FXNO#E]*UQ93.J+=HYE!,1#') 8$$@=>,XKVB"]M+J:>&
MWN899;=@DR1R!FC8C.& Z''K4] 'D&NZ5>:AX,G?3O!<NFR7-_:S?9%4-/*(
MWW,\F.!QP 3G@^M>A:CXD;3]>TC3FTN[D@U$E1>  )$^"0K \Y(!_P YK=J!
MK*V>]2]>!&N8T*)(1DJIZ@>F>^.M '*_$K3[Z_\ #EHUA9RWDMKJ5M=-##@N
MR(X+8!(R<5C"+49O'7B#57T74(K>[T-((B\(),HR2GRDC/S >F0>:]*J">]M
M+::"&XN88I;ABD*22!6D8#)"@]3CTH \7LM!UO2-,\*:I/X6N=4CL]-?3KW3
MLA986WAED49^;.,<=J]3\)VGV/0D']C0Z,LDC2+91$$Q@_WR.-QZG'3..<9K
M0.KZ:([F0ZA:;+4[;AO.7$)]'.?E/UJRDT4D"SI(C0LN]9 P*E<9SGTQ0!YM
MHV@ZC?Z;\0M.DM+BR;5[JX>TGFC*JZ21[%/KU'(ZX--\%6=X][IT=_X#73+W
M38V2?49G5ESL*GR<$DECC/8#/)XKTBTO+:_MUN+.XAN(&)"R0N'4D'!P1QP0
M1^%/FC\Z!XM[IO4KN0X89[CWH \/\+6EWXI^#6A^&K73;M'>Z#O>/&!"D:W+
M.SAL\G *[1SGVYKI(=/U?1;?QKH<FD7=Z-9NKFZL;B%5:-_/0+L=B?DVD<[N
M,=*[KP[X>LO"^C1:3IIF%I$S&-)7WE=QR0#Z9)/XU>>^M([R*SDNH4NI06CA
M:0!W ZD+U.* /.]"\/W^A_$#0(WM+B>TL?#BZ;)>+&?+$P96Z^F!U]\4D=EJ
MMC?_ !!MFT:^D34@TUK<1JK))NA"!1SG=N]N,$G%>F44 >2Z+I^J0ZG\-FGT
MB_C72=/GM[UFA.(7:-47/KDJ>G0$5F76FWL/@?7;>YTF^6[NO%)O+%-H60AY
M%9'16(#D!6^3(/K@<U[;67KOA[3?$=I%;ZE"[K#()H7CE:-XG'1E92"#R>]
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M/';W,,SV[^7,L<@8QMUVL!T/L: /+UM;K4_#NOSQ> I='NY=)GL@SX>>:1P
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M))/+$YQQ@<^E>HT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYEE>2#[-NRO[H%E8G[VWC!XZG@5WWB30+;Q-X;OM$NV9(;N+877DJ<@AO?!
M/X5RUIX*\1RZ_H&I:QKNGW0TB*: ".R96G2154ECOQN('4# ]#0!%8?$/4=2
MN=(N;/2)+C3=3G\H".UG#VZ-D)*[E=A7INQTSU.*H:)XUUFPTK7[_67M[J1=
M>?3+:.)7'[W*(J@ $A ,MP"QYZDUK>'/ ^O^'IX=/3Q2TGARVE\R"T^S@3!0
MVX1F3/W0>OJ..!4$WPVO+BSUVR;6DB@O=4;5K*6&W(FM;@LK D[L,!MQ@ =2
M<], $=[\0M;T[2O$-Q)HJR_V9"D\%T\,]O#.K<,,.N=RGMG!'<5+<^-/%6GO
MHWVW0=.5=6ODM[<+>,65'CW#=\O!!R">>G /6I;SP;XGUCPIJ>F:UXEAN[N]
MB%NCK:^7%$F<EMH/S.<#D\#MWS=UGPIJNJ)X7*WUHDFC7$=S(3$Q$S*NW Y^
M4$$^M &'/\0/$MM8>)7?2-,,_AV0?:F%R^R9"H8",;<AL=2>.G7MKZAKJR^,
MO!T1T>RF.I6]S/;74S9EMR(0S*OR_*""H)!/?BJEWX"U6YM_&,/]HV:CQ$5P
M?);]P NSU^;Y1[<U;E\(:O)K/A/4?M]F&T&WDA9/);]^70(QSGY>%!'7G- &
M(GQ)U_\ L5-:FTC3TL8]6_LZX1;AS(?WFS<GRXX]^OH*T=:\?WT%SJRZ+IIO
MO[+F6!X!;3N]P^%9PC(I5,!@.<Y(/ &":C?#?5G\(2Z$=3LMTFJ_VCYPA? ^
M??MQN]>^>E7YO!7B&U\17NH:!XF73K34W66^MFM1+MEV@,\1;H3CO^O H -6
M\27VN_V]I.D6EJ!8:>DMW]O#9+RQEUB"CH0HR2>A(&*N_"T _"_P\#R/L@_F
M:J7?@?5+77]0U+0-8AMX]5MH[>_AO8&FW%$V+(I#*=VWCGCJ>:WO!VA3^&?"
MFGZ-<74=T]I'Y8ECC* CZ$G\_P!!0!YGX=UW6_#&A^*]2T_2K*XTFQU^\DN5
M:<I*4WKGRU VC:.>3SZ5V5EXZED\5W>E7\-O:V9TT:G971+?OXC@DD=BO.1G
MMFH%\ Z@EEKNC#5;?^QM9O9;N<_9S]H02$%XU.[;SC&XCC/2J^J0>&O%WBK2
M-(T^=VOO#URWVE8D=1%"$*M$S$ %68(N,G(SVS0!V^ESW]SHMO<7MO%!?21!
MWA5B51B,A2>O'0_C7C&O:EK.L_"/Q1=ZR]M<O!J_E1F-2"C)<1IA0> N!@=^
M3GJ:]UKS2]^&^L7'AS7=!BUJS6RU'46O8BUJQ>+=*)""=^#RH X'&?; !H/X
M[O=)UW6;'7["WABL=*_M6-K64R$Q[BI1L@?-D=N*ET3QAJU_XBLK"YTIFM+R
MW:7[3#:SHMLX&=CM(H# CHPQDCIS2:CX&N=:\47VI:C=VYL[[1SI4T$4;!@"
M2V]6)Z[B<#'2I_"WAKQ-I,T$>L^*/[1LK-=EM$EL(F?C:#*V26P#T]<$DD4
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M:C'EI%17 9!D9"]3C)J#_A.]4@T?1/$5W86HT759XXO+C9C/;I*<1NQZ-VR
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M(FT,<8R%)./IDUYT\6G>"O T/@SQ1J"W_P!MAEM;"&ULI \RCHN1N&_+#!X
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MTA.I:BEI),\YAPA5FV^8%8H6*@9 SR<8/( .QK)\3>(+?PMH%UK-W!<36]L
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MZL64@]@1B@#T^BO,KJ369?$\/@]+YY9+71TG,LFIR6LEQ,S,K2[D1BP7;PO
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M8>&S.HRWD@D5E!D5Y$4["&&1D\D>M &]K>OV&@00O>.YEN)!%;V\*%Y9W/\
M"BCD_P AWQ52/Q5#_;%CI=WIFI65S?%Q!Y\2E&VJ6/S(S ' /!.?:N6UMFC^
M/?AIKM@+1M,G6SW=//R=^/?9MKNM4CA>&,L8UNE9OL;.0")2C*-OJ=I;\,T
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MX?'UC<7>I6D.EZM)<:;M^UQK;@M%N4LO&[G(!/&:ZHJ"02 <'(SVKSSP4?\
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M''/;CIQ73T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=7!^T:A ]MYB%2_^KP5R.3@$\<XYZ5U:?\(W_P +GLY%_LP6J^&RRGY-@;S
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MY 8D #C/%='K5]IECXP\=?9[6&[MW\/Q VMM($\[J& *\\*03CD"O9\#TI:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;[81/$0 4* K\W/K]/>E;PUX@?P_X_L_[(<2ZW<R2V8,\7*NH7YOFXQC)^M
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M#9. ,'J17%^(-%O?#EEX=F>!9M0O_&/]HO;)(,*T@<B,,>,@ #/3.>U:FO\
M@35O%Q\0ZG)&-,O+RVMX+&WED5R#"_F9D*$J-S<8!.!S[4 =9%XRMX]872]4
MT^[TNYEMGNH/M)1EE1.7 *,WS*.2/2F:?XWM;RR&HW%A=66F-8M?I>S-&R-$
MNW/W&8AL,#@C/7N*S;G3-<U_7-*UNZTE=/GT>TNO*@EG247%Q*@0 ;21Y8P>
M203D<"N;3X;WUVVIVUA82>'=/O\ 398;JT-V)8'N204>-5)VJ#G)^7C@#DT
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MGP6FF7T]]?6IO$L\Q*\< ( =R7V@$D8&2>>G!QGS_$_2(-&LM2^Q:BZW-_\
MV:\*1*9+>XS@HZ[NO!^[G/XT[4]%U33?B!;>)]+LOM]L^G?V=<VD<J1N@#[T
M=-Y"D=B,C\:YZ^\&:W%864UO8^?>3>*1K]U"DR!84!_U89B-S;=O3C.>>F0"
M9O$/F?$G1=4NH]1TRVDTFZ>:SOG*%"D@4$IN*@G'!'7(KT/3+V34+%+F2PNK
M$N,B&Z""0#W"LP'TSFN!\<>";OQ=XRLI9+*==.AL)(1=Q3(KPSE@R.HW _*5
M%7(?$7C#1?"VE/K.A0S:C]I2VNV%X@WH>!(@&=S'CY1WZ<= #I_$_B&W\*^'
M[K6;NWN)[>V ,BVX4M@G&>2!C)'>L7_A8,!UIM(70M8:^>V%U:1>4@^TQYQN
M!+X3'^WM_/ JQ\1M*O\ 7? >IZ3IEL;B[NT6-%WJ@'S DDL1QQ69'INM?\+$
MT[7&T>86D.BM9R?OHMPE+!\ ;^1QC/K[<T 7HOB%IEUX?TC5;2TO9SJMS]DM
MK4*JR>:"P8-E@H V-DYJO)\3=+AT)]5ET_40D6I'3)XEC1GAF#!3G#8(Y'*Y
MS7+:=X8\8V'@[0M,_LUFCM=1GDU"QCO4C-S$[,RX<'[H+<KD9QW%0#P9XF@\
M-:CI46@0QB3Q&-3A6"ZCV+#O5MH!Q@ +@<#Z"@#N8O'ULSZY#<:1J=M<Z/;B
MZFMY%BWR1$$ADP^T\ \$@_C5B'QM837GARW6TO<^(+=KBT<JFU0L8D*O\V0<
M$= 1D]:PY?#NKWWC/Q/=M8M!9:KI"V4,LDD9PX5A\P5B0/F_2LO1_#_BW^TO
M DE[HMO;Q>'X9K:=OMBL7!B6,. ,\'&0.O!SCC(!6&J1:UJ'BW4_$5IK%M:Z
M-=+Y$L%PBM:+$BL4 1SEF).< @Y&2,#'9V'CRQGN[ZUU"SNM+ELK%=0E^U%"
M! <\Y1FY&.1UKFX]#\80Z;XY&G6IL+[5;HW6GS-/&2!A5*G#':Q4'!Z GJ,5
MFQ> =9O]4U57T6'2[+5M#^QR2&]$TD<X8D-(0,NQ.,G)X[YXH [4>.-T[6XT
M'4DN)+!K^U23RU$Z*1QN#D(W(.&Q@'UXK.\/?$1[KP[X>OM7TJ\BDUJY%M#+
M%Y1BWN6*_P >X+@$9(SQTJ;PVOCBXMH].U[3["RM[6W,+W$-QYIO&V;5(7'R
M+_$<\Y &,9KG;?POXKA^'WAFQ_LB#^T/#^IPW(@^UJ?M,:;P2&Z+D/QD]C]*
M .IU'XB:=IMMXAEET_46.@O&ETJK&2=XRK+\_(QCK@\]*S=9\5Z;JVG:<^H:
M3X@L[>35[>&VD"B#S';!C<_-DQG=R.O!! (K$U/PIXJU&P\=A](A277_ +.;
M9$NT;:410=Q.!@8P3Z] 1S71>,M*UK5_#_AV*RTMGNK2_M;R>(S1J$$7++DM
M@D]L?I0!+?\ Q*L[&?78ET35YSHA4WICCC 1"I;>"7&1CG'7VZUJ3^,+(7>F
M6=E;W%[=ZC:F\@ABVJ1" #N8L0!G( 'K7)W?AW7IY/B(5TB4#7H$CLLSQ<E8
M?*.[Y^.3GZ>_%9U]:ZW'K'A:UTS3R=9TO1=ETL%]#%/&#M3!+JZ,A*L1P3GG
MY>A /1/"OB>U\6Z,NJV5M=06[LR+]I558E20V &/0@C\*R-0^(VGZ==WB/I]
M])9V5['87%X@38DKXP "P8@;AD@=^]6/ )CM=#?1ETB72WTV3RI()+A9\LP$
MF[>O!)WY/3!/3I7#>)/"'B[5WUL3Z3%J$YU..YT^[>]4".V5T(BC0_<; .3Q
MGGD\9 .PU#XD:?87>MVPTC6+B3155[SR8$PD94MO!9P,;1GU.> <'&A/XMLY
M7L+73[6ZU"YU"S^V1PVY5&6 @?.S,RA<E@!SG/T-<E-H?B.>Z^(<SZ%*IUZP
MBAM MS"P,BP&(@G>,#+9!(' / /%&G>'_$^A:KH&O6>D+=R)H<6D7]A)=(CQ
M%"")$;)4C(Z9SCWZ &G\(+J>\\$--</<,YO[D8N9"\BCS#A222<CIUK93Q?%
M<:I/:VFFW=Q!;7JV,]U&T>V*4XZJ6W[06 SC].:I_#?1M6T+PY<6FKVL5O.U
M[/.JQS"3*NY8<@>__P"JL+4?"6IWOB^#5['2&TO4TU(/-J=M=JL5S:*_22,-
MDL4P/N]>I'0 &[<?$;3;7P_K.LRZ?J(@T>]-E=1A8MX<%1E?GP5RZ]\^U.U'
MQ[#9:_=Z);Z'J]]?V\"W!2VB0AXR2,@EQZ=\$]@:X_7_  CXLGTGQIH5EI=O
M-;ZQ?B^M[MKI4&"T99"IYR-G? Z\G@&_'>ZE9_&34G@TA[V9M$MQ+##<(IC.
M]N[E01GC/7V- &N/BCI$T&B2VEAJ=W_;(E%LD,*EA)&#NC8%AA@1CTYSG'-8
MOC+Q;!XA^&/BAK:/4-,U+2RJ3V\KF*6)BPP24;!4@G')!K*DT6^\(:W\/+86
MXOM0-UJ-Q+!#(%!:2/<RHS8'R@\9QG';-:NN>#M;U/0/&EU'8;=3\1O D5GY
MR?N(XE"J7;.W)PQ(4GJ.O- '76GBNV/B>#PQ+:7B7K6(NTG<)Y4B# .T[MQ.
M>V.WI6MI&IIK&G1WT=O-!'(6V";;E@"0&&TD8.,CGIBN'\8:>-7C\.BROX]/
M\3VEQ'$D:R(TT<<BXF4@$\!-SY_V/>O0;>WBM+:*V@0)#"@C1!T50, ?E0!S
M4GCNR6YMS'87TUA/?C3EOXE4Q><25Z;MVT,"N[&,_G7'Z9XO7PIJGCB:ZM=6
MU"TM-25G:-O-%O&47G,C#C)Z+DCT K1\.:1XW\,2R^'+2TL)=&-W)+!JKS_/
M#$[ERIBQEGY..V3Z52OO"_B&YT?Q]:II+B37)P]GF>+!&T*=WS<?=S^- '5Z
MUX\L])NIX(K"]OC;:?\ VE<-;[ L<&3@_.RY)P3@>E5K_7-(O_$?@V4QZF9;
M^*6YT]XG"1,##N82+NR3MQ@8ZGKUKF]=\->*M7DN;>?24O+&;11;6L,MXB)9
MW&PAF9>0[9Y5N<<<KR:M6V@^(TN_AY-)HQ T*V>*\"W,9QNA$0QR,GY<GM@C
MDGH :2_%33C:?;3HVKI9)?FPGN&CC"P2[@OS#?DC)_A!Q]>*[RO'YO"/B67P
M!J>D#1W%Y<ZX;^,&XBV^491)R=_7 QCU(KUY&+QJS(R$@$JV,K['&1^5 #J*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***Y+Q[K^J^'K/2)M+^REKK5(+
M.1+A&.5D.."#\O3T/6@#K:*\QG\2^,(K[Q?IOV[2C)H5LEZEU]C?]XK1LXCV
M;^/ND;LGZ'/%N[\8:O<Z;X8NH);6QCU33S=3%8C<3-*44K'%$#N(RQ).#@#D
MCK0!Z'17E=CX\\2:II/@:YM_[.BDUYY8;@/ [!60-\R_-T^7.WOTR*LP>,?$
M2>'O$RRS:8^HZ1J8LUNY1Y,7EDIEV4MU 8_*&Y.!SW /2Z*\SL_'^JQ:?XVD
M>'[>VA)%):LUJ]N\JO'N^=#R ,9SQD5-;^+]:M_$4%O/>65WIG]A?VQ<2I;'
M>N."BD/@ ]02#T/7K0!Z-17GFB^)/%NIW6B7::>9--U*(R7&ZV"+:!EW1LK;
M\R#G!R!GJ,=!B0^//%[>&-+UYGTEQ-JYTV2U$#KY@,K(&W[CMQ@<8/KD]* /
M7J*\WE\=:MX?N/&$&L&UOCHMM!<0/;PF'>90<(06;@-@9STS5A-<\96]U>"2
MT#V2Z<\ZW=Q:>4(KA>=FT2$LA'3G(]30!Z!17E^D>,O$TLG@JZOIM/>U\0JR
M201V[*T3",L&#[N<GJ,#'3GK6E\-)M7N9?$\FI:D+L1:W<V_,.TY0(H(.<!=
MH VX_&@#OJ*@O9I;>PN)H41Y8XF=%=PJLP!(!)Z#WKSCPWXTUW4/$FFZ5/=V
M=P;_ $R2X:1+1A%#.N/E1PV)4&<$J><<-0!Z7-$D\+PONV.I5MK%3@^A'(_"
ML>.+0/ OAY]K1:;I4!+$-(Q1"3SC).,GG [DUY_I/COQ3/H'A'7[N733;:OJ
MJZ=-:QVS!@&DD7>'+<8V=,?CS1XRUO5/$_@7QO/9W5O;Z=ILTM@(3#N>;R]O
MF,6SQDD@8';G.: /6(98YX8YHF#1R*&5AW!&0:?69I3M'X8LG10SK91E5+;0
M2$'&>U<'X:\<:U>>*=!TZ^N+2Y34[:XDG^SVY6."2, [8I=Q64#."02,]Z /
M3Z*Y+QUXDN?#5OITZEX+"6X*7M\EL9_LR;202@[%L#/./3)%9MOXLU(WG@Y(
MM0L-0M-8FN(I[B&(@.$5V1E^;Y3@ %3G!R* ._(!!!&0:9%%'!$D4,:1QH-J
MHB@!1Z #I7EVI^/?$-GX9\3W\)L&N-(UL6$>^!L21%HUYPW#9?KR..E:#ZWX
MO'C'5/#@OM*!CT]=1ANOLC_N@6*^7LW_ #<C[Q(^G.  >B45YA;>._$&HZ5X
M&N[9=/B?7G>*Y62)V"LJM\RX;IQG;^&1UJI=>-/&%IH'BB[:YTII/#EX8F?[
M*_\ I:_*<8W_ +OANH+9]L9(!ZU17G?B_P 7:SIL\ALY[6V@32&OHD$)N9II
MAD[2BG*1@#ER .>O%59?%WBS4[_PQ::0^EV[ZWHQOB9X780R;%8\AN1EL 8X
MSGG&* /3J*\^3Q9K6E>)=:T?7I+4O'IRWFF-;PE?M!Z.O+'+!\ #C.<UVD4T
M]EHRSZG)&\T,&^X>)=JD@9;:,GCK0!=K)UGQ/HWA\#^U+Y+<E#(1M9BJ @%B
M%!(7) R>,FN)?QKKT'@_2_&DC6KZ==7$8GT]8<-'!(^Q2LF[EQE2<C!R>E26
M<5_<_&W689[RWD@72H5,36V0T)D8[/O=>3D\YSTH [>_U[2M,TR+4KR]BBLI
M2BQS9RK%\;<8]<BFMX?TQM?77#;DZDL?E"?S7R$_NXSC;WQC&>>M8GC_ %:[
M\/>'[.>PCLRAOK>W>*>#>-C.%^7! !'T-86I^*/%?]K^-[6SN],ABT"VBNH6
M>T9F=6B>38?GZG;C=[=.> #TNBO.W\::O!<^"-0N/LL>BZ_%&ESB(EH;AXPR
M*&W?=9CCD<8-3W?C#4HK:S\E[<OK.L&QTZ1HCB. $@RL-WSYVL5Z9!7WH Z?
M7]#T/6;+=KEC;7,%L#('F7)BP.2#U' [>E1^%[70(M%AN?#D%M'870$BR0)C
MS.V23R?QKGCXCUJQUW7O#]W+:7%Q;:9_:5E=& A63)5DD0-R=PXP1P:J^'_%
MNI:Y!X;TFU:ULKR]T@ZE<3+!E$4,$"HF0!EFSST"^^0 >BT5P$GB?Q';R:-H
M=];QQZY<6\UQ=O90^<JI&X5=BE@,MN4G)..1CGBC>>-?$FDZ%I=QXALVTI7N
MIH;V^2T,PC11F-S&K':'SSR<8/KP >FTP0Q+,\RQH)7 5G"C<P'0$^V3^=9O
MAN^?4O#UG=R7MM?-(I/VFV&(Y1D@,!DXX'3L>*N:A?V^EZ;<W]V^RWMHFED;
MT51DT .CO;6:\GM([B)[F *TL2L"T8;.TD=LX./I3[BXAM+:6YN)4A@B0O))
M(P544#)))Z "O%-(U4:)\3=&UN>YE8^)XFM]1C=6"V\Y.Z%1D#H"L8_W2>]>
MTW=K!?6<UI=1B6WG1HY(VZ,I&"#^% &0/&OA8N$'B+2MS#<!]K3)'KUK5LKZ
MTU*SCN[&YAN;:3.R6%PZM@D'!'!Y!'X5P>HG;\?=% [Z',/_ "(:GU;7M1AU
MW4]!\.6S1O8VXN7,=J)M\\S.X!RR[5R"2>22W;'(!WM4+C6M-M=7M-)GO(DU
M"\#-!;D_,X4$D@>@ /Y5R5IXE\0:SJ-IH8A@TC5AI0O[SS8_-VR%RBHHS@#(
M+$Y/! ]ZR-=?7IO%_P -FNX[*WUMA?B8#+PH_D ,0 <G R<9'/&1UH ]0CAB
MA+F*-$+MO<JH&YO4^IK.NM!TN?6(-;N(";ZU0K%/YKCRU[@ '&#WXY[UYY/X
M\\36W@S5+W=ITFH:9KYTJ1S RI.@=%# ;OD/S^_2M_3==\0+XQUSP]?75A.]
MO8)>VT\=JR!"Q(*LN\[@,>H- '6:5JUCKFF0ZEIMRMS9S F.500&P2#U]P:N
M5YIX:\9ZCK.D>$[&$6EI?ZO;W%S-*D'[N)(V(PB9ZDD=3Q@]:OZAK?BG2M(T
MM-3ETVUNIKYX+FZ1?,S$-Q0QQ9W,[X7Y1DC)X] #:\60^&EM[2^\2R)'%:SJ
MUO(\SILES\I4*1\WH>HK?FFCMXFEF=8XU&69C@"O'/$'B*^\2_!/6+G4%3[1
M;ZJEJ66(Q[PES& 2A)VG'45[-0!BVOB_PU?310VOB#2YI9FVQI'=H2Y] ,\G
MZ5M5X#X;T;5O%WP-TKP[I^ENGF7;.=2FEC$<*K.S%E 8N6ZC&T=^:[JV\0>*
M[GQIK^G)<Z6FEZ'/;/.[P/YDD+Q[V4?,?F SSW(' H ]$HKS*3QOKL/@O3_&
M[M:MIMQ<)YVGB'YHX'D\M2LF[EQE2>,')Z5)XB\:ZS:7/C#[&]K:CP_!!+#%
M/%O^U;UW$GY@=O\ "-O?OVH ])HKS6[U_P ;S>)M.T*RGTB*XN]'-\SS6DBB
M)PP&"-Y)ZX]LD\XQ23>,?%6H)>7F@Z<UV+._:T%J+<;)UC;9(?-+@J2=Q''
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ML+7[.-LD*.4=O-+C#<%AQ@<#GK73>/M:O_#O@G4]7TUH!<VL8=1/&74C(&,
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M)?7274GV&T*R+%Y?R_-@$9//6@#T:BBB@ HHHH **** "BBB@ HHHH ****
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MH@"*/()  ZDX&6.2<#I72T4 <]=^&'NO&UCXD%^4:TMWMUMQ$"'1N6R<YSD
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MW.WOWSSFMJ7PM2[MM9T^SU^]LM(U:4W$]BL4;JLA8,Q5F&5!(Z#_ .M7H5%
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MAN[K_7S+>S;I?3<?*YI-1T;6]7NK:ZU'P]X8N;BU),$DMU*S1D^A\GCH#^%
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M"0Z''<16MI>2,L,@C<@AN#N^49P #WS5FTTM#XB^'J?;=0V:SI$O]H8O9/\
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M222 ?)]SSUYJQJ>AZWK-Q!/J.@>'+F6 AH6DOIR8R.A7]UP?<4 /U^PU"P\
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M.<[K>%-0>*\B;PQX8:.]8/<J;R;$S Y!;]US^-.O_"U_JEM:6U_X6\*W,5H
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MV=W()9X3=S%9'SG<08NN>_6M>V7Q79VT5M;:5X>A@B4)'''>2JJ*.  !#P*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M HI"< GTK 3QKH)U6\TY[Y(;BT8+*)OD&3V!/6@:3>QT%%9'_"4Z%_T%K/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\/\ A1_PJH_] 74?_ ^'_"O;\48HY$'UFH>(?\*J/_0%U'_P/A_PH_X54?\
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M%'_"JC_T!=1_\#X?\*]OQ1BCD0?6:AXA_P *J/\ T!=1_P# ^'_"C_A51_Z
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M;LXKR5;*]M+HS6^1L9HPI4],Y^;^596F:GJDL'Q!A;4[G.FW#BSD)4M"!$'
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21110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>modificationno14effectiv011.jpg
<TEXT>
begin 644 modificationno14effectiv011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^9S^-2']G^\,_GGQWJ'G>5Y/F>0=WEXQLSYF=N.W2O4=&\3:9J<\6G17HDU
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9.=P_.GZ);7^BZYH.IW5E>/8R^'H=/D$=N[O:SH0Q#(!N ;.,XZJ,]J]'HH
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MQW<1DAGB)#8.T@@@C((]: (K?QC>7VE:7=PZ+);-=B;[2]ZYBBL_+X^=]O\
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M>-K>,R ,V<,V.B\<MT%:%>6V5]J6C_#WX>R6FI3C[;=Z=!.KJC;HG0;D!VY
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M:M#K-C]K@AN(D\QX]MQ$8VRK%2<'MQP:XOPY97D/Q2UR*ZUB\NY8-,L@[N$
MD)\P'Y<849RV!CD\YK,B\3>()?!NBW8U5Q>7'B46$LIA0AXC<,F",#LHZ8H
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MC$GF2 @DJ2=N.F%)Z]'6NI7GB#Q1K6D)J4EG'IEM;;7M0N9))59S)E@<J,
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MTEO=&UMY)5Q)N1BBDX)7Z4_P_J$NK^&=+U*942:\LXIW5 =JLZ!B!DYQD^M
M&7H?@+0_#VH&[T];I%#,T-L]T[00%L[C'&3A2<D9]"12/X#T9]'U/22;L6.I
M2M+-"+AMH+-O8+_=!;GC^59*>.-8:V\3W::5:3PZ!<R0RHL[(\R(H=F7*D [
M3]T^G6NJTW7M/U/1[+4XYTBAO+=+B-9F"L%;&,C/JP'U- $-SX;L[C48-26:
MY@OX8/LWVF%PK219SM88P1GD<9!Z8J.3PEI3?V2(XY(4TJ4S6J1O@!R""S9S
MN)RV2>N2>M:\EY:Q7$=O)<PI/)]R-G 9OH.IHN+JWM%#7-Q%"K' ,CA03Z<T
M <_=>!-'O(M028W6Z^NTO9)%FVLDZ8VNA'W2, >G%.7P1I0DU:3S+UGU:W6W
MO"]RS>8H4KGGOM)&>W;%=!+/# %,LL<8;@%V SQG^0)J.2^LX4A>2Z@19L"(
MM( ),]-OK^% #=/LH=+TRVL8"Y@MHEBCW'<VU1@#WX%<3X(\)LNB7$.L17D8
M;4Y[DV4K#RI/WI>-\>GW3C.,CD9KN9[VTM9$CN+J&%Y/N+)(%+?0'K1+>VL$
MZ02W,,<T@RD;R ,P]AWH YR^^'VB:@-425KU(=3E6>XABN66,R@J=X7IN.U<
M_2M2P\.V6G:S>:K ]P;J\CCBF,DI8,L8(3KW&3SWSS4^N7L^FZ%?W]ND;RVL
M#S!),@/M4G&1TSCK7(1^/K^UT;PWK6I:9;_V?K<D,6ZWF8R6[RC*94CYAV."
M"/0T =3H_AZQT*6]>R,X6\N'N'C>4LBNYRVU>@R>:9=^&[.YU=M4CDN;6\DA
M%O-);2;/.C!R WTR<,,,,\&M*XN[:T"&YN(H0[;5,CA=Q]!GJ:=+/#!_K98X
M^"WSL!P.I_"@#(OO"FEWUGI=H4D@M]+FCGM(X&V"-T!"GWQD\'@]ZU;JUAO;
M*:TN5\R&>-HI%)QN4C!''L:5;F![;[2LT9@V[O-##;CUSTQ20W=M<6_VB&XB
MD@P3YB."O'7D<4 8-OX)TNVBT>-9KUQH[;K0R3EMIV[.<]0%XQT_'FG2^"-$
MN;/6+2ZADN(-7F\^Z21^LF  RD8*D;5QCTJYJ/B72-+^SBYO[=7N)TMXT$BY
M9VQ[]@=Q]JO&_LUGC@:[@$L@#)&9!N8'H0,\T 9^@>&[+PY;R1VLMW.\F-\U
MY</-(0,[5W,> ,G '')J2YT&TNM?M-:=YA>6D3PPE6^55?&[C'.<#\JT)IX;
M9-\\L<29QN=@HS^--6[MFF$*W$1E(W! XW$=<XH Y]? ND)HT.E*UU]EAO/M
MR#S>1-OWYSC^\2<=*O?\(U8'6+[5'\UY[ZW%K<!G^5HQG QVZGIZU+>7EXUS
MIS:=+I[VDDY2Z::0[BNTX$>."V1T/;-8$GBW44N?&L2VMJQT"%);<;F'F[H3
M+\Q_(<"@"['X'TJ/2=,TP2WK6^F7$=S:[[@L4>,83D]E'1>GKFHKSX>Z)>KJ
M:.UZD.HW"W4T,=TRH)@RMY@7H&)49^E;/A_4)=6\-Z7J4RHDMW:13NJ9VAG0
M,0,]N:L+J%DTDL:W=N9(O]8HD&4^HSQ0!2M_#UG;:^VM(]P;QK5;0EY"P,:G
M('/4Y).>O-4/$RWVK2/X<_L-KG3-0MBEQ?M,H2')P1M^\6 Y&.^/<C?%Y:GR
ML7,)\W_5_./G^GK2/?6D3[)+J!&+B/#2 '>1D+]<=J *.M>&]+U_1#I%_;!K
M,;=BH2AC*_=*D<J1VQ6:? >COH1TN22_E'G)<"ZENW>X$B'*,)"21C' Z#GC
MFNCCN(999(HYHWDB($B*P)3/3([5&M]:/*D274#22 E$$@);!P<#O@@YH YV
MX^'VBW2ZLLSWSC5HXX[S==,?,"# //?CK^6*V;G1H+LZ<99KK-A*)8RDQ7>0
MI7Y\?>'/0U<BN8+B,R0SQR1J2"R." 1U&13;>]M+N-I+:ZAFC4X9HY P!]R*
M )ZQ]-\-V6E:SJ6JV\EP;K4F1KHN^0Y087C'&!QQBGZM?W!T>XET2XTV2\C"
M,INY2(0I()+%>1E<D?AVJ[-?V=N_ESW<$3XSM>0*?R- &1+X/TR?^W-[W)_M
MQ0E]^\^^ FP <?+\O''\ZK:EX T35/[.DE-Y#=:?"((+JUN6AF\H?P%EQD?_
M %_4UT$E_9PP)-+=P)%(<([2 *Q] <\U8H Q4\+:;%JNG:A$LL<NG0M!;JK_
M "JC8W @_>S@<GGBJ6H> ="U'7WUF2.ZBN9@JW*V]R\4=T%Z"55(##MSU[YK
M?%]:-*D2W4!D?<$02#+;>#@=\8YIS7=LLPA:XB$I(4(7&<D$@8]< _E0!SNH
M^ -$U.35FG^UK'JRJ+N&*Y98W8  /M'&[ 'MQTJ^?#-F=9L=5,UTUW90M!"S
M2[AL;&[.>I.!R?3C%:0O+5KLV@N83<@;C"'&\#UQUI9+NVBGC@DN(DED^Y&S
M@,WT'>@##D\$:',-8CG@EEMM78R75L\S&(N0N7"]F^53GJ".,5'9^!M)L]"O
M=)$M_-#>1&":2XNGED\HC&Q6;.U<$\#'6N@FN[:V_P!?<11?+N^=PO&0,\]L
MD#\10UW;)<I;-<1+<.,K$7 9AZ@=30!B:CX82YT_2;*VNKR!=.EC:*2.X*$*
M@P V/O\ '&#QZ^^MJFFVNL:5=:;>H7M;J)H95!P2K#!Y[5(U[:I="V>YA6X8
M9$1D <CUQUH6]M&NFM5NH3<+]Z(2#>._(ZT 9$7A*PBN](NC/>23Z2KI;/).
M6.' 5MV>N0 /;'&*K3> M"N=)U#3;B*:6WOKQKZ0M*0R3DY,B,,%3GTX_,U>
M\5>(;?PMX;OM8N%$@MXRR1;@ID;LH/UIEAJ5[')<SZI=:4=,PAMKJ%RF6.=R
M,&)'!Q@@\YZ"@"SH>A6F@69M[:2YF+MNDFNIVFE<XP,LQ)X'0=!20:#:6_B&
MZUM&F^V7420RY?*E%SM ';&3^=:#3Q(B.TJ*CD!6+ !B>@'UH2XAE@\^.:-X
M<$^8K K@=>: .=T[P%H6E:U+J=FEU'YDIF^RBY?[,LAZN(L[=W\NV*Q?#GA5
M[N?Q2FKQ7L5I?:O+.+9FVQ7,)";21UP2IR,C(X((JYJOCV#_ (1^VU;0GM;R
M*34XK)BS9&UIO*+#:?8D'O7817$,Y<0S1R&-MCA&!VMZ''0T 9=UX;LKC5O[
M3B>XM+PP?9Y)+:39YD8.0K#!'&3@C!&>#3'\*:6;K1IXHY(/['#"S2)L*FY=
MK9'?*\<_SK5@N[:ZW_9[B*;RVVOY;AMI]#CH:=-<06X!FFCB!S@NP7. 2>OL
M"?PH S?^$=LAXDDUY&N([V6!8)-DI".%SM)7H2-QZUG)X$TB/2[;3E>[%O;7
MW]H1#SN1/N+;LXR?F)..G-= ][:1M"LEU"K3_P"J#2 &3_=]?PI9KNVM@QGN
M(H@J[R7<+A<XSSVYH Y?Q%X6#:?XBO-.MI;O4=7MT@N(&N/+$J+\N%/ 5@C-
MCD GK5/0-*OUU*WGMV\4VL:-F9-7O4FC9<'*A=SDGISP!UR>A[62Y@BMS<23
M1I !N,C, N/7/3% NK=K87*SQ& C<)0XVX]<]* .2\?:5=:M/X92V@N)$MM7
MCN9W@X,481QOS[%EXY^AK6G\):3>Z=J-E?PM>KJ./M<DYR\NT87D8QMQQC&#
MSU)-37GB71[&_LK*>_MQ<7<CQQIYBY!169B>> -N/J0*DM[F^&KZDEV]@MA$
ML;6QC<^: 0=YE!X R/EQV!H R[7P-I-KH-[H_FW\\%['Y,TEQ=/+*8\8V!FS
MM7!/ QUJYJ'A>PU/1+32+E[@VMJT31[9,,3&04R<<X('Y<UJ1W5O-*T45Q$\
MBJ&**X) /0X]#0MW;/<M;K<1-.HRT0<%@/<=: ,NY\,6-QJDVHI+<VUS<PK!
M=-;R[/M"#. WN,D!AAAGK46H^#](O_[.9(Y;*;35V6DUE(8GB3&"@(ZJ0!P>
M*W7D2*-I)'5$499F. !ZDU'%=6\\KQ17$4DD>-Z(X)7/3([4 4-"\.V'AR"Z
MAT\3!;FX>ZE,LS2%I'.2?F-12^%[&>X#S2W4L NA>?9GEW1>:&W!L'D8;G .
M,\XS6HEW;2W$EO'<1/-'R\:N"R_4=14<EXDD,R6<]L]R(V9%:3C(R/FQSC<,
M'\: ,:;P3I-Q8:S92FY:#6)?.O%\S[[8 ../EX4#CTJ*[\ Z/>S:E)-)??\
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MBM8YMP^<E$4;!M4OP03@9!SC(NM2-M<>-I()X[VWBU/3KR\CM%P)K8+&9BJ
MG*D#!.3D9R37MODQ>3Y/EIY6,;-HVX^E*(T5F944%L9('6@#S'Q!J7A?4_!?
MC75?#\RS&[TPB[N(RPB+A&5%P>-^#R!STSVI^GQV-E\0O!QLQ!$USH<RRF/
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MI#I^J6H"S1PADRDZCCGY<-QDJ>,YKM?#1T1O#]J?#HMQI7S>1]G&$^\=V/\
M@6?QK32&*)F:.-$+G+%5 R?>E1%C4*BA5'0 8 H =1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM- %+I.@'#9P002".#T-<A9V,VH:-?27OP]L[%I(!;RVBO"9;E2PW!77 "@
MD9(R<=,9*:+;ZYX4L-;GM[74M1TV,1-IUC?W4?GJ>?,'F%CB, C&XY^4_4@'
M=7,QM[:6989)BBEA''C<^.PR0,_4BN8\,^-%UKPM8:M<V<T4U](RV]NB@F4Y
M8@+SV5>2<#@G@5TEI<"^T^"Y5'C$\2R!''S+N&<'WYKRFR\,>([/P3X8'_"/
MQ75YH4LBSZ;=21%;N-]P8H<D C*D;L=^/4 ]"M_%NEW-E-<*\JR0W7V*2V9/
MWJSY_P!7M[DY!R#C'.<<US/C?Q2)O!6IW&FW-W8WNG7]M;W*9V21%I8P02I(
M(*/U!(YIFI:+K-QHMCJNC^&[/3+^QU)+Y-+5XU:X4(R,'=?E#D.<=<8'/.!)
MXH@\1^*/ ]W&/#SVMU-<VS169N(FDVI*CL[-N"CA< 9)X]\  Z&'QCIDD^IP
MR1WEO+IT N9DFMF5FA.<.JXR1\I[9XY%1Z9XXTC5+S3+:%;N,ZI 9[.2:W9$
MF 4,R@_W@#G^IK'U32-6F\9:[J$.FS/;7/A\6<+B2,;I@SG;@MD?>')X]ZJ6
M&@:S OPX633)1_8\+)?'S(_W1-OY?][YOF],\4 ;VEZUI-M)XCO#J>H2QV]\
M([A+O<5ADVH!'"N,X.5P!G)/&<U9?QEI5O%JK7OGV;Z6D<ES%,GS!9/N$;20
MVX@@8.<\'%<?<^%?$%U:^*GMK7[/>/K<.J:=YTB%+CRA&0IVL<9*'KCJ*UM2
MOO&&K^%+Z:V\/'3;X>4J6\D\4LLHW@R%3]P87=MW=2<X&!D VU\06^J1ZO81
M+=6FH6,(::&50KH'4E&!!((.#T/&.U0_#V\N+_X>Z%=WD\D]Q+:(\DLC%F<G
MJ23UK!T?2-2M?%?B*^&BWD-IJ&FP)"T]PDDAD4295R7)W?,.Y&.XZ5T'@'3[
MW2? FC:=J-LUM=VMLL4L3,K8(]U)!_.@"E)\2M BCFG87XM;>[:TN;K[&XBM
MW#!?WAQ\HR<?SQD5>N?&NE6VNRZ/LO9KR$P^8L-J[A5E.%;('W0>IZ#(KAM*
MM;W6_"WC;0+73Y'>^UN^A6Y8IY4>YP"S<[OEZX YXQWQU6A:-?:=X_UBZ>TE
M&GRV%I;P7+.A#M$&#9 .X?>'4>M &E<>,-+MAYTGG?8!<_9&O@F8$EW;-I.<
M@;OEW8VYXS3]1\5Z=IL]_%(L\ITZ!;B]:&/<+>-LX+<Y/"L<+DX&<=*XZ/PO
MK)^'E]X%ELG):62*'4"Z&)H'EW^8>=P8 D;<<D#L<@UFVN6\4^(4L=(U2YL[
MVTAL;Z73I8'+D(<Y$CJ5<(X'&>#GJ1@ Z>]\>:+9"PXOIVU""2>U2&SD+2H@
M!.T$ DX(./0YZ<U->>,=,LK)[Z5+K[%#L^TSB+Y;;>%(#@_,#AE)P#MSSBL&
M*UFU#Q/X-U'2])N8=*TVWO+6992BM;'"QJA4MDX,9&5R.G)JI+HFIZ?XEU:!
M_!UAKMEJ5R;F"^F>(>26 #)*'!;:""1M!X/2@#L+CQ)9PW<T"0W%P('CCGE@
M0,L3. 5#<YY#*<@$ ')Q2CQ):M>&!(+J2,7/V0W"1@QB7H5/.1@\9QC/&<UR
M7B+P]J,NMRZAH5C?:?K4;P1QWEO,BVMW$ N1-&6Z*-XQC/ QGI4D^@:BOBZ+
M5-%M+_2[A]0!U ><C6=W;@\R%-Q.\J!@@ Y//'- 'H-<Y>:AI\'CB"*;4;^*
MYCTV6<VV2+4Q!ES(W&"PS@'/ S5S1M8N=3N]2MKK2Y;%[.?8F^5'$R'.UQM/
MRYQG:>0"/6L/5]-U-OB)!JL&EM=64>C7%J6+H%:5G5E0@MG!VXSC'- &O%XI
ML6MY+F>*YM;9;1KT3SQ@(T(P2P()[$'!P?:FW/BNUL=.OKZ]L[ZVBLH%N)0\
M:D^6<X8;6(/W3D9R/2N4TGP]J.E3W\6G:7?GP_-ILBMHNHW".GGDC$<1W-M4
MKN!R=O(Z]JZ^$=7.A>)M'TQ;^'1[O3#'96>ISJ[0W!W92-MS$1XVCDXR>.*
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M_M*VX_[2@U2BT/6;'1?%?AT:>]RFJ3W4MG=[T\O;< Y$F3N!0L<\'(QC)XH
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MK5[5+.4O(J2>7(ZR_<!!#$*0<@=03P =O6)<^$=%NM2EU!K>:*ZF(,KVUW+
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M>\;0 H/WCR3V.*U?#7A^W\,Z*FFVS!D6224[5VJ&=RY"K_"H)P!V'KUK7HH
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M[#U/.?I6%#X&,=KJVF2:CYND:G>R7<\!@Q+^\;<\?F!L;21C[N<$C/>NOHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYG%M,L\(\QUV2+T8;2.1G@TE[X?TO4+^SO[FUWWEED6]P'99$!ZC<""0?0T
M<3I%WK/B*Q@UNWU2"UF@U%UN0UW(R[%E9# T.-H)7: ?O9P<Y-9\L.I7^F^/
M;P>(=5@GTB^G>R*715(MD*. 1T9<\;3D8SQDDUW:>"_#D?B)M?32+<:HQW&<
M \M_>VYV[O?&?>L70/!X_M;Q)<ZQ8OY=_J1N(D-P3'+%M4 .BMM;E2<,#UH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBN$^,B+_PJS6IMH\V)8VC?'S(?-09![<'% '=T5X7XECE\/?!WPMXM
MT29K#5;:WM&EDA.T7(=!N$JCA^<'G/?UKL[WXFFQO?"UH=%EN'\06BSQ>5,
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M96N!'LXSAQM.,9&2">_!QS7'Q<T^W\.ZU?ZEI\EMJ&D7GV*>Q24/OE)(7:^
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MGJ&S1;+[-/&L"YD8HRL5^?H-W&>N.U;7Q#^,>@^+O!UWH5CI^K1/=%,RSP(
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MG6KW5W,L4*8!9O4G  ]220 !R2:R;+QAHU_K9T:&:==1&_=!+;2(5V@$Y+*
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M>VN9H(XIQY@?=E=N,93C*@C)]JOKX!TM?!S^&#=7QLC*9DD\Q1+$_F>;E2%
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M;BXDDU*833+*5*A@H4;<*". !WZ5'>>&+:]\46/B![N[2ZLHWBBC0IY>U_O
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MUR&Q-O;Q*T$<#LJX>0J#YW).%8XXR*UX/ASIUO%I]LFIZL;/3KQ;RRM6G0I
MR[L*#LW%?F/#$XQP1SE9OASILL5U"NHZI';SZ@-22%)4VPSAPY9,H3@D=&)'
M/&* *C>(=4TKQ3KNBZA=F626V2YT4F-%WACL*$@<L)"HY[$&D\6>(;[P[>11
M7U_>66GM9J(]5CM$EB%UE@1.-I*K]PC  Y;GCB];P#Q'XDM+N\T&[L_["EF6
M"XO-N9F8; 4P3E2,L2<<A<9YQJZMX>75WN/,U*^A@NK;[-/;Q&/RY$^;/WD)
M!(8@D$<8]!0!:O;B5-!GNK::,RK;-)'*!N4G;D'W%>?V'B3Q/!HW@[Q!>:E#
M=VVKS6]K=68ME3:9A@2*PYR#C(Z8/05WU];1VOANXM+6%A'%:-%%%&I8X"85
M0!R>PKEO WA=E\(^&_[6DOVFT^%'2RNE55@F"E<XVACC+8W$@9R.@P +X3OO
M$>N:CJL]QJT"VFGZK=V0MUM!F15 "'=G(P2#WSSD],4?#/C'4]9TOPG:W-R$
MOM96[EFN8XE!5(6(P@(*@G*]0> >YS77Z)X=M]!74EM;JZ?[?=R7DAE*'9(_
MWBN%'' X.:S+3P!IECI6E65M=7T<FDRO+978=/.BWD[USMVE3D@@J?T% '.:
M]XOU[1]!\86R7,;:AH<EN8+QH5_>Q3%=NY1\N\98$@8X!Q7?Z5;:E;0SC4]0
M2\D>8O&R0"(1H0,)@$YP<\GG!&:R]2\%Z=JNB:CIES/=$:C(LEW<JR"64KMV
M\[<  *H  ' ]S70HI2-59V<@ %FQEO<XP* /*K#7;[P]IOC75'OY[N>/739P
MK=!"@9A"B.VU0<*&' (&!TSS762:EJ6C^-](TBXNWOK/58)RK2QHKPRQ!6X*
M  J0W0@D$=:E;P+I,JZY#.]U-9ZRYEN;5W'EK(0H+I@!@?D4\DX(XQ5^R\/Q
M6M[;WMS>75_=6T+002W10F-6QNQL51D[5R3D\?6@#G?B MT=8\(+!J%S;1RZ
MNL;I%LPW[MV#'<IR05XSQ[9P1S]Y/JNGZU\3=1TS4!;2V$=M<@F%7,A2U#8.
M> " 0<#//!&.?0M>\/6WB 6!FN+FWEL;I;J"6W90P< KSN!!!#'M5&3P58R_
M\)!NO+XC7HEBNQO3A1'Y8V_+P=O&3GUZT 9)\2:OKD\]II<=Q#/#IUM<AK<0
M,/-F5F <2G[@V@?+SUY'%=9IMS>MH=O<ZK!'!>B$-<Q0MO57 ^8*>XR#6!>?
M#S3KF?3[J'4M6L;RSMEM/M-E<B)YX5Z))A<$#V -=3;V\5K;1V\*[8HU"J"2
M3CW)Y)]S0!Q.C:WXEUJ+0]8M()#87Q#W44K0"**%QD&,J2Y=3M!#=>>!P*C@
MU[68O&5SX1OM059YI1=6-\$C&ZV&"\.W&/-'T^ZV[L =/1_A]I>A:@T]C>ZF
MMH)#-%IK71-K"Y.=RICUY )(!YQD"IK_ ,$V6HZ?:VT]_?\ FVMZ;Z.[5HQ,
M)22<[MF,<XP!TP.E &1)>>)]6\7^*-'T_68K*/3X;62U/V17.Z17."6Z@D<]
M^F,<YKV7C75=3TWP)?KY=N-8N6AO8A'G)5'SM)Z#<F?H>M36&B7UQ\1O%,S7
M.J65M<6]I%'/%$JK<;48/AF0C()'*XZG'MT$_A#391H:0M/:PZ*X>TB@*A00
MI7YMRDG@D=>_K0!SVA:MXEU&;Q!?3:Q9):Z3J-Y:B"6W"(Z)&"A:3.5"D@D\
M\;O;$.D:_K-SXAL](GU.>6*_T5[HW2VZ1[)U9 6AR@RGS'&]3G ()KI+?P;I
M\.EZYISS74UOK4LTUT)&7(:5=K;2JC' 'KTJ&P\$6MCJ>FZ@VJ:G<W%A:M:(
M9Y$(>(E3M8*@Z;1R,$]\T <9I&LZMHWP+TO6;;4'>[D>'<TZ*^!).$8#@==Q
M.3DYKK4U34]?U/Q'9Z;??87TF5+>#$:.)9#&')DW G;E@,+@X!.>1A5^'NFK
MX07PP+_43IZ2(\>9$WH%?>J@[,8##TR>Y-7Y/"MM_:UWJ5K?7MG/>QK'=_9V
M0"?:,*QW*<,!QE<?H* .5L_&&L:_=^"C:3QV$.N65U+<IY(<H\2K]TGW8X_#
M.>E=#X%UB_U?2+Y=2F6>YL=2N;$SA GFB-RH8J. 2/3BK)\):<NJ:+?0/-;_
M -CPO!:01%1&J.H5@05)/"KW[58T'P_;>'HKV.VGN)1=W<EY)YQ4XDD.6QA1
MQGM0!K4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 445QGQ$O?L5KH?VH[-(EU6&/47;[@B(; ?
M_8+[ <\=CP: -33O$,M]XQU?0VMHTBL(()DF60L9/,W=1@8QM]ZW&EC2-Y'D
M18T!+,6 "@=<GM7D-W=:%I'B+XAS1N8[%M)M3(NFNJODB13LQPIY'/09R:=9
M16:>,]5T]!IGV>X\+*PM;,AHF82.!GM(X&/FP.,<4 >JZ?J-KJFFP:A:2A[6
M=!)')T#*>AJUUKQ;2=1TW3O"_@-9KFRL])N+-EO)WA5XA=>7'Y?F]@<>9RW>
MO1/!%I866B31:9JAU&Q-U*\4JX\I 3DI$1QL!) QG'([4 =(6 (!(R>@]:QM
M:UW^S=1TG3((U>]U262.$R'"($C9V9L<G@8QW)ZBN&86^K>'_'AU?:-5LKZY
M\F1N)H$"@VS1GJH^Z5QU.>Y-2ZI9"[\5?#4ZW9VTFHSPSB]62)3O<6N2#D<@
M,3]* .T76Y=,\,S:KXEB@TYK97:<1R^8F%) *GC.X8('7G'6H9O$4L7C6PT(
M6R>1=6,MWY_F'<-C*-NW&/XNN:ROBS;Q2_"W70\*/Y=ON3*@[2".1Z'&:R[F
MPTB_^)/AVT2"TFT\Z/=8A0*8F_>1Y!4<$9SP>_O0!Z1D8SD8ZYH!! (((/0B
MO%M-U0:9X+\/K=7*VVB1ZW>6UQ(\?F11('E$2N.FP-CKP,+Z5Z%X*M=/MK;4
M&TK5EU&RFN3*IA"^1$Y W+%MXQGD@< D]\T =.6 (!(!/3/>@L%QD@9.!FO+
M[R]\/WOB'Q7HWC&[BM+@RQFQDFD$;"VV*4,#'^(2!R=O.3[5I60M-8\;>)[#
MQ#;HZ):VS6<=V!@6QC.]EST._=N([A?04 =_D#OUJGJ6JV6DZ>]]>SK';I@;
MB>I)P /4DD 5Y/IL$]^OPN36P\T\IO%?SR=TL0A?9N]<KMSGKGGJ:HZE:6D7
MP]\7VHAB%I8>*E6WC*@I;H98"0H_A7YFX'')H ]Q+ =2*-R[MN1NQG&>:\SF
MT+0]7^+;63VMO+8?\(_'*D4+;4W+<MAAM(Y&!6#JE[ITMQ;:I8RQ0RCQ=&LD
MES(&NB1+Y;C(QLB X"G=\I&<4 >U%@& )&3T%4[?5K*[U6]TV"97NK)(VG5>
M=F_=M!]\*3CT(]:\WM-0\.:G=:U:>(KM(M<MM::6W42!+ET5@;<0]V4IM&%Z
MY/KFM7PY;Z?!\6_&.8;6.X(LFA^50Y+1.7*]^>2<?C0!W[,JC+$ >I-+D#OU
MKAO%DNEW7C+2M.O/)^T+97$Z?;V'V0*2JL2A^_)Z#*X!8YKB/#?D:IIGPMCN
M9%N3YM[#*&?)*K%)A6YZ8P,'MQT- 'MX(89!!'J*P4\0ROX\?P[]GC\E=-^W
M"X60DD^9LV[<<=#W->;M=MHOA;Q/;VP,.D6_BM8+E(1@6]FQB,H4#[J\L,#^
M\:Z'2CHT?QI<:2UDL4WAU6Q:E=K'S^OR\9VX_#% '<WFK65A?6%E<3*MS?R-
M';Q]W*H7)QZ *>?IZUF^'_$,NLZAKMK/;1P?V9??9%*R%O,&Q6W<@8/S=*Y[
MQU;Z>WCCP3/?PVIB-S<I+).J[=H@<@$GMGGGO7):]I]G<:#\3[V6%'NK2_\
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MFG1ZY9P_"-VTFR;3#IUS%#JUDH+R6P$R_:-PSELKN.2>030!ZH&##(((]0:
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MG^(MD!INQ] CFCM[-1Y0=8Y>5'=A@?, .@X%;>H)IZ:1\.&L5ME!U6V#&#:
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MMMZY[4 ;']E:=]B:R^P6OV1CEH/)7RR<YY7&.M6(HHX(EBBC6.-!M5$& H]
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M/?#RB3&I7>"/[PV\\9K%U;69V\:^"VL[R<:=J$5W+)"HPLH6$,A(QG//3]*
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MA"QY[XZUZ=$_F1*^UER/NL,$?44^FNZQHSNP5%&2S'  H \F.A:X/A?/H/\
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MN;I-=L$^R31,FS<MN8V5LG(.<8XYS5Q=*U0:W\/I7TZ=4TVTFCO3E2(6:!4
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M*W>JQ:=;SS6FKC2W"3D))F15$B9'0AP<''UIUOX U*ST?2;2#5K9I=.U.6^
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M8;&[//.:SY=9U+4?A_K?BF&_GM]3T^XNGBC$A$2+!(P$31_=;*KR2,Y;@CC
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MHN]K*-) 0.X63=\Q _V!G':G/X@FO_$UWH.D"'SK"))+VYF4LD)?E$"@@LQ
M)Z@ 8ZYQ0!JC2K$:RVKBW3[>UN+8S]S&&+!?S.:RM2\#>&M6UM=8O=*CEO@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KA/C&Z#X5ZU&6 >18U1<\L?-3@#O7=T4 >9C;X1\=6VK7DK7^
MAZM&MO;ZA/(96TZ7'W-Y)Q$^.OJ.:H:C>Z5/JWB+P[XHOM3A;4;L36L%O '6
M]A*IY?E,(V.X%0.HP1]:];HH \QQH-O\5M;36_L2H^CVH'VW:0QS(&Y/!;'X
MFL[PLE[X;N/!KZ[OATH65W# ]P=HMI'EW1>83]TF$;1GIR*]#M?#SVWC&_\
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M*GA@#U!J]10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M--B77M1FM#!]E>1K9495!/[Q<GDD]..U>G>+]+DUOPEJ>E17BVDMY 84F8X
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M%4LAW$[OO'GCITYXX?QCK^J^*_!'@S7[X6D<5YKBE((48&(*SJ!N).[(4DG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=RN1]U<X]/>LN*+QQ'I]OHY\ WSZ';ZC_:,=D8),[^<1E\<Q@DG&,^]?4M%
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MC^S77G*WVC(RWR#E=IXYZT ?..IWGQ'N_&,/BK3_  =J>F:KY(AN7MX&99U
M Y5U('  []!W%7?$WB/QGXML;31M2^'-[(UI+%=*S1REV"G!R=O1AD'Z^U?1
M]% 'BX^)WQ* P/AK<8_ZYR_X5RDVJ_$.'Q;-XFT;P)?:;J%RFR[58))(;@<<
MLA'#<#D$?J:^DZ* /GN[\4_$;5M*O[#6? -_>I?0^3(/+DC5%_V% P#GG)R<
M@<X %9NF:C\0K/5-%O[SP'>7KZ):&TL UO(@12-NYL#YFV@#/ ]LU]+51N[J
M_AU*P@MM.^T6LQ<7-SYRK]G 7*G:>7W'CCIUH ^??"6M_$?PI?ZU=Q^!+RY.
MK7)NI5:WD4(Y+$[<#I\W?TH\.ZW\1_#WB;7=:3P)>32:Q())HFMY J$$XVG&
M?XCUKVSQ-XN@T'PQJFM6L*WXTZ012Q)+L^;*@C=@]-PS^/>NDH ^8=)N?B-H
M7B/4=1TOPAJUK9:C-Y]SIZ0ML9LD\,5W*,D],'!QGIBU-JOQ%O=0LKG4O EY
M>_8;]K^U:2V<2Q,69A&) ,F,$CY<9^4<X&*^B[J_MK.6VBGE5)+J7RH5/5VP
M6P/P!/X5FZ/XA.JZ]KNEM:>2=*EBC+^9N\W>@<'&!C@CUH ^:X]5\=W.I^+%
MLO"]XK^(?EO(A:N2B_,"$..OS$9YZ].F-A;SQU97NA7VD_#R\L[O1K8VD+M#
M)(LL1!&'&!DY).01R37TO2'.#@ GMDT ?+%[:^.+KP-_PB\?@34(89+K[9<7
M/DNTDTIZD\8';MT J[;W?Q"7Q9J.O7?@2[N6U&P^P7-L;:14:/:JG'<$[!^9
MKW#2?%U]K::JUCHFXZ;>RV4J-=!2\D>,[?EQ@Y&,D?A3I_%\T>NZ3I$>DNUQ
MJ5HUU'YDP3RPH!97&,@C(]: /G@6'Q$_LW1]-;PMJYL]'NS<V2?9CN0[BV"=
MOS<^WX5JSWOQ(3QK<>)]*\(:KIES>1B.\BA@9TF QS\Z':>!S_B<^^VWBB$^
M($T+4;2:PU":-I;82,K1W*K][RW!Y([@@''.,4>*/%NG^$XK"2_)Q>7<=JNW
M^'<<%S_LCO\ 4>M '@VHZE\2+[QK;>)T\$7L5Q;61LHHC;RNNPAQDD\DY<GK
MZ5B#2/&Q\$0^&I/ ^ID6UT;NUO$AD66)SU[8(_+MZ5]94CE@A* %L< G /XT
M ?,VMWOQ%\3>$_[%USP;JM[.)%FCO3$R/&ZC *JJA>A.>YR>>F)[W7/BOJ7A
M:;2+WP[KLEQ*4_TZ)'BD4(<@ *H'/.3U/<\ 5[1H7BZ^\1:/)J5AHF8DEEB\
MM[L*[,C%2!\N.HXYKIK:;[1:Q3;&3S$#['&"N1G!]Z /%(/B-\48--BMO^%?
MW4L\<(C^T2PRDNP&-Q&!U/-<_P#VMX]NM'TC3M4^'=S>C2KI+F"4P2(2RYP&
M&,$<\],\5](44 ?-&J:I\2]3\>:=XL/@F[CN=/C,4$ M9"FTA@=W<GYSW':H
MM-NOB-HWB74M4TOP?JUI::G+YUW81Q,4=^2=K%=R9)/3!YZ],?3E% 'S''=_
M$:S\7ZAKVE^#]6T]=3P;ZUAA8K,>Y!*DJ3DG(Y&3@C-6VU?XB+X__P"$NM_
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MUAT2SG\!W]SINB7#W-E;O!(#O+;EWL!\P4DXX'OFH+V/XB7MYXFN&\&WRGQ
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MY_$EP"#G:C$,5 ;+'.<CKVZ&_P#"UK'X8OM(T"UL-,^TCD); 1-DC<&5<9#
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M*G"J60,<9[<UYY<W.E6=]XZTC6A;V\K6B1Z=%/A0]H(,(L6>N'W<#G<:[3P
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M4;S2GBU*$26GV>0K(C!2SAP21M&  V1DG&WJ:X/[3:#X9_$N"2YMY#'J5VR
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MARZ9+%;S*P\E;SY,Y/3=L#@>^X>M 'H\<B2QK)&ZNC#*LIR"/8URT_B35/\
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MB/[(>%?,DE<>=YB;QP =N.G>KOA_Q0-7U+4=(O+-K#5]/*^?;E_,5D;E9$?
MW*?H".A KF?#&K:;:?$OQ^USJ%I"K36>#),J@X@P>I['@TNF7,4OCSQ!XYF8
MV^A6VFI917$@*K<;6WO(N>JC[H/?MF@#<O\ QK!8_$'3?"[0$K>0N6N?X4E
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MKY(OF>>VE10?J5<@CW)H ]4CFBF#&*1'"G:VU@<'T-<OJ7BBXD\1W/A[1I;
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MI3Y<\@2)U66?"ECPN%^9<\9"CN*[CP%:Z6;K7M4L;W3;E]0OC<%+*9)?(4J
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MRMN&?EQC.,<XSBK'@_Q9"VF>%=(N[>^6YO\ 2XY(+J91LN&2)3( =V[/.<D
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MH))S@#)X- &Z      .@%-,,1.3$A)[E16+_ ,)7I\@T@6BS74NK0&YM(H@
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M?.F5)('0AAC)]:?I&AM8W3WMU):RWKQ^46M;46Z!<YP%W,3SCJQZ<8YSLT4
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MJ"S,1U(  YY(%EM*UBZ\4>$-3DTTPPZ=;7,=R//1BAD1%7OS]TYQGKWKMJ*
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MR-H.K6R-<6W=KD*T>[V&PJ?]Y5/:H8=!\4Z7\-9+"TNTF\0C8OF[@OF(C*@
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M-#U73F6UNXB]K??/R;25?W@![LI *^YS5G7;#69?$6EK;6BW>@+ \<]HLRQ
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M9VLUO9ZOYLR2N5++Y<6X* .#CG)_*@#U-KRU2\CLVN85NI$+I"7 =E'4A>I
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MEQ*%7>[.V!ZLQ)/XFLRW\*:-:REH;5EC,_VG[/YSF$2YW;Q'G:#GG@=>>O-
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M\/00:;#!:30KIC.;0QW<RM&'.77<&R5/<$XH X*[U*^U3X/6TVHSM/<Q:W%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 53O\
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MP49=KX!P"1SP1R* +M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU: )#$6)E0LVXE>0"..E ';T5R>A^)+_ /X3"_\ "FM+"U[!;K>6MU I1;B
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M 9XKSW1DO)/$7@:_;2M4A2WM+J&ZC^P/##:.T: 1JF!M0$$!CG/'S'''K5%
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M)F;!#8X9<KZ8->L5CZGX;L]6U6TO[J>]_P!&4K]GCN62&7D']X@X;!'?\<T
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MF!(99K5TWE6D) 4C(/(^4@'VK!\-1ZEINA^"+*\T6^A2*TGBFN8[%GN+>4D
M1_=)C5QU;'8<CK7K=% 'C>EZ?J-IX*\'++I.I*VF>(GEN8_LKM(D9>?#;0"S
M#YUY&1SUZUT5G'>:7<>,;#4-.O+@:I,]W9R1V[2+,LD2IY1900I4KM^8@8.>
MG->A44 >:Z)H-]I/BOPA;7=M-,+#0'M)[A8F:))3Y?R[\8Z*P^GUJ]KVA7J^
M/K:?3POV/7+8VFJKG&%BPPDQW)0M'GMN%=TTB*RJSJ"QPH)Z_2LK2O#EII%]
M>7D5Q>SS74C/_I5RTHB#')6,'A5)QP/0>@H O7YE33;IK>W6XF6%S'"QP)&P
M<*?8GBO+M$BO9/$?@:^?2M3A6"VNH+F/[ \,-F[(@$:ICY4!! 8YSC[QQQZU
M1U% 'CMK)91PC3[Z'6;?2[37)-10C29I?NRLP'G)E2N[YLXZ'';-:-[&]KXG
MUVUU3P]K.L:9K4B3VL^G2R-#(IB1#%* ZJH^3@MP0:ZVQ\%V>GQ"U@U'5?[.
M7A;%KHF)5_N@XW[?;=C''2NC "@   #@ =J .%L[*:U^)LL_]GSQV<?AV&U6
M1(7:,.LK,8U?'S$ CZUS&AP:SX<\.^!=6DT34;F/3;>YM+^SBMV-Q%YA7:XC
M."V-G..QKV*B@#SOQ;!-J'P_SI^@7-J9M1M[A;..U_>[1,CN[HF<,<,Q[],\
M\5!JL<MEXOUF#4] US5-,UD1O;OI[R>7_JEC>*50ZJH^7.6XPQS7I=% 'F7B
M/2[NSD:;P\NI6&KV]E# EK';/<V5\BKA8G)! QDKN)! .3[>E1&0PH95"R%1
MN"G(![XI]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %<EJ6N:O#\1]+T2V@MC9364UPY:9E9BK(O/RG&-QP.^>HQ
M76US6J:%J$WCC2=>LI+4Q6UM+:SQS%@0KLC;EP#D_+T..O6@"M=>.5@T2;Q#
M'8>;H4$[127*S?O-JR>6TBQ[<% P/\0.!G%=8RQS188*\;#H1D$5PD7@>_A\
M*W_A 3VYT6XF<Q7!=A-#"[[VCV;<$@E@&W#J#CC![G:8H D**2JX16; X]\&
M@#PS2;C28?@S>W4]I>_VK&UWY%[;VLP=)!(XC/GJ,*H^7)+8 &#Z5ZMI^JSV
M'@&RU/49H[RZ2PC>5X'#">4J.%(X)9B ,<$FL/PYX:\2Z!X*?P^JZ0\CF?%R
MT\C*OF.S?ZORQG&[&-PSBKNF^#I-)T3P_P"'T-O>:389:Z^TD[IVP2,)@C:&
M;=@GLOI0!F_#^XU'2O$6N^%]:NOM-X&75(9>SI-_K H_NK("!]:QM7N_#^E?
M$[Q+/K\(;3TTNW<_N&D5'9B"?E'R$\#=QSWKJ=5\(3Q^+-#UOP[;:;9FR\R.
M[4@Q?:(G &WY5/0C()[TY/"EU/XWUG5=0BLIM,U*PCLFM][,V%SG(*XP=Q[T
M 9.F:?JUI\&=5AUUWDG%G=26ZRR^;)%%M8QAGR<L!CD$XXYXJ?PYX7L=6^&>
MB/$&LM1ETR"1;^U8QS+*8P=Y9<%N>2#D'O5BP\*Z[IO@_5_#"W=K=V;PRV^F
MSSRN)(HG4A4D^4YVYX(/( '%36.B>)K;P;8^'8Y]/LF@LX[1KZ.1YG"J@4LB
M%5 8@<98X]Z (O"/C*;4_A;:>)+^/?=B%D=$&/.E5S& ON[ 8]VJG\/KC4=*
MU[7O"NLW?VF]C==2AF[2)-S)M']U9-P_&MJ'PFEA8Z'H=E;VKZ#8 F:*X8EY
M6 .TE=I5OF)<YQ\V.F*JZGX1GB\7Z)KGAZVTVT^R++%>(<Q?:(GQ\ORJ1P1N
M!/>@#I-9U%M)TBYOH[.>\>)<K;VZEGD).  ![GD]ADUSH\>PP/XABO[6..;1
M+=+B;[-<><CJP; #;0005(((XZUJ>+]*U'6_#%U8:7=I:W<A0J[LRJP#@LA*
M\@, 5./6L*S\,:_9:]JFJ6Z:- +RQMX$MEWF.,QLV4QM&5(8\X!]AUH Z71M
M4GU-&DD@MA 41X;BTNO/BE!SG#;5Y&/3N*S[_P 4O!KEUI-E:07-W:VZ3M!)
M=>5+*&W?ZM=IWXV\\CDXJ#PIX5;0-6U6]C@M;"VOA&1I]G*SQ)(N[=(,JH!;
M(&  /E]^*OC#PC=>*3-#);:=@;38Z@9'2YLFXRR[5^;D9 W#W]@#6N?$5P]]
MJ=GI&GK?3:8B&X5I_*RS*6$:?*<MMP><#YEYZX@L?&EIK2Z8FBQBYGU"S:]1
M)G\I8XE8*=Y 8@[FVX /(/I4<&@:KH_B35=1TJ2UG@U1(VFCNI&0Q3HNS>-J
MG<& &1QR.#S5#3_ D_AN[T.\T2>*>2PL7L+B.Z8QB>-W$A8,H;:P?)Q@@@XR
M.M $MQ\0H[?1&O?[+F:Z@U--+NK02J#%*S!<ANC [@0>,@CI6KHOB.74=>U3
M1KS3_L=W8+%+\LPE62.3.TYP,'Y2"/R)K"U/P/>W6F3"WDM?MUYK,6J73.[!
M!Y;*0BD*2?E11D@9.3QTK9T_0KZU\=:MKDK6_P!EO;6"!$5V+J8]W)&W&#N]
M>U $VN:_<Z7=);VVG>>/LTES)<3RF&"-4P-IDVL-Q+<#T!-9EKX^M]1@T,V4
M$*3ZO:-=0QWMSY((!4%%8*VY\MT'89J;6M!U:^\66FHP2V<VGI:/ ;>Z+?N)
M2V?.0 $,V/EP<8'0\FL.S\#:H/!=AX;U6PT34[:VM3#B2:1#'("<2(_ED@X/
M/0^A]0#OH9IYM.CG^S^7</$'\B1L;6(SM) /0\9Q7DFH:WJ7B'X=Z+J^IVL!
MF/B&$Q>1)N;B[9=H!  P %!R<]3BO4]"L)]*T#3]/N;M[N>VMTBDN'ZR,H +
M?C7#P^!==B\)66@^=IS+8ZNM[%+YC@O&)VFPPV\,=P&!D<9R>E &['XWBM[C
M7X-7LC92:.D4K[)A()8Y =A4X&&)!7![XYJ;2/%T>I>('T=X8?,^S?:8Y[2X
M\^(C=M*,VT;7&0<<Y'>LS4O!%UJ^K^)I;FXBAM=8M+>")X7)EA>(L5?! 'WB
M#U[>]:WARV\61D?\)+>Z9*(DV(+"-P93_?<MT.!]U1CD^U #M;\22:3KVC:3
M%IS7,NJ&98W\T(J&-"_/!XZ?_7Z'"?XC7$.AWVJSZ"R1:7?FQU$"[!\M@ZJ6
MC^7]X/F4\[>O>MK6]"O=0\7>'-6@:W%OI;SM*LCL&?S(]GR@*1QUY-<]>^!=
M7NO"?BK2!-8K-K.IM>Q.9'VQJS(<-\G7Y.WK0!N:YXS@TFXOK>!+:>>QB66:
M*6Z$+MD%@D8P=S8&<' ^9>>3B"Z\?68@WV4<,D@LH[UH;NY%N^UP2J $$E\
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M7(_[P/'L&W*_CSCT]Z +VH>/X["VN)6LH3/9!/MEFUXHG5RBNR1J 1(5##N
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MK*9=Z@YRHP,GY01Q@5IW6B^+];\):OINM76CB[N[1[6%;19%B&X8,CELG/H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-SG3FVWA%C.1 <9^8A, 8YSTQS5R_P#$NCZ9H/\ ;MS>K_9>Q7^TQ(TJ[3@
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M<GGYN2>?RKM+K4/$.I:AKNEZ-<NMSI1BBAD=X@'D:)9 TJE.5);;\N. <<]
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MZC.FRF:WECN&$FX@ABSG);<&.3UYZTEWX/TZ\N]7N99;H/JUJ+2Z"R !H@"
M!QQPS<]>:Z"B@#!3PI8Q76C72R7!ET:!H+,%Q@*RA2&XYR%49]JXO3M#U@0/
M"D?BS3M29G<JE_$]DDC,6)4L6)3)ST+8[9KU*LCQ/X@@\+Z!<:Q<V\T\,&T,
MD.W=\S!0>2.,D4 0OX6M9Y0UU=7=Q#]I6[-J[@Q><#N# 8R &&=N<9[5?L-+
MBT^YOIXY[F1KR;SG6:4NJ' &$!^Z..E7J* "BBB@ HHHH **** "BBHH;B&X
M\SR9%?RW,;;3T8=1^% $M%%% !1110 4444 %%%% !1110 45D6OB""Z\47^
M@K;S)/901SO(^W8ZN6 VX)/\)ZXK7H **** "BBB@ HHHH **C-Q$MREN9%$
MSHTBIGDJI )_ LOYU)0 45%-<PV[1+-*J&9_+C!/WFP3@>^ 3^%2T %%-D<Q
MQ,X1G*@G:N,GV&<"LSPWKL'B;P]9ZS:Q2Q072ED27&X ,1S@D=J -6BBB@ H
MHJMJ%XNG:=<WKQR2I;Q-*R1@%F"C) R0,\>M %FBJ&AZK%KNA6&K01O'%>0)
M.B/C<H89 .._-7Z "BBLW3M7%WI45]=V=QIIDD\OR+L!7!+[%S@D?,<8^HH
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M<^99EANBD.1O9%8'<>R\]Z8NM7<7BO4=/CO+N2S\20QR:+*UP[>7AMDQCYX
M5O-&/X1^ ]"M]%TVTT;^Q[>RACT[RVB-NJX4JV=P/KG)SZYJ0Z98F:SE^RQ^
M99 K;,!_J@5VD+Z<<4 5/$=U'IGA74KA]0-@D-J^+LJ93"=N V#RQ!QQW-<1
MI=SJ5MXPN=->?4(K5_#?VH1W-VTLAE$FWS#DMY;$=E8CIWZ>BWUC:ZG83V-[
M D]K.ACEB<9#*>HK)M_!?A^UGCGAT_;-';FU67SI"_E'^$L6R?;/3M0!P6@W
MNI16/PXU)]6U">?4V,-V)KEF253"[<IG;D%00V,^I-4O$D\GB/X2:]KEU>77
MVL:@T9MUG81PJER$6(Q@[?N@$DC.3G/2O3H_">B16^G01V6V+37WV:B5\0MZ
MCGW(^AJO=^!?#-]<7DUQI,3M>,'N%WL$E8$$,4!VELCKC/7UH M>*]3N=&\(
MZOJ=G&)+FUM)9HE(R-RJ2"1Z#K7/O-_9>D?\))INM75\CZ1+)'9RRM*MW*J>
M8L@R?E/!!"@#Y@.,"NU\J/R?*V*8]NW81QCIC%8VB>#?#OARYGN-(TFWM)9P
M0[(">"<[1D_*,]A@4 <HUU>V>E>"M<L=1N[J?4;FV@O%DG9X[A)D)=MA.U2I
M&X;0, $=*Y[5+K58O!_C75TUS5%O-)U^1;,BZ8*B!H1L*]&7#$8;(_$G/J=A
MX;TC2WC:SLQ&(F9HH_,9DA+9R8T)*IG)^Z!U/K4#^#]!DT^^L'L=UK?S_:+J
M(S.1+)D$L?FZY _(>E &)8_:;#XIW.D#4;Z>SNM%%VZ3SL^V83;-R9^YD'HN
M![5QVFW6JR>#/!&KG7=5^W7NLBSFD-TQ5HGDE!!0Y4GY1@D$CZ8%>K_V%IW]
MK?VIY+_;OL_V;S_.?=Y6<[>OKS]>>M5$\'Z#%IUGIZ6.VTLKC[3;1"9\12Y)
MW#YNN23^)H XBZUV_P##9\?107MS+!ITMDUNUS,TS6XG5?,8,V3A<E@.0,=*
MT-0AU73M.US48=;5;271)I[>WBO9+AA*@R)D=^0N" 0.#P:[&/P_I<=YJ%V+
M16FU%0EX79F$R@;0&4D@@#CITJAIW@;PUI-A>V-AI,-O;WJ&.X5&;,B'.5+9
MSMY/ ..30!R>ES7MOKG@(MJFH3C6=+F^VK-<LRN5AC=6"YPK D_,,$]R3S6C
M\*+2.W\,7;(TQ)U*[3#S.XPLS@8!) /J>I[YKID\,Z1'+IDJ6A#Z6ACLCYK_
M +E2,$#GH0 .>PQ4NF:%IFC274FGVJP-=2F67:Q(+$DD@$X&22<# H YA[JY
M_P"%C^(+%KRY%H-$BG6+SV"HY>0%EY^4X4<C'2N9TJ]U35+3X91S:SJ*#4H+
MD7C1W!#3[8"P+'KGWZCJ,$ CTB_\-:/JFI1ZC>62RW<<1A$FYEW1DYVL 0&7
M/.#D5SFK>#$.N>$8M,T_RM'TEK@RB&<QM&'CVKM(8-G=R2#^= '.C7-4T"]U
M#P_)J-U<V"^(+.PBOIY2TL4,T?F.AD/.1PNXG(W]<XK8U.>_T?Q!KNF6EY>-
M82:!)?H9+AY'MIT8J-KL2P##G&>JG%=>_AW2)=)FTN6PBELYF+RQR98R.3G<
MS'DMD [B<\#FG)H.FK:7-L8'=+J/RIVDF=Y)$P1M+L2V.3QGN?4T <!HEU?V
M^H?#B=M4OYVU>P<7JSW#.DF+82*=IX# _P 0&3W)KK/&=T(;/3;<7US;276H
M11+%:C]Y==6,0;<NP$*<MD8 /K5Z/POHT1TLI9[3I8*V7[U_W (VD#GTXY[<
M5/J^AZ=KUO%!J5L)DAE$T1#LC(XSAE92"#R>A[T >5W^JZU!X0\4Q_VE>03:
M?X@AMX'2Z:1XXW:'*>8PRP^=NOK72VUM<GQYX@\.+JVI?8[G2H;I':Z=I()6
M=T+1L3E>@.!QGMCBM]O!'AMX[J,Z6@2ZE6>95D<!W7&&P#P?E!X[@&I-1TDV
M;WFM:-813ZZT B0W%PZK(H.0K') '4CCK]<T <WX(U2]U:.RTB]FN/[1T)I(
M]48S/F25<I'N.?F5P3)S_=%:WCC59M.M]&M8IFMTU/5(;*:X1MK1QL&8X/8M
MMVY[;N.<5J:%87%M'<WE_%;QZC?2":Y6 [E4A0BJ&(!;"J.2.N:LZKI&GZYI
MTFGZG:1W5K)C='(...0?8CU% 'E^L7<_A/Q)X[O],>:2XM]$MI8?/D:8H=T@
MSEB20/O8)_2NFOI+G1O$7A>73+R[NK;4W>WN89KAI1(OE&195W$[2"O\. 0V
M/2MVQ\)Z%ITTTUOIT?FSPBWFDE9I6DCY^5BY)(Y[U/IWA_3-),9L[<IY2&.(
M/*\@B4XRJ!B=@X'"X' ]!0!R?A2Y;Q#H6B>)GUVY@N7G;[9!YK-%(S%D\CRR
M=J[25P0,\9YR37/WFKZE%\._$=RNIWJW-IXE>W@E^TOO2,72)LSG)&TD8->@
MVO@OPW9:_)KEMI%M%J4C%FG4'[QX+ 9P"<G) R<GUIMSX(\-WDMY)<:5%(;R
M59IU+-L>0$$/MS@-D#) R>^: .4U-+R_\5^-[1M7U.&"UTRWGMTM[IXQ#(5D
M.Y=I!'*CCH>^>,0:/J&I+>_#K4)-4O9I=:M76^228F.3_1_,!"?=4AAU !/<
MFN]/AO23=7US]E(FOXA#<L)7'F(!@*>>  2./4TV/POH\7]F;+0K_98(LL3/
M^X!&W Y]./IQ0!QFCW6L>(K*UURWU:&UF@U%UN5:[D9=@E*F!H?N D;0#][.
M#G)YR=8GU/\ LKXAWRZWJB3:1>"2QV73*L6(T?&T<,O)&TY'MGFO0T\&>'(O
M$3:^FD6RZHQW&X .=W][&<;O?&:?)X3T2:#4H)++=%J3[[Q#*^)F]3S[ ?A0
M!R:P)<_&"*Z:66.1O#:W&?M#A%?SAU ;&WU7H>XJ7PEJ%[:^([?1]?AU*UU?
M[')AGNWN+2_P4W2QDGY6']W P'^E=7-X9T>XO;6\ELP]S;0F"*0R-D1YSM//
MS#(!&<X/(I^G^'],TR9)K6!Q)'&8HVDF>7RT)!*IO)VC@<# X'H* .5\<V45
MSXT\$&1IP6OID/ESNG'D.>-I&#[CGMTJHU[=ZUH'C+4FU&\L[_2KRZBM1%.R
M+ (%!3<@.U@V-QW Y#8Z 5W&J:'INM"V_M&U6?[-+YT)+%2C8(SD$=B01T/>
MH9O#6D7%[/=R68\VX"K<!794G"\#S$!VO@<?,#QQ0!+HE[/J7AO3KZYC$5Q<
MVD<TB#HK,@)'YFO(]!@OM+^&'A+7=.U34%NQ=P0?9!.3!-').4:/R_N]"3NQ
MN]_3VW QC'%9&G^&-'TMD^QV8B2)S)%%YC&.)CG)1"=J'D_= ZGU- '&VMQK
M'B2WNM1M=6AL;JPU66.3==R;8TCF*^4\(^0[D Y/.6R#79^)H]0E\.W<>E31
M17S*JPM+(45B6'R[ARI894$<@D&J\O@OPW-XA&OR:1;-J@8-]HP<EAT8C."P
M[$C-:NH:?:ZI9/9WL7FP.5++N*\JP8'(((((!X]* /+-8\0S_P#"%:Z8!K&D
M:O875F)[6XO'D:#?*HRDFX[T9=WY'BMW5;NY'C[7[$74QM/^$:\_R#*2BR%Y
M%+!2< X Z5U#>%]&DL+VRFLA/!? "Z\^1Y6EP,#<[$L<8XYX[4EGX5T2PNS=
M0:?']H:W^RM+(S2,T62=K%B2>O?GMV% 'G&BPW^C>&_AWJFGZG?O)>M:6=S9
M/,6ADA>,DD1]%*!<Y S@'.:@OKS5(_!OB+6$UK4UO--\2O!:M]J;:L?VB./8
MRYPZ[6/# C]<^HZ;X<TK2!$+*U,:PJ5A5I7=80>H0,2$'LN*@;PAH3Z=<Z>U
MB3:75Q]JGB,TF))<AMY^;KD _4 T 8NF-<67Q0U+1UOKR:RFTF*\*7$[2;)3
M*Z$ID_*" .!@>@KC(WGU;P-X$NM0O+RXN'\3&)Y6N7#,OG3@9((Y 50#U&.,
M5ZRNAZ>NK/JHA?[<\ MVF\U\F,'(7KZ\_7FJ?_"':"-&AT@6 %C#.+B*(2O^
M[D#%MRMG*G))X/<^M '".[>'O$OQ)U2Q^T27%A86LT(DN))!N\F0Y8%CN Z\
MYQVQ6O'-J6FQ_P#"1VNJQ75@VFS2BT^UR7'VQU3>CIN^X>"#MP#GIP*ZR/PY
MI$6JOJ<=C&MV\2PLX)PR*" "N=IP"1G&<$CI5?1?!OAWPY<7$^D:3;VDLX(D
M9 3P3D@9/RC/88% ' W2"[L?AQK+W]S=W-[J<$LSO<,T;.\,C'"$[5P<@  8
M'%=#\7X$F^&6JLY<&,Q,NUV7GS4'.#R,$\&M:W\!>%[26*2#2(D\FX^TPIO<
MI%)S\R(3M7J>  .GH*V-3TRRUG39].U&W6XM)UVR1,2 PZ]N>HH Y=9#?>/+
MOPW-<7D-E::9'/"B7<BO,SNP9S(&W';M4#GC)]L6_ 5_?WWAR1-1E>>:TO;B
MS6Y?K.D4C(KGWP,$]R#6E+X;TF9K1S;,DMHK)#-%,\<BJWWAO4AB">3DG)Y-
M:-M;06=M';VT210QC"(@P * ):*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "L6]\5:38^([70I[N)+ZXC:4*S@!5& ,Y[DD8'4\UM5P^M2K9_%KP_
M<SAU@DTZY@1PA(,A>,A>!UP"?PH L>&/&"7B7\>MZA86]RFL7-A;)N$7FB-@
MJA59B23^/6NDNM6TVQGC@N[^UMY9" B2RJI8DX& 3W/ KQ^]B0_#GQ@5B!G?
MQ.TBX3YW7[5&P8=R-N3D=LUJZC<Z=_;?B+0O$W]KF+5;@2VBVD+217L1C0*J
ME5.&!7')&.#F@#U602&-A$RK)CY2R[@#[C(S^=<+X7\1>)_$W@BWUV.32([J
M8R*EJ;:0*Q21DVAS+P3MZXXS7:Q%+6QC\QO+2.,!C(^=N!W;O]:\Y^$VAV<_
M@;1KJ<7"WMI<SRA&FD 0F20#,9.!E6].^: -P:[KEQ\0[_PY!+IT5M;V,=VD
MKVKNYW,5VG$@';K5O2_$MS_PE-QX9UF"*'4%@^U6TT!/E74.<$@'E6!ZKD^N
M36#%J%I9_&G5KBYN(X8#I$,(E<X4N)"2H/3.".*ECBDUSXE1^)C%+;:+H]A)
M!'<3H8_M$CGYBH;!V*O\6,$],T :/B7QI_PC_B?0],^SA[:\G6*\G/2W\P,L
M/TW.K=>RGVKKJ\VU;P_/XL\#ZQ>KJ$47]JK]LC5X<-$4 ,*ELY4@*N1C@EO6
MNI\%:^?$GA+3]1E5H[IHE6YC=2K)*!AL@].1D>Q% &G>ZSIFG2+'?:C:6SL
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MCAB%*@D=SCJ#0!ZDFN:3)!/,FIV;16\GE3.)U(C?CY6.>#R./>FOK^C1Z?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***YG6[C34\;>&(+JUNGOI#<FSFCDVQ)B++AUW?
M,2 ,9!H Z:BN+?XC6J6ES>MI&H+96FI'3KJ=O+ A?>(]V-V6&YA]W/'Y5TVL
M:B=(T>[U$6LMT+:)I6AAQO95&3MR0"<=J +U%<U'XSM)+WP[ +>3R]>A:6UG
MWKL&$#[6YSG!XQFL+Q?J<CZOX1NHH;C UF2'RHI,^<%CD'3('++P3]<@4 >A
M45QUSXHL=5\)^)FU#3;Z)=,6:WU"T5U\W:(]Q*,K8Y1L@Y!ZU;M/$-O%IFGV
MNEV-Q<R_V;'=K;B0%HX=H"[F)Y8X('7)4_6@#IJ*\ZUC63=>,_ >IV=O?,EY
M;WL@M&RCG]TI4,K$*"-QY/YUUWASQ!#XCTZ6YCMY;:6"XDM;B";&Z*6-MK+D
M$@_4>M &O17'P>+[A?%_B.ROK46^EZ1;0S/<%U.U661F=AUP0H  ST]\5?C\
M5Q+?:9!>6-Q:1:J,6<TA4JS;=P1L'Y6*Y('.<$9SQ0!T-%8WB?Q'!X6T?^TK
MFVGGB$L<1$ !(+L%!P2.,D=,GVJDWC&.,+#<:?+9W[>8PM;R>*([$;&[=N(P
MV>,9[]@30!TU%<A:?$/3KX^'I+>UN#;:V[Q0SMM"Q2IG=&_/#?*0,9!(J;Q3
MJ]C_ ,(GXADU&RNIM.M$:*;[/*%:4;06VG<,8S@\]01SB@#J:*Y>^\7:=HUJ
M88T\UK6S2XDA-PBNL9!V@;R-SD*>/S(R,OM?&EE>ZKI%G;6\SQ:O9M>6=R2H
M1PH!*=<A@".,?RH Z6BN=T?Q;#K6G-=6]G*DJ7[V#V\CKO616PV<$C@9;K]T
M9K0UO6(]$L%N7MY[EY)HX(H8%RSN[!5'/ &3R3P!0!F6?A>^L-]O;^)+\6#2
M.X@:*)G7>Q9@)"N<9)Y.3[UT-O!%:VT5O @2&) B(.BJ!@#\JY2Z^(%G9:)K
MM_<:?="71)A#=VZ%&.2%*LIR 5(8>_7BKUKXL@EU^XTB\LKBPECL_MR27!3;
M)"&VLW!.W!QP<'!H Z&BO-O$.MS:KJG@>[@M+J"RNM51XI6E $L9B<C<@/&>
M&&>PYP>*['Q1XA@\*^'[C6+FVGGA@*AD@ +?,P4'DCC)'O[4 ;%%<O%XUC&L
MW.E7NDW]E=):M>6Z2^6?M,2\,5(; 8?W6(/-0:=\0+:^T>/5I-*U"WLIXX6M
M9) G^DO*VQ8T ;.[=@<X'.<XYH W]:TZ?5=*EM+;4KG3IG*E;FVQO3!!XR".
M<8_&I]/LDT^RCMDDDEVY+22$%I&))9CC R22> !SP!6))XM\B]O]/GTNY74K
M6T^VI;(ZM]IAS@F,YP2#P0<<D>N:GTOQ1;ZQI.BZA9P.\>J\QKN&Z-=I8EOI
MC!QW(% &[65KNBOK$5J8=1N;"XM9O/AF@VGYMI7#*P(888\'\,5@Z9K^B::O
MBB_CMKR!H-3\FY65][33E4"B,;B!N+* ..3VK/CU.6'XNSS:C%+8P0^''GD6
M2;?& )ERXP<# &#QV[]: .OT_29[>X%U?ZC+?W*H41WC2-8U)!.U5 Z[1R2>
MG&.:U*YBQ\<:=>:[9:45\N6_B>6U82I)NV %E8*25;!S@]@><C%:VI:O'I]S
M9VBQ-/>7C,L$*D#(499B3T4#'/N..: -&BN>@\76TMC;2O97<%W<W;V45G*@
M61I5W;L'.-N%+;LXP/7BH+CQO:V5GKCW=C<QW>BQ">ZM5*%FC*E@Z'(#*0#Z
M'((Q0!>T309-)EGFNM6O=3FD8B-[LKF)"<[%V@>V2>N!Z"MJN3C\;A]5M=._
ML2_$U]:&[LN8\3@8W#[WR$;@?FQ^?%,_X6#8CPY::P;"]VSWXTYX %+PS>9Y
M9#<\@$?PYSQ0!U]%<@_CMDFUFU.@:A]MTJ-9YH-\7,+*6#AM^WHI^7.<BKLG
MC+339Z;-;NKMJ-K]K@2658?W6%.6+'@_,!CDYSV!( .BHKCH/B-IUY!HDEG8
MWMQ_:TLL$2H$S')&&+(WS=?EQD<=\XJGK?Q!FA\#:WJ]AILL=_IMR;*>"=U_
M<R94;L@D,/G4C'7VH [VLK7=%?6(K4PZC<V%Q:S>?#-!M;YMI7#*P(888\52
MNO%36]U/9QZ7-->VUJ+N>V26/S A+ ;1GYS\AZ<=.<G%;=[="RL9[IHWD6&-
MI"B8W, ,X&2!G\: *6GZ3/;W"W5_J,M_=*AC1WC2-44D%L*H'7:O))Z<8YSJ
M5QFG_$2WO#HDTVCZA:6&L[4M+R;9L,K+E4(#;AG! )&"1QQS4^G>-%UNYO+:
MWT+5#!;SW%I/-^[ 22(#*_?[\@$<=.>> #K**XSPSXATF'PGX=BTBUNMFHHX
ML+6:3=)M7)8NQ)P !R<GJ .U27OQ!L=.T'5M2N;"[6;29UM[RT&TR1LQ4*W7
M!0[E((['IP: .OHJAI6HS:C;S23:;=6+1S-&L=QMW.HP0XP2,'/\ZYC1?'$L
MUGX@O]7LS;6VGZE)9Q['5R2I1%0>K,S?3YL9XH [:BL6V\1(VOKHE[:2V=[+
M ;BWWLK),@(#;6!^\N1D>^1FN=^*L\EIH.ESPW%S W]K6L;M;R.C-&SX9?E.
M2".U '1>(?#_ /;SZ4QNO(_LZ^CODQ'NWN@( /(X^8_I6U7,Z<-+EUP?V>VI
MK<6T)>2.8SJDBMD 8E(!.1G(Z8[9K.@^)5K/I^F:C_8^HI8W]Z;%9B$)27>R
M*"H;)R5ZC(&>O6@#MZ*YF#QK9;M<2_MI]/ET?RS<),48E9!F,J5)!W8QC/6H
MH_'FGF[U"S>%S=6=B=0\N"6.7S(0<'#!L!@>H)'48)H ZNBN0M?'\$^CPZG+
MI-_;V]T+461D"?Z4\YPJ+\W!!ZDXXYZ8JS'XUM$O-:M;VTN+5]&1'NY"R-'A
MQE-ISEMPS_".1@T =-17+0^.K"2_O+%XF-U;V9OECAECE\V('# $-@,#C*D]
MQ@FHM,\?6^HW&A(=+O;>#6X6DLYY-FUF5-Y0@-D';G!(P<<>M '745Q.C:K?
M>,]+\26=[:W%I'%>SV2-:W(1U\O:NT..0Q.3GISBM1=1;0(-&T.0R7VI30,$
M,DP!D$87<2[8W'YAVR>IQ@F@#HJ*KV-T;VPAN6MY;=I%#&&8#>A]#@D9'L:Q
M]'\3_P!MQ6]S::?*UG=1/)!<"1"IV_PN <JQSTYZ'.",4 =!17)VWCVRNM%\
M/ZJEE<BWUJ[%G$#MW1N2P!89Z?(>F>U<WIGB6;PYJ7C:Z;3-2U&TMM4WSO"Z
MM]GB\E"3AV!;')PN<#TXH ]0HKEW\:P2ZNNF:=IMW?S2Z:NI0-$R*DL3-A<%
MF&/QQ^-5K'XAV5_;Z%>)IU]'8:S*+>&YD" ),0V$*[MW56&<8R* .QHKC)-?
MT72?$WBB\DMKR.ZL;:U-W(\H*2JV\1A 6PON3MZ\^M:=UXI73;"YN]2L9+98
M6A1&,J%)3*VQ=KYP!DC).,?3J =!17&^+M8M/^$'UB?7=)OA:6[HDT5O, T@
MRC*R.&'RY8 G@\'BMFZUX1:C/IMA9RWUY;0+/-&CJH16)"C+'[S;6P/;DCC(
M!LT5R1^(&G20:#-9V=[=+K,CQ0"-5!1T4ED<%AA@5(].#SBM/PYXBB\0P7I%
MK/:7%C=/:7,$Q4E)% /!4D$$,"#0!M45R:^)[W_A8=YHDMHL6GVNGK=-,9%Y
M#,1O;/0#:1C\3[3+XTMO+TJ[FLKF'3=5E2*TNVVX+/\ ZO<N<J'['W&<9H Z
M:BN;\>:_=^&/!FHZM96XFGA3"[F "%B%#'UP2..]86JWUY#\3]"E6RNGEDTN
MZ_T-)@06#I@\ML'&>?Z\4 =K?:;#?26\S$QW-LQ>"9/O(2,$>X(X(/7Z@$7*
MY6S\>:;>:+8WRHT,UY)+"EM<2)&4>,D2!F)P ".HSG(QUJ*;Q'9^)O NO75D
MTD4MG%<P2JLF&AF1">&4\]B&!Z$4 =$VF0RZM'J,[-++"I6W5L;8<CYB!_>/
M3)[<#&3F[7F_@V33=5\.^%XWO]2.KRVT-T\GVB8[R@5GWY.U@W0CG[WM4GAR
MS74?'WC:UNKF^>"UGMA;QK>S((@\.Y@H5AC)YXH ]$HKB/#6I7VG^.]8\(WE
MY->P16T=_8S3MND2)CM:-FZMANA/..I-9NL^(=2L?B!I6K>>1X;-TVB2)G@S
M, ?-],"1?+SVV-ZT >DT444 %%%% !1110 4444 8VN:#+K5Q:,-7OK.WBWB
M>WMRH6Y5@ 5?()'3J,'D]#R-@    8 Z 4M% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %<QKNCW][XT\,:I;Q1M:Z8UR;@M)AOWD>P;1
MWP>3T_&NGHH \SN?!NNS^"O$.DK#;BZU#6VU"#,WRB,SI+ACCAL*1@ ]N:]*
M'SI\RXR.5//X4ZB@#S;_ (5M>1>%9M/@OT6]LK[[1HDQ&1:HLA=%/KD,RGVV
MCM6[KOAZ[N+WPI_9\:/;Z1=B64R288H(V3CU/S9[=*ZRB@#@V\,:N;'QY"L,
M.[72_P!DS+P-T B^?CCD9XSQ4">'?%.AW^E:MHL-C<S#2H=-O[*YG,:YCR5D
M1P#T);C'0],]/0Z* .0N]$UJZ\5^%=4G\B4:<EU]L9&VC=,H " ]0N,9.#C'
M4U9\&:-?:-'K:WT<:F\U:XO8MC[OW<C @'T([_SKIJ* .$U+PAJ&H>(?%2L(
M1INOZ?%;&X$AWP,B2+]S'S<L#U'&:LQ:#JNJVWARUUF""#^QIX[F66*7>+B2
M-&1-@P" 2VXYP1C'.<CLJ* .9\>:-?:_X:^P:<D;3FZ@F_>/L7$<BN><'LN*
MJ^(])U^/Q':>(= ALKJ3[,;2ZLKQR@=-VY65P#A@2>W(-=A10!R/B7PYJ?B#
MP2;5WMHM<A=;RU>'(CAN$;<@4D9Q_#DCG).!TJ3Q!X<N[SX<7V@6;)+>W-JT
M1DD;:KRMR[GTRQ)_&NJHH X*;1O%.E:Z-3T:TTV\BOK6"&\M;R8H898P5#HX
M4Y7!Y&,\"M/Q+X:O]9T[2'MKR.WU?3KN*X2Y1,* ?EE 'H49L ^@R>]=510!
MR>D^#AH_C*]U*UE":9/!$PM/[MRJF,R#_MG@>Y)JWXQL=9O])MX]%=?,2[BD
MN83,8OM$ )WQAP,KGCGT!'>NAHH \LOO VNS:/XTT^VL-/MTUEX'M5CGPD>U
M4!!&P8 VGGN>W>M[5?"U[K'BV:[E18M/N= ETN1A(#(CR,#D#N /?K7:T4 >
M;1>'?%L]MX4L;RUTX#0;Z-WNENFQ<1)&R!@FS*M@C@GK[=-3XMY_X5AJ^,9S
M!C/_ %WCKM:JZCIMEJUFUIJ%K%=6S$%HI5W*2#D9'?GF@#F[W0]0UG7(M8NK
M6.W:RL+BVMX!*&:227:&8MC 4!0!W.22!C!SD\&ZH_PTT/1]\$.L:.]O<0$N
M6B:6%L@$@9VL,CIQGVKOE4(H5>@&!2T <Y:Z1=7OBR'Q#?6ZVK6]DUK# ) [
M$NP9V)'&/E 'U).*I^#_  E<>&]2U8R3J^G_ &B0Z9"/^6$4A$DB_B_&/11Z
MUU]% 'F]UX(UF\LO$:H]O;7=SK,>K:<[/N3='LVK( .,[.V>OM4\WAG7?$7B
M2YO]6M+2PM;O09=*E2*Z,KJSOG</E (_^M]*]!HH Y+PM!XN@:"UUVWTE(;1
M-GVJU=F>ZP, [2!L]3R>> ,4OB[1M:N-3T;7?#_V:2_TQI5-K<N42>*4 ,-P
MSAAM4BNLHH XO5-#\0ZG'HNKR_8UU?3;[[4+-)#Y7ELA1XA)C);!)W$8R<=.
M:AUSPI?ZS;^)KX0QQ7^J:8--MH&DXC0;SN=AQDLYZ9P%'KQW5% '&1Z!J@\4
M>&-1:",0:;ITMK<#S1NWN$ VCN,I[=:QO^$-UP>&(]/$%N9U\1?VI_KOE\GS
M_-QG'WL<8Z>]>F44 <7)X>U-O$?BR_$,?DZKI\5M;_O!G>BN#N'8?./7I69#
MX7\3:+8^&[W2X;"YO]/TQ=-O;*YE*QRH-I#(X!P05/4=#7H]% '&7NB:Y?:S
MX4U">*SWZ?<33W:POA4#QL@5,C+8SR3C.#TS@9-_X+UF]\+^-=.5+=)]7U W
MEIF7@J/+PK<<']W[CFO2:* . \5^&=1\3QEY=&MX=32 '3]1M[TI+9R\_>8*
M"4'!XSGD8Z&NMU%)(_#-VDTGFRK9N'DQC<=AR<=LUI5'-#'<0/#,@>*12K*>
MA!ZB@#S;PGI%]XA\">"8+BWC@M+ VU\9A+N,OEKF-5&,@DE<YZ8(&<UT7A/1
MM2T:SU\74$?F7NJ7-[ J29!60@J"<<'CG^M='96-KIMG'9V4$=O;1#;'%&,*
MH] .PJQ0!YOHW@S6M&TCP?<(L$FI:$DUO<6_FX2>*7[VUL?>&%(R!G!%2>(O
M!>IZMHGBB2WC@74M=EML1-+A(HX=NW<V.6(#$X'<#G&:]$HH 1260%EVDCD'
MM7G$W@C6;G2/$^E[K6'[7J[:K877F$Y?>CJKKC@90@G/?@&O2** .:32;S5O
M$NE:WJ5LEFVFP3)'"LHD+22[0QR!]T!>.YW<@8Y@\?Z'J6OZ7I]MID43R0:C
M!=N99=@VQMN('!Y-=910!C&;6IK^VQIT%O;@DSRF</(5 )"J,8Y;;DD\#/?D
M<9;>#=<@\%Z#I+0VYNM/UQ=0EQ-\K1BX:7 ./O8;&,=1UKTRB@#@-3\%ZEJV
MJ^+W\U+6+5HK/['.&W-'+;Y8%E]-VWUX!J[;6OBW4M!U&WUFRTJUGDLI+>-+
M.4MYTC+C>20-B^W)Y]L'LJ* //-5T^XL?AMX>T"YALFU-6M+6*.2Y,8:2( E
MHY IVMA"02/;!Z&)M)O]6AUG1;[3!INJZO;B?[>+U;DL\)0)N4*NU02N,+CK
MW//?W^G66JVC6FH6<%W;MRT4\8=3^!J+3=&TS1HFCTS3[6S1^6$$2IN^N!S0
M!S^GP^++W2+V+6K#2[:?[,\,:V<I83R$8W$D#8OMR>?;!S+'PGK%M:^ HGBA
M)T$$79$O7]R8_DXYY.><<5Z#10!RWA#1M3T2[UZ&[B@^RW>J3WT$R2DLRRD$
M KCC'.>:?XOT--?CMK2ZT6#4K+#LY,WE30R<;&C;M_%GD'IUZ5TU% &1X9T^
M_P!*\,V%AJ5X;R]@BVR3LQ8L>PR>3@8&3UQFN:T+PG>67BNVUF*PBT??#(-4
MAMKG?!>2D#:RIC P<G=@'MSDFN\HH \NLO!OB6WT+PUHQ@L/*T/6%NO/-RW[
M^(-(<@;?E.' QSS[5KIX=UNVN/%MM##;-#KLQD@NC+Q"&B$;;TQDD8R,9!Z9
M'6NZHH XO2_"UUHOC*TO+:)7TNTT&/2XR9!YC,C[@<=,$<9SU[5D6'@S6[7P
M=X/TIXK<W.CZJEW<E9OE:-6D/RG')PXX('0\UZ710!Q4N@ZJGB?Q/J*6%G=6
MVIVUK#%!<2?+((]P=7&#@,KG'7IR*IZ9X/NM)L=8M[33(9-(O7A\K1+RX\R.
M-1GSB"<A=V1A>1E1TSQZ#10!YC<^!-5'@3Q%H.G*(K>_F0Z=97%R7%H@V%@7
MYP"58A1G''/)QT2:1JFE^,K[7+*W2YM]4M88[F!I0CQ319"L#T*E6(/<8R,U
MUE% 'GUOX)U#3I/"BPF&8:=?W-]>OOVY:8/D(#U +]\<#UK;\*Z-?:5J?B.>
M\C18]1U$W4&Q]QV%%7#>A^7/?K7344 <;J'AF^N_'%_>F.)]+U+1QI\S^:5D
MB(9R2%P<Y#\<CO\ C4MO"^LW7AS0?#VIK (M)N8'DNTDR)XX#F,*N,ACM4-G
MIS@FN]HH YWQWH=UXD\$ZKI%DT8N;B("/S#A2P8-@GMG&*IMI6KW7CG1]=GM
M(8H;:PG@F1)]Y5W92,<#( 7D\<FNNHH \OM?!OB;2]-T^\L4L6U33]0O)A;3
MR$Q7$%P^XKN RK#Y>V,BNOFM-8O?"&HV]W;VL>H7EO)&EO;OF.(LA4 N0"WJ
M3COP..>AHH P_"&EW&D>$='TR^C075C;1PL5;<NY5VDJ?0UBZ/I.O:3XM\4:
MJ-/MY8=5FA>!3=;2HCCV?-\IQGKQFNVHH XZQ\.ZM876N>(Y3:W7B*_B$4$2
ML5@MT4?(@8C)&>6; SV J'7_  %8ZEX%NM+M].A747M_W4S$!A..1(SCONY)
MZG)]:[>B@#"L9O$B6FBQW5G9M,1LU.3SS\I"?>CXYRW8XQ^M;M%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/4 ]KHJGJEW#9Z->WDKR+!#;O*[P\N%"DDK[X'%>6>'#:6OC'P<;*2"*VO\
M29]X64--.N(RC3L,!I"6)Z<'=R: /7ZR_$>K/H/AO4M6CMUN#96[S^4TFS>%
M!)&<''3TKR+2[2"#P1X2U:(,+\>)Q"+C>2XC:[D5D!)^Z1U'0]:T=:N;'5M
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M2,].K?F:W_&5I'9R7VHV%AI.JZ/:V(2\TX%8IK1 9&,L# ;03EL]"2@P<C@
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MDD!&SR>F,YKM+.RNO^%J:CJ+6LPLIM*@@29D(5G61V*_DPKJA=6YNC:B>(W
M7>8@XWA>F<=<>]0ZIIMMK&F7&G7@<V]PA20(Y1L'T(((H Y'P7H%WHVLZK8N
MZ-I&G7+_ -F*#DH)@LC(1VV9P/9S5OXD6-WJ7A$VEE:RW,[7=L_EQKD[4F1F
M/Y*:Z+3-,M-'T^*QLHRD$0P SEF)[DL222?4U(;^R!(-W ".QD'^- '%>++:
M^L_%MEKB:#<:UITEF;2:"V($T+;]ZN%)&0<D'GC%5-9M!I2>%;BQT">VN;2X
MGN([.P1)6A1D(<-'O7=G>NXJ<!CU.1GT:.1)4#QNKH>C*<@UEZOX=L-9N+>Y
MG-S#=6X98KBUN'AD56QN7*D9!P.#D<4 <!?Z<=4^'OB+3-*L-2_M>>Z34KB&
M]M_(>9VF5R4!.W&(RH )^[SR<G=TY;^Z^)LVN/I-[;:>^B) LDR@-O$S-M*@
MDYP>G/ZUUFGZ7;:8C"#SG=\;Y9YFED?'3+,2<#)P.@R<5/'=6\TTL,4\4DL)
M E17!9,],CM^- 'EGAZRUW2O#?A&QN-$O!##)=K>F"-?M,#,S&,*Q/RJP8Y9
M2#T&1S5>UT/6;;PAI<3:-?"33_%(OI(L!G:'SG.Y?FRW##GO[UZW)=6\4\,$
MD\233$B*-G 9R!D[1WP 3Q1#=6]R\J03Q2M"_ERA'#%&QG:V.AY'!H XS38=
M0T7Q%XD>[TZZN+75VCN[5HTWG?Y01H7P2%(VC!/RX/6LK0_#&IZ'J_@*VG@D
MG72].NH;NX1<I&\@3:,]QD,,^PZ9KTB>ZM[54:XGBA5W"*9'"AF)P ,]R>U2
MT <-XB\/W<OCO3[NP9%M]4MWLM6C)^]"AWAL>OWH\]O,%=K,9%MY#"JM*%.Q
M6. 3C@&LS2O#.EZ-J%]?V<,@N;V1I)7DF=\%CDA0Q(4$\X&.@]!C7H \ETFP
MUJ36?!6HW>AZC%-9R7*7R!$CA@+Q,H$<:MM" G[V.1C))J*W6-8YK*ZTC7_[
M(BUJ34D%O9B=25E+#$JMDH6&_&W/.,GK7K]<Y:^"='LLQV[7Z6F219"^F\@9
MY(\O=C;_ +/3VH Y2>RN;;Q'JZ7/A67Q!IFM2K=6EU"Z[5W1JICF#$;5&T$'
MG@]#T%^/2[VW\7>))_[/E6VET6"VA:*,['D0/E4^FX 9KOP !@<"H4NK>23R
MTN(FD_NJX)_*@#R[2;/Q!X7MO"6K+HEY?QV^C_V9?V4('GP-E6#JK$!N5P>>
MF*Z#Q3I=UJ_P]FN%LTTO4;)O[1LHAMS!)&2ZABO&XC(../F/7J>WK(U'PSI>
MK:O9:G>0R27-F"(L3.J=0?F4'#<C/(H FT.UGM=*C^UA1>S$SW.TY D?E@#W
M ^Z/917!^,[+6M3N?%=B-(NW@GTL)I\EFJJMPVQMWG/D,Q#'"H>,$\'->FT4
M >?Z'9W\?CK3M1GTZ[@M4\-):.\D?W91*&VG&>=HS^G7BL'0-'US0M*\$ZC+
MI%W,-*^VP7MG&H,T8F;*R*I/S8P,X.<'ZUZ]10!QO@JTOH=:\57=WIUQ9PWV
MH+/;^=M!=?*1>@)[@U2N+Y;'XTW#M;W,RMX?C'[B(R$'SWQD#GGUZ>N*[J"Y
MM[H.;>>*81N8W,;AMK#JIQT([BJ*Z%:)XDDUX-+]M>V%JQ+?+Y88L!CZDG/6
M@#S[3O"VI:3/X.WV,I6#5+R]N8XQN6T28/L4D<<;E!QGG/;FNCM8;[0O'6OW
M<]G<W5CJR02V\L";]CQIL:)@/NYP&!.%Y.2*[&HY9X8 #-*D8/0NP&?SH \U
MN/!FJZ=\+-(@M(@^OZ),-0MHT;.7\QG:('N"K,OO@5J>,M$U"?X4:CI<$#W6
MJ7409TB&=\S.'?'H,YQGH !7;Q313+NBD20>JL#3Z .&B&I:+\0-2U)M)O;W
M3]8M+98I+=06@DB# HZL1M!WYST]:Y;2M"US1?"_A&]N/#MS?#3X+JVO=.5U
M$RK+(KK(@S@D; ",@\U[%10!C>&;:.WTIGBT8:0MQ*TWV4[=^3CYI-I(WG&3
MR>W>N(O])U46?Q'L%TJ[=]4W26<B*"DNZ!4 !SUW ]N,<UZA10!Y[-I-_=>)
M/"LBVMS'##HUQ:SS>61Y$CI&%!]\J?RJ'P;87*_V;IFJ^#&M[_2@JMJ4C*\!
MV+M#Q'.XLP[8&,G)['TBH'O+6,X>YA4\C#2 =.#0!@_$#0+GQ/X%U32+,J+J
M9%:'<< NCJX&>V2N/QIFH7UQK^@2:9'I=_!=WL1AF$T.Q;?<,,S.?E;'/W2V
M>*Z%+RUDW;+F%MHR=K@X'K2?;K0J6%U!M'!/F#% &-KACN[J;3-7T22_T6:W
M0F18/.42;F!4H,OG&T@@<>HKB8/A[J;^#I[&RDDMS8:RNI:%!>N6,2)C:CGD
M@$[\#J,C/.17J<4\,X)BE20#^XP-.5T?=M8-M.#@YP?2@#A?&DU[XE\ :CI$
M.B:@FJWD(C6V>'*J^0>9?]7@8Z[J[33X#;:;:P,H5HH40@=!@ 58J![ZTC<H
M]U K#@@R $4 >;W7P_U"\_X2310XAT>25M1TME;!2ZD&>W14=6./^F@]*NZ_
MIFLZC\'=0MY[)Y==U*W$DUO$N3YK$?+Z?*H"_P# :[^*:*==T4B2+G&48$9I
M] '$I;7MM\3X=4_L^ZDL9]#2U\Y$XCD64L0P)!'!STYZ#FN:M-#U:/P!X:LG
MTRZ6[M?$2W<T7E_-'$+EY"Y_X"PZ9/.*];HH Y_QL=2_X1&]_LFR6]NSLQ T
M:R;EWKN(5N"P7) /<#KTKA;[2=4FN_&;P:1JSIJN@)!;O<89GEVRC!^8[3EA
MQQC/0"O6J* . @TZ^_X2CP-<?8K@0V.F3PW3F,@1.R1A5/XHU7O'=CJ$C:/J
MMCIK:HFGW#M<6"/M>6-T*EDSP67@X[\UV-% '&6D49\/W0A\)O8IJLPBDMIH
MPSE6 5I9@I(P!GY<Y.!R,\8NFVWB+P_X9\0^&+;2FU$6D3_V3<W$0*72$?ZN
M0' ++TR>&  KTVB@#R*Y\.:KK.KWODV6J0QZEX8DL1<WNT;9R^<,H.$&.-J@
M#K@5U_A?5=8U5;>'5/#$^FW5K!Y=Q<W&PHS8 (A*DD@D YP!@=^*ZN::*WA>
M::1(XHU+.[L J@<DDGH*C-]:!K=3=0AKG_4#S!^]XS\O][CGCM0!R_PRM;W3
M? FGZ7J%A<6ES9*T4@E  8[V.5P3D8QS[UEZ=_;>B:SK6B3>')M1M]0U&2]M
M+Y2AMU60AL2Y.5V$=@2<<#I7?0W5O</*D,\4CPMLD5'!*-C.#CH:EH XFRM[
M_0?$_B8W-C<7EIJKI<VLT,>_+",(T3_W<;1@GY<'J*YNRT^?PCKWPYTZ]26X
MFM=-O8YOLZ&0J2(R< <D G' )]J]:K,NM"M+S7;'6)3+]KLDD2##84*^-X([
MYP/RXH Y.W\&'5M!\60WL;6BZY>O<VZ-PT&%41R$#HVY-^.O(!YS6[X*34)/
M#5M?ZQL.IWL:37!3[N=H5<?\! ./4FKFM^&],\0M:'4HI9!:R&2-4F= 21@A
M@I&X'T/]36C//!9VSSW$L<$$2Y>21@JH!W)/ % '(26\EI\9H;V4$07^B-;0
MMV\V.7>5^NUL_@?2L;4=(U.:#XF*FG7+'5(U2R'E_P"N/V<1\?\  AW^M>B7
M=K;7UNHG 9%(D1PV"A'1E8<@]>1V)J2WN8+N!9[::.:%L[9(V#*<'!P1[B@#
MAM+M-0T3Q1::K/9W4UC=Z-!:2&.(N]M-$2=I0?-M;<>0#R.?6LQ_#.IV-IX?
M"V4SG_A*)-5FAC&X6L+F7 ... ZY SR3C->HTR6:*")Y9I$CC099W8 */4DT
M <'9^'M0OO$GC &ZU/28KR[MIK>\M<(TBI"$8 L",9'I]*75?#]_9ZCX/C2?
M4=76RU)Y[BZN<.Z(T;*"Q4 8!8=LUWD<B31)+$ZO&ZAE=3D,#T(/<4Z@#SG5
M[*\T_P 9:K+<^%KC7M-U=8C$]LZ$PNL8C:.168 *=H.>G)JQ;VFH^&O&PO%T
M6:XTR]TNWM%6P 86<D1;]W@D80AN&Z<<XKOJ@6^M&F>%;J RIRZ"0;E^H[4
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MH*MNVD\@E=I(] :Z+X?6-]8V&M"_L9K1KC6;NYB64KEHW?*G@FNOHH ****
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MBK(D5U]FS'+'(<O&Z%N1P.<]LXH ZOPSK%WK6E-<7VFSZ?<QS/"\<L;J'VG
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M"-P05< D9Y!';O3K7P^_]O/KVHSQW.I+ ;>W"(4BMXR<D*"22Q.,L>P  '<
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M#ME%=WB3-')/';CREW$,[!5SDCC)%6]0O8M-TZYOIPYAMXFE<(NYMJC)P._
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M5,26.0N$=6*-M8 YVG .#^!%9GAV/5%\.VT.M7=O<ZBBM'//:GY68,1D<#G
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MNI75C Q[Q)(=OX ';]!7:T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M9^MZ)8^(=*FTS4HWELYL"2-9&3< <X)4@]0*T*9++'!$TLTB1QH,L[L %'J2
M: ,V\\.Z?>S64\JS"YL@RP7$<S+(H888;@<D' R#GH*BN_"FCWNF0:=-;/\
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MJZE]K$N[& %WN .O.X'MCFNKM]2L;RR^VVU[;SVF"?/BE5DP.OS XXKG=/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *X_XE/'#X8@N);D0"#4+68%U8Q,5E4A9"
M <(<<G!QQP>A["LG7M'FU>&V^S:E/87%K.)XY(U5U) *X=&X888^F#@@Y% '
M P'2]=MO'VH:9J6G7NH:KIQ5+.RE\QXU2!D!.0#EB1GC'"]:BTG5K+4/$7PS
M-I-YPATZYBE9%)$;^1$"K'& P(P1VX]17H>GZ1<072WFHW_VVZ1#'&RP+$J*
M2"< 9.3@=2>G&.<ZU 'BQF>#P[X@FMXVFL(/&1N+^*!=Q:T#(6.T=5R 3CJ
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MG-CX<N7^Q3L<^:DBYA&>Y1'D4_5?2M3XAO=0Z'87$,;R6EOJEK-?HBEB;99
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MN+&ZU&2T$UTP=XY6E9?G+-\J;L@'L,9Q7476MVME-=K<K)'%:0K-+-@%?F)
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M#K<P>*(GU%P/$&!,1$,Q#8(_EY_N@=>]=-->6\%Q;P2RJLMPQ6)#U<A2QQ]
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MP90%&%5<@< >O<DUI:7XACU/Q!K6D+:R12:4T*N[L")/,3<",=L8Z^M;- '
M>.%DFU_3XYKJ]L;:.V<BX33!>V\DC,!M*;6VL IPQQPQ /6I4\.7?B;0UM[_
M %.YC>SN%GTO48;3['-$0N/]6?X>2.0,@GC@$]I=S26]G/-% ]Q)'&SI"A :
M0@9"@GC)Z<TEC/+=6%O<3VSVTTL2N\#D%HF(R5)'!(Z<4 <S>^"IM3\-/I5_
MKMW=3RSQ337DL:;F\M@RJJJ JKE1QCN?6K<OA5+CQ%?ZM/=LWVW3QI\L*I@!
M 6.0<GG+&NBHH R?#6BOX>T"TTIKZ2\6UC6*.1T52$4!5&![#J:1_#=A)XKC
M\1,K?;$M3:XS\I7=D$CU&6&?1C6C)=0Q7$=NSCSY59HX^[!<9(^F1^8K,\->
M((_$NF2WL=M);B.YEMC'(P+9C<J3QQU% $>E>%;+0_#EQHNG,8H)FF8,PW;/
M,). /100![ 5G+X&5-&\-Z:-2?R]!GCGA8Q#,I12JAN>F&.<5UU% &+IGA\:
M=XDUG61=&1M4\GS(BF!'Y:[5P<^AYS^E)=>'OM/BVRU\7922TMI+=8?+RK*Y
M!))SG.5%9DGC2\GLDO\ 1O#EWJUC+)+%');S(K%HV*DE6QA"5;!R3QT&176@
MY )&/:@#C1\/T'AU-&_M-_+34O[1$GDC=O\ -\W;UZ;OT_.F:K\.UU1/$$/]
MLW4-KK922>)8D;9*H4 AB,[?D'R_K7;5C>(_$,?AV"QEDM9)Q=WL-F-C !#(
MP4,<]OI0!D7_ ( M]5NM6GO[YISJ5E':OF( QF/)212.C!F)_ 4:AX(NKX:9
M=Q^([VVUK3XS NI11INFB.,K(ARK<@'Z\UV%8U[XACLO%6EZ$UK(SZA%-*DV
MX;5$8!(QUS\PH OZ?9?8+*.W,\UPZ\O-,07D8]6. !^   Z  "N0?X<YMOLR
M:[=I;QZL-5MU,49,<N\N06(RPR3C/XYKN3P"<9]JQO#/B&/Q+ITUY';26PBN
MI;8QR$%LQL5)XXZB@"/1O#K:-J&LWB7IE?4YQ<,KQ@"-PH7C!Y& *RX_A_"G
MP_B\)C4[CRH'62&Z"+O4K)YBY7HPW=NX_.NQJEI][<W<EXMQI\UH(+AHHFD9
M3YZ #$BX/ .3P>>* .8N_A^U[)KDD^MW#/K5E':77[E /D##<N!QPQP/SS5]
MO#+0ZOI>L?:GFFTJQDM4A2,#S@P&>IX/R#':MV_O8--T^YOKI]EO;1--*^,[
M54$D_D*SM)UNZU*Y17TF:"TFM4NH+KS%9&#8^1AU5\$''(]Z //O#Z:G$D<M
MAJUZ=58%GL[[0,.'8Y9))]BY&>"^><9'85U7_"!^3KUY?6&O:C96.H2^?>Z=
M$5,<LA^\0Q&Y-W?;@GU%:_A_Q#'K[:J$M9+<Z??R6+B1@2S(JDMQV^;]*V:
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M'80)>/$L+3(NUMBC &1TP"1]*EL-(T_2]._LZQM(H+(;@($'R -U&/?)_,T
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MZ&,D^EAYADJ2QBR>GO7#^&)S;Z7\.='WRI8:I8R27.)6_>2)"I1,YX'+':,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHKC-5^*/AK1M4N-.NY+D7%NVQPL
M)(S]:3:6Y48REHD=G17 ?\+D\)?\]KO_ ,!S_C1_PN3PE_SVN_\ P'/^-+F7
M<KV-3L=_17 ?\+D\)?\ /:[_ / <_P"-'_"Y/"7_ #VN_P#P'/\ C1S+N'L:
MG8[^BN _X7)X2_Y[7?\ X#G_ !H_X7)X2_Y[7?\ X#G_ !HYEW#V-3L=_17
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M2_Y[7?\ X#G_ !HYEW#V-3L=_17 ?\+D\)?\]KO_ ,!S_C1_PN3PE_SVN_\
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M #VN_P#P'/\ C1S+N'L:G8[^BN _X7)X2_Y[7?\ X#G_ !H_X7)X2_Y[7?\
MX#G_ !HYEW#V-3L=_17 ?\+D\)?\]KO_ ,!S_C1_PN3PE_SVN_\ P'/^-',N
MX>QJ=COZ*X#_ (7)X2_Y[7?_ (#G_&C_ (7)X2_Y[7?_ (#G_&CF7</8U.QW
M]%<!_P +D\)?\]KO_P !S_C1_P +D\)?\]KO_P !S_C1S+N'L:G8[^BN _X7
M)X2_Y[7?_@.?\:/^%R>$O^>UW_X#G_&CF7</8U.QW]%<!_PN3PE_SVN__ <_
MXT?\+D\)?\]KO_P'/^-',NX>QJ=COZ*X#_A<GA+_ )[7?_@.?\:/^%R>$O\
MGM=_^ Y_QHYEW#V-3L=_17 ?\+D\)?\ /:[_ / <_P"-'_"Y/"7_ #VN_P#P
M'/\ C1S+N'L:G8[^BN2T'XC>'_$>JIINGR7#7#JS /$5& ,GFNMIIW)E%Q=F
M@HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5YAXA^'"ZMK][?G11-Y\F[S/[6,6[CKM\DX_,UZ?12:N
M7";@[H\=_P"%3I_T+X_\'9_^,4?\*G3_ *%\?^#L_P#QBO8J*7(C3ZQ/^KGC
MO_"IT_Z%\?\ @[/_ ,8H_P"%3I_T+X_\'9_^,5[%61XE\1V?A719-6OXKA[2
M)E60P*&*[B "02.,D#CUHY$'UB?]7/-/^%3I_P!"^/\ P=G_ .,4?\*G3_H7
MQ_X.S_\ &*]?B<R0H[1M&64$H^,K['!(S^-/HY$'UB?]7/'?^%3I_P!"^/\
MP=G_ .,4?\*G3_H7Q_X.S_\ &*]BHHY$'UB?]7/'?^%3I_T+X_\ !V?_ (Q1
M_P *G3_H7Q_X.S_\8KV*L'5O&6AZ+JMCI5U> W][/';Q6\0W,&<X!;'W1WY_
M#-'(@^L3_JYYW_PJ=/\ H7Q_X.S_ /&*/^%3I_T+X_\ !V?_ (Q7IVM:]::%
M':FY2>66[G%O;PP1EWED()P.PX4G)( QUJ'2?$UIJNJ7>EFWNK/4;15DDM;I
M%#;&Z.I4E67((R">>M'(@^L3_JYYO_PJ=/\ H7Q_X.S_ /&*/^%3I_T+X_\
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M_P!"^/\ P=G_ .,4?\*G3_H7Q_X.S_\ &*]BHHY$'UB?]7/'?^%3I_T+X_\
M!V?_ (Q1_P *G3_H7Q_X.S_\8KV*BCD0?6)_U<\=_P"%3I_T+X_\'9_^,4?\
M*G3_ *%\?^#L_P#QBO8J*.1!]8G_ %<\=_X5.G_0OC_P=G_XQ1_PJ=/^A?'_
M (.S_P#&*]BHHY$'UB?]7/'?^%3I_P!"^/\ P=G_ .,4?\*G3_H7Q_X.S_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G?B$WJ_&70CI
M\=N\_P#9%S@7#LJXWKW )KT2L2Y\,6MUXJM?$375VMY;1&&-%=?+V'[RD;><
M_7/IB@#GSH<7AS3?$6MZUK4EM>ZQ+&;BZL4(,07"1QQ AB3@[<XR2W %5=%N
M9[?XJI8PPZK9V-SHSSM;7USYH>194 D WN5.&(.<$^E=GKVA67B/29--OQ)Y
M+LKAHG*.CJ0RLK#H00#67;>#+33]7CUN&ZO[C58K=X/.N;C>9D.#M?(X&0"-
MN,<GN<@'FQ75-8\.K#Y^LR^+7UEHIG@FN$B$2SD,-R$((A&,<$<^]=->7%W?
M_$.\T(6FI7>F:3IT CM[>]\HL\F?WCNSJSD!0!DGG)Z\U@66A:A9>#S%9W/C
M"S\2*CM'8P>:+6.=F)"@LIC\O)ZESQWS7H-UX.BU.YLM5N;V\L];BM5MY[S3
MY?+,HZE2"""N[)''% $W@N#7+7PZMOKY=KN*:18VDE$CM#N/E[V!.6VX!/M5
M;QK<R3VUGX;M'*7>MRF!F0X,=N!F=_\ OGY1[N*Z&PL8M.LUMH6E95))::1I
M'8DY)+,22235<:+:?\)"VN-YC7GV86J[F^5(]VX[1V).,GV'I0!>AACMX(X(
M45(HU"(BC 50, "GT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
..444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>modificationno14effectiv012.jpg
<TEXT>
begin 644 modificationno14effectiv012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K/UG6]/\/Z<^H:G,T%I'C?+Y3N$YQSM!P.
M>IK0KC/BS_R2SQ!_U[C_ -"6@#?T[Q#IFKZ+_:]A/)<6!!*RI!)\P!P2HVY/
M.>@[5)H^MV&OV"WVFRO-:O\ <E:%T#CU7<!D>XKPGP7XV^Q:?X2\,>(;22R\
M/W5JWEW/F#9=.9& $A[1YX*Y[C=\I(KU?XC>,!X"\&OJ=O;1RSF1;>VB;A Y
M!QG'8!2<#TQQ0!U]%><_\)#XSD?7+"SLVFEM;);JPOI].EACGD &^$JV.23\
MN.W7.,TO@?QMJ/C3PUI%S!<V\>HO=2)J$?DY"(@RVT9X^]& <G[_ +4 =WJ6
MI6NDV$U]>NT=M"I>1UC9]B@9)(4$X [UA0?$3PI<645ZFK*ME+)Y274L,D<)
M?^[YC*%S^-7/&7_(C>(/^P;<_P#HIJ\J\ 6EO>_LVZQ#<HK1>3>/\W9E!93^
M! /X4 >WJRNBNC!E89!!R"*J:IJEGHVFS:A?RF&T@7=+($9MH]2%!.*\,\'?
M$6_\,? VWNFC%Q=C4FTVQ\[)4*0'!;')"Y88'H!75>(M<UJ\\+>.=+U&RN&L
M[?33)9ZB]E);B<%/G4AAU#'C':@#MY/&OAV+3=,U!]4C6TU240V<A1L2N3@#
MID=.IP*WJ\%@\17GA_X:?#DV]M87$=U<B)EN[?S#&=YPZ'/RL,GFNN3QQJ^E
M?%>\\,^(+BSATQK-[JQN%A*EP!N^8EB. LF>.2OO0!Z917FNM^.=8T/_ (1;
M2;D1_P!K:W+NFD6V9OLT.02!&"2SX..XR#Q5;5_'?B?3/AWKVL36'V6_TN^$
M,,ES9O''>0F1560*Q!&0V?J/?% 'J=%>=:;KWC^YT/\ M[^S=,NK6?2$N+6S
MA9EF:X;:1N).-I!+8^@Z\FGHOQ%U*Y^)&D^'IFM;BVU+3_M$AC49MIPKEXPR
MDJX!0COSWX- '=:1XGT?7;V_LM-O!-<V#A+J(QNC1,21@[@.ZG\J-:\3Z-X=
MEM(]6O/LS7;^7 6C<AV],@$ \]Z\;\-2ZY;>,?BG=Z'<V<$UM<&=OM,!D\S:
MTQ"###;G!R>>W%0^-O%+>,O!'@/6Y(%@FFU<++&A)4.K;3C/8XS^- 'T#17F
M&K_$+5I_%GB'1M"M]S:+:>8B+9R7#7=QP0GR?<7JN>#GO4.N_%"]TK5=%MM1
MMVT.'4--%P)KNV9T2Z)QY4G((1<<D<_,#P* /5:*JZ9+-<:39S7!C:>2!&D,
M1!0L5!.TC@C/2K5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%NM3L+&".>[O;>"*0XC>24*'.,\$]>.>*C.M:4MC%?'4K,6DQ"QS^>NQR3@
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M=J]A;65O<0H45?++E]V3U/W1U-<'X:N]"UOPM8Z+X@UN\BUNRNP9=,W1I/\
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M^2QFU&TCNY&") \RAV8C( 7.<XYQ7G&GQ7=AK7PKL]5?;?QV-VLJ.WS ^0N
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEA@F.+;D?@*^?9/^03!_UWD_]!2JM)8.+Z@\3)=#Z*C\:>!841(KFQ18W\Q
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M#BNHUB6^A]#_ /"Q_"G_ $%XOR-'_"Q_"G_07B_(U\UT4_J4>XOK,NQ]*?\
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M+-_U\)_Z"U4JNI_R!9O^OA/_ $%JF6PXE*BBBJ$%%%% !1110 4444 %%%%
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MC_C7FM>E?!C_ )&6Z_ZX_P"-88G^$S6C_$1[I1117DGH!1110 4444 %%%%
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MG4=;NKIKR6]WMQ<2H$:0   E1TX%9U%%:I65C-NX4444 6I/^03!_P!=Y/\
MT%*JU:D_Y!,'_7>3_P!!2JM3'8<@HHHJA!1110 4444 %%%% !1110 4444
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M\&/^1ENO^N/^-88G^$S6C_$1[I1117DGH!1110 4444 %%%% !1110 4444
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M?5EW/GK^S[W_ )\[C_OTW^%']GWO_/G<?]^F_P *^A)I([>"2:3B.-2['&<
M#)I+>:*YMHKB([HY4#H<8R",BCZZ^P?5EW/GS^S[W_GSN/\ OTW^%']GWO\
MSYW'_?IO\*^A\#T%&!Z"CZZ^P?5EW/GC^S[W_GSN/^_3?X4?V?>_\^=Q_P!^
MF_PKZ N[NWLDC>=MHDE2%?E)RS'"CCW-3X'H*/KK[!]67<^>/[/O?^?.X_[]
M-_A1_9][_P ^=Q_WZ;_"OH? ]!1@>@H^NOL'U9=SYX_L^]_Y\[C_ +]-_A1_
M9][_ ,^=Q_WZ;_"OH);B!KI[974S1HKLG<*<@']#^5/D:.*-I)&5$4%F9C@
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M  KZ'P/048'H*/KK[!]67<^>/[/O?^?.X_[]-_A1_9][_P ^=Q_WZ;_"OH?
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@"NG_(0E_ZY)_-JL573_D(2_\
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M1K#I@%%%% @HHHH KW76#_KJ/ZU8JO==8/\ KJ/ZU8H **** "BBB@ HHHH
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M5U/AJTA;PK!;M<BZ5U82R1S,V22<@,?FXZ=CQVJ]J&E1:A-;SF:>">WW>7+
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M.>46]O),4=]BEMD:[F; Z =S[5P?E7^F:9::E96UP07NK6WA*G<D,A)AR.H
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M*AC;[K!A@_0TP.3T&#3$\623:-:F&S:P"EEB9(R^\=,C&<8SC\><TS4]*?\
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M P"J,DGZ5;U75(=*TF;4''F(BY558#>3T /O4UK<--:K),(HY-NYU27>J_\
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MZ8-<386C6+:9/JNG7$UJD%R@06S3&*1IL@E "?F7H<?SHL[![,Z7)J6F3S6
M2[$=L+<S&WWRAHPR@''R97T'3B@#KM*U!=4T];M8S&&>1-I.?NNR_P#LN:BO
M=<M-/U:QTZ<2"6]W>6P7Y5Q@?,<\9+ #W-9WA;S=.T/3K&73[J%I);@;=G$
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M#CVJ:TL[>PM4MK6(10IG"CW.2?<DDG-3T4 %%%% !1110 4444 5T_Y"$O\
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M (KBVANX3#<1K)&65MK=,@@C\B :EHHH **** "BBB@ HHHH **** "BBB@
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M@^F=IY]JZN.Z@EM5NHYD>W9-XD5LJ5QG.?2J7_"0:3]F:Y%_"85<(7#9!8]
M/4]>GH: ,%[:;49[9K329[)+6PGA<2H$W%E 6-<'Y@",YZ<#UI\.E7=FNC/9
MV$8E@TF:)T( 7S"L956^K!OUK>;6]+2RBO&O[=;:8D1REQM8\\#WX/'M2'7-
M+&GK?&^A^S,^P2;NK9QMQUSQTZT <G#8:K=/?SRPWC&;1Y+<>?#'%^][(JKS
MCDXSGZUJ^)HF3P$\,D.]EC@5HCCD[T!']*V#K>EBQ2]-_ +9V*+(7X+ $E?K
MP>.O%9Y\0Z-J=W<:7OBG=8DF"2$!9,@L /IM!/'&10,R[E=1DN+[4-.TJ6W3
M[/;P>7+"N]MLA+,J9P2BGCL3TSBJZZ-?7-I?K/;7$R7.JVLW^DHBM)$OE;B5
M7  PIXQG YYKIF\1:9;VEO->WMM \T"S[/-#?*PZ@]QUYQVS4EYKVE:>(C=7
M\$0E3>A+]5_O?3WH I36[P>,H;K[%(\$MIY(EC0$(X?/S>G!ZUO4V*1)HDEC
M8,CJ&5AT(/0TZ@055;_D*1?]<7_FM6JJM_R%(O\ KB_\UH M54OM3LM-$9O+
MA(O,)"!NKD=@!U/M5NLO4+&:XUO2+I%!BMGE:0D]-R%1^IH +?Q'H]U/!!!?
MQ223\1@9Y//RDXP&X/!YXZ4D&L:,NHR6D$\2W$LQ5]J$!Y0,$;L8+8&,9SQ[
M5F)HEXMM$GEH&76GO#AA_JS(QS]<$<5!!I.J"QL]%:R"PVUZL[7OFKM9%E\P
M$+G=N/ .1CD\T#-T:_I1O5LQ>QF=I##M&>'&?E)Z \'@]>U9=QXQMFTK5+FR
M ,UB^TB52%(!4;NW'-(=$O#821"-/,.M"\'S#_5^<&S]=HZ5#<Z3J,NGZ]IX
MM 1=7!GAF\Q=K@E/EQG((P>HQ0!T&GZO8:HTJV5PLK18WC!! /0\CD'L>AJE
MK/B!=(O;.W^SF593F=PV/(C+*F\\<_,X_ $]JFBLID\475\5'D26<,*G/.Y7
MD)X^C"LR\\.7FKWFK27-]+:PW2"V2.-8WW0JO4E@2"69SQCM0(U[_7=,TR4Q
M7EVD4@02%,$MMY&[ &<<')[=Z2\UW2[#;]IO(U+1^:H&6+)_> &<CWK+L=-U
M-[EKF^C3SGTI+5R'!W2AGS^!R#^-.T?1[NTN=/>XC7;#I$=I)\P/[P$9'TXZ
MT ;4>H6DL@2.X1V,(G&TYS&>C#VJM/K^EVUO#<270\J:/S4=49@4Z[C@' YZ
MFN?L-)UC2HM/\NR2XD&DI92#SE412*<Y)[KSVR>.E,ET?7%T?3M.593"FF+;
MND%PL86<+@ESU*XXXSWXH Z.+4FE\0-8IY;6_P!C2Y61>22SL.O3& *S=2\2
MW5A/J;+IT<MGINPSR?:-LA#*&)5=N#@'NPS4ND:7=6FI6\TR*$32X;9B&!_>
M*22/UZTT>&X+O7M3O-0@,L,TD31(9FV-M0#YD!VGD=P: -'^V]--\UE]J7[0
MHW.F#\@V[LL<848YYI++7M,U&1H[6[5V5/,PRE<I_>&0,K[CBLZXT.XN4\3Q
M_)$=34)#)GMY(3G'.,YJEJ4=_<P&^O=/%C%I]A<!@SK)YC,F,*%/W!C/.">.
M* -6S\0Z"5G6TN8D2-'N9-L3*-I)9GZ8()R<]^:F;Q#I26RW!NLQNY1"L;$N
M0,G: ,L,<Y''O7&V$4EU8WFF;C<W]YH[PV["[CE5(U& K;%7&2_4YSCKQ70:
MSI%V]YIMY;QW$BVT#P/#:W A<;MA!!) (^3!&>X]*0S5EU[2X8+>=[Q#'<J6
MB* MN4=3P#P,C)Z#O4@U:Q;4CIZS@W0X*!20#C=@G& <<XSG%<Y=Z-=0Z79+
MI>G74%["DOD3+=H6A9VW$29.'4G!(&>G'K5R.QU&+Q(EQ;P2V\4C[KUS,K0W
M V8!5/O*^0O/ P.<TQ&O?:M8Z;)%'=W CDE!,:;2S/C&<  DXR*8-=TPZC]@
M%VOVG?Y>W!QOQG;NQC=CMG-1W-C++XFT^^"*88+:>-F)Y#.8\8'T5JPK+0+F
MWOQ#<VM[/$M\UU',EX!",R%P2A.=PSR "#CKS0!O+XATE[P6B7L;3&4PX .!
M("04)Q@-P>"<FE_M_2Q?_8OMB^?YGE8VG;O_ +N[&W=[9S7+Z=;ZAJ%O-91V
M2K;#7)9VN_,7A4N2Q&WKN)7'I@]>U7!I6J&P_L0V0$/V[S_MWFKMV>=YN=OW
MM_;ICOF@9IZCXJTO3[:]D,QF>S1FDCC4G!7C:3C .?7Z]*G_ .$ATO9;L;K'
MG@E!L;. <$D8X&>,G K/?1+I_#OB&R"HLU_)<M%SP=XPI-0:E:ZK>"TNK/3K
MBSU)(PBS"YCVQC=RLBY(9> > 3]#0(Z.]OK73K<W%W,L4>0N3W)Z  <DGT%5
M1K^E&Q:]-[&MNC^6[/E=C?W6!&0?8U%KMI=3-IUW:0BXDLKGSC 6"^8"C(<$
M\9&[(SZ5E2:/?WSS7DMJL#W&HVLYMVD5BL<17)8CC<<$X&>U '1_VA:BP^W&
M0K;XSN9"#UQT(SG/;%-L-2M-2C=[27>(VV."I5E; ."" 1P146MI?R:3,NFL
M5NB5VX(!*[AN )X!*Y )[XK/\.:;=V5WJ<]S'*BW+QM&)I_-DP$P=Q]?S^M
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M\T^UM%M_,NW=2]P2%4*I;M6O61J^C+JNI:9)-#!-;6SR-+',H8'*$# (P>:
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M6O\ USD_I0!U%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@'FJ-OH^I:;=6U]%;I<O'->AH1*%.R:;>K*3QG@9'O[5WW_"-I_T$+S\T_\
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M?]!"\_-/_B: .3CM-0L]2U6[@ABD^U3P%%>3;\@15<].HP<#O6U6E_PC:?\
M00O/S3_XFC_A&T_Z"%Y^:?\ Q-,1FT5I?\(VG_00O/S3_P")H_X1M/\ H(7G
MYI_\30!FU5;_ )"D7_7%_P":UN?\(VG_ $$+S\T_^)JF^@H-:AA^W76&MW;=
M\F1AE&/N^] $-%:7_"-I_P!!"\_-/_B:/^$;3_H(7GYI_P#$T 9M%:7_  C:
M?]!"\_-/_B:/^$;3_H(7GYI_\30!FT5I?\(VG_00O/S3_P")H_X1M/\ H(7G
MYI_\30!FT5I?\(VG_00O/S3_ .)H_P"$;3_H(7GYI_\ $T 9M%:7_"-I_P!!
M"\_-/_B:/^$;3_H(7GYI_P#$T 9M%:7_  C:?]!"\_-/_B:/^$;3_H(7GYI_
M\30!FT5I?\(VG_00O/S3_P")H_X1M/\ H(7GYI_\30!FT5I?\(VG_00O/S3_
M .)H_P"$;3_H(7GYI_\ $T 9M%:7_"-I_P!!"\_-/_B:/^$;3_H(7GYI_P#$
MT 9M%:7_  C:?]!"\_-/_B:/^$;3_H(7GYI_\30!FT5I?\(VG_00O/S3_P")
MH_X1M/\ H(7GYI_\30!FT5I?\(VG_00O/S3_ .)H_P"$;3_H(7GYI_\ $T 9
MM%:7_"-I_P!!"\_-/_B:/^$;3_H(7GYI_P#$T 9M%:7_  C:?]!"\_-/_B:/
M^$;3_H(7GYI_\30!FT5I?\(VG_00O/S3_P")H_X1M/\ H(7GYI_\30!FT5I?
M\(VG_00O/S3_ .)H_P"$;3_H(7GYI_\ $T 9M2Z=_P AZU_ZYR?TJ[_PC:?]
M!"\_-/\ XFHX=,73]=LBMS--OCE_UFWC&WI@"@#?HHHI#"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MSM>_Y 5[_P!<C6C6=KW_ " KW_KD:T: "BBB@ HHHH HZE]ZS_Z^5_D:O51U
M+[UG_P!?*_R-7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** *,7_(=N?^O:+_ -"DJ]5&+_D.W/\ U[1?^A25>H X_P 57ES9:O!+>76H
MV>ABW.ZYL%!\J;=UE^4D+MQ@XVYSGM5:ZUS4K+Q-JLVGP#4K2+2;:Y)DN_+0
M+F8EEPI!9@!T '')'%=#K.D7NJ;XX=8GM+::$PS1)"C9!SDJ2,JV#CN.!Q44
M'A6SMENHX))$BGTZ+3@G79'&'"D'N<.>OI0!G:YXW71K6WOC#9&SE@2?;/?"
M*X=6[1Q[3N('N,UGZS?7<>JZRJ74RJFI:4B!9" JM(@8#T!R<^M7[OP%#<17
M,$>IW$,-U:16LZK&C,PC7:I#$97CJ!^E:5YX7M[RZO)WN)5-U<6MPP '!@96
M4#V.WF@";6+W[)J>AQYF'VF\:'$;A5/[F1OF&#N'R]!CG!SQ@Y>F^+[F]FTN
M2;21;V.I326\,WVC>XD0.>4V\*1&V#G/'(%;E_I<>H7>FW#R,K6-P;A O1B8
MW3!]L.3^%4;?PO;VUGI%LMQ*5TRZ:YC) R[,LBX/M^]/Y"@#)OO$&I:IX1U;
M4;>P%OITFGW,EK=+=?OOE1MK%-HVYQD88GIG%7%\4?9=*U>1[9I&TBPCN6)D
MYFS$7QTX^[C//6EA\)20Z9=:2-7N/[*E@F@BMO*3,2R C[^,D+DX_7-,U'P8
MM[]LCBU2YMK>^M$M;J.-4/F!5*J02#M.#@XZCTH CU[Q%?F'4K72].$YM; 3
MW,IN?*:/>K;0@VG<P"D\E1TYR:RW^($6CZ;:0,;.:6VTV"XN?M=^(99-R9VQ
MJ0?,? SR0.0,Y/&_?^%3=W5Q+;ZG<VD=W:K:W21*I\Q5R 02#M.&()';T(S3
M$\*26<J2Z9JDEHYMHK>;= DHD$8VJV#]UL''H>..* -:ZU'R]&.H6RQ.#&LB
M>?-Y*;3CEF(.T '/0U1\,>)$\10WN%MA):3^2[6ER)XGRJL&5\#(^;'3@@U:
MUK1DUK2?L,D[QLLD<JRA0<.C!E)4C!&5&13=&T3^R9KZ=[N6ZGO95EE=U5>0
M@3 "@ #"C_Z] &3'XQ=TUZ;['!Y.DI.6C^U?OR8L_>CV_(K8)4Y/'UK0E\0K
M'>QVWV8G?ILE_NW] I0;>G??U]NE5YO":7VHS7>I7TET'MIK1%$21E8I<;@S
M*,M@# ]/3/-)9>$V@N!<7>K7-Y*M@]@I=$4"-BIS@#[WR\GOF@"G;^+M5NGT
MY(] 17U2V-S9[[T8PH4MYN%^7AP1MW9]N<2P^+[F]CTA+#21)=:E!/+LEN0B
M0M$RJP9MI)&6(R >@XYR-.V\/06LNC2+-(3I5JUK&#CYU94&3[_(/SJ+3?"]
MOIL^G2QW$KFQBN(T# ?,)G5SGZ%>* *&E^,+F_GTIIM(^S6>HR26\<K7 9UF
M16+ J!C;^[<!LYXZ#-%IXPFN=<?2/LVFO=M!++"EOJ0E*LA V2@)^[)W=1NZ
M&KT'A6V@M=+MQ<2E=/NI;E#QERXD!!]OWIZ>@JMHO@Y-'N-/D_M&:>/3H)+>
MVB:-%"HVWJ5&6;Y1SW].N0#/T7Q#J5YH?A>]U5-DM]<*@:WG&V4&&1MSKL&!
M\OW0>N#GC%7++Q==7(TZ]ETM(M(U*80VMP+C=+\V?+9X]H #8XPQ(R,^T]AX
M26SL],LY-0EG@TRY\ZU4QJ"%".@1B.O#GGV%-L_"'V5[&&34YYM-T^7S;2S9
M% 0C(0,P&6"YX''09SB@"*Q\7W-W-822Z2(-/O;N2SCG-R&?S$WX.P+]T^6P
MSG.>V.:T]7UBYM-0L],TZSCNKZZ224++,8HXXTVAF9@K'JR@  YS[5%#X7MX
M+'3;47$I6PO7O4) RS,9#@^W[P_D*GU71GOKVUO[2]>RO;97C658PX9'QN5E
M/4953[$4 <GJVL7^O7.A6D=AL5[^>WO+?[>\698HY,KO1<E> X/? X';>\3Z
MKJ^FZAH<6F6UO,EW>&&42S;-W[J1@OW&P/ESGVQCG(EL_"MO9OITOVF:6:TN
M9KIY7QF>6565BV!@??. .F *MZWH[:LMFT5V]K<6=P+B&54#@-M9""#U!5VH
M Y<^(M3TG5O$UPUC]JT^UOH1*[W6#$K0PY$:;3G!)8@E1SQDDU8U7XAVFF:M
M=6V+)H;.9(9Q)?*EPQ;:28XB/G W#/(S@XSBM:Y\+V]U::S;O<RXU69)96 &
M4*HB<?\ ?L'\30WAZ>'5+F[T_5'M8KN433P^0D@+@!25+?=R%&>OK0!=UO49
M-+T\W,8M,A@"UY="WB0>I?!_+'>L.T\:/J=C8?V=8P3W]Y-/"L?VK]PODDAW
M\T*<KTP0O.X=*U]<T0:Q]BD6Y:WN+*X^T0R!%<;MK*<JW!X8^X.#6='X.%M!
M;M::G/'?6]S/<I=/&C$F8DR*RX (.>V,$"@!@UK7SXQL=.;3[:.WEL6FFC-U
MDH1(BE@0G. QP.,YYQBF:+XJB\NUANEF2&:&ZF6ZN)@Y)AE*NIPHZ+AA[ CM
MDZ1T"?\ M/3M1&J3&[MHF@F=XD/VB-F5B"  %.5&".@JC>^!;&^T&UTF2YN%
M2WN))A*A 9A(7WH?]EA(RGVH RM5\5ZBNEZC?V=M)!=KH27Z0S3@I$"TF#MV
M<N ,D$X. .,9K2NO$4FEW<%QJT3P%-+N;N6*"X\R/$;1^J*2Q#<=,<CG.:T=
M2\,VNIS:@\TDBK>Z=_9[HF!M3+'(]_G/Y5#+X4COTC&JWDEXPL9[&0A!'O24
MH2<#H0$% &3:?$..:&_+VUI/-;6+7RQZ=?+=952 58A1M8$CU')P3BNFT349
M-5TU+N1;3YR=K6ESY\;#U#[5^G3M56UT?5+>"6)]>ED/EA(I/LT892"/F;CY
MCQ@]!R>_2;0M$318;H>>9IKNX-Q,^P(I<@+\JC@#"CZG)/6@#5HHHH ****
M"LZ3_D8K?_KUE_\ 0DK1K.D_Y&*W_P"O67_T)* -&BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2:"VBNIT9HD#L8SR0I)QG!QG('0UB:_X5E^TVTUA!<W$)NI[FY2*X6.7=(H
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M &1JEQ)=F:W:&YE+'+[@0V#U Y('MBJ">#;4PW:76H7]T]U8'3WDE= 5A.>
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M)_R,5O\ ]>LO_H25HUG2?\C%;_\ 7K+_ .A)0!HT444 %%%% !1110 4444
M%%%(2 ,D@#WH 6BB@D $DX [T %%-1TD0.C*RGD,IR#3J "BBB@ HI 01D$$
M>U+0 4444 %%-=TC7<[!5Z9)Q3J "BBDR,XR,]<4 +1110 44F1G&1GKBEH
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MBLH[B"T=E*R1++N\I6+$A2PP#R0/>M^#POIENI1%G,0NA=I$T[%(Y Q?*C/
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M,FIPZI%8&0*ZPLLB!U?;DD$!AE<GH>>:M>-1=)X"NA,T4UTOD[BBF-&;S4Z
MEBH_$UH0>&=.@MXXCY\K)=B]:664L\DPX#,>_&!CI@ 5<U?3K/5=+GL]0&;1
MP#)\^WA2&Z]NE '+:CXKU709+ZTU%+.>Y6*WDMI+:&3;^]E,6&3+,=I&?EY8
M<  UF:WK.KZKX+UZ"0(/)\I?M+Z?/;I/&YPRA)#D$'@G)&#[UU-OX5TF2RN=
MTUS>B]2/-S+<EWVH=T>Q^VTG<".YSDU8_P"$<MI--N;"[N[Z\BN-N\W$Y8@
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MTU@@F12TNPDC>QR0">2!G ]@* -VLZZ_Y#FG?[DW\EK1K.NO^0YIW^Y-_):
M-&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** ,[7O^0%>_\ 7(UHUG:]_P @*]_ZY&M&@ KS:X@B
MET*^\0,O_$ZAULQQW&?WB!;L1+$#_=*8&WH=Q/>O2:R/^$9TDZF;_P"S-YQE
M\\IYS^49?^>GEYV;O]K&: ,34=+T^3Q=8)I5JBZLER+N^NTSNCAP<J[=?G/
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M)=+T6TL9[I[J6",(TSYRY'U)/YD_4T 7Z*** "LZZ_Y#FG?[DW\EK1K.NO\
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M&<*3W'S-Q[GUH X-=;O=,\B[U#5[N2"]T.2^FV1QYAD!B \H;<#_ %I&&R.
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M]\]@F@Z1'JAU--,M%OB23<"%=^2,$YQG..]2FTT]2EN;>V!,AN5CV+RX;)D
M]=QSGU- '%QZ]=R>*=,FM+C47L+S49K1S<O#Y3A%DR$1?G&UD&&/7'.<BM?P
MB[1^#IG4X9;F^(/H?M$M:5CIN@W$[:I8V-@\SRL6N8X5W&1258[L9SG<#^-7
MA9PQVDEM!''#&X?B-0 "Q))P.Y))/N: .!TK6KZVLO#FJ76NSW::E8RRWB%$
M*QA(?,+H%7@J1M/7);GFDM==U2&XU-!/?K$^AR7\'VZ2%Y X^ZX$?"@@_=/'
M%=9H'A72] L;>*"SMC<I;);RW2P*KS!5 );ZXR1FK5KX?T:QC>.TTJR@1T:-
MQ' J[E;&5.!R#@<>PH XV^TZ\N&\'37&N:@9KJ[WO(OE@(S6LC?("AQT( .>
M">_-='XFN;J.31["WNWM$O[SR);I,;E41N^%)! 9B@7.._'-:EYI.G:C9K9W
MMC;W%LA!6*6,,JD=, ],4S48]+N4ATW48[:5+HE8[>90PD*C=P#Z 9_"@#@M
M9^V7-K>Z:^JW<L-AKEC'%<@IO.]XB58[<$H6R#],YKTF%#%"D;2/(54*7?&Y
ML=S@ 9_"JL&D:;;626<%A;1VT;B185B4*'!W!L8ZY .>N>:DN;^VM)[2">3;
M)=RF*$;2=S!6<CCI\JL>?2@"S6=)_P C%;_]>LO_ *$E:-9TG_(Q6_\ UZR_
M^A)0!HUS/B:ZNEUG0=/@U)["*^FECE= NY@(RP52P."2,9Z\UTU8^L^'K77+
MW3Y;U8Y8+1I"T$L8=9=R;><],=?PH X]M:UF3[)I,-Q=W0.H7<'VF"2*.:9(
ML%5W,-N?F() R?+/O5[S/$4C>'M,O;^>SEN)KI9WC,;2R1("4RP!4-C&2/?\
M.JET+29M,CTV33+1[&,@QVYA78A'<#& >3^=26VE:?9QV\=M8VT*6V[R1'$%
M\O=][;@<9[^M '&RZE?G5;G2DO7MHI]=%HUTB*'1!:))M!QC<S#&3GKQVILN
MJ:E%=3:&NJSM!_;$-D-0.TRHCPF5DW8QNW +G&?G'>NTN-)TZ[@G@N+"VEBN
M'$DR/$I$C  !FXY. .?8>E1_V%I(TLZ9_9EI]@)R;?R5V$YSG&,9SSF@#G?"
M,D5CJ'B<7&IBY5=4CB%S,R@LWD1*%)& 6!PON1ZUV54H]&TN&W\B/3K1(=ZR
M>6L*A=RXVMC'48&#VP*NT %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %9UU_R'-._W)OY+6C6==?\AS3O]R;^2T :
M-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 9VO?\@*]_P"N1K1K.U[_ ) 5[_UR-:- !1110 44
M44 4=2^]9_\ 7RO\C5ZJ.I?>L_\ KY7^1J]0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!1B_Y#MS_P!>T7_H4E7JHQ?\AVY_Z]HO_0I*
MO4 <=JUI ?B9H\TUY<0[K"?8!<%%9EDAPH&><YY'? ]*Q=&CGT^UTK48+^\W
M7&O7-M) 93Y)C:>8$;.F<@-GKGOCBO19[2VN6B:XMXI6B;?&9$#%&]1GH?>J
MUC<V-^;F*WB7_0KIHG!C "R@!B1_WWU]S0!PVA7>MZAJT%\UY'')_:$L=S%+
MJ;8\L,R^4+?;A6 "D$')QG)S72Z]>7-OXBTF&*9TBDMKQG53@,55"I/TR:VC
MIUB;W[:;*W^U]//\I=__ 'UC-4!KNESW<$14M,]Y+81EH^DBHS.,]AA#SWH
MYGP[->PW'A.XEU.]N6U;3&DNEGE+*7$<;AE7HI&2..H/.3S6?X='V[6O"5_?
MZC=?:)]":0LURRB2020<8SSG/([X%>E+!"OE[8D'E#;'A1\@]!Z=*C>PLY!
M'M(&%N0T(,8/ED=U]/PH \\.LR76D6EM/<W1NV:_E\TZD;-%2.X9 2XR6*C:
M N",9S6AX8O9]1UGPU>73[[B?PXSR.?XF+PY/XFNS>PLY1&)+2!_*<R1[HP=
MC$Y)''!SWJ1((8RI2*-2B[%*J!M7T'MP.* .,\0ZAJ-CK%WH\-U,LNM"$:>X
M;F%LA)]OIM3$GU)K-CNM;O=?NY(KQ();751 JS:HR*(%91L-OMPQ=.0V<DL"
M#QBNS2TM-6U2SUE)9'%FLT44;(5 <L%9N0#D;2H[8)]:L-:Z5<ZH7>"SEU"!
M58L45I8P<[3GJ <''T- '##7)9/%VFS6<]PD,^J36DJ3ZB7,@42!A]GZ(H91
MAL@],]:V?#-TD&E7NN:MJD^W[9=0EKB<B*)%N'10%Z#H.>O.,XP*Z9;&S2X>
MX6U@69R&:01@,Q' )/4FJ-WJ-C;:C;Z-]CDFDN5:4QQ0@HB[AEW[ ;F'J>]
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M%% &=KW_ " KW_KD:T:SM?.-!O3C/[HU7_X2%/\ GPN__(?_ ,70!LT5C?\
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MQ%)W55!:!6^0':<AB#D'(^E=F=>A9E8Z==%EZ$^7D?\ CU+_ ,)!'_T#[O\
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M_P ^%W_Y#_\ BZ/^$A3_ )\+O_R'_P#%T ;-%8W_  D*?\^%W_Y#_P#BZ/\
MA(4_Y\+O_P A_P#Q= &S16-_PD*?\^%W_P"0_P#XNC_A(4_Y\+O_ ,A__%T
M;-%8W_"0I_SX7?\ Y#_^+H_X2%/^?"[_ /(?_P 70!LT5C?\)"G_ #X7?_D/
M_P"+H_X2%/\ GPN__(?_ ,70!LUG2?\ (Q6__7K+_P"A)5?_ (2%/^?"[_\
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M9HK&_P"$A3_GPN__ "'_ /%T?\)"G_/A=_\ D/\ ^+H V:*QO^$A3_GPN_\
MR'_\71_PD*?\^%W_ .0__BZ -FBL;_A(4_Y\+O\ \A__ !='_"0I_P ^%W_Y
M#_\ BZ -FBL;_A(4_P"?"[_\A_\ Q='_  D*?\^%W_Y#_P#BZ -FBL;_ (2%
M/^?"[_\ (?\ \71_PD*?\^%W_P"0_P#XN@#9HK&_X2%/^?"[_P#(?_Q='_"0
MI_SX7?\ Y#_^+H V:*QO^$A3_GPN_P#R'_\ %T?\)"G_ #X7?_D/_P"+H V:
MSKK_ )#FG?[DW\EJO_PD*?\ /A=_^0__ (NHHM16_P!=L@+>:+9'+_K-O.=O
MH30!O4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!G:]_P @&^_ZY&L.MS7O^0#??]<C6'3 ****
M!!1110!7NNL'_74?UJQ5>ZZP?]=1_6K% !1110 4444 %%%% !1110 4444
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ML5>6XU:.9,J,O&'CY^F _P"M.U31KF>?5TCL]\%Q=6+JN!M=4=?,./8#GZ4
M= NN:2Z1NNJ63+))Y2$3KAG_ +HYY/(X]ZDDU33XKU;*2^MDNWQM@:50YSTP
MN<US6K:'-,OBIH+(%[NTC6W( !=PAZ?CM_(5%K=MK-]>SP"&Y\M+NWDA6&.+
MRG160EW<_-N!## (Z#J,T ;O_"2Z=(VHQ6T\,US8@[XO.1=V%#'!)P ,X)/
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M]JEP]E+9LB""6- )CG/F%N=N,?=SWXI]OH]VMU-))"N&T:*T!+ _O 9-R_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBNX2@\NXLPD4<=ZT<<,F#NW  >9G(QGCCH*W[*PFM]<U*\?;Y5Q' J8/.4#
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M^'9["XM8;BSEG6UE9X[DZC(8_P"+:PB)P&PV",8Y/-7O#VG7UA=W&Z V>GE
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MUT%F"9>->I&UCR..#@\BJ$'AW5"VGK<ZC L=A!)!&8(B';<FP.23P1P<#_\
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M^E15+IW_ "'K7_KG)_2@#J****0PHHHH **** "BBB@ HHHH **** "BBB@
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M\=*9I,.JZ9836@L8W9+MWCD:8!9(Y)F<GCD$*W0]30(Z"BBB@ HHHH ****
M"I=._P"0]:_]<Y/Z5%4NG?\ (>M?^N<G]* .HHHHI#"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH SM>
M_P"0#??]<C6'6YKW_(!OO^N1K#I@%%%% @HHHH KW76#_KJ/ZU8JO==8/^NH
M_K5B@ HHHH 1D5UVNH8=<$9I:** "BBB@ HHHH **** "BBB@ HHHH ****
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MO[3[0H-U?"Z#;?N@.C8_\=_6DU'P]+>7M[=Q7*1RR?9G@W+D*\+LPW>H.[%
MR;^V&:[L$FAN+$S2R1M#/&I+;8RV=RL0!QU&?3BEL/$5O?W$$8M+N!+E&DMI
MID4+.HYRN"2.#GY@.*CETF^U":RFU&6V!@DE+) K %'B*8R3UR2<\55T+PP=
M'FA!M-)Q!&8UNHK?;._&,GL"1UZYH$6;/Q5;7QMC%97P6ZA:6V9XU43;1DJO
MS9W8]< ]B14_AS5YM;TB*\FLY+9F'\6-K<GE<$G'UQ5>Q\/R6D&@1F=6.EHR
ML0O^LS&4X].N:LZ!I]UI6FK8W$D,B0DB)XP02N2?FSWY[4 9EWXF>>ZTY+*W
MNXX)K\0?:6C7RYE&X,!R2.1P2!G'%7D\2V\ETD:VEWY$DS0176U?*DD7.5'S
M9ZJ0"0 2.M4H?#FHQ"PM3>6_V&QN_M$8$9\QURQ"L<X&-W;K[4FF^%%TW4%=
M;/2I8DF:5+E[?_2 "20,],C.-WH.E RSI/B&YU#3[BY?2+L/'/)$J($^?;(R
MX&7QD;><D#/3-/\ [>CN([5T\ZV8WXM)898E9@^#\IPV!V.X$_K5.7PYJ#:?
M<6(N+9H/MK74:.&Q*K2,[1R8[9;MZ#(I;'PJ]I;QQ"6W0+J8OMD$6Q%&T#8!
MGCZT"+VB7]Q<:+-<SA[B5+BY4*@ 9@DKJJCH.@ JIIWBHW.A6%[<:?<BYO"%
MBMX@I,K;=Q*9;A0 3EB.E:NCZ>VF6+6[2!R9YI<@8X>1G _#=BL:U\/:G9Z?
MID<=S:FYTMBL#%6VRQE2I#]P<'/&>10!MZ;J<6IQ2LD4L,L,ABFAF #QL #@
MX)!X(.02,&L2]\2O+=6$5E;W:02:@MN;HHIBE )#J#DD<CJ0,X.#6MI&GS6?
MVN>[DCDN[R;SI3$"$7"JH49YX"CGN<UE0^'-0B%G:?;+?[#9WOVF/]V?,<;F
M8*3G QN(R.N!T[@%Z#Q);7%W%$+:Z6">5H8;ME7RI'7.0/FW?PG!( ..*2+Q
M-:RZ?<:@UO<QV40)29E7$V&V_* 2<YXP0#S5'2O"BZ7?1E;/2I(HI&=+EK?%
MQ@DD#/3(SC=Z#I4;>%+FX-^TDUK:M<QJ MI&P1I5<.)64G&<@<#L3R:!FG/X
MB2TM%GN]-OX&>98$A9$9W9ONXVL0?3KQWK/UC7KFWLM3>-IH)K>*UE\EHE+1
M!Y"",@L&)"G@=.V<U?ET[4K]+4WTUHKV]W'.%@5L;5!R,D]3GTX]ZAU7P[-J
M$FJ/'=+$;V*V124SL,3LV??.[]* )1XFMD6Y%S:7=M- L;""5%WR"0[4VA6(
M.6&,9!!ZXJYIVJIJ$EQ";>>UN;<J)89PNX!AE3E200<'H>QK%O/#%WK"W4NI
MSVC7+I"D*QQ$Q 1OO^8$\[B<$=A6GH>E'3$GS9:;:F0CBQB*@XS]X]^O'I0(
M='KD4U]+!%:73PQ2&*2["KY2.!D@_-NXZ$XQGO4-GXEM[R>U7[)>0P7F?LMQ
M*BA)L MQ@EAD D;@,@4VWTF_MI[JW2:V;3;F:29PR-YHWY+*.<=2<'T[5#9:
M'J*'2X+VYMI+33"&A,:,))2$**6R<# 8YQU/I0 J>+[200,EAJ#1W#-'!((1
MB609R@YSG@\D!>#SQ4O_  E%K]DMY?LMX99[A[5;<1@R+*H;*GG ^Z><X[YQ
MS3;;P_)!9Z- ;A2=/N6G8[?O@K(,#T^^/RK.O])O[2^T[['(C32:M/=!VC)1
M%:*3AL?EGWI#-,^*+5;2.8VMV)GNC9_9MBF19MI;:?FQR!USCD<XHN?$\%J9
M/,LKSRX ANY%5"ML6 .'^;)(!!.W=@&HH/#UP#!/<7$9N?[2-_/L4[3^[,85
M<\\#;R?0U!>^%!-K%W>I9Z5=+=LKO]N@WM&0H4[3W!"@XXYSZTP!_$KZ?K&L
M1W<-U+9VTL0\V-%V0(T:$EB2">23QDCZ5?O?$EM8W,\;6UU+#;%1<W$:J8X"
MP!&[+ G@@G . :BOO#TEW;:]$LZ+_:>W:2O^KQ&J<^OW<U5O?"BRZQ=WBV>E
M727;J[_;;?>\9"A3M/<$*#CCG/K0!=N_$]K9W-U"UK=NEI(B7,R1C9%N"D,2
M3R/F&<9(YXQ5J#6([G59[&&VN'$#^7+< +Y:OM#;3\V[H1SC'O5*]\/R75MK
ML0N%4ZFRLI*_<Q&J\^OW?UI7T6YE\2Q:F3:PK$Q)D@1EEF3:0$DYP0"0<\]!
MC% A=*\06]S!$DTSF0VIN3,\8C5D#%6. 3C! R/<4V3Q7:I )TLKZ6)($N)V
M1%_T=&&07!;.<<X7) JC<^#Y)]&TVR6\$<EL7CFD"_ZR!S^\3VSQS[5+J7A5
M;C5Y[Z*STNY%PB*R7T&[RRHQE2.Q&...G6@9,NNBWUR^CN)&>TW6L<)51A#*
M&&2?0G:._45KVFH0WL]W%"'/V67R78CY2VT,0/7&X9]ZQ=5T4+8Z].[92XM$
M")"AW(T2L05'<YP0/:K_ (;LIK#0K=+KF[ES/<GUE<EF_4X_"@1JU5;_ )"D
M7_7%_P":U:JJW_(4B_ZXO_-: +5%%% !2;5#E]HW$8)QR12T4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5+IW_(>M?\ KG)_2HJET[_D/6O_ %SD_I0!U%%%%(84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M &=KW_(!OO\ KD:PZW->_P"0#??]<C6'3 ****!!1110!7NNL'_74?UJQ5>Z
MZP?]=1_6K% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %
M=/\ D(2_]<D_FU6*KI_R$)?^N2?S:K% &)=ZO?0>*;33(K$RVTMN\K2!U!&&
M09Y/0;CD8R<C%9^B>(;D1P17MK<-%/?7%LEVS*06$DFT8SG&%VY]1^-;%YIL
M\VLV6HVUS'$\"/#(DD1</&Q4G&&&#\@YYZ]*KQ^'A'96=M]I)^SW[WF[9][<
M[OMZ\??QGVH B@\66\^H10BW86\T[6T5QYJ'<XR/N9W!25(!^GK5S5-8;3[N
MSM(;*6ZN+O?Y:HP4#: 3N)Z#!JEI_AMM-O 87L6M5E:5=]GF==Q)VB3=V)X.
M,XXK4N-.^T:M8W_F[?LJRKLVYW;PO?MC;0!F-XKMUO\ R3;M]G^TBT,_FIQ(
M3M^YG=C=\N?7VYJ6/Q&LO]IR+:2&WL/-#R>8N2T?4;<Y&><$]<5#!X;>TU.2
M>![ V\ER;@B:RWS*6;<P63<.^<9!QFED\-O=ZK->7ES"5>&6#%O;^6[H_&)&
MW'=M'3@>M %N36(W>&W1'62XLI+M&XPH7:,'W^<?E6/H>NZE-/H]G):-/'-I
M<-Q).77<6(4%CD].3QC.:NV7AZ[AN8)[S4DG,%D]DBI;[!M8H=Q^8_-\G/;T
M [NM?#\]A-I<EM>H#:62V4OF0Y\Q!MY&&&T_+[CF@9:T36?[;MC=1VKQ6[<Q
M.TBMN&3U .5(QT/K4=YKQL-2@MI[-UAFF6%)O-3)9N =F<[<\9_2FZ3HDMCJ
M=U?W%Q \TZ*C+;6_DJV"3O8;CECGK5*7PD9=4>Z-U#L-['>@FV!FRI4[#)N^
M[\O'''OW!&C::S)?W3K;V$S6:RR0_:MZ@;DR#\N<XR",^O;'-97A?Q!<W.G:
M1!?6UPKW=MF.ZD93YKJN6X!R,C)&>N*T[#2;W3[AXX;Z+^SC-),(3!^\!<EB
MN_=C&YB?NY[9IEGX>%I!HD7VDO\ V6A0'9CS,H4]>.N>] %&#Q8JZ=8>7%+>
M7$MH+ES(\<3;.@)Y W$@X ]#TJTOBVP:WN[C9*L4%G'>J2!F6-P2-HSUR-N/
M7%5$\'FVCLC;SVDDUO:K:N;NT\U'522"!N!4Y)[GK5O4/#$>HSZ9*]P(C:!4
MF2*+:LZ!E;9C/RC<@/?N.] QESXM@M9Y%>U?R8&1+F0RH#$S '&W.6P&&<?A
MG%5O$_B&YATS5X]/M+AOLB;)+N-E BD*AA@$Y. 5R1TS]:M3>&W&JW%W;O8>
M7<R"61;JR\UU8  [6W# (4<$'!S]*;J7AFYO1JD$&I+;VFI$/*GD;W5]H4[6
MW8P0HR,9ZX(S0!T8Z457AAN$N[B22Y\R%]OE1>6!Y6!SSU.3SSTJQ0(****
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MW_A']*_Y\H_U_P :/^$?TK_GRC_7_&M*B@#!O]#TV,VNRT0;KA5/7D8-7/\
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M$NH;*5S/%%LSA23@ _*3Z@\=: -,Z+HPF6$VT(E92RH6^8@8R0,]!D?F*?\
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M_P (_I7_ #Y1_K_C6E10!F_\(_I7_/E'^O\ C1_PC^E?\^4?Z_XUI44 9O\
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M** "BBB@ HHHH **** "BBB@ HHHH **** ,[7O^0%>_]<C6C6=KW_("O?\
MKD:T: "BBB@ HHHH HZE]ZS_ .OE?Y&KU4=2^]9_]?*_R-7J "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** *,7_(=N?^O:+_T*2KU48O\
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MWY; VG(YZ<U!>WFN7^LZGF\M[&\M6@^SBXU:2V6)3&C$F$(5D4L7!+'MCC%
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M P*, $G')ZU6@OHI[VZM%2426VS>S1D*=PR-K'AO?'2K5 ";1NW8&?6@ #.
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MC./6JUKXHBEU#3[$PS2M=V:W GA@D*9.W&/EX7YLY)XZ&@#JO[;U+_GWM/\
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M;U+_ )][3_OMO\*/[;U+_GWM/^^V_P *JT4 6O[;U+_GWM/^^V_PH_MO4O\
MGWM/^^V_PJK10!:_MO4O^?>T_P"^V_PH_MO4O^?>T_[[;_"JM% %K^V]2_Y]
M[3_OMO\ "C^V]2_Y][3_ +[;_"JM% %K^V]2_P"?>T_[[;_"C^V]2_Y][3_O
MMO\ "JM% %K^V]2_Y][3_OMO\*/[;U+_ )][3_OMO\*JT4 6O[;U+_GWM/\
MOMO\*/[;U+_GWM/^^V_PJK10!:_MO4O^?>T_[[;_  HM+ZZO-=LQ<1PH%CEQ
MY;$Y^[ZU5J73O^0]:_\ 7.3^E '44444AA1110 4444 %%%% !1110 4444
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M.F:,)+43"66>*$21(&*!G52<'C."0.O)%,778]/CNVO9YY$MEMPRM;_O5,G
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M'5/$3C1-5>VBN+.^LX5DV7"+D!B=K#D@@X;\J .DHHHH *JM_P A2+_KB_\
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M(2_]<D_FU6* ,]M/=O$,>I;U\M+1X"G?)=6S]/EK/L/#\]I#H2--&QTY9%?
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M]_R ;[_KD:PZW->_Y -]_P!<C6'3 ****!!1110!7NNL'_74?UJQ5>ZZP?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK9!=:MON894FMY4M@HC901DKD[LAB#R/;%6-;U-]-@B9)K&(NQ&;N4J#QT4
M$L?Y5FVWB6\U*/3%L+*#SKZUEG)FF(6/8RJ>@R02WM0!8_X1QI1)+=WIFNY;
MF"XDE6/:N(F#*BKDX'![D\FI+WP\EZNJC[2Z-?\ E'(4'RS&!M/OR :ALO$P
MGCL9KF 6\%U:R2ER^=DD9^=.GID@_P"R:FFUN>W\(-K<MH%E%M]H^SE^F1D
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M44444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+1KUI1$3%$[;GW<8)"A<CNU=%X5U/^U/#UO*9DFEBS!+(C;@SH=I;/O@-^-
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M+'5);GPY_:D_DV^^-YD,A*HL?)0L?]W!/XUB+XMNHK;5F<07+6=O'/'(MO)
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M_P!<7_FM6JJM_P A2+_KB_\ -: +5%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4NG?\
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M$L-W"\!9+Q@TX+M\Y"JH.<\<*O3TKGK/4K]_#\=_>:G/YUW-Y,,5M;QE@0[
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MX[58L;C4=3M+G4'O52V\RXB^R"$'"HS(/FZ[LKD]N<8[T =%'(DL:R1NKQN
MRLIR&!Z$&G5QWAFXU"SA\.VT]TD]M>Z?E8Q$%\HHB%<'J>#@Y[^G2NQH ***
M* "I=._Y#UK_ -<Y/Z5%4NG?\AZU_P"N<G]* .HHHHI#"BBB@ HHHH ****
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MQUJ2'1-.@MEMX[8>6)A<?,S,QD!!#%B<DY ZGM6A10!E:CHZZAK6E7LFSR[
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MW7:.BY[XQ6C10 4444 %56_Y"D7_ %Q?^:U:JJW_ "%(O^N+_P UH M53O\
M2K+4_*^UQ%S$2T95V0J2,'!4@]*N5B:U->?VII-E:W;6R73RB5T16;"H6XW
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M21QW<UO% $5455? )P,D^^>GYU5TN&WO?$?B(W\<<T\<L<:K,H;9!Y8*X!Z
MDOGU- &E8^'-(TV>.:TLQ&T8(C&]BJ9&"54G )[D#)I;;P[I-G<+/!9JLB%B
MA+,=F[.0H)PH.3P.*P[J[NF@UNYM-4-G#I("V\$:H8V"Q*X+Y!)#;L#!' XY
MJ/4-2U:6/6[J&^DM1I]I%<Q0+&A!8QERK$@DCC'&.O6@#H(O#NE10S1"U++,
MJH_F2.Y*@Y"@L20 >PXJQ)I=E-'=I);JRW;!YQD_.0  3^"C\JYZV6X'BG6K
MM;^X 6R@E$.(RIR)< _+G (R.?KFF6]W??V!I+W&I:C<7^I(DJI:QPJ3^[W$
M#< J@#&23GCCKB@#?N-#T^YO#=R0N)VQO:.9XP^.FX*0&Q[YI1H>G?;7NS;E
MIFW<M(S*NX88JI.%)'4@"N<TS5-2U>'2+22]FMGG6[::=%C\Q_)E"*O0J"<Y
M.!VXXJ<6]U'XR\TZG<S>7IBN558P)<.01]WH2,\<Y/!QQ0!OV&DV6F&1K6)E
M>3 =WD:1B!T&6).!DX'09JEJ&CZ$DCW]_ B[Y49F=VV>9D*K;<XW9P,XS658
M7VH+%H&H/JCW/]J.!+;%4"*&C9_DP,C:0!R3QG/-6] MYM8TFUO]4O);IFD\
MU8BJK&I1F"G &3V/)Z@'C% &C_PC^E_;3=_9!YWF^>"7; D_O!<X!/<@<]Z;
M:Z,D6MZIJ,HC9KU8XP .0BKCGW))_ "J5G=WL/B>6VU&>X"W#2?8U41F!T4
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M>>,<_E5>#2=.M4E2WT^UB688D$<*J''O@<UQ-U:"Z\#7&HW=Y>R2M=99FNI
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M2+)&X#*Z'(8'H0>XI]<[X'6V7PCIXMYS*?(C\T&<R;'V#*\D[<?W1@#TKHJ
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MCTJ6&":R,49%L/W,F\$%@/N\<Y-4M-LI?(T"Q33+B"]L)@]W<O%M7A6#D/\
MQ[R>V>N3C% '8Q7=M/*T45Q%)(@!9$<$@'H2*BGU&VB^T(L\3W$$9D: 2#>
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M5O\ D*1?]<7_ )K0!:HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^0#??]<C6'3 ****!!1110!7NNL'_74?UJQ5>ZZP?]=1_6K% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% %=/^0A+_P!<D_FU6*KI_P A
M"7_KDG\VJQ0!3NM5L;*ZBMKB<+-+RJ!2QQG&3@<#/&3@5D6WB+3GUBZAOGMX
MKN"Z-I VPY",$(!;G;N;W&=H]*77;&_FU."YTRWECNU54%VLZB/;ORR2(>67
M'(P"<GM45QHEY)INL0K&GF76I1W$?S#E T1)/_?#4 ;#:UIR:@MBUP!<,^P
MHVTMC.W=C;G';.:S(=?N9+ZW@,46V34YK,D Y")&[ ]>N5%4;W2M;O=75YEE
M>*+48IXW^T*L0@5@<!!R6'.<_@>U68-%O4U"VF9%V1ZO/=-\P_U;1.H/YL.*
M!FU?:O8:8Z)>7*Q/(I9$P2S@8S@#D]1TJ.;7=,@M;:Y>[4Q7(W0>6I<R#&<@
M*"2,>W%,GL9I/$]C?!08(;6>)CGD,S1D<?16K%T_2]4T<Z==+9?:FBMYK>6&
M.50R[I ZL"Q (XP>?2@1IS^*M+AN=/B$QD2^5FCEC4LH ^@]<CV[UGZGXA33
M$"6WV*">YU%H&D$;RJ,+R[!0I+X"C&>_4XI(-(U*Q.EW8M5FDCN;F:>"*0#R
M_.+$!2V 0N<']*E71;T7$3E%PNM/>'YA_JC&P!^N2.*!FTFJ69MDF-S&5,WV
M?(!&9=VW;CKG/:J^I>(+/2]3L[&X+A[D,0P4D* .^!WK$2PD?X@26RE3818U
M-E'\,[*8@#_WRS?6M?6+:[.J:5?6ML;@6SR"2-753AUQD;B!P:!$5AXGM)K^
MYLKN>**X2\>VB4*V#C[N3T#'GC(SVJZ^NZ9'J(L&NU%QO$>W!P'(R%+8P&/I
MG-9,NB7C:=>PK&GF2ZNEVGS#_5B5&)^N%-54T"XCU.>.XM;RXMY;_P"U))%>
M!8E!<.-R$@Y4CL#G H Z#5=4.G"VBBA\^ZNI?)@BW;03@DDG!P  23@U4NM9
MOM/MXDN[")KVXG$%M%!.2DA()R6*@J  2>#T[U)KEA=3SZ=J%DBR7-C,7\IF
MV^8C*58 ]C@Y&?2JFH6^J:E]BOX[%;>>PNA+'!+,I:5"A5P2,A3AN.3T[4 2
M_P!O7-I=S6>I6<4=PMJ]U"T,Q=)53[RY*@@C(['@TFF>(+JYOK*UO;&* WUL
M;F!H;@RC VY# JN#\P]14$^G:CJ]_+?7%I]D6*QFM[>%Y%9V>3&68KD ?* .
M3U--T?PZVBW^GW%I;1QK):""_4-T90"K#\=P..N0>U S9OM:T_39 EY<>42N
MX_(Q"KG&6(&%'!Y.*CO?$&E:=,\-U>QQR(H=EP254]&.!P..O05C>*=,UK4V
MO;:W$TEK-9F. 17"Q*LAW!O,'5@05P.1USCK5F;1[MWUUA&O^EZ=';PG<.7"
MR @^G+"@1=U;Q!8:5$XEN8UG\DRHI!(QV+$= 3QDXI?[92W\,1ZS>#"_94G=
M8QU)4'"CW)P*R)-,U2U>[6"R2Y%[I\5ON:4*(G164AL\E?FSQGG/UJ_<Z+->
M^"DTAF6.Y%K&@)Y"R(%(SCMN44 .?5[[3[*XO]6L8+>TB@,I,,YD=2/X""H&
M3[$C/YU&=<U"T>R?4]-B@M[R585,5P7>)V^Z'!4#D\<$X/KUIFH6^J>(-%N]
M,N; 6)E@*^<TRN/,X(VA<DKGN<'VIES;ZMK;:?;W=@MG%;W$=Q<2F97#E#N"
MH!S@L!R<<4 ;[W4$=W%:O(HGE5G1#U8+C)'TW#\ZJ_VS8R6<5Q;W,4BS[Q <
MG#LH)(R!T&TY/M5+Q/IU]=VUO<:4$^WVSMY>YMHVNI1N?;(;_@(K-T[PQ<Z?
MJ%S"BI_9MO!(MB-W.Z15WY';!4_]]F@#3MO%%G-J5MI[G]_/;).&C#,A+8P
M<<CG.>*9H'B>TU>"WCDGB6^D#$Q("!E3R 3P2!@D9S5?3=-U#3;[2)&M?-1-
M,CLYRDB_NG4@DG)Y'7IGI18Z)>V]CX=B>-0]E<R23X8<*4E''KRZT :">(;*
M*S@FO;F".28R!%B9GW[&VD+P"2..,5H6]W#>6:75K(LT4B[D93PPKG]*T2]M
M;K2))HU M1>>80P./,D#+C\,UI:%9W&FZ(()HP9EEG<(&'(:1V7GZ$4 1VNJ
MWXUB+3]1LH(6GA>:)H)S)C:5!5LJ,'YAR..M)I_B :CKMU81V^((H]\=QO\
M];AMK8&.@8$9SS@U0TVTU:YFO)=2LY;:\NXFB^U1S(PMDYVJ@!SP3G/<\GL
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MN1K#I@%%%% @HHHH KW76#_KJ/ZU8JO==8/^NH_K5B@ HHHH **** "BBB@
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M%X@BU*%#+*OF7%S<);@(1N2-R!GT.W'7%6I-?T^.W282O('F>!$CB9G=T)#
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M1;F.X+#G<S;L@'ID<8YYZ5BWOASR+CPYIT,K,/+-O=MMXEA0K(<^F74#Z.:
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M?TJ*I=._Y#UK_P!<Y/Z4 =11112&%%%% !1110 4444 %%%% !1110 4444
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M!L ^WUI 6]4U6YM-0LK"SLTN)[M9&4R3>6J;-N<D*3SN[#KCZC)/C6#^UA;
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M0V,KO;0,%"J&5A@X&6QN."?\:LP^'[>&UT^W$LI6RN6N4)QEF._@^W[P_D*
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M/_A3 DHJ/?+_ ,^5[_X#/_A1OE_Y\KW_ ,!G_P *!$E%1[Y?^?*]_P# 9_\
M"C?+_P ^5[_X#/\ X4 1W76#_KJ/ZU8JI=/+F#-G>#]Z.MNXSU]JGWR_\^5[
M_P" S_X4 245'OE_Y\KW_P !G_PHWR_\^5[_ . S_P"% $E%1[Y?^?*]_P#
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M\I./L[Y'+=L5/OE_Y\KW_P !G_PH RKW4-0?6CINFK;*\5NMQ(]P&((9F55
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M_P ^5[_X#/\ X4;Y?^?*]_\  9_\* )**CWR_P#/E>_^ S_X4;Y?^?*]_P#
M9_\ "@"2BH]\O_/E>_\ @,_^%&^7_GRO?_ 9_P#"@"2BH]\O_/E>_P#@,_\
MA1OE_P"?*]_\!G_PH DHJ/?+_P ^5[_X#/\ X4;Y?^?*]_\  9_\* )**CWR
M_P#/E>_^ S_X4;Y?^?*]_P# 9_\ "@"2BH]\O_/E>_\ @,_^%&^7_GRO?_ 9
M_P#"@"2BH]\O_/E>_P#@,_\ A1OE_P"?*]_\!G_PH DHJ/?+_P ^5[_X#/\
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MU4=2^]9_]?*_R-7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR3BF^?#Y0E\U/+(R'W#&/7-<CXY-F-4\,_;[62ZM!>R&2)(C)D"%R"4'+ $
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M;^2UHUG77_(<T[_<F_DM &C1110 4444 %%%% !1110 4444 %%%% !1110
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MM;APRCR9'@5><'GYP3QGD9J7PKI$\%]827UMK27-C9FW#7+V_D)G:"J>7\S
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MHNO,$6-C;0Y&0A?&T,1CY<YYJ6TUO3KZ_FL;:X\R>$L' 1MN5.& ;&TD$@$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF\0KJ]U%!!NT\VS0I*7*OYF[KM&1BK/AG39M'\+Z7IMRR-/:VL<,AC)*EE4
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MI-22*6-H9M'@T^$L3NW1B49;CI\Z^O>@#=NM4LK+2VU.>=5LU02>8 3D'&,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[Z25'#D?\"<GGM4%CX8U*'3--T^>:T\O3M06YBDC+9DC!<_,".&^8="1QUH
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MLZZ_Y#FG?[DW\EK1K.NO^0YIW^Y-_): -&BBB@ HHHH **** "BBB@ HHHH
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MPC,0?F!P>N:NZ1IC6&EM:LEE S%B1I]OY*+GN!D\^_Z5SNA^!KC1[RVNUN[
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M!M8KA;6:[#1[(Y6(&-N[<0"P!(& ?H:IP^#[NSTK3XK2^MTNK&_>]B5H&\A
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MUM;1",J"F7?GA5'4GZ#J0*+SP5-<Z NBB_MC:,TS2&:RWNIDD9]T9WC8R[L
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MI9(E/VA 2<\8VG+'...>@JOIWA22SETY+C59KNRTSFSMWB52AVE%+L.6*JQ
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MBBB@ HHHH **** "LZZ_Y#FG?[DW\EK1K.NO^0YIW^Y-_): -&BBB@ HHHH
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M)=0V\7RJI"&&1I$.",'YFY!X(%1KX0C:.[^TZA/--=7=O=RR%%7YH2A4  8
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M@*]_ZY&M&@ HHHH **** *.I?>L_^OE?Y&KU4=2^]9_]?*_R-7J .;\=&?\
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M@MHTDEM/LTLLC GNZ';%QG!8'-&M>)=9LY]?>SAL?LNBQ)/)YP<O,I3>RC!
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M3MQCCG(.*V[;P?IEI>P7,;71^S3O<6\+3DQPLX;=M7I@[SUSCMBK7_".Z?\
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M* "BBB@ HHHH **** "BBB@ HHHH SM>_P"0%>_]<C6C6=KW_("O?^N1K1H
M**** "BBB@"CJ7WK/_KY7^1J]5'4OO6?_7RO\C5Z@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@"C%_P AVY_Z]HO_ $*2KU48O^0[<_\
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MW0,# Z4 %%%% !6=)_R,5O\ ]>LO_H25HUG2?\C%;_\ 7K+_ .A)0!HT444
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MVWVYH9)8W/F#/[OC!VKP>F#V-7-6U75_#SZO&-3ENS_9(O(WGC3]S+O*$@*
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M@7I/3RC4?_"1V']VY_\  =_\* -:BLG_ (2.P_NW/_@._P#A1_PD=A_=N?\
MP'?_  H UJ*R?^$CL/[MS_X#O_A1_P )'8?W;G_P'?\ PH L:E]ZS_Z^5_D:
MO5SU]KUE(;7:+CY9U8Y@<<8/M5O_ (2.P_NW/_@._P#A0!K45D_\)'8?W;G_
M ,!W_P */^$CL/[MS_X#O_A0!K45D_\ "1V']VY_\!W_ ,*/^$CL/[MS_P"
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M4E7JYZ/7[(:O<2XN-K01J/W#YR&<],>XJW_PD=A_=N?_  '?_"@#-U**6_\
M'=E8O>7<5HNGR7#0P3M&'=9$"DE2#QN/'?OQ7.>'[G5[_5[:\DO[>*?[?*EU
M%+JSDE SKY0MBFU2 %((.>,Y.:[/_A(-.W[_ "[C>!C=]F?./3I47]K:-]K^
MU_9'^TXQYWV-M^/KC- ')(M[-96.H'6-36>XUV>R?;<G:(#-*FP+T& HPV-P
M[$8&&7=[J%I')I4=U*]E'KKVIEN=0DA81?9Q*J-/AG WM@'J<!<\UVG]NZ8
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M_P#"1V']VY_\!W_PH_X2.P_NW/\ X#O_ (4 :U%9/_"1V']VY_\  =_\*/\
MA([#^[<_^ [_ .% &M163_PD=A_=N?\ P'?_  H_X2.P_NW/_@._^% &M6=)
M_P C%;_]>LO_ *$E1?\ "1V']VY_\!W_ ,*HOKUD=;AF N-JV[J?W#YR67MC
MV- '245D_P#"1V']VY_\!W_PH_X2.P_NW/\ X#O_ (4 :U%9/_"1V']VY_\
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M (4 :U%9/_"1V']VY_\  =_\*/\ A([#^[<_^ [_ .% &M163_PD=A_=N?\
MP'?_  H_X2.P_NW/_@._^% &M163_P )'8?W;G_P'?\ PH_X2.P_NW/_ (#O
M_A0!K45D_P#"1V']VY_\!W_PH_X2.P_NW/\ X#O_ (4 :U%9/_"1V']VY_\
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MC%=L\$DXFWC: A0?KO'Y4 :%%,>:*--[R(JXW9+ #'K223PPQB225$0]&9@
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M.,# ]*!'?$@=3BD) ZD#->7RQ32:=HMG=68N&6PN$,-Q;RR>63(JJ^Q%9@5
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M7?8I[*&)VCCH,5;L[."PM4MK:/RX4SM7)/4Y/)Y/)- $]%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<VWB6=;:WN18RO-+/]IA4>7(2.8W'+!CDXYQ[=*Z>B@04444 %%%% !1110
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M /@.?_BJ/[!O_P#G^M__  '/_P 56#_PN3PE_P ]KO\ \!S_ (T?\+D\)?\
M/:[_ / <_P"-',NX>QJ=C>_L&_\ ^?ZW_P# <_\ Q5']@W__ #_6_P#X#G_X
MJL'_ (7)X2_Y[7?_ (#G_&C_ (7)X2_Y[7?_ (#G_&CF7</8U.QMR>';Z39F
M_@^5@PQ >O\ WU3_ .P;_P#Y_K?_ ,!S_P#%5@_\+D\)?\]KO_P'/^-'_"Y/
M"7_/:[_\!S_C1S+N'L:G8WO[!O\ _G^M_P#P'/\ \51_8-__ ,_UO_X#G_XJ
ML'_A<GA+_GM=_P#@.?\ &C_A<GA+_GM=_P#@.?\ &CF7</8U.QO?V#?_ //]
M;_\ @.?_ (JC^P;_ /Y_K?\ \!S_ /%5@_\ "Y/"7_/:[_\  <_XT?\ "Y/"
M7_/:[_\  <_XT<R[A[&IV-[^P;__ )_K?_P'/_Q5']@W_P#S_6__ (#G_P"*
MK!_X7)X2_P">UW_X#G_&C_A<GA+_ )[7?_@.?\:.9=P]C4[&]_8-_P#\_P!;
M_P#@.?\ XJC^P;__ )_K?_P'/_Q58/\ PN3PE_SVN_\ P'/^-'_"Y/"7_/:[
M_P# <_XT<R[A[&IV-[^P;_\ Y_K?_P !S_\ %4?V#?\ _/\ 6_\ X#G_ .*K
M!_X7)X2_Y[7?_@.?\:/^%R>$O^>UW_X#G_&CF7</8U.QO?V#?_\ /];_ /@.
M?_BJ/[!O_P#G^M__  '/_P 56#_PN3PE_P ]KO\ \!S_ (T?\+D\)?\ /:[_
M / <_P"-',NX>QJ=C>_L&_\ ^?ZW_P# <_\ Q5']@W__ #_6_P#X#G_XJL'_
M (7)X2_Y[7?_ (#G_&C_ (7)X2_Y[7?_ (#G_&CF7</8U.QO?V#?_P#/];_^
M Y_^*H_L&_\ ^?ZW_P# <_\ Q58/_"Y/"7_/:[_\!S_C1_PN3PE_SVN__ <_
MXT<R[A[&IV-[^P;_ /Y_K?\ \!S_ /%4?V#?_P#/];_^ Y_^*K!_X7)X2_Y[
M7?\ X#G_ !H_X7)X2_Y[7?\ X#G_ !HYEW#V-3L;0\.7JSO*+^#<RA3^X..,
M_P"U[U)_8-__ ,_UO_X#G_XJL'_A<GA+_GM=_P#@.?\ &C_A<GA+_GM=_P#@
M.?\ &CF7</8U.QO?V#?_ //];_\ @.?_ (JC^P;_ /Y_K?\ \!S_ /%5@_\
M"Y/"7_/:[_\  <_XT?\ "Y/"7_/:[_\  <_XT<R[A[&IV-[^P;__ )_K?_P'
M/_Q5']@W_P#S_6__ (#G_P"*K!_X7)X2_P">UW_X#G_&C_A<GA+_ )[7?_@.
M?\:.9=P]C4[&]_8-_P#\_P!;_P#@.?\ XJC^P;__ )_K?_P'/_Q58/\ PN3P
ME_SVN_\ P'/^-'_"Y/"7_/:[_P# <_XT<R[A[&IV-[^P;_\ Y_K?_P !S_\
M%4?V#?\ _/\ 6_\ X#G_ .*K!_X7)X2_Y[7?_@.?\:/^%R>$O^>UW_X#G_&C
MF7</8U.QO?V#?_\ /];_ /@.?_BJ/[!O_P#G^M__  '/_P 56#_PN3PE_P ]
MKO\ \!S_ (T?\+D\)?\ /:[_ / <_P"-',NX>QJ=C>_L&_\ ^?ZW_P# <_\
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M_P ]KO\ \!S_ (T?\+D\)?\ /:[_ / <_P"-',NX>QJ=C>_L&_\ ^?ZW_P#
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M^-',NX>QJ=C>_L&__P"?ZW_\!S_\51_8-_\ \_UO_P" Y_\ BJP?^%R>$O\
MGM=_^ Y_QH_X7)X2_P">UW_X#G_&CF7</8U.QO?V#?\ _/\ 6_\ X#G_ .*H
M_L&__P"?ZW_\!S_\56#_ ,+D\)?\]KO_ ,!S_C1_PN3PE_SVN_\ P'/^-',N
MX>QJ=C>_L&__ .?ZW_\  <__ !5']@W_ /S_ %O_ . Y_P#BJP?^%R>$O^>U
MW_X#G_&C_A<GA+_GM=_^ Y_QHYEW#V-3L;W]@W__ #_6_P#X#G_XJC^P;_\
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M_P#Y_K?_ ,!S_P#%4?V#?_\ /];_ /@.?_BJP?\ A<GA+_GM=_\ @.?\:/\
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M+X_\'9_^,4?\*G3_ *%\?^#L_P#QBO8JY:[\=Z?;1ZC<)8:G<V6FRO#>7<,
M,<3)]_@L&8+W*@@4<B#ZQ/\ JYPW_"IT_P"A?'_@[/\ \8H_X5.G_0OC_P '
M9_\ C%>F7_B/3;#2[34&E,T5ZT:6BPC<UPSC*!!WR.>P R3@4FD>([+5Y[ZV
M1)K:]L&5;JUN% DBW#*DX)!!'(()%'(@^L3_ *N>:?\ "IT_Z%\?^#L__&*/
M^%3I_P!"^/\ P=G_ .,5VJ?$+2FL[346M-1BTF[E6*'49( L)+'"DC=O52>
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M $+X_P#!V?\ XQ7L5%'(@^L3_JYX[_PJ=/\ H7Q_X.S_ /&*/^%3I_T+X_\
M!V?_ (Q7L5%'(@^L3_JYX[_PJ=/^A?'_ (.S_P#&*/\ A4Z?]"^/_!V?_C%>
MQ44<B#ZQ/^KGCO\ PJ=/^A?'_@[/_P 8H_X5.G_0OC_P=G_XQ7L5%'(@^L3_
M *N>._\ "IT_Z%\?^#L__&*/^%3I_P!"^/\ P=G_ .,5[%11R(/K$_ZN>._\
M*G3_ *%\?^#L_P#QBC_A4Z?]"^/_  =G_P",5[%11R(/K$_ZN>._\*G3_H7Q
M_P"#L_\ QBC_ (5.G_0OC_P=G_XQ7L5%'(@^L3_JYX[_ ,*G3_H7Q_X.S_\
M&*/^%3I_T+X_\'9_^,5[%11R(/K$_P"KGCO_  J=/^A?'_@[/_QBC_A4Z?\
M0OC_ ,'9_P#C%>Q44<B#ZQ/^KGCO_"IT_P"A?'_@[/\ \8H_X5.G_0OC_P '
M9_\ C%>Q44<B#ZQ/^KGCO_"IT_Z%\?\ @[/_ ,8H_P"%3I_T+X_\'9_^,5[%
M11R(/K$_ZN>._P#"IT_Z%\?^#L__ !BC_A4Z?]"^/_!V?_C%>Q44<B#ZQ/\
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M_P"A?'_@[/\ \8H_X5.G_0OC_P '9_\ C%>Q44<B#ZQ/^KGCO_"IT_Z%\?\
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MN[JXMFN8FCDC52JG#?>88()%'(@^L3_JYP/_  J=/^A?'_@[/_QBC_A4Z?\
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M'4C<,G!H F\%S:W-X9@_X2&%X]1C=XV+A0TBAB$<A> 2N,X[YK ^(\$4,_A
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M$ 9X       P *UJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
IBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>modificationno14effectiv013.jpg
<TEXT>
begin 644 modificationno14effectiv013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH P/&]Q-:>#-4N+>5XIHXMR.AP5.17SY_PF?B3_ *#=[_W]->_>/_\
MD1-8_P"N']17S+7?@XQ<7=')B)--69N?\)GXD_Z#=[_W]-'_  F?B3_H-WO_
M ']-8=%=?LX=D<_/+N;G_"9^)/\ H-WO_?TT?\)GXD_Z#=[_ -_36'11[.'9
M!SR[G36_B[Q"]E>.VLWI9%4J?-/&6 JK_P )GXD_Z#=[_P!_35"T_P"0??\
M^XG_ *&*I5,:<+O0;G*RU-S_ (3/Q)_T&[W_ +^FC_A,_$G_ $&[W_OZ:PZ*
MKV<.R%SR[FY_PF?B3_H-WO\ W]-'_"9^)/\ H-WO_?TUAT4>SAV0<\NYN?\
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M/Q)_T&[W_OZ:/^$S\2?]!N]_[^FL.BCV<.R#GEW-S_A,_$G_ $&[W_OZ:/\
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M?^_IH_X3/Q)_T&[W_OZ:PZ*/9P[(.>7<W/\ A,_$G_0;O?\ OZ:/^$S\2?\
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M7D2^:VHF\\UGR-I3;@]R?>FE5>XGR=#4\->$M&\0+;6R:AJ(OIU;+I99@A8
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MO3YB#);2M$Q7H2#C(JI4UY,MQ>SS('"22,RB1][ $\9;N?>H:ZEMJ8,****
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M-#URWU+3K*.^LK1KNWN[: 1,-O56QU!X_6N;\%^(X/#&NM?W%O)/&T#PE(V
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MIRC:***U("BBB@ HHHH **** "BBB@ KUWX)_P"LO_H?_9*\BKUWX)_ZR_\
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MV?\ &C_A6VB?]-O^^S_C1]<I^8?5YGC]%>P?\*VT3_IM_P!]G_&C_A6VB?\
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MTV_[[/\ C1_PK;1/^FW_ 'V?\:/KE/S#ZO,\?HKV#_A6VB?]-O\ OL_XT?\
M"MM$_P"FW_?9_P :/KE/S#ZO,\?HKV#_ (5MHG_3;_OL_P"-'_"MM$_Z;?\
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MQ^BO8/\ A6VB?]-O^^S_ (T?\*VT3_IM_P!]G_&CZY3\P^KS/'ZMO_R"8?\
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M:/\ A6VB?]-O^^S_ (T?7*?F'U>9X_17L'_"MM$_Z;?]]G_&C_A6VB?]-O\
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MQH_X5MHG_3;_ +[/^-'URGYA]7F>/UZ[\$_]9?\ T/\ [)3_ /A6VB?]-O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT2.SA>1Y/M%NS2*P1PJR*68'@ @ GBD'AJ&2"Z6ZO+FYFN7B:2=]H;$;!D4
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M0%P2=Z],^M;5MI-G:7,4\$?EF*V%JB@_*L8.0,4S4=(AU*>WG:>X@FM]WEO
M^T@-C(Z'T% '*_VV8_!D$%Q?O;W5Q>-9/+/+M>W&\E@SG^)8QC=W..>:B35W
MO/!UO$+J:[EMM3BLII+:?YYU$@ (<,,[D*\YZFNJM/#VGV4T$L22,\/F$&1R
MQ9I""[MGJQQU]*67P_8RWLMT5=9)989G"MA2\1RIQ^0/K@4AG*_:+E_#^M&.
M:]@MA?V\,,,\[&> ;XPX+9+ '.1\QX/O6T@?1O%-I90W,\EE=VTKO%/,TOE-
M&5PP9B2 =Q!&<=*OWGA^RO6O6<RH;SRC*8WQ\T9RK#T/ _(4U/#EF%NC)+=3
M3W,)MWN)92T@C/\ "IZ*._ ZTP.>\/:_'<^)%D_M2.X35ED9+83AOLYC/R#;
MGY=T>2?<5W%49M)LYH+6'R]BVLB20[."I3I^&./H:O4""BBB@ HHHH ****
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MCD /RMM)P<>O)&?2J%SX9M+F><M<W:6US()+BT1P(I6XY/&1G R 0#WK:HH
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M0MLPC$SNTLOEDE=S'.!GG & /8"GSZ!I]S+>O(DI%]&8[B,3,$D& N=H.-V
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MW<\TLD<R^><SI%</&DW&/G52 >..>M:U% %9-/M8KI;F.%4D2'R%V\ 1YSM
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M_P !G_PH DHJ/S)?^?*]_P# 9_\ "CS)?^?*]_\  9_\* )**C\R7_GRO?\
MP&?_  H\R7_GRO?_  &?_"@"2BH_,E_Y\KW_ ,!G_P */,E_Y\KW_P !G_PH
M DHJ/S)?^?*]_P# 9_\ "CS)?^?*]_\  9_\* )**C\R7_GRO?\ P&?_  H\
MR7_GRO?_  &?_"@"2BH_,E_Y\KW_ ,!G_P */,E_Y\KW_P !G_PH DHJ/S)?
M^?*]_P# 9_\ "CS)?^?*]_\  9_\* (;?_C]N_\ >7_T$5:JE \GVRZ_T2[)
MW+P+=R1\O<8XJSYDO_/E>_\ @,_^% '.+;V^J>--3AU**.X2UMH?LT,RAE"O
MNWN >,Y &?;%.;[9)J%YIVFWJ:=;:=!'L41*X9F#'G=T0;<8&._-:=[I=KJ,
MJ2W.EWK2H-JR)!*C@>FY<''MTJ"?P]IEPL:R:+=!8X_* 2"5 4_NG;C</8Y'
M- QFG:[<7^F6<XTVY\RYM%F\Q57RE8INQG=GKQTJGX3TW3KCP[IFI26\,M]*
MBSR73*/,,IY;YNO7(Q^%=&A:-%1+"\5%&%5;5P /0<5G1Z'I\-W]ICT>Z60/
MY@ MY=@?^\$^Z#[XS0(Y>"RL+KX=7.L74<?]HR02W$EV>)4F!)&&ZC:0  /3
M%4-926=M8N;G3()I!9VOFW;X\RS)0[G48R<=>".E=J^@::]R9VT6Z+&3S2OV
M>787Z[BGW2<\YQFKC6D3/<NVF71:Y4)-FU?YU ( /'H32&5-8NKG3O#K7EK)
MYK6RI*[$;O,C4@O^)7=6$_BB]>_OK:)HP+B:.+3'"@YQ)Y<I/KM.6^E=4D"Q
MV:VBZ=>?9UC$0C-LY&W&,=/2JL6CV,'V+R]&N%^PAA;8M9/W6X8...],1S?G
MZAI\NN:C;WBK#%JR*]L8@1(&$*MENHX;C&.G.<U876-;NM5F>T@NG@AOC;&$
M0Q^48U8*S%R=V[JWIT&.]="^GV[Q3Q-I5T4N)1-*/LTGSN,8)X_V5_*HGT>S
M>_-Z=+OA.6#L5BF568="5'!/ Y([4#,6YU;5D.H7JWB"WLM2CMA;B$?O$8Q@
MY;KGY^,8Z<YK5\0W5[;IIT5C,D,EU>+ TC)NVJ58D@>O'%6FT^W>*:)M*NRD
M\HFD7[-)\S@@@]/]E?RJ:>%;EH3-IUXYAD$D>;9_E8 C/3T)H$<K>ZKKHO[V
MWL%N[A]/\N-0D$12X;8KDR$D%<[L?*!CKSTJ76-4U55U^YM+V.V32HAMA>)6
M$I\L.2Q//\6!CN._2MJ[T>SO;K[3/I=\9B K,D4R;P.@8+@-^.:J:[X=MM9M
M;S.FW2W<]NT0E-O+MS@A2RCAL$Y&1QVH&5+[7;VWT_Q),LB![&W22 E1PQBW
M<^O-,U;5+JQN]<DM%@2>*WLV1VC&6+R.IW'J1C\N:U+G0-/OF\R\T:YFD,0B
M<M;28<#ID8P<9.">1VJU-I]M<-,TNE73F=460FVD^8(25'3L2:!&!J-]K%OJ
M<>E07-W-(EK]H>>"VB9G9G( (8@!1CMSR.?5YOM9U"46K3IIL\.FQW,Z&-7#
M2.6!4YZ*-AZ'/S=:VK[3+;4GCDN=,OFDC!"R)#*C 'J-RX./:HY]%L+HP&;2
M+M_)C\I,V\O*?W6_O#CH<B@9'X3(_P"$0T5<C/V&$X_X *V:H0:?;6TEO)#I
M5TCV\/D1$6TGR1\?*..G _*K?F2_\^5[_P" S_X4")**C\R7_GRO?_ 9_P#"
MCS)?^?*]_P# 9_\ "@"2BH_,E_Y\KW_P&?\ PH\R7_GRO?\ P&?_  H DHJ/
MS)?^?*]_\!G_ ,*/,E_Y\KW_ ,!G_P * )**C\R7_GRO?_ 9_P#"CS)?^?*]
M_P# 9_\ "@"2BH_,E_Y\KW_P&?\ PH\R7_GRO?\ P&?_  H DHJ/S)?^?*]_
M\!G_ ,*/,E_Y\KW_ ,!G_P * )**C\R7_GRO?_ 9_P#"CS)?^?*]_P# 9_\
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M#/\ X4>9+_SY7O\ X#/_ (4 245'YDO_ #Y7O_@,_P#A1YDO_/E>_P#@,_\
MA0!)14?F2_\ /E>_^ S_ .%'F2_\^5[_ . S_P"% $E%1^9+_P ^5[_X#/\
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M1K.OO^0KI?\ UTD_]%FM&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#/LO\ D+:G_OQ_^@"M"L^R_P"0MJ?^_'_Z *T* ,W5M>TW0_LO
M]HW'D_:IE@B^4G+GIG X'N>!FDOM=MM/OGM)4E,B64MZ2H&-D94$=>OS#%<M
MXBL-2\2:_J5K;6%O/:6U@;,/<7#0A99<,S)A&W%0L?I@YJG%=7NK+!=W5M*E
MT?#=Y#<*4(Q,KQJP_$J2/:@#T*SNDO;&WNX@PCGC610W4!AD9_.IJX[6HIV^
M%2PQB59OL4"XCR'!^3.,<@UD>)]*M+'6+.S=-.M=%%FWE"\MY)(O/+_.?E9<
M.1M().?O8YS0!Z117F4ZZ5#K>BV_B.Z>^M%T3'G2QOY<K[P SKSR1G&[O[XI
MEFENJ:,/%\<C:<-+/V=;Q&91+YAX<8_UGE^7C//WL<YH ]0J"VO+>[\[[/*L
MGDR&*3'\+CJ/UK@-%TJ74;[PY!J]O<201Z==R"*XW=!/'Y(D!ZL(R.#SD9ZB
MJ\>F:1;V'BBP:5-+NS?%C(T+,!"71EW =8VZ'D<$\T >G45SOA6Z+>%/,CTU
M+<1-*L<-MN$<H5CAH]P!"MU [9]*XO07:74Y9[.V@MXKC1+AI8;2&5=DH,>%
MD=OOR#+#. >3ZB@#U:J4^IPV^K6>FNKF:[25T8 ;0(]N<\_[0Q7"6FESZ8FB
M3Z3!*E_=:#<><Y+$R3!(C'O)ZD,6QGIR.E,\-6^D?\)-X>GTBWF5QI\PO7*.
M!YI$?#D\>9D-GOZ]J /2B0JDGM532=2AUC2+/4[=76&[A69%D # ,,C.,\UR
M7B9-/D\6;->ADDLCIW^@A5<_O][;]FWGS,>7C'/7'>L/2HM-ALM$C\5PM_9Z
M:%;K:I.C&-9AN\T8 _UF/+QWQG'>@#U6BO,;:.%#I \8I*UE_9?^CBZ5FQ-Y
MASNQSYOE^7C//WL<YI=9OQ:V?BS3U%Y]IN9[>2SB$<A9HC#"-P.. "K9)Z$<
M\F@#TVBO.O$>E+>3^-+N2":2>VLHWLF#-^[D$3$,@'&[('(Y[=ZBUC3+K36U
M:+1(;B-KC1HY)3'O9I)/-(=NN6DV%N<[CQ[4 >E5#=74%C9S7=S((H($:21V
MZ*H&23^%>8"TC3PYX@?2K^T>.2VA7[-IEO+"L;A_O\L<.0<'&#\HS5[7M!A@
M3Q;IME8N;670TG2)0S![@><-P]7^5,]S@9H ]&5@RAE.01D&H3>6XOELC*OV
MEHS*(^Y0$ G\R*\XUJ72;C3M/LK"QLFM&LI7MYYX)95,F0#'&BX_>9YSG([=
MZL:;:V8\0^%M0U:#-Q<:+&JSS*26N08B 3_?QGK[T >@6ERMY;+.D<L:MGY9
MHRC#!QRIY'2IJ\OLUM5CT;_A)HV.D"*\VBX5C%]H^T'&\=,[,[<^^.:L:9I9
MU"Y\.VU]!<2Z=C46BBG+X,'F)Y(D!ZC9C ;V]* /2**YSP<DL7@^*&02 Q27
M,:!\Y"+-($'/. H 'MBN-72OL7@/PS+Y4<<5QY3ZK+=Q/*&_<MM\X ABH<@8
M)P/ESP* /5:*\R$%M;Z/I,=[=PWOAYM4E:X\F%UMXD,;&-""23&)/?;D@=!4
M>FW,%K9PWL#7":7:>)G+,X<^7"8"BY!Y"Y9<9Z B@#TNXN5MVA#1ROYT@C'E
MQEMI()RV.@XZGCI4U>=VTT]VXN(TN1%)XH5UWQLA,7E#!P>0IJJVE2Q>"[R^
MBA87<^J2K=RRH[L+47C;EP"&\O: 2JD<%CWH ].JE;ZG#<ZM>Z<BN)K1(GD8
M@;2'W8QS_LFO/EMTA\+ZBUK?6]SI<E[;-<P:;!)''%#O43!06)P5Y8+VSZUM
M>#8-/B\2^(7TF!XM/>.U,)V,L;<29\O/\.?3C.: .GT_4X=1EOHX5=39W)MI
M-X RP56R.>F&%7:\HU&*R%WXE40SCQ ^IJVFML?.=L6&C/3J#NQV'/&*UKA+
MH>-O^$8'F_9+B\76"^3@0J,LG_?Y5./1Z /0:*** "BBB@ JBG_(=G_Z]H__
M $)ZO513_D.S_P#7M'_Z$] %ZBBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)_P"9N_[<
M/_:E:U9/_,W?]N'_ +4H UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH HZM_QY+_U\0?\ HU*O
M51U;_CR7_KX@_P#1J5>H **** "BBB@#.OO^0KI?_723_P!%FM&LZ^_Y"NE_
M]=)/_19K1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S
M[+_D+:G_ +\?_H K0K/LO^0MJ?\ OQ_^@"M"@#&N_$<5MJTNFQ:??W=Q%$DL
MGV>-2$5RP7)+#^XU2ZEX@L-*U/3]/NF<3W[E(MJY P0,L>P)90/<BL<Z/<W?
MCO5+G[5?V<'V.U57@PJ2D--D$LISC(Z=-WO67K&CZ]XAO=>FMH;:%"$M+1[K
M>KKY1\P2(,8P9#U[[!0!TFJ>*;72[^>T>TOIVM[=;F=[>$.L4;%@"><_P-T!
MZ5I?VC9C2_[3-P@LO)\_SB?E\O&[=],<UP-[I>K>)KC4;V(:AITUQH=MB$J8
MTEEW3%H7)&>X!P00&SW%;VK6,^O_  QGL[&R:TGN=/"Q6DBE#&=HQ&0<8Z;:
M &_VY9--/X@.DZI&8M.D:*:6+:DT2_O,#D[2<<;@IKHX+V&:&V<NB/<('2-F
M&XY&?QKG=1UI-9\,:G9VNG:DMU)I\P:*2RD3RV\L_)D@ G)P N<_2N4\16U]
M<QR6\>E>7<PPVA@>/2WEFFVA26\X<1[3D8Z\>XH ]5WJ 26''!YZ4WS8_.\K
MS$\W&[9NYQZXKSKQ!]HB3Q?IZZ??S7%_<0S6PAMG=73RHE+;@-HP4;(SGVYJ
M\;<VWC]Y;&V-U+=3$W#7%@X:TQ#M$D<Y&TH< ;>>6..] ';+/$\CQI*C2)]Y
M0P)7ZCM69J7B"+3M2BT];*]N[F2%IPEM&K80$*2<D=R*XOP9I30ZEI+74LD.
MIVL;K=1KI#Q&1BI#^9/]UP6^8'^(@$5T'BN/2OM:S7*ZQ'J"V[);S:<MQD@G
M.W,?RDY4'#>U &IJ6OC3(UD?2]2G3RO.E:&$$0KWW$L,D<\+D^U7EOH9--%_
M"7F@:'SD,2%F=<9&T#DDCH*XS4-5U==!TG1=1@ODO+RS4ZE>V]E+,(@1AU7R
MU(\P\CT')] >DCU2UL;6*"WT^_\ LT5CY\>RT? 1< 1@$;M^.BD9XH ;:>)8
M+F6Y@EL;^UNK>#[0;>:$&22/D!D"%L\C&.N>U):^)([I[J Z;J$%Y;Q+,;66
M-1)(C$@,N&*GD$=<COBL;0=5$\^H:[J%GJ0U![?(M1I\Z^3 A)$2ED >0ELG
M'4].%S5CPM=C4=1O-4O8+R+4;B)0(I;*:)+>%2=L89T 9LL2<=2>.!0!IZ=X
MCAU#5Y-,-C?6MRD N"+B-0-A;:.0QZG/Y'TJ35_$5AHL]I!=&8RW4J1(L49;
M;N8(&8]%&Y@,GUXS65X>L]1N;'4M8<FQU+5)]Z"XA+-!"AVQHR$CG:"2.,%S
M4/BZ>>#1;"TG6[O;L7MK,[VEA*ZE4N$9CA P7"@\$Y..* -O5?$-AH]U9VUR
M93-=RI%&L<9;!9@H+'HHR0,G\,UJUR/B_44ET_2Q%:ZA*6OK2ZQ%83.5C656
M8L GRD 'Y3@^U;\&L6MSJ*V,8F\YK5;O#Q%=J,<#<#@JV0>" >#Z4 9^I>+;
M+2[R[MYK:]D6SC66ZGAAWI"C9(+<YZ DX!Z5M"ZMV,0$\>91NC&X9<>H]:Y"
MY\/76L>*/$$4MW>6FG7-O;Q2"*-0+A=KAE#LIQP<';SS6+XMM+B:_O+2UTE(
MWMS:_9)(M,>66=%*DL)QP@3D8Z\>XH ]#@U.SN;ZZLH9U:XM2HF3GY2PR/KQ
MZ5/'<0RJS1S1NJG#%6! /O7GVJ:28]5\7QV&F^5JE]:A[&XCM2-^8L.!*!A6
M+ YR022#WJB-)CDT+Q#)IQF>:71I+?[)!HTEF"V#MR#]YQR,#GF@#TN>^MK>
MVN+B69!%;J6E(.=@ R<@>W:E@O(+JS2[@D#P.@D5AW!&?Y5Q=YX;B34M0M;+
M2D6VNM"9'58<1R3ACLW=BXR3D\UM>%DM%\'VT=E9-:[8 LL1MC ?-" -E2!D
MY[]_6@!=*\86&JS642V][;F_B,UHUQ%M6=0 QVD$\X.<''%:UO?PS64%S*&M
M1, 5CN"%8$]CSC/XUP7AC1+W2I/"%W=K?W<;6'V=HIU/_$OE,8.0H V@@,AW
M9(XYY.>=FT^XFT_3-,N-/9W701%*DUB]PUMO=@7"#E'&WC/WL<?=- 'JW]MV
MRZY+ICD(4MH[CSF<!2'9E 'O\A_.FV;:7IVK76G02[;RZ8WTD;$G.["D@].P
MXKE/[$TS5]3DN8M/CO--_P"$>A2RD:#*'+2\*,8#8*\=1GMFF:5IT-IKF@7N
MIZ5(T\NB0Q>>;-G=;E=N=Q"DJ^.YQT//% 'H"2QREA'(CE#M8*P.T^AI]<%X
M0L[FV2^T[2PL4$<47DZG/ICPRL=S9CE5MOF,!_$,?>YYKM[5)X[:-+F99I@/
MGD5-@8_[N3C\Z )J*** "JBZ;;)J\NJ;2;J2%8"Q.0$4EL =N6.?7 ]*MT4
M%%%% !1110 513_D.S_]>T?_ *$]7JHI_P AV?\ Z]H__0GH O4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %9/\ S-W_ &X?^U*UJR?^9N_[</\ VI0!K4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!1U;_CR7_KX@_P#1J5>JCJW_ !Y+_P!?$'_HU*O4 %%%% !1110!
MG7W_ "%=+_ZZ2?\ HLUHUG7W_(5TO_KI)_Z+-:- !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% &?9?\A;4_P#?C_\ 0!6A6?9?\A;4_P#?
MC_\ 0!6A0!C7_B#[/JG]EV5A<:A>K$)I8X615B0D@%F8@ G!P!D\>E2Z1KUE
MK%OYD1:&43/ ]O/A9$D3[RD9.2.O!(QS6.PNM"\8ZIJ,EC=75EJ,$&V2UC\Q
MHY(]P*LHYP0P(/3K60^C:M;Z-=:[%I[_ -J?VR=4@L@1YGEE5B,9(.-QC!)&
M>I]J .]%W;%%<7$15G\M3O&"^2-H]\@C'M4<&IV%U<&WM[ZVEG""0QQRJS;#
MT; .<<CFN"\-^&=5L-;L-/O(9&TZTSJ9G8Y5KEXE1D_!S,__  (5)I/AR\M=
M)\()!9?9;N"&=+F0(%,1>!AEL?[>W\0* .YMM3L+RXFM[6^MIYX3B6.*56:/
M_> .1^-1'6])6*65M4LA'"%,KFX3"!AE=QSQD=,]:XWPAI$L%YI7VL:K'=V%
MJT+))91QPJ2H##S%4;P2,CDYQDT6V@K9?#SP_;S6=[;7MKY4VZTMA,\4X5LE
MTYW#YF!^O;K0!TUUXFL;/6(;2XFMXK66S:Z%Y).JI@.J@<\'.[.<]JO-J4:W
MBQ'9Y!MVN/M!E3:%!';.<8.<XQ[US.EZ7>7VN:/?:QI4"-'H[QNHB&R*4NGR
M@<[3MSQ]16&NDZA9>&8VN;62);?PK=V\A8?<?*$*??"G\J /1K;4;&\GF@M;
MVWGEA.)8XI59H_\ > /'XUGS^)+*SU^XTV]E@M4BMH9UGFG"!S(TB[ #CD>7
MGKSGIQ7/^&X&NM8T:ZM=(GTZ"RTMX)VEB""1G,95%Q]X#8S9''(]33M<@,'B
M^_OKC0;G4;>?28[6-X81)\^^8LGJ,@KST'&<4 =C]JM\3'[1%B 9E^<?NQC/
MS>G'//:JFJZYIVBVT%Q?7*1132I%&Q8<EV !^G.2>PYKS^YT&_L)M$T5OG_M
MK3X+'4BK=#;@,[>^Z,NF?]VNO\9V3W6B0&&S:Z-M>VL[11H&8QI,C/M'?Y0>
M.] $P\4Z<NL7-E<7-K!#%#;RQ7$EPH68RF3 7/\ USSP3G/M6E=:G86,L4=Y
M?6UO),<1+-*J%SZ*">?PKDKS1?[1OO$=Y_91*W.BPPVGFP@-G$VY #T/*9'T
MK)O]$O3=3+J U/[+>Z7;VX^R6:7!^56#QMN4E#DYSP#GKD4 >@ZIJ=KHVF3Z
MA>R%+>%<L0,D\X  [DD@ >IJM8ZO<3O)]MTJZTZ-8S*);AXRNT=02K':1Z'\
M^M9_B72+N^\'):6*M-=6[6\T<<S -*8G5]K'ID[<>F3577KNZ\0:#/;6NC:C
M\CPS317$0C\U4E1GB&3\Q*AAQ\IZ9YH Z.VU?3;RUDNK74+2>WC_ -9+%,K(
MGU(.!5.XUG0M/MM3U7[7:'[,N;QXI%9QM!PIP>O4 >I]ZY/6-/NM:@\276G:
M3<VT,^D?9$CEA\I[F4%B,)U^4'&3USQTJYKGAR26YUB&PTY%AG\/M:Q!$"H9
M06VKZ9&1CTH Z@:YI1LTO#J5HMNZ[ED:=0N,@'G.."0/J14J:II\E^U@E]:M
M>*,M;B93(![KG-<Q:V"ZCKGAR\_LJ6*VM;*Z5UG@V>5(?* RI[G#X/?FLTVN
MLWOB?3Y9[*XB%KJ\DCI':(D"Q;9%63S/O.S J3SC).0,"@#M)]<TJV>YCEU&
MT$MLADFB\Y=Z+ZE<Y%,MO$6D76C1ZLNH6R63JI\V255"D@$*Q)P&Y'!KF]!L
MS'H[:+=Z'/\ VC&MP)+J2 &-V8L=XD/7?D=.?7&*I6%O+;V'A2ZFT2\:#3(&
MM[JW%KETG,:*)0G5@-KKN&?O9H [E]4T^.T2[>_M5MG!9)FF4(P R2&S@\ F
MK*.DD:NC!D8 JRG((/<5P%CH,\]_I-Q+ICQV9UBYO5MY4 ^SH86"%EZ*2XW8
M[%AWKLK#4X;Z\O[6"*118RK"\A V,Q0-A2#SC< >F#0 L6J0E)VN#';+%.\(
M,DR8;:,YX/'&3@X( Y%9VHV/AO58!K-U<0^1Y>QKR*]:)'0$_*SHP#+DG@Y'
M)K"?0KJXOHA<6!D@_P"$F>[8.@*^5]G8!R#VW8_&HY-*N[.[^TR:;--86^OR
MW36T4>XM&T&U9%3^("1LX'/4]J .DAUBPM+[3=,LDM_L$ME+/%/%(/+CCB,:
M@#'&,/USQMK8$\+2)&)8R[H750PRR\<@=QR.?<5QFIZ;/J]Q ]AIDMI!+I&H
MP!)8Q'LDD:/;N Z%L,WKZX-58X-6U:: V^FWED\?AZYLQ+<*$VW#>5@#G/!4
M\]#VZ4 =(?%%E)K5MIUC);WOFPSR.\%PK>6T>SY2!QD[^Y&,5<76[".P@NKR
MZMK,2Q)*5FN$&T-T^;.#SQD'![5Q^FV+W&L://;>'[BP2UTF:UG>2$1_.1'M
M0=V VM@].>">:DT'P],)M+:_TT'R?#<-J3+&#LE_B3GOCK0!V-WJVFV'E?;-
M0M;;S?\ 5^=,J;_ID\U:CD2:-)(W5XW 964Y# ]"#Z5X]-I]\]M#I\UK<$1>
M'+2VU 1VR3/"OSEL%I$V/QV#9QG' KTW2]<LM0N1:6*2-$MG#=+*% 39)G8O
MJ&PN<8Z$4 1P>);)M8O]-NI;>UDMKA((O-G4&<M&C_*#CGY\8&?UK4>ZMXUF
M9[B)1#_K27 \OC/S>G!SS7GNNZ;/+=^+[4:#<W%QJYCCL[I8@4R(8U!+=4"M
MELGC@XY%2>(;/4TC\6V$.F7=W)JD43V\L2#8V(E1LG. 04)QU.1C- '8P:_I
MESK5SI$=W$;VW"EXMXR<@G YY(VG/I6G7,6EL;/Q_J,TFGR%+VW@,-RD.45D
M$F\,W\)Y'7KFNGH **** "J*?\AV?_KVC_\ 0GJ]5%/^0[/_ ->T?_H3T 7J
M**RO$6O0^'-(>_F@FN,,%6&  NYY)P#Z*&/T!H U:*IOJVGQ645Y+>V\5O+'
MYB22R!%9<9SD^W-!U;35LXKPZA:BUE!,<QF78XP3PV<'@$_@: +E%5;?4K"[
MB@EM[VWFCN"1"\<JL)" 20I!YP >GH:;<ZMIMG;/<W.H6L,$;F-Y))E55<=5
M))Z^U %RBLF?785OM&AM?+N8-3DD59XY 5 6-GR,9#9VXJ>75H8=;CTMU8.]
MJ]UYA("A495(/_?8_*@"_16?'KND3-,L>JV+F"/S90MPA\M/[S<\#W-6I+JW
MB8+)<1(Q1I &< E%QN;Z#(R>V10!-15&UUG2[ZU>ZM-2LY[=&VM+%.K(I]"0
M< \C\ZJWGBC1;/1[W53J-M-:V>?.:"57PP_@X/WO04 ;%%9UOK%M>7<"6DL%
MQ;S0O*MQ%.C [652  <GKR1P,8/)%.M-;TF_\_['J=G<?9QF;RIU;RQ_M8/'
M3O0!?HJG:ZMIU]<206E_:W$T0!DCBF5V0'H2 >*S=4\2/I^JO80:5=7LD5J+
MN4PO&NU"S#C<PR?E/% &]162GB71O[*L=2FU&VM;:]C62!KF58MX(! ^8]>:
MLWNL:9IJ[K[4;2U& V9YE3@G /)H NT51O=9TO388IK[4K2UBF_U;S3J@?Z$
MGFG7.K:;9I&]SJ%K"L@!0R3*H<$X&,GG.1^= %RBLK1_$>E:ZUPFGWD,SV\C
M1NJR*3\IQN !^Z>Q[U0N/%Q@GU(C1[Z:STV7RKBXA,;;2$5R0FX,0 PZ GVH
M Z2BJMOJ-E=1)+!=0NCPK< AQ_JV^Z_T.#S[&HKK6]*L8H);O4[.WCN.87EG
M51)_NDGGJ.E %^BFO(D<;2.ZK&HW,S'  ]2:I6NMZ3?6LUS::G9W%O "998I
MU98P!GYB#@<>M %^BJEIJ>GW\LT5G?6UQ) <2I#*KF,^C 'BF7FLZ7I]S%;7
MNI6EM/-_JXIIU1GYQP"<GF@"]152?5-/MKJ.UGOK:*XD952)Y5#L6SM !.3G
M!Q]#5N@ HHHH *R?^9N_[</_ &I6M63_ ,S=_P!N'_M2@#6HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"CJW_'DO\ U\0?^C4J]5'5O^/)?^OB#_T:E7J "BBB@ HHHH SK[_D
M*Z7_ -=)/_19K1K.OO\ D*Z7_P!=)/\ T6:T: "BBB@ HHHH **** "BBB@
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M7)(HM8N;N[BMH66_MXH0ZI(3@*BKD@$Y)[8&:OZ]X?N[J7Q7%968$=[HL4$
M&%5YE\X8^H!0?E6KJWB&_P!(OK?S])C.GSW<5HLRW7[TLY"AA'MP5R?[V<<X
MJ.Z\5RV\MS<)IPDTJTNEM)[GS\.')52RQ[>54M@G<#P< XH RM9TW4->Q)86
M4]IYNAWMJHF41E)7:+:I&>,[6Y_&FW%I<:Q-%)9:'<Z<EII5S;LLT:Q[BZJ$
MB7!^8 J3GIT]:T+SQYI_]EZ_-ISI+=Z2KDQ.>'VJIW#'\.6Q]0:W=-US2]7>
M9-/OH+EX<>8(VS@'H?H<'!Z'% &#I6BS66K>&I([(0Q6VD2V\Y10 CDPD*<>
MZN?SJ/7_  M+K_B2\9I;NVA?25@BN()VC'F>8YPP!PPP1PP(YKH9]>TJUU)-
M.GOX$O'*@1%N<M]T'T)[ ]>U);>(-)O-0:PM[^"2Z7=^[5N3M.&QV..^.E '
M%3:?JC3:=>W%KJ%E"^E+9R6VG6T,PAD5CO7:ZMA&!&"O91GM3HXXM%\4Z9'_
M &3?7Z6^@)"F8TDGC&\CYAGJ0,$C^7-=%8>+[$^'['4=6N8+-[K?M3)YVL02
M!UP !D]LU:O-9\/Z?/'?W5[9Q32VX\N4N"TD6<_+CJO?CZT <MH^FW_AR73;
MC4-*N;Q1I"6@2V02FWD#LS)C/0AE7(X_=_2K/AOP[>66IZ&]]9@"UTNX3DAA
M [RHRQ@^H3*Y'8&NFO/$.CZ?%;2W>HV\4=RNZ%BXPZX!W _W>1STYK.T[QCI
M[^'=-U+5;JWLY+R#SMF3@#N?]T>IXH /"]O+87FL6DUC+"S7TUPDVP>7)&[9
M7#>O/3MBLY6U6PG\36L&B7=Q-?7;26T@*+"0T,: LQ;@ J<\$\=*Z6XUS2[2
MX@@GOH5FN IB3=DN&. 0!U'!YIVIZQIVC0I+J-W';I(VU-YY8XSP.IX!- '&
MQZ/J'AUH[6&PN-0#Z##IR20!=OFQE\[B2-H.\$'V/>JKZ+J5M_9KW U-+=M$
MM[)TLK>&<HZ@[T=75L [AR.#MYZ"NFTSQAI\^A1:G?W5O DT\\<6UBP=8Y60
M,,9)X4$GIS6S!J=C=.J07<,K/ MPNQP=T1Z./4<=: ,/5M'GD^'R:7913S/%
M! HAN&7S)4C*%D8_=W,JE3VR?2L?5;&]UQ=>N[+2;FU230I;%$G01O<2MDJ
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MM-N;B#6[Z[C:&ZU.:1460<QPH#'$#^ +?\#-.F\-,_@*3P]&\*7#Z;]B,P7
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MUJR?^9N_[</_ &I0!K4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!1U;_CR7_KX@_\ 1J5>JCJW
M_'DO_7Q!_P"C4J]0 4444 %%%% &=??\A72_^NDG_HLUHUG7W_(5TO\ ZZ2?
M^BS6C0 4444 %%%% !1110 4444 %%%% #'ABDDCDDB1GB):-F4$H2""0>QP
M2/QI]%% !1110 4444 %%%% &?9?\A;4_P#?C_\ 0!6A6?9?\A;4_P#?C_\
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M07PH8$8(7 ST&#ZU'+X.O#X6BT7[3I]T/,GDEEN[0L=TDC.'0*PVLNX__6H
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M4 %9/_,W?]N'_M2M:LG_ )F[_MP_]J4 :U%%% !1110 4444 %%%% !1110
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MXA *8W^;(KD]>,;<?C5&]\!6U]H5AICWLJ?9)I',J* 9(Y"WF1D9Z,&Q^ -
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M0NHS\AW%O7AL=JV;?P[Y6HZ?=,;:-+:PFM&@MH?+C/F-&V5&3M V'CWK>HH
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M,;S+(CYZ\8V8_&NEHH XJU\#2PZ_;ZC+/92-;W\MV+C[,?M,JN' 1Y"W1=^
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M'_M2@#6HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"CJW_'DO\ U\0?^C4J]5'5O^/)?^OB#_T:
ME7J "BBB@ HHHH SK[_D*Z7_ -=)/_19K1K.OO\ D*Z7_P!=)/\ T6:T: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,^R_Y"VI_[\?\
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M5!]MM?\ GYA_[^"C[;:_\_,/_?P4 3T5!]MM?^?F'_OX*/MMK_S\P_\ ?P4
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M_OX* )Z*@^VVO_/S#_W\%'VVU_Y^8?\ OX* )Z*@^VVO_/S#_P!_!1]MM?\
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M_GYA_P"_@K-CECF\6EHY%<"QQE3G_EI0!LT444 %%%% !1110 4444 %%%%
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M (_(A_YY)_WR*/(A_P">2?\ ?(J2B@"/R(?^>2?]\BCR(?\ GDG_ 'R*DHH
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MY\DKR&PNXG(XZ4 2^1#_ ,\D_P"^11Y$/_/)/^^1227,,4\,#N!),2(UQ][
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MO3YVA:6QMI&@&V(M$I\L>B\<#Z5R]_=7<E[?6ZWMQ$IUJV@!CDP5C:&,E1Z
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M!C@UQVG%+S6/#%_?W<RSW&D%RWVAD#R9A., @'.3D=^_2D\/W&I7E]9W<EY
MDS3R"ZB?4G9F'S#RQ 5VH5(&,'HO?- CKYVL+2:U26*)9)[@^3B/_EJ59B>G
M!(#<_P"-/GTVQNH)(+BSMY8I'WNCQ AF]2".3[UPUA-#<W?ABZDU*>;49[IW
MN;=YRRHWER _(>$VGY1C'XUTM[J:6'BN%;J[$%HUA(V)'VHSATYYZD F@#9C
MMX(;<6\4,:0*NT1JH"@>F.F*%MH$,16&,&)=D9"CY%XX'H.!^0KC=-DN=5A\
M+PSWUX([BQGDG\N9D:4CR\;F'/<]P?UJ*TO&NHM'M=3U*XAM&CN\S_:3$TCQ
MRA$#."#PN3UYQSTH ZB.UT;6M.C_ -"MKBT61PB20#:K*Q5L CCD&K%QI&FW
M=M%;7&GVLL$7^KC>%2J?0$<5P%C<7!T[1[1)\V<GVQ]\E\]IYSB<XS(BDDX)
M.WC/)[5MQ1WES<^'K&\U*217MKEIWM+EL3;&CVY=<$D9ZC'.?4TAG236.FDV
MBS6MIF%L6H>-?D8#/R>AP.WI[4EHUA+<31VT40ELI#&V(\;&<!S@X[A@3CK6
M+XMM[>2]T&2XN)H(Q?%&=+AH@ 8I.<@C!R ,]>2.]9-_"\3>)]3@N[J.:VO(
M3$(YF5,^5#DE1PV0<?-FF(W[S2+74+]6LYXHI;+?&\)@62,&3:Y.TXPW0Y'J
M?6M#2=,BTG2X[&-S(B;B68 9+,6/ X R3@#H*YW4I;N>[UF!-06$1W=OLCEN
M3"'7R@S1JXY7/)R/2I[G5'D\!+?63W$ (16D>3>\:>8%=MW.<+N(;T - S=@
MTG3K5&2WT^UB5PRL(X54$'J#@=#@41:3IT!G,-A:QFX&)MD*CS!Z-QS^-<Y?
M265N+&TM=8G_ +/GO-EU,+UG,?[MBJ>8264,P7OWXQFJK3SN39VFI736/]L1
M013I.68H8LN@<Y) ;(R2<=,\4 =5_9NDVM@UF;.SBLY6 :'RU6-V) &1T))Q
M^E68;2WMAB"WBB^14^1 /E7[HX[#)P.V:X;480;"]MY[NZ-M9:Y;(CO<OE(V
M\ECE\Y(!<D$GC\*V( '\17I-Y>26EC96\L,:7#$,3YF6//SDA1UR#0(W+;2]
M/LF+6MC;0,<Y,42J><9Z#O@?D*C33-)L+><)965O#-\LP$2HKYXPW'.<XY]:
MXFRUB\$\TNG2.WG://=11-?M=,9!LV%E(PC?,1A20?PJQJT&F2^$Y'@UBYN6
M_P!&FES?N^,R*"Y&[Y<Y/' X''%(9W%O;06END%M#'#"@PL<:A54>P%2U#:+
M$EI&L$K2Q!<*[2&0L/\ >))-34Q!5=?^0C)_UR3^;58JNO\ R$9/^N2?S:@"
MQ7.W]Y:V/C6TEN[F&WC.G3 /*X09\R/C)KHJ9)#%*1YD:/CIN4'% '"V-R++
MR;V&8V^EW>O.T;%MB-$86&?3:T@R.QR#276KW%S87#V]WYEI)K9@:5KEHD$7
ME@@"0 E%+8&1Z^^:[N2*.6,QR1JZ'JK#(/X4&*,HR&-"C?>4C@_6@#'\,+<+
M8W"SW4$Z"X;RA%=-<>6F%^0R, 20<GGL17*G7=0TZ\03W,[6^A2LFH%B29DE
M<K$S>I"[6KT**&*",1PQI&@Z*B@#\A2F*-MV44[_ +V1U^M '$JM]+!9VM]<
MW+/<Z1=7,R"9@0Y>-@.#_#N*CVXJ*RM+2[M?",$-Y.T;(YD:.Z8L#Y )7=G*
MCV!&/:N\VKN#8&X# ..U,C@AB&(XHT )/RJ!R>IH Y'2[JZ6[TJV-U.\::C?
M6_SR%BZ)YFT,3][&!U]*BT)[B,>%[M[Z[FEOXW2X$T[.K@1EA\I. 05'(&>N
M<UV$,D$TDJQH0T,A5BT97YB 202.>#U%++);6JQF5HXUWK''NP/F8X 'N<XH
M R_$$X^SM:QZU::;.\;$F=58E>F0"P_/FL'0;VTL[S3IKH1V-N=&1(/.?"C:
MYW89L9R-A^F*[2:W@N-OG0QR;3E=Z@X/MFEDABF4++&C@'(#*#@^M '*VTEW
MI_PT::V#QSI;.\7R<HI8E3CV4@X]J9>W.DV.GK#9ZA/>"XGBC.=5<*I*L06E
MR2@(4].IQQS7854A2RD%Q;1VR!(WVR(8=JEL ]QANHY&: ..L+F:YT_2O-E\
MT1ZZT:$3&8! LF '(RP]">U)X=GU"[O[&ZEO;=)WFD%W$^I.[OPV8Q 5"H5(
M!&#P%[YKN_+08^1>#D<=_6H)Q96@DOIUABV+EYV4 @>YH&<AI#W$:>';]KZ\
MEFO+F6"82SLR,FR4@;>@P47G&>N2:I6\T%Q-X?N)=1GDU2746-Q;-<%@I D!
M'EDX3;P!@#\:]#$: * BX7E>.GTIH@A5V=8D#L<LP49)]30(XC1]4:Y\3:;)
M;2.D%VLYDB?4'G<@#(+QD8C((XP?45M^#HW;P[:7LUQ<3W-S$K2/-,S],XP"
M<#CT'/?-;B011L62)%9CN)"@$GUI25AB)  1!G ':@#SZ6:&ZDLKBXU"<ZF=
M<$<EJ;@E559L*/+S@ *%.<#KUYJQ'JIF\3V,EK(\:RZA+;RI)J#N[*JN"#!C
M:BY4$'.>GK77V4UG?646IPPJ%N8DF#,@#%2,C/O4>G7UCJ*PW%O"P:Y@2Y#-
M#C*MTRW3/MG- SF;&]OI[]M)DOY86T>.=KFY=C\V>(&<GK\A+'/=:TO"-QF.
M[LI':6>V,?FS+=M<1RDK]Y6;E2<9*]LCUK8M--AM+R^N@S/+>.K2%L<!5"A1
M[#'ZFI=UI8K%&/*@65]B* %#,03@#UX/Y4".)$0T^TU:6.ZNX8I-8$%Q-]I<
M^7$2FYLDG:><;NH!Z\4Z^NGMK37H-*U&X>TBCMC',+AI3#*SD.JN23]W:<9X
MS[UVL<D$TEQ J',;;9 T9 )(!ZD8;@CIGTIZ6\,47E1PQI'_ '%4 ?E0 RSM
M$LK98(WE=5YW2R-(Q)ZY+$FIZ** "BBB@ HHHH *ET7_ )&23_KS_P#9Q452
MZ+_R,DG_ %Y_^SB@#J****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,SQ!_R!Y/^ND7_ *,6L6MK
MQ!_R!Y/^ND7_ *,6L6F(*XB"XLI9_%-GI%Q:&22V5;6*W=>2(2/E ]#Z5V],
M6&)&W+&BGU"@4 <I8WEGJ&I^&QI\L<GD6DC2+&03$A15 ;^[\V.#_=/I774Q
M(HXRQ1%4L<L5&,GWI] %6X_X_+3_ 'F_]!-6JJW'_'Y:?[S?^@FK5 '/^*?/
MW:+]F\OSO[239YF=N?+DZXYJC-:S: UE<W5\JF\U?SKR1/W<0#1,H7K]W(3K
MU/-=:0#C(!QR*1XTE0I(BNIZJPR#0!P-]?Q7VEW$\M])]D77T"SJY^2,!>5/
M8=3D?7WJ1I$,SPVMR]QI\6LV8@=IC* QVEU#$DD X[\$D5W6Q",;5QUQBD2*
M.- B1HJ+R%50 * .(6\,]U;P:E?31:?)?WZNYN&C!9)/W:%P00,;B!G^$57\
M3:G!':3KI]VQ>TL5F@N9-3D0OG=M,:C/FGY>2>O S7?O#%(A1XT9"<E64$$T
M&&)F5C&A*@@$J.!Z4#.4BCMH_&]]-)<21W$EA!)$AN7 =OWH;"[L$ 8XQ@=>
M,UG:?=07EO8KKNISP0C1[>>%C=M#YCL&\QRP(+,,+USC/3FN],4;.KLBEUSM
M8CD?2FO!#(%#Q1L$.5#*#CZ4".,T]+S5Y["WU*ZO4W:0)76.9HBS[\!SM(.<
M<_6JSZG+_9FA:I>7OGXL8FEM$NVAF9V(Q*J@_O"<$;3QUQ7?X&<X&>F:88(F
M9&,2%D^X2HROT]* )**** "BBB@ HHHH **** *MO_Q^W?\ O+_Z"*M55M_^
M/V[_ -Y?_015J@"*2W@EE262&-Y(^49E!*_0]J#;6YN!<&"+SP,"38-V/KUK
ME-9M?MFJ:^99+C;;:;%) J3,@63]Z=P (Y^452G@N(8+@6DERT]YX?FFD/FL
MQ>8;=K#GAOG/3';TH&=WY<9!&Q<$[B,=3ZU!<"RA;SKA8%:4B'>X&6W' 7/?
M)[5RW]JV^J:C+]DU-DM_[&DW7,9)6)RR_-GIN7.?4>U9,GV.X\/JLJQ&WL=3
MMO-N[>Z=X)%+)N<,3Q@=?0\YH$=U?36>DZ9-<RPJMO"H+*B#H#Q@5<,<9# H
MN&.2,=3Z_I7/^*!"W@2]^S,7@-J/+9&WY7C!!YSQWKGKRX14U(^&[J6:W^Q1
MFX=)7?:YE ))Y(?R]Y..>![4 >@^5&23L7).XG'?U^M4M1TF+4&MW\Z6WF@F
M\Z.6$+G=M*\A@0>"1R*QO"2QBXO6MM0L9[8K'B"SG:58V^;)RQ."1CC_ &:@
M\^.#QP5$\5[)<2% B3L)K0"/HR9P8SC.>.6'7B@#H=,TN/3$N-LTLTEQ*9I9
M9=NYF( Z* !PHZ"C39K*^M1>VL*JLKL<E K%@2I)]^#7*:)J@N&\*V:W4DES
M$LB7B9)*.(F&V3WR#P>>,U2T-K-3I"V5Q(=7^W2">+S&R(<N6RIX"8VD'&,X
M[F@9Z$EO#$Q:.&-&)+$JH!)/4U7FCL8F2"2VC/VF3H(=P9P"<M@8' ZFN,MK
M'S;'1;IYKLSW6HRP3M]H?YHOWOR8SPOR+T_K5FU\V&:RLTDF^SQ:Y-"JEV/[
MKR9"%SU(!/'T% CIKIM.O-*N(9+B-;6X+6SLCA?F9BA4'^]N./K4-GH26M[#
M=RWES=200&"+S1& BG&>$5<_='7-<2;+2D\.7:,Q$MKK -RAG?,4?VLX9AG@
M;"3G\?>K&L,DNJ7,?]I6=K;"UB_LV>XNI$ 7:?GC(.&;=UZG@=C2&=Q,EEIE
MA=3_ &:*.%(VDE6.,#< "3QWXIYN;867V^1DCA\KS&D? VIC/)["N)\0O:O+
MK::M<R"Y6R3["J2,N_*-N**#\V6R#UX SQ6WK=K]J^'=U%L9V_LXE54G)81Y
M'3KSVIB-V*SM(HV6&WA1)/O!$ #?7'6I)(8I2ADB1RAW*64':?4>E<5)-HC7
ME@MS>H-#-H[0.UT1$\V[Y@6W<L!T!/KCI6SH8N[GP<$9Y?.>.98'E)WE-S"(
MDGG.W;UH L1:QHUY<PV\9$I5RL,GV=C$''&%DV[<C'8U&VMZ#'?NY:,3*_E/
M="W;8&SC:9=NT'/&,^U4_#6K6">']-TM)TAU!+=8&M2/WD<BK@[EZ@9!.3Q6
M,E_9CX<G0FQ_:QM&M?L.,RF8Y7.WKC=\V[ICG- SI[C6M#TZ^FAF=(9D96F<
M0-M4L."SA=HX/4GO5^_EM+:SDO;Q4,5JC3%F7<5"C)(]\5P^JV6H,/$6R=G@
MC2W^U6Z("UP@B7>%8\@XS71>*4@O/ NI-&"T1LGDBVDC^#*]/PXH UK&5;FU
MBG^R26QP0L<JJ&4?@2!GCO4KVT$J!)((W16W!60$ ^OUKD+R/2K/5DM=8N&M
M]-2Q5K42W#*C2%F\PYSDN!LP,Y /%)IEO<:C>Z'#J;W+J--EE9'=EWD21A"^
M,9.TYY[T".PEMH)HO*E@CDC)SL9 1GUQ3EBC0*%C50@PN!C:/05B>)HC<2Z+
M;EY5BEU +*(W*[E\J0E21V.!7,ZHCKK5_;27]I8/"8ET]KFXD1D0(N#&,X;Y
MMP/4GH>U 'H,L,5Q&8YHTD0]5=01^1J*![>ZBD:-,H79'W1E<E3M/!'/3K7)
M3&]C\2R>'Q).8KJ\2_67<?E@ W.F>P\Q ,>CU0O)[@F%+F>)+ ZC?"1[N5TB
MW"3]VK,#P,;L \9 ]J!G?RVT$R,LL,<BN06#J"#CIFG[%"; HV8QMQQCTKAK
MBYN]%\/:9JT5[]O2 SPDP.SJZON\L9/WMKK&N3[U+X<&H?VS#I%U//)_8JR&
M65F/[XR8\K)[X4O^(H$=@MG:K;FW6VA$!ZQA!M/X=*<D$,<:1I$BHG*JJ@!?
MH.U<GKLVFCQ='%K%V\-D; L%:9HXR^\]<$#..F?YU!HEO-J.H:0-2>Y<)I8E
MV.[+N;S/E9AW;;CK0!U\+6U];,ZQAHI&96$D97<0=IR"/:I4BCB&(XU0 !?E
M&.!T%<)#/$[6"ZW<M'I9FO\ +2RE$:43D(KMD<;=V >./:I+2-[Y=%MI9+EM
M/EOKH19D8&2W"N8PQSDKP,9ZC% '9/\ 8[",RL(;=-V"V HRQ _,G'Z4Y+2V
MC21$MXE63[ZJ@ ;Z^M87C2U@?PLWF*WEP2P/D,PVJ)%!)P>@7/7ZUEW<VB'4
MYDU.^V:>MG&=.;[2P1Q\V]D(/S/G;ZGICK0!VL<:11K'&BHBC"JHP /I3JSM
M!:[;P_IS7^[[6;=#+O\ O;MHSGW]:T: "JZ_\A&3_KDG\VJQ5=?^0C)_UR3^
M;4 6*YW4[--1\66MK<^:UJ;"9VC61E5F#Q@9P1G@FNBI"0.I SQ0!PFD)):Q
M^';_ #=37-Q',EP6D9FE58V*J03CJHQ_]<U6T>[\[4'EM/*CAGTF>1XX)I)"
ML@*8#LW_ "T&XCUYY[5Z*2!U.*1F"C)- '$V-J]JVCO;M<--?:3,;@O*SF1P
ML94G)X(+-CZXIFGZM%>G0(HKZ3,6F3"Z=-Q\MPD8^;_:!!XZ_G76V&IP7VC0
M:H,Q6\L(F_>$#8I&>>W%5X?$6G3Z3=ZG'(YM+0OYK&-@?E&3@$9/% SCK:X1
M-'>U61)+*"ZMEO;^TG=HYXCG<22?E.0-^">#R:U9K;3+Z[T2VT^9Y-,>XGWB
M*9C&^(\XSGE<]AQU]ZZ6QU!;\.5MKJ$+C_7PE,Y],]:MY (&1GTH$<'JLWD&
M_6>>XBM5UN"-C&[ K%Y$>0".<=<X]ZK7D-A/974T+E]%@U6U:*42MY:+E!*5
M;/W0>_0'-=Y>64%^8!*6S;S+.H4X^9>F?:FZ;J,6IZ;#>QJR1R@E0^,CDC^E
M(9RYFL[?Q;:/;7$-\LWE1Q0I.WFVR;.'49PT9'))]>IJWXJFM(]7T5-0N'AL
M7:838D9$/RC&\C^'/KQZUU!( R>!5:>R@GOK6\D+"6VWB/G ^88.:8CCK.'[
M<NCVQ>=]-EU"Z$0WL/,@"N4!/4KD<9ZC%.U!S#=W\4\LT>EKJD"7)#L D/V9
M>">R[]N?J<UUNFZC%J>FP7L:LD<PRJOC/4C^E7"0.IH X"18[B&XATVXF.D2
M:G:1Q/#*V.2!*$;/W>G3C.:W?%>G0_\ "$:C:PPG9%;LT:*3Q@9_&NA) ')
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M&9X@_P"0/)_UTB_]&+6+6UX@_P"0/)_UTB_]&+6+3$%%%% !1110!5N/^/RT
M_P!YO_035JJMQ_Q^6G^\W_H)JU0 4444 %%%% !1110 4444 %%%% !1110
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MR7K&%WMV8^40 F' P$V\'G'7-95MIVF1>&Y;1HX[*YAOV:8/9,\;XDD,:R
M;D*].<=/:O0Z*!&-H=_NL-.MY+"2TEEMRXB2-A'&%(&,D?+G((!YQ]*V:**
M"BBB@ J71?\ D9)/^O/_ -G%15+HO_(R2?\ 7G_[.* .HHHHI#"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV1JW]VR_[^O_ /$UTM% '-?V1JW]VR_[^O\ _$T?V1JW]VR_[^O_ /$UTM%
M'-?V1JW]VR_[^O\ _$T?V1JW]VR_[^O_ /$UTM% '-?V1JW]VR_[^O\ _$T?
MV1JW]VR_[^O_ /$UTM% '-?V1JW]VR_[^O\ _$T?V1JW]VR_[^O_ /$UTM%
M'-?V1JW]VR_[^O\ _$T?V1JW]VR_[^O_ /$UTM% '-?V1JW]VR_[^O\ _$T?
MV1JW]VR_[^O_ /$UTM% '-?V1JW]VR_[^O\ _$T?V1JW]VR_[^O_ /$UTM%
M'-?V1JW]VR_[^O\ _$T?V1JW]VR_[^O_ /$UTM% '-?V1JW]VR_[^O\ _$T?
MV1JW]VR_[^O_ /$UTM% '-?V1JW]VR_[^O\ _$T?V1JW]VR_[^O_ /$UTM%
M'-?V1JW]VR_[^O\ _$T?V1JW]VR_[^O_ /$UTM% '-?V1JW]VR_[^O\ _$T?
MV1JW]VR_[^O_ /$UTM% '-?V1JW]VR_[^O\ _$T?V1JW]VR_[^O_ /$UTM%
M'-?V1JW]VR_[^O\ _$T?V1JW]VR_[^O_ /$UTM% '-?V1JW]VR_[^O\ _$T:
M5;7-KXF=+D1!S9Y'E,2,;_<"NEK)_P"9N_[</_:E &M1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %'5O\ CR7_ *^(/_1J5>JCJW_'DO\ U\0?^C4J]0 4444 %%%% &=??\A7
M2_\ KI)_Z+-:-9U]_P A72_^NDG_ *+-:- !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% &?9?\A;4_]^/_ - %:%9]E_R%M3_WX_\ T 5H
M4 9&IZ;/=ZYH=Y%L\JRFE>7)P<-$R#'KRPK,U3P]>WD7BY8_*SJMDL%MN;^(
M1,OS<<#+"FS:[=/X^DTL&^BL[2S6=UBM0ZS,QDSN;!.W" #;C+9'/2M"+Q7I
MQ%X;I;FP-I +F1;N$H?*.1O'J,@C'7/:@#GKWPA</J6H&73Y-1M=0\MF5=6F
MMD0B-8V5T4X8?)G."><8X%=+XETB;6-($-K)''>6\\5U;-)G8)(W# -CG!Q@
M_6LS4?&RV5K;3)H^IDRW44!26V93M<XW#U/H.N>#BM9O$-BD5^\GG1_8+9;J
MX5XR&1&5F''KA3Q0!EZI:Z]K=@N_3[2UEM+B&ZAC:Z+^<\;ABI(7Y5('!Y.2
M.!BJ6H>']7ULZG>W$$%I/<QVL$-N)M^$BF\QF9@,9.X@ >GO6Y?^)[/3522>
MWO3;%$=[E+=C%&K="S?SQG'>LC4O$&HVVI:E#%*H2#4=/MXP4!PDS(''X[C]
M* )-<\-WVI/XF\EH0-2TZ&V@+,?OIYN=W' ^=>?K5ZVL;^X\266L75M';A-/
MEMY(A+O*NTB,,''(PIJS'XCTZ6"UE5W_ -)NVLHTV'=YJE@P([8V,2?04NIZ
M_::7?6UE)'<S75TKO#%!$7+!2NX^V-P/- ',V?AK6Y/$6FWVH,9#:75P\UPU
M_(XD1XY%3RX<;$QO4'H>O6K5AH^M+X0E\+SVEK%#'ITEE'>+.6\P[=B-LVY&
M1R<G@],UJIXKTY]26T"76QK@VJW7DGR6F&04#^N01Z9&,YJ,>,=+:\^SA;O8
M+LV3W!@81)-NVA"WN< $<<CIF@"A'9:[;WNG:NNF027$5DUC/:?:@,#<K!U?
M;CJIR/0CTQ1I7AF^L[O1KF=H"\$U[<W(1CM5YR6VIQR 3C/'K6D/%VF'[>V+
MGR;%GCGF\@[!(K;?+!_B8DC &<Y%(/%VG+9WL]Q'=VSV9C$MO- 1+^\.(\+W
MW'@8[YH 7Q-9:G>P6:Z>SF))]UU#'<FW>6/:1@2+RN&*GC&0.M<+?Z=>: FA
MVD]Y!8W'VG4+A9Y+\QH@=PP!G=&+'#="N6P3D%:[Z?Q);P6]L[65^;BX+^7:
M+;DS83[Q*] !D<YQR,9R*BF\5:2;6PD"SW/]H*YMXH[=G=RF-RE<<$9YSC&#
MG&* ,CPU:#4$\-ZC9VJ6]EI\%U;;#*9,Y955T; WJVPG=QD$5':^$YK;5W6X
MT^2[MSJ+7L=Q_:TR1INE,HS #M+*3Z8. 3C)J_/XWMUN-&%I8WES!J)D!9(6
MW1E V5V_W@RD$=L9J]XC\1'0'TT"QN+K[9<B ^2A;:,$]NIXX'?GTH P=+\)
M36&HQQ7.GR74,5\]U%=?VM,(U!=G4F#.W<-V, 8/7/-:.A:1J-CX@N)UMQ8:
M:\;E[5;LS)),S@^8BD#RQC=D#&2W3C-0?\)FECKFL0:A'=?9+9X"KI;$K;H\
M:DF1AT^8GU(Y[5J:AXJT[3;R:WF2Z=;<*;F:*$M';[NF]NW'/&<#DX% %+4=
M#OKG7-7"(AL=7TY;1YQ)A[=E$HSMQ\P/F#OV-,T_3-9NM1T234;.VM(M(C<;
MHI_,\]S'Y?RC VK@D\\]..*Z&^U*VTXVHN691=3K;QD+D;V!P#Z9QCZD503Q
M5I,L<SQSLXAU ::P5"3YY8#:!Z<]?0&@#'\6Z%K6LW5Q%;LTEC-8F&.,7TEL
ML4Q+9=PG,@(*C!..#QSFIK/3-9T34I9K2SM[Q+RVMHW+W'E^2\:E3GY3N4@@
MC'.0?6KT7B[39KR.%4NO)EG-M%=F B"24$C:&^H(!Z$C -9^J^,$DT?4)M(6
M?S+.=8'GD@Q&'$ZQN@)ZGD]* +&C6&K:9Y^DM9P/8/<W$OVT3X;9*[.!LV_>
M!;'7&!GVJAH>AZY;W/AQ+VWM(K;1K9[8O'.7:8[ @<#:,#Y1QG//MST^FZM:
M:L+AK-FDB@E,)EVD([#KM/\ $ >,CC(-4K?Q5I]RTS*ETMI$LC&]: B!A'G?
MA_;!YZ'!QF@#'30=:L_!.A:7;M^]M/+6]B@N3"9D"L"JR 97YBIXQD C(S4%
MMX8U:PT>S\N&&6YM-9DU 0&Z9]\;>8-OF.,E@),Y;KCWK<M/%NGW3%7AO+8F
MW:ZB^TP%/.C7&YD]<9'!P>1Q3M.\6:9J<ZQ1?:8A);FZBDN(&C26,8W,I/7&
MX?F",CF@#GY/"=P=6OC<:;)?6U]=+=9&K30I'D+E7B4[6P5R#@YXSC%)XBTV
MZTG0->U4&,74>JIJ5CR3N(6*,(?=L.F/]JKT7C%=0\0Z/;6D=U%:74,TS-/;
M%!,BJ"K(3V_(\C(Y%;4.OZ;=PZ7(KDIJ<1GMBZ8!4*'R?3@B@"'2](NM+\'1
M:9;3JE^MJP\]AD>>P)+GU^<DUS-IX4UES?S7*%)KG1I;$F;4)+EGF;'S?,,(
MI]%_*M74?'=M;Z!>ZI9Z??W$<,!GAD:W98IU'&0W8=.3VY&15^?Q3:V\4)-C
MJ+S21M*;>.V)EC13@LR]AGIW/8&@"A?>&+N^:&/S(XX_[#N-.=P<E9)/+ ('
M<#:?THT[3M<FU[2+W4+.TM8+"REMF6.<R,SMY?(^4 +\G'>M"Z\5Z;;K:M$+
MB\^TP?:D^R0M*1#Q^\('0<CW/8&G^$]1N-7\)Z9J%TX>>X@61V"X!)]J -FB
MBB@ HHHH **** "J*?\ (=G_ .O:/_T)ZO513_D.S_\ 7M'_ .A/0!>HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *R?^9N_[</\ VI6M63_S-W_;A_[4H UJ*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH HZM_QY+_U\0?^C4J]5'5O^/)?^OB#_P!&I5Z@ HHHH **** ,
MZ^_Y"NE_]=)/_19K1K.OO^0KI?\ UTD_]%FM&@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#/LO\ D+:G_OQ_^@"M"L^R_P"0MJ?^_'_Z
M *T* ,"]T2]GU?5KVUNUMWN]+2S@D7.^*16E._Z#S%_(UST/@2^ECU#SVM+1
M[K3UMAY4\MP?-5]PD9G )!.,C]3UKJ[GQ!:6K:NLB3$Z5;K<S[5'*E68;>>3
MA#UQVJG?^+K>RG>&/3K^[E2S2^=;=%^6)BPR2S 9&P\=3VSS@ AU'3_$.K:8
MGVB+3(;NVN[>Y@CCGD9',;AF#.4!7..,*<>]5=6\/ZY>2ZL;1M/1=8T]+:X\
MV1SY#JKJ2F%^<$/CG;C&<'I5S4O%T$4+KI]I>WS&R%XTEJBD0QN#L8AB"<X)
MPH)P#Q56P\7F'0-.DFL[W4+D:9!>7LELJ?N@Z9W,"RY)PQVJ">.G2@"CKW@O
M5=6^T0^=:RPR6T4<+37$J_9F0?-MC4;6W'G<<$>AQBM._P##%W=W^H7"30A;
MF_L;I02<A8&0L#QU.TXK0;Q+;OK$&F6MK=7<LMO%=>9"J^6L+LRAR68=-O0<
M\\ \XAU7Q#=:?XHTO2HM+GN8;N*5WEC*<%2HXRXX&[)X[C&>: ,G3=(D/Q,U
M.<,3I]HOVA$VX"W,R*KX/?Y$S]9370SZ7++XIL=5#H(;>SGMV4YW%G:)@1[?
MNS^8K!TCQ=*EQ<0:A:WLD1UB:RCO B")"966-.H8]AD C)&3UJX/%4=LSPF.
MZO[J349K2"&*-(VR@W$99PI '<D$^E %#3O!LFGZJ"VGZ?=6ZWKW4=W)<R+*
MFYRX'E[2I92< [AT'%5-+TK5]5BOK)A:1Z6=?FN7E+,)L1W)?:%Q@Y91\V1@
M$\&NRU'5K?2]);4;I)50!,1!<R,S$!4 _O%B!]35"7Q-]GMXC/I&HQWD\_D0
MV1$9DE;;N)!#E-H&226&,&@"C<^$IKOPUJNF//$)+K4'O8FYVC]\)55N_8 X
M]>*9:^&YH],U&-] T99;I8T:$W<LJ3*I)(9V3*XR<8!P:N-XRLX[5'>QOQ<F
M]^P-9B-3*DVPN <-MP5 (8$CD<]<4[_QK+%803VFCWCS?VDEA<6\GEAXF)7(
M^_@DAAM()'/.* *!\%:AY-A/.+:^GMC<(+2XO)0B12,K*JS;2Q*; ,E>03TP
M*VK/P[);W>AS)#:6D=@EP)(('9ES+@_*2 3SDDG'6K4?B-9M7;3(]-OFN(HX
MY;@[4VP!P2-QW<G@C"YZ'MS4,?BRV26YCU&RO--,%HUZ3=!#NA4X9AL9N1D<
M'!Y% &?'X:U2QCTR:U:SFN++4+NX,<LC(CI.TA^\%)# ..V.#SWK7\1Z;>:A
M!8R6'D&XL[Q+I4G<HDFT,"I8 D<,><'I65JOC&]L]'%[%X=U%&,]NBK<"(!D
MDD"YXDX/.,'D$KD8R:U]8U1[+PU+J3>=9LB*[!HUD>/+#(*AMI/..M &7J'A
MF]OK'Q1'YMNDNL1(L?S,5C(B"')QTR#^%5-2\&R3:WJ%VNGZ?J$&H%&=;NYD
MB,1"*A&%5@ZD*#@X[UIWWC&TL;R]@:QOY([":.*[N$C7RX=ZJP8DL"1AQG )
M&#D8QG:OKI[.U,L=I/=OD 0P;=QS_O$ #W)H I^(M*?6-"GLX'2*Y^62WD?H
MDJ,'0G'.-RC\*YS2? USI^M:9=27<+VL$*S7,0!S+>!74R#CH1(W7G(6KMSX
MDDO(]*DM%GM';6!97<$RKN7"N64X)'93D&KWAC49[SPZUY>2&61;F[4M@ [4
MGD51QZ*H'X4 95KX:UB.UL-&F:R_LJRO$N4N%D<S2*DGF(A3;@'( +;CD#IS
M4\OA6YE\'WNBM+ 9+B]EN-QSMV-<F7!XSG:<?6I],\96FIR66+"_MX+^)I;2
M>>-56;:NX@ ,6!QDC( (!()IMOXTM[K2[6_ATO462]9%LHRL8>Y)4L=H+\ !
M226P,#(SQ0!=\.Z3<:%:2Z:TR2V$+XL3D[TB/\#>NT\ ]QC/3G(MO#>J_P#"
M.7/ABX:R73&MYK=+J-W,S*V=N4*@ C//S'..V:NGQC:_9;=DL;Q[R:Z>T%D!
M&)5E52S DL$X49SNYR,9S5K_ (2*-M8CTR+3[R2;RHYIR @%NLA(7<"P)Y4Y
MV@XQ0!EOH>MZK<0S:K]@A-I9S00BVD=_-DD4*7;*C:H ^Z,]>O%2-X6GFCT:
M*6>,1V>E3V$Q7.29$B7<O'0;#U]16IK6NPZ+]C1[:YN9KR;R((K=069]K-SD
M@ 84\]!WP.:I7'BZWMIG$FGWOV>!XXKJY C,=L[A3M;Y\G&Y<E00,]: *6GZ
M!KC7VBOJ+Z>EOIEM);XMW=FEW(%W\J O0?+SCU-0:;X4U=$T6TOYK(6>E6TM
MHK0,YDF1H]BN<@!3@#CGOSVJY!XCDM;[6H[A9[MUU1;2RMH0N]LV\<A49(&!
M\[$D\#-7X?$7VK36N;;2[Z:XCG-O+9J(Q)$X&3N)<)C&#D,0<CUH RAH.NW/
MA"Y\.7C:>D(T\V<%S$[EI&"A59E*@(,#D MSTJ/4O#6HZCJ-OJUQI^FW%T;7
M[-/:O>RI&FUV96214R?O'(*CZ\<Z/_"8VKVMC);V-[/<7DLL26BB-9%:(D2
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M]FN+6YMG"36]P%#ID9!^4D$$'@@FN>NO!MYJ5MJC:A<V<MS>74%TB>23"IB
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M%ENYHV2$?-G: ">6(4G XZ<C- %*+PIJ=A&L>G:C;)YVF06%R\T)8@Q*P5T
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M7B--9NKNS> 075JJ.ZI.DRLCYVD,ONK CMCWH SYO"\TGA[^S4T[P\B/*SO
MMHRQ D8#+@@AQZ\?ABF3>$;V:31U>\MG.G"#&H-$PNSLQN7=NP5?!R#V8\$\
MU+!/JGB'6-82VU273K33K@6L:PQ1LTL@179GWJ?E^<  8Z'GT(YM5UO7=2LH
MM6DL;?3/*A9[:&,O/,R!V)\P, H#* ![\T :^I:6U_J6D72RA!87+3,I&=X,
M3QX'I]_/X5@W'@I3KUW?1V6B74=W.L[/?V?F2Q-A00K9Y'RY .,$FM/PSJMW
MJ>BW!O2AO+.YGM)9(UVJ[1L5W =L@ X]:R/!_BB\N=+T"VU&QN0]]9!HKN21
M6,[H@+$C.1GD@GK[4 2ZIX)^WS7=PS6<\CZD+Z*&[@\R(CR%A*.N>> 2#V./
M2DN/!\TVE6EM'!H]N(;LSR64-L5M9P4*X=0?F(R#D\9 XJS%XR1+J]M[[3Y+
M>6VLY+W9',DS%$QN4A3P_(X[YZUK:'JDFL::MX]J+=),&/$R2AU(!!#*<=\8
M]10!S9\$W$?A=-$C.E31^=/*3+:LHB,CEE:(*WR%=Q &?3D=TN? A.HR7:PZ
M1J3SQ1)*^JVGFN'1 F\$'G( )7U'7FM!_&4<=MJ5Y)ITR65C,]L9FD4>;,L@
MC"J,]"2/F. /PJ.+QQ;F"\6:S87MN\,:V\,R2B9IF*QA7!QRP(.<8Q0!-/X<
MN;CQ3::INL8$MGR);>)EGE385\ISG!7)S^ P!UK<L([R*UVWUQ'//O<[XX]@
MVECM&,GH,#\*Q;WQ3+IT%LEYIA@O[F5HXK>2ZC"LJJ&+^9G 7D#IG)QCO53_
M (2]+J+3KRVBNB9!=J]G&8VWR0J25+<YY4[2IP<C- &E'H+I%XA3SU/]JRM(
MIV_ZO,*1X/K]S/XU5G\)"[BT^">YS#;Z5/ITH5<%Q(L:EAZ8\L_G1+XWTR.V
M@N0LKP2Z:=1+KCY(\J%4\_>8M@#U4TR#QO:B'46OK8V\EE;BY*13I/YB$D#:
M5.-V1C!]1ZT +X:\,-HER'>QT.,I#Y0GLK/RI9.1RQSP#CD<\]^*ZBN3TS5]
M3O/&[6E[93V"+IOF^0TJR(Q,@&X%>^,@_P"'-=90 4444 %44_Y#L_\ U[1_
M^A/5ZJ*?\AV?_KVC_P#0GH O5SNH:[J%KXQT_2(--:>UN+:65Y0Z @J\8R,L
M.%#G(QDY&.AKHJQ]1TBYN-=T[5;.ZBADM4DAD26$N)(Y"A;&&&&_=C!Y'/2@
M#"\/^*;I5CAU"SNGAGU2ZLX[YF0KN$TFQ<9W;<*%SCJ,>]7H/&MK/J<5N+60
M6DUTUG%=>:F&E!(^YG<%+*0#CKCL<U+'X5\O3[2U^V9^SZH^H[O*^]NE>39C
M/'W\9]NE5M-\(-I6HAX#I;V@N'G4RZ>#<KN8MM$H8=">"5R!Q[T 7-=U&\&L
M:5HMA,+>:^\V22XV!VCBC SM!XW$LHYR!SP:IZA<ZS87>E:%'J@EN=0FE/VZ
M2W3?%#&@8C:,*SDD ' &#TXYU-:T674;FQOK.Z6UU"Q=C#(\?F(RL,,C+D$@
MX'0@@@53N_#^HWILKV;5(1JUE.TL$T=KB)59=K1E-^2I'?=G/<=* $TR^U&S
M\63:#?79OHVLA>07#QJD@P^QE;: IZJ00!U-&J^+TTRYU&-=+N[F/38TFNY8
MR@6.-AG<,D%B "< =C[9LZ7HEQ;ZO<:QJ5Y'=:A-"MNIBA\J.*($MM52S'DG
M))/.!TQ4=]X9^VIXB7[7L_MFU%O_ *O/DXC9,]?F^]G''2@"._\ %?V6>]%K
MI=S>V^GHKWD\3(!'E0^%#$%B$(8@>H[\4VU\1WEWXQETR+3S)IWV*"Y2Y5U'
M#F3YC\V=IV@ 8SD'/!%177A;4-^HQZ?JT5M:ZFJBZ5[;>ZL(Q&6C;< "54=0
MV",^U7H= ELM?@O[&YCCMA91V4MO)$6)2,L4*L&&#\Y!R#0!4U77/[(\42O<
MS.+"#27N'B7NXE &!ZG.!]:C_P"$YMH+349;VRE@FLH4G,*S1R;T9MH(96VC
MYN#DC'7IS5O7/"L.N75S+/<%$GL#9[ @.T[PX?)/."!QCFH[+P_?VEI=HK:'
M'-*BHIM]+,:, >?,'F'<".,9&/>@!]WXH>SMM/\ ,TN7[9?RM%#!Y\>#A2V?
M,W;<$#CN?2I/%.M7FB^%;G5+.S,EQ&@;RY"/DS_>Y&<>QK+7P9<1>'I-*CN=
M-:.>:266*:P+P)OQ@1)Y@V;>HY/)/2M>\\/B[\'MX?-W)S:+;"Y<;F)50 Y'
M<Y&3SS0!D7>O:M!XIM8X]*NY3)ILDK6*RQ_(PE4;BV[;G' P3U'OBY=^+TAT
M*VUFVTZ>YL9K871D\V.,JN,[<,P)?'8?G5VTTBZ&LP:M>W<,MREFUJZPPE$;
M+AMPRQ(Z 8Y]?:N<D^'3-96MJ+^VD6+31I[/<V0E*@$GS(@6PC'=SUZ+Z4 :
M]]XN6WG>&STR[OF2Q2_8Q%% B8M_>(^;Y#QWS4OB'698O M]K.EJ\CFP:X@9
M< J"FX/SQP.<>U+!X:$%Q++]KW>9I<6G8\OILW_/U[[^GMUJ5]!W^"V\._:<
M9T_[#Y^S_IGLW;<_CC/XT 8-MKSZ%:1->+JCB+3'O9;>9TF;:LBAGWY))PV<
M9QCWK8U+Q;8Z=+<1^7),88X6!C*X=YF*QH"2!DXSD\ <FISH$;ZM%>2RB2--
M/:Q:$IPX9E).<_[.,8[]:Q+;P!'!X9DTN74#=7!N([A+J:$,,Q!1&K)GYE"H
M%(SSD]": -O0]?CUIKN$P-;W5HZK+$9%D&&&58,I(((_4&L*ZU75GTGQ#J-B
M]P98]12TMTAB,QCB1T21E3!R>93T[#TK?T/2YM,AF$RZ:K2,"!86?V=< =QN
M;)_*J&FV&IV;ZW:6KI;LU\;NVGFA,D;K( S+@,O(;>.O&0: ,^YUASX-U>^L
M]:N;R[TW_2&$T'V>1/+PYC=-JD!@".1R#6GXNU.6S\'S:C9R2*X:!E:,98JT
MJ @#W!(_&LW4_#E^NAZ^SS"\U76UCM7,$)CCB0CRP0I).%#,Q)//Z5O:YH@U
M?P])I,-P;0'R]DH0.4V.K#@]?NT 4'\8):_:4U#3+JTN(?(;R69&+I-)Y:L"
MI(X;.1VQWJ;5/%=II1U02P3,=/2W9\%0',S%5 ).!R.2< "J5SX1O=2BU"74
MM4B>^N(H8H98+8HD(BD,BG:6.XE^3R..!BIX?#NII+JEY+J5G/>:A'"C+)9$
MP*(]V5V;\D$-W.<\^P )I-9E%YHPGCN+1KMI@UN/+<-M0L,L">.,C;UR,U!I
M?C*'47L6ETZZL[6_MFN+:><IAPJAF! )(X.1GJ :9IO@[[!'IH-XF;.>XFV1
MP[8_WJL-B+N.Q5W<#)Z5+;>$HX;+0+62Z\R/2K5K9OW>/.#1",GK\O3/>@"*
MP\;VMY-&);.:"*>W>YMI#(CF5$&X@JI)5MIR ??N,4Y?&48\-KK4NG31PS/$
MMN/.C(D\P@*2P;:O)YR>/>F:)X5N=%"1Q2Z2$A@,4,\>FA)SQA2[[\$CO@#=
M[4VS\*7EG%J;I<:7YU^\9D@%@1:X4$',?F<LV>3GL..* .ELYY;BTCEFMVMY
M&'S1,RL5/U4D&IZR_#NC_P!@Z)!IWG";RR[;E38HW,6VJN3M49P!DX %:E !
M63_S-W_;A_[4K6K)_P"9N_[</_:E &M1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %'5O\ CR7_
M *^(/_1J5>JCJW_'DO\ U\0?^C4J]0 5S^DZ'JEAK=[J-SJUO<+>;?-B2R,?
M*KM7!\PX]^.?:N@HH Y_1]#U/3M9OK^ZU6WN5O2K2QI9F/YE0(N#YAP,#TKH
M*** ,Z^_Y"NE_P#723_T6:T:SK[_ )"NE_\ 723_ -%FM&@#.U725U233G:7
M8+.[6YQMSOPC+M]OO9S[4:II0U.33F\WR_L=VMR %SNPK+M]OO=?:M&B@#F+
M[PI)+K5WJ-G/8*;S89TO+ 7&&50H9#O7;\H'!R.*GO?#D]_XAM-1EO+=8K.3
MS(!':[9Q\I789=W*9))&WGUKH** ,#1?#LVG:Q>:I=7=O+<7,2Q.+6U\A&VD
MG>XW-N?G&>..U,O?"D=[;:Y&;MD?4YX[B.14YMY$2-48<\X,8;MZ5T5% '+7
M'A*8ZM<WUM<Z?F\*/<+=Z>)SO50I9#O&W(4<'//-.U+P='J$][<BZ03S7D5[
M#YD D2-TB$6&7(W@KNSR.OM73T4 <K=>$[B\TNWMY;K3EG@O!=*(M.VV[X4K
MM>+>=W7.=W4#TJ)O!<XT";28[^S:&YFFEG$^GAU_>'/R*' 4KS@\]>G%=?10
M!R<W@UX[S[1975H2\$4,W]H60N68QKM#@[E(8CKG(.!Q5J^\-SZAKEC?37=L
M(+*598E2TQ.,+@IYN[[A.21M]LUT5% !1110 4444 %%%% &?9?\A;4_]^/_
M - %:%9]E_R%M3_WX_\ T 5H4 85YH-T-<EU?2=0CM+FXA2&X2:W\Z.4*3M;
M 92&&XC.<8[57E\.:JEW-=6.NK#/=P)%=O+9A]S+D!T 90C88CG<.!QQS%XF
M\7GPY<C?_9K0J$+1/>;;AP6P2D>T]/<\X/2F:MXMOM/N-9,&EQ2VFD>6]S*]
MSM9D9 YV*%.6 )ZD#@>O !>LO"MOI\O^C3L(5TN/341ER0J%B&)[D[OTJ.U\
M,3V%QHDUIJ"*VGV(L)1)!N$\0V<C##8V4Z\CGH:R_%VO:F^E^)K73+*)X;"R
M=;B=K@QR*SQ%LQ@*<[5*MR1G.!71W-^]AX=2\#6P98D):[G\J,9P"6?!QU].
M>E &9/X0$GA>#1TO%S!=?:5>6#?&Y\UI-KQY&Y?FQC(Z U#!X+DM;8M;ZC''
M?+J)U"&5;4"-',0C9/+#<H5W=P>1SD9,-OXYDN-&DNH+*WN[E-233@MO=9BD
M9@I#*Y7I\XSQQSUJ:?Q=?6-O?176EQ/J-K=VUOY,%QE)!.RA&#,HQR2"".U
M%V?0]2GN=*OFU6$W]DTH=S:?NY$DQE0F_*D #!W'ISFJJ^$;D+]@_M1#HGVS
M[7]E^S?O<^9YNSS-V-F_G[N<<9J.Y\77^GQ7\-WI<+:A:3VL:Q07!*2K<.$0
MAF4$$'<#D=O>K+ZWKDE^^FV>FV,M[;6ZSW9>Z98P7+!$0[,DD(220 />@#4T
MC2AI27BB8R_:;N6ZY7&W><[??'K5"?P[-=^)K75KB[MREH[/"([79-@J5V-+
MN.Y.<XVCD#GBJ$/CVU>TGNI;5HHETI=2AR_S2CD.F,<,K!1WSN%4[WXB?8;J
M6.:"QC-H8EN[=[PB?>RJS")-OS!0PZD;B".* -FV\*+;V.B6OVQB-+N'G#!,
M&3<DBXZ\?ZS.>>E4=#\#'2+JRF:^@D%E;RV\?E68B:17Q\TC;B6?Y>O&<GBJ
M7C'7M4GT;7X].M(_L=BRV\US]H*2[R%9BBA<$+N4'D$\XZ<]=K-^VFZ;)=(U
MHI4@%KR?R8U!/4M@_ECF@#/T3PPNC2V$@NS+]DTQ-/ ,>W<%(._KQTZ?K5>^
M\*22ZS=ZA9SV"?;-AG2\L!<$,JA=R-O7;\H'!R.,U4M_&\UUI,-Q;6-O<W,F
MI_V;MANOW3-M+!U?;G;C';/7KCG;T'5KC4UOXKRVC@NK&Z-M*L4A=&.Q7!4D
M X(<=1US0!5O_"RWUOXBB-V4_MF$1$^7GR<1[,]>?7M1?>')M0U^ROY[NW$-
MG*LL*I:XG&%P4\W=]PDDD;?;-5;;QCO\4Q:/-_9K^<90/LEYYLD)09Q(NT8R
M >AX(QSUK,_M[5]6U/PI>&QBM]/OKB26 I=$LR_9Y2JR+M&,C#<$XQ]* -.Q
M\'W-G<Z:&U;S+'3+J2>UMQ;@-AUD&UWW'=CS#@@#@<@]1/+X1BE\-R:0UT2?
MMCWD<QB!V.9C,,J>& )P1W&>F:;8>+CJ$6EB&S N;J&>6XB>; MO*^5P3C_G
MH0O;N>V*H6_CO='K.^/3[F33[!KY387AFC<#=E"Q48/RCG!X- '0Z+IMQIT<
MHN'L&=R"/L5G]G7 ]1O;)_&LRZ\)S7$.N6@U%%LM5<S;#;Y>*0A 3NW8*X3I
MC//6H)?&-SIXNVU33$B"6'V^W2"?S&==P78V5 #99>F1SUXJ74_$NHZ#I?VC
M5[/3X9IIXX+<K>-Y6YLD[V* J%"DY .>U $^M>$X=;NKV::Y9!<VD-N%" [&
MCE:17YZ_,1Q[>]7-$TJYTT3&YDT]VDV@?8K'[..,]?G;/7VQ6':^-Y+VQVVU
MK:SZ@U^+"(17):WD8Q^9O$FW.T(&R,9RI'O5KPC<WUSJ'B3^T(Q%.FH*GE+*
M9$0?9XOND@<'KT'7UH L/X?OK75;Z]TC5([1;]EDN(9K7SAO"A=Z89=I( SG
M(XZ4C^'[^VU.ZO\ 2M52":\2,70N;7SE=D7:) %9-K8P#U' XJ"'Q1>26-WK
M+V$"Z';BX)E$Y,Y6+<"VS;C!*$ ;L\@T^U\0:G'?V=OJVFV]N+Z%Y+<P7!D*
MLB[BCY4<[><C(X- &GH^C1:-I0L8Y9)69GDEFDQNED<EF8X]2369#X12+3]#
MM/MTF-*MGMPZIM:3=%Y>X<_*1U[U2L/%^K7=II5W-HL$4>K0,UFBW99_,$1D
M57^0 !@IY&<<9'/&IIGB9-6O--AM;?*75A]ME8M@P D!5(QR2=X[8V&@#.T;
MP5/H]Q'<1ZA:B:&P>RB,-@(Q@E"'<;CN;Y.>0#GMWT_#N@-HC7TLDT#RWDHE
M=+:W\B%"%"_*FYL$XR3GDU4U#Q)J,=SJO]FZ;!<6VD@?:7EN#&SML$A6,!2,
MA6')(Y./>J&ESW6L?$*XNV@A>R@L;>6V8W+AHUD$IW!-NTLV,')X &">@ -2
M;PG#<:#J.ER7)(N[Q[Q9/+'[MS+YB\'A@& ^HJ$^%KF;3I()KNPBN!-%/;S6
M6G^2$DC;<"REVWC/49'&>G6F^)_%Y\.7(W_V:T*A&:*2\VW#@M@E(]IZ>YYP
M1Q3=6\6WVGW&L&#2XI;32!')<RO<[69&0.=BA3E@">I X'KP 37_ (9OM32T
MN+S4+.;4;25VC=[#,&QU *&,OD] <[LY]N*LV_A]UN-)N)KBW\RP:9BMM;>5
M&_F*1PNX[<?4YJK=^+3:RZI;&RW7EI<6\-O%YO\ Q\"; C;...=P/!QL-7]?
MUBXTA=/2ULUNI[V[%JBM+Y84E';<3@\#9SQ^?2@#(M/ %G;:?K5D]U))%J/R
M1_(!]FB#,Z(O7(5G8\_3%6%\*S7&DZAI]]<6 6ZA\H26-A]G93V8_.VXYP<<
M#BJ[^+K^*/[,^EPG5%U,:<\2W!\O+1&59 Q7.W&,C&>O7'-35_B"=(O+JWEB
MT\O8+']KB-X5E=F4,PA79\^ PQG&3QQ0!NZ;H=]!KAU?4=32[N#:_9=D5MY2
M ;@V0-S'/7//TQ6[7.Q^))9?%TVBB&VC2%5;,TY6:8%-V^--N&4'Y3SUSZ<N
M\*^(I?$5M-<216L(4@>3'.7EA/.4E4J-C# ]>I],D Z"BBB@ JBG_(=G_P"O
M:/\ ]">KU44_Y#L__7M'_P"A/0!>K$U36[NUU2+3=-TT7UT8#<R*TXB"1@[1
M@D'+$YP.!P<D5MUC:EH4UWJT6I6>HR6-P(&MI2D:OOC)##&>C YP>>IX- '.
M:9XHN]-\":1?S+;SM);L\DE_J @9B"?E!(;<WY#WK3'C>T$%Q/+;21Q)I<>J
M0$L,S1L#\H'9@=HQ_M"HD\"QP0V,=MJ4L?V:T>S9WA21FC9MV1D?*V>_/TJ'
M4_"0EG\)642RR0:;B.>?@!H8U4A6'?=)'$<>QH TK/Q+/=^)'T<V$43PQQO/
MYET!(-R;LHFWYU!^4MD<YXXJ?5]<N;'5K'2[+3OMES>12RJ6G$2((RF=QP3C
MY^P)SCCG(;?>'I-1URTOKF^W06DPG@A$"AE8*5QYG7;R3C]<<55UW2=2OO%F
MCW5A<O:+;VMRKW C5U!9HL*RGJ" QXQ]WK0!&GC">ZBTM+/23)>WQN(S#)<!
M%ADA;:X9MIXSG! YXXYX1/$LD$UU:V]M/>7TFJ/:00RS*J@B)9&.X+\J 9[,
M<^N>+VG^%X-/ETN5;F622Q%P6=P,S/,0SNV.AW9.!ZU%/X34S275K?R6][]O
M:^BFV!@C-&(V0J?O*5'L?RH KR^,;B"'RGTACJ:Z@NGO:I< J'>/S%</CE"N
M#G (YXXYL^*=6U72?"AO[6V@%Z&B$B&7*Q[F ."5^;DXZ#KGMBB'PHH:*>YO
MI)[P:@M_-/L"^8ZQF-5VC[JA<#\/>M+6]*36]'N-/>5H1,!B10"48$,#@]>0
M.* ,R;7]5-XUC9Z+%<7L%NL]TC7NQ(]Q8*JML.YCL8] !QSS4EYK\EQX%FU[
M28MSM9&XB28[=ORYYX/(YX[D8J.;P[J!NVO;;7&M[R>W6"ZD6V4K*%+%652?
ME8;F&<D>H.*T8M#M(/#8T*+S%M!:FU!W9;:5VDY]>_UH YB;6==>_P#"\BV2
MM<W5O<,]LMWMB?Y8R'=MO&,DXVDC-32^/XDLM/86UM#>79G#17M\L$<7DOY;
MYD(.?FX&!SUXQ6M8^'I+>72IKK4&N9=.CDBC81! RL%'(!Z@*/KFJG_"'+ M
MM+97[0W=O)<E99(5D5DFD\QD93C.#C!!!X]Z -#3M;AUKPN-6@#QI)"[85P2
MK+D'#<@X(.#T-9.F>+'N+G1M.BM@[76GV]TTEU=*DC*XP=@VXD9<9;&WJ/7%
M='%9R#2_L<\_FNT;(\HC"9SGD*.!UK"F\'F>RTO3WU$M86"V^V,VZ%RT.,%7
MZKG:,_C@C- "6WC!KF#6KD640@TQ9R5^U S%HB1AX]OR;L$J<G(YXK0_M_=?
MVMI':LTEQI[WR_.!]TH-G/KO'/M523PF+S4;F[U&^:X,MI+9+LA6)A%)C.YA
M]XC QT YXYJNO@EIUD&HZQ<W1?39--&V-8PL;[?F&/XOEZ]_04 11>.T\C6F
MFMK5Y=,LC>$65\+A'7YOE+!1M;Y>A'<5:;Q>;)[X:MIKV@M[+[='LE$K21Y(
M((  #YP,9(Y'-1CP2);?44NM1:1[[3_[/8QP)$L:?-@JH[_,>I/Y<5?U+PO:
M:K/.]S+)LFT]K!D7C"E@=P/J,4 4[[Q5>Z1IRW&KZ7;V<DTT<-LKWZ^6S,&)
MWN5&S:%)/!'IFKWAKQ%%XBM+F1$B66VG,$H@G$T9;:&!1P!N!##L.<C'%59_
M#-[?6B)?ZW)/<V\R36LWV9%$3*&&2O\ %N#$')QZ8K7TRTN;.V:.ZNDN9"Y;
M<D B &!P%&?3N3UH PH_%UP_D7K:4%T:XNQ:QW?V@&3)?RU<Q[>$+X&=V>0<
M5%X*>_N[S6KW4(720WTL(/VUY5 5L; A 4!<=0.<FK$/A!HC!:MJDSZ3;W0N
MHK+RE!#!]ZJ7ZE W(&,\#DXK8TO2TTI+M4D9_M%U)<G<.A<Y(^@H R9?%AMO
M$UOI%Q;VBBYG:"/R[U7F!"LP9XL?*I"]<GJ,CFH;7QA<7$UI(^D&*PN;Z2P6
MX-P"WF*SJ#L ^Z2A&<@@]B.:=;>"TMM1@G&H.8+>_DOXH?)0'>^_<&?JP_>'
M'MUSQBW%X7@BL+*T%S(5M-0>_5L#+,TCOM/M^\(_"@!MGXI2\&E(MHRW-]--
M#)"7YM_*W"0DXYPP"]L[A705S&C:&\'C+7-6DC>.&1ECM48C'*H974=@S*GX
MH3WKIZ "BBB@ HHHH *R?^9N_P"W#_VI6M63_P S=_VX?^U* -:BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM=I/LB5T*#:=JA<%<,0<@_?Z]*L:3IEKH2:C<'4);AKF7[5<37#J2"$52>
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MN&8(^T-@'"KTR3U)X(J>SU[6M=;1H;*:ULFOM'%_([PF7:^4&%&X<9?OG@4
M;]MX;TFSO#=6]J8Y"6;:)7\L%L[B$SM&<GH.]1Q^%=&A@FB2T8"8*&8SR%P%
M.5"N6W* >0 0!6'IOB'5_$2Z5!:36UA+/IHOKB4PF7+%MH55)'RY#$G.>@]Z
MJWOBC7SJ=_'86\DYT^>. P0V#.EPVU&<F3=\GW^!SC )SF@#M=/TZTTNT%K9
M0B*(,6QDDEB<DDGDDGN:HQZ'HFDVXD\B.""";[4IDE;9$^"-PW'"C#-P,#FF
M>(M1O+/^S;.P>.*YU"[%NLTJ;EB 1W9L9&3A" ,]37)>([K5;O2[_2;F\MWE
ML=4L%,XMN)DDEC*AEW8!!//8@#IF@#L9-"T74H/-^SQR)--]K$T,K ERH7>K
M*<\J .#@BI[70M+LEM5MK**);5WD@5!@1L^=Q ]]Q_.J^K7;:1H*%KR*WFS'
M"LBVC2;G) PD2G))YP,G'OBN:M_%.M3:4RH8A>)K2:<);FU:/*,JMN:/=D$;
MO7G';- ';6MG;V2R+;1",2RM,X'=V.6/XFH$T?3XX+:%+5!';3&XA7GY)"6)
M8>_SM^=<U'X@U>RFN8[R6WN(K#58K6YF6'86AEC0JV,G!5Y%R>F >E;GA_4K
MC5K.YO90@MWNI5M-HP3$IVACZY*LWT(H M0:1I]M?7M[#:1)<WNW[3(!S+M&
M!G\*@TWP]IFD3&6Q@>)MI0*9G947.<*I)"C@< "N7TCQ)KIL/#VJZC/:30:L
M3&]M! 5,?[IY P8L<G]W@C&.>.G,MGKFNM9Z%JEQ=VC6^M2+&MLD'-OYD;/&
M0V[YL8 8'KSC&* .BGT5)M>_M$LICELVM+F)E_UJ[LKS[9<?\"I+3P]8:89Y
M].@"7LD1C6>>1Y2H[#+$D+G!P,"N-T[6]:TWPC922WK7EQ?ZC+:Q.MHTCQ /
M,6.W=E^$P!QCCJ!6D/$'B!-'AWPK%=R:JEE%-=VK1B6)P"',>[(()(Z\[>V>
M #IM(TJ+2=#M=+5C(D,(C9CU<X^9C]3D_C5?3?"VB:1<)-86"0O&ACCPS%8U
M.,[5)(7.!D@#/>N4U74M=EMI;+^TXX[FQUVTMC<1P%?-20Q,N5#=M^",X8#M
MFM"?5'TW5=;26YMK>X2WL5^UK:-(TLCF1<"-6RQ.,*!T)[T :]OX7\/:8PDB
ML8(20T*%G)PK\%%R> >RCCG@5-!X9T>WMYH$L]R3LCRF21Y&<H<IEF). 1D#
M.!7'OK%YJNG+#?;FELO$5G KO;F!W4M$X+(2<'Y\>^ :ZCQ#J&HV^H:-8:=+
M!$]_.\3RS1E]BK$SY !'/R_2@#0?1]/D@N87M4,=S,)YEY^>0;<,??Y%_*H7
M\.:5)J9U VS+<EUD8I,ZJ[#&&9 =K'@<D=JYH^(==>*UL(I[3[:=:DTR6Y:$
M[618GDWA0>&P!QG&0:BO/$NO+J5[#8Q3W/\ 9TT=NT4>GLRW+;$9R9 V$)W\
M#M@$YS0!U \-:0+J>Y-F&EG5U<O(S !_O[03A<]]N,U8TW1['2$E6RA*&5@T
MCO(TCN0,#+,23@>]8L6LZBGB^:POI%MH7<K8PM;'9<J(PV1-G <'=E2.@Z'K
M3O"6L7VH"X@U>;9J<:H\UFUJ83!G/W3DB1"1PP]#]  7CX6T0WQO3I\9G,XN
M 2S$+*"#O5<X5L@9( SWS1_PCFAVEV=2-I%'+'(UQYCN=L;G.Y@"<+G))QC/
M4UA7?B/5K6'Q-J9>W-II$KP0VPB):5O+1@6;/ !<=!TS[5G:CJ>LW/A7Q/;:
MA'/);C2)I$N9;%K;#[6#)@DY&,$'ZYS0!U=AX?A@U77;^=89&U5T#*JX_=+&
M$ /J3\Q_$5<TW1K#2/--E 4:8@R.\C2.V.F68DX'89XKC;[Q1K8OKZ'2K::4
M::8HUMTL6E%PQC5V#2 C9PP X[9.<U;UCQ1>66NQK:77VBV6_@LYH5L6\N/S
M&12#-G&\;\\<= 1F@#0T_P &:=;ZE=ZA=P1SW4M\]W&P9@!DY7<N<,R\X)!Q
MVK9;2;![:^MFMD,-\6-RG.)2RA6S]0 *Y>?Q3?Z7?:TVJ'ROLL-Q/:69MB!<
M11C<&2;)!./O+U&>G%3^&=8UR]U18;^*:2TEM3,9WL6MQ%("OR DG<I#$CO\
MOO0!K7WA;1=1N//NK%7?8L;8=E$BKT5U! <#T8&M&*RMH;N>ZCB59YU19''5
M@N=H_#)_.IZ* "J*?\AV?_KVC_\ 0GJ]5%/^0[/_ ->T?_H3T 7J*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "LG_ )F[_MP_]J5K5D_\S=_VX?\ M2@#6HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#/UJ1(M.#R,JHL\)+,< #S5IW]MZ5_T$K3_O\O\ C47B#_D#R?\
M72+_ -&+6)M7^Z/RH Z#^V]*_P"@E:?]_E_QH_MO2O\ H)6G_?Y?\:Y_:O\
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M!*T_[_+_ (T?VWI7_02M/^_R_P"-<_M7^Z/RHVK_ '1^5 '0?VWI7_02M/\
MO\O^-']MZ5_T$K3_ +_+_C7/[5_NC\J-J_W1^5 '0?VWI7_02M/^_P O^-']
MMZ5_T$K3_O\ +_C7/[5_NC\J-J_W1^5 '0?VWI7_ $$K3_O\O^-']MZ5_P!!
M*T_[_+_C7/[5_NC\J-J_W1^5 '0?VWI7_02M/^_R_P"-']MZ5_T$K3_O\O\
MC7/[5_NC\J-J_P!T?E0!HVFK:<NIZB[7]L%=DVDRK@X0#CFK_P#;>E?]!*T_
M[_+_ (URL"K]LN^!]Y>W^R*M;5_NC\J +\__  CESJL>IR7T'VI(O))6[*JZ
M<G:ZAL, 6)&0>M5].L/"FE74=Q:W<.^%"D EOFD6!3U$:LQ"#MQCCCI6)<^(
M-&L[DV]Q>11S [2A!SGKZ59M;^SO9I8K=@[1*C-\N!AQE3^5(9MWS>'M1O+2
M[GOX1<6A)ADBO#&0#C*G:PRIVC(/!Q2*OAE8(X!<V@CCNC>*OVGI,7+ENO\
M>8G'3FJ&U?[H_*C:O]T?E3 LV]MX9M;\WEOJ*Q,9&E,*:@ZP[SU;RPVS)R3T
MZ\]:MW<_A^^GAFN+RU>2%72-A<[2H<8;H>XK+VK_ '1^5&U?[H_*@"2/3O"\
M44J)J;"25E9Y_P"U)/..T$*/,W[L ,>,XY-+)IOA&2WLX/M,$:68<0F*^9&
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MD#N< MYD9Q]< UTE(2%&20![T <'#+]A$6JN7M-/N==:?+@H!$T+(&8'H&<
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M48LYI;"2=T&.3$RL-K!LG&,].HJ[=PQ0^+X91&E_/,8H98YK5M\*[3F2.3&
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M@CT)J;5=;2PDLH8$AGGO'(C#SB-=H4L6+8/I@<<DU;L=3L]1,PM9UD,,C1N
M>A'7\/>@1PLRR75OI;7-G8VFFHMP@62P>6W+[QM<1Y4KN&XJ3TR?45;6UL[9
MM+36=]_I:64B0R26KE/,W\90Y(.S 4GL#CK7:-=6Z7"V[W$2S-RL9<!C]!UJ
MA!K(N=>N--ACC9+95\V4S -N(S@)CD#C)R,9H&<QJ\PMK;Q+;1VUWNO+&/[)
M&L#L6'E%?3C'?/(K9L]-CF\67]U<VV\Q6]MY#R+D*V'W%<]^!R.:W9;RU@D$
M<US#&Y&0KN 2/H:5KJW2X6W:>(3,,K&7&XCV'6@1P>CZ=:PW/A>XU+3QN;3/
M)#R6Y8K.&C* \<'&[!/O5W0(9W\0C2Y5?R-!$@1CT?S#^Z_[YCR/QKL?-CV;
M_,3;G&[/&<XQ^?%5;2.P@O;M;=XS=3/YLZB3<^<!1D9R!@ 4 <]KJ1Q>*;6[
MCB2\N?W,8M9;9F*C>3YD4F,*1DENQ"C.*SU@LM*MM?CCT>%[HW>2C6Q*F!F3
MYCM'S(,D[1Z&NY%U;LY03Q%AC*AQD9.!^O%$=S!+'YD<T;INV[E<$9SC&?7-
M ' 064KZ7J5LD/\ HTFJ6;1BVMGMT*%HMY1,DJ.#D@^IJW?Z?]C36K6VLWCT
MW[39R20PQD*8LKYVT#KE1R![UV0O;0JK"ZA(=]BGS!RWH/?VISW,$<R0R3QI
M*_W$9P&;Z#O0,X/;:6TNNRZ?I(.GS?8U"RVSB'&Y]SA,99%SD@8!_'--M;"6
M72KJT\@FU?6K<JL-L\"&(B/<50DE5^]GG'4]Z[Y[F")@LDT:,S!0&< DGM]:
MABU2SGU">PCG0W, 4NF>><XQZ]#]* .3UFPTZ+4[ZWN]-+Q?8$738X8"0C9?
M>(]HPK9V'/'&.<57$*VTN@W'D"ZO%M+2$V<]LY9,$9>-\81AD[O91G%=U-=6
M]N"9YXH@,??<+UZ=?H:62XAB*B2:-"Q  9@,D]* ,'Q,D+7>EM?PM+I2R/\
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MP^FJVCSQIHS"19U)7S-T8PP/!.,\'TSVK2TYKBU^'B%[22YGCLV'V=\[GP"
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ME@;OD&[!^O7WKIO[%U3_ )ZV?_CU']BZI_SUL_\ QZ@9YCJ:12^(=3GO(O\
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M+JG_ #UL_P#QZC^Q=4_YZV?_ (]0!6HJS_8NJ?\ /6S_ /'J/[%U3_GK9_\
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M,^F2WX0P'>40IELYP,!ONXR<]>*PO#.DZLFA>&M2TTVJS+I M)DN]PV [6#
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M\S=_VX?^U* -:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!G/.*J7'A6[$7F6EY +F/5VU./S8R4.Y678<'/1CS6[?IJ;6L?\ 9\UJEPK
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M;O\ MP_]J4 :U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M444 %%%% &9?_P#(;TG_ 'I?_0*TZS+_ /Y#>D_[TO\ Z!6G0 4444 %%%%
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MY=/MXDB-J)AY<JH<C=QGZX(SWH LZYJEW:76FZ?IZ0_:[^5D62<$I&JH79B
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M!!'J.G27LVW.4*1H^%_[[/Y5H1^'K426LMQ/=7<MOYNV2XEW%O,&&SP!C X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK)_YF[_MP_\ :E:U9/\ S-W_ &X?^U* -:BBB@ HHHH **** "BBB@ HHHH
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MN< [E!..OXFI;KP_IM[]M,]N6:\\LS,)&!S']QE(/RD=01@YH I>%]3U._\
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MOMZ(EP1(P+!,[<8/!&<Y&*?;Z+9V\WG@2R3_ &<6S2RS,[-'DM@DGDY)YZT
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M:]>=7%[K.I)H .JF"XBUNXL998X1B4QK.H<KTY"<KTR<]A7H@!"@$Y..3ZT
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M",_A4E !63_S-W_;A_[4K6K)_P"9N_[</_:E &M1110 4444 %%%% !1110
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MJ)OKB]D2U2WN(1*\2H6Q))C:,#/3DX'7)KJ[VPTMK&[%[9VSVLF9KA7A#*Y
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M]=PY%=UJ>B:;K(B&H6<<YBSL+<%<]0".<' R.^*BN?#>C7=O;03:=!Y=LNV
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M3GPW:1!([J0ZC9+LG(593YZ##8!P#WP#UZ=JV[C1=-NM,BTV>SB>SB"B.+&
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MG1%C1410J* %51@ >@H =6=%_P C%=?]>L7_ *%)6C6=%_R,5U_UZQ?^A24
M:-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !63_S-W_;A_P"U*UJR?^9N_P"W#_VI0!K4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!G:S_QYQ?]?4'_ *,6M&L[6?\ CSB_Z^H/_1BUHT %
M%%% !1110!F7_P#R&])_WI?_ $"M.LR__P"0WI/^]+_Z!6G0 UXTD*ET5BIW
M+D9P?4>]1RVEM.DJ36\4BR@"0.@(?'3/K4U% %4:;8"R-D+*V%J>L B78?\
M@.,54LM LK/^TD\M)8+^<3/ Z HN(T0*!C&,1@UJT4 0K:6R*%2WB50P8 (
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M,NT,7R?EXYKUSCI1QGWH \LOH+I(]5O+FX+Z'%XA#WMHD0#%0T9#[^N%;:Q
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MW?\ ;A_[4H UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2.HR,X(['VJ[0 5G1?\ (Q77_7K%_P"A25HUG1?\C%=?]>L7_H4E &C1110
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MRV/J:CTZU73]3E_M?1;J\-S:6:6S+9F8($3#(3C$9#Y;YB!S7;/?V<:3N]W
MJV[!9BT@ B) (#>AP0>?4>M5[K7=(L;A;>[U2S@G9P@CDG56W$ @8)Z\C\QZ
MT <1%;ZI>>+=-N)-.DMS;ZK.TJ1:?Y<:1E)0K^=_RT+Y4G'&3R <9GL="N9[
MC38+RQE^S->ZMYX9#@1RO)M)]F!X^M=C>ZYI.FW,5M?:E:6T\OW(YIE1FYQP
M"?7BDO-=TC3I?*O=4L[:3*C9+.JMD].">] '*^!+>\GO)YM0!+Z/%_8T+DYW
M[&R\G_ @(OQ4U'J^BZB_BR73(+61]%UB>"\NY@/DB:+_ %BG_?V1#WRU=)JE
MQ!X6\/75W:6J%4D\QH]Q&YI)!N8GGG+$U:MM>T>\5FMM4LIE6586*3J0'8X5
M>O4]AWH XZY@U*TDNQ_9[^1/K4TC7'V$W3QH8E"LB?[1!7=@@<UK>$[#4+;P
M$;)DDM;W-TL0D4(4S+)L.!P!@J>.,=*Z=;B%[B2!)HVFC"M)&&!9 V<$CJ,X
M./H:YR#QAYET@DTNXCLY+]]/2Z\Q"#*KLG*YR 64\\]J ,#PEHYBN+!I5U"&
M]L[%X'A;3/(C!(4,IE"XD^89!!.>O>G:-X5BAM_! ET:-3!:O]LW0#Y7,2GY
M^.N\=^XKIKWQ5:6/BBST.2&5GN0,SC&R)F#E%;W;RWQ]/>J^J>+SIEUJ:_V5
M<7%KI:))=SQR("JLN[(4D$X'- '-QVFHV>EZ=8-I;QV_FWX\U=.^TR1YG8QQ
MA3PB,ISN(QA1TZTEMH^J+H6GQ265QYL?A2YM74H<B4^5A/\ >.#Q[5U=QXEF
M&JS65AI-Q?"&VBN9'BE1#MD+[0 Q&3\A]*DD\4V7_"++KULDMQ#)M6*%1MD>
M1GV"/!Z-O.WZT 5M7%[;>"+=(+%;F=4MUDB>#SBBY7<PC_C91E@/45S$&DNV
MF:PU[%J4<;ZK#=6LL>F98E84PYMP#E=RD$8SW.#R/0-,U*#5=(M=2@)$-Q$L
MHW<%01G!]QT/TJAIGB[0M5L[J[MM3M?)M'=9F:9/D"L5WG!X4XR">HH SI(-
M7U/X:7-N+5+35)[.5%AB7RADYQ@9^0L,'&>"WM65+8#5KLG1-%N=/ABT>YM9
M?.M3;;V<*(X@& W8(8Y&0/7FNVT_4[#5;<SZ?>0740;:7AD#@'T..]8=YXYT
ME++7FL;F"YO-(BD=[?SES)L0,<8).T$[2<<$$=J ,C3X[C5M4TL/I%[';V^B
M36TK7=N8U,I,/R8;K]P\]#V)P:;H%C*-/\%1Q:7<6SV$I2]#VS1;7%HZ%CD#
M<"Q W<@^M=A8ZYI>HQS/::A:3?9Q^_\ *F5O*_WL'CH>OH:?IVKZ;J\;R:;?
MVUXB':[02API]#B@#B_#WA^5[KPX-3TPM%;:7<JXGBRL<C2Q[00>A*[OPS6=
M'I.HVUGH#WL-W':P6,UL433OM;0N9!@&/!(!0 9 [8XS7;W>O3+JLVFZ;ITE
M]<6Z+)<$2K&D8;.U<GJQ )QZ=2,U'+XDFDU :?I^E37-XD"3W,;RI&MN'SM5
MFR?G.#P,].M '.1Z;%IMSI O--OM4TQ-*>VA$EF9'20N#ADQ\FY<#)P!MP2*
MU_#^GW5K\-(;"6UDBN5LI(_(8?,#AL"GCQDD]O9&STZXFN[F[ELVM7=4:&6-
M69PQ)QP$/3KD5JZ'K46N64LZ02V\D$[V\\,N-T<B'##()!^H- '(VOAUKEI#
M?:7YF/#-M;)YL6<2#S=R#/\ %RN?J*V+G^T;?X<6P2P^UWZ6=NLEO-#YIS\@
M<E.-Q4;CM[D5M6FN:3J%U+:V>I6EQ<1 EXHIE9E ."2 ?7BBTUO2K^Z-K9ZG
M9W$XC$ACAG5VV'&&P#TY'/N* .?\%VEU!J.N3313K!<2PO"\UJ+?S/W>"0G&
M.@'(!XYK,O- E6S\1R1Z27$FLPS-$D0#7-LHMVD5?[P.U^.Y!'>NCG\6:=_;
MNGZ5975I=3W%R\$Z1S@M!MB=\D#W3%6]6UH:;<6EG#;27=]>%A! C!>%&69F
M/"J,CGGDC - '%ZMITNJVOB:XTK2;JWM+G3HK=8FMF@:XF#,2PC(#<*0,D#/
M;I6_>>'[5O%FA!-+A;3[6SNEQY(,<;$PA>V,X#8^AJU<^))K1+2";29QJEW(
MT<-FLB'=M&6??G 0 CD\\XQFI]*UW[?J%UIEU:/9ZA:HDCPLX=61LX9&'49!
M'08(H Y31O#\VG6GA:6#2S%<P7USYY$>UEB*3!0QZ[>(@,_[/M4/AZRO[SQ'
MIEU>::\,?V&>&[A_LX6\,+,8SY0)YD7@X/(.,CJ17=ZI>75C;>=:V#7A&2ZK
M*J;0!G/S=:P4\8S'1+#5I],^R6E[+;"-YKA2/+E_C..F 0>: )? $ M/"-E9
MO82V=S;1K%<+);F+=(!@D$@;Q_M#(/K73UGQZ]I$VF2:E'JEF]C&2'N!,IC4
M^A;. >1^=6+*_L]2M5NK&ZAN8&R!)"X=3CKR* +%9T7_ ",5U_UZQ?\ H4E:
M-9T7_(Q77_7K%_Z%)0!HT444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9/_,W?]N'_ +4K
M6K)_YF[_ +</_:E &M1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO#;F&>XU.[F9/-C6=W)2,+N4G'F,<]/D!KK=3U[2]'95O[Q(692^""<*.K'
M.![GBH]0\3:+I;A+W48(G,0F"YR3&<_, .HX//;% %+PGIVH:/'J.FWI66%+
MIIK:=$V*Z2?.RA<DC:Y<8ST(K .EZBFESV9TJ>0V>MM?L@"[;J$SM( A)P2
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M:LR><8Y N) -V."@^7.<'\*6!=3?7-3\3'2+@!;*.TM+)W19I@'9V8\X7E@
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M82VH52VY\LV5XP3A>2* +-MH%P(](D@LKN QZNU[<K>W"228,,B%B5)')*\
MFLZX\+Z[#X?TTZ:D<>JQ/=VTI,@&V"=V);/<J?+<#V(KJ+'Q5IU_?0VL0N5%
MQO\ LTTD++%<;?O;&[\ GW R,BH]-\8Z5JL]G';BZ"7@;[--);LD<K*"2H8]
MP ?R/I0!@:EX6GM-4N!;6>I7.F7%C#:+%874<101AEVN'9<J0PP1G^+BMW1]
M'EL/$5[=&#9;/86EO"6<,V8_,W GKQN7GO3[/Q=IE[=P0Q"Y$5R[1VUR\#+#
M.PR2%;OT./7'&:S[[Q_9Q:2^H6-C?7<27$=OO%NP0L9 C8..2.?8G ZT )XN
ML->U&YEMK-;J2PFLGC5;:>.(+.<\REOF*8Q]W/?(Z4ZRT&^AO7EDA4 Z#!8@
M[@?WJE]R_3YEYZ5OW&K6MGH[:G=>;!;J@=A)&0XSP!MZ[B2!CKDUGKXMTX6U
M_-<QW=HUC!]IGBN8"CB+GYP.XX(X[B@"K<:+?2?"YM#6-?MYT?[+Y>X8\SRM
MN,].O>J:V.H6NAW<.A>'6T>Z8Q%F22#=,H8;PI#$!MN[!;C)K?TWQ#9:I>RV
MD*7,<R1K,%N(&C\R,D@.NX<C(Q3;_P 16FFWBP7,%XL9D2(W/V=O)5G("@M[
ME@,C@$\F@#E8?#&J2VU_YUK*1<ZQ97:I=W"2R&&,Q;]Y!QD!&XY]!FNAN=)N
M9O$]]>^4K6\VE+:HQ(Y??(2,>F&%:.JZQ9Z+;Q3WC2!)95A01QL[,YS@ *"3
MG%92^-])+[&COHV2=;>??:N!;NQ 42'&%R2,?4'I0!SJ^&=5LAILLEMJ%PO]
MC6UC/%87<<;QR1AMV=[ ,IW=0>W3FKYT;4=,GGCL-(-S;7FD06,8DN$_T9HP
MXVR$G)4AQRH;D'CFMJY\7:9:WDT#K=-%;RK#/=) S0PN<85G[?>&>PSSBDO?
M%^EV%Y<VTWVDFUE2.YD2W9HX=X4J6;& #N'Z^E %G1-/>W\*:=IM[&N^.QB@
MGCSD9"!6'OWKF?#WA[Q!IMCJ;S-"-0MK,Z=I,C,&!C3<4=O3<2F0?[E7[GQ=
M(T_B.RALKF*;3(&>.=XCL9A&6R<C Y''J*?IWBZ'4-,**MQ%?_V<;M&GMVC6
M4 #<R9'(#$?F.QH PAX=UV\AUJ6>WN_-O-$>S07MU&[M,=W]SY54D\?R%3ZS
MHFN?9_$5G9Z:+D:O81Q1S>>B+$ZQ%&5LG/H1@$'/)'6MW2?%%K+H NKZ;;/:
MZ=#>7A*8 5X]VX>HX;IW&*=XEUU])T>QU")FCCEO+9),Q%F\MW 8;<9S@]!S
M0!@:KX:O9-7U8RV>I7EEJ:1@K97D<2KB,1LD@=AQQG(SU/%=%XITBYU71(XK
M$I]LM;B&Z@$K85GB<,%8^^,9]Z?!XFM+BWN72UO_ #[9UCEM3;-YP+#*G;Z$
M=^G!YXJ/_A+=--E%.J73RRW+6JVJP'SO-4$LNWM@ G/3'>@"EJXUK7--"IHC
MVSVMQ!=+%<7,?[]HY%<H-I8 $ X+$<XX],_5-%U;7_[8O3IILVN+>VM8;::5
M"[B.8R,[[25'#8 R3P?7%;MUXDMK&[D>ZG\JU33Q>&-K=Q* 6QD_H-N,YK4L
M+T7]MYPM[B#DJ8[B(HP/T/\ ,4 <UKWAV_U*;Q0($0+J.D16L#,P :5?.R#Z
M??7GW]JN6]I?7WB?3=8N-/>U2+3[B%XY71GCD:2(C[I(Y"-R#]<=*Z.B@#@X
M-(\177B73;O44N6%G?S222-<1^1Y1CE6/RXUYZ,H.[GKU[3Z9INKQ>$)O"\N
ME>48[&:V6],R>7*Q4JK  ELMG)R!CGK7:T4 9VA-<G1;5+NRDLYXXUC:*1T8
MY4 9RI(P>W]*T:** "LZ+_D8KK_KUB_]"DK1K.B_Y&*Z_P"O6+_T*2@#1HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *R?^9N_P"W#_VI6M63_P S=_VX?^U* -:BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** ,[6?\ CSB_Z^H/_1BUHU5O[0WMKY2R^4P='5]N[!5@PX_"
MH?LFI_\ 047_ ,!A_C0!H45G_9-3_P"@HO\ X##_ !H^R:G_ -!1?_ 8?XT
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M:G_T%%_\!A_C1]DU/_H*+_X##_&@#0HK/^R:G_T%%_\  8?XT?9-3_Z"B_\
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M<OOSRJYR![\UE7WAB[NK7Q!$DT .I7L-Q$23\JHL((;CK^[;IGJ*VOLFI_\
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M"B_^ P_QH^R:G_T%%_\  8?XT :%9T7_ ",5U_UZQ?\ H4E+]DU/_H*+_P"
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M"B_^ P_QH^R:G_T%%_\  8?XT :%%9_V34_^@HO_ (##_&C[)J?_ $%%_P#
M8?XT :%%9_V34_\ H*+_ . P_P :/LFI_P#047_P&'^- &A63_S-W_;A_P"U
M*F^R:G_T%%_\!A_C26VG31:D;VXN_.D,/D@",* ,Y]: -&BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#_A<GA+_ )[7?_@.?\:/^%R>$O\ GM=_^ Y_QHYEW#V-3L=_17 ?\+D\)?\
M/:[_ / <_P"-'_"Y/"7_ #VN_P#P'/\ C1S+N'L:G8[^BN _X7)X2_Y[7?\
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MS@%L?='?G\,T<B#ZQ/\ JYYW_P *G3_H7Q_X.S_\8H_X5.G_ $+X_P#!V?\
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M6MPH$D6X94G!(((Y!!(HY$'UB?\ 5SS3_A4Z?]"^/_!V?_C%'_"IT_Z%\?\
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M/_!V?_C%'_"IT_Z%\?\ @[/_ ,8KV*BCD0?6)_U<\=_X5.G_ $+X_P#!V?\
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M);W%I?:=*(;NTN0H>,D94Y4D$$<@@\UN4<B#ZQ/^KGCO_"IT_P"A?'_@[/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\[
M\0F]7XRZ$=/CMWG_ +(N<"X=E7&]>X!->B5B7/ABUNO%5KXB:ZNUO+:(PQHK
MKY>P_>4C;SGZY],4 <^=#B\.:;XBUO6M:DMKW6)8S<75BA!B"X2..($,2<';
MG&26X JKHMS/;_%5+&&'5;.QN=&>=K:^N?-#R+*@$@&]RIPQ!S@GTKL]>T*R
M\1Z3)IM^)/)=E<-$Y1T=2&5E8="" :R[;P9::?J\>MPW5_<:K%;O!YUS<;S,
MAP=KY' R 1MQCD]SD \V*ZIK'AU8?/UF7Q:^LM%,\$UPD0B6<AAN0A!$(QC@
MCGWKIKRXN[_XAWFA"TU*[TS2=.@$=O;WOE%GDS^\=V=6<@* ,D\Y/7FL"RT+
M4++P>8K.Y\86?B14=H[&#S1:QSLQ(4%E,?EY/4N>.^:]!NO!T6IW-EJMS>WE
MGK<5JMO/>:?+Y9E'4J0005W9(XXH F\%P:Y:^'5M]?+M=Q32+&TDHD=H=Q\O
M>P)RVW )]JY^/2M<\%VGB62WDTN31KF>XU(3W$CK+;;UW.IC"X< CCYUKN+"
MQBTZS6VA:5E4DEII&D=B3DDLQ)))-4M4\/6>M7,;ZA)<3VR ?Z$9,0.P.0SJ
M/O=N&)' XH R?AE8W&G?#70+:Z4K,+57*MU 8E@#^!%=9110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
C 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>modificationno14effectiv014.jpg
<TEXT>
begin 644 modificationno14effectiv014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0?!54# 2(  A$! Q$!_\0
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M;P/L6BOCK_A,_%G_ $-&L?\ @8_^-'_"9^+/^AHUC_P,?_&C_57'_P!W[_\
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MO ^Q:*^.O^$S\5_]#1K'_@8_^-'_  F?BO\ Z&C6/_ Q_P#&C_57'_W?O_X
M>W@?8M%?'7_"9^*_^AHUC_P,?_&C_A,_%?\ T-&L?^!C_P"-'^JN/_N_?_P
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M:Q_X&/\ XT?ZJX_^[]__   ]O ^Q:*^.O^$S\5_]#1K'_@8_^-'_  F?BO\
MZ&C6/_ Q_P#&C_57'_W?O_X >W@?8M%?'7_"9^*_^AHUC_P,?_&C_A,_%?\
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M (T?ZJX_^[]__ #V\#[%HKXZ_P"$S\5_]#1K'_@8_P#C1_PF?BO_ *&C6/\
MP,?_ !H_U5Q_]W[_ /@![>!]BT5\=?\ "9^*_P#H:-8_\#'_ ,:/^$S\5_\
M0T:Q_P"!C_XT?ZJX_P#N_?\ \ /;P/L6BOCK_A,_%?\ T-&L?^!C_P"-'_"9
M^*_^AHUC_P #'_QH_P!5<?\ W?O_ . 'MX'V+17QU_PF?BS_ *&C6/\ P,?_
M !H_X3/Q9_T-&L?^!C_XT?ZJX_\ N_?_ , /;P/L6BOCK_A,_%G_ $-&L?\
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M@?8M%?'7_"9^+/\ H:-8_P# Q_\ &C_A,_%G_0T:Q_X&/_C1_JKC_P"[]_\
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M/]5<?_=^_P#X >W@?8M%?'7_  F?BO\ Z&C6/_ Q_P#&C_A,_%?_ $-&L?\
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MCZLHI%Z4M> :A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC7[-I\L@17R#R<\=1C)X'Y5+\79_#TUEI*V1TW^V4R+E-,DWPHF.!D #KC'
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MTLRP]2G[24E%7MJTNB?=]P<&G8Y6BMW0/!OB#Q/YYT?39+A8#B1BRHJGTRQ
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MM;:=W;OV2?S:-I5$X\J(Z***^B,0HHHH **** "BBB@ HHHH **** "BBB@
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M_P#0.L_^_"_X4?V-I?\ T#K/_OPO^%7:* *7]C:7_P! ZS_[\+_A1_8VE_\
M0.L_^_"_X5=HH I?V-I?_0.L_P#OPO\ A1_8VE_] ZS_ ._"_P"%7:* *7]C
M:7_T#K/_ +\+_A1_8VE_] ZS_P"_"_X5=HH I?V-I?\ T#K/_OPO^%']C:7_
M - ZS_[\+_A5VB@"E_8VE_\ 0.L_^_"_X4?V-I?_ $#K/_OPO^%7:* *7]C:
M7_T#K/\ [\+_ (4?V-I?_0.L_P#OPO\ A5VB@"E_8VE_] ZS_P"_"_X4?V-I
M?_0.L_\ OPO^%7:* *7]C:7_ - ZS_[\+_A1_8VE_P#0.L_^_"_X5=HH I?V
M-I?_ $#K/_OPO^%']C:7_P! ZS_[\+_A5VB@"E_8VE_] ZS_ ._"_P"%']C:
M7_T#K/\ [\+_ (5=HH I?V-I?_0.L_\ OPO^%']C:7_T#K/_ +\+_A5VB@"E
M_8VE_P#0.L_^_"_X4?V-I?\ T#K/_OPO^%7:* *7]C:7_P! ZS_[\+_A1_8V
ME_\ 0.L_^_"_X5=HH I?V-I?_0.L_P#OPO\ A1_8VE_] ZS_ ._"_P"%7:*
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M@ HHHH **** "BBB@!110** $HHHH **** "BBB@ KF/%O\ Q\Z!_P!A6/\
M] :NGKF/%O\ Q\Z!_P!A6/\ ] :@#IZ*** "BBB@ HHHH **** "BBB@ HHH
MH .]<=I/_(U>*/\ KYA_]$)78]ZX[2?^1J\4?]?,/_HA*J.Y$]C;HHHK1&(4
M444P"BBB@ HHHH **** "N<\<_\ (L-_U]VO_I1'71USGCG_ )%AO^ONU_\
M2B.DP.C[?B:*.WXFBA %%%%, HHHH **** "N;M_^2D:A_V"X/\ T;+725S=
MO_R4C4/^P7!_Z-EI,#I****$ 4444P"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *YWP]_R'_$__7ZG_HF.NBKG?#W_ "'_
M !/_ -?J?^B8Z3 Z*BBBA %%%%, HHHH **** "BBB@ HHHH **** "BBB@
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M50HC4=\8))Z=,$YKM***8-A1110(**** "BBB@ HHHH **** "BBB@ HHHH
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M10 4444 %%%% !1110 4444 %%%% "BB@44 )1110 4444 %%%% !7,>+?\
MCYT#_L*Q_P#H#5T]<QXM_P"/G0/^PK'_ .@-0!T]%%% !1110 4444 %%%%
M!1110 4444 '>N.TG_D:O%'_ %\P_P#HA*['O7':3_R-7BC_ *^8?_1"54=R
M)[&W1116B,0HHHI@%%%5;W4['3C"+V\@MS/((HA+(%,CDX"J#U/- %JBBB@
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M,L*'JY52Q ^@!-,"Q15*\U:PT^:&*[N5A>9U2/>" S,<* >F2>U7: "BBB@
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M14R''<[D=_K2T@[_ %I:R-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA1LUBP7Y!A>)5Z#L*["N1\>,)K?2+6(-)/\ VM9RE$4DA!*,L<=A@\UUU =
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MTG_D:O%'_7S#_P"B$KL>]<=I/_(U>*/^OF'_ -$)51W(GL;=%%%:(Q"BBBF
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M* "BBB@ HHHH *YCQ;_Q\Z!_V%8__0&KIZYCQ;_Q\Z!_V%8__0&H Z>BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *1ON-]*6D;[C?2DP.?\ !/\ R+*?]=Y__1S5T-<]X)_Y
M%E/^N\__ *.:NAH0!1113 **** "BBB@ K)U_11K%O;M%*(+ZSF%S:3XR$D
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M3_\ 7ZG_ *)CKHJYWP]_R'_$_P#U^I_Z)CI,#HJ***$ 4444P"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "D;[C?2EI&^XWTI,#G_  3_ ,BRG_7>?_T<U=#7/>"?^193_KO/
M_P"CFKH:$ 5S'B?5=3TS6_#L=K/ MG?7PMIXS#ESE';(;. /E'&,^]=/7&>-
MW;^U_"VRWNI1!JBSRM#;22!$\MUR2H(')%#&MSLB,J0"02.H[5PGA[5-9UB^
M\1I<:W]F@TO4)+9&%O'RBC.6)'7\J[LL%4L<X SP,UY1X=L]';5O%DNO^'[B
M9;K4I);>2?1II2\1'53Y9/7-#&C?UO5-<TQ/".[44+WFII;77E1+MGC8,0>1
ME> .F.IKH;SQ3HUA>"VNKLQL9E@,AA<Q+(>B&0+L#<C@GO7'^(;NXU2+PC/#
MI&II#;ZTDFTVDK.D$89/,<!?DR2" ><$'UQD6^G207NI>'M9\*ZSJ<L]_+/;
M7$<\OV*57D+JTA#A4P3SP3QZTKCL>C:AXKT32KAX+V]\MHV1)6$3LD3/]T.X
M!5"<C[Q'6LZ/Q[I1\0:QILWFP1Z7$C2SR0N%+'<6[< !1@G[V>,US45Q?Z'J
M_B/0]1\*WVLPZIJ#7EG+' )+>0.%PLC,<(%*KR?3Z9=?)>V7BGQOYVFWTHU3
M3(5MY;:U>2-F6%U(R >=Q QUYHN*R.LL_'/AJ_MKFXMM6BDBMHXY)6VL,"3[
MF,CDD\8&3GCKQ5B/Q7HLD5[(;PQ?85#W*3PR1/$IZ$HZAL'L<5P\NEZB?AEX
M1FM-.NOM&D7%G<7=EY)2618L[U"D DY.X#OVJSJ\$NKZYJ_B"SM+T6:^'Y;#
MYK25))YG8E56,KN;'KC'/L<.["R.JT_QIX>U2^MK*RU-)9[J,RP+L<"10-QV
MDC!('49R.XJ#3-;LHY->O)_$27=I;W #*T01;/@?N]W\>2?UQ7&V$-TDOPQS
MINHI]@@D2[S92CR"81'\WR\98'K]>G-5+S3]8ND\63:?IMZTT6MV^HP0RV[Q
M"[CCVY"E@,\KG ]*5QV1ZAIFO:;K$]U!9SNT]J5$\,L+Q21[AE<JX!P1T.*Q
M-6UV^N_&EMX5TB9+9UMC>7UV4#M''G:JH#QN)/4@@#L:G\,ZL-<O;G4(_#EW
MI:O&J2SWT AFG89PN,DE5!/)]>.]9&J6%]X?^)0\5165Q>Z;>60L[M;:,R2P
M,&!5]@Y9> .,D<TQ6U-^&TURRU^VW:I+?:6\4GFB>&,.D@V[3N15&#\W:I+?
MQ;HEU>06T5Z2]RS);NT+K',PZA)"NQSP>A-07E[/XATN]L]+M[J%9[66/[5<
MPO;['9"%VJZAB<G.<8&.N>*XV&UO=9\(^%O#PTV]M=4TR[M3<&:V=$A6'AG$
MA&UL@<;22=WUP7"QUL_Q#\)VS2++K4 ,4QADPK$(PQU(' Y')X]^*TH/$6E7
M.M2Z1#=;[^*(3-$(VX0XPV<8(.1R#7FMK<12VOQ%TA;&ZN;R^U"XC@6*U=U=
MFC 4%P-JX.#\Q& <UHZ[X:U71;;PEJ&D2Q_VS9P1:1.Q/RRQN@3=[[&^;\SV
MI7861Z'8:C:ZI9K=V<AD@8D*Q1ES@X/! /4&L'1?'.F:Q+K)S);6^F2LCRW$
M;1@JJJ68D@!>21@\X&<5T%C9PZ?86]E;C$-O&L2 ^@&!7E&H:1K-SI?CG2;7
M3KS[7-JO]H0YB*Q7$0,;;0YX).T\#TIM@DF>E:?XCTO4[TV5M/(+H1"80SP2
M0NT9.-RAU!9<]QD5JUQ&'\2^./#NL6=I>6\&FP7)NFNK9X#F1558_F W$').
M,@8Z\BNWIH3"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %<WXQ_
MU6A?]ARR_P#1HKI*YOQC_JM"_P"PY9?^C14R*CN=R._UI:0=_K2UD;A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "BB@44 )1110 4444
M%%%% !7,>+?^/G0/^PK'_P"@-73US'BW_CYT#_L*Q_\ H#4 =/1110 4444
M%%%% !1110 4444 %%%% !WKCM)_Y&KQ1_U\P_\ HA*['O7':3_R-7BC_KYA
M_P#1"54=R)[&W1116B,0HHHI@%%%% !1110 4444 %<YXY_Y%AO^ONU_]*(Z
MZ.N<\<_\BPW_ %]VO_I1'28'1]OQ-%';\310@"BBBF 4444 %%%% !7-V_\
MR4C4/^P7!_Z-EKI*YNW_ .2D:A_V"X/_ $;+28'24444( HHHI@%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5SOA[_ )#_
M (G_ .OU/_1,==%7.^'O^0_XG_Z_4_\ 1,=)@=%1110@"BBBF 4444 %%%%
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N=\/?\
M(?\ $_\ U^I_Z)CKHJYWP]_R'_$__7ZG_HF.DP.BHHHH0!1113 **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP7!_Z-EI,#I****$ 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *YWP]_R'_$__7ZG_HF.NBKG?#W_ "'_ !/_ -?J
M?^B8Z3 Z*BBBA %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&^XWTI:1ON-]*3 Y_P3
M_P BRG_7>?\ ]'-70USW@G_D64_Z[S_^CFKH:$ 4444P"BBB@ HHHH ****
M*6JZI::+ID^H7LA2"$9.!DDDX"@=R20 /4UDW_BB338],MI].9]9U)F$&GQ2
M@D <DN_0!5QD\\\#/6LCXE^:?^$40 FW;Q!:";TQDXS[9_I577I/[*^,VA:I
M?-Y>G7.GR644S\(DVYFP3V)& /6DV4D=,-:U2WUG3[#4-'CCCO6=%N;>[\U$
M949\,"BG)"G';KS4-IXGN-:FNO[ T^*\M;64PM=3W/DQR2#[PCPC%@.F2 /3
M-;%Y<VRRPVC2@7-QN$( RP^4Y;V '?IR!W%<9\(<V/@UM$NAY6HZ9=2Q74+<
M,I+%@WT((P>AH%T-JU\7+>Z=>3PV$OVO39?+U"Q9P)80!DE<9#\<C!&X=\\5
MOV=W;W]G#=VDJS6\R"2.1#D,I&017#>#HFOOB)XQURW&[3+AX+:&;^&5XDVO
MM]0"",U-\(S(?A];*V=B7%PL>>RB5L >W6A,;1W-%%%,D**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF_&/^JT+_L.67_H
MT5TE<WXQ_P!5H7_8<LO_ $:*F14=SN1W^M+2#O\ 6EK(W"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** %%% HH 2BBB@ HHHH **** "N8\
M6_\ 'SH'_85C_P#0&KIZYCQ;_P ?.@?]A6/_ - :@#IZ*** "BBB@ HHHH *
M*** "BBB@ HHHH .]<GHD!E\4^*,-C_28?\ T0E=9WKF?#W_ "-'BC_KZA_]
M$)1>PFD]S:^Q-_?I/L3?WZN4M-29/)$I?8F_OT?8F_OU=HI\S#DB4OL3?WZ/
ML3?WZNT4<S#DB4OL3?WZ/L3?WZNT4<S#DB4OL3?WZ/L3?WZNT4<S#DB4OL3?
MWZYOQY:%/"S'?_R]VG_I1'78US'C_P#Y%1O^ORT_]*(Z3DPY(FU]B.,;_4T?
M8F_OU;7H?K2TU)AR1*?V)O[]'V)O[]7**.9AR1*?V)O[]'V)O[]7**.9AR1*
M?V)O[]'V)O[]7:*.9AR1*7V)O[]<W;6A/Q(U%=W(TNW_ /1DM=A7,6G_ "4S
M4O\ L%V__HR6DY,.2)M_8F_OT?8F_OU=HIJ3#DB4OL3?WZ/L3?WZNT4<S#DB
M4OL3?WZ/L3?WZNT4<S#DB4OL3?WZ/L3?WZNT4<S#DB4OL3?WZ/L3?WZN44<S
M#DB4_L3?WZ/L3?WZN44<S#DB4_L3?WZ/L3?WZNT4<S#DB4OL3?WZ/L3?WZNT
M4<S#DB4OL3?WZ/L3?WZNT4<S#DB4OL3?WZ/L3?WZNT4<S#DB4OL3?WZ/L3?W
MZNT4<S#DB4OL3?WZ/L3?WZNT4<S#DB4OL3?WZ/L3?WZN44<S#DB4_L1_OUSG
MAVU+>(/%"[^1?)_Z(CKKZYGPY_R,GBK_ *_X_P#T1'2<F')$VOL3?WZ/L3?W
MZN44U)AR1*?V)O[]'V)O[]7:*.9AR1*7V)O[]'V)O[]7:*.9AR1*7V)O[]'V
M)O[]7:*.9AR1*7V)O[]'V)O[]7:*.9AR1*7V)O[]'V)O[]7:*.9AR1*7V)O[
M]'V)O[]7:*.9AR1*7V)O[]'V)O[]7**.9AR1*?V)O[]'V)O[]7**.9AR1*?V
M)O[]'V)O[]7*6CF8<D2E]B;^_1]B;^_5VBCF8<D2E]B;^_1]B;^_5VBCF8<D
M2E]B;^_1]B;^_5VBCF8<D2E]B;^_1]B;^_5VBCF8<D2E]B;^_1]B;^_5VBCF
M8<D2E]B;^_1]B;^_5VDHYF')$I_8F_OT?8F_OU<HHYF')$I_8F_OT-9':?G[
M5<I&^Z?I0Y,.2)R7@:UW>%XSNZW$_P#Z.>NB^Q'^_6-X%_Y%6+_KXG_]'/73
M4E)AR1*7V)O[]'V)O[]7:*?,PY(E+[$W]^C[$W]^KM%',PY(E+[$W]^C[$W]
M^KM%',PY(E+[$W]^C[$W]^KM%',PY(F)K/ANWUS2YM/NV;RY,$,APR,""K*>
MQ! (^E)%H<EWI"V>MBUO6(VRYB!CEP>"5.<9&"1S@UN44<S#EB8NG>&=-TA6
M73;&ULP_WO(A5-WUP.:CU#PGI&JRK+J&FV=W(HP'G@5R!Z9(Z>U;M%',PY48
M&IZ+>MI(L=&FM[$MB/S=G^HCQR44<%O0' &<\XP;&E>'[;1=*MM-LAY=M;1B
M.->^!W/J3U)]36O11S,.6)3^Q-_?H^Q-_?JY2T<S#DB4OL3?WZ/L3?WZNT4<
MS#DB4OL3?WZ/L3?WZNT4<S#DB4OL3?WZ/L3?WZNT4<S#DB4OL3?WZ/L3?WZN
MT4<S#DB4OL3?WZ/L3?WZNT4<S#DB4OL3?WZ/L3?WZNTE',PY(E/[$W]^C[$W
M]^KE%',PY(E/[$W]^C[$W]^KE%',PY(E/[$W]^C[$W]^KM%',PY(E+[$W]^C
M[$W]^KM%',PY(E+[$W]^C[$W]^KM%',PY(E+[$W]^N;\8V;"'1#G.-:LS^4@
M-=C7->,O]3HO_88M?_0Z3=QJ*Z'2+WYI:!12*"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** %%% HH 2BBB@ HHHH **** "N8\6_\ 'SH'
M_85C_P#0&KIZYCQ;_P ?.@?]A6/_ - :@#IZ*** "BBB@ HHHH **** "BBB
M@ HHHH .]<UX=_Y&CQ1_U]0_^B$KI>]<UX=_Y&CQ1_U]0_\ HA* .EHHHH *
M*** "N6U_4/%XNYH_#>F:;)!;1AI)-0D=#,Y&=D04=ACYB<9..QKJ:X/QIX_
MT?2M1'AM]9@L+N:/-S<N2?LL9'8 ',A!^4=!]X]@0#I/"VO)XG\+Z?K4<#0"
M[BWF)CDH<D$9[\@\UL5B^%+W1K[PY:MX?_Y!40,%NP0JK*AVY&>2,@\]\5M4
M %%%% !7,>/_ /D5&_Z_+/\ ]*(ZZ>N8\?\ _(J-_P!?EG_Z41T =*GW3]:=
M34^Z?K3J "N0\+WU]?7/B>YN;Z:3[%JD]M!&0"B1JB$#:HR<%C[UU]<?X"_X
M^/%O_8P7'_HN*@#)\*>*=<U#Q+Y%^@6.Y<>8GDRE8ML"LH0$ Q;_ +^)<=2!
MD\U'?^+-=@\8M"BK]GC:6! ()2C)YL(\QH\;V*Y*[E^0[\Y&#7HD5I;P3SSQ
M01I-<$--(J@-(0, L>^  .>U!M+=KQ+PP1FY1#&LQ4;PA()4'K@D X]A0!S/
MB2[O=/\ %/AA;:]F2&^OF@G@X*,HA=AVR.5!ZUUE<=XQ_P"1H\%?]A23_P!)
MY:[&@ KF+3_DIFI?]@NW_P#1DM=/7,6G_)3-2_[!=O\ ^C): .GKG_$^M7FD
MW&B6]DL&_4M0%HSS(6" QN^0 1D_(._>N@KCO&__ "&/!O\ V&U_]$34 +XI
M\92>'+JTM'CB+L(IIIV(V&/S LH"[MRD Y#-\O8G-.U[QF^F>%+;58K/;+>Q
M-Y DEC=8Y"A*;MK?."<#Y"3S6YJ6@Z?JLL,MS"/-BEBD$B?*S>6VY58]2N<_
M+TY-)>^']+O]);39+.&.V\EX(Q$@0PJZE6\L@?*<$CB@"KI&M3^(-%DN[(PP
M.DIB\R0"9'V@;B C@@9R &(88Y%+X.UN;Q'X0TS6+B*.*:[A$CI'G:IR>F:T
MK:PM=/M7BM8$B#?,Y50"[8 W,>[$ 9)YXKFOA;_R3#P__P!>H_F: .OHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X4ZG)HJ>/\
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MYADF3.Z-9 67'!R.U3T %<W;_P#)2-0_[!<'_HV6NDKF[?\ Y*1J'_8+@_\
M1LM)@=)1110@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7&KJ+Z.GCG4XXUD>S<SJC' 8K;(V#^5=E7G^K?\@'XD
M?]<I?_21*4AHZ"?Q!-IOARWU6_B63S_+SY"X6(.,@MELD ]<9// J'0_%;:I
MX:EU)[*1IK6!6F2$KMDDV!G6/+=CD?-C\>M7[&PMM0\.:9'=0I($@B>,LH)C
M?9@,N>C#)P:=8>'-*T_2CIR6<4L#PI#,945FN%50H\PX^8X&.:$&AE^&?%X\
M0W=Q;K#R-\L<B8"K%D! X)SO.3T&..O2KFC:S=WGB#6M)NDASIWD%98@1O\
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M<UN44P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYSXG>_\ !FKZ]'X:DNOL[:&;N:-YGE$,WFA!("Q)#;=QZ\[<]JVI[6#3=?\
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MA6/_ - :NGKF/%O_ !\Z!_V%8_\ T!J .GHHHH **** "BBB@ HHHH ****
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MPHV#M SRQH ZFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M++YB$D95E; R"/4 BNAH *YKQE_J=%_[#%K_ .AUTM<UXR_U.B_]ABU_]#H
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MI2TC?=/TH YOP)_R*L/_ %\3_P#HYZZ6N:\"?\BK%_U\3_\ HYZZ6@ HHHH
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MQV9Z-17*^*II['6/#<MM<W$9NM42WF42ML>/RI#C;G'51SC/%=53$%<W;_\
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M:V<*PP*S,$!)Y9BQZ^I8G\:I^']%'A_2+?3(KN:XM[>-8XO-"@JH]P!FM6A
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M'%,+W.PHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+_T:*Z2N;\8_ZK0O^PY9?^C14R'#<[D=_K2T@[_6EK,W"BBB@ HHHH ****
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M_HB.@#IZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHH **** "BBB@ HHHH *1ONGZ4M(WW3]* .;\"?\BK#_ -?$_P#Z.>NEKFO
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M/8 FN8U;_DKWAO\ [!M[_.*I]0AC\0>/H+"5?,LM)LWGF7L9IP8T!]Q&)?\
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M2_Y$S0O^P?;_ /HM:V* "N:\9?ZG1?\ L,6O_H==+7->,O\ 4Z+_ -ABU_\
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M0 4444 %%%% !1110 4444 %%%% !7,>'/\ D9/%7_7_ !_^B(ZZ>N8\.?\
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M_*E^UQ_[7Y4<K#F1/14'VN/_ &ORI/M<?^U^5'*PYD6**@^UQ_[7Y4GVN/\
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M**Z2N;\8_P"JT+_L.67_ *-%3(J.YW([_6EI!W^M+61N%%%% !1110 4444
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M%% !1110 4444 %%%% !7!ZC_P @;XC?]<I?_21:[RN=\/?\A_Q/_P!?J?\
MHF.DQHN>&+F"Y\,Z:;>>.4):Q*QC<-M.P<''>M:C&.E%"$%<=X?N8+OXC^*)
M;::.:/[)8C?&P89_>\9%=C1@#H*8PHHHH$%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C?<;Z4M(WW
M&^E)@<_X)_Y%E/\ KO/_ .CFKH:Y[P3_ ,BRG_7>?_T<U=#0@"BBBF 4444
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MARR_]&BNDKF_&/\ JM"_[#EE_P"C12D..YW([_6EI!W^M+61N%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ***!10 E%%% !1110 4444
M%<QXM_X^= _["L?_ * U=/7,>+?^/G0/^PK'_P"@-0!T]%%% !1110 4444
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M** "BBB@ HHHH **** "N=\/?\A_Q/\ ]?J?^B8ZZ*N=\/?\A_Q/_P!?J?\
MHF.DP.BHHHH0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1ON-]*6D;[C?2DP.?\$_\
MBRG_ %WG_P#1S5T-<]X)_P"193_KO/\ ^CFKH:$ 4444P"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"34]%%V'*B#[)'_DT?9(_\FIZ*+L.5$'V2/_)H^R1_Y-3T478<J(/LD?\
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MV'*B#[)'_DT?9(_\FIZ*+L.5$'V2/_)H^R1_Y-3T478<J(/LD?\ DT?9(_\
M)J>BB[#E1!]DC_R:/LD?^34]%%V'*B#[)'_DT?9(_P#)J>BB[#E1!]DC_P F
MC[)'_DU/11=ARH@^R1_Y-'V2/_)J>BB[#E1!]DC_ ,FC[)'_ )-3T478<J(/
MLD?^31]DC_R:GHHNPY40?9(_\FC[)'_DU/11=ARH@^R1_P"31]DC_P FIZ*+
ML.5$'V2/_)H^R1_Y-3T478<J(/LD?^31]DC_ ,FIZ*+L.5$'V2/_ ":/LD?^
M34]%%V'*B#[)'_DT?9(_\FIZ*+L.5$'V2/\ R:/LD?\ DU/11=ARH@^R1_Y-
M'V2/_)J>BB[#E1!]DC_R:/LD?^34]%%V'*B#[)'_ )-<WXQM(_*T3CIK-H>O
MH^:ZNN:\8_ZG1?\ L,6O_H=%V%D=*****0PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!110** $HHHH **** "BBB@ KF/%O_ !\Z!_V%
M8_\ T!JZ>N8\6_\ 'SH'_85C_P#0&H Z>BBB@ HHHH **** "BBB@ HHHH *
M*** #O7->'?^1H\4?]?4/_HA*Z7O7->'?^1H\4?]?4/_ *(2@#I:*** "BBB
M@!LDB0Q/)(P1$!9F8X  ZDU0T77M-\0V<EWI=QY\$<S0,^QE^=>HPP!K1KS_
M ,&&<>&/%QML_:/[8U+RL==VXX_6@#HK?QCHEUJ*645TY:69[>*8PN(995^\
MBR$;688/ /8^AK>KPO[OP-\"FVSYPU:U,>/O>9YSYQ[YS7NE !1110 5S'C_
M /Y%1O\ K\L__2B.NGKF/'__ "*C?]?EG_Z41T =*GW3]:=34^Z?K3J "L63
M7V_X2T^'X+,R2I:)>23-(%549V3 &"2?E)K:KCH/^2R7O_8 @_\ 2B6@"U<>
M.M*M]=.F-YA""199!&VY)5>-50)C<V[?D,,C"GT.)M<\7V&AW]O93!FGD9"X
M.4"1,2#(&(PVW'*@YY%5[OP+IMWKRZE))-M(=Y$$C[VE9T97$F[<H4(0%'&&
M/OF?7_!]EK]Y!=3.RR(Z"3<2ZO$-Q*!2<(6W<L.>!Z4 +KGBJ/1_#'_"0QV<
MES8")9FY,4@5B /E8 YYZ'%=#7$?$BTBL/A+JMI"9#%#;1QH9'+M@.H&6)))
M]S7;T %<Q:?\E,U+_L%V_P#Z,EKIZYBT_P"2F:E_V"[?_P!&2T =/1110!DV
M'B*PU&:^2#S?+L9I(+B9TVQHZ?>&X^F>O2BP\2Z5J-]+:6]W&9$=4C)8;9\Q
MK+F(Y^<;6!)%8/@6,RV_BR,.4+Z]>*& !*YV\X/'YT>&_ G]@ZY+>K=?N8W(
M@50I,J-$H;S!MPI\P,PV8'//H #<?Q3HZ:G]A:^A#!'9I=Z^4C*ZQE&;. ^Y
MU&WKS4EUKUG9:Q9:9<+.DUZYCMV\LE'8(7(SVX!Z^E<W<> #-XK_ +4%Z5C9
MVN6D"IY@E\Q"JA=FPH$##)!;)SGTL>+?^1R\$?\ 80G_ /2:2@#L**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N2TBT@O]8\8V=U
M$LMO/=I%+&W1U:WC!!^H-=;7,>'/^1D\5?\ 7_'_ .B(Z -ZQL+?3K86]JKK
M$OW5:1GP,8P-Q.!QTJS110 C*&4J<X(P<'%4K#1[#3);F6T@V2W+!IY"[.TA
M P"2Q).!Q5ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ I&^Z?I2TC?=/TH YOP)_R*L/\
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M4F6WDFC;[1;PIM,;1'S5&U@#P%.23G.10![313(2Q@C+,6;:,DKMR<>G:GT
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MLUO:3O%8W<LMQ-LPB*T#J#D]>6 XKK:* "BBB@ HHHH **** "BBB@ HHHH
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M* "BBB@ KF/%O_'SH'_85C_] :NGKF/%O_'SH'_85C_] :@#IZ*** "BBB@
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M%V/\^7UH\^7UIE%'*@NQ_GR^M<YXPN)A'HG(P=:LP?\ OX*Z"N;\8_ZK0O\
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M!)+A8]*HJ&TD>6S@DD:-G>-69HSE22.H]O2IJ9(4444 %%%% !1110 4444
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M]*,'TH **,'THP?2@ HHP?2C!]* "N&N8);K3OB%;V\;2S2K(D<:#)9C:H
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M10 E%%% !1110 4444 %<QXM_P"/G0/^PK'_ .@-73US'BW_ (^= _["L?\
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M,KSK1]*^(EI?O/=KX<::[G0W=Z)IGE$0;[D:E0 %4D*.F22<DDGT6@ HHHH
M*YCQ_P#\BHW_ %^6?_I1'73US'C_ /Y%1O\ K\L__2B.@#I4^Z?K3J:GW3]:
M=0 5Q.@^*M1E^' \5:@UK+(T+2^26%O&,.5QO8G&0!U[_6NVKC?A:BO\,=%5
MU#*8WX(R/]8U !X.\77&N7=S97<:++&)9P781R!/.947R^2<* "^<;ACGK6?
MH'Q N=5\0Q6LUO;I!>[5@ N$*(5#[RD@_P!=DJN H'&<XQ7:Z?I5EI4;QV<
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MC7._\(9X9_Z .G?^ ZT?\(9X9_Z .G?^ ZT<H>T1T7]O:/\ ]!:Q_P# A/\
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ML?\ P(3_ !KG- UK2H_$WB9WU*S57N82K&=0&_<(..>:7_A#/#6,#0M._P#
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M?^@#IW_@.M<U;^%=!_X63>69T6P^SKI4,@C\D;0YD<$X]Z.4/:(]'_M[1_\
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MPS_T =._\!UH_P"$,\,_] '3O_ =:.4/:(Z+^WM'_P"@M8_^!"?XT?V]H_\
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MT1T7]O:/_P!!:Q_\"$_QH_M[1_\ H+6/_@0G^-<[_P (9X9_Z .G?^ ZT?\
M"&>&?^@#IW_@.M'*'M$=%_;VC_\ 06L?_ A/\:/[>T?_ *"UC_X$)_C7._\
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M2>8N3\N<D;1@8QQQ1=^#+OQ1)XIOK^ V#ZK:1V=G!*RLT83Y@\FPD<O@X!.
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "BB@44 )1110
M4444 %%%% !7'_$#_4:%_P!A:'_V:NPKC_B!_J-"_P"PM#_[-0MQ/8VAT%%
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M<MK"Z&"95W8;<[;U(R,C'2LCP):W.IZAXJ;5?L-W$FN2!D-L2?,C6/:REF(
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MGCN#C\\Q7&A6<&N3W^A>.X])@O @O+='AE$A50NY2Q^1B!UP:]%_X1/P]_T
M]._\!4_PH_X1/P]_T ]._P# 5/\ "BXN3S//M<T?3]<M[O3I_%FF-I%PT16"
M4))+;A%1?W<ADX)VDDE3]X^IST&NR^'/$.A7>D7FJV7V>YCV,5NH\KW!'/4$
M _A70_\ ")^'O^@'IW_@*G^%'_")^'O^@'IW_@*G^%','L_,XFRM[,WNF76L
M>*M+OWTM&6T*;(OF9=I>3]XVYL<<;1R3CIB3PO%8^'KG5Y)_%&EW:ZE>/>LJ
M;(O+=L9 /F-D8 _QKLO^$3\/?] /3O\ P%3_  H_X1/P]_T ]._\!4_PHY@]
MGYG+SSV5QXJM=6?Q)I9M+6%XXK3*9#/C+[_,Z_+@?+T)'?-9NI6-G=^.K+Q/
M:>*]*M7MH/L[0%4?SHR22&;S1ZY''!]:[K_A$_#W_0#T[_P%3_"C_A$_#W_0
M#T[_ ,!4_P *.8/9^9QWC+3_  WXRTJ"QN]:L8O)N4G21;A"1@_,/O=U)'Y'
MM70)KNB1HJ)JFGJJC  N8\ ?G6C_ ,(GX>_Z >G?^ J?X4?\(GX>_P"@'IW_
M ("I_A3Y@]GYG,Z%-I.BV-TC:]I\]W=74MU+,9D4,[MD<;N@7:O7HM01QZ-/
MKL.LZMX@L+RZM@RVD:3)'#;[A@LJ[B2Q'!8GZ 5UO_")^'O^@'IW_@*G^%'_
M  B?A[_H!Z=_X"I_A2Y@]GYG :EH^E75QK$=IXIL+73M:*M?P;T9R0-K&-]X
M"[E&#D-ZBM74FTR_T]=)A\1V%EI?E"%X[>5!*8P,; Y?"@CC[N<="*ZK_A$_
M#W_0#T[_ ,!4_P */^$3\/?] /3O_ 5/\*.8/9^9D6.I>'=,L(+&SU#3H;:!
M!''&MRF%4=!UJQ_;^C?]!:P_\"4_QJ__ ,(GX>_Z >G?^ J?X4?\(GX>_P"@
M'IW_ ("I_A3YA>R\RA_;^C?]!:P_\"4_QH_M_1O^@M8?^!*?XU?_ .$3\/?]
M /3O_ 5/\*/^$3\/?] /3O\ P%3_  HY@]EYE#^W]&_Z"UA_X$I_C1_;^C?]
M!:P_\"4_QJ__ ,(GX>_Z >G?^ J?X4?\(GX>_P"@'IW_ ("I_A1S![+S*']O
MZ-_T%K#_ ,"4_P :/[?T;_H+6'_@2G^-7_\ A$_#W_0#T[_P%3_"C_A$_#W_
M $ ]._\  5/\*.8/9>90_M_1O^@M8?\ @2G^-']OZ-_T%K#_ ,"4_P :O_\
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M6'_@2G^-']OZ-_T%K#_P)3_&K_\ PB?A[_H!Z=_X"I_A1_PB?A[_ * >G?\
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M  B?A[_H!Z=_X"I_A1_PB?A[_H!Z=_X"I_A1S![)=RA_;^C?]!:P_P# E/\
M&D;Q!HP4_P#$VL>1U^T(<?K6A_PB?A[_ * >G?\ @*G^%)_PB?AX'(T33O\
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M6'_@2G^-']OZ-_T%K#_P)3_&K_\ PB?A[_H!Z=_X"I_A1_PB?A[_ * >G?\
M@*G^%','LO,H?V_HW_06L/\ P)3_ !H_M_1O^@M8?^!*?XU?_P"$3\/?] /3
MO_ 5/\*/^$3\/?\ 0#T[_P !4_PHY@]DNY0_M_1O^@M8?^!*?XT?V_HW_06L
M/_ I/\:O_P#")^'O^@'IW_@*G^%'_")^'O\ H!Z=_P" J?X4<P>R\RA_;^C?
M]!:P_P# I/\ &C^W]&_Z"UA_X$I_C5__ (1/P]_T ]._\!4_PH_X1/P]_P!
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M%% HH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!110** $HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH 444"B@!**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M%%% HH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!110** $HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH 444"B@!**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M %%% HH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!110** $HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH 444"B@!**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* %%% HH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!110** $HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH 444"B@!**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** %%% HH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!110** $HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH 444"B@!**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** %%% HH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!110** $HI<48H 2
MBEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&*
M$HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B
M@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<4
M8H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7
M%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2B
MEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $
MHI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@
M!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48
MH 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%
M&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BE
GQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>modificationno9effective001.jpg
<TEXT>
begin 644 modificationno9effective001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M/[.ALP5MR</%()%<@M@KD#*]QGFMJR\1V4]G;RS3P[YWD""#>XPDGEDGY00
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MT ]ZJZ;X0O\ 2S;S17MN]PMI-:2AXSL*O*9%8#.<J201_$.XJG_PI?P!_P!
M)_\ P.N/_CE'_"E_ '_0"?\ \#KC_P".4 3/X 9;"?3;:_5+232[2Q5I(M[J
MUNS%&/(!4[AE?;'?C;CT#S_#5]I5XEG ;Z*2*8Z?!Y2@,FPD DY..Y]AVKGO
M^%+^ /\ H!/_ .!UQ_\ '*/^%+^ /^@$_P#X'7'_ ,<H M:AX.OM2L9UGO;<
M7C:7_9B2)&0FTL"TA&>IVC"]N>3GB?4/#%_>S:K(MS;)]MN+.=058[/(96(/
MKG9^&>]9W_"E_ '_ $ G_P# ZX_^.4?\*7\ ?] )_P#P.N/_ (Y0!;O?!UW>
MIJ*O<6X-U?/>0R+O22W8Q+&KHZD$,NW/H0Q!]:+OP;=SR:G)'?I&]]9RVTK*
M& N"Z!5>1,[=R 'YA@D$ XQ53_A2_@#_ * 3_P#@=<?_ !RC_A2_@#_H!/\
M^!UQ_P#'* +LO@R>>#4K1[N/[-JHMVN@%.Y&C5$;8?1EC7&?NG)YZ5*?"]\;
MAY/M-OAM974\;6^Z$";/KQG/Z5F_\*7\ ?\ 0"?_ ,#KC_XY1_PI?P!_T G_
M / ZX_\ CE &MH_AW4-&N)Y+:[MTCN)(FEMPCF+AF,CHN[]VSAAP/E!7.#FN
MGK@O^%+^ /\ H!/_ .!UQ_\ '*/^%+^ /^@$_P#X'7'_ ,<H [VBN"_X4OX
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M_P#@=<?_ !RC_A2_@#_H!/\ ^!UQ_P#'* .]HK@O^%+^ /\ H!/_ .!UQ_\
M'*/^%+^ /^@$_P#X'7'_ ,<H [VBN"_X4OX _P"@$_\ X'7'_P <H_X4OX _
MZ 3_ /@=<?\ QR@#O:*X+_A2_@#_ * 3_P#@=<?_ !RC_A2_@#_H!/\ ^!UQ
M_P#'* .]HK@O^%+^ /\ H!/_ .!UQ_\ '*/^%+^ /^@$_P#X'7'_ ,<H [VB
MN"_X4OX _P"@$_\ X'7'_P <H_X4OX _Z 3_ /@=<?\ QR@#O:*X+_A2_@#_
M * 3_P#@=<?_ !RC_A2_@#_H!/\ ^!UQ_P#'* .]HK@O^%+^ /\ H!/_ .!U
MQ_\ '*/^%+^ /^@$_P#X'7'_ ,<H [VBN"_X4OX _P"@$_\ X'7'_P <H_X4
MOX _Z 3_ /@=<?\ QR@#O:*X+_A2_@#_ * 3_P#@=<?_ !RC_A2_@#_H!/\
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MM+4H(#<I"\TD5C(948#) 1B!NR .W4UQW@_XA:QXEO;&0Z;I<NG7BLS&QO\
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M4?\ "=>&/^@Q;_DW^% '0T5SW_"=>&/^@Q;_ )-_A1_PG7AC_H,6_P"3?X4
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MR;_"@#H:*Y[_ (3KPQ_T&+?\F_PH_P"$Z\,?]!BW_)O\* .AHKGO^$Z\,?\
M08M_R;_"C_A.O#'_ $&+?\F_PH Z&BJFG:I9:O:_:;"X2>'<5WKG&1V_6K=
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M^6TB1ID.H!!"J!QC/XT 8%UXQNX-5AL#?:'"7L8;I9II'"3&1Y !'Z@! ?\
M@526/BZYO->FL&N]&A,5ZUMY#N_G.%.,@=,GM731Z;%'K=QJ@=S+/;Q6[*<;
M0J-(P(]\R'\A6=:^';FROIYK76[N.WGNFN7MO*B*DL<L,E-V#]: (=.UG6M5
M6'4;6QM&TN:<QJAE(F\L,5\W)^7MNV=<=\\51?Q#X@M6UUKF'3&CTBV,S^69
M,R'RBZ@9Z<@ UHP^%A;S)'%JMZFG1W'VE;%=@4-NW[=P7=LW<[<^W3BK5SX?
MM[E=:5I91_:T/DS8Q\@V%,KQUP>^: ,YO%,\=AJ6ZUC_ +0@FBAMH=QVS><%
M\IO7&6(/IL;TJKI_BZXO]=FL3>:/#Y5]);?9W=_/94<KD#ID@9%;,OANSEUJ
MPU1I)?-LX_+" C;)@,$+#')4/)C_ 'S[5%9^';FPO)9+;6[M+:6Z>Y>V,414
MEVW,NXINP23WS0 W4-3U<^(CI>EPV)V6:W+-=,XR2[+M&W./N]<&LZ\\<&'1
M],OX;'<TX>:\B9\FV@B(6=\@?-M8@#IFM;4- EN]7_M*UU>[L)C;BW?R$B;<
MH8L/OJV#EC5:+P+H 9/M5C%?1QVR6T,=Y&LHC52Q+#(SN8MECWP/2@!)-4UT
M>*XM+C73#;2PO<K(=^[RU=5QZ;L/].*I>%O%UQX@GM]]WHX\U69K6%W,Z8SQ
MSQZ9K:TSP[#ILUA*MS/,]E9&Q0RD$LF5(+<<GY ,U#HOAVYT5+>"/6[N:R@!
M5;:2*+!'. 6"!N,^O:@#>HHHH **** "BBB@ HHHH **** .>_YJ+_W"?_:M
M.?Q$[^+[?1[>!7MRDHGN">DJA6V+ZX# D]L@=<X;_P U%_[A/_M6I3X1T3^W
M(-8CL(8KV)I'WQQJ-[OU9N,D]3GW- "^*M9ET+11>0M C-<P0%[A24022*A8
M@$$X#9Z]JYM_'-\NGW<T<NG3Q175O;IJ,<,GV=C(Q5QMSDLF!G#'[P[@BNON
MM(COM/M;6ZN)Y3;S03><=H>1XG5P6P .2HS@#J<8K/O_  E:WEQ=3Q7EW9O<
M3PW+?9RF!-$>) &5AN("@]B%'&>: *,'B/4;H6EI:7.G75Y>2R!)U@DCBACC
M4%BREMS'+*  1][KQ3XO$U_%JUOI-Y!;F[_M!;662+<$>-K>2574$Y4YCVD$
MG&#R<BKTGAN2>.)I];U&6\MY#);W96%9(LC:5 6,*5(ZAE/Z#%*U\#P6UM+&
M=7U*6Y:Y2ZCO971YXY%38/F*X(VY&"#P3ZT /?Q-<KXE.F"WB:/^TOL8;)W%
M?L1N,]<9W#'TK)M?&VHM87]Q<#3Q<V^G37C6)22&>V=%R$97.9%SD%U ' ]1
M6]!X2M(Y(II[JZNKE;M[N2:5E#3.T)@^8*H  0X 4#H/?-<^"H)H&@O=5U&\
MA6UEM8%F:/,*2+L8A@@+-MXRQ;\3S0 UM3\0-XEL]/CETP6]U:R78+02%U5&
MC4KG?@D^9UQVZ5#8>)-5UN9+/3X[."X59I9YIT9T5%GDB0!0P)+>6Q)R,8Z'
M-= -)@&J6NH;Y/-MK5[5!D;2KLA)/'7]VOYFLU?"4%L(7L-0O;*YC\T>?$8V
M9UDD,A5@RE2 S''&1Z\G(!D#QY<0:I8VU[8QQP9N(M0E1R1;O'(D:N/6,EUS
MGD!@3T-+J/C2\M=!>]AAMA-&UZS^;G8L<$YA!/(Y)*$_\"K;M?">FVK(2)9Q
M]GG@E$Y#>>)G5Y&?CDDK[#!(QTQ3L_ NF6>CS:6EQ>/!)%Y.Z20,ZCS7E)!(
MZEGY)SD*._- &=!XTNS-)$DNF:E$L]G']LL=WE#SIQ$R'YC\P!W##'KR!WL^
M(_%MUI&J7%G%]DB2/['B>X5F5?.>96) (SCRACZFNCU;3(=8TY[.=Y(P621)
M(B \;HP=&4D$9#*#R"..:S(O"<'VC[5=W]Y>7AGAF:XE\M2?*W;$PJA0HWL>
M!G+'F@#)L_&-]=P^5;I9WDL]ZEG9WL2NEO*3&SN<').P(^<$Y.!D'.+M]K^I
MZ"+/^V4M#'-?K;_:;=7PT9B=\B/+%6#)C&2,<_2W<>$[*:6[DCGN;=[BX2[4
MPLH\B=1CS$!! +#A@<@^G)RL/A>%;B&ZN;^]N[N.Z6Z\Z9D!8K&T:KM50H4!
MVX '/))H RY?&K3VVJMIR0RRQ7L-E8B4,@D>1$;+YP<+N8G'931?>,)SI>D7
M]H(;6UO86DFNKF"2:.W==H\I@A&"27&XD ;#U)%:<_A'2[O6)-0NT:YWR^<;
M:8*\/F>6L0;:1U"J<<_Q-[8B3P?;V;E]*U&^TT^9(Z+;>7L19-I9 C(5V[EW
M#C(+'!P<4 9%SXSO!>6< NM)M%FT^.[:1EDN4=F9EPC(PRORY!]ZU_$.O7&C
MZ-IURD]FLES/%"\\T;&)=RDE@H8''' SWIL7@V.SEAET[5]1L7CM_L[-$(7\
MP;V<LV^-N2SL>,#GI6K<:3'>1:>MS<32O93).LAVAI'52,M@ <Y). /PH XY
M_'5]]E@=)=.,,NH_9$U(0RF"1?(>0E4SDD,FPX)'/L0-:'7]2O'L+"RGT^>\
MNTFG-UY$BPQQ1LBGY"VYF+.HQN ZGM@V;KP?;2WANK74+VQD^V?;E%OY95)C
M&\;,%=&'S*YS[\\'.9)_#3W$<#RZUJ)OH"XBO@(5E".!N3 C"%3M!Y7.0#G@
M4 6-"U2XO_MUM>Q11WMA<?9YO*)*/E%D5ESR 5=>#T.1D]:S+KQ;)9>*[O2;
MBV1;58$-O<Y.#,5=O+;TR%.#_LD=2*NZ%X;_ +"B:./5+VYWW!GEDN"KR3$H
M$Q(VW)Q@$$8/R@<CJ_4/#&GZHNJ+=>:PU&...3#8*&/.QD.,A@3G/J!0!DZ9
MX@USQ!;M+I<6GQ"WAA,PN0Y\V9X4E*+@C8H61?F.[DGCCGH=%U./6M$LM3BC
M:-+J%90C=4R,D'Z=*RD\(16L:II^JZC8*8(X)O(:/]\$4(K'<AVOM &Y<< >
M@QKV&G1:;%';VK.EI%!'!#;<;(PF1D'&[)! .2?NCISD N4444 %%%% !111
M0 5Q?CG5CH>IZ'J"Q"5XVG5$9B S,H49(!(&6'0&NTKE/%%K)>>(_#L,-W+:
MREYV2:+&5(0'H>"#C!'<$B@#7T'5'U?3?M,AMMXD9&6W=V"D=CO56#>H(KG=
M;\<3Z3J&KQK%IC1:;L_<S7ACN+C,:OB--IR3NP!W/%=#I>CR:;)+*;YYI;F9
MKBZ8QJ!*Y55& /NA510 /3G-/M=%MK;5;_4<"2:\D20EE&4VHJ8!Z_PY_&@#
MEYO'TD6H7<"KI<CV][]E%D+PB\D&X+N6/:<GG./;J.M7I_%.H)I][K<6GV[Z
M+922K(QG(G=(F*R2*NW& 58A2<D#J,XJ[/X5MYK2>-;B6.=[YK^&X4#?!*2#
M\OJ.H(/4$@]:AG\(^=%=6*ZG<1Z1=RO+/9*B\[V+2('QD(Q))'7YC@@4 .\4
M>)W\/1,\=LDX&GW=Z-S[>850A>G0[NO;%4H/&;-8W%P)M%U!U>&&*'3;XRDR
MRN$0.=ORJ2>O/ /'%3W_ (,_M-KY;O5KJ6*>VNK:!&52;=;@@O@]6Q@!0> .
M.:M3>'[R^LIK74M9EN$;8\31P)&T,B,'1U(SR&4'D8H ;-?^);>UNC)ING%X
M4$JRBY;RW7#;E^[N## [8(/4'BHX_$&H1>!+KQ%>6EJ)([!KZ*"&5F#*(MX5
MB5&#VX!J[:Z+<J;N2_U6>\EN(?('RB..->>0@XW'/).>@Z"G3:##-X1D\/&9
MQ"]@;$R@#<%,>S=Z9QS0!CR>.X(K6&XDM'7%G=37,.[]Y#- T2F+'0DF3@].
MAZ&K]OK&JVVJV-GK%E:0K?[U@>UG:39(JERC949^56(8?W3P.*CO_!6F:AK=
MQJ4QE'VFQDL[B%6PL@;9\_LX"*,CL!Z"I(O#UT;N&ZO=9GNYK6-UM&:%%$3,
MNTR, /F?&1V')XYH T=6U$:78F81^;,[K#!$#CS)'(55SV&3R>P!/:L$>+;F
M76(=,M[)7DDOI+?S<.4\J)%\Q^ <'S&V $^Y-:VJZ?/=/I,D9$C6=XDTF<#<
M-CH3^&_=^%1:7X;@TR\BNEGDEDC2X4;@.3/,)9&^I8#\!0!8FU^PM]32PE,Z
MRM((@_D/Y>\KN"[\;<D>_P#.J4/C70YK-[M9YU@$*3JSVTB^9&[!59 5RV6(
M'&>H]165K'@=IKB[U2TN!)J"M-<6PDB0-YKPO&JM)C=L4L"!QC'?C!<^"KD0
MZ?##J,LC0R6\0F9$'D00$R( N,,3(L>[UQVQ0!=OO&EK"L?V5"6)G69;A'C:
M$QJ#\R[2W+/$.G1P1FKP\4Z69)DWSMY(<F1+:1D<HP5PC!<.0Q P,G/3.#5#
M_A";>2Y6YGO9Y9S()9G*@>8WFQRGCL#Y,:X_NJ.O6AO!I;36T\ZM.;16!@@:
M-3& )/,Q(O\ RT!QM.<<>Y)(!)<^,K.-[)8+>ZF::Z>WFB%O)YL.R(R$[-N3
M_![8<'-*GC*PDOFCCWS6[PP26SP1M(\S2*SD! ,X"!&S_M]N]6U\"C3S$]AJ
MLUK*AN,M'!& ?.92V% P"-BA2!QCOS4<WPYTTK'Y$@4Q$B,30).J(8HHMH5P
M1D+"A#>N>N2* -RTUR&]U.VM[?$EO=67VR"89&X!@""#T^^GZUK5B:3HGV+4
MGN-BQPP6R65G$,?+$O+,<< L<<>B#U(&W0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%9/B6XFL]#FN8;PVC1%290$("[@#G<"
M,8/Z5FPZV\$>H2V^HKJ]I;6;W!G 3"2+R$W( K9&3@#*XY^\* .HHK M8[O3
M=2TY)K^>Z%Y&ZSB4@CS0H8,H_A'##:..1Z<U9)[PVMQK0O)@T5\T2VX;]UY2
M3>4RE>Y(#-NZ@D=AB@#J:*P;F*[U35+^*&_GM1:1HL'E' \U@6+L/XARHVGC
MKZ\,^VS:S#HD:2R6J7]N;N8Q-AMH53L#=1RXY'.%]Z .AHKG1=W\6@:I&DLD
MMS92O"LP0,^SA@VW'S,J-TQR5Z<TW1-3@?7)M/L[Z6_M#;"9)G?S KAL.H?^
M+[R'';\<  Z2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#GM0_P"1^T'_ *\;W_T*WKH:Y[4/^1^T'_KQO?\
MT*WJ"]U34?MEW%'J-G8W*2>7:6MW%A9Q@8.\D;B2>-O3H02#0!U%%9MUJYAN
MWM;:PNKV6-0TH@\L"//0$NRC)P>!GWQD9:^NVYM;:6WAN+F6Y+".WC4"3*_?
MSN("[3P<D8/'4@4 :E%4[#45OC+&T$UM<0D"2"8+N7/(.5)!!]03T(Z@BK4@
M9HV",%<@A6(S@^N* '45Q>E^)YY6TQ9-6L;NYNY!'):)#M=>NX@[CC;C/(YQ
MCJ16]=/<P>(+ +>2FWN/,5[<JFP;5R"#MW9S[XH UJ*S[S5/LUT+6"SN;RYV
M>8T<&P;$)(!8NR@9(( SDX/H:C.NVYLHIXX;B2664P);*H$OF#.Y#D@ C:QR
M3C SDY&0#4HK,@U"34?M=J;:]TZXBC5BTBQDC=NP5(+*?NG],BJ?AW7VU6UM
M(_(GG?[+$]Q>*$$(D9<E>N=V>H XR,XH WZ**R-0DO8-;THI>$6L]PT+VXC7
M##R97R6.3U1>F/QH UZ*Q/$&K&QDL[-+@V\EVS?O5B,KA%QGRT .YR64 8.!
MDD'&*8-0D&GV,6GWKW,UY<-"MQ=QC,6T,S;D 7D;"NT@')YZ4 ;U%9ME%JT-
M](EW<PW-GY8,<@BV2!\\AL'!&,8( K2H **** "BBB@ HHHH Y[_ )J+_P!P
MG_VK70USW_-1?^X3_P"U:Z&@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KGM8_Y&_P -?[US
M_P"BJZ&N>UC_ )&_PU_O7/\ Z*H Z&BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*\@C!5AD<,P!SC&1ZUL:9X1\.7JR&Z\#Z59E2-H:""3=_P!\YQ^- %W4"/\
MA/="Y'_'C>_^A6].NM(U2ZM+S3YM4MY+*Z:7<SVY,L<;L3L4[L' . 2.,#@U
MA7W@OPNGC;1;=?#NE"&2SO&>,6<>UBK08)&.2-QQ]36K'X2\"RW3VL>A: ]P
MGWHEMHBZ_48S0!-J?AF"[U234(X-,FDF15D6^M!-RO 93D$<<$<@X'3G*77A
M>WN;"QC,>FF>S+E%:R4VY#G++Y6>!T.0<@COD@PW?A/P)8*C7FA^'[=7.U3-
M;0H&/H,CFB?PGX$MH5FN-#\/Q1.<*\EM"JD^Q(H U-%TM=+6;]UIT)E(.RRM
M1"HQZ\G<>>O'TK2D+&-A&ZJ^#M+#(![9&1G\ZY<^%O 0M1='1?#PMB=HF^SP
M[,^F<8J2V\'^![V,R6N@:#.@."T5K$P!^H% #[?0=1&FVVFW6IV<EI"T;'RK
M1DD;8P888R$#D#G'TP>:M7^GZK<ZG;W5OJ%C%';EC&DEHSGYEP<D2#/Y"J4_
M@[P7;/ DOAK1P\\GE1@6,9+-@M_=]%)_"F7'A7P%:3I!<Z+X>AFD&4CDMX59
MA[ CF@#5N;&\%_\ ;K&ZMTG>%89EFB+(X4L5(PP*D%V]<Y]LU!_8DL=M"\5Z
MG]H1W#7)G>+*.[ JP* Y"[3@<Y&U>3SFJ/!W@DSO /#^A&5%W/&+6+<H]2,<
M"HT\+> I+1[I-%\/-;1_?F%O"47ZG&!U% &S#%J?DW!N+VU,SKB)4@(CCZ\G
MYLMG/J.@X')-#1_#\F@FTAL+N".QCMTCGM_(XD=0!YB8;"$XY&#GZ\U!;>#_
M  1>Q"6UT#09XST>*UB8?F!4_P#P@GA'_H6-'_\  */_  H W]P]161JEAJ5
MY?6<]K?V<,=K*9526V:0EC&Z')$B\8<GIVJO_P ()X1_Z%C1_P#P"C_PH_X0
M3PC_ -"QH_\ X!1_X4 7M0L);IK.YAFA2]M6+([Q[D8,NUE(SD ]>#P0.O(-
M8:+(+16^V(-16Y:[%P(_D$A!4C9GE=IVXSGOG/-1?\()X1_Z%C1__ */_"C_
M (03PC_T+&C_ /@%'_A0!I64>H+*\M]>0."H5(H(MBK[DDDD_D/8]:N[AZBL
M#_A!/"/_ $+&C_\ @%'_ (4?\()X1_Z%C1__  "C_P * -_</44;AZBL#_A!
M/"/_ $+&C_\ @%'_ (4?\()X1_Z%C1__  "C_P * -_</44;AZBL#_A!/"/_
M $+&C_\ @%'_ (4?\()X1_Z%C1__  "C_P * -_</44;AZBL#_A!/"/_ $+&
MC_\ @%'_ (4?\()X1_Z%C1__  "C_P * &Y'_"Q>H_Y!/_M6NAW#U%<'_P (
M7X7_ .$\^S?\([I7D?V9YGE_8X]N[S<9QCKCO5[5_"GA;3+)KF/P7I5TJ9:3
M;;V\?EJ 26)? QQ0!UVX>HHW#U%<GI/A/PEJNDVM^W@W3;7[1&)!#-8Q;U!Z
M9P#@XP?QJH-&\#'Q2V@_\(II?G"'S/.^PQ>7OX)CSC._:0V/0T =ON'J*-P]
M17G-C9^$;K[)-/X"L;:QNYS;PW36MNR[]Q50P'S+N(P#CJ1G&:KPS^ )O"5I
MKX\'6 2YN%MUMC8P^8&)[\8QM^?_ ': /3MP]11N'J*\Y:+P#%K5KILWA+38
MVN;BXMEF-C%L5XFC7YCC@,TB@>Y [TMQ#X#M89)I?"&G".-+YV*V,1.+60(_
M;N3D?KB@#T7</44;AZBN!MM"\/W,$K)\.M/,JJCH%AMVCE1L\K(/ER,<CW'7
M-4+:#PQ=:?I5U'\.K#_B:@-:HT-L"R>69-Q/0<#I0!Z;N'J*-P]17G\VC>'(
MKJRLQ\/=->\NH9I_)$5O\B1LBG+=#GS%Z>]58(/"-]);Q6'@"PGEDCE=T:"V
M3RS'*8F!)X/S \@D$<T >E;AZBC</45YY-I?AN.]FM8OAS97$EM;17%PL-O;
M93?NPH!(W$;#TJS?:1X*M]'T_4K/PCI5['J#Q+;+':0IN\P;E.6  &* .ZW#
MU%&X>HKSVWLO!,GD_:?!FG6JM>-8S/):0,L,V 5!9<@AL@ CO@'!XK0L/#W@
MB^TA]5/A;2(+$;W266RB >)?^6G3A2!D9[8/>@#LMP]11N'J*\VO4\#6$3F;
MP;IJ2^7;,D;V<*EFG=EC0Y'!PA9O05M77AWP#I[01W^A^'[6:8 K');1 ]AZ
M=,D#/3)% '7[AZBC</45YY-'\.(;LP-X?T8!;YK)Y&LX@JNL1D)Z<CC9Z[N/
M>M,:#\.S<6]N-)\.F6Y57A46\1+JWW2.._./7M0!V&X>HHW#U%<>N@_#R2SN
M[N+1M DM[0$SR1VL3"/ R<D#VK/TRW^'.IWB6J>']%AEDBA>-9;2$,QD4L$Q
MCJ!C\^,T >@;AZBC</45Q::1\-G6=ETWPV5@QYK>1#A<MM!)QTW<9]>*M6WA
M?P'>63WEMH6A36R;MTB6D9 V]<\=J .JW#U%&X>HKSS3XOAS?1%Y/#VC6C);
MV\\BSV<0V&8$JG3E\8R/]H=:OSZ1\-;9('FT[PU&LZ"2(M!" ZDX##CIGO0!
MVFX>HHW#U%<G;^&O %W937EOHF@2VT.X22I:Q%4VC)R<>G/T-8MA;^![^S^V
M)X,TU;4S01+*;6!@?-<(N=N=K E25." P]P #T;</44;AZBL#_A!/"/_ $+&
MC_\ @%'_ (4?\()X1_Z%C1__  "C_P * -_</44;AZBL#_A!/"/_ $+&C_\
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M+1?]\-_A1_PG7AG_ *"T7_?#?X4 =#17/?\ "=>&?^@M%_WPW^%'_"=>&?\
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M"VL:P]QJ%U!8?:Y9K3%FEW((Q# SM@RA VXF5NB\8%=)X?LY[&RDAGL(+/\
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M(2#]\@]B$#$'UQZUF6U[;V-MK^FZJL=G;QPO=^5#,'*0.I,F, '(8.W3C>M
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MUN8TG8%278J?W:D  ;B1QW- ':26%G+(7DM('<]6:,$F@VEI-#&IMX)(E'R
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MS>7D-A;-<7!D$2_>*1-(1^"@FH4UBPDTG^U$N UEM+>8%8\ X/&,YSQC&<T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF$;;6,D#Q\Y((^8#)!!!QTIJZU8-JO\ 9GFNMX02L;Q.H8#^ZQ&#T/0]CZ4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '/?\U%_[A/\ [5KH:Y[_ )J+_P!PG_VK70T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!SW_-1?^X3_P"U
M:Z&N>_YJ+_W"?_:M=#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!FZU;F:Q+G6;C2HX29)+B$Q#Y0.=Q
MD5@!W[=*R;31I[^V6YL_'&KW$#YVRPFT=3@X."(<=:M^,+:>[\,SPV\4DCF6
M$GREW.BB5"SHO\3* 6 YR0!@]#5\)">T@NXYXKQUN;Z66&XN(#&\JE5)>1<
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M]U-@*K\Q!'E\ \55NO#^N?V?JQDFN9[)M2$ES8I"@>ZA CW-&Q!.<C.!UVD
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MY08%>1P$#R,CD_)F264=,\9':@#>FT*ZMU5I_&NLQ!CM4O\ 9%R?3F'K4O\
MPC6H?]#AKO\ WS:__&*K:O:R?\)!=7%QHCZK%+8I!:)A"B/N?S%;<?DW9CRV
M.0OM@YLL/B6'>MI'?1O')(DH$@:,6WF!8Q"">9!'\V2,Y!!Z@4 ;(\.7Q) \
M8ZX2O4 6O'_D"A?#E\V=OC'7#@X.!:\'_OQ7-#3?$Z7,K6C7UO'=SR2(7Q)(
MC@K'&9#O'RB.,, 20<G(+8KK_#^Z5]5O1_Q[W=Z9(/=%C2/</8M&S ]P0>]
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M#L9GLT"J3@$YAX&>/K6#-%+JGA6[TUSJ-ZTD,*M!/HLEL-HD3<-Q0!N,\9Z
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M6H?]#AKO_?-K_P#&*Z&B@#GO^$:U#_H<-=_[YM?_ (Q1_P (UJ'_ $.&N_\
M?-K_ /&*Z&B@#GO^$:U#_H<-=_[YM?\ XQ1_PC6H?]#AKO\ WS:__&*Z&B@#
MGO\ A&M0_P"APUW_ +YM?_C%'_"-:A_T.&N_]\VO_P 8KH:* .>_X1K4/^AP
MUW_OFU_^,4?\(UJ'_0X:[_WS:_\ QBNAHH Y[_A&M0_Z'#7?^^;7_P",4?\
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M\FO#?11^,[U;6VT75;335MI+'3\DM"6+?:0^U=WR[PI RN"#S71^,=*T33/
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MVB6*W@C6.*->BJ!@ ?0"LS5?"6@ZW="ZU'2X)KC;L,N"K,O]TD$$CV/%;-%
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MRB3S067<-^<[L'C.>:LZMX3T'7+H7.I:9!/.$\LR'*LR_P!UB"-P]CD5LT4
M4X]*L(I[6:*TACDM(F@MRBX\J-MN54#@#Y5_(4'2=/-[<WAM(C/=1"&=RO\
MK4&<*PZ'&3U]:N44 8-AX*\-:9>QWEGHUK%/&<Q-MSY7^X#PGX8K6N+&UNYK
M:6XA622UD\V%FZH^TKD>^&(_&K%% &>VB:8VCRZ2UC"VGRAP]N5RC;B6;CW)
M)J'4?#&BZM%;1WNG0RBV79 W*M&N,85@00.!QFM:B@#.AT'2;>SL[."P@BM[
M.436\:+M6-QGYACOR>?>M&BB@ HHHH **** "BBB@#GO^:B_]PG_ -JUT-<]
M_P U%_[A/_M6NAH *X7P]J.MP+JL=IH NH1JUYB7[8B9_?-V(KNJ\LEN[^UC
MU-X9;Q;>*?4YE%G*BLLRS?*\@8C* 9]5_O=J .R_M?Q)_P!"L/\ P81_X4?V
MOXD_Z%8?^#"/_"N+;5]<,VH:M(;^..VO[022+= 0P1M%;M(GD'[WWWZ<_-QR
M*[[Q5<S6G@_6[JVD:.>&PGDCD4X*L(V((]P10!5_M?Q)_P!"L/\ P81_X4?V
MOXD_Z%8?^#"/_"LJ>^_X174[9WU&\N;.33KBZN8;B4RLGEA"'4GD9+%<9P21
MW%9%EJ.HW>@:U9ZG>ZG!J-M:'4H9")+9LM&=Z#(!9$D!QVPRT =9_:_B3_H5
MA_X,(_\ "C^U_$G_ $*P_P#!A'_A7.W,-_'?Z!96T^KWB7&GW%U,B:B8W+@V
MX!+$]!O;Y?\ :J\EG/>>(9;*XU+5+**VTFWF"K>G*.TDP9F;D,<*O)R.* -3
M^U_$G_0K#_P81_X4?VOXD_Z%8?\ @PC_ ,*J6VO7\GP_T[42RG4;Q8((Y2F%
M+RNL:R[?3Y@^/3BLZ^DN;?51.=3OGT_[3!96]U;7.[[-,&6,I-$<>9N?@M\Q
M^;HH&: -S^U_$G_0K#_P81_X4?VOXD_Z%8?^#"/_  K%TDZCJ^I76H3IJ1LF
MOY5AECU'RXEBC<H/W8/(.PGWS3O"*ZGJ:6>JWL6IA+HM=+*VH?NMCDO&OE ]
M-I48QVH V/[7\2?]"L/_  81_P"%']K^)/\ H5A_X,(_\*HZG>M)<^*;B>[N
M8K#2[2(;8)C&1(J/,YR.>5>(?A63)9ZM:'P_I27.K7MW+:M=ZAB_,;DHJ)PQ
M/R@O)G Z[?:@#I/[7\2?]"L/_!A'_A1_:_B3_H5A_P"#"/\ PKG+O6;K0O$N
ME)/<7<&G6L#/J$4\YG8F593'EN=Q!@P /[];?@JZU74+75KW4Y6\R6_D6&%C
ME;=555\L8_NL'!/<@F@"Q_:_B3_H5A_X,(_\*/[7\2?]"L/_  81_P"%8$][
MXB_X0_6[N/68_MCZA);6\PMN%PP@"1KN^7]Z#R=W4]3R.FM+B8>+K^R\UW@B
ML+:0*QSM<O,"?J0J_E0!!_:_B3_H5A_X,(_\*/[7\2?]"L/_  81_P"%=#10
M!SW]K^)/^A6'_@PC_P */[7\2?\ 0K#_ ,&$?^%=#10!SW]K^)/^A6'_ (,(
M_P#"C^U_$G_0K#_P81_X5T-% '/?VOXD_P"A6'_@PC_PH_M?Q)_T*P_\&$?^
M%=#10!SW]K^)/^A6'_@PC_PH_M?Q)_T*P_\ !A'_ (5T-% '/?VOXD_Z%8?^
M#"/_  H_M?Q)_P!"L/\ P81_X5T-% '/?VOXD_Z%8?\ @PC_ ,*/[7\2?]"L
M/_!A'_A70T4 <]_:_B3_ *%8?^#"/_"C^U_$G_0K#_P81_X5T-% '/?VOXD_
MZ%8?^#"/_"C^U_$G_0K#_P &$?\ A70T4 <]_:_B3_H5A_X,(_\ "C^U_$G_
M $*P_P#!A'_A70T4 <]_:_B3_H5A_P"#"/\ PH_M?Q)_T*P_\&$?^%=#10!S
MW]K^)/\ H5A_X,(_\*/[7\2?]"L/_!A'_A70T4 <]_:_B3_H5A_X,(_\*/[7
M\2?]"L/_  81_P"%=#10!SW]K^)/^A6'_@PC_P */[7\2?\ 0K#_ ,&$?^%=
M#10!SW]K^)/^A6'_ (,(_P#"C^U_$G_0K#_P81_X5T-% '/?VOXD_P"A6'_@
MPC_PH_M?Q)_T*P_\&$?^%=#10!SW]K^)/^A6'_@PC_PH_M?Q)_T*P_\ !A'_
M (5T-% '/?VOXD_Z%8?^#"/_  H_M?Q)_P!"L/\ P81_X5T-% '/?VOXD_Z%
M8?\ @PC_ ,*/[7\2?]"L/_!A'_A70T4 <]_:_B3_ *%8?^#"/_"C^U_$G_0K
M#_P81_X5T-% $=N\DEM$\T7DRL@+Q[MVPXY&1UQZU)110 4444 %%%% !111
M0 4444 %%%% !2')4@'!QP:6B@#ET\":1_PB<NA31K,9HI$EO&C7SF=R2TF<
M?>W$M4%SX'>YBU)'UFXS?_999&\I"5G@\O;(/KY2Y4\=:E@\<1WGFM9^']<N
MH8YI(?.B@0HS(Y1L9<<94UH6/BG3M0\3ZGX>B\Y;_3D1Y0Z85@RAOE.><!ES
MZ9% %27P?%/I&LV$M[*QU6Y6YFE" %6"1KP/0^4#^)K=MH9XI+EIKMIUDEWQ
M*R*OE+@#8,#D9!.3SS7.2_$'1T75#%%>7#:=>QV$BQ1 F29VV*$R1GYN.W(J
MS_PER1V5_>7FB:O96]E:R74DEQ"@!5!DA<.<MC.![4 5KCP==^9?1:?XBO++
M3[^1Y9[588Y-K/\ ?\MV&4SDG'."3C%:-UX:M)]/T>QB=X+?2IX)H%7G(B&%
M4Y[8JG#XUMC-9K>:3JUA%>2)##<7,"^67?[BDJS8R>!GN:DNO&%O%?7-I9:7
MJ>J-:-LN7LH59(FQG:2S+N8 C(7)&: $U7PU=WGB%=9T_6IM.N/LHM6"VZ2A
ME#EOXAP<FIYM GU#PW=Z1JVJ2WCW (%SY*1M'T*D!1C*L P/K56X\<:<D6E2
M6=K?:C_:D<DENMI$"VV/;OW!BN""P&.N<TE]XYL-)TE=2U>PU'3;<W*6V;F)
M006_BX8_*,')_2@!;GP=%+X0MM AOIH3!+%.+O8K.TJ2"4N0>"6<$GZFKNEZ
M7K%I=^;?>(9;^':1Y+6D48SZY49I^I>(+;3KRWM/L]S=7%S!+<0QVRABZQE
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M4CKVK.TJTNO";^%]3U:TN([=;:^CN?)B:7[(T\R3(K! 3@ %<@8! ]:]1HH
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MX3_[5KH: "N>\(?\>6I_]A:\_P#1S5T-<]X0_P"/+4_^PM>?^CFH Z&BBB@
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M#J[+YJQN'4, <'E1]0,'CBM#4-*L]4-H;N(NUI<+<P,&*E)%S@Y'L2,="":
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M2V,]W&/,A4Q(SEU ;G<JJ0,\;^<XP9]<N/$NE:!=W0U2Q,MJ_P KBU),J-L
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MX*IO_B:Z&B@#GO\ A,+7_H$Z]_X*IO\ XFC_ (3"U_Z!.O?^"J;_ .)KH:*
M.>_X3"U_Z!.O?^"J;_XFC_A,+7_H$Z]_X*IO_B:Z&B@#GO\ A,+7_H$Z]_X*
MIO\ XFC_ (3"U_Z!.O?^"J;_ .)KH:* .>_X3"U_Z!.O?^"J;_XFC_A,+7_H
M$Z]_X*IO_B:Z&B@#GO\ A,+7_H$Z]_X*IO\ XFC_ (3"U_Z!.O?^"J;_ .)K
MH:* .>_X3"U_Z!.O?^"J;_XFC_A,+7_H$Z]_X*IO_B:Z&B@#GO\ A,+7_H$Z
M]_X*IO\ XFC_ (3"U_Z!.O?^"J;_ .)KH:* .>_X3"U_Z!.O?^"J;_XFC_A,
M+7_H$Z]_X*IO_B:Z&B@#GO\ A,+7_H$Z]_X*IO\ XFC_ (3"U_Z!.O?^"J;_
M .)KH:* .>_X3"U_Z!.O?^"J;_XFC_A,+7_H$Z]_X*IO_B:Z&B@#GO\ A,+7
M_H$Z]_X*IO\ XFC_ (3"U_Z!.O?^"J;_ .)KH:* .>_X3"U_Z!.O?^"J;_XF
MC_A,+7_H$Z]_X*IO_B:Z&B@"IIVH)J=KY\<%U NXKLN8&B?Z[6 ./>K=%% !
M1110 4444 %%%% !1110 4444 %%%-D021LASA@0<4 <DGC'4;RSEU/2O#<]
M[I$9;;<"Y1))U4D%HHR/F'!QDJ3V'(JYXC\86WA_1+74A:3W7VHYC@0;9-@0
MR.Q!Y&U%8D>V.]<O##J^F>%;3PQ/H^O-=:>ODVUUI,Z1QW"J"J,S[QM&,9##
M@CO4]EX;\2:GJ&GG4]0EM)-*TJ*U,_EI/]IGD4>>WS@Y'RHN<=VH ZO4/$$=
MI=Z1;V\'VHZH9! ZR!5^6)I <^AVX_&LBT\6:[=:]/I!\+!)K9(I9V_M!"$2
M0L 1\O/W&XK(T30]:LKOPQI]U;S2P:'?W4*W38Q);&!Q"_\ X\J8]5KI=/L+
MJ+Q_KE\\++:SV-G'%*>C,C3;@/IN7\Z );+Q+'>^&K[6A;,J6CW2F(MDMY#N
MAY]]F?QK,C\9:A?WZVND^'S=M]@M[V0O>+%L$V[:O(Y(V&L2S^']K/X2UA[W
M3)O[5FFOWC'GNN[=+(8S@-MY!7\^:I+H+6VLQ3:MX<UF]B_L6QMT-A*4V21B
M3S%;;(G]Y?7O0!U][XGU6TNM)L!X?#ZCJ$<\A@^VJ%B6(H/O[<'(<&HF\=+9
MVFL'5-*GM;S2UA:2W65)!()B5C*OP.6!!SC&,]*S)_#L6NZOX8/]EZK9Z9:6
M]ZCI+<R12Q,QBV;G23<<[6Q\QZ5%9Z#J?A^R\0:3;Z+%JT<LB3Q3W9WF^@)P
M\,C,>9%7<%+<$%?>@#?7Q/J5J;E=7\/RVACM);N)XIQ/$XC +(6 &QN1@$8/
M."<5!I_C*]FDTAM2T"2RM-694MKA;I)AO9"ZAE&",A3SSSUKG+?1[HRW<?A[
M1]9TO37TZYCNK2^E_=22,F(UBC+MM;.<E<+CCG-5M%\/2QS>&6TSPWK&GZE9
M20_:[R]FS"(@N)E"F1LEAD#"C&>PH [^P\1QWV@7^JK;,BV<MU$8RV2WDNR$
MY]]F?QK+C\9WU]>VMKI6A?:GFTR#4G+W:Q!%E+ +RIR1M-9*G6-%T;7?#Z>'
M[^[GNKF\>SN(-A@=9W9U+,6&S!?!R.W&:6#P)]H\010ZA]L6VMO#]I91W5I=
MR09E1I0V-C#. 5/S CF@#83QS!_9$]Q-IMRFH0W_ /9O]GJRN[W) 8*K9VD%
M6#;B1@9STJ[8:[J;:K#8:MH,EB;A&:&>&<7$9*C)5R "C8Y&1@X/.:Y.S\/:
MQI^C64,.EK)?^']5-PI4A!J<3(RF0,3CS2LG.X_>7J 15^W.KZKXTT^_L[3Q
M!8V22.]^FH3A("OE,JHD88Y.\JV0,<'F@#9U?Q=!H_BS1M"FM9&_M-7(N PV
MQ$$!01_M,RK]2*KZMXYMM+\27&C?8Y)G@TV74'E5P%'EC/E_[V"#[;A5+QAX
M=OM:U\26L1&S1YU@G[)=":&2+_QZ//X&L6?P_K5[LU2;39$O;_3]5>YCR"8I
M)5A2&(GUV1JOU4T =%;^-+V."PO-6\/RV.G7K1(EVETDRQF3 3>!@J"2!GG!
M(S6]K.J2Z7;0FWL)KZXN)EABABX&X@G+,>%4 ')/L.217&2C5O$/A?3?#*>'
M]1L@/LJW=W>"-(XTB9&;;ARS,=F!QWR<5TWB_4M7TW2%.B:?-=WDTHBW1H'\
MA3G=(5)&[&.!D9)':@"D/&QVM:'2I1K2WPL!8"92#(8_-W>9TV>7\V<9[8S2
MGQJ/L4033)3JDFH'338M*HV3!#(<R=-NP;@>I!'&>*Q+;3I;2'1]4LM%U=GT
M_4))KU;Q4^TW7FPLCS##$,067CC@$ < 56N]#U"]+ZE?Z1=RZ;>:TU[<Z=&0
M)Q$L"Q0L0&[,@<J#GD=<$4 =/#XJO[W33<V&@R3RPSRV]Y"UW''Y#QG!^8\,
M#UR/QQ56R\=7&HV&EO;:%,;W4S*]M;M.H4PQXS*7[*=RXX).X=N:RH-$U4>!
MM0TBTL;FTM-0U(16]N[#S;:RD=!*6.3CCS2!DD!A]*VO%>G;9-(N+2SU)/LF
M^-+G263SK="H&WRW4JZ-M /'!"GW !-'XMN+ZWM_[+T.ZN;IVF2>)W6-+9HF
MV.KR<C=N^Z!G(YX'-.N/&NG0>"4\3F.8P21;XK? \QWY_=@#C.0>>F 3T&:Y
M[3-,O-'\.FPU30;V^T_4Y[FYNHXI?,N(6>0-&KX8;LK]X@\-[<U4'@WQ/+X7
MMV^W012VNGW,%OIUS;>>T8<OM =9%'F>44CSAL8/7)R =5K?C>QT+PW:ZM/;
MSRR74"S0VL2EF((4DD@855W#+'C\2!5G5/$5Q:ZRNDZ;I4FH7BV_VJ91,L2Q
MQEBJ\MU9BK8'L<D5D:CI&K3?"1M*E1;C4_L*1[(H]F2,87!8\@#!YY()XZ4[
MQ79S+KT%_;6>M!VM&A:YTF6/=)\V1#(KC ')(<8(R>1W .FTG5+;6M)M=2M"
MQM[F,2)N&& /8CL1T/TJ[6'X.T>70/"&EZ7.%$T$($BJVX*Q)) /< DC/M6Y
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!SI('Q$R3@#2>3_ -M:PX-0B-Y C:O/_8/VT^3J
M!NVW2S=H"V[_ %><@-T; 'HS[O\ S47_ +A/_M6MW[/!L">3'M!R%VC /K0!
M)7%Z9;37FC7T$-G'=9UZXD*R7!A5/+N#(K9"L3\R*,8[UVE<]X0_X\M3_P"P
MM>?^CFH SETZ"\FUF^O;1H9;61G:*VOG>)Y?( \P95<.$8#.,9YZBK.E6,.J
M6]CNM;.U2PBV6YL+]G>(-'LV'Y%Q\I]3R >U:FFVMQ:Z"1-;K)>2B2>:!F&#
M(Y+%,\C )VY] *I6ENS:M;W5MHLFGQ6MM)&RD1*TN=NV-0K$8&"<D@ XQU.
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M:58?Q#'KZGU-,L_"NGV5Q!*LEW*+4$6L<UR[I;@C;\@)ZX) )R0"0, UMT4
M1P1""WCA#NXC4*&D8LS8&,DGJ?>I*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .>_YJ+_W"?\
MVK70USW_ #47_N$_^U:Z&@ KGO"'_'EJ?_86O/\ T<U=#7/>$/\ CRU/_L+7
MG_HYJ .AHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEU"_2.5$&69&+X8 <\=1R,CFA+?PJUE/>.?$T-M! UP\L]UJ,:[ ,\%F&3Z
M<F@#OJ*X[3]!T'4I'2)/$L109)N;W4(0?H7<9_"J-W!X2LH%GDF\120M<-;!
MX;W4)%\U9/**Y5SSO^4>IZ4 =_17 -;^%Q.8%7Q2\RQK(\<=QJ3-&&)QN ;Y
M2=IX/-6H-*\*7$NI1K?:LK:8%-YOU>\7R@4WC.9/[OY<CM0!VM%<=!HGA>XT
M.+6A?ZI'ITL(G6>;6;R,;",@G=(,<>M5)[;P?;V=K=O>ZV8+FW%TCIJ5^P6'
MC]X^'^1>1RV/T- '>45RUOX6T&ZEN8XI]7+VTODR@ZQ>#:VU6Q_K?[K*?QJQ
M_P (5I'_ #UU?_P<W?\ \=H Z&BN>_X0K2/^>NK_ /@YN_\ X[1_PA6D?\]=
M7_\ !S=__': .AHKGO\ A"M(_P">NK_^#F[_ /CM'_"%:1_SUU?_ ,'-W_\
M': .AHKGO^$*TC_GKJ__ (.;O_X[1_PA6D?\]=7_ /!S=_\ QV@#H:*Y[_A"
MM(_YZZO_ .#F[_\ CM'_  A6D?\ /75__!S=_P#QV@#H:*Y[_A"M(_YZZO\
M^#F[_P#CM'_"%:1_SUU?_P '-W_\=H Z&BN>_P"$*TC_ )ZZO_X.;O\ ^.T?
M\(5I'_/75_\ P<W?_P =H Z&BN>_X0K2/^>NK_\ @YN__CM'_"%:1_SUU?\
M\'-W_P#': .AHKGO^$*TC_GKJ_\ X.;O_P".T?\ "%:1_P ]=7_\'-W_ /':
M .AHKGO^$*TC_GKJ_P#X.;O_ ..T?\(5I'_/75__  <W?_QV@#H:*Y[_ (0K
M2/\ GKJ__@YN_P#X[1_PA6D?\]=7_P#!S=__ !V@#H:*Y[_A"M(_YZZO_P"#
MF[_^.T?\(5I'_/75_P#P<W?_ ,=H Z&BN>_X0K2/^>NK_P#@YN__ ([1_P (
M5I'_ #UU?_P<W?\ \=H Z&BN>_X0K2/^>NK_ /@YN_\ X[1_PA6D?\]=7_\
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M\_\ !=<?_$4 =#17/?\ ";Z%_P ]KS_P77'_ ,11_P )OH7_ #VO/_!=<?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/[ UK_H<=3_\!;7_ .-4 =#17/?V!K7_ $..I_\ @+:__&J/[ UK_H<=3_\
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M$T>J2V7C#6HXM.N6MY9)[2S56*C.Y<1GY2.03CZ4 >@T5YEIGB"ZU*[L8_\
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M,/G9&Y0,;?7'/:@#TZBO,;[7=3L!8QRZMXI-]>)+(EBMGI_FA(R S'C:>HP
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M]@:U_P!#CJ?_ ("VO_QJ@#H:*Y[^P-:_Z''4_P#P%M?_ (U1_8&M?]#CJ?\
MX"VO_P :H Z&BN>_L#6O^AQU/_P%M?\ XU1_8&M?]#CJ?_@+:_\ QJ@#H:*Y
M[^P-:_Z''4__  %M?_C5']@:U_T..I_^ MK_ /&J .AHKGO[ UK_ *''4_\
MP%M?_C5']@:U_P!#CJ?_ ("VO_QJ@#H:*Y[^P-:_Z''4_P#P%M?_ (U1_8&M
M?]#CJ?\ X"VO_P :H Z&BN>_L#6O^AQU/_P%M?\ XU1_8&M?]#CJ?_@+:_\
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M_",7G_0VZ]^=O_\ &: .AHKGO^$8O/\ H;=>_.W_ /C-'_",7G_0VZ]^=O\
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MO_\ &: .AHKGO^$8O/\ H;=>_.W_ /C-'_",7G_0VZ]^=O\ _&: .AHKGO\
MA&+S_H;=>_.W_P#C-'_",7G_ $-NO?G;_P#QF@#H:*Y[_A&+S_H;=>_.W_\
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M_P (Q>?]#;KWYV__ ,9H Z&BN>_X1B\_Z&W7OSM__C-'_",7G_0VZ]^=O_\
M&: .AHKGO^$8O/\ H;=>_.W_ /C-'_",7G_0VZ]^=O\ _&: .AHKGO\ A&+S
M_H;=>_.W_P#C-'_",7G_ $-NO?G;_P#QF@#H:*Y[_A&+S_H;=>_.W_\ C-'_
M  C%Y_T-NO?G;_\ QF@#H:*Y[_A&+S_H;=>_.W_^,T?\(Q>?]#;KWYV__P 9
MH Z&BN>_X1B\_P"AMU[\[?\ ^,T?\(Q>?]#;KWYV_P#\9H Z&BN>_P"$8O/^
MAMU[\[?_ .,T?\(Q>?\ 0VZ]^=O_ /&: .AHKGO^$8O/^AMU[\[?_P",T?\
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MY413F4-'+OVY)5<,#&V1R.G-2R>&M'FNYKF2Q1I)M^\%FVY9=K,%SM#%206
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M%I>P&:(A6$@22*5HFP2!D90XR!P>E;TNE6,]Z+R6V1K@>61(<Y^3=L_+>_\
MWU2-I-@^GS6#6R&UF=WDBYPS.Y=C^+,3^- ')'QIJ-I/+;36$=Q<R7MTD C:
M4J(82H);9$S Y=1T(Y/(Z5./&U_.R-;:&!$TEM$1=7)BD1YT#*"FPXVE@&YS
MZ ]*W)_#.D7+R/):$/)*9B\<KHP=AAB"I!&1U P#WS4\>A:7"@2*RB1%>)U5
M1@ Q@!,#M@  ?2@"'3-3NM7T)[J*"&"\#S0>6[EXUDCD:,\@ E<J3T!QZ5Q>
MK^-+[3/A\KOJ5NFMS07;I<RJJ*/*+<JIX+$A55>>3GD UZ):VD%G"8K>,1QF
M1Y"H_O.Q9C^+,3^-0G2K$Z7+IAMT^Q2H\;P\X97SN'XY/YT 6+>>*YMHIX9%
MDBD0.CH<A@1D$'TK*\5"Z7PY?7-GJ%Q936L$DZO L9W%4) .]6&,^F#[UJ);
MQ1SR3(I$D@4.<GG'3CMUI;B"*ZMI;>= \,J%'0]&4C!'Y4 <1+J^MZ++9F.=
M]6C.E3W\ZWDJ0GY3%]TI%Z%L CN<G@5=M?&YO=<6S@TJX>T-PML;@)(2K% V
MXXCV;02 3OSWQBNBDTJQFQYELC8MVM1G/^J;&Y?H=H_*JZ>'=)2_2^6S43H0
MP(9MNX+M#;<[2P7C=C..] &-?^(M2TWQ)J"?9H[C38!9!MTVQXS+(R$J IW=
MB02.G%0R>.IH+.*^FTM!:744DMFRW.7<(P'SKM^0D'(P6Z8.*Z>?2K&Y>=YK
M9':?R_,)S\WEMN3\CS5,>%M$!N"=/C87"/&ZLS%0KG+A5)P@8\G;C)&: *5S
MXHN1KITFSTZ.:87GV;?+<F-0! DQ8X0GHV /4#D9X9XF\7MX>N3&MG'<K'"L
M\P$K;U0L1PJHV.A.7*KVSUQJV7A[2M/E66VM LHD,OF,[.Y<J$+%F)).T <^
ME)J/AS2=6G>:^M!*[QB)_G90Z DJ& (#8))&<X)R,4 8-SXYEL5N+JZTM5L(
MY+R))([C=(S6X<GY"H #"-L?-P?SK0T;4]4FUS5X-5AAMUMH+>1(H9?-4;O,
MW'=M4G[H&".W'6M-M$TUT"/9Q,@DEEVL,C=)N$A(/7=O;/UI--T33](:9K*
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M;QO?2PVHFTB".YOH+::SC6[+*1,2 )&V#:5QDX#9Z"NFL-%T_3(I8[2WV"4
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MM%-U.86#+"TC.ZA"5SMX7J0RGC-;Y\+Z(94D.G192,1@<XP%V#(S@D+\H)Y
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MF!XSU/ISM)I5A'86UBEK&MK;&,PQ ?+'L(*8^A _*EM=+L;+[/\ 9K9(OL\
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M/;M(SC*KM5MN<%@O 8C('>G/X?TE[6.V:QB,,<"VR+@_+&I!51Z8*@@]00*
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M"//4$':H'!P1P016GI6G0Z/H]EIEN6,-I D$9;J550HS[\4 7**** "BBB@
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MA1]LUS_H#VW_ ('?_84 :U%9/VS7/^@/;?\ @=_]A1]LUS_H#VW_ ('?_84
M:U%9/VS7/^@/;?\ @=_]A1]LUS_H#VW_ ('?_84 :U%9/VS7/^@/;?\ @=_]
MA6E TKP(TT8CE(^9%;<%/IG S0!FZQJES9W-A965O%+=7KNJ&:0HB!5+$D@$
MD\  8[^U9$7BZ\=S,VGVXLX;RWL;@K=;W$LHCY3"X909D&<@D9.. #T5_IEE
MJD*Q7MNLRHV],Y!5L$9!'(."1QV)JLGAS1H[N&YCTVW26$*(RJ8"[1A3@<9
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MLNC^=>P"=ITA\Z1"(Y"@"E(V(W8)RP 'O5A_&]Q"[7,VF(NFK<RVVX3'SLI
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MTT][N8VSW+825AM4@!1Y:/@DGJ< 8]ZUUT/2XX'@2P@6)XD@9%3 ,:$E5QZ
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MHL=NMM!"BA5A0$D@?4XS_NBHH_#&B1Z@;]=-@^U>:9O,*YQ(3DL > <D\^]
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M2QNJ$@_Q@[@1CJ/0\5//XH6'498OL,K6<-Y%8RW0=?EFDV;0%ZE<R("?4]"
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MF0JD<O\ K%4;L*#[=,#'04 58O%5RUY/8PZ?+=WR22LT(D1!&D8CW ,>IS(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\LEHC+?D&Z7G$N %Y'T 'N ,TZ^TC3]2DCDO+5)GC1D5FSD*Q4D<=B44_@*
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M'X>3:[/>:T+HZ0+E9;I+3R&D*!MR",;OH&['GFM6UO-8O?%&IQ^=KIM;?41
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M4+ 9P#@=LF@"]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7)P_7@G/7B@"3Q-K^JZ3=:=8V<<+S3V\TTL[1KMS'LX"O*@&=Y/WB0%/!ZC
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M_&-C+-;D+-''8(S1D] P$G'0]: .JHKGO[*\3_\ 0SV__@L'_P 71_97B?\
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M;TD0<C*J5P02<8('S'CIAE]I>H7NASV#:E$9K@,LLSVV5"L""$4,,>V2WXT
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MZ=J&^Y=;AX_.::: 0,KD A5'S*1D[0#G( .:?+=ZQ?7VI>3]MC:UG:*-8)(
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M7O\ P'3_ .+H Z&BN>_X2J3_ *%O7O\ P'3_ .+H_P"$JD_Z%O7O_ =/_BZ
M.AHKGO\ A*I/^A;U[_P'3_XNC_A*I/\ H6]>_P# =/\ XN@#H:*Y[_A*I/\
MH6]>_P# =/\ XNC_ (2J3_H6]>_\!T_^+H Z&BN>_P"$JD_Z%O7O_ =/_BZ/
M^$JD_P"A;U[_ ,!T_P#BZ .AHKGO^$JD_P"A;U[_ ,!T_P#BZ/\ A*I/^A;U
M[_P'3_XN@#H:*Y[_ (2J3_H6]>_\!T_^+H_X2J3_ *%O7O\ P'3_ .+H Z&B
MN>_X2J3_ *%O7O\ P'3_ .+H_P"$JD_Z%O7O_ =/_BZ .AHKGO\ A*I/^A;U
M[_P'3_XNC_A*I/\ H6]>_P# =/\ XN@#H:*Y[_A*I/\ H6]>_P# =/\ XNC_
M (2J3_H6]>_\!T_^+H Z&BN>_P"$JD_Z%O7O_ =/_BZ/^$JD_P"A;U[_ ,!T
M_P#BZ .AHKGO^$JD_P"A;U[_ ,!T_P#BZ/\ A*I/^A;U[_P'3_XN@#H:*Y[_
M (2J3_H6]>_\!T_^+H_X2J3_ *%O7O\ P'3_ .+H Z&BN>_X2J3_ *%O7O\
MP'3_ .+H_P"$JD_Z%O7O_ =/_BZ .AHKGO\ A*I/^A;U[_P'3_XNC_A*I/\
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MZ/\ A*I/^A;U[_P'3_XN@#H:*Y[_ (2J3_H6]>_\!T_^+H_X2J3_ *%O7O\
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M_ =/_BZ/^$JD_P"A;U[_ ,!T_P#BZ .AHKGO^$JD_P"A;U[_ ,!T_P#BZ/\
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MQLNK27>HPACMFC\Z1XG''WU60J?8]>* .G3XD>'F2^=O[2B2P0O=-+ILZ"'
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M@I8H8MN\':,\CI2W'CO1[5;/S8=4$MXLC0P#3)S*50@,2@3< -PY([UR.J^
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MJ99LCV'X5K:?X1\2-:>'=$U!=.CTW09TF2[@F8R7/EJRQCRRH"?>^;YCTXH
MW=.^(GAO4T#0W-RBM;O<Q&>SEB$T:#+&,LH#X'.!DU)%X\T2XO8[2V&H7,KQ
MPRY@L)I%195#(695(7(.><8Y]*Y#3_ OB6;0]&TO48]-MXM&L[B*)X;EY&N)
M9(6B7(**$4;R3R>U:OA?X?R:=K#:AJ<C[X[6PB@%K>2HN^&(*^]5*JXW 8W
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M (%Q_P"- &K165_PD^@?]!S3/_ N/_&C_A)] _Z#FF?^!<?^- &K16%?^,=
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M_@7'_C1_PD^@?]!S3/\ P+C_ ,: -6BLK_A)] _Z#FF?^!<?^-'_  D^@?\
M0<TS_P "X_\ &@#5HK*_X2?0/^@YIG_@7'_C1_PD^@?]!S3/_ N/_&@#5HK*
M_P"$GT#_ *#FF?\ @7'_ (T?\)/H'_0<TS_P+C_QH U:*RO^$GT#_H.:9_X%
MQ_XT?\)/H'_0<TS_ ,"X_P#&@#5HK*_X2?0/^@YIG_@7'_C1_P )/H'_ $'-
M,_\  N/_ !H U:*RO^$GT#_H.:9_X%Q_XT?\)/H'_0<TS_P+C_QH U:*RO\
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MHK*_X2?0/^@YIG_@7'_C1_PD^@?]!S3/_ N/_&@#5HK*_P"$GT#_ *#FF?\
M@7'_ (T?\)/H'_0<TS_P+C_QH U:*RO^$GT#_H.:9_X%Q_XT?\)/H'_0<TS_
M ,"X_P#&@#5HK*_X2?0/^@YIG_@7'_C1_P )/H'_ $'-,_\  N/_ !H U:*@
MM+VTOX?.L[J&YBSMWPR!USZ9%3T %%%% !1110 4444 %%%% !1110 4444
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M%[:&-;Z"V$SVLDY57@DD)V(P+'* <= 30!U7]D:9_P! ZT_[\+_A1_9&F?\
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M\*7-VYL8M2@O+6*01HTZ)'.\>#M5LL55V4@'ED/;B@#M?[(TS_H'6G_?A?\
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MTZ<.#/-(CGRCM9P BXQWSR>@ .P_LC3/^@=:?]^%_P */[(TS_H'6G_?A?\
M"J.B:E/<:9<7=W=K<B)C\R:=+:$  $C9(Q)^HX[=JHZ;JFO3:9::[=-8'3KB
MW^TRVL<3"6",H77#[B)&Z C:O7(/&" ;G]D:9_T#K3_OPO\ A1_9&F?] ZT_
M[\+_ (5SL&MZY!:Z3JE^UB]EJ,L,;6T,3"2W\WA/WA8A\$J#\J]21C&#0T+Q
MOJ.KZ9H4<\-M:ZK?2()TV,R>5);2S1RH-P)!* 'GJKCT- '8_P!D:9_T#K3_
M +\+_A1_9&F?] ZT_P"_"_X5Q]QX@\26.F^(+R>]TR0:7<+;*$T^0;B5B;>?
MWQZ>:1M'7'6I;/QG/%%K5S=307UEIUMYC7$5E):8FY_<E9&;+$;3D8QN&>HH
M ZO^R-,_Z!UI_P!^%_PH_LC3/^@=:?\ ?A?\*Y>R\77UYHUK"AL&UF743ILC
MQY>WC<*TF_ ;)!C7<!NZD#/>K6L77BC2O#FJWIN]+:6QADN(Y/LCD3HL9;:4
M\P;#D8SN;(["@#>_LC3/^@=:?]^%_P */[(TS_H'6G_?A?\ "C2Q??84.H7%
MO/.WS;H(#$H!'3:7;GWS5R@"G_9&F?\ 0.M/^_"_X4?V1IG_ $#K3_OPO^%7
M** *?]D:9_T#K3_OPO\ A1_9&F?] ZT_[\+_ (5<HH I_P!D:9_T#K3_ +\+
M_A1_9&F?] ZT_P"_"_X5<HH I_V1IG_0.M/^_"_X4?V1IG_0.M/^_"_X5<HH
M I_V1IG_ $#K3_OPO^%']D:9_P! ZT_[\+_A5RB@"G_9&F?] ZT_[\+_ (4?
MV1IG_0.M/^_"_P"%7** *?\ 9&F?] ZT_P"_"_X4?V1IG_0.M/\ OPO^%7**
M *?]D:9_T#K3_OPO^%']D:9_T#K3_OPO^%7** (X+>&VC\N"&.),YVQJ%&?H
M*DHHH **** "BBB@ HHHH **** "BBB@ HHHH JZAI\6I6AMII;F)"0=UM</
M"_'^TA!_6LC_ (0VP_Z"&N_^#FZ_^.5T-% '/?\ "&V'_00UW_P<W7_QRC_A
M#;#_ *"&N_\ @YNO_CE=#10!SW_"&V'_ $$-=_\ !S=?_'*/^$-L/^@AKO\
MX.;K_P".5T-% '/?\(;8?]!#7?\ P<W7_P <H_X0VP_Z"&N_^#FZ_P#CE=#1
M0!Q/B;PC8P^%-8E6_P!:9DL9F ?5[EE.$)Y!?!'L:ZW3?^07:?\ 7%/_ $$5
M1\5_\B=KG_8/G_\ 1;5>TW_D%VG_ %Q3_P!!% %&X\-:7=MJ375LL[:B-LQE
M 8A=@3:O' QD_4DU=L[46$#(;F>90%^:=P2H"A>N!_=R?<FK517$"75M+;R9
MV2H4;!YP1@T <A%=Z+J4,]LUKJ45CKET)8[R1 L4\FU=NPY+*"(QC< #V)R*
M9)?:-XAN[.ZN;'5((K_9;6]RX01N5D\U1\K$C+1]P/3O5F#0];EL])TF^^P+
M8Z=+#(;F&5C)<"$@QCRRH"9*J3\S="!UXK:5X&DT@Z%=PM"][9L5NDEE=XG5
M@06C!!V.,\$ 9!8'KD %6PN-%OKFSN677+;3[R?[;:07&W[-+,,S C!+ Y!<
M*2!D=*L7FJ6>J63>)/LNO:7%#I[3F^A$2^;;A=^W!9L\<C(R,G!&32Z=X:UU
MM(T72-033H;72PK>;;W+RO.R(RJ,&-0@R<GENF/>J=GX+U2'PE=:+_9FE6\\
MVDO8?:X]2FDW.8]H)1H@ "<$X/'O0!L^'QIEEK26<6G:AI]V]@$B2[*L)8HG
M)+!E9LMNFR<G)W UF6D7@^QL?$-BT4MP-,@2WO$N$#N(5B 4)ZKC=_P(M6WI
MWAA='\3MJ%B$-I/;>5,L\CO)$P((,;-D[6_B7(&54CO61KO@>]U&SU5[.YMX
M-0N;F1HI&)VM!(B*\<G&?X-PQG!53ZB@"#5;7PX=(UC2+NTU6]T_S$;4+] &
M$$B11INW9#$A$4L55L9;/<5T5YX9L[R6YN8;Z^M8[P W,=I,%2X^4+DY!P2H
M RI!( YJE/HNN00:MINGBP:SU&6607$\K"2W\W[_ ,@4A\$DCYEZX/3)Z"QM
MI+6T^Q[$6&!5BMV#EF9 @&6X&#G(P,\ '/.  <;I#Z%=ZREOI.K:K827]A;Z
MFENA0(\1C6-<;E8[@L2Y&??UK8U*XTS5M'T?7/-O+8S-#]CN+?"RI]H*J 0<
M@@[ER"". >H%95EX&O8=.A1[FWCOK72["WM+B,EO*N+<2@MR!E&$FTCJ5+#
MK4C\.7B>#=!T<R0?:-/:Q,K!CL;R'C9]IQGG8<9 [9Q0!CVE_I-A<SSR:3KB
M3:3YM]=W-QY;$LT)RSD.<DHN  ,# ' %1WJ:;8Z;<:M)9^(=*M[.5[Q#'Y7#
M2X5EC7+=2=V/4GZ5NZEX=N[R'Q4D<D .KV8@@W,?E;RF3+<<#+#IFLZ/POJ#
M:7<60TO3;$R"$^;%J4T^XI(K8*M$N. >0>N/J !)+'08M6T*RM-0U&*^O([B
M>"YMY S2APKNTC,#][8N./X<# %::#2+/Q)!IMQ=W%[J=S9M"PFP^8@6?Y\
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M?V=J=I//=73ZG&T5U<3.#(ZE2N!@ * "<  #DGJ36U10 U$$:*@Z* !3J**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BJNH/?I:$Z;#;37.1A+F5HTQWY56/Z5D?:/&7_0
M+T'_ ,&,W_QB@#H:*Y[[1XR_Z!>@_P#@QF_^,4?:/&7_ $"]!_\ !C-_\8H
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M^T>,O^@7H/\ X,9O_C%'VCQE_P! O0?_  8S?_&* .AHKGOM'C+_ *!>@_\
M@QF_^,4?:/&7_0+T'_P8S?\ QB@#H:*Y[[1XR_Z!>@_^#&;_ .,4?:/&7_0+
MT'_P8S?_ !B@#H:*Y[[1XR_Z!>@_^#&;_P",4?:/&7_0+T'_ ,&,W_QB@#H:
M*Y[[1XR_Z!>@_P#@QF_^,4?:/&7_ $"]!_\ !C-_\8H Z&BN>^T>,O\ H%Z#
M_P"#&;_XQ1]H\9?] O0?_!C-_P#&* .AHKGOM'C+_H%Z#_X,9O\ XQ1]H\9?
M] O0?_!C-_\ &* .AHKGOM'C+_H%Z#_X,9O_ (Q1]H\9?] O0?\ P8S?_&*
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M,O\ H%Z#_P"#&;_XQ1]H\9?] O0?_!C-_P#&* .AHKGOM'C+_H%Z#_X,9O\
MXQ1]H\9?] O0?_!C-_\ &* .AHKGOM'C+_H%Z#_X,9O_ (Q1]H\9?] O0?\
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M#-<V@NQ%<WHA+@LR[(LJ?,?Y>1\H&Y<GFM;1["ST#4;C3;>\B6*Z9KJUT\*
M81P)-O/W"S XQP6/8@#$3PRTMDVA6FM6-S':VZ6]W;7ED+A4)W,KJN\;&(;O
MD'"G'J ;7B+Q/'X=TZQO9K21X[FY2&0%@IA4JS,YZ_=522/:JNH>-;:PUN_T
MXVDLOV."-]Z,,R32.JK"H/<^9'R3CYZCU^UT:TT_1--U34"D-NWRK,ID>Y18
M6B8''M("3_C69I?A?3+ZVBBB\0?;;B2SWBYC4;V<3ATFZD?*T:KC_9P: -2_
M\77FC13+JFD1Q77V=KBW2&[\R.8*RJRER@*L"ZG&TC!X)P:?=>+;C3%NH]4T
MH074-N+F-(KCS$F3>J-AMH(*EER"/XAC/;!U?[#J:.=7\46;W3616U:WLG6.
M)'D&Z1EWL6),./O  *<=S4VJQ:?<++-KGB>R>YN[)4MY;>W*10P,X<OC>W#%
M%^8L!\O'>@#;T_Q/<:EK,]E%:6*Q0W4ENQ>_Q,=A(+"+9[9Z]*H1>/)+LV8M
MK&QC^T:=!?G[;J(@P)2X"CY#NQL.3QU%:>F6FD:.-7O'GMI)(+J:YN;@Q@-
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MLI1 -06REE5\^4IMEG,I&/N@-@^@!/M5X^*XQJTEC]DD;9=26V]&R6VVZ3Y
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MG(AT+P?<>'1 ;:ZMII(8XK6-C;E=L 93)G+DEV"@<87('RT =?1110 4444
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M\S1L4.7"C<0 6QR0.@_4_G0!P']@:RMFUQ?->W=PD]M!)Y5P0TEND<8E9!N
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M7-Z)(9IV4O*OV:%<\ ?Q*PZ#I7,:?X5U>VM;>_AMO*U6QT:QAA#N )61)!-
MQ'8Y7GH&"GG%>ET4 <BFD7X\$^%[$V[?:;-]/,\>1E/+*;^^.,'I3-=T?4+J
MW\:K!;,YO],6&U (_>/Y4@P.>.6'7UKL:* .#NK&_P!4T.ZT^2WUR?S)+8E-
M2%N$VK,A8#R\?P@GGL*9HN@:Q'XATN\OX&(T\R6,<A<'= D;!)3SU<MR/85W
M]% '/7^D2_\ "6VFIV-M"DQL;F*6Y91]\F+RPV.2/E;CV/3-9/AW3M4\,W^J
M7&I11SQ3_9E\ZW!+SRLQ5G.3ZOD_H.,5V]% '.:[I-_J'B71Y[.ZGLXX(+E9
M;B%8V*EO*VKAU8<[3V[50BTJ;PKK,-S:6-]J5J]K)'*\1C:7SFF,I9@2H^8N
MW3@8Z 5V5% 'G&G>$O$,8E,&H3Z5<_V/;QJT7E/&TPEN'9'RI.%\Q1E2/O'!
M/8GTJ^@LK<6&B:MI\W]F16T:VDT,RDH&'DSI*2I ).'[ACR*]'HH \_O['68
MM.\2Z9_9$D\^MP@136Q001NULD+!LL"H5D)Z'((QD\4M]H7B"35;CQ! (?-M
M+J+[+:-#F:6"(,A42>8%7>))B 5/WES[=_10!YJ_A75[6".:QMN;S6_-U"W+
M 9C74#-'..?O!  1U*D?W0*[&RL[B+Q=J]X\9%O/;6J1OD?,RF7</PW+^=;-
M% &-=V=Q)XQTF]2,FWALKN.1\CY6=H"H_'8WY5S::;JG_",6WA8Z5.)XIX]U
M^63R=J3!_.!W;MQQG&,[CZ<UWM% &-XCL[B]BTT6\9D,6HV\SX(&$5LD_A6!
MJWAG4+^Y\5S1W5] +J$+;Q02($G(@"\Y!/7CJ*[BB@#SW2['5=,UB_:2#7DC
MEN()$6S^SF%P+>%#NW_-]Y&!QV'%:GBG0-2\3:FEI'+#:V$%I)^]FA,N^:4%
M,J ZE610W/\ TT]N.NHH X&$Z_;QZC->:'<W%YJ>GQ1'[.T>U9T5T8-EAM4D
MA@?0^HQ6S%I%W;7WA9=F^/3[:2*>13P#Y:J/S(-=+10!Y\_A74VTF9A<7_FM
MKQNA9"1/*,7V_P S=C&?N?/U_P *D.FZI_PC#>%O[*G\\SG_ $_<GD[3-YGG
M9W;MW?&,[O;YJ[VB@#SUO#6L);O.\MW<6O\ ;<MS-I.8PDD1N&=75@ V1\LF
MTM@X(QS5]=&U >&8;7[,WGKKYNRF1Q%]O,N[K_<.[UKLZ* .9U[P^-1\2:/=
MB%VAW,E\%8!9(U!>,./X@) I'U/8FI]<M[J+6M)U>"TDO(K19HY8(BN\>8%Q
M(H8@$C81C.<.<9Z5OT4 <!+H&JZGK,&I+'=:9'/K'VDB-H_-AC6RDBWMG<N6
M;:,<G!'0YQO>)=*N[KP?-IUO-<7-R3$!*Q02'$BDMT"Y !/3M70T4 <?K'A[
M5+^6PTQ;Y[JS1Y+JXN-1A656(4(D6R,QY&69\]B@^E9EAX>\237%O'+J-UI]
MQ9:;)8K?0I$XG99<1N5<,<,H5B!@YR,UZ'10!R,&C:E<>!['2X((K"56"WD%
MP[2"103O&X')#MSGNK$<$\8LFDZT/ 4&BS:3*;M[)HEDLW3&X$[8I=W_ "S.
M03@X(R..,^D44 <WXHTY]=\+:C:MIPEO(D86X=5(:39]^/)X^\1DX/6L_4],
MU"35M0MHK*61+_4+*[CN@5V1)$8BX;)R"/*) QR7'OCM** /-];L]2N'O+[^
MS+FTMXK!HKJ&1D:-4$L;,L&WDAD20MD<_*.#Q5R32[YO%E]=VME=K)<:G;7$
M-\LX\C[.L4*R@KN[A77&WDE3_#D=Y2*JH@1%"JHP !@ 4 <_X7D?;>J(9#:S
MWUU-!+QL"^9@CKGYF+L.,$<YZ9Z&D1%C1410JJ,!0, "EH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG^SR3)I,)C5^,\YZ#(JNVNSKX>U'7&\8W L]/F>"X_XED6Y74@8 [YR,>Q%
M'HE%<%'>ZW/J$UI;ZYJD_DS""2:/283&K8!ZYZ ,*+;4[N[LYKJ#QC,Z07PT
M^5?[-BW+,9!& 1Z$L.?0YH [VBN!TZ^UO4M3DT^/6M5BEB($K3:3"JQY7<,G
M/<4^[O=3M+B:V_X2B\FN8[E;400Z9$S22&+S<+V^YDDD@#!H [NBN)\_5!H%
MUK+^*KJ.VM$E>='TR-9$\O.\%2.HP?KVXJG<ZKJUCIMSJ.H:[JMG:VX0O)/I
M$0SN8*, 9)Y84 >A45Q%S/J\,S10^)KR[D$$=QMM=-A?=&Y8*P[$?*:SX=<U
M2XLK&ZBUO5V2_(^RJ-(AW2@H7W 9Z;1F@#T>BN DU#7(YH+?^V-7:YFB>40#
M28=ZHK!22,\<D5&-8U*8VRVGB+4[MIX6F"P:1$615?8P8'&"&!&/44 >AT5Y
M_<:GJ]M<O ^NZL[Q6\=Q/Y>CQOY*/NQN YS\K< 'I6A,-5ALK2\_X3"22WNY
M(HX9([")@YD("'Z'(YH ["BN!L=4N]2TRUO[3QA/+#<W!M4 TV+<) "=I';A
M<_B/6H8=9U.22\6;Q!J=K'9 FYEN-)B5(OD#X)&>2", =<B@#T2BN'L)]9OK
MU;-_$6H6=R\9EBCN]*BC,J @$K],C(.",C(JM=ZMJ5E=WL,WB34?*L9%BN;E
M=)B:*(E%?DCG 5U)..,T >@T5Q+3ZFNG2WQ\6S^1%=FS8_V=%GS/-\KIZ;^_
MI5.'5]2FECSXBU*.WDNC:)<OI,7E&7>8\9'3+C:"1C.* /0J*X.UO]4O+Q((
M_$M^(Y9'BAN6TJ,12NF[<%;_ ("V"0 <<9J>";4[BUT>YC\6S^7J^W[+G3HL
MG,32C/I\JF@#M:*X ZK=_P!G:O?#QA<-#I3NESMTR,GY>I48^89!&1U(/I4\
MEUJFV VWBJZO#<6OVN$6VFQ.9(]R+D?]]J?IF@#N**X72;G6]9T^:]MM>U)8
M8U++YNE0J9<9!"#/)RN/RJK!K6I2Q7DLOB'4[:&S8I-)-I$0 ?Y<( ,DL=RX
M '.: /1**XG3I-9U"\>S/B2^M+M8_-$%UI<2,R9QN7J",X!P<C(R!D4^)]3G
MUZXT9/%\IO;>(2NO]G18P<9 ..2 R$CMO7UH [.BN'6ZU.33=*OX_%=T\6J
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M_@!%0!T-%<]_8WB+_H:Y/_ "*C^QO$7_ $-<G_@!%0!T-%<]_8WB+_H:Y/\
MP BH_L;Q%_T-<G_@!%0!T-%<]_8WB+_H:Y/_   BH_L;Q%_T-<G_ ( 14 =#
M17/?V-XB_P"AKD_\ (J/[&\1?]#7)_X 14 =#17/?V-XB_Z&N3_P BH_L;Q%
M_P!#7)_X 14 =#17/?V-XB_Z&N3_ , (J/[&\1?]#7)_X 14 =#17/?V-XB_
MZ&N3_P  (J/[&\1?]#7)_P" $5 '0T5SW]C>(O\ H:Y/_ "*C^QO$7_0UR?^
M $5 '0T5SW]C>(O^AKD_\ (J/[&\1?\ 0UR?^ $5 '0T5SW]C>(O^AKD_P#
M"*C^QO$7_0UR?^ $5 '0T5SW]C>(O^AKD_\  "*C^QO$7_0UR?\ @!%0!T-%
M<]_8WB+_ *&N3_P BH_L;Q%_T-<G_@!%0!T-%<]_8WB+_H:Y/_ "*C^QO$7_
M $-<G_@!%0!T-%<]_8WB+_H:Y/\ P BH_L;Q%_T-<G_@!%0!T-%<]_8WB+_H
M:Y/_   BH_L;Q%_T-<G_ ( 14 =#17/?V-XB_P"AKD_\ (J/[&\1?]#7)_X
M14 =#17/?V-XB_Z&N3_P BH_L;Q%_P!#7)_X 14 =#17/?V-XB_Z&N3_ , (
MJ/[&\1?]#7)_X 14 =#17/?V-XB_Z&N3_P  (J/[&\1?]#7)_P" $5 '0T5S
MW]C>(O\ H:Y/_ "*C^QO$7_0UR?^ $5 '0T5SW]C>(O^AKD_\ (J/[&\1?\
M0UR?^ $5 '0T54TZVN[6U\N]OS>R[B?-,2Q\>F%XJW0 4444 %%%% !1110
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MJ /<DXXK)M/"6JVU[9ZR=19]1^W/<7-L2GD[)?E=58)O.U F,G!,:].W:T4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M::93([DGO@2+[98CM734 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\
MXU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO
M_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\
MXU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!
MJ?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_
M:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!
MJ?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP
M_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4
M <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP
M_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\
MZ%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU
M70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\
MZ%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7
MBO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:
MG_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7
MBO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU
M1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[
M#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <
M]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:
MG_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO
M_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70
MT4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[
M#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_
M:7BO_H6[#_P:G_XU70T4 <]_:7BO_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\
MXU70T4 <]_:7BO\ Z%NP_P#!J?\ XU1_:7BO_H6[#_P:G_XU70T4 <]_:7BO
M_H6[#_P:G_XU1_:7BO\ Z%NP_P#!J?\ XU70T4 <]_:7BO\ Z%NP_P#!J?\
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MVN?]@^?_ -%M5[3?^07:?]<4_P#010!9HK)O-3OXM66QM=/AGW0F8.]SLX!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8X(X8;L<A<XYQ<_M#Q;_ -"]I?\ X-W_ /C%']H>+?\ H7M+_P#!N_\ \8H
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MF[H'P59<J=VW<,\?-C!/.:H7]E?WVGZ_<+ISQRWUB+2&U9X][$"0;V(;:/\
M6>IX7UX$_P#:'BW_ *%[2_\ P;O_ /&*/[0\6_\ 0O:7_P"#=_\ XQ0!9,=P
MWB#3+A;"2.W2RFC=BR8B9S$0I ;_ *9D<9'(K8KGO[0\6_\ 0O:7_P"#=_\
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M:+!N!C(W%<,R[&/?GG&<U'!<^*+:%(8/#.CQ1(,*D>JLJJ/8"#BI/[0\6_\
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M:YOVE=;6)T_=;UVC))"]MS8/5CC/4K_:'BW_ *%[2_\ P;O_ /&*/[0\6_\
M0O:7_P"#=_\ XQ0!J:7-/+:*MQ8SVC1J%Q*R'=QU&QF_6KM<]_:'BW_H7M+_
M /!N_P#\8H_M#Q;_ -"]I?\ X-W_ /C% $T9OM/U/4MFF3W*7=PLT<L<D851
MY4:$-N8,.4)X!X(^E"Q7*:[JUT=.E:.2UBCC<-'^]*;R5'S9'W_XL#K4/]H>
M+?\ H7M+_P#!N_\ \8H_M#Q;_P!"]I?_ (-W_P#C% &>FD:E':Z+=&*]66VL
M!:306\T0E4_+\P+':0=O/S _=],5N:#9O:VURTD-S$\\YE87,J.Y^55R=GRC
M[O0$^N<FJ?\ :'BW_H7M+_\ !N__ ,8H_M#Q;_T+VE_^#=__ (Q0!T#L51F"
MEB!D*,9/MS7,^'-&$<2/?Z=>PW$+LZ?:;OS8]S,QRB"1E4@'T&,\5-_:'BW_
M *%[2_\ P;O_ /&*/[0\6_\ 0O:7_P"#=_\ XQ0!F7UEK=QM+V>H7%Q'>Q3,
MWVN-(&C297PB;N3M48W '/5O75UJ.XFU?3)ET:>\BM':7<K0_*Q4@8#N#D9Z
M_K3?[0\6_P#0O:7_ .#=_P#XQ1_:'BW_ *%[2_\ P;O_ /&* +NL0W%UIL+P
M6[/+'/#.8-RAB%=690<[<X![XSW[U-%?73VLLS:5<QLGW(&DB,C_ $P^T?BU
M9G]H>+?^A>TO_P &[_\ QBC^T/%O_0O:7_X-W_\ C% #=.M[ZYT>_P!,N;&Z
ML&N&NF6X9XF"^;([+C:Y.X!P?3@\U5LM+O3+807-IJ0^RR(VYKF'[.I7NNWY
MR,< ;1D'!Q5S^T/%O_0O:7_X-W_^,4?VAXM_Z%[2_P#P;O\ _&* *>HV6I2S
M:A]ETV[BN+ASMECN(FMI?E"J98W8XX #!5S@<<].MKGO[0\6_P#0O:7_ .#=
M_P#XQ1_:'BW_ *%[2_\ P;O_ /&* .AHKGO[0\6_]"]I?_@W?_XQ1_:'BW_H
M7M+_ /!N_P#\8H Z&BN>_M#Q;_T+VE_^#=__ (Q1_:'BW_H7M+_\&[__ !B@
M#H:*Y[^T/%O_ $+VE_\ @W?_ .,4?VAXM_Z%[2__  ;O_P#&* .AHKGO[0\6
M_P#0O:7_ .#=_P#XQ1_:'BW_ *%[2_\ P;O_ /&* .AHKGO[0\6_]"]I?_@W
M?_XQ1_:'BW_H7M+_ /!N_P#\8H Z&BN>_M#Q;_T+VE_^#=__ (Q1_:'BW_H7
MM+_\&[__ !B@#H:*Y[^T/%O_ $+VE_\ @W?_ .,4?VAXM_Z%[2__  ;O_P#&
M* .AHKGO[0\6_P#0O:7_ .#=_P#XQ1_:'BW_ *%[2_\ P;O_ /&* .AHKGO[
M0\6_]"]I?_@W?_XQ1_:'BW_H7M+_ /!N_P#\8H Z&BN>_M#Q;_T+VE_^#=__
M (Q1_:'BW_H7M+_\&[__ !B@#H:*Y[^T/%O_ $+VE_\ @W?_ .,4?VAXM_Z%
M[2__  ;O_P#&* .AHKGO[0\6_P#0O:7_ .#=_P#XQ1_:'BW_ *%[2_\ P;O_
M /&* .AHKGO[0\6_]"]I?_@W?_XQ1_:'BW_H7M+_ /!N_P#\8H Z&BN>_M#Q
M;_T+VE_^#=__ (Q1_:'BW_H7M+_\&[__ !B@#H:*Y[^T/%O_ $+VE_\ @W?_
M .,4?VAXM_Z%[2__  ;O_P#&* .AHKGO[0\6_P#0O:7_ .#=_P#XQ1_:'BW_
M *%[2_\ P;O_ /&* .AHKGO[0\6_]"]I?_@W?_XQ1_:'BW_H7M+_ /!N_P#\
M8H Z&BN>_M#Q;_T+VE_^#=__ (Q1_:'BW_H7M+_\&[__ !B@#H:*Y[^T/%O_
M $+VE_\ @W?_ .,4?VAXM_Z%[2__  ;O_P#&* .AHJIITM_-:[M2M(+6?<1Y
M<%P9EQV.XJOY8JW0 4444 %%%% !1110 4444 %%%% !1110!6OM0LM,MC<Z
MA>6]I;@@&6XE6-03T&20*;I^J:=JT#3Z;?VM["K;&DMIED4-@'!*D\X(X]ZY
MGXEZ=>ZEX8MXK&"XFECU"VF9;=%>1460%F56^4D#G!XJ?PI<SVUE%;366LNT
MUPX,UY:00&,!,Y818&WC ."<G'2@#<N=:TJS>1+K4[.!HV1'66=5*L^2H.3P
M3@X'?%-N-=T>T>Y2YU6QA>U"FX62X13"&QM+Y/RYR,9ZYKS/QKX-U/Q!KFMP
MI92FVO;S3]DPZ!5AF5G_ . EEK"7PCXKOK'5[Z]TV9-3U>"SEF!4-MD2]/&,
M\[8E0D>E 'M,>O:/+ILFI1ZM8O81G#W*W"&)3[MG ZCO3&\2:$FFIJ3:UIRV
M,C[$N3=((F;T#9P3P>/:N#U3P+=:2+;4T1]<?^UXK[4+6*".(2(L31KLC!"D
MJ2&P3R1ZUFWGA?6-8U*34++3)]*M+S7;6>.&2&,O"L<$B/.T?*C<Q7@\G )H
M ]+E\5>'8;:&YEU[2XX)RPBE:\C"R;<9VG.#C(SCUJQ!K.EW/V3R-2LY?MF[
M[-Y<ZMY^W[VS!^;'?'2O,CX2U(?#K7]-N-+>;6GU,3-*(T"7.98OWD0  52B
M#*]00<YI?%7ASQ/J/B>YUW2=,MDBT0Q#38W<QO)L/F2F-0,$/N*<D?=H ]/;
M5=.59V:_M0MO((IB9EQ&YP K<\$Y& >>1ZU5B\3^'Y[X6,.NZ9)=ES&($NXS
M(6'\.T'.?:O*M6\)>(I+W6-5TZSGV:IK,(NK23@M;JT,B3*,]599%/LQ]*[R
MVT0Q?$K5-2.GJMJ^F0)',J 9E$DI;'^U@KS[B@#KJ*HZ,,:+9@K>KB)?EOFW
M3CC^,Y.6]>:O4 %4=1UG3-(6,ZC?V]J),[/.D"EL=<9ZX[^E7JYF],^E>+YM
M5DL+J[MKBPCMT:VC\QH71Y&8%>H#AUYZ?)SCB@#HXI8YX4FAD62)U#(Z'(8'
MH01U%+))'#$\LKJD:*69V. H'4D]A7GUY:ZR0WDZ9?6$[6L/]EV]E,1!:R;F
M+B380G=2VX$$9"YYS#J>@:S<Z/?JO]I2W%['JT4L;W3E2I:3[. I;:HP$QC'
M!QT)H ])ZC(HKSJ?3]2%O<W,<>L%9KZ**,27%PWDVHMT.3$KAF_> @X(;).3
M@$%FFVVN+;VPU>#6Y66$I:+;SNA647$O,AWD8,?DX+EA@,,DDY /18Y8YDWQ
M2*ZY*Y4Y&0<$?@01^%/KS&'2]1LK.2V>UUSR$-\($MIY WVAIV:-B0W*E"N"
M3M!W9P3SU7A?3]1AN-1N]6DN7O'E5%W3L8M@BCSL3.T#?OY SUH Z2BBB@ H
MHHH **** "LF34[Y[^ZMK+3HYEMV5'>2X\O)*AN!M/8BM:L"._CTW6=5%Q!>
MXEE1XVBLII58>4@ZHI'4&@"W:ZE=MJ:65[8I;M)"\R,D_F A2@(/RC'WQ^M:
M$$\-U;Q7%O(LL,J!XY$.592,@@]P16-#>)J'B6VF@ANQ'%9SJ[S6DL(!9XB!
MEU&3\K=/2N4TFV\10:CH,ERNIS2BVM4N4F>0*O[H"1MX?8<')977<3R#TP >
MD4R66.")Y99%CC12SNYP% ZDGL*Y'7--U2?6;^\MWOQY*V1LUBN'6/(E;S?D
M!"M\N,Y!XK!U/2=<U#1]1LQ!JKWTMG?)>^9._DS,0WDB,%MO)VXVXPN0W7%
M'I]%0VA4V<!1953RUVK-G>!CHV[G/KGFIJ "L*XUR[349[:&VL=L<XMT:YO3
M$TC^4LI"J(VZ*WK_  FMVN$\1Z>FJC5M(O%O8;6YODF>6'3Y9BR"",#8RH5!
MWK@^P(QSF@#HM.UJ>ZG1)[>V$4ML;F&6UN3,LB @=T7^\",9S6E!>07"Q;7"
MO+&)5B8X?:?5>M<]8-/J%U$&BE$D>FO!+(UI+;QF0E?NAU''!.!G%9&D^$=4
MT_6M,N1%;*L*0?:)"ZR*VRW$1V@IO5\C *L%*\D9R" =VUQ"CE'FC5@"Q4L
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MYA^4<#!QG)^=OQR&\&ZK]OOFABMHH)I'?YW5R2URDN4;8' (5BRLS#. ..:
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M\)YX=_Y^[C_P"G_^(H_X3SP[_P _=Q_X!3__ !% '245S?\ PGGAW_G[N/\
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MZP+32+:YM-**^<QO"DS@QK(=B>65) ;@%ADCM0!/_P )OH/_ #VO/_!?<?\
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MLF3CYBLA"XXSR>U4=+^($NHZ3)J/EZ(52RDNS:P:J9+@;4+;63RQ@]CSQ[T
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M%5UIDTEK?:=$;U8(72.VN"ZR233-$B!F1<#(4EB.,G@XY )_^$WT'_GM>?\
M@ON/_B*/^$WT'_GM>?\ @ON/_B*HZIXNU+0X;B/4-'@>]%O]HM8[6[+).!(D
M;+N9%*L#(G;!!Z]<:FF>)+?5[^&&U0F&6S%T)&.&4[RA1E[$$$'T((H A_X3
M?0?^>UY_X+[C_P"(H_X3?0?^>UY_X+[C_P"(I=1\3?9+N:VM;0W4J31VJ*'V
M^9<.-X3.. J?.S=@> 3Q48\4_P!GW5Q::_!%9S1I%)&UL[SK*)'**%&P-NW#
M&,=P?7  _P#X3?0?^>UY_P""^X_^(H_X3?0?^>UY_P""^X_^(J5/%^B/.D/V
MJ5&?>%:2VE1244LXW%<94*=PSD$8//%*/%VC>7N::X1O-6$126DJR,[*64!"
MNXY"MC [&@"'_A-]!_Y[7G_@ON/_ (BC_A-]!_Y[7G_@ON/_ (BGCQ9IS@31
M/)+:BW$[F.WF>1 695S&$) RDF<X(*]*=%XOT2=+9X[J5DN$C=&^S2@*KMM0
MN=OR!CTW8S0!%_PF^@_\]KS_ ,%]Q_\ $4?\)OH/_/:\_P#!?<?_ !%/'BJR
MN-;L],L@\\D\DJO(8W1%6-6W,K%=KX<*IVG@M^!%\560\0W>DS+)&T,D<*2^
M6[(\C1^9M+!=JG:1@$Y.?S &?\)OH/\ SVO/_!?<?_$4?\)OH/\ SVO/_!?<
M?_$5IV6L6&HM$MI<"4RVR7:X4_ZI_N,>.,X. >>#Z5F?\).6T8:@EIGS=2^P
MP1^9_K!]H\G?G' P"^/04 '_  F^@_\ /:\_\%]Q_P#$4?\ ";Z#_P ]KS_P
M7W'_ ,12:?K^IZF+>^M=)C?2+B0+'+]I_?&,G EV;<;3UQNSM.<9XJOX:\7/
MXCG1H?[(%NX=PD6H^9<! 2%+1;!C/&?FXS0!9_X3?0?^>UY_X+[C_P"(H_X3
M?0?^>UY_X+[C_P"(JU+XHT>&YN();IHS;A_,=H7$8*@%@'QM+ $< YII\5:2
M(?,,MQO\WR?(^R2^=OV[\>5MW_=YSC&* *__  F^@_\ /:\_\%]Q_P#$4?\
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M?9(%8KAB&(& 2>:3_A,-&(?$USYB2B%H?L4WFARA?'E[-WW06Z=,'N* (_\
MA-]!_P">UY_X+[C_ .(H_P"$WT'_ )[7G_@ON/\ XBMV">*ZMXKB%P\4J!T8
M=&4C(-85KXQTF80*]P/,F,6TPQ2N@65ML)9]@"[^,9QR<<]2 '_";Z#_ ,]K
MS_P7W'_Q%'_";Z#_ ,]KS_P7W'_Q%)<^,=.$3?8B]S,98HXU,;QK+OE6+<CE
M<. 6Y*YJV_B?1X[:&X:\_=SPF>(B-B70,J9 QDDLZ@#J2> : *O_  F^@_\
M/:\_\%]Q_P#$4?\ ";Z#_P ]KS_P7W'_ ,15:/QSI[SW32$06EM(ZO+.)$<J
MD:,[!-F1M:5%(.._TJ__ ,)9H^QCYUQO64PF$6DOFA@JN?W>W=@*RG.,88<\
MT 0_\)OH/_/:\_\ !?<?_$4?\)OH/_/:\_\ !?<?_$5?.O::-&@U<7!>RG"&
M%TC9C)O(";5 W')(Q@=ZK'Q;HJB,FYDPZAF/V>3]T"Q0&3Y?W?S CY\=#Z&@
M"'_A-]!_Y[7G_@ON/_B*/^$WT'_GM>?^"^X_^(ID7C"T-Q.)PD4,4DL8P7>1
MRDHB7:BJ<[G$@P#GY1@')PR\\;6%OY#6Z27*RM''Y:12B56>4QC*;. "DN<X
M.4Q@YH F_P"$WT'_ )[7G_@ON/\ XBC_ (3?0?\ GM>?^"^X_P#B*;J'C72K
M&RO9D^TS26T+RK$MM(//VL$/EL5PPW,HR,@;@>E//B_3(3.;B4J(V; BAED=
M415+LZA,H%9B"3QQUSD  3_A-]!_Y[7G_@ON/_B*/^$WT'_GM>?^"^X_^(JT
MOB;27U,:>ERSSF4096%RGF&,2!=^-N2ASUJM:^+].FFV2NT8DE"PLL;NI1FV
MQN[!=J;V!VY/(*GO0 G_  F^@_\ /:\_\%]Q_P#$4?\ ";Z#_P ]KS_P7W'_
M ,14J^,-#,$DYO'6)%1P[P2*)%=PBLF5^=2Q RN1R/456G\<:3#/ O\ I'E,
MEQ)/(]M(GV=(5!<N"N1C*CG'WAZC(!)_PF^@_P#/:\_\%]Q_\11_PF^@_P#/
M:\_\%]Q_\14Z^*]),L49DN5,K(@9[.95!=MJ;F*X7<>F<9R,=152_P#&^DVE
MK++#]HN75E2-([:7$Q:01C8VW#C<P&5SU'J,@$G_  F^@_\ /:\_\%]Q_P#$
M4?\ ";Z#_P ]KS_P7W'_ ,16AJ>N6&C^6+R213(KNJQPO(=BXW,0H)"C<,D\
M#(IDWB+2X8C(UT-HF>#(4\R(C2,.G958YZ<=: *7_";Z#_SVO/\ P7W'_P 1
M1_PF^@_\]KS_ ,%]Q_\ $5'8>,K._P!+M+@@6UW+]G\VWN1)'Y?F#<<$I\P"
MK)AL;3L/(Y(M)XLT:2"29;F4*@C(5K:57D#DA"BE<N&(."H.<4 0_P#";Z#_
M ,]KS_P7W'_Q%'_";Z#_ ,]KS_P7W'_Q%36'BBRU361I]G'</_HQN'E:%T"?
M.4"G<HPV5?@X(VD?2.;QGH<-Q) UQ.TD;2H1':3."T9PZJ54ABO<#.!STH ;
M_P )OH/_ #VO/_!?<?\ Q%'_  F^@_\ /:\_\%]Q_P#$59_X2C23<0PK/*QF
MV['6WD:,EEW*N\+M#%<$*3GD<<BLK3OB!IM^49K>[@B:U6YWR6\G*O(4B &W
MYB^"0!UZ#- %S_A-]!_Y[7G_ (+[C_XBC_A-]!_Y[7G_ (+[C_XBK*>*-)DD
MM8DFF::Z9UCA%M)ORC*K[EVY7:77)8# .>E37'B#2[2[6UGNU2=KB.U"%6R9
M77<J].X[]* *'_";Z#_SVO/_  7W'_Q%'_";Z#_SVO/_  7W'_Q%1V_C;2[C
M5VM%9S;E;?RKE8I&1WE9E520N%!PF"2 V\8][/\ PE^A^3-,;QEBB3S/,:&1
M5=-P7<A*X<;B!E<]1ZB@"+_A-]!_Y[7G_@ON/_B*/^$WT'_GM>?^"^X_^(JS
M;^)]*NKN.UCEG$KOY8\RUE0!]N[8S,H"OMYVD@]..1575/%<.F^(8]->(^4L
M'GW,[)(=@9MD:H%0AV9L@#(Z8&3Q0 O_  F^@_\ /:\_\%]Q_P#$4?\ ";Z#
M_P ]KS_P7W'_ ,14\OBO2(K1;EI;@H3("BVDK.FS[^Y NY0,C)('4>HITGBG
M1XKB2%KHYC7<T@A<QC]WYN"X&W.SYL9SB@"M_P )OH/_ #VO/_!?<?\ Q%'_
M  F^@_\ /:\_\%]Q_P#$5%IWC.SNKV:TNU^SR1ND0D59&B=S LS*'* # 8\'
M!.T\#I4VE>+K#48+$2[X+JZCC+1>6[)$[H'$;2;=H?:1P2#R/44 )_PF^@_\
M]KS_ ,%]Q_\ $4?\)OH/_/:\_P#!?<?_ !%:?]HA==_LR2/:7M_M$+Y^^%8*
MXQVV[D^N_P!JO4 <]_PF^@_\]KS_ ,%]Q_\ $4?\)OH/_/:\_P#!?<?_ !%=
M#10!SW_";Z#_ ,]KS_P7W'_Q%'_";Z#_ ,]KS_P7W'_Q%=#10!SW_";Z#_SV
MO/\ P7W'_P 11_PF^@_\]KS_ ,%]Q_\ $5T-% '/?\)OH/\ SVO/_!?<?_$4
M?\)OH/\ SVO/_!?<?_$5T-% '/?\)OH/_/:\_P#!?<?_ !%'_";Z#_SVO/\
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M[XQ&@18U?/RI\H;"@<^O2EM?!!C2SCN=4:>*RBMX($$ 0".&19 #SR6*1Y/
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M[M L2@>5)#'&B D@@32L2>,L,>@L6W@9+18YX+FUBOX9HY8I8;!(XQL1T 9
M<MD2,3\W7!&,8KKZ* ,C2]%ET_4;B\EOY+MY[>&%VE0!LQ[CG(XP2['&.,U0
M/@Y#9F$7T@?['=VPE"#(>X<.\G7KD<?C7344 <@_@2)]52\^V@"&9I8?W ,J
M9B:,)YA.=J[@5  Q@9SUIC> DDM$ADO8I/+BM$C#VH9 8 P4%2W*D,WRYR"<
MYKLJ* ,'1/"]OHMRMQ'(K.(#%A(5C7+.7=@%X&?D&/1!DGK5+7/ UMKFHW=[
M)>SPO/'#&OE@?NBD@=F4_P!Y@JKGL!QUKJZ* .?_ .$3M<NHE*Q/?1W;1JH
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M#9Z:7M+2V*/*);NY>.+.1\H 8;SSG!/';/;J:* .&BU*QF\!2'4=2GC,=U+
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** ,>>TU2VO[N?31:.MWM9_M#LIB<*
M%W  '>,!?ERO3KSQ3N-#NX5TNWM8+.ZM;*S:V*W<K*7!"KT",.B_K7244 9=
MI'J\-K=M*EHT[R@V\"S-Y<:!47;NV9ZAC]WOBDT&UU"QL!:WT=L/+SL:"5GW
M9))R"HQU'K6K10!G6":PNHZBVH2V;V3.OV%8$82*N/F\PG@G/3%:-%% &5/:
M7]KJ$UWIJV\RW(7SH+B1HP'48#JP5NP (QV'(YS%/9:K+<:7-(;.9H)'>X)+
M(,,"N%&#G ;N1G';/&U10!S=OX>N['3=9M()HI5NODM%D)7RH]@4*Q .=O('
M'0#/.35_0M*CTRTV_P!FZ?9S$!6^Q@8< <$G:ISUK5HH QK719(->FO&F4V@
MWO;P@<QR2;?,)_%<C_KH]"VFJZ>\\6G"SEMII7E4W$C*T+.2S<!3O&XEL97K
MC/ILT4 8%[H<FHZO:27]K87MG%:O!*9QEF9]I+!"I ^YTSW]N7/I%]]@CMO.
MBF-G<K+:^>S'S$7HDG&<C. W)RJL<GBMVB@#"_LJ^ET_6#(+6.[U!"HBC=C&
MGR; 2VT%CZG:. !VR7PV.IW,MFU_]DBBLSO2*!V<RN%*@LQ48 R3@ \XYXP=
MJB@#F;30KZWL5D$5C%J,-[+<Q-&[%7660LZ,=H/(8CH>55NV*V=0LGOA:(65
M8H[A)I5_O!,LH'_ PA^@-7:* ,2^T9]1U:?[7!;S:9/;+#(K2L'RK%@0 /4C
MN",9J!M%OIH=4206D?GWD-U JLSJ?+$8".-HP#Y0Z9QN]N>BHH S--L[I+^[
MO[Q8(IKA8X_)@<NH";OF+$+ECN]!PH':M.BB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD)X+E@K/%(5<["<8.-B'D9P_T-:%LES8:];6CZA<74=Q:32OYVWAT:( K@#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** *DFE:=+>B\DL+5[I2")VA4N".GS8SQ4E
MW8VE_#Y-Y:PW,6=VR:,.N?7!JC+J=[+>7$&FV$5PMLP2:2:X,0WE0VU<*V2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>.01STH V:*H0HVEVEQ<7NISW$2)YC-,D8\M5!)(V*.WUZ5B6>HZE%K.GQ7
MU'R;UG7;>K;*!A&<%1&=X/RXPV>#S@T =517*7-SJT,>O7W]JR&/39F,-N(8
M]KJ(TD*N=N3]X@$$$#&<FK6J6=Q<>+=.,6IW-J#9W'RQ)&0,/#_>0]<_I]:
M.AHJG>K<1:-<+#>I%<I;L$N[A051@O#N!@8!Y/04:2T[:/9M=7<-Y.85,EQ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRI_=!]*IMXBLT^U!HKO=;3I;NOV=LL[8("\<\$'CU%%AXAL]1N5MXH[I';S
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M') D. V1NP.YJ!/$^N3V,NHZ7>3WLICNY6MI+<>5;Q;\0-\J;B=I5L9.Y=Q
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M_%U0FU#QA#KMGI9DT,O=6\TXD\F;"B-HP1C?W\P?E785SU]_R4'1/^P=??\
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M;/DNT;1M^\Q_ST0\G'4%QUQ0!W.SQE_S\:#_ -^)O_BZ-GC+_GXT'_OQ-_\
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MR_Y^-!_[\3?_ !=<9JMYI]I;:E/?V]I<^)H[Z=EBGNV@N_+#L8!;81F.4$8
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MV54L638%C7<",G>3C!)"X'J "39XR_Y^-!_[\3?_ !=&SQE_S\:#_P!^)O\
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M"XEC4*0T@$[-@*><X[5RHOH-0F\$ZC:MX?L8Y=4A>VT[3HP9X8W5@V^0,.Q
M8! ,D<U[&]I;274=T]O$UQ$"L<K("Z ]0#U&:AATG3;:1Y(-/M(G=Q([)"JE
MF'1B0.3[T <AX4TFPF\<>,=1FM8I+N/48XXY77<8P+>(_+G[O)Y(ZX'H*XWP
M?+?6J>'=2URWA/AR*\N;:TPY/DW#S/LGD'3!):,9^[D'^*O:DBCC9V2-%:0[
MG*J 6.,9/KP!3#9VQMC;&WA,!ZQ;!MZYZ=.O- '&?%PH/A]<&23RD%W:;I-V
MW:/M$>3GMCUK%^UZ3%X]\.RZ%XD?7[R622WF@>Y6Z$%NR$O*K+_JR"J G/S
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MMQ'$EQ(WS;A(8V(DP-OSG!)8]>M7;[_DH.B?]@Z^_P#0[:NAKGK[_DH.B?\
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M5K=EN+=02#,=@WJ?HF#G^ZO3G(!MT444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 (SJB[G8*/4G%1_:K?\
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MH+R3%M!*IB^;G*C@_(>"![9HCM_"$VC6=VG@O3C>W=PUHEB;*$2"9=V]6)&
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M]XO^^Q1]JM_^>\7_ 'V*R/\ A"_"O_0LZ-_X Q?_ !-'_"%^%?\ H6=&_P#
M&+_XF@#7^U6__/>+_OL4?:K?_GO%_P!]BLC_ (0OPK_T+.C?^ ,7_P 31_PA
M?A7_ *%G1O\ P!B_^)H U_M5O_SWB_[[%'VJW_Y[Q?\ ?8K(_P"$+\*_]"SH
MW_@#%_\ $T?\(7X5_P"A9T;_ , 8O_B: -?[5;_\]XO^^Q1]JM_^>\7_ 'V*
MR/\ A"_"O_0LZ-_X Q?_ !-'_"%^%?\ H6=&_P# &+_XF@#7^U6__/>+_OL4
M?:K?_GO%_P!]BLC_ (0OPK_T+.C?^ ,7_P 31_PA?A7_ *%G1O\ P!B_^)H
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MP^U6_P#SWB_[[%'VJW_Y[Q?]]BN%GB\&V<:->^#+&W8V;W31/IT.\%9%C\L
M#EBS@#!P>.>:2[LM!TW3[Z[U'X>6$"V]H]TNRU@D5PF,H6 PK\C /!YP3@T
M=W]JM_\ GO%_WV*/M5O_ ,]XO^^Q7 7DG@>WL(KR#PEI<\<MC+>*/L,*D;'C
M1D8%>&#28(/0J:DGL-"M+$SS^ ='#M/#;Q1HEN^]I'VC)"_+@D=: .[^U6__
M #WB_P"^Q1]JM_\ GO%_WV*Y/2M$\+ZA=75E<^#=+LKZU"/)#)9P,"CYVNK*
M,$$JP['*GBM7_A"_"O\ T+.C?^ ,7_Q- &O]JM_^>\7_ 'V*YZ^N(/\ A/\
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M("DCN,XS4VAZ7X=UR.&X3P#86]G,I9+B2VMB".WRC+<_2@#M/M5O_P ]XO\
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M+X<T_4+&QM?!.DWEQ=I*ZJ+:&,*J;<Y)7_;% '7_ &JW_P">\7_?8H^U6_\
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MS3S?ZK3+1]JD=V=^&*C/)X7MM)QG1TBPBM(2X:%YB-C&%0J(!T10.@&?ZT6
MP[/P2++4_#]]%>[6TV!8KJ,)\MTR0-$C]?E8!V]<C /059O/"PNM'U>PEN(R
MFH7PNFWQY4*&C)4C/.0A'XUM7NHV]@JB5BTKY$<,8W22'T5?Z]!W(K"MX[[Q
M)=/-J'^CZ1$2JVBD$7##J7;NHZ8'!.?O  DL!F0^$[._EOHM(*V6@7LL+W,,
M,7EK,R'),+*00K *"0,'!*GDFKI\%R6EY)<Z7J#1%;I+VW6Z,EQMF\MHI-S,
M^YE=& Z\$9]JV6UJ*4B+2X&OWSMW1$")/]Z0\<>@R?:E73[N\);4KH^6>EM;
M$H@^K_>;_P ='M18#,N=-O=6T36=+O=5BFN[^-H@((CY5J"FT#&2?<Y/)/ %
M7+_2;X:S_:VE7-O%<26ZVT\=S$71U5F9"-I!!!=_7(;\:UX8(K:%88(TBB08
M5$7  ]@*DI <<GP^TZ>>-]76WU)3!<+.)H!\TLT@D9UY.S&"!CD#'-/@\'7!
MTV2VNM2$D\26\=G<+#@QB"0R1,RYP3D@-C ;;VSQUU% '(ZEX4U#7HKIM6OK
M4S/9O9P+! PC179&=F#,2Q/EJ,<  'KFKU_X0TJZCL+>'3[&"TM[T74MNMJN
MR;$;I@J!C/S Y.>E=!10!RFL>#TN]0T^XL;71UM[2WE@6UN[+S(AO9&W*H("
MGY#_ -]&H9_ %AJ;W<FJP6+R36<%M"UO;!/LIC+D-$3DK]Y>/]GN*[&B@#FH
MM$UNSN'N[/4;'[5=0QI>>=:L4:5%V^:@#C&1C*DD<#D<YHCX;Z1,'BU"..]B
M.GQVB/+$/-1U>5VE5OX68R9XQ@BNSHH R8;^WT33K.UUK5[%+I8@IDD=81+C
MC<%)X_#BM**>&<$PRI(!@$HP.,@$=/8@_0BN/U*VO9/&EQ<E-5B@%O!;Q/:6
M\,B/AG9B3(I(Y8#C'W?I66--\5R:I(8C/9PW,[3JR*3AC.XRY$BCY84AX8,#
MDX!/% 'HY(49) 'J:6O/9].U;4;* 7]IK/G/=1->!+O;&,2A_P!VJMD*H0*"
M,</DY(RKO[.\1_8TA=]5-W<6,4D<R71V0WC%O,+_ #<(@V87&TC=P30!WLLL
M<$3RS2+'&BEG=S@*!U))Z"GUP,VE^(9_LQ\V_P WGF&[5IR5C62ZC8*%S@;(
M?-''MUI OB%[&W+6FKK=S[1>L;D&-7PS,(T5P0H8! 59 0P))P: .[>X@CD$
M;S1JYQA2P!.3@<>YJ2O+O[-UH:8M[J\LMI-%:+YEU-+@QE;>0K\Q).1+<D Y
M)S%U/4]23K,_A.YO'6ZAU&^"NL,6&:T5L* %+#E5^9@"#G=@]* .F,B"58BZ
MB1@65<\D#&2![9'YBG5YI-<:QIHLGU5KJVM2?+D O,2NA:9FV,[[@<1P$C<6
M5789XXN:7::[=Z=9W?FZFA8VKQ)+<ME4:9I9-_/S8B98_FS]V@#OZC-Q J.Y
MFC"QG:[%AA3Z'TZBO/+"V\7LJ3ZC+?;)3&M]#""K@DEF\LF5L8("90+\K9&2
M.-)],O$\%6]HUI?&2YOUGN$60-/'&9_-Y8GDA0%)R3]30!VM(2%4LQ  &23V
MKA+/^V5U6'2S<W)66.6:X4W'F26D*S%HU)R3O=&"9SG"DY.T&MK7;:XN-$LA
M#:W-Q#]JBFNK9V#2/%NW,IR<'!QE<\@$#/2@#8M]2L;M0UM>VTRL_E@QRJP+
M8SMX/7 )QZ5:KAM6M]2N+T7]EH,ENRAV61'42L<)$CL!G!5)9R%Y.$[$X%%-
M/\4O9WI<ZA^ZCNI;6$7#J7D_=K"I)D8E<K(V"Q&'_"@#T19HG@$ZR(T)7>)
MP*E<9SGTQWJ"RU*PU)7:QO;:Z"'#&"57V_7!XKD5TW6+/X<:KIC13S:BL4EG
M%Y?W63&R-HUSA0$*G'7(.23R<^+3=;M[B:2VM-0:"<06R3S+'%.B()&(*PE/
MD+% #E6R3DX R >B^;'YWD^8OF[=VS/S8Z9QZ4^O,-/TSQC%>1ZC*DTDIT](
M!$TF&,Z1/,F]MQ)C\R1HR,\E5R2*T=*TGQ%<3VT5_>Z@+1Y@\Y#O"Y"Q.#SY
MK,-SNG *C]V<  Y(!WU%%% !7/\ CK_DGWB3_L%W/_HIJZ"N?\=?\D^\2?\
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MK$\B6MFJFX\^:*1WMV*Q_P"E)%'GISY9=R,]AT!% '1?:/$'_0,TS_P82?\
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MF:M.YDRNP[RT1+_+Q\V<#I47]@7/E(@T2P!1]XD&L7 D)V[>7\K<1MP,$XP
M.U=910!S-[I5_?V]K!+HVGI':'-N+?5YX/+^4KP8X@0-I(QZ&JLOANXG9&FT
M>UD*Q>2=^NW3>8FXMM?,?SC+-][/7'2NPHH P1;ZJMW!=+HNE+-!"T$1&HR
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M1P.2+6I^+KE4O[);<+<V7FFZV2%?+0.GDD'L75PW_ 6% &MY/C+_ )_]!_\
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M))-^UR+?S3^]4,JD88%& . 6&>A -;R?&7_/_H/_ (!3?_':/)\9?\_^@_\
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M_P#CM'D^,O\ G_T'_P  IO\ X[70T4 <]Y/C+_G_ -!_\ IO_CM'D^,O^?\
MT'_P"F_^.UT-% '/>3XR_P"?_0?_  "F_P#CM'D^,O\ G_T'_P  IO\ X[70
MT4 <C;:'XCL[J:ZMI/#D4\Q)=UL)LG)W'_EKQD\GU/-619>+5N'G%YH'FNH1
MG^PS9*C.!_K>G)_.NEHH Y[R?&7_ #_Z#_X!3?\ QVCR?&7_ #_Z#_X!3?\
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M ..UT-% '/>3XR_Y_P#0?_ *;_X[1Y/C+_G_ -!_\ IO_CM=#10!SWD^,O\
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M7_/_ *#_ . 4W_QVCR?&7_/_ *#_ . 4W_QVNAHH Y[R?&7_ #_Z#_X!3?\
MQVCR?&7_ #_Z#_X!3?\ QVNAHH YJ*R\6PF0Q7F@(9'WOBQFY; &?];["J]_
MHGB/5 @OI?#EP$SM\RPF. >H_P!;T.!D=#76T4 <[Y/C+_G_ -!_\ IO_CM+
MY/C+_G_T'_P"F_\ CM=#10!SWD^,O^?_ $'_ , IO_CM'D^,O^?_ $'_ , I
MO_CM=#10!S,UAXKN'B>:Y\.R-"^^,OI\I*-C&1F7@X)Y]ZE\GQE_S_Z#_P"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4C*&4JP!4C!!'!%+7/>.F=?
MNM&,X<6KX^;';U'2@#7L]-L=.C>.RLK:VC<Y98(E0,?4@#FI8K:" @PP1QD(
ML8V(!\JYVKQV&3@=LUPCZ=K.@L]W:I8Z2MW+:V:V]O.]T@+S8:4AU0!MK8
M^I/ JNOB_7%U.[MVFM \,EU"8IPHVK%&Y24JA,GS%58\8VOQSC(!Z%'9VT._
MRK>%-XP^U -W)//KRS'\3ZU7;1M*::*9M,LS+$JK&Y@7* = #C@#M7#V/B^^
MN5BMI]5AM5:Y*37\BPLB#RMZJKJQC8L<G) ( P1D@U/;:WJ>H7L4\M[;SVB:
ME:VT:);&,-OMXY3)R=PY<X!Z \YH [L00@2@11@2DF0!1\Y(QD^O  I@LK5;
M=[=;:$02##QB,;6&,<CH> !7E>E>+=3T[PEI26FH6^HAM-MFFD"KFQ)>*/YR
M6QG:SGYR.8R3QP+UQXJU*YTN:&YU2TL8?(O"EXP1A<-'L"IE6V[OF;.TY.WC
M'( !Z#%I.FPW9NXM/M([DY)F2%0YSU^;&:LF*,RK*8U,B@JKD<@'&0#Z' _(
M5Q6K73P:9X,<ZHFGAYE#W,N"!FTEZ[N,DXQGOBH[+Q3K,\NEVLBQ&7550VLR
M1$*5CD;SWQG@&((Z^[XYH [.\TZQU#R_MME;W/EG<GG1*^T^HR.*F$48E,HC
M42%0I<#D@9P,^G)_.N/\326?_"2I%K;0?V?]@+6<5W/Y5O+<[CN#MTR%V8R#
M@%B <&N::[L[ZQTUIKBQBAB6Z2&UU6]=K:=1+@/%<8&2H&%)5CM(QW) /3TT
M^RC7:EG;JN5; B4#*G<#T[$DCWJ0VT!@> P1^5)NWQ[!M;<26R.^23GUS7F-
MYJ>J:M9Z6^C6.ISG2;&*\*^>A8SD@HDC,RE\QHX. 21*#C.*W/$SKX@?PJ]@
MEO=V]Y*\J)<.RQR(8&8$[03Z'ZT =4='TQK)+(Z=:&T1MR0&!?+4^H7& :??
M6$.H6P@EW*%D21&0X9'5@RD?0@?RKSS6)=2M;V+^R],F:/P[$LLD=C*OE"9R
M'E0AV5F_<YQ@'_6].!5'55DO3XCU:WAMVL_M\8_M5)G\^SB-O ?-1  "J[MW
MWAU)P>A /56M+9H&@:WB,3L6:,H-I).XDCUSS]:K)HFDQW?VM-+LEN=Q?SEM
MT#[CWSC.?>J&NW#'4-!MU+-;SW3.^P_ZS9$\B*/^!*&_X#7"7.I:K)+XC-_#
M?6=Q<VVGLPG<+#;!KB1-I*L2(]I&YA@D*YXXH ]4^S6Y\[]Q%^__ -;\@_><
M8^;UXXY[4XQ1M$8BBF,KM*$<8Z8QZ5QFA37R^"]>737CFN[>2Z6S:W8O"6V;
MD$1/506"X[,&'05BZG-X:C\)ZA)HE_))J+Z)=M(8)R[MB$DO<<DA@V,%L$,2
M/44 >F-;P.%#PQL%!5<J#@$8('X55N-%TJ[E66YTRSFD10JO) K$ = "1TKA
M]6T.:QT*"/\ LS3(9;G4;1/+@GDV2KOZ.2N0.>P-0P&?3=*\3LRI8W]A)#/#
MI\$C/&A7E'1FQD2\J< =",9SD ]%CL;2*[ENX[6!+F4 23+& [@= 6ZFDFL+
M.XMI+>>T@E@D;<\3QAE8YSD@\$YYKD/'@B-W9-/J5C;)!:W$H@O5DV3L/+Q@
MJRC(&1U)^;(4XJH][:OXCT6ZMG,5])<Q)>6;S/\ :(PT'$:H>#$N0S<8R"<Y
M% ';IIMLFH1WBKAXH/L\2# 6-"03M Z9VKG_ '1T[VZ\_P#$6I:'?>(+2WMM
M7MUU&58)5N7O52.VB#DYC&1N=^1@9R,;N  :Z:E<R^*=2EUV+5+"UETR7< <
M+;PK( &!1B<D9)8#()QT4&@#TBBN4\$RKNUJWADAEMHKT&%K60O JF)/E0GN
M""6'3+'UQ75T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB7";D21)-N<9*G<N?4 @'\*L44 -9%?&Y0V#D9&<&C8F_?M&_&-V.<>E.HH
M9Y49.2BY'M3\#.<<T44 -1%C4*BA5'0 8%.HHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>modificationno9effective002.jpg
<TEXT>
begin 644 modificationno9effective002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH HR:WI
M44C1R:G9)(A*LK7"@J1U!&:;_;^C?]!:P_\  E/\:R+OX=^#[Z\FN[KP[82W
M$\C22R/'DNQ.23[DFHO^%8>"/^A8T[_OU0!N?V_HW_06L/\ P)3_ !H_M_1O
M^@M8?^!*?XUA_P#"L/!'_0L:=_WZH_X5AX(_Z%C3O^_5 &Y_;^C?]!:P_P#
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M_P# E/\ &C^W]&_Z"UA_X$I_C6'_ ,*P\$?]"QIW_?JC_A6'@C_H6-._[]4
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M._[]4?\ "L/!'_0L:=_WZH W/[?T;_H+6'_@2G^-']OZ-_T%K#_P)3_&L/\
MX5AX(_Z%C3O^_5'_  K#P1_T+&G?]^J -S^W]&_Z"UA_X$I_C1_;^C?]!:P_
M\"4_QK#_ .%8>"/^A8T[_OU1_P *P\$?]"QIW_?J@#<_M_1O^@M8?^!*?XT?
MV_HW_06L/_ E/\:P_P#A6'@C_H6-._[]4?\ "L/!'_0L:=_WZH W/[?T;_H+
M6'_@2G^-']OZ-_T%K#_P)3_&L/\ X5AX(_Z%C3O^_5'_  K#P1_T+&G?]^J
M-S^W]&_Z"UA_X$I_C1_;^C?]!:P_\"4_QK#_ .%8>"/^A8T[_OU1_P *P\$?
M]"QIW_?J@#<_M_1O^@M8?^!*?XT?V_HW_06L/_ E/\:P_P#A6'@C_H6-._[]
M4?\ "L/!'_0L:=_WZH W/[?T;_H+6'_@2G^-']OZ-_T%K#_P)3_&L/\ X5AX
M(_Z%C3O^_5'_  K#P1_T+&G?]^J -S^W]&_Z"UA_X$I_C1_;^C?]!:P_\"4_
MQK#_ .%8>"/^A8T[_OU1_P *P\$?]"QIW_?J@#<_M_1O^@M8?^!*?XT?V_HW
M_06L/_ E/\:P_P#A6'@C_H6-._[]4?\ "L/!'_0L:=_WZH W/[?T;_H+6'_@
M2G^-']OZ-_T%K#_P)3_&L/\ X5AX(_Z%C3O^_5'_  K#P1_T+&G?]^J -S^W
M]&_Z"UA_X$I_C1_;^C?]!:P_\"4_QK#_ .%8>"/^A8T[_OU1_P *P\$?]"QI
MW_?J@#<_M_1O^@M8?^!*?XT?V_HW_06L/_ E/\:P_P#A6'@C_H6-._[]4?\
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MFMFBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?5#J.L.$*&YR<E$ ^Z.!S[ ^U78?A78Z'XLT?7?##FR-LSI>13S22_:(F&,
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M\.@V5TD\B)<7'E[6MHPB0",[HPB_[+$MSU)/;@ $\2Z]%>VPGEL+FV=B)S'
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MCZU-IUBFG6,=LCM)M+,TC]7=B69CCC)8D\>M %JBBB@ HHHH **** "BBB@
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M5_\  6;_ .(KN5D1S\KJWT.:"Z!PA9=Y&0N>30!PW_"YOA__ -#"O_@+-_\
M$4?\+F^'_P#T,*_^ LW_ ,17<^8F[;O7=Z9YI!+&<XD4XY/- '#_ /"YOA__
M -#"O_@+-_\ $4?\+F^'_P#T,*_^ LW_ ,17<>;&02)%P.IS3@RE=P((]0:
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MD+GG%()8R<!U)] : .'_ .%S?#__ *&%?_ 6;_XBC_A<WP__ .AA7_P%F_\
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MS?\ Q%=W10!PG_"YOA__ -#"O_@+-_\ $4?\+F^'_P#T,*_^ LW_ ,17=T4
M<)_PN;X?_P#0PK_X"S?_ !%'_"YOA_\ ]#"O_@+-_P#$5W=% '"?\+F^'_\
MT,*_^ LW_P 11_PN;X?_ /0PK_X"S?\ Q%=W10!PG_"YOA__ -#"O_@+-_\
M$4?\+F^'_P#T,*_^ LW_ ,17=T4 <)_PN;X?_P#0PK_X"S?_ !%'_"YOA_\
M]#"O_@+-_P#$5W=% '"?\+F^'_\ T,*_^ LW_P 11_PN;X?_ /0PK_X"S?\
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MN1?>1;F,B V\@"3< [_,,9 ;YL@GUKTLS1!]AE0/_=+#-*[I&A=V"JHR68X
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M=I^1F /')QGGO6IINF6L5[_I^FV%K>R)-''%;)E)(,QD[CM&>0O4#J>*TO[
MT@VCVC:;:O!(P=XWB#!V'0MGJ?<T0:!H]L[O!I=G&SHT;,D"@E#U4\=#@<4
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M !@\4^[T72[]XWN].M)VB79&9858HOH,C@4 <I]DC&D7-C?VEHK6^L6SM!$
MT$0>2,@)D<<'G('+,<8(K6NK&RE\379-K;NYTS$I,8)(+$#/UVG_ +Y]JV8M
M,L(;)[**RMDM7!#P+$H1L]<KC!S4<.CZ;!:S6T=C (9_]:FP$2=OFSUXXYH
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ML3<(N.>2/3)Z6STVRT^-X[2UBA1SEPB@;CC'/KQQ266F6.G;_L=I# 7QO**
M6QTR>IQ0!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT2)G<NX#*JJ 2Q(.<+G]*DTS6+/5A,+9I!) P66&:)HI(R1D95@",CH>A[4
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MB@#A-GQ7_P">O@W_ +XN?\:-GQ7_ .>O@W_OBY_QKNZ* .$V?%?_ )Z^#?\
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M10!PFSXK_P#/7P;_ -\7/^-&SXK_ //7P;_WQ<_XUW=% '";/BO_ ,]?!O\
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M>^&T'A,75I;)<O(8[C858X '.<_A7?1>)=.FC@*-(99KIK-8-G[Q95SN!7L
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MHHH **** "BBB@ HHHH **** "N$M/\ DNFI?]@"'_T<U=W7"6G_ "734O\
ML 0_^CFH [NL7Q-<RPZ=!;02-%)?745IYB'#(K-\Y!['8&P>QQ6U6=K>G-J>
MG&*)U2XBD2>!VZ+(C!ES[$C!]B: (+M9-1ULZ>;B:&V@MUFD$,A1I6=F &X<
M@#8>A&=P],%R:3=+IM_9MJES(9RWV>9CB2!2@ &X=<,"<GDYYSU-B^TQ;R6*
M=+B>UN8P56: KNVGJI# J1P.H[<8IAT^YM]*NH+2\D>\F#%;FY;=AR,!L
M#CY0 ./<F@!/#^I/K'AS3=2D0))=6T<KJ.BL5!('MG-:55M/L8=,TVUL+92L
M%M$L,8/95  _059H *\R%\FE_&#Q;J$BEDM=!BG8#N%RQ_E7IM>;VMK%>_&K
MQ/:3KNAGT2&.1?56)!'Y&@#I;G^T8/"EB7U":.^>:V$\\84DF25 X 8$ ?.<
M<<8%7+9KNQUJ*QFO9;R&X@DE1IE0/&R,@(RB@$$..HR".ISPP:/=W/ARTTZ[
MO6CN(&B+3P@$N8F!5L,,<[5)'U%6K/2S;W;7=Q>37ESL\M7E"J(T)!(4* !D
M@$GDG ]!0!7\/W<TRZC9W$C22Z?>/;^8W5E*K(F?4A)%!/<@FN5^$7_(&\0_
M]C!>?S6NPT73I+""YDN"INKNY>YF*'(!. JCUVHJ+GOMS7'_  B_Y WB'_L8
M+S^:T >A4444 %%%% !1110 5SVG7=SJ6DZM?_:I8M]Q<1V^S'[I86,8P"".
M61FY'\6.U=#6-9Z/-:VFIV*S^7;W$\DT#I@M&)3N<$$8^^SD>S#TH S/#ES=
M:D]I,FJZE)Y*1R7<=Y;+$L@>-ONCRU;AMISTX[UJ07<T/BV[T^21GAFM4NH0
M?X"#L=1[?<(]RU,MM!GA-BLNKW,T-FP*1M'&H;"E1DA0>AJS;Z=(/$%YJ<Y7
MYH8[>W53G:@RS$^Y9L8]$7U- &E1110 5S7Q#_Y)QXD_[!L__H!KI:YKXA_\
MDX\2?]@V?_T T 7_  M_R*.B_P#7A!_Z+6M:LGPM_P BCHO_ %X0?^BUK6H
M**** "BBB@ HHHH **** "BBB@ HHHH QM%NIM2FU:Y:5Q$+M[6!!T18OD8_
M4OO.?3;Z5AZ3<WVHN;6/6]5^V(\K%IK6-862.;9C/E#=D?W3^(KH=-TV73[G
M4U1U%M<S_:(L?>1V'SC'3&X;L_[9';EVD:7+I4#PM?S72%F=1(B+M+,6/W0.
MYH A%W-;^,/L#R,\%Y9-<1J?^6;1.JOCV(ECX]5/K6Q6:FG2/XCDU.8KLCMA
M;6R@\@,P:0GZE4&/]CWK2H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#G]1\<^%M(OY;'4=>L+6[BQYD,LP5ER 1D?0@_C57_A9?@G_H:-,_[_
M (K=GT;2[J9IKC3;.:5OO/) K,>W)(J/_A']%_Z ^G_^ R?X4 8W_"R_!/\
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M'_"/Z+_T!]/_ / 9/\* ,;_A9?@G_H:-,_[_ (H_X67X)_Z&C3/^_P"*V?\
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M9?@G_H:-,_[_ (K9_P"$?T7_ * ^G_\ @,G^%'_"/Z+_ - ?3_\ P&3_  H
MQO\ A9?@G_H:-,_[_BC_ (67X)_Z&C3/^_XK9_X1_1?^@/I__@,G^%'_  C^
MB_\ 0'T__P !D_PH QO^%E^"?^AHTS_O^*/^%E^"?^AHTS_O^*V?^$?T7_H#
MZ?\ ^ R?X4?\(_HO_0'T_P#\!D_PH QO^%E^"?\ H:-,_P"_XH_X67X)_P"A
MHTS_ +_BMG_A']%_Z ^G_P#@,G^%'_"/Z+_T!]/_ / 9/\* ,;_A9?@G_H:-
M,_[_ (H_X67X)_Z&C3/^_P"*V?\ A']%_P"@/I__ (#)_A1_PC^B_P#0'T__
M ,!D_P * ,;_ (67X)_Z&C3/^_XH_P"%E^"?^AHTS_O^*V?^$?T7_H#Z?_X#
M)_A1_P (_HO_ $!]/_\  9/\* ,;_A9?@G_H:-,_[_BC_A9?@G_H:-,_[_BM
MG_A']%_Z ^G_ /@,G^%'_"/Z+_T!]/\ _ 9/\* ,;_A9?@G_ *&C3/\ O^*/
M^%E^"?\ H:-,_P"_XK9_X1_1?^@/I_\ X#)_A1_PC^B_] ?3_P#P&3_"@#&_
MX67X)_Z&C3/^_P"*/^%E^"?^AHTS_O\ BMG_ (1_1?\ H#Z?_P" R?X4?\(_
MHO\ T!]/_P# 9/\ "@#&_P"%E^"?^AHTS_O^*/\ A9?@G_H:-,_[_BMG_A']
M%_Z ^G_^ R?X4?\ "/Z+_P! ?3__  &3_"@#&_X67X)_Z&C3/^_XH_X67X)_
MZ&C3/^_XK9_X1_1?^@/I_P#X#)_A1_PC^B_] ?3_ /P&3_"@#&_X67X)_P"A
MHTS_ +_BC_A9?@G_ *&C3/\ O^*V?^$?T7_H#Z?_ . R?X4?\(_HO_0'T_\
M\!D_PH QO^%E^"?^AHTS_O\ BC_A9?@G_H:-,_[_ (K9_P"$?T7_ * ^G_\
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MP3_T-&F?]_Q6S_PC^B_] ?3_ /P&3_"C_A']%_Z ^G_^ R?X4 8W_"R_!/\
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M@G_H:-,_[_BC_A9?@G_H:-,_[_BMG_A']%_Z ^G_ /@,G^%'_"/Z+_T!]/\
M_ 9/\* ,;_A9?@G_ *&C3/\ O^*/^%E^"?\ H:-,_P"_XK9_X1_1?^@/I_\
MX#)_A1_PC^B_] ?3_P#P&3_"@#&_X67X)_Z&C3/^_P"*/^%E^"?^AHTS_O\
MBMG_ (1_1?\ H#Z?_P" R?X4?\(_HO\ T!]/_P# 9/\ "@#&_P"%E^"?^AHT
MS_O^*/\ A9?@G_H:-,_[_BMG_A']%_Z ^G_^ R?X4?\ "/Z+_P! ?3__  &3
M_"@#&_X67X)_Z&C3/^_XH_X67X)_Z&C3/^_XK9_X1_1?^@/I_P#X#)_A1_PC
M^B_] ?3_ /P&3_"@#-L_'_A+4+R&SM/$.GSW,SA(XDF!9V/0 5T=4(M$TF"5
M98=+LHY$.5=+= 5/J"!5^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGA__ +!-U_Z$M '=T444 %<)\'O^2<VO_7U=?^CWKNZX3X/?\DYM?^OJZ_\
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MP^&M2DCD:-EMG_>*<%!CE@>V!S52"QM-,\3VL%A;Q6T4UC*98XD"JWEO$$)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPO)+625($FCEAB9%^8L,%2QS@KG.1G/08YJ^&SK$D#R7M[:S1"[ND(6W</\
M+,ZC#&0X QP,<# H Z"BBL36=0U"TNXX[=1';F,L9S92W66S]W;&05XYR>*
M-NBN5OI;J]C\,7T L3?R7!'G#+QJ&MY2^T\%AD XR,D#)%7?[8N[>QOA/'!-
M>6UW':*8P8XY&D$90D$L5 \T9Y/0X]* -VBL0W>KVUR+*=[*:>XAD>VECA:-
M5=<?*ZER2#G.01T(QTK.M_%<E_':6]FT7VYVMC)YD!$;K(N]MGSYRJ<G.>P[
M\ '645S-UJVLP_VW<)]@^RZ6Y.TQN7F41+*5SNPAPV-V&SZ#'/34 %%5[V*>
M:TDBMWA21AC,T9=<=\@,IZ>]9^F7,@\&V=U96:&0:>DD-JC84GRP50$]!T&3
M0!L45@:1JM[=:E]FN9H'4PM)M-E-:R @J.%D)WKR<L.AQZUOT %<-:/_ ,7P
MU),?\P& _P#D9_\ &NYKA+3_ )+IJ7_8 A_]'-0!W=%%% !1110 4444 %<-
MJ3[?C5H0Q][1[H?^/H?Z5W-<)JG_ "6SP_\ ]@FZ_P#0EH [NBBB@ K@_@X-
MOPULE_NW%T/_ ".]=Y7"?![_ ))S:_\ 7U=?^CWH [NBBB@ HHHH **** "B
MBB@ HHHH **** "N,^+'_)+/$'_7M_[,M=G7&_%C_DEGB#_KV_\ 9A0!U&FC
M&EV@_P"F*?\ H(JU5;3_ /D&6O\ UQ3^0JS0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !6%XV_P"1"\1?]@RY_P#135NUA>-O^1"\1?\
M8,N?_134 )X(_P"1!\._]@RV_P#12U9C\/V44D>UKC[/$XDCM3,WE(P.1A?0
M'HO08& ,"JW@?_D0?#G_ &#+;_T4M;%M=17D320L2JR/$21CYD8HWZJ: *,F
M@64D6IQ,UR4U(YN!Y[\_*%^7GY?E ''84LVAV\KHXN+R)Q$L+O%<,K2(N2 Q
MZ\9;D8/)YJ>SU%+N:\A,4D+VUQ]G(D*_.=BN"N">"''7!]JMLRH,LP4>I.*
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M\I?8I() '3G YZ\=:T*** "N$M/^2Z:E_P!@"'_T<U=W7"6G_)=-2_[ $/\
MZ.:@#NZ*** "BBB@ HHHH *X35/^2V>'_P#L$W7_ *$M=W7":I_R6SP__P!@
MFZ_]"6@#NZ*** "N$^#W_).;7_KZNO\ T>]=W7"?![_DG-K_ -?5U_Z/>@#N
MZ*** "BBB@ HHHH **** "BBB@ HHHH *XWXL?\ )+/$'_7M_P"S"NRKC?BQ
M_P DL\0?]>W_ +,* .IT_P#Y!EK_ -<4_D*LU6T__D&6O_7%/Y"K- !1110
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M4U "^#?^1&\/_P#8-MO_ $4M;=8G@W_D1O#_ /V#;;_T4M;= !1110 4444
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M^P?;_P#HM: -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI<=C_:5Z52Z%UYI$6]F$GF8/R8QNYX&??%;-% !6?J^EG5K7[,;ZZM8R"'$
MC^?IUWHWIVQ4DVI10:C;V4D4P:X)6.39\A8*S;<^N%)J6[N1:6S3F*:4*0-D
M*;F.2!P/QS]* ()M,%SIGV*YNKB9@P<7#;%D#*VY6&U0N00,<8XYSS26>E1V
MHN#+-+=RW./.EG"Y90,!<*  H&> .Y/4FK]% &58:''8SQ2M>75SY$1AMUG*
MD0H<9 PH)/RJ,L2<#KR<C:+*VKC4?[7O@P!41!8=FPL"5_U><<#G.?>M6B@
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MW=<)JG_);/#_ /V";K_T): .[HHHH *X3X/?\DYM?^OJZ_\ 1[UW=<)\'O\
MDG-K_P!?5U_Z/>@#NZ*** "BBB@ HHHH **** "BBB@ HHHH *XWXL?\DL\0
M?]>W_LPKLJXWXL?\DL\0?]>W_LPH ZG3_P#D&6O_ %Q3^0JS5;3_ /D&6O\
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MR734O^P!#_Z.:@#NZ*** "BBB@ HHHH *X35/^2V>'_^P3=?^A+7=UPFJ?\
M);/#_P#V";K_ -"6@#NZ*** "N$^#W_).;7_ *^KK_T>]=W7"?![_DG-K_U]
M77_H]Z .[HHHH **** "BBB@ HHHH **** "BBB@ KC?BQ_R2SQ!_P!>W_LP
MKLJXWXL?\DL\0?\ 7M_[,* .IT__ )!EK_UQ3^0JS5;3_P#D&6O_ %Q3^0JS
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNF6FD68M+&(QPAV?!=G)9F+,26)))))Y/>K=% !1110 4444 %%%% !1110
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M!SL ^Z5483YN>_3FNEK TWPZMGJBWGD:=;)&K!([*V\O<3W<YYP,@#'<UOT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLCJ5W96J1Q6XE$7G%0!C<>!TS0!H7LTT%JTEO;FXFR%2/=M!)(&2>P&<DX/
M/!Z54T^_N9KVYL;V"**X@CCES#(71D<L!U (.4;C'ISV!?76I1Z,)[/3_,OW
M5?\ 1S(O[LG&[)) ;;SQD9QU&<U!HD<T,=PKZ?=Q3-B1[B[DB+7$AR#GRV;
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M\EL\/_\ 8)NO_0EKNZX35/\ DMGA_P#[!-U_Z$M '=T444 %<)\'O^2<VO\
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MU3_DMGA__L$W7_H2T =W1110 5PGP>_Y)S:_]?5U_P"CWKNZX3X/?\DYM?\
MKZNO_1[T =W1110 4444 %%%% !1110 4444 %%%% !7&_%C_DEGB#_KV_\
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M 4444 %<):?\ETU+_L 0_P#HYJ[NN$M/^2Z:E_V (?\ T<U '=T444 %%%%
M!1110 5PFJ?\EL\/_P#8)NO_ $):[NN$U3_DMGA__L$W7_H2T =W1110 5PG
MP>_Y)S:_]?5U_P"CWKNZX3X/?\DYM?\ KZNO_1[T =W1110 4444 %%%% !1
M110 4444 %%%% !7&_%C_DEGB#_KV_\ 9A795QOQ8_Y)9X@_Z]O_ &84 =3I
M_P#R#+7_ *XI_(59JMI__(,M?^N*?R%6: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A>-O^1"\1?\ 8,N?
M_135NUA>-O\ D0O$7_8,N?\ T4U ">!_^1!\.?\ 8,MO_12UO5@^!_\ D0?#
MG_8,MO\ T4M;U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<):?\ )=-2
M_P"P!#_Z.:N[KA+3_DNFI?\ 8 A_]'-0!W=%%% !1110 4444 %<)JG_ "6S
MP_\ ]@FZ_P#0EKNZX35/^2V>'_\ L$W7_H2T =W1110 5PGP>_Y)S:_]?5U_
MZ/>N[KA/@]_R3FU_Z^KK_P!'O0!W=%%% !1110 4444 %%%% !1110 4444
M%<;\6/\ DEGB#_KV_P#9A795QOQ8_P"26>(/^O;_ -F% '4Z?_R#+7_KBG\A
M5FJVG_\ (,M?^N*?R%6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *PO&W_(A>(O^P9<_^BFK=K"\;?\ (A>(O^P9<_\ HIJ &^"#CX?^
M'2>@TNV_]%+5NT\1:9>R1I#/(#*2L9E@DB#GT4LH!/!X'/!JIX)('@#PZ2<
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MHO+5QGC@L<#&><Y&15[5X(-(2QU=6F^S:<"LRF5V'D,,%B,G)7ALG/RAL=J
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9:_]<4_D*LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N$M/^2Z:E_V (?_ $<U=W7"6G_)=-2_[ $/_HYJ .[H
MHHH **** "BBB@ KA-4_Y+9X?_[!-U_Z$M=W7":I_P EL\/_ /8)NO\ T):
M.[HHHH *X3X/?\DYM?\ KZNO_1[UW=<)\'O^2<VO_7U=?^CWH [NBBB@ HHH
MH **** "BBB@ HHHH **** "N-^+'_)+/$'_ %[?^S"NRKC?BQ_R2SQ!_P!>
MW_LPH ZG3_\ D&6O_7%/Y"K-5M/_ .09:_\ 7%/Y"K- !1110 4444 %%%%
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N$M/^2Z:E_V
M(?\ T<U=W7"6G_)=-2_[ $/_ *.:@#NZ*** "BBB@ HHHH *X35/^2V>'_\
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MJU\VF:1>7ZQ"4VT+3&,MMW!1DC.#V%7!G'/6LWQ!!/=>'-2MK:$S3SVTD4:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "L+QM_R(7B+_ +!ES_Z*:MVL+QM_
MR(7B+_L&7/\ Z*:@!/ __(@^'/\ L&6W_HI:WJP? _\ R(/AS_L&6W_HI:WJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *X2T_P"2Z:E_V (?_1S5W=<)
M:?\ )=-2_P"P!#_Z.:@#NZ*** "BBB@ HHHH *X35/\ DMGA_P#[!-U_Z$M=
MW7":I_R6SP__ -@FZ_\ 0EH [NBBB@ KA/@]_P DYM?^OJZ_]'O7=UPGP>_Y
M)S:_]?5U_P"CWH [NBBB@ HHHH **** "BBB@ HHHH **** "N-^+'_)+/$'
M_7M_[,*[*N-^+'_)+/$'_7M_[,* .IT__D&6O_7%/Y"K-5M/_P"09:_]<4_D
M*LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A>-O^1"\
M1?\ 8,N?_135NUA>-O\ D0O$7_8,N?\ T4U ">!_^1!\.?\ 8,MO_12UO5S_
M (*=8_A[X>=V"HNEVY8DX 'E+4JZ_<-';W/]CW9L[B2-(Y0R[P'8*'9,Y5>0
M>Y Z@<X -NBL>'Q%:+?7EGJ$]I9S0W/D1*UR,R@HC!@"!@_.!CGD=35V]U.P
MTW9]NO;>VWYV>=*J;L=<9//6@"W156?4]/MH(IY[ZVBAE&8Y))557&,Y!)YX
MY^E+;ZA97EJUS;7<$UNN=TL<@91CKDCIB@"S15"VUS2+R5(K;5+*:20D(D<Z
ML6(&3@ \\<TY-7TV6^-C'J%JUV"08%F4OD=1MSG(H NT45G:SJ<NE69N4LI+
MJ-02^R15*]/4\]: -&BLN^UN#2='.H:H%LP#@QR2KG.> #G!..:MV>HV.H1M
M)97EO<QH<,T,JN%/H2#0!9HJC:ZSI=ZTBVNHVDYC7<XBF5MJ^IP>GO4*>)-"
MDQLUG3VR54;;E#DGH.O?!_*@#4HHJKJ-\FG6,MRZL^W 2-?O2.3A5'N20!]:
M +5%4M)OGU+2X+N2%89'!W1J^\*02#@X&>GH*MR2)%&TDCJD: LS,<!0.I)H
M =165I/B32=:4"RO[:24E_W*S(SX5B"< GCC/XU9?5M-COA8OJ%JMV2 (#,H
M<D]!MSF@"Y114-Q>6MGY?VFYA@\UQ''YKA=[GHHSU)]* )J*J0ZII]S'/)!?
M6TJ6^?.9)5(CQUW$'CH>M+9:G8:D'-C>V]R$QN\F4/MSTS@\4 6J*I6NL:9?
M7#6]IJ%K/,H),<4RLP X)P#5/6_$=GI%I=E;BSDOH(C*+22Y$;/@9QT)!(!Q
MQS0!LT4 Y -075Y:V,!GN[B*WB!P7E<*N?3)H GHJO;WUI=VOVJWNH9;<9S+
M'(&48Z\CCBHK/6-,U&1H[+4+6Y=1N*PS*Y ]< ]/>@"[116#K/BBTTO4(=/6
MXT[[6Z-(RW=Z(%15V]3ACD[A@8Y //% &]15*;4[6QM89M2NK6T,@ ^><;2V
M,D*QQN_(5))<22V0GTX6]R7 :/=-M1P>^Y5;M[&@"S1533;TZCH]I?K$$:YM
MTF$9;(7<H.,X]^N*CTN_GO1=I=6\<$UM/Y++%*9%/R*V02JGHP[=J +]%4QJ
MVFF_^PC4+7[7G'D><N_.,XVYSG'-/CU"RF:Y6.\MW:V.)PLJDQ'_ &N?EZ'K
M0!9HJB^M:4EE%>-J5F+64XCF\]=CGG@'.#T/3TJS;75O>VZW%K/%/ ^=LD3A
ME.#@X(XZ@T 2T51L-274'O#&F(+>=H!*6XD90-Y'H V5^JFEM-8TR_=TL]1M
M+AD7<PBF5B!ZG!Z4 7:*RU\2Z"PRNM:<1D#(ND/)Z=_8_E5B]U;3M.=%OK^U
MMF<9432JA(]1DT 7**A-W;+<QVQN(A/(I=(BXW,HZD#J14(U?36M?M0U"T-N
M9/*\T3+LWYQMSG&<]J +E%5+75-/OH9)K2^MIXHO]8\4JL$XSR0>.*J:7XET
MC6"4L]0M9)O,D01+.C.=C%20 >AVY'L10!K4454O=4T_3=GVZ^MK;?G;YTJI
MNQUQDT 6Z*RK[7(+)M.F,EL=/O'*&[:X"JG[MG4CC# [",Y'4=:NP7UI=6GV
MNWNH9;;!/FI("O'7D<<4 6**HP:UI=S!-/!J5I+# NZ61)U*QCKECG@<'DT]
M]5TZ*VAN9+^U2WG8+%*TRA9">@4YP2?:@"W15!]<TB.X^SOJEDLV_P ORS.H
M;?Q\N,]>1Q[BK] !15>]O(+"TDN+B:&%%'WYI BY[ D].:+2Y,VFP74QB4O"
MLCE) R#(R<-W'O0!8HJE9ZQIFHR-'9:A:W,BKN*PS*Y ]< ]/>KM !7"6G_)
M=-2_[ $/_HYJ[NN$M/\ DNFI?]@"'_T<U '=T444 %%%% !1110 5PFJ?\EL
M\/\ _8)NO_0EKNZX35/^2V>'_P#L$W7_ *$M '=T444 %<)\'O\ DG-K_P!?
M5U_Z/>N[KA/@]_R3FU_Z^KK_ -'O0!W=%%% !1110 4444 %%%% !1110 44
M44 %<;\6/^26>(/^O;_V85V5<;\6/^26>(/^O;_V84 =3I__ "#+7_KBG\A5
MFJVG_P#(,M?^N*?R%6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *PO&W_(A>(O\ L&7/_HIJW:PO&W_(A>(O^P9<_P#HIJ *_A6U6^^&
M6BVCL56?1X(BPZ@-"!G]:NVM]J:I!:RZ1+YZE4EF\Q!#@=74Y+'C.!MSG ..
MM0^!_P#D0?#G_8,MO_12UO4 <K=65Y)9^+532)3->Y6W;=%FX7R%C&#OX 8,
M?FQP?PJQJ#:K)<PLL&I);&W4B.T:#?YN3N$A8X&!MQM./O9/2NBHH X^UL=1
M70]#M;K2)Y);:]#S*9(6V@;B'SN (R01@9XZ"K=UIU[>2ZW$MF4266"6)I77
MR[C9M+*=I) .S:<CH>AKI:* .8BDGN_&]G--IQLB-,N4#2.C2M^\@/\  2 H
M[9.2<\#OGV&C:C!8V&EW7]L2BU>+)3[(("48'S VT/C(S_>Z]>M=99:7I^G;
M_L-C;6WF8W^3$J;L=,X'/6K= !6/XE^UR:1+;6>GW%Y),N/W3QJ%P1UWNOZ9
MZ5L44 9.II<ZGX<N4CM)8KAT.VWE9-V0>!E6*\X]>_.*AU 7>O:)J%C'9W-D
M\L!1)+@Q@,3VP"W'8Y'0]ZW** .6LK6]DU*SGN(M:<VN]@+C[(J+E"NW,8!;
M.1P#C@$]*SUT74&T** :2\<_]AW%F5+Q965MN%)#8^8@G(R/7%=S10 V-B\:
MLR,A(!*-C*^QP2/R-9NL:;+>FWN(;F>.2T9I4CB5&WMM('W^,X) R0.?RU**
M ,;PM;WEIX?@AOXY4N%9RRR[-P!<D?<)7H?6MFBB@##T>2[LD&GRZ9=?+/*3
M.&C\O:SLP;[V>A'&,^U4)K.^&BWVB#2Y));AYMMV&3RB78L)6.[<",@D8SD<
M<8-=710  8 &<^]8OBB":[T<VD.G37PEECWQQM&OR+(K-G>R]@>E;5% &!JM
MC<:IX=\FVM);&5)(F6 ^5N*QN&VC&Y.0#C/&<9Q5>RM=0;4)+W;J;7,=K)%$
MVH?9UCW$J0I$0W'E1ST'..M=/10!QT$&KOJVCSR6NK3)!,3<M<O;*J;HG7*J
MI&0"PSCMT#=C5K&_?PWK>B1Z*]Y->?:3'+OC$4GF%F4L2V05RHZ?PC''3L:*
M (X':2WC=XGA8J"8W(++['!(_(FLW7/M_EVPLQ<^5YA\\VHC,H7:<8W\8SC.
M.?3N1K44 <C8V>HC2_$,-WI-W.+N7=''<7$0:>-H8XRI9#A6^5NOMR:NZ3#?
M'6!++%>_9TMW3??K#YB,64A4:/DC .[=GD+@]:Z&B@ K!OI;Z/Q+;7$6CWES
M;PVLT1EBDA +.T3# :0'^!L\5O44 8UVMQ9ZY_:*V,MY$]LL $)7?"0S,3AB
M.&RN<'^!?J$T];O3=/FF.FS.]Q<O*MG \>85;U+,%R2"QP3RQQGK6U10!B>'
MFO+;PW:6]UI=U!/:6L<9C9XB9&5 "%*N1U'<CK3=%EOAJ&H_:-(N[:.YN?.2
M25X2 /+1<';(3G*GM6[10!R8L[[^P4T'^S)!.I"F]W)Y>X-GS\[MV_/S8QG=
M[?-3=8T[74UBYNM*1C"@2]1%F"?:+@ 1F(\_=,:]^,LI[5UU% ',7.GSV,&C
MP16E[)]DM3%]LLI(Q)&<(,%'.&#8)/!P5%:F@PW,&EA+N+RY#+(X#*@<AG)R
MX3Y=QSDXXR:TZ* .9T5+RTT#5K"V53J5K<W9C#_=9I':6,GU!$BY]\CM5>T@
MU0>(;"Z:UU::WCBECEDNY+<;6;;@A5(X^4YQQTP#U'744 <0-&U"32X(_P"R
M7BE.FZA;E6>+*22LC+DAB/FVGD9]\5K0F\L+V[N'TBYN?MJQNIC:(O'A OE-
MEP, AF!!*Y=NG?H:* .:CL;S3++17^RM<&T9_,AMV4^6K*V%7<1E5R%^F#BJ
ML]MJ5UHVII-H<[-<:C%*+8RPMOB!C)SE]O1""">O3(YKKZ* ,F&.X'BFXF-G
M(ML]E$@G+)M+*[G;@-NSA_3'7FH=*DN[$R6,FF73;KR>3SU:/RPCS.X;);/1
MAQC.>W>MRB@ KGM7BN?[8\Z"SU%<6ZHMW8R1$L=S$HR2<<<$'!^\>1WZ&B@#
MF?L5[]G\,QRZ6)#:W'F3"+RE2W BD1206'(+K]P'&#CME);"^NDUV/\ L]T6
M2_AN(EE=-MRB+%N488XW>4P^8#[PSWKIZ* ,...?4]9ANI=.EM(8;>2*0W!3
M=+O*_( K'Y1M))/?&,\UBZ5HVOI=:>+\N]J747$;3!A$+=<1,HS_ !L-YQR.
M >E=M10!RMU8WDMCXO5-)E\^^RMN=T6;@>0L8P=_ #*3\V.#]173Q,SQ(S(T
M;,H)1L94^AP2,_0FGT4 5[RXEMH0\5G/=L3CRX2@8>_SLHQ^/>L*QBO3X(73
MKG1)S-%8I;/;2S1CS_D"L%97('?DD5TM% '.Z3#?'6%EDBO?LR6[IOOQ"71B
MRD*C)\Q'!W;B1PN#UKHJ** "N$M/^2Z:E_V (?\ T<U=W7"6G_)=-2_[ $/_
M *.:@#NZ*** "BBB@ HHHH *X35/^2V>'_\ L$W7_H2UW=<)JG_);/#_ /V"
M;K_T): .[HHHH *X3X/?\DYM?^OJZ_\ 1[UW=<)\'O\ DG-K_P!?5U_Z/>@#
MNZ*** "BBB@ HHHH **** "BBB@ HHHH *XWXL?\DL\0?]>W_LPKLJXWXL?\
MDL\0?]>W_LPH ZG3_P#D&6O_ %Q3^0JS5;3_ /D&6O\ UQ3^0JS0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !6%XV_P"1"\1?]@RY_P#1
M35NUA>-O^1"\1?\ 8,N?_134 -\$Y_X5_P"'=N,_V7;8S_UR6CP[=:U<Q.UZ
MEH8A=7*%TF8N LSJ  5 P, =>@I? _\ R(/AS_L&6W_HI:MQ:-Y%R9(=0O(X
M#,TQM5*>669MS<[=^"Q)QNQSZ<4 8WVW4=,N/$<]M!%+9VEQY[^=.VYOW$;L
MJ#!V]SZ9;H.M7-6\1BSU,:?"UM'*(%G>2Y9@H5BP4 *"23L;/3''7-6I-!CE
MAU6)KV[V:F<RCY/DRH0[?E_NJ!SGIZ\T^;1_,:*:*_NX+I(A$UQ%LW2*.0&!
M4J>22/EXR<8R: )-&U/^UM.6Y\ORVW,C*"2N5.,J2!E3U!P.#T!XJ74;T:?8
MR7)C,C JJ1J<%W9@JKGMEB!GWI]I;&UMQ$9YIVR2TDS99B?H !]  *6[M8;Z
MUDMKA=T4@PP!(/U!'(/<$<B@#-6\ODNH;/5+>W$=YNCC>VE8X<*6*'(!^Z&(
M8>G0<5DZ/JFJ6GAJVO9[6)K"%,2%IV:;RP<&3I@\<[<Y([YXK:AT;RYQ//J-
MY=3(C)"\QC_<Y&"5"H 6]V!/YG-:U\+6]I;16@O[Z2Q1@YM9'4H[9W9)V[L%
MN=N=O;&.* )-4A1=<T2Y4NLC731-B1@&7R)FP5S@\@'IV%+XE>2/1Y'$$<T*
MD-*K3-&V P(VE0><CVJ2_P!&>_O(;C^U+V#R'\R)(A%M1MI0GYD)/#-U)ZT[
M4=(;4K-;634;R*/9LD\L1YEZ<ME#SQVQUH ?J=]-:"VAMHDDN;J7RHA(VU%(
M5F)8@$X 4\#J<#CJ*5IJU^-1O[74+>T@CLK9)FN!.=K[B_/*_*H"'.3Q[CFK
M-UIH?3/+GDN[V:%O-BD5DCF#C.-I 50<$CG@@D'()K-TW03-_:KWL-Q$FH11
MPLL\X>8[=WSDJ2JGY\ +P H]<  DTGQ%+?:LEC,D)\V!YT>%9  %9 1EU&X'
M>,,/3I2Z7=:W-J^J1S1V9MXKU4'[YMR+Y,384;.?O$]>I-68=",>IP:A+JE_
M<7$*-&OFM&%*-@E2JH!U53D#/'7'%22:-NO9[B'4+RV6X</-%$4VNP4+G)4L
M/E51\I'3UH S+[Q2T6I7=K;&S7[(P1_M,CJ9&*AL#:IVC##DYYSQQDW!K-Q?
M)8KIMNHENK?[2WVHE1"G'! Y+$G&.G!.>@-BXT??=2W%K?W=D\V#,+?RR)"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %8?C09\"^(0?^@9<_\ HIJW
M*P_&?_(B^(/^P;<_^BFH /!@ \"^'P.@TVV_]%+6Y6)X-_Y$;P__ -@VV_\
M12UMT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P]HH_X7=J;8Y_L&#_T
M<]=Q7$6G_);-3_[ 4'_HZ2@#MZ*** "BBB@ HHHH *X?45!^-.ADCD:/<D?]
M_$KN*XC4/^2T:)_V!KG_ -&1T =O1110 5P7P;Y^&=@3U,]R3_W_ )*[VN"^
M#7_),=/_ .N]S_Z/DH [VBBB@ HHHH **** "BBB@ HHHH **** "N,^+/\
MR2SQ!_U[?^S+79UQGQ9_Y)9X@_Z]A_Z$M '4Z;SI=G_UP3_T$5:JKIG_ ""K
M/_K@G_H(JU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M'XS_ .1%\0?]@VY_]%-6Y6'XS_Y$7Q!_V#;G_P!%-0 O@W_D1O#_ /V#;;_T
M4M;=8G@W_D1O#_\ V#;;_P!%+6W0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7$6G_);-3_[ 4'_HZ2NWKB+3_DMFI_\ 8"@_]'24 =O1110 4444 %%%
M% !7$:A_R6C1/^P-<_\ HR.NWKB-0_Y+1HG_ &!KG_T9'0!V]%%% !7!?!K_
M ))CI_\ UWN?_1\E=[7!?!K_ ))CI_\ UWN?_1\E '>T444 %%%% !1110 4
M444 %%%% !1110 5QGQ9_P"26>(/^O8?^A+79UQGQ9_Y)9X@_P"O8?\ H2T
M=3IG_(*L_P#K@G_H(JU573/^059_]<$_]!%6J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHJAK&KVNB:=)>W9?RT_AC7<S<9.!WP 2?8$]J +]%%% !1110 4444
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M=%A@R E>5ZA2P*@]SCC!!H V:*R+_7#9SW*Q64MS%9QB2ZD1@/+!!.%!^\P
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M)14<=Q!+(\<<T;O&<.JL"5^H[54&HN-;&G26KH'A>:.;>"KA2@88ZCF0?D:
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M#0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N/\;0WXLK^[5+:6V73Y884>1U=9'5@Q"A&W$C:!TQ\W]ZNPHH CMY3-;12G
M;ET#'821R.Q(&1^ J2BB@ HHHH **** "L+QM_R(7B+_ +!ES_Z*:MVL+QM_
MR(7B+_L&7/\ Z*:@"'PA.+;X<:#.4D<1Z5;MMC0LS?NEX ')-95K%J5C;:5J
MTS22L;AWFMXM.E$H$S'S 3DG:I(8949$:@=JVO __(@^'/\ L&6W_HI:WJ ,
M"UNVT5;FSN+.\E8W$TT+6]NTBRB21G R!A2"VWYB.F>E07BWNJ>(((8U-JMK
M;%S]HLWEB>2088!@57*KQU.?,([&NFHH X6%'OK/2M,O(-0/D^=:&X^Q2KQC
M;')DK\IQM.3T(/I5VRWZ'J&HL;>]O98[)'DDCM747$WF2.^WC'608 )P..=I
MKK:* .?T.<7-\\]S'=O?R1DM)):2Q10H",1H749ZYSU;!)P  *D27#6=MHGV
M2X$T-\LCRF)A$(DF\T/OQM)8*HV@Y!;I@$UU=% '-WLEQI]QK,2V5Q</?@26
MQBB9E9_+$>QF PF"@.6P,-[&I9HGTB[TFX>.:>WM[22TD:")I&4GRRK;5!)'
M[LC@'J.V36_10!F:##-%IA:>)HGFGFG\MNJJ\C,H/H<$9'KFI=9)&B7V$D=C
M ZA8T+L200   2>M7J* .4TVSFM;C3-0DDU"]@>(0;+F,A[1\8WA J\'E22"
M0"#D*6K*ATJ>.W6SNS="_6;>9(=+W,\F[/F+/]T9ZY+# X([5Z!10!@Z[>I'
M?Z:GV>]D\BZ$LC0V<LBA?+<9RJD'EAP.:BUV5KB2P)BG2S9&D\Y-/:>5'^7:
MNTJ2F06R2O;''?HZ* .!:"9_!(T^72[^:3^U QM3;[&>(70E[?(!Y?N%_AX/
M%:4MH]_->/H5M+8%M-FMS,]NUMNF;;Y7RD G9A_FQ@;N,\XZRB@#B]+L5&H:
M=LCNH);9O]6NE>0$7:0RM)]UE_W2V2 1G&:T[O4HT\46LAMK]HX+:XA=TL9F
M4,SPD8(7!!V-R..*Z&B@#G?$LEMYEGFQN)KF*XAE62*RDEV() 6PRJ0. >,Y
MI-:BM-4O/#SRV$UQ&+PR?O+1SY8\IU!<%?E^9D^]CIGMD='10!R;V3S6^M6U
MO8R&W748Y?LQB,:SQ!8O,5=V%(++)QT8]>&S1IT-K+XW-U%I!L_] (#R1A&<
M[P"=HY''&3@GZ 5TUW/;VUI)-=SQP0*/GEDDV!0>/O9&.M4M.BTFUS+9SQR-
M<*A\Y[DS-(ISL^9F)*_>P,XZX[T :=%0/>6L>_S+F%-@8OND VA0"V?3 ()]
M,TMI>6M_;K<6=S#<0-G;+"X=3@X."..M $U%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5PEI_R734O^P!#_ .CFKNZX2T_Y+IJ7_8 A_P#1S4 =W1110 4444 %
M%%% !7":I_R6SP__ -@FZ_\ 0EKNZX35/^2V>'_^P3=?^A+0!W=%%% !7"?!
M[_DG-K_U]77_ */>N[KA/@]_R3FU_P"OJZ_]'O0!W=%%% !1110 4444 %%%
M% !1110 4444 %<;\6/^26>(/^O;_P!F%=E7&_%C_DEGB#_KV_\ 9A0!U.G_
M /(,M?\ KBG\A5FJVG_\@RU_ZXI_(59H **** "BBB@ HHHH Y+Q+_R//@K_
M *^KK_TFDKIEL;1)!(EK K@N0PC .6.6.?? SZU5U70M-UIK9K^!I'M7+PNL
MKQLC$8)!4@].*T: ,37[.UM?"NL&WMH82-.DB'EH%^14;:O'89.!VR:?X2_Y
M$W0_^P?;_P#HM:N:II=GK-B]E?1M);O]Y%D9,^Q*D''M4]K;0V5I#:VZ"."%
M%CC0?PJ!@#\A0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !6%XV_Y$+Q%_V#+G_T4U;M87C;
M_D0O$7_8,N?_ $4U %/PW=/8_"O2;R-/,>#18953^\5A!Q^E2W-F^E:?!J4=
M_=37:R1>:[SLR7 9U5AY9.T9W?+M P<8XR#-X( /@#PZ",C^R[;_ -%+5B#P
M]:020XDN'MX&#P6KRYBB(Z8'4X[ DA>, 8& #+TT:M'=:S'IL5E';P7K;(YM
MV928T8@$'$8R>N&Y)X];&JO:ZKH>EZJL(W-<6<L#.!OC#S19&>V0<&IQX7M$
MENGCNKZ/[6Y>Z5+@@3' '/IP ,K@X &>!5B_T.VOXH86FN((8=FR*WDV*"C!
MEX'H0/RH MWT4\UG)%;M$'<;?WJEEP>O (/3WK*M=2%KX-TZ\@ME!DM[=(8-
MY"AI-BHI8Y. 6&3R<>M:#Z=OLDMOMEX-ASYHEPYZ\$^G/Z"H;30K2TTMM-+3
M7%H8Q$(YY"^U0, #TH JQ7NLQ>(+33;LV,D4UO+<&:)&0_(8UV;2Q[R [LG.
M#P*K1>))FU6V17CGM+F<PH8K*95 PQ#"8_(_3MCKP3CE^DZ++%KBZE+;20>7
M;/;CS[QKF1]S(W5B=JC9Z\ECGIS.OA:S M4-U?&*T96M8_M!"PX&  !][CCY
MLG% $3OK3^*KV&WNK1;=;6!TCEB=L9:4$\,.?EZ^@'I3M8UV:TU-=.ML)((1
M/),UI+<!020H"Q]SM;DD8QWSQH7FDQW5T+E+FYMIM@C=X' WH"2 <@]"3@C!
M&3S27&CPS>0Z3W,$\">6D\<I+[>.&+9W=/X@>>>M &?#KMW<V%L([41WT]RU
MLIF1TC^56<R88!BNU>!Z\9ZFFZ0MW'XMU9+Q+?S#:6K^; "JR_-,,E225/R@
M=3P!SV&BVC6\EDMN\UR[))YJ3M,QD5_[P;MU(P.,$C&"13+'0K>QU&74%GNI
M;N:-8YI)9=WF!22N1T&-S8P .3ZT :E<1%JD-KXKEN8[V\,#7@L6@DDEDBP>
M#(N[*J?-(3C  !KMG7>C+DC(QD'!%9/_  CMI_8;Z1YUT;9\Y/G'?SR?FZ]>
M?6@#.GUC6QJD]M"FG^4M^ME&75]WS0B7><'L#C;_ !>JU9@UB_ODM+:V2VCN
MY5E:6616:-!&^PD*""<GH,C SD],V8_#]K'(TGG73R-<I=%GE)/F*NP?AM !
M%*= M1&@AEN898Y))(YHY/G3S&W.O.05)_A((X'H* *KZQ?16L@>.W^TVM]#
M;3XR4=9"@W+SD'$@.#G!!'/!JXMW>-J]_9?N-L=O'- VTY!8N,-SSRF>,=:<
M-$M!ITUF?-83/YDDK2$R-)P0^[U&U<=AM ' Q45OH$%O=7%U]KO9+FXA$,LL
MDY)*@DC ^ZI&3C '4T 4M*UC5)X='NK^.T6+5%&V* -NA8Q-(,L3A@0I[#!(
MZ]:=8/K4FNZJANK0VT5R@"-$Y*H8T. =V >?3KS5V+0;6&#3(4EN=FFG, ,I
M_NE1N]?E)'XTZYT:*>[DN$NKNW,P F6"78),# )XR#CC*D'@>@H 75Y]5@BM
MCI-G!=2-<(LZS3>6$B/WF!P<D<<5HUG:OHMMK4-K%<R7"+;7"7*&"9HR63H"
M0>1STK1H YSQV ?"<P(R#<VO_I1'5/5_!USJ/BNTU>&_>&&#:/+#8.,,#M^7
MC'!7KRS],UM>(M)EUO1)K&&=()6>*1)'0NH*2*XR 1D?+CJ.M:-N)A;QBY>-
MYPH\QHU*J6[X!)('XF@#E++P?<VOC*?6GU!W@EW#RBWS8PF,_+SG:0WLD7/R
MU;\$@#1[T 8 U;4, ?\ 7U+70RB0PN(6192IV,ZDJ&[$@$9'XBLSP[I,^C:6
M]M<W$=Q/)<SW+O'&47,LK2$ $D@#=CJ>E &M1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %<):?\ETU+_L 0_P#HYJ[NN$M/^2Z:E_V (?\ T<U '=T444 %%%%
M!1110 5PFJ?\EL\/_P#8)NO_ $):[NN$U3_DMGA__L$W7_H2T =W1110 5PG
MP>_Y)S:_]?5U_P"CWKNZX3X/?\DYM?\ KZNO_1[T =W1110 4444 %%%% !1
M110 4444 %%%% !7&_%C_DEGB#_KV_\ 9A795QOQ8_Y)9X@_Z]O_ &84 =3I
M_P#R#+7_ *XI_(59JMI__(,M?^N*?R%6: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *P_&@SX$\0@_P#0,N?_ $4U;E8?C/\ Y$7Q!_V#
M;G_T4U !X+ 7P+X> Z#3;;_T4M;E8G@W_D1O#_\ V#;;_P!%+6W0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7#VBC_A=VI-W_L& ?^1G_P *[BN(M/\
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M4 %<9\6?^26>(/\ KV_]F6NSKC?BQ_R2SQ!_U[?^S"@#J--&-+M!_P!,4_\
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M2-J.;^"0R).81L&004V @E,'INST.>*8-$:XM]1&H77G3W\'V:1XH_+5(P&
M"J2V/OL<DGD^F +DFJV$5A'?/>0K:R %)2XP^>@'J3Z58MYXKJVBN('#PRH'
M1QT92,@_E0!E0:5J7]KV^HW>J0RM#!) (H[7RT(<H<\N3NRB]\8XP.M1KH5V
M-(BLC?PETO1=&3[,<'$OF[=N_CYN^>G;O6[52UU2QOKJXMK6ZBFEM\>:L;9V
M9) R>F<JP_"@"O>:?=OJ O;"[A@E,7DR"> RJR@Y!&'4@C)[GK3-4TR_U#31
M9IJ$,8=-LTCVQ<N>.1AP%_6K%]K%AITJQW4Q1BN\[8V8(O\ ><@$(O\ M-@<
M'TJ2]U&VT^))+AV D;8BQQM(SG!.%502> 3P.@)H J7NG7]]80P27UN)DN(Y
MFD6V.U@CAP-N_CD#G)I)]%^UWVH2W$X:WO+>.#RT0JR;"Q#!\]<N3T&,#TYN
MKJ%FUA]O^TQ+:;=QF9@J@>Y/3\:@77=(>UFNEU2R-O!CS9?/7;'G@;CGC/O0
M!C64%W=^)+2XDN;ZXCM(Y59Y[4VZ#=@#@@%V..H^4 =L\]35634]/BGMX)+Z
MV2:X&8(VE4-+_NC.3^%0_P!MZ?\ ;?LGGGS-_E;O+;R]_P#<WXV[O]G.?:@"
M'4].U"]O+2:WOK>!+:3S41[4R$ML9#DAQQASQBI;BPN9]1T^Z^U1*+8-O3R2
M?,+#!P=WR_K4TNJ6,.H0Z>]U$+R;[D.[+'@GIVX4]?2K= &9;:?>6D5]Y=Y"
M9;BX,R,UN=L><<$;_FX'7(J+3M&FM]#_ +(O[F*ZM1;+:J$A,1V!=IR=QR2/
M3%:=S<PV=N]Q<2+'$@RS-T%0V6I6NH"3[.[[HR \<D;1NN>F58 @'L<<T 4H
M])OI);<7^I+<V]LXD1%M]CR,/NF1MQ!QU^4+R ?:IY;&^?7X+Y-4=+!(&C>P
M$*E9')R'W]1CIBELM:L=1D"VKS/N7<KFWD5&'J&*@'\ZEBU2QGU!["*ZBDNH
MU+/&C9*@$ Y]"-PXZ\T 6Z*HW^KV.F,BW4S*S*7PD;.0HZL0H.%&1EC@#/6I
M+O4;6RMTGFE^20A8]BEVD)&0%502QP"> > : +5%06=Y;W]N)[:3>F2IR"I4
MC@@@\@CT/-3T %%5++5=.U,R"PO[6Z,6!)Y$RR;,],X/&<5;H **** "BBB@
M HHJI_:NG;;IOM]KMM#BY/G+B$_[?/R_C0!;HID,T5Q DT$J2Q2*&1T8,K ]
M"".HI] !1110 4450O=:T_3YO*N9RKA0[[8V<1J?XG*@A%X/+8'!]* +]%5;
MW4;73XXWN'8>8VV-8XVD=SC.%502> 3P.@S2-JEDNG#4#<)]E8 B0<YR<  =
M223C'7/'6@"W156SU*UOHI)()#B([9%D1HV0XS\RL 1QSR.E)8:G9:I'+)8W
M,=Q'$_EL\9R-V V,]^&!X]: +=%%4[W5=.TYD6^O[:V9P2HFE5,@=3R: +E%
M4;G6=+L[=+BZU*S@@DR$DEG55;'7!)P:FN+^SM$B>YNX(4F<)$TD@4.QZ 9/
M)/8"@"Q158:C9&_-@+RW-X%W&W$J^8!Z[<YQR*LT %%%5+K5+&SN8;:XNHHY
MYB%CC+?,V3@<=<9XSTH MT5!>7EO86YGN9-D8(7A2Q))P  .22> !R:;;ZA:
MW5HUU%,/)3.]G!0ICJ&#8*D=P<4 6:*I6&JV>I%Q:R,60!BKQM&VTYPP# $J
M<'!'!P:2/6M*EO/L<>I6CW6XKY*S*7R.HQG.10!>HJE_;&F?99[K^T;3[/;O
MY<TOGKLC;CY6.< \C@^HIL^M:?;Q02&X\U9UWQ?9T:8NO&6 0$E>1STY'K0!
M?HJI)JEA#8)?27<*VL@!24N-KYZ8]<]@*GMYXKJVBN('#PRH'1AT92,@_E0!
M)1110 5PEI_R734O^P!#_P"CFKNZX2T_Y+IJ7_8 A_\ 1S4 =W1110 4444
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MS'!9PKO>9S\JCUI\ME:SOOFMH9&QC<\8)_6GR012P&"2)'A8;3&R@J1Z8]*
M*=_J>FV^DKJ%S)&]H=CQMC=O)(*;1W).,>^*J:/+'/=7FH3W-N;N2*,/!#*K
M^1$I<H"1U.6<D],\#.,G7>"&6+RI(D>/^XR@C\J2&UM[;=Y$$46[KL0+G\J
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MIKEHSE'#8 "-V'7-2:A;7MQ'87<,<(O+67S6A,IV/E&1EW[<_P 60<=0.F:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*X2T_P"2Z:E_V (?_1S5W=<):?\ )=-2_P"P!#_Z.:@#NZ*** "BBB@ HHHH
M *X35/\ DMGA_P#[!-U_Z$M=W7":I_R6SP__ -@FZ_\ 0EH [NBBB@ KA/@]
M_P DYM?^OJZ_]'O7=UPGP>_Y)S:_]?5U_P"CWH [NBBB@ HHHH **** "BBB
M@ HHHH **** "N-^+'_)+/$'_7M_[,*[*N-^+'_)+/$'_7M_[,* .IT__D&6
MO_7%/Y"K-5M/_P"09:_]<4_D*LT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5A>-O^1"\1?\ 8,N?_135NUA^,_\ D1?$/_8-N?\ T4U
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M;7[;9R6WGS0;P!YD+;7'.>#3=-T^#2M+M-.M0PM[6%((@QR=J@ 9/?@5:HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !6'XS_Y$7Q!_P!@VY_]%-6Y6'XS_P"1%\0?]@VY
M_P#134 +X-_Y$;P__P!@VV_]%+6W6)X-_P"1&\/_ /8-MO\ T4M;= !1110
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M_015J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L/QG_R
M(OB#_L&W/_HIJW*P_&?_ "(OB#_L&W/_ **:@!?!O_(C>'_^P;;?^BEK;K$\
M&_\ (C>'_P#L&VW_ **6MN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N
M(M/^2V:G_P!@*#_T=)7;UQ%I_P ELU/_ + 4'_HZ2@#MZ*** "BBB@ HHHH
M*XC4/^2T:)_V!KG_ -&1UV]<1J'_ "6C1/\ L#7/_HR.@#MZ*** "N"^#7_)
M,=/_ .N]S_Z/DKO:X+X-?\DQT_\ Z[W/_H^2@#O:*** "BBB@ HHHH ****
M"BBB@ HHHH *XSXL_P#)+/$'_7L/_0EKLZXSXL_\DL\0?]>P_P#0EH ZG3/^
M059_]<$_]!%6JJZ9_P @JS_ZX)_Z"*M4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5A^,_P#D1?$'_8-N?_135N5A^,_^1%\0?]@VY_\
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M9\6?^26>(/\ KV'_ *$M '4Z9_R"K/\ ZX)_Z"*M55TS_D%6?_7!/_015J@
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MHHH *XSXL_\ )+/$'_7L/_0EKLZXSXL_\DL\0?\ 7L/_ $): .ITS_D%6?\
MUP3_ -!%6JJZ9_R"K/\ ZX)_Z"*M4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5A^,_\ D1?$'_8-N?\ T4U;E8?C/_D1?$'_ &#;G_T4
MU "^#?\ D1O#_P#V#;;_ -%+6W6)X-_Y$;P__P!@VV_]%+6W0 4444 %%%%
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M^2N]K@O@U_R3'3_^N]S_ .CY* .]HHHH **** "BBB@ HHHH **** "BBB@
MKC/BS_R2SQ!_U[#_ -"6NSKC/BS_ ,DL\0?]>P_]"6@#J=,_Y!5G_P!<$_\
M015JJNF?\@JS_P"N"?\ H(JU0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !6'XS_Y$7Q!_V#;G_P!%-6Y6'XS_ .1%\0?]@VY_]%-0 O@W
M_D1O#_\ V#;;_P!%+6W6)X-_Y$;P_P#]@VV_]%+6W0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7$6G_);-3_ .P%!_Z.DKMZXBT_Y+9J?_8"@_\ 1TE
M';T444 %%%% !1110 5Q&H?\EHT3_L#7/_HR.NWKB-0_Y+1HG_8&N?\ T9'0
M!V]%%% !7!?!K_DF.G_]=[G_ -'R5WM<%\&O^28Z?_UWN?\ T?)0!WM%%% !
M1110 4444 %%%% !1110 4444 %<9\6?^26>(/\ KV'_ *$M=G7&?%G_ ))9
MX@_Z]A_Z$M '4Z9_R"K/_K@G_H(JU573/^059_\ 7!/_ $$5:H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#\9_\B+X@_P"P;<_^BFK<
MK#\9_P#(B^(/^P;<_P#HIJ %\&_\B-X?_P"P;;?^BEK;K$\&_P#(C>'_ /L&
MVW_HI:VZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XBT_P"2V:G_ -@*
M#_T=)7;UQ%I_R6S4_P#L!0?^CI* .WHHHH **** "BBB@ KB-0_Y+1HG_8&N
M?_1D==O7$:A_R6C1/^P-<_\ HR.@#MZ*** "N"^#7_),=/\ ^N]S_P"CY*[V
MN"^#7_),=/\ ^N]S_P"CY* .]HHHH **** "BBB@ HHHH **** "BBB@ KC/
MBS_R2SQ!_P!>P_\ 0EKLZXSXL_\ )+/$'_7L/_0EH ZG3/\ D%6?_7!/_015
MJJNF?\@JS_ZX)_Z"*M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5A^,_^1%\0?\ 8-N?_135N5A^,_\ D1?$'_8-N?\ T4U "^#?^1&\
M/_\ 8-MO_12UMUB>#?\ D1O#_P#V#;;_ -%+6W0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7$6G_ "6S4_\ L!0?^CI*[>N(M/\ DMFI_P#8"@_]'24
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %8?C/\ Y$7Q!_V#;G_T4U;E8?C/_D1?$'_8-N?_ $4U "^#?^1&\/\
M_8-MO_12UMUB>#?^1&\/_P#8-MO_ $4M;= !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %<1:?\ELU/_L!0?^CI*[>N(M/^2V:G_P!@*#_T=)0!V]%%% !1
M110 4444 %<1J'_):-$_[ US_P"C(Z[>N(U#_DM&B?\ 8&N?_1D= ';T444
M%<%\&O\ DF.G_P#7>Y_]'R5WM<%\&O\ DF.G_P#7>Y_]'R4 =[1110 4444
M%%%% !1110 4444 %%%% !7&?%G_ ))9X@_Z]A_Z$M=G7&?%G_DEGB#_ *]A
M_P"A+0!U.F?\@JS_ .N"?^@BK55=,_Y!5G_UP3_T$5:H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO7$:A_R6C1/^P-<_^C(Z .WHHHH *X+X-?\ ),=/_P"N]S_Z/DKO:X+X-?\
M),=/_P"N]S_Z/DH [VBBB@ HHHH **** "BBB@ HHHH **** "N,^+/_ "2S
MQ!_U[#_T):[.N,^+/_)+/$'_ %[#_P!"6@#J=,_Y!5G_ -<$_P#015JJNF?\
M@JS_ .N"?^@BK5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %8?C/_ )$7Q!_V#;G_ -%-6Y6'XS_Y$7Q!_P!@VY_]%-0 O@W_ )$;P_\
M]@VV_P#12UMUB>#?^1&\/_\ 8-MO_12UMT %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(OB#_L&W/_HIJ %\&_\ (C>'_P#L&VW_ **6MNL3P;_R(WA__L&VW_HI:VZ
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M_P#0EKLZXSXL_P#)+/$'_7L/_0EH ZG3/^059_\ 7!/_ $$5:JKIG_(*L_\
MK@G_ *"*M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A
M^,_^1%\0?]@VY_\ 135N5A^,_P#D1?$'_8-N?_134 +X-_Y$;P__ -@VV_\
M12UMUB>#?^1&\/\ _8-MO_12UMT %%%% !1110 4444 %%%% !1110 4444
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MW/\ Z*:@!?!O_(C>'_\ L&VW_HI:VZQ/!O\ R(WA_P#[!MM_Z*6MN@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "N(M/\ DMFI_P#8"@_]'25V]<1:?\EL
MU/\ [ 4'_HZ2@#MZ*** "BBB@ HHHH *XC4/^2T:)_V!KG_T9'7;UQ&H?\EH
MT3_L#7/_ *,CH [>BBB@ K@O@U_R3'3_ /KO<_\ H^2N]K@O@U_R3'3_ /KO
M<_\ H^2@#O:*** "BBB@ HHHH **** "BBB@ HHHH *XSXL_\DL\0?\ 7L/_
M $):[.N,^+/_ "2SQ!_U[#_T): .ITS_ )!5G_UP3_T$5:JKIG_(*L_^N"?^
M@BK5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8?C/_D1
M?$'_ &#;G_T4U;E8?C/_ )$7Q!_V#;G_ -%-0 O@W_D1O#__ &#;;_T4M;=8
MG@W_ )$;P_\ ]@VV_P#12UMT %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5Q%I_P ELU/_ + 4'_HZ2NWKB+3_ )+9J?\ V H/_1TE ';T444 %%%% !11
M10 5Q&H?\EHT3_L#7/\ Z,CKMZXC4/\ DM&B?]@:Y_\ 1D= ';T444 %<%\&
MO^28Z?\ ]=[G_P!'R5WM<%\&O^28Z?\ ]=[G_P!'R4 =[1110 4444 %%%%
M!1110 4444 %%%% !7&?%G_DEGB#_KV'_H2UV=<9\6?^26>(/^O8?^A+0!U.
MF?\ (*L_^N"?^@BK55=,_P"059_]<$_]!%6J "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *P_&?_(B^(/^P;<_^BFK<K#\9_\ (B^(/^P;
M<_\ HIJ %\&_\B-X?_[!MM_Z*6MNL3P;_P B-X?_ .P;;?\ HI:VZ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *XBT_Y+9J?_ & H/_1TE=O7$6G_ "6S
M4_\ L!0?^CI* .WHHHH **** "BBB@ KB-0_Y+1HG_8&N?\ T9'7;UQ&H?\
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MR6C1/^P-<_\ HR.NWKB-0_Y+1HG_ &!KG_T9'0!V]%%% !7!?!K_ ))CI_\
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MBBB@ HHHH **** "BBB@ KA;1S_PO'4E[?V#"?\ R,W^-=U7"6G_ "734O\
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M3_\ D&6O_7%/Y"K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %87C;_D0O$7_ &#+G_T4U;M87C;_ )$+Q%_V#+G_ -%-0 G@?_D0?#G_
M &#+;_T4M;U8/@?_ )$'PY_V#+;_ -%+6]0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7"6G_ "734O\ L 0_^CFKNZX2T_Y+IJ7_ & (?_1S4 =W1110
M 4444 %%%% !7":I_P EL\/_ /8)NO\ T):[NN$U3_DMGA__ +!-U_Z$M '=
MT444 %<)\'O^2<VO_7U=?^CWKNZX3X/?\DYM?^OJZ_\ 1[T =W1110 4444
M%%%% !1110 4444 %%%% !7&_%C_ ))9X@_Z]O\ V85V5<;\6/\ DEGB#_KV
M_P#9A0!U.G_\@RU_ZXI_(59JMI__ "#+7_KBG\A5F@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "L+QM_R(7B+_L&7/_HIJW:PO&W_ "(7
MB+_L&7/_ **:@!/ _P#R(/AS_L&6W_HI:WJP? __ "(/AS_L&6W_ **6MZ@
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M/Y"K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "L+QM_R(7B+_L&7/\ Z*:MVL+QM_R(7B+_ +!ES_Z*:@!/ _\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7"6G_)=-2_[ $/_ *.:N[KA
M+3_DNFI?]@"'_P!'-0!W=%%% !1110 4444 %<)JG_);/#__ &";K_T):[NN
M$U3_ )+9X?\ ^P3=?^A+0!W=%%% !7"?![_DG-K_ -?5U_Z/>N[KA/@]_P D
MYM?^OJZ_]'O0!W=%%% !1110 4444 %%%% !1110 4444 %<;\6/^26>(/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<):?\ETU+_L 0_^CFKNZX2T_P"2Z:E_V (?_1S4 =W1
M110 4444 %%%% !7":I_R6SP_P#]@FZ_]"6N[KA-4_Y+9X?_ .P3=?\ H2T
M=W1110 5PGP>_P"2<VO_ %]77_H]Z[NN$^#W_).;7_KZNO\ T>] '=T444 %
M%%% !1110 4444 %%%% !1110 5QOQ8_Y)9X@_Z]O_9A795QOQ8_Y)9X@_Z]
MO_9A0!U.G_\ (,M?^N*?R%6:K:?_ ,@RU_ZXI_(59H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .8?XB^#$=D;Q/I893@@W*\&D_P"%D>"O^AHTK_P)7_&FW.F>#(->
MMM)N- TL7EY&\L1:PCVOMZC=C[W4X[@'TJA:+X+OW@^R^$K66&1(&>9--A*P
M^:H9 P^]T9<D @9Y(P: -'_A9'@K_H:-*_\  E?\:/\ A9'@K_H:-*_\"5_Q
MJG80>!=2$/V?P_IA:6]DL=K:?&"DJ*[G<,< JA(/<$>M+>V?A#3]1^QW/A&S
M0>7)*)_[/@,>Q%W,W'( X&2.I [B@"W_ ,+(\%?]#1I7_@2O^-'_  LCP5_T
M-&E?^!*_XU1:'P5%HG]JW/A>PMX#((T1["$NY..@7/OGTVDG %6(--\&W&J&
MP3PSIP;<\:3'3XO+D=,;U4XSD9[CL<9P< $W_"R/!7_0T:5_X$K_ (T?\+(\
M%?\ 0T:5_P"!*_XU7-CX*74GLW\.::@1VB^T-I\0B,BIYC(#C.0F3TQP><@B
MK.FZ)X.U731?V_AW2Q;EI%S+I\:$;&*MD%<CE3UH 3_A9'@K_H:-*_\  E?\
M:RO$_CKPCJ?A36+"U\3:2UQ<V4T,2FZ0 LR$ 9SQR:D8>!S86UW#X8L9EN;B
M2WB1=.B1F9"P8X<+@97OZCUJW%I?A&35$L6\*6432%DCEDTZ()(ZC+*.,\#O
MC!P<$T 9_A?QUX2TSPGHUA=>)M)6XM;&&&51=(0&5 ",@\\BM;_A9'@K_H:-
M*_\  E?\:HW47@:ROKFVN/#NG(ML&$DW]GQ% RQ"5EX&<A"&Z8[9SQ3'7P7'
MF-O"5K]J5F62T&FPF5 JHQ) X(Q(G ))W  $\4 :/_"R/!7_ $-&E?\ @2O^
M-'_"R/!7_0T:5_X$K_C4$>E^%9-<&E-X/M(Y61I%D?3X=A12!GCD DC&0,_@
M:U?^$/\ #'_0N:1_X Q?_$T 4?\ A9'@K_H:-*_\"5_QH_X61X*_Z&C2O_ E
M?\:O?\(?X8_Z%S2/_ &+_P")H_X0_P ,?]"YI'_@#%_\30!1_P"%D>"O^AHT
MK_P)7_&C_A9'@K_H:-*_\"5_QJ]_PA_AC_H7-(_\ 8O_ (FC_A#_  Q_T+FD
M?^ ,7_Q- %'_ (61X*_Z&C2O_ E?\:/^%D>"O^AHTK_P)7_&KW_"'^&/^A<T
MC_P!B_\ B:/^$/\ #'_0N:1_X Q?_$T 4?\ A9'@K_H:-*_\"5_QH_X61X*_
MZ&C2O_ E?\:O?\(?X8_Z%S2/_ &+_P")H_X0_P ,?]"YI'_@#%_\30!1_P"%
MD>"O^AHTK_P)7_&C_A9'@K_H:-*_\"5_QJ]_PA_AC_H7-(_\ 8O_ (FC_A#_
M  Q_T+FD?^ ,7_Q- %'_ (61X*_Z&C2O_ E?\:/^%D>"O^AHTK_P)7_&KW_"
M'^&/^A<TC_P!B_\ B:/^$/\ #'_0N:1_X Q?_$T 4?\ A9'@K_H:-*_\"5_Q
MH_X61X*_Z&C2O_ E?\:O?\(?X8_Z%S2/_ &+_P")H_X0_P ,?]"YI'_@#%_\
M30!1_P"%D>"O^AHTK_P)7_&C_A9'@K_H:-*_\"5_QJ]_PA_AC_H7-(_\ 8O_
M (FC_A#_  Q_T+FD?^ ,7_Q- %'_ (61X*_Z&C2O_ E?\:/^%D>"O^AHTK_P
M)7_&KW_"'^&/^A<TC_P!B_\ B:/^$/\ #'_0N:1_X Q?_$T 4?\ A9'@K_H:
M-*_\"5_QH_X61X*_Z&C2O_ E?\:O?\(?X8_Z%S2/_ &+_P")H_X0_P ,?]"Y
MI'_@#%_\30!1_P"%D>"O^AHTK_P)7_&C_A9'@K_H:-*_\"5_QJ]_PA_AC_H7
M-(_\ 8O_ (FC_A#_  Q_T+FD?^ ,7_Q- %'_ (61X*_Z&C2O_ E?\:/^%D>"
MO^AHTK_P)7_&KW_"'^&/^A<TC_P!B_\ B:/^$/\ #'_0N:1_X Q?_$T 4?\
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M:5_X$K_C1_PLCP5_T-&E?^!*_P"-7O\ A#_#'_0N:1_X Q?_ !-'_"'^&/\
MH7-(_P# &+_XF@"C_P +(\%?]#1I7_@2O^-'_"R/!7_0T:5_X$K_ (U>_P"$
M/\,?]"YI'_@#%_\ $T?\(?X8_P"A<TC_ , 8O_B: */_  LCP5_T-&E?^!*_
MXT?\+(\%?]#1I7_@2O\ C5[_ (0_PQ_T+FD?^ ,7_P 31_PA_AC_ *%S2/\
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M'*1HN N>_P Q=L\?>K0HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF:;?V^I:6D^_,'VN5V,C2[(W8;(BYY8]#S_<^A/5444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT=0]WEMY&[[Q]2."-OM78T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
H0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>modificationno9effective003.jpg
<TEXT>
begin 644 modificationno9effective003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV!*LI]PP(_"M2N4^&VEW6D> ]/M[U)8[ES+<.DWWU\R1G ;_ &L,,^^:ZN@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M +4GQ-T6,3RFSU0V=M=-:W5X+7]S;N'V?.V>F<'C. 1G&:=)XTNX_B._AO\
ML>\DM1:1R":.#)#M(5+D[L>4!CG&<@UCW/AC6)/A7XFT=;(F_O+N\D@AWK\Z
MO.64YS@9'/)K:O+74['XF6^KPZ7->6-UIJ6$DD,B#R'$Q;<X9@=NUNV3QTH
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M(9R'5CSMP?F&.V:BAT37-(T3X?W:Z1-=W&B1&.\LX9(Q(N^W,>068*<-C/-
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M.QYH Z:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&;]W"8L>4P'8R!)3[Y%:C"^\8^--:L#JU_I^DZ,8H!'83>2\\SIO9F<<X4$
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MHX]9\2VTL#22LD84(G^L<8:/F,\J<YVCO7K=1S017,+0SQ)+$PPR.H93]0:
M.!\!726OB'5-&\FSN+@PQW<^HVE_)=^822BI(\GS!@!D#)&/2M/4]*US3?&4
MOB'1+6TOTN[-+6YM9[@P,K(S%'5MK C#$$8]*ZBULK6PB\JSMH;>/.=D,809
M^@J>@#SU?!&J_P!AQ+++:MJ-QXABUF\",1&@$BDHA(R<*H R!DUUGB>WU*\\
M,ZC:Z.T::A/ T4+R,55"W&[(!Z D_45K44 >=:K\++2'PW!#H,]XFJ:>8IK!
MKG4)WA66,@CY"Q4 @$<#C/%7Y]'\1:)XHO\ 7-!MK&]AU5(C>6-Q<&$QS(NT
M.CA6!!& 01VS7;44 <+?>%]:\4ZKI#^)#;PV5DLT[1:==2HWGMA8P'&UOE3=
MEAC);&,5$W@.XTO6]3ET61VL=5TJ2UNEN[N25_/&1$^YRQ(PS+UXKOZ* /,]
M8^'>J7^C^&+>UNHK:>WL(]*U<JQ_>VNU/,53CDY0XZ?>-=$VAZC:>+]2UG3X
M[4QMH\5I:1.Y4>:CR, V!POS+R/>NJHH X'P?I?BK2+R275=(TZ:[OI=^H:F
M-29I&QT"IY0 51P%S@>M4V\*>*+;P]J7@ZRCT_\ L>]FF$>HO<,)(+>9RSH8
MMOS,-S '<!R.E>E44 <*-"U_PSK^I7?ARSL;VSU*&!3%<W+0FWEB3RPW"MN4
MJ%R.#D54MO!&K>&X?#M[H[6U_J&FQ3PWD4TAA6Y$[>8Y5L':0_(R.E>BT4 <
MUX5T2_LKS6-9U?R$U'5ITD>&W<ND,:($1-Q W$#))P.34NGZ+=6WCG6M8D,?
MV6\M;6&+#?-NC,F[([?>%=!10!P=OX'OI?A%%X4GGAAOXXAME4ED619?,7MR
M,@9_&K$>E^(]?\0:->Z[96.GVVDN\X2VN6G:XF*% 1E5VH S'N>E=I10!Y])
MX,U1OAK>Z #;_;9M0>Y4[SLV&[\X<XZ[?UKH9=%NG^(5IK@,?V2+2Y;1AN^;
M>TL;#CTPIKH** .?UO1;K4/%/AG483'Y&FSSR3[FP</ R# [\D5E_P#"/ZG:
MR^*9AIVGZE'JE['*EI=2[4DB$2(P8[6 .5.,@BNTHH \R@\"ZY%H.;?[+:W%
MIJ\>IZ;IK7+RPP*B[3%YA&0&RYX& 2,5K:YI_BSQ'X>:.>TL;.1;N&7[#%>N
M?M$*G+QO*%&-WL.W/6NWHH \MB\ ZH=.\91PZ;I>F#6M/B@M;6VE++&ZB0'>
MVT<G<#D#O[9/I<-N!81VTRJX\H1NIY!XP1]*GHH \M^&GA]IDUV2[N/M%I;F
M30M/E'7[+&[DD'ORP7/_ $S%2^&O LVBG3K*Y\(>'+AK)T']L!P)'53Q)L\L
MGS, ?Q8SSFO28((;:(1011Q1@DA(U"@9.3P/>I* /)?$7P_UW6!KL#Z?IE[<
M7ETT]KJMU=.9((L@K$L>T[2 -N00,<]>*[K3=%NK3QOKVKR&/[-?6]K'%AOF
MS&)-V1V^\*Z"B@#@K/PWJ[^.;763I>GZ0(FD-]/97;-_: *D*&CV*.I#9;)&
M.*U?'-EXCU+1X['P^8%\Z3;>,]P87\GNL;A6VD],XX'3VZBB@#A+CPWJNL^!
MKKP\^EZ=H?D"$Z=]FNFG17C8.-V44@95<]2<D_6>WTOQ%K/B;3=9UNRL;%=)
MAF^SV\%T9O.FD7:6+;!M4+D <GFNTHH \\\-:9XQT_69]3U;1M+N]0O9 EQ?
M#4FS#!NXCBC\KA5'.-WS'DGT27PYXJTVVU_1-(AT^73]7N)IXKV:X9'M!-_K
M 8PIWX)8K@CJ,UZ)10!DC1WL_"(T33+EK>2&P^R6UP>L9$>U7^HX-<-X?\#Z
MK:>(_#FI3Z/I=B=-65;RXBNFFGNV:%DWDE1QN.<$D\GTY]/HH \_F\&:I)\-
M-;\/@V_VV]NKF6([SLVO.77)QQP:N7&D^(](\7:KJFAVUA=P:O%")!=7#1&V
MEC4H&P%.]2I' P<BNTHH Y[P-HEWX=\'6.E7[QO<P&3>T7W3ND9@1^#"N;AT
MSQG%XLN]<N]&TK49P6BL"^IM&MK!Z*GE'YFZLV<GIP.*]%HH XF;2O$NA^)=
M9O\ 0;2PO;?6/+D9+FY:$VTZIL+<*V]2 IP,'(-96H>#?$5GX3T3PSI@M;W3
M8E9M5$ETUL]TQ8L4#!&PC,S$]R.,CFO2Z* ,&SGU^'0'SH6G07L)6.WLHK\^
M48Q@??\ *&W SQM/0>O&7X"TSQ!HMO=V6K:?90PRW,]VLT%X93NDD+["IC7@
M GYL]NG-=E10!P_BOPWJ>J>)K:^73[+6--6T, L;VY:*.&;?GS<!6#9&!TR,
M<5S,^AZQX9T;P!I4(LGU2VU6X*J680ME)WQD#(!4XS@X/KBO7JCD@AE>-Y(D
M=XFW1LR@E#C&1Z'!(_&@#RSQ7H^K?\(KXW\1ZW%;6US>::MM#:6\IE$44>3E
MGP,L68G@<#%;UMI'B36M>T&ZUN#3[:ST??,'MIVD-W*T912%*CRU 8G!).>/
M>NVFABN(7AGB26)QAD=0RL/0@]:>!@8% '%:=X,N&^&5YX6OY4CFNOM:^9&=
MP7S99'0]LX#+D5 -&\4Z[+H5KKEKIUI::5=17<L]O<M*UU)$#LVJ4&Q2>3DD
M]J[RB@#R73(/%%];>-=,TBVTZ2UOM8O(/M$\[(]L6"JS%0IWC!!&".1S77:/
MX5GTCQ5:743HVGVNA1:8A)^<LCYR1Z8QWKJ(H(8-_E1)'O8N^Q0-S'J3ZGWJ
M2@#@-4\(ZW/;^+/L4\4;ZG?P7,*^<T?FQ(D:O&S*,INV,,C/6D\->#KNQ\1Z
MGJ,FE:=I%I>:<MJMM9RF0JP9B68[5!)![>@KT"B@#SFW\+>(IOAY8^&[NVL8
M9].GLUCECN2ZSQQ2JS-C8-IVKP.>?2KRZ5XH\/:QKCZ'::??6FK7'VM'N;EH
MFMIBBJVX!&WK\H(P0>H]Z[BB@#AM(\$7.BW?@U(9HYK?1;:ZCN9&.&=Y0O*C
MTW!OH,5(WA[4[9_$\G]F:=JD.J7Z3"TNI=JR0B)$()VL VY<@$8X[5VM% '$
M>'-%\1^'M"FAM8;)6FU$216,MU)+'9VIVAD5R 21AF Q@$UV]%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8$*)+Y;$!PIR5R,'!H Z:BN&TG7O$.HZQKES-/8P:)HU]-;NBP,TTZH@;KN
M7&1S@YYZ5A:3\1=4O6T?4#<VMQ%J-S'')I<-A,'MXI#A6$Q.&*Y!;@ \XH ]
M6HKAM-\3:E=^-[O3+W4;+3S#=/'!ID]HPDNH .)4E+ ,3UP < 8/K4<WC'4T
M^'_BC6PMO]KTR[O(8!L.TK%(57<,\G YH [5;ZU;4'L%N(S=QQK,\(;Y@A)
M8CT)!'X58KSG43>2^.?$+65Q';W1\-V[+*\9<+^]F)X!';(Z\=:V/AH-4;P'
MH\VI7\5T);*%X=L)1D4H.'8L=Y]^/I0!UU4=6UK3-"M!=:K?06<!8('F<*"Q
M[#U/!_*N3_MCQ3KUSKD^A7.G6EII5S):117-LTK74L:@ON8.NQ<G P">IK U
M+4M4\5ZQ\/-7TZ[M;);Y)I8XI[4S>5+Y#%R?G7<,<#ICKD]* /5HI8YHDEB=
M7C=0RLIR&!Y!%137UK;W=M:S7$:7%T6$$;-AI"HW-@=\#FN1^*[:A%\/+Z6P
MO%MFC,9D;RR69=ZC"D,-IR0<\\ COFL[Q-#K\7B;P1$MY83ZL9[P"X:W:.$
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M0LR3QJ<KE3C# DX(/?%,A\!VL%CID"WL[RVFJ_VM/<2 %[F<A@Q;& ,[^W0
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M<-,)Q)YAE[?,6S^=0GX<Z=_:WAR]CN9431;=(! %&VX$8_=EO=6);ZFNSHH
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M8UJTT*U2YO$NFC=_+ MK62=LX)Y5%) XZ]*YSX736P\"VUK%"\#6=Q-:SAY
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MDJFPO'LY?, &7558E<$\88>E>=Z,)]:D\&^'9-0O;/3U\-1WS"SN&@>>0"-
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M3-:=% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA]/I$X-U=W:22;;@N;E?(<F5U).6R?O?[1%>M_8K7[8]Y]FB^TO&(GFV#>R
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M(]X5 6R6'H/4UU]% 'G/B;1=1U+Q/XJAL(9%>]\,K!%+M*H\N^4;=W3."![
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MLH)7(>,.A0@KP>YR,<5UWA;7-#T3POX?TRREO+E9[IM.3?!LE6<;VD\Q#@H
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M236K1N64-N8 @AL$@GE:UOA_8:E8Z9JK:K9&SN+K5KFZ$.\/A7;(PPZ_7VH
MT/\ A+M(&B:KJ[RNEMI<LL-UN3#(\?WACOGC'KD57U3QM8:0'>XL-6:"&-9;
MB>*Q=HX%(W?,WL#DXSCO7,ZYX6U:X\<O9VUJ7\.ZS<6U[J$NX!8W@SN3'7]Y
MMA_(U%XPLO$>I7OB.RDL];N8)[;R]*6PN%BML&+#>:=P).XG(.<C  H Z-]8
ME/Q)M+>.Z9M-DT&6[\M3E6831@/]=I/YUHKXMTI]#TK6 \OV35)88;8^7\Q:
M4X3([<U@:9H6HIXGT:>:V>."+PP;*60XPDQ>([3[X4_E7.VECXC?PQX5\./X
M;O(I-'U&T:[NGDC\HI%(/FCPQ+Y'/08 />@#N-3\<:5I=Y=V[Q7UP+( WLUK
M:M+':@C/SL/;D@9(')KH4N(9;9;E)4:!D$BR _*5(SG/IBO+I_#D^G:YXABO
M]+\1WUKJ=X]U ^DWQ2)U=5#1R)YB@$$$9(P1CGBN]ET=)/!KZ):HUHC:>;2)
M7;<808]@!.3G'KD]* ,RU^(>B7=S:JJ7\=K>2B&UOY;1TMYW/ "N?7'!. >U
M8VE:Y=:W\4]5M))-;@M=.,4<$"0;(#E&9VF)'\1QMYY &*I&TUW6?"6B^$)?
M#MW8S6DEHEW>2-']G1(&4EHV#$L6V# QWYQBNJT+3KRU\<>*[Z:!DMKQK3R)
M#C$FR+:V/H>* (M?$]SXX\.Z>+V[M[:2WNYI$MYC'YC(8=N['4#<W'O6+;ZU
MXG;Q_P#8WBC-CY[#R_M1V"3RTW1[_*YVH?,"]V)&[C%;&NW,%K\1_##W$\<*
MM9WRAI'"@DF# Y[UUU 'G-EK7B=_'WV26*,V)G<>7]K)4/LCW(&\H;MJ'>%X
MR6(W?+BMKPJ)[;Q'XETY[V[N;>UFMQ#]JG:5D#0AB 3SU-=97(^%[F"[\9>+
MIK:>.:(S6N'C<,I_<+W% #;KQM):_$,>&SI=[) ;02^=%:NQWEPN<CCRP#RW
M8C%3:A\0-&T^ZO(VBU">"Q?9>7=M:/)#;,.2'8#J 1G&<=Z@U.&_L/B78ZQ'
MI=U>64^FM8,]MM)AD,RL"X9AA<9Y&>E8<4.NZ%H_B'PY'X<O+Z:_NKJ2SNXF
MC\B19R2#(Q8%2NX@C!Z<9H ]'%U";/[6L@> Q^8'3Y@5QG(QUX]*P].\9Z?J
M&K0::UIJ5E<7*-);?;;1H1.%Y;;GN <X.#BIK/3;_1O D&EV$D<FI6>FK;P.
M_P!UI4CVJ3GMN KA=$TK6[KQ;X5U"[L-?W68G_M"?4[A602M R_NT5B N[N
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M QE6)<$X/08%9/AG0-JZ'8:KH'B7[9IS1%GEU O91R1C D4&7!7C@!<C.,4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI\EF+73(6499D8,20,_=/&!CCKS6]X.T2;PWX0TO1KB6.6:T@$;O'G:Q]LT
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M5DEC6+3#<&1&SN?S(]@Q]#2:)H$FFZAXAGN)(Y(M4O/M"*N<JOE(F#[Y4]*
M.</Q!U1=#7Q2VA0CPPSC][]K/VD0E]HF\O9MQWV[LXJ[J/B[6_[?UG2M&T*"
M[.EPQ3R33W?E*RNA;: %)W'! [<<D=*S%\#>(6\,IX.FU'3F\/(PC-P$?[4U
MN&W"/'W <#;NST[9KIK/P]/;>(_$6I&:,Q:I#;QQ(,Y3RT93G_OH=* ,.P\?
MZA=C0M1FT);?1-:F2V@E:ZW3J[J2K,@7&TE2/O9Z$@=*[VN*A\%WD7A3PEI!
MN8#+HMU;3S.,[9!&&!"\=3GO7:T %%%% !1110 4444 %%%% !1110 4444
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M2)-%(<)(C'KA6!I]>;^'GT;2=#O=3TCP=+I-];:4\OVJ>P6)9MJAMNY3D@D
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;?EE9_OEAW)[T </XBDL]>U;[$VDRZC>V^FQW$[RZD]I!;H^[##&<OP>=O
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MS?:G+<-9ZS#>.ZW*_,^R2,GY<)P, KP,8KKK+P;X;T[41J%GHEE!=*Q99$B
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M@Z5IS6S6=A!"UK$T$!1>8T8AF4>Q(!-*VA:4\,T36$!CFN1=R*4X:8$$.?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "L7Q3X@'AG13J!M)+MC-% D*.%+-(X0<G@<FMJN(^*JR/X.B6&01RG4
MK,([+N"MYZ8)&1GZ9H MVOCF&.ZOK/7=-N-&NK.S:_9)G21'@4X9U9"0<'@C
MKR*CL/',\U_I<6IZ!=Z;:ZL=MC<RRH^]MI95=5.48J"0.?2L3Q7X+U&7PSXD
MU2]U-]5UF72GM8/+MQ"D<0.\HB DDL1U))/ I=8US3/%#>![31KR"ZN&U*"^
M:.%PS10QQL7+@?=QD+SCDXH TKOXB_9XKO4HM#NY] L[AH+C4DD3@JVUW6/.
MYD5N"1Z' .*O:CXPN$U:ZTW1-$GUB:RB26[:*9(UC#C*J"WWF(&<#L1SS7!V
MVKV%C\$]6\.W%Q%_;4?VO3S8EAYSSR2N$ 3J<[U.16UX6U&Q\)>(_%%EKU_;
MV<N+6Y1[B0)YL8MU0E<_>PR,.* -Y_'MK<Z?HLVBV,^I7>L1M):VH98RJI]\
MR,3A0I.#UYX&:C'Q"MDTFXEN-,NXM5@ODTYM,W*TC7#@%%5L[2I!W;LXP#Z5
MQ'@PCP[J7A#4-8865I?:;?11/<'8L;R7 F123PI*'C/7%:"V6F^(]5\4:T=9
MBTZS.K6CZ;J6]-AN((=I9=WRN,EE]\&@#N-#\3RZCK%UHVI:7+IFIV\*W'DO
M*LJR1,2 ZLO7!!!&!BNAKS/PT\UU\1]2UF?78M6L]/TG[+->Q0K% CM)YA1=
MI.=JKDG)QN XKT2POK74[""^LIUGM9T#Q2IT93T(H L4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M44 10VMO;VXMX((HH ,"-$"J!Z8'%.BBC@B6**-8XT&%1!@*/0"GT4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
@0 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099580253280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Aug. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EMERGENT BIOSOLUTIONS INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">14-1902018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">400 Professional Drive Suite 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Gaithersburg,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-3200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par Value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EBS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,807,027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001367644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577940272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 88.6<span></span>
</td>
<td class="nump">$ 642.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">290.1<span></span>
</td>
<td class="nump">158.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">354.3<span></span>
</td>
<td class="nump">351.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">44.7<span></span>
</td>
<td class="nump">57.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">777.7<span></span>
</td>
<td class="nump">1,210.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">395.5<span></span>
</td>
<td class="nump">817.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">592.8<span></span>
</td>
<td class="nump">728.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">218.2<span></span>
</td>
<td class="nump">218.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">194.6<span></span>
</td>
<td class="nump">191.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,178.8<span></span>
</td>
<td class="nump">3,166.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">108.3<span></span>
</td>
<td class="nump">103.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">31.2<span></span>
</td>
<td class="nump">34.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">69.6<span></span>
</td>
<td class="nump">88.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Debt, current portion</a></td>
<td class="nump">455.2<span></span>
</td>
<td class="nump">957.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">28.9<span></span>
</td>
<td class="nump">45.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">693.2<span></span>
</td>
<td class="nump">1,229.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Debt, net of current portion</a></td>
<td class="nump">448.0<span></span>
</td>
<td class="nump">448.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">57.9<span></span>
</td>
<td class="nump">71.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">23.4<span></span>
</td>
<td class="nump">33.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,222.5<span></span>
</td>
<td class="nump">1,783.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001 per share; 15.0 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share; 200.0 shares authorized, 57.4 and 55.7 shares issued; 51.8 and 50.1 shares outstanding, respectively</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost, 5.6 and 5.6 common shares, respectively</a></td>
<td class="num">(227.7)<span></span>
</td>
<td class="num">(227.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">895.8<span></span>
</td>
<td class="nump">873.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), net</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">289.7<span></span>
</td>
<td class="nump">734.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">956.3<span></span>
</td>
<td class="nump">1,383.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 2,178.8<span></span>
</td>
<td class="nump">$ 3,166.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099579097472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="nump">15,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000.0<span></span>
</td>
<td class="nump">200,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">57,400,000<span></span>
</td>
<td class="nump">55,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">51,800,000<span></span>
</td>
<td class="nump">50,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">5,600,000<span></span>
</td>
<td class="nump">5,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099580435728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 337.9<span></span>
</td>
<td class="nump">$ 242.7<span></span>
</td>
<td class="nump">$ 503.0<span></span>
</td>
<td class="nump">$ 550.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">190.6<span></span>
</td>
<td class="nump">169.8<span></span>
</td>
<td class="nump">345.7<span></span>
</td>
<td class="nump">325.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">306.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">306.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">26.0<span></span>
</td>
<td class="nump">49.8<span></span>
</td>
<td class="nump">66.6<span></span>
</td>
<td class="nump">96.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">91.4<span></span>
</td>
<td class="nump">81.1<span></span>
</td>
<td class="nump">191.9<span></span>
</td>
<td class="nump">165.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">16.1<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">33.1<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">630.8<span></span>
</td>
<td class="nump">314.7<span></span>
</td>
<td class="nump">944.0<span></span>
</td>
<td class="nump">615.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(292.9)<span></span>
</td>
<td class="num">(72.0)<span></span>
</td>
<td class="num">(441.0)<span></span>
</td>
<td class="num">(65.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(28.6)<span></span>
</td>
<td class="num">(7.8)<span></span>
</td>
<td class="num">(46.5)<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">42.7<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
<td class="nump">29.7<span></span>
</td>
<td class="num">(21.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(250.2)<span></span>
</td>
<td class="num">(82.8)<span></span>
</td>
<td class="num">(411.3)<span></span>
</td>
<td class="num">(86.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="num">(26.4)<span></span>
</td>
<td class="nump">33.0<span></span>
</td>
<td class="num">(26.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (261.3)<span></span>
</td>
<td class="num">$ (56.4)<span></span>
</td>
<td class="num">$ (444.3)<span></span>
</td>
<td class="num">$ (60.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Net loss per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (5.15)<span></span>
</td>
<td class="num">$ (1.13)<span></span>
</td>
<td class="num">$ (8.80)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (5.15)<span></span>
</td>
<td class="num">$ (1.13)<span></span>
</td>
<td class="num">$ (8.80)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">50.7<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
<td class="nump">50.5<span></span>
</td>
<td class="nump">50.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">50.7<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
<td class="nump">50.5<span></span>
</td>
<td class="nump">50.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Services</a></td>
<td class="nump">$ 302.2<span></span>
</td>
<td class="nump">$ 237.2<span></span>
</td>
<td class="nump">$ 445.6<span></span>
</td>
<td class="nump">$ 474.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">134.9<span></span>
</td>
<td class="nump">91.0<span></span>
</td>
<td class="nump">237.8<span></span>
</td>
<td class="nump">171.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember', window );">CDMO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Total CDMO</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="nump">59.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">55.7<span></span>
</td>
<td class="nump">78.8<span></span>
</td>
<td class="nump">107.9<span></span>
</td>
<td class="nump">154.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Services</a></td>
<td class="nump">26.4<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">39.8<span></span>
</td>
<td class="nump">54.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember', window );">Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments', window );">Leases</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember', window );">Contracts and grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Services</a></td>
<td class="nump">$ 6.6<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="nump">$ 16.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease Income And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482964/270-10-50-6A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577805920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (261.3)<span></span>
</td>
<td class="num">$ (56.4)<span></span>
</td>
<td class="num">$ (444.3)<span></span>
</td>
<td class="num">$ (60.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gains (losses) on hedging activities</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustment for gains on hedging activities</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Reclassification adjustment for gains on pension benefit obligation</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss, net of tax</a></td>
<td class="num">$ (263.9)<span></span>
</td>
<td class="num">$ (53.2)<span></span>
</td>
<td class="num">$ (449.0)<span></span>
</td>
<td class="num">$ (50.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577768240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (444.3)<span></span>
</td>
<td class="num">$ (60.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">15.1<span></span>
</td>
<td class="nump">22.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_LongTermIncentivePlanNoncashExpense', window );">Long-term incentive plan expense</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">67.5<span></span>
</td>
<td class="nump">75.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent obligations, net</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">9.9<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(10.2)<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of travel health business</a></td>
<td class="num">(74.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">306.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(130.6)<span></span>
</td>
<td class="nump">97.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(23.8)<span></span>
</td>
<td class="num">(75.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(17.8)<span></span>
</td>
<td class="num">(19.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">10.9<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(13.8)<span></span>
</td>
<td class="num">(36.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation</a></td>
<td class="num">(13.4)<span></span>
</td>
<td class="num">(14.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable', window );">Income taxes receivable and payable, net</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="num">(46.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="num">(7.7)<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(298.4)<span></span>
</td>
<td class="num">(52.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(27.6)<span></span>
</td>
<td class="num">(64.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from sale of travel health business, net</a></td>
<td class="nump">270.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">242.6<span></span>
</td>
<td class="num">(64.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(81.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Principal payments on revolving credit facility</a></td>
<td class="num">(347.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfMediumTermNotes', window );">Principal payments on term loan facility</a></td>
<td class="num">(156.8)<span></span>
</td>
<td class="num">(16.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock-based compensation activity</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid for stock-based compensation activity</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from at-the-market sale of stock, net of commissions and expenses</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities:</a></td>
<td class="num">(497.4)<span></span>
</td>
<td class="num">(101.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash, cash equivalents and restricted cash</a></td>
<td class="num">(554.0)<span></span>
</td>
<td class="num">(218.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">642.6<span></span>
</td>
<td class="nump">576.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">88.6<span></span>
</td>
<td class="nump">358.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">38.8<span></span>
</td>
<td class="nump">14.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">26.9<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental information on non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property, plant and equipment unpaid at period end</a></td>
<td class="nump">$ 7.7<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_LongTermIncentivePlanNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Incentive Plan, Noncash Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_LongTermIncentivePlanNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfMediumTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfMediumTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099575198816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>$0.001 Par Value Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 1,619.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (152.2)<span></span>
</td>
<td class="nump">$ 829.4<span></span>
</td>
<td class="num">$ (16.1)<span></span>
</td>
<td class="nump">$ 957.8<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation activity (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation activity</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchases of common stock</a></td>
<td class="num">(52.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (52.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">1,575.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (204.4)<span></span>
</td>
<td class="nump">834.8<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
<td class="nump">954.1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">1,619.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (152.2)<span></span>
</td>
<td class="nump">829.4<span></span>
</td>
<td class="num">(16.1)<span></span>
</td>
<td class="nump">957.8<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(60.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchases of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (75.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">1,513.2<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (227.7)<span></span>
</td>
<td class="nump">849.2<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="nump">897.7<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">1,575.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (204.4)<span></span>
</td>
<td class="nump">834.8<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
<td class="nump">954.1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(56.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation activity (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation activity</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchases of common stock</a></td>
<td class="num">(23.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">$ 1,513.2<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (227.7)<span></span>
</td>
<td class="nump">849.2<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="nump">897.7<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">55.7<span></span>
</td>
<td class="nump">55.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 1,383.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (227.7)<span></span>
</td>
<td class="nump">873.5<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">734.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (183.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation activity (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation activity</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 1,202.6<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (227.7)<span></span>
</td>
<td class="nump">878.2<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">551.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">55.7<span></span>
</td>
<td class="nump">55.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 1,383.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (227.7)<span></span>
</td>
<td class="nump">873.5<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">734.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (444.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">$ (4.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">57.4<span></span>
</td>
<td class="nump">57.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 956.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (227.7)<span></span>
</td>
<td class="nump">895.8<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">289.7<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">$ 1,202.6<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (227.7)<span></span>
</td>
<td class="nump">878.2<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">551.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(261.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(261.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation activity (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation activity</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">At-the-market sale of stock, net of commissions and expenses (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">At-the-market sale of stock, net of commissions and expenses</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">$ (2.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">57.4<span></span>
</td>
<td class="nump">57.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 956.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (227.7)<span></span>
</td>
<td class="nump">$ 895.8<span></span>
</td>
<td class="num">$ (1.6)<span></span>
</td>
<td class="nump">$ 289.7<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577825232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584204704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the business and organization<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Nature of the business and organization</a></td>
<td class="text">Nature of the business and organization<div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization and business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emergent BioSolutions Inc., including its consolidated subsidiaries (&#8220;Emergent,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) is a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate, and naturally occurring Public Health Threats ("PHTs"). The Company's solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing ("CDMO") services portfolio.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is focused on the following four PHT categories: chemical, biological, radiological, nuclear and explosives ("CBRNE"); emerging infectious diseases ("EID"); emerging health crises; and acute/emergency care. The Company has a current product portfolio of 12 products (vaccines, therapeutics, and drug-device combination products). The revenue generated by the products comprises a substantial portion of the Company's revenue. The Company structures the business with a focus on markets and customers. As such, the key components of the business structure include the following four product and service categories: Anthrax - Medical Countermeasures ("MCM") Products, NARCAN, Smallpox - MCM Products and CDMO Services. The Company operates as two operating segments: (1) a products segment ("Products") consisting of the Anthrax - MCM products, NARCAN, Smallpox - MCM products and Other products and (2) a services segment ("Services") focused on CDMO services (Note 17, "Segment information</span><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company's products and services include:</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Anthrax - MCM Products</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Anthrasil</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Anthrax Immune Globulin Intravenous (human)), the only polyclonal antibody therapeutic licensed by the United States Food and Drug Administration (&#8220;FDA&#8221;) and Health Canada for the treatment of inhalational anthrax in combination with appropriate antibacterial drugs;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">BioThrax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Anthrax Vaccine Adsorbed), the only vaccine licensed by the FDA for the general use prophylaxis and post-exposure prophylaxis of anthrax disease;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">CYFENDUS&#8482; (Anthrax vaccine adsorbed (AVA), adjuvanted), previously known as AV7909, which was recently approved by the FDA for post-exposure prophylaxis of disease following suspected or confirmed exposure to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bacillus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">anthracis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. CYFENDUS&#8482; is procured by certain authorized government buyers for their use;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Raxibacumab injection, the first fully human monoclonal antibody therapeutic licensed by the FDA for the treatment and prophylaxis of inhalational anthrax;</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">NARCAN</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">NARCAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone approved by the FDA (including in over-the-counter form) and Health Canada for the emergency treatment&#160;of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression;</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Smallpox - MCM Products</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">ACAM2000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (Smallpox (Vaccinia) Vaccine, Live), the only single-dose smallpox vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">CNJ-016</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Vaccinia Immune Globulin Intravenous (Human) (VIGIV)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada to address certain complications from smallpox vaccination; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">TEMBEXA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an oral antiviral formulated as 100 mg tablets and 10 mg/mL oral suspension dosed once weekly for two weeks which has been approved by the FDA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients, including neonates.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Products</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">BAT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)), the only heptavalent antitoxin licensed by the FDA and Health Canada for the treatment of symptomatic botulism; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Ebanga&#8482; (ansuvimab-zykl), a monoclonal antibody with antiviral activity provided through a single IV infusion for the treatment of Ebola. Under the terms of a collaboration with Ridgeback Biotherapeutics ("Ridgeback"), Emergent will be responsible for the manufacturing, sale, and distribution of Ebanga&#8482; in the U.S. and Canada, and Ridgeback will serve as the global access partner for Ebanga&#8482;;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">RSDL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Reactive Skin Decontamination Lotion Kit), the only medical device cleared by the FDA that is intended to remove or neutralize chemical warfare agents from the skin, including: tabun, sarin, soman, cyclohexyl sarin, VR, VX, mustard gas and T-2 toxin; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt">Trobigard&#174; atropine sulfate, obidoxime chloride auto-injector, a combination drug-device auto-injector procured product candidate that contains atropine sulfate and obidoxime chloride. It was approved in Belgium in 2021 but has not been approved by the FDA. Trobigard is procured by certain authorized government buyers under special circumstances for potential use as a nerve agent countermeasure outside of the U.S.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Sale of Travel Health Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2023 the Company completed the sale of its products segment's travel health business, including rights to Vivotif&#174;, the licensed typhoid vaccine; Vaxchora&#174;, the licensed cholera vaccine; the development-stage chikungunya vaccine candidate CHIKV VLP; the Company&#8217;s manufacturing site in Bern, Switzerland; and certain of its development facilities in San Diego, California. For additional information refer to Note 3, "Divestiture".</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Services - Contract Development and Manufacturing</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's services line focused on CDMO offerings cover development services, drug substance manufacturing, drug product manufacturing, and when necessary, suite reservations, which depending on facts and circumstances could be considered a lease. These services are provided to customers from across the pharmaceutical and biotechnology industries as well as the U.S. Government (&#8220;USG&#8221;) and non-governmental organizations. The Company's technology platforms include mammalian, microbial, viral, plasma and advanced therapies utilizing the Company's core capabilities for manufacturing to third parties on a clinical and commercial (small and large) scale.&#160;Additional services include fill/finish formulation and analytical development services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, aseptic filling, lyophilization, final packaging and stability studies, as well as manufacturing of vial and pre-filled syringe formats on multiple platforms.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099578826512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of significant accounting policies</a></td>
<td class="text">Summary of significant accounting policies<div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of presentation and consolidation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements include the accounts of Emergent and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements included herein have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X issued by the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022, as filed with the SEC.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All adjustments contained in the accompanying unaudited condensed consolidated financial statements are of a normal recurring nature and are necessary to present fairly the financial position of the Company as of June&#160;30, 2023. Interim results are not necessarily indicative of results that may be expected for any other interim period or for an entire year.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Going concern</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, there is $250.2&#160;million outstanding on the Company's Revolving Credit Facility and $206.1&#160;million on Term Loan Facility that matures in May 2025. The Company determined that there is substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. This evaluation considered the mitigating effect of management&#8217;s plans that have been implemented as of June&#160;30, 2023. Management may evaluate the mitigating effect of its plans to determine if it is probable that (1) the plans will be effectively implemented within one year after the date the financial statements are issued, and (2) when implemented, the plans will mitigate the relevant conditions or events that raise substantial doubt about the entity&#8217;s ability to continue as a going concern. The Company's plans include (A) amending the agreement for the Senior Secured Credit Facilities which occurred on May 15, 2023 with the Fourth Amendment to Amended and Restated Credit Agreement, Waiver and First Amendment to Amended and Restated Collateral Agreement (the &#8220;Credit Agreement Amendment&#8221;), and (B) the execution of the capital raise requirement prescribed in the Credit Agreement Amendment, as further described below.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company executed the Credit Agreement Amendment and extended the maturity date on the Senior Secured Credit Facilities to May 15, 2025, the Credit Agreement Amendment also requires the Company to raise at least $75.0&#160;million through the issuance of equity and/or unsecured indebtedness by April 30, 2024. As a result of this provision, the Company has determined it is appropriate to continue to classify the debt as a current liability on the Condensed Consolidated Balance Sheets. While the Company expects to complete these actions, management cannot make the assumption that it is probable that the Company will be successful. As a result, the Company continues to evaluate a number of uncertain factors related to its assessment of its ability to satisfy the capital raise requirement, including its ability to comply with the terms and operating and financial covenants required by the Senior Secured Credit Facilities, other market conditions, economic conditions, particularly in the pharmaceutical and biotechnology industry, disruptions or volatility caused by factors such as lingering impacts of the COVID-19 pandemic, regional conflicts, inflation, and supply chain disruptions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Condensed Consolidated Financial Statements have been prepared assuming the Company will continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-launch inventory</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Company's Products segment, costs relating to raw materials and production of inventory in preparation for product launch prior to regulatory approval are capitalized when the review process has progressed to a point where objective and persuasive evidence exists that regulatory approval is probable, the future economic benefit is expected to be realized, and the Company believes that material uncertainties related to the ultimate regulatory approval have been significantly reduced. Pre-launch inventory is recorded to research and development expense unless these criteria are met. For pre-launch inventory that is capitalized, the Company considers a number of specific facts and circumstances, including the product candidate&#8217;s current status in the drug development and regulatory approval process, results from related clinical trials, results from meetings with relevant regulatory agencies prior to the filing of regulatory applications, potential obstacles to the approval process, historical experience, viability of commercialization and market trends. This policy is not applicable to pre-launch inventory purchased to satisfy a performance obligation related to a CDMO contract as CDMO pre-launch inventory may be capitalized if it has future economic benefit based on the terms of the contract.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant accounting policies</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of the policy on pre-launch inventory discussed above, there have been no significant changes to the Company's summary of significant accounting policies during the six months ended June 30, 2023 contained in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022, that have materially impacted the presentation of the Company's financial statements.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value measurements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value include:</span></div><div style="margin-bottom:9pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Observable inputs for identical assets or liabilities such as quoted prices in active markets;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs other than quoted prices in active markets that are either directly or indirectly observable; and</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use.</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, the Company measures and records money market funds (Level 1), interest-rate swap arrangements and time deposits (Level 2) and contingent purchase consideration (Level 3) using fair value measurements in the accompanying financial statements. The carrying amounts of the Company's short-term financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable approximate their fair values due to their short maturities. The carrying amounts of the Company&#8217;s long-term variable interest rate debt arrangements (Level 2) approximate their fair values.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New accounting standards</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board that the Company adopts as of the pronouncement's specified effective date. There were no new accounting pronouncements that were issued or became effective since the issuance of the Company&#8217;s 2022 Annual Report on Form 10-K that had, or are expected to have, a material impact on its consolidated financial position, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584331520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestiture<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Divestiture</a></td>
<td class="text">Divestiture<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;15, 2023, pursuant to the Purchase and Sale Agreement (the &#8220;Purchase and Sale Agreement&#8221;), by and between the Company, through its wholly owned subsidiaries Emergent International Inc. and Emergent Travel Health Inc. and Bavarian Nordic ("Bavarian Nordic&#8221;), the Company completed the previously announced sale of the Company&#8217;s travel health business, including rights to Vivotif&#174;, the licensed typhoid vaccine; Vaxchora&#174;, the licensed cholera vaccine; the development-stage chikungunya vaccine candidate CHIKV VLP; the Company&#8217;s manufacturing site in Bern, Switzerland; and certain of its development facilities in San Diego, California.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing, Bavarian Nordic paid a cash purchase price of $270.0&#160;million, exclusive of customary closing adjustments for cash, indebtedness, working capital and transaction expenses of the business at closing. Bavarian Nordic may also be required to pay milestone payments of up to $80.0&#160;million related to the development of CHIKV VLP and receipt of marketing approval and authorization in the U.S. and Europe, and earn-out payments of up to $30.0&#160;million based on aggregate net sales of Vaxchora and Vivotif in calendar year 2026.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the divestiture, during the three months ended June&#160;30, 2023, the Company recognized a pre-tax gain of $74.9&#160;million, net of transaction costs of $4.0&#160;million, which was recorded within "Gain on sale of business" on the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the disposal of the travel health business does not qualify for reporting as a discontinued operation since it does not represent a strategic shift that has or will have a major effect on our operations and financial results. No adjustments were made to prior period results as a result of the disposal. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the divestiture, the Company entered into a Transition Services Agreement (&#8220;TSA&#8221;) with Bavarian Nordic to help support its ongoing operations. Under the TSA, the Company will provide certain transition services to Bavarian Nordic, including information technology, finance and enterprise resource planning, research and development, human resources, employee benefits and other limited services. Income from performing services under the TSA was recorded within "Other income (expense), net" on the Condensed Consolidated Statements of Operations and was $1.0&#160;million for the three and six months ended June 30, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099708323568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and impairment costs<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and impairment costs</a></td>
<td class="text">Restructuring and impairment charges<div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Impairment of long-lived assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests its long-lived assets that are held and used for recoverability whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. During the preparation of our financial statements for the three months ended June&#160;30, 2023, due to deterioration in performance and resulting downward revisions to our internal CDMO forecast made during the second quarter, including future expected cash flows, the Company determined there were sufficient indicators of impairment on certain asset groups within the CDMO reporting unit to require an impairment analysis. As a result, the Company performed recoverability tests on certain asset groups within the CDMO reporting unit and concluded that the impacted asset groups were not recoverable as the undiscounted expected cash flows did not exceed their carrying values. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset groups are written down only to the extent that their carrying value is higher than their respective fair value. The Company, with the assistance of a third-party valuation firm, applied valuation methods to estimate the fair values for each of the assets within the different asset classes. An orderly liquidation value was applied to estimate the fair value of the personal property assets and market and cost based approaches were applied to estimate the fair value of the real property assets, each representing Level 3 non-recurring fair value measurements. Based on this analysis, the Company allocated and recognized a non-cash impairment charge of $306.7&#160;million during the three months ended June&#160;30, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the total impairment charge by asset class for the three months ended June&#160;30, 2023:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Buildings, building improvements and leasehold improvements</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81.5&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction-in-progress</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total impairment on long-lived assets</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306.7&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">January 2023 Organizational Restructuring Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company initiated an organizational restructuring plan (the &#8220;January 2023 Plan&#8221;) intended to reduce operating costs, improve operating margins, and continue advancing the Company&#8217;s ongoing commitment to profitable growth. As part of the January 2023 Plan, the Company eliminated approximately five percent of its total headcount. The Company made a $(0.1)&#160;million adjustment to the incurred charges in connection with the January 2023 Plan during the three months ended June&#160;30, 2023 and incurred approximately $9.6&#160;million in charges during the six months ended June 30, 2023. These charges consist primarily of charges related to employee transition, severance payments and employee benefits. All activities related to the January 2023 Plan were substantially completed during the first quarter of 2023. Restructuring costs are recognized as an operating expense within the Condensed Consolidated Statement of Operations and are classified based on the Company's classification policy for each category of operating expense.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total restructuring costs associated with the Company&#8217;s segments as well as unallocated corporate and research and development ("R&amp;D") charges for the three and six months ended June 30, 2023:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.011%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring costs by segment</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring costs</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.6&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total restructuring costs, by function, for the three and six months ended June 30, 2023:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee transition</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severance payments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee benefits</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring costs</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.6&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of and changes in the Company's restructuring accrual during the three and six months ended June 30, 2023:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.997%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Employee Transition</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Severance Payments</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Employee Benefits</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash payments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.0)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.3)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash payments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.6)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.7)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//420/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584305584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories, net</a></td>
<td class="text">Inventories, net<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:59.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials and supplies</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143.4&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventories, net</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">354.3&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">351.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is stated at the lower of cost or net realizable value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584137872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment, net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract', window );"><strong>Property Plant and Equipment Income Statement Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, plant and equipment, net</a></td>
<td class="text">Property, plant and equipment, net<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023 </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land and improvements</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.9&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Buildings, building improvements and leasehold improvements</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">327.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">412.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">567.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction-in-progress</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, gross</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">786.9&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,201.4&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Accumulated depreciation &amp; amortization</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(391.4)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(383.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property, plant and equipment, net</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">395.5&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">817.6&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended June&#160;30, 2023, the Company recorded a non-cash impairment charge of $306.7 million related to certain CDMO long-lived assets. See Note 4, "Restructuring and impairment charges" for more details regarding the impairment charge.</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, construction-in-progress primarily included costs incurred to advance the Company's MCM Product capabilities. As of December&#160;31, 2022, construction-in-progress primarily included costs incurred due to construction to advance the Company's CDMO capabilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net is stated at cost, less accumulated depreciation and amortization. During the year ended December&#160;31, 2022, the Company recorded accelerated depreciation of $12.7&#160;million reflecting a shortening of the useful life of certain property, plant and equipment which were to be used in the manufacturing process to fulfill the manufacturing services agreement with Janssen (the "Agreement"). For additional information related to the termination of the Agreement, refer to Note 13, "Revenue recognition".</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099708323568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible assets and goodwill</a></td>
<td class="text">Intangible assets and goodwill<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's intangible assets consist of products acquired via business combinations or asset acquisitions. The following table summarizes the Company's Intangible assets, net:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:16.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.000%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Weighted Average Useful Life in Years</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr style="height:35pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net Carrying Amount </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.6</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">849.1&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">256.3&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">592.8&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">982.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">728.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">883.2&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290.4&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">592.8&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,016.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">287.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">728.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the Company sold $102.9 million of intangible assets, net as part of the sale of its travel health business to Bavarian Nordic. See Note 3, "Divestiture" for more information on the sale of the business.</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense associated with the Company's intangible assets was recorded as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the changes in the carrying amount of goodwill by reportable segment:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Products </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Services </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218.2&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218.2&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.37pt;font-weight:400;line-height:120%;position:relative;top:-3.43pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">Amounts for the Company's Products segment include gross carrying values of $259.9&#160;million as of June&#160;30, 2023 and December&#160;31, 2022 and accumulated impairment losses of $41.7&#160;million.</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.37pt;font-weight:400;line-height:120%;position:relative;top:-3.43pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">Amounts for the Company's Services segment include gross carrying values of $6.7&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, and accumulated impairment losses of $6.7&#160;million.</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $218.2&#160;million of total goodwill which is attributable to its Products segment. Quantitative impairment assessments performed during the quarter ended June&#160;30, 2023 indicated that the fair value of the reporting unit was approximately 14% in excess over its carrying value as of the assessment date. There is the risk of future impairments in our reporting unit as any further deterioration in their performance compared to forecast, changes in order volumes or delivery schedules for major customers, decline in our stock price, as well as any changes in economic forecasts and expected recovery in the biopharmaceutical industry, may require the Company to complete additional impairment tests in future quarters and could result in a reporting unit&#8217;s fair value falling below carrying value in subsequent quarters. In the event the Company experiences factors that it believes indicate a decline in fair value, including negative changes to long-term growth rates or if discount rates increase, we may be required to record impairments of goodwill and other identified intangible assets. Further, if the composition of the Company&#8217;s reporting units' assets and liabilities were to change and result in an increase in a reporting unit&#8217;s carrying value, it could lead to additional impairment testing and further impairment losses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584207968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair value measurements</a></td>
<td class="text">Fair value measurements<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about the Company's assets and liabilities that are regularly measured and carried at fair value and indicates the level within the fair value hierarchy of the valuation techniques the Company utilized to determine fair value:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="12" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="12" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market accounts</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time deposits</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Contingent consideration</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration payments in an asset acquisition not required to be accounted for as derivatives are recognized when the contingency is resolved, and the consideration is paid or becomes payable. Contingent consideration liabilities associated with business combinations are measured at fair value. These liabilities represent an obligation of the Company to transfer additional assets to the selling shareholders and owners if future events occur or conditions are met. These liabilities associated with business combinations are measured at fair value at inception and at each subsequent reporting date. The changes in the fair value are primarily due to the expected amount and timing of future net sales, which are inputs that have no observable market. Any changes in fair value for the contingent consideration liabilities related to the Company&#8217;s products are classified in the Company's statement of operations as "Cost of product sales."</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below is a reconciliation of the beginning and ending balance of the Company's contingent consideration liability: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.342%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.6)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, the current portion of the contingent consideration liability was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.6&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $3.1&#160;million, respectively, and was included in "Other current liabilities" on the Condensed Consolidated Balance Sheets. The non-current portion of the contingent consideration liability is included in "Other liabilities" on the Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurement for the Company's contingent consideration liability include the following significant unobservable inputs: </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Contingent Consideration Liability</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Fair Value as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Valuation Technique</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Unobservable Input</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Range</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty based</span></td><td colspan="3" rowspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$7.4 million</span></td><td colspan="3" rowspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discounted cash flow</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discount rate</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.7%</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Probability of payment</span></td><td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0% - 75%</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected year of payment</span></td><td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 - 2028</span></td></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derivative instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9, "Derivative instruments and hedging activities</span><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information about the Company's derivative instruments.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Non-variable rate debt</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and December&#160;31, 2022, t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he fair value of the Company's 3.875% Senior Unsecured Notes was $252.9&#160;million and $225.1&#160;million, respectively. The fair value was determined through market sources, which are Level 2 inputs and directly observable. The carrying amounts of the Company&#8217;s other long-term variable interest rate debt arrangements approximate their fair values (see Note 10, "Debt").</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584051616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative instruments and hedging activities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative instruments and hedging activities</a></td>
<td class="text">Derivative instruments and hedging activities<div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risk management objective of using derivatives</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk primarily by managing the amount, sources and duration of its assets and liabilities and the use of derivative financial instruments. From time to time, the Company enters into interest rate swap transactions to manage exposures that arise from payments of variable interest rate debt associated with the Company's senior secured credit agreements. The objective and strategy with respect to these interest rate swaps is to protect the Company against adverse fluctuations in interest rates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June&#160;30, 2023, the Company terminated its designated interest rate swap transactions with a total notional value of $350.0 million. Hedge accounting was also discontinued at that time. As of June&#160;30, 2023, the remaining accumulated other comprehensive income associated with the terminated interest rate swaps, before tax, was $3.5&#160;million and will be amortized to earnings over the remaining term of the interest rate swaps prior to termination.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company&#8217;s derivative financial instruments designated as hedges as well as their classification on the Condensed Consolidated Balance Sheets:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.149%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Fair Value of Asset Derivatives</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Current Assets</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of the interest rate swaps is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each interest rate swap. This analysis reflects the contractual terms of the interest rate swaps, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments (or receipts) and the discounted expected variable cash receipts (or payments). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. We incorporate credit valuation adjustments in the fair value measurements to appropriately reflect both our own nonperformance risk and the respective counterparty&#8217;s nonperformance risk. These credit valuation adjustments were not significant inputs for the fair value calculations for the periods presented. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as the posting of collateral, thresholds, mutual puts and guarantees. The valuation of interest rate swaps fall into Level 2 in the fair value hierarchy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amount of gains or losses reclassified from "Accumulated other comprehensive income (loss), net" into "Interest expense" on the Condensed Consolidated Statement of Operations during the three and six months ended June 30, 2023 and 2022:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:23.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.210%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps gain (loss)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.9)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.3)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099669651600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the components of the Company&#8217;s debt:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.148%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior secured credit agreement - Term loan due 2025</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">206.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">362.8&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior secured credit agreement - Revolver loan due 2025</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">250.2&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">598.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.875% Senior Unsecured Notes due 2028</span></div></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">909.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,413.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Unamortized debt issuance costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.1)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Current portion of long-term debt, net</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(455.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(957.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-current portion of debt, net</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">448.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">448.5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, excludes the unamortized debt issuance costs related to the revolver loan which are included within "Other current assets" on the accompanying Condensed Consolidated Balance Sheet.</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June&#160;30, 2023, the Company reclassified the debt issuance costs associated with the revolver loan to "Other current assets." Prior to the second quarter of 2023, the debt issuance costs associated with the revolver loan were classified as a direct offset to the carrying value of the debt within "Other current liabilities." As of June&#160;30, 2023 and December&#160;31, 2022, the Company had $13.5&#160;million and $1.3&#160;million of debt issuance costs associated with the revolver loan, respectively.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">3.875% Senior Unsecured Notes due 2028 </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 7, 2020, the Company completed its offering of $450.0&#160;million aggregate principal amount of 3.875% Senior Unsecured Notes due 2028 (the "2028 Notes") of which the majority of the net proceeds were used to pay do</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">wn the Revolving Credit Facility. Interest on the 2028 Notes is payable on February 15th and August 15th of each year until maturity, beginning on February 15, 2021. The 2028 Notes will mature on August 15, 2028.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after August 15, 2023, the Company may redeem the 2028 Notes, in whole or in part, at the redemption prices set forth in the related Indenture, plus accrued and unpaid interest. Prior to August 15, 2023 the Company may redeem all or a portion of the 2028 Notes at a redemption price equal to 100% of the principal amount of the 2028 Notes plus a &#8220;make-whole&#8221; premium and accrued and unpaid interest. Prior to August 15, 2023, the Company may redeem up to 40% of the aggregate principal amount of the 2028 Notes using the net cash proceeds of certain equity offerings at the redemption price set forth in the related Indenture. Upon the occurrence of a change of control, the Company must offer to repurchase the 2028 Notes at a purchase price of 101% of the principal amount of such 2028 Notes plus accrued and unpaid interest.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Negative covenants in the Indenture governing the 2028 Notes, among other things, limit the ability of the Company to incur indebtedness and liens, dispose of assets, make investments, enter into certain merger or consolidation transactions and make restricted payments.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Senior Secured Credit Facilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2023, the Company entered into the Credit Agreement Amendment. The Credit Agreement Amendment amends the Existing Credit Agreement to, among other things, (a) extend the maturity date of the Senior Secured Credit Facilities from October 13, 2023 to May 15, 2025, (b) reduce the available commitments under the Revolving Credit Facility from $600.0&#160;million to $300.0&#160;million, (c) remove the Company's ability to incur incremental loans and (d) amend certain mandatory prepayment triggers, affirmative covenants, negative covenants and events of default thereunder. In connection with the Credit Agreement Amendment, the Company used the approximately $270.0&#160;million of proceeds from the sale of its travel health business to Bavarian Nordic, which closed on May 15, 2023, together with approximately $217.2&#160;million of cash on hand, to repay approximately $144.4&#160;million in outstanding principal amount of loans under the Term Loan Facility and $342.8&#160;million outstanding principal amount of loans under the Revolving Credit Facility.The Credit Agreement Amendment also requires that we make quarterly principal payments on the Term Loan Facility of approximately $3.9&#160;million, which commenced on June 30, 2023 and will extend through March 31, 2025.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement Amendment also (w) amends the consolidated debt service coverage ratio financial covenant to require the minimum level to be 2.25 to 1.00 for the fiscal quarters ending March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, and then 2.50 to 1.00 for each fiscal quarter ending thereafter, (x) amends the consolidated leverage ratio to require the maximum level to be 4.50 to 1.00 for the fiscal quarter ending March 31, 2024 and each fiscal quarter ending thereafter, (y) adds minimum Consolidated EBITDA requirements and maximum capital expenditure requirements for each of the months ending April 30, 2023 through February 29, 2024 and a minimum liquidity requirement as of the end of each calendar month and (z) requires the Company to increase its liquidity by April 30, 2024 by raising at least $75.0&#160;million of equity or unsecured indebtedness.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Credit Agreement Amendment replaces the interest rate benchmark such that borrowings under the Revolving Credit Facility and the outstanding principal amount of the Term Loan Facility shall bear interest at a rate per annum equal to (a) a rate based on SOFR, EURIBOR or CDOR plus a margin of 6.00% until March 31, 2024 and thereafter, a margin ranging from 2.75% to 4.00% depending on the Company&#8217;s consolidated leverage ratio, or (b) a base rate (which is the highest of the prime rate, the federal funds rate plus 0.50%, and a SOFR rate for an interest period of one month plus 1%) plus a margin of 5.00% until March 31, 2024 and thereafter, a margin ranging from 1.75% to 3.00% depending on the Company&#8217;s consolidated leverage ratio. In addition, the commitment fee the Company is required to pay in respect of the annual daily unused commitments under the Revolving Credit Facility shall be 0.15% to 0.40% per annum, depending on the Company&#8217;s consolidated leverage ratio.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Credit Agreement Amendment, the Company and the other guarantors have also agreed to provide a lien over certain assets as additional collateral for the benefit of the lenders, including owned real property, equity interests of foreign subsidiaries and certain deposit accounts.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099671629904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation and stockholders' equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stock-based compensation and stockholders' equity</a></td>
<td class="text">Stock-based compensation and stockholders' equity<div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stock-based compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the Company granted stock options to purchase 0.7&#160;million shares of common stock, 1.4&#160;million restricted stock units and 0.5&#160;million performance stock units under the Emergent BioSolutions Inc. Stock Incentive Plan. Performance stock units are presented at the target payout percentage of 100% of target shares granted. Typically, the stock options and restricted stock unit grants vest over three equal annual installments beginning on the day prior to the anniversary of the grant date. The performance stock units settle in stock at the end of the three-year performance period based on the Company's results compared to the performance criteria. During the six months ended June 30, 2023, 0.6&#160;million of stock options and 0.4&#160;million shares of restricted stock units were forfeited prior to the completion of the applicable vesting requirements or expiration. Additionally, an immaterial amount of performance stock units were forfeited during the six months ended June 30, 2023, as the award targets or vesting requirements were not achieved. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense, net of forfeitures was recorded in the following financial statement line items:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:44.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product sales</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of CDMO</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.2&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">2021 Share Repurchase Program</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 11, 2021, the Company announced that its Board of Directors authorized a stock repurchase program of up to an aggregate of $250.0&#160;million of Common Stock (the "Share Repurchase Program"), of which $187.9&#160;million was utilized to purchase approximately 4.4&#160;million shares. The Share Repurchase Program expired on November 11, 2022. During the three and six months ended June 30, 2022, the Company utilized $23.3&#160;million and $75.5&#160;million to purchase approximately 0.7&#160;million and 1.8&#160;million shares, respectively. The Share Repurchase Program did not obligate the Company to acquire any specific number of shares. Repurchased shares are available for use in connection with the Company's stock plans and for other corporate purposes.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">At-the-Market Equity Offering Facility</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, from time to time, sell up to $150.0&#160;million aggregate gross sales price of shares of our common stock through Evercore Group L.L.C. and RBC Capital Markets, LLC, as sales agents, under an &#8220;at-the-market&#8221; equity offering program (the &#8220;ATM Program&#8221;) that we entered into on May 18, 2023. During the three months ended June&#160;30, 2023, we sold 1.1&#160;million shares of our common stock under the ATM Program for gross proceeds of $9.1&#160;million, representing an average price of $8.22 per share. As of June&#160;30, 2023, $140.9&#160;million aggregate gross sales price of shares of our common stock remains available for issuance under the ATM Program. We intend to use proceeds obtained from the sale of shares under the ATM Program for general corporate purposes.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accumulated other comprehensive income (loss), net of tax</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes changes in accumulated other comprehensive income (loss), net of tax by component:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.756%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.830%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Defined Benefit Pension Plan</span></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Derivative Instruments</span></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Foreign Currency Translation Adjustments</span></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December&#160;31, 2022</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.4)</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.5)</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.0)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.1)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.7)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.5)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.9)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.4)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.5)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.7)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.6)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.1)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.6)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.0)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.1)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present the tax effects related to each component of other comprehensive income (loss):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit pension plan</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.1)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.5)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.4)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.7)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total adjustments</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.4)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.6)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit pension plan</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.1)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.5)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.0)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.7)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total adjustments</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.1)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.7)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584170224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per common share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Loss per common share</a></td>
<td class="text">Loss per common share<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic loss per common share is calculated using the treasury method by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted loss per common share adjusts basic loss per common share for the effects of potentially dilutive common shares and is calculated using the treasury stock method. Potentially dilutive common shares include the dilutive effect of shares issuable under our equity compensation plans, including stock options, restricted stock units and performance stock units. Diluted loss per share excludes anti-dilutive securities, which represent the number of potential common shares related to shares issuable under our equity compensation plan that were excluded from diluted loss per common share because their effect would have been antidilutive.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted loss per share:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#1b51bf;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(261.3)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(56.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(444.3)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(60.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average number of shares outstanding-basic</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average number of shares outstanding-diluted</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.5&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss per common share - basic</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.15)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.13)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8.80)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.19)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss per common share - diluted</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.15)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.13)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8.80)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.19)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-dilutive securities</span></td><td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584202112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue recognition<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue recognition</a></td>
<td class="text">Revenue recognition<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as two operating segments (see Note 17, "Segment information"). The Company's revenues disaggregated by the major sources were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales, net</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150.5&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302.2&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118.2&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119.0&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237.2&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total CDMO</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">182.8&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">337.9&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">242.7&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales, net</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176.6&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">269.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">445.6&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">221.6&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">252.7&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">474.3&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total CDMO</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">316.9&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">503.0&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">236.9&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">313.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">550.2&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Termination of manufacturing services agreement with Janssen Pharmaceuticals, Inc.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2020, the Company, through its wholly owned subsidiary, Emergent Manufacturing Operations Baltimore, LLC, entered into the Agreement with Janssen, one of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, for large-scale drug substance manufacturing of Johnson &amp; Johnson&#8217;s investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant based on the AdVac technology (the &#8220;Product&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 6, 2022, the Company provided to Janssen a notice (the &#8220;Notice&#8221;) of material breach of the Agreement for, among other things, failure by Janssen (i) to provide the Company the requisite forecasts of the required quantity of Product to be purchased by Janssen under the Agreement and (ii) to confirm Janssen&#8217;s intent to not purchase the requisite minimum quantity of the Product pursuant to the Agreement and instead, wind-down the Agreement ahead of fulfilling these minimum requirements. Later on June 6, 2022, the Company received from Janssen a purported written notice of termination (the &#8220;Janssen Notice&#8221;) of the Agreement for asserted material breaches of the Agreement by the Company, including alleged failure by the Company to perform its obligations in compliance with current good manufacturing practices ("cGMP") or other applicable laws and regulations and alleged failure by the Company to supply Janssen with the Product. Janssen alleged that the Company&#8217;s breaches were not curable and that, therefore, termination of the Agreement would be effective as of July 6, 2022. The Company disputes Janssen's assertions and allegations, including Janssen's ability to effect termination pursuant to the Janssen Notice. The Company and Janssen disagree on the monetary amounts that are due to the Company as a result of termination by any means. The Company believes the amounts due to the Company include, but are not limited to, compensation for services provided, reimbursement for raw materials purchased and non-cancelable orders, and fees for early termination. Janssen has alleged that no additional amount is due to the Company and that the Company should pay Janssen an unspecified amount as a result of the Company's alleged failure to perform under the Agreement. The Company has not recorded any contingent liabilities related to Janssen's allegations as the Company believes they are without merit and intends to vigorously defend the Company's position during the dispute resolution process through arbitration.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023, there were no impacts on previously recognized revenue or depreciation related to the conclusion of the Agreement. As of June&#160;30, 2023, the Company has no billed or unbilled net accounts receivable related to the Agreement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the fourth quarter of 2022, because the arbitration process is expected to extend longer than one year, the Company reclassified amounts related to the Janssen Agreement from "Inventories, net" and from "Prepaid expenses and other current assets" to "Other assets", resulting in $152.7&#160;million in long-term assets related to the Janssen Agreement on the Condensed Consolidated Balance Sheet as of December&#160;31, 2022. The long-term asset balance within "Other Assets" related to the Agreement as of June&#160;30, 2023 was $154.0&#160;million. These assets include termination penalties, certain inventory related items and raw materials inventory representing materials purchased for the Agreement which Janssen has not reimbursed. The Company evaluated the net realizable value of the inventory as of June&#160;30, 2023, concluding that because the Agreement specifies the Company is entitled to, among other things, reimbursement of raw materials and non-cancelable orders in the event of a contract termination for any reason, the Company is entitled to payment from Janssen for these raw materials. Additionally, the Company has $5.2&#160;million of non-cancelable orders as of June&#160;30, 2023 which have not been received and Janssen has not reimbursed.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CDMO operating leases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain multi-year CDMO service arrangements with commercial customers include operating leases whereby the customer has the right to direct the use of and obtain substantially all of the economic benefits of specific manufacturing suites operated by the Company. The associated revenue is recognized on a straight-line basis over the term of the lease. The weighted average remaining term on the Company's operating lease components approximates 3.2 years. The Company utilizes a cost-plus model to determine the stand-alone selling price of the lease component to allocate contract consideration between the lease and non-lease components. Excluding future amounts related to the Agreement as discussed above, the Company estimates future operating lease revenues to be $0.6&#160;million in the remainder of 2023, $0.9&#160;million in 2024, $0.9&#160;million in 2025, $0.9&#160;million in 2026, $0.9&#160;million in 2027 and $0.9&#160;million in years beyon</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d 2027.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transaction price allocated to remaining performance obligations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the Company has future contract value on unsatisfied performance obligations of approximately $452.0&#160;million associated with all arrangements entered into by the Company. The Company expects to recognize $443.2&#160;million of unsatisfied performance obligations within the next 24 months. The amount and timing of revenue recognition for unsatisfied performance obligations can change. The future revenues associated with unsatisfied performance obligations exclude the value of unexercised option periods in the Company&#8217;s revenue arrangements. Often the timing of manufacturing activities changes based on customer needs and resource availability. Government funding appropriations can impact the timing of product deliveries. The success of the Company's development activities that receive development funding support from the USG under development contracts can also impact the timing of revenue recognition.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers accounts receivable and deferred costs associated with revenue generating contracts, which are not included in inventory or property, plant and equipment and that the Company does not currently have a contractual right to bill, to be contract assets. As of June&#160;30, 2023 and December&#160;31, 2022, the Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">had $30.3 million an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$34.8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, of contract assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> recorded within "Accounts receivable, net" on the Condensed Consolidated Balance Sheets.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract liabilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performance obligations are not transferred to a customer at the end of a reporting period, cash received associated with amounts allocated to those performance obligations is reflected as contract liabilities on the Condensed Consolidated Balance Sheets and is deferred until control of these performance obligations is transferred to the customer. The following table presents the roll forward of the contract liability balances:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.6pt;font-weight:400;line-height:120%">Revenue recognized in the period from amounts included in contract liability at the beginning of the period:</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.8)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023 and December&#160;31, 2022, the current portion of contract liabilities was $14.3&#160;million and $26.4&#160;million, respectively, and was included in "Other current liabilities" on the Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts receivable and allowance for expected credit losses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, including unbilled accounts receivable contract assets, consist of the following:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:61.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Billed</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">238.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unbilled</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowance for expected credit losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for expected credit losses, which represents the estimated aggregate amount of credit risk arising from the inability or unwillingness of specific customers to pay our fees or disputes that may affect our ability to fully collect our billed accounts receivable. We estimate the current-period provision for expected credit losses on a specific identification basis and we consider factors such as the age of the receivables balance, knowledge of the specific customers' circumstances and historical collection experience for similar customers. Accounts receivable, net of the allowance for expected credit losses, represents the amount we expect to collect. Our actual experience may vary from our estimates. At each reporting date, we adjust the allowance for expected credit losses to reflect our current estimate.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584199680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is the lessee for operating leases for offices, R&amp;D facilities and manufacturing facilities. The Company determines if an arrangement is a lease at inception. Operating leases are included in right-of-use assets and liabilities. For a discussion of lessor activities, see Note 13, "Revenue recognition."</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:&#160;</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs are reflected as components of cost of product sales, cost of contract development and manufacturing, R&amp;D expense and selling, general and administrative expense.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to lessee activities is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.583%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.863%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Leases</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1014"><span style="-sec-ix-hidden:f-1015">Other assets</span></span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current portion</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1018"><span style="-sec-ix-hidden:f-1019">Other current liabilities</span></span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1022"><span style="-sec-ix-hidden:f-1023">Other liabilities</span></span></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584188592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income taxes</a></td>
<td class="text">Income taxes<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated effective annual tax rate for the years ended December&#160;31, 2023 and 2022, excluding the impact of discrete adjustments, was (8)% and 29%, respectively. The decrease in the estimated effective annual tax rate is primarily due to a valuation allowance charge. The Company recorded a discrete tax expense of $0.0&#160;million and $0.0&#160;million for the three and six months ended June 30, 2023, respectively, and $0.2&#160;million and $0.6&#160;million for the three and six months ended June 30, 2022, respectively. The discrete tax expense in 2023 was due to share-based compensation activity which was entirely offset by a valuation allowance charge. The discrete expense in 2022 was primarily due to share-based compensation activity offset by return to provision adjustments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes valuation allowances for deferred income tax assets in accordance with U.S. GAAP, which provides that such valuation allowances shall be established unless realization of the income tax benefits is more likely than not. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. At each reporting period, the Company considers the scheduled reversal of deferred tax liabilities and assets, available taxes in carryback periods, tax planning strategies and projected future taxable income in making this assessment.</span></div>In 2022, the Company determined that it was more likely than not that certain deferred tax assets would not be realized due to reductions in estimates of future profitability and disclosure related to substantial doubt about the Company's ability to continue as a going concern. Accordingly, the Company recorded an additional valuation allowance charge of $127.5 million in calculating the estimated annual tax rate for the year ended December&#160;31, 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584202112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Litigation</a></td>
<td class="text">Litigation<div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Securities and shareholder litigation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the specific legal proceedings and claims described below, unless otherwise noted, the amount or range of possible losses is not reasonably estimable. There can be no assurance that the settlement, resolution, or other outcome of one or more matters, including the matters set forth below, during any subsequent reporting period will not have a material adverse effect on the Company's results of operations or cash flows for that period or on the Company's financial condition.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2021, May 14, 2021, and June 2, 2021, putative class action lawsuits were filed against the Company and certain of its current and former senior officers in the United States District Court for the District of Maryland on behalf of purchasers of the Company&#8217;s common stock, seeking to pursue remedies under the Securities Exchange Act of 1934. These complaints were filed by Palm Tran, Inc. &#8211; Amalgamated Transit Union Local 1577 Pension Plan; Alan I. Roth; and Stephen M. Weiss, respectively. The complaints allege, among other things, that the defendants made false and misleading statements about the Company's manufacturing capabilities with respect to COVID-19 vaccine bulk drug substance (referred to herein as "CDMO Manufacturing Capabilities"). These cases were consolidated on December 23, 2021, under the caption In re Emergent BioSolutions Inc. Securities Litigation, No. 8:21-cv-00955-PWG (the "Federal Securities Class Action"). The Lead Plaintiffs in the consolidated matter are Nova Scotia Health Employees&#8217; Pension Plan and The City of Fort Lauderdale Police &amp; Firefighters&#8217; Retirement System. The defendants filed a motion to dismiss on May 19, 2022 and the Lead Plaintiff filed an opposition to that motion on July 19, 2022. A hearing on the motion to dismiss was conducted on April 19, 2023 and a decision on the motion is expected in the coming months. The defendants believe that the allegations in the complaints are without merit and intend to defend the matters vigorously. Given the uncertainty of litigation, the preliminary stage of the cases, and the legal standards that must be met for, among other things, class certification and success on the merits, the Company cannot reasonably estimate the possible loss or range of loss, if any, that may result from the consolidated action.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2021, Lincolnshire Police Pension Fund (&#8220;Lincolnshire&#8221;), and on August 16, 2021, Pooja Sayal, filed putative shareholder derivative lawsuits in the United States District Court for the District of Maryland on behalf of the Company against certain of the Company's current and former officers and directors for breach of fiduciary duties, waste of corporate assets, and unjust enrichment, each allegation related to the CDMO Manufacturing Capabilities. In addition to monetary damages, the complaints seek the implementation of multiple corporate governance and internal policy changes. On November 16, 2021, the cases were consolidated under the caption In re Emergent BioSolutions Inc. Stockholder Derivative Litigation, Master Case No. 8:21-cv-01595-PWG. On January 3, 2022, the Lincolnshire complaint was designated as the operative complaint in the consolidated action. On April 13, 2022 the Court approved the parties' joint stipulation to and stay of the proceedings and discovery until the close of fact discovery in the Federal Securities Class Action. The defendants believe that the allegations in the complaints are without merit and intend to defend the matter vigorously.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 15, 2021, September 16, 2021 and November 12, 2021, putative shareholder derivative lawsuits were filed by Chang Kyum Kim, Mark Nevins and Employees Retirement System of the State of Rhode Island, North Collier Fire Control and Rescue District Firefighters Pension Plan, and Pembroke Pines Firefighters &amp; Police Officers Pension Fund, respectively, in The Court of Chancery of the State of Delaware on behalf of the Company against certain of its current and former officers and directors for breach of fiduciary duties, unjust enrichment and insider trading, each allegation related to the CDMO Manufacturing Capabilities. In addition to monetary damages, the complaints seek the implementation of multiple corporate governance and internal policy changes. On February 2, 2022, the cases were consolidated under the caption In re Emergent BioSolutions, Inc. Derivative Litigation, C.A. No. 2021-0974-MTZ with the institutional investors as co-lead plaintiffs. On March 4, 2022, the defendants&#8217; filed a motion to dismiss the complaint. Ruling on this motion is stayed pursuant to a March 29, 2022 order staying all proceedings pending a final, non-appealable judgment in the Federal Securities Class Action.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2021, December 22, 2021 and January 18, 2022, putative shareholder derivative lawsuits were filed by Zachary Elton, Eric White and Jeffrey Reynolds in the Circuit Court for Montgomery County, Maryland on behalf of the Company against certain of its current and former officers and directors for breach of fiduciary duty, unjust enrichment, waste of corporate assets, failing to maintain internal controls, making or causing to be made false and/or misleading statements and material omissions, insider trading and otherwise violating the federal securities laws, each allegation related to the CDMO Manufacturing Capabilities. The complaints seek monetary and punitive damages. On February 22, 2022, the Court entered an order consolidating these actions under case number C-15-21-CV-000496. On March 9, 2022, the parties filed a Joint Stipulation of Stay of Proceedings and Discovery, pursuant to which the parties agreed to stay all proceedings until 30 calendar days after a ruling on the defendants&#8217; motion to dismiss the Federal Securities Class Action. The Court approved the Joint Stipulation on March 14, 2022.</span></div>In addition to the above actions, the Company has received inquiries and subpoenas to produce documents related to these matters from the Department of Justice, the SEC, the Maryland Attorney General&#8217;s Office, and the New York Attorney General&#8217;s Office. The Company produced or is producing documents as required in response and will continue to cooperate with these government inquiries. The Company also received inquiries and subpoenas from Representative Carolyn Maloney and Representative Jim Clyburn, members of the House Committee on Oversight and Reform and the Select Subcommittee on the Coronavirus Crisis and Senator Murray of the Committee on Health, Education, Labor and Pensions. The Company produced documents and provided testimony and briefings as requested in response to these inquiries.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584168992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment information</a></td>
<td class="text">Segment information<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports segment information based on the internal reporting used by management for making decisions and assessing performance. We manage our business with a focus on two reportable segments. Our Products segment, which includes the Anthrax - MCM products, NARCAN products, Smallpox - MCM products and Other products, and our Services segment consisting of our CDMO services. The Company evaluates the performance of these reportable segments based on revenue and Adjusted Gross Margin, which is a non-GAAP financial measure. Segment revenue includes external customer sales, but it does not include inter-segment services. The Company defines Adjusted Gross Margin as segment revenue less segment cost of sales reduced for significant restructuring events, inventory step-up provisions and changes in fair value of contingent consideration. The Company does not allocate research and development, selling, general and administrative costs, amortization of intangibles assets, interest and other income (expense) or taxes to operating segments in the management reporting reviewed by the chief operating decision maker ("CODM"). The accounting policies for segment reporting are the same as for the Company as a whole.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its assets on a total company basis, not by operating segment, as the Company's operating assets are shared or commingled. Therefore, the Company's CODM does not regularly review any asset information by operating segment and, accordingly, the Company does not report asset information by operating segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes segment revenues and a reconciliation of the Company's segment adjusted gross margin to the consolidated statement of operations for each of the Company's reporting segments:</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.281%"><tr><td style="width:1.0%"></td><td style="width:42.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues:</span></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302.2&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">445.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">474.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.3&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total segment revenues</span></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">331.3&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">235.4&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">489.9&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">533.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants revenues</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">337.9&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">242.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">503.0&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">550.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Less: Cost of sales:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Products</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237.8&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Services</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55.7&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cost of sales</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190.6&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">345.7&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">325.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167.3&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207.8&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">303.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(95.4)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140.7&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144.2&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjustments to gross margin:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in fair value of contingent consideration</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring costs</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory step-up provision</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products adjusted gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169.6&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147.5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">213.6&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">304.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services adjusted gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(95.4)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated adjusted gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143.0&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150.0&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">209.4&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other reconciling items:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants revenue</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to gross margin</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.3)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.8)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(306.7)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 10pt 0 1pt;text-indent:-9pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(306.7)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.0)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(66.6)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(96.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(91.4)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(81.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(191.9)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(165.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16.1)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33.1)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.6)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46.5)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of business</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 10pt 0 1pt;text-indent:-9pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.6)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss before income taxes</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(250.2)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(82.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(411.3)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(86.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Total segment revenues less total cost of sales.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Consolidated gross margin plus adjustments to gross margin.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes depreciation expense for each segment:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:41.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.572%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation:</span></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.3&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.8&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.4&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584173808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent events</a></td>
<td class="text">Subsequent events<div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">FDA Approval of CYFENDUS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2023, the FDA approved CYFENDUS&#8482; for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. In December 2018, CYFENDUS vaccine was the subject of a pre-emergency use authorization package submitted to the FDA. The following year, the USG began procuring this product for national preparedness efforts.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Ebanga Procurement Contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2023, the Company was awarded a 10-year contract by the Biomedical Advanced Research and Development Authority ("BARDA") for advanced development, manufacturing scale-up, and procurement of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> treatment for Ebola. The contract consists of a base period of performance with two option periods valued at approximately $121&#160;million, and five option periods for procurement of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over five years valued at up to $583&#160;million. If all option periods are exercised, the total contract value will be valued at up to approximately $704&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emergent is responsible for the manufacturing, sale and distribution of Ebanga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and Canada pursuant to a collaboration agreement with Ridgeback, the developer of the treatment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, Emergent will pay Ridgeback $6.3&#160;million in contingent consideration as a result of the award of the BARDA contract payable in the third quarter of 2023. In addition, the Company could owe up to $50.4&#160;million in contingent consideration to Ridgeback if activities under the awarded contract have not ceased by June 1, 2026.</span></div><div style="margin-bottom:9pt;padding-left:18pt"><span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">August 2023 Organizational Restructuring Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2023, The Company announced an organizational restructuring plan (the &#8220;August 2023 Plan&#8221;) intended to strengthen its core business and financial position by reducing investment in and de-emphasizing focus on its CDMO services business for future growth. The August 2023 Plan includes a reduction of the Company&#8217;s current workforce by approximately 400 employees. Decisions regarding the elimination of positions are subject to local law and consultation requirements in certain countries, as well as the Company&#8217;s business needs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates that it will incur approximately $19.0&#160;million to $21.0&#160;million in charges in connection with the August 2023 Plan, which it expects to incur in the third quarter of fiscal 2023. These charges consist primarily of cash charges related to severance (base bonus), transition services, and estimated benefits cost.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimates of the charges and expenditures that the Company expects to incur in connection with the August 2023 Plan, and the timing thereof, are subject to a number of assumptions, including local law requirements in various jurisdictions, and actual amounts may differ materially from estimates. In addition, the Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the August 2023 Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577766944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (261.3)<span></span>
</td>
<td class="num">$ (183.0)<span></span>
</td>
<td class="num">$ (56.4)<span></span>
</td>
<td class="num">$ (3.7)<span></span>
</td>
<td class="num">$ (444.3)<span></span>
</td>
<td class="num">$ (60.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099579511984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099579097184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of presentation and consolidation</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements include the accounts of Emergent and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements included herein have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X issued by the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022, as filed with the SEC.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All adjustments contained in the accompanying unaudited condensed consolidated financial statements are of a normal recurring nature and are necessary to present fairly the financial position of the Company as of June&#160;30, 2023. Interim results are not necessarily indicative of results that may be expected for any other interim period or for an entire year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Pre-launch inventory</a></td>
<td class="text">Within the Company's Products segment, costs relating to raw materials and production of inventory in preparation for product launch prior to regulatory approval are capitalized when the review process has progressed to a point where objective and persuasive evidence exists that regulatory approval is probable, the future economic benefit is expected to be realized, and the Company believes that material uncertainties related to the ultimate regulatory approval have been significantly reduced. Pre-launch inventory is recorded to research and development expense unless these criteria are met. For pre-launch inventory that is capitalized, the Company considers a number of specific facts and circumstances, including the product candidate&#8217;s current status in the drug development and regulatory approval process, results from related clinical trials, results from meetings with relevant regulatory agencies prior to the filing of regulatory applications, potential obstacles to the approval process, historical experience, viability of commercialization and market trends. This policy is not applicable to pre-launch inventory purchased to satisfy a performance obligation related to a CDMO contract as CDMO pre-launch inventory may be capitalized if it has future economic benefit based on the terms of the contract.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value measurements</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value include:</span></div><div style="margin-bottom:9pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Observable inputs for identical assets or liabilities such as quoted prices in active markets;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs other than quoted prices in active markets that are either directly or indirectly observable; and</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use.</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, the Company measures and records money market funds (Level 1), interest-rate swap arrangements and time deposits (Level 2) and contingent purchase consideration (Level 3) using fair value measurements in the accompanying financial statements. The carrying amounts of the Company's short-term financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable approximate their fair values due to their short maturities. The carrying amounts of the Company&#8217;s long-term variable interest rate debt arrangements (Level 2) approximate their fair values.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text">The valuation of the interest rate swaps is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each interest rate swap. This analysis reflects the contractual terms of the interest rate swaps, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments (or receipts) and the discounted expected variable cash receipts (or payments). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. We incorporate credit valuation adjustments in the fair value measurements to appropriately reflect both our own nonperformance risk and the respective counterparty&#8217;s nonperformance risk. These credit valuation adjustments were not significant inputs for the fair value calculations for the periods presented. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as the posting of collateral, thresholds, mutual puts and guarantees. The valuation of interest rate swaps fall into Level 2 in the fair value hierarchy.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">The Company reports segment information based on the internal reporting used by management for making decisions and assessing performance. We manage our business with a focus on two reportable segments. Our Products segment, which includes the Anthrax - MCM products, NARCAN products, Smallpox - MCM products and Other products, and our Services segment consisting of our CDMO services. The Company evaluates the performance of these reportable segments based on revenue and Adjusted Gross Margin, which is a non-GAAP financial measure. Segment revenue includes external customer sales, but it does not include inter-segment services. The Company defines Adjusted Gross Margin as segment revenue less segment cost of sales reduced for significant restructuring events, inventory step-up provisions and changes in fair value of contingent consideration. The Company does not allocate research and development, selling, general and administrative costs, amortization of intangibles assets, interest and other income (expense) or taxes to operating segments in the management reporting reviewed by the chief operating decision maker ("CODM"). The accounting policies for segment reporting are the same as for the Company as a whole.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099581391840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and impairment costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock', window );">Details of Impairment of Long-Lived Assets Held and Used by Asset</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the total impairment charge by asset class for the three months ended June&#160;30, 2023:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Buildings, building improvements and leasehold improvements</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81.5&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction-in-progress</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total impairment on long-lived assets</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306.7&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total restructuring costs associated with the Company&#8217;s segments as well as unallocated corporate and research and development ("R&amp;D") charges for the three and six months ended June 30, 2023:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.011%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring costs by segment</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring costs</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.6&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total restructuring costs, by function, for the three and six months ended June 30, 2023:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee transition</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severance payments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee benefits</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring costs</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.6&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of and changes in the Company's restructuring accrual during the three and six months ended June 30, 2023:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.997%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Employee Transition</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Severance Payments</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Employee Benefits</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash payments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.0)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.3)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash payments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.6)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.7)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for impairment of long-lived assets held and used by an entity which includes a description of the impaired long-lived asset and facts and circumstances leading to the impairment, aggregate amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584199680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:59.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials and supplies</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143.4&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventories, net</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">354.3&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">351.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584205536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract', window );"><strong>Property Plant and Equipment Income Statement Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023 </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land and improvements</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.9&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Buildings, building improvements and leasehold improvements</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">327.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">412.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">567.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction-in-progress</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, gross</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">786.9&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,201.4&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Accumulated depreciation &amp; amortization</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(391.4)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(383.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property, plant and equipment, net</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">395.5&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">817.6&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended June&#160;30, 2023, the Company recorded a non-cash impairment charge of $306.7 million related to certain CDMO long-lived assets. See Note 4, "Restructuring and impairment charges" for more details regarding the impairment charge.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577760496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text">The following table summarizes the Company's Intangible assets, net:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:16.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.000%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Weighted Average Useful Life in Years</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr style="height:35pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net Carrying Amount </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.6</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">849.1&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">256.3&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">592.8&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">982.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">728.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">883.2&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290.4&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">592.8&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,016.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">287.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">728.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the Company sold $102.9 million of intangible assets, net as part of the sale of its travel health business to Bavarian Nordic. See Note 3, "Divestiture" for more information on the sale of the business.</span></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Finite-lived Intangible Assets Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense associated with the Company's intangible assets was recorded as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the changes in the carrying amount of goodwill by reportable segment:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Products </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Services </span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218.2&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218.2&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.37pt;font-weight:400;line-height:120%;position:relative;top:-3.43pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">Amounts for the Company's Products segment include gross carrying values of $259.9&#160;million as of June&#160;30, 2023 and December&#160;31, 2022 and accumulated impairment losses of $41.7&#160;million.</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.37pt;font-weight:400;line-height:120%;position:relative;top:-3.43pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%">Amounts for the Company's Services segment include gross carrying values of $6.7&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, and accumulated impairment losses of $6.7&#160;million.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099578832720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Fair Value Measurements, Recurring and Nonrecurring</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about the Company's assets and liabilities that are regularly measured and carried at fair value and indicates the level within the fair value hierarchy of the valuation techniques the Company utilized to determine fair value:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="12" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="12" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market accounts</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time deposits</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below is a reconciliation of the beginning and ending balance of the Company's contingent consideration liability: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.342%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.6)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurement for the Company's contingent consideration liability include the following significant unobservable inputs: </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Contingent Consideration Liability</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Fair Value as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Valuation Technique</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Unobservable Input</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Range</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty based</span></td><td colspan="3" rowspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$7.4 million</span></td><td colspan="3" rowspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discounted cash flow</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discount rate</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.7%</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Probability of payment</span></td><td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0% - 75%</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected year of payment</span></td><td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 - 2028</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2C<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099581794752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative instruments and hedging activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company&#8217;s derivative financial instruments designated as hedges as well as their classification on the Condensed Consolidated Balance Sheets:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.149%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Fair Value of Asset Derivatives</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Current Assets</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amount of gains or losses reclassified from "Accumulated other comprehensive income (loss), net" into "Interest expense" on the Condensed Consolidated Statement of Operations during the three and six months ended June 30, 2023 and 2022:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:23.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.210%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps gain (loss)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.9)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.3)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584333696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the components of the Company&#8217;s debt:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.148%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior secured credit agreement - Term loan due 2025</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">206.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">362.8&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior secured credit agreement - Revolver loan due 2025</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">250.2&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">598.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.875% Senior Unsecured Notes due 2028</span></div></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">909.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,413.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Unamortized debt issuance costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.1)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Current portion of long-term debt, net</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(455.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(957.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-current portion of debt, net</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">448.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">448.5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, excludes the unamortized debt issuance costs related to the revolver loan which are included within "Other current assets" on the accompanying Condensed Consolidated Balance Sheet.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584493632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation and stockholders' equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Share-based Payment Arrangement, Expensed and Capitalized, Amount</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense, net of forfeitures was recorded in the following financial statement line items:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:44.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product sales</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of CDMO</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.2&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes changes in accumulated other comprehensive income (loss), net of tax by component:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.756%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.830%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Defined Benefit Pension Plan</span></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Derivative Instruments</span></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Foreign Currency Translation Adjustments</span></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Total</span></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December&#160;31, 2022</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.4)</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.5)</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.0)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.1)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.7)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.5)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.9)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.4)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.5)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.7)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.6)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.1)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.6)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.0)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.1)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present the tax effects related to each component of other comprehensive income (loss):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit pension plan</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.1)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.5)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.4)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.7)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total adjustments</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.4)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.6)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Pretax</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Tax Expense</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Net of tax</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit pension plan</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.1)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.5)</span></td><td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.0)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.7)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total adjustments</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.1)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.7)</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 45<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584349600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per common share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic and Diluted Net Income per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted loss per share:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#1b51bf;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(261.3)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(56.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(444.3)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(60.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average number of shares outstanding-basic</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average number of shares outstanding-diluted</span></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.5&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss per common share - basic</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.15)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.13)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8.80)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.19)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss per common share - diluted</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.15)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.13)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8.80)</span></td><td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.19)</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-dilutive securities</span></td><td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577815680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The Company's revenues disaggregated by the major sources were as follows:<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales, net</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150.5&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302.2&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118.2&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119.0&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237.2&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total CDMO</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">182.8&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">337.9&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">242.7&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Non-USG</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">&#160;Total</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales, net</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176.6&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">269.0&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">445.6&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">221.6&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">252.7&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">474.3&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMO:</span></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total CDMO</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.3&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants</span></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">316.9&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">503.0&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">236.9&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">313.3&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">550.2&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Rollforward of Contract Liabilities</a></td>
<td class="text">The following table presents the roll forward of the contract liability balances:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.3&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.6pt;font-weight:400;line-height:120%">Revenue recognized in the period from amounts included in contract liability at the beginning of the period:</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.8)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_ScheduleOfAccountsReceivableNetTableTextBlock', window );">Schedule of Accounts Receivable, Net</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, including unbilled accounts receivable contract assets, consist of the following:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:61.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Billed</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">238.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unbilled</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51.8&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowance for expected credit losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ScheduleOfAccountsReceivableNetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Accounts Receivable, Net [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ScheduleOfAccountsReceivableNetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099579108064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:&#160;</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Leases Supplemental Balance Sheets</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to lessee activities is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.583%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.863%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Leases</span></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">June 30, 2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1014"><span style="-sec-ix-hidden:f-1015">Other assets</span></span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current portion</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1018"><span style="-sec-ix-hidden:f-1019">Other current liabilities</span></span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1022"><span style="-sec-ix-hidden:f-1023">Other liabilities</span></span></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.7&#160;</span></td><td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099585143904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes segment revenues and a reconciliation of the Company's segment adjusted gross margin to the consolidated statement of operations for each of the Company's reporting segments:</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.281%"><tr><td style="width:1.0%"></td><td style="width:42.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues:</span></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302.2&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">445.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">474.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.1&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.3&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total segment revenues</span></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">331.3&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">235.4&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">489.9&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">533.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants revenues</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">337.9&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">242.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">503.0&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">550.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Less: Cost of sales:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Products</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237.8&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Services</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55.7&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cost of sales</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190.6&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">345.7&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">325.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167.3&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207.8&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">303.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(95.4)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140.7&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144.2&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjustments to gross margin:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in fair value of contingent consideration</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring costs</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory step-up provision</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products adjusted gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169.6&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147.5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">213.6&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">304.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services adjusted gross margin</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(95.4)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated adjusted gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143.0&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150.0&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">209.4&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other reconciling items:</span></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts and grants revenue</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to gross margin</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.3)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.8)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(306.7)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 10pt 0 1pt;text-indent:-9pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(306.7)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.0)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(66.6)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(96.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(91.4)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(81.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(191.9)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(165.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16.1)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33.1)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.6)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46.5)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of business</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 10pt 0 1pt;text-indent:-9pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.6)</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss before income taxes</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(250.2)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(82.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(411.3)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(86.6)</span></td><td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Total segment revenues less total cost of sales.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Consolidated gross margin plus adjustments to gross margin.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes depreciation expense for each segment:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:41.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.572%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#19415e;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation:</span></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.5&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.3&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.8&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.4&#160;</span></td><td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099579097136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the business and organization (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>segment </div>
<div>product </div>
<div>category </div>
<div>Category</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_NumberOfCategoriesOfPublicHealthThreats', window );">Number of categories of public health threats | category</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_NumberOfRevenueGeneratingProducts', window );">Number of revenue generating products | product</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_NumberOfProductAndServiceCategories', window );">Number of product and service categories | Category</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_NumberOfCategoriesOfPublicHealthThreats">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Refers to the number of categories of public health threats.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_NumberOfCategoriesOfPublicHealthThreats</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_NumberOfProductAndServiceCategories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Product And Service Categories</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_NumberOfProductAndServiceCategories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_NumberOfRevenueGeneratingProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Refers to the number of revenue generating products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_NumberOfRevenueGeneratingProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099580363952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of significant accounting policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>May 15, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 909.3<span></span>
</td>
<td class="nump">$ 1,413.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.2<span></span>
</td>
<td class="nump">598.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 206.1<span></span>
</td>
<td class="nump">$ 362.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember', window );">Senior secured credit agreement - Term loan due 2025 | Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_DebtInstrumentCovenantConsiderationThreshold', window );">Debt instrument, covenant, consideration threshold</a></td>
<td class="nump">$ 75.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentCovenantConsiderationThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Consideration Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentCovenantConsiderationThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099671662800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestiture (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>May 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="nump">$ 74.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 74.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_DispositionOfBusinessTransactionCosts', window );">Transaction costs</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">42.7<span></span>
</td>
<td class="num">$ (10.8)<span></span>
</td>
<td class="nump">29.7<span></span>
</td>
<td class="num">$ (21.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_TravelHealthBusinessMember', window );">Travel Health Business | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Cash purchase price for sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_TravelHealthBusinessMember', window );">Travel Health Business | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Development-Based Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable', window );">Milestone payments receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_TravelHealthBusinessMember', window );">Travel Health Business | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Sales-Based Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable', window );">Milestone payments receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Maximum Contingent Consideration Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DispositionOfBusinessTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposition Of Business, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DispositionOfBusinessTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_TravelHealthBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_TravelHealthBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ebs_DevelopmentBasedMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ebs_DevelopmentBasedMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ebs_SalesBasedMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ebs_SalesBasedMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099580372176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and impairment costs - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">$ 306.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 306.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=ebs_RestructuringPlanJanuary2023Member', window );">January 2023 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent', window );">Number of positions eliminated, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="nump">$ 9.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=ebs_RestructuringPlanJanuary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=ebs_RestructuringPlanJanuary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099575134512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and impairment costs - Details of Impairment of Long-Lived Assets Held and Used by Asset (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">$ 306.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 306.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings, building improvements and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">81.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">117.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">$ 107.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099572036336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and impairment costs - Restructuring and Related Costs (Details) - January 2023 Restructuring Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="nump">$ 9.7<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Total restructuring costs by segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Total restructuring costs by segment | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Total restructuring costs by segment | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ebs_UnallocatedResearchAndDevelopmentMember', window );">R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeTransitionMember', window );">Employee transition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeBenefitsMember', window );">Employee benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=ebs_RestructuringPlanJanuary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=ebs_RestructuringPlanJanuary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ebs_UnallocatedResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ebs_UnallocatedResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeTransitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeTransitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099571938416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and impairment costs - Schedule of Restructuring Reserve by Type of Cost (Details) - January 2023 Restructuring Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Accruals</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeTransitionMember', window );">Employee transition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Accruals</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Accruals</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeBenefitsMember', window );">Employee benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Accruals</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=ebs_RestructuringPlanJanuary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=ebs_RestructuringPlanJanuary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeTransitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeTransitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ebs_EmployeeBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099585536544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories, net - Schedule of Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials and supplies</a></td>
<td class="nump">$ 140.3<span></span>
</td>
<td class="nump">$ 143.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">149.3<span></span>
</td>
<td class="nump">116.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">64.7<span></span>
</td>
<td class="nump">92.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories, net</a></td>
<td class="nump">$ 354.3<span></span>
</td>
<td class="nump">$ 351.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577949408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment, net - Schedule of Property, Plant, and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 786.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 786.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,201.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation &amp; amortization</a></td>
<td class="num">(391.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(391.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(383.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">395.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">817.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">306.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">306.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings, building improvements and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">226.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">412.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">64.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 53.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 185.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099571965424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">$ 190.6<span></span>
</td>
<td class="nump">$ 169.8<span></span>
</td>
<td class="nump">$ 345.7<span></span>
</td>
<td class="nump">$ 325.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ebs_JansenPharmaceuticalsIncMember', window );">Jansen Pharmaceuticals, Inc. | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ebs_JansenPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ebs_JansenPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099574761600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 883.2<span></span>
</td>
<td class="nump">$ 1,016.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">290.4<span></span>
</td>
<td class="nump">287.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">592.8<span></span>
</td>
<td class="nump">728.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Travel Health Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent', window );">Intangible assets disposed of in sale</a></td>
<td class="nump">$ 102.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life in Years</a></td>
<td class="text">13 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 849.1<span></span>
</td>
<td class="nump">982.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">256.3<span></span>
</td>
<td class="nump">253.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 592.8<span></span>
</td>
<td class="nump">728.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life in Years</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 28.6<span></span>
</td>
<td class="nump">28.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">28.6<span></span>
</td>
<td class="nump">28.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_ContractDevelopmentAndManufacturingMember', window );">CDMO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life in Years</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 5.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_TravelHealthBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_TravelHealthBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_ContractDevelopmentAndManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_ContractDevelopmentAndManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099578349904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill - Finite-lived Intangible Assets Amortization Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 16.1<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
<td class="nump">$ 33.1<span></span>
</td>
<td class="nump">$ 28.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577912544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets and goodwill - Goodwill Roll Forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 218.2<span></span>
</td>
<td class="nump">$ 218.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">218.2<span></span>
</td>
<td class="nump">218.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross</a></td>
<td class="nump">259.9<span></span>
</td>
<td class="nump">259.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, impaired, accumulated impairment loss</a></td>
<td class="nump">41.7<span></span>
</td>
<td class="nump">41.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, impaired, accumulated impairment loss</a></td>
<td class="nump">$ 6.7<span></span>
</td>
<td class="nump">$ 6.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099578390800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets and goodwill - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 218.2<span></span>
</td>
<td class="nump">$ 218.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 218.2<span></span>
</td>
<td class="nump">$ 218.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099578017216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value measurements - Fair Value Hierarchy of Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">20.1<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">20.1<span></span>
</td>
<td class="nump">320.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">179.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">20.1<span></span>
</td>
<td class="nump">320.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market accounts | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">20.1<span></span>
</td>
<td class="nump">320.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market accounts | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market accounts | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember', window );">Time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">170.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember', window );">Time deposits | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember', window );">Time deposits | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">170.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember', window );">Time deposits | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099581417664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurements - Contingent Consideration Roll Forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Unobservable Input Reconciliation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, beginning of period</a></td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, end of period</a></td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="nump">$ 7.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099572020768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value measurements - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 07, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Business combination, contingent consideration, liability, current</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member', window );">3.875% Senior Unsecured Notes due 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 252.9<span></span>
</td>
<td class="nump">$ 225.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099571936992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value measurements - Fair Value Level 3 of Significant Unobservable Inputs (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability value</a></td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability value</a></td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Discounted cash flow | Level 3 | Fair Value, Recurring | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, contingent consideration, liability, measurement input</a></td>
<td class="nump">0.097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Discounted cash flow | Level 3 | Fair Value, Recurring | Probability of payment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, contingent consideration, liability, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Discounted cash flow | Level 3 | Fair Value, Recurring | Probability of payment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, contingent consideration, liability, measurement input</a></td>
<td class="nump">0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=ebs_MeasurementInputProbabilityOfPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=ebs_MeasurementInputProbabilityOfPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099581794752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative instruments and hedging activities - Narrative (Details) - Interest Rate Swaps - Designated as Hedging Instrument<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 350,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociBeforeTaxAttributableToParent', window );">AOCI before tax, attributable to parent</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated equity from transactions and other events and circumstances from non-owner sources, attributable to parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners (distributions to owners).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099580293872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative instruments and hedging activities - Fair Value by Balance Sheet Location (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swaps | Designated as Hedging Instrument | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Asset, Subject to Master Netting Arrangement, before Offset</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099578941408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative instruments and hedging activities - Cash Flow Hedging on AOCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest expense | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="num">$ (0.9)<span></span>
</td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="num">$ (2.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099578722960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 07, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 909.3<span></span>
</td>
<td class="nump">$ 1,413.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Less: Unamortized debt issuance costs</a></td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">(8.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of long-term debt, net</a></td>
<td class="num">(455.2)<span></span>
</td>
<td class="num">(957.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-current portion of debt, net</a></td>
<td class="nump">448.0<span></span>
</td>
<td class="nump">448.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Term Loan | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">206.1<span></span>
</td>
<td class="nump">362.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 250.2<span></span>
</td>
<td class="nump">$ 598.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member', window );">3.875% Senior Unsecured Notes due 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 450.0<span></span>
</td>
<td class="nump">$ 450.0<span></span>
</td>
<td class="nump">$ 450.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_OtherLongTermDebtFacilityMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_OtherLongTermDebtFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_OtherLongTermDebtFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099576166560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>May 15, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 07, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 14, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsCurrentNet', window );">Debt issuance costs, current, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">909.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 217.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Travel Health Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Cash purchase price for sale of business</a></td>
<td class="nump">270.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 598.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="nump">$ 144.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member', window );">3.875% Senior Unsecured Notes due 2028 | Prior to August 15, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member', window );">3.875% Senior Unsecured Notes due 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450.0<span></span>
</td>
<td class="nump">$ 450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member', window );">3.875% Senior Unsecured Notes due 2028 | Maximum | Prior to August 15, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member', window );">3.875% Senior Unsecured Notes due 2028 | Maximum | Upon the occurrence of a change in control</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Federal Funds Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Until March 31, 2024 | SOFR, EURIBOR, or CDOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_DebtInstrumentCovenantLeverageRatioMaximum', window );">Debt instrument, covenant, leverage ratio, maximum</a></td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Line of Credit | Fiscal Quarters Ending in 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum', window );">Debt instrument, covenant, interest coverage ratio, minimum</a></td>
<td class="nump">2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Line of Credit | Fiscal Quarters Ending After 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum', window );">Debt instrument, covenant, interest coverage ratio, minimum</a></td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Maximum | Fiscal Quarters Ending After March 31, 2024 | SOFR, EURIBOR, or CDOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Maximum | Fiscal Quarters Ending After March 31, 2024 | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Minimum | Fiscal Quarters Ending After March 31, 2024 | SOFR, EURIBOR, or CDOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Minimum | Fiscal Quarters Ending After March 31, 2024 | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="nump">$ 342.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 206.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 362.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Current borrowing capacity</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Required quarterly principal payments</a></td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amended Credit Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Line of credit facility, unused capacity, commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amended Credit Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Line of credit facility, unused capacity, commitment fee percentage</a></td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember', window );">Senior secured credit agreement - Term loan due 2025 | Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_DebtInstrumentCovenantConsiderationThreshold', window );">Debt instrument, covenant, consideration threshold</a></td>
<td class="nump">$ 75.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentCovenantConsiderationThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Consideration Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentCovenantConsiderationThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Minimum Consolidated Interest Coverage Ratio Required</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum allowed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -SubTopic 470<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsCurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsCurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_TravelHealthBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ebs_TravelHealthBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_SeniorUnsecuredNotesDueAugust2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=ebs_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=ebs_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtTermsAxis=ebs_UntilMarch312024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtTermsAxis=ebs_UntilMarch312024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=ebs_SOFREURIBOROrCDORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=ebs_SOFREURIBOROrCDORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtTermsAxis=ebs_FiscalQuartersEndingIn2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtTermsAxis=ebs_FiscalQuartersEndingIn2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtTermsAxis=ebs_FiscalQuartersEndingAfter2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtTermsAxis=ebs_FiscalQuartersEndingAfter2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtTermsAxis=ebs_FiscalQuartersEndingAfterMarch312024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtTermsAxis=ebs_FiscalQuartersEndingAfterMarch312024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099578145184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation and stockholders' equity - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Nov. 11, 2022</div></th>
<th class="th"><div>Nov. 11, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Nonvested options forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.3<span></span>
</td>
<td class="nump">$ 52.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ebs_AtTheMarketOfferingMember', window );">At-The-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_SaleOfStockConsiderationReceivedOnTransactionGross', window );">Sale of stock, consideration received on transaction, gross</a></td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share)</a></td>
<td class="nump">$ 8.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares', window );">Sale of stock, amount remaining available for sale of shares</a></td>
<td class="nump">$ 140.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.3<span></span>
</td>
<td class="nump">$ 52.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75.5<span></span>
</td>
<td class="nump">$ 187.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Equity instruments other than options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Equity instruments other than options, forfeited in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Equity instruments other than options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage', window );">Target payout percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Tranche One | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Tranche One | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Tranche Two | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Tranche Two | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember', window );">Tranche Three | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember', window );">Tranche Three | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Amount Remaining Available For Sale Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_SaleOfStockConsiderationReceivedOnTransactionGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Consideration Received On Transaction, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_SaleOfStockConsiderationReceivedOnTransactionGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Target Payout Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ebs_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ebs_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577692112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation and stockholders' equity - Schedule of Stock-based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 12.3<span></span>
</td>
<td class="nump">$ 15.1<span></span>
</td>
<td class="nump">$ 22.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of product sales | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of product sales | CDMO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 6.4<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 10.8<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099576958608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation and stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 1,202.6<span></span>
</td>
<td class="nump">$ 1,383.0<span></span>
</td>
<td class="nump">$ 1,575.3<span></span>
</td>
<td class="nump">$ 1,619.0<span></span>
</td>
<td class="nump">$ 1,383.0<span></span>
</td>
<td class="nump">$ 1,619.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">956.3<span></span>
</td>
<td class="nump">1,202.6<span></span>
</td>
<td class="nump">1,513.2<span></span>
</td>
<td class="nump">1,575.3<span></span>
</td>
<td class="nump">956.3<span></span>
</td>
<td class="nump">1,513.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
<td class="num">(16.1)<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="num">(16.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Defined Benefit Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Derivative Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(6.6)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(6.6)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (4.1)<span></span>
</td>
<td class="num">$ (6.7)<span></span>
</td>
<td class="num">$ (6.7)<span></span>
</td>
<td class="num">$ (7.1)<span></span>
</td>
<td class="num">$ (4.1)<span></span>
</td>
<td class="num">$ (6.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099575116944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation and stockholders' equity - Tax Effects Related to Each Component of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Pretax</a></td>
<td class="num">$ (4.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7.1)<span></span>
</td>
<td class="nump">$ 14.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Tax Expense</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">$ (2.1)<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Defined Benefit Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Pretax</a></td>
<td class="num">(4.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Tax Expense</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Derivative Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Pretax</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Tax Expense</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Pretax</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Tax Expense</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099576948992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per common share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (261.3)<span></span>
</td>
<td class="num">$ (183.0)<span></span>
</td>
<td class="num">$ (56.4)<span></span>
</td>
<td class="num">$ (3.7)<span></span>
</td>
<td class="num">$ (444.3)<span></span>
</td>
<td class="num">$ (60.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of shares outstanding-basic (in shares)</a></td>
<td class="nump">50.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.5<span></span>
</td>
<td class="nump">50.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of shares outstanding-diluted (in shares)</a></td>
<td class="nump">50.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.5<span></span>
</td>
<td class="nump">50.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (in dollars per share)</a></td>
<td class="num">$ (5.15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8.80)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (5.15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8.80)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities (in shares)</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099576025520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue recognition - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">$ 191.3<span></span>
</td>
<td class="nump">$ 194.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetNoncurrent', window );">Contract with customer, asset, noncurrent</a></td>
<td class="nump">34.8<span></span>
</td>
<td class="nump">30.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Current portion of contract liabilities</a></td>
<td class="nump">26.4<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-07-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 443.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember', window );">Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Lessee, operating lease, remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear', window );">Lessor, operating lease, payment to be received, remainder of fiscal year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths', window );">Lessor, operating lease, payment to be received, year one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears', window );">Lessor, operating lease, payment to be received, year two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears', window );">Lessor, operating lease, payment to be received, year three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears', window );">Lessor, operating lease, payment to be received, year four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour', window );">Lessor, operating lease, payment to be received, after year four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ebs_JansenPharmaceuticalsIncMember', window );">Jansen Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Increase in other assets</a></td>
<td class="nump">$ 152.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent', window );">Non-cancelable orders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessor, Operating Lease, Payment To Be Received, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-07-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-07-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ebs_JansenPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ebs_JansenPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577584592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue recognition - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 337.9<span></span>
</td>
<td class="nump">$ 242.7<span></span>
</td>
<td class="nump">$ 503.0<span></span>
</td>
<td class="nump">$ 550.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ebs_UnitedStatesGovernmentMember', window );">USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">155.1<span></span>
</td>
<td class="nump">124.4<span></span>
</td>
<td class="nump">186.1<span></span>
</td>
<td class="nump">236.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ebs_NonUnitedStatesGovernmentMember', window );">Non-USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">182.8<span></span>
</td>
<td class="nump">118.3<span></span>
</td>
<td class="nump">316.9<span></span>
</td>
<td class="nump">313.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">302.2<span></span>
</td>
<td class="nump">237.2<span></span>
</td>
<td class="nump">445.6<span></span>
</td>
<td class="nump">474.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net | USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">150.5<span></span>
</td>
<td class="nump">118.2<span></span>
</td>
<td class="nump">176.6<span></span>
</td>
<td class="nump">221.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net | Non-USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">151.7<span></span>
</td>
<td class="nump">119.0<span></span>
</td>
<td class="nump">269.0<span></span>
</td>
<td class="nump">252.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember', window );">Contract Development And Manufacturing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Total CDMO</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="nump">59.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember', window );">Contract Development And Manufacturing [Member] | USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Total CDMO</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember', window );">Contract Development And Manufacturing [Member] | Non-USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Total CDMO</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="nump">59.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">26.4<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">39.8<span></span>
</td>
<td class="nump">54.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services | USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services | Non-USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">26.4<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">39.8<span></span>
</td>
<td class="nump">54.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember', window );">Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments', window );">Leases</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember', window );">Leases | USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments', window );">Leases</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember', window );">Leases | Non-USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments', window );">Leases</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember', window );">Contracts and grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember', window );">Contracts and grants | USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember', window );">Contracts and grants | Non-USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease Income And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482964/270-10-50-6A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ebs_UnitedStatesGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ebs_UnitedStatesGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ebs_NonUnitedStatesGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ebs_NonUnitedStatesGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099584221296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue recognition - Contract Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_ChangeinContractWithCustomerLiabilityRollForward', window );"><strong>Change in Contract With Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning of period</a></td>
<td class="nump">$ 31.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">End of period</a></td>
<td class="nump">19.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized in the period from amounts included in contract liability at the beginning of the period:</a></td>
<td class="num">$ (6.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ChangeinContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Contract With Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ChangeinContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577682896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue recognition - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BilledContractReceivables', window );">Billed</a></td>
<td class="nump">$ 238.5<span></span>
</td>
<td class="nump">$ 102.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled</a></td>
<td class="nump">51.8<span></span>
</td>
<td class="nump">56.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for expected credit losses</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 290.1<span></span>
</td>
<td class="nump">$ 158.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BilledContractReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BilledContractReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099671659744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of Lease Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Operating lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total operating lease cost</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099580377440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 15.7<span></span>
</td>
<td class="nump">$ 19.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">Other current liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 5.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other liabilities<span></span>
</td>
<td class="text">Other liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="nump">$ 14.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 16.7<span></span>
</td>
<td class="nump">$ 20.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (years)</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577842240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective annual tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Discrete tax expense (benefits)</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective annual tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance, deferred tax asset, increase, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099577832432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099575855376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 337.9<span></span>
</td>
<td class="nump">$ 242.7<span></span>
</td>
<td class="nump">$ 503.0<span></span>
</td>
<td class="nump">$ 550.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Less: Cost of sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">190.6<span></span>
</td>
<td class="nump">169.8<span></span>
</td>
<td class="nump">345.7<span></span>
</td>
<td class="nump">325.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Consolidated gross profit</a></td>
<td class="nump">140.7<span></span>
</td>
<td class="nump">65.6<span></span>
</td>
<td class="nump">144.2<span></span>
</td>
<td class="nump">207.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_ProductsSegmentAbstract', window );"><strong>Products:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_AdjustedGrossMargin', window );">Adjusted Gross Margin</a></td>
<td class="nump">143.0<span></span>
</td>
<td class="nump">66.9<span></span>
</td>
<td class="nump">150.0<span></span>
</td>
<td class="nump">209.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Other reconciling items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_GrossProfitAdjustments', window );">Adjustments to gross margin</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="num">(306.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(306.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="num">(26.0)<span></span>
</td>
<td class="num">(49.8)<span></span>
</td>
<td class="num">(66.6)<span></span>
</td>
<td class="num">(96.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="num">(91.4)<span></span>
</td>
<td class="num">(81.1)<span></span>
</td>
<td class="num">(191.9)<span></span>
</td>
<td class="num">(165.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="num">(16.1)<span></span>
</td>
<td class="num">(14.0)<span></span>
</td>
<td class="num">(33.1)<span></span>
</td>
<td class="num">(28.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(28.6)<span></span>
</td>
<td class="num">(7.8)<span></span>
</td>
<td class="num">(46.5)<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Gain on sale of business</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(250.2)<span></span>
</td>
<td class="num">(82.8)<span></span>
</td>
<td class="num">(411.3)<span></span>
</td>
<td class="num">(86.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember', window );">Contracts and grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsAndServicesSegmentsMember', window );">Products And Services Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">331.3<span></span>
</td>
<td class="nump">235.4<span></span>
</td>
<td class="nump">489.9<span></span>
</td>
<td class="nump">533.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">302.2<span></span>
</td>
<td class="nump">237.2<span></span>
</td>
<td class="nump">445.6<span></span>
</td>
<td class="nump">474.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Less: Cost of sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">134.9<span></span>
</td>
<td class="nump">91.0<span></span>
</td>
<td class="nump">237.8<span></span>
</td>
<td class="nump">171.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Consolidated gross profit</a></td>
<td class="nump">167.3<span></span>
</td>
<td class="nump">146.2<span></span>
</td>
<td class="nump">207.8<span></span>
</td>
<td class="nump">303.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_ProductsSegmentAbstract', window );"><strong>Products:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in fair value of contingent consideration</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_InventoryStepUp', window );">Inventory step-up provision</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_AdjustedGrossMargin', window );">Adjusted Gross Margin</a></td>
<td class="nump">169.6<span></span>
</td>
<td class="nump">147.5<span></span>
</td>
<td class="nump">213.6<span></span>
</td>
<td class="nump">304.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="nump">59.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Less: Cost of sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">55.7<span></span>
</td>
<td class="nump">78.8<span></span>
</td>
<td class="nump">107.9<span></span>
</td>
<td class="nump">154.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Consolidated gross profit</a></td>
<td class="num">(26.6)<span></span>
</td>
<td class="num">(80.6)<span></span>
</td>
<td class="num">(63.6)<span></span>
</td>
<td class="num">(95.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_ProductsSegmentAbstract', window );"><strong>Products:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_AdjustedGrossMargin', window );">Adjusted Gross Margin</a></td>
<td class="num">$ (26.6)<span></span>
</td>
<td class="num">$ (80.6)<span></span>
</td>
<td class="num">$ (63.6)<span></span>
</td>
<td class="num">$ (95.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_AdjustedGrossMargin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted Gross Margin</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_AdjustedGrossMargin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_GrossProfitAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Profit, Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_GrossProfitAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_InventoryStepUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory Step Up</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_InventoryStepUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease Income And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ProductsSegmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Products Segment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ProductsSegmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsAndServicesSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsAndServicesSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099571941280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAbstract', window );"><strong>Depreciation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Total</a></td>
<td class="nump">$ 16.8<span></span>
</td>
<td class="nump">$ 28.5<span></span>
</td>
<td class="nump">$ 34.4<span></span>
</td>
<td class="nump">$ 45.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAbstract', window );"><strong>Depreciation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Total</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAbstract', window );"><strong>Depreciation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Total</a></td>
<td class="nump">7.5<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">14.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAbstract', window );"><strong>Depreciation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Total</a></td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="nump">$ 20.8<span></span>
</td>
<td class="nump">$ 16.3<span></span>
</td>
<td class="nump">$ 28.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ebs_ProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ebs_ServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140099574834016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent events (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Aug. 08, 2023 </div>
<div>USD ($) </div>
<div>employee</div>
</th>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>USD ($) </div>
<div>productCandidate</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.3<span></span>
</td>
<td class="nump">$ 31.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Current portion of contract liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="nump">$ 26.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | August 2023 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated', window );">Expected workforce reduction | employee</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | August 2023 Restructuring Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected restructuring charges</a></td>
<td class="nump">$ 19.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | August 2023 Restructuring Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected restructuring charges</a></td>
<td class="nump">$ 21.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_EbangaMember', window );">Ebanga | Subsequent Event | Ridgeback | BARDA Contract, Payable in Third Quarter of 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Current portion of contract liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_EbangaMember', window );">Ebanga | Subsequent Event | Ridgeback | BARDA Contract, Contract not Ceased Prior to June 1, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Maximum contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ebs_BARDAMember', window );">BARDA | Ebanga | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_RevenueFromContractWithCustomerTermOfContract', window );">Term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 704.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ebs_BARDAMember', window );">BARDA | Ebanga | Two Year Option | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods', window );">Number of option periods | productCandidate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ebs_BARDAMember', window );">BARDA | Ebanga | Five Year Option | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_RevenueFromContractWithCustomerTermOfContract', window );">Term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods', window );">Number of option periods | productCandidate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 583.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Number Of Option Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_RevenueFromContractWithCustomerTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Term Of Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_RevenueFromContractWithCustomerTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Variable Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected number of positions to be eliminated as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=ebs_RestructuringPlanAugust2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=ebs_RestructuringPlanAugust2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_EbangaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_EbangaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ebs_RidgebackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ebs_RidgebackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ebs_BARDAContractPayableInThirdQuarterOf2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ebs_BARDAContractPayableInThirdQuarterOf2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ebs_BARDAContractContractNotCeasedPriorToJune12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ebs_BARDAContractContractNotCeasedPriorToJune12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ebs_BARDAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ebs_BARDAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerDurationAxis=ebs_TwoYearOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerDurationAxis=ebs_TwoYearOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerDurationAxis=ebs_FiveYearOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerDurationAxis=ebs_FiveYearOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>ebs-20230630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ebs="http://emergentbiosolutions.com/20230630"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ebs-20230630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-15</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ebs:DevelopmentBasedMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-15</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ebs:SalesBasedMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-15</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:UnallocatedResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:UnallocatedResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeTransitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ebs:EmployeeBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanJanuary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:JansenPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ebs:TravelHealthBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ebs:MeasurementInputProbabilityOfPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ebs:MeasurementInputProbabilityOfPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:OtherLongTermDebtFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:OtherLongTermDebtFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-07</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-07</startDate>
            <endDate>2020-08-07</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-07</startDate>
            <endDate>2020-08-07</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:SeniorUnsecuredNotesDueAugust2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-07</startDate>
            <endDate>2020-08-07</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-14</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-15</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-15</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingIn2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingAfter2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-15</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:UntilMarch312024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ebs:SOFREURIBOROrCDORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingAfterMarch312024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ebs:SOFREURIBOROrCDORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingAfterMarch312024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ebs:SOFREURIBOROrCDORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ebs:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingAfterMarch312024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ebs:DebtTermsAxis">ebs:FiscalQuartersEndingAfterMarch312024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2021-11-11</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-11</startDate>
            <endDate>2022-11-11</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ebs:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ebs:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ebs:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:NonUnitedStatesGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:JansenPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:JansenPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-07-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsAndServicesSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsAndServicesSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsAndServicesSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ebs:ProductsAndServicesSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-31</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">ebs:TwoYearOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-31</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">ebs:TwoYearOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">ebs:FiveYearOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-31</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">ebs:FiveYearOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:BARDAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ebs:RidgebackMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ebs:BARDAContractPayableInThirdQuarterOf2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ebs:RidgebackMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:EbangaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ebs:BARDAContractContractNotCeasedPriorToJune12026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-08</startDate>
            <endDate>2023-08-08</endDate>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-08</instant>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ebs:RestructuringPlanAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-08</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="category">
        <measure>ebs:category</measure>
    </unit>
    <unit id="product">
        <measure>ebs:product</measure>
    </unit>
    <unit id="category2">
        <measure>ebs:Category</measure>
    </unit>
    <unit id="segment">
        <measure>ebs:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="productcandidate">
        <measure>ebs:productCandidate</measure>
    </unit>
    <unit id="employee">
        <measure>ebs:employee</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-25">0001367644</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag contextRef="c-1" id="f-27">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-29">Q2</dei:DocumentFiscalPeriodFocus>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-273" decimals="4" id="f-857" unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-274" decimals="4" id="f-858" unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-275" decimals="4" id="f-859" unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-276" decimals="4" id="f-860" unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-277" decimals="4" id="f-861" unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-278" decimals="4" id="f-862" unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-1014">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-1015">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-1018">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-1019">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-1022">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-1023">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-33137</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">EMERGENT BIOSOLUTIONS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">14-1902018</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">400 Professional Drive Suite 400</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Gaithersburg,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">20879</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">240</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">631-3200</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par Value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">EBS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">51807027</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-30" unitRef="usd">88600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-31" unitRef="usd">642600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-5" id="f-32" unitRef="usd">290100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-5" id="f-33" unitRef="usd">158400000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-34" unitRef="usd">354300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-35" unitRef="usd">351800000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-5" id="f-36" unitRef="usd">44700000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-37" unitRef="usd">57900000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-5" id="f-38" unitRef="usd">777700000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-5" id="f-39" unitRef="usd">1210700000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-5" id="f-40" unitRef="usd">395500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-5" id="f-41" unitRef="usd">817600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-3" decimals="-5" id="f-42" unitRef="usd">592800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-5" id="f-43" unitRef="usd">728800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-3" decimals="-5" id="f-44" unitRef="usd">218200000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-5" id="f-45" unitRef="usd">218200000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-5" id="f-46" unitRef="usd">194600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-47" unitRef="usd">191300000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-5" id="f-48" unitRef="usd">2178800000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-5" id="f-49" unitRef="usd">3166600000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-5" id="f-50" unitRef="usd">108300000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-5" id="f-51" unitRef="usd">103500000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-52" unitRef="usd">31200000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-53" unitRef="usd">34900000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-54" unitRef="usd">69600000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-55" unitRef="usd">88300000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c-3" decimals="-5" id="f-56" unitRef="usd">455200000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c-4" decimals="-5" id="f-57" unitRef="usd">957300000</us-gaap:NotesPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-58" unitRef="usd">28900000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-59" unitRef="usd">45900000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-60" unitRef="usd">693200000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-61" unitRef="usd">1229900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-3" decimals="-5" id="f-62" unitRef="usd">448000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-5" id="f-63" unitRef="usd">448500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-3" decimals="-5" id="f-64" unitRef="usd">57900000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-5" id="f-65" unitRef="usd">71800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-66" unitRef="usd">23400000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-67" unitRef="usd">33400000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-5" id="f-68" unitRef="usd">1222500000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-5" id="f-69" unitRef="usd">1783600000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-70"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-71"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="-5" id="f-72" unitRef="shares">15000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="-5" id="f-73" unitRef="shares">15000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-74" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-75" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-76" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-77" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="-5" id="f-78" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-5" id="f-79" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-80"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-81"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="-5" id="f-82" unitRef="shares">200000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="-5" id="f-83" unitRef="shares">200000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="-5" id="f-84" unitRef="shares">57400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-5" id="f-85" unitRef="shares">55700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="-5" id="f-86" unitRef="shares">51800000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-5" id="f-87" unitRef="shares">50100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-5" id="f-88" unitRef="usd">100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-5" id="f-89" unitRef="usd">100000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="-5" id="f-90" unitRef="shares">5600000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="-5" id="f-91" unitRef="shares">5600000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue contextRef="c-3" decimals="-5" id="f-92" unitRef="usd">227700000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="c-4" decimals="-5" id="f-93" unitRef="usd">227700000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-5" id="f-94" unitRef="usd">895800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-5" id="f-95" unitRef="usd">873500000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-5" id="f-96" unitRef="usd">-1600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-5" id="f-97" unitRef="usd">3100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-98" unitRef="usd">289700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-5" id="f-99" unitRef="usd">734000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-100" unitRef="usd">956300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-5" id="f-101" unitRef="usd">1383000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-5" id="f-102" unitRef="usd">2178800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-5" id="f-103" unitRef="usd">3166600000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-104" unitRef="usd">302200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-105" unitRef="usd">237200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-106" unitRef="usd">445600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-5" id="f-107" unitRef="usd">474300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-5" id="f-108" unitRef="usd">26400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-5" id="f-109" unitRef="usd">2700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-5" id="f-110" unitRef="usd">39800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-5" id="f-111" unitRef="usd">54500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-13" decimals="-5" id="f-112" unitRef="usd">2700000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-14" decimals="-5" id="f-113" unitRef="usd">-4500000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-15" decimals="-5" id="f-114" unitRef="usd">4500000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-16" decimals="-5" id="f-115" unitRef="usd">4500000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-17" decimals="-5" id="f-116" unitRef="usd">29100000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-18" decimals="-5" id="f-117" unitRef="usd">-1800000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-19" decimals="-5" id="f-118" unitRef="usd">44300000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-20" decimals="-5" id="f-119" unitRef="usd">59000000.0</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-21" decimals="-5" id="f-120" unitRef="usd">6600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-22" decimals="-5" id="f-121" unitRef="usd">7300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-23" decimals="-5" id="f-122" unitRef="usd">13100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-24" decimals="-5" id="f-123" unitRef="usd">16900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues contextRef="c-25" decimals="-5" id="f-124" unitRef="usd">337900000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-26" decimals="-5" id="f-125" unitRef="usd">242700000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-1" decimals="-5" id="f-126" unitRef="usd">503000000.0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-27" decimals="-5" id="f-127" unitRef="usd">550200000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-5" id="f-128" unitRef="usd">134900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-6" decimals="-5" id="f-129" unitRef="usd">91000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-7" decimals="-5" id="f-130" unitRef="usd">237800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-8" decimals="-5" id="f-131" unitRef="usd">171300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-17" decimals="-5" id="f-132" unitRef="usd">55700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-18" decimals="-5" id="f-133" unitRef="usd">78800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-19" decimals="-5" id="f-134" unitRef="usd">107900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-20" decimals="-5" id="f-135" unitRef="usd">154400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-25" decimals="-5" id="f-136" unitRef="usd">306700000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-26" decimals="-5" id="f-137" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="-5" id="f-138" unitRef="usd">306700000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-27" decimals="-5" id="f-139" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-25" decimals="-5" id="f-140" unitRef="usd">26000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-26" decimals="-5" id="f-141" unitRef="usd">49800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-142" unitRef="usd">66600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-27" decimals="-5" id="f-143" unitRef="usd">96200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-25" decimals="-5" id="f-144" unitRef="usd">91400000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-26" decimals="-5" id="f-145" unitRef="usd">81100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-146" unitRef="usd">191900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-27" decimals="-5" id="f-147" unitRef="usd">165900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-25" decimals="-5" id="f-148" unitRef="usd">16100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-26" decimals="-5" id="f-149" unitRef="usd">14000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-150" unitRef="usd">33100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-27" decimals="-5" id="f-151" unitRef="usd">28000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-25" decimals="-5" id="f-152" unitRef="usd">630800000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-26" decimals="-5" id="f-153" unitRef="usd">314700000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-1" decimals="-5" id="f-154" unitRef="usd">944000000.0</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c-27" decimals="-5" id="f-155" unitRef="usd">615800000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-25" decimals="-5" id="f-156" unitRef="usd">-292900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-26" decimals="-5" id="f-157" unitRef="usd">-72000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-158" unitRef="usd">-441000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-27" decimals="-5" id="f-159" unitRef="usd">-65600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="c-25" decimals="-5" id="f-160" unitRef="usd">28600000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-26" decimals="-5" id="f-161" unitRef="usd">7800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-5" id="f-162" unitRef="usd">46500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-27" decimals="-5" id="f-163" unitRef="usd">16000000.0</us-gaap:InterestExpense>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-25" decimals="-5" id="f-164" unitRef="usd">74900000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-26" decimals="-5" id="f-165" unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-1" decimals="-5" id="f-166" unitRef="usd">74900000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-27" decimals="-5" id="f-167" unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-25" decimals="-5" id="f-168" unitRef="usd">-3600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-26" decimals="-5" id="f-169" unitRef="usd">-3000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-170" unitRef="usd">1300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-27" decimals="-5" id="f-171" unitRef="usd">-5000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-25" decimals="-5" id="f-172" unitRef="usd">42700000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-26" decimals="-5" id="f-173" unitRef="usd">-10800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-174" unitRef="usd">29700000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-27" decimals="-5" id="f-175" unitRef="usd">-21000000.0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-25" decimals="-5" id="f-176" unitRef="usd">-250200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-26" decimals="-5" id="f-177" unitRef="usd">-82800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-178" unitRef="usd">-411300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-27" decimals="-5" id="f-179" unitRef="usd">-86600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-25" decimals="-5" id="f-180" unitRef="usd">11100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-26" decimals="-5" id="f-181" unitRef="usd">-26400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-182" unitRef="usd">33000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-27" decimals="-5" id="f-183" unitRef="usd">-26500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-25" decimals="-5" id="f-184" unitRef="usd">-261300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-26" decimals="-5" id="f-185" unitRef="usd">-56400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-186" unitRef="usd">-444300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-27" decimals="-5" id="f-187" unitRef="usd">-60100000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-25"
      decimals="2"
      id="f-188"
      unitRef="usdPerShare">-5.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-26"
      decimals="2"
      id="f-189"
      unitRef="usdPerShare">-1.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-190"
      unitRef="usdPerShare">-8.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-27"
      decimals="2"
      id="f-191"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-25"
      decimals="2"
      id="f-192"
      unitRef="usdPerShare">-5.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-26"
      decimals="2"
      id="f-193"
      unitRef="usdPerShare">-1.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-194"
      unitRef="usdPerShare">-8.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-27"
      decimals="2"
      id="f-195"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-25" decimals="-5" id="f-196" unitRef="shares">50700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-26" decimals="-5" id="f-197" unitRef="shares">50000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-198" unitRef="shares">50500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-27" decimals="-5" id="f-199" unitRef="shares">50300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-25" decimals="-5" id="f-200" unitRef="shares">50700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-26" decimals="-5" id="f-201" unitRef="shares">50000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-202" unitRef="shares">50500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-27" decimals="-5" id="f-203" unitRef="shares">50300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-25" decimals="-5" id="f-204" unitRef="usd">-261300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-26" decimals="-5" id="f-205" unitRef="usd">-56400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-206" unitRef="usd">-444300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-27" decimals="-5" id="f-207" unitRef="usd">-60100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-25" decimals="-5" id="f-208" unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-26" decimals="-5" id="f-209" unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-210" unitRef="usd">2500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-27" decimals="-5" id="f-211" unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-25" decimals="-5" id="f-212" unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-26" decimals="-5" id="f-213" unitRef="usd">1900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-1" decimals="-5" id="f-214" unitRef="usd">-3200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-27" decimals="-5" id="f-215" unitRef="usd">6800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-25" decimals="-5" id="f-216" unitRef="usd">2900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-26" decimals="-5" id="f-217" unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-1" decimals="-5" id="f-218" unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-27" decimals="-5" id="f-219" unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-25" decimals="-5" id="f-220" unitRef="usd">3500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-26" decimals="-5" id="f-221" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-1" decimals="-5" id="f-222" unitRef="usd">3500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-27" decimals="-5" id="f-223" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-25" decimals="-5" id="f-224" unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-26" decimals="-5" id="f-225" unitRef="usd">3200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-226" unitRef="usd">-4700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-27" decimals="-5" id="f-227" unitRef="usd">10000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-25" decimals="-5" id="f-228" unitRef="usd">-263900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-26" decimals="-5" id="f-229" unitRef="usd">-53200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-5" id="f-230" unitRef="usd">-449000000.0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-27" decimals="-5" id="f-231" unitRef="usd">-50100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-232" unitRef="usd">-444300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-27" decimals="-5" id="f-233" unitRef="usd">-60100000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-234" unitRef="usd">15100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-27" decimals="-5" id="f-235" unitRef="usd">22200000</us-gaap:ShareBasedCompensation>
    <ebs:LongTermIncentivePlanNoncashExpense contextRef="c-1" decimals="-5" id="f-236" unitRef="usd">2400000</ebs:LongTermIncentivePlanNoncashExpense>
    <ebs:LongTermIncentivePlanNoncashExpense contextRef="c-27" decimals="-5" id="f-237" unitRef="usd">0</ebs:LongTermIncentivePlanNoncashExpense>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-5" id="f-238" unitRef="usd">67500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-27" decimals="-5" id="f-239" unitRef="usd">75400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-1" decimals="-5" id="f-240" unitRef="usd">1900000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-27" decimals="-5" id="f-241" unitRef="usd">1800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-5" id="f-242" unitRef="usd">9900000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-27" decimals="-5" id="f-243" unitRef="usd">2000000.0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-1" decimals="-5" id="f-244" unitRef="usd">-10200000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-27" decimals="-5" id="f-245" unitRef="usd">2600000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-1" decimals="-5" id="f-246" unitRef="usd">74900000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-27" decimals="-5" id="f-247" unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="-5" id="f-248" unitRef="usd">306700000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-27" decimals="-5" id="f-249" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-5" id="f-250" unitRef="usd">-9500000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-27" decimals="-5" id="f-251" unitRef="usd">-2200000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-5" id="f-252" unitRef="usd">130600000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-27" decimals="-5" id="f-253" unitRef="usd">-97700000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-5" id="f-254" unitRef="usd">23800000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-27" decimals="-5" id="f-255" unitRef="usd">75500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-5" id="f-256" unitRef="usd">17800000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-27" decimals="-5" id="f-257" unitRef="usd">19400000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-5" id="f-258" unitRef="usd">10900000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-27" decimals="-5" id="f-259" unitRef="usd">-7600000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="-5" id="f-260" unitRef="usd">-13800000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-27" decimals="-5" id="f-261" unitRef="usd">-36400000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="-5" id="f-262" unitRef="usd">-13400000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-27" decimals="-5" id="f-263" unitRef="usd">-14100000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable contextRef="c-1" decimals="-5" id="f-264" unitRef="usd">14200000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable contextRef="c-27" decimals="-5" id="f-265" unitRef="usd">-46400000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-5" id="f-266" unitRef="usd">-7700000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-27" decimals="-5" id="f-267" unitRef="usd">2700000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-268" unitRef="usd">-298400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-27" decimals="-5" id="f-269" unitRef="usd">-52900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-5" id="f-270" unitRef="usd">27600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-27" decimals="-5" id="f-271" unitRef="usd">64300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="c-1" decimals="-5" id="f-272" unitRef="usd">270200000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="c-27" decimals="-5" id="f-273" unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-5" id="f-274" unitRef="usd">242600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-27" decimals="-5" id="f-275" unitRef="usd">-64300000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-5" id="f-276" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-27" decimals="-5" id="f-277" unitRef="usd">81900000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-1" decimals="-5" id="f-278" unitRef="usd">347800000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-27" decimals="-5" id="f-279" unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfMediumTermNotes contextRef="c-1" decimals="-5" id="f-280" unitRef="usd">156800000</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:RepaymentsOfMediumTermNotes contextRef="c-27" decimals="-5" id="f-281" unitRef="usd">16900000</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-1" decimals="-5" id="f-282" unitRef="usd">1300000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-27" decimals="-5" id="f-283" unitRef="usd">3000000.0</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-5" id="f-284" unitRef="usd">2300000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-27" decimals="-5" id="f-285" unitRef="usd">5400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-5" id="f-286" unitRef="usd">8200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-27" decimals="-5" id="f-287" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-5" id="f-288" unitRef="usd">-497400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-27" decimals="-5" id="f-289" unitRef="usd">-101200000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-5" id="f-290" unitRef="usd">-800000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-27" decimals="-5" id="f-291" unitRef="usd">400000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-5" id="f-292" unitRef="usd">-554000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-27" decimals="-5" id="f-293" unitRef="usd">-218000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-294" unitRef="usd">642600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-28" decimals="-5" id="f-295" unitRef="usd">576300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-296" unitRef="usd">88600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-29" decimals="-5" id="f-297" unitRef="usd">358300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-5" id="f-298" unitRef="usd">38800000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-27" decimals="-5" id="f-299" unitRef="usd">14800000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-5" id="f-300" unitRef="usd">26900000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-27" decimals="-5" id="f-301" unitRef="usd">20000000.0</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-5" id="f-302" unitRef="usd">7700000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-27" decimals="-5" id="f-303" unitRef="usd">7300000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-304"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-28"
      decimals="INF"
      id="f-305"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-306"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-29"
      decimals="INF"
      id="f-307"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-30"
      decimals="INF"
      id="f-308"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-31"
      decimals="INF"
      id="f-309"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="c-32" decimals="-5" id="f-310" unitRef="shares">55700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-5" id="f-311" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-33" decimals="-5" id="f-312" unitRef="shares">5600000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-5" id="f-313" unitRef="usd">-227700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-5" id="f-314" unitRef="usd">873500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-5" id="f-315" unitRef="usd">3100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-5" id="f-316" unitRef="usd">734000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-5" id="f-317" unitRef="usd">1383000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-37" decimals="-5" id="f-318" unitRef="usd">-183000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-38" decimals="-5" id="f-319" unitRef="usd">-183000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-39" decimals="-5" id="f-320" unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-40" decimals="-5" id="f-321" unitRef="usd">4700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-38" decimals="-5" id="f-322" unitRef="usd">4700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-41" decimals="-5" id="f-323" unitRef="usd">-2100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-38" decimals="-5" id="f-324" unitRef="usd">-2100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued contextRef="c-42" decimals="-5" id="f-325" unitRef="shares">56000000.0</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-5" id="f-326" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-43" decimals="-5" id="f-327" unitRef="shares">5600000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-5" id="f-328" unitRef="usd">-227700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-5" id="f-329" unitRef="usd">878200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-5" id="f-330" unitRef="usd">1000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-5" id="f-331" unitRef="usd">551000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-5" id="f-332" unitRef="usd">1202600000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-47" decimals="-5" id="f-333" unitRef="usd">-261300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-25" decimals="-5" id="f-334" unitRef="usd">-261300000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-48" decimals="-5" id="f-335" unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-49" decimals="-5" id="f-336" unitRef="usd">9400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-25" decimals="-5" id="f-337" unitRef="usd">9400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-48" decimals="-5" id="f-338" unitRef="shares">1100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-49" decimals="-5" id="f-339" unitRef="usd">8200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-25" decimals="-5" id="f-340" unitRef="usd">8200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-50" decimals="-5" id="f-341" unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-25" decimals="-5" id="f-342" unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued contextRef="c-51" decimals="-5" id="f-343" unitRef="shares">57400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-51" decimals="-5" id="f-344" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-52" decimals="-5" id="f-345" unitRef="shares">5600000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-52" decimals="-5" id="f-346" unitRef="usd">-227700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-5" id="f-347" unitRef="usd">895800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-5" id="f-348" unitRef="usd">-1600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-5" id="f-349" unitRef="usd">289700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-350" unitRef="usd">956300000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-351"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-28"
      decimals="INF"
      id="f-352"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-353"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-29"
      decimals="INF"
      id="f-354"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-30"
      decimals="INF"
      id="f-355"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-31"
      decimals="INF"
      id="f-356"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="c-56" decimals="-5" id="f-357" unitRef="shares">55100000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-56" decimals="-5" id="f-358" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-57" decimals="-5" id="f-359" unitRef="shares">3800000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-57" decimals="-5" id="f-360" unitRef="usd">-152200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-58" decimals="-5" id="f-361" unitRef="usd">829400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-59" decimals="-5" id="f-362" unitRef="usd">-16100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-60" decimals="-5" id="f-363" unitRef="usd">957800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-5" id="f-364" unitRef="usd">1619000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-61" decimals="-5" id="f-365" unitRef="usd">-3700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-62" decimals="-5" id="f-366" unitRef="usd">-3700000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-63" decimals="-5" id="f-367" unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-64" decimals="-5" id="f-368" unitRef="usd">5400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-62" decimals="-5" id="f-369" unitRef="usd">5400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-65" decimals="-5" id="f-370" unitRef="shares">1100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-65" decimals="-5" id="f-371" unitRef="usd">52200000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-62" decimals="-5" id="f-372" unitRef="usd">52200000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-66" decimals="-5" id="f-373" unitRef="usd">6800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-62" decimals="-5" id="f-374" unitRef="usd">6800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued contextRef="c-67" decimals="-5" id="f-375" unitRef="shares">55300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-67" decimals="-5" id="f-376" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-68" decimals="-5" id="f-377" unitRef="shares">4900000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-68" decimals="-5" id="f-378" unitRef="usd">-204400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-69" decimals="-5" id="f-379" unitRef="usd">834800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-70" decimals="-5" id="f-380" unitRef="usd">-9300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-71" decimals="-5" id="f-381" unitRef="usd">954100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-5" id="f-382" unitRef="usd">1575300000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-72" decimals="-5" id="f-383" unitRef="usd">-56400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-26" decimals="-5" id="f-384" unitRef="usd">-56400000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-73" decimals="-5" id="f-385" unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-74" decimals="-5" id="f-386" unitRef="usd">14400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-26" decimals="-5" id="f-387" unitRef="usd">14400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-75" decimals="-5" id="f-388" unitRef="shares">700000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-75" decimals="-5" id="f-389" unitRef="usd">23300000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-26" decimals="-5" id="f-390" unitRef="usd">23300000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-76" decimals="-5" id="f-391" unitRef="usd">3200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-26" decimals="-5" id="f-392" unitRef="usd">3200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued contextRef="c-77" decimals="-5" id="f-393" unitRef="shares">55500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-77" decimals="-5" id="f-394" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-78" decimals="-5" id="f-395" unitRef="shares">5600000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-78" decimals="-5" id="f-396" unitRef="usd">-227700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-79" decimals="-5" id="f-397" unitRef="usd">849200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-80" decimals="-5" id="f-398" unitRef="usd">-6100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-81" decimals="-5" id="f-399" unitRef="usd">897700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-5" id="f-400" unitRef="usd">1513200000</us-gaap:StockholdersEquity>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-401">Nature of the business and organization&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Organization and business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Emergent BioSolutions Inc., including its consolidated subsidiaries (&#x201c;Emergent,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; and &#x201c;our&#x201d;) is a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate, and naturally occurring Public Health Threats ("PHTs"). The Company's solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing ("CDMO") services portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is focused on the following four PHT categories: chemical, biological, radiological, nuclear and explosives ("CBRNE"); emerging infectious diseases ("EID"); emerging health crises; and acute/emergency care. The Company has a current product portfolio of 12 products (vaccines, therapeutics, and drug-device combination products). The revenue generated by the products comprises a substantial portion of the Company's revenue. The Company structures the business with a focus on markets and customers. As such, the key components of the business structure include the following four product and service categories: Anthrax - Medical Countermeasures ("MCM") Products, NARCAN, Smallpox - MCM Products and CDMO Services. The Company operates as two operating segments: (1) a products segment ("Products") consisting of the Anthrax - MCM products, NARCAN, Smallpox - MCM products and Other products and (2) a services segment ("Services") focused on CDMO services (Note 17, "Segment information&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;"&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The Company's products and services include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Anthrax - MCM Products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;Anthrasil&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Anthrax Immune Globulin Intravenous (human)), the only polyclonal antibody therapeutic licensed by the United States Food and Drug Administration (&#x201c;FDA&#x201d;) and Health Canada for the treatment of inhalational anthrax in combination with appropriate antibacterial drugs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;BioThrax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Anthrax Vaccine Adsorbed), the only vaccine licensed by the FDA for the general use prophylaxis and post-exposure prophylaxis of anthrax disease;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;CYFENDUS&#x2122; (Anthrax vaccine adsorbed (AVA), adjuvanted), previously known as AV7909, which was recently approved by the FDA for post-exposure prophylaxis of disease following suspected or confirmed exposure to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bacillus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;anthracis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. CYFENDUS&#x2122; is procured by certain authorized government buyers for their use;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;Raxibacumab injection, the first fully human monoclonal antibody therapeutic licensed by the FDA for the treatment and prophylaxis of inhalational anthrax;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;NARCAN&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;NARCAN&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone approved by the FDA (including in over-the-counter form) and Health Canada for the emergency treatment&#160;of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Smallpox - MCM Products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;ACAM2000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, (Smallpox (Vaccinia) Vaccine, Live), the only single-dose smallpox vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;CNJ-016&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Vaccinia Immune Globulin Intravenous (Human) (VIGIV)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada to address certain complications from smallpox vaccination; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;TEMBEXA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an oral antiviral formulated as 100 mg tablets and 10 mg/mL oral suspension dosed once weekly for two weeks which has been approved by the FDA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients, including neonates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;BAT&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)), the only heptavalent antitoxin licensed by the FDA and Health Canada for the treatment of symptomatic botulism; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;Ebanga&#x2122; (ansuvimab-zykl), a monoclonal antibody with antiviral activity provided through a single IV infusion for the treatment of Ebola. Under the terms of a collaboration with Ridgeback Biotherapeutics ("Ridgeback"), Emergent will be responsible for the manufacturing, sale, and distribution of Ebanga&#x2122; in the U.S. and Canada, and Ridgeback will serve as the global access partner for Ebanga&#x2122;;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;RSDL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Reactive Skin Decontamination Lotion Kit), the only medical device cleared by the FDA that is intended to remove or neutralize chemical warfare agents from the skin, including: tabun, sarin, soman, cyclohexyl sarin, VR, VX, mustard gas and T-2 toxin; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.66pt"&gt;Trobigard&#xae; atropine sulfate, obidoxime chloride auto-injector, a combination drug-device auto-injector procured product candidate that contains atropine sulfate and obidoxime chloride. It was approved in Belgium in 2021 but has not been approved by the FDA. Trobigard is procured by certain authorized government buyers under special circumstances for potential use as a nerve agent countermeasure outside of the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Sale of Travel Health Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 15, 2023 the Company completed the sale of its products segment's travel health business, including rights to Vivotif&#xae;, the licensed typhoid vaccine; Vaxchora&#xae;, the licensed cholera vaccine; the development-stage chikungunya vaccine candidate CHIKV VLP; the Company&#x2019;s manufacturing site in Bern, Switzerland; and certain of its development facilities in San Diego, California. For additional information refer to Note 3, "Divestiture".&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Services - Contract Development and Manufacturing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's services line focused on CDMO offerings cover development services, drug substance manufacturing, drug product manufacturing, and when necessary, suite reservations, which depending on facts and circumstances could be considered a lease. These services are provided to customers from across the pharmaceutical and biotechnology industries as well as the U.S. Government (&#x201c;USG&#x201d;) and non-governmental organizations. The Company's technology platforms include mammalian, microbial, viral, plasma and advanced therapies utilizing the Company's core capabilities for manufacturing to third parties on a clinical and commercial (small and large) scale.&#160;Additional services include fill/finish formulation and analytical development services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, aseptic filling, lyophilization, final packaging and stability studies, as well as manufacturing of vial and pre-filled syringe formats on multiple platforms.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <ebs:NumberOfCategoriesOfPublicHealthThreats
      contextRef="c-1"
      decimals="INF"
      id="f-402"
      unitRef="category">4</ebs:NumberOfCategoriesOfPublicHealthThreats>
    <ebs:NumberOfRevenueGeneratingProducts
      contextRef="c-1"
      decimals="INF"
      id="f-403"
      unitRef="product">12</ebs:NumberOfRevenueGeneratingProducts>
    <ebs:NumberOfProductAndServiceCategories
      contextRef="c-1"
      decimals="INF"
      id="f-404"
      unitRef="category2">4</ebs:NumberOfProductAndServiceCategories>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-405"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-406"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-407">Summary of significant accounting policies&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of presentation and consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements include the accounts of Emergent and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements included herein have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X issued by the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022, as filed with the SEC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All adjustments contained in the accompanying unaudited condensed consolidated financial statements are of a normal recurring nature and are necessary to present fairly the financial position of the Company as of June&#160;30, 2023. Interim results are not necessarily indicative of results that may be expected for any other interim period or for an entire year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Going concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, there is $250.2&#160;million outstanding on the Company's Revolving Credit Facility and $206.1&#160;million on Term Loan Facility that matures in May 2025. The Company determined that there is substantial doubt about the Company&#x2019;s ability to continue as a going concern within one year after the date that the financial statements are issued. This evaluation considered the mitigating effect of management&#x2019;s plans that have been implemented as of June&#160;30, 2023. Management may evaluate the mitigating effect of its plans to determine if it is probable that (1) the plans will be effectively implemented within one year after the date the financial statements are issued, and (2) when implemented, the plans will mitigate the relevant conditions or events that raise substantial doubt about the entity&#x2019;s ability to continue as a going concern. The Company's plans include (A) amending the agreement for the Senior Secured Credit Facilities which occurred on May 15, 2023 with the Fourth Amendment to Amended and Restated Credit Agreement, Waiver and First Amendment to Amended and Restated Collateral Agreement (the &#x201c;Credit Agreement Amendment&#x201d;), and (B) the execution of the capital raise requirement prescribed in the Credit Agreement Amendment, as further described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company executed the Credit Agreement Amendment and extended the maturity date on the Senior Secured Credit Facilities to May 15, 2025, the Credit Agreement Amendment also requires the Company to raise at least $75.0&#160;million through the issuance of equity and/or unsecured indebtedness by April 30, 2024. As a result of this provision, the Company has determined it is appropriate to continue to classify the debt as a current liability on the Condensed Consolidated Balance Sheets. While the Company expects to complete these actions, management cannot make the assumption that it is probable that the Company will be successful. As a result, the Company continues to evaluate a number of uncertain factors related to its assessment of its ability to satisfy the capital raise requirement, including its ability to comply with the terms and operating and financial covenants required by the Senior Secured Credit Facilities, other market conditions, economic conditions, particularly in the pharmaceutical and biotechnology industry, disruptions or volatility caused by factors such as lingering impacts of the COVID-19 pandemic, regional conflicts, inflation, and supply chain disruptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Condensed Consolidated Financial Statements have been prepared assuming the Company will continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Pre-launch inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within the Company's Products segment, costs relating to raw materials and production of inventory in preparation for product launch prior to regulatory approval are capitalized when the review process has progressed to a point where objective and persuasive evidence exists that regulatory approval is probable, the future economic benefit is expected to be realized, and the Company believes that material uncertainties related to the ultimate regulatory approval have been significantly reduced. Pre-launch inventory is recorded to research and development expense unless these criteria are met. For pre-launch inventory that is capitalized, the Company considers a number of specific facts and circumstances, including the product candidate&#x2019;s current status in the drug development and regulatory approval process, results from related clinical trials, results from meetings with relevant regulatory agencies prior to the filing of regulatory applications, potential obstacles to the approval process, historical experience, viability of commercialization and market trends. This policy is not applicable to pre-launch inventory purchased to satisfy a performance obligation related to a CDMO contract as CDMO pre-launch inventory may be capitalized if it has future economic benefit based on the terms of the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With the exception of the policy on pre-launch inventory discussed above, there have been no significant changes to the Company's summary of significant accounting policies during the six months ended June 30, 2023 contained in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022, that have materially impacted the presentation of the Company's financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair value measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:9pt;padding-right:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:88.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 &#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Observable inputs for identical assets or liabilities such as quoted prices in active markets;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 &#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inputs other than quoted prices in active markets that are either directly or indirectly observable; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 &#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a recurring basis, the Company measures and records money market funds (Level 1), interest-rate swap arrangements and time deposits (Level 2) and contingent purchase consideration (Level 3) using fair value measurements in the accompanying financial statements. The carrying amounts of the Company's short-term financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable approximate their fair values due to their short maturities. The carrying amounts of the Company&#x2019;s long-term variable interest rate debt arrangements (Level 2) approximate their fair values.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New accounting standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board that the Company adopts as of the pronouncement's specified effective date. There were no new accounting pronouncements that were issued or became effective since the issuance of the Company&#x2019;s 2022 Annual Report on Form 10-K that had, or are expected to have, a material impact on its consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-408">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements include the accounts of Emergent and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements included herein have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X issued by the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022, as filed with the SEC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All adjustments contained in the accompanying unaudited condensed consolidated financial statements are of a normal recurring nature and are necessary to present fairly the financial position of the Company as of June&#160;30, 2023. Interim results are not necessarily indicative of results that may be expected for any other interim period or for an entire year.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:LongTermDebt contextRef="c-82" decimals="-5" id="f-409" unitRef="usd">250200000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-83" decimals="-5" id="f-410" unitRef="usd">206100000</us-gaap:LongTermDebt>
    <ebs:DebtInstrumentCovenantConsiderationThreshold contextRef="c-84" decimals="-5" id="f-411" unitRef="usd">75000000</ebs:DebtInstrumentCovenantConsiderationThreshold>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-412">Within the Company's Products segment, costs relating to raw materials and production of inventory in preparation for product launch prior to regulatory approval are capitalized when the review process has progressed to a point where objective and persuasive evidence exists that regulatory approval is probable, the future economic benefit is expected to be realized, and the Company believes that material uncertainties related to the ultimate regulatory approval have been significantly reduced. Pre-launch inventory is recorded to research and development expense unless these criteria are met. For pre-launch inventory that is capitalized, the Company considers a number of specific facts and circumstances, including the product candidate&#x2019;s current status in the drug development and regulatory approval process, results from related clinical trials, results from meetings with relevant regulatory agencies prior to the filing of regulatory applications, potential obstacles to the approval process, historical experience, viability of commercialization and market trends. This policy is not applicable to pre-launch inventory purchased to satisfy a performance obligation related to a CDMO contract as CDMO pre-launch inventory may be capitalized if it has future economic benefit based on the terms of the contract.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-413">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:9pt;padding-right:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:88.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 &#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Observable inputs for identical assets or liabilities such as quoted prices in active markets;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 &#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inputs other than quoted prices in active markets that are either directly or indirectly observable; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 &#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a recurring basis, the Company measures and records money market funds (Level 1), interest-rate swap arrangements and time deposits (Level 2) and contingent purchase consideration (Level 3) using fair value measurements in the accompanying financial statements. The carrying amounts of the Company's short-term financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable approximate their fair values due to their short maturities. The carrying amounts of the Company&#x2019;s long-term variable interest rate debt arrangements (Level 2) approximate their fair values.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="c-1" id="f-414">Divestiture&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;15, 2023, pursuant to the Purchase and Sale Agreement (the &#x201c;Purchase and Sale Agreement&#x201d;), by and between the Company, through its wholly owned subsidiaries Emergent International Inc. and Emergent Travel Health Inc. and Bavarian Nordic ("Bavarian Nordic&#x201d;), the Company completed the previously announced sale of the Company&#x2019;s travel health business, including rights to Vivotif&#xae;, the licensed typhoid vaccine; Vaxchora&#xae;, the licensed cholera vaccine; the development-stage chikungunya vaccine candidate CHIKV VLP; the Company&#x2019;s manufacturing site in Bern, Switzerland; and certain of its development facilities in San Diego, California.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the closing, Bavarian Nordic paid a cash purchase price of $270.0&#160;million, exclusive of customary closing adjustments for cash, indebtedness, working capital and transaction expenses of the business at closing. Bavarian Nordic may also be required to pay milestone payments of up to $80.0&#160;million related to the development of CHIKV VLP and receipt of marketing approval and authorization in the U.S. and Europe, and earn-out payments of up to $30.0&#160;million based on aggregate net sales of Vaxchora and Vivotif in calendar year 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the divestiture, during the three months ended June&#160;30, 2023, the Company recognized a pre-tax gain of $74.9&#160;million, net of transaction costs of $4.0&#160;million, which was recorded within "Gain on sale of business" on the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that the disposal of the travel health business does not qualify for reporting as a discontinued operation since it does not represent a strategic shift that has or will have a major effect on our operations and financial results. No adjustments were made to prior period results as a result of the disposal. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the divestiture, the Company entered into a Transition Services Agreement (&#x201c;TSA&#x201d;) with Bavarian Nordic to help support its ongoing operations. Under the TSA, the Company will provide certain transition services to Bavarian Nordic, including information technology, finance and enterprise resource planning, research and development, human resources, employee benefits and other limited services. Income from performing services under the TSA was recorded within "Other income (expense), net" on the Condensed Consolidated Statements of Operations and was $1.0&#160;million for the three and six months ended June 30, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="c-85" decimals="-5" id="f-415" unitRef="usd">270000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <ebs:DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable contextRef="c-86" decimals="-5" id="f-416" unitRef="usd">80000000</ebs:DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable>
    <ebs:DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable contextRef="c-87" decimals="-5" id="f-417" unitRef="usd">30000000</ebs:DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-25" decimals="-5" id="f-418" unitRef="usd">74900000</us-gaap:GainLossOnSaleOfBusiness>
    <ebs:DispositionOfBusinessTransactionCosts contextRef="c-3" decimals="-5" id="f-419" unitRef="usd">4000000</ebs:DispositionOfBusinessTransactionCosts>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-88" decimals="-5" id="f-420" unitRef="usd">1000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-89" decimals="-5" id="f-421" unitRef="usd">1000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="c-1" id="f-422">Restructuring and impairment charges&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests its long-lived assets that are held and used for recoverability whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. During the preparation of our financial statements for the three months ended June&#160;30, 2023, due to deterioration in performance and resulting downward revisions to our internal CDMO forecast made during the second quarter, including future expected cash flows, the Company determined there were sufficient indicators of impairment on certain asset groups within the CDMO reporting unit to require an impairment analysis. As a result, the Company performed recoverability tests on certain asset groups within the CDMO reporting unit and concluded that the impacted asset groups were not recoverable as the undiscounted expected cash flows did not exceed their carrying values. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asset groups are written down only to the extent that their carrying value is higher than their respective fair value. The Company, with the assistance of a third-party valuation firm, applied valuation methods to estimate the fair values for each of the assets within the different asset classes. An orderly liquidation value was applied to estimate the fair value of the personal property assets and market and cost based approaches were applied to estimate the fair value of the real property assets, each representing Level 3 non-recurring fair value measurements. Based on this analysis, the Company allocated and recognized a non-cash impairment charge of $306.7&#160;million during the three months ended June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the total impairment charge by asset class for the three months ended June&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.210%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.590%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Buildings, building improvements and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;117.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;107.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total impairment on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;January 2023 Organizational Restructuring Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, the Company initiated an organizational restructuring plan (the &#x201c;January 2023 Plan&#x201d;) intended to reduce operating costs, improve operating margins, and continue advancing the Company&#x2019;s ongoing commitment to profitable growth. As part of the January 2023 Plan, the Company eliminated approximately five percent of its total headcount. The Company made a $(0.1)&#160;million adjustment to the incurred charges in connection with the January 2023 Plan during the three months ended June&#160;30, 2023 and incurred approximately $9.6&#160;million in charges during the six months ended June 30, 2023. These charges consist primarily of charges related to employee transition, severance payments and employee benefits. All activities related to the January 2023 Plan were substantially completed during the first quarter of 2023. Restructuring costs are recognized as an operating expense within the Condensed Consolidated Statement of Operations and are classified based on the Company's classification policy for each category of operating expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total restructuring costs associated with the Company&#x2019;s segments as well as unallocated corporate and research and development ("R&amp;amp;D") charges for the three and six months ended June 30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.106%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.009%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total restructuring costs by segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total restructuring costs, by function, for the three and six months ended June 30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.009%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.298%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee transition&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Severance payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the components of and changes in the Company's restructuring accrual during the three and six months ended June 30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.336%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.997%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Employee Transition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Severance Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Employee Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-25" decimals="-5" id="f-423" unitRef="usd">306700000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock contextRef="c-1" id="f-424">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the total impairment charge by asset class for the three months ended June&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.210%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.590%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Buildings, building improvements and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;117.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;107.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total impairment on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-90" decimals="-5" id="f-425" unitRef="usd">81500000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-91" decimals="-5" id="f-426" unitRef="usd">117500000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-92" decimals="-5" id="f-427" unitRef="usd">300000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-93" decimals="-5" id="f-428" unitRef="usd">107400000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-25" decimals="-5" id="f-429" unitRef="usd">306700000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent contextRef="c-94" decimals="2" id="f-430" unitRef="number">0.05</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent>
    <us-gaap:RestructuringCharges contextRef="c-95" decimals="-5" id="f-431" unitRef="usd">-100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-94" decimals="-5" id="f-432" unitRef="usd">9600000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="c-1" id="f-433">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total restructuring costs associated with the Company&#x2019;s segments as well as unallocated corporate and research and development ("R&amp;amp;D") charges for the three and six months ended June 30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.106%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.009%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total restructuring costs by segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total restructuring costs, by function, for the three and six months ended June 30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.009%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.298%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee transition&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Severance payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCharges contextRef="c-96" decimals="-5" id="f-434" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-97" decimals="-5" id="f-435" unitRef="usd">2000000.0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-98" decimals="-5" id="f-436" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-99" decimals="-5" id="f-437" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-100" decimals="-5" id="f-438" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-101" decimals="-5" id="f-439" unitRef="usd">2000000.0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-102" decimals="-5" id="f-440" unitRef="usd">100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-103" decimals="-5" id="f-441" unitRef="usd">5100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-104" decimals="-5" id="f-442" unitRef="usd">-200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-105" decimals="-5" id="f-443" unitRef="usd">2500000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-95" decimals="-5" id="f-444" unitRef="usd">-100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-94" decimals="-5" id="f-445" unitRef="usd">9600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-106" decimals="-5" id="f-446" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-107" decimals="-5" id="f-447" unitRef="usd">300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-108" decimals="-5" id="f-448" unitRef="usd">100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-109" decimals="-5" id="f-449" unitRef="usd">8800000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-110" decimals="-5" id="f-450" unitRef="usd">-200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-111" decimals="-5" id="f-451" unitRef="usd">500000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-95" decimals="-5" id="f-452" unitRef="usd">-100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-94" decimals="-5" id="f-453" unitRef="usd">9600000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="c-1" id="f-454">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the components of and changes in the Company's restructuring accrual during the three and six months ended June 30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.336%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.997%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Employee Transition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Severance Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Employee Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve contextRef="c-112" decimals="-5" id="f-455" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-113" decimals="-5" id="f-456" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-114" decimals="-5" id="f-457" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-115" decimals="-5" id="f-458" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges contextRef="c-116" decimals="-5" id="f-459" unitRef="usd">300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-117" decimals="-5" id="f-460" unitRef="usd">8700000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-118" decimals="-5" id="f-461" unitRef="usd">700000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-119" decimals="-5" id="f-462" unitRef="usd">9700000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring contextRef="c-116" decimals="-5" id="f-463" unitRef="usd">200000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-117" decimals="-5" id="f-464" unitRef="usd">2000000.0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-118" decimals="-5" id="f-465" unitRef="usd">100000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-119" decimals="-5" id="f-466" unitRef="usd">2300000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-120" decimals="-5" id="f-467" unitRef="usd">100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-121" decimals="-5" id="f-468" unitRef="usd">6700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-122" decimals="-5" id="f-469" unitRef="usd">600000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-123" decimals="-5" id="f-470" unitRef="usd">7400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges contextRef="c-106" decimals="-5" id="f-471" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-108" decimals="-5" id="f-472" unitRef="usd">100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-110" decimals="-5" id="f-473" unitRef="usd">-200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-95" decimals="-5" id="f-474" unitRef="usd">-100000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring contextRef="c-106" decimals="-5" id="f-475" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-108" decimals="-5" id="f-476" unitRef="usd">3600000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-110" decimals="-5" id="f-477" unitRef="usd">100000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-95" decimals="-5" id="f-478" unitRef="usd">3700000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-124" decimals="-5" id="f-479" unitRef="usd">100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-125" decimals="-5" id="f-480" unitRef="usd">3200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-126" decimals="-5" id="f-481" unitRef="usd">300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-127" decimals="-5" id="f-482" unitRef="usd">3600000</us-gaap:RestructuringReserve>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c-1" id="f-483">Inventories, net&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.119%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.522%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;140.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;149.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;116.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;354.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;351.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;net&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; is stated at the lower of cost or net realizable value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-484">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.119%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.522%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;140.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;149.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;116.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;354.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;351.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves contextRef="c-3" decimals="-5" id="f-485" unitRef="usd">140300000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves contextRef="c-4" decimals="-5" id="f-486" unitRef="usd">143400000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-3" decimals="-5" id="f-487" unitRef="usd">149300000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-4" decimals="-5" id="f-488" unitRef="usd">116200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-3" decimals="-5" id="f-489" unitRef="usd">64700000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-4" decimals="-5" id="f-490" unitRef="usd">92200000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-491" unitRef="usd">354300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-492" unitRef="usd">351800000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-493">Property, plant and equipment, net&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.009%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.154%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023 &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Buildings, building improvements and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;226.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;327.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;412.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;567.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;185.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;786.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,201.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Accumulated depreciation &amp;amp; amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(391.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(383.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;395.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;817.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the three months ended June&#160;30, 2023, the Company recorded a non-cash impairment charge of $306.7 million related to certain CDMO long-lived assets. See Note 4, "Restructuring and impairment charges" for more details regarding the impairment charge.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, construction-in-progress primarily included costs incurred to advance the Company's MCM Product capabilities. As of December&#160;31, 2022, construction-in-progress primarily included costs incurred due to construction to advance the Company's CDMO capabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net is stated at cost, less accumulated depreciation and amortization. During the year ended December&#160;31, 2022, the Company recorded accelerated depreciation of $12.7&#160;million reflecting a shortening of the useful life of certain property, plant and equipment which were to be used in the manufacturing process to fulfill the manufacturing services agreement with Janssen (the "Agreement"). For additional information related to the termination of the Agreement, refer to Note 13, "Revenue recognition".&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-494">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.009%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.154%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023 &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Buildings, building improvements and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;226.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;327.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;412.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;567.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;185.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;786.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,201.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Accumulated depreciation &amp;amp; amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(391.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(383.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;395.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;817.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the three months ended June&#160;30, 2023, the Company recorded a non-cash impairment charge of $306.7 million related to certain CDMO long-lived assets. See Note 4, "Restructuring and impairment charges" for more details regarding the impairment charge.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-128" decimals="-5" id="f-495" unitRef="usd">30000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-129" decimals="-5" id="f-496" unitRef="usd">54900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-130" decimals="-5" id="f-497" unitRef="usd">226400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-131" decimals="-5" id="f-498" unitRef="usd">327900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-132" decimals="-5" id="f-499" unitRef="usd">412300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-133" decimals="-5" id="f-500" unitRef="usd">567500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-134" decimals="-5" id="f-501" unitRef="usd">64700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-135" decimals="-5" id="f-502" unitRef="usd">65600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-136" decimals="-5" id="f-503" unitRef="usd">53500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-137" decimals="-5" id="f-504" unitRef="usd">185500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-5" id="f-505" unitRef="usd">786900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-5" id="f-506" unitRef="usd">1201400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-5" id="f-507" unitRef="usd">391400000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-5" id="f-508" unitRef="usd">383800000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-5" id="f-509" unitRef="usd">395500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-5" id="f-510" unitRef="usd">817600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-25" decimals="-5" id="f-511" unitRef="usd">306700000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-138" decimals="-5" id="f-512" unitRef="usd">12700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-513">Intangible assets and goodwill&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's intangible assets consist of products acquired via business combinations or asset acquisitions. The following table summarizes the Company's Intangible assets, net:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.130%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.995%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.003%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.995%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.995%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.003%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.000%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Weighted Average Useful Life in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:35pt"&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net Carrying Amount &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;849.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;256.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;592.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;982.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;253.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;728.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CDMO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;883.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;290.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;592.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,016.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;287.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;728.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="42" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June 30, 2023, the Company sold $102.9 million of intangible assets, net as part of the sale of its travel health business to Bavarian Nordic. See Note 3, "Divestiture" for more information on the sale of the business.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense associated with the Company's intangible assets was recorded as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.267%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.272%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the changes in the carrying amount of goodwill by reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.144%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Products &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Services &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.37pt;font-weight:400;line-height:120%;position:relative;top:-3.43pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%"&gt;Amounts for the Company's Products segment include gross carrying values of $259.9&#160;million as of June&#160;30, 2023 and December&#160;31, 2022 and accumulated impairment losses of $41.7&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.37pt;font-weight:400;line-height:120%;position:relative;top:-3.43pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%"&gt;Amounts for the Company's Services segment include gross carrying values of $6.7&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, and accumulated impairment losses of $6.7&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has $218.2&#160;million of total goodwill which is attributable to its Products segment. Quantitative impairment assessments performed during the quarter ended June&#160;30, 2023 indicated that the fair value of the reporting unit was approximately 14% in excess over its carrying value as of the assessment date. There is the risk of future impairments in our reporting unit as any further deterioration in their performance compared to forecast, changes in order volumes or delivery schedules for major customers, decline in our stock price, as well as any changes in economic forecasts and expected recovery in the biopharmaceutical industry, may require the Company to complete additional impairment tests in future quarters and could result in a reporting unit&#x2019;s fair value falling below carrying value in subsequent quarters. In the event the Company experiences factors that it believes indicate a decline in fair value, including negative changes to long-term growth rates or if discount rates increase, we may be required to record impairments of goodwill and other identified intangible assets. Further, if the composition of the Company&#x2019;s reporting units' assets and liabilities were to change and result in an increase in a reporting unit&#x2019;s carrying value, it could lead to additional impairment testing and further impairment losses.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-514">The following table summarizes the Company's Intangible assets, net:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.130%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.995%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.003%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.995%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.995%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.003%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.000%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Weighted Average Useful Life in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:35pt"&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net Carrying Amount &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;849.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;256.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;592.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;982.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;253.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;728.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CDMO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;883.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;290.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;592.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,016.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;287.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;728.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="42" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June 30, 2023, the Company sold $102.9 million of intangible assets, net as part of the sale of its travel health business to Bavarian Nordic. See Note 3, "Divestiture" for more information on the sale of the business.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-139" id="f-515">P13Y7M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-139" decimals="-5" id="f-516" unitRef="usd">849100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-139" decimals="-5" id="f-517" unitRef="usd">256300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-139" decimals="-5" id="f-518" unitRef="usd">592800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-140" decimals="-5" id="f-519" unitRef="usd">982100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-140" decimals="-5" id="f-520" unitRef="usd">253300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-140" decimals="-5" id="f-521" unitRef="usd">728800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-141" id="f-522">P0Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-141" decimals="-5" id="f-523" unitRef="usd">28600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-141" decimals="-5" id="f-524" unitRef="usd">28600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-141" decimals="-5" id="f-525" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-142" decimals="-5" id="f-526" unitRef="usd">28600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-142" decimals="-5" id="f-527" unitRef="usd">28600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-142" decimals="-5" id="f-528" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-143" id="f-529">P0Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-143" decimals="-5" id="f-530" unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-143" decimals="-5" id="f-531" unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-143" decimals="-5" id="f-532" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-144" decimals="-5" id="f-533" unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-144" decimals="-5" id="f-534" unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-144" decimals="-5" id="f-535" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-3" decimals="-5" id="f-536" unitRef="usd">883200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-3" decimals="-5" id="f-537" unitRef="usd">290400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-3" decimals="-5" id="f-538" unitRef="usd">592800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-5" id="f-539" unitRef="usd">1016200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-5" id="f-540" unitRef="usd">287400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-5" id="f-541" unitRef="usd">728800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent contextRef="c-145" decimals="-5" id="f-542" unitRef="usd">102900000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock contextRef="c-1" id="f-543">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense associated with the Company's intangible assets was recorded as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.267%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.272%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-25" decimals="-5" id="f-544" unitRef="usd">16100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-26" decimals="-5" id="f-545" unitRef="usd">14000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-546" unitRef="usd">33100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-27" decimals="-5" id="f-547" unitRef="usd">28000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-548">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the changes in the carrying amount of goodwill by reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.144%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Products &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Services &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:6.04pt;font-weight:700;line-height:120%;position:relative;top:-3.25pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.37pt;font-weight:400;line-height:120%;position:relative;top:-3.43pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%"&gt;Amounts for the Company's Products segment include gross carrying values of $259.9&#160;million as of June&#160;30, 2023 and December&#160;31, 2022 and accumulated impairment losses of $41.7&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.37pt;font-weight:400;line-height:120%;position:relative;top:-3.43pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:120%"&gt;Amounts for the Company's Services segment include gross carrying values of $6.7&#160;million as of June&#160;30, 2023 and December&#160;31, 2022, and accumulated impairment losses of $6.7&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-146" decimals="-5" id="f-549" unitRef="usd">218200000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-147" decimals="-5" id="f-550" unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-5" id="f-551" unitRef="usd">218200000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-148" decimals="-5" id="f-552" unitRef="usd">218200000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-149" decimals="-5" id="f-553" unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-3" decimals="-5" id="f-554" unitRef="usd">218200000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross contextRef="c-146" decimals="-5" id="f-555" unitRef="usd">259900000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross contextRef="c-148" decimals="-5" id="f-556" unitRef="usd">259900000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="c-148" decimals="-5" id="f-557" unitRef="usd">41700000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="c-146" decimals="-5" id="f-558" unitRef="usd">41700000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillGross contextRef="c-147" decimals="-5" id="f-559" unitRef="usd">6700000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross contextRef="c-149" decimals="-5" id="f-560" unitRef="usd">6700000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="c-147" decimals="-5" id="f-561" unitRef="usd">6700000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="c-149" decimals="-5" id="f-562" unitRef="usd">6700000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill contextRef="c-3" decimals="-5" id="f-563" unitRef="usd">218200000</us-gaap:Goodwill>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-564">Fair value measurements&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents information about the Company's assets and liabilities that are regularly measured and carried at fair value and indicates the level within the fair value hierarchy of the valuation techniques the Company utilized to determine fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.313%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;320.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;320.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;320.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;179.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration payments in an asset acquisition not required to be accounted for as derivatives are recognized when the contingency is resolved, and the consideration is paid or becomes payable. Contingent consideration liabilities associated with business combinations are measured at fair value. These liabilities represent an obligation of the Company to transfer additional assets to the selling shareholders and owners if future events occur or conditions are met. These liabilities associated with business combinations are measured at fair value at inception and at each subsequent reporting date. The changes in the fair value are primarily due to the expected amount and timing of future net sales, which are inputs that have no observable market. Any changes in fair value for the contingent consideration liabilities related to the Company&#x2019;s products are classified in the Company's statement of operations as "Cost of product sales."&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below is a reconciliation of the beginning and ending balance of the Company's contingent consideration liability: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.342%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023 and December&#160;31, 2022, the current portion of the contingent consideration liability was &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.6&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $3.1&#160;million, respectively, and was included in "Other current liabilities" on the Condensed Consolidated Balance Sheets. The non-current portion of the contingent consideration liability is included in "Other liabilities" on the Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurement for the Company's contingent consideration liability include the following significant unobservable inputs: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.802%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.066%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Fair Value as of June&#160;30, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Royalty based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$7.4 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0% - 75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 - 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivative instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 9, "Derivative instruments and hedging activities&lt;/span&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;" &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information about the Company's derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Non-variable rate debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and December&#160;31, 2022, t&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he fair value of the Company's 3.875% Senior Unsecured Notes was $252.9&#160;million and $225.1&#160;million, respectively. The fair value was determined through market sources, which are Level 2 inputs and directly observable. The carrying amounts of the Company&#x2019;s other long-term variable interest rate debt arrangements approximate their fair values (see Note 10, "Debt").&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="c-1" id="f-565">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents information about the Company's assets and liabilities that are regularly measured and carried at fair value and indicates the level within the fair value hierarchy of the valuation techniques the Company utilized to determine fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.313%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;320.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;320.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;320.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;179.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-150" decimals="-5" id="f-566" unitRef="usd">20100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-151" decimals="-5" id="f-567" unitRef="usd">20100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-152" decimals="-5" id="f-568" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-153" decimals="-5" id="f-569" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-154" decimals="-5" id="f-570" unitRef="usd">320800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-155" decimals="-5" id="f-571" unitRef="usd">320800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-156" decimals="-5" id="f-572" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-157" decimals="-5" id="f-573" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-158" decimals="-5" id="f-574" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-159" decimals="-5" id="f-575" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-160" decimals="-5" id="f-576" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-161" decimals="-5" id="f-577" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-162" decimals="-5" id="f-578" unitRef="usd">170700000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-163" decimals="-5" id="f-579" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-164" decimals="-5" id="f-580" unitRef="usd">170700000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-165" decimals="-5" id="f-581" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DerivativeAssets contextRef="c-3" decimals="-5" id="f-582" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-166" decimals="-5" id="f-583" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-167" decimals="-5" id="f-584" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-168" decimals="-5" id="f-585" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-4" decimals="-5" id="f-586" unitRef="usd">8500000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-169" decimals="-5" id="f-587" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-170" decimals="-5" id="f-588" unitRef="usd">8500000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-171" decimals="-5" id="f-589" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-3" decimals="-5" id="f-590" unitRef="usd">20100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-166" decimals="-5" id="f-591" unitRef="usd">20100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-167" decimals="-5" id="f-592" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-168" decimals="-5" id="f-593" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-4" decimals="-5" id="f-594" unitRef="usd">500000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-169" decimals="-5" id="f-595" unitRef="usd">320800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-170" decimals="-5" id="f-596" unitRef="usd">179200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-171" decimals="-5" id="f-597" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-3" decimals="-5" id="f-598" unitRef="usd">7400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-166" decimals="-5" id="f-599" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-167" decimals="-5" id="f-600" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-168" decimals="-5" id="f-601" unitRef="usd">7400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-4" decimals="-5" id="f-602" unitRef="usd">6800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-169" decimals="-5" id="f-603" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-170" decimals="-5" id="f-604" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-171" decimals="-5" id="f-605" unitRef="usd">6800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-3" decimals="-5" id="f-606" unitRef="usd">7400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-166" decimals="-5" id="f-607" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-167" decimals="-5" id="f-608" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-168" decimals="-5" id="f-609" unitRef="usd">7400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-4" decimals="-5" id="f-610" unitRef="usd">6800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-169" decimals="-5" id="f-611" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-170" decimals="-5" id="f-612" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-171" decimals="-5" id="f-613" unitRef="usd">6800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-614">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below is a reconciliation of the beginning and ending balance of the Company's contingent consideration liability: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.342%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-4" decimals="-5" id="f-615" unitRef="usd">6800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-38" decimals="-5" id="f-616" unitRef="usd">1500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="c-38" decimals="-5" id="f-617" unitRef="usd">700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-30" decimals="-5" id="f-618" unitRef="usd">7600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-1" decimals="-5" id="f-619" unitRef="usd">400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="c-1" decimals="-5" id="f-620" unitRef="usd">600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-3" decimals="-5" id="f-621" unitRef="usd">7400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="c-3" decimals="-5" id="f-622" unitRef="usd">3600000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="c-4" decimals="-5" id="f-623" unitRef="usd">3100000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c-1" id="f-624">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurement for the Company's contingent consideration liability include the following significant unobservable inputs: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.802%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.066%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Fair Value as of June&#160;30, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Royalty based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$7.4 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0% - 75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 - 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-172" decimals="-5" id="f-625" unitRef="usd">7400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-173" decimals="3" id="f-626" unitRef="number">0.097</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-174" decimals="3" id="f-627" unitRef="number">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-175" decimals="3" id="f-628" unitRef="number">0.75</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-176"
      decimals="INF"
      id="f-629"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-177"
      decimals="INF"
      id="f-630"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtFairValue contextRef="c-177" decimals="-5" id="f-631" unitRef="usd">252900000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-176" decimals="-5" id="f-632" unitRef="usd">225100000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-633">Derivative instruments and hedging activities&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Risk management objective of using derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk primarily by managing the amount, sources and duration of its assets and liabilities and the use of derivative financial instruments. From time to time, the Company enters into interest rate swap transactions to manage exposures that arise from payments of variable interest rate debt associated with the Company's senior secured credit agreements. The objective and strategy with respect to these interest rate swaps is to protect the Company against adverse fluctuations in interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the quarter ended June&#160;30, 2023, the Company terminated its designated interest rate swap transactions with a total notional value of $350.0 million. Hedge accounting was also discontinued at that time. As of June&#160;30, 2023, the remaining accumulated other comprehensive income associated with the terminated interest rate swaps, before tax, was $3.5&#160;million and will be amortized to earnings over the remaining term of the interest rate swaps prior to termination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company&#x2019;s derivative financial instruments designated as hedges as well as their classification on the Condensed Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.721%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.009%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.149%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Fair Value of Asset Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Current Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation of the interest rate swaps is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each interest rate swap. This analysis reflects the contractual terms of the interest rate swaps, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments (or receipts) and the discounted expected variable cash receipts (or payments). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. We incorporate credit valuation adjustments in the fair value measurements to appropriately reflect both our own nonperformance risk and the respective counterparty&#x2019;s nonperformance risk. These credit valuation adjustments were not significant inputs for the fair value calculations for the periods presented. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as the posting of collateral, thresholds, mutual puts and guarantees. The valuation of interest rate swaps fall into Level 2 in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amount of gains or losses reclassified from "Accumulated other comprehensive income (loss), net" into "Interest expense" on the Condensed Consolidated Statement of Operations during the three and six months ended June 30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.210%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate swaps gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c-178" decimals="INF" id="f-634" unitRef="usd">350000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:AociBeforeTaxAttributableToParent contextRef="c-178" decimals="-5" id="f-635" unitRef="usd">3500000</us-gaap:AociBeforeTaxAttributableToParent>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="c-1" id="f-636">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company&#x2019;s derivative financial instruments designated as hedges as well as their classification on the Condensed Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.721%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.009%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.149%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Fair Value of Asset Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Current Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-179" decimals="-5" id="f-637" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-180" decimals="-5" id="f-638" unitRef="usd">8500000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-639">The valuation of the interest rate swaps is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each interest rate swap. This analysis reflects the contractual terms of the interest rate swaps, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments (or receipts) and the discounted expected variable cash receipts (or payments). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. We incorporate credit valuation adjustments in the fair value measurements to appropriately reflect both our own nonperformance risk and the respective counterparty&#x2019;s nonperformance risk. These credit valuation adjustments were not significant inputs for the fair value calculations for the periods presented. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as the posting of collateral, thresholds, mutual puts and guarantees. The valuation of interest rate swaps fall into Level 2 in the fair value hierarchy.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="c-1" id="f-640">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amount of gains or losses reclassified from "Accumulated other comprehensive income (loss), net" into "Interest expense" on the Condensed Consolidated Statement of Operations during the three and six months ended June 30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.210%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate swaps gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-181" decimals="-5" id="f-641" unitRef="usd">2900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-182" decimals="-5" id="f-642" unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-183" decimals="-5" id="f-643" unitRef="usd">5300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-183" decimals="-5" id="f-644" unitRef="usd">5300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-184" decimals="-5" id="f-645" unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-646">Debt&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the components of the Company&#x2019;s debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.831%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.148%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior secured credit agreement - Term loan due 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;206.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;362.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior secured credit agreement - Revolver loan due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;250.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;598.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.875% Senior Unsecured Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;450.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;450.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;909.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,413.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Unamortized debt issuance costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Current portion of long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(455.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(957.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-current portion of debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;448.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;448.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, excludes the unamortized debt issuance costs related to the revolver loan which are included within "Other current assets" on the accompanying Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the quarter ended June&#160;30, 2023, the Company reclassified the debt issuance costs associated with the revolver loan to "Other current assets." Prior to the second quarter of 2023, the debt issuance costs associated with the revolver loan were classified as a direct offset to the carrying value of the debt within "Other current liabilities." As of June&#160;30, 2023 and December&#160;31, 2022, the Company had $13.5&#160;million and $1.3&#160;million of debt issuance costs associated with the revolver loan, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;3.875% Senior Unsecured Notes due 2028 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 7, 2020, the Company completed its offering of $450.0&#160;million aggregate principal amount of 3.875% Senior Unsecured Notes due 2028 (the "2028 Notes") of which the majority of the net proceeds were used to pay do&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;wn the Revolving Credit Facility. Interest on the 2028 Notes is payable on February 15th and August 15th of each year until maturity, beginning on February 15, 2021. The 2028 Notes will mature on August 15, 2028.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after August 15, 2023, the Company may redeem the 2028 Notes, in whole or in part, at the redemption prices set forth in the related Indenture, plus accrued and unpaid interest. Prior to August 15, 2023 the Company may redeem all or a portion of the 2028 Notes at a redemption price equal to 100% of the principal amount of the 2028 Notes plus a &#x201c;make-whole&#x201d; premium and accrued and unpaid interest. Prior to August 15, 2023, the Company may redeem up to 40% of the aggregate principal amount of the 2028 Notes using the net cash proceeds of certain equity offerings at the redemption price set forth in the related Indenture. Upon the occurrence of a change of control, the Company must offer to repurchase the 2028 Notes at a purchase price of 101% of the principal amount of such 2028 Notes plus accrued and unpaid interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Negative covenants in the Indenture governing the 2028 Notes, among other things, limit the ability of the Company to incur indebtedness and liens, dispose of assets, make investments, enter into certain merger or consolidation transactions and make restricted payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 15, 2023, the Company entered into the Credit Agreement Amendment. The Credit Agreement Amendment amends the Existing Credit Agreement to, among other things, (a) extend the maturity date of the Senior Secured Credit Facilities from October 13, 2023 to May 15, 2025, (b) reduce the available commitments under the Revolving Credit Facility from $600.0&#160;million to $300.0&#160;million, (c) remove the Company's ability to incur incremental loans and (d) amend certain mandatory prepayment triggers, affirmative covenants, negative covenants and events of default thereunder. In connection with the Credit Agreement Amendment, the Company used the approximately $270.0&#160;million of proceeds from the sale of its travel health business to Bavarian Nordic, which closed on May 15, 2023, together with approximately $217.2&#160;million of cash on hand, to repay approximately $144.4&#160;million in outstanding principal amount of loans under the Term Loan Facility and $342.8&#160;million outstanding principal amount of loans under the Revolving Credit Facility.The Credit Agreement Amendment also requires that we make quarterly principal payments on the Term Loan Facility of approximately $3.9&#160;million, which commenced on June 30, 2023 and will extend through March 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement Amendment also (w) amends the consolidated debt service coverage ratio financial covenant to require the minimum level to be 2.25 to 1.00 for the fiscal quarters ending March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, and then 2.50 to 1.00 for each fiscal quarter ending thereafter, (x) amends the consolidated leverage ratio to require the maximum level to be 4.50 to 1.00 for the fiscal quarter ending March 31, 2024 and each fiscal quarter ending thereafter, (y) adds minimum Consolidated EBITDA requirements and maximum capital expenditure requirements for each of the months ending April 30, 2023 through February 29, 2024 and a minimum liquidity requirement as of the end of each calendar month and (z) requires the Company to increase its liquidity by April 30, 2024 by raising at least $75.0&#160;million of equity or unsecured indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Credit Agreement Amendment replaces the interest rate benchmark such that borrowings under the Revolving Credit Facility and the outstanding principal amount of the Term Loan Facility shall bear interest at a rate per annum equal to (a) a rate based on SOFR, EURIBOR or CDOR plus a margin of 6.00% until March 31, 2024 and thereafter, a margin ranging from 2.75% to 4.00% depending on the Company&#x2019;s consolidated leverage ratio, or (b) a base rate (which is the highest of the prime rate, the federal funds rate plus 0.50%, and a SOFR rate for an interest period of one month plus 1%) plus a margin of 5.00% until March 31, 2024 and thereafter, a margin ranging from 1.75% to 3.00% depending on the Company&#x2019;s consolidated leverage ratio. In addition, the commitment fee the Company is required to pay in respect of the annual daily unused commitments under the Revolving Credit Facility shall be 0.15% to 0.40% per annum, depending on the Company&#x2019;s consolidated leverage ratio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Credit Agreement Amendment, the Company and the other guarantors have also agreed to provide a lien over certain assets as additional collateral for the benefit of the lenders, including owned real property, equity interests of foreign subsidiaries and certain deposit accounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c-1" id="f-647">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the components of the Company&#x2019;s debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.831%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.148%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior secured credit agreement - Term loan due 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;206.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;362.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior secured credit agreement - Revolver loan due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;250.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;598.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.875% Senior Unsecured Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;450.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;450.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;909.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,413.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Unamortized debt issuance costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Current portion of long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(455.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(957.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-current portion of debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;448.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;448.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, excludes the unamortized debt issuance costs related to the revolver loan which are included within "Other current assets" on the accompanying Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt contextRef="c-83" decimals="-5" id="f-648" unitRef="usd">206100000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-185" decimals="-5" id="f-649" unitRef="usd">362800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-82" decimals="-5" id="f-650" unitRef="usd">250200000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-186" decimals="-5" id="f-651" unitRef="usd">598000000.0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-177"
      decimals="INF"
      id="f-652"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-177" decimals="-5" id="f-653" unitRef="usd">450000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-176" decimals="-5" id="f-654" unitRef="usd">450000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-187" decimals="-5" id="f-655" unitRef="usd">3000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-188" decimals="-5" id="f-656" unitRef="usd">3000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="-5" id="f-657" unitRef="usd">909300000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-4" decimals="-5" id="f-658" unitRef="usd">1413800000</us-gaap:LongTermDebt>
    <us-gaap:DeferredFinanceCostsNoncurrentNet contextRef="c-3" decimals="-5" id="f-659" unitRef="usd">6100000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet contextRef="c-4" decimals="-5" id="f-660" unitRef="usd">8000000.0</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:LongTermDebtCurrent contextRef="c-3" decimals="-5" id="f-661" unitRef="usd">455200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-5" id="f-662" unitRef="usd">957300000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-3" decimals="-5" id="f-663" unitRef="usd">448000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-5" id="f-664" unitRef="usd">448500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredFinanceCostsCurrentNet contextRef="c-3" decimals="-5" id="f-665" unitRef="usd">13500000</us-gaap:DeferredFinanceCostsCurrentNet>
    <us-gaap:DeferredFinanceCostsCurrentNet contextRef="c-4" decimals="-5" id="f-666" unitRef="usd">1300000</us-gaap:DeferredFinanceCostsCurrentNet>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-189"
      decimals="INF"
      id="f-667"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-189" decimals="-5" id="f-668" unitRef="usd">450000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-189"
      decimals="INF"
      id="f-669"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-190"
      decimals="INF"
      id="f-670"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-191"
      decimals="INF"
      id="f-671"
      unitRef="number">0.40</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-192"
      decimals="INF"
      id="f-672"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity contextRef="c-193" decimals="-5" id="f-673" unitRef="usd">600000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity contextRef="c-194" decimals="-5" id="f-674" unitRef="usd">300000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="c-85" decimals="-5" id="f-675" unitRef="usd">270000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:Cash contextRef="c-195" decimals="-5" id="f-676" unitRef="usd">217200000</us-gaap:Cash>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-196" decimals="-5" id="f-677" unitRef="usd">144400000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-197" decimals="-5" id="f-678" unitRef="usd">342800000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-198" decimals="-5" id="f-679" unitRef="usd">3900000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <ebs:DebtInstrumentCovenantInterestCoverageRatioMinimum
      contextRef="c-199"
      decimals="INF"
      id="f-680"
      unitRef="number">2.25</ebs:DebtInstrumentCovenantInterestCoverageRatioMinimum>
    <ebs:DebtInstrumentCovenantInterestCoverageRatioMinimum
      contextRef="c-200"
      decimals="INF"
      id="f-681"
      unitRef="number">2.50</ebs:DebtInstrumentCovenantInterestCoverageRatioMinimum>
    <ebs:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="c-201"
      decimals="INF"
      id="f-682"
      unitRef="number">4.50</ebs:DebtInstrumentCovenantLeverageRatioMaximum>
    <ebs:DebtInstrumentCovenantConsiderationThreshold contextRef="c-84" decimals="-5" id="f-683" unitRef="usd">75000000</ebs:DebtInstrumentCovenantConsiderationThreshold>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-202" decimals="4" id="f-684" unitRef="number">0.0600</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-203" decimals="4" id="f-685" unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-204" decimals="4" id="f-686" unitRef="number">0.0400</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-205" decimals="4" id="f-687" unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-206" decimals="2" id="f-688" unitRef="number">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-207" decimals="4" id="f-689" unitRef="number">0.0500</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-208" decimals="4" id="f-690" unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-209" decimals="4" id="f-691" unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="c-210" decimals="4" id="f-692" unitRef="number">0.0015</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="c-211" decimals="4" id="f-693" unitRef="number">0.0040</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-694">Stock-based compensation and stockholders' equity&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June 30, 2023, the Company granted stock options to purchase 0.7&#160;million shares of common stock, 1.4&#160;million restricted stock units and 0.5&#160;million performance stock units under the Emergent BioSolutions Inc. Stock Incentive Plan. Performance stock units are presented at the target payout percentage of 100% of target shares granted. Typically, the stock options and restricted stock unit grants vest over three equal annual installments beginning on the day prior to the anniversary of the grant date. The performance stock units settle in stock at the end of the three-year performance period based on the Company's results compared to the performance criteria. During the six months ended June 30, 2023, 0.6&#160;million of stock options and 0.4&#160;million shares of restricted stock units were forfeited prior to the completion of the applicable vesting requirements or expiration. Additionally, an immaterial amount of performance stock units were forfeited during the six months ended June 30, 2023, as the award targets or vesting requirements were not achieved. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense, net of forfeitures was recorded in the following financial statement line items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.137%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.137%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.137%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of CDMO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 11, 2021, the Company announced that its Board of Directors authorized a stock repurchase program of up to an aggregate of $250.0&#160;million of Common Stock (the "Share Repurchase Program"), of which $187.9&#160;million was utilized to purchase approximately 4.4&#160;million shares. The Share Repurchase Program expired on November 11, 2022. During the three and six months ended June 30, 2022, the Company utilized $23.3&#160;million and $75.5&#160;million to purchase approximately 0.7&#160;million and 1.8&#160;million shares, respectively. The Share Repurchase Program did not obligate the Company to acquire any specific number of shares. Repurchased shares are available for use in connection with the Company's stock plans and for other corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;At-the-Market Equity Offering Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may, from time to time, sell up to $150.0&#160;million aggregate gross sales price of shares of our common stock through Evercore Group L.L.C. and RBC Capital Markets, LLC, as sales agents, under an &#x201c;at-the-market&#x201d; equity offering program (the &#x201c;ATM Program&#x201d;) that we entered into on May 18, 2023. During the three months ended June&#160;30, 2023, we sold 1.1&#160;million shares of our common stock under the ATM Program for gross proceeds of $9.1&#160;million, representing an average price of $8.22 per share. As of June&#160;30, 2023, $140.9&#160;million aggregate gross sales price of shares of our common stock remains available for issuance under the ATM Program. We intend to use proceeds obtained from the sale of shares under the ATM Program for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes changes in accumulated other comprehensive income (loss), net of tax by component:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.756%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.825%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.968%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.825%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Defined Benefit Pension Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present the tax effects related to each component of other comprehensive income (loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.210%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.257%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Tax Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Tax Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Defined benefit pension plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.210%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.257%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Tax Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Tax Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Defined benefit pension plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="c-1" decimals="-5" id="f-695" unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-212"
      decimals="-5"
      id="f-696"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-213"
      decimals="-5"
      id="f-697"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <ebs:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage contextRef="c-214" decimals="2" id="f-698" unitRef="number">1</ebs:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-213" id="f-699">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="c-1" decimals="-5" id="f-700" unitRef="shares">600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-212"
      decimals="-5"
      id="f-701"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-702">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense, net of forfeitures was recorded in the following financial statement line items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.137%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.137%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.137%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of CDMO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-215" decimals="-5" id="f-703" unitRef="usd">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-216" decimals="-5" id="f-704" unitRef="usd">1900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-217" decimals="-5" id="f-705" unitRef="usd">2600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-218" decimals="-5" id="f-706" unitRef="usd">3600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-219" decimals="-5" id="f-707" unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-220" decimals="-5" id="f-708" unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-221" decimals="-5" id="f-709" unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-222" decimals="-5" id="f-710" unitRef="usd">1000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-223" decimals="-5" id="f-711" unitRef="usd">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-224" decimals="-5" id="f-712" unitRef="usd">1500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-225" decimals="-5" id="f-713" unitRef="usd">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-226" decimals="-5" id="f-714" unitRef="usd">2600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-227" decimals="-5" id="f-715" unitRef="usd">6400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-228" decimals="-5" id="f-716" unitRef="usd">8300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-229" decimals="-5" id="f-717" unitRef="usd">10800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-230" decimals="-5" id="f-718" unitRef="usd">15000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-25" decimals="-5" id="f-719" unitRef="usd">8300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-26" decimals="-5" id="f-720" unitRef="usd">12300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-721" unitRef="usd">15100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-27" decimals="-5" id="f-722" unitRef="usd">22200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-231" decimals="-5" id="f-723" unitRef="usd">250000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-232" decimals="-5" id="f-724" unitRef="usd">187900000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-232"
      decimals="-5"
      id="f-725"
      unitRef="shares">4400000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-75" decimals="-5" id="f-726" unitRef="usd">23300000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-233" decimals="-5" id="f-727" unitRef="usd">75500000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-75" decimals="-5" id="f-728" unitRef="shares">700000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-233"
      decimals="-5"
      id="f-729"
      unitRef="shares">1800000</us-gaap:StockRepurchasedDuringPeriodShares>
    <ebs:SaleOfStockConsiderationReceivedOnTransactionGross contextRef="c-234" decimals="-5" id="f-730" unitRef="usd">150000000</ebs:SaleOfStockConsiderationReceivedOnTransactionGross>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-235"
      decimals="-5"
      id="f-731"
      unitRef="shares">1100000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <ebs:SaleOfStockConsiderationReceivedOnTransactionGross contextRef="c-235" decimals="-5" id="f-732" unitRef="usd">9100000</ebs:SaleOfStockConsiderationReceivedOnTransactionGross>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-236"
      decimals="2"
      id="f-733"
      unitRef="usdPerShare">8.22</us-gaap:SaleOfStockPricePerShare>
    <ebs:SaleOfStockAmountRemainingAvailableForSaleOfShares contextRef="c-236" decimals="-5" id="f-734" unitRef="usd">140900000</ebs:SaleOfStockAmountRemainingAvailableForSaleOfShares>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-735">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes changes in accumulated other comprehensive income (loss), net of tax by component:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.756%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.825%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.968%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.825%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.830%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Defined Benefit Pension Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity contextRef="c-237" decimals="-5" id="f-736" unitRef="usd">3500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-238" decimals="-5" id="f-737" unitRef="usd">6200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-239" decimals="-5" id="f-738" unitRef="usd">-6600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-5" id="f-739" unitRef="usd">3100000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-240" decimals="-5" id="f-740" unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-241" decimals="-5" id="f-741" unitRef="usd">-4400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-242" decimals="-5" id="f-742" unitRef="usd">-100000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-38" decimals="-5" id="f-743" unitRef="usd">-4500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-240" decimals="-5" id="f-744" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-241" decimals="-5" id="f-745" unitRef="usd">-2400000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-242" decimals="-5" id="f-746" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-38" decimals="-5" id="f-747" unitRef="usd">-2400000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-240" decimals="-5" id="f-748" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-241" decimals="-5" id="f-749" unitRef="usd">-2000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-242" decimals="-5" id="f-750" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-38" decimals="-5" id="f-751" unitRef="usd">-2100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-243" decimals="-5" id="f-752" unitRef="usd">3500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-244" decimals="-5" id="f-753" unitRef="usd">4200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-245" decimals="-5" id="f-754" unitRef="usd">-6700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-5" id="f-755" unitRef="usd">1000000.0</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-246" decimals="-5" id="f-756" unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-247" decimals="-5" id="f-757" unitRef="usd">1200000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-248" decimals="-5" id="f-758" unitRef="usd">2600000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-25" decimals="-5" id="f-759" unitRef="usd">3800000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-246" decimals="-5" id="f-760" unitRef="usd">3500000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-247" decimals="-5" id="f-761" unitRef="usd">2900000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-248" decimals="-5" id="f-762" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-25" decimals="-5" id="f-763" unitRef="usd">6400000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-246" decimals="-5" id="f-764" unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-247" decimals="-5" id="f-765" unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-248" decimals="-5" id="f-766" unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-25" decimals="-5" id="f-767" unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-249" decimals="-5" id="f-768" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-250" decimals="-5" id="f-769" unitRef="usd">2500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-251" decimals="-5" id="f-770" unitRef="usd">-4100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-5" id="f-771" unitRef="usd">-1600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-252" decimals="-5" id="f-772" unitRef="usd">-4000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-253" decimals="-5" id="f-773" unitRef="usd">-4500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-254" decimals="-5" id="f-774" unitRef="usd">-7600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-59" decimals="-5" id="f-775" unitRef="usd">-16100000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-255" decimals="-5" id="f-776" unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-256" decimals="-5" id="f-777" unitRef="usd">4900000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-257" decimals="-5" id="f-778" unitRef="usd">500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-62" decimals="-5" id="f-779" unitRef="usd">5400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-255" decimals="-5" id="f-780" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-256" decimals="-5" id="f-781" unitRef="usd">-1400000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-257" decimals="-5" id="f-782" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-62" decimals="-5" id="f-783" unitRef="usd">-1400000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-255" decimals="-5" id="f-784" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-256" decimals="-5" id="f-785" unitRef="usd">6300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-257" decimals="-5" id="f-786" unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-62" decimals="-5" id="f-787" unitRef="usd">6800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-258" decimals="-5" id="f-788" unitRef="usd">-4000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-259" decimals="-5" id="f-789" unitRef="usd">1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-260" decimals="-5" id="f-790" unitRef="usd">-7100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-70" decimals="-5" id="f-791" unitRef="usd">-9300000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-261" decimals="-5" id="f-792" unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-262" decimals="-5" id="f-793" unitRef="usd">1900000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-263" decimals="-5" id="f-794" unitRef="usd">400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-26" decimals="-5" id="f-795" unitRef="usd">2300000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-261" decimals="-5" id="f-796" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-262" decimals="-5" id="f-797" unitRef="usd">-900000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-263" decimals="-5" id="f-798" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-26" decimals="-5" id="f-799" unitRef="usd">-900000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-261" decimals="-5" id="f-800" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-262" decimals="-5" id="f-801" unitRef="usd">2800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-263" decimals="-5" id="f-802" unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-26" decimals="-5" id="f-803" unitRef="usd">3200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-264" decimals="-5" id="f-804" unitRef="usd">-4000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-265" decimals="-5" id="f-805" unitRef="usd">4600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-266" decimals="-5" id="f-806" unitRef="usd">-6700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-80" decimals="-5" id="f-807" unitRef="usd">-6100000</us-gaap:StockholdersEquity>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-808">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present the tax effects related to each component of other comprehensive income (loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.210%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.257%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Tax Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Tax Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Defined benefit pension plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.210%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.250%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.257%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="background-color:#19415e;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Tax Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Tax Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Defined benefit pension plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-246" decimals="-5" id="f-809" unitRef="usd">-4100000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-246" decimals="-5" id="f-810" unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-246" decimals="-5" id="f-811" unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-261" decimals="-5" id="f-812" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-261" decimals="-5" id="f-813" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-261" decimals="-5" id="f-814" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-247" decimals="-5" id="f-815" unitRef="usd">-2400000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-247" decimals="-5" id="f-816" unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-247" decimals="-5" id="f-817" unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-262" decimals="-5" id="f-818" unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-262" decimals="-5" id="f-819" unitRef="usd">1000000.0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-262" decimals="-5" id="f-820" unitRef="usd">2800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-248" decimals="-5" id="f-821" unitRef="usd">2100000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-248" decimals="-5" id="f-822" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-248" decimals="-5" id="f-823" unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-263" decimals="-5" id="f-824" unitRef="usd">1300000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-263" decimals="-5" id="f-825" unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-263" decimals="-5" id="f-826" unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-25" decimals="-5" id="f-827" unitRef="usd">-4400000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-25" decimals="-5" id="f-828" unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-25" decimals="-5" id="f-829" unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-26" decimals="-5" id="f-830" unitRef="usd">5100000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-26" decimals="-5" id="f-831" unitRef="usd">1900000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-26" decimals="-5" id="f-832" unitRef="usd">3200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-267" decimals="-5" id="f-833" unitRef="usd">-4100000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-267" decimals="-5" id="f-834" unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-267" decimals="-5" id="f-835" unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-268" decimals="-5" id="f-836" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-268" decimals="-5" id="f-837" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-268" decimals="-5" id="f-838" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-269" decimals="-5" id="f-839" unitRef="usd">-5000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-269" decimals="-5" id="f-840" unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-269" decimals="-5" id="f-841" unitRef="usd">-3700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-270" decimals="-5" id="f-842" unitRef="usd">12400000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-270" decimals="-5" id="f-843" unitRef="usd">3300000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-270" decimals="-5" id="f-844" unitRef="usd">9100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-271" decimals="-5" id="f-845" unitRef="usd">2000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-271" decimals="-5" id="f-846" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-271" decimals="-5" id="f-847" unitRef="usd">2500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-272" decimals="-5" id="f-848" unitRef="usd">2000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-272" decimals="-5" id="f-849" unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-272" decimals="-5" id="f-850" unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-851" unitRef="usd">-7100000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-1" decimals="-5" id="f-852" unitRef="usd">-2400000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-853" unitRef="usd">-4700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="c-27" decimals="-5" id="f-854" unitRef="usd">14400000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-27" decimals="-5" id="f-855" unitRef="usd">4400000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-27" decimals="-5" id="f-856" unitRef="usd">10000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-863">Loss per common share&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic loss per common share is calculated using the treasury method by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted loss per common share adjusts basic loss per common share for the effects of potentially dilutive common shares and is calculated using the treasury stock method. Potentially dilutive common shares include the dilutive effect of shares issuable under our equity compensation plans, including stock options, restricted stock units and performance stock units. Diluted loss per share excludes anti-dilutive securities, which represent the number of potential common shares related to shares issuable under our equity compensation plan that were excluded from diluted loss per common share because their effect would have been antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of basic and diluted loss per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.313%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.662%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.548%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#1b51bf;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(261.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(56.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(444.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(60.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average number of shares outstanding-basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average number of shares outstanding-diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net loss per common share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8.80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net loss per common share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8.80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-864">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of basic and diluted loss per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.313%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.662%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.548%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#1b51bf;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(261.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(56.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(444.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(60.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average number of shares outstanding-basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average number of shares outstanding-diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net loss per common share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8.80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net loss per common share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8.80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-25" decimals="-5" id="f-865" unitRef="usd">-261300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-26" decimals="-5" id="f-866" unitRef="usd">-56400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-867" unitRef="usd">-444300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-27" decimals="-5" id="f-868" unitRef="usd">-60100000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-25" decimals="-5" id="f-869" unitRef="shares">50700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-26" decimals="-5" id="f-870" unitRef="shares">50000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-871" unitRef="shares">50500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-27" decimals="-5" id="f-872" unitRef="shares">50300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-25" decimals="-5" id="f-873" unitRef="shares">50700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-26" decimals="-5" id="f-874" unitRef="shares">50000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-875" unitRef="shares">50500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-27" decimals="-5" id="f-876" unitRef="shares">50300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-25"
      decimals="2"
      id="f-877"
      unitRef="usdPerShare">-5.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-26"
      decimals="2"
      id="f-878"
      unitRef="usdPerShare">-1.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-879"
      unitRef="usdPerShare">-8.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-27"
      decimals="2"
      id="f-880"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-25"
      decimals="2"
      id="f-881"
      unitRef="usdPerShare">-5.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-26"
      decimals="2"
      id="f-882"
      unitRef="usdPerShare">-1.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-883"
      unitRef="usdPerShare">-8.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-27"
      decimals="2"
      id="f-884"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-25" decimals="-5" id="f-885" unitRef="shares">3600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-26" decimals="-5" id="f-886" unitRef="shares">1800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-5" id="f-887" unitRef="shares">3400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-27" decimals="-5" id="f-888" unitRef="shares">3000000.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-889">Revenue recognition&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as two operating segments (see Note 17, "Segment information"). The Company's revenues disaggregated by the major sources were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.302%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.974%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Non-USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Non-USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;150.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;151.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;119.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;237.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CDMO:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total CDMO&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts and grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;182.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;337.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;124.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;242.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.302%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.974%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Non-USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Non-USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;176.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;269.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;445.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;221.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;252.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;474.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CDMO:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total CDMO&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts and grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;316.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;503.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;236.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;313.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;550.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Termination of manufacturing services agreement with Janssen Pharmaceuticals, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 2, 2020, the Company, through its wholly owned subsidiary, Emergent Manufacturing Operations Baltimore, LLC, entered into the Agreement with Janssen, one of the Janssen Pharmaceutical Companies of Johnson &amp;amp; Johnson, for large-scale drug substance manufacturing of Johnson &amp;amp; Johnson&#x2019;s investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant based on the AdVac technology (the &#x201c;Product&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 6, 2022, the Company provided to Janssen a notice (the &#x201c;Notice&#x201d;) of material breach of the Agreement for, among other things, failure by Janssen (i) to provide the Company the requisite forecasts of the required quantity of Product to be purchased by Janssen under the Agreement and (ii) to confirm Janssen&#x2019;s intent to not purchase the requisite minimum quantity of the Product pursuant to the Agreement and instead, wind-down the Agreement ahead of fulfilling these minimum requirements. Later on June 6, 2022, the Company received from Janssen a purported written notice of termination (the &#x201c;Janssen Notice&#x201d;) of the Agreement for asserted material breaches of the Agreement by the Company, including alleged failure by the Company to perform its obligations in compliance with current good manufacturing practices ("cGMP") or other applicable laws and regulations and alleged failure by the Company to supply Janssen with the Product. Janssen alleged that the Company&#x2019;s breaches were not curable and that, therefore, termination of the Agreement would be effective as of July 6, 2022. The Company disputes Janssen's assertions and allegations, including Janssen's ability to effect termination pursuant to the Janssen Notice. The Company and Janssen disagree on the monetary amounts that are due to the Company as a result of termination by any means. The Company believes the amounts due to the Company include, but are not limited to, compensation for services provided, reimbursement for raw materials purchased and non-cancelable orders, and fees for early termination. Janssen has alleged that no additional amount is due to the Company and that the Company should pay Janssen an unspecified amount as a result of the Company's alleged failure to perform under the Agreement. The Company has not recorded any contingent liabilities related to Janssen's allegations as the Company believes they are without merit and intends to vigorously defend the Company's position during the dispute resolution process through arbitration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023, there were no impacts on previously recognized revenue or depreciation related to the conclusion of the Agreement. As of June&#160;30, 2023, the Company has no billed or unbilled net accounts receivable related to the Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in the fourth quarter of 2022, because the arbitration process is expected to extend longer than one year, the Company reclassified amounts related to the Janssen Agreement from "Inventories, net" and from "Prepaid expenses and other current assets" to "Other assets", resulting in $152.7&#160;million in long-term assets related to the Janssen Agreement on the Condensed Consolidated Balance Sheet as of December&#160;31, 2022. The long-term asset balance within "Other Assets" related to the Agreement as of June&#160;30, 2023 was $154.0&#160;million. These assets include termination penalties, certain inventory related items and raw materials inventory representing materials purchased for the Agreement which Janssen has not reimbursed. The Company evaluated the net realizable value of the inventory as of June&#160;30, 2023, concluding that because the Agreement specifies the Company is entitled to, among other things, reimbursement of raw materials and non-cancelable orders in the event of a contract termination for any reason, the Company is entitled to payment from Janssen for these raw materials. Additionally, the Company has $5.2&#160;million of non-cancelable orders as of June&#160;30, 2023 which have not been received and Janssen has not reimbursed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CDMO operating leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain multi-year CDMO service arrangements with commercial customers include operating leases whereby the customer has the right to direct the use of and obtain substantially all of the economic benefits of specific manufacturing suites operated by the Company. The associated revenue is recognized on a straight-line basis over the term of the lease. The weighted average remaining term on the Company's operating lease components approximates 3.2 years. The Company utilizes a cost-plus model to determine the stand-alone selling price of the lease component to allocate contract consideration between the lease and non-lease components. Excluding future amounts related to the Agreement as discussed above, the Company estimates future operating lease revenues to be $0.6&#160;million in the remainder of 2023, $0.9&#160;million in 2024, $0.9&#160;million in 2025, $0.9&#160;million in 2026, $0.9&#160;million in 2027 and $0.9&#160;million in years beyon&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Transaction price allocated to remaining performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, the Company has future contract value on unsatisfied performance obligations of approximately $452.0&#160;million associated with all arrangements entered into by the Company. The Company expects to recognize $443.2&#160;million of unsatisfied performance obligations within the next 24 months. The amount and timing of revenue recognition for unsatisfied performance obligations can change. The future revenues associated with unsatisfied performance obligations exclude the value of unexercised option periods in the Company&#x2019;s revenue arrangements. Often the timing of manufacturing activities changes based on customer needs and resource availability. Government funding appropriations can impact the timing of product deliveries. The success of the Company's development activities that receive development funding support from the USG under development contracts can also impact the timing of revenue recognition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers accounts receivable and deferred costs associated with revenue generating contracts, which are not included in inventory or property, plant and equipment and that the Company does not currently have a contractual right to bill, to be contract assets. As of June&#160;30, 2023 and December&#160;31, 2022, the Company &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;had $30.3 million an&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$34.8 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively, of contract assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; recorded within "Accounts receivable, net" on the Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When performance obligations are not transferred to a customer at the end of a reporting period, cash received associated with amounts allocated to those performance obligations is reflected as contract liabilities on the Condensed Consolidated Balance Sheets and is deferred until control of these performance obligations is transferred to the customer. The following table presents the roll forward of the contract liability balances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.010%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.6pt;font-weight:400;line-height:120%"&gt;Revenue recognized in the period from amounts included in contract liability at the beginning of the period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023 and December&#160;31, 2022, the current portion of contract liabilities was $14.3&#160;million and $26.4&#160;million, respectively, and was included in "Other current liabilities" on the Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts receivable and allowance for expected credit losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, including unbilled accounts receivable contract assets, consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.202%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.175%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Billed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;238.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unbilled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;290.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;158.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain an allowance for expected credit losses, which represents the estimated aggregate amount of credit risk arising from the inability or unwillingness of specific customers to pay our fees or disputes that may affect our ability to fully collect our billed accounts receivable. We estimate the current-period provision for expected credit losses on a specific identification basis and we consider factors such as the age of the receivables balance, knowledge of the specific customers' circumstances and historical collection experience for similar customers. Accounts receivable, net of the allowance for expected credit losses, represents the amount we expect to collect. Our actual experience may vary from our estimates. At each reporting date, we adjust the allowance for expected credit losses to reflect our current estimate.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-890"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-891"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-892">The Company's revenues disaggregated by the major sources were as follows:&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.302%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.974%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Non-USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Non-USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;150.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;151.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;119.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;237.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CDMO:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total CDMO&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts and grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;182.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;337.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;124.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;242.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.302%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.974%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Non-USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Non-USG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;176.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;269.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;445.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;221.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;252.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;474.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CDMO:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total CDMO&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts and grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;316.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;503.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;236.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;313.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;550.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-279" decimals="-5" id="f-893" unitRef="usd">150500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-280" decimals="-5" id="f-894" unitRef="usd">151700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-895" unitRef="usd">302200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-281" decimals="-5" id="f-896" unitRef="usd">118200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-282" decimals="-5" id="f-897" unitRef="usd">119000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-898" unitRef="usd">237200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-283" decimals="-5" id="f-899" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-284" decimals="-5" id="f-900" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-285" decimals="-5" id="f-901" unitRef="usd">26400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-5" id="f-902" unitRef="usd">26400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-286" decimals="-5" id="f-903" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-287" decimals="-5" id="f-904" unitRef="usd">2700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-5" id="f-905" unitRef="usd">2700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-288" decimals="-5" id="f-906" unitRef="usd">0</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-289" decimals="-5" id="f-907" unitRef="usd">0</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-290" decimals="-5" id="f-908" unitRef="usd">2700000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-13" decimals="-5" id="f-909" unitRef="usd">2700000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-291" decimals="-5" id="f-910" unitRef="usd">0</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-292" decimals="-5" id="f-911" unitRef="usd">-4500000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-14" decimals="-5" id="f-912" unitRef="usd">-4500000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-293" decimals="-5" id="f-913" unitRef="usd">0</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-294" decimals="-5" id="f-914" unitRef="usd">29100000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-17" decimals="-5" id="f-915" unitRef="usd">29100000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-295" decimals="-5" id="f-916" unitRef="usd">0</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-296" decimals="-5" id="f-917" unitRef="usd">-1800000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-18" decimals="-5" id="f-918" unitRef="usd">-1800000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-297" decimals="-5" id="f-919" unitRef="usd">4600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-298" decimals="-5" id="f-920" unitRef="usd">2000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-21" decimals="-5" id="f-921" unitRef="usd">6600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-299" decimals="-5" id="f-922" unitRef="usd">6200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-300" decimals="-5" id="f-923" unitRef="usd">1100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-22" decimals="-5" id="f-924" unitRef="usd">7300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues contextRef="c-301" decimals="-5" id="f-925" unitRef="usd">155100000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-302" decimals="-5" id="f-926" unitRef="usd">182800000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-25" decimals="-5" id="f-927" unitRef="usd">337900000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-303" decimals="-5" id="f-928" unitRef="usd">124400000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-304" decimals="-5" id="f-929" unitRef="usd">118300000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-26" decimals="-5" id="f-930" unitRef="usd">242700000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-305" decimals="-5" id="f-931" unitRef="usd">176600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-306" decimals="-5" id="f-932" unitRef="usd">269000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-933" unitRef="usd">445600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-307" decimals="-5" id="f-934" unitRef="usd">221600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-308" decimals="-5" id="f-935" unitRef="usd">252700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-5" id="f-936" unitRef="usd">474300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-283" decimals="-5" id="f-937" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-284" decimals="-5" id="f-938" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-309" decimals="-5" id="f-939" unitRef="usd">39800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-5" id="f-940" unitRef="usd">39800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-310" decimals="-5" id="f-941" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-311" decimals="-5" id="f-942" unitRef="usd">54500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-5" id="f-943" unitRef="usd">54500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-288" decimals="-5" id="f-944" unitRef="usd">0</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-289" decimals="-5" id="f-945" unitRef="usd">0</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-312" decimals="-5" id="f-946" unitRef="usd">4500000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-15" decimals="-5" id="f-947" unitRef="usd">4500000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-313" decimals="-5" id="f-948" unitRef="usd">0</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-314" decimals="-5" id="f-949" unitRef="usd">4500000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments contextRef="c-16" decimals="-5" id="f-950" unitRef="usd">4500000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-315" decimals="-5" id="f-951" unitRef="usd">0</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-316" decimals="-5" id="f-952" unitRef="usd">44300000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-19" decimals="-5" id="f-953" unitRef="usd">44300000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-317" decimals="-5" id="f-954" unitRef="usd">0</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-318" decimals="-5" id="f-955" unitRef="usd">59000000.0</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-20" decimals="-5" id="f-956" unitRef="usd">59000000.0</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-319" decimals="-5" id="f-957" unitRef="usd">9500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-320" decimals="-5" id="f-958" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-23" decimals="-5" id="f-959" unitRef="usd">13100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-321" decimals="-5" id="f-960" unitRef="usd">15300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-322" decimals="-5" id="f-961" unitRef="usd">1600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-24" decimals="-5" id="f-962" unitRef="usd">16900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues contextRef="c-323" decimals="-5" id="f-963" unitRef="usd">186100000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-324" decimals="-5" id="f-964" unitRef="usd">316900000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-1" decimals="-5" id="f-965" unitRef="usd">503000000.0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-325" decimals="-5" id="f-966" unitRef="usd">236900000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-326" decimals="-5" id="f-967" unitRef="usd">313300000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-27" decimals="-5" id="f-968" unitRef="usd">550200000</us-gaap:Revenues>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-327" decimals="-5" id="f-969" unitRef="usd">152700000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-328" decimals="-5" id="f-970" unitRef="usd">154000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent contextRef="c-328" decimals="-5" id="f-971" unitRef="usd">5200000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-329" id="f-972">P3Y2M12D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear contextRef="c-329" decimals="-5" id="f-973" unitRef="usd">600000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths contextRef="c-329" decimals="-5" id="f-974" unitRef="usd">900000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears contextRef="c-329" decimals="-5" id="f-975" unitRef="usd">900000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears contextRef="c-329" decimals="-5" id="f-976" unitRef="usd">900000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears contextRef="c-329" decimals="-5" id="f-977" unitRef="usd">900000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears>
    <ebs:LessorOperatingLeasePaymentToBeReceivedAfterYearFour contextRef="c-329" decimals="-5" id="f-978" unitRef="usd">900000</ebs:LessorOperatingLeasePaymentToBeReceivedAfterYearFour>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-3" decimals="-5" id="f-979" unitRef="usd">452000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-330" decimals="-5" id="f-980" unitRef="usd">443200000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-330" id="f-981">P24M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent contextRef="c-3" decimals="-5" id="f-982" unitRef="usd">30300000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent contextRef="c-4" decimals="-5" id="f-983" unitRef="usd">34800000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-984">The following table presents the roll forward of the contract liability balances:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.010%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.6pt;font-weight:400;line-height:120%"&gt;Revenue recognized in the period from amounts included in contract liability at the beginning of the period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability contextRef="c-4" decimals="-5" id="f-985" unitRef="usd">31700000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-3" decimals="-5" id="f-986" unitRef="usd">19300000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="-5" id="f-987" unitRef="usd">6800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-5" id="f-988" unitRef="usd">14300000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-5" id="f-989" unitRef="usd">26400000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <ebs:ScheduleOfAccountsReceivableNetTableTextBlock contextRef="c-1" id="f-990">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, including unbilled accounts receivable contract assets, consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.202%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.175%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Billed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;238.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unbilled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;290.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;158.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ebs:ScheduleOfAccountsReceivableNetTableTextBlock>
    <us-gaap:BilledContractReceivables contextRef="c-3" decimals="-5" id="f-991" unitRef="usd">238500000</us-gaap:BilledContractReceivables>
    <us-gaap:BilledContractReceivables contextRef="c-4" decimals="-5" id="f-992" unitRef="usd">102700000</us-gaap:BilledContractReceivables>
    <us-gaap:UnbilledContractsReceivable contextRef="c-3" decimals="-5" id="f-993" unitRef="usd">51800000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable contextRef="c-4" decimals="-5" id="f-994" unitRef="usd">56400000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-3" decimals="-5" id="f-995" unitRef="usd">200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-5" id="f-996" unitRef="usd">700000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-5" id="f-997" unitRef="usd">290100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-5" id="f-998" unitRef="usd">158400000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-999">Leases&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is the lessee for operating leases for offices, R&amp;amp;D facilities and manufacturing facilities. The Company determines if an arrangement is a lease at inception. Operating leases are included in right-of-use assets and liabilities. For a discussion of lessor activities, see Note 13, "Revenue recognition."&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.273%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.986%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.273%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.278%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease costs are reflected as components of cost of product sales, cost of contract development and manufacturing, R&amp;amp;D expense and selling, general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to lessee activities is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.583%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1014"&gt;&lt;span style="-sec-ix-hidden:f-1015"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1018"&gt;&lt;span style="-sec-ix-hidden:f-1019"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1022"&gt;&lt;span style="-sec-ix-hidden:f-1023"&gt;Other liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-1000">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.273%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.986%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.273%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.278%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-25" decimals="-5" id="f-1001" unitRef="usd">900000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-26" decimals="-5" id="f-1002" unitRef="usd">1400000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-5" id="f-1003" unitRef="usd">2000000.0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-27" decimals="-5" id="f-1004" unitRef="usd">2800000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-25" decimals="-5" id="f-1005" unitRef="usd">200000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-26" decimals="-5" id="f-1006" unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-1" decimals="-5" id="f-1007" unitRef="usd">400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-27" decimals="-5" id="f-1008" unitRef="usd">600000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCost contextRef="c-25" decimals="-5" id="f-1009" unitRef="usd">1100000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-26" decimals="-5" id="f-1010" unitRef="usd">1700000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-5" id="f-1011" unitRef="usd">2400000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-27" decimals="-5" id="f-1012" unitRef="usd">3400000</us-gaap:LeaseCost>
    <ebs:AssetsAndLiabilitiesLesseeTableTextBlock contextRef="c-1" id="f-1013">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to lessee activities is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.583%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1014"&gt;&lt;span style="-sec-ix-hidden:f-1015"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1018"&gt;&lt;span style="-sec-ix-hidden:f-1019"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1022"&gt;&lt;span style="-sec-ix-hidden:f-1023"&gt;Other liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e5e5e5;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e5e5e5;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e5e5e5;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ebs:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-5" id="f-1016" unitRef="usd">15700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-1017" unitRef="usd">19400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-5" id="f-1020" unitRef="usd">3600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-1021" unitRef="usd">5800000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-1024" unitRef="usd">13100000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-1025" unitRef="usd">14800000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-5" id="f-1026" unitRef="usd">16700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-5" id="f-1027" unitRef="usd">20600000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-1028">P6Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-1029">P5Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="3" id="f-1030" unitRef="number">0.045</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="3" id="f-1031" unitRef="number">0.041</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1032">Income taxes&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated effective annual tax rate for the years ended December&#160;31, 2023 and 2022, excluding the impact of discrete adjustments, was (8)% and 29%, respectively. The decrease in the estimated effective annual tax rate is primarily due to a valuation allowance charge. The Company recorded a discrete tax expense of $0.0&#160;million and $0.0&#160;million for the three and six months ended June 30, 2023, respectively, and $0.2&#160;million and $0.6&#160;million for the three and six months ended June 30, 2022, respectively. The discrete tax expense in 2023 was due to share-based compensation activity which was entirely offset by a valuation allowance charge. The discrete expense in 2022 was primarily due to share-based compensation activity offset by return to provision adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes valuation allowances for deferred income tax assets in accordance with U.S. GAAP, which provides that such valuation allowances shall be established unless realization of the income tax benefits is more likely than not. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. At each reporting period, the Company considers the scheduled reversal of deferred tax liabilities and assets, available taxes in carryback periods, tax planning strategies and projected future taxable income in making this assessment.&lt;/span&gt;&lt;/div&gt;In 2022, the Company determined that it was more likely than not that certain deferred tax assets would not be realized due to reductions in estimates of future profitability and disclosure related to substantial doubt about the Company's ability to continue as a going concern. Accordingly, the Company recorded an additional valuation allowance charge of $127.5 million in calculating the estimated annual tax rate for the year ended December&#160;31, 2023.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-331"
      decimals="2"
      id="f-1033"
      unitRef="number">-0.08</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-332"
      decimals="2"
      id="f-1034"
      unitRef="number">0.29</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-25" decimals="-5" id="f-1035" unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-1" decimals="-5" id="f-1036" unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-26" decimals="-5" id="f-1037" unitRef="usd">200000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-27" decimals="-5" id="f-1038" unitRef="usd">600000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-331" decimals="-5" id="f-1039" unitRef="usd">127500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:LegalMattersAndContingenciesTextBlock contextRef="c-1" id="f-1040">Litigation&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Securities and shareholder litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to the specific legal proceedings and claims described below, unless otherwise noted, the amount or range of possible losses is not reasonably estimable. There can be no assurance that the settlement, resolution, or other outcome of one or more matters, including the matters set forth below, during any subsequent reporting period will not have a material adverse effect on the Company's results of operations or cash flows for that period or on the Company's financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 20, 2021, May 14, 2021, and June 2, 2021, putative class action lawsuits were filed against the Company and certain of its current and former senior officers in the United States District Court for the District of Maryland on behalf of purchasers of the Company&#x2019;s common stock, seeking to pursue remedies under the Securities Exchange Act of 1934. These complaints were filed by Palm Tran, Inc. &#x2013; Amalgamated Transit Union Local 1577 Pension Plan; Alan I. Roth; and Stephen M. Weiss, respectively. The complaints allege, among other things, that the defendants made false and misleading statements about the Company's manufacturing capabilities with respect to COVID-19 vaccine bulk drug substance (referred to herein as "CDMO Manufacturing Capabilities"). These cases were consolidated on December 23, 2021, under the caption In re Emergent BioSolutions Inc. Securities Litigation, No. 8:21-cv-00955-PWG (the "Federal Securities Class Action"). The Lead Plaintiffs in the consolidated matter are Nova Scotia Health Employees&#x2019; Pension Plan and The City of Fort Lauderdale Police &amp;amp; Firefighters&#x2019; Retirement System. The defendants filed a motion to dismiss on May 19, 2022 and the Lead Plaintiff filed an opposition to that motion on July 19, 2022. A hearing on the motion to dismiss was conducted on April 19, 2023 and a decision on the motion is expected in the coming months. The defendants believe that the allegations in the complaints are without merit and intend to defend the matters vigorously. Given the uncertainty of litigation, the preliminary stage of the cases, and the legal standards that must be met for, among other things, class certification and success on the merits, the Company cannot reasonably estimate the possible loss or range of loss, if any, that may result from the consolidated action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 29, 2021, Lincolnshire Police Pension Fund (&#x201c;Lincolnshire&#x201d;), and on August 16, 2021, Pooja Sayal, filed putative shareholder derivative lawsuits in the United States District Court for the District of Maryland on behalf of the Company against certain of the Company's current and former officers and directors for breach of fiduciary duties, waste of corporate assets, and unjust enrichment, each allegation related to the CDMO Manufacturing Capabilities. In addition to monetary damages, the complaints seek the implementation of multiple corporate governance and internal policy changes. On November 16, 2021, the cases were consolidated under the caption In re Emergent BioSolutions Inc. Stockholder Derivative Litigation, Master Case No. 8:21-cv-01595-PWG. On January 3, 2022, the Lincolnshire complaint was designated as the operative complaint in the consolidated action. On April 13, 2022 the Court approved the parties' joint stipulation to and stay of the proceedings and discovery until the close of fact discovery in the Federal Securities Class Action. The defendants believe that the allegations in the complaints are without merit and intend to defend the matter vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 15, 2021, September 16, 2021 and November 12, 2021, putative shareholder derivative lawsuits were filed by Chang Kyum Kim, Mark Nevins and Employees Retirement System of the State of Rhode Island, North Collier Fire Control and Rescue District Firefighters Pension Plan, and Pembroke Pines Firefighters &amp;amp; Police Officers Pension Fund, respectively, in The Court of Chancery of the State of Delaware on behalf of the Company against certain of its current and former officers and directors for breach of fiduciary duties, unjust enrichment and insider trading, each allegation related to the CDMO Manufacturing Capabilities. In addition to monetary damages, the complaints seek the implementation of multiple corporate governance and internal policy changes. On February 2, 2022, the cases were consolidated under the caption In re Emergent BioSolutions, Inc. Derivative Litigation, C.A. No. 2021-0974-MTZ with the institutional investors as co-lead plaintiffs. On March 4, 2022, the defendants&#x2019; filed a motion to dismiss the complaint. Ruling on this motion is stayed pursuant to a March 29, 2022 order staying all proceedings pending a final, non-appealable judgment in the Federal Securities Class Action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 3, 2021, December 22, 2021 and January 18, 2022, putative shareholder derivative lawsuits were filed by Zachary Elton, Eric White and Jeffrey Reynolds in the Circuit Court for Montgomery County, Maryland on behalf of the Company against certain of its current and former officers and directors for breach of fiduciary duty, unjust enrichment, waste of corporate assets, failing to maintain internal controls, making or causing to be made false and/or misleading statements and material omissions, insider trading and otherwise violating the federal securities laws, each allegation related to the CDMO Manufacturing Capabilities. The complaints seek monetary and punitive damages. On February 22, 2022, the Court entered an order consolidating these actions under case number C-15-21-CV-000496. On March 9, 2022, the parties filed a Joint Stipulation of Stay of Proceedings and Discovery, pursuant to which the parties agreed to stay all proceedings until 30 calendar days after a ruling on the defendants&#x2019; motion to dismiss the Federal Securities Class Action. The Court approved the Joint Stipulation on March 14, 2022.&lt;/span&gt;&lt;/div&gt;In addition to the above actions, the Company has received inquiries and subpoenas to produce documents related to these matters from the Department of Justice, the SEC, the Maryland Attorney General&#x2019;s Office, and the New York Attorney General&#x2019;s Office. The Company produced or is producing documents as required in response and will continue to cooperate with these government inquiries. The Company also received inquiries and subpoenas from Representative Carolyn Maloney and Representative Jim Clyburn, members of the House Committee on Oversight and Reform and the Select Subcommittee on the Coronavirus Crisis and Senator Murray of the Committee on Health, Education, Labor and Pensions. The Company produced documents and provided testimony and briefings as requested in response to these inquiries.</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1041">Segment information&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports segment information based on the internal reporting used by management for making decisions and assessing performance. We manage our business with a focus on two reportable segments. Our Products segment, which includes the Anthrax - MCM products, NARCAN products, Smallpox - MCM products and Other products, and our Services segment consisting of our CDMO services. The Company evaluates the performance of these reportable segments based on revenue and Adjusted Gross Margin, which is a non-GAAP financial measure. Segment revenue includes external customer sales, but it does not include inter-segment services. The Company defines Adjusted Gross Margin as segment revenue less segment cost of sales reduced for significant restructuring events, inventory step-up provisions and changes in fair value of contingent consideration. The Company does not allocate research and development, selling, general and administrative costs, amortization of intangibles assets, interest and other income (expense) or taxes to operating segments in the management reporting reviewed by the chief operating decision maker ("CODM"). The accounting policies for segment reporting are the same as for the Company as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages its assets on a total company basis, not by operating segment, as the Company's operating assets are shared or commingled. Therefore, the Company's CODM does not regularly review any asset information by operating segment and, accordingly, the Company does not report asset information by operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes segment revenues and a reconciliation of the Company's segment adjusted gross margin to the consolidated statement of operations for each of the Company's reporting segments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.281%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.170%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.652%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;237.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;445.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;474.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;331.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;235.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;489.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;533.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts and grants revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;337.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;242.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;503.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;550.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Less: Cost of sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;237.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;171.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;78.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;107.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;154.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;169.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;345.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;325.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Products gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;146.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;207.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;303.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Services gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(63.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(95.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidated gross margin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;140.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;207.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Adjustments to gross margin:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Products:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory step-up provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Products adjusted gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;169.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;213.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;304.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Services adjusted gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(63.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(95.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidated adjusted gross margin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;150.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;209.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other reconciling items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts and grants revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments to gross margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(306.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 10pt 0 1pt;text-indent:-9pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(306.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(26.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(49.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(66.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(96.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(91.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(81.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(191.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(165.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(33.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(28.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(28.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(46.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain on sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 10pt 0 1pt;text-indent:-9pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(250.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(82.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(411.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(86.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Total segment revenues less total cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Consolidated gross margin plus adjustments to gross margin.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes depreciation expense for each segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.633%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.432%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.569%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.569%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Depreciation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-1042">The Company reports segment information based on the internal reporting used by management for making decisions and assessing performance. We manage our business with a focus on two reportable segments. Our Products segment, which includes the Anthrax - MCM products, NARCAN products, Smallpox - MCM products and Other products, and our Services segment consisting of our CDMO services. The Company evaluates the performance of these reportable segments based on revenue and Adjusted Gross Margin, which is a non-GAAP financial measure. Segment revenue includes external customer sales, but it does not include inter-segment services. The Company defines Adjusted Gross Margin as segment revenue less segment cost of sales reduced for significant restructuring events, inventory step-up provisions and changes in fair value of contingent consideration. The Company does not allocate research and development, selling, general and administrative costs, amortization of intangibles assets, interest and other income (expense) or taxes to operating segments in the management reporting reviewed by the chief operating decision maker ("CODM"). The accounting policies for segment reporting are the same as for the Company as a whole.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1043"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1044"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="c-1" id="f-1045">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes segment revenues and a reconciliation of the Company's segment adjusted gross margin to the consolidated statement of operations for each of the Company's reporting segments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.281%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.170%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.652%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;237.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;445.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;474.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;331.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;235.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;489.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;533.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts and grants revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;337.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;242.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;503.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;550.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Less: Cost of sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;237.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;171.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;78.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;107.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;154.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;169.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;345.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;325.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Products gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;146.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;207.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;303.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Services gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(63.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(95.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidated gross margin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;140.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;207.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Adjustments to gross margin:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Products:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory step-up provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Products adjusted gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;169.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;213.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;304.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Services adjusted gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(63.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(95.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidated adjusted gross margin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;150.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;209.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other reconciling items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts and grants revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments to gross margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(306.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 10pt 0 1pt;text-indent:-9pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(306.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(26.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(49.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(66.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(96.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(91.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(81.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(191.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(165.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(33.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(28.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(28.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(46.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain on sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 10pt 0 1pt;text-indent:-9pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(250.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(82.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(411.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(86.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Total segment revenues less total cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Consolidated gross margin plus adjustments to gross margin.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-333" decimals="-5" id="f-1046" unitRef="usd">302200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-334" decimals="-5" id="f-1047" unitRef="usd">237200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-335" decimals="-5" id="f-1048" unitRef="usd">445600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-336" decimals="-5" id="f-1049" unitRef="usd">474300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-337" decimals="-5" id="f-1050" unitRef="usd">29100000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-338" decimals="-5" id="f-1051" unitRef="usd">-1800000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-339" decimals="-5" id="f-1052" unitRef="usd">44300000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-340" decimals="-5" id="f-1053" unitRef="usd">59000000.0</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-341" decimals="-5" id="f-1054" unitRef="usd">331300000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-342" decimals="-5" id="f-1055" unitRef="usd">235400000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-343" decimals="-5" id="f-1056" unitRef="usd">489900000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-344" decimals="-5" id="f-1057" unitRef="usd">533300000</ebs:OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-21" decimals="-5" id="f-1058" unitRef="usd">6600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-22" decimals="-5" id="f-1059" unitRef="usd">7300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-23" decimals="-5" id="f-1060" unitRef="usd">13100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-24" decimals="-5" id="f-1061" unitRef="usd">16900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues contextRef="c-25" decimals="-5" id="f-1062" unitRef="usd">337900000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-26" decimals="-5" id="f-1063" unitRef="usd">242700000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-1" decimals="-5" id="f-1064" unitRef="usd">503000000.0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-27" decimals="-5" id="f-1065" unitRef="usd">550200000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-333" decimals="-5" id="f-1066" unitRef="usd">134900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-334" decimals="-5" id="f-1067" unitRef="usd">91000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-335" decimals="-5" id="f-1068" unitRef="usd">237800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-336" decimals="-5" id="f-1069" unitRef="usd">171300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-337" decimals="-5" id="f-1070" unitRef="usd">55700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-338" decimals="-5" id="f-1071" unitRef="usd">78800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-339" decimals="-5" id="f-1072" unitRef="usd">107900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-340" decimals="-5" id="f-1073" unitRef="usd">154400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-25" decimals="-5" id="f-1074" unitRef="usd">190600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-26" decimals="-5" id="f-1075" unitRef="usd">169800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-1076" unitRef="usd">345700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-27" decimals="-5" id="f-1077" unitRef="usd">325700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-333" decimals="-5" id="f-1078" unitRef="usd">167300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-334" decimals="-5" id="f-1079" unitRef="usd">146200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-335" decimals="-5" id="f-1080" unitRef="usd">207800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-336" decimals="-5" id="f-1081" unitRef="usd">303000000.0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-337" decimals="-5" id="f-1082" unitRef="usd">-26600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-338" decimals="-5" id="f-1083" unitRef="usd">-80600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-339" decimals="-5" id="f-1084" unitRef="usd">-63600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-340" decimals="-5" id="f-1085" unitRef="usd">-95400000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-25" decimals="-5" id="f-1086" unitRef="usd">140700000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-26" decimals="-5" id="f-1087" unitRef="usd">65600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-5" id="f-1088" unitRef="usd">144200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-27" decimals="-5" id="f-1089" unitRef="usd">207600000</us-gaap:GrossProfit>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-333" decimals="-5" id="f-1090" unitRef="usd">400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-334" decimals="-5" id="f-1091" unitRef="usd">1300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-335" decimals="-5" id="f-1092" unitRef="usd">1900000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-336" decimals="-5" id="f-1093" unitRef="usd">1800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:RestructuringCosts contextRef="c-333" decimals="-5" id="f-1094" unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-334" decimals="-5" id="f-1095" unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-335" decimals="-5" id="f-1096" unitRef="usd">2000000.0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-336" decimals="-5" id="f-1097" unitRef="usd">0</us-gaap:RestructuringCosts>
    <ebs:InventoryStepUp contextRef="c-333" decimals="-5" id="f-1098" unitRef="usd">1900000</ebs:InventoryStepUp>
    <ebs:InventoryStepUp contextRef="c-334" decimals="-5" id="f-1099" unitRef="usd">0</ebs:InventoryStepUp>
    <ebs:InventoryStepUp contextRef="c-335" decimals="-5" id="f-1100" unitRef="usd">1900000</ebs:InventoryStepUp>
    <ebs:InventoryStepUp contextRef="c-336" decimals="-5" id="f-1101" unitRef="usd">0</ebs:InventoryStepUp>
    <ebs:AdjustedGrossMargin contextRef="c-333" decimals="-5" id="f-1102" unitRef="usd">169600000</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-334" decimals="-5" id="f-1103" unitRef="usd">147500000</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-335" decimals="-5" id="f-1104" unitRef="usd">213600000</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-336" decimals="-5" id="f-1105" unitRef="usd">304800000</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-337" decimals="-5" id="f-1106" unitRef="usd">-26600000</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-338" decimals="-5" id="f-1107" unitRef="usd">-80600000</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-339" decimals="-5" id="f-1108" unitRef="usd">-63600000</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-340" decimals="-5" id="f-1109" unitRef="usd">-95400000</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-25" decimals="-5" id="f-1110" unitRef="usd">143000000.0</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-26" decimals="-5" id="f-1111" unitRef="usd">66900000</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-1" decimals="-5" id="f-1112" unitRef="usd">150000000.0</ebs:AdjustedGrossMargin>
    <ebs:AdjustedGrossMargin contextRef="c-27" decimals="-5" id="f-1113" unitRef="usd">209400000</ebs:AdjustedGrossMargin>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-21" decimals="-5" id="f-1114" unitRef="usd">6600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-22" decimals="-5" id="f-1115" unitRef="usd">7300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-23" decimals="-5" id="f-1116" unitRef="usd">13100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-24" decimals="-5" id="f-1117" unitRef="usd">16900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ebs:GrossProfitAdjustments contextRef="c-25" decimals="-5" id="f-1118" unitRef="usd">-2300000</ebs:GrossProfitAdjustments>
    <ebs:GrossProfitAdjustments contextRef="c-26" decimals="-5" id="f-1119" unitRef="usd">-1300000</ebs:GrossProfitAdjustments>
    <ebs:GrossProfitAdjustments contextRef="c-1" decimals="-5" id="f-1120" unitRef="usd">-5800000</ebs:GrossProfitAdjustments>
    <ebs:GrossProfitAdjustments contextRef="c-27" decimals="-5" id="f-1121" unitRef="usd">-1800000</ebs:GrossProfitAdjustments>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-25" decimals="-5" id="f-1122" unitRef="usd">306700000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-26" decimals="-5" id="f-1123" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="-5" id="f-1124" unitRef="usd">306700000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-27" decimals="-5" id="f-1125" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-25" decimals="-5" id="f-1126" unitRef="usd">26000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-26" decimals="-5" id="f-1127" unitRef="usd">49800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-1128" unitRef="usd">66600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-27" decimals="-5" id="f-1129" unitRef="usd">96200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-25" decimals="-5" id="f-1130" unitRef="usd">91400000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-26" decimals="-5" id="f-1131" unitRef="usd">81100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-1132" unitRef="usd">191900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-27" decimals="-5" id="f-1133" unitRef="usd">165900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-25" decimals="-5" id="f-1134" unitRef="usd">16100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-26" decimals="-5" id="f-1135" unitRef="usd">14000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-1136" unitRef="usd">33100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-27" decimals="-5" id="f-1137" unitRef="usd">28000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:InterestExpense contextRef="c-25" decimals="-5" id="f-1138" unitRef="usd">28600000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-26" decimals="-5" id="f-1139" unitRef="usd">7800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-5" id="f-1140" unitRef="usd">46500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-27" decimals="-5" id="f-1141" unitRef="usd">16000000.0</us-gaap:InterestExpense>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-25" decimals="-5" id="f-1142" unitRef="usd">74900000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-26" decimals="-5" id="f-1143" unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-1" decimals="-5" id="f-1144" unitRef="usd">74900000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-27" decimals="-5" id="f-1145" unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-25" decimals="-5" id="f-1146" unitRef="usd">-3600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-26" decimals="-5" id="f-1147" unitRef="usd">-3000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-1148" unitRef="usd">1300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-27" decimals="-5" id="f-1149" unitRef="usd">-5000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-25" decimals="-5" id="f-1150" unitRef="usd">-250200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-26" decimals="-5" id="f-1151" unitRef="usd">-82800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-1152" unitRef="usd">-411300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-27" decimals="-5" id="f-1153" unitRef="usd">-86600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1154">&lt;div style="margin-bottom:5pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes depreciation expense for each segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.633%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.432%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.569%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.569%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#19415e;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#19415e;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9.3pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Depreciation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ededed;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ededed;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ededed;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Depreciation contextRef="c-333" decimals="-5" id="f-1155" unitRef="usd">7500000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-334" decimals="-5" id="f-1156" unitRef="usd">6700000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-335" decimals="-5" id="f-1157" unitRef="usd">15500000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-336" decimals="-5" id="f-1158" unitRef="usd">14100000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-337" decimals="-5" id="f-1159" unitRef="usd">8400000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-338" decimals="-5" id="f-1160" unitRef="usd">20800000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-339" decimals="-5" id="f-1161" unitRef="usd">16300000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-340" decimals="-5" id="f-1162" unitRef="usd">28600000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-345" decimals="-5" id="f-1163" unitRef="usd">900000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-346" decimals="-5" id="f-1164" unitRef="usd">1000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-347" decimals="-5" id="f-1165" unitRef="usd">2600000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-348" decimals="-5" id="f-1166" unitRef="usd">2400000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-25" decimals="-5" id="f-1167" unitRef="usd">16800000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-26" decimals="-5" id="f-1168" unitRef="usd">28500000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-1169" unitRef="usd">34400000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-27" decimals="-5" id="f-1170" unitRef="usd">45100000</us-gaap:Depreciation>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1171">Subsequent events&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;FDA Approval of CYFENDUS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 20, 2023, the FDA approved CYFENDUS&#x2122; for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. In December 2018, CYFENDUS vaccine was the subject of a pre-emergency use authorization package submitted to the FDA. The following year, the USG began procuring this product for national preparedness efforts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Ebanga Procurement Contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 31, 2023, the Company was awarded a 10-year contract by the Biomedical Advanced Research and Development Authority ("BARDA") for advanced development, manufacturing scale-up, and procurement of Ebanga&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; treatment for Ebola. The contract consists of a base period of performance with two option periods valued at approximately $121&#160;million, and five option periods for procurement of Ebanga&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over five years valued at up to $583&#160;million. If all option periods are exercised, the total contract value will be valued at up to approximately $704&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Emergent is responsible for the manufacturing, sale and distribution of Ebanga&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. and Canada pursuant to a collaboration agreement with Ridgeback, the developer of the treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, Emergent will pay Ridgeback $6.3&#160;million in contingent consideration as a result of the award of the BARDA contract payable in the third quarter of 2023. In addition, the Company could owe up to $50.4&#160;million in contingent consideration to Ridgeback if activities under the awarded contract have not ceased by June 1, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt"&gt;&lt;span style="color:#19415e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;August 2023 Organizational Restructuring Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 8, 2023, The Company announced an organizational restructuring plan (the &#x201c;August 2023 Plan&#x201d;) intended to strengthen its core business and financial position by reducing investment in and de-emphasizing focus on its CDMO services business for future growth. The August 2023 Plan includes a reduction of the Company&#x2019;s current workforce by approximately 400 employees. Decisions regarding the elimination of positions are subject to local law and consultation requirements in certain countries, as well as the Company&#x2019;s business needs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates that it will incur approximately $19.0&#160;million to $21.0&#160;million in charges in connection with the August 2023 Plan, which it expects to incur in the third quarter of fiscal 2023. These charges consist primarily of cash charges related to severance (base bonus), transition services, and estimated benefits cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimates of the charges and expenditures that the Company expects to incur in connection with the August 2023 Plan, and the timing thereof, are subject to a number of assumptions, including local law requirements in various jurisdictions, and actual amounts may differ materially from estimates. In addition, the Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the August 2023 Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <ebs:RevenueFromContractWithCustomerTermOfContract contextRef="c-349" id="f-1172">P10Y</ebs:RevenueFromContractWithCustomerTermOfContract>
    <ebs:RevenueFromContractWithCustomerNumberOfOptionPeriods
      contextRef="c-350"
      decimals="INF"
      id="f-1173"
      unitRef="productcandidate">2</ebs:RevenueFromContractWithCustomerNumberOfOptionPeriods>
    <us-gaap:ContractWithCustomerLiability contextRef="c-351" decimals="-5" id="f-1174" unitRef="usd">121000000</us-gaap:ContractWithCustomerLiability>
    <ebs:RevenueFromContractWithCustomerNumberOfOptionPeriods
      contextRef="c-352"
      decimals="INF"
      id="f-1175"
      unitRef="productcandidate">5</ebs:RevenueFromContractWithCustomerNumberOfOptionPeriods>
    <ebs:RevenueFromContractWithCustomerTermOfContract contextRef="c-352" id="f-1176">P5Y</ebs:RevenueFromContractWithCustomerTermOfContract>
    <us-gaap:ContractWithCustomerLiability contextRef="c-353" decimals="-5" id="f-1177" unitRef="usd">583000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-354" decimals="-5" id="f-1178" unitRef="usd">704000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-355" decimals="-5" id="f-1179" unitRef="usd">6300000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <ebs:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-356" decimals="-5" id="f-1180" unitRef="usd">50400000</ebs:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
      contextRef="c-357"
      decimals="INF"
      id="f-1181"
      unitRef="employee">400</us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1 contextRef="c-358" decimals="-5" id="f-1182" unitRef="usd">19000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1 contextRef="c-359" decimals="-5" id="f-1183" unitRef="usd">21000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-25" id="f-1184">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-25" id="f-1185">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-25" id="f-1186">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-25" id="f-1187">false</ecd:Rule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>128
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MQBED6/9X#DP_67&18:6[8NW*7 !.;%)&W<#SAFZ&"7.BJ1U;B&C*"T4)@X5
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M2A<_MIGJ^A2$"=#/5YRKQXZI@.J*-_H#4$L#!!0    ( %.5"%==8"#[J0@
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M>$II)M%*\.),8=N?T8[]Y=0NRO'%6TS<TA/[Z=FD"@S\GF60+LLW]'V=-S_
MOT- GDD<&Y0XQO8L.'CJF866IWCNS9L/S=;L3-YXL?S->7.EWHX/"5M&1WY&
M'^6-$I3(G7A#4I_%.$\+[6UG<#(]D0/*L[!OEW4LNR5TY"?TDX ]*MN27(.N
M/B?6Q_I[GN_-YAJVL4RA%4DU7=Z<KCBH',5V^5;;79 P44ONR$]NMWQSGI1S
M4OIU.Y@<)A-;M\MNTH>7J'.N[&?WR6+5=VI7I[K;!1O8H748&]E[V9X4CUJF
M1WZF_VI*)5/IK[CXF^)=>+?5N^#>5SA%+=LC+T9/!I^H(533PX*(K[ "'[AA
MO#*8J$[,BH))?=>KJK\/Q;C3M<02/1N%\Z._4S^3B[.C97GD9[E5>;6'9F<.
MPR,'H&/8O9Z67BZ[, C[#B:BEN21G^0_KE8T->-.7]/J#!-J1HK2^L "8DM[
M=E/YIVN2/<Q:61];P *O!$OU#3#]O=-#QP8XL'/?M@IZ@Z_%?'0!YIN#V?_3
MCYD5-\,DL>;)887#GM/9J"5]=.9T^6+I-VA)UZPL=>SIPI(*QC.G/_86>N*H
M71QFR7325[O$+<9C/\:_Q2.J=^$^7V*;X+/9*/$M XXF43+K]:OE?!QZ:[+G
MW7:;FQO!P,J,R33G4*!4MP*TLZL<>F1E]3@!K''.52'VUA+?6K!=J[?C$6E+
MA]A?.IA[X0W!6 E% TRPTVV[ (AFUE+AL KCOAL@<5LEQ&=V^"<R_3<48L<.
M?F(=4\5V18![8!-W[AK'ET=8)Y+T4EWR<FC"K+.#*;/+<11[JY%O#KPK]78\
M4&WI$9\I/2[>8:-=:6:>J'J1T4N.<WP2ZX:[?;KC-#I=6,:=)U **M;FP1R)
MS %I]0A'\VGS\,^#>>3EY/-WX>UC]0A/VTWU1-$G(H $$N5T!5T&HRGH$M5#
M.M4;Q;?F.9<E5XH7YA+V[AD5V@"^7W&N#F_T#S2/2BW^ E!+ P04    " !3
ME0A71<UJH^(,   ,C   &    'AL+W=O<FMS:&5E=',O<VAE970W+GAM;+V=
M77/;NA&&_PI'S;0G,]$'/R6EMF=.1 )-IVDS2<_I1:<7C,18FDBB#TG'R;\O
M*#&"0*P@0GJ=7,22O7@6Y"Y!\,62O'G*BR_E,LLJY]MFO2UO>\NJ>G@]');S
M9;9)RT'^D&W%7S[GQ2:MQ-?B?E@^%%FZV#7:K(?>:!0--^EJV[N[V?WN?7%W
MDS]6Z]4V>U\XY>-FDQ;?WV3K_.FVY_9^_.+#ZGY9U;\8WMT\I/?9QZSZ[>%]
M(;X-#Y3%:I-MRU6^=8KL\VWO5_<U'^\:["Q^7V5/Y=%GI]Z43WG^I?[R=G';
M&]4]RM;9O*H1J?CQ-9MEZW5-$OWXHX'V#C[KAL>??]#9;N/%QGQ*RVR6K_^S
M6E3+V]ZDYRRRS^GCNOJ0/_TM:S8HK'GS?%WN_G>>&MM1SYD_EE6^:1J+'FQ6
MV_W/]%NS(XX:N/Z)!E[3P&LU\$]Y\)L&?MM#>*)!T#0(6@V\\8D&8=,@;#4(
MHA,-HJ9!U.[2Y$2#<=-@O O6?N_N0A.G57IW4^1/3E%;"UK]81??76L1D=6V
M3L6/52'^NA+MJKM9OEV(Q,H6COA4YNO5(JW$EX^5^"$RKBJ=_+,S6Z;;^ZQT
M5EOQAWS^99FO%UE1_L5)_GA<5=^=OO/;Q]CYY<5+IURFQ=[PW6J]%KE6OG)>
M''^]&5:BU[7OX;SIX9M]#[T3/?QW7J5KHMG,W.S%:# :N<[[M'!^3]>/F=B^
MS29O-H# Q6=Z(8[S\K'X?K)]8F[_ZV*QJH^]="VZM%KTWVZ=6?JPHC>-G6'-
MYX^;Q_4N4/^JEEE1;YL8B);U"/$U<]YNY_DF<W[Y1UZ6+PD\-^,_9)48P@0[
M28OM:GO?BME09-@AS;Q#FGD[9G""^2:[7VUKF!@WUNEV+GHGDF*?+2^=M'+B
M;#YP?/>5XXT\ETH2([\>L%^7#^D\N^V)'5%FQ=>L=_?G/[G1Z*]4ZNQAXQVL
M'JR_WH7A0+C]>IP02(\)$L:0, Z"*6GA']+"MTR++JFP9TZ/HN=&[E2-WFQO
M%!T9C;0(ZS9]-_0&GFJ6Z&83;SH(5"M&P:*V2ZY;3</Q8'*P4G9C<-B-P3,?
M74:^[=&%A,6!=JCV_:/]M8\0TB-#PC@(IJ1%>$B+<$?W3Z2%. _49RV1#2+^
MNT\O3Y["__LA7Z\=,;M[2HO%_Z@4"9$I@H3%2%B"A#$DC(-@2BI%AU2*C"/,
M/\5%T5I,)ZC$B*@C=-P:CHUXVX C80D2QI P?F;'*H$<'P(Y-@;R8WU2Z-<7
M;PM'S!+%%6V9RFO">B0X.G50T3;B;8>!L;:%H_;9-T8Z3) PAH1Q$$Q)BLDA
M*2;7)065"!-]#MV>$\V,;FV/>B0LZ=![AG3(03 EOM-#?*?&^'[('AZ+^5+$
M=W<Y7]83@'/'N9%H>YPC8?%4'Q;=]CP[07ID2!@'P91$<$=2[AG9I,)\+XJ4
M)T2--PU-V=GZ%=+,[-0VP TM,CM-H$X9E,91-#7*1Z*>:XSR7A6:*ZI0/7U[
MY6S%1$[$O4J_D>%VM7!'[8NMF=FW=;"1M 1*8UUV!T>Y5$,MA377K*PEVX7A
MPO]=6APN_#TRXE!=S26%-;\UHX/Z3* T!J5Q%$W-#:FNN69YK94;G?+!UR+H
MAF,MAC.WB[Y&&/6]4=">:"6$TXD?M(\T1ICUIP-_=/ROK;<1;:9A<-13===*
MQ<TU2V[7'G90P0U*BUU"<@L&TW;,H)H;E,91-#4WI.SF&J48@!QK=F"='F&7
MY0ZHSP1*8U :1]'4])!2FFO6TBY;]&B@H7G5H[$Z,RSK1N2ZAZL+4-3"!V%&
MK7P09H:E#U<*6JY9T0(<;5!-"TJ+75TB(]8_H#X9E,91-#4]I+3E3G[B(HB+
MU(1F4%H,I250&H/2.(JFII14TURSG&9:#'$)=2K2AN"9V8-UY)&T!$IC4!I'
MT=0B%JF>>5;J62<AU8RTKER!*FT>(>^YVMD%ZI-!:1Q%4Q-""FV>66BSE%/-
M-.M<@ IQ#4V9%8H+_["=#%"%#4KC*)J:#$<U;F8I[E+5M<$J4_M1ZX1A=FT=
M:VQM&[:X#5O=]AP*G"<5.,]*@6M=F?S]<2NN3$:G92(SW7J\T+6P4#O 8ZC/
M!$IC4!I'T=3<D!*B9R4A=LH'79IS0]?7UN,:.[,,0!CU/6_<+MU)"*>38-KV
MR0BSOJX"4+#I^%15BR<U-\^LN5U[H$$%-R@M]G3YKA\.HG:4H((;E,91-#4W
MI.#FV0INMG*]V8%U>NA*&+%*!O690&D,2N,HFIH>4D#T; 7$3BFA"W/D0EEC
M=V8HUHW(A3+"*;501IB=72@CVA@6RCRIOWGFVC+ P0?5W*"TV-/KR(BU,JA/
M!J5Q%$U-#ZFE>=.?*,]ZT*HU*"V&TA(HC4%I'$53;RF2(IUO%NE,\JQ/U;-%
M6MVJV8-MY*&T!$IC4!H_NWO5D$J9S3?+;%=7K9OYM@.#K]>%Z77K4)<)E,:@
M-(ZBJ<DA93??++M=5+WNZY5JKC;?FID]6X\#4-6MTQ8PJ$^.HJF1/KI;U*RF
M7;+\8D9:'_E(6NP3!6TC37^!^F10&D?1U(20$IIOEM LEU]\0J+R?.V2S>S4
M.LB4S*8Y3:!.&93&430URE+;\\W:WJ7K*KXNG.E2J=FW=;"A1710&NNR.SC*
MI1IJ*=7Y9JGN2AG73+<>[$F=KKU> O690&D,2N,HFIH;4J?SS3K=!>LEOJZK
MD>LEA!WQM A*I"/62WQ"I"/62P@S8KV$@IU>+_&E+.>;9;EK#S2H)@>EQ3ZA
MR>GK)5"?#$KC*)J:&U*3\\WU;585M71ZZ%5P8N1L/Q.@DU5L[JSU^ K5S: T
MCJ*ISY"1NEE@ULW.UJ63H6Z@RM-X_$E[2AWHMW3J RQA1 ZP@:XR3<9^^\3,
M"#-?&U\;H^/:F[%_0J\*I%X5F/6JZX^@0)>8]$%L9NZ&[<#9R6<"]<F@-(ZB
MJ6&72E3@_<3%C !Z:R:4%D-I"93&H#2.HJDI)26OP"QYF18S OU!:'U7'WJA
MDA64ED!I#$KC#2T\M7?5@!X]JLTL65V]E&'F6P\+NB0VTDI1H"X3*(U!:1Q%
M4Y-#*EV!6>FZ:"DCT'6=0)MKFQU;CP)0F:O+!C"H2XZBJ7&6,E=@EKDN530#
MXE9+3[NYR.S<.M90?0M*8YWV!T?Y5(,M=:O 2K<RE#_Y9,RA=Z<VM..S6ABU
MAWOH(]>@- :E<11-S0PIP@56(ERG;)CHBJ:PU:\,=3OB@ELWHB^X=45M,IYH
MBF9CIMS'TCX4=9,P/%%C&$C!*C +5M<>8="J,2@M#HC[28EK<JBJ!:5Q%$U]
M!*Y4M4);5<M6B@EU'8D0,SM9Q>;.V@ZM4!J#TCB*IH9=*G"AK0+7*=1N%S$S
MU.^4U,=6PH@<6T-==*/$3,),%S,;HTYB9BA5K1#X['YZM^JE2H28:>Z&[<#9
MR6<"]<F@-(ZBJ6&7RE/H_T0Q,X2684%I,9260&D,2N,HFII24OL*S=J72<P,
MB3*I( BTXBRS"^O00Y4M*(U!:1Q%4T-_]"J"YZGA:K!J6NB3+^S[!+ O%,"^
M40#[2H'GD,%"*8.%J&HO\KHM).JSQEH-=R>KV-Q3ZYA#52XHC:-H:LRE&A9>
M4\5%QUDOO)J&D7YFZ%+$11C1TW*J[BK4[K0DS/IN>Y;)"2MO,CU5Q!5*_2A$
M%7'1^[5+H=3,W ?KL;53<1;4)X/2.(JFQEQJ7>&5Q5EGY2ZS ^NI^/2\H SU
MF$!I#$KC*)KZDAXI=D47E'"=38A(K[LB-67"3A]@"2-R@(VH(BY=4X[T^JRV
MZD&8G-24(RD@15>6<)W?K=![#J&T..I4Z@7UR: TCJ*IZ2%%L>AGEGI%T%(O
M*"V&TA(HC4%I'$534TH*;M'EI5X1<:>@%[G:'-CLPCKT4&$,2F-0&C^_?]6@
M2LDK>N9R+S/?>FCH4NX%=9E :0Q*XRB:FAQ2%(N>H=PKTJNEM&>RS\R.K<<!
MJ"#690,8U"5'T=0X'[T\TZQS_5KUJV76WZ3%%S'&E^DZ.]R^?M _ZWN75V59
MOR/=2;<+)_M6IT-6GAT?H+<\1KI8IKU;+8:Z3* T!J5Q%$W-&ZF516:M[)J\
M(7.%$+4&[E3YUQY(H&\S@-(2^\UAT YP%$U-#RG_16;Y[](UE8@J^]*O]J&Z
M'Y260&DL(C1);7]PE$\UV%+WBZZI<3NK]4;$O9;Z6DDGJ]C<4^M80N4\*(VC
M:.JKFJ6<-S;+>1>LE8QU^8U:*R',="F/,"*E/,*.6BNA</I:"6%E6"L92SUO
M;-;SKCQ^QIWNQS3WP7;,[.0S@?ID4!I'T?8Q'Y;++*OBM$KO;A[2^^Q=6MRO
MQ+1GG7T6^-%@+&;YQ>I^>?A2Y0^W/=&%3WE5Y9O=QV66+K*B-A!__YSGU8\O
M0\%_RHLO.Q]W_P=02P,$%     @ 4Y4(5[O%3F&> @  X @  !@   !X;"]W
M;W)K<VAE971S+W-H965T."YX;6RMEEUOFS 4AO^*Q::ME;I ($FK+D%J\]5-
MFA2UVG8Q[<*!DV#5V-0V2?OO=VPH2B72<9&;X(_SO#G&K\YAO)?J46< ACSG
M7.B)EQE37/N^3C+(J>[) @3N;*3*J<&IVOJZ4$!3!^7<#X-@Y.>4"2\>N[65
MBL>R-)P)6"FBRSRGZN46N-Q/O+[WNG#/MIFQ"WX\+N@6'L#\+%8*9WZCDK(<
MA&92$ 6;B7?3OUY&-MX%_&*PUP=C8D^REO+13KZE$R^P"0&'Q%@%BH\=3(%S
M*X1I/-6:7O.7%CP<OZHOW-GQ+&NJ82KY;Y::;.)=>22%#2VYN9?[.ZC/,[1Z
MB>3:_9)]'1MX)"FUD7D-8P8Y$]63/M?OX0#H#XX 80V$78&H!J*NP* &!EV!
M80T,NP*C&AAU!2YKX-)=5O5VW=7,J*'Q6,D]438:U>S W:^C\4:8L$Y\, IW
M&7(FGDJ1HJ\@)3C2DK.4&IP\&'R@X8PF<D.F&15;T(0)W)#)8R9Y"DI_)O.G
MDID7<K:B"F,S,"RA_)Q\(1^)3W2&JWKL&TS3_IF?U"G=5BF%1U+Z7HH>B8(+
M$@9AU()/W\=_4(5X_R@^>Q^?0=+@80L^[YY\&[[HGGP;ONR>?/\M[J,Q&G>$
MC3M"IQ<=T6ML8%W0>O5_;M;:*"PH?]LNNE(?M*O;(GNM"YK Q,,JJD'MP(L_
M?>B/@J]MUWY*L=DIQ>:G%%N<4FQY(K$WYHD:\T3OJ6-IR7-L-MK:YH(45)$=
MY260,RPCJ>2<*DT*4%6=.&^S3Z5_Y?1M2]W%02\(T-B[0U]TBIIUBIIWBEIT
MBEK^+ZIZJ?Y![;:]'RO E@E-.&R0"WJ7V%%4U4^KB9&%*^=K:; YN&&&GR"@
M; #N;Z0TKQ/;(9J/FO@?4$L#!!0    ( %.5"%<^C0;0T0P  #8?   8
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M#^"H<W=S3O+MT8YRC;$#.+\\3J^=5'AR^.KY,=NK-YP71:4%^P#<KE#&4&*
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MJ"9(6UJ ]W.#+$L_Z(+F4_F[/P!02P,$%     @ 4Y4(5U3ORX!U#0  >20
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MG*76%);S8#N9_XQ*<1$/5#X$%@/+_:T0BG8LAPT\W\*#K4?FNZRE3/H&8)%
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MRE*S^VU%TQ6U2Z#X0BF[-=P!_;R>_@102P,$%     @ 4Y4(5SE'L0"7!
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M'9-0?3M1%-)SS_0$)OTQ>17241L?2Y\V5QA$*)O61M_:A^GK!*FE+BNF'NC
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MB\?#"$PS=34+IZLPZ:RTH[DIO!8TJ*+Q D/?_<1_N_ &VM%W_B]02P,$%
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M#.+  R9\QL+1J_[@!=K_:)S_#5!+ P04    " !3E0A734([J=(&  "@$@
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ML]6#E!$SRB.4?['6/&CKY0Y&O5VWAZ_[]E"\&1[U,Q\E[@*K[\Q*UM#)?_-
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MO%8D03(6.&9> G$WX /6'Z6N_@502P,$%     @ 4Y4(5^'\$.F'!P   Q,
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M*<1E-4<E%,<L<+PN,+E=IHBKYE0W4^Q5$'(OY(!6CSG2S1SR(4_"MW6)7(!
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MXH7!6^H <EWEK-U?TG2G>:J2=H]7TCX=3AMR5Z[)]!00B72+551@=Z*LQ_Q
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MV]!M\?Y5)PE8UMH^ K,.VO;%!\D6W@6UXR1\C%[.HC-%#U5P%_6SW6GCR3#
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M_]VVW4R;=E,V[89FT4Y2AAZ%H<^V3>I^O>JT*-UI42@'J"PTQ_L2094,JW#
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M]*@(S8I><:C] IK?*<K%MN,=]._"U3]02P,$%     @ 4Y4(5X*P0F;Z#@
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M+*544IN-XK&*VC:"/*H!(: ZG2"U?_N*VLL@\&,7?-TUAC=.VY>M]6N=4?+
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M01-Q+3*;#/W$[+3UDT#^807]\)$J+Y3TOPZL[]:_K;SR/RELEOL?9KZ3%N7
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M)#D3%0=TB1[N)^C3Q6=T@0A%MR3/5?Z(H2.5:2W@)(V9<6W&?\-,@&X9E9E
M4YI"VL&?'>='1_B.<KGUV]_Z/?:/"OZLJ(T"]POR73_H.,_-<?HMYHKNO4F?
MG&[=[Z!/3[?>19_]G^_S=Q]^+Q1!FX*!T0O>DX)=J5;+A=UR^ND>B!(G,++4
MVRR K\&*/W[P(O=;5YS/*38YI]CTG&*S<XK-SR2VERUAFRWA,?7XEZK.*C4Z
MWZ":&1FF+L'K^-*//%OE^'HWY#7LZR[,NSH 33JT>I$=[J.F':C [N^#9AV@
M, P/CS7O@$6N[;6H^KJ<G;>^ +XR95R@A%54UO^Y=K7M%*Y-@3Q8'WN#J=>Q
M/E.=1=T(_).OVQ+U[*P(%2B'I3+EVGU5TWA=ZNN)9*6I-(],JKIEAIGJCH!K
M@-I?,B:W$VV@[;?B5U!+ P04    " !3E0A76(TFE40"  "*!@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970R."YX;6R=E5UOFS 40/^*Q:0]M8% /K8,D))N
MTU*I4Y1VV[.#+V#5V,PV2?OO9QO"LBFA4E[ -O<>GVO$)3X(^:Q* (U>*L95
MXI5:UPO?5UD)%58C40,W3W(A*ZS-5!:^JB5@XI(JYH=!,/,K3+F7QFYM(]-8
M-)I1#AN)5%-56+ZN@(E#XHV]X\*6%J6V"WX:U[B 1] _ZHTT,[^G$%H!5U1P
M)"%/O.5XL9K;>!?PD\)!G8R1K60GQ+.=K$GB!58(&&3:$K"Y[>$.&+,@H_&[
M8WK]EC;Q='RD?W6UFUIV6,&=8+\HT67B?? 0@1PW3&_%X1MT]4PM+Q-,N2LZ
MM+'11P]EC=*BZI*-045Y>\<OW3F<)!C.^82P2PB==[N1L_R,-4YC*0Y(VFA#
MLP-7JLLV<I3;E_*HI7E*39Y.U^9X"4CT)#&AO$!+*3$OP!R[5K&OS0XVSL\Z
MVJJEA1=H$7H07)<*?>$$R+_YOC'K]<*CWBH<!-XW?(2BX :%01@-\**^W,CQ
MH@N\<V7>H-TK6G-"]Y0TF)VKNH5.SD/M=[-0-<X@\<R'H4#NP4O?OQO/@D\#
MRI->>3)$3[<- S0.=M/;\:DV6A)1Z_\/N=4=!N:8*1@0F_9BTT'.=\%OKY ;
MAKXE-^OE9E>=VA-(\Q7A"V[#S+?<YKW;_.J#&_8;YE[T\T_Z0P6R<%U0H4PT
M7+>MHE_M&^VR[2]_P]LN_8!E0;E"#'*3&HSFYG7*MO.U$RUJUVUV0IO>Y8:E
M^5F M 'F>2Z$/D[L!OWO)_T#4$L#!!0    ( %.5"%>9=3+JI@P  "8B   9
M    >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;*U::7,;N1']*RANU<:JHBA9
M\E4^5"7+SL9)O%:L/5*5R@=P!B2QG@'& (:4_.OSNG%P*(ZXFTJ^V.(0:/3Q
M^G4WAJ\WUGWQ*Z6"N&T;X]],5B%T+T].?+52K?0SVRF#;Q;6M3+@HUN>^,XI
M6?.FMCDY.SU]=M)*;287K_G9M;MX;?O0:*.NG?!]VTIW]U8U=O-F\GB2'WS6
MRU6@!R<7KSNY5#<J_-Q=.WPZ*5)JW2KCM37"J<6;R>7CEV]?T'I>\(M6&S_X
M6Y E<VN_T(</]9O)*2FD&E4%DB#QWUI=J:8A05#C:Y(Y*4?2QN'?6?J?V7;8
M,I=>7=GF5UV'U9O)BXFHU4+V3?AL-W]1R9ZG)*^RC>=_Q2:N??ID(JK>!]NF
MS="@U2;^+V^3'P8;7IP^L.$L;3ACO>-!K.4[&>3%:V<WPM%J2*,_V%3>#>6T
MH:#<!(=O-?:%BYL8#&$7PNNET0M=21/@K,KV)FBS%)UM=*65%X^NTU]'KT\"
MCB8!)U4ZYFT\YNR!8YZ)C]:$E1?O3:WJW?TG4+GH?9;U?GMV4.!?>S,3YZ=3
M<79Z=GY WGGQPSG+.W] WN76X&RF^-?EW <'W/Q[S. H[\FX/,JEE[Z3E7HS
M0;)XY=9J<O']=X^?G;XZH.V3HNV30](OWDJO/<6,99L@(\)-+2IK//2O^<F8
MVH<%_[12'/NVD^:.G-$;V=<Z*)9<(QG5\ Q\6&@C3:5E(SS44,C7X(4V5=/7
M2H0DKJ>'4/=]J]Q2$;Z@JL:SS<HVS=VQW1B(\OW<ZUI+!^?/Q&73[$!2FZ!<
MTFPKE 0A1L9+SG(O5G*MQ%PI(U2CD3"LI#:[CID),O1_LJT6*^44!&\/1# Z
MZ>)QI*"KL5LAH<-*_#R[F0F8KIR$P?2UZNB(8:(YB-9=0ZDV^>'R\GIR),"Z
MT7#=#K31)K)Q#OK(>>1Y;0#?/ODE6$$T)AZ?'O^#-UVZH*M&X0%%YK-:]DV4
M>'/\3Z&][Z'=_(X%W:BJ=SI03M#.][?52IJE$E>V;;&2-CV:W+R_FAS-Q)5R
M ;5@3\>%M<'8H$2M?=58WP.YPM 2\D=QZDZD'@K!(4>3XP8QV486GK2M#B2T
MZYWO"5-PBN^KE7!]DVQSQ0^>0>+5?P4.O[)] [\I014R6?-;;V()*I$9X.YW
M!)).Y#9/^YR"PMA##H[6D["KF!-_\N+2F![;/ZO.NB!P8([XWQA(M/A.22<4
MD;!XIRK5SI43YX^91L^F0GIHT>"[HBFB&E-1UK^A&D6E]E3X/U &XDDXE D3
M\!\PYT@>4AA@84_0(@.UO:>:!6<D_A,+J5T3P;J5WEFOV>^0.W 468DGJ""J
M5)"9^)"R# )1T*,^<'PY3C-*:W 1M1$D(*\,*QE0DN\HZNJV0[M!-L+?=):E
ML)44[O"O92C&[Q&)H%V,RNQ 77A:ZL+3@_1][=1Q(P&W%8Y<0[AU=V-%X+"4
M7Q'\/6Q=.UN#2P!QM:2(31%3CX].4;H@3(B&DQLX@DR5381N%W>E(!2="#<Q
MB2-!D#?24I'T!QL29&W.2-HE.RQ:([(4G$IV.LA&?R.XKE34UZDU=8)81E$#
M#Q!9V"5"12B$- E4(!JT@P W_TUQ6QB5540+GCY"#)!;44"USS$>TT3S 7,Y
M;]0TPJ]GM"H@'G13 11&+72@A04<T",R!&L_C45L - Y2I=:JP*MZ%$D5A7)
ME9F8'1^%T5Y 4=/*42VW?#BHJ  T.+2O5#T38\ AE9&%8-=X"J6:=%A!ZM;0
MK[$=(8'M0I9#OX:<'B)KHF"0VARK5H49D1$%??\<MA*'#2(ZW?$'L0?BX3S1
M0\^<1?TJO$FF(/FKQ)25=E7?@E7@*3]-587!"6D98+"]9B;Z_KL79X^?O\+!
M8!HRA.BH]YG4:M<O=^P<U(<=[R:T30LC+)QM2WPJI!?\W:!-H;2XMZI%XPX%
M?61<[%%K*DS#8] U<#M:,B*R7$-V,0T--6J8H."O*8 >B%YPLD4?*RLJ<6GW
MONHKP-PZUI/"B18,+IR*M99SG!1X0 #'HW\C:M7?MH4=X\,7#(\!'JRY9E)*
M4 O- "(*36HA11)E[T, %1D]1<I1#^%^<4>YJAQW$92)=M[H93QV 'TIKMY]
M_,05B3IUXG9^,'I*(NDA<VBP4F">>"AQYZR6C9@ I%N?ZTD^]!!S/RO,_>P@
MY_X9!4P@(CTEBZ3NB,OB&'G_84%P/^93KM.2TQ*A39T;L%2IF'B;;<=2*7!?
MKEW8XQ%72EJI(\U0G[U \DG19%Q,N8K=PD\L<IJ3)S6S!#XG6E0*-!"$;*#9
M(L42:')74HXJ<KFU0]$ ^7!AW[;X4#5LB,J2#!01-+(XBF>,>/K A8(R?29^
M@4<B>(*J5D9_[9$-?0)<6LY=1 X"FAV:LS%"?(MS#!93X)%+&.88S-IT?2(>
M#!I[*WNSMS;.'6'EE#H&B;OAB2M\)GJ%2S<KG2L@&IAOL?G+Q['2\$Y4FDA@
M("3UT2_%WXFWQ&/!''?V2GS:4YM'BYH8@I*>(^"'(2#*X>88V/G:6^Z;*<0^
M=MU<-6,(_*MTW%DY[D,\(W8_@)GY/1$1BU0KE.9--?JBBFH43T#;3\6.5^SX
M>/!Y.?CG?:?38=&CL"K@,20:F^$#>,A4Y;/C20ONMN$BE2O =AK*5:GWY'SE
M8]V-.( ;^[9+$U?L&19T 84/UJ>$DR/(35F(V,[$)_AFT/[.:=;?K8<)KWEB
MH1*-E+)&W97$ZD'&XE%"P=$T=J#0]=A1C^ WLH.9CKA@.V? $#*7V^:R^>PH
MWRM0G:*$REQ=RG+,J[3^_"@Y9C'.:*,CP]A$$'.E@I:\1+;E%F&W,<7(Y<(Q
M$?/.A$RC+\O)4<UW$I7TL87A/]377D/)N+#<*D0J9 QQ5//S3M[%AU0_;V._
M!6WT,)%!NKU*A1;/6#WJX=($_8?,*IU)8\TRVK;&")) '2,I.)*UFH?=2 [B
M=DC+0T7K>2E:SP_6FG?H$]8\#XT6JL.;R0WKPLK)_EWC"*8^EC'R 5>R"*X-
M<#>\1EF/T/NP_Z-+!W*T2F%?-+!4&MG<\46:2=4Q]>=E"<=%24;/?<52JU.$
MI$SW.ZT!C>,[/<.(@7M]:AP2J2Y%U-S%"0'DX(?E)Z;Z<>Q/(M4-1>V>!#99
M)\+0+=HQ\IFER:T9H'((8A[7]H,AF1'O18-+;B0>ZKUKZ6IJ^5>VMHU=<N]H
M5 AYZ2 8J>E:Z-OL=J18PC%HFO.P"_ZHC$B#O25<)3580-[# K*THVC@[LJ'
MCH)"I>GC[H;.*3!-*N\X!R)0*S9D=W3T$9SD8C-%7?Y>U$:C,Q._<@6WKK/Q
M,>8S=%9;< \O81*//D2SU!M3_J/@0A3/>K$2S5&4A>TQ0FT,ZJ 9]MA.^R_%
MU5"O2]-Q=+FC@K7EII&]Y<KLD.(;E:Y6=F]W2U-RSRIT)U6^DBO?QQSQ^?Z'
M1M@/^90,LX$,ZMM@<5WXJB3H5J1:+,@]A-5]PU!$5)RB<]%3T4E()IEV)81S
MP3!WPZDGN4.9%0E,52GW5FR.C6KSD-70<.-D,^5&$?6CJ;&\[9E,2L>Y["5(
M/ZB<NSM4.I:Y"]E0700N<K.VCZ#2@QZJ#B]*=7AQD.!OXD41 E-N@L>JQ&$A
M/PW:'L?WFN4&:N>*>6=*8_,-7R+2#KZ4]+&!0TAEK)0<^%9^X?*@*NT98*F)
MPTS,5_);&'!RQMV,I3E1'UUW\. N(:WJ8R79V'0NQSXIBRA]PJ[]6[2=YB2B
MX=(@\/)6'(N/5Q_SM04@\./EYZO+'P</;NCRO+/W5[(1G[B+WJZE9Z3W#8B(
M6_#L109T@1\MX0':IW4173D$*L(L*;HSGB_2Q<^([=OH.$#/]+&KNN1LQ?,?
MG(4?/TJWU*8XA.]ZK#GF^_QM8Y<X;B8RNK+$XD%UFX(?WY[""1[]'3PP[P/-
M^K55\5HB-X2,EN/LCG&[XQSMQW6F+/;WU.&;L*V+/5,$*Y(OW1A_0PJDA*77
M-7&H(SFQH.?;"YS;'?<=Q70]0&N<Z+D>[#+>H&7?Z=3O69;= 2C9*EX@CM_S
M@;)40[=.T_PB*V9+3<,OO2A-Q,J3%/I:)-ZW(2-!33WG]RP\:VYGDHC-=%&.
MJ4")1^E*\8AFM2!OX\T5AC 7[YH+L!*%#;)ZF_+Q+G@[MU5@M\5 2$YZ(@$<
M_6AR]>G=QTGJ%,9>@'/ 2ISS,6E:1'!;Q2]04CT9O&V0_)Y3C9+JR>#=/;\=
MI5\H^%AQXVO\\K3\".(ROOO?+H^_H(AHQ-"@%MAZ.GO^=(+BQ;]*B!^"[?B7
M &@!D!G\YTI)X((6X'MZ1Y<_T 'EIR$7_P%02P,$%     @ 4Y4(5TVNFR.J
M!   HPP  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&ULK5=;;]LV%/XK
MA%ID,9#(LA0K;N(8B)T6[= "@>UN#\,>:.G8(BJ1*DG%\;_O(2G+5N8(R[ '
M2[R<^_<=BAYOA?RA,@!-GHN<JSLOT[J\Z?=5DD%!E2]*X+BS%K*@&J=RTU>E
M!)I:I2+OAT$0]PO*N#<9V[5'.1F+2N>,PZ,DJBH**G=3R,7VSAMX^X4YVV3:
M+/0GXY)N8 'Z>_DH<=9OK*2L *Z8X$3"^LZ[']Q,8R-O!?Y@L%5'8V(R60GQ
MPTR^I'=>8 *"'!)M+%!\/<$,\MP8PC!^UC:]QJ51/![OK7^RN6,N*ZI@)O(_
M6:JS.V_DD136M,KU7&P_0YW/T-A+1*[LDVR=;!Q[)*F4%D6MC!$4C+LW?:[K
M<*0P"EY1"&N%T,;M'-DH'ZBFD[$46R*--%HS YNJU<;@&#>@++3$789Z>C('
MI665Z$HROB&4IX05)642ZZY)(I16Y'Q)5SFHWKBOT:%1ZR>U\:DS'KYB/";?
M!->9(A]Y"FE;OX^!-M&&^VBG8:?!WRONDRBX(&$01AWVHB;[R-J+_G7V<\BI
MAI3<&[8PS4"1O^Y7*(7T^?M4!9R#J],.3$O=J)(F<.=ASRB03^!-SMX-XN"V
M(_RK)ORK+NN3!]"4Y8J(-?ER0 UG7P7?7'Y%NF,B2@&"^!GRU";X7>'B:N?6
M3R74Z?)T0LL,B#8D(2O3Y<3N</2JS8;0-&^Q*J-R R8&:F(@28YO@N>+$\\D
M "D<;\#PAB#JT*!^0Y96XIA9;0DRK5B>(J#J@JSJH?$OQ1,4-BQ3AQRPES.1
MI^VM]V0T\(?D4R4Y0UJ E86?%2MM[(/!->XNQ%IO*6X&?D1F@CL2X2%SR?@E
M&MM@_HH,@FO_BBQ?IH]'46[@R2T\U,'S'J./_6O208IA0XIA)RE>Y_3,M/,I
MR#L-O@[Y6N2(MO'BP#\!NVP%X\X33%DDS$:T93JSTC.!!>*[LW>C<'!]JXB"
M30V5(EL\LLV[XA3])58Q$;(4$H<V0>.7RB2SDQ2>D(0.KG-O?D:+\O;!Z]6T
M>TDTHZ'8\UL)MT"5UL*C%"GF:9"T282W. K]@"RP7BQ!O_OE_7OY:H&P,^K\
M&V%C:=;D'/@#,L1?G1QZ.@_\L(=2PPZS5FK0P_<'/R;_'< +$^"ZXI;Q%_]/
M/=L-_(_J?BS*7.Q0"<]AO _8[_EQH4T?+A!WW$TP#;ISY#%U&OFC@_H*.*R9
M^:;9>@5OJ%='9\9-9\:=G;G &U5:89WQA&YWZ=RUE2GL<E=: =.LIWJUT\5;
M>E4\L10<U EVG^"V9.C90(C-PDVS,'[<GK^I%X6B22(K+%_JIF^C08/*\@#J
M <3'/8B-V'0/GH-L2G,K2#5Y@ 2*%4@2#:SQL$6.KM&]2T!9!HWP  [P]P%_
M,ZJR Y$<7<ZQ"WLU*7 <]8YC^&8/H#J R')R@$]SJ)MQC$_S.6@<[B,P8K5Y
M:[CM>"]U'OEQXSKRKUNNV\VS]QSY8=T99GR:P/VCBV,!>#R:Z[%"/E1<NSMD
ML]K<P._=Q?,@[J[OF/^&<87?U36J8AGQHR+=E=A-M"CM-70E-%YJ[3##?Q$@
MC0#NKX70^XEQT/POF?P"4$L#!!0    ( %.5"%?!PVNU?P(  'H%   9
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M:$9N2<%C(843F&.7<<>X 2SG52&YD=N:=:FW33AZ3WW'ED_$I!FA4I%PYS&
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M^*CUW0S_18 A YQ?:NWJ#]J@^5^R^ =02P,$%     @ 4Y4(5[QD4K*W P
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MVN^](PK9=FBV&V_J,*C6QM/8"\N2?F>@90&ZSXWQNPT[Z'ZYS/X#4$L#!!0
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M68@*@SK_XCWSMH*3:F:@(50#Y/J*SFJM997>T36BS13>(R?9[TC:?J)WWJF
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MR97"-@Q M_6U'5BU]35MI2Q52-^MZ$E"[0QH?:V4W0_<!OTC-_\-4$L#!!0
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M/W?0CS.% O!_(Z5I)JB@[? 7_P%02P,$%     @ 4Y4(5Z0D#FEL P  5 @
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MP";YZ&D,"A,JG^G9C^<Q>OKX&7J,"$-GA%)=)'+F*KT@@W6SQOFB=N[?XCQ
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MRR[7&(68:P/U?,F8?!KHD^3R/P>S_P!02P,$%     @ 4Y4(5RA'Z6FV @
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MFW%L\UW"=P:5WAD3ZV0AY9,-IMG("ZP@X) :RT#QM8$Q<&Z)4,;OAM-KM[3
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MWT_;,!#^5ZP,34R")DW:%+$V$BU#8Q(2 K$]3'MPDVMCX=B9[;3LO]_92;,
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M( 2,FQ- 9B,6->-"NHB&"LV!SV%\B-,31N'.!/C+Y#,:]]8L2%JZRNCTS7D
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M*:_QCAR610]23+28VD?V7FAZLNTPH;8-I5&@];$0>C4Q!JI&L/\'4$L#!!0
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M3JN+_/YWV7Z@L.;%>5HV_Y+[]KW.B,3KLLJ7[<)J#99)MOE??&^_B)T%//?
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MR?/J\<E$\>_SXFO3QOG_ 5!+ P04    " !3E0A7YX4GRJD)  #H;@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6S%G6USF[@:AO^*QMLYV\ZDM@&_
M)#E)9M(@T)[9MIDV/?MAYWQ0;-EFBL$KL+/9.3]^Q4L,<HALTGO'^9#8F.>2
M"#<\TG,;N'B(Y?=D(41*_ER&47+96:3IZKS72R8+L>1)-UZ)2'TRB^62I^JM
MG/>2E11\F@<MPY[=[X]Z2QY$G:N+?-FMO+J(UVD81.)6DF2]7'+Y^$&$\<-E
MQ^H\+?@2S!=IMJ!W=;'B<_%5I-]6MU*]ZVTITV IHB2((R+%[+)S;9VSP2 +
MR-?X;R >DMIKDFW*?1Q_S][\,KWL]+,>B5!,T@S!U9^-N!%AF)%4/_XHH9UM
MFUE@_?43W<LW7FW,/4_$31S^%DS3Q67GM$.F8L;78?HE?F"BW*!AQIO$89+_
M)@_ENOT.F:R3-%Z6P:H'RR J_O(_RW]$+4!QF@/L,L#>#1B\$."4 <ZA 8,R
M8'!HEX9EP/#0%D9EP&@W8/1"P+@,&!_:PFD9<)KOW6)WY/O2Y2F_NI#Q Y'9
MVHJ6O<@%D4>K71A$F7:_IE)]&JBX].IK&D^^O\_V_I1,XJ4Z)!)>B"J:DB3[
M<!&'4R&3GXGX8QVDC^0]^<2EY)GDR%M7I#P(DW=JZ;>O+GG[YAUY0WHD67 I
M$A)$Y%L4I,E);<''( P57RU[4W][T4O5UF1]ZDW*GG\H>FZ_T'.'?(RC=)$0
M&DW%M"&>FN-'^^)]<[QE&P ]M1NV^\)^VA<?;"/Q/^NH2YS^";'[MM/0H9O#
MP^V&<-<<_I%+%6Z]&$Y_K//>CW7>-X=_BC==8KW<>79XN&78D\[VJ')RGO/2
M497)O3RJ;NI'U;4Z<J*Y4"?_E-P_DOIZM_PQ7WS]P.64_/ZK0I)?4K%,_M=T
M;!3M#YK;SQ+>>;+B$W'941DM$7(C.E?_^LD:]?_=I"LDS$7"*!+F(6$^$L9
M,$VK@ZU6!R9ZD0%(O,KTF9"YTF>JU/A6G9N+D_:[)OD9D6WEAX2Y2!@M8.,<
MEHT"-U?][OBBMZFK"MF@CX0Q$$Q3U7"KJJ%159_B:".23$E/RE+C[)D(#M"6
M$=Q66TB8BX3188.V1CO:0C;H(V$,!-.T-=IJ:W3 &4N*U5I.%BIWDI6,U7EK
M>4+X.EW$,OA+B8POXW64-NG+"&^K+R3,1<(H$N8A83X2Q@K86>TPLH?][6&D
MZ6N\U=>XE;ZF9+J6030G*R&#>'I"-CQ<BR9I&;EMI57 1O4M<[J.?H9PGZ\T
MM+NVOA)%=LM#PGPDC(%@FF9.MYHY-6KF.GU_MQ#OU23JNTC)Y]E,9(IITHB1
MTU8C2)B+A%$DS$/"?"2,@6":YLZVFCL[\BSS#*E5),Q%PB@2YB%A/A+&0#!-
MJU:_*C3VS5F5AX+$LZ*H>$*B]?)>R'Q!61M,DK42J)H;I$J]"2]JVWOF"F6;
M]5&TU;7T]'=C[EA;Y4%I%$KSH#0?2F,HFBZ_6IW;:B._B9J2!E,ABQ.F%!,1
M;++)JJ:^$S*7<=)<F[:>#;S.G@O/V*76PD/2:$FK#YRMVL"YU!.R21]*8RB:
MKB>[TI/=1D\K&4Q$-D$HSE;Y>6L:AR&72;6T^116M),='ML]<=JU[7[MYYFP
MC'UK+2PDC;YB>SQH#WPHC:%HNLXJ)\$R%G]W=5:4-=0)*_.ELSDIW_ @Y/=J
MI5FL9/:T=IXR&^7F/#MQ68-^]VQ785!/ $JCAVV"!VW4A](8BJ:+JBKY6^::
M_YT4/%E+-37(5-4H$VB%'TISH30*I7E0F@^E,11-%UWE"%C#(T]7+:AU *6Y
M4!J%TCPHS8?2&(JFB[:R&JQV7L/AM6 SN+481X=4@QO6:B@'0WOF-;0Y'G:'
M>IM^PUK6Z7@W9S-4U_2]717^K1^L_)>UBGU5":@/4-*,+K3;L-*S0@B%]LMK
M;/)T=[\_7VG0'>SN]7^B<F]5I7O+7+O_(I)43=\R:[H00/ZEM<8="RW>0VDN
ME$:A- ]*\Z$TAJ+IXJMJ^-:QB_@6M(H/I;E0&H72/"C-A](8BJ9_3[6JY=OF
M6CXMO@H<1.K$N<ZDF) X70A)T@6/VGZ7S-Q66WU":2Z41NTFMV(G&7K0)GTH
MC:%HNNRJ&KYMKN$?)+N3VC?-E/"*D=M>#2)+TS=0F@NET9*FCR:?:1!:]X?2
M&(JF:["J^]OFNO^MD/D50]%$%#FY<:!HAK36$[3<#Z51*,V#TGPHC:%HNO J
M(\ ^]C4%-O2B BC-A=(HE.9!:3Z4QE T7;25T6";C0;L0!'J24!I+I1&2YJ>
MI(>[21IJ-4!I#$7395=9#;;YZH,[+N<B)2O^&*_3; @X4=+C\\8Z;8FRK/JH
M?,<--3?76BM0*^" _GO0%GTHC:%HNE2J K]M+O 7J3&[5J6J\S;*!%K.A])<
M*(WN^8<YY%%PV33J]:#]\*$TAJ+I,JN<!=OL+-RI%#=9"/)9C<#^3PZO.)NQ
MK66'I+E0&H72/"C-A](8BJ9+L;([[--C3R2@-@F4YD)I%$KSH#0?2F,HFB[:
MRB:QC17MG30MLSN2)"?[1G90XP-*<Z$T6M*R[TK4)@R.^MD="$(]#2B-H6CZ
M'1LJ3\,Q>QIZAB[2\N=B@MHD+C.MK;B@-!=*HU":!Z7Y4!I#T70%5O:&8QTY
M,3M0FP-*<Z$T"J5Y4)H/I3$431=MY8<X9C_D-8G9C&PM0Z@[ J71DK8_,4.;
M]:$TAJ+I"JO=2\E\!<138KY[B%M-G<W8UBK#WB0)>Y<D[&V2L/=)PMXHZ9^P
M,YS*SG &Q\[04(\#2G.A- JE>5":#Z4Q%$T7;66&.&8SY%49&GHE!93F0FFT
MI!V0H:$>"I3&4#1=896'XI@M 3U#[Y\Z0ZT4*,V%TBB4YD%I/I3&4#1=@96]
MXHR/G9BA1@R4YD)I%$KSH#0?2F,HFB[:RHAQ]MPSZC6)&6JM0&DNE$9+V@&)
M&>J:0&D,1=,55KDFCMDUV2;FA13M?&<SN+7.H-X)E$:A- ]*\Z$TAJ+IMQFN
M#)9!_\@Y>@#U9* T%TJC4)H'I?E0&D/1=-%6GLS ?,G):W*T&=E:AE"7!4JC
M)6U_CH8VZT-I#$73%589* .S@;*;H_=.G\V\UO*"NB=0&H72/"C-A](8BJ9K
ML+)8!L>^MF0 -6.@-!=*HU":!Z7Y4!I#T731UIY;8:R;ORXU0^T5*,V%TFA)
M.R U0YT3*(VA:(7">K7'9"V%G.>/3$O()+NC7O%LG^W2[6/9KO.'D>TL_V"=
MNU;#<FJ=>\5#URI\\0RXCUS.@R@AH9BIIOK=L=HMLGBL6O$FC5?Y0[KNXS2-
ME_G+A>!3(;,5U.>S.$Z?WF0-;!]N=_4W4$L#!!0    ( %.5"%?RPW$0800
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M-4RUJJ%7,C1EF< 0_=H)<;LA7C?$5]_XT7FMB8T/4ZN5F&JQY 450U-6*8;
MXW#2';9.B-<-\=6..#ILFMCXL+5*C=E#JM%0_L][A6C>':).B-<-\7MU)U 2
M\=N\K<2!E6O>'D5Z0Z :@1J(>F0'>*21O0?&[^Y/H*;A/=6NWK%Z]>Z2/+H/
MRS=-T(>TH/DN8145.&:KB8ZMF[2RN5K9/*ULOE:V0!<;GRZM3H'Q*Y7A6*<H
MX&AE<[6R>5K9?*UL@2XV/IU:,06KQ91>93B698B)*$0Y ,@602X ,D6UR@-
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M)RA_OT_3XOG+[@2'MZS-_@=02P,$%     @ 4Y4(5WL$7'&< @  (08  !D
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MW;+ &0[*&N#]1DJSVUB"_E\A^0M02P,$%     @ 4Y4(5VE">S*E @  !0<
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M5=3HX.2H\FY0=HPLW.$WE@:/4M=<X'4*E 7@]YF49M.Q">H+6O8'4$L#!!0
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MQ:N"6-60;&OJ,0],2E::RPW@'+@>H.ZO&)//#1V@J4HN?P!02P,$%     @
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M2\I,_4/7PNIIIII#?#VG7#KT ,!%R) K@KCPV-C0JF_7++\_Y9*IL58B]O7
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M1L*KD\\F6VB5+;+%U@]-*\FQ>>'=/ 1876ZWRA9:98MLL?6CT I_;!;^IB$
M6.HFV@2^ F"8>-.AP =@=!%H%0X \U0=0$8&@E;B8[/$/PT$H*'&IE<GFTVV
MT"I;9(NM'X2V\L#F97YSE[>ZSF^5+;3*%MEBZT>A+7NPN>PQ=7F]4B$.UDL
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ML^KCGL6JHBP!ZO];SN7I2WF#\RN,R_\!4$L#!!0    ( %.5"%>9]]-0IP,
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MPCDIU>4.P1Q1:2#N;PCAIX8<H#UTB_\'4$L#!!0    ( %.5"%?:2&Z6+@8
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MN&Y\R6?SW\"O_@!02P$"% ,4    " !3E0A7!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( %.5"%>=
MI6SI[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( %.5"%>97)PC$ 8  )PG   3              "  <L!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 4Y4(5^WOBIKM!0
M[AX  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( %.5"%<J34(G, 8  ,$9   8              " @2\.
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !3E0A7P!Q3
M(@@#  #]"@  &               @(&5%   >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ 4Y4(5UU@(/NI"   H3@  !@
M ("!TQ<  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( %.5
M"%?D\8(G @0  +D/   8              " @;(@  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    " !3E0A7N\]3WB\(   V)0  &
M        @('J)   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ 4Y4(5T7-:J/B#   #(P  !@              ("!3RT  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( %.5"%>[Q4YAG@(  . (   8
M              " @6<Z  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    " !3E0A7/HT&T-$,   V'P  &               @($[/0  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ 4Y4(5U3ORX!U#0
M>20  !D              ("!0DH  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    " !3E0A7 @SBS58&  !<#@  &0              @('N
M5P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( %.5"%<0
MN:[7/0@  /85   9              " @7M>  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ 4Y4(5WJBY*&6 @  NP4  !D
M     ("![V8  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %.5"%<#N5=6B H   8=   9              "
M@4:$  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ 4Y4(
M5XFNUW(M"0  SAH  !D              ("!!8\  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    " !3E0A7G,>DBND#   C"@  &0
M        @(%IF   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( %.5"%>"L$)F^@X  'TJ   9              " @8F<  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ 4Y4(5^%3 ;,/!   D@D
M !D              ("!NJL  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    " !3E0A7&2%N:T4$   N"@  &0              @($ L
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( %.5"%?LR0S)
M; H  .X;   9              " @7RT  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ 4Y4(5SEXLZF&!P  ;!,  !D
M ("!'[\  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !3
ME0A7>/ ,0T('  "F$   &0              @('<Q@  >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( %.5"%?+UGQ?KP(  'L)   9
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M970S,2YX;6Q02P$"% ,4    " !3E0A74D&CCI #  "Z!P  &0
M    @($JZ   >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M %.5"%?H-CM_MP0  %,,   9              " @?'K  !X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ 4Y4(5]O'SOV2!   HPP  !D
M             ("!W_   'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    " !3E0A7O&12LK<#  #%"   &0              @(&H]0  >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( %.5"%=G,[U38 ,
M $,'   9              " @9;Y  !X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ 4Y4(5Q'%J["M!0  .!$  !D              ("!
M+?T  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " !3E0A7
M9 -/>/8"  #P!@  &0              @($1 P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    ( %.5"%?_BA/[H@0  .T+   9
M      " @3X& 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ 4Y4(5Z0D#FEL P  5 @  !D              ("!%PL! 'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " !3E0A7=E6OCL0%   H#@
M&0              @(&Z#@$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+
M 0(4 Q0    ( %.5"%=&/8-HO0(  - &   9              " @;44 0!X
M;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ 4Y4(5QCRT<Z1
M P  _Q   !D              ("!J1<! 'AL+W=O<FMS:&5E=',O<VAE970T
M,RYX;6Q02P$"% ,4    " !3E0A7EO.VN-\$   R(   &0
M@(%Q&P$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( %.5
M"%>\6[ F>@,  /H/   9              " @8<@ 0!X;"]W;W)K<VAE971S
M+W-H965T-#4N>&UL4$L! A0#%     @ 4Y4(5UB8L_0N!   $1L  !D
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M=#4P+GAM;%!+ 0(4 Q0    ( %.5"%=B*_MP/0,  ,X.   9
M  " @3\[ 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @
M4Y4(5VP9$6W*!   11@  !D              ("!LSX! 'AL+W=O<FMS:&5E
M=',O<VAE970U,BYX;6Q02P$"% ,4    " !3E0A7*$?I:;8"   1"   &0
M            @(&T0P$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4
M Q0    ( %.5"%>>0J=(2 ,  .X.   9              " @:%& 0!X;"]W
M;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ 4Y4(5\.EQGQ< @
M< <  !D              ("!($H! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX
M;6Q02P$"% ,4    " !3E0A7[!%&><4%  !Z*P  &0              @(&S
M3 $ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( %.5"%<<
M4Z25U (  .8'   9              " @:]2 0!X;"]W;W)K<VAE971S+W-H
M965T-3<N>&UL4$L! A0#%     @ 4Y4(5U/D;L(3 P  N0H  !D
M     ("!NE4! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4
M" !3E0A7HH':4@L$   7&   &0              @($$60$ >&PO=V]R:W-H
M965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( %.5"%=/)H?580(  #$%   9
M              " @49= 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L!
M A0#%     @ 4Y4(5ZS^[)>J @  G08  !D              ("!WE\! 'AL
M+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " !3E0A78I8NV!4#
M   4"@  &0              @(&_8@$ >&PO=V]R:W-H965T<R]S:&5E=#8R
M+GAM;%!+ 0(4 Q0    ( %.5"%>I-C^-4@0  (P7   9              "
M@0MF 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ 4Y4(
M5Q>JDU_J#   G)L  !D              ("!E&H! 'AL+W=O<FMS:&5E=',O
M<VAE970V-"YX;6Q02P$"% ,4    " !3E0A7YX4GRJD)  #H;@  &0
M        @(&U=P$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0
M   ( %.5"%?RPW$0800  ,L9   9              " @96! 0!X;"]W;W)K
M<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ 4Y4(5\,_KFSJ!P  6CL
M !D              ("!+88! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q0
M2P$"% ,4    " !3E0A7U/5GD=$%  "/)P  &0              @(%.C@$
M>&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( %.5"%=>BGVX
M& 0  "04   9              " @5:4 0!X;"]W;W)K<VAE971S+W-H965T
M-CDN>&UL4$L! A0#%     @ 4Y4(5Q&V>51#!0  AQH  !D
M ("!I9@! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " !3
ME0A78 )&OB((  !Q30  &0              @($?G@$ >&PO=V]R:W-H965T
M<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( %.5"%=[!%QQG (  "$&   9
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M970W-BYX;6Q02P$"% ,4    " !3E0A7(T+JNR0"  "H!   &0
M    @($0MP$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    (
M %.5"%<A]WYFT @  ,XX   9              " @6NY 0!X;"]W;W)K<VAE
M971S+W-H965T-S@N>&UL4$L! A0#%     @ 4Y4(5YGWTU"G P  @!,  !D
M             ("!<L(! 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"
M% ,4    " !3E0A7VDANEBX&  "V-   &0              @(%0Q@$ >&PO
M=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( %.5"%?>/SJ46P,
M ) 6   -              "  ;7, 0!X;"]S='EL97,N>&UL4$L! A0#%
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K 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !8 %@ 'Q@   _< 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>359</ContextCount>
  <ElementCount>301</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>98</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Nature of the business and organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Natureofthebusinessandorganization</Role>
      <ShortName>Nature of the business and organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Summary of significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Summaryofsignificantaccountingpolicies</Role>
      <ShortName>Summary of significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Divestiture</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Divestiture</Role>
      <ShortName>Divestiture</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Restructuring and impairment costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Restructuringandimpairmentcosts</Role>
      <ShortName>Restructuring and impairment costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Inventories, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Inventoriesnet</Role>
      <ShortName>Inventories, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Property, plant and equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Propertyplantandequipmentnet</Role>
      <ShortName>Property, plant and equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Intangible assets and goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Intangibleassetsandgoodwill</Role>
      <ShortName>Intangible assets and goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Fair value measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Fairvaluemeasurements</Role>
      <ShortName>Fair value measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Derivative instruments and hedging activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Derivativeinstrumentsandhedgingactivities</Role>
      <ShortName>Derivative instruments and hedging activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Stock-based compensation and stockholders' equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Stockbasedcompensationandstockholdersequity</Role>
      <ShortName>Stock-based compensation and stockholders' equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Loss per common share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Losspercommonshare</Role>
      <ShortName>Loss per common share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Revenue recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Revenuerecognition</Role>
      <ShortName>Revenue recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Incometaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Litigation</Role>
      <ShortName>Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Segment information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Segmentinformation</Role>
      <ShortName>Segment information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Subsequentevents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954701 - Disclosure - Summary of significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies</Role>
      <ShortName>Summary of significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954702 - Disclosure - Restructuring and impairment costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsTables</Role>
      <ShortName>Restructuring and impairment costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Restructuringandimpairmentcosts</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954703 - Disclosure - Inventories, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/InventoriesnetTables</Role>
      <ShortName>Inventories, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Inventoriesnet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954704 - Disclosure - Property, plant and equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/PropertyplantandequipmentnetTables</Role>
      <ShortName>Property, plant and equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Propertyplantandequipmentnet</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954705 - Disclosure - Intangible assets and goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillTables</Role>
      <ShortName>Intangible assets and goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Intangibleassetsandgoodwill</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954706 - Disclosure - Fair value measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/FairvaluemeasurementsTables</Role>
      <ShortName>Fair value measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Fairvaluemeasurements</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954707 - Disclosure - Derivative instruments and hedging activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesTables</Role>
      <ShortName>Derivative instruments and hedging activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Derivativeinstrumentsandhedgingactivities</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954708 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Debt</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954709 - Disclosure - Stock-based compensation and stockholders' equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTables</Role>
      <ShortName>Stock-based compensation and stockholders' equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Stockbasedcompensationandstockholdersequity</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954710 - Disclosure - Loss per common share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LosspercommonshareTables</Role>
      <ShortName>Loss per common share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Losspercommonshare</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954711 - Disclosure - Revenue recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenuerecognitionTables</Role>
      <ShortName>Revenue recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Revenuerecognition</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954712 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Leases</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954713 - Disclosure - Segment information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SegmentinformationTables</Role>
      <ShortName>Segment information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Segmentinformation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954714 - Disclosure - Nature of the business and organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/NatureofthebusinessandorganizationDetails</Role>
      <ShortName>Nature of the business and organization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Natureofthebusinessandorganization</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954715 - Disclosure - Summary of significant accounting policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails</Role>
      <ShortName>Summary of significant accounting policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954716 - Disclosure - Divestiture (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DivestitureDetails</Role>
      <ShortName>Divestiture (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Divestiture</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954717 - Disclosure - Restructuring and impairment costs - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails</Role>
      <ShortName>Restructuring and impairment costs - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954718 - Disclosure - Restructuring and impairment costs - Details of Impairment of Long-Lived Assets Held and Used by Asset (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails</Role>
      <ShortName>Restructuring and impairment costs - Details of Impairment of Long-Lived Assets Held and Used by Asset (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954719 - Disclosure - Restructuring and impairment costs - Restructuring and Related Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails</Role>
      <ShortName>Restructuring and impairment costs - Restructuring and Related Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954720 - Disclosure - Restructuring and impairment costs - Schedule of Restructuring Reserve by Type of Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails</Role>
      <ShortName>Restructuring and impairment costs - Schedule of Restructuring Reserve by Type of Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954721 - Disclosure - Inventories, net - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails</Role>
      <ShortName>Inventories, net - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954722 - Disclosure - Property, plant and equipment, net - Schedule of Property, Plant, and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails</Role>
      <ShortName>Property, plant and equipment, net - Schedule of Property, Plant, and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954723 - Disclosure - Property, plant and equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails</Role>
      <ShortName>Property, plant and equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954724 - Disclosure - Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails</Role>
      <ShortName>Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954725 - Disclosure - Intangible assets and goodwill - Finite-lived Intangible Assets Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillFinitelivedIntangibleAssetsAmortizationExpenseDetails</Role>
      <ShortName>Intangible assets and goodwill - Finite-lived Intangible Assets Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954726 - Disclosure - Intangible assets and goodwill - Goodwill Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails</Role>
      <ShortName>Intangible assets and goodwill - Goodwill Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954727 - Disclosure - Intangible assets and goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails</Role>
      <ShortName>Intangible assets and goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954728 - Disclosure - Fair value measurements - Fair Value Hierarchy of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails</Role>
      <ShortName>Fair value measurements - Fair Value Hierarchy of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954729 - Disclosure - Fair value measurements - Contingent Consideration Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/FairvaluemeasurementsContingentConsiderationRollForwardDetails</Role>
      <ShortName>Fair value measurements - Contingent Consideration Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954730 - Disclosure - Fair value measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair value measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954731 - Disclosure - Fair value measurements - Fair Value Level 3 of Significant Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails</Role>
      <ShortName>Fair value measurements - Fair Value Level 3 of Significant Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954732 - Disclosure - Derivative instruments and hedging activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails</Role>
      <ShortName>Derivative instruments and hedging activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954733 - Disclosure - Derivative instruments and hedging activities - Fair Value by Balance Sheet Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails</Role>
      <ShortName>Derivative instruments and hedging activities - Fair Value by Balance Sheet Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954734 - Disclosure - Derivative instruments and hedging activities - Cash Flow Hedging on AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails</Role>
      <ShortName>Derivative instruments and hedging activities - Cash Flow Hedging on AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954735 - Disclosure - Debt - Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DebtScheduleDetails</Role>
      <ShortName>Debt - Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954736 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954737 - Disclosure - Stock-based compensation and stockholders' equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails</Role>
      <ShortName>Stock-based compensation and stockholders' equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954738 - Disclosure - Stock-based compensation and stockholders' equity - Schedule of Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails</Role>
      <ShortName>Stock-based compensation and stockholders' equity - Schedule of Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954739 - Disclosure - Stock-based compensation and stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Stock-based compensation and stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954740 - Disclosure - Stock-based compensation and stockholders' equity - Tax Effects Related to Each Component of Accumulated Other Comprehensive (Loss) Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails</Role>
      <ShortName>Stock-based compensation and stockholders' equity - Tax Effects Related to Each Component of Accumulated Other Comprehensive (Loss) Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954741 - Disclosure - Loss per common share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LosspercommonshareDetails</Role>
      <ShortName>Loss per common share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/LosspercommonshareTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954742 - Disclosure - Revenue recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails</Role>
      <ShortName>Revenue recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954743 - Disclosure - Revenue recognition - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue recognition - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954744 - Disclosure - Revenue recognition - Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenuerecognitionContractLiabilitiesDetails</Role>
      <ShortName>Revenue recognition - Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954745 - Disclosure - Revenue recognition - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails</Role>
      <ShortName>Revenue recognition - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954746 - Disclosure - Leases - Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails</Role>
      <ShortName>Leases - Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954747 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954748 - Disclosure - Income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IncometaxesDetails</Role>
      <ShortName>Income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Incometaxes</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954749 - Disclosure - Segment information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SegmentinformationNarrativeDetails</Role>
      <ShortName>Segment information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954750 - Disclosure - Segment information - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails</Role>
      <ShortName>Segment information - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954751 - Disclosure - Segment information - Schedule of Segment Reporting Information, by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails</Role>
      <ShortName>Segment information - Schedule of Segment Reporting Information, by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ebs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954752 - Disclosure - Subsequent events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SubsequenteventsDetails</Role>
      <ShortName>Subsequent events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Subsequentevents</ParentRole>
      <Position>80</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 6 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage -  ebs-20230630.htm 4</Log>
    <Log type="Warning">[dqc-0015-Negative-Values] Fact us-gaap:OperatingLeaseLeaseIncomeLeasePayments has a value of -4500000 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:OperatingLeaseLeaseIncomeLeasePayments fact are: Context: c-14, Unit: usd, Rule Element Id: 7022. ebs-20230630.htm 4</Log>
    <Log type="Warning">[dqc-0015-Negative-Values] Fact us-gaap:OperatingLeaseLeaseIncomeLeasePayments has a value of -4500000 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:OperatingLeaseLeaseIncomeLeasePayments fact are: Context: c-292, Unit: usd, Rule Element Id: 7022. ebs-20230630.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="ebs-20230630.htm">ebs-20230630.htm</File>
    <File>a311-millercert063023.htm</File>
    <File>a312-lindhalcert063023.htm</File>
    <File>a321-millercert063023.htm</File>
    <File>a322-lindhalcert063023.htm</File>
    <File>ebs-20230630.xsd</File>
    <File>ebs-20230630_cal.xml</File>
    <File>ebs-20230630_def.xml</File>
    <File>ebs-20230630_lab.xml</File>
    <File>ebs-20230630_pre.xml</File>
    <File>ebs-brginterimmanagement.htm</File>
    <File>modificationno10effectiv.htm</File>
    <File>modificationno13effectiv.htm</File>
    <File>modificationno14effectiv.htm</File>
    <File>modificationno9effective.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ebs-20230630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1085">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>134
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ebs-20230630.htm": {
   "axisCustom": 1,
   "axisStandard": 37,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1085,
    "http://xbrl.sec.gov/dei/2023": 29,
    "http://xbrl.sec.gov/ecd/2023": 4
   },
   "contextCount": 359,
   "dts": {
    "calculationLink": {
     "local": [
      "ebs-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ebs-20230630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ebs-20230630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ebs-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ebs-20230630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ebs-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    }
   },
   "elementCount": 653,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 12,
    "http://xbrl.sec.gov/dei/2023": 5,
    "total": 17
   },
   "keyCustom": 22,
   "keyStandard": 279,
   "memberCustom": 36,
   "memberStandard": 56,
   "nsprefix": "ebs",
   "nsuri": "http://emergentbiosolutions.com/20230630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://emergentbiosolutions.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Summary of significant accounting policies",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://emergentbiosolutions.com/role/Summaryofsignificantaccountingpolicies",
     "shortName": "Summary of significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Divestiture",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://emergentbiosolutions.com/role/Divestiture",
     "shortName": "Divestiture",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Restructuring and impairment costs",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://emergentbiosolutions.com/role/Restructuringandimpairmentcosts",
     "shortName": "Restructuring and impairment costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Inventories, net",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://emergentbiosolutions.com/role/Inventoriesnet",
     "shortName": "Inventories, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Property, plant and equipment, net",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://emergentbiosolutions.com/role/Propertyplantandequipmentnet",
     "shortName": "Property, plant and equipment, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Intangible assets and goodwill",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://emergentbiosolutions.com/role/Intangibleassetsandgoodwill",
     "shortName": "Intangible assets and goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Fair value measurements",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://emergentbiosolutions.com/role/Fairvaluemeasurements",
     "shortName": "Fair value measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Derivative instruments and hedging activities",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://emergentbiosolutions.com/role/Derivativeinstrumentsandhedgingactivities",
     "shortName": "Derivative instruments and hedging activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://emergentbiosolutions.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Stock-based compensation and stockholders' equity",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://emergentbiosolutions.com/role/Stockbasedcompensationandstockholdersequity",
     "shortName": "Stock-based compensation and stockholders' equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Loss per common share",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://emergentbiosolutions.com/role/Losspercommonshare",
     "shortName": "Loss per common share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Revenue recognition",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://emergentbiosolutions.com/role/Revenuerecognition",
     "shortName": "Revenue recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://emergentbiosolutions.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Income taxes",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://emergentbiosolutions.com/role/Incometaxes",
     "shortName": "Income taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Litigation",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://emergentbiosolutions.com/role/Litigation",
     "shortName": "Litigation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Segment information",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://emergentbiosolutions.com/role/Segmentinformation",
     "shortName": "Segment information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Subsequent events",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://emergentbiosolutions.com/role/Subsequentevents",
     "shortName": "Subsequent events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "shortName": "Pay vs Performance Disclosure",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "shortName": "Insider Trading Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954701 - Disclosure - Summary of significant accounting policies (Policies)",
     "menuCat": "Policies",
     "order": "29",
     "role": "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies",
     "shortName": "Summary of significant accounting policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954702 - Disclosure - Restructuring and impairment costs (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsTables",
     "shortName": "Restructuring and impairment costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954703 - Disclosure - Inventories, net (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://emergentbiosolutions.com/role/InventoriesnetTables",
     "shortName": "Inventories, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954704 - Disclosure - Property, plant and equipment, net (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetTables",
     "shortName": "Property, plant and equipment, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954705 - Disclosure - Intangible assets and goodwill (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillTables",
     "shortName": "Intangible assets and goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954706 - Disclosure - Fair value measurements (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://emergentbiosolutions.com/role/FairvaluemeasurementsTables",
     "shortName": "Fair value measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954707 - Disclosure - Derivative instruments and hedging activities (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesTables",
     "shortName": "Derivative instruments and hedging activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954708 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://emergentbiosolutions.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954709 - Disclosure - Stock-based compensation and stockholders' equity (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTables",
     "shortName": "Stock-based compensation and stockholders' equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954710 - Disclosure - Loss per common share (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://emergentbiosolutions.com/role/LosspercommonshareTables",
     "shortName": "Loss per common share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954711 - Disclosure - Revenue recognition (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://emergentbiosolutions.com/role/RevenuerecognitionTables",
     "shortName": "Revenue recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954712 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://emergentbiosolutions.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954713 - Disclosure - Segment information (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://emergentbiosolutions.com/role/SegmentinformationTables",
     "shortName": "Segment information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ebs:NumberOfCategoriesOfPublicHealthThreats",
      "reportCount": 1,
      "unique": true,
      "unitRef": "category",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954714 - Disclosure - Nature of the business and organization (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://emergentbiosolutions.com/role/NatureofthebusinessandorganizationDetails",
     "shortName": "Nature of the business and organization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ebs:NumberOfCategoriesOfPublicHealthThreats",
      "reportCount": 1,
      "unique": true,
      "unitRef": "category",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954715 - Disclosure - Summary of significant accounting policies (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails",
     "shortName": "Summary of significant accounting policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfBusiness",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954716 - Disclosure - Divestiture (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://emergentbiosolutions.com/role/DivestitureDetails",
     "shortName": "Divestiture (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-88",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NonoperatingIncomeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954717 - Disclosure - Restructuring and impairment costs - Narrative (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails",
     "shortName": "Restructuring and impairment costs - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-94",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954718 - Disclosure - Restructuring and impairment costs - Details of Impairment of Long-Lived Assets Held and Used by Asset (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails",
     "shortName": "Restructuring and impairment costs - Details of Impairment of Long-Lived Assets Held and Used by Asset (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-90",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-95",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954719 - Disclosure - Restructuring and impairment costs - Restructuring and Related Costs (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
     "shortName": "Restructuring and impairment costs - Restructuring and Related Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-100",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-123",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954720 - Disclosure - Restructuring and impairment costs - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails",
     "shortName": "Restructuring and impairment costs - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-95",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsForRestructuring",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954721 - Disclosure - Inventories, net - Schedule of Inventory (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails",
     "shortName": "Inventories, net - Schedule of Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954722 - Disclosure - Property, plant and equipment, net - Schedule of Property, Plant, and Equipment (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails",
     "shortName": "Property, plant and equipment, net - Schedule of Property, Plant, and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954723 - Disclosure - Property, plant and equipment - Narrative (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails",
     "shortName": "Property, plant and equipment - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-138",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954724 - Disclosure - Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails",
     "shortName": "Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954725 - Disclosure - Intangible assets and goodwill - Finite-lived Intangible Assets Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillFinitelivedIntangibleAssetsAmortizationExpenseDetails",
     "shortName": "Intangible assets and goodwill - Finite-lived Intangible Assets Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954726 - Disclosure - Intangible assets and goodwill - Goodwill Roll Forward (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails",
     "shortName": "Intangible assets and goodwill - Goodwill Roll Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillGross",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-148",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954727 - Disclosure - Intangible assets and goodwill - Narrative (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails",
     "shortName": "Intangible assets and goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954728 - Disclosure - Fair value measurements - Fair Value Hierarchy of Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails",
     "shortName": "Fair value measurements - Fair Value Hierarchy of Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954729 - Disclosure - Fair value measurements - Contingent Consideration Roll Forward (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://emergentbiosolutions.com/role/FairvaluemeasurementsContingentConsiderationRollForwardDetails",
     "shortName": "Fair value measurements - Contingent Consideration Roll Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-38",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954730 - Disclosure - Fair value measurements - Additional Information (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails",
     "shortName": "Fair value measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954731 - Disclosure - Fair value measurements - Fair Value Level 3 of Significant Unobservable Inputs (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails",
     "shortName": "Fair value measurements - Fair Value Level 3 of Significant Unobservable Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-172",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-178",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954732 - Disclosure - Derivative instruments and hedging activities - Narrative (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails",
     "shortName": "Derivative instruments and hedging activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-178",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-179",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954733 - Disclosure - Derivative instruments and hedging activities - Fair Value by Balance Sheet Location (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails",
     "shortName": "Derivative instruments and hedging activities - Fair Value by Balance Sheet Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-179",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-181",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954734 - Disclosure - Derivative instruments and hedging activities - Cash Flow Hedging on AOCI (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails",
     "shortName": "Derivative instruments and hedging activities - Cash Flow Hedging on AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-181",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954735 - Disclosure - Debt - Schedule (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://emergentbiosolutions.com/role/DebtScheduleDetails",
     "shortName": "Debt - Schedule (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNoncurrentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsCurrentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954736 - Disclosure - Debt - Narrative (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsCurrentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954737 - Disclosure - Stock-based compensation and stockholders' equity - Narrative (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails",
     "shortName": "Stock-based compensation and stockholders' equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954738 - Disclosure - Stock-based compensation and stockholders' equity - Schedule of Stock-based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails",
     "shortName": "Stock-based compensation and stockholders' equity - Schedule of Stock-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-30",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954739 - Disclosure - Stock-based compensation and stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Stock-based compensation and stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954740 - Disclosure - Stock-based compensation and stockholders' equity - Tax Effects Related to Each Component of Accumulated Other Comprehensive (Loss) Income (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails",
     "shortName": "Stock-based compensation and stockholders' equity - Tax Effects Related to Each Component of Accumulated Other Comprehensive (Loss) Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954741 - Disclosure - Loss per common share (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://emergentbiosolutions.com/role/LosspercommonshareDetails",
     "shortName": "Loss per common share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-56",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-61",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954742 - Disclosure - Revenue recognition - Narrative (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails",
     "shortName": "Revenue recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954743 - Disclosure - Revenue recognition - Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
     "shortName": "Revenue recognition - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-301",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954744 - Disclosure - Revenue recognition - Contract Liabilities (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://emergentbiosolutions.com/role/RevenuerecognitionContractLiabilitiesDetails",
     "shortName": "Revenue recognition - Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ebs:ScheduleOfAccountsReceivableNetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954745 - Disclosure - Revenue recognition - Accounts Receivable (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails",
     "shortName": "Revenue recognition - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ebs:ScheduleOfAccountsReceivableNetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954746 - Disclosure - Leases - Components of Lease Expense (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails",
     "shortName": "Leases - Components of Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ebs:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954747 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ebs:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-332",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954748 - Disclosure - Income taxes (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://emergentbiosolutions.com/role/IncometaxesDetails",
     "shortName": "Income taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-332",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NumberOfOperatingSegments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954749 - Disclosure - Segment information - Narrative (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://emergentbiosolutions.com/role/SegmentinformationNarrativeDetails",
     "shortName": "Segment information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NumberOfOperatingSegments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954750 - Disclosure - Segment information - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
     "shortName": "Segment information - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954751 - Disclosure - Segment information - Schedule of Segment Reporting Information, by Segment (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails",
     "shortName": "Segment information - Schedule of Segment Reporting Information, by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-25",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical",
     "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-30",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954752 - Disclosure - Subsequent events (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://emergentbiosolutions.com/role/SubsequenteventsDetails",
     "shortName": "Subsequent events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-357",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Nature of the business and organization",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://emergentbiosolutions.com/role/Natureofthebusinessandorganization",
     "shortName": "Nature of the business and organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 98,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ebs_AdjustedGrossMargin": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Gross Margin",
        "label": "Adjusted Gross Margin",
        "terseLabel": "Adjusted Gross Margin"
       }
      }
     },
     "localname": "AdjustedGrossMargin",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_AmendedCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended credit agreement dated October 15, 2018.",
        "label": "Amended Credit Agreement [Member]",
        "terseLabel": "Amended Credit Agreement"
       }
      }
     },
     "localname": "AmendedCreditAgreementMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Schedule of Leases Supplemental Balance Sheets"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ebs_AtTheMarketOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-The-Market Offering",
        "label": "At-The-Market Offering [Member]",
        "terseLabel": "At-The-Market Offering"
       }
      }
     },
     "localname": "AtTheMarketOfferingMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_BARDAContractContractNotCeasedPriorToJune12026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BARDA Contract, Contract Not Ceased Prior To June 1, 2026",
        "label": "BARDA Contract, Contract Not Ceased Prior To June 1, 2026 [Member]",
        "terseLabel": "BARDA Contract, Contract not Ceased Prior to June 1, 2026"
       }
      }
     },
     "localname": "BARDAContractContractNotCeasedPriorToJune12026Member",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_BARDAContractPayableInThirdQuarterOf2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BARDA Contract, Payable In Third Quarter Of 2023",
        "label": "BARDA Contract, Payable In Third Quarter Of 2023 [Member]",
        "terseLabel": "BARDA Contract, Payable in Third Quarter of 2023"
       }
      }
     },
     "localname": "BARDAContractPayableInThirdQuarterOf2023Member",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_BARDAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BARDA",
        "label": "BARDA [Member]",
        "terseLabel": "BARDA"
       }
      }
     },
     "localname": "BARDAMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ChangeinContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract With Customer, Liability [Roll Forward]",
        "label": "Change in Contract With Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract With Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeinContractWithCustomerLiabilityRollForward",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ebs_ContractDevelopmentAndManufacturingLeasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Development And Manufacturing, Leases",
        "label": "Contract Development And Manufacturing, Leases [Member]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "ContractDevelopmentAndManufacturingLeasesMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ContractDevelopmentAndManufacturingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue earned during the period arising from manufacturing sale under the terms of a contract.",
        "label": "Contract Development And Manufacturing [Member]",
        "terseLabel": "Contract Development And Manufacturing [Member]",
        "verboseLabel": "CDMO"
       }
      }
     },
     "localname": "ContractDevelopmentAndManufacturingMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ContractsAndGrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue earned from products sold or services provided under the terms of a contract, including, but not limited to, government contracts and grants.",
        "label": "Contracts and Grants [Member]",
        "terseLabel": "Contracts and grants"
       }
      }
     },
     "localname": "ContractsAndGrantsMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_DebtInstrumentCovenantConsiderationThreshold": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Consideration Threshold",
        "label": "Debt Instrument, Covenant, Consideration Threshold",
        "terseLabel": "Debt instrument, covenant, consideration threshold"
       }
      }
     },
     "localname": "DebtInstrumentCovenantConsiderationThreshold",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_DebtInstrumentCovenantInterestCoverageRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Minimum Consolidated Interest Coverage Ratio Required",
        "label": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum",
        "terseLabel": "Debt instrument, covenant, interest coverage ratio, minimum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantInterestCoverageRatioMinimum",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ebs_DebtInstrumentCovenantLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum allowed",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Debt instrument, covenant, leverage ratio, maximum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ebs_DebtTermsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt, Terms",
        "label": "Debt, Terms [Axis]",
        "terseLabel": "Debt, Terms [Axis]"
       }
      }
     },
     "localname": "DebtTermsAxis",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ebs_DebtTermsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt, terms [Domain]",
        "label": "Debt, terms [Domain]",
        "terseLabel": "Debt, Terms [Domain]"
       }
      }
     },
     "localname": "DebtTermsDomain",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_DevelopmentBasedMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development-Based Milestones",
        "label": "Development-Based Milestones [Member]",
        "terseLabel": "Development-Based Milestones"
       }
      }
     },
     "localname": "DevelopmentBasedMilestonesMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DivestitureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Maximum Contingent Consideration Receivable",
        "label": "Disposal Group, Including Discontinued Operation, Maximum Contingent Consideration Receivable",
        "terseLabel": "Milestone payments receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationMaximumContingentConsiderationReceivable",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DivestitureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_DispositionOfBusinessTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposition Of Business, Transaction Costs",
        "label": "Disposition Of Business, Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "DispositionOfBusinessTransactionCosts",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DivestitureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_EbangaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ebanga",
        "label": "Ebanga [Member]",
        "terseLabel": "Ebanga"
       }
      }
     },
     "localname": "EbangaMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_EmployeeBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Benefits",
        "label": "Employee Benefits [Member]",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "EmployeeBenefitsMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_EmployeeTransitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Transition",
        "label": "Employee Transition [Member]",
        "terseLabel": "Employee transition"
       }
      }
     },
     "localname": "EmployeeTransitionMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_FiscalQuartersEndingAfter2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Quarters Ending After 2024",
        "label": "Fiscal Quarters Ending After 2024 [Member]",
        "terseLabel": "Fiscal Quarters Ending After 2024"
       }
      }
     },
     "localname": "FiscalQuartersEndingAfter2024Member",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_FiscalQuartersEndingAfterMarch312024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Quarters Ending After March 31, 2024",
        "label": "Fiscal Quarters Ending After March 31, 2024 [Member]",
        "terseLabel": "Fiscal Quarters Ending After March 31, 2024"
       }
      }
     },
     "localname": "FiscalQuartersEndingAfterMarch312024Member",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_FiscalQuartersEndingIn2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Quarters Ending in 2024",
        "label": "Fiscal Quarters Ending in 2024 [Member]",
        "terseLabel": "Fiscal Quarters Ending in 2024"
       }
      }
     },
     "localname": "FiscalQuartersEndingIn2024Member",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_FiveYearOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Year Option",
        "label": "Five Year Option [Member]",
        "terseLabel": "Five Year Option"
       }
      }
     },
     "localname": "FiveYearOptionMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_GrossProfitAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Profit, Adjustments",
        "label": "Gross Profit, Adjustments",
        "terseLabel": "Adjustments to gross margin"
       }
      }
     },
     "localname": "GrossProfitAdjustments",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncometaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ebs_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncometaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ebs_InventoryStepUp": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Step Up",
        "label": "Inventory Step Up",
        "terseLabel": "Inventory step-up provision"
       }
      }
     },
     "localname": "InventoryStepUp",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_JansenPharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jansen Pharmaceuticals, Inc.",
        "label": "Jansen Pharmaceuticals, Inc. [Member]",
        "terseLabel": "Jansen Pharmaceuticals, Inc."
       }
      }
     },
     "localname": "JansenPharmaceuticalsIncMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_LessorOperatingLeasePaymentToBeReceivedAfterYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Operating Lease, Payment To Be Received, After Year Four",
        "label": "Lessor, Operating Lease, Payment To Be Received, After Year Four",
        "terseLabel": "Lessor, operating lease, payment to be received, after year four"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentToBeReceivedAfterYearFour",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_LongTermIncentivePlanNoncashExpense": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Incentive Plan, Noncash Expense",
        "label": "Long-Term Incentive Plan, Noncash Expense",
        "terseLabel": "Long-term incentive plan expense"
       }
      }
     },
     "localname": "LongTermIncentivePlanNoncashExpense",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_MeasurementInputProbabilityOfPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Probability Of Payment",
        "label": "Measurement Input, Probability Of Payment [Member]",
        "terseLabel": "Probability of payment"
       }
      }
     },
     "localname": "MeasurementInputProbabilityOfPaymentMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_NonUnitedStatesGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-United States Government",
        "label": "Non-United States Government [Member]",
        "terseLabel": "Non-USG"
       }
      }
     },
     "localname": "NonUnitedStatesGovernmentMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_NumberOfCategoriesOfPublicHealthThreats": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the number of categories of public health threats.",
        "label": "Number Of Categories Of Public Health Threats",
        "terseLabel": "Number of categories of public health threats"
       }
      }
     },
     "localname": "NumberOfCategoriesOfPublicHealthThreats",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/NatureofthebusinessandorganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_NumberOfProductAndServiceCategories": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Product And Service Categories",
        "label": "Number Of Product And Service Categories",
        "terseLabel": "Number of product and service categories"
       }
      }
     },
     "localname": "NumberOfProductAndServiceCategories",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/NatureofthebusinessandorganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_NumberOfRevenueGeneratingProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the number of revenue generating products.",
        "label": "Number Of Revenue Generating Products",
        "terseLabel": "Number of revenue generating products"
       }
      }
     },
     "localname": "NumberOfRevenueGeneratingProducts",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/NatureofthebusinessandorganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Lease Income And Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Operating Lease, Lease Income And Revenue From Contract With Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "totalLabel": "Total CDMO"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_OtherLongTermDebtFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Long Term Debt Facility [Member]",
        "label": "Other Long Term Debt Facility [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLongTermDebtFacilityMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ProductsAndServicesSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products And Services Segments",
        "label": "Products And Services Segments [Member]",
        "terseLabel": "Products And Services Segments"
       }
      }
     },
     "localname": "ProductsAndServicesSegmentsMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ProductsSegmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products Segment",
        "label": "Products Segment [Abstract]",
        "terseLabel": "Products:"
       }
      }
     },
     "localname": "ProductsSegmentAbstract",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ebs_ProductsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products Segment",
        "label": "Products Segment [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductsSegmentMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_RestructuringPlanAugust2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Plan August 2023",
        "label": "Restructuring Plan August 2023 [Member]",
        "terseLabel": "August 2023 Restructuring Plan"
       }
      }
     },
     "localname": "RestructuringPlanAugust2023Member",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_RestructuringPlanJanuary2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Plan January 2023",
        "label": "Restructuring Plan January 2023 [Member]",
        "terseLabel": "January 2023 Restructuring Plan"
       }
      }
     },
     "localname": "RestructuringPlanJanuary2023Member",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_RevenueFromContractWithCustomerNumberOfOptionPeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Number Of Option Periods",
        "label": "Revenue From Contract With Customer, Number Of Option Periods",
        "terseLabel": "Number of option periods"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerNumberOfOptionPeriods",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_RevenueFromContractWithCustomerTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Term Of Contract",
        "label": "Revenue From Contract With Customer, Term Of Contract",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTermOfContract",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ebs_RevenueRemainingPerformanceObligationVariableConsiderationAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Remaining Performance Obligation, Variable Consideration Amount",
        "label": "Revenue, Remaining Performance Obligation, Variable Consideration Amount",
        "terseLabel": "Maximum contingent consideration"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationVariableConsiderationAmount",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_RidgebackMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ridgeback",
        "label": "Ridgeback [Member]",
        "terseLabel": "Ridgeback"
       }
      }
     },
     "localname": "RidgebackMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_SOFREURIBOROrCDORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SOFR, EURIBOR, or CDOR",
        "label": "SOFR, EURIBOR, Or CDOR [Member]",
        "terseLabel": "SOFR, EURIBOR, or CDOR"
       }
      }
     },
     "localname": "SOFREURIBOROrCDORMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_SaleOfStockAmountRemainingAvailableForSaleOfShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Amount Remaining Available For Sale Of Shares",
        "label": "Sale Of Stock, Amount Remaining Available For Sale Of Shares",
        "terseLabel": "Sale of stock, amount remaining available for sale of shares"
       }
      }
     },
     "localname": "SaleOfStockAmountRemainingAvailableForSaleOfShares",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_SaleOfStockConsiderationReceivedOnTransactionGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Consideration Received On Transaction, Gross",
        "label": "Sale Of Stock, Consideration Received On Transaction, Gross",
        "terseLabel": "Sale of stock, consideration received on transaction, gross"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransactionGross",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_SalesBasedMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-Based Milestones",
        "label": "Sales-Based Milestones [Member]",
        "terseLabel": "Sales-Based Milestones"
       }
      }
     },
     "localname": "SalesBasedMilestonesMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DivestitureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ScheduleOfAccountsReceivableNetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Accounts Receivable, Net [Table Text Block]",
        "label": "Schedule Of Accounts Receivable, Net [Table Text Block]",
        "terseLabel": "Schedule of Accounts Receivable, Net"
       }
      }
     },
     "localname": "ScheduleOfAccountsReceivableNetTableTextBlock",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ebs_SecuredOvernightFinancingRateSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_SeniorUnsecuredNotesDueAugust2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes Due August 2028",
        "label": "Senior Unsecured Notes Due August 2028 [Member]",
        "terseLabel": "3.875% Senior Unsecured Notes due 2028"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDueAugust2028Member",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Services Segment",
        "label": "Services Segment [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServicesSegmentMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Target Payout Percentage",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Target Payout Percentage",
        "terseLabel": "Target payout percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPayoutPercentage",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ebs_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan dated December 2013.",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Senior secured credit agreement - Term loan due 2025"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_TravelHealthBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Travel Health Business",
        "label": "Travel Health Business [Member]",
        "terseLabel": "Travel Health Business"
       }
      }
     },
     "localname": "TravelHealthBusinessMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DivestitureDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_TwoYearOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Year Option",
        "label": "Two Year Option [Member]",
        "terseLabel": "Two Year Option"
       }
      }
     },
     "localname": "TwoYearOptionMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_UnallocatedResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unallocated Research And Development",
        "label": "Unallocated Research And Development [Member]",
        "terseLabel": "R&amp;D"
       }
      }
     },
     "localname": "UnallocatedResearchAndDevelopmentMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_UnitedStatesGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States Government [Member]",
        "label": "United States Government [Member]",
        "terseLabel": "USG"
       }
      }
     },
     "localname": "UnitedStatesGovernmentMember",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_UntilMarch312024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Until March 31, 2024",
        "label": "Until March 31, 2024 [Member]",
        "terseLabel": "Until March 31, 2024"
       }
      }
     },
     "localname": "UntilMarch312024Member",
     "nsuri": "http://emergentbiosolutions.com/20230630",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "auth_ref": [
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "localname": "Additional402vDisclosureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToCompAmt": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "localname": "AdjToCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AdjToCompAxis": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "localname": "AdjToCompAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "localname": "AdjToPeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AggtErrCompAmt": {
     "auth_ref": [
      "r758",
      "r769",
      "r779",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "AggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "auth_ref": [
      "r761",
      "r772",
      "r782",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AllAdjToCompMember": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "localname": "AllAdjToCompMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllExecutiveCategoriesMember": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "localname": "AllExecutiveCategoriesMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllIndividualsMember": {
     "auth_ref": [
      "r765",
      "r773",
      "r783",
      "r800",
      "r808",
      "r812",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "localname": "AllIndividualsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllTradingArrangementsMember": {
     "auth_ref": [
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "localname": "AllTradingArrangementsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AwardExrcPrice": {
     "auth_ref": [
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "localname": "AwardExrcPrice",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "perShareItemType"
    },
    "ecd_AwardGrantDateFairValue": {
     "auth_ref": [
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "localname": "AwardGrantDateFairValue",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AwardTmgDiscLineItems": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "localname": "AwardTmgDiscLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgMethodTextBlock": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "localname": "AwardTmgMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "localname": "AwardTmgMnpiDiscTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "localname": "AwardTmgPredtrmndFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "auth_ref": [
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "localname": "AwardUndrlygSecuritiesAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "auth_ref": [
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "localname": "ChangedPeerGroupFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CoSelectedMeasureAmt": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "localname": "CoSelectedMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_CoSelectedMeasureName": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "localname": "CoSelectedMeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "auth_ref": [
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "auth_ref": [
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "auth_ref": [
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "auth_ref": [
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "auth_ref": [
      "r758",
      "r769",
      "r779",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "localname": "ErrCompAnalysisTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompRecoveryTable": {
     "auth_ref": [
      "r755",
      "r766",
      "r776",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "localname": "ErrCompRecoveryTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ExecutiveCategoryAxis": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "localname": "ExecutiveCategoryAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "auth_ref": [
      "r762",
      "r773",
      "r783",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "auth_ref": [
      "r762",
      "r773",
      "r783",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "auth_ref": [
      "r762",
      "r773",
      "r783",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "auth_ref": [
      "r762",
      "r773",
      "r783",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ForgoneRecoveryIndName": {
     "auth_ref": [
      "r762",
      "r773",
      "r783",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "ForgoneRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_IndividualAxis": {
     "auth_ref": [
      "r765",
      "r773",
      "r783",
      "r800",
      "r808",
      "r812",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "localname": "IndividualAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTradingArrLineItems": {
     "auth_ref": [
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "localname": "InsiderTradingArrLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "auth_ref": [
      "r754",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "localname": "InsiderTradingPoliciesProcLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "auth_ref": [
      "r754",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "auth_ref": [
      "r754",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_MeasureAxis": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "localname": "MeasureAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureName": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "MeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "localname": "MnpiDiscTimedForCompValFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonNeosMember": {
     "auth_ref": [
      "r762",
      "r773",
      "r783",
      "r800",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "localname": "NonNeosMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "auth_ref": [
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoMember": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "localname": "NonPeoNeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "NonRule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "NonRule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_OtherPerfMeasureAmt": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "localname": "OtherPerfMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "auth_ref": [
      "r760",
      "r771",
      "r781",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "OutstandingAggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "auth_ref": [
      "r763",
      "r774",
      "r784",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "localname": "OutstandingRecoveryCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryIndName": {
     "auth_ref": [
      "r763",
      "r774",
      "r784",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "OutstandingRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "localname": "PayVsPerformanceDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "localname": "PeerGroupIssuersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "localname": "PeoActuallyPaidCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoMember": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "localname": "PeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_PeoName": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "localname": "PeoName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_PeoTotalCompAmt": {
     "auth_ref": [
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "localname": "PeoTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PvpTable": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "localname": "PvpTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PvpTableTextBlock": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "localname": "PvpTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "auth_ref": [
      "r755",
      "r766",
      "r776",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDateAxis": {
     "auth_ref": [
      "r756",
      "r767",
      "r777",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "localname": "RestatementDateAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDeterminationDate": {
     "auth_ref": [
      "r757",
      "r768",
      "r778",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "localname": "RestatementDeterminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "dateItemType"
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "auth_ref": [
      "r764",
      "r775",
      "r785",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "Rule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "Rule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "auth_ref": [
      "r759",
      "r770",
      "r780",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TabularListTableTextBlock": {
     "auth_ref": [
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "localname": "TabularListTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TotalShareholderRtnAmt": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "localname": "TotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TradingArrAxis": {
     "auth_ref": [
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "localname": "TradingArrAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TradingArrByIndTable": {
     "auth_ref": [
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "localname": "TradingArrByIndTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrAdoptionDate": {
     "auth_ref": [
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "localname": "TrdArrAdoptionDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrDuration": {
     "auth_ref": [
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "localname": "TrdArrDuration",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "durationItemType"
    },
    "ecd_TrdArrIndName": {
     "auth_ref": [
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "TrdArrIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrIndTitle": {
     "auth_ref": [
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "localname": "TrdArrIndTitle",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "auth_ref": [
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "sharesItemType"
    },
    "ecd_TrdArrTerminationDate": {
     "auth_ref": [
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "localname": "TrdArrTerminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "auth_ref": [
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "localname": "UndrlygSecurityMktPriceChngPct",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "pureItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r245",
      "r280",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r307",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r369",
      "r371",
      "r372",
      "r865",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r245",
      "r280",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r307",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r369",
      "r371",
      "r372",
      "r865",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r242",
      "r243",
      "r378",
      "r405",
      "r546",
      "r701",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r312",
      "r721",
      "r869",
      "r921",
      "r922"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r441",
      "r554",
      "r598",
      "r623",
      "r624",
      "r677",
      "r678",
      "r679",
      "r680",
      "r688",
      "r692",
      "r693",
      "r711",
      "r718",
      "r731",
      "r736",
      "r867",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r441",
      "r554",
      "r598",
      "r623",
      "r624",
      "r677",
      "r678",
      "r679",
      "r680",
      "r688",
      "r692",
      "r693",
      "r711",
      "r718",
      "r731",
      "r736",
      "r867",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r312",
      "r721",
      "r869",
      "r921",
      "r922"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r309",
      "r558",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r695",
      "r719",
      "r735",
      "r828",
      "r863",
      "r864",
      "r869",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]",
        "verboseLabel": "Products and Services [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r309",
      "r558",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r695",
      "r719",
      "r735",
      "r828",
      "r863",
      "r864",
      "r869",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r433",
      "r441",
      "r467",
      "r468",
      "r469",
      "r553",
      "r554",
      "r598",
      "r623",
      "r624",
      "r677",
      "r678",
      "r679",
      "r680",
      "r688",
      "r692",
      "r693",
      "r711",
      "r718",
      "r731",
      "r736",
      "r739",
      "r861",
      "r867",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r433",
      "r441",
      "r467",
      "r468",
      "r469",
      "r553",
      "r554",
      "r598",
      "r623",
      "r624",
      "r677",
      "r678",
      "r679",
      "r680",
      "r688",
      "r692",
      "r693",
      "r711",
      "r718",
      "r731",
      "r736",
      "r739",
      "r861",
      "r867",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r242",
      "r243",
      "r378",
      "r405",
      "r546",
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r442",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncometaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r259",
      "r442",
      "r826",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncometaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r259",
      "r442",
      "r826",
      "r827",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncometaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r33",
      "r734"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Accounts Payable, Trade",
        "terseLabel": "Non-cancelable orders"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Accounts receivable, net",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r7",
      "r17",
      "r45",
      "r225",
      "r226",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Pension Plan"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r70",
      "r199",
      "r574"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation &amp; amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r216",
      "r225",
      "r226",
      "r497",
      "r704",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [
      "r224",
      "r225",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r44",
      "r45",
      "r137",
      "r206",
      "r571",
      "r603",
      "r604"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss), net"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r224",
      "r225",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r5",
      "r17",
      "r45",
      "r504",
      "r507",
      "r545",
      "r599",
      "r600",
      "r832",
      "r833",
      "r834",
      "r840",
      "r841",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r6",
      "r17",
      "r45",
      "r225",
      "r226",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r127",
      "r734",
      "r925"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r612",
      "r840",
      "r841",
      "r842",
      "r901",
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r471",
      "r475"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r207",
      "r315",
      "r319",
      "r320",
      "r321",
      "r920"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for expected credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r140",
      "r396",
      "r534",
      "r837"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r12",
      "r63",
      "r67"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of intangible assets",
        "terseLabel": "Amortization of intangible assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillFinitelivedIntangibleAssetsAmortizationExpenseDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LosspercommonshareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociBeforeTaxAttributableToParent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated equity from transactions and other events and circumstances from non-owner sources, attributable to parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners (distributions to owners).",
        "label": "AOCI before Tax, Attributable to Parent",
        "terseLabel": "AOCI before tax, attributable to parent"
       }
      }
     },
     "localname": "AociBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r171",
      "r203",
      "r240",
      "r278",
      "r299",
      "r305",
      "r316",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r495",
      "r499",
      "r524",
      "r566",
      "r645",
      "r734",
      "r749",
      "r865",
      "r866",
      "r910"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r194",
      "r210",
      "r240",
      "r316",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r495",
      "r499",
      "r524",
      "r734",
      "r865",
      "r866",
      "r910"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r91",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BankTimeDepositsMember": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.",
        "label": "Bank Time Deposits [Member]",
        "terseLabel": "Time deposits"
       }
      }
     },
     "localname": "BankTimeDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BilledContractReceivables": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.",
        "label": "Billed Contracts Receivable",
        "terseLabel": "Billed"
       }
      }
     },
     "localname": "BilledContractReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings, building improvements and leasehold improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r494",
      "r836"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent obligations, net",
        "verboseLabel": "Changes in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r1",
      "r85",
      "r493"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r2",
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Business combination, contingent consideration, liability, current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Business combination, contingent consideration, liability, measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r53",
      "r54",
      "r55"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property, plant and equipment unpaid at period end"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r180",
      "r568",
      "r613",
      "r640",
      "r734",
      "r749",
      "r829"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r51",
      "r197",
      "r697"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r51",
      "r147",
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r3",
      "r147"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental information on non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r737",
      "r738",
      "r739",
      "r741",
      "r742",
      "r743",
      "r746",
      "r840",
      "r841",
      "r901",
      "r923",
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "$0.001 Par Value Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r126",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r126",
      "r632",
      "r651",
      "r927",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r126",
      "r570",
      "r734"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.001 per share; 200.0 shares authorized, 57.4 and 55.7 shares issued; 51.8 and 50.1 shares outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r46",
      "r221",
      "r223",
      "r229",
      "r562",
      "r578"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r696",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r86",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation and consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DivestitureDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DivestitureDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Rollforward of Contract Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetNoncurrent": {
     "auth_ref": [
      "r417",
      "r419",
      "r430"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Contract with customer, asset, noncurrent"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerDurationAxis": {
     "auth_ref": [
      "r723",
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract with Customer, Duration [Axis]",
        "terseLabel": "Contract with Customer, Duration [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerDurationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerDurationDomain": {
     "auth_ref": [
      "r723",
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract with Customer, Duration [Domain]",
        "terseLabel": "Contract with Customer, Duration [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerDurationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r417",
      "r418",
      "r430"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period",
        "terseLabel": "Contract with customer, liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionContractLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r417",
      "r418",
      "r430"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Current portion of contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedTerseLabel": "Revenue recognized in the period from amounts included in contract liability at the beginning of the period:"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r26",
      "r298",
      "r299",
      "r300",
      "r301",
      "r307",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r142",
      "r558"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods and services sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Goods and Services Sold [Abstract]",
        "terseLabel": "Less: Cost of sales:"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of product sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r162",
      "r238",
      "r374",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r390",
      "r397",
      "r398",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r30",
      "r123",
      "r124",
      "r172",
      "r173",
      "r245",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r535",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r39",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [
      "r245",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r399",
      "r535",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r40",
      "r245",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r535",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Required quarterly principal payments"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Prior to August 15, 2023"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Upon the occurrence of a change in control"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt instrument, redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r40",
      "r78",
      "r79",
      "r104",
      "r105",
      "r107",
      "r109",
      "r164",
      "r165",
      "r245",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r399",
      "r535",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsCurrentNet": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Current, Net",
        "terseLabel": "Debt issuance costs, current, net"
       }
      }
     },
     "localname": "DeferredFinanceCostsCurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "negatedTerseLabel": "Less: Unamortized debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r478",
      "r479",
      "r567"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r12",
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation [Abstract]",
        "terseLabel": "Depreciation:"
       }
      }
     },
     "localname": "DepreciationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r12",
      "r283"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r212",
      "r213",
      "r523",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r638",
      "r639",
      "r681",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r703",
      "r739",
      "r924"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative instruments"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [
      "r622",
      "r624",
      "r637",
      "r638",
      "r639",
      "r641",
      "r642",
      "r643",
      "r644",
      "r646",
      "r647",
      "r648",
      "r649",
      "r660",
      "r661",
      "r662",
      "r663",
      "r666",
      "r667",
      "r668",
      "r669",
      "r681",
      "r682",
      "r684",
      "r686",
      "r737",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r28",
      "r94",
      "r135",
      "r211",
      "r703"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative Asset, Subject to Master Netting Arrangement, before Offset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r92",
      "r95",
      "r97",
      "r98",
      "r622",
      "r624",
      "r637",
      "r638",
      "r639",
      "r641",
      "r642",
      "r643",
      "r644",
      "r646",
      "r647",
      "r648",
      "r649",
      "r660",
      "r661",
      "r662",
      "r663",
      "r666",
      "r667",
      "r668",
      "r669",
      "r681",
      "r682",
      "r684",
      "r686",
      "r703",
      "r737",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r169",
      "r502",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative instruments and hedging activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Derivativeinstrumentsandhedgingactivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r19",
      "r92",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r898",
      "r899"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r19",
      "r87",
      "r88",
      "r90",
      "r99",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock": {
     "auth_ref": [
      "r71",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for impairment of long-lived assets held and used by an entity which includes a description of the impaired long-lived asset and facts and circumstances leading to the impairment, aggregate amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported.",
        "label": "Details of Impairment of Long-Lived Assets Held and Used by Asset [Table Text Block]",
        "terseLabel": "Details of Impairment of Long-Lived Assets Held and Used by Asset"
       }
      }
     },
     "localname": "DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [
      "r429",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r429",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DivestitureDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DivestitureDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r13",
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DivestitureDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Cash purchase price for sale of business"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DivestitureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r113",
      "r119",
      "r155",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current",
        "terseLabel": "Intangible assets disposed of in sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Divestiture"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Divestiture"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r729",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DivestitureDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r230",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r261",
      "r263",
      "r265",
      "r266",
      "r267",
      "r271",
      "r512",
      "r513",
      "r563",
      "r579",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per common share - basic (in dollars per share)",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/LosspercommonshareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r230",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r263",
      "r265",
      "r266",
      "r267",
      "r271",
      "r512",
      "r513",
      "r563",
      "r579",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per common share - diluted (in dollars per share)",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/LosspercommonshareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Net loss per common share"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r260",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Loss per common share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Losspercommonshare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r525"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective annual tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncometaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Severance payments"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r18",
      "r190",
      "r224",
      "r225",
      "r226",
      "r246",
      "r247",
      "r248",
      "r250",
      "r256",
      "r258",
      "r273",
      "r317",
      "r318",
      "r416",
      "r472",
      "r473",
      "r474",
      "r486",
      "r487",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r511",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r545",
      "r599",
      "r600",
      "r601",
      "r612",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [
      "r515",
      "r516",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r515",
      "r516",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r23",
      "r101",
      "r103",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r388",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r516",
      "r550",
      "r551",
      "r552",
      "r714",
      "r715",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r515",
      "r516",
      "r518",
      "r519",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair value measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Fairvaluemeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r388",
      "r434",
      "r439",
      "r516",
      "r550",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r388",
      "r434",
      "r439",
      "r516",
      "r551",
      "r714",
      "r715",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r388",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r516",
      "r552",
      "r714",
      "r715",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Unobservable Input Reconciliation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsContingentConsiderationRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r21",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r21",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair value measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsContingentConsiderationRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsContingentConsiderationRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "terseLabel": "Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsContingentConsiderationRollForwardDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r388",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r550",
      "r551",
      "r552",
      "r714",
      "r715",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r514",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r91",
      "r93",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Federal Funds Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted Average Useful Life in Years"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r201",
      "r340"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Finite-lived Intangible Assets Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r341",
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r153",
      "r560"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r64",
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r153",
      "r559"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r498",
      "r837"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "Gain on sale of travel health business",
        "terseLabel": "Gain on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/DivestitureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r200",
      "r325",
      "r561",
      "r712",
      "r734",
      "r849",
      "r856"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r327",
      "r334",
      "r712"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Goodwill, gross"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r327",
      "r334",
      "r712"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Goodwill, impaired, accumulated impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r141",
      "r240",
      "r278",
      "r298",
      "r304",
      "r307",
      "r316",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r524",
      "r709",
      "r865"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Consolidated gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Profit [Abstract]",
        "terseLabel": "Adjustments to gross margin:"
       }
      }
     },
     "localname": "GrossProfitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r19",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the impaired assets to be held and used by the entity.",
        "label": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the categories used to group impaired long-lived assets held and used by the type of asset.",
        "label": "Impaired Long-Lived Assets Held and Used by Type [Axis]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used by Type [Axis]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Impaired Long-Lived Assets Held and Used [Line Items]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used [Line Items]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r12",
      "r68",
      "r157"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "negatedTerseLabel": "Impairment of long-lived assets",
        "terseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r138",
      "r175",
      "r278",
      "r298",
      "r304",
      "r307",
      "r564",
      "r576",
      "r709"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Loss before income taxes",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r729",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DivestitureDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DivestitureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r15",
      "r24",
      "r31",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r120",
      "r121",
      "r122",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DivestitureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r342",
      "r348",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r348",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r241",
      "r477",
      "r482",
      "r483",
      "r485",
      "r488",
      "r490",
      "r491",
      "r492",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Incometaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r179",
      "r188",
      "r257",
      "r258",
      "r286",
      "r480",
      "r489",
      "r580"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r897"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Discrete tax expense (benefits)"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r50",
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r555",
      "r836"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": {
     "auth_ref": [
      "r836"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.",
        "label": "Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable",
        "terseLabel": "Income taxes receivable and payable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r836"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "terseLabel": "Increase in other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible assets and goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Intangibleassetsandgoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r62",
      "r65"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r106",
      "r177",
      "r227",
      "r282",
      "r533",
      "r657",
      "r747",
      "r926"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r232",
      "r234",
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r694",
      "r744",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Inventoriesnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r152",
      "r699"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r209",
      "r698",
      "r734"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories, net",
        "verboseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r181",
      "r196",
      "r208",
      "r322",
      "r323",
      "r324",
      "r557",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Pre-launch inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r152",
      "r830"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials and supplies"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r152",
      "r700"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/InventoriesnetScheduleofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held.",
        "label": "Land and Land Improvements [Member]",
        "terseLabel": "Land and improvements"
       }
      }
     },
     "localname": "LandAndLandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r540",
      "r733"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total operating lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Operating lease cost:",
        "verboseLabel": "Operating leases:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails",
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r908"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Litigation"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Litigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Lessee, operating lease, remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Four",
        "terseLabel": "Lessor, operating lease, payment to be received, year four"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year One",
        "terseLabel": "Lessor, operating lease, payment to be received, year one"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear": {
     "auth_ref": [
      "r909"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year",
        "terseLabel": "Lessor, operating lease, payment to be received, remainder of fiscal year"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Three",
        "terseLabel": "Lessor, operating lease, payment to be received, year three"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Two",
        "terseLabel": "Lessor, operating lease, payment to be received, year two"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r240",
      "r316",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r496",
      "r499",
      "r500",
      "r524",
      "r631",
      "r708",
      "r749",
      "r865",
      "r910",
      "r911"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r131",
      "r174",
      "r573",
      "r734",
      "r839",
      "r847",
      "r903"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r38",
      "r195",
      "r240",
      "r316",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r496",
      "r499",
      "r500",
      "r524",
      "r734",
      "r865",
      "r910",
      "r911"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Current borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Line of credit facility, unused capacity, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r30",
      "r173",
      "r387",
      "r401",
      "r714",
      "r715",
      "r919"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Total debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.",
        "label": "Long-Term Debt, Current Maturities",
        "negatedTerseLabel": "Less: Current portion of long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r205"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Non-current portion of debt, net",
        "verboseLabel": "Debt, net of current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r40",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market accounts"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r147",
      "r148",
      "r149"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r139",
      "r149",
      "r176",
      "r193",
      "r219",
      "r222",
      "r226",
      "r240",
      "r249",
      "r251",
      "r252",
      "r253",
      "r254",
      "r257",
      "r258",
      "r264",
      "r278",
      "r298",
      "r304",
      "r307",
      "r316",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r513",
      "r524",
      "r577",
      "r653",
      "r670",
      "r671",
      "r709",
      "r747",
      "r865"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss)",
        "netLabel": "Net loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/LosspercommonshareDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LosspercommonshareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/DivestitureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Debt, current portion"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/NatureofthebusinessandorganizationDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r29",
      "r45"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r278",
      "r298",
      "r304",
      "r307",
      "r709"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r906"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncomeLeasePayments": {
     "auth_ref": [
      "r272",
      "r544"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income, Lease Payments",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r837"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r542",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r541",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Total restructuring costs by segment"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r111",
      "r167",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Nature of the business and organization"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Natureofthebusinessandorganization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r10",
      "r16",
      "r168"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments, net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r10",
      "r16",
      "r168"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent",
        "terseLabel": "Pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r214",
      "r215"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized gains (losses) on hedging activities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r215",
      "r217"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassification adjustment for gains on hedging activities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r185",
      "r215",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r10",
      "r16",
      "r168",
      "r220",
      "r223"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive loss, net of tax",
        "totalLabel": "Total other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r9",
      "r137",
      "r218",
      "r440"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Reclassification adjustment for gains on pension benefit obligation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": {
     "auth_ref": [
      "r10",
      "r16",
      "r168"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent",
        "negatedTerseLabel": "Tax Expense"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r91",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r37",
      "r734"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r347",
      "r835"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Taxes paid for stock-based compensation activity"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r125",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r125",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r125",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r125",
      "r632",
      "r651",
      "r927",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r125",
      "r569",
      "r734"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.001 per share; 15.0 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r831"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Gain on sale of business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from sale of travel health business, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from at-the-market sale of stock, net of commissions and expenses"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r8",
      "r22"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from stock-based compensation activity"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product sales, net",
        "verboseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r154",
      "r182",
      "r186",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Propertyplantandequipmentnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r156",
      "r198",
      "r575"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant and Equipment Income Statement Disclosures [Abstract]",
        "terseLabel": "Property Plant and Equipment Income Statement Disclosures [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails",
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r14",
      "r565",
      "r575",
      "r734"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Total property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r29",
      "r45"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r59",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r59",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r49",
      "r838"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Principal payments on revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r49",
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "terseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfMediumTermNotes": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.",
        "label": "Repayments of Medium-term Notes",
        "negatedTerseLabel": "Principal payments on term loan facility"
       }
      }
     },
     "localname": "RepaymentsOfMediumTermNotes",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fair value of reporting unit in excess of carrying amount.",
        "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount",
        "terseLabel": "Reporting unit, percentage of fair value in excess of carrying amount"
       }
      }
     },
     "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r110",
      "r476",
      "r918"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "negatedTerseLabel": "Research and development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "R&amp;D"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r344",
      "r345",
      "r347",
      "r350",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and impairment costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Restructuringandimpairmentcosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r346",
      "r349",
      "r353",
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected restructuring charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected number of positions to be eliminated as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Expected Number of Positions Eliminated",
        "terseLabel": "Expected workforce reduction"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated, Period Percent",
        "terseLabel": "Number of positions eliminated, percent"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r12",
      "r351",
      "r353",
      "r862"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges",
        "verboseLabel": "Accruals"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r346",
      "r347",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r349",
      "r353",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r12"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails",
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r347",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r128",
      "r166",
      "r572",
      "r602",
      "r604",
      "r610",
      "r633",
      "r734"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r190",
      "r246",
      "r247",
      "r248",
      "r250",
      "r256",
      "r258",
      "r317",
      "r318",
      "r472",
      "r473",
      "r474",
      "r486",
      "r487",
      "r503",
      "r505",
      "r506",
      "r508",
      "r511",
      "r599",
      "r601",
      "r612",
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r279",
      "r280",
      "r297",
      "r302",
      "r303",
      "r309",
      "r311",
      "r312",
      "r428",
      "r429",
      "r558"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Services",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r189",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Revenuerecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r183"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r228",
      "r240",
      "r279",
      "r280",
      "r297",
      "r302",
      "r303",
      "r309",
      "r311",
      "r312",
      "r316",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r524",
      "r564",
      "r865"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility",
        "verboseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r45",
      "r904",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r92",
      "r97",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Basic and Diluted Net Income per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LosspercommonshareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r64",
      "r66",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r64",
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r712",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a long-lived asset to be held and used by an entity, the table may include a description of the impaired long-lived asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported.",
        "label": "Schedule of Impaired Long-Lived Assets Held and Used [Table]",
        "terseLabel": "Schedule of Impaired Long-Lived Assets Held and Used [Table]"
       }
      }
     },
     "localname": "ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsDetailsofImpairmentofLongLivedAssetsHeldandUsedbyAssetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r32",
      "r132",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/InventoriesnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails",
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentnetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r349",
      "r353",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsNarrativeDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r72",
      "r74",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r73",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r275",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r312",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r349",
      "r355",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r712",
      "r828",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r290",
      "r301",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Segmentinformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment, Reconciliation of Other Items from Segments to Consolidated [Abstract]",
        "terseLabel": "Other reconciling items:"
       }
      }
     },
     "localname": "SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r311",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryofsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedTerseLabel": "Selling, general and administrative",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails",
      "http://emergentbiosolutions.com/role/DebtScheduleDetails",
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/PropertyplantandequipmentNarrativeDetails",
      "http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "terseLabel": "Equity instruments other than options, forfeited in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Equity instruments other than options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Stock options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-Based Payment Arrangement, Tranche Three [Member]",
        "terseLabel": "Tranche Three"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r871"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting rights, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "terseLabel": "Nonvested options forfeited (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r150",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of significant accounting policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Summaryofsignificantaccountingpolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r191",
      "r275",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r312",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r343",
      "r349",
      "r355",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r712",
      "r828",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillGoodwillRollForwardDetails",
      "http://emergentbiosolutions.com/role/IntangibleassetsandgoodwillNarrativeDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://emergentbiosolutions.com/role/SegmentinformationScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r18",
      "r43",
      "r190",
      "r224",
      "r225",
      "r226",
      "r246",
      "r247",
      "r248",
      "r250",
      "r256",
      "r258",
      "r273",
      "r317",
      "r318",
      "r416",
      "r472",
      "r473",
      "r474",
      "r486",
      "r487",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r511",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r545",
      "r599",
      "r600",
      "r601",
      "r612",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityTaxEffectsRelatedtoEachComponentofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r273",
      "r558",
      "r607",
      "r614",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r632",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r641",
      "r642",
      "r643",
      "r644",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r652",
      "r654",
      "r655",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r672",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r273",
      "r558",
      "r607",
      "r614",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r632",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r641",
      "r642",
      "r643",
      "r644",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r652",
      "r654",
      "r655",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r672",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r18",
      "r125",
      "r126",
      "r166",
      "r608",
      "r672",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "At-the-market sale of stock, net of commissions and expenses (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r18",
      "r125",
      "r126",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation activity (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r18",
      "r125",
      "r126",
      "r166",
      "r612",
      "r672",
      "r689",
      "r748"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "At-the-market sale of stock, net of commissions and expenses"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r82",
      "r125",
      "r126",
      "r166"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation activity"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r18",
      "r125",
      "r126",
      "r166",
      "r609",
      "r672",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Repurchases of stock (in shares)",
        "terseLabel": "Stock repurchased during period, shares (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r18",
      "r125",
      "r126",
      "r166",
      "r612",
      "r672",
      "r690",
      "r748"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchases of common stock",
        "terseLabel": "Stock repurchased during period, value"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r126",
      "r129",
      "r130",
      "r151",
      "r634",
      "r651",
      "r673",
      "r674",
      "r734",
      "r749",
      "r839",
      "r847",
      "r903",
      "r927"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.",
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityChangesinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r163",
      "r239",
      "r402",
      "r404",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r510",
      "r675",
      "r676",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity.",
        "label": "Equity [Text Block]",
        "terseLabel": "Stock-based compensation and stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Stockbasedcompensationandstockholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [
      "r532",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r532",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r532",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r532",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r532",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/SubsequenteventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r547",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/Subsequentevents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Ending balance (in shares)",
        "negatedPeriodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r42",
      "r80",
      "r81"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost, 5.6 and 5.6 common shares, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r346",
      "r347",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsRestructuringandRelatedCostsDetails",
      "http://emergentbiosolutions.com/role/RestructuringandimpairmentcostsScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Valuation allowance, deferred tax asset, increase, amount"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Discounted cash flow"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairvaluemeasurementsFairValueLevel3ofSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockbasedcompensationandstockholdersequityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r262",
      "r267"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LosspercommonshareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted-average number of shares outstanding-diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/LosspercommonshareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r261",
      "r267"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LosspercommonshareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average number of shares outstanding-basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations",
      "http://emergentbiosolutions.com/role/LosspercommonshareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/LosspercommonshareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205-20/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org//235/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org//360/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org//470/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org//505/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org//810/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org//815/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Subparagraph": "b.",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147481160/942-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org//606/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org//260/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-6A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org//280/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org//330/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//350-30/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org//420/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org//740/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//842-20/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org//855/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(4)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "47",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r751": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r752": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r753": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r754": {
   "Name": "Form 20-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "16",
   "Subsection": "J",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r755": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r756": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r757": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r758": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r759": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r761": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r762": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r763": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "iii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r764": {
   "Name": "Form 20-F",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r765": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r766": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r767": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r768": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r769": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r771": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r772": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r773": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r774": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r775": {
   "Name": "Form 40-F",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r776": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r777": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r778": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r779": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r781": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r782": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r783": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r784": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r785": {
   "Name": "Form N-CSR",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r786": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r787": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r788": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r789": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r791": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r792": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "vi",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r793": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r794": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r795": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r796": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r797": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r798": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r799": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r801": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r802": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r803": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r804": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r805": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r806": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r807": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r808": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r809": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r811": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r812": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r813": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r814": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r815": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r816": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r817": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "F",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r818": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r819": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "A",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r821": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "B",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r822": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "C",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r823": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "D",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r824": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r825": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(3)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(18))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(i)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>135
<FILENAME>0001367644-23-000155-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001367644-23-000155-xbrl.zip
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MXI!,$/B>ZBK#F#!@RG$)L*:8;/IP-R.5$:SU!(HU"MR=J8'V3/' "4M4&@+
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MTG9_WV_R(\?S[;7\C#AQGR__ E!+ P04    " !3E0A7P3K29GQC @!$_QP
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M.]H7/J3.94]69O1O%3V,SCNED24O9&2=$^&+OI!\^)1&'F=(R%!>< ;)4+Y
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M+O7#9^"'+A0K_;")93FX5X-?(TP?P6T+17M'#YI<5$HQ<M02-$)I&N%2YJE
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MB@+ATH6GJPAR*A!I"Y=Z/&E%D!<*A,MD;F9(^.'1*8*<G,*V< G+DX9 +NZ
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M47Z#L<]32JES6(_X\L1B6=O<>*'(S.OQ%%#0"RJHHU:#C?MG[Z5LUE'@FJ<
M >'8R8T3FB\5@K%?)KY6 K[J)O@#[B^EF]OKF#0V7X7D2RR/_!%WOL>E"\1L
MF3>V/RX;CE<.'PB6!,P#/*LZXU2]U&VH9^UJZZRJS79&1D/MQN[ZQ":8H'9\
MVRB'!!_P/Y\/17YW=)C-J/%O1X(C^_5@+=CE*UW.G .KLW&++:PF3J!8SQG%
MI/<S7=G4*I2(ZOPKI.\ZEN^M_LI^^F"E;>6%73"#[XS8W(49TG*?4?*S3 8>
M9>?$>B%3%_>LQO?[JC?R[/>U_():\M)%M5-7&W0K%"9K2'45[2J^,)U'1 -/
M3-_8>H5GD[%IG&F8A)G43:AR19K=->@P)6@[5;BQ/_4NOEUA-X3+N]NGJ]NG
MU?W95N?B"[A5MU%I=9J9Y[?;S4J]NOKRUMGX2J.:K+93M$UDZ4M+=@!\DM*2
M8'#@8(1[',_!+Z ,[RIU[PG6?F2RPVSUYKGT._ISI,@7(LQ8E!%#A_,O"7IR
M5I&5S%-N*LKU++2[L0-/$Y[ZY1-Y:TFS3SK/N+UOGL:Y?7GQ-.584O 40C0\
M65-1*RNXERW3WGR_C#?//;;0/2MW5H5TDKWIV3L7U=E9X.X^>3TS0KEJY!7I
MR+R9"%%U6OXUUJO5-U$E-N IY>.F+-VZ#Z6?!V)B]L=+C5ADC=C$\GVD*F:H
MY^=0PR\7Q )%297'$:6>^U]_:6NJ]ID+7U$GBBU%%3RDNL!S"#*J/)OQE>I!
M__Q:D&?%>6G2C!7 C#6E&9-F3)JQ##5C9Z49FWOYN#QQ-PD/%(L,VA.\@RK%
M-0DP<9[9-E^+/8GO#M^@<!5T&R_R3 KO9726O SI6!3(L0#6-:5C(1T+Z5AD
MI RQE"Z18X%%0(R.\!RSYP+[$SC?;X[K%GH"Q^':X4P*[]KA)([#M<.9%-VU
MPSE(UZZ0KAVRKB5=.^G:2=<N*V782.K:$7>D7%O.2^$707#*X$X4>OS*D;@3
MC2-P)QK2G2BJ.P&L:TMW0KH3TIW(2AFVD[H3?/^9B]O3^&:ED6/!V]R_*5=_
M^*8W/9+D1?L8DA?MHTE>M(_ VVA+;Z.HW@:PKB.]#>EM2&\C(V584['ECP=C
M\AQEA=LA*]V+JS&1OVI5JDRYORGC/6O5<(.3)C<X'2M_OQ.;#+FZ_YNK?#5=
MW0\.+D>ON6<3:^J:/!"=VP<T($%#&[SG@;J^];9<4AJ.8A@.CH":*BV'M!S9
M:A;LB<,M1TU:CF/E[S^Q[9CI\<X[W!3 !U;T.UH2RW%];/33ZSN^IWPG["?U
ME ?3_2G-0T', [*Y+FN$I7G(6GVT0O-0WZMYB-,%TD(<CL40*7@,N,BMPSUS
M=&J@09#JORCJOY5>_6L"JW_9)4GT+DFU69NDFXIRQ]NXRAY)A;8#-=DDZ>CY
M^XT.B148>'Z&F+3P1;'PR+VZW"D@M7[66J$9:?V>5/O'RF!,Y2G71/<<)C5^
M831^4VI\J?'WH! ZLE;@V/G[PPZ.Y:!XP.\CL8)#'()*],7CLC'=]\.E>#$,
M"J1]*(Q] #ZWI'V0]B%C_5'79$7 L?/W*QT07@SV8X(GT%/;=-B"79 VH" V
M 'DI;8"T 9GKB,9!EOVE#<B1O]_A.Q ;#"B$! M%8%+W%T7W-Z3NE[I_#[JA
M'>K^AM3]Q\K?I 4;4NL+I_7;4NM+K9^]5FBHH=9O2JU_K/R]>AV9?5/N%B^,
MLD>FI57VC>-5]GE@1G;8.#9%V,)FF4.;>#+;4215"&QKK6TV](D?!!Y]OD#S
M<!AU/!1\XKA\1_PYHQ;?_S@_"_P_ESD5GB1>G7^%]%T\>W[U5]XQ=TF&U?8J
M&:[R/\NTOV;$_@E45'YUO)&I*Q>.\W,WEK]MJ;7P-\[!-'XI)3L=.?S2B,WE
M8DC+?4;)SS(9P+3/B?5"IF[IT_(!\*9=7F3%*BJ*>]C]U?>KAU^O;I^4BYN[
MQ[MO/YYN[FX?E9O;RTH<:5=.Z1"Z/'X"][V')WZN]<UM[_;RIO<-!G]]]_"]
MAS-9GH. H[_L<8KW'GY3;N^>KI2'JU][#U]O;G]58 [_AA_+W^[N_AM_?WSJ
M/0&S;I\>DT]J$66_^ZYG#J8[B&^FROII9+JX9YL!]*VI\D G#O,4QU:N'396
MU&KYGXIIZY9OP"L'#GLAS"A;H"_ 5L%09TTJ7TS0)+;BC:@RIL3&J\Z _WK/
MS&>X;;$RZ!O\,^2J&MZ':2*EIWMXO]KI-"I*S[(6'GVF.#RAY(TX<1;;8L+0
M/8>A550&1/?.PI&^&1JC0Q@T'Y'/E(&/MEF94,;S4[9.SY2^[P)=7!>^!1:$
M#J?PSED7DS-E,&MZ$JGK,WCH,[7]L,J)$H8SAELGS/F=ZMA)2W=<+_C G< G
M^*,%;.+W.WV\"0P$G\5XUGM%(3"RU42N*/^FRI#:,#(+6&4B= !)Z]C2GRHX
MMZ'RXC##52SS)U5*N&%?-R=PTUE)*?6I9<)D\$<=T&+"K(*??<O 'RC =1S>
M2U]Q+O@3O)/JQ.4_#QUBX;\FJ$^;?V=,IO@/SIC_RZAA!M]S1]%S7TR+?^LE
M_  )XYJ <,(4> _X3]B!!BC$E&?"S( 9B"A&G<$9AY9-AT&?@=FG?=_#7USX
MB+*QRPEJ._PS>"B @Q^U@PCEI(](R*GFZZ,E8E^O)BL^MD^P>QI &%$%T&;(
M0$Z"$#:<L(,0(9QPX1SF@ S!B%C"-_[F^$I (+@'M,6?.#,"3QTH@3O*!TI<
MUQ]/@D<!O& ^@$\=1H!2!M2"NW_:SHN-/_MV\",SW9]N\($.CB2!<:(@(E^!
MM/BF,P4DR >,L["5#P> 8IB# 0A?="/ ;L"<,9_SXIR"L2-9."L0'8I.?+P&
M1.(<<%  =(HS\2F\Q3+Y4<&\@= :#"L(2A@O/ :?;-J@'];>#^)&<*XVC)6X
MD18R.'%LY07\G=$;7BLF4L+@[2O.$"9TXN%7&?W#-['($:3((B]GR@L\Q^&S
MX>SPR$_*!^_TK4B?P33]"7_9^EG!?4 F"P@(*'X!#LZRY6<A')!;NLET?PS?
M DJYE2.Q-\!%CA2BV#X_BQ@%<8QF!Q035^0.<P/@!Q@$(&$9*4#N#42!B"OP
MZ8T<%^4"U [O:P@<Y#Q?K2H7C >(PMA!<X%8=L\3DAW=O*4XN];<S(CR:D[$
MN3R/0 0\7AO5USUS5G%"39A]:&M:<Y9^.#P8ELFEUBO-)A(#Q94\$S $?=/"
MFF+ QX_*8P6B%0B";2X^'TH_'G\M?00%:@>*%(4%7L< (2BX%N<ZZASF@&8,
M9 Z>@R :HS$"% &XT-\'8\!K$Q:]A\O?KJ]NO_YXW MMFI5&(N*\BR8]9W)>
MKO%OO\T&@"T*\B9/WY7\&%KJ?NC9WHB15^5?8)&P!J1GN [K R\^]/[5^W@&
MO__N/X.<4^,C.D?TV71\%Z0V,%.@='O_:G6JG3/EPG2>\$G%8\%__45MU7,4
MJU)76<F&CT%'O\O>=PV&(&F[#6T?QV!G)LZK\B&@KDD^1G0^@]#FF7Y<LA]G
MB.H7"C$-<>-UE $&WW(FD8Y:H9\^*](0'=80<8\CM$' IC&E7N#L.^.QZ061
M 'S^!V]X-N62!9<FH6,+T3#@9&9TB.VC:P,A,")C%EU^EDS-E:D00CJ>R?UU
M(^AG"I('OL6RX\# P; LYZ4,'OY<A-'I6.-0@)/R_?([."GP*,/'+W"?=D2>
M,1:=\,@"GH!Q,,2*P4<PWM6(D/S/R+M$ ::,9W06'<U%#Q!O\\QQF,=:O@M%
M&BQ4&>XIASQ7;GL/E[U;:5"W,:@@<LZK U[*WR]O/BJWQ,7V\Q-&IE(YYB <
M$(J3(!M+@F2CJ8/UPJZ=0?X&5&  ]@ Z:]C'+6*8X@J^HKBX7?04V=HG^L\A
M V5AE,/1#/B?SR(9PS I'F2W0E<G,G:8X.=:$8SC&D6)2=P)U<T!)E[";">J
M([P3/5T+%!,S3Q,#0K&:.<^F06<,7@I"D(O+#NN'TN77[W?@R\"0GDT]6 L*
M$JO+W_OD+/JZ?/-WZ/Y$5Z-?=?B=GSKB1CZR#JQTP#"["KA)L^2KA2\(UTWL
M^<> .6[")))RR<_-4W.+:@(3MUP%^!,(@Y"3&#?A:@/\?S$XXMHD6C09.LY;
MO$WP:1QGG.]\ 9#1H0^JQ&&+"7?)?F$"*%S'0"VQ8#20>>%"';\)5T@ ,@.?
M<8XN!M(+^9# 1;? X0X+>OAS##JQG&F4)-$)>"G!$#"A'[D9"Y[],J#F)HV^
MFBZW1\MCE3C*%T?(<%P-8]0<]WWF!I$W6AE&7F;K.P&D)F2&@] >*0.*-BE:
MF@Q8&YD3R=H<+ 2;GP@SH798DS$[NE2QYB4@R-'A?&G'M)^QY"!4[Y$*,<%Q
M</C:.HAV%*($:^]1]89D<]X2#.9].@\4PB0G5BQ@'#@KHM&!U_"SM[S C@]C
M]-FQGO$;.E:,\,7@X/$?\(&EA]GUR^#Z=7B]%*QKX#,P :=8#I#HS9>?\,(W
MO##[5K#@[SE#RLW1;.0KWQ.4G906>UK@"7I+-T%P4_JXE/3'8=4J[5;C/Z-N
M&#]L-_QN<" ?5D1H5:T-?G;\':6/$MWYHAOT&6""U[> MN(8=;"6Q@[R_U&\
MBVG_T".>GZHXQ_YB#5'DV+Z8+L7J!/!VW8&/)0Q!11A_CF6"B!@X!GPP0]7)
M12THU$)TD>7A2)SD8.QBJ@QBPES0<KBR@$:,5U\%/NE"6$-\;^2$-9)\K0 T
M*#C(B];QS9O"8J[9$L1LJ6'"4(L 5'[8YNP\<5>YQE +D?>5^4.E9XQ-V^1%
MCPC=#YS$U<_77WO\)_7SQS#SQY5X,+@_PR*E8+4+ CAWX@3F?7%H,-6%0<]F
M[/B>BUF'L"@+JSHD7O/6:U&A(0TK^M >4YL.3&]6/8=IVPC8@)9G:BDC^!Z8
MRUGI+#SJ@O!"31M,%@,XR@7K?-/WW =C0V*',HNNUXC80XJ>"<BO[6 QJ(&&
MY1\0*Q-00'A2NA3(? 5R5M:-&I;HW$/FOC4P$JO4(HFC075YH.[C\ZK<AKC
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MYLR: ]BLZ-!*& Y=CY)#W7FLJIHY.J6&JPR8,][0ZX0GP)434]E9:NR0UM=
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M9&6$DFP%^-&?3"R*%5?$4@S3U2W']1FOC^$6=F Y+XII!TOT0/;5B\'I^@V
MDZ$8CH\G2QRFX4"B%QYG,=0E[\\35;6:(,[H)^T2LA1<:2>:XO'H[(WGD02
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M]+5*7?6LUDY]@GU.\K=-*Y>ZV M,JX\MLAPWR8)OQBG%55U:"Y13# ^HW1G
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MRZM&H[7W,QQMN^'4]S.:VI;$Z>QG./7MAE.K[F<XC2V'H^YG.$W<?E6MOM^
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M_VJL,]4.4W$8!5L%6P5;!5L%VU<!VUKF_+.WPQSJ.))8I98H,CMQV.[3;CH
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M,N\T-O5CX P:T!#Q2?H-%N$"+8=-C?^T^"S29CR0]P-S86_+:&2#C5_^UR@
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M;]P+Q.B]?SD26L 1L]7K(3#$*82.>Y"5]<@96[VT)=<Y9G->=,K:3N T*X%
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M ^_/V+,RQ0"PW)^".F%SNTPQ:&F+I.:0$63%@2 ("^0$@P>S.)KX >S"UAZ
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M<BW4M(OP79AW8S]M0:W),P/QZ0<BFYB<_=2?A%(LD<4%*6>GU$FR:82Y\N@
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M;>BRG^'U>J?56Y,UOOE)?<900SR]3@W%PM%]2RVJVH?8:UP.*L]P,<\J3^(
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M3-J;]3*ME:0P@ 4-MWKL^FN=_O[[N>)B]<T6I#(J=LBH(&:].JM"@;0*I/?
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MK5.W-1SV3R4\WV_IIEKL@1;;50VS]ARI3]U,WU?&I!4$U^<ZI-&(KU71" 7
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MZ9V*HIAKV.+=F+J&8=M7'CPZ%@_O?=>NS>",QJ5NK,RSR9C<V.5P 3F5%DX
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M<S71:*.:V-E=353DILCMM9);N9IHZ(W+OC'874U\)M(ZHP8JUW$(+^>!J ?
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MZ-8<6-@#0RAJS'X$\,#>W-B*8HG>0!&%I]4R5(^7#]S$08*@?\4L@ UB\RX
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M:WAB"QOPA5?^>V2CGF_SZCT/?S[<K&ZS[0XR<KVPTA]4#1SOB=GV%#0(WKP
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M2G?8'Q]D1'>U5<5F3[79@7*4X>=;6[]-SFZ \R-MLO&%-=?XL-9<XZ"CL M
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MP=52&'^*$53#'1.H&C7*2&SQ0K:8&2^1=X5&-S9;5MX;YO.&*KK&Y]],UM?
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MB1%8Y'[VP)3B=[+$:C#T.5BR#[SZW8I_^0@KO;,<_4?"_>AW) )>R1(6]=V
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M#&?$@(]57=\LW8U?(A'ZEC0FDP6NF17*N>\LB\?#H8BN^,;T@4;T_ X.E':
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MQ9X0<55%''B:U%OK/G0I6.\T6S/ )PQ<+P ODW(.AK M;<I=&'!97<(T"S6
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M"8ZUCA/2IGQN+U4[,],&1L-@9JA%D2I= IX8OM6T<> OU3G #E3]8\QR.=<
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MA^8,H8["XZ+KS, "!BB Y6E%CXE?9?G"&.U..#WP*,9QKBW'^4%S V)(,X_
M?G:L9Z UT_O!UD&'GKI1& _J2O_C!"%)ZF VS *+GNC9!$9"V'4>EH3B\"L@
M"Y 2NG@?^8L_\Q<_1"\&(Y@DO&, U7]'H$HC];\C(Z;S'?8H?02C H[_$"Q
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M;JT]@.P7!]N33^%7ZQE>KSH8K.R\CL.5T4KGX3'_2:B/&GMP"9I8EV SE-6
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MKPF>7&HEKL%K+8C?E>X!$LF/X!'0L[!5E#:8II,\41R1PM3H$+CZ1C(!NT?
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MQQ&GYNDO[!#D@X>YFV:@,&6X"WB"[$0'H%8WBA(J6:Y)Z(8CI;%D6BM/A01
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M$(<$CO'U:4^5&\"; U+Q8(1.S\  @PI_W6DW.X[\#9DG,#'P?V2',;.#T.S
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M&</A3"*R.K40,W-#T\+6;IV6I8F$K+--(<N$XEQM1"A6S((@U^^2Y_Z=@<"
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M89"/>Z4Q?L3 7 O\)!:N?K,QSTJ>*;$$7K/_LI97:3!&I9Q$.%<(*.KD@ZO
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MO6[Y@TN9,N Z')L^/^3T^>GI:7/^#,H]2H#8]/DN7<5.N[6 5:Q#:!W"EY!
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MK?:CVBSJ4Q'R! [#C>R[ 9$>PC)PQB ,JV#!"0TGHO>C&F=-C4<[D %G;OI
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M29@HV'T'QOVQ0=W LLT2@C#"5JF[+.;IX-K*HA**847FF^60\L&;L.J4Z=R
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MH@ \E823-C\GL$"!)^[Y 8N*\U4?,ATAG:O.)#1P7H-&P6O04R FB8)[8\*
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ML3E&8##(C1N@>,E(<0\<Z+,Q'XYLO:3/](4B(F.+YX_T502);KSJI$/'7S9
M)EE_[*>)L=?"!OT$)P)@ZLYK\++1:<1.M3':F[]D],*/QU\@)\EW$F@3=@1&
M7J*:W9CL1-*K2X@PXDPUV.+&P/=[OY@79",@ORO*)"(0$:4Q\TO[1%$]4T%2
M#QN4LQ!L(<,:25NJ@C!33HU1$FEB8%?G,BE=$OGS*7FD%ECV:^%3Z#[ ^UR$
M]:3C0OL+YY20+Q"+.S?VV)>7A,E%K.E\TNLB%KD+@1L2E?UXG"F"8-TQM8)
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M3 F;[")P<I_'F1FP;0K5/></,OJ<YE6IW,*Q5QSP+%[(43B,4-R"$&_KN&>
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M< 4QCRTOXMC1+06(F&#<P'N@+0B3U7W/?'370X7O(H538EF!M*&IP^)454!
ML'%YV0 >*54URDYD>7$A)U6KRPLY)=DL85%1*E5%QX7\6Z%$]H54]P3B3H;L
MX&)FC ECL\]UE;?O83[-V\!E8R8@>!*!W^(C*]3?('"N#A68)?+FT&690]4
M+84'9SEAVY7F#U'\ _VCK_^\39R1JXK$/7G;.D#\KH&?C'7*N5!$/LQB4MWZ
M8PV&#U=I6[=A<A"<=!*%H0B,)*^.6XB=U//P[D,"!RJ%U'!"<4=WM<5.Y&2$
MZHSL>,-@)GY%,5'MIF1%) >254@)BMIRW@[<M3S#A&9X\(C&*&'$. QS![Y'
M,0RH'7G#E26-@GHAAR$D'AH@0F@?1YA'[.JQ1U%R^J.<KPRND,A9Q4=K6*:
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M_:(DPJBT5=0-'\8@7%,3S.K%M_<77,<K[D4L(<=2SJ,462P(> PO^ZN8:<,
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M-ZH89Z2J3X%<,JS.E]Q0P%K.Y1K]-/3\6)X3OM\#-D%8K-E.']]-Y,!'II<
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M1(\%/A:D/HH./,*-'P,N6C0%B&L)B*'SMD_"T(%'8!4AN$P(#O@@U!TH,8;
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M2A%U&V"YD<!@I<>IHXA@#@20,##>.#AE?VA[^4%N@V.RVA.F4ZI;?ALDSQY
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M+>:+NH7F]LAZ[K!^I^5\;KV6<ZYQU9%<+KP/J?.FZS0AGN X2P5@6R,6%H4
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M2A#B>ISD]@SV&WE\0P=9&.^?5>DZZ,3C31Z=!O_(@&>PDR-//M:K8<ODNB'
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M6WM):T%_9&F)6%3.?2HK9Z]$*9V+L,\784\A/=K3-=_QL#O8>F*1? 1,>3^
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MB-:FRZ('50ZOH*V*=";%#4 :RHB\*6=/.<X:L3H!(.E1X<I0/C8X2D1WY+N
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M>QY5O6_RT)2/$=ZI!(NO?.QQ(>@3!E.3R"1YYRA8NOI#L7,C7C/&9/P)Z;4
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M5I"9LKL*TE/".F#U/.[Q\ZTR8:$X.Y2(3=R3XU"PJ0[N<YDW)&8I7079R*A
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M1;.:?%^')Y4O;#5HNLCGPIX(,A'6J]1$^S1?JDG[W\^>?'WX-%B<Y1)MF\@
M_:.K"A[J/SW)P.,2F=!C\#6M_W][7]K<-I)L^U<0OGXQ]@N*)K7+OO=&T!+E
MYATM'E'NGOGT B2*%)Y!@(-%R_OUKW*I#00I4M9*8R*F6RV!(%"5E965>?*<
M-$UNO&(*__%^J]5JMNA#ZF;&75T(Q7/AOL\=7Z,)9>"QWV_NM)J;^I'0:LQ;
MT+<2S_J<AVUZY['7*<9 !KR'OVIA]5T)MM#( *,B=^V^W]Z9>7A_/ 9"Z-PN
M4)C,V[R<AR8=>+^ULU6^)1<\8+-@NGCF]T00//NI(+F)%X]976JHCW&_>HS#
MY@:(*1I <*.(=!$C8_740P&?W/3AT>FY9AJMT[<O,%N<>Y=+53M+BY* =DJ*
M\XC?<8R)4RM/JI;=W)QI6,_LB\QL2>P96FI'[K%YZ$\AB /N-A#>TA0X<"DB
MS$(BH# ?JR?R!292UUNMGK/J5$L]/2\P/=E0GA<:U$V.X8>#_L(V!SZA.*2Q
M.E*J)^V9)ZVZV .G>MTG; COD#M0$^'-4WL$S@/S-R1,L65?58AJ&X!B'ZBG
M_W5$/="E1QI#KGP0)YR ZIR 7R@U9%_.,[E*]T4]F8\XF=K'SNKI&B]K5P/4
M.41KOS:L(TF @D2#XMEHW9\\_>.47Y:OJ9@+2^D(4CIB=6Q*M&ZH1*LCSR=2
M,;A#5BL[+PRB)"9;>\-5>"18-FE@)WVKPAU+.U!3/"G>6+O>A'(J0THYJ@R[
M^PR.M*Z?HAP8W9B>9PIZ=)0_))4L#2N-<028'" "IOMTI7(5XN^ U ;5_XS<
MG96*LM/G.BWE/B43^TY01R2'H8/<.#+7^W>0Y[0I?L-L#KVO@;Y79;=U'XKF
M^[62UE8LNM9Y:X4R4[NUT=AKZ*1UZ1H86H8UEJ0P5;M/PV40QX89TM=15@IH
MMY=D GL[<[I81A%B.92^! Q8.%'=4K$_5CAO"[9(&$, E/@@.'%' J6$,50R
M _K:[,:?9JI;RM('-;/)JQTNQ(:JU"Y6.'407)!RE9+ZA;QH#JR2NJE&X:V\
M"GY!(G_L-1O$C\4@2C(GS-(BY>_,HVM"=\L4L0>;<)8^%T]LXX18V1*4TOY3
MT?59_AJ8!^6_+(R\Q6YBZ/V.2)H1:H@*E0-Y:KE6XL;,]_\MJ^0HI89*F"C"
M]*7^- R8C1>G1SK>/$+'';*6W8UN$3184T0(LJ"FQ;F.[.#<O(5 AK*.;,7J
MY:( .%?B8%'\Q4;I0.O7.$6KBM<K?2<1X+B30"@8Q^P& JA;H*:# E\Q$;F%
M$6?+!W[\$YBA0:JG=!A2]"^X&7-3IG1QW&(%VP0RG?G&[K2:3VFNE"OCD<:"
M'"E $P..*D'SOFI_^NUXG]7[C)1JEUO6,,610I/)6V5E+=B+XTZE%OF[H3QO
MSC5HU)/1*3[T#;$0 2NHSLK+NQ#^*H&E,93EW$J+"A0K28(7VK2E" UZ3^HQ
M!3^W*Z\2A%%A-V*J:K(E8[HFI=K.G-IC0U4QBUA5P07W%NHF0["L:WF.X2:H
M]_O[S=U2\1'YG %]8@/<EBJH8CGSH+FEZJ= E)8E5JW4,X]*82?0[99KKE:4
MF]Q3CL2'+961^3.SY6DE@811EC08U@G9,:K6]L$D!$E?$F6E[^SHXTA'_C/
MG]1"52AOWR)IL_1<&](/RXU5[BYR*=TQC0E^<L(9!C)H ))$O-G'WON]G69+
MOY9J:T TO S351$=[D,#\0G9-=4IS D>I$/M3-,P4N._S9$_[^!*.1>A)_\N
MI'L5(*1BBL]VWQQVW-Z&$SI2O-]J'MA#7XT,* 4A]G<J76]AGH>.(TY_8E(
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M0;L/Q%H"@^" !27$N^&*P7A0GI?D36*KQY;.;)JU5\:TJ58%POC7U&T#JP<
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M_% L'.ICEAO>GQ'LM?8J:M W;RD_IH=/]5:+<)I3C4"E3%0ZB\[>12ZG4&$
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MLW:2"M)9B8RFLP:C)7V+((!1)S:"TNZF8_]29J!&RD)X!MT=]F9FZJGFQ9V
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MJKH/R?>^F33]BL6-KX*J9L V0VK;P%U'I!)3+$E= S%H8*6G,\5F@?P1A(?
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M\O^!^F*>L"9.V*<\F/W;?G/W8'_N7UO-]MR_+;SK0;/=VESJMI_PB>FIY;C
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MQ;C,)9>,M[X]N0;@T6OYX>+L$,OZ"6<3VF3F;_/L_4><Y1]'X[-%3E\/9 )
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M)J<HF62M4X(&)<(](>'A>+"+H!L'?V]!^M\X.</9EZJ95:@R)JD-*Z"U1-H
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M(? 8P>52K-2>!]6ZE_>13I/M39;V^NBPH]PQMS09X42DS9,,.'(:LO7@E-.
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M!).,R3RA8JIU0N4&* =(OUD-&R;NU!)["Z*X6K"J%""9DZ#I-'?<DP5I6^<
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M<" >["+GQN7B[_-D-)W]/IG7J]B<7D\7>?[C67YV]N%LOB#MN%7H,#DE@F*
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MX&Q,X++SN6@RRE3KZIX&L/]B].#*[YG1MK],+\(,3*1HZENHD?R+8C4MQ0A
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M"QF=;A[^&)H4]]@D0W-B%XEWX,*;Q<<\>W$VJW5 RTNQU<A9FVA+S%X#=\J
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MTT+4_DJL)NHA2#I0I$N!/++6 >IC[RS9@0.[2'F0IG))>,=$4*"%)BM2QD2
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M;00;'6&TM==69@QDU%@$<A%SZWCX/9">C#'<4/(=FM#< 6\U<&P+@+W,X/O
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M O9"M*<_,G:H3.=[ZT8HRXB86 ++HTO\*V4^U7PTR\M!YLM^>^P<*$U")TF
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M3\*YLQJ"4CSQVA[N/5BZ> 6/C#GX#-/+9>_&97=3S\!IEM!]\>C#*H6;:]!
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MGVIYH?L@J&=O&O0C_AX2JN\!N&$#-P'88[3H07"'"Q95)+69RG1DI*=@T<-
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M#TL92P""DBC9,6$39F77+VZC5BXN$8#D0T' QV),[<0@HBRC:0BTUS06ZT4
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M%2BR6BX[*L>@8E1+KRC]ZS4X4%\/V<\;+PB<]>>0 =%4#.GX[D1^QVZYC3E
MQ-;;L,TWDP3@;#RY^[#6][K9*9Q4QOKQ$X"%;N1LO\6;!C<++"(;WGX23T4
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MN 33I1OP\HXB7L$#_8WIYOD/^">83LZK$JVN& ?90A;U#I 6NX$G@O>._%<
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MAR56\:#/KCS<I#PEIU#($4#A^31"B7*0Z4:4WS7<E4"35F%.I?N/OF3J'PR
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M*LE+@QM K3"H< AE,HQM?$4>A H6E,J\OV[K,-^^2H?.0F^A,Y%0<84P<^8
MC"8X[YO0-:0-5>0W]U"YL BV-K#8Y!%Q9A*6D+2Q*,7<!9X,^G+FRF,X(0OI
MGA ?]]:'I;0$8$A$@  T2QPC]XC]E\J<O[=8?\(;L! 794]]/JE0<'?C\TZ.
MJA9YSZ\Q^_>SBPM-G>$HD>OZ3:OO#Y&KT@85O)S5"J8Q R]5^Z&.L**]!9YD
M/BKIT0"D>:X#4DZ-9V.]#=@:T<IKRUHW7.W_ZAY3&[Z%'RI":Y=$V(JW>,:9
M@#^%A$V70=%L8Z%*1\F9-LV5"@I'4Y8( +AIN>ZFJ2]*[-1#3$IG7N<6\GE
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MDYJ!,SD2V9PC4<-/=L9ZJO_B^>^1H9<B4 V3ARFZ /N\)<7BF=E;E9/F9_
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M$U>2RWE 1*8+>A)[(U\R0?,@&YA2M+7-1_7+:WJ8GIVQ4.V&#F"E3CO(0)_
M+)3C(SSV\9"$A-#-BZ^UU&6)#7U_"B7E'32>TZC(-HHB_X*-[J Y\0!S2?):
M-QQ+E-W[V@JNN94,?8!QQ -O\("0NY5;W3O_OY['IJ/7I4>OPTCYRH73RZ3'
MZ!3&DLZ>HV\^= 8@492Z)41>A ?V0VHJ5VDJ\4!5' *=!<!'C-"Q.-]8/( ^
MR(<'#LF ,3QP:CS0JHX'\, >4SPPFKE3R!@X:K"USP /#)^OQ&@"4%0^AB ;
M90D_&#+"9X-V)B% [R*F.!%XP$< #RQ= A!OJI?XL'L)7XHZ;H#C\H:@=;P(
M*BWE$1[ $3?A@;=J1/^MNR%:DZ^2=E#K<6QJ<.*^^_2C9$I6AT+[(0-.%:)K
M"O23S,];F5>^\0C^J[&2G\0K3A1EFA&RVM.Q4*4+?D]<99H:=8#.[<GVTY?5
MG*P!^ZI *ST&K4\QPIXGX[R2KJ)$.K#=3)JM2R^9;!O=_>K!+ KOW(@]KZ#@
M(X@8UB58'O2=;3=__I3DU1?2+9A\< IV03S$[PSLT7?LO3^G80U(6ZE'F(*L
M3T]D](9HN'/A&58Y78<$ZG1JP69I"_J7_ZVD]M?:#=$@1F#I:=D3EY@WW8MJ
MKY+(3(^.1;C2T[E:VS;J^ H03;Y(@;S\;OM0*+=7!WR%("Q+%K&%Z56;ES\O
M1-I5 U(HA8<9V@D/D(9LK$?[4CTV$*\"W3DN;A88>N<#'ZUJE ""Y/R<8,V7
M+C=5*P?>J"=VUN]I"O@=G<1V7#G$CBS!00!V#]IH;.J5TV.RJ_Z5Q6_TY,0V
M7_9S(1>42.0WKDHXJBF#VK\/^?ZQY]%D6AQ=7G!NY7/'B?U9_7R H>?C4RU1
M=2Q@_?/GW2<8 LCO0 +&0QY>"]V9ZYA#RN*W,XX%0LPLFP[ZCFZ4X(6\[:L+
M"'4L>SDO9W^1<=,D=/Z@F<CB1M0:[+%/4GD:KDUB/HPL4];*(RW;*"5JV_JT
M,?0V/-E0_B$!73T/C>:C[=;6FL3%"6D$+V$_>8_EL1SL\$MBJIK.Q<%<M&[:
M1(PR)WL-A@H.;9BI)"Y%3E'0@C1PM.9^E5-'\4!$23(&*4._ 666XB ZRA%_
MT['7YD3+BQ5B3^FE^7-5DWR5%O/45+A 2U=)1/&QNXC%5+;<60QSHL-K6S'>
M*^O(+FN!4JO$\H=)(*462:0=DEUP:A\_D_BLTK KK&R)H4:?M7'(0*6MA.3$
MAS-4S %BOMR(*C_FS?<@L>].G8*>]J!!7W/:[-'O,L8#,B4>KQE"3Q[7V+@#
M=Z.[,PGG02Y[-#[C!<&:?WY6U*^T0;6RA+%VKE*.G2]]44@]?Y(E>FRH1/*6
M%:O8@%U2'.PY><_?GU?_ W:S9N/'S-==A*2NOH'P='( G1$_U204>CO'Q%?S
M?K!?_6H*Y-G,=T7%'^R]_FEQM4'"F-Z.'KHQ"Q089([;/A%C2FY77:@\LV$0
M++"YAIK)J*3@0,/1,(3KPG#!(GD75XECQ094]>3LIS+X_07>1X71*8F7Q8W9
M]>B,HD)3_-I?'4[02_JA&\.C$T([W1C.TMS[W#>!]$U>FB60L1Z!"UJ/E"<<
M[E@S>+*T65FGBN%;D2_NR?&H_XNY(G:[@#\D$U"SKTWE[#QB54E#QI/IF_*$
MW^6)V#F^1A@71@Q9IP6SRB?+NOQ$9+%JA?:)3\/8#<8H-A^&A'%NF!HS 4Z-
MG.W#3G<*9\9S,] KW3=1?^PZ=E/(5 5^BP'R<=SHONM5S+9:2Y'F:6^@BA&0
M(+ITU.([J/VOT]-O9UDUN%VY+&)9N=9;N7HIBAQ+\?V<L#]@+I_Q[!93WEV>
MXQU\L1ZTI)KEE]:T-7K;O$UA*294X3+0Q"0^5&Z/GY.X8]GK=^:.]D3^,<>;
M&[1[O5_32UX5.!@MS"H>](4"8#+PQ5QQ&LY5X57IX*&=B.<9,?._,\3@:4NO
M"+Z157R 7S;YX67FHANCW'1.W. 5W@5* >;;SJ9&S4QTAYQ:R$FSJ+)_F5XE
M,89H>6P%5*_M(.V,H)UU&@XF _4$8S9 67B@R5 ,.XP=!8V9?='%S5OI7T#0
MH)Z*0Q[\#^I$X==+*0Y'WQQ6PO@)DD./"Z[6W1];X*3;O*\FN-"OK'/32/F&
MB4ZJ_VFY.X"F)ITF8 LP:I(F_?SW_@&35'?K2_HW>'!_NKOW4J7W/$:3-O'P
M!YLP(_:Y803QBYF*$-^&?E8NE^Q6S>CNR,6AAJ1B" ,/ZX1;NWM=28('IAAQ
M=[DX->.JI4;YHSXA#3G;QJ%WS/ZJ:M4LH;+'*KPNVOXPLKK4B56+Z]%.Z3_B
M,FSJD?KU?_HKY%^KHM=>X8&G!#P_1:'?O-]R*Z\3C1D:R\#1;J;UW^B&F>PF
M$//7&O/VXX'.J?:6X&1%A];6*[?8.5-@H8^_)OW?AS]_@:7^C#RZ72^[F_7Z
MN[VL.\OR8E E9&RI^;Y'&.W%Y^3K+1VWH$+DB+*3)&3;3P\]H[4U 5<YG%YO
M%Q)X$JKP(3N;7.!9PB&695)68N: ,*HO!?_\$ F,%4JFCP?,#"J$FGKH>5Q*
M[J.>A;Z&WHYMW>N!N7TJO^4E$;&)/<6O,!?,'5V <O(X5ZG;VBF?Z3F=0G?I
MY9K3%#5"W4O7?63YG3>ZS\*DV#G U&+\]$YX30M,S"_&XO<:'*Y FOE;R6Z=
MSQ\/[+/VL!+X^)&DI-W8)EX%*:Y?4)TTF'3>2E^F"464;#?=YU0<;L44'75C
M[ZM]U&*M1IKR,XKB/#4Q9NSW8]BZ2,M^R4IX V=&C-],QKVX0F#8 G7!VJE_
M(:EAM[KL#RE1_'9A#+SWBL%RM%Y$^<Y38VAI OFSC;[JD'I530Y?1?4##DV7
M@V_P.D;TXI("T_S?MI!QU^G @Z2A\7,8W,H$Q8VS92ALD^['U-!SX] 1IP:B
M5CQ G6"+V$-$#$G:*6Y_KXL'+J<M6G0''-OWB,,)O5/?7I_3[/T_$_(/,"%_
MGLO^6^V]G4N;#)AP#(L4HR&GQ '/4F$F&3I:%HBL_P.FXGIY:N'C@A-<7Z<=
MUZ/IEZ#;9@,NM]0]/E[.V!(L^&1!@\B>S GSJ1.W>%FW,'A/QO/0SW6?_L?+
M#!Q5?7.%CR'U57&_9187II#H]@/0[02BR+K&9]YZ<D0?LRA98*P]COL7*?3*
M S+V7VF!HDKDF!+I/)X&%G*R+ N&G3MZ?_6WF$J@*3P08$!\O.N\6]Z=\)3G
M]2[S![1T ]5,I]K.(LIJ0@4W:+)/&27K]_>_M:26W<-S\6PJ%>7>'2-.DPX@
MJ@)Y<]V^\,ND__MGM?R@V7?3..9WMVSZ&='0C(ZM/NQUHDBDYT8 _2FE%)N[
MY9>VF$6/C@1>I4PWTHJZ_E37IFW-H.>2L]'2P3<M20\Z<MP477'(C(\>B:.J
MY!]=],?[]?+ Q\5I%Q12QNR3ZAY/P 7&S7W)-ONB)A27F\:W!!?ST7>NI;9<
MF'_E]G83AS1S*+K[X<?S.^M!@P>05UJV9J$X[ZZYX>+D+*PJ\CU. C&"B)<N
M+C?^='H7-M>?W"5IUT*F9J=UW4%//&!P@T =ZO&@J6^B@K^]2]+NR.K/R9':
MM:A_B"&HG_#""P33_3WA*-)3S*>LOG?/?[VH^?.%GNV&P/UQHB^'$ T' 6B.
MT9;J$A0L[5,_IX3IF."5$HY&ZUSKFI6H67JXEY2]K@&U8,.7_N<K^97)RB]"
ME]O>:?27-C#D:9J*@UM7.IE)AWTI "]_C.12#;-$>_L:?^RI:Y*9@2CET!1F
MCY>P96:7Q@C=R_>9)GXED>.3E,8P5K!6I-*XZQ@U423CO>6F@]#1$)12LII]
MB$^Y#KD:^&V%-/I,%IJGZ)W,D&5U\G.Y#$=CL3TNM4J("E$Y>YBI\7.5:JGX
M7=K:1"]'\ #%#.Q$Z>'+5_GL.&N=@[D@BPJ3^^XMU+B1)^PC\42B%H>+ F\'
M&<R<LREBK^9DW: 4Q0IH;2] %*^:4.[CHHJ88^W_U;KH_P#)"*B1J)2D]KGX
M]N8L:GA8U;,&R,U-?9#4<5ME9?%-]XN:KGTX$=^QI&\QE7;9Q34K*C%^.WZN
M1Q/+JQJ)T1N>K20;N!F[$=-^<+P9W%B]G8OM!68J@R+$\Y*RY2[I)0U"$6B8
M_,<1.]NWM4OM-T:1FI_*\N"OQKGOK^Z(O"W6X0R,VT=$CPX>6"7),]_['*L]
MX^%ELT008_LQ;?-%LU"!73S$G]N"?M?":9UCIZB*Y<'BUK8!ECJJ%2K_36$#
M1 #=@ >.A:;AQN%;&A3'P9-=GV&\/>X&:VUXH*+RG3K]5JP6RV^0RY!8A"5B
M3<)@>P/1^#'R_]\DO1\DVJXFK?S^T-N/U R^BQ&U''TOH7=RTX&FJ9IH16YL
M02FP,'7<F96K5\M0!B[IH3'RH))T1F#Z5C7U:2]MT$2,X :[JJ8=^DEC,;T"
MM6#2%SQ,-. !7\JM\W$Z6WF/SQH/E+V\S<Q^)\FNW\T3W4)GY.M<N(=@RG8X
M,7A>[N/N%Z7N'V")$-7WUS%Q]Y6@M+WD^\,D^?E?H1C_,WM(ZZ4HW:ADF ^.
M(7TD#.Z(ZDU-.#95-YR#3K4S>ZW>>'=V:>7<<K!)S3O%1X8PE26X;Q$"W#0^
M4[RX+^*T$LS"! _8:VXJUDDJ'GBY&:U*$V#_]2S(;Y;](C$.0XW%W06O5A1L
MPVMS%FK6-=44X;(RT#-H[G7/5Y6]3J.B(K:,T$(YS0RC3C B[ACX!<-0YC&1
M\</T:UJ!(]L0BBO[>4\2%_N[]OG%P#\ZBYL;#R9$!I,/$UUBO;8+(KWM)44@
ML%XXUK8$#[1=2S</^4Z7DU__FEWFR/WA>4+_7/9=#GU@DWVE_-%.!;!1%.XV
ME2^I5  QI2M8F#HH?B*BU.SYC%)PM))U^Q5AK!>X$2>"8J_S9U])&Q2^EQQQ
MU3Y.BNW%L&B:;5X_F OF500^-WB#MG!^'+,S$3;?Y<-H+/?SZ[EC0\TPO>[9
M)2G<BY:K_P/-_P/-?SAHWEE<#=[:!(:C)U4&K??,:/G$#Z(9ZK1\6C8,H$?A
M=BA[F@HU*.C"_GZ%UL;'XJS7GN[,A;2]Y%?/$DSI=D3FW)>OL74(Y,6*,!I
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MF*O3W]QQ&'U^Q^B /^-8J,]LBWR4F\$#??R).9"MP#D'[!8/N#OJ-WEUQO$
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M2I 4N]7&O$E","+G17+FXIWQ8,8-8N/6?3S@<\:HNC=;KB1,(IWA'>]5)?&
M/+WX1LJ!BB:5H@[MIL( ;D>QS6LAK(R.(P"C.5+)\.I?X4C_]87\ H?L\S:S
M%^YLR_X=/*%^"R0,/B=>;,K.R(B!%[S%<HQ4A 82A#X5WLC0"\TJRKC,K\FT
M>5!QK?A!166R@W6Q^"Z$Q^]:0/C>_P=02P,$%     @ 4Y4(5_U"[5L (0$
MRO0+ !0   !E8G,M,C R,S V,S!?;&%B+GAM;-2]ZW+D.)(F^G^> J?/VIDJ
M,Z&+%_#6.S-K2F5F=>YFI30I5?>.E:V%X2IQ*A14DPQ5:I_^ +Q$4(H($F"
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MO^#\=UZ"2FU0,Y7FB=<PB .G@E;QFYAC-*&[4#$$U,Z9F#8\HT($!IJ>+3I
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M;^GC]E$N2!%#,260!G$(48A]2+@3PBB(1,0]%B%?:V/=3.S2"*VJCIGN5+\
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M<U84JR"*. U=R1 N#B&B?@!C%KC016X4^23R(QJ9$(:VY*7Q1ZOX!4@;U2\
MWBO?_+:Z.+^6ZIM1BWY_Z#'-)"A/3#Q[@#_M .[H#?:*@\]] !L3D3%8EGA)
M7^ZL-&4,QUO6,F]@[#7?IK)V=3GO!N?7^:W*A<"J0L8W/*_J:ZX"AR="92*0
M8"32Y6$,QF$001)RXF#$6>"%9G=]=<0NC;YV6K?7>I]P#IZKBL\_I!O LO4:
MYP5XDBY]H?0_G;/]G+[08R_["$],77MP;VMPI<[RHPQJK9O"VE+ONMZNS9N^
M)D!9N^ZK)73F.[\F0!Q>_#5ZVP9;52VOF$N2.*0"QDX00^0["!**8G52Y&'B
MN7&<&)T/'9'Q7XB'_IOS9\=Q]Q3TWX$;_-FIOR\ WI8/69[^7^46;++VMVE1
MJ$J)<JQEV[(H\89I[T/W=<P8GC*&>VY2JA2\J!(0V(A_T4!A$L:I)7Q'>GEE
M8C^7O'YT[,ERW>#'=*,R$EQE15GL+_]^X>4J"D00\H1"==@DR<.1:S3/BZ#P
MO  A!R=Q0%8;E8N.LSN3T^8!P5H?]J3^L!^(GS*^I2C^ GZ5CZC[.9(P *M"
M'MO$&U098GHR/=0'>HQA!](Y(QE;T"I5+SH9 ^3W/7601AQ@:R)C[31[2-[,
M1]N:YA^><^N^./(B\)84_!];V=:'9_GE3K;R/GO$Z6;E1XE+@]!75=D11%00
M2** 0#>)*8]B5U#!C:[WGI*T-!=FKRBH- 5*5?!;K:QI=H"3\.H1BA70)B:2
MD7B9WYH=PL+67=B3<N:]X3ID[L&]U<$7SD^W]CY]YD69EMN<7XMWVR+=J+I-
MQ<J-J!\'',& <;6^B1-('-^#S D\)XK\4 C#E<Z@S*71QL]8)3+:[-*KD4;3
M\0G43H&MNWJQ"N'DJYEN$K6.O@K*O<;39%$;@&>"/&JG)'ZW3&H#$/3E4AMZ
M=1SK?,1I7BVOZO1'EQO6.2W[A6-UA99=;[YRY0JEFWOY@/2+\O;'=[A(BSH3
M#_4"X2+BPD NI"#RW AB+XAAXGJ)%_DTP8Z1(V--LZ4QF#*LW478:5\E@^SJ
M/RY-DKWNU&._[]))$W.DI?XQIDKK6%HB5'MZS4J[UN%\2\[V!8RC\ \XW\CV
MBG:'_7VZWI:<K5C >8R2&$:<AQ#%$8(Q#AB,$\>/0L3B.&"K9YZ33)>23T@R
M&;M=>1-NNM2*63F3.P5O0'CHHT1 &A,BX64"QKXOX?5PH%;N7DB-\G)9 '>.
MV>L+KR,S*CQIG7FW@A5 P&: 76]>L@#FQ+-,J^'^0/,"-%K:FU(&8+ T09R2
M,BO=#YCZEKR''A^9)&87F'$M5*6LS])G9_7T\%>^9A^S_->"KP0642025<#*
MEZMX1D*8,.Q"%B >.8Q3P8P*6&E)71J/=.*0Y-)SK>JYK97>X](3:^%.L$@2
M'_ER0G0BB'R/0*(8V_%"!R<N#P1%(PYX[,$__R'/=^@%/0*W_IF>F,[W^EZ
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M]]^+"R"_/'&JII:U81'4([#KL=!(*.?AFQV&W=!]>_QRVG9+3')$P*R<<=K
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M,4MB)PR86;BD1>661DB5BN"YUG'4BMMJUVFZ9M^I0Z;VUY3.L%+Z3>V O66
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M.B2@$20D4+=_'=^)F7 Q-CJV[!>WM(FAJZUR#]/]\AE7"IO1^@#6.!"$!W$
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MZ@BQ.[S^MF[R&E@SU1U?-S$D"RX8RD)IV*9A@B!"40Y)0D+($ISAE/)0"-M
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M49!5%S#G]5E')WZC<JVZ@%RNWJH]@KE_LN=P/O@[[]=X5:M24JJ80[VI%WE
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M@:9R.R+0?=PV ^$XS?,KWWS\2Q694/-4%?NS7"X72(0B82AI6UH@2IEDA#B
M/"*"8I1(1C"Z^-&9=&[TT$MYQEW*\XI?CB2V!UO/H' -H6?".),P+B4&O^QE
M!CNA+_MQ+(*S]3%R%F6M,>7$X=+Z()S&/1N\:\<_;1U6O)2<MGUJTLM+4=+^
M63LD8<@3ED/*F3RL1#R$!0X(Y*)(0IQQ(G*C\A>C,\Z->78"@T9B<"RRI6=C
M''8]&G(*IF<.NA)'8_K1QL81]XS/-RGQ:*O_FG7T7[RV+/.A@D*O@,(N&_SS
MZFQ[9[X6U?I1M;HZQ%_$+,,BE(<EF@AU/1-&L,B*"(J8R/_C89C%9DG<KB6<
M':6=+5UQTR^Y8%MSV=6:ZO'?FZZ4;[X<7R2OU3"]8>N\UK(K^=ZHYK)C>"_7
M7G8]D772_9KCFG_@[9]JXM?=X[Y7R^6G:JW*/B]RP:3ER9G\!) "HIA( [0@
M#&9Q$+,@#?.<&!F@AO//C;MWXH-?=@K\396C[.OP_X)6"_"'T@-TBAB:J*;+
MI'MN]@:^]R.T<]QMTIUMT'.7PFPT^]1IR3;0G$DUMAK&,'V8LH4JX\8^_L7I
M5A'R-R%M;#G#I]7!!-+)#-89:&X,U@@,]A*#G<@W<L=4FU6UT>QBJX?B,"\Y
M!] S"XUCYSCPV@B@@0L!.4[',90=J$5O]&GR7DT4W>>]&KUD?D_XH4N1_E36
MM#'&RHI]DO]6+RCA<2(*#!DMJ#SSJF*,>9K"@J0%"8L0)XE6=-'@+'-CCIV@
MH)44M**"1E;]&\++H([?#SJ!RO?!T08EH[O!412L;@8OCSK9O>"H8OU;P?&'
M71>H_KWF8KO\4@J^0"G*XHAPB$D@(!)%!$DA?T0A2@*2XKP(C1(@=":=&QW\
M)R\??C892,]\C1\X:$4%2E9EF_^+X[5I0JL.]GI''=>(>F:-P0+3-WUHIZ@H
M?0J1]S+2O2EG4COZ% 3]@M%GWC4_H]P]/[WJ9:1Y)CEY<6[4<8=?P',->NZM
M7N[B#;@?+ ^A@=/XJ>,JB#QSP1ET?'B:!V&P.DN<CC;9V>&B(OVSPN6'S#?G
M_9K=KM>?5^R^W"SUFD>?O#6W;=D(I;_O7D$PONGLM?>\X^[7N G#Z35"5#'
MK'PNV5;:\,/ &.VX\QA8;;=70TVVU\ZKT-]H%YZP,\B[.H.KAR_*)?CQ+]6V
MDB_2),289 CR3,7ILCB&. E"& @2I#%+,X&-:DZ=G65N&W17-Q%4*[!LW.'+
M0WLT,U/[/*IZMO756'G>SGOY0"/@#>A$=&<Z#R+@R%8^/\>DQO&@FJ^MX>&'
M+:-5SO:K722"QYPE#,J=GD,4% *2H" 0Q3C#) DR1,PZ@I^=9FZ[O[D+Z3IU
MTWXK:#[R\3:!5H\!K@?,,P6<[8;=_W;__[E[T^:Z<61M\*\@8F9N5$4('5S
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M70Q$Y"/?BS'T&(GDY%3<YQX1D%)."?)YD,K6#<ZD3 58VAS>\B#CE@>Y84D
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M074Y*0T+C6%*L ]IQI*(2].B6:#4N:1+<TF:V"/2%WMT!3[^5%JJ"D4%DUN
MIUQNXY1R5T:DX>Z_ #U;MXAQ=6PQ1\+)QH=TIEAA1R-@/6K8MIQO%#_L".[^
M2&)7'4[(SF?_O"N_EL4M+[_R4G7_J3#/T!]J9&EF70K[7&WJJ;\I@90:WGZ\
M 5_E__?!!Y_*<E.4&Y/$_4$H1VXM;*+HV(@: N@BIU\'J6EY_8,MSY?;KZ/@
M07Z_U@M3SZF4Q/DJ;VW1-E3C=EV*?/.EK*I/4OJV:&UU5ZI"#>4J9\W.L9L
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MG6D804Q\!C-!:"*]3AIY1G2FYSI9FJ7^9CF<;XLE)R@,2 I9A"E$/HLAX8+
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M>1PG6>1%"?0YCB%"20!3^4]07?X+GJ6""RU>K>%NEC;W&TE!(RKH9-5?BP<
M'7=5[,#D>/J?1V@"X<0 5/K.BQW(9G)A##\N(V=F'(@!EV;@Y=D<FW$%]MT;
MC:>GQMJSNHH+7JFZR9^+]_@IW^#5/4,$AR0.8<B1@(AY%&)&":1Q(H(LSCAA
M1K4<>OI9FCW<B5F7,(=Y 6@CJ6D ^WE8]<X<+8#E^F1FAY,2487]OQ_!:4+@
M]R *UF*WS_<R<_CUH*JG$=3#CT\S!34'(<$59_O>[5X8YKO7W2.W#>U8?7AT
M\Z0>K+Z6Q0NO-KS[^Z=R+7@N__[U61FJ&]&0'-XGS(LPIRGT,E]E,GH!)$@(
M2+V,^C@->&Q6Q7@FN9=FJK9B@[*1&XA.\.E,J'-] WIV<($CZ]BNU@+!=TJ?
MHSWF'D$\>07[S[6*@UKS*]#J>@5V'TC[3V"KO_QEC8"B;&PPL&>V9QXT2\O
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M'XIX'LCAN6\%'L>3WA@9HW#$0>TGQ2.>;W&V@,1!A?8C$H<?- ]TJ.]NI3W
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M*V %'L>SWQB9"5QE/=I?0%9VW.+,;&4]"IW2E?4]:*=4[1Y/_Y=M15$>Q23
ME,$X3N3<]C&'691@&$K/7Z3<#QAFE]2=/=?ITJ;[8 T+BU5@SPZ GF=@&U;'
M9L("HA<76!V"R%&UU+-=OFGITR$0QNJ8#KX[\<9S58\C9^=9'C[^5#_R^Y@2
M&B(_ACB-(XB$SR".!(:1AUF:8;DW(48GV7K=+LTLW94;N<36)4C/\>/S1FK#
MZTF] ="\?+0.JVNS-$88\W$$4_/K0B.(;%T&ZG4Z[U6?$1 G%WEF;YO'77TM
MBV_/*^Y[)/(5?^3ZL=BP3RO\H!MUU=O TJR*%!0J28$2%?H'X8#J5$EELPZ4
M-C1 ;MB(6 /-L<W0PPO\J<2V%'TU"LNDV*O^5F>+O!I5;#_N:OSA:3[(I[S(
M-_R+*HC[N=C(L<S)BE]7%=]4;2ET+_9]D3+(J4\@(CR"&?43B D3/J6<$F'$
M[C+6X=(L1"T4>(_7Z]<Z7MB 9%(;8ST'PR9RCLU$(RJL904[84$CK;7JV*;(
M6/(H1KN;U9?05?[8B]!^[Y(PGSO\LW5'WO&"BWQS3Q(_R9+(AX$(L;0GE,*,
M1!QR[F=I$E./$2-6N9Y^EF9&VIRA#?ZIZ.5>\DIM6GXAC;"&E;SZH-4S(Q8
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MT9X@P*R&=SI Q\;S@I;,+WR:FZ4[_)-7=^H.Z3Z*I4,?9M*J$<^7GGZ<PC1
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M3CCT*99&@F>^W)?(O0J.(QIY J5I&MS+EDBI:R:,^C>9#?M2N)L4M5C@E[P
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M)FD40X2"#*8HSJ#G13Y/XS!*.#7)<SW3AY$1F"$95<D$U""!LA&V+$R9Z<\
MJ>>/7 B/X_F^E>Z0J<TB^UJ_^K8(U<[T,"]'6K^*)[1G X_:.'?ZQAE_K$^D
MFPS#N[^ZL&I" XP)D;N:.%'TL_*G3$09# ,_9"%A'F)&9>8T^UV:._#'4UF
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M^%Z_(B;G=2S#]Z5.5?512!&1ZE&&- IE5_>\X/AB+F$*!%0 J)#JUX\YN),
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MCI-V<NX"-A_"U]>9Q#<MTXO#BTM+6$PV(3F$)%S%OS/@.8E+>@J;DI Q.]\
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M&&5.\P ?>_M^T.C^"+*!:+N R.LY/8W$,?V"K\(Z7+(U0?39(D4SP5?A1./
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M4M1E7\V))C-!L0*%K,X&4+HVTV3UFI\FYXDKIF1I'K@]0L^XV:#N$-U,=1W
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M+&N]<LXUM9LT")X%;:T!;?-:MT?(.;VKP(-'WT#:6AXIAJFQ"Z%966G!2Q]
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M$V13.SIH#!"DD7468HK$>["B>>.[PT@<][3_69#97E6]>[ /IZ8=[:CN?-3
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M$SJ$R"7%4%FB E54 J\Y YV#U^BMXMCZ!C\/9[TDBP=U!#H$20='YR &;P0
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M##4,G-IJY 6G\AOLGSGDIY\KNW26'32'/?"RY(Q/CF DZ@XM7A2$&H%I94U
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MW$5?&#/%M=X+\]+2#0?I^Z!TPR'"/QI)WW$1YPWJAJMO_G8>9G=X$)%+954
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M(P\F[L<"'J^A?JS=)KKZ@+6FLLY7^QZF%[4\[9?Y8ONW-AY'X3YE32)C<3T
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M'<1@3]?$1+I<2EEW]]86@"0S>),Y6)^31![1R_9W_C^C(NT@'!Q4D7:(4CI
MV,,E,;%DZTQB4#AY,2IH =%*#84%$:Q#E0>RU"^H(NT@1>]5D7:(U#N 3IL"
M$E]<T+: =W7/M".7W#O)P9<L(OV*"3Y@A<4++1!J )]!BH$.T&5?^-VKK*1(
MY8PR :3.U4EQ#!PK##)S0B?&<TH#UK+U7PPT*"J;:Z@O #Y55")\2CII!,_K
MKB.>,P2G-7"AE>'>!N_^'0M_!H5;*WWTA;+]*@ ,*QJEK,OE:YZJY%"W&!E
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M5M+MOS=SQY3)GNF"X$6LDYP4W<FV./ !N5)9EWCW<?#8KLPQE]ZUA\AP4N[
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M?I,>W=>[^8T/;>>?]5=]_R<($5!NIKI[6.9-XXC(6!7?+AWAS?EPJQP7E:[
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M?)LG$<.Z"I027]O4\Q$.,E-6;GT0U*?59X#<RU.@S1QY!^X81)&(4 >L&V'
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M,/BD703MJR% 1T3IZ\4 A0$6"5@LZ;Q7X+F:UX@=AT;/"/:,6"$1+@8C57H
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M?JDYZ11Q24B].$49J0#[IU8;>X],+?O(;:%*H].LGQAR_TI,^D,<;;1<^:"
MFZANF#U@ O<N:MSESY<_Y^7KC>J*VE9,SRHW:FZ? K+EV.N!W))9O:WQO6LH
M. [UB4;OX)!RCR'4 UH6+"77DT:9[%.3]=ZNTLN_?HN1.I?;TC$OC;*4MAM$
M?!+XE/MXV3<OH,W8-!"&_R#=TB[BN8''#JEC@O:,(J ,.:"4@?^;0=C>N'[
MQA$#\Q2>]"?4U##<1SUI/N:K7UN5>P/5+MJWMIGO'8WFRN3/$VE6Q\AN)W6M
MV5AM00QK<E]E8OGI"RE3WH'&/I7NTA^9MI[\EFGKR?.T]>3_.VWEAL31Q#DB
MOOEP9&X^G.#=>YBO8ZZW.#\_O[K1.CXQ:4%I0R_FF]^VU/)(<Q0^1AH,&7FG
M[D[,8Z:/4/AS@AQ%#U)<@@/C)7A.X36<UE!M-)UR5X^3\1.3C.?G^1R3\KER
M5*M;8&)]JRA::KC'ER1/I/8@%,[O![Y<\-EJPLSEA/QH5^WWB*NYX;V%A'K
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M8N6"VW!\:*%[09X6>)[-L[68'B93=:."+7+5+Q5RM-GU8641S)^K3"14?WI
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MOC85[@>-A:I<J#HHL:OY)5ZA(@S</!;X,>I:[1=L&FZ:$Z]CBR'%7/Q#11%
M+F$EJDM!B7(8.&Y5BRN]7VX2/>-\*3G*BU7*>I40''.45TO!%8XS "5NR<(Y
M.,.J[\4^)#]\#CBOP X+5.H!S3L@)DS7P:X4;5ZR5=)C/-.-#;ZB^^1CKVIY
M"8GS>IQ[^,S24(+]4CVPRU0*8"9V$0 Z43MMS0&(7DBD\JC67$4EC?(R84'3
M<WT)&/+--9@YFYV<;([VQTM.'F6F6#_RN#]E@$JX"@!=$G'SLJF&&K@NY??A
M;<Z\A,[OMAQ@N>S_C(!J&V"0A21'XW05NTM]K=O<7J$:7V6IYVM6$Z*:_UA9
M5&RM6-3?*--PT >\$C@"=X'_:YCA7H>S3TFBH8XYR2]B%!VF6KO.\A6;DUJ2
MB2GKR>K*1B\5+>BW"%1J%<4[?9I5.SY8L#B*9DU("I3%#"&UIS5\LW)C&HR_
MRC?/!=SXFP4HT9;#C+YD(]"=2_H,78Z/F&WN[7!>QMYGRD+7.('<.7E2,&6W
M8OJ5'I8^:F*GY8X8AX%-MCFXNRM&5CVY+XKO/.-K"%W&[>5FQ5>4LB>_?;&5
M4#N NX/26]%!LY"4.*5<Y8!/!29O$&.6AZ@+0G?#6367AXV*JK62$4"^,+7\
M#?C #JE#I&Z;":.<G>>W1?C^FGEGSEJU>!E'C%U<5NJ+I2:Z+SS5?(NO\@]C
MGT\#KU0(\$A!]03 P=?(&G0M/\4)3,.L&H(Q2GXYD"^9U)NB;4/Q0E"&[Z56
M2"L)@;<E6< B9BKV[^TW]SQ8"ZN4DL[IX@-I+1'"=_GC0FPO"(=%YQ6;EP3-
M8_=1!96]"Q]S_1A1*)039O#.R!3[6TK=+RHL*,Q1))5E5-PH<DG]I,'7C//S
MUT8^-$S8 K75%59FKNRM8O[UQ.$H?1R;(W6P,U=_]7G T@>FRCJ648[>W*RM
M70*()>U5G9Q?_I%-E]/?LNER^KSI<OJ'G!6>'K0G4,M[E<KO56MOE":75*=H
M:TG8R/AR+J-DD046#;:8PU(9PDJ[UG8PJ'I]!:H*?)*$*3 _!C(8@4PA7I6M
MV+(8UZBA+ZT*C/(Q%<B$X4N] &//A$%SYQV[0C"78JLY77S0U\R=DE-)1G+)
M4AFF4:7&R[("XNV+6^2\"I]]2Q/@K'E.>P*UOGD"NG=&!]ZJ8%,)*-)IZ%*>
MU?)NG>/F^W:UK55IT_#5D4I;2XKHVM"^XNL%",CRFY*!SLW,24K"V;;)=!BL
M9<-FL4J1,^N>CYRS-.@QRB"'N%$V9^1'.+^J&22B1(D2>;[THE\+@+J@^K\V
M?%A%* 4N6J>U1;U!^O8?6ZCID^5IAGY1X%BU1_2UYE E3;;D9S8O7(Z5R^XQ
M4EUWNY:?S!3]9UFQ<5@I[27H!_PGAVW +,GC^E[_+V___8INIM18'K_D3](/
MM.3*2I[#E.=T4@N6L>&E.CIO!%2SH(94F(^(C2)09%R5GI7\.BK<56D P%DB
MJ,.6E+M[52Q:#M5?$8*X*&0K69L ^5)U5Y2.2;52*RHTJ;!1/>KJ\QD@P"GW
MRKD:+>M<^GZMZ)/63%FQOJ+]$AJK/\)Z@0/D<7EYNU][ZIX-P_B!K$"F'<K1
MOK8__K6!_KYWZOP]=^]_UZA\\(=_("V_E^8?9/\/4$L#!!0    ( %.5"%?$
M:X6E#QX  '9P   <    ;6]D:69I8V%T:6]N;F\Q-&5F9F5C=&EV+FAT;>U=
M^W/;1I+^/7]%Q[FSJ11)$:(DZ^&X"B(IB5Z)5$C*WMS5U14$@A36(,#@(9FY
MVO_]ONX9 $.*M)6LM,[6.@])! 8S/?W\NC$S?',^NKQX^]V;\X[=?OOF^UJ-
MVI&;S;PPI:D7>K&3>F.Z6="'*/[HWSG4#5VJU?# J#NZZ+R=16-_XKM.ZD=A
M&%F[WF3BN:E_]V9;W?_NS;;T_-V;DW[[%[J9NE$0Q3^]N+_U4^\%+K>[[\D)
M_&GXTPL7@WIQ?C%)%X'WTXN9$T_]L!9XD_3(\F;']_XXO3VRFOM[QR\4O9M(
M:#2L^M_F4T6MT>/<&8_]<%I+H_G1#GKD ;N79Y3$+H;[?&<O*/53[B0)_+%G
MO2 AYZ<75F-O[P7=>O[T-L4G4*>G\?;-:;\WHL3_#0^AO:9A$H5IC2\>6?/T
M6'ARI%EB7W9Z;?P_HOXI#?L7W59W9(^Z_=[V9;_=/>VVY /?;*'G@=T:$>W4
MJ7ALN5FO7Z=FG3JGIYW6J/N^0VU[U"&Z:F!"NS3T/#H)(O<C6?LMHOTZ=8?#
MZTZ;3GY![^T.V4.Z&M1.[$';IN4/.XT&=&'LS3W\"%V/[#NO7J6D?E^G013-
M:'^W43LC^N DM^!V&H74;N&IG89%=%"G'@@FN]<FN]T>=(9#<T+] 55Z$?>6
MQIZ75LF-LC!=5&F80AW)"<?T7]TK:D5C;XOHLC,X8W9=#?KM:W"CW7G?N>A?
M"0O/[.[HO#,8GEP/SJC;:]4?TYP(<\/M4Y %'MH7U![\0!8NDD56O>1[MZVX
M1+N8<^?GZ^ZP*X*ZNAZTSNUAAR_61034'S:MYNO=UT2O(:OV9;?7'8XZ \7J
M2G="47KKQ93>.B%U4P_LVWH<PS6SFP<;F?UR#NZ-CR^(#FU#3U;52]%Y"-&P
MBK2I,NQTJ#OJ7))E@98NE,8^Z_!3_'O(O.C2+O_:JS.WWD'!I ^>C3.?!["B
MFX %)#HAC.K:PW)"'?FO271&II0NVR#\X/5A<]<Z)/HK!FB [$VZO]T?M#L#
M1?OY^; /*6'2^U#O9J/%SZZ;3Q-$"3ULJ ?[AW1JM[H7W9%6^L;A=K.QS=V@
M \A[=-X=JB?[O8M?R+ZZNNB" :-^R<SA*C?!GY<_'.XWF\<TNH7*WD1W'H79
M[,:+X4^3"-SQ4_$RY"?DS%BH8W(22KR4)E&<WI*O-<&"=G$?MU$6B^Z/V0B2
MN>?"4^$AM*;8<SU_GE(TH3X\5IQ0&]UZGU+IMRJ?PB@MKK!&JG:S+$G)<3^&
MT7W@C:>>V55ZF],F\6 >^Q@JC7!],S6@FF\OS1!/.>4D7_YPL+.S?\Q!)0H]
M-8Z'601!= _EI9F7WD;CY(@JSA:=+&#\LWG@I7Q+&)+0@0QL[57E=^RE61SR
M;3>:^UZ2]U@0?DR5&^FIG":WWCQ1D.PY[BWWM\A[BYA=E&0W,S_ED'C,LZJX
MTB^$-G<X4A+H1 CC6UZ N!%'H>_R!&99J(,*P<V[+%PWR,8@U@$=Z%DL6K-V
MB7<\PY(RI4%)'1K;O;@>B#G^TK\>D-WZ2Z__X:+3/NN(<4,Y3V!=@TZK Z\/
M+XM+\&Q7%W8+,: S[)[UQ"I.X6OYAC2\$J?01ZP8L.?I\KV^W#Z7,>"M)7P,
MKSHM6",>O[1_P:/#ZPLXPQ[^8B>@+53(4ITAK$Q8W'=^G&;>&H8OHHS ##\6
M'KAP@E-V\YKI3A![SGAA,!^1(6/YJ(8S9T$W_&OL\2A?ED$5JAS=^:R,2M"/
M$-O,^0AI?5E6RS.KRS4_4<IVAP&7C"B",V=5W&!,L%*+0WNKU;_NC;J],Q4P
MK^!M(1WE"R$0NQ),,,"O&?@WWJ(>/ A0&GB6>$?TWS_^^#\<"9IUZ_!PK[EO
MU7?V&P<'Z+GY.<^VR=\.E<,=0J0CW8@?@(JL\<B(7U"UUJ![ E6!?BCO"W=&
MK?-.ZR\8%!! 4X& V>/P(@\S50J(()0.KVU1:#B$H7 &AIS!1<1^NMA20\NS
M0QIV1JS0HW-C,+)A)9<V!Y_>$IU$):%%\P;BTDE=VMDG?<"EWO7EB83IE>F!
M0CW[-K-KT#F]X/@G#^KH/K %<.7$541EX0>5UB;L*>?.@L4/-?==#[$<83..
MH"%*G: ,3I6\U*UOK9U:U>2.&OIZ=-X?<""#R$[M >U"[(TFW!_S7'-Z> TQ
MBY< LK'/!AWE,7 'OV2NW1[Z,_LV^SWBH,Q]7SEQF@\ 3UVC$S^ ^L9.0)<&
MBDZ(VG7J<X O!9@NYN('3+BM7%TI6>I ,)=7F#2H. +:"]/8<5-83Q[-NK[_
M/\JXE.ZS625()901CO,\I@P2]+_R#S +?NAHH4W13Y*LE 5;'O14:>]5;@0;
M,':E'T^=$&!>$J7KUBGB@2LSNH7?0J=)5?M['L#T&-NNGA3[MK_A(;@9\43W
M (.(B3!A'Q@*\J>1\XGQ9D\"@#;K]C5PQM*5ZTY7_\6(89[%\R@I'>X2MWV9
MNO?)BUT?;5H74"PD!9:P*YN+)[('HV[K LI[4F]27_&! T.K,ZSBVAY#V?=V
M#R'ENL=> 9)JPTWA9JL>U F?1YT<:W[H#_Y2%0<VU$'B'73F H;"=Q&@1G;K
M7+ 4F'\*Q)I0_P:)H22@5Z77!-VF>AW1?\A\5Y^X]P&AT)!^L';S-J,HA7*N
MMD2O;?R1-Q)%\\,,=^IUD-+YY'I "3#<(FBP<'Q$$2<("-("(F&>099C7VF\
MQ@R%!A9A8UR@ND.R.=Y8U+"KW#GWF4; <IYV$$!ML3=S?'27A?J2BB8A33*,
MC+:N2H94DDJLM'NVD5I)"B[(%.&>S6\D9A=S$ K3+21]:UOGKHX##N(WI/WP
M45A_%M '/PA\!_/'P =U(W_;EK@/_$"OI.&KZMWD_ZKIY+(V>4>O)MO'Q_\Y
M/=Z>O-JJ3^8O?\VB]'A[>O2J6K72ZO:K=Z_&1T='VR]_V-_; X!^=10?'X<:
M-?)82EKOLA 3J$IL TP_:C2ITX97KPSA 1Q8N^C]'&B)78MR*[^5/H*G$'MW
M?I0!)RNY@<]9PCD+T?#]%;QK'(TS-TWH)$O\T$L2>A>%CLK1SJ+P-R?P?N.9
MM^H:%C&7VR *K+CN=1E>B04,M>^ W=B<:"\W7YX(CR #G-;+,6I#FN;<V/3[
M^$ASZ+B>7ZHKSL9EF]6'?JO[C4:U7O6J&&*9<;F[99?5%Y\8@V5BX4C?.!9=
M4K-!E4'G?1WLEW1)\31Q8_]&^<*SH2VAHK)[0*W3P1;M->L[NTCY6EZ<0K4)
MY@1CTXD#%'JF?-,M#.+&\QAUQ1_+I,+[=.O?^"ENN4X&GX4_X0UND#I3Q=^2
MD##C".3#RMDN*CZNWD=9,*; _^@%R"7D.<XHD%"D &08*I[E,0"3GLV=< %W
M#<W)X"%</#/V$S> &P4<:T<9JX>3\"#)1\08#X."7S.$#[;\.KW9YH+/VS?;
M7/SY[LW5VS?G U"6W *=OL7'E5+4U*O= *E]K-UX;/M'3G#O+)+C%V]?AC?)
M_#CO1O_Z?+EKYRG+73L/RUT[SU'N G("YN 0PD ,AM+NMZXE9IQTV &Q3^GV
M& KF?ZJ@.SSO !(]S/FW=6E+^;4\G8$GPG]&?8DZOZ]LE%<*%/9B4@5& ?QN
M#SN#]QP1X7KL+:X8X(^3=QPXYGZL]%EY+#N;4M,20]\#^AS91X1P:@/SU>F7
MN'ZD/$#+[AV1QNJ(4H(*6H&3("'6R/T*RH? !B/%7V(TB"Q'9MD"^MPXV&ZR
M5?)0]GBL2PD6AQJ5:J,_(^BCB?A 6,XPBY%4M9RY YBRH$KGVA9KH@LX@3"!
M?\ LR_!IS[@XIU%';]BCUWN[C5K#JEE[.[6#QOYKHI\91S)Z9*^H?@B( *-:
M6U1IX_\.]PD8 ,'9EYSMX-XIKJF0K* 'X*IR.\U]>)3: ?N;X1Q6%\6ENS']
M3<#^QK(:]#6MLOF45ME\:)7-Y[#*AZ4T;597X TU6?<@J4=B3+FT6 LF'X4E
M\R<W@DK6S@)4EIC2@)1E'QB\OCQZC5K7V@H*^E4MSC 4M"C-;IAQ>=-+MA$0
M$B_YD4Q#I*$7W\%2$E)](KQ[<!]5T\1&)W!G"HWV$+3 (T:97(YH14FJM;["
M0)43>B08<V&G^ =EGO1SYB!R<IZ4WL91-KTM+9;ZR)*0$XBS*<U7GC9M&* :
MY (AR33R4>7G)(YFJAB!Z2*HAMD$6$ ]]LAF/UZ#^MAP,6%$ 8,H@3?RN,HT
M>/KR<<S,)"?F0(\\46/S&X^!MYNQC3NIQ.DL]*4:R4Q.4O%"4F"M&U+>J$](
M.C:*.:R7NI"7*4\!>O.+4%2I73O3V%.IHZKK,$A2U&-RJ4RAY \H]F.#.=*8
M>28\1&:>CP1S2AC00Z!(]NX<UP7JU/W> VD#JP"PI/<1(,E$$HITB17JW8 D
ML0HOL:WJ5"3O#;::U@Q!U>G]TCAC+P J8EY_9@:>HE]HNI%\)9;D1/I0U/"X
MW %K%U\MQC&'D!S-D7:!/_$(7&7X9FC(*KEKQA0.?&Y@)3)YD!$BR)!\+EP4
M3(F"\<-1:8E+.A<@.G$PDIB]R:'<!DQ21TM5[502"]_((KDD'I*7I/Y,/ZU5
M2'2^Y%*F[(A5$&IYDZ6FY2K3K5P/^T6PS$L)127U2%(FJ9^O4+Q*LNZAHVD:
M%UY&7C*T%4EP,)5N4<YH.3. 8+J(TD13,#:8H_\N'#B,SZBI;.M"LJJC#+?9
MFQO^?:.9?CX>D/&:+ 5^9R\C@A=^PR;"-+>*,SB-..04O2J?C1H3H 'GV/QF
M(;E5F3X:A##W)'' @T1[>82G7S,G4%2J;#/T@FJ1B%2)BU-S-0:3 E[[ 0*!
MIVI8\M[OWA?UU8H!)+-,'),>(CRP54*J<Q5LI)&\$9WI*?$[^N472$NE%C^1
M5G::.NXM/P/B'?F@:QKHFRF40KI#-.<"G^947JBJ:\%^14"U^Y2 :O<AH-I]
M#D#U-1FV]Y0,VWO(L+UG6091@#>RCM<9>:_S5R1JG5YGH!)"I!CG _NO]-YN
MM;H]?O=U>D76?@TPMC;L7]00OSD5HO>O#QN'9.LHFT<_NO@^*,P_XRSH@6%Q
M;<.9L1?7Y8(U39[.\]QX2V7M54>TUA/]44=4_8(G6J*V]$5?=D7%"SNXHMA+
M.%<3[JV(ACBWV./RY?<T=*.YIU*+1/Y$9_?<&4<@R3"*FGGQ#C47ZMB[\X)H
MKEPFJZMRLSE #G+LJU#:A'GIAR!GY06TPZ_.CI@+T]B9<8"$Z-3DPPAC^OQ2
M$/PL_XJ]:18X$-Y"L18>=09ORQ^7<!^_XE&5XC2.@@3I[V5KJ[YFLDZ01,8[
M8F,N$;@ZG\._Y]@H_JC>C6MM$;\.5GX_1H[NB]%J=D8""_ACGJL]E%AEV/^P
MI=,VKF<SY&$VE=JV3(LSOI.<1[3$9#_'&2V5G/TG/NQ[ZKN)3D(\+GT$>:I8
M.;FPMY3&2"E-O0WB]V%WNIK'\WV9W"Z.:=.D[27:9IZGTH4U$^]_R,6_(ON0
MG4'E<*O4,JA-R*5&;Z;?OD-JR&FVCJ@ [CK':5A4LW.*,51GY@&CANZ"KGFR
MN@2MIXNT;*M:JF2UF*O6H,!S8F$M%[$U^,PYR22?\A*:"J/1K0=T=.U:2PL/
M3SMT=<N@=:=06!7"DS0;+[BDKY8>\4??,UZF:>/G@53*I[+0!\-9.U13>)"3
MB$\+=^$*R[BPJOGKEM3PQ\_1PY-7?FPA:R/&@+_ H*4\)@#R#'PWS%V(@0Z@
MUWD6NSP2KR.+8MBP8NTXA[$&9S=TUJ2:HG57M&^#XFWD3&,7L&NYG%8SJ@ Z
MK<WMI:"%5:/HLR:\6>UXO_8DW2IXOBK/QDKGF,13=@\K^8/]B_BT\Q@;@SVH
M(5QCL'>Y2=)C;7*"(?Y>I7>;;/)Q1AFP*OV=7:Z?%"^"B_<<;%]SA$)\=,0E
MI0Z_1^#NX?MJZA.'NM*GJ"PY22+7EYSLP\D0UC#VI)DL7Y%.V)+1!?^I0?J5
M#F"710"C?/ZI1ADZTJ^)=8:C5P'*</SJ61V>)"/EB@=CB,!'P!=H8+C'KIZ\
M]O3LDB3+*(9*HRJ_98%A\9OPU)F6B[AR+INQ9>ZDMT##9:V%"]&*:V?1=B_"
M3[1W?7DC(Y=5F)(T/-)YW"<]4CY0-TR]::Q?-JLQV\:85X$3EI4:),A(YX''
M<BV5E3]P3Q_5$@*:^0$2^XC+'7++GWD21Q(-8Q!0Q$D)0[1WU(Y?KW93C%HW
M?4,0A0:HJ>AZRDTVGB+T5>!\Q_!1+CO/!.DY"/BH8%OY3#FG?CB-F'H/^IX5
MDA)7K%55NV8N"*@+;NP+ME2QVG75VS-=WW(H2]1HT%U5]V.4XVM=0'C&TXH[
MGGNKXH!:\,"H-/?.7!7=*+<UW*GK>NN.?I\J]6KKJ[X V'_*]&O_8?JU_QSI
M5ZX5EPX0,OX77)Q;K2QC29W)A'6L=AMEB5?B6H<+MUM:[@ILFW43+NW&J:^?
M@.C&/$]/%C$PJEU)*A@-ESK:%G7.:>&D)/$\H2:[<8L,JEB.D61!ZG" +HE)
M,I<IF61!/DSASV'A(5=8#/MB@RH@3**T->%R218(J '$9_XD#ZLD1=!3MLTT
MFN/-H.AYD!,WMNQ2O=R_J*EJ9Q$(C<?@V40)1'<CE45>@#KS8(Z)T> VNF>Z
M$O,V A OTU((?W5./BS83=&%*OFJ .C(>E4=*X0BC "E"#SC29E%OF.$E[6R
M<Q"C9G==N#UTPF#\6+D,EC\O%YCG[B;G=(V]218*WY)%PN!;O EZ ;_5.F)5
M)Y7+-X[<#'/7EQ=51?(P3;"/HP X+)Y0LV"<>Y4"6SKW3JP65,NB@B)8ZO!L
MJAAG*.@'\Q/GSB3X22EW%7.-GDNE BMY=O%8-$%\=L>)6?7>P_-Z1KBN(RJI
MA 4))BBKEA0IA3FBB*.5A'#>.%#&L$M9H\ WI1;,X8N--:_:0KV0L*HUIV<P
M$2D9SA(Q6U4O%WDJQ!,L0+,R4^7%ET5KIJ3:(>>X22&'S60INI3N1UDJ:<-'
M#UGS\@AE-*TJ?JF%+1+L:V>1^E2$_)6P1*40),4]8;\^CNY#I+]QINK>%1IG
M7F[MAPV$KX78](IBR-AJ:5S"=1#) D!9F2RM637S*J'!$N2KM/H#)/T1,@,N
MC[#@5)_C-9P:%I892@U)&*L6_4/!N9=K]>8#\ :X0:C>H$TT5(94Z;R_'&[E
MJ9D!P_+LV'!C)9'B>Q286GK;>6EX,D:^(L.!=^=[]U2YNCP9;!EKJB%G7@4.
MF?#*MB"WOS5<0Y+=WQ(!@EOYL">7 WXD<I$@K)'6BKB,L*'P@0Y@*J"Q]?I
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MM2Y;?U\S-ZD(>'FX-IXTB"HS+&."/*=RD@\F\MB9Z-J:-3:J4C9/ZDF+S/*
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M7+[_\/K7Y?7-Q?MWY_\'4$L! A0#%     @ 4Y4(5\ :D2"V!@  MR   !D
M             ( !     &$S,3$M;6EL;&5R8V5R=# V,S R,RYH=&U02P$"
M% ,4    " !3E0A7D.EF#K,&  #V(   &@              @ 'M!@  83,Q
M,BUL:6YD:&%L8V5R=# V,S R,RYH=&U02P$"% ,4    " !3E0A7&M.7?](#
M  !<#0  &0              @ '8#0  83,R,2UM:6QL97)C97)T,#8S,#(S
M+FAT;5!+ 0(4 Q0    ( %.5"%>37$S1Q@,  ,4,   :              "
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M+3(P,C,P-C,P7V1E9BYX;6Q02P$"% ,4    " !3E0A73Z,J9V**  "()P$
M$P              @ &!*0, 96)S+3(P,C,P-C,P7V<Q+FIP9U!+ 0(4 Q0
M   ( %.5"%?]0NU; "$! ,KT"P 4              "  12T P!E8G,M,C R
M,S V,S!?;&%B+GAM;%!+ 0(4 Q0    ( %.5"%>9:NS;C+T  #^U"  4
M          "  4;5! !E8G,M,C R,S V,S!?<')E+GAM;%!+ 0(4 Q0    (
M %.5"%?2]48E)!0  '4W   <              "  023!0!E8G,M8G)G:6YT
M97)I;6UA;F%G96UE;G0N:'1M4$L! A0#%     @ 4Y4(5^1I[IDK$@  /HL
M !P              ( !8J<% &UO9&EF:6-A=&EO;FYO,3!E9F9E8W1I=BYH
M=&U02P$"% ,4    " !3E0A7M&FM4J\7  "7/0  '               @ ''
MN04 ;6]D:69I8V%T:6]N;F\Q,V5F9F5C=&EV+FAT;5!+ 0(4 Q0    ( %.5
M"%?$:X6E#QX  '9P   <              "  ;#1!0!M;V1I9FEC871I;VYN
M;S$T969F96-T:78N:'1M4$L! A0#%     @ 4Y4(5UNO^E6F$@  =Y<  !P
M             ( !^>\% &UO9&EF:6-A=&EO;FYO.65F9F5C=&EV92YH=&U0
52P4&     !  $ !5!   V0(&

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
